PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Akimune, K; Okawa, Y; Sakai, K; Kiwa, T; Tsukada, K				Akimune, Kosuke; Okawa, Yuki; Sakai, Kenji; Kiwa, Toshihiko; Tsukada, Keiji			Multi-ion sensing of buffer solutions using terahertz chemical microscopy	APPLIED PHYSICS EXPRESS			English	Article							ION-SELECTIVE ELECTRODES; DETECTION LIMIT; SENSORS	Terahertz chemical microscopy (TCM) has been proposed and developed to visualize electric potential and/or chemical changes in water solutions. To simultaneously detect two types of ions mixed in buffer solutions, five membranes for sodium ions and four membranes for potassium ions were integrated on a sensing plate, and the selectivity to each ion was evaluated. The results suggest that TCM can be used for multi-ion sensing in mixed solutions. (C) 2014 The Japan Society of Applied Physics.	[Akimune, Kosuke; Okawa, Yuki; Sakai, Kenji; Kiwa, Toshihiko; Tsukada, Keiji] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	Kiwa, T (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.	kiwa@okayama-u.ac.jp	Kiwa, Toshihiko/D-2523-2015		Industry Academia Collaborative R&D of the Japan Science and Technology Agency (JST)	This study was partially supported by the Industry Academia Collaborative R&D of the Japan Science and Technology Agency (JST).	Heng LY, 2001, ANAL CHIM ACTA, V443, P25, DOI 10.1016/S0003-2670(01)01195-3; Zhang QT, 2005, SENSOR ACTUAT B-CHEM, V105, P304, DOI 10.1016/j.snb.2004.06.018; Kiwa T, 2008, APPL OPTICS, V47, P3324, DOI 10.1364/AO.47.003324; Oh HJ, 2003, B KOR CHEM SOC, V24, P37; ZHANG XC, 1992, J APPL PHYS, V71, P326, DOI 10.1063/1.350710; Bakker E, 2000, ANAL CHEM, V72, P1127, DOI 10.1021/ac991146n; CATTRALL RW, 1971, ANAL CHEM, V43, P1905, DOI 10.1021/ac60307a032; HAFEMAN DG, 1988, SCIENCE, V240, P1182, DOI 10.1126/science.3375810; SMALL H, 1975, ANAL CHEM, V47, P1801, DOI 10.1021/ac60361a017; Bergveld P, 2003, SENSOR ACTUAT B-CHEM, V88, P1, DOI 10.1016/S0925-4005(02)00301-5; FJELDLY TA, 1985, SENSOR ACTUATOR, V8, P261, DOI 10.1016/0250-6874(85)80027-5; Kiwa T, 2007, JPN J APPL PHYS 2, V46, pL1052, DOI 10.1143/JJAP.46.L1052; Kiwa T., 2013, SPIE NEWSROOM, DOI [10.1117/2.1201312.005281, DOI 10.1117/2.1201312.005281]; Kiwa T, 2012, OPT EXPRESS, V20, P11637, DOI 10.1364/OE.20.011637; Kiwa T, 2013, SENSOR ACTUAT B-CHEM, V187, P8, DOI 10.1016/j.snb.2012.08.051; Maruizumi T., 1986, MIKROCHIM ACTA, V88, P331, DOI 10.1007/BF01206726; ODONNELL J, 1993, ANAL CHIM ACTA, V281, P129, DOI 10.1016/0003-2670(93)85347-M; Sartore T., 1992, SENSOR ACTUAT A-PHYS, V32, P431; SCHEFER U, 1986, ANAL CHEM, V58, P2282, DOI 10.1021/ac00124a036; Szigeti Z, 2006, ELECTROANAL, V18, P1254, DOI 10.1002/elan.200603539; TSUKADA K, 1989, SENSOR ACTUATOR, V18, P329, DOI 10.1016/0250-6874(89)87039-8	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							122401	10.7567/APEX.7.122401		4	Physics, Applied	Physics	AW2MM	WOS:000346122300014		
J	Aoyama, K; Yoshioka, R; Yokota, N; Kobayashi, W; Yasaka, H				Aoyama, Konosuke; Yoshioka, Ryuichi; Yokota, Nobuhide; Kobayashi, Wataru; Yasaka, Hiroshi			Experimental demonstration of linewidth reduction of laser diode by compact coherent optical negative feedback system	APPLIED PHYSICS EXPRESS			English	Article							FM NOISE; SEMICONDUCTOR-LASERS; ELECTRICAL FEEDBACK	We demonstrate the linewidth reduction of a laser diode from 6.4 MHz to 6.5 kHz using a compact coherent optical negative feedback system, which consists of only a lens and an optical filter. The FM noise power spectral density (PSD) and the relative intensity noise (RIN) of the laser output are measured to discuss the performance of the system. The FM noise PSD is reduced by similar to 30 dB at <100 MHz. The RIN of similar to 130 dB/Hz is not found to be increased by the feedback at <7 GHz, where the system is driven under negative feedback conditions. (C) 2014 The Japan Society of Applied Physics.	[Aoyama, Konosuke; Yoshioka, Ryuichi; Yokota, Nobuhide; Yasaka, Hiroshi] Tohoku Univ, Res Inst Elect Commun, Sendai, Miyagi 9808577, Japan; [Kobayashi, Wataru] NTT Corp, NTT Device Technol Labs, Atsugi, Kanagawa 2430198, Japan	Aoyama, K (reprint author), Tohoku Univ, Res Inst Elect Commun, Sendai, Miyagi 9808577, Japan.	k-aoyama@riec.tohoku.ac.jp					Zhao Y, 2012, IEEE PHOTONIC TECH L, V24, P1795, DOI 10.1109/LPT.2012.2214029; KIKUCHI K, 1989, IEEE J QUANTUM ELECT, V25, P684, DOI 10.1109/3.17331; DAHMANI B, 1987, OPT LETT, V12, P876, DOI 10.1364/OL.12.000876; OKOSHI T, 1980, ELECTRON LETT, V16, P630, DOI 10.1049/el:19800437; YASAKA H, 1991, IEEE J QUANTUM ELECT, V27, P193, DOI 10.1109/3.78220; Aoyama K., IEEE PHOTONICS UNPUB; Aoyama K., 2014, INT TOP M MICR PHOT; Li Y, 2010, CHINESE PHYS LETT, V27, DOI 10.1088/0256-307X/27/7/074208; OHTSU M, 1985, IEEE J QUANTUM ELECT, V21, P1905, DOI 10.1109/JQE.1985.1072610; OHTSU M, 1990, IEEE J QUANTUM ELECT, V26, P231, DOI 10.1109/3.44954; Savory S, 2004, IEEE PHOTONIC TECH L, V16, P930, DOI 10.1109/LPT.2004.823720; Seimetz M., 2008, OPT FIB COMM C OFC 2; SHIN CH, 1993, IEEE J QUANTUM ELECT, V29, P374, DOI 10.1109/3.199292	13	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							122701	10.7567/APEX.7.122701		3	Physics, Applied	Physics	AW2MM	WOS:000346122300016		
J	Hatanaka, D; Mahboob, I; Onomitsu, K; Yamaguchi, H				Hatanaka, Daiki; Mahboob, Imran; Onomitsu, Koji; Yamaguchi, Hiroshi			Mechanical random access memory in a phonon circuit	APPLIED PHYSICS EXPRESS			English	Article							NANOMECHANICAL OSCILLATORS; NANOCAVITIES	A phonon waveguide (WG) constructed via a one-dimensional array of mechanical resonators is used to access a localized mechanical resonator. This resonator plays the role of a memory node in which binary information can be written, stored, and read via the mobile mechanical excitations in the phonon WG. The phonon WG-localized resonator architecture demonstrates the viability of mechanical circuits for information processing applications. (C) 2014 The Japan Society of Applied Physics	[Hatanaka, Daiki; Mahboob, Imran; Onomitsu, Koji; Yamaguchi, Hiroshi] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan	Hatanaka, D (reprint author), NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan.		Yamaguchi, Hiroshi/E-6123-2010		JSPS KAKENHI [23241046]	The authors are grateful to Y. Ishikawa for growing the heterostructure and T. Watanabe for helping with the sample preparation. This work was partly supported by JSPS KAKENHI Grant Number 23241046.	Hatanaka D, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807838; Bagheri M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.213902; Zhang MA, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.233906; Heinrich G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.043603; Shim SB, 2007, SCIENCE, V316, P95, DOI 10.1126/science.1137307; Khelif A, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.214301; Badzey RL, 2005, NATURE, V437, P995, DOI 10.1038/nature04124; Matheny MH, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.014101; Westra HJR, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.117205; Hatanaka D, 2014, NAT NANOTECHNOL, V9, P520, DOI [10.1038/nnano.2014.107, 10.1038/NNANO.2014.107]; Nozaki K, 2012, NAT PHOTONICS, V6, P248, DOI 10.1038/nphoton.2012.2; Mahboob I, 2008, NAT NANOTECHNOL, V3, P275, DOI 10.1038/nnano.2008.84; Gil-Santos E, 2009, NANO LETT, V9, P4122, DOI 10.1021/nl902350b; Notomi M, 2005, OPT EXPRESS, V13, P2678, DOI 10.1364/OPEX.13.002678; Badzey RL, 2004, APPL PHYS LETT, V85, P3587, DOI 10.1063/1.1808507; Mohammadi S, 2011, AIP ADV, V1, DOI 10.1063/1.3676168; Karabalin RB, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.165309; Lee TH, 2010, SCIENCE, V329, P1316, DOI 10.1126/science.1192511; Truitt PA, 2007, NANO LETT, V7, P120, DOI 10.1021/nl062278g; Gaidarzhy A, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3604797; Massel F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1993; Nishiguchi K, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766946; Venstra WJ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3511343	23	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							125201	10.7567/APEX.7.125201		4	Physics, Applied	Physics	AW2MM	WOS:000346122300026		
J	Hayakawa, Y; Fukuno, T; Nakamura, K; Miyake, H; Hiramatsu, K; Yamada, Y				Hayakawa, Yuya; Fukuno, Tomonori; Nakamura, Katsuto; Miyake, Hideto; Hiramatsu, Kazumasa; Yamada, Yoichi			Binding energy of localized biexcitons in AlGaN-based quantum wells	APPLIED PHYSICS EXPRESS			English	Article							EPITAXIAL LAYERS; LUMINESCENCE; GAN; SEMICONDUCTORS; LINEWIDTHS; EXCITONS; ALLOYS	The excitonic optical properties of Al0.60Ga0.40N/Al0.70Ga0.30N multiple quantum wells were studied by photoluminescence (PL) and PL excitation spectroscopies at room temperature. The binding energy of localized biexcitons in quantum wells was evaluated to be 136meV on the basis of the energy separation between the exciton resonance and the two-photon biexciton resonance. This value was 2.4 times larger than the biexciton binding energy of 56meV in an Al0.61Ga0.39N ternary alloy epitaxial layer with almost the same aluminum composition as the quantum-well layers. This increase unambiguously resulted from the effect of quantum confinement on biexcitons. (C) 2014 The Japan Society of Applied Physics.	[Hayakawa, Yuya; Fukuno, Tomonori; Nakamura, Katsuto; Yamada, Yoichi] Yamaguchi Univ, Dept Mat Sci & Engn, Ube, Yamaguchi 7558611, Japan; [Miyake, Hideto; Hiramatsu, Kazumasa] Mie Univ, Dept Elect & Elect Engn, Tsu, Mie 5148507, Japan	Yamada, Y (reprint author), Yamaguchi Univ, Dept Mat Sci & Engn, Ube, Yamaguchi 7558611, Japan.	yamada@yamaguchi-u.ac.jp			Japan Society for the Promotion of Science [25420289]	This work was partly supported by a Grant-in-Aid for Scientific Research (No. 25420289) from the Japan Society for the Promotion of Science.	KLINGSHIRN C, 1981, PHYS REP, V70, P315, DOI 10.1016/0370-1573(81)90190-3; Feneberg M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.075208; Coli G, 2002, APPL PHYS LETT, V80, P2907, DOI 10.1063/1.1471932; Coli G, 2001, APPL PHYS LETT, V78, P1829, DOI 10.1063/1.1357212; Fukuyo F, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.01AF03; Funato M, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.082001; Furutani Y, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.072401; Hirano D, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.113202; HVAM JM, 1976, J LUMIN, V12, P611, DOI 10.1016/0022-2313(76)90149-6; Kawakami Y, 1996, APPL PHYS LETT, V69, P1414, DOI 10.1063/1.117599; KAWAKAMI Y, 1994, PHYS REV B, V50, P14655, DOI 10.1103/PhysRevB.50.14655; Kittaka R, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3559226; Kyhm K, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.193102; Langbein W, 1999, PHYS REV B, V59, P15405, DOI 10.1103/PhysRevB.59.15405; Leute RAR, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3186044; Nakayama M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2037855; Okada K, 1996, JPN J APPL PHYS 2, V35, pL787, DOI 10.1143/JJAP.35.L787; Yamada Y, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.195210; Yamada Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2906894; Yamada Y, 2004, APPL PHYS LETT, V84, P2082, DOI 10.1063/1.1689749; Zimmermann R, 1997, PHYS REV B, V56, P12722	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							122101	10.7567/APEX.7.122101		3	Physics, Applied	Physics	AW2MM	WOS:000346122300012		
J	Higashino, T; Cho, JM; Mori, T				Higashino, Toshiki; Cho, Joung-min; Mori, Takehiko			Extracting parameters in ambipolar organic transistors based on dicyanomethylene terthiophene	APPLIED PHYSICS EXPRESS			English	Article							FIELD-EFFECT TRANSISTORS; HIGH-PERFORMANCE AMBIPOLAR; THIN-FILM TRANSISTORS; TRANSPORT; ELECTRON; MOBILITIES; CRYSTAL; INDIGO	Ambipolar organic transistors based on dicyanomethylene terthiophene show electron and hole mobilities of up to 0.6 and 0.3 cm(2) V-1 s(-1), respectively, on tetratetracontane, which are thousands of times larger than the reported value. The intrinsic electron and hole threshold voltages are determined by analyzing the output and transfer characteristics, from which the ambipolar characteristics are quantitatively reproduced. Since the transistor is operated mostly in the unipolar region, the trap density of states is estimated from the temperature dependence of the transfer characteristics. (C) 2014 The Japan Society of Applied Physics	[Higashino, Toshiki; Cho, Joung-min; Mori, Takehiko] Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan; [Mori, Takehiko] JST, ACT C, Kawaguchi, Saitama 3320012, Japan	Higashino, T (reprint author), Tokyo Inst Technol, Dept Organ & Polymer Mat, Meguro Ku, Tokyo 1528552, Japan.	higashino.t.aa@m.titech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23350061]	This work was partly supported by a Grant-in-Aid for Scientific Research (B) (No. 23350061) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akiyama Y, 2014, AIP ADV, V4, DOI 10.1063/1.4863296; Zhao Y, 2013, ADV MATER, V25, P5372, DOI 10.1002/adma.201302315; Baeg KJ, 2008, ADV FUNCT MATER, V18, P3678, DOI 10.1002/adfm.200800378; Pappenfus TM, 2002, J AM CHEM SOC, V124, P4184, DOI 10.1021/ja025553j; Yuen JD, 2013, ENERG ENVIRON SCI, V6, P392, DOI 10.1039/c2ee23505f; Zaumseil J, 2007, CHEM REV, V107, P1296, DOI 10.1021/cr0501543; Bisri SZ, 2014, ADV MATER, V26, P1176, DOI 10.1002/adma.201304280; Kalb WL, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.035327; Irimia-Vladu M, 2012, ADV MATER, V24, P375, DOI 10.1002/adma.201102619; Kraus M, 2010, J APPL PHYS, V107, DOI 10.1063/1.3354086; Gorce JP, 2004, J PHYS CHEM B, V108, P3130, DOI 10.1021/jp030794e; Butko VY, 2003, APPL PHYS LETT, V83, P4773, DOI 10.1063/1.1631736; Kraus M, 2011, ORG ELECTRON, V12, P731, DOI 10.1016/j.orgel.2011.02.001; Smits ECP, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205316; Ito Y, 2009, J AM CHEM SOC, V131, P9396, DOI 10.1021/ja9029957; Chen ZY, 2012, ADV MATER, V24, P647, DOI 10.1002/adma.201102786; Chesterfield RJ, 2003, ADV MATER, V15, P1278, DOI 10.1002/adma.200305200; Chiu LY, 2014, J MATER CHEM C, V2, P1823, DOI 10.1039/c3tc31546k; Cho JM, 2013, AIP ADV, V3, DOI 10.1063/1.4828415; Kromer J, 2001, TETRAHEDRON, V57, P3785, DOI 10.1016/S0040-4020(01)00254-X; Lang DV, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.086802; Opitz A, 2012, ORG ELECTRON, V13, P1614, DOI 10.1016/j.orgel.2012.04.032; Pitayatanakul O, 2014, J MATER CHEM C, V2, P9311, DOI 10.1039/c4tc01563k; Stallinga P, 2006, ORG ELECTRON, V7, P592, DOI 10.1016/j.orgel.2006.10.003	24	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							121602	10.7567/APEX.7.121602		4	Physics, Applied	Physics	AW2MM	WOS:000346122300009		
J	Kamata, Y; Koike, M; Kurosawa, E; Kurosawa, M; Ota, H; Nakatsuka, O; Zaima, S; Tezuka, T				Kamata, Yoshiki; Koike, Masahiro; Kurosawa, Etsuo; Kurosawa, Masashi; Ota, Hiroyuki; Nakatsuka, Osamu; Zaima, Shigeaki; Tezuka, Tsutomu			Operation of inverter and ring oscillator of ultrathin-body poly-Ge CMOS	APPLIED PHYSICS EXPRESS			English	Article							TRANSISTORS	A Ge CMOS inverter and a ring oscillator composed of Si-passivated ultrathin-body (UTB, 10 nm) depletion-type poly-Ge p- and n-MISFETs with a single metal gate have been successfully fabricated and demonstrated for the first time. A low I-off coming from a depletion-type thin channel, a thermally stable gate stack interface against interlayer deposition for interconnection due to Si passivation, and a large V-th difference between p- and n-MISFETs originating from Si passivation enabled poly-Ge CMOS IC operations. (C) 2014 The Japan Society of Applied Physics	[Kamata, Yoshiki; Koike, Masahiro; Kurosawa, Etsuo; Ota, Hiroyuki; Tezuka, Tsutomu] AIST, Collaborat Res Team Green Nanoelect Ctr, Tsukuba, Ibaraki 3058569, Japan; [Kurosawa, Masashi; Nakatsuka, Osamu; Zaima, Shigeaki] Nagoya Univ, Grad Sch Engn, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan	Kamata, Y (reprint author), AIST, Collaborat Res Team Green Nanoelect Ctr, Tsukuba, Ibaraki 3058569, Japan.	yoshiki.kamata@toshiba.co.jp	KUROSAWA, Masashi/F-4737-2010		JSPS through the FIRST Program	This work was supported by a grant from JSPS through the FIRST Program initiated by CSTP.	FUJII M, 1990, APPL PHYS LETT, V57, P2692, DOI 10.1063/1.103802; Colinge JP, 2010, NAT NANOTECHNOL, V5, P225, DOI [10.1038/nnano.2010.15, 10.1038/NNANO.2010.15]; Rios R, 2011, IEEE ELECTR DEVICE L, V32, P1170, DOI 10.1109/LED.2011.2158978; Kamata Y, 2008, MATER TODAY, V11, P30, DOI 10.1016/S1369-7021(07)70350-4; Haesslein H, 1998, PHYS REV LETT, V80, P2626, DOI 10.1103/PhysRevLett.80.2626; Razavi P, 2012, J APPL PHYS, V111, DOI 10.1063/1.4729777; Batude P., 2011, IEDM, P731; De Jaeger B., 2005, MICROELECTRON ENG, V80, P26; Kamata Y., 2013, INT SEM DEV RES S, pWP3_04; Kamata Y, 2010, S VLSI TECH, P211, DOI 10.1109/VLSIT.2010.5556231; Kamata Y., 2009, S VLSI TECHN, P78; Kamata Y., 2009, MATER RES SOC S P, V1155, pC02; Kamata Y., 2013, S VLSI TECHNOLOGY DI, pT94; Mitard J, 2008, INT EL DEVICES MEET, P873; Sadoh T, 2007, JPN J APPL PHYS 1, V46, P1250, DOI 10.1143/JJAP.46.1250; Sunamura H., 2013, S VLSI TECHN, pT250; Usuda K, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.056501; Yamamoto T., 2007, IEDM, P1041; Yamamoto Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.060001; Zhao DD, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.04DA03	20	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							121302	10.7567/APEX.7.121302		4	Physics, Applied	Physics	AW2MM	WOS:000346122300006		
J	Kasatani, Y; Yamada, S; Itoh, H; Miyao, M; Hamaya, K; Nozaki, Y				Kasatani, Yuichi; Yamada, Shinya; Itoh, Hiroyoshi; Miyao, Masanobu; Hamaya, Kohei; Nozaki, Yukio			Large anisotropy of Gilbert damping constant in L2(1)-ordered Co2FeSi film	APPLIED PHYSICS EXPRESS			English	Article							HEUSLER ALLOY-FILMS	We experimentally demonstrated anisotropic damping of the magnetization dynamics in a highly ordered Heusler compound Co3-xFexSi (x = 1.0, 2.0, and 3.0). The field-swept ferromagnetic resonance linewidth as a function of the resonant frequency was measured to exclude extrinsic contributions from two-magnon scattering and inhomogeneous line-broadening. In L2(1)-ordered Co2FeSi film, a wide variation in the intrinsic Gilbert damping constant from 0.0023 to 0.0061 was clearly observed in the (111) plane, where a weak uniaxial magnetic anisotropy was formed via low-temperature epitaxial growth. The large anisotropy of the Gilbert damping constant was suppressed by increasing x, which suppresses the half-metallicity in Co3-xFexSi films. (C) 2014 The Japan Society of Applied Physics.	[Kasatani, Yuichi; Nozaki, Yukio] Keio Univ, Dept Phys, Yokohama, Kanagawa 2238522, Japan; [Yamada, Shinya; Hamaya, Kohei] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Itoh, Hiroyoshi] Kansai Univ, Dept Pure & Appl Phys, Suita, Osaka 5648680, Japan; [Itoh, Hiroyoshi; Hamaya, Kohei; Nozaki, Yukio] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 102, Japan; [Miyao, Masanobu] Kyushu Univ, Dept Elect, Fukuoka 8190395, Japan	Kasatani, Y (reprint author), Keio Univ, Dept Phys, Yokohama, Kanagawa 2238522, Japan.		Hamaya, Kohei/D-5423-2013		Japan Science and Technology Agency (JST)	We thank Professor G. Tatara, Professor J. Shibata, and Professor A. Sakuma for theoretical discussions of the Gilbert damping mechanism, and also thank Professor S. Mizukami for analytical advice regarding TMS contributions. This work was partly supported by a CREST award from the Japan Science and Technology Agency (JST).	Ando Y, 2009, J APPL PHYS, V105, DOI 10.1063/1.3065985; Wustenberg JP, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.064407; Fecher GH, 2007, J PHYS D APPL PHYS, V40, P1582, DOI 10.1088/0022-3727/40/6/S12; Nakatani TM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3432070; Hamaya K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2996581; Kandpal HC, 2007, J PHYS D APPL PHYS, V40, P1507, DOI 10.1088/0022-3727/40/6/S01; Gilmore K, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.027204; Kambersky V, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.134416; Gercsi Z, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2338025; Gilmore K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.174414; Hamaya K, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.144411; Kambersky V., 1970, Canadian Journal of Physics, V48; Krivosik P, 2007, J APPL PHYS, V101, DOI 10.1063/1.2717084; Kubota T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3105982; Miyamoto K, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.100405; Mizukami S, 2009, J APPL PHYS, V105, DOI 10.1063/1.3067607; Oogane M, 2007, J APPL PHYS, V101, DOI 10.1063/1.2709751; Seib J, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.092418; Sukegawa H, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.184418; Takahashi Y, 2011, IEEE T MAGN, V47, P4682, DOI 10.1109/TMAG.2011.2158847; Tanikawa K, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.014402; Wada Y., 2013, J MAGN SOC JPN, V37, P166; Wurmehl S, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.184434; Yamada S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3330895; Yilgin R, 2005, IEEE T MAGN, V41, P2799, DOI 10.1109/TMAG.2005.854832; Yilgin R, 2007, JPN J APPL PHYS 2, V46, pL205, DOI 10.1143/JJAP.46.L205	26	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							123001	10.7567/APEX.7.123001		4	Physics, Applied	Physics	AW2MM	WOS:000346122300020		
J	Kasu, M; Murakami, R; Masuya, S; Harada, K; Sumiya, H				Kasu, Makoto; Murakami, Ryuichi; Masuya, Satoshi; Harada, Kazuya; Sumiya, Hitoshi			Synchrotron X-ray topography of dislocations in high-pressure high-temperature-grown single-crystal diamond with low dislocation density	APPLIED PHYSICS EXPRESS			English	Article							CVD DIAMOND; GHZ	Individual dislocations in high-pressure high-temperature-grown single-crystal diamond with a dislocation density of less than 47 cm(-2) in the (001) growth sector were observed using synchrotron X-ray topography in the Laue geometry. By analyzing image contrasts for various g vectors using photoluminescence images, we found that dislocations in the (001) growth sector run in the [001] direction; some are pure edge dislocations having Burgers vectors (b) of a/2[(1) over bar 10] or a/2[110] while others are mixed dislocations. Dislocations in the (111) growth sector have b= a/2[(1) over bar 10] and run in the direction from [111] to [331]; they are classified as edge dislocations. (C) 2014 The Japan Society of Applied Physics	[Kasu, Makoto; Murakami, Ryuichi; Masuya, Satoshi; Harada, Kazuya] Saga Univ, Dept Elect & Elect Engn, Saga 8408502, Japan; [Sumiya, Hitoshi] Sumitomo Elect Ind Ltd, Adv Mat R&D Labs, Itami, Hyogo 6640016, Japan	Kasu, M (reprint author), Saga Univ, Dept Elect & Elect Engn, Saga 8408502, Japan.	kasu@cc.saga-u.ac.jp			Mazda Foundation; Kyushu Bureau of Economy, Trade, and Industry;  [24360124]	The authors deeply appreciate Drs. Kotaro Ishiji and Seiji Kawado of SAGA-LS and Dr. Rajanish N. Tiwari and Professor Toshiyuki Oishi of Saga University for stimulating and fruitful discussions. A part of this work was supported by a Grant-in-Aid for Scientific Research (No. 24360124), the Mazda Foundation, and Kyushu Bureau of Economy, Trade, and Industry.	Sumiya H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.090102; Isberg J, 2002, SCIENCE, V297, P1670, DOI 10.1126/science.1074374; Hirama K, 2007, INT EL DEVICES MEET, P873, DOI 10.1109/IEDM.2007.4419088; Kato Y, 2012, DIAM RELAT MATER, V29, P37, DOI 10.1016/j.diamond.2012.07.008; Ueda K, 2006, IEEE ELECTR DEVICE L, V27, P570, DOI 10.1109/LED.2006.876325; Kasu M, 2004, DIAM RELAT MATER, V13, P226, DOI 10.1016/j.diamond.2003.10.025; Sumiya H, 1997, J CRYST GROWTH, V178, P485, DOI 10.1016/S0022-0248(96)00797-X; Gaukroger MP, 2008, DIAM RELAT MATER, V17, P262, DOI 10.1016/j.diamond.2007.12.036; Tamasaku K, 2005, J PHYS D APPL PHYS, V38, pA61, DOI 10.1088/0022-3727/38/10A/012; BLACK DR, 1993, DIAM RELAT MATER, V2, P121, DOI 10.1016/0925-9635(93)90041-Y; Hirth J. P., 1968, THEORY DISLOCATIONS; Ishiji K, 2011, PHYS STATUS SOLIDI A, V208, P2516, DOI 10.1002/pssa.201184271; Kasu M, 2005, ELECTRON LETT, V41, P1249, DOI 10.1049/el:20053194; Kato Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.090103; Kohn E., 1998, LOW PRESSURE SYNTHET; Lang AR, 1998, DIAM RELAT MATER, V7, P1698, DOI 10.1016/S0925-9635(98)00250-7; LANG AR, 1993, DIAM RELAT MATER, V2, P106, DOI 10.1016/0925-9635(93)90039-5; Lang AR, 1997, DIAM RELAT MATER, V6, P1226, DOI 10.1016/S0925-9635(97)00026-5; Tanner B. K., 1976, XRAY DIFFRACTION TOP; Umezawa H, 2011, DIAM RELAT MATER, V20, P523, DOI 10.1016/j.diamond.2011.02.007; Watanabe K., 1997, Diamond and Related Materials, V6, DOI 10.1016/S0925-9635(96)00764-9; WIERZCHOWSKI W, 1991, J CRYST GROWTH, V114, P209, DOI 10.1016/0022-0248(91)90695-2	22	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							125501	10.7567/APEX.7.125501		4	Physics, Applied	Physics	AW2MM	WOS:000346122300027		
J	Kobayashi, T; Suda, J; Kimoto, T				Kobayashi, Takuma; Suda, Jun; Kimoto, Tsunenobu			Impact of conduction type and doping density on thermal oxidation rate of SiC(0001)	APPLIED PHYSICS EXPRESS			English	Article							SILICON; MOBILITY; TEMPERATURE; DEPENDENCE; INTERFACE; MOSFETS; OXYGEN; STEAM; OXIDE; N2O	We discovered that the oxidation rate of SiC depends on the conduction type. The oxidation was faster in n-type SiC than in p-type SiC. The linear rate constant B/A was higher for n-type SiC than for p-type SiC, which may be caused by the stability of Si vacancies. The parabolic rate constant B was nearly constant for n-type SiC, whereas it decreased dramatically for heavily doped p-type SiC. Secondary-ion mass spectrometry measurements revealed that a high density of Al atoms was incorporated in the oxide of p-type SiC, which may hinder the diffusion of O-2 or COx. (C) 2014 The Japan Society of Applied Physics	[Kobayashi, Takuma; Suda, Jun; Kimoto, Tsunenobu] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan	Kobayashi, T (reprint author), Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan.				Super Cluster Program of the Japan Science and Technology Agency	This work was supported in part by the Super Cluster Program of the Japan Science and Technology Agency.	LIGENZA JR, 1960, J PHYS CHEM SOLIDS, V14, P131, DOI 10.1016/0022-3697(60)90219-5; Yoshioka H, 2012, J APPL PHYS, V112, DOI 10.1063/1.4740068; Bockstedte M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.205201; Ueno K, 1997, PHYS STATUS SOLIDI A, V162, P299, DOI 10.1002/1521-396X(199707)162:1<299::AID-PSSA299>3.0.CO;2-X; Noborio M, 2009, PHYS STATUS SOLIDI A, V206, P2374, DOI 10.1002/pssa.200925247; Song Y, 2004, J APPL PHYS, V95, P4953, DOI 10.1063/1.1690097; Chung GY, 2001, IEEE ELECTR DEVICE L, V22, P176, DOI 10.1109/55.915604; DEAL BE, 1963, J ELECTROCHEM SOC, V110, P527, DOI 10.1149/1.2425807; Lu CY, 2003, IEEE T ELECTRON DEV, V50, P1582, DOI 10.1109/TED.2003.814974; Cooper JA, 1997, PHYS STATUS SOLIDI A, V162, P305, DOI 10.1002/1521-396X(199707)162:1<305::AID-PSSA305>3.0.CO;2-7; Kimoto T, 2005, JPN J APPL PHYS 1, V44, P1213, DOI 10.1143/JJAP.44.1213; DEAL BE, 1965, J APPL PHYS, V36, P3770, DOI 10.1063/1.1713945; Li HF, 1997, APPL PHYS LETT, V70, P2028, DOI 10.1063/1.118773; Atalla M. M., 1960, PROPERTIES ELEMENTAL, V5, P163; Daas BK, 2011, IEEE T ELECTRON DEV, V58, P115, DOI 10.1109/TED.2010.2088270; McDonald K., 2009, J APPL PHYS, V105; Kosugi R, 2002, IEEE ELECTR DEVICE L, V23, P136, DOI 10.1109/55.988816; UENO K, 1994, JPN J APPL PHYS 2, V33, pL1121	18	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							121301	10.7567/APEX.7.121301		3	Physics, Applied	Physics	AW2MM	WOS:000346122300005		
J	Masago, A; Fukushima, T; Sato, K; Katayama-Yoshida, H				Masago, Akira; Fukushima, Tetsuya; Sato, Kazunori; Katayama-Yoshida, Hiroshi			Computational nano-materials design for circularly polarized luminescence in (Eu,Mg,O)-codoped GaN	APPLIED PHYSICS EXPRESS			English	Article							P-TYPE GAN; DOPED GAN; CODOPING METHOD; SEMICONDUCTORS; FABRICATION; MOLECULES; DIAMOND; ALN	We describe the production of circularly polarized luminescence from a luminescent center, which is generated by the spontaneous spinodal nano-decomposition of Eu, Mg, and O impurities doped into GaN. In this material, Zener's p-f exchange interaction creates an electronic structure suitable for the production of circularly polarized luminescence. Moreover, the P-7(2) ground state causes finite magnetic moments due to the reduction of the local symmetry around the Eu atom. These factors provide us with an expectation of not only circularly polarized luminescence but also potential control of the lifetime, color, and intensity, using the self-organized magnetic nano-structures. (C) 2014 The Japan Society of Applied Physics	[Masago, Akira; Fukushima, Tetsuya; Katayama-Yoshida, Hiroshi] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Sato, Kazunori] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan	Masago, A (reprint author), Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan.				Advanced Low Carbon Technology Research and Development Program (ALCA); Japan Science and Technology Agency (JST); Japan Society for the Promotion of Science (JSPS) (KAKENHI) [A242260090]; JSPS Core-to-Core Program (A) Advanced Research Networks ("Computational Nano-materials Design on Green Energy")	This work was partly supported by the Advanced Low Carbon Technology Research and Development Program (ALCA), the "High-efficiency Energy Conversion by Spinodal Nano-decomposition" program of the Japan Science and Technology Agency (JST), and the Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI), Grant Number A242260090. This work was partly supported by the JSPS Core-to-Core Program (A) Advanced Research Networks ("Computational Nano-materials Design on Green Energy"). One of the authors (H.K.Y.) also thanks the Future Research Initiative Group Supported Project on "Computational Nano-Materials Design: New Strategic Materials". We wish to acknowledge our valuable discussions with Professor Y. Fujiwara and Dr. D. Lee at the Graduate School of Engineering, Osaka University, Professor T. Gregorkiewicz at the Van der Waals-Zeeman Institute, University of Amsterdam, and Dr. B. Mitchell at the Department of Physics, Lehigh University.	RIEHL JP, 1993, METHOD ENZYMOL, V226, P539, DOI 10.1016/0076-6879(93)26024-4; Zhang YJ, 2014, SCIENCE, V344, P725, DOI 10.1126/science.1251329; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Laporte O, 1925, J OPT SOC AM REV SCI, V11, P459, DOI 10.1364/JOSA.11.000459; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Katayama-Yoshida H, 2001, J PHYS-CONDENS MAT, V13, P8901, DOI 10.1088/0953-8984/13/40/304; Feneberg M, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.155207; ZENER C, 1951, PHYS REV, V81, P440, DOI 10.1103/PhysRev.81.440; Sato K, 2010, REV MOD PHYS, V82, P1633, DOI 10.1103/RevModPhys.82.1633; AMANO H, 1989, JPN J APPL PHYS 2, V28, pL2112; SCHULZ H, 1977, SOLID STATE COMMUN, V23, P815, DOI 10.1016/0038-1098(77)90959-0; Yamamoto T, 1997, JPN J APPL PHYS 2, V36, pL180, DOI 10.1143/JJAP.36.L180; Schadt M, 1997, ANNU REV MATER SCI, V27, P305, DOI 10.1146/annurev.matsci.27.1.305; Lunkley JL, 2008, J AM CHEM SOC, V130, P13814, DOI 10.1021/ja805681w; RICHARDSON FS, 1977, CHEM REV, V77, P773, DOI 10.1021/cr60310a001; Steane A, 1998, REP PROG PHYS, V61, P117, DOI 10.1088/0034-4885/61/2/002; Cruz AVB, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.045203; Kachkanov V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00969; Katayama-Yoshida H, 2001, J CRYST GROWTH, V231, P428, DOI 10.1016/S0022-0248(01)01474-9; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Lee DG, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4704920; Lee DS, 2002, APPL PHYS LETT, V81, P2331, DOI 10.1063/1.1509111; Manago T, 2002, APPL PHYS LETT, V81, P694, DOI 10.1063/1.1496493; Masago A., JPN J APPL PHY UNPUB; Masago A, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.061001; Masago A, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.071005; Meining CJ, 2010, J APPL PHYS, V107, DOI 10.1063/1.3354021; Morishima S, 1999, PHYS STATUS SOLIDI A, V176, P113; Sanchez-Carnerero EM, 2014, J AM CHEM SOC, V136, P3346, DOI 10.1021/ja412294s; Sircar N, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.041301; STEINBERG IZ, 1978, ANNU REV BIOPHYS BIO, V7, P113, DOI 10.1146/annurev.bb.07.060178.000553; Suzuki M, 2014, J SYNCHROTRON RADIAT, V21, P466, DOI 10.1107/S1600577514004780; Wetzel C., 1996, P 23 INT C PHYS SEM, P2929	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							121002	10.7567/APEX.7.121002		4	Physics, Applied	Physics	AW2MM	WOS:000346122300002		
J	Matsubara, Y; Takahashi, KS; Tokura, Y; Kawasaki, M				Matsubara, Yuya; Takahashi, Kei S.; Tokura, Yoshinori; Kawasaki, Masashi			Single-crystalline BaTiO3 films grown by gas-source molecular beam epitaxy	APPLIED PHYSICS EXPRESS			English	Article							DIELECTRIC-PROPERTIES; STRONTIUM-TITANATE	Thin BaTiO3 films were grown on GdScO3 (110) substrates by metalorganic gas-source molecular beam epitaxy. Titanium tetra-isopropoxide (TTIP) was used as a volatile precursor that provides a wide growth window of the supplied TTIP/Ba ratio for automatic adjustment of the film composition. Within the growth window, compressively strained films can be grown with excellent crystalline quality, whereas films grown outside of the growth window are relaxed with inferior crystallinity. This growth method will provide a way to study the intrinsic properties of ferroelectric BaTiO3 films and their heterostructures by precise control of the stoichiometry, structure, and purity. (C) 2014 The Japan Society of Applied Physics	[Matsubara, Yuya] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9088577, Japan; [Matsubara, Yuya; Takahashi, Kei S.; Tokura, Yoshinori; Kawasaki, Masashi] RIKEN, CEMS, Wako, Saitama 3510198, Japan; [Tokura, Yoshinori; Kawasaki, Masashi] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Tokura, Yoshinori; Kawasaki, Masashi] Univ Tokyo, Quantum Phase Elect Ctr, Bunkyo Ku, Tokyo 1138656, Japan	Takahashi, KS (reprint author), RIKEN, CEMS, Wako, Saitama 3510198, Japan.	kei.takahashi@riken.jp	Kawasaki, Masashi/B-5826-2008; Tokura, Yoshinori/C-7352-2009; Takahashi, Kei/B-2498-2013		"Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST)" of the Japan Society for the Promotion of Science (JSPS); JSPS [24226002, 24224009]; RIKEN Junior Research Associate Program	This work was partly supported by the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST)" of the Japan Society for the Promotion of Science (JSPS) initiated by the Council for Science and Technology Policy, and by JSPS Grants-in Aid for Scientific Research, Nos. 24226002 and 24224009. Y.M. is supported by the RIKEN Junior Research Associate Program.	TABATA H, 1994, APPL PHYS LETT, V65, P1970, DOI 10.1063/1.112837; Son J, 2010, NAT MATER, V9, P482, DOI [10.1038/nmat2750, 10.1038/NMAT2750]; Brooks CM, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3117365; TSURUMI T, 1994, JPN J APPL PHYS 1, V33, P5192, DOI 10.1143/JJAP.33.5192; TUFTE ON, 1967, PHYS REV, V155, P796, DOI 10.1103/PhysRev.155.796; Choi KJ, 2004, SCIENCE, V306, P1005, DOI 10.1126/science.1103218; Weber U, 2001, J AM CERAM SOC, V84, P759, DOI 10.1111/j.1151-2916.2001.tb00738.x; ARLT G, 1985, J APPL PHYS, V58, P1619, DOI 10.1063/1.336051; Biegalski MD, 2008, J APPL PHYS, V104, DOI 10.1063/1.3037216; MITSUYU T, 1980, J APPL PHYS, V51, P2464, DOI 10.1063/1.328019; Ohnishi T, 2008, J APPL PHYS, V103, DOI 10.1063/1.2921972; Jalan B, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3184767; Setter N, 2006, J APPL PHYS, V100, DOI 10.1063/1.2336999; MERZ WJ, 1954, PHYS REV, V95, P690, DOI 10.1103/PhysRev.95.690; Spinelli A, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.155110; Ito M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4881059; Tsao J. Y., 1993, MAT FUNDAMENTALS MOL, P65	17	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							125502	10.7567/APEX.7.125502		3	Physics, Applied	Physics	AW2MM	WOS:000346122300028		
J	Matsuda, T; Sano, T; Arakawa, K; Sakata, O; Tajiri, H; Hirose, A				Matsuda, Tomoki; Sano, Tomokazu; Arakawa, Kazuto; Sakata, Osami; Tajiri, Hiroo; Hirose, Akio			Femtosecond laser-driven shock-induced dislocation structures in iron	APPLIED PHYSICS EXPRESS			English	Article							ABLATION; SPALLATION; PULSES; ALUMINUM; METALS; MATTER; PHASE; DYNAMICS; CONTRAST; DENSITY	We found that a femtosecond laser-driven shock wave induces marked changes in dislocation structure in iron over a fluence range from 1.3 to 8.3 J/cm(2). Transmission electron microscopy observations showed a change in dislocation structure from lath structures with twist boundaries to only laths, and an increase in depth where laths begin to appear, with increasing fluence. X-ray diffraction results showed the distribution of crystallite sizes corresponding to the change in dislocation structure. We proposed that the dislocation structure is determined by the laser fluence, through the change in the duration of the shock wave. (C) 2014 The Japan Society of Applied Physics.	[Matsuda, Tomoki; Sano, Tomokazu; Hirose, Akio] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan; [Sano, Tomokazu; Arakawa, Kazuto] JST, CREST, Suita, Osaka 5650871, Japan; [Arakawa, Kazuto] Shimane Univ, Interdisciplinary Fac Sci & Engn, Dept Mat Sci, Matsue, Shimane 6908504, Japan; [Sakata, Osami] NIMS, Synchrotron Xray Stn SPring 8, Sayo, Hyogo 6795148, Japan; [Tajiri, Hiroo] Japan Synchrotron Radiat Res Inst SPring 8, Sayo, Hyogo 6795198, Japan	Matsuda, T (reprint author), Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	t-matsu@mapse.eng.osaka-u.ac.jp	SAKATA, Osami/H-2621-2011		JSPS KAKENHI Grant [22224012, 25420778]	The authors wish to thank Professor Narumi Inoue and Professor Masayuki Okoshi of the National Defense Academy of Japan for their support of the laser irradiation experiments. This work was supported in part by JSPS KAKENHI Grant Numbers 22224012 and 25420778, JSPS core to core program on International Alliance for Material Science in Extreme States with High Power Laser, and X-ray Free Electron Laser Priority Strategy Program (MEXT). The synchrotron radiation experiments were performed at BL13XU of SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal No. 2014A1698).	Milathianaki D, 2013, SCIENCE, V342, P220, DOI 10.1126/science.1239566; Gahagan KT, 2000, PHYS REV LETT, V85, P3205, DOI 10.1103/PhysRevLett.85.3205; Cheng J, 2013, OPT LASER TECHNOL, V46, P88, DOI 10.1016/j.optlastec.2012.06.037; Cuq-Lelandais JP, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/6/065402; Colombier JP, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.165406; Ungar T, 1996, APPL PHYS LETT, V69, P3173; Evans R, 1996, PHYS REV LETT, V77, P3359, DOI 10.1103/PhysRevLett.77.3359; Ungar T, 1999, J APPL CRYSTALLOGR, V32, P992, DOI 10.1107/S0021889899009334; Gattass RR, 2008, NAT PHOTONICS, V2, P219, DOI 10.1038/nphoton.2008.47; Tamura H, 2001, J APPL PHYS, V89, P3520, DOI 10.1063/1.1346996; Nolte S, 1997, J OPT SOC AM B, V14, P2716, DOI 10.1364/JOSAB.14.002716; Matsuda T, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4890389; Anisimov SI, 2008, APPL PHYS A-MATER, V92, P939, DOI 10.1007/s00339-008-4607-y; Zhigilei LV, 2009, J PHYS CHEM C, V113, P11892, DOI 10.1021/jp902294m; Feng Q, 2005, SCRIPTA MATER, V53, P511, DOI 10.1016/j.scriptamat.2005.05.006; Anisimov SI, 2008, APPL PHYS A-MATER, V92, P797, DOI 10.1007/s00339-008-4608-x; Ashitkov SI, 2013, JETP LETT+, V98, P384, DOI 10.1134/S0021364013200022; Armstrong MR, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4890087; Chichkov BN, 1996, APPL PHYS A-MATER, V63, P109, DOI 10.1007/BF01567637; Colombier JP, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.104105; Crowhurst JC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.144302; Demaske BJ, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.054109; Eidmann K, 2000, PHYS REV E, V62, P1202, DOI 10.1103/PhysRevE.62.1202; Humphreys F. J., 1995, RECRYSTALLIZATION RE, P127; Ionin AA, 2011, JETP LETT+, V94, P34, DOI 10.1134/S002136401113008X; Kinslow R., 1970, HIGH VELOCITY IMPACT; Ledbetter H. M., 1973, Journal of Physical and Chemical Reference Data, V2; MURR LE, 1978, ACTA METALL MATER, V26, P847, DOI 10.1016/0001-6160(78)90034-2; Perez A. D., 2003, PHYS REV B, V67; Povarnitsyn ME, 2009, APPL SURF SCI, V255, P5120, DOI 10.1016/j.apsusc.2008.07.199; Sakata O, 2003, SURF REV LETT, V10, P543, DOI 10.1142/S0218625X03004809; Sano T, 2013, MATER TRANS, V54, P926, DOI 10.2320/matertrans.MD201229; Sano T, 2003, APPL PHYS LETT, V83, P3498, DOI 10.1063/1.1623935; Sokolowski-Tinten K, 1998, PHYS REV LETT, V81, P224, DOI 10.1103/PhysRevLett.81.224; Tsujino M, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.022703; Vidal F, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.184125; Whitley VH, 2011, J APPL PHYS, V109, DOI 10.1063/1.3506696; Wu CP, 2014, APPL PHYS A-MATER, V114, P11, DOI 10.1007/s00339-013-8086-4; Zel'dovich Y. B., 2002, PHYS SHOCK WAVES HIG	39	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							122704	10.7567/APEX.7.122704		4	Physics, Applied	Physics	AW2MM	WOS:000346122300019		
J	Mizumoto, Y; Chantana, J; Hironiwa, D; Yamamoto, A; Yabuki, K; Nakaue, A; Minemoto, T				Mizumoto, Yuta; Chantana, Jakapan; Hironiwa, Daisuke; Yamamoto, Atsuya; Yabuki, Kazuhisa; Nakaue, Akimitsu; Minemoto, Takashi			Evaluation of junction quality of buffer-free Zn(O,S):Al/Cu(In,Ga)Se-2 thin-film solar cells	APPLIED PHYSICS EXPRESS			English	Article							MULTILAYER PRECURSOR METHOD; CONDUCTION-BAND OFFSET; PERFORMANCE; LAYERS; EFFICIENCIES; 18-PERCENT	Cu(In,Ga)Se-2 (CIGS) solar cells without buffer layers, namely, buffer-free solar cells, and those with conventional CdS buffer layers were fabricated. Zn(O,S):Al (AZOS) was used as a transparent conductive oxide layer. The AZOS/CIGS interface in the buffer-free solar cells and the AZOS/CdS/CIGS interface in the CdS-buffered solar cells were investigated by bright-field scanning transmission electron microscopy, high-angle annular dark-field scanning transmission electron microscopy, and fast Fourier transform. It was found that the open-circuit voltage and fill factor of the buffer-free solar cells are lower than those of the CdS-buffered solar cells, which is attributed to the nonepitaxial growth of AZOS on the CIGS layer, forming defects and deteriorating the junction quality of the buffer-free solar cells. (C) 2014 The Japan Society of Applied Physics	[Mizumoto, Yuta; Chantana, Jakapan; Hironiwa, Daisuke; Minemoto, Takashi] Ritsumeikan Univ, Dept Elect & Elect Engn, Kusatsu, Shiga 5258577, Japan; [Yamamoto, Atsuya; Yabuki, Kazuhisa; Nakaue, Akimitsu] Kobelco Res Inst Inc, Kobe, Hyogo 6512271, Japan	Chantana, J (reprint author), Ritsumeikan Univ, Dept Elect & Elect Engn, Kusatsu, Shiga 5258577, Japan.	jakapan@fc.ritsumei.ac.jp	Minemoto, Takashi/F-9342-2011; Chantana, Jakapan/O-5110-2015	Chantana, Jakapan/0000-0002-5711-4979	New Energy and Industrial Technology Development Organization of Japan (NEDO)	This work was partly supported by the New Energy and Industrial Technology Development Organization of Japan (NEDO).	Ogawa Y, 1996, APPL SURF SCI, V92, P232, DOI 10.1016/0169-4332(95)00236-7; Hsieh TP, 2011, SOLID STATE ELECTRON, V56, P175, DOI 10.1016/j.sse.2010.11.019; Ramanathan K, 2005, THIN SOLID FILMS, V480, P499, DOI 10.1016/j.tsf.2004.11.050; Nakada T, 2001, SOL ENERG MAT SOL C, V67, P255, DOI 10.1016/S0927-0248(00)00289-0; Minemoto T, 2013, CURR APPL PHYS, V13, P103, DOI 10.1016/j.cap.2012.06.019; Minemoto T, 2001, SOL ENERG MAT SOL C, V67, P83, DOI 10.1016/S0927-0248(00)00266-X; Chantana J, 2014, SOL ENERG MAT SOL C, V130, P567, DOI 10.1016/j.solmat.2014.08.012; Hashimoto Y, 1996, JPN J APPL PHYS 1, V35, P4760, DOI 10.1143/JJAP.35.4760; Hironiwa D, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.106502; Klenk R, 2014, PROG PHOTOVOLTAICS, V22, P161, DOI 10.1002/pip.2445; Jackson P, 2014, PHYS STATUS SOLIDI-R, V8, P219, DOI 10.1002/pssr.201409040; Kushiya K, 2001, SOL ENERG MAT SOL C, V67, P11, DOI 10.1016/S0927-0248(00)00258-0; Chantana J, 2014, THIN SOLID FILMS, V556, P499, DOI 10.1016/j.tsf.2014.01.009; Minemoto T, 2001, J APPL PHYS, V89, P8327, DOI 10.1063/1.1366655; Jackson P, 2011, PROG PHOTOVOLTAICS, V19, P894, DOI 10.1002/pip.1078; Chantana J, 2014, APPL SURF SCI, V314, P845, DOI 10.1016/j.apsusc.2014.06.186; Chantana J, 2013, J APPL PHYS, V114, DOI 10.1063/1.4819087; Julayhi J, 2013, PHYS STATUS SOLIDI C, V10, P1026, DOI 10.1002/pssc.201200802; Nakada T, 2002, JPN J APPL PHYS 2, V41, pL165, DOI 10.1143/JJAP.41.L165; Okuda K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FW04; Repins I, 2008, PROG PHOTOVOLTAICS, V16, P235, DOI 10.1002/pip.822	21	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							125503	10.7567/APEX.7.125503		4	Physics, Applied	Physics	AW2MM	WOS:000346122300029		
J	Murakami, T; Hori, T; Shiga, T; Shiomi, J				Murakami, Takuru; Hori, Takuma; Shiga, Takuma; Shiomi, Junichiro			Probing and tuning inelastic phonon conductance across finite-thickness interface	APPLIED PHYSICS EXPRESS			English	Article							LATTICE-DYNAMICAL CALCULATION; THERMAL-BOUNDARY CONDUCTANCE; MOLECULAR-DYNAMICS; SUPERLATTICE NANOWIRES; MISMATCH MODEL; CONDUCTIVITY; RESISTANCE; TEMPERATURES; SCATTERING; TRANSPORT	Phonon transmission across an interface between dissimilar crystalline solids is calculated using molecular dynamics simulations with interatomic force constants obtained from first principles. The results reveal that, although inelastic phonon transmission right at the geometrical interface can become far greater than the elastic one, its contribution to thermal boundary conductance (TBC) is severely limited by transition regions, where local phonon states at the interface recover the bulk state over a finite thickness. This suggests that TBC can be increased by enhancing phonon equilibration in the transition region, for instance, by phonon scattering, which is demonstrated by increasing the lattice anharmonicity. (C) 2014 The Japan Society of Applied Physics	[Murakami, Takuru; Hori, Takuma; Shiga, Takuma; Shiomi, Junichiro] Univ Tokyo, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Shiomi, Junichiro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Shiomi, J (reprint author), Univ Tokyo, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan.	shiomi@photon.t.u-tokyo.ac.jp			JST; PRESTO; JSPS KAKENHI [26709009]	This work is partially supported by JST, PRESTO, and JSPS KAKENHI Grant Number 26709009.	Chen G, 1998, PHYS REV B, V57, P14958, DOI 10.1103/PhysRevB.57.14958; Tian ZT, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.235304; Dames C, 2004, J APPL PHYS, V95, P682, DOI 10.1063/1.1631734; Borca-Tasciuc T, 2000, SUPERLATTICE MICROST, V28, P199, DOI 10.1006/spmi.2000.0900; LITTLE WA, 1959, CAN J PHYS, V37, P334; Schelling PK, 2002, APPL PHYS LETT, V80, P2484, DOI 10.1063/1.1465106; Majumdar A, 2004, APPL PHYS LETT, V84, P4768, DOI 10.1063/1.1758301; Stevens RJ, 2007, INT J HEAT MASS TRAN, V50, P3977, DOI 10.1016/j.ijheatmasstransfer.2007.01.040; Hopkins PE, 2011, J HEAT TRANS-T ASME, V133, DOI 10.1115/1.4003549; Lyeo HK, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.144301; YOUNG DA, 1989, PHYS REV B, V40, P3685, DOI 10.1103/PhysRevB.40.3685; Mingo N, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.245406; Reddy P, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2133890; GIANNOZZI P, 1991, PHYS REV B, V43, P7231, DOI 10.1103/PhysRevB.43.7231; SWARTZ ET, 1989, REV MOD PHYS, V61, P605, DOI 10.1103/RevModPhys.61.605; Chalopin Y, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4816738; Zhao H, 2005, J APPL PHYS, V97, DOI 10.1063/1.1835565; Chen YF, 2004, PHYSICA B, V349, P270, DOI 10.1016/j.physb.2004.03.247; Hopkins PE, 2008, J HEAT TRANS-T ASME, V130, DOI 10.1115/1.2787025; STONER RJ, 1993, PHYS REV B, V48, P16373, DOI 10.1103/PhysRevB.48.16373; Carlborg F., 2008, PHYS REV B, V78; Chalopin Y, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766266; Esfarjani K, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.085204; Landry ES, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.165304; Prasher RS, 2001, J HEAT TRANS-T ASME, V123, P105, DOI 10.1115/1.1338138; Saaskilahti K., ARXIV14053868; Shiomi J, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.104302; Shiomi J., 2014, ANN REV HEAT TRANSFE, V17, P177; Wu XF, 2014, J APPL PHYS, V115, DOI 10.1063/1.4859555	29	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							121801	10.7567/APEX.7.121801		4	Physics, Applied	Physics	AW2MM	WOS:000346122300010		
J	Nomura, Y; Kawagoe, H; Hattori, Y; Yamanaka, M; Omoda, E; Kataura, H; Sakakibara, Y; Nishizawa, N				Nomura, Yoshitaka; Kawagoe, Hiroyuki; Hattori, Yuji; Yamanaka, Masahito; Omoda, Emiko; Kataura, Hiromichi; Sakakibara, Youichi; Nishizawa, Norihiko			Supercontinuum generation for ultrahigh-resolution optical coherence tomography at wavelength of 0.8 mu m using carbon nanotube fiber laser and similariton amplifier	APPLIED PHYSICS EXPRESS			English	Article							PHOTONIC CRYSTAL FIBER; CONTINUUM GENERATION; IN-VIVO; SPECTRAL-DOMAIN; REAL-TIME; MICROSTRUCTURE; REGION; NM	We demonstrated supercontinuum (SC) generation for ultrahigh-resolution optical coherence tomography (UHR-OCT) in the 0.8 mu m wavelength region using an ultrashort-pulse fiber laser system. An Er-doped ultrashort-pulse fiber laser with single-wall carbon nanotubes was developed as the seed pulse source. A 46 fs, highest quality, pedestal-free, clean, ultrashort pulse was generated with a similariton amplifier. Then, a 60 fs ideal ultrashort pulse was generated at a wavelength of 0.8 mu m with a second-harmonic generation (SHG) crystal, and a Gaussian-like SC was generated in a photonic crystal fiber. UHR-OCT was demonstrated using the generated SC, and precise images of a biological sample were observed. (C) 2014 The Japan Society of Applied Physics.	[Nomura, Yoshitaka; Kawagoe, Hiroyuki; Hattori, Yuji; Yamanaka, Masahito; Nishizawa, Norihiko] Nagoya Univ, Dept Quantum Engn, Nagoya, Aichi 4648603, Japan; [Omoda, Emiko; Kataura, Hiromichi; Sakakibara, Youichi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Nishizawa, N (reprint author), Nagoya Univ, Dept Quantum Engn, Nagoya, Aichi 4648603, Japan.	nishizawa@nuee.nagoya-u.ac.jp					Wang H, 2007, OPT EXPRESS, V15, P3085, DOI 10.1364/OE.15.003085; Drexler W, 2004, J BIOMED OPT, V9, P47, DOI 10.1117/1.1629679; Nishizawa N, 2008, OPT EXPRESS, V16, P9429, DOI 10.1364/OE.16.009429; Ishida S, 2012, BIOMED OPT EXPRESS, V3, P282, DOI 10.1364/BOE.3.000282; Kawagoe H, 2014, BIOMED OPT EXPRESS, V5, P932, DOI 10.1364/BOE.5.000932; Wang YM, 2003, OPT LETT, V28, P182, DOI 10.1364/OL.28.000182; Drexler W, 1999, OPT LETT, V24, P1221, DOI 10.1364/OL.24.001221; Aguirre AD, 2006, OPT EXPRESS, V14, P1145, DOI 10.1364/OE.14.001145; Wojtkowski M, 2004, OPT EXPRESS, V12, P2404, DOI 10.1364/OPEX.12.002404; Hartl I, 2001, OPT LETT, V26, P608, DOI 10.1364/OL.26.000608; Cimalla P, 2009, OPT EXPRESS, V17, P19486, DOI 10.1364/OE.17.019486; BOUMA B, 1995, OPT LETT, V20, P1486, DOI 10.1364/OL.20.001486; Nishizawa N, 2004, OPT LETT, V29, P2846, DOI 10.1364/OL.29.002846; Zhi ZW, 2012, OPT LETT, V37, P812, DOI 10.1364/OL.37.000812; Bourquin S, 2003, OPT EXPRESS, V11, P3290, DOI 10.1364/OE.11.003290; Drexler W, 2008, BIOL MED PHYS BIOMED, P1, DOI 10.1007/978-3-540-77550-8; Ishida S, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.052501; Kray S, 2009, OPT LETT, V34, P1970, DOI 10.1364/OL.34.001970; Nishiura M, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.012701; Nishizawa N, 2012, BIOMED OPT EXPRESS, V3, P735, DOI 10.1364/BOE.3.000735; Nishizawa N, 2009, J OPT SOC AM B, V26, P426, DOI 10.1364/JOSAB.26.000426; Nozaki Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.020301; Sakakibara Y., 2005, ECOC 05, V1, P37; Wang YM, 2005, J OPT SOC AM A, V22, P1492, DOI 10.1364/JOSAA.22.001492	24	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							122703	10.7567/APEX.7.122703		4	Physics, Applied	Physics	AW2MM	WOS:000346122300018		
J	Ogino, J; Miyamoto, S; Matsuyama, T; Sueda, K; Yoshida, H; Tsubakimoto, K; Miyanaga, N				Ogino, Jumpei; Miyamoto, Sho; Matsuyama, Takahiro; Sueda, Keiichi; Yoshida, Hidetsugu; Tsubakimoto, Koji; Miyanaga, Noriaki			Two-stage optical parametric chirped-pulse amplifier using sub-nanosecond pump pulse generated by stimulated Brillouin scattering compression	APPLIED PHYSICS EXPRESS			English	Article							LIGHT-PULSES; PHASE-CONJUGATION; REPETITION-RATE; LASER-PULSE; PEAK-POWER; AMPLIFICATION; ENERGY; WAVELENGTH; OPERATION; CRYSTAL	We demonstrate optical parametric chirped-pulse amplification (OPCPA) based on two-beam pumping, using sub-nanosecond pulses generated by stimulated Brillouin scattering compression. Seed pulse energy, duration, and center wavelength were 5 nJ, 220 ps, and similar to 1065 nm, respectively. The 532 nm pulse from a Q-switched Nd:YAG laser was compressed to similar to 400 ps in heavy fluorocarbon FC-40 liquid. Stacking of two time-delayed pump pulses reduced the amplifier gain fluctuation. Using a walk-off-compensated two-stage OPCPA at a pump energy of 34 mJ, a total gain of 1.6 x 10(5) was obtained, yielding an output energy of 0.8 mJ. The amplified chirped pulse was compressed to 97 fs. (C) 2014 The Japan Society of Applied Physics.	[Ogino, Jumpei; Miyamoto, Sho; Matsuyama, Takahiro; Yoshida, Hidetsugu; Tsubakimoto, Koji; Miyanaga, Noriaki] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Sueda, Keiichi] Osaka Univ, Photon Pioneers Ctr, Suita, Osaka 5650871, Japan	Ogino, J (reprint author), Osaka Univ, Inst Laser Engn, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ogino-j@ile.osaka-u.ac.jp	Miyanaga, Noriaki/F-1340-2015; Tsubakimoto, Koji/O-9200-2015	Miyanaga, Noriaki/0000-0002-9902-5392; 			Feng CY, 2014, OPT LETT, V39, P3367, DOI 10.1364/OL.39.003367; HON DT, 1980, OPT LETT, V5, P516, DOI 10.1364/OL.5.000516; Adachi S, 2007, OPT LETT, V32, P2487, DOI 10.1364/OL.32.002487; Hadrich S, 2011, OPT LETT, V36, P313, DOI 10.1364/OL.36.000313; Xu XZ, 2014, OPT EXPRESS, V22, P13904, DOI 10.1364/OE.22.013904; Yasuhara R, 2008, OPT LETT, V33, P1711, DOI 10.1364/OL.33.001711; Herrmann D, 2009, OPT LETT, V34, P2459, DOI 10.1364/OL.34.002459; Witte S, 2005, OPT EXPRESS, V13, P4903, DOI 10.1364/OPEX.13.004903; StPierre RJ, 1997, IEEE J SEL TOP QUANT, V3, P53, DOI 10.1109/2944.585814; Ishii N, 2005, OPT LETT, V30, P567, DOI 10.1364/OL.30.000567; DUBIETIS A, 1992, OPT COMMUN, V88, P437, DOI 10.1016/0030-4018(92)90070-8; Park H, 2006, JPN J APPL PHYS 1, V45, P5073, DOI 10.1143/JJAP.45.5073; Yoshida H, 2009, OPT EXPRESS, V17, P13654, DOI 10.1364/OE.17.013654; Dubietis A, 2006, IEEE J SEL TOP QUANT, V12, P163, DOI 10.1109/JSTQE.2006.871962; Brignon A., 2004, PHASE CONJUGATE LASE, P24; DAMZEN MJ, 1983, OPT LETT, V8, P313, DOI 10.1364/OL.8.000313; DANE CB, 1995, IEEE J QUANTUM ELECT, V31, P148, DOI 10.1109/3.341719; Dubietis A, 1998, J OPT SOC AM B, V15, P1135, DOI 10.1364/JOSAB.15.001135; Herrmann D, 2010, OPT EXPRESS, V18, P4170, DOI 10.1364/OE.18.004170; Jovanovic I, 2002, APPL OPTICS, V41, P2923, DOI 10.1364/AO.41.002923; Kiriyama H, 2003, OPT LETT, V28, P1671, DOI 10.1364/OL.28.001671; Kuwahara K, 2000, J OPT SOC AM B, V17, P1943, DOI 10.1364/JOSAB.17.001943; Ogawa K, 2009, OPT EXPRESS, V17, P7744, DOI 10.1364/OE.17.007744; Ogawa K, 2008, JPN J APPL PHYS, V47, P4592, DOI 10.1143/JJAP.47.4592; Riesbeck T, 2001, APPL PHYS B-LASERS O, V73, P847, DOI 10.1007/s003400100745; ROCKWELL DA, 1988, IEEE J QUANTUM ELECT, V24, P1124, DOI 10.1109/3.236; Ross N., 1997, OPT COMMUN, V144, P125; Schiemann S, 1998, IEEE J QUANTUM ELECT, V34, P407, DOI 10.1109/3.661446; Shilov AA, 2001, OPT LETT, V26, P1565, DOI 10.1364/OL.26.001565; SUMIDA DS, 1994, IEEE J QUANTUM ELECT, V30, P2617, DOI 10.1109/3.333716; Yoshida H, 2003, OPT LETT, V28, P257, DOI 10.1364/OL.28.000257; Zeromskis E, 2002, OPT COMMUN, V203, P435, DOI 10.1016/S0030-4018(02)01182-3	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							122702	10.7567/APEX.7.122702		4	Physics, Applied	Physics	AW2MM	WOS:000346122300017		
J	Oku, T; Zushi, M; Imanishi, Y; Suzuki, A; Suzuki, K				Oku, Takeo; Zushi, Masahito; Imanishi, Yuma; Suzuki, Atsushi; Suzuki, Kohei			Microstructures and photovoltaic properties of perovskite-type CH3NH3PbI3 compounds	APPLIED PHYSICS EXPRESS			English	Article							SENSITIZED SOLAR-CELLS; ORGANOMETAL HALIDE PEROVSKITES; EFFICIENCY; FABRICATION; DEPOSITION; OXIDES; LAYERS	TiO2/CH3NH3PbI3-based photovoltaic devices were fabricated. The microstructures of these devices were investigated by X-ray diffraction, transmission electron microscopy, and their calculations. Structure analysis indicated phase transformation of the perovskite structure from a tetragonal to a cubic system by annealing, which resulted in the improvement of photovoltaic properties of the devices. Effects of a multiple spin-coating method using a mixture solution were also investigated. The result showed an increase in the efficiencies of the devices, due to the microstructural change of the perovskite compound layers. (C) 2014 The Japan Society of Applied Physics	[Oku, Takeo; Zushi, Masahito; Imanishi, Yuma; Suzuki, Atsushi; Suzuki, Kohei] Univ Shiga Prefecture, Dept Mat Sci, Hikone, Shiga 5228533, Japan	Oku, T (reprint author), Univ Shiga Prefecture, Dept Mat Sci, Hikone, Shiga 5228533, Japan.	oku@mat.usp.ac.jp					Grinberg I, 2013, NATURE, V503, P509, DOI 10.1038/nature12622; Yamada Y, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.032302; Kojima A, 2012, CHEM LETT, V41, P397, DOI 10.1246/cl.2012.397; Liu DY, 2014, NAT PHOTONICS, V8, P133, DOI 10.1038/nphoton.2013.342; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Wojciechowski K, 2014, ENERG ENVIRON SCI, V7, P1142, DOI 10.1039/c3ee43707h; Chung I, 2012, NATURE, V485, P486, DOI 10.1038/nature11067; Im JH, 2011, NANOSCALE, V3, P4088, DOI 10.1039/c1nr10867k; Zushi M, 2014, CHEM LETT, V43, P916, DOI 10.1246/cl.140127; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050; Wang JTW, 2014, NANO LETT, V14, P724, DOI 10.1021/nl403997a; ONODAYAMAMURO N, 1990, J PHYS CHEM SOLIDS, V51, P1383, DOI 10.1016/0022-3697(90)90021-7; Kawamura Y, 2002, J PHYS SOC JPN, V71, P1694, DOI 10.1143/JPSJ.71.1694; Baikie T, 2013, J MATER CHEM A, V1, P5628, DOI 10.1039/c3ta10518k; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Oku T, 2011, PROG NAT SCI, V21, P122; POGLITSCH A, 1987, J CHEM PHYS, V87, P6373, DOI 10.1063/1.453467; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Yamada Y, 2014, J AM CHEM SOC, V136, P11610, DOI 10.1021/ja506624n; Mashiyama H, 1998, J KOREAN PHYS SOC, V32, pS156; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Oku T, 2013, MATER TECHNOL, V28, P21, DOI 10.1179/1753555712Y.0000000042; OKU T, 1994, J APPL PHYS, V75, P2522, DOI 10.1063/1.356225; Oku T, 2012, NANOTECHNOL REV, V1, P389, DOI 10.1515/ntrev-2012-0018; Oku T, 2014, NANOTECHNOL REV, V3, P413, DOI 10.1515/ntrev-2014-0003; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; WEBER D, 1978, Z NATURFORSCH B, V33, P1443	28	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							121601	10.7567/APEX.7.121601		4	Physics, Applied	Physics	AW2MM	WOS:000346122300008		
J	Tanuma, R; Nagano, M; Kamata, I; Tsuchida, H				Tanuma, Ryohei; Nagano, Masahiro; Kamata, Isaho; Tsuchida, Hidekazu			Three-dimensional imaging and tilt-angle analysis of dislocations in 4H-SiC by two-photon-excited band-edge photoluminescence	APPLIED PHYSICS EXPRESS			English	Article							THREADING DISLOCATIONS; EXTENDED DEFECTS; EPITAXIAL-GROWTH; TOPOGRAPHY; EPILAYERS	We demonstrate the three-dimensional imaging of threading screw dislocations (TSDs), threading edge dislocations (TEDs), and basal plane dislocations (BPDs) in 4H-SiC using two-photon-excited band-edge photoluminescence. Three-dimensional images of TSDs, TEDs, and BPDs are obtained successfully as dark contrasts on a bright background of band-edge emission. Dislocation images extending similar to 200 mu m from the surface are demonstrated. The tilt angles of TSDs and TEDs in 4H-SiC epilayers are also measured, and the mechanisms governing the line directions of TEDs and TSDs are discussed. (C) 2014 The Japan Society of Applied Physics	[Tanuma, Ryohei; Nagano, Masahiro; Kamata, Isaho; Tsuchida, Hidekazu] CRIEPI, Mat Sci Res Lab, Yokosuka, Kanagawa 2400196, Japan	Tanuma, R (reprint author), CRIEPI, Mat Sci Res Lab, Yokosuka, Kanagawa 2400196, Japan.	tanuma@criepi.denken.or.jp			Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology" (FIRST Program)	This research was partly supported by the Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology" (FIRST Program). We would like to thank Ms. Masako Ino of Nikon Corporation and Mr. Ken Shiya of Nikon Instech Co., Ltd. for operating the multiphoton microscopy system.	Kamata I, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3499431; Skowronski M, 2006, J APPL PHYS, V99, DOI 10.1063/1.2159578; Onda S, 2013, PHIL MAG LETT, V93, P591, DOI 10.1080/09500839.2013.826395; Tsuchida H, 2009, PHYS STATUS SOLIDI B, V246, P1553, DOI 10.1002/pssb.200945056; Kamata I, 2009, J CRYST GROWTH, V311, P1416, DOI 10.1016/j.jcrysgro.2008.11.017; Ohno T, 2004, J CRYST GROWTH, V260, P209, DOI 10.1016/j.jcrysgro.2003.08.065; Tanuma R, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.061301; Stahlbush RE, 2007, MATER SCI FORUM, V556-557, P295; Feng G, 2011, J APPL PHYS, V110, DOI 10.1063/1.3622336; Berechman RA, 2010, J APPL PHYS, V107, DOI 10.1063/1.3432663; Chen Y, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2793705; Dudley M, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3597226; Kamata I, 2009, MATER SCI FORUM, V600-603, P305, DOI 10.4028/www.scientific.net/MSF.600-603.305; Liu KX, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2721139; Liu KX, 2009, MATER SCI FORUM, V600-603, P345, DOI 10.4028/www.scientific.net/MSF.600-603.345; Masters B. R., 2008, HDB BIOMEDICAL NONLI, P260; Nagano M, 2014, MATER SCI FORUM, V778-780, P313, DOI 10.4028/www.scientific.net/MSF.778-780.313; Nagano M, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CP09; Stahlbush RE, 2010, MATER SCI FORUM, V645-648, P271, DOI 10.4028/www.scientific.net/MSF.645-648.271; Sugawara Y, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.081301; Tajima M, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1862330; Tanuma R, 2014, MATER SCI FORUM, V778-780, P338, DOI 10.4028/www.scientific.net/MSF.778-780.338; Tanuma R, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.021304; Tanuma R, 2013, J APPL PHYS, V114, DOI 10.1063/1.4812496; Tanuma R, 2009, MATER SCI FORUM, V615-617, P251; Tanuma R., 2014, EUR C SIL CARB REL M; Tsuchida H, 2014, J CRYST GROWTH, V402, P260, DOI 10.1016/j.jcrysgro.2014.06.034; Zipfel Warren R., 2003, Nature Biotechnology, V21, P1369, DOI 10.1038/nbt899	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							121303	10.7567/APEX.7.121303		4	Physics, Applied	Physics	AW2MM	WOS:000346122300007		
J	Tayagaki, T; Kishimoto, Y; Hoshi, Y; Usami, N				Tayagaki, Takeshi; Kishimoto, Yuko; Hoshi, Yusuke; Usami, Noritaka			Light trapping by direction-dependent light transmission in front-surface photonic nanostructures	APPLIED PHYSICS EXPRESS			English	Article							SILICON SOLAR-CELLS; PHOTOVOLTAIC DEVICES; QUANTUM DOTS; ABSORPTION; FILM; ENHANCEMENT; GENERATION; EFFICIENCY; TEXTURES; GRATINGS	Front-surface photonic nanostructures contribute both reduced reflection loss and light trapping to increase optical absorption in solar cells. We investigated the effect of sub-wavelength photonic nanostructures on light trapping in thin-film crystalline silicon solar cells. We clarified that, even though the angle distribution of scattered light is small compared with that in the case of Lambertian scattering, light trapping enhances with increasing depth of the surface photonic nanostructure, which originates from the direction-dependent light transmission in the surface photonic nanostructure. Our findings indicate that this direction-dependent light transmission contributes to the advanced photon management in thin-film solar cells. (C) 2014 The Japan Society of Applied Physics.	[Tayagaki, Takeshi; Kishimoto, Yuko] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Hoshi, Yusuke; Usami, Noritaka] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan	Tayagaki, T (reprint author), Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan.	tayagaki@scl.kyoto-u.ac.jp	Usami, Noritaka/C-1720-2009; Tayagaki, Takeshi/E-7830-2010; Hoshi, Yusuke/A-2135-2012		Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST); MEXT KAKENHI [26800168]	Part of this work was supported by the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST) and MEXT KAKENHI Grant Number 26800168.	Gjessing J, 2011, J APPL PHYS, V110, DOI 10.1063/1.3611425; Zhu HB, 2011, OPT LETT, V36, P1308, DOI 10.1364/OL.36.001308; Zeman M, 2013, SOL ENERG MAT SOL C, V119, P94, DOI 10.1016/j.solmat.2013.05.037; Pfeiffer C, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.023902; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Ulbrich C, 2008, PHYS STATUS SOLIDI A, V205, P2831, DOI 10.1002/pssa.200880457; Wang KXZ, 2012, NANO LETT, V12, P1616, DOI 10.1021/nl204550q; Tayagaki T, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4756895; Tanaka Y, 2013, OPT EXPRESS, V21, P20111, DOI 10.1364/OE.21.020111; YABLONOVITCH E, 1982, J OPT SOC AM, V72, P899, DOI 10.1364/JOSA.72.000899; Nagel JR, 2010, OPT EXPRESS, V18, pA139, DOI 10.1364/OE.18.00A139; Yu ZF, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2716359; Green MA, 2002, PROG PHOTOVOLTAICS, V10, P235, DOI 10.1002/pip.404; Zhao JH, 1996, SOL ENERG MAT SOL C, V41-2, P87, DOI 10.1016/0927-0248(95)00117-4; Xi JQ, 2007, NAT PHOTONICS, V1, P176, DOI 10.1038/nphoton.2007.26; Ingenito A, 2014, ACS PHOTONICS, V1, P270, DOI 10.1021/ph4001586; Yu ZF, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.173901; Yu ZF, 2014, NANO LETT, V14, P66, DOI 10.1021/nl403653j; CAMPBELL P, 1987, J APPL PHYS, V62, P243, DOI 10.1063/1.339189; Usami N, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/18/185401; Tayagaki T, 2014, OPT EXPRESS, V22, pA225, DOI 10.1364/OE.22.00A225; Ganapati V, 2014, IEEE J PHOTOVOLT, V4, P175, DOI 10.1109/JPHOTOV.2013.2280340; Green MA, 2012, NANO LETT, V12, P5985, DOI 10.1021/nl3034784; Greenberg M, 2004, OPT EXPRESS, V12, P4013, DOI 10.1364/OPEX.12.004013; Hoshi Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.080202; Jager K, 2013, OPT EXPRESS, V21, pA656, DOI 10.1364/OE.21.00A656; Jager K, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3254239; Khanikaev AB, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.126804; Kuang P, 2013, OPT LETT, V38, P4200, DOI 10.1364/OL.38.004200; Martins ER, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3665; Nelson Z. J., 2003, PHYS SOLAR CELLS; Schuster CS, 2014, OPT EXPRESS, V22, pA542, DOI 10.1364/OE.22.00A542; Tayagaki T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02703; Ulbrich C, 2010, OPT EXPRESS, V18, pA133, DOI 10.1364/OE.18.00A133; Wang W, 2012, OPT EXPRESS, V20, P3733, DOI 10.1364/OE.20.003733	35	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							122301	10.7567/APEX.7.122301		4	Physics, Applied	Physics	AW2MM	WOS:000346122300013		
J	Uedono, A; Yoshihara, N; Zhang, YH; Sun, M; Piedra, D; Fujishima, T; Ishibashi, S; Sumiya, M; Laboutin, O; Johnson, W; Palacios, T				Uedono, Akira; Yoshihara, Nakaaki; Zhang, Yuhao; Sun, Min; Piedra, Daniel; Fujishima, Tatsuya; Ishibashi, Shoji; Sumiya, Masatomo; Laboutin, Oleg; Johnson, Wayne; Palacios, Tomas			Vacancy clusters introduced by CF4-based plasma treatment in GaN probed with a monoenergetic positron beam	APPLIED PHYSICS EXPRESS			English	Article							THRESHOLD VOLTAGE; DEFECTS	Vacancy-type defects introduced by CF4-plasma treatment in GaN grown on Si substrates have been studied using a monoenergetic positron beam. By positron annihilation spectroscopy, it was found that vacancies were introduced below the surface (<= 30 nm),and this region expanded to a depth of 50 nm after 400 degrees C annealing. The major species of such defects were identified as vacancy clusters coupled with fluorine. The charge transition between these defects and optically active native defects was studied. The defects introduced by plasma treatment were found to introduce deep levels into the bandgap of GaN and act as nonradiative recombination centers. (C) 2014 The Japan Society of Applied Physics	[Uedono, Akira; Yoshihara, Nakaaki] Univ Tsukuba, Fac Pure & Appl Sci, Div Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Zhang, Yuhao; Sun, Min; Piedra, Daniel; Fujishima, Tatsuya; Palacios, Tomas] MIT, Microsyst Technol Labs, Cambridge, MA 02139 USA; [Ishibashi, Shoji] Natl Inst Adv Ind Sci & Technol, NanosystRes Inst RICS, Tsukuba, Ibaraki 3058568, Japan; [Sumiya, Masatomo] Natl Inst Mat Sci, Wide Bandgap Mat Grp, Tsukuba, Ibaraki 3050044, Japan; [Laboutin, Oleg; Johnson, Wayne] IQE, Taunton, MA 01581 USA	Uedono, A (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Div Appl Phys, Tsukuba, Ibaraki 3058573, Japan.	uedono.akira.gb@u.tsukuba.ac.jp			DARPA NEXT Hayashi Seed Fund program; ONR PECASE Hayashi Seed Fund program; MIT MISTI Hayashi Seed Fund program	The work performed by MIT has been partially funded by the DARPA NEXT, the ONR PECASE, and MIT MISTI Hayashi Seed Fund programs.	Reshchikov MA, 2005, J APPL PHYS, V97, DOI 10.1063/1.1868059; Lu B, 2012, IEEE ELECTR DEVICE L, V33, P360, DOI 10.1109/LED.2011.2179971; VANVEEN A, 1990, AIP CONF PROC, V218, P171; Tuomisto F, 2013, REV MOD PHYS, V85, P1583, DOI 10.1103/RevModPhys.85.1583; Demchenko DO, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.087404; Zhang YH, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4815923; Tajima M, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.020203; Pearton SJ, 1999, J APPL PHYS, V86, P1, DOI 10.1063/1.371145; Armitage R, 2003, APPL PHYS LETT, V82, P3457, DOI 10.1063/1.1578169; Wang MJ, 2009, J APPL PHYS, V105, DOI 10.1063/1.3106561; Lyons JL, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3492841; Polyakov AY, 2013, J VAC SCI TECHNOL B, V31, DOI 10.1116/1.4773057; Li BK, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2888743; Chang CT, 2010, ELECTRON LETT, V46, P1280, DOI 10.1049/el.2010.1939; Kanamura M, 2010, IEEE ELECTR DEVICE L, V31, P189, DOI 10.1109/LED.2009.2039026; Cai Y, 2006, IEEE T ELECTRON DEV, V53, P2207, DOI 10.1109/TED.2006.881054; Ishibashi S, 2014, J PHYS CONF SER, V505, DOI 10.1088/1742-6596/505/1/012010; Wang MJ, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3081019; Ha WJ, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3697684; Janotti A, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3247890; Uedono A, 2012, J APPL PHYS, V111, DOI 10.1063/1.3675516; Uedono A, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866966	22	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							121001	10.7567/APEX.7.121001		4	Physics, Applied	Physics	AW2MM	WOS:000346122300001		
J	Yamanaka, A; Okada, S				Yamanaka, Ayaka; Okada, Susumu			Electron injection into nearly free electron states of graphene nanoribbons under a lateral electric field	APPLIED PHYSICS EXPRESS			English	Article							BORON-NITRIDE NANOTUBES; INTERCALATION COMPOUNDS; SURFACE-STATES; GRAPHITE; PHOTOEMISSION; PREDICTION; NANOSHEETS; SYSTEMS; BULK; GAS	Using density functional theory with the effective screening medium method, we studied the electronic properties of graphene nanoribbons with zigzag and armchair edges under a lateral electric field. Our calculations showed that a nearly free electron (NFE) state emerges in the vacuum region outside the leftmost edge of the ribbons and shifts downward with increasing electric field. We also found that electrons are injected into this NFE state of graphene nanoribbons by the critical electric field, which is inversely proportional to the ribbon width. (C) 2014 The Japan Society of Applied Physics	[Yamanaka, Ayaka; Okada, Susumu] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Okada, Susumu] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020076, Japan	Yamanaka, A (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan.	ayamanaka@comas.frsc.tsukuba.ac.jp	Okada, Susumu/D-7461-2012		CREST; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported in part by CREST, the Japan Science and Technology Agency, and a Grant-in-Aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. Computations were performed on an NEC SX-8/4B at the University of Tsukuba, on an NEC SX-9 at the Institute for Solid State Physics, The University of Tokyo, and on an NEC SX-9 at the Cybermedia Center, Osaka University.	Otani M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.115407; Otani M, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.073701; Golberg D, 2010, ACS NANO, V4, P2979, DOI 10.1021/nn1006495; Boero M, 2001, J CHEM PHYS, V115, P2219, DOI 10.1063/1.1379767; POSTERNAK M, 1983, PHYS REV LETT, V50, P761, DOI 10.1103/PhysRevLett.50.761; DRESSELHAUS MS, 1981, ADV PHYS, V30, P139, DOI 10.1080/00018738100101367; Konabe S, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.113702; CATELLANI A, 1987, PHYS REV B, V36, P6105, DOI 10.1103/PhysRevB.36.6105; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; MIYAMOTO Y, 1995, PHYS REV LETT, V74, P2993, DOI 10.1103/PhysRevLett.74.2993; BLASE X, 1994, EUROPHYS LETT, V28, P335, DOI 10.1209/0295-5075/28/5/007; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Chhowalla M, 2013, NAT CHEM, V5, P263, DOI [10.1038/nchem.1589, 10.1038/NCHEM.1589]; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Morikawa Y, 2001, APPL SURF SCI, V169, P11, DOI 10.1016/S0169-4332(00)00631-0; BLASE X, 1995, PHYS REV B, V51, P6868, DOI 10.1103/PhysRevB.51.6868; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; CONRAD H, 1976, SURF SCI, V58, P578, DOI 10.1016/0039-6028(76)90492-1; Cuong NT, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/13/135001; HEIMANN P, 1977, J PHYS C SOLID STATE, V10, pL17, DOI 10.1088/0022-3719/10/1/004; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Liu QH, 2011, CHINESE J CHEM PHYS, V24, P22, DOI 10.1088/1674-0068/24/01/22-24; LOUIE SG, 1978, PHYS REV LETT, V40, P1525, DOI 10.1103/PhysRevLett.40.1525; Okada S, 2005, SURF SCI, V585, pL177, DOI 10.1016/j.susc.2005.04.022; Okada S, 2000, PHYS REV B, V62, P7634, DOI 10.1103/PhysRevB.62.7634; Otani M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.073405; POSTERNAK M, 1984, PHYS REV LETT, V52, P863, DOI 10.1103/PhysRevLett.52.863; Yamanaka A, 2013, PHYS STATUS SOLIDI C, V10, P1624, DOI 10.1002/pssc.201300234; Yamanaka A, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.06JD05	31	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1882-0778	1882-0786		APPL PHYS EXPRESS	Appl. Phys. Express	DEC	2014	7	12							125103	10.7567/APEX.7.125103		4	Physics, Applied	Physics	AW2MM	WOS:000346122300025		
J	Chen, CL; Lv, SH; Wang, ZC; Akagi, K; Lichtenberg, F; Ikuhara, Y; Bednorz, JG				Chen, Chunlin; Lv, Shuhui; Wang, Zhongchang; Akagi, Kazuto; Lichtenberg, Frank; Ikuhara, Yuichi; Bednorz, Johannes Georg			Atomic and electronic structure of the SrNbO3/SrNbO3.4 interface	APPLIED PHYSICS LETTERS			English	Article							OXIDES	We have determined the atomic-scale structure of the SrNbO3/SrNbO3.4 interface and related it to the electronic structure. Experimentally, transmission electron microscopy observations reveal that SrNbO3 and SrNbO3.4 show orientation relationships [(1) over bar 10](SrNbO3) // [010](SrNbO3.4) and (110)(SrNbO3) // (001)(SrNbO3.4), and that their interface is coherent and atomically abrupt. Theoretically, this interface is found to be strongly anisotropic in electronic structure, and takes on quasi-one-dimensional nature. We also find that the interface impacts greatly the electron occupation of Nb d orbitals, particularly d(z)(2) orbital. The combined study represents a relevant advance in atomically bridging structures to properties of heterointerfaces. (c) 2014 AIP Publishing LLC.	[Chen, Chunlin; Lv, Shuhui; Wang, Zhongchang; Akagi, Kazuto; Ikuhara, Yuichi] Tohoku Univ, Adv Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Lv, Shuhui] Changchun Univ Sci & Technol, Sch Mat Sci & Engn, Changchun 130022, Peoples R China; [Lichtenberg, Frank] Swiss Fed Inst Technol, Dept Mat, CH-8093 Zurich, Switzerland; [Ikuhara, Yuichi] Univ Tokyo, Inst Engn Innovat, Bunkyo Ku, Tokyo 1138656, Japan; [Ikuhara, Yuichi] Japan Fine Ceram Ctr, Nanostrct Res Lab, Atsuta Ku, Nagoya, Aichi 4568587, Japan; [Bednorz, Johannes Georg] IBM Corp, Div Res, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland	Lv, SH (reprint author), Tohoku Univ, Adv Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	shlv@wpi-aimr.tohoku.ac.jp; zcwang@wpi-aimr.tohoku.ac.jp; ikuhara@sigma.t.u-tokyo.ac.jp	Akagi, Kazuto/H-1182-2011; Chen, ChunLin/N-4611-2013; Ikuhara, Yuichi/N-1001-2015; Ikuhara, Yuichi/F-3066-2010	Ikuhara, Yuichi/0000-0003-3886-005X; 	MEXT of Japan; Elements Strategy Initiative for Structural Materials (ESISM) via MEXT by Japan; JSPS; NSFC [11332013]; CAS under the Japan-China Scientific Cooperation Program; Murata Science Foundation;  [26820288];  [24686069]	This work was conducted in part at the Research Hub for the Advanced Nano Characterization and "Nanotechnology Platform" at the University of Tokyo supported by MEXT of Japan, and was supported in part by the Elements Strategy Initiative for Structural Materials (ESISM) via MEXT by Japan and JSPS Grant-in-Aid for Scientific Research on Innovative Areas "Nano Informatics." C.C. acknowledges support from the Grant-in-Aid for Young Scientists (B) (Grant No. 26820288). Z.W. thanks the financial support from the Grant-in-Aid for Young Scientists (A) (Grant No. 24686069), the NSFC (Grant No. 11332013), the JSPS and CAS under the Japan-China Scientific Cooperation Program, and the Murata Science Foundation. F.L. thanks Nicola Spaldin for her support. Calculations were conducted at the ISSP, University of Tokyo.	Kuntscher CA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.245123; Kobayashi W, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.085118; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; PENNYCOOK SJ, 1988, NATURE, V336, P565, DOI 10.1038/336565a0; Reyren N, 2007, SCIENCE, V317, P1196, DOI 10.1126/science.1146006; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Gozar A, 2008, NATURE, V455, P782, DOI 10.1038/nature07293; Abrahams SC, 1998, ACTA CRYSTALLOGR B, V54, P399, DOI 10.1107/S0108768197019642; Lichtenberg F, 2001, PROG SOLID STATE CH, V29, P1, DOI 10.1016/S0079-6786(01)00002-4; Herranz G, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.216803; LIU DH, 1992, MATER RES BULL, V27, P387, DOI 10.1016/0025-5408(92)90068-B; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; LICHTENBERG F, 1991, Z PHYS B CON MAT, V84, P369, DOI 10.1007/BF01314010; Willmott PR, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.155502; Lichtenberg F, 2008, PROG SOLID STATE CH, V36, P253, DOI 10.1016/j.progsolidstchem.2008.10.001; Hwang HY, 2012, NAT MATER, V11, P103, DOI [10.1038/nmat3223, 10.1038/NMAT3223]; Thiel S, 2006, SCIENCE, V313, P1942, DOI 10.1126/science.1131091; Findlay SD, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3265946; Nakagawa N, 2006, NAT MATER, V5, P204, DOI 10.1038/nmat1569; RIDGLEY D, 1955, J AM CHEM SOC, V77, P6132, DOI 10.1021/ja01628a011; Siemons W, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196802; de Campos A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.125117; ISAWA K, 1994, PHYS REV B, V49, P3534, DOI 10.1103/PhysRevB.49.3534; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kuntscher CA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.236403; Kuntscher CA, 2000, PHYS REV B, V61, P1876, DOI 10.1103/PhysRevB.61.1876; Okamoto S, 2004, NATURE, V428, P630, DOI 10.1038/nature02450; Sakai A, 2010, J APPL PHYS, V108, DOI 10.1063/1.3510585; Salvador PA, 1999, APPL PHYS LETT, V75, P2638, DOI 10.1063/1.125103; TURZHEVSKY SA, 1994, PHYS REV B, V50, P3200, DOI 10.1103/PhysRevB.50.3200; Weber JE, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.235414	32	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	DEC 1	2014	105	22							221602	10.1063/1.4902970		5	Physics, Applied	Physics	AW4QH	WOS:000346265200020		
J	Iwahashi, T; Yang, R; Okabe, N; Sakurai, J; Lin, J; Matsunaga, D				Iwahashi, Takashi; Yang, Rong; Okabe, Noriaki; Sakurai, Junpei; Lin, Jun; Matsunaga, Daisuke			Nanoimprint-assisted fabrication of high haze metal mesh electrode for solar cells	APPLIED PHYSICS LETTERS			English	Article							TRANSPARENT ELECTRODES; LITHOGRAPHY	We propose a concept of transparent electrode for solar cells surpassing conventional transparent conductive oxide. Transparent electrode requires low electrical resistivity, high optical transparency, and high optical haze. Although transparent conductive oxide by chemical vapor deposition is widely used as a transparent electrode for solar cells, a breakthrough of the trade-off between electrical and optical properties is required for further improvement of solar cell efficiency. We demonstrate solution-processed electrode fabrication by using nanoimprint technology and metal nanoparticle ink. Silver mesh electrode is self-aligned on nanoimprinted texture with concave pattern as a template for mesh grid. Our electrode concept can realize desired high optical haze by nanoimprinted texture, as well as low electrical resistivity and high optical transparency by metal mesh electrode simultaneously, which boosts solar cell efficiency. (C) 2014 AIP Publishing LLC.	[Iwahashi, Takashi; Yang, Rong; Okabe, Noriaki; Sakurai, Junpei; Lin, Jun; Matsunaga, Daisuke] Tokyo Electron Ltd, Nirasaki City, Yamanashi, Japan	Lin, J (reprint author), Tokyo Electron Ltd, 650 Mitsuzawa,Hosaka Cho, Nirasaki City, Yamanashi, Japan.	jun.lin@tel.com	Sakurai, Junpei/I-7754-2014				Nasuno Y, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2176857; Kang MG, 2010, SOL ENERG MAT SOL C, V94, P1179, DOI 10.1016/j.solmat.2010.02.039; Domine D, 2008, PHYS STATUS SOLIDI-R, V2, P163, DOI 10.1002/pssr.200802118; Fay S, 2007, THIN SOLID FILMS, V515, P8558, DOI 10.1016/j.tsf.2007.03.130; WENAS WW, 1991, J APPL PHYS, V70, P7119, DOI 10.1063/1.349794; Dumond JJ, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.3661355; Soderstrom T, 2008, J APPL PHYS, V103, DOI 10.1063/1.2938839; Zhu R, 2011, ACS NANO, V5, P9877, DOI 10.1021/nn203576v; Battaglia C, 2011, NANO LETT, V11, P661, DOI 10.1021/nl1037787; Schift H, 2008, J VAC SCI TECHNOL B, V26, P458, DOI 10.1116/1.2890972; Lee JY, 2008, NANO LETT, V8, P689, DOI 10.1021/nl073296g; Fan X, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2475623; Guo LJ, 2004, J PHYS D APPL PHYS, V37, pR123, DOI 10.1088/0022-3727/37/11/R01; Soderstrom K, 2011, PROG PHOTOVOLTAICS, V19, P202, DOI 10.1002/pip.1003; Battaglia C, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3432739; Huang XW, 2010, SOL ENERG MAT SOL C, V94, P1005, DOI 10.1016/j.solmat.2010.02.005; Lin J., 2013, P 28 EUR PHOT SOL EN, P2152, DOI [10.4229/28thEUPV-SEC2013-3B0.5.1, DOI 10.4229/28THEUPVSEC2013-3B0.5.1]; Lin J., 2014, P 40 IEEE PHOT UNPUB; Sato K., 1992, REP RES LAB, V42, P129	19	2	2	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	DEC 1	2014	105	22							223901	10.1063/1.4903061		4	Physics, Applied	Physics	AW4QH	WOS:000346265200101		
J	Kanai, S; Tsujikawa, M; Miura, Y; Shirai, M; Matsukura, F; Ohno, H				Kanai, Shun; Tsujikawa, Masahito; Miura, Yoshio; Shirai, Masafumi; Matsukura, Fumihiro; Ohno, Hideo			Magnetic anisotropy in Ta/CoFeB/MgO investigated by x-ray magnetic circular dichroism and first-principles calculation	APPLIED PHYSICS LETTERS			English	Article							TOTAL-ENERGY CALCULATIONS; WAVE BASIS-SET; MAGNETOCRYSTALLINE ANISOTROPY; TRANSITION-METALS; MONOLAYERS; MOMENT; FIELDS; IRON	We study the spin and orbital magnetic moments in Ta/Co0.4Fe0.4B0.2/MgO by x-ray magnetic circular dichroism measurements as well as first-principles calculations, in order to clarify the origin of the perpendicular magnetic anisotropy. Both experimental and theoretical results show that orbital magnetic moment of Fe is more anisotropic than that of Co with respect to the magnetization direction. The anisotropy is larger for thinner CoFeB, indicating that Fe atoms at the interface with MgO contribute more than Co to the observed perpendicular magnetic anisotropy. (C) 2014 AIP Publishing LLC.	[Kanai, Shun; Matsukura, Fumihiro; Ohno, Hideo] Tohoku Univ, Lab Nanoelect & Spintron, Elect Commun Res Inst, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Tsujikawa, Masahito; Shirai, Masafumi] Tohoku Univ, Ctr Spintron Integrated Syst, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Tsujikawa, Masahito; Miura, Yoshio; Shirai, Masafumi; Matsukura, Fumihiro; Ohno, Hideo] Tohoku Univ, Elect Commun Res Inst, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Miura, Yoshio] Kyoto Inst Technol, Dept Elect & Informat Sci, Kyoto 606, Japan; [Matsukura, Fumihiro; Ohno, Hideo] Tohoku Univ, WPI AIMR, Aoba Ku, Sendai, Miyagi 9808577, Japan	Matsukura, F (reprint author), Tohoku Univ, Lab Nanoelect & Spintron, Elect Commun Res Inst, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	f-matsu@wpi-aimr.tohoku.ac.jp			FIRST program of JSPS; R&D Project for ICT Key Technology of MEXT;  [26889007]	The authors thank J. Okabayashi, A. Okada, M. Yamanouchi, H. Sato, S. Ikeda, I. Morita, T. Hirata, H. Iwanuma, and Y. Kawato for their technical supports and discussion. This work was performed under the approval of the Photon Factory Program Advisory Committee, KEK (No. 2012G657), and was supported in part by FIRST program of JSPS, R&D Project for ICT Key Technology of MEXT, and Grants-in-Aid for JSPS Fellows and for Young Scientists (Start-up) (No. 26889007).	Endo M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3429592; Yang HX, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.054401; STOHR J, 1995, PHYS REV LETT, V75, P3748, DOI 10.1103/PhysRevLett.75.3748; Koide T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.257201; Maruyama T, 2009, NAT NANOTECHNOL, V4, P158, DOI [10.1038/nnano.2008.406, 10.1038/NNANO.2008.406]; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; WU RQ, 1994, PHYS REV LETT, V73, P1994, DOI 10.1103/PhysRevLett.73.1994; Tsai WC, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4707380; CHEN CT, 1995, PHYS REV LETT, V75, P152, DOI 10.1103/PhysRevLett.75.152; Shimabukuro R, 2010, PHYSICA E, V42, P1014, DOI 10.1016/j.physe.2009.11.110; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; CARRA P, 1993, PHYS REV LETT, V70, P694, DOI 10.1103/PhysRevLett.70.694; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Ikeda S, 2010, NAT MATER, V9, P721, DOI [10.1038/nmat2804, 10.1038/NMAT2804]; Amemiya K, 2002, J ELECTRON SPECTROSC, V124, P151, DOI 10.1016/S0368-2048(02)00051-8; THOLE BT, 1992, PHYS REV LETT, V68, P1943, DOI 10.1103/PhysRevLett.68.1943; Mizunuma K, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3265740; [Anonymous], 1996, PHYS REV B, V4, P11169; BRUNO P, 1989, PHYS REV B, V39, P865, DOI 10.1103/PhysRevB.39.865; Chiba D, 2008, NATURE, V455, P515, DOI 10.1038/nature07318; Weisheit M, 2007, SCIENCE, V315, P349, DOI 10.1126/science.1136629; Brand J. A. C., 1994, ULTRATHIN MAGNETIC S; He KH, 2012, J APPL PHYS, V111, DOI 10.1063/1.3672855; Hindmarch AT, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3332576; Ikeda Shoji, 2012, SPIN, V2, DOI 10.1142/S2010324712400036; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; NEEL L, 1954, J PHYS-PARIS, V15, P225, DOI 10.1051/jphysrad:01954001504022500; Tsujikawa M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3540677; WELLER D, 1995, PHYS REV LETT, V75, P3752, DOI 10.1103/PhysRevLett.75.3752	29	4	4	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	DEC 1	2014	105	22							222409	10.1063/1.4903296		4	Physics, Applied	Physics	AW4QH	WOS:000346265200055		
J	Kashiwagi, Y; Koizumi, A; Takemura, Y; Furuta, S; Yamamoto, M; Saitoh, M; Takahashi, M; Ohno, T; Fujiwara, Y; Murahashi, K; Ohtsuka, K; Nakamoto, M				Kashiwagi, Y.; Koizumi, A.; Takemura, Y.; Furuta, S.; Yamamoto, M.; Saitoh, M.; Takahashi, M.; Ohno, T.; Fujiwara, Y.; Murahashi, K.; Ohtsuka, K.; Nakamoto, M.			Direct transparent electrode patterning on layered GaN substrate by screen printing of indium tin oxide nanoparticle ink for Eu-doped GaN red light-emitting diode	APPLIED PHYSICS LETTERS			English	Article							CONDUCTING OXIDES; DEVICES; LITHOGRAPHY; FILMS; LEDS	Transparent electrodes were formed on Eu-doped GaN-based red-light-emitting diode (GaN:Eu LED) substrates by the screen printing of indium tin oxide nanoparticle (ITO np) inks as a wet process. The ITO nps with a mean diameter of 25 nm were synthesized by the controlled thermolysis of a mixture of indium complexes and tin complexes. After the direct screen printing of ITO np inks on GaN:Eu LED substrates and sintering at 850 degrees C for 10 min under atmospheric conditions, the resistivity of the ITO film was 5.2m Omega cm. The fabricated LED up to 3mm square surface emitted red light when the on-voltage was exceeded. (C) 2014 AIP Publishing LLC.	[Kashiwagi, Y.; Yamamoto, M.; Saitoh, M.; Takahashi, M.; Ohno, T.; Nakamoto, M.] Osaka Municipal Tech Res Inst, Joto Ku, Osaka 5368553, Japan; [Koizumi, A.; Fujiwara, Y.] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan; [Takemura, Y.; Murahashi, K.; Ohtsuka, K.] Okuno Chem Ind Co Ltd, Joto Ku, Osaka 5360011, Japan; [Furuta, S.] Tomoe Works Co Ltd, Amagasaki, Hyogo 6600092, Japan	Kashiwagi, Y (reprint author), Osaka Municipal Tech Res Inst, Joto Ku, 1-6-50 Morinomiya, Osaka 5368553, Japan.	kasiwagi@omtri.or.jp	Fujiwara, Yasufumi/D-9052-2012		Adaptable and Seamless Technology Transfer Program through Target-Driven R&D of Japan Science and Technology Agency; Osaka Central Area Industry-Government-Academia Collaboration Project on the "City Area Program" from the Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [19GS1209, 24226009]	This research was partly supported by the Adaptable and Seamless Technology Transfer Program through Target-Driven R&D of Japan Science and Technology Agency, partly by the Osaka Central Area Industry-Government-Academia Collaboration Project on the "City Area Program" from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 2007-2009, and partly by a Grant-in-Aid for Creative Scientific Research (Grant No. 19GS1209) and a Grant-in-Aid for Scientific Research (S) (Grant No. 24226009) from the Japan Society for the Promotion of Science.	Liu HY, 2010, SUPERLATTICE MICROST, V48, P458, DOI 10.1016/j.spmi.2010.08.011; Buhler G, 2007, ADV MATER, V19, P2224, DOI 10.1002/adma.200602102; Hwang MS, 2011, MATER SCI ENG B-ADV, V176, P1128, DOI 10.1016/j.mseb.2011.05.053; Walker SB, 2012, J AM CHEM SOC, V134, P1419, DOI 10.1021/ja209267c; Hong SJ, 2008, IEEE T NANOTECHNOL, V7, P172, DOI 10.1109/TNANO.2008.917846; Fortunato E, 2007, MRS BULL, V32, P242, DOI 10.1557/mrs2007.29; Wu YL, 2007, J AM CHEM SOC, V129, P1862, DOI 10.1021/ja067596w; Puetz J, 2004, ADV ENG MATER, V6, P733, DOI 10.1002/adem.200400078; Nishikawa A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3478011; Habas SE, 2010, CHEM REV, V110, P6571, DOI 10.1021/cr100191d; Kim KY, 2004, MATER CHEM PHYS, V86, P210, DOI 10.1016/j.matchemphys.2004.03.012; Gutsch A, 2005, SMALL, V1, P30, DOI 10.1002/smll.200400021; Kim JS, 1999, CHEM PHYS LETT, V315, P307, DOI 10.1016/S0009-2614(99)01233-6; Nishikawa A, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.071004; Furukawa N, 2011, PHYS STATUS SOLIDI A, V208, P445, DOI 10.1002/pssa.201000598; GROTH R, 1965, PHILIPS TECH REV, V26, P105; AKASAKI I, 1991, J LUMIN, V48-9, P666; Byeon KJ, 2012, EUR PHYS J-APPL PHYS, V59, DOI 10.1051/epjap/2012120166; Gilstrap RA, 2009, THIN SOLID FILMS, V518, P1136, DOI 10.1016/j.tsf.2009.06.065; Gross M, 2009, ADV ENG MATER, V11, P295, DOI 10.1002/adem.200800292; Holland L., 1953, Vacuum, V3, DOI 10.1016/0042-207X(53)90411-4; Kuo CH, 2004, MAT SCI ENG B-SOLID, V106, P69, DOI 10.1016/j.mseb.2003.09.018; Nakamoto M., 2004, KAGAKU TO KOGYO, V78, P503; Nakamoto M., 2009, J SURF FINISH SOC JP, V60, P17; Suganuma K, 2010, IEEE Nanotechnology Magazine, V4, DOI 10.1109/MNANO.2010.938016; Yang KY, 2010, J ELECTROCHEM SOC, V157, pH1067, DOI 10.1149/1.3489293; Yang KY, 2009, J VAC SCI TECHNOL B, V27, P2786, DOI 10.1116/1.3243170	27	3	3	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	DEC 1	2014	105	22							223509	10.1063/1.4903234		4	Physics, Applied	Physics	AW4QH	WOS:000346265200093		
J	Matsuzaki, K; Okazaki, T; Lee, YS; Hosono, H; Susaki, T				Matsuzaki, Kosuke; Okazaki, Tetsushi; Lee, Yih-Shu; Hosono, Hideo; Susaki, Tomofumi			Controlled bipolar doping in Cu3N (100) thin films	APPLIED PHYSICS LETTERS			English	Article							COPPER NITRIDE; SOLAR-CELLS; GROWTH	We have fabricated insulating, p- and n-type Cu3N(100) films on SrTiO3(100) by plasma assisted molecular beam epitaxy. By controlling the Cu/N flux rate, p-type doping with 10(18)-10(20) cm(-3) in Cu-poor condition and n-type doping with 10(19)-10(20) cm(-3) in N-poor condition were obtained without introducing foreign species. Together with formation of insulating Cu3N films with an optical absorption coefficient of similar to 10(5) cm(-1) in the photon energy above similar to 2.2 eV and an estimated indirect bandgap of similar to 1.3 eV, the bipolar doping in Cu3N films would be promising for solar energy conversion applications. (c) 2014 AIP Publishing LLC.	[Matsuzaki, Kosuke; Okazaki, Tetsushi; Lee, Yih-Shu; Hosono, Hideo; Susaki, Tomofumi] Tokyo Inst Technol, Mat & Struct Lab, Secure Mat Ctr, Midori Ku, Yokohama, Kanagawa 2268503, Japan; [Hosono, Hideo] Tokyo Inst Technol, Frontier Res Ctr, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Matsuzaki, K (reprint author), Tokyo Inst Technol, Mat & Struct Lab, Secure Mat Ctr, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 2268503, Japan.	matsuzaki@lucid.msl.titech.ac.jp	Susaki, Tomofumi/E-6394-2014; Hosono, Hideo/J-3489-2013	Hosono, Hideo/0000-0001-9260-6728	Ministry of Education, Culture, Sports, Science and Technology, Japan (Elements Science and Technology Project and Elements Strategy Initiative to Form Core Research Center); JSPS KAKENHI [25286056]	This work was financially supported by Ministry of Education, Culture, Sports, Science and Technology, Japan (Elements Science and Technology Project and Elements Strategy Initiative to Form Core Research Center) and by JSPS KAKENHI Grant No. 25286056.	Amoruso S, 1999, APPL SURF SCI, V138, P250, DOI 10.1016/S0169-4332(98)00402-4; ROTHWARF A, 1977, IEEE T ELECTRON DEV, V24, P381, DOI 10.1109/T-ED.1977.18744; Minami T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.062301; Borsa DM, 2002, APPL PHYS LETT, V80, P1823, DOI 10.1063/1.1459116; Zakutayev A, 2014, J PHYS CHEM LETT, V5, P1117, DOI 10.1021/jz5001787; Caskey CM, 2014, MATER HORIZ, V1, P424, DOI 10.1039/c4mh00049h; TERADA S, 1989, J CRYST GROWTH, V94, P567, DOI 10.1016/0022-0248(89)90038-9; Yang MH, 2013, ENERG ENVIRON SCI, V6, P2994, DOI 10.1039/c3ee40621k; MARUYAMA T, 1995, J APPL PHYS, V78, P4104, DOI 10.1063/1.359868; Zakutayev A, 2014, CHEM MATER, V26, P4970, DOI 10.1021/cm5018135; Wadia C, 2009, ENVIRON SCI TECHNOL, V43, P2072, DOI 10.1021/es8019534; Hahn U, 1996, PHYS REV B, V53, P12684, DOI 10.1103/PhysRevB.53.12684; ASANO M, 1990, JPN J APPL PHYS 1, V29, P1985, DOI 10.1143/JJAP.29.1985; Nosaka T, 1999, THIN SOLID FILMS, V348, P8, DOI 10.1016/S0040-6090(98)01776-3; Wang DY, 1998, J VAC SCI TECHNOL A, V16, P2084, DOI 10.1116/1.581314; Todorov TK, 2010, ADV MATER, V22, pE156, DOI 10.1002/adma.200904155; HERION J, 1980, SOL ENERG MATER, V4, P101, DOI 10.1016/0165-1633(80)90022-2; GILL WD, 1970, J APPL PHYS, V41, P3731, DOI 10.1063/1.1659500; SHAY JL, 1975, APPL PHYS LETT, V27, P89, DOI 10.1063/1.88372; Jackson P, 2011, PROG PHOTOVOLTAICS, V19, P894, DOI 10.1002/pip.1078; Borsa DM, 2004, SURF SCI, V548, P95, DOI 10.1016/j.susc.2003.10.053; Delbos S., 2012, EPJ PHOTOVOLTAICS, V3, P35004, DOI DOI 10.1051/EPJPV/2012008; Li ZW, 2006, CHEM VAPOR DEPOS, V12, P435, DOI 10.1002/cvde.200606485; Luque A., 2011, HANDBOOK OF PHOTOVOL; Modin A, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/23/235212; Sze S. M., 2002, SEMICONDUCTOR DEVICE; ZACHWIEJA U, 1990, J LESS-COMMON MET, V161, P175, DOI 10.1016/0022-5088(90)90327-G	27	2	2	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	DEC 1	2014	105	22							222102	10.1063/1.4903069		4	Physics, Applied	Physics	AW4QH	WOS:000346265200038		
J	Murata, Y; Mashoff, T; Takamura, M; Tanabe, S; Hibino, H; Beltram, F; Heun, S				Murata, Yuya; Mashoff, Torge; Takamura, Makoto; Tanabe, Shinichi; Hibino, Hiroki; Beltram, Fabio; Heun, Stefan			Correlation between morphology and transport properties of quasi-free-standing monolayer graphene	APPLIED PHYSICS LETTERS			English	Article								We investigate the morphology of quasi-free-standing monolayer graphene (QFMLG) formed at several temperatures by hydrogen intercalation and discuss its relationship with transport properties. Features corresponding to incomplete hydrogen intercalation at the graphene-substrate interface are observed by scanning tunneling microscopy on QFMLG formed at 600 and 800 degrees C. They contribute to carrier scattering as charged impurities. Voids in the SiC substrate and wrinkling of graphene appear at 1000 degrees C, and they decrease the carrier mobility significantly. (c) 2014 AIP Publishing LLC.	[Murata, Yuya; Beltram, Fabio; Heun, Stefan] Ist Nanosci CNR, NEST, I-56127 Pisa, Italy; [Murata, Yuya; Beltram, Fabio; Heun, Stefan] Scuola Normale Super Pisa, I-56127 Pisa, Italy; [Mashoff, Torge; Beltram, Fabio] Ist Italiano Tecnol, Ctr Nanotechnol Innovat NEST, I-56127 Pisa, Italy; [Takamura, Makoto; Tanabe, Shinichi; Hibino, Hiroki] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan	Murata, Y (reprint author), Ist Nanosci CNR, NEST, Piazza San Silvestro 12, I-56127 Pisa, Italy.	yuya.murata@nano.cnr.it; stefan.heun@nano.cnr.it	Murata, Yuya/J-8768-2014; Heun, Stefan/B-4406-2011; Hibino, Hiroki/D-2072-2014; Takamura, Makoto/C-4352-2013	Murata, Yuya/0000-0002-3450-8801; Heun, Stefan/0000-0003-1989-5679; Hibino, Hiroki/0000-0002-8604-8640; Takamura, Makoto/0000-0002-9454-6754	CNR; Italian Ministry of Foreign Affairs, Direzione Generale per la Promozione del Sistema Paese; European Union [604391]	We acknowledge financial support from the CNR in the framework of the agreement on scientific collaboration between CNR and JSPS (Japan), joint project title 'High-mobility graphene monolayers for novel quantum devices', and from the Italian Ministry of Foreign Affairs, Direzione Generale per la Promozione del Sistema Paese. We also acknowledge funding from the European Union Seventh Framework Programme under Grant Agreement No. 604391 Graphene Flagship.	Sutter P, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245411; Ji SH, 2012, NAT MATER, V11, P114, DOI [10.1038/nmat3170, 10.1038/NMAT3170]; Speck F, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3643034; Forti S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.125449; Goler S, 2013, CARBON, V51, P249, DOI 10.1016/j.carbon.2012.08.050; Riedl C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.246804; Chae SJ, 2009, ADV MATER, V21, P2328, DOI 10.1002/adma.200803016; Wang CG, 2013, PHYS CHEM CHEM PHYS, V15, P2764, DOI 10.1039/c2cp44033d; Low T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.096601; Biedermann LB, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125411; Mashoff T., APPL PHYS L IN PRESS; Murata Y, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.165408; Rhim SH, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4726281; Slawinska J, 2014, CARBON, V74, P146, DOI 10.1016/j.carbon.2014.03.016; Tanabe S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04EN01	15	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	DEC 1	2014	105	22							221604	10.1063/1.4902988		4	Physics, Applied	Physics	AW4QH	WOS:000346265200022		
J	Nouchi, R				Nouchi, Ryo			Experimental signature of bandgap opening in bilayer graphene at metal contacts	APPLIED PHYSICS LETTERS			English	Article								Bilayer graphene (BLG) possesses a finite bandgap when a potential difference is introduced between the two graphene layers. The potential difference is known to be introduced by surface charge transfer. Thus, it is expected that a finite bandgap exists at the metal contacts. The bandgap at the metal-BLG interface can be detected by the superlinear current-voltage characteristics in back-gate field-effect transistors, caused by carriers tunneling through the bandgap. The superlinearity was higher in the positively gated region, attributed to hole doping from the Cr/Au electrodes. The control experiments using single-layer graphene (SLG) did not have a superlinearity, which is consistent with the fact that a sizeable bandgap is not expected at the metal-SLG interface. The opening of a bandgap at the metal-BLG interface is an additional source of electrode-contact resistance. (C) 2014 AIP Publishing LLC.	Osaka Prefecture Univ, Nanosci & Nanotechnol Res Ctr, Sakai, Osaka 5998570, Japan	Nouchi, R (reprint author), Osaka Prefecture Univ, Nanosci & Nanotechnol Res Ctr, Sakai, Osaka 5998570, Japan.	r-nouchi@21c.osakafu-u.ac.jp	Nouchi, Ryo/A-4880-2010		Special Coordination Funds for Promoting Science and Technology; Ministry of Education, Culture, Sports, Science and Technology of Japan [26107531]; JFE 21st Century Foundation	This work was supported in part by the Special Coordination Funds for Promoting Science and Technology, and a Grant-in-Aid for Scientific Research on Innovative Areas (No. 26107531) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and by a Technology Research Grant from the JFE 21st Century Foundation. The graphite crystal used was supplied by M. Murakami and M. Shiraishi.	Berger C, 2006, SCIENCE, V312, P1191, DOI 10.1126/science.1125925; Gunlycke D, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2718515; Di Bartolomeo A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/27/275702; Yu YJ, 2009, NANO LETT, V9, P3430, DOI 10.1021/nl901572a; Sun D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.136802; Min HK, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155115; Mueller T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.245430; Moser J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2898501; Park J, 2012, ADV MATER, V24, P407, DOI 10.1002/adma.201103411; Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803; Hwang EH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.186806; Nouchi R, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.035101; Zhang YB, 2009, NATURE, V459, P820, DOI 10.1038/nature08105; Castro EV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.216802; Nouchi R, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3456383; Barreiro A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.076601; Martin J, 2008, NAT PHYS, V4, P144, DOI 10.1038/nphys781; Ryu S, 2010, NANO LETT, V10, P4944, DOI 10.1021/nl1029607; SIMMONS JG, 1963, J APPL PHYS, V34, P2581, DOI 10.1063/1.1729774; Huard B, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.121402; Nagashio K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.070108; Nouchi R, 2012, J APPL PHYS, V111, DOI 10.1063/1.4705367; Meric I, 2008, NAT NANOTECHNOL, V3, P654, DOI 10.1038/nnano.2008.268; Chen ZH, 2007, PHYSICA E, V40, P228, DOI 10.1016/j.physe.2007.06.020; Oostinga JB, 2008, NAT MATER, V7, P151, DOI 10.1038/nmat2082; Ohta T, 2006, SCIENCE, V313, P951, DOI 10.1126/science.1130681; Ohta T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206802; Golizadeh-Mojarad R, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.085410; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Miyazaki H, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.014708; Miyazaki H, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.034007; Morozov SV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.016602; Nouchi R, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4891428; Perebeinos V, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.195442; Sze S. M., 2007, PHYS SEMICONDUCTOR D; Varykhalov A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.121101; Zhang LM, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.235408; Zheng JX, 2013, SCI REP-UK, V3, DOI 10.1038/srep02081	38	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	DEC 1	2014	105	22							223106	10.1063/1.4903249		5	Physics, Applied	Physics	AW4QH	WOS:000346265200073		
J	Okamoto, H; Kusaka, K; Yamaguchi, K; Ohtsu, T; Haraguchi, M; Okamoto, T				Okamoto, H.; Kusaka, K.; Yamaguchi, K.; Ohtsu, T.; Haraguchi, M.; Okamoto, T.			Self-imaging confirmed in plasmonic channel waveguides at visible wavelengths	APPLIED PHYSICS LETTERS			English	Article							POLARITONS; SPLITTERS	We experimentally confirm self-imaging induced by multi-mode interference of plasmon polaritons in a channel waveguide at visible wavelengths. A designed plasmonic channel waveguide, fabricated as three structural segments at two different channel depths, operates as a single-and multi-mode waveguide. Illuminated by incident light of wavelength 635 nm, the channel plasmon polaritons propagate towards the output port if the length of the multi-mode waveguide is equivalent to twice the beat length for multi-mode interference. If the length of the multi-mode waveguide is equivalent to the beat length, only a few of these plasmon polaritons propagate to the output port as most of them are reflected at the far end of the multi-mode segment of the waveguide. Experimental results enable a clear characterization of self-imaging induced by the multi-mode interference of channel plasmon polaritons. (c) 2014 AIP Publishing LLC.	[Okamoto, H.; Kusaka, K.] Anan Coll, Natl Inst Technol, Anan 7740017, Japan; [Yamaguchi, K.; Ohtsu, T.] Kagawa Univ, Fac Engn, Dept Adv Mat Sci, Takamatsu, Kagawa 7610396, Japan; [Haraguchi, M.; Okamoto, T.] Univ Tokushima, Fac Engn, Dept Opt Sci & Technol, Tokushima 7708506, Japan	Okamoto, H (reprint author), Anan Coll, Natl Inst Technol, Anan 7740017, Japan.	okamoto@anan-nct.ac.jp					JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Oskooi AF, 2010, COMPUT PHYS COMMUN, V181, P687, DOI 10.1016/j.cpc.2009.11.008; Han ZH, 2007, OPT COMMUN, V278, P199, DOI 10.1016/j.optcom.2007.05.058; Tanaka K, 2003, APPL PHYS LETT, V82, P1158, DOI 10.1063/1.1557323; Bozhevolnyi SI, 2006, OPT EXPRESS, V14, P9467, DOI 10.1364/OE.14.009467; Min BK, 2009, NATURE, V457, P455, DOI 10.1038/nature07627; Chen CH, 2013, OPT EXPRESS, V21, P4036, DOI 10.1364/OE.21.004036; Dufaux T, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3503534; Sorger VJ, 2009, NANO LETT, V9, P3489, DOI 10.1021/nl901682n; Tiwari K, 2014, SENSOR ACTUAT A-PHYS, V216, P128, DOI 10.1016/j.sna.2014.05.020; Chandran A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.085416; Zektzer R, 2014, OPT EXPRESS, V22, P22009, DOI 10.1364/OE.22.022009; Hussain FFK, 2014, IEEE J QUANTUM ELECT, V50, DOI 10.1109/JQE.2014.2320700; Kou Y, 2011, OPT EXPRESS, V19, P6042, DOI 10.1364/OE.19.006042; Li J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2936302; Okamoto H, 2012, APPL PHYS B-LASERS O, V108, P149, DOI 10.1007/s00340-012-5081-y; Okamoto H, 2014, PLASMONICS, V9, P1351, DOI 10.1007/s11468-014-9748-6; Okamoto H, 2014, APPL PHYS A-MATER, V115, P19, DOI 10.1007/s00339-013-7955-1; Pluchery O, 2011, EUR J PHYS, V32, P585, DOI 10.1088/0143-0807/32/2/028; Tsai YJ, 2009, OPT EXPRESS, V17, P17471, DOI 10.1364/OE.17.017471	21	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	DEC 1	2014	105	22							221106	10.1063/1.4903177		4	Physics, Applied	Physics	AW4QH	WOS:000346265200006		
J	Qiu, W; Mizuno, Y; Tabaru, M; Nakamura, K				Qiu, Wei; Mizuno, Yosuke; Tabaru, Marie; Nakamura, Kentaro			Can lubricant enhance the torque of ultrasonic motors? An experimental investigation	APPLIED PHYSICS LETTERS			English	Article							EFFICIENCY IMPROVEMENT; DESIGN	Lubrication has been proven to be an effective approach to drastically improve the efficiency of ultrasonic motors without losing the output torque. This phenomenon is attributed to the effective modulation of the friction force by lubricant, according to the theory described in the Stribeck curve. Previous findings even show a potential to increase the motor output torque with lubrication. Here, the torque enhancement of ultrasonic motors using lubricant is extensively studied in hybrid transducer-type ultrasonic motors (HTUSMs) with a size of 25mm in diameter. The lubricated HTUSMs could withstand static preload as high as 267N and maximum torque as large as 1.01N m was obtained with lubrication, which were 3.5 times and 2.6 times higher than those in dry condition, respectively. This result clearly reveals that lubrication can enable ultrasonic motors to be operated under much higher static preload and hence significantly improve the motor output torque, instead of only reducing the friction force. (C) 2014 AIP Publishing LLC.	[Qiu, Wei; Mizuno, Yosuke; Tabaru, Marie; Nakamura, Kentaro] Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Qiu, W (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268503, Japan.	qiu@sonic.pi.titech.ac.jp			Japan Society for the Promotion of Science (JSPS) [26011842]	The work of W. Qiu was supported by a Grant-in-Aid for the research fellow of Japan Society for the Promotion of Science (JSPS) (Grant No. 26011842). The authors are indebted to Professor K. Adachi at Tohoku University, Japan, for his insightful discussion and Idemitsu Kosan Co., Ltd. for providing the lubricant. They also appreciate the staff members of the Precision and Manufacturing Center, Technical Department, Tokyo Institute of Technology, Japan, for machining the metal components of the motor used in the experiment.	Watson B, 2009, SENSOR ACTUAT A-PHYS, V152, P219, DOI 10.1016/j.sna.2009.04.001; NAKAMURA K, 1991, IEEE T ULTRASON FERR, V38, P481, DOI 10.1109/58.84293; NAKAMURA K, 1991, IEEE T ULTRASON FERR, V38, P188, DOI 10.1109/58.79602; Wallaschek J, 1998, SMART MATER STRUCT, V7, P369, DOI 10.1088/0964-1726/7/3/011; Aoyagi M, 1999, JPN J APPL PHYS 1, V38, P3342, DOI 10.1143/JJAP.38.3342; Czichos H., 1978, TRIBOLOGY SYSTEM APP; Glazounov AE, 1999, APPL PHYS LETT, V75, P862, DOI 10.1063/1.124538; Ishii T, 1996, JPN J APPL PHYS 1, V35, P3281, DOI 10.1143/JJAP.35.3281; Ishii T, 1999, JPN J APPL PHYS 1, V38, P3338, DOI 10.1143/JJAP.38.3338; Morita T, 1996, JPN J APPL PHYS 1, V35, P3251, DOI 10.1143/JJAP.35.3251; Nakamura K, 1998, ELECTRON COMM JPN 2, V81, P57, DOI 10.1002/(SICI)1520-6432(199804)81:4<57::AID-ECJB7>3.0.CO;2-2; NAKAMURA K, 1993, IEEE T ULTRASON FERR, V40, P395, DOI 10.1109/58.251288; Qiu W, 2013, IEEE T ULTRASON FERR, V60, P786, DOI 10.1109/TUFFC.2013.2627; Satonobu J, 2000, IEEE T ULTRASON FERR, V47, P216, DOI 10.1109/58.818764; Uchino K, 1998, SMART MATER STRUCT, V7, P273, DOI 10.1088/0964-1726/7/3/002; Uchino K., 1992, PIEZOELECTRIC ACTUAT; Ueha S., 1993, ULTRASONIC MOTORS TH	17	1	1	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	DEC 1	2014	105	22							224102	10.1063/1.4903238		4	Physics, Applied	Physics	AW4QH	WOS:000346265200105		
J	Takahashi, M; Ohnishi, N				Takahashi, Masayuki; Ohnishi, Naofumi			Computational studies for plasma filamentation by magnetic field in atmospheric microwave discharge	APPLIED PHYSICS LETTERS			English	Article							PROPAGATION; FRONTS	Plasma filamentation is induced by an external magnetic field in an atmospheric discharge using intense microwaves. A discrete structure is obtained at low ambient pressure if a strong magnetic field of more than 1 T is applied, due to the suppression of electron diffusion, whereas a diffusive pattern is generated with no external field. Applying a magnetic field can slow the discharge front propagation due to magnetic confinement of the electron transport. If the resonance conditions are satisfied for electron cyclotron resonance and its higher harmonics, the propagation speed increases because the heated electrons easily ionize neutral particles. The streamer velocity and the pattern of the microwave plasma are positively controlled by adjusting two parameters-the electron diffusion coefficient and the ionization frequency-through the resonance process and magnetic confinement, and hot, dense filamentary plasma can be concentrated in a compact volume to reduce energy loss in a plasma device like a microwave rocket. (C) 2014 AIP Publishing LLC.	[Takahashi, Masayuki; Ohnishi, Naofumi] Tohoku Univ, Dept Aerosp Engn, Sendai, Miyagi 9808579, Japan	Takahashi, M (reprint author), Tohoku Univ, Dept Aerosp Engn, Sendai, Miyagi 9808579, Japan.				JSPS KAKENHI [13J05089]	The computations in this work were performed on Silicon Graphics International (SGI) Altix UV1000 at Advanced Fluid Information Research Center, Institute of Fluid Science, Tohoku University. This work was supported by JSPS KAKENHI Grant Number 13J05089.	Chaudhury B, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3517177; Hidaka Y, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3083218; BIRDSALL CK, 1991, IEEE T PLASMA SCI, V19, P65, DOI 10.1109/27.106800; Boeuf JP, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.015002; Nam SK, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.055004; MARDER B, 1987, J COMPUT PHYS, V68, P48, DOI 10.1016/0021-9991(87)90043-X; Ebert U, 1997, PHYS REV E, V55, P1530, DOI 10.1103/PhysRevE.55.1530; Zhou QH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3583452; Oda Y, 2006, J APPL PHYS, V100, DOI 10.1063/1.2399899; Hidaka Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.035003; WOO W, 1984, PHYS FLUIDS, V27, P475, DOI 10.1063/1.864645; Cook A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462320; Brodskii Yu. Ya., 1983, Soviet Physics - JETP, V57; Ebert U, 1996, PHYS REV LETT, V77, P4178, DOI 10.1103/PhysRevLett.77.4178; Li C, 2007, J APPL PHYS, V101, DOI 10.1063/1.2748673; MUR G, 1981, IEEE T ELECTROMAGN C, V23, P377, DOI 10.1109/TEMC.1981.303970; Oda Y., 2008, THESIS U TOKYO; Raizer Y P, 1991, GAS DISCHARGE PHYS; Vikharev A. L., 1988, Soviet Physics - JETP, V67	19	0	0	AMER INST PHYSICS	MELVILLE	CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	DEC 1	2014	105	22							223504	10.1063/1.4903232		5	Physics, Applied	Physics	AW4QH	WOS:000346265200088		
J	Yamaguchi, T; Moriya, R; Inoue, Y; Morikawa, S; Masubuchi, S; Watanabe, K; Taniguchi, T; Machida, T				Yamaguchi, Takehiro; Moriya, Rai; Inoue, Yoshihisa; Morikawa, Sei; Masubuchi, Satoru; Watanabe, Kenji; Taniguchi, Takashi; Machida, Tomoki			Tunneling transport in a few monolayer-thick WS2/graphene heterojunction	APPLIED PHYSICS LETTERS			English	Article							LAYERED MATERIALS; HETEROSTRUCTURES; ELECTRONICS; GRAPHENE; TRANSISTORS; DICHALCOGENIDES; FILMS; MOS2	This paper demonstrates the high-quality tunnel barrier characteristics and layer number controlled tunnel resistance of a transition metal dichalcogenide (TMD) measuring just a few monolayers in thickness. Investigation of vertical transport in WS2 and MoS2 TMDs in graphene/TMD/metal heterostructures revealed that WS2 exhibits tunnel barrier characteristics when its thickness is between 2 and 5 monolayers, whereas MoS2 experiences a transition from tunneling to thermionic emission transport with increasing thickness within the same range. Tunnel resistance in a graphene/WS2/metal heterostructure therefore increases exponentially with the number of WS2 layers, revealing the tunnel barrier height of WS2 to be 0.37 eV. (C) 2014 AIP Publishing LLC.	[Yamaguchi, Takehiro; Moriya, Rai; Inoue, Yoshihisa; Morikawa, Sei; Masubuchi, Satoru; Machida, Tomoki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Masubuchi, Satoru; Machida, Tomoki] Univ Tokyo, Inst Nano Quantum Informat Elect, Meguro Ku, Tokyo 1538505, Japan; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan	Moriya, R (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	moriyar@iis.u-tokyo.ac.jp; tmachida@iis.u-tokyo.ac.jp	WATANABE, Kenji/H-2825-2011; 	WATANABE, Kenji/0000-0003-3701-8119; Moriya, Rai/0000-0001-7471-7432	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports and Technology (MEXT)	This work was partly supported by a Grant-in-Aid for Scientific Research into the Science of Atomic Layers from the Japan Society for the Promotion of Science (JSPS), and a Grant-in-Aid for Scientific Research into Innovative Areas and Project for Developing Innovation Systems from the Ministry of Education, Culture, Sports and Technology (MEXT). S. Morikawa acknowledges the JSPS Research Fellowship for Young Scientists.	Das S, 2014, ACS NANO, V8, P1681, DOI 10.1021/nn406603h; Walia S, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4840317; Liu Y, 2014, NANO LETT, V14, P1413, DOI 10.1021/nl404484s; Yu WJ, 2013, NAT MATER, V12, P246, DOI [10.1038/nmat3518, 10.1038/NMAT3518]; Yu YJ, 2009, NANO LETT, V9, P3430, DOI 10.1021/nl901572a; Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Das S, 2013, NANO LETT, V13, P100, DOI 10.1021/nl303583v; Britnell L, 2013, SCIENCE, V340, P1311, DOI 10.1126/science.1235547; Georgiou T, 2013, NAT NANOTECHNOL, V8, P100, DOI [10.1038/nnano.2012.224, 10.1038/NNANO.2012.224]; Myoung N, 2013, ACS NANO, V7, P7021, DOI 10.1021/nn402919d; Yu WJ, 2013, NAT NANOTECHNOL, V8, P952, DOI [10.1038/nnano.2013.219, 10.1038/NNANO.2013.219]; Jiang H, 2012, J PHYS CHEM C, V116, P7664, DOI 10.1021/jp300079d; Yamaguchi T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.073001; Kosmider K, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.075451; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; SIMMONS JG, 1963, J APPL PHYS, V34, P2581, DOI 10.1063/1.1729774; Moriya R, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4894256; Novoselov KS, 2011, REV MOD PHYS, V83, P837, DOI 10.1103/RevModPhys.83.837; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Britnell L, 2012, NANO LETT, V12, P1707, DOI 10.1021/nl3002205; MICHAELSON HB, 1977, J APPL PHYS, V48, P4729, DOI 10.1063/1.323539; Zhao WJ, 2013, NANO LETT, V13, P5627, DOI 10.1021/nl403270k; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Taychatanapat T, 2011, NAT PHYS, V7, P621, DOI [10.1038/nphys2008, 10.1038/NPHYS2008]; Lee GH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662043; Peelaers H, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.241401; SIMMONS JG, 1964, J APPL PHYS, V35, P2655, DOI 10.1063/1.1713820; STRATTON R, 1962, J PHYS CHEM SOLIDS, V23, P1177, DOI 10.1016/0022-3697(62)90165-8	28	4	4	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0003-6951	1077-3118		APPL PHYS LETT	Appl. Phys. Lett.	DEC 1	2014	105	22							223109	10.1063/1.4903190		4	Physics, Applied	Physics	AW4QH	WOS:000346265200076		
J	Usuki, Y; Wakamatsu, Y; Yabu, M; Iio, H				Usuki, Yoshinosuke; Wakamatsu, Yosuke; Yabu, Minoru; Iio, Hideo			Access to Fluorine-Containing Asparagine and Glutamine Analogues via Palladium-Catalyzed Formate Reduction	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						asparagine; fluorine; formate reduction; glutamine; palladium	DIPEPTIDE ISOSTERES; STEREOSELECTIVE-SYNTHESIS; PEPTIDE ISOSTERES; ACIDS; CONFORMATIONS; FLUOROOLEFINS; DERIVATIVES	A synthesis of fluorine-containing asparagine and glutamine analogues via palladium-catalyzed formate reduction of fluorinated carbonate esters is described. Primary amide moieties at the side-chain of asparagine and glutamine were successfully replaced with fluoroolefins, which are proposed to be aprotic mimics for amides due to their electronic properties.	[Usuki, Yoshinosuke; Wakamatsu, Yosuke; Yabu, Minoru; Iio, Hideo] Osaka City Univ, Grad Sch Sci, Div Mol Mat Sci, Sumiyoshi Ku, Osaka 5588585, Japan	Usuki, Y (reprint author), Osaka City Univ, Grad Sch Sci, Div Mol Mat Sci, Sumiyoshi Ku, 3-3-138 Sugimoto, Osaka 5588585, Japan.	usuki@sci.osaka-cu.ac.jp	Usuki, Yoshinosuke/J-8374-2015	Usuki, Yoshinosuke/0000-0003-2308-8693			ABRAHAM RJ, 1986, TETRAHEDRON, V42, P2101, DOI 10.1016/S0040-4020(01)87627-4; ALLMENDINGER T, 1990, TETRAHEDRON LETT, V31, P7301, DOI 10.1016/S0040-4039(00)88549-4; Konno T, 2006, J ORG CHEM, V71, P3545, DOI 10.1021/jo0602120; Couve-Bonnaire S, 2007, ORG BIOMOL CHEM, V5, P1151, DOI 10.1039/b701559c; LIU DTY, 1992, TRENDS BIOTECHNOL, V10, P364, DOI 10.1016/0167-7799(92)90269-2; Dutheuil G, 2007, ANGEW CHEM INT EDIT, V46, P1290, DOI 10.1002/anie.200604246; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Fujii K, 1997, ANAL CHEM, V69, P5146, DOI 10.1021/ac970289b; Oishi S, 2009, ORG BIOMOL CHEM, V7, P2872, DOI 10.1039/b907983a; Laue KW, 1999, TETRAHEDRON, V55, P10413, DOI 10.1016/S0040-4020(99)00581-5; Asakura N, 2003, J FLUORINE CHEM, V124, P81, DOI 10.1016/S0022-1139(03)00194-5; Asakura N, 2006, J FLUORINE CHEM, V127, P800, DOI 10.1016/j.jfluchem.2006.02.016; BOLD G, 1992, HELV CHIM ACTA, V75, P865, DOI 10.1002/hlca.19920750321; BOROS LG, 1994, TETRAHEDRON LETT, V35, P6033, DOI 10.1016/0040-4039(94)88067-0; Dutheuil G., 2007, ANGEW CHEM, V119, P1312, DOI 10.1002/ange.200604246; Hansen Jr D. W., 2001, PCT Int. Appl., Patent No. [WO 2001078654 A2 20011025, 2001078654]; Hayashi T, 2010, SYNLETT, P2843, DOI 10.1055/s-0030-1259013; Hayashi T, 2010, J FLUORINE CHEM, V131, P709, DOI 10.1016/j.jfluchem.2010.03.005; Hollenstein M, 2005, J ORG CHEM, V70, P3205, DOI 10.1021/jo047753e; Jakobsche CE, 2008, ANGEW CHEM INT EDIT, V47, P6707, DOI 10.1002/anie.200802223; Jakobsche C. E., 2008, ANGEW CHEM, V120, P6809, DOI 10.1002/ange.200802223; Kukhar V. P., 1995, FLUORINE CONTAING AM; Lubke M, 2013, J FLUORINE CHEM, V152, P144, DOI 10.1016/j.jfluchem.2013.03.011; Nakamura Y, 2005, TETRAHEDRON, V61, P5741, DOI 10.1016/j.tet.2005.04.034; Otaka A, 2001, TETRAHEDRON LETT, V42, P5443, DOI 10.1016/S0040-4039(01)01010-3; Paintner FF, 2005, ORG LETT, V7, P1423, DOI 10.1021/ol0503182; Taguchi T., 2009, FLUORINE MED CHEM CH, P257, DOI 10.1002/9781444312096.ch10; Takeuchi Y, 1996, TETRAHEDRON, V52, P225, DOI 10.1016/0040-4020(95)00910-Z; TSUJI J, 1984, CHEM LETT, P1017, DOI 10.1246/cl.1984.1017; Welch J. T., 1991, ACS SYMPOSIUM SERIES, V456; Yagupolskii L. M., 1993, ORGANOFLUORINE COMPO; Yamaki Y, 2009, J ORG CHEM, V74, P3272, DOI 10.1021/jo900134k; Yanai H, 2011, EUR J ORG CHEM, P5939, DOI 10.1002/ejoc.201100495	33	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	DEC	2014	3	12					1270	1272		10.1002/ajoc.201402164		3	Chemistry, Organic	Chemistry	AW1TN	WOS:000346073200004		
J	Nishikawa, T; Wang, C; Akimoto, T; Koshino, H; Nagasawa, K				Nishikawa, Toru; Wang, Chao; Akimoto, Takafumi; Koshino, Hiroyuki; Nagasawa, Kazuo			Synthesis of an Advanced Model of Zetekitoxin AB Focusing on the N-Acylisoxazolidine Amide Structure Corresponding to C13-C17	ASIAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						2-azaadamantane N-oxyl; N-acylisoxazolidines; saxitoxin; structure elucidation; zetekitoxin AB	FROG ATELOPUS-ZETEKI; SODIUM-CHANNEL; SAXITOXIN DERIVATIVES; INHIBITORY-ACTIVITY; TOXINS; SHELLFISH; OXIDATION; ALCOHOLS; ANALOGS; SKIN	Zetekitoxin AB (ZTX) is a neurotoxin bearing a saxitoxin core structure together with a characteristic nine-membered macrocyclic lactam involving a N-acylisoxazolidine moiety and a N-hydroxylcarbonylmethyl group. We describe a synthesis of an advanced model for ZTX bearing saxitoxin core structure with N-acylisoxazolidine moiety, i.e., C13-C17. In this synthesis, the isoxazolidine amide moiety of a ZTX analogue was constructed by reaction of an isoxazolidine with the carboxylic acid at C13 of STX, which was obtained by oxidation of the axially oriented alcohol at C13 2-azaadamantane N-oxyl (AZADO) in the presence of NaClO and NaClO2. The C-13 NMR signal of C13 in the resulting ZTX analogue was discussed by comparison with the reported spectral data for natural product of ZTX.	[Nishikawa, Toru; Wang, Chao; Akimoto, Takafumi; Nagasawa, Kazuo] Tokyo Univ Agr & Technol, Dept Engn Biotechnol & Life Sci, Koganei, Tokyo 1848588, Japan; [Koshino, Hiroyuki] RIKEN, Global Res Cluster, Wako, Saitama 3510198, Japan	Nagasawa, K (reprint author), Tokyo Univ Agr & Technol, Dept Engn Biotechnol & Life Sci, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	knaga@cc.tuat.ac.jp	Nagasawa, Kazuo/B-9959-2013; Koshino, Hiroyuki/N-7948-2015		JSPS [24651258]; JSPS Predoctoral Fellowships for Young Scientists	This study was supported in part by a Grant-in-Aid for Challenging Exploratory Research from JSPS (no. 24651258). T.A. is grateful for financial support from JSPS Predoctoral Fellowships for Young Scientists. We would like to dedicate this article to celebrate the 20th anniversary of the Department of Biotechnology and Life Science at Tokyo University of Agriculture and Technology.	Shinohara R, 2011, CHEM-EUR J, V17, P12144, DOI 10.1002/chem.201101058; Nishikawa T, 2009, HETEROCYCLES, V79, P379, DOI 10.3987/COM-08-S(D)44; Thottumkara AP, 2014, ANGEW CHEM INT EDIT, V53, P5760, DOI 10.1002/anie.201308235; Akimoto T, 2013, ORG BIOMOL CHEM, V11, P6642, DOI 10.1039/c3ob41398e; Yotsu-Yamashita M, 2004, P NATL ACAD SCI USA, V101, P4346, DOI 10.1073/pnas.0400368101; GENENAH AA, 1981, J AGR FOOD CHEM, V29, P1289, DOI 10.1021/jf00108a047; SCHANTZ EJ, 1975, J AM CHEM SOC, V97, P1238, DOI 10.1021/ja00838a045; Llewellyn L, 2004, TOXICON, V43, P101, DOI 10.1016/j.toxicon.2003.10.016; FUHRMAN FA, 1969, SCIENCE, V165, P1376, DOI 10.1126/science.165.3900.1376; Iwamoto O, 2010, ORG LETT, V12, P2150, DOI 10.1021/ol1006696; Shibuya M, 2006, J AM CHEM SOC, V128, P8412, DOI 10.1021/ja0620336; Llewellyn LE, 2006, NAT PROD REP, V23, P200, DOI 10.1039/b501296c; Kunishima M, 2001, TETRAHEDRON, V57, P1551, DOI 10.1016/S0040-4020(00)01137-6; BORDNER J, 1975, J AM CHEM SOC, V97, P6008, DOI 10.1021/ja00854a009; KOEHN FE, 1981, BIOORG CHEM, V10, P412, DOI 10.1016/0045-2068(81)90053-5; BROWN GB, 1977, TOXICON, V15, P115, DOI 10.1016/0041-0101(77)90030-7; Iwamoto O, 2007, ANGEW CHEM INT EDIT, V46, P8625, DOI 10.1002/anie.200703326; Iwamoto O, 2009, CHEM-ASIAN J, V4, P277, DOI 10.1002/asia.200800382; Iwamoto O, 2012, PURE APPL CHEM, V84, P1445, DOI 10.1351/PAC-CON-11-09-10; Iwamoto O, 2006, HETEROCYCLES, V70, P107; Iwamoto O., 2007, ANGEW CHEM, V119, P8779, DOI 10.1002/ange.200703326; MOCZYDLOWSKI E, 1984, J GEN PHYSIOL, V84, P687, DOI 10.1085/jgp.84.5.687; Onodera Hideyuki, 1997, Natural Toxins, V5, P146; Oshima Y, 1995, MANUAL HARMFUL MARIN, P81; Shibuya M, 2009, CHEM COMMUN, P1739, DOI 10.1039/b822944a; SULLIVAN JJ, 1985, J FOOD SCI, V50, P26, DOI 10.1111/j.1365-2621.1985.tb13269.x; Usup G, 2004, TOXICON, V44, P37, DOI 10.1016/j.toxicon.2004.03.026; WICHMANN CE, 1981, J AM CHEM SOC, V103, P6977, DOI 10.1021/ja00413a042	28	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2193-5807	2193-5815		ASIAN J ORG CHEM	Asian J. Org. Chem.	DEC	2014	3	12					1308	1311		10.1002/ajoc.201402206		4	Chemistry, Organic	Chemistry	AW1TN	WOS:000346073200010		
J	Yamagishi, K; Ikeda, A; Moriyama, Y; Chei, CL; Noda, H; Umesawa, M; Cui, R; Nagao, M; Kitamura, A; Yamamoto, Y; Asada, T; Iso, H				Yamagishi, Kazumasa; Ikeda, Ai; Moriyama, Yuri; Chei, Choy-Lye; Noda, Hiroyuki; Umesawa, Mitsumasa; Cui, Renzhe; Nagao, Masanori; Kitamura, Akihiko; Yamamoto, Yorihiro; Asada, Takashi; Iso, Hiroyasu		CIRCS Investigators	Serum coenzyme Q10 and risk of disabling dementia: The Circulatory Risk in Communities Study (CIRCS)	ATHEROSCLEROSIS			English	Article						Coenzyme Q10; Antioxidant; Dementia; Epidemiology; Follow-up study	AGED TRANSGENIC MICE; FRIEDREICHS-ATAXIA; AMYLOID PATHOLOGY; DISEASE; Q(10); HYPERTENSION; PLASMA; TRIAL	Objective: To examine whether coenzyme Q10, a potent antioxidant, is associated with risk of dementia, which has not yet been elucidated. Approach and results: We performed a case control study nested in a community-based cohort of approximately 6000 Japanese aged 40-69 years at baseline (1984-1994). Serum coenzyme Q10 was measured in 65 incident cases of disabling dementia with dementia-related behavioral disturbance or cognitive impairment incident between 1999 and 2004, and in 130 age-, sex- and baseline year-matched controls. Serum coenzyme Q10 was inversely associated with dementia: the multivariate odds ratios (95% confidence intervals) were 0.68 (0.26-1.78), 0.92 (0.33-2.56), and 0.23 (0.06-0.86) for individuals with the second, third, and highest quartiles of coenzyme Q10, respectively, as compared with the lowest quartile (P for trend = 0.05). A similar association was found for the coenzyme Q10/total cholesterol ratio: the respective ORs were 0.67 (0.25-1.78), 0.73 (0.28-1.92), and 0.21 (0.05-0.90) (P for trend = 0.04). Conclusions: Serum coenzyme Q10 levels were inversely associated with risk of disabling dementia. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Yamagishi, Kazumasa; Chei, Choy-Lye; Umesawa, Mitsumasa] Univ Tsukuba, Fac Med, Dept Publ Hlth Med, Tsukuba, Ibaraki 3058575, Japan; [Asada, Takashi] Univ Tsukuba, Fac Med, Dept Psychiat, Tsukuba, Ibaraki 3058575, Japan; [Yamagishi, Kazumasa; Kitamura, Akihiko] Osaka Ctr Canc, Osaka, Japan; [Ikeda, Ai] Juntendo Univ, Dept Publ Hlth, Tokyo, Japan; [Moriyama, Yuri; Noda, Hiroyuki; Cui, Renzhe; Nagao, Masanori; Kitamura, Akihiko; Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Social Med, Suita, Osaka, Japan; [Chei, Choy-Lye] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore; [Umesawa, Mitsumasa; Nagao, Masanori] Dokkyo Med Univ, Dept Publ Hlth, Mibu, Tochigi, Japan; [Yamamoto, Yorihiro] Tokyo Univ Technol, Sch Biosci & Biotechnol, Hachioji, Tokyo, Japan	Yamagishi, K (reprint author), Univ Tsukuba, Fac Med, Dept Publ Hlth Med, Tennodai 1-1-1, Tsukuba, Ibaraki 3058575, Japan.	yamagishi.kazumas.ge@u.tsukuba.ac.jp		Iso, Hiroyasu/0000-0002-9241-7289	Health and Labour Science Research Grants for Dementia, Ministry of Health, Labour and Welfare, Japan [H21-Ninchisho-Wakate-007, H24-Ninchisho-Wakate-003]	The authors thank Kimiko Yokota, Yumi Shiina, Miyuki Hori, Tomoko Tanaka, and Kumi Otsuka, for technical assistance. We also thank Ms Flaminia Miyamasu, Medical English Communications Center, University of Tsukuba, for editorial assistance. This work was supported by Health and Labour Science Research Grants for Dementia (H21-Ninchisho-Wakate-007, 2009-2012, and H24-Ninchisho-Wakate-003, 2012-2015), Ministry of Health, Labour and Welfare, Japan. We have no potential conflicts of interest to declare. The full list of CIRCS investigators is presented in reference [13].	Ishrat T, 2006, BEHAV BRAIN RES, V171, P9, DOI 10.1016/j.bbr.2006.03.009; Feigin A, 1996, MOVEMENT DISORD, V11, P321, DOI 10.1002/mds.870110317; Galasko DR, 2012, ARCH NEUROL-CHICAGO, V69, P836, DOI 10.1001/archneurol.2012.85; [Anonymous], 1991, LAW MED HLTH CARE, V19, P247; Yang XF, 2008, J MOL NEUROSCI, V34, P165, DOI 10.1007/s12031-007-9033-7; Rosenfeldt F, 2003, BIOFACTORS, V18, P91; Yamashita S, 1997, ANAL BIOCHEM, V250, P66, DOI 10.1006/abio.1997.2187; Dumont M, 2011, J ALZHEIMERS DIS, V27, P211, DOI 10.3233/JAD-2011-110209; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Burke BE, 2001, SOUTHERN MED J, V94, P1112; Li G, 2008, BIOFACTORS, V32, P169; Block G, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-30; Cooper JM, 2003, BIOFACTORS, V18, P163; Ikeda A, 2008, CEREBROVASC DIS, V25, P324, DOI 10.1159/000118377; Imano H, 2012, PREV MED, V55, P603, DOI 10.1016/j.ypmed.2012.09.013; Kaikkonen J, 1999, SCAND J CLIN LAB INV, V59, P457; Lodi R, 2002, FREE RADICAL RES, V36, P461, DOI 10.1080/10715760290021324; Nakamura Masakazu, 2003, J Atheroscler Thromb, V10, P145	18	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	DEC	2014	237	2					400	403		10.1016/j.atherosclerosis.2014.09.017		4	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AW1RG	WOS:000346066600033		
J	Kaida, H; Tahara, N; Tahara, A; Honda, A; Nitta, Y; Igata, S; Ishibashi, M; Yamagishi, S; Fukumoto, Y				Kaida, Hayato; Tahara, Nobuhiro; Tahara, Atsuko; Honda, Akihiro; Nitta, Yoshikazu; Igata, Sachiyo; Ishibashi, Masatoshi; Yamagishi, Sho-ichi; Fukumoto, Yoshihiro			Positive correlation between malondialdehyde-modified low-density lipoprotein cholesterol and vascular inflammation evaluated by F-18-FDG PET/CT	ATHEROSCLEROSIS			English	Article						F-18-FDG PET/CT; Vascular inflammation; MDA-LDL; hsCRP; ADMA	POSITRON-EMISSION-TOMOGRAPHY; CORONARY-ARTERY DISEASES; C-REACTIVE PROTEIN; MODIFIED LDL; PLAQUE INFLAMMATION; METABOLIC SYNDROME; OXIDIZED LDL; DAL-PLAQUE; ATHEROSCLEROSIS; SERUM	Objective: The purpose of this study was to investigate the relationship between serum levels of malondialdehyde-modified low-density lipoprotein cholesterol (MDA-LDL) and vascular inflammation evaluated by fluorine-18 fluorodeoxyglucose (F-18-FDG) positron emission tomography/computed tomography (PET/CT). Methods/results: The study involved 106 consecutive patients (75 males and 31 female, mean age 62.5 +/- 7.7 years) who visited our hospital for cardiovascular risk screening and underwent carotid ultrasonography, F-18-FDG PET/CT, complete history, physical examinations, and determination of blood chemistry including high-sensitivity C-reactive protein (hsCRP), asymmetric dimethylarginine (ADMA), and MDA-LDL. Vascular inflammation, was measured as blood-normalized standardized 18F-FDG uptake value, known as the target-to-background ratio (TBR) of carotid arteries. Univariate and multiple stepwise regression analyses were performed for determining independent correlates of carotid TBR values. Median MDA-LDL, mean carotid TBR values and carotid intima-media thickness (IMT) were 127.5 (IQR 92.0-147.8) U/l, 1.55 +/- 0.22, and 0.72 +/- 0.15 mm, respectively. Univariate analysis revealed that carotid TBR values positively correlated with MDA-LDL (p = 0.043) and carotid IMT (p = 0.049). Multiple stepwise regression analysis demonstrated that MDA-LDL (p = 0.043) and carotid IMT (p = 0.038) were independently associated with carotid TBR values. Conclusion: The present study reveals that serum levels of MDA-LDL are independently associated with vascular inflammation evaluated by F-18-FDG PET/CT. Circulating MDA-LDL may be a more useful clinical biomarker for vascular inflammation within the atherosclerotic plaques than hsCRP or ADMA. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kaida, Hayato; Ishibashi, Masatoshi] Kurume Univ, Sch Med, PET Ctr, Div Nucl Med, Kurume, Fukuoka 830, Japan; [Kaida, Hayato; Ishibashi, Masatoshi] Kurume Univ, Sch Med, Dept Radiol, Kurume, Fukuoka 830, Japan; [Tahara, Nobuhiro; Tahara, Atsuko; Honda, Akihiro; Nitta, Yoshikazu; Igata, Sachiyo; Fukumoto, Yoshihiro] Kurume Univ, Sch Med, Dept Med, Div Cardiovasc Med, Kurume, Fukuoka 8300011, Japan; [Yamagishi, Sho-ichi] Kurume Univ, Sch Med, Dept Pathophysiol & Therapeut Diabet Vasc Complic, Kurume, Fukuoka 830, Japan	Tahara, N (reprint author), 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	hayato@med.kurume-u.ac.jp; ntahara@med.kurume-u.ac.jp			JSPS KAKENHI [21791225, 23591072]	The authors thank Kouichi Nitta (Hitachi-Medical Co.) and radiation technologists at Kurume University Hospital for their excellent technical assistance. They would also like to thank Yuri Nishino, Mami Nakayama, Miho Nakao-Kogure, Katsue Shiramizu, Miyuki Nishikata and Makiko Kiyohiro for their efforts. This work was supported by JSPS KAKENHI grant numbers 21791225 (HK) and 23591072 (NT).	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Rudd JHF, 2009, CIRC-CARDIOVASC IMAG, V2, P107, DOI 10.1161/CIRCIMAGING.108.811752; Noh TS, 2013, J NUCL MED, V54, P2070, DOI 10.2967/jnumed.113.119602; Tahara N, 2010, JACC-CARDIOVASC IMAG, V3, P1219, DOI 10.1016/j.jcmg.2010.09.015; KOTANI K, 1994, BBA-LIPID LIPID MET, V1215, P121, DOI 10.1016/0005-2760(94)90100-7; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Fayad ZA, 2011, LANCET, V378, P1547, DOI 10.1016/S0140-6736(11)61383-4; Kondo A, 2001, CLIN CHEM, V47, P893; Galle J, 2006, ATHEROSCLEROSIS, V185, P219, DOI 10.1016/j.atherosclerois.2005.10.005; Ishii H, 2010, CLIN THER, V32, P2337, DOI 10.1016/j.clinthera.2010.12.001; Fuster D, 2008, J CLIN ONCOL, V26, P4746, DOI 10.1200/JCO.2008.17.1496; Nakajima K, 2006, CLIN CHIM ACTA, V367, P36, DOI 10.1016/j.cca.2005.12.013; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; Tawakol A, 2005, J NUCL CARDIOL, V12, P294, DOI 10.1016/j.nuclcard.2005.03.002; Tahara N, 2007, EUR HEART J, V28, P2243, DOI 10.1093/eurheartj/ehm245; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; Tanaga K, 2002, ARTERIOSCL THROM VAS, V22, P662, DOI 10.1161/01.ATV.0000012351.63938.84; Tahara N, 2009, J NUCL MED, V50, P331, DOI 10.2967/jnumed.108.060376; Tahara N, 2007, J AM COLL CARDIOL, V49, P1533, DOI 10.1016/j.jacc.2006.11.046; Tahara N, 2012, DIABETES CARE, V35, P2618, DOI 10.2337/dc12-0087; Rudd JHF, 2002, CIRCULATION, V105, P2708, DOI 10.1161/01.CIR.0000020548.60110.76; Lardinois D, 2003, NEW ENGL J MED, V348, P2500, DOI 10.1056/NEJMoa022136; Tawakol A, 2006, J AM COLL CARDIOL, V48, P1818, DOI 10.1016/j.jacc.2006.05.076; Libby P, 2002, NATURE, V420, P868, DOI 10.1038/nature01323; Miyazaki T, 2005, ATHEROSCLEROSIS, V179, P139, DOI 10.1016/j.atherosclerosis.2004.09.013; Ehara S, 2001, CIRCULATION, V103, P1955; Duivenvoorden R, 2013, JACC-CARDIOVASC IMAG, V6, P1087, DOI 10.1016/j.jcmg.2013.03.009; Ehara S, 2002, J DIABETES COMPLICAT, V16, P60, DOI 10.1016/S1056-8727(01)00210-0; Hanada N, 1990, STROKE, V21, P1567; Krempl TK, 2005, EUR HEART J, V26, P1846, DOI 10.1093/eurheartj/ehi287; Mizuno T, 2004, INT J CARDIOL, V97, P455, DOI 10.1016/j.ijcard.2003.10.035; Roger VS, 2011, CIRCULATION, V123, pe1; Rudd JH, 2009, J AM COLL CARDIOL, V23, P2527; Saam T, 2010, EUR J NUCL MED MOL I, V37, P1203, DOI 10.1007/s00259-010-1432-2; Shiraki R, 2006, LIFE SCI, V80, P59, DOI 10.1016/j.lfs.2006.08.027; Yamagishi S, 2007, INT J CARDIOL, V118, P270, DOI 10.1016/j.ijcard.2006.06.058	36	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	DEC	2014	237	2					404	409		10.1016/j.atherosclerosis.2014.10.001		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AW1RG	WOS:000346066600034		
J	Momiyama, Y				Momiyama, Yukihiko			Serum coenzyme Q10 levels as a predictor of dementia in a Japanese general population	ATHEROSCLEROSIS			English	Editorial Material						Antioxidants; Coenzyme Q10; Dementia	ALZHEIMERS-DISEASE; AMYLOID PATHOLOGY; OXIDATIVE STRESS; TRANSGENIC MICE; ANTIOXIDANTS; BRAIN; Q(10)	Mitochondrial impairment and increased oxidative stress are considered to be involved in the pathogenesis of neurodegenerative diseases, such as Alzheimer's disease. Coenzyme Q10 (CoQ10) is a component of the electron transport chain localized on the inner membrane of the mitochondria. In addition to its bioenergetic activity required for ATP synthesis, CoQ10 also has antioxidant activity in mitochondrial and lipid membranes, which protects against the reactive oxidative species generated during oxidative phosphorylation. Several previous studies had reported no significant differences in serum CoQ10 levels between patients with and without dementia, such as Alzheimer's disease. However, in this issue of Atherosclerosis, Yamagishi et al. demonstrate for the first time that a lower serum CoQ10 level is associated with a greater risk of dementia in a Japanese general population. These findings suggest that assessing serum CoQ10 levels could be useful for predicting the development of dementia, rather than as a biomarker for the presence of dementia. (C) 2014 Published by Elsevier Ireland Ltd.	Natl Hosp Org, Tokyo Med Ctr, Dept Cardiol, Meguro Ku, Tokyo 1528902, Japan	Momiyama, Y (reprint author), Natl Hosp Org, Tokyo Med Ctr, Dept Cardiol, Meguro Ku, 2-5-1 Higashigaoka, Tokyo 1528902, Japan.	ymomiyamajp@gmail.com					Elipenahli C, 2012, J ALZHEIMERS DIS, V28, P173, DOI 10.3233/JAD-2011-111190; von Arnim CAF, 2012, J ALZHEIMERS DIS, V31, P717, DOI 10.3233/JAD-2012-120634; Ferreira IL, 2010, CURR DRUG TARGETS, V11, P1193; Molina JA, 2002, J NEURAL TRANSM, V109, P1195, DOI 10.1007/s00702-001-0761-5; Galasko DR, 2012, ARCH NEUROL-CHICAGO, V69, P836, DOI 10.1001/archneurol.2012.85; SODERBERG M, 1992, J NEUROCHEM, V59, P1646; Pratico D, 2002, ARCH NEUROL-CHICAGO, V59, P972, DOI 10.1001/archneur.59.6.972; Yang XF, 2008, J MOL NEUROSCI, V34, P165, DOI 10.1007/s12031-007-9033-7; Polidori MC, 2004, DEMENT GERIATR COGN, V18, P265, DOI 10.1159/000080027; Jomova K, 2010, MOL CELL BIOCHEM, V345, P91, DOI 10.1007/s11010-010-0563-x; Dumont M, 2011, J ALZHEIMERS DIS, V27, P211, DOI 10.3233/JAD-2011-110209; Choi H, 2013, NEUROTOXICOLOGY, V33, P85; de Bustos F, 2000, J NEURAL TRANSM, V107, P233, DOI 10.1007/s007020050019; Giavarotti L., 2013, OXID MED CELL LONGEV, V2013; Langedijk J, 1996, J LIPID RES, V37, P67; Linnane AW, 2007, MITOCHONDRION, V7, pS51, DOI 10.1016/j.mito.2007.03.005; Sharma LK, 2009, CURR MED CHEM, V16, P1266; YaAtamna H, 2007, MITOCHONDRION, V7, P297; Yamagishi K, 2014, ATHEROSCLEROSIS, V237, P400, DOI 10.1016/j.atherosclerosis.2014.09.017	19	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	DEC	2014	237	2					433	434		10.1016/j.atherosclerosis.2014.08.056		2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AW1RG	WOS:000346066600038		
J	Yoshiyama, S; Chen, ZY; Okagaki, T; Kohama, K; Nasu-Kawaharada, R; Izumi, T; Ohshima, N; Nagai, T; Nakamura, A				Yoshiyama, Shinji; Chen, Zhenyi; Okagaki, Tsuyoshi; Kohama, Kazuhiro; Nasu-Kawaharada, Ritsuko; Izumi, Takashi; Ohshima, Noriyasu; Nagai, Takeharu; Nakamura, Akio			Nicotine exposure alters human vascular smooth muscle cell phenotype from a contractile to a synthetic type	ATHEROSCLEROSIS			English	Article						Vascular smooth muscle; Nicotine; Atherosclerosis; Contractile type; Synthetic type	RECEPTOR ALPHA-7 SUBUNIT; ACETYLCHOLINE-RECEPTOR; GROWTH-FACTOR; ATHEROSCLEROSIS; MIGRATION; RAT; MODULATION; DIFFERENTIATION; PROLIFERATION; EXPRESSION	Objective: Cigarette smoking is a known risk factor for arteriosclerosis. In atheromatous plaques, vascular smooth muscle cells (VSMCs) display a phenotype that is different from the contractile type under normal conditions. Nicotine is the major pharmacological agent in cigarette smoke. However, any direct effect of nicotine on VSMCs remains uncertain. Because nicotine promotes VSMC migration, its phenotype may change due to nicotine. Approach and results: We used human aorta primary smooth muscle cells (HuAoSMCs), differentiated with transforming growth factor-beta, to investigate changes in the protein levels of differentiation markers and in the activity of mitogen-activated protein kinases (MAPKs) after exposure to 0.1 mu M of nicotine for 48 h. After nicotine exposure, the protein levels of myosin II 10 (2.93-fold) and beta-actin (1.66-fold), synthetic type markers, were increased. In contrast, the levels of the contractile type markers, myosin II 11 (0.63-fold), high-molecular-weight caldesmon (0.40-fold) and SM22 (0.66-fold), which concern differentiated VSMC, were decreased. Moreover, nicotine exposure induced enhanced activation of p38 MAPK (1.30-fold) and extracellular signal-regulated kinase (1.91-fold). These results indicated that the phenotype of HuAoSMCs had changed to a synthetic-like type because of nicotine exposure. Thus, nicotine is one factor that can alter protein expression of differentiation markers in VSMCs. Besides, the increase of intracellular Ca2+ levels suggested that these effects of nicotine were mediated through nicotinic acetylcholine receptors. Conclusion: Nicotine has already been reported to promote VSMC migration from the tunica media to atheromatous plaques in the vascular intima. This phenomenon may occur because nicotine directly induces VSMC transformation from contractile type to synthetic-like type via nicotinic acetylcholine receptors and G protein-coupled receptors. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Yoshiyama, Shinji; Chen, Zhenyi; Nakamura, Akio] Gunma Univ, Grad Sch Med, Dept Mol Pharmacol & Oncol, Maebashi, Gunma 3718511, Japan; [Okagaki, Tsuyoshi] Mie Univ, Dept Bioresources, Tsu, Mie 5148507, Japan; [Kohama, Kazuhiro] Musashino Univ, Pharmaceut Sci Res Inst, Tokyo 2028585, Japan; [Nasu-Kawaharada, Ritsuko] Takasaki Univ Hlth & Welf, Dept Hlth & Nutr, Takasaki, Gumma, Japan; [Izumi, Takashi; Ohshima, Noriyasu] Gunma Univ, Grad Sch Med, Dept Biochem, Maebashi, Gunma 3718511, Japan; [Nagai, Takeharu] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Nakamura, A (reprint author), Gunma Univ, Grad Sch Med, Dept Mol Pharmacol & Oncol, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	gacho@gunma-u.ac.jp			Smoking Research Foundation; Ministry of Education, Culture, Sports, Science and Technology in Japan [23590295]; Takeda Science Foundation	This study was supported by grants from the Smoking Research Foundation (to A.N.), by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan (23590295 to A.N.) and by the Takeda Science Foundation (to A.N.).	Hopkins PN, 2013, PHYSIOL REV, V93, P1317, DOI 10.1152/physrev.00004.2012; Kanda Y, 2007, LIFE SCI, V80, P1409, DOI 10.1016/j.lfs.2006.12.033; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; AIKAWA M, 1993, CIRC RES, V73, P1000; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Nelson PR, 1998, J VASC SURG, V27, P117, DOI 10.1016/S0741-5214(98)70298-8; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Gu ZZ, 2013, VASC PHARMACOL, V58, P87, DOI 10.1016/j.vph.2012.08.003; Worth NF, 2001, CELL MOTIL CYTOSKEL, V49, P130, DOI 10.1002/cm.1027; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Libby P, 2001, CIRCULATION, V104, P365; WITTEMAN JCM, 1993, CIRCULATION, V88, P2156; Benowitz NL, 1996, ANNU REV PHARMACOL, V36, P597, DOI 10.1146/annurev.pa.36.040196.003121; Cucina A, 2008, J SURG RES, V150, P227, DOI 10.1016/j.jss.2007.10.019; Armstrong DW, 1998, CHIRALITY, V10, P587, DOI 10.1002/(SICI)1520-636X(1998)10:7<587::AID-CHIR6>3.0.CO;2-#; Bruggmann D, 2003, LIFE SCI, V72, P2095, DOI 10.1016/S0024-3205(03)00067-5; Bruggmann D, 2002, HISTOCHEM CELL BIOL, V118, P441, DOI 10.1007/s00418-002-0475-2; Bryant B, 2010, ACS CHEM NEUROSCI, V1, P246, DOI 10.1021/cn900042c; Carty CS, 1997, J VASC SURG, V25, P682, DOI 10.1016/S0741-5214(97)70295-7; Di Luozzo G., 2005, ATHEROSCLEROSIS, V178, P271, DOI 10.1016/j.atherosclerosis.2004.09.017; GIMONA M, 1992, EUR J BIOCHEM, V205, P1067, DOI 10.1111/j.1432-1033.1992.tb16875.x; Holmberg J T, 1976, Acta Chir Scand Suppl, V465, P71; JONAS MA, 1992, CIRCULATION, V86, P1664; Li S, 2004, J PHARMACOL SCI, V94, P334, DOI 10.1254/jphs.94.334; OWENS GK, 1986, J BIOL CHEM, V261, P3373; Saito K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2248; Santanam N, 2012, ATHEROSCLEROSIS, V225, P264, DOI 10.1016/j.atherosclerosis.2012.07.041; Stein JJ, 2011, AM J SURG, V202, P545, DOI 10.1016/j.amjsurg.2011.06.016; Tang YF, 2011, J VASC RES, V48, P485, DOI 10.1159/000327776; THYBERG J, 1983, DIFFERENTIATION, V25, P156; UEKI N, 1987, P NATL ACAD SCI USA, V84, P9049, DOI 10.1073/pnas.84.24.9049; Yoshiyama S, 2011, J PHARMACOL SCI, V115, P532, DOI 10.1254/jphs.10283SC	33	1	2	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	DEC	2014	237	2					464	470		10.1016/j.atherosclerosis.2014.10.019		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AW1RG	WOS:000346066600044		
J	Tanaka, N; Ishida, T; Nagao, M; Mori, T; Monguchi, T; Sasaki, M; Mori, K; Kondo, K; Nakajima, H; Honjo, T; Irino, Y; Toh, R; Shinohara, M; Hirata, K				Tanaka, Nobuaki; Ishida, Tatsuro; Nagao, Manabu; Mori, Takeshige; Monguchi, Tomoko; Sasaki, Maki; Mori, Kenta; Kondo, Kensuke; Nakajima, Hideto; Honjo, Tomoyuki; Irino, Yasuhiro; Toh, Ryuji; Shinohara, Masakazu; Hirata, Ken-ichi			Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanese patients with dyslipidemia	ATHEROSCLEROSIS			English	Article						Eicosapentaenoic acid; n-3 fatty acid; High-density lipoprotein; Dysfunctional HDL; Cholesterol efflux; Paraoxonase; Adhesion molecule	CORONARY-ARTERY-DISEASE; POLYUNSATURATED FATTY-ACIDS; INCREASES HDL PARTICLES; CHOLESTEROL EFFLUX; HYPERCHOLESTEROLEMIC PATIENTS; CARDIOVASCULAR RISK; PRIMARY-PREVENTION; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; IN-VITRO	Objective: It has been reported that high-density lipoprotein (HDL) loses anti-inflammatory function and promotes atherosclerosis under pathological conditions. However, no pharmacological therapy to improve HDL function is currently available. We aimed to evaluate the effect of oral administration of eicosapentaenoic acid (EPA) on HDL function. Methods: Japanese patients with dyslipidemia were treated with EPA (1800 mg/day, 4 weeks), and anti-inflammatory functions of HDL were assessed utilizing in vitro cell-based assays. Results: The EPA treatment did not change serum cholesterol and triglyceride levels, but it significantly increased EPA concentrations in the serum and HDL fraction. The EPA/ arachidonic acid ratio in the HDL was in proportion to that in the serum, suggesting that the orally administered EPA was efficiently incorporated into the HDL particles. The HDL after EPA treatment showed significantly increased activity of anti-oxidative enzyme, paraoxonase-1. In addition, the EPA-rich HDL significantly improved endothelial cell migration, and markedly inhibited cytokine-induced expression of vascular cell adhesion molecule-1, in human umbilical vein endothelial cells, compared to HDL before the EPA treatment. Moreover, the EPA-rich HDL augmented cholesterol efflux capacity from macrophages. Conclusion: Oral administration of EPA regenerated anti-oxidative and anti-inflammatory functions of HDL, and promoted cholesterol efflux from macrophages. Therefore, EPA may transform "dysfunctional HDL" to "functional", in patients with coronary risk factors. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Tanaka, Nobuaki; Ishida, Tatsuro; Nagao, Manabu; Mori, Takeshige; Monguchi, Tomoko; Sasaki, Maki; Mori, Kenta; Kondo, Kensuke; Nakajima, Hideto; Honjo, Tomoyuki; Shinohara, Masakazu; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan; [Irino, Yasuhiro; Toh, Ryuji] Kobe Univ, Grad Sch Med, Div Evidence Based Lab Med, Kobe, Hyogo 6500017, Japan	Ishida, T (reprint author), Kobe Univ, Grad Sch Med, Div Cardiovasc Med, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	ishida@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (JSPS KAKENHI) [24591050, 25461085]	This work was supported by Grants-In-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (JSPS KAKENHI Grant Numbers 24591050 and 25461085).	Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172/JCI11871; Arii K, 2009, ATHEROSCLEROSIS, V202, P439, DOI 10.1016/j.atherosclerosis.2008.05.013; Iso H, 2001, JAMA-J AM MED ASSOC, V285, P304, DOI 10.1001/jama.285.3.304; Annema W, 2013, CIRC J, V77, P2432, DOI 10.1253/circj.CJ-13-1025; Barter PJ, 2004, CIRC RES, V95, P764, DOI 10.1161/01.RES.0000146094.59640.13; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Haraguchi Y, 2014, ATHEROSCLEROSIS, V234, P288, DOI 10.1016/j.atherosclerosis.2014.03.009; Graner M, 2006, J AM COLL CARDIOL, V47, P2429, DOI 10.1016/j.jacc.2006.01.074; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Aviram M, 2004, FREE RADICAL BIO MED, V37, P1304, DOI 10.1016/j.freeadbiomed.2004.06.030; Roncaglioni MC, 2013, NEW ENGL J MED, V368, P1800, DOI 10.1056/NEJMoa1205409; VanLenten BJ, 1995, J CLIN INVEST, V96, P2758, DOI 10.1172/JCI118345; MACKNESS MI, 1995, ATHEROSCLEROSIS, V115, P243, DOI 10.1016/0021-9150(94)05524-M; Saito Y, 2008, ATHEROSCLEROSIS, V200, P135, DOI 10.1016/j.atherosclerosis.2008.06.003; Rye KA, 2014, J LIPID RES, V55, P168, DOI 10.1194/jlr.R039297; Satoh N, 2007, DIABETES CARE, V30, P144, DOI 10.2337/dc06-1179; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JC126206; Yamada H, 2008, ARTERIOSCL THROM VAS, V28, P2173, DOI 10.1161/ATVBAHA.108.171736; Mackness B, 2003, CIRCULATION, V107, P2775, DOI 10.1161/01.CIR.0000070954.00271.13; Baker PW, 1999, J LIPID RES, V40, P345; Bays HE, 2013, AM J CARDIOVASC DRUG, V13, P37, DOI 10.1007/s40256-012-0002-3; Wang CC, 2006, AM J CLIN NUTR, V84, P5; Calabresi L, 2004, METABOLISM, V53, P153, DOI 10.1016/j.metabol.2003.09.007; Miyamoto-Sasaki M, 2013, J ATHEROSCLER THROMB, V20, P708; Navab M, 2004, CIRCULATION, V109, P3215, DOI 10.1161/01.CIR.0000134275.90823.87; Mineo C, 2011, J CLIN INVEST, V121, P2545, DOI 10.1172/JCI57671; Berrougui H, 2012, FREE RADICAL BIO MED, V52, P1372, DOI 10.1016/j.freeradbiomed.2012.01.019; Iso H, 2006, CIRCULATION, V113, P195, DOI 10.1161/CIRCULATIONAHA.105.581355; Aviram M, 2013, CURR OPIN LIPIDOL, V24, P339, DOI 10.1097/MOL.0b013e32835ffcfd; Baker PW, 2000, J LIPID RES, V41, P1261; Burillo E, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-116; DOLECEK TA, 1992, P SOC EXP BIOL MED, V200, P177; Valagussa F, 1999, LANCET, V354, P447; Hara T, 2011, J LIPID RES, V52, P57, DOI 10.1194/jlr.M008417; Hirafuji M, 2002, BRIT J PHARMACOL, V136, P613, DOI 10.1038/sj.bjp.0704768; Hu Y.W., 2009, ATHEROSCLEROSIS, V204, P35; Inoue M, 2000, METABOLISM, V49, P1400, DOI 10.1053/meta.2000.17724; Chadli FK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061109; LADU BN, 1988, AM J HUM GENET, V43, P227; MACKNESS MI, 1993, ATHEROSCLEROSIS, V104, P129, DOI 10.1016/0021-9150(93)90183-U; Pan B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048530; Soumyarani V.S., 2014, J BIOCH MOL IN PRESS; Stahlman M, 2008, J LIPID RES, V49, P481, DOI 10.1194/jlr.D700025-JLR200; Toth PP, 2010, J CLIN LIPIDOL, V4, P376, DOI 10.1016/j.jacl.2010.08.011; Xu SW, 2013, INT J CARDIOL, V168, P3157, DOI 10.1016/j.ijcard.2013.07.210; Zuliani G, 2009, CURR PHARM DESIGN, V15, P4087, DOI 10.2174/138161209789909773	48	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	DEC	2014	237	2					577	583		10.1016/j.atherosclerosis.2014.10.011		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AW1RG	WOS:000346066600060		
J	Harada, K; Amano, T; Kataoka, T; Takeshita, M; Harada, K; Kunimura, A; Takayama, Y; Shinoda, N; Kato, B; Uetani, T; Kato, M; Marui, N; Ishii, H; Matsubara, T; Murohara, T				Harada, Ken; Amano, Tetsuya; Kataoka, Takashi; Takeshita, Masahiro; Harada, Kazuhiro; Kunimura, Ayako; Takayama, Yohei; Shinoda, Norihiro; Kato, Bunichi; Uetani, Tadayuki; Kato, Masataka; Marui, Nobuyuki; Ishii, Hideki; Matsubara, Tatsuaki; Murohara, Toyoaki			Impact of abdominal and epicardial fat on the association between plasma adipocytokine levels and coronary atherosclerosis in non-obese patients	ATHEROSCLEROSIS			English	Article						Epicardial fat volume; Plasma adipocytokine level; Coronary atherosclerotic plaque; Abdominal visceral fat area; 64-Slice computed tomography; Non-obese	PERIVASCULAR ADIPOSE-TISSUE; ARTERY-DISEASE; VISCERAL FAT; CARDIAC ABNORMALITIES; INSULIN-RESISTANCE; RISK-FACTOR; OBESITY; ACCUMULATION; INFLAMMATION; VOLUME	Objective: Ectopic fat accumulation is associated with coronary artery disease. Visceral adipose tissue has paracrine and systemic effects and is a source of adipocytokines. It has been implicated in the pathogenesis of coronary atherosclerosis; however, nothing is known about whether increases in epicardial fat have the same effect on coronary atherosclerosis as increases in abdominal visceral fat. Methods: We examined 216 consecutive patients suspected to have coronary artery disease. Individuals with acute coronary syndrome and inadequate computed tomography (CT) imaging were excluded. We enrolled 164 patients (65 +/- 10 years old; 70% men; body mass index [BM], 23.8 +/- 3.6 kg/m(2)). The plasma concentrations of adiponectin, interleukin-6 (IL-6), plasminogen activator inhibitor-1, and vascular endothelial growth factor were measured. The characteristics of coronary plaque, abdominal visceral fat area, and epicardial fat volume (EFV) were determined by 64-slice CT imaging. Results: EFV was greater in subjects with noncalcified plaque than in those with no plaque or with calcified plaque (126 +/- 39 mL vs. 98 +/- 34 mL and 97 +/- 45 mL, respectively; P = 0.010). EFV was significantly correlated with BMI, triglycerides, and the triglyceride/high-density lipoprotein cholesterol ratio (r = 0.51, 0.19, and 0.20, respectively) but not with plasma levels of adipocytokines. The plasma adiponectin and IL-6 concentration was significantly correlated with abdominal visceral fat area in coronary plaque patients (r = -0.49 and 0.20). Conclusions: In non-obese Japanese patients, epicardial fat may have unique mechanisms affecting the development of coronary atherosclerosis, which is different from abdominal visceral fat. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Harada, Ken; Kataoka, Takashi; Takeshita, Masahiro; Harada, Kazuhiro; Kunimura, Ayako; Takayama, Yohei; Shinoda, Norihiro; Kato, Bunichi; Uetani, Tadayuki; Kato, Masataka; Marui, Nobuyuki] Chubu Rosai Hosp, Dept Cardiol, Minato Ku, Nagoya, Aichi 4558530, Japan; [Amano, Tetsuya] Aichi Med Univ Hosp, Dept Cardiol, Nagoya, Aichi 4801195, Japan; [Ishii, Hideki; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668560, Japan; [Matsubara, Tatsuaki] Aichi Gakuin Sch Dent, Dept Internal Med, Chikusa Ku, Nagoya, Aichi 4648651, Japan	Harada, K (reprint author), Chubu Rosai Hosp, Dept Cardiol, Minato Ku, 10-6 1 Chome Komei, Nagoya, Aichi 4558530, Japan.	haraken@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014				Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Okada K, 2014, J CARDIOVASC MED, V15, P384, DOI 10.2459/JCM.0b013e32836094da; Konishi M, 2010, ATHEROSCLEROSIS, V209, P573, DOI 10.1016/j.atherosclerosis.2009.10.008; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Kopelman PG, 2000, NATURE, V404, P635; Henrichot E, 2005, ARTERIOSCL THROM VAS, V25, P2594, DOI 10.1161/01.ATV.0000188508.40052.35; Verhagen SN, 2011, ATHEROSCLEROSIS, V214, P3, DOI 10.1016/j.atherosclerosis.2010.05.034; Greif M, 2009, ARTERIOSCL THROM VAS, V29, P781, DOI 10.1161/ATVBAHA.108.180653; Oka T, 2012, INT J CARDIOL, V161, P45, DOI 10.1016/j.ijcard.2011.04.021; Alexopoulos N, 2010, ATHEROSCLEROSIS, V210, P150, DOI 10.1016/j.atherosclerosis.2009.11.020; Gustafson B, 2010, J ATHEROSCLER THROMB, V17, P332; Yoshizumi T, 1999, RADIOLOGY, V211, P283; Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319; Malavazos AE, 2007, INT J CARDIOL, V121, P132, DOI 10.1016/j.ijcard.2006.08.061; Shimabukuro M, 2013, ARTERIOSCL THROM VAS, V33, P1077, DOI 10.1161/ATVBAHA.112.300829; Taguchi R, 2001, ATHEROSCLEROSIS, V157, P203, DOI 10.1016/S0021-9150(00)00709-7; Murdolo G, 2006, NUTR METAB CARDIOVAS, V16, pS35, DOI 10.1016/j.numecd.2005.10.016; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; ROSSNER S, 1990, INT J OBESITY, V14, P893; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Wang TD, 2010, ATHEROSCLEROSIS, V213, P279, DOI 10.1016/j.atherosclerosis.2010.07.055; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Hirata Y, 2011, INT HEART J, V52, P139; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Shin HY, 2012, CLIN ENDOCRINOL, V77, P47, DOI 10.1111/j.1365-2265.2011.04217.x; Hirata Y, 2011, J AM COLL CARDIOL, V58, P248, DOI 10.1016/j.jacc.2011.01.048; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Greenberg Andrew S, 2006, Am J Clin Nutr, V83, p461S; Hibi K, 2011, ATHEROSCLEROSIS, V219, P743, DOI 10.1016/j.atherosclerosis.2011.08.024; Malavazos AE, 2007, NUTR METAB CARDIOVAS, V17, P294, DOI 10.1016/j.numecd.2006.01.001; Tanaka S, 2003, ACTA DIABETOL, V40, pS302, DOI 10.1007/s00592-003-0093-z	33	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	DEC	2014	237	2					671	676		10.1016/j.atherosclerosis.2014.10.014		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AW1RG	WOS:000346066600073		
J	Wu, HX; Cheng, XW; Hu, LN; Hao, CN; Hayashi, M; Takeshita, K; Hamrah, MS; Shi, GP; Kuzuya, M; Murohara, T				Wu, Hongxian; Cheng, Xian Wu; Hu, Lina; Hao, Chang-Ning; Hayashi, Mutsuharu; Takeshita, Kyosuke; Hamrah, Mohammad Shoaib; Shi, Guo-Ping; Kuzuya, Masafumi; Murohara, Toyoaki			Renin inhibition reduces atherosclerotic plaque neovessel formation and regresses advanced atherosclerotic plaques	ATHEROSCLEROSIS			English	Article						Aliskiren; Angiotensin II; Toll-like receptor 2; Cathepsin S; Atherosclerosis	ISCHEMIA-INDUCED NEOVASCULARIZATION; CYSTEINE PROTEASE CATHEPSINS; APOE-DEFICIENT MICE; TOLL-LIKE RECEPTORS; ANGIOTENSIN-II; APOLIPOPROTEIN-E; INTIMAL NEOVASCULARIZATION; TYPE-1 RECEPTOR; GROWTH; ANGIOGENESIS	Objective: The interaction between the renin-angiotensin system and toll-like receptors (TLRs) in the pathogenesis of advanced atherosclerotic plaques is not well understood. We studied the effects of the renin inhibitor aliskiren on the progression of advanced atherosclerotic plaque in apolipoprotein E-deficient (ApoE(-/-)) mice with a special focus on plaque neovessel formation. Methods and results: Fourwk-old ApoE(-/-) mice were fed a high-fat diet for 8 wks, and the mice were randomly assigned to one of three groups and administered a vehicle, hydralazine, or aliskiren for an additional 12 wks. Aliskiren reduced the atherosclerotic plaque area and plaque neovessel density. It increased the plaque collagen and elastin contents, and reduced plasma angiotensin II levels and plaque macrophage infiltration and cathepsin S (CatS) protein. Aliskiren also decreased the levels of AT1R, gp91phox, TLR2, monocyte chemotactic protein-1, and CatS mRNAs in the aortic roots. Hydralazine had no beneficial vascular effects, although its administration resulted in the same degree of blood pressure reduction as aliskiren. CatS deficiency mimicked the aliskiren-mediated vasculoprotective effect in the ApoE(-/-)mice, but aliskiren showed no further benefits in ApoE(-/-)CatS(-/-)mice. In vitro, TLR2 silencing reduced CatS expression induced by angiotensin II. Moreover, aliskiren or the inhibition of CatS impaired the endothelial cell angiogenic action in vitro or/and ex vivo. Conclusion: Renin inhibition appears to inhibit advanced plaque neovessel formation in ApoE(-/-)mice and to decrease the vascular inflammatory action and extracellular matrix degradation, partly by reducing AT1R/TLR2-mediated CatS activation and activity, thus regressing advanced atherosclerosis. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Wu, Hongxian; Cheng, Xian Wu; Hao, Chang-Ning; Hayashi, Mutsuharu; Takeshita, Kyosuke; Hamrah, Mohammad Shoaib; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Cheng, Xian Wu; Hu, Lina; Kuzuya, Masafumi] Nagoya Univ, Grad Sch Med, Dept Community Healthcare & Geriatr, Nagoya, Aichi 4668550, Japan; [Shi, Guo-Ping] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Cheng, Xian Wu] Yanbian Univ Hosp, Dept Cardiol, Yanji, Peoples R China	Murohara, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	xianwu@med.nagoya-u.ac.jp; murohara@med.nagoya-u.ac.jp	Takeshita, Kyosuke/B-7008-2012; Murohara, Toyoaki/M-4958-2014; Kuzuya, Masafumi/I-1583-2012	Takeshita, Kyosuke/0000-0002-8283-3799; 	Hori Sciences and Arts Foundation [26-007737]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24659385, 20249045]	This work was supported by the Hori Sciences and Arts Foundation (no. 26-007737 to H.W.), and partly by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (no. 24659385 to X.W. C.; no. 20249045 to T.M.).	Ahn KO, 2007, TRANSPLANTATION, V83, P938, DOI 10.1097/01.tp.0000258589.39006.94; Wang B, 2006, J BIOL CHEM, V281, P6020, DOI 10.1074/jbc.M509134200; Hu LN, 2014, HYPERTENSION, V63, P607, DOI 10.1161/HYPERTENSIONAHA.113.02141; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Cheng XW, 2012, CIRCULATION, V125, P1551, DOI 10.1161/CIRCULATIONAHA.111.066712; Celletti FL, 2001, NAT MED, V7, P425, DOI 10.1038/86490; Imanishi T, 2008, HYPERTENSION, V52, P563, DOI 10.1161/HYPERTENSIONAHA.108.111120; Edfeldt K, 2002, CIRCULATION, V105, P1158, DOI 10.1161/01.CIR.0000012489.17433.31; Egami K, 2003, J CLIN INVEST, V112, P67, DOI 10.1172/JCI200316645; Liu X, 2008, ATHEROSCLEROSIS, V196, P146, DOI 10.1016/j.atherosclerosis.2007.03.025; Daugherty A, 2004, TRENDS CARDIOVAS MED, V14, P117, DOI 10.1016/j.tcm.2004.01.002; Sukhova GK, 2003, J CLIN INVEST, V111, P897, DOI 10.1172/JCI200314915; Matsumoto M, 2008, ATHEROSCLEROSIS, V197, P524, DOI 10.1016/j.atherosclerosis.2007.07.023; Cheng XW, 2011, HYPERTENSION, V58, P978, DOI 10.1161/HYPERTENSIONAHA.111.180935; Monaco C, 2009, CIRCULATION, V120, P2462, DOI 10.1161/CIRCULATIONAHA.109.851881; Cheng XW, 2010, CIRCULATION, V122, P707, DOI 10.1161/CIRCULATIONAHA.109.909218; Cheng XW, 2011, HYPERTENSION, V57, P981, DOI 10.1161/HYPERTENSIONAHA.110.168385; Michelsen KS, 2004, P NATL ACAD SCI USA, V101, P10679, DOI 10.1073/pnas.0403249101; Moreno PR, 2004, CIRCULATION, V110, P2032, DOI 10.1161/01.CIR.0000143233.87854.23; Cheng XW, 2007, CIRC RES, V100, P904, DOI 10.1161/01.RES.0000260801.12916.b5; Lu H, 2008, J CLIN INVEST, V118, P984, DOI 10.1172/JCI32970; Rodgers KJ, 2006, ARTERIOSCL THROM VAS, V26, P851, DOI 10.1161/01.ATV.0000203526.75772.4b; Shi GP, 2003, CIRC RES, V92, P493, DOI 10.1161/01.RES.0000060485.20318.96; Moulton KS, 1999, CIRCULATION, V99, P1726; Ji YY, 2009, CELL PHYSIOL BIOCHEM, V23, P265, DOI 10.1159/000218173; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Jiang HY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4838; Kuzuya M, 2006, ARTERIOSCL THROM VAS, V26, P1120, DOI 10.1161/01.ATV.0000218496.60097.e0; Sasaki T, 2010, ATHEROSCLEROSIS, V210, P430, DOI 10.1016/j.atherosclerosis.2009.12.031; Sun Y, 2009, CIRC RES, V104, P455, DOI 10.1161/CIRCRESAHA.108.182568	30	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	DEC	2014	237	2					739	747		10.1016/j.atherosclerosis.2014.10.098		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AW1RG	WOS:000346066600083		
J	Natsuaki, M; Morimoto, T; Furukawa, Y; Shiomi, H; Ono, K; Kimura, T				Natsuaki, Masahiro; Morimoto, Takeshi; Furukawa, Yutaka; Shiomi, Hiroki; Ono, Koh; Kimura, Takeshi		CREDO-Kyoto PCI CABG Registry	Effect of statin therapy on cardiovascular outcomes after coronary revascularization in patients >= 80 years of age: Observations from the CREDO-Kyoto Registry Cohort-2	ATHEROSCLEROSIS			English	Article						Statin; Coronary artery disease; Elderly patients	RANDOMIZED CONTROLLED-TRIAL; DENSITY-LIPOPROTEIN CHOLESTEROL; HEART-DISEASE; PREVENTION; PRAVASTATIN; RISK; INDIVIDUALS; SIMVASTATIN; MORTALITY; SURGERY	Objective: Effects of statin therapy on cardiovascular outcomes in super-elder population >= 80 years of age have been poorly understood, despite its established role in non-super-elder population. Methods: Among 14,834 patients undergoing first coronary revascularization in the CREDO-Kyoto Registry Cohort-2, patients were divided into 2 strata based on age and patients in each stratum were further divided into 2 groups based on statin therapy at discharge; >= 80 years of age: 2017 patients (statin group: N = 765, no-statin group: N = 1252) and <80 years of age: 12,817 patients (statin group: N = 6523, no-statin group: N = 6294). Results: Through 5-year follow-up, cumulative incidences of major adverse cardiovascular events (MACE: composite of cardiovascular death, myocardial infarction and stoke) were significantly lower in the statin group than in the no-statin group in both strata (23.4% versus 32.0%, P = 0.0003 in patients >= 80 years of age and 11.5% versus 16.1%, P < 0.0001 in patients <80 years of age). After adjusting confounders, statin therapy was associated with significantly reduced risk for MACE not only in patients < 80 years of age (hazard ratio (HR) 0.82, 95% confidence interval (CI) 0.74-0.91, P < 0.0001), but also in patients >= 80 years of age (HR 0.77, 95% CI 0.64-0.93, P = 0.006). There was no interaction between age and the effect of statins (P interaction = 0.86). Conclusions: Statin therapy at discharge from first coronary revascularization was associated with significantly reduced risk for cardiovascular events even in patients >= 80 years of age. There was no difference in the direction and magnitude of treatment effect of statins between the super-elder and non-super-elder patients. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Natsuaki, Masahiro] Saiseikai Fukuoka Gen Hosp, Div Cardiol, Fukuoka, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Dept Internal Med, Div Gen Med, Nishinomiya, Hyogo 6638501, Japan; [Furukawa, Yutaka] Kobe City Med Ctr Gen Hosp, Dept Cardiovasc Med, Kobe, Hyogo, Japan; [Shiomi, Hiroki; Ono, Koh; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan	Kimura, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, 54 Shogoin, Kyoto 6068507, Japan.	taketaka@kuhp.kyoto-u.ac.jp			Pharmaceuticals and Medical Devices Agency (PMDA) in Japan	Pharmaceuticals and Medical Devices Agency (PMDA) in Japan.	Serruys PW, 2005, J AM COLL CARDIOL, V46, P575, DOI 10.1016/j.jacc.2004.12.082; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Natsuaki M, 2012, CIRC J, V76, P1369, DOI 10.1253/circj.CJ-11-1356; Afilalo J, 2008, J AM COLL CARDIOL, V51, P37, DOI 10.1016/j.jacc.2007.06.063; Schatz IJ, 2001, LANCET, V358, P351, DOI 10.1016/S0140-6736(01)05553-2; Shahian DM, 2014, CIRCULATION, V130, P399, DOI 10.1161/CIRCULATIONAHA.113.007541; Masoudi FA, 2013, J AM COLL CARDIOL, V62, P1931, DOI 10.1016/j.jacc.2013.05.099; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Kimura T, 2012, CIRCULATION, V125, P584, DOI 10.1161/CIRCULATIONAHA.111.046599; PEDERSEN TR, 1994, LANCET, V344, P1383; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; FRIEDEWA.WT, 1972, CLIN CHEM, V18, P499; Collins R, 2002, LANCET, V360, P7; Kimura Takeshi, 2011, Cardiovasc Interv Ther, V26, P234, DOI 10.1007/s12928-011-0065-0; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Steg PG, 2007, JAMA-J AM MED ASSOC, V297, P1197, DOI 10.1001/jama.297.11.1197; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9	19	2	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	DEC	2014	237	2					821	828		10.1016/j.atherosclerosis.2014.10.108		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AW1RG	WOS:000346066600097		
J	Homma, T; Caurette, P; Silva, HJ; Yamada, I; Makrydaki, E; Bovens, S; Pedrigi, R; Petretto, EG; Krams, R				Homma, T.; Caurette, P.; Silva, H. J.; Yamada, I.; Makrydaki, E.; Bovens, S.; Pedrigi, R.; Petretto, E. G.; Krams, R.			TRANSCRIPTOME ANALYSIS OF LOCAL SHEAR DEPENDENT GENE EXPRESSION IN ENDOTHELIAL CELLS DURING THIN-CAP FIBROATHEROMA(TCFA) DEVELOPMENT	ATHEROSCLEROSIS			English	Meeting Abstract	Autumn Meeting of the British-Atherosclerosis-Society (BAS)	SEP 25-26, 2014	Queens Coll, Cambridge, ENGLAND	British Atherosclerosis Soc	Queens Coll				[Homma, T.; Silva, H. J.; Makrydaki, E.; Bovens, S.; Pedrigi, R.; Krams, R.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London SW7 2AZ, England; [Caurette, P.; Yamada, I.] Gifu Univ, Gifu, Japan; [Petretto, E. G.] Univ London Imperial Coll Sci Technol & Med, Inst Clin Sci, London SW7 2AZ, England								0	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0021-9150	1879-1484		ATHEROSCLEROSIS	Atherosclerosis	DEC	2014	237	2					E9	E9				1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AW1RG	WOS:000346066600027		
J	Tanihara, S; Akashi, C; Yamaguchi, J; Une, H				Tanihara, Shinichi; Akashi, Chinami; Yamaguchi, Junichi; Une, Hiroshi			Effects of family structure on risk of institutionalisation of disabled older people in Japan	AUSTRALASIAN JOURNAL ON AGEING			English	Article						disabled older people; family structure; living with a daughter; long-term care insurance; risk of institutionalisation	TERM-CARE INSURANCE; NURSING-HOME ADMISSION; PREDICTORS	AimTo examine the relationship between family structure and the risk of institutionalisation of disabled older people. MethodsThe participants were 286 disabled older people aged 65 or older who were eligible to receive formal care services under the long-term care insurance system in a town in western Japan. Family structure was categorised as living alone, living only with a spouse, living with a son, living with a daughter and living other relatives. The risks of institutionalisation were estimated by logistic regression analyses. ResultsParticipants living with a daughter had a significantly low odds ratio (OR) for institutionalisation (OR: 0.35, 95% confidence interval (CI): 0.13-0.93) and those living alone had a significantly high OR (OR: 2.31, 95% CI: 1.02-5.20), when compared to participants living with a son (regarded as the reference). The ORs of participants living only with a spouse and living with other relatives were 1.50 (95% CI: 0.59-3.79) and 0.66 (95% CI: 0.15-2.82), respectively. ConclusionLiving with a daughter could reduce the risk of institutionalisation for disabled older people.	[Tanihara, Shinichi] Fukuoka Univ, Sch Med, Dept Prevent Med & Publ Hlth, Fukuoka 81401, Japan; [Akashi, Chinami] Nagasaki Univ, Dept Nursing, Nagasaki 852, Japan; [Yamaguchi, Junichi] Bur Hlth & Welf, Chiba, Japan; [Une, Hiroshi] Fukuoka Univ, Sch Med, Dept Med Res Ctr, Fukuoka 81401, Japan	Tanihara, S (reprint author), Fukuoka Univ, Sch Med, Dept Prevent Med & Publ Hlth, Fukuoka 81401, Japan.	taniyan@cis.fukuoka-u.ac.jp			Japanese Ministry of Education, Culture, Sport, Science and Technology [22590617]	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sport, Science and Technology (22590617).	Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Campbell JC, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.3.26; Nihtila EK, 2008, EUR J PUBLIC HEALTH, V18, P77, DOI 10.1093/eurpub/ckm025; Bharucha AJ, 2004, J AM GERIATR SOC, V52, P434, DOI 10.1111/j.1532-5415.2004.52118.x; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; IKEGAMI N, 1995, NEW ENGL J MED, V333, P1295, DOI 10.1056/NEJM199511093331922; Noel-Miller C, 2010, J GERONTOL B-PSYCHOL, V65, P370, DOI 10.1093/geronb/gbq020; Cabinet Office Government of Japan, 2003, KOUR KAIG NI KANS SE; Freedman VA, 1996, J GERONTOL B-PSYCHOL, V51, pS61; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Hanaoka C, 2008, SOC SCI MED, V67, P1002, DOI 10.1016/j.socscimed.2008.05.006; Health Labour and Welfare Statistics Association, 2011, KOK EIS NO DOUK; Ikebe T, 2001, J Epidemiol, V11, P8; Ikegami N, 2003, INT J GERIATR PSYCH, V18, P217, DOI 10.1002/gps.818; Kodama H, 2009, GERIATR GERONTOL INT, V9, P320, DOI 10.1111/j.1447-0594.2009.00536.x; Kuzuya Masafumi, 2010, Nihon Ronen Igakkai Zasshi, V47, P461, DOI 10.3143/geriatrics.47.461; Ministry of Health Labour and Welfare of Japan, 2009, KOK SEIK KIS CHOUS; Ministry of Internal Affairs and Communications, 2007, SHUUG KOUZ KIH CHOUS; Nihtila E, 2008, SCAND J PUBLIC HEALT, V36, P35, DOI 10.1177/1403494807086421; Ohwaki K, 2009, AGING CLIN EXP RES, V21, P323; Oura A, 2006, GERONTOLOGY, V52, P66, DOI 10.1159/000089828; Pot AM, 2001, INT J GERIATR PSYCH, V16, P273, DOI 10.1002/gps.331.abs; Sauvaget C, 1997, J Epidemiol, V7, P77; Takeda Shumpei, 2004, Nihon Koshu Eisei Zasshi, V51, P157; Tanihara S, 2008, KENKOU SHIEN, V10, P7; Yoshinaga K, 2005, EUR J EPIDEMIOL, V20, P49, DOI 10.1007/s10654-004-9557-x	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-6381	1741-6612		AUSTRALAS J AGEING	Australas. Ageing	DEC	2014	33	4					E12	E17		10.1111/ajag.12071		6	Geriatrics & Gerontology; Gerontology	Geriatrics & Gerontology	AW0LO	WOS:000345984000003		
J	Inoue, S; Masuyama, H; Hiramatsu, Y				Inoue, Seiji; Masuyama, Hisashi; Hiramatsu, Yuji		Soc Obstet Gynecology	Efficacy of transarterial embolisation in the management of post-partum haemorrhage and its impact on subsequent pregnancies	AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY			English	Article						complication; hysterectomy; post-partum haemorrhage; subsequent pregnancy; transarterial embolisation	UTERINE ARTERY EMBOLIZATION; CONSERVATIVE MANAGEMENT; FERTILITY	BackgroundTransarterial embolisation (TAE) has been attracting attention as a treatment option for post-partum haemorrhage (PPH). AimsWe investigated cases in which TAE was performed for PPH to determine the efficacy of TAE for the treatment of PPH and its impact on subsequent pregnancies and childbirth in a multi-institutional case-series study. Materials and MethodsA total of 211 women who underwent emergency (n=161) or prophylactic (n=50) TAE for the management of PPH from 2002 to 2011 in the Chugoku and Shikoku regions of Japan were evaluated. Data on maternal background, treatment efficacy, adverse events in 113 cases followed up after TAE and subsequent pregnancies in 76 women were obtained. ResultsThe overall success rate of emergency and prophylactic TAE was 91.9 and 96.0%, respectively. The rate of complications such as infection, uterine necrosis and amenorrhoea was 13.3% among women followed up after TAE. Forty women became pregnant after TAE, and the pregnancy rate among those who desired fertility was 52.6%. Twenty-eight gave birth, including four preterm deliveries. Five (16.7%) were associated with a hysterectomy due to placenta accreta. ConclusionsTo reduce haemorrhage and avoid hysterectomy, TAE may be considered as a treatment option for PPH, however short and long terms complications are not uncommon.	[Inoue, Seiji; Masuyama, Hisashi; Hiramatsu, Yuji; Soc Obstet Gynecology] Okayama Univ Grad Sch Med Dent & Pharmaceut Sci, Dept Obstet & Gynecol, Okayama 7008558, Japan	Masuyama, H (reprint author), Okayama Univ Grad Sch Med Dent & Pharmaceut Sci, Dept Obstet & Gynecol, Kita Ku, 2-5-1 Shikata, Okayama 7008558, Japan.	masuyama@cc.okayama-u.ac.jp					Awan N, 2011, AUST NZ J OBSTET GYN, V51, P210, DOI 10.1111/j.1479-828X.2010.01278.x; Gaia G, 2009, EUR RADIOL, V19, P481, DOI 10.1007/s00330-008-1140-5; Doumouchtsis SK, 2007, OBSTET GYNECOL SURV, V62, P540, DOI 10.1097/01.ogx.0000271137.81361.93; Sentilhes L, 2010, BJOG-INT J OBSTET GY, V117, P84, DOI 10.1111/j.1471-0528.2009.02381.x; Ornan D, 2003, OBSTET GYNECOL, V102, P904, DOI 10.1016/S0029-7844(03)00769-5; Kobayashi T, 2012, INT J HEMATOL, V95, P57, DOI 10.1007/s12185-011-0974-9; BROWN BJ, 1979, OBSTET GYNECOL, V54, P361; Kirby JM, 2009, J VASC INTERV RADIOL, V20, P1036, DOI 10.1016/j.jvir.2009.04.070; Badawy SZA, 2001, CLIN IMAG, V25, P288, DOI 10.1016/S0899-7071(01)00307-2; Chauleur C, 2008, HUM REPROD, V23, P1553, DOI 10.1093/humrep/den122; Barkane N, 2010, CURR OPIN OBSTET GYN, V22, P242; Chitrit Y, 2006, EUR J OBSTET GYN R B, V127, P140, DOI 10.1016/j.ejogrb.2004.01.047; Committee on Gynecologic Practice American College of Obstetricians and Gynecologists, 2004, OBSTET GYNECOL, V103, P403; Cunningham FG, 2010, OBSTET HEMORRHAGE WI; Gibert L, 1987, BRIT J OBSTET GYNAEC, V94, P67; Goldberg J, 2002, OBSTET GYNECOL, V100, P869, DOI 10.1016/S0029-7844(02)02347-5; Hovsepian DM, 2004, J VASC INTERV RADIOL, V15, P535, DOI 10.1097/01.RVI.0000127893.00553.CC; LasFolie T, 2007, J OBSTET GYNAECOL RE, V33, P624; Mathe ML, 2007, J PERINAT MED, V35, P532, DOI 10.1515/JPM.2007.113; Timmermans S, 2007, OBSTET GYNECOL SURV, V62, P529, DOI 10.1097/01.ogx.0000271133.27011.05; Touboul C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003819; Vegas G, 2006, EUR J OBSTET GYN R B, V127, P68, DOI 10.1016/j.ejogrb.2005.09.008	22	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0004-8666	1479-828X		AUST NZ J OBSTET GYN	Aust. N. Z. J. Obstet. Gynaecol.	DEC	2014	54	6					541	545		10.1111/ajo.12228		5	Obstetrics & Gynecology	Obstetrics & Gynecology	AW1UC	WOS:000346074900008		
J	Umali, DV; Ito, A; del Valle, FP; Shirota, K; Katoh, H				Umali, Dennis V.; Ito, Akira; del Valle, Fletcher P.; Shirota, Kazutoshi; Katoh, Hiromitsu			Antibody Response and Protective Immunity of Chickens Vaccinated with Booster Dose of Recombinant Oil-Adjuvanted Leucocytozoon caulleryi Subunit Vaccine	AVIAN DISEASES			English	Article						chicken; Leucocytozoon caulleryi; oil adjuvant; R7 protein; recombinant; vaccine	MONOCLONAL-ANTIBODIES; SERA	Leucocytozoon caulleryi is an economically important poultry pathogen that causes subclinical to fatal disease in chickens. Because of limited preventive and treatment options against this disease, an oil-adjuvanted recombinant vaccine (O-rR7) targeting the R7 protein of L. caulleryi second-generation schizonts was developed. Different vaccination programs, namely, single vaccination at 45 days (0.1-ml dose), single vaccination at 130 days (0.25 ml), and initial vaccination at 45 days (0.1 ml) followed by a booster dose at 130 days (0.25 ml) were explored to compare the effects of single and booster vaccination on antibody response, duration of protective immunity, and degree of clinical signs after experimental L. caulleryi infection. Of the three treatments groups, initial vaccination at 45 days followed by a booster vaccination at 130 days of age resulted to rapid increase in antibody titers, which persisted for up to 182 days. Antibody titers reached peak values 35 days and 14 days after initial and booster vaccination, respectively. In comparison, single vaccination at 45 days of age resulted in production of antibodies above 1600 ELISA units for 56 days postvaccination, and single vaccination at 130 days of age produced peak antibody titers 35 days postvaccination, which remained above 1600 ELISA units for 126 days. Experimental infection of L. caulleryi at 256 days, when antibody titers had waned, did not result to severe clinical disease in chickens that received booster vaccination, whereas mild to severe disease was observed in chickens that received a single vaccination. Evaluation of immune response at 15 and 21 days postinfection showed that chickens that received booster vaccination had a twofold increase (P < 0.01) in antibody titers as compared to those receiving a single vaccination. Administering booster shots of O-rR7 is therefore recommended, especially in farms located in areas where Leucocytozoon is endemic.	[Umali, Dennis V.; Katoh, Hiromitsu] Univ Philippines Los Banos, Coll Vet Med, Dept Vet Clin Sci, Laguna 4031, Philippines; [Ito, Akira] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, Sapporo, Hokkaido 0628517, Japan; [Umali, Dennis V.; del Valle, Fletcher P.; Shirota, Kazutoshi; Katoh, Hiromitsu] Poultry Prod Qual Control, Nihonmatsu, Fukushima 9640062, Japan	Katoh, H (reprint author), Univ Philippines Los Banos, Coll Vet Med, Dept Vet Clin Sci, Laguna 4031, Philippines.	h_katoh@ppqc.co.jp					AKIBA KAZUO, 1958, BULL NATL INST ANIMAL HEALTH [JAPAN], V34, P163; Akiba K., 1970, National Institute of Animal Health Quarterly, V10, P131; Salk JE, 1944, J IMMUNOL, V49, P87; Imura T, 2014, PARASITOL RES, V113, P823, DOI 10.1007/s00436-013-3712-9; BEARD CW, 1970, B WORLD HEALTH ORGAN, V42, P779; FOGED NT, 1991, VACCINE, V9, P817, DOI 10.1016/0264-410X(91)90219-V; Gotanda T, 2002, J VET MED SCI, V64, P281, DOI 10.1292/jvms.64.281; ISOBE T, 1986, AVIAN PATHOL, V15, P199, DOI 10.1080/03079458608436281; ISOBE T, 1991, AVIAN DIS, V35, P559, DOI 10.2307/1591220; Ito A., 2004, J VET MED SCI, V66, P438; Ito A., 2002, J VET MED SCI, V54, P405; Mathis C, 1909, CR SOC BIOL, V67, P470; MORII T, 1990, PARASITOL RES, V76, P630, DOI 10.1007/BF00932576; MORII T, 1981, INT J PARASITOL, V11, P187, DOI 10.1016/0020-7519(81)90047-3; MORII T, 1972, NATL I ANIM HEALTH Q, V12, P161; Morii T., 1978, Journal of the Japanese Society of Poultry Diseases, V14, P2; MORII T, 1989, PARASITOL RES, V75, P194, DOI 10.1007/BF00931275; OKADA I, 1988, Japanese Poultry Science, V25, P366; Soekardono S., 1989, B PENELIT KESEHAT, V17, P154; Van Wettere A., 2010, MERCK VET MANUAL, P2387	20	0	0	AMER ASSOC AVIAN PATHOLOGISTS	ATHENS	953 COLLEGE STATION RD, ATHENS, GA 30602-4875 USA	0005-2086	1938-4351		AVIAN DIS	Avian Dis.	DEC	2014	58	4					609	615				7	Veterinary Sciences	Veterinary Sciences	AW2AF	WOS:000346089800013		
J	Han, QX; Wang, GX; Li, W; Liu, F				Han, Qingxiang; Wang, Guangxi; Li, Wei; Liu, Fan			Genetic diversity of Potamogeton pectinatus L. in relation to species diversity in a pair of lakes of contrasting trophic levels	BIOCHEMICAL SYSTEMATICS AND ECOLOGY			English	Article						Potamogeton pectinatus; AFLP; Genetic diversity; Species diversity; Habitat variability	CLONAL DIVERSITY; POPULATION; DIFFERENTIATION; COMMUNITIES; DISTANCE; NUMBER	Understanding the correlation between genetic diversity and species diversity in freshwater communities is important to elucidate the influences of local selective forces on the genetic diversity of local aquatic plant populations across different communities. This study employed amplified fragment length polymorphism (AFLP) to assess the genetic diversity of Potamogeton pectinatus L populations between two sister-lakes with contrasting trophic levels, eutrophic and oligotrophic, in the Yunnan Plateau in southwest of China. The results showed high genetic differentiation between eutrophic lake and oligotrophic lake. The genetic distances between P. pectinatus populations were significantly correlated with the species evenness, but not with difference in species richness of aquatic plant communities. The results underpinned that genetic diversity at inter-population levels and local species diversity in plant communities are positively correlated. In addition, our results also suggested that habitat types might play an important role in the genetic diversity of the P. pectinatus populations between these two lakes. (C) 2014 Elsevier Ltd. All rights reserved.	[Han, Qingxiang; Li, Wei; Liu, Fan] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan 430074, Hubei, Peoples R China; [Han, Qingxiang; Li, Wei; Liu, Fan] Chinese Acad Sci, Wuhan Bot Garden, Hubei Key Lab Wetland Evolut & Ecol Restorat, Wuhan 430074, Hubei, Peoples R China; [Han, Qingxiang] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan; [Wang, Guangxi] Meijo Univ, Fac Agr, Lab Plant Conservat Sci, Nagoya, Aichi 4688502, Japan	Li, W (reprint author), Chinese Acad Sci, Wuhan Bot Garden, Wuhan 430074, Hubei, Peoples R China.	liwei@wbgcas.cn; fanliu@wbgcas.cn			National Natural Science Foundation of China [31370262]	We thank Feng Yi Chang, Yu Cao and Xiangrong Fan for their help in the field, Prof. Hiroaki. Setoguchi (Kyoto University, Japan), Saara Olsen for their valuable and helpful comments on the manuscript. This study was supported by the National Natural Science Foundation of China (grant No. 31370262).	MANTEL N, 1967, CANCER RES, V27, P209; [Anonymous], 2006, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2005.01155.X; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Hangelbroek HH, 2002, MOL ECOL, V11, P2137, DOI 10.1046/j.1365-294X.2002.01598.x; NEI M, 1978, GENETICS, V89, P583; Linhart YB, 1996, ANNU REV ECOL SYST, V27, P237, DOI 10.1146/annurev.ecolsys.27.1.237; Odat N, 2004, MOL ECOL, V13, P1251, DOI 10.1111/j.1365-294X.2004.02115.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Triest L, 2010, HYDROBIOLOGIA, V656, P15, DOI 10.1007/s10750-010-0434-1; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Kaplan Z, 2002, FOLIA GEOBOT, V37, P141, DOI 10.1007/BF02804229; Vellend M, 2004, ECOLOGY, V85, P3043, DOI 10.1890/04-0435; LEVIN SA, 1976, ANNU REV ECOL SYST, V7, P287, DOI 10.1146/annurev.es.07.110176.001443; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Chen YY, 2009, FRESHWATER BIOL, V54, P1178, DOI 10.1111/j.1365-2427.2008.02165.x; Doyle JJ, 1990, FOCUS, V12, P13; Haynes R., 1998, POTAMOGETONACEAE FLO, P408; Hollingsworth PM, 1996, PLANT SYST EVOL, V202, P233, DOI 10.1007/BF00983385; Jeppesen E., 1997, STRUCTURING ROLE SUB; Jing C.Y., 2004, YUNNAN ENV SCI, V23, P110; KALKMAN L, 1984, AQUAT BOT, V20, P343, DOI 10.1016/0304-3770(84)90098-6; Li Y., 2003, J LAKE SCI, V15, P285; Mader E, 1998, AQUAT BOT, V62, P147, DOI 10.1016/S0304-3770(98)00096-5; NEVO E, 1988, EVOL BIOL, V23, P217; SCHAAL BA, 1975, AM NAT, V109, P511, DOI 10.1086/283023; Schneider S, 2000, ARLEQUIN VER 2 000 S; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.2307/2409452; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Stearns S. C., 1992, EVOLUTION LIFE HIST; WASER NM, 1987, HEREDITY, V58, P249, DOI 10.1038/hdy.1987.39; Wei XZ, 2012, NEW PHYTOL, V193, P779, DOI 10.1111/j.1469-8137.2011.03957.x; Yeh F.C., 1997, POPGENE USER FRIENDL; [张立原 ZHANG Liyuan], 2006, [地质科技情报, Geological Science and Techology Information], V25, P8	35	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0305-1978	1873-2925		BIOCHEM SYST ECOL	Biochem. Syst. Ecol.	DEC	2014	57						60	66		10.1016/j.bse.2014.07.003		7	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	AW3WJ	WOS:000346213700011		
J	Tatsuzawa, F				Tatsuzawa, Fumi			Acylated anthocyanins in flowers of Matthiola tricuspidata (L.) R. Br. and Matthiola fruticulosa (L.) Maire (Brassicaceae)	BIOCHEMICAL SYSTEMATICS AND ECOLOGY			English	Article						Matthiola fruticulosa (L.) Maire; Matthiola tricuspidata (L.) IL Br.; Brassicaceae; Acylated cyanidin 3-sambubioside5-glucoside	CYANIDIN 3-SAMBUBIOSIDE-5-GLUCOSIDES; INCANA		Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan	Tatsuzawa, F (reprint author), Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan.	fumi@iwate-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [25450037]	Author thanks Prof. T. Nishio (Tohoku University) for the donation of seeds of M. tricuspidata and M. fruticuiosa (accession numbers: MAT-TRI-1 and MAT-TRS-1: Tohoku University Brassica Seed Bank). This work was supported in part by a Grant-inAid for Science Research (C) [No. 25450037] from the Japan Society for the Promotion of Science (JSPS).	SAITO N, 1995, PHYTOCHEMISTRY, V38, P1027, DOI 10.1016/0031-9422(94)00659-H; Sanchez JL, 2005, PLANT SYST EVOL, V253, P81, DOI 10.1007/s00606-005-0307-7; Sanchez J.L., 2006, BOCCONEA, V19, P243; Tatsuzawa F, 2012, BIOCHEM SYST ECOL, V44, P374, DOI 10.1016/j.bse.2012.06.001; Tatsuzawa F, 2014, PHYTOCHEM LETT, V9, P17, DOI 10.1016/j.phytol.2014.03.011; Tatsuzawa F, 2012, J JPN SOC HORTIC SCI, V81, P91	6	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0305-1978	1873-2925		BIOCHEM SYST ECOL	Biochem. Syst. Ecol.	DEC	2014	57						399	402		10.1016/j.bse.2014.09.023		4	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	AW3WJ	WOS:000346213700066		
J	Katahira, K; Fujimura, T; Matsuda, YT; Okanoya, K; Okada, M				Katahira, Kentaro; Fujimura, Tomomi; Matsuda, Yoshi-Taka; Okanoya, Kazuo; Okada, Masato			Individual differences in heart rate variability are associated with the avoidance of negative emotional events	BIOLOGICAL PSYCHOLOGY			English	Article						Heart rate variability; Reinforcement learning; Emotional picture; Decision making; Motivational value	DECISION-MAKING; BRAIN; RESPONSES; PICTURES; LOOKING; MODELS; CORTEX; ERRORS	Although the emotional outcome of a choice generally affects subsequent decisions, humans can inhibit the influence of emotion. Heart rate variability (HRV) has emerged as an objective measure of individual differences in the capacity for inhibitory control. In the present study, we investigated how individual differences in HRV at rest are associated with the emotional effects of the outcome of a choice on subsequent decision making using a decision-making task in which emotional pictures appeared as decision outcomes. We used a reinforcement learning model to characterize the observed behaviors according to several parameters, namely, the learning rate and the motivational value of positive and negative pictures. Consequently, we found that individuals with a lower resting HRV exhibited a greater negative motivational value in response to negative pictures, suggesting that these individuals tend to avoid negative pictures compared with individuals with a higher resting HRV. (C) 2014 Elsevier B.V. All rights reserved.	[Katahira, Kentaro; Fujimura, Tomomi; Matsuda, Yoshi-Taka; Okanoya, Kazuo; Okada, Masato] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Okanoya Emot Informat Project, Wako, Saitama, Japan; [Katahira, Kentaro; Okanoya, Kazuo] Univ Tokyo, Ctr Evolutionary Cognit Sci, Meguro Ku, Tokyo, Japan; [Katahira, Kentaro; Fujimura, Tomomi; Matsuda, Yoshi-Taka; Okanoya, Kazuo; Okada, Masato] RIKEN Brain Sci Inst, Wako, Saitama, Japan; [Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Okada, Masato] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778561, Japan	Katahira, K (reprint author), Nagoya Univ, Grad Sch Environm, Dept Psychol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	katahira@brain.riken.jp; okada@k.u-tokyo.ac.jp			Japan Science and Technology Agency; Okanoya Emotional Information Project;  [24700238];  [26118506]	This work was supported, in part, by funding from the Japan Science and Technology Agency, Exploratory Research for Advanced Technology, the Okanoya Emotional Information Project, and the Grants-in-Aid for Scientific Research (KAKENHI) grants 24700238 and 26118506.	Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Yechiam E, 2005, PSYCHOL SCI, V16, P973, DOI 10.1111/j.1467-9280.2005.01646.x; Melzig CA, 2009, INT J PSYCHOPHYSIOL, V71, P109, DOI 10.1016/j.ijpsycho.2008.07.013; Ahern GL, 2001, EPILEPSIA, V42, P912, DOI 10.1046/j.1528-1157.2001.042007912.x; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Appelhans BM, 2006, REV GEN PSYCHOL, V10, P229, DOI 10.1037/1089-2680.10.3.229; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Harle KM, 2010, J ABNORM PSYCHOL, V119, P440, DOI 10.1037/a0018612; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Niv Y, 2012, J NEUROSCI, V32, P551, DOI 10.1523/JNEUROSCI.5498-10.2012; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Thayer JF, 2005, PSYCHONEUROENDOCRINO, V30, P1050, DOI 10.1016/j.psyneuen.2005.04.014; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Lane RD, 2009, NEUROIMAGE, V44, P213, DOI 10.1016/j.neuroimage.2008.07.056; Dunn BD, 2012, COGN AFFECT BEHAV NE, V12, P419, DOI 10.3758/s13415-012-0092-z; Codispoti M, 2001, PSYCHOPHYSIOLOGY, V38, P474, DOI 10.1017/S004857720198028X; GRAHAM FK, 1966, PSYCHOL BULL, V65, P305, DOI 10.1037/h0023258; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Corrado GS, 2005, J EXP ANAL BEHAV, V84, P581, DOI 10.1901/jeab.2005.23-05; Daw ND, 2011, DECISION MAKING AFFE, VXXIII, P3; EFRON B, 1992, J ROY STAT SOC B MET, V54, P83; Fujimura T., 2012, PSYCHOLOGY, V3, P578; Johnsen BH, 2003, J ANXIETY DISORD, V17, P75, DOI 10.1016/S0887-6185(02)00178-0; Katahira K, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00311; Lang P. J., 2008, A8 IAPS; LeDoux J. E., 1996, EMOTIONAL BRAIN; Sutterlin S, 2011, SOC NEUROSCI-UK, V6, P169, DOI 10.1080/17470919.2010.495883; Sutton R. S., 1998, REINFORCEMENT LEARNI, V1; Camm AJ, 1996, CIRCULATION, V93, P1043	30	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-0511	1873-6246		BIOL PSYCHOL	Biol. Psychol.	DEC	2014	103						322	331		10.1016/j.biopsycho.2014.10.007		10	Psychology, Biological; Behavioral Sciences; Psychology; Psychology, Experimental	Psychology; Behavioral Sciences	AW0HF	WOS:000345971200041		
J	Togashi, D; Otsuka, I; Borsali, R; Takeda, K; Enomoto, K; Kawaguchi, S; Narumi, A				Togashi, Daichi; Otsuka, Issei; Borsali, Redouane; Takeda, Koichi; Enomoto, Kazushi; Kawaguchi, Seigou; Narumi, Atsushi			Maltopentaose-Conjugated CTA for RAFT Polymerization Generating Nanostructured Bioresource-Block Copolymer	BIOMACROMOLECULES			English	Article							LIVING RADICAL POLYMERIZATION; TRIMETHOXYSILANE-CONTAINING GLYCOPOLYMER; 1,3-DIPOLAR CYCLOADDITION REACTION; STRUCTURED POROUS FILMS; GLYCOCONJUGATED POLYMER; ASYMMETRIC HYDROGENATION; ANTICOAGULANT ACTIVITY; CELLULOSE DERIVATIVES; TRIBLOCK COPOLYMER; TERMINAL ALKYNES	We now describe the synthesis of a new family of oligosaccharide-conjugated functional molecules, which act as chain transfer agents (CTAs) for the reversible addition-fragmentation chain transfer (RAFT) polymerization. The synthesis was started from the catalyst-free direct N-glycosyl reaction of 5-azidopentylamine onto maltopentaose (Mal(5)) in dry methanol at room temperature and subsequent N-protected reaction with acetic anhydride, producing a stable oligosaccharide-building block, such as Mal(5) with an azidopentyl group (Mal(5)-N-3). The azido group was hydrogenated using platinum dioxide (PtO2) as a catalyst to give Mal(5) with aminopentyl group (Mal(5)-NH2), which was then reacted with CTA molecules bearing activated ester moieties. These reactions produced Mal(5)-modified macro-CTAs (Mal(5)-CTAs, 1), which were used for the RAFT polymerizations of styrene (St) and methyl methacrylate (MMA) in DMF. The polymerizations were performed using the [M](0)/[1](0) values ranging from 50 to 600, affording the Mal(5)-hybrid amphiphilic block copolymers (BCPs), such as Mal(5)-polystyrene (2) and Mal(5)-poly(methyl methacrylate) (3), with a quantitative end-functionality and the controlled molecular weights between 4310 and 20 300 g mol(-1). The small-angle X-ray scattering (SAXS) measurements were accomplished for 2 and 3 to ensure their abilities to form phase separated structures in their bulk states with the increasing temperatures from 30 to 190 degrees C. The featured results were observed for 2 (phi(Mal5) = 0.14) and 3 (phi(Mal5) = 0.16) at temperatures above 100 degrees C, where phi(Mal5) denotes the volume fraction of the Mal(5) unit in the BCP sample. For both BCP samples, the primary scattering peaks q* were clearly observed together with the higher-ordered scattering peaks root 2q* and root 3q*. Thus, these Mal(5)-hybrid amphiphilic BCP samples have a body centered cubic (BCC) phase morphology. The domain spacing (d) values of the BCC morphology for 2 (phi(Mal5) = 0.14) and 3 (phi(Mal5) = 0.16) were 10.4 and 9.55 nm, respectively, which were determined using Braggs relation (d = 2 pi/q*). The present RAFT agents were shown to eventually provide the phase separated structural polymeric materials in which 5.4 nm bioresource-spherical domains were periodically arrayed at the interval of about 10 nm.	[Togashi, Daichi; Takeda, Koichi; Enomoto, Kazushi; Kawaguchi, Seigou; Narumi, Atsushi] Yamagata Univ, Grad Sch Sci & Engn, Dept Polymer Sci & Engn, Yonezawa, Yamagata 9928510, Japan; [Otsuka, Issei; Borsali, Redouane] Univ Grenoble Alpes, CERMAV, F-38000 Grenoble, France; [Otsuka, Issei; Borsali, Redouane] CNRS, CERMAV, F-38000 Grenoble, France	Narumi, A (reprint author), Yamagata Univ, Grad Sch Sci & Engn, Dept Polymer Sci & Engn, Jonan 4-3-16, Yonezawa, Yamagata 9928510, Japan.	narumi@yz.yamagata-u.ac.jp			JSPS KAKENHI [25350550]; CNRS; PolyNat Carnot Institute; Lab Ex ARCANE [ANR-11-LABX-0003-01]	The authors acknowledge Hayashibara Biochemical Laboratories Inc., Japan, for providing maltopentaose (Mal<INF>5</INF>). The authors thank Dr. Y. Jinbo for his help with the SAXS measurements. The authors thank Prof. O. Haba for the HPLC measurement. This study was partly supported by JSPS KAKENHI 25350550. The authors acknowledge support from CNRS, the PolyNat Carnot Institute, and Lab Ex ARCANE (ANR-11-LABX-0003-01). The authors thank the Japan Society for the Promotion of Science (JSPS) - Ministere des Affaires Etrangeres et Europeennes (MARE) joint project (SAKURA program) during 2011-2013.	Aissou K, 2011, LANGMUIR, V27, P4098, DOI 10.1021/la104936k; Bathfield M, 2006, J AM CHEM SOC, V128, P2546, DOI 10.1021/ja057481c; CHARYCH DH, 1993, SCIENCE, V261, P585, DOI 10.1126/science.8342021; Giacomelli C, 2009, BIOMACROMOLECULES, V10, P449, DOI 10.1021/bm801282d; Min EH, 2010, J POLYM SCI POL CHEM, V48, P3440, DOI 10.1002/pola.24129; Matsen MW, 1996, MACROMOLECULES, V29, P1091, DOI 10.1021/ma951138i; Seto H, 2014, ACS APPL MATER INTER, V6, P13234, DOI 10.1021/am503003v; Tanaka T, 2009, CHEM COMMUN, P3378, DOI 10.1039/b905761g; Imamura K, 2006, J PHYS CHEM B, V110, P15094, DOI 10.1021/jp057527o; Stenzel MH, 2003, J MATER CHEM, V13, P2090, DOI 10.1039/b304204a; AMAKO K, 1987, APPL ENVIRON MICROB, V53, P603; Ahmed M, 2012, BIOCONJUGATE CHEM, V23, P1050, DOI 10.1021/bc3000723; Fang ZQ, 2014, NANO LETT, V14, P765, DOI 10.1021/nl404101p; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Bernard J, 2008, J POLYM SCI POL CHEM, V46, P2845, DOI 10.1002/pola.22618; Ifuku S, 2012, NANOSCALE, V4, P3308, DOI 10.1039/c2nr30383c; Huang CY, 2006, P NATL ACAD SCI USA, V103, P15, DOI 10.1073/pnas.0509693102; Akeroyd N, 2009, MACROMOLECULES, V42, P3014, DOI 10.1021/ma802846g; Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0; Moad G, 2005, POLYMER, V46, P8458, DOI 10.1016/j.polymer.2004.12.061; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Sun XL, 2002, BIOMACROMOLECULES, V3, P1065, DOI 10.1021/bm025561s; Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e; Seto H, 2012, ACS APPL MATER INTER, V4, P411, DOI 10.1021/am2014713; Isono T, 2013, MACROMOLECULES, V46, P1461, DOI 10.1021/ma3026578; Cushen JD, 2012, ACS NANO, V6, P3424, DOI 10.1021/nn300459r; Gudmundsdottir AV, 2008, ORG LETT, V10, P3461, DOI 10.1021/ol801232f; Otsuka I, 2010, LANGMUIR, V26, P2325, DOI 10.1021/la902743y; Dedola S, 2007, ORG BIOMOL CHEM, V5, P1006, DOI 10.1039/b618048p; OKAMOTO Y, 1984, J AM CHEM SOC, V106, P5357, DOI 10.1021/ja00330a057; Stenzel MH, 2002, J POLYM SCI POL CHEM, V40, P4498, DOI 10.1002/pola.10532; Otsuka I, 2012, BIOMACROMOLECULES, V13, P1458, DOI 10.1021/bm300167e; Besset C, 2009, TETRAHEDRON LETT, V50, P7043, DOI 10.1016/j.tetlet.2009.09.173; Blanco JLJ, 1997, CARBOHYD RES, V303, P367; Modolon SD, 2012, BIOMACROMOLECULES, V13, P1129, DOI 10.1021/bm3000138; Gouin SG, 2007, TETRAHEDRON LETT, V48, P2875, DOI 10.1016/j.tetlet.2007.02.092; GRAY DG, 1985, FARADAY DISCUSS, V79, P257, DOI 10.1039/dc9857900257; Gyorgydeak Z, 2006, ADV CARBOHYD CHEM BI, V60, P103, DOI 10.1016/S0065-2318(06)60004-8; Haddleton DM, 2000, BIOMACROMOLECULES, V1, P152, DOI 10.1021/bm005531u; HANESSIAN S, 1978, CARBOHYD RES, V63, P265, DOI 10.1016/S0008-6215(00)80951-9; ICHIDA A, 1984, CHROMATOGRAPHIA, V19, P280, DOI 10.1007/BF02687754; Isono T, 2013, MACROMOLECULES, V46, P8932, DOI 10.1021/ma4019526; Kakuchi T, 2003, MACROMOLECULES, V36, P3914, DOI 10.1021/ma021296r; KAMIDE K, 1983, POLYM J, V15, P309, DOI 10.1295/polymj.15.309; KAWABATA Y, 1976, CHEM LETT, P1213, DOI 10.1246/cl.1976.1213; KOBAYASHI K, 1988, J MACROMOL SCI CHEM, VA25, P655, DOI 10.1080/00222338808053391; KUSANAGI H, 1976, MACROMOLECULES, V9, P531, DOI 10.1021/ma60051a028; Loos K, 2002, BIOMACROMOLECULES, V3, P368, DOI 10.1021/bm0156330; Miyagawa A, 2006, BIOMATERIALS, V27, P3304, DOI 10.1016/j.biomaterials.2006.01.049; MIYAMOTO T, 1995, MACROMOL SYMP, V99, P141, DOI 10.1002/masy.19950990115; MORTELL KH, 1994, J AM CHEM SOC, V116, P12053, DOI 10.1021/ja00105a056; MURATA J, 1991, CANCER RES, V51, P22; Murphy PV, 2007, EUR J ORG CHEM, P4177, DOI 10.1002/ejoc.200700248; MUZZARELLI R A A, 1971, Water Air and Soil Pollution, V1, P65, DOI 10.1007/BF00280780; NAKAMAE K, 1994, MACROMOL CHEM PHYSIC, V195, P2663, DOI 10.1002/macp.1994.021950733; Narumi A, 2002, POLYMER, V43, P4835, DOI 10.1016/S0032-3861(02)00301-4; Narumi A, 2006, J POLYM SCI POL CHEM, V44, P4864, DOI 10.1002/pola.21582; Narumi A, 2006, J POLYM SCI POL CHEM, V44, P3978, DOI 10.1002/pola.21495; Narumi A, 2006, BIOMACROMOLECULES, V7, P1496, DOI 10.1021/bm0601068; Narumi A, 2002, MACROMOLECULES, V35, P699, DOI 10.1021/ma011239i; Narumi A, 2001, POLYM J, V33, P939, DOI 10.1295/polymj.33.939; Narumi A, 2005, J POLYM SCI POL CHEM, V43, P4373, DOI 10.1002/pola.20847; Narumi A, 2001, J POLYM SCI POL CHEM, V39, P4061, DOI 10.1002/pola.10063; NATTA G, 1955, MAKROMOLEKUL CHEM, V16, P77; Otsuka I, 2013, NANOSCALE, V5, P2637, DOI 10.1039/c3nr00332a; Otsuka I, 2012, ACS MACRO LETT, V1, P1379, DOI 10.1021/mz300543u; Otsuka I, 2013, LANGMUIR, V29, P15224, DOI 10.1021/la403941v; Ryno LM, 2014, BIOMACROMOLECULES, V15, P2944, DOI 10.1021/bm500572v; Sato H, 2007, BIOMACROMOLECULES, V8, P753, DOI 10.1021/bm061095I; SEUFERT M, 1995, ANGEW CHEM INT EDIT, V34, P340, DOI 10.1002/anie.199503401; Shimamoto S, 1998, CHEM MATER, V10, P1720, DOI 10.1021/cm980110t; Srinivasan R, 2009, ORG BIOMOL CHEM, V7, P1821, DOI 10.1039/b902338k; Sun XL, 2002, J AM CHEM SOC, V124, P7258, DOI 10.1021/ja025788v; URAGAMI T, 1981, POLYMER, V22, P1155, DOI 10.1016/0032-3861(81)90125-7; WATANABE K, 1992, CARBOHYD POLYM, V17, P29, DOI 10.1016/0144-8617(92)90020-Q; Wen S, 2001, ORG LETT, V3, P3773, DOI 10.1021/ol0101988; YAMASHITA M, 1989, B CHEM SOC JPN, V62, P942, DOI 10.1246/bcsj.62.942	77	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	DEC	2014	15	12					4509	4519		10.1021/bm501314f		11	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	AW2JR	WOS:000346114400014		
J	Tatsumi, M; Kimura, F; Kimura, T; Teramoto, Y; Nishio, Y				Tatsumi, Mio; Kimura, Fumiko; Kimura, Tsunehisa; Teramoto, Yoshikuni; Nishio, Yoshiyuki			Anisotropic Polymer Composites Synthesized by Immobilizing Cellulose Nanocrystal Suspensions Specifically Oriented under Magnetic Fields	BIOMACROMOLECULES			English	Article							CHIRAL NEMATIC PHASE; POLYVINYL-ALCOHOL; ALIGNMENT; ORIENTATION; WHISKERS; NANOCOMPOSITES; CRYSTAL; POLYSACCHARIDES; DIFFRACTION; FIBERS	Novel polymer composites reinforced with an oriented cellulose nanocrystal (CNC) assembly were prepared from suspensions of CNC in aqueous 2-hydroxyethyl methacrylate (HEMA) via magnetic field application to the suspensions followed by polymerization treatment. The starting suspensions used at similar to 6 wt % CNC separated into an upper isotropic phase and a lower anisotropic (chiral nematic) one in the course of quiescent standing. A static or rotational magnetic field was applied to the isolated isotropic and anisotropic phases. UV-induced polymerization of HEMA perpetuated the respective states of magnetic orientation invested for the CNC dispersions to yield variously oriented CNC/poly(2-hydroxyethyl methacrylate) composites. The structural characterization was carried out by use of X-ray diffractometry and optical and scanning electron microscopy. The result indicated that CNCs were aligned in the composites distinctively according to the static or rotational magnetic application when the anisotropic phases were used, whereas such a specific CNC orientation was not appreciable when the isotropic phases were sampled. This marks out effectiveness of a coherent response of CNCs in the mesomorphic assembly. In dynamic mechanical experiments in tensile or compressive mode, we observed a clear mechanical anisotropy for the polymer composites synthesized from wholly anisotropic suspensions under static or rotational magnetization. The higher modulus (in compression) was detected for a composite reinforced by locking-in the uniaxial CNC alignment attainable through conversion of the initial chiral nematic phase into a nematic phase in the rotational magnetic field.	[Tatsumi, Mio; Kimura, Fumiko; Kimura, Tsunehisa; Teramoto, Yoshikuni; Nishio, Yoshiyuki] Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Sakyo Ku, Kyoto 6068502, Japan	Nishio, Y (reprint author), Kyoto Univ, Grad Sch Agr, Div Forest & Biomat Sci, Sakyo Ku, Kyoto 6068502, Japan.	ynishio@kais.kyoto-u.ac.jp	TERAMOTO, Yoshikuni/A-1773-2013	TERAMOTO, Yoshikuni/0000-0003-3850-3570	Japan Society for the Promotion of Science [26252025]	The authors wish to acknowledge Professor K. Takabe of Kyoto University for having afforded the microtome for preparing the specimens in POM observations. This work was financially supported by a Grant-in-Aid for Scientific Research (A) (No. 26252025 to Y.N.) from the Japan Society for the Promotion of Science.	FAVIER V, 1995, POLYM ADVAN TECHNOL, V6, P351, DOI 10.1002/pat.1995.220060514; Moon RJ, 2011, CHEM SOC REV, V40, P3941, DOI 10.1039/c0cs00108b; FAVIER V, 1995, MACROMOLECULES, V28, P6365, DOI 10.1021/ma00122a053; Majoinen J, 2012, CELLULOSE, V19, P1599, DOI 10.1007/s10570-012-9733-1; Pullawan T, 2012, BIOMACROMOLECULES, V13, P2528, DOI 10.1021/bm300746r; Kimura T, 2002, ADV MATER, V14, P1380, DOI 10.1002/1521-4095(20021002)14:19<1380::AID-ADMA1380>3.0.CO;2-V; Habibi Y, 2010, CHEM REV, V110, P3479, DOI 10.1021/cr900339w; Eichhorn SJ, 2011, SOFT MATTER, V7, P303, DOI 10.1039/c0sm00142b; Kimura T, 2003, POLYM J, V35, P823, DOI 10.1295/polymj.35.823; Dong XM, 1998, CELLULOSE, V5, P19, DOI 10.1023/A:1009260511939; Kimura T, 2006, LANGMUIR, V22, P3464, DOI 10.1021/la053479n; MARCHESSAULT RH, 1959, NATURE, V184, P632, DOI 10.1038/184632a0; REVOL JF, 1992, INT J BIOL MACROMOL, V14, P170, DOI 10.1016/S0141-8130(05)80008-X; Dong XM, 1996, LANGMUIR, V12, P2076, DOI 10.1021/la950133b; STEIN RS, 1958, J POLYM SCI, V31, P327, DOI 10.1002/pol.1958.1203112309; Tatsumi M, 2012, BIOMACROMOLECULES, V13, P1584, DOI 10.1021/bm300310f; Uddin AJ, 2011, BIOMACROMOLECULES, V12, P617, DOI 10.1021/bm101280f; Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273; SUGIYAMA J, 1992, MACROMOLECULES, V25, P4232, DOI 10.1021/ma00042a032; REVOL JF, 1994, LIQ CRYST, V16, P127, DOI 10.1080/02678299408036525; Kvien I, 2007, APPL PHYS A-MATER, V87, P641, DOI 10.1007/s00339-007-3882-3; Urena-Benavides EE, 2010, LANGMUIR, V26, P14263, DOI 10.1021/la102216v; Belamie E, 2004, J PHYS CHEM B, V108, P14991, DOI 10.1021/jp048152u; Boltoeva MY, 2013, LANGMUIR, V29, P8208, DOI 10.1021/la401448e; GRAY DG, 1994, CARBOHYD POLYM, V25, P277, DOI 10.1016/0144-8617(94)90053-1; Kimura F, 2009, Journal of Physics: Conference Series, V156, DOI 10.1088/1742-6596/156/1/012002; Kimura F, 2005, LANGMUIR, V21, P2034, DOI 10.1021/la0475728; Kimura T, 2004, LANGMUIR, V20, P5669, DOI 10.1021/la049347w; SUGIYAMA J, 1991, MACROMOLECULES, V24, P4168, DOI 10.1021/ma00014a033; TIMBRELL V, 1972, J APPL PHYS, V43, P4839, DOI 10.1063/1.1661036; Wilkes G, 1971, ADV POLYM SCI, V8, P91	31	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	DEC	2014	15	12					4579	4589		10.1021/bm501629g		11	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	AW2JR	WOS:000346114400022		
J	Ulset, AST; Mori, H; Dalheim, MO; Hara, M; Christensen, BE				Ulset, Ann-Sissel T.; Mori, Hideki; Dalheim, Marianne O.; Hara, Masayuki; Christensen, Bjorn E.			Influence of Amino Acids, Buffers, and pH on the gamma-Irradiation-Induced Degradation of Alginates	BIOMACROMOLECULES			English	Article							RADIATION-INDUCED DEGRADATION; SODIUM ALGINATE; CHAIN STIFFNESS; CELLS; PERIODATE; DEPOLYMERIZATION; SPECTROSCOPY; MANNURONAN; VIABILITY; MECHANISM	Alginate-based biomaterials and medical devices are commonly subjected to ?-irradiation as a means of sterilization, either in the dry state or the gel (hydrated) state. In this process the alginate chains degrade randomly in a dose-dependent manner, altering alginates material properties. The addition of free radical scavenging amino acids such as histidine and phenylalanine protects the alginate significantly against degradation, as shown by monitoring changes in the molecular weight distributions using SEC-MALLS and determining the pseudo first order rate constants of degradation. Tris buffer (0.5 M), but not acetate, citrate, or phosphate buffers had a similar effect on the degradation rate. Changes in pH itself had only marginal effects on the rate of alginate degradation and on the protective effect of amino acids. Contrary to previous reports, the chemical composition (M/G profile) of the alginates, including homopolymeric mannuronan, was unaltered following irradiation up to 10 kGy.	[Ulset, Ann-Sissel T.; Dalheim, Marianne O.; Christensen, Bjorn E.] Norwegian Univ Sci & Technol NTNU, Dept Biotechnol, NOBIPOL, N-7491 Trondheim, Norway; [Mori, Hideki; Hara, Masayuki] Osaka Prefecture Univ, Grad Sch Sci, Dept Biol Sci, Naka Ku, Sakai, Osaka 5998570, Japan	Christensen, BE (reprint author), Norwegian Univ Sci & Technol NTNU, Dept Biotechnol, NOBIPOL, N-7491 Trondheim, Norway.	bjorn.christensen@ntnu.no	Christensen, Bjorn E./G-6033-2015	Christensen, Bjorn E./0000-0002-1135-9815	NTNU [81726300]; Research Council of Norway [211935]	This work was supported by grants from NTNU (Project 81726300, Ph.D. Grant M.O.D.) and the Research Council of Norway (Grant No. 211935). Mr. Takaya Yamamoto (Osaka Prefecture University) is thanked for technical help in preparing samples for gamma-irradiation.	Andersen T., 2012, SPR CARB CH, V37, P227, DOI DOI 10.1039/9781849732765-00227; Andersen T, 2012, BIOMACROMOLECULES, V13, P3703, DOI 10.1021/bm301194f; Vold IMN, 2006, BIOMACROMOLECULES, V7, P2136, DOI 10.1021/bm060099n; Higuchi A, 2012, CHEM REV, V112, P4507, DOI 10.1021/cr3000169; HICKS M, 1986, FEBS LETT, V199, P92, DOI 10.1016/0014-5793(86)81230-3; Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3; Nishiyama Y, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3002759; Ioan CE, 2000, MACROMOLECULES, V33, P5730, DOI 10.1021/ma000282n; Kristiansen KA, 2011, CARBOHYD POLYM, V86, P1595, DOI 10.1016/j.carbpol.2011.06.069; Campa C, 2004, BIOCHEM J, V381, P155, DOI 10.1042/BJ20031265; Nagasawa N, 2000, POLYM DEGRAD STABIL, V69, P279, DOI 10.1016/S0141-3910(00)00070-7; Vacharathit V, 2011, BIOMATERIALS, V32, P3721, DOI 10.1016/j.biomaterials.2010.12.048; Wu MH, 2010, LAB CHIP, V10, P939, DOI 10.1039/b921695b; Tasoglu S, 2013, CHEM SOC REV, V42, P5788, DOI 10.1039/c3cs60042d; GRASDALEN H, 1979, CARBOHYD RES, V68, P23, DOI 10.1016/S0008-6215(00)84051-3; Onoe H, 2013, NAT MATER, V12, P584, DOI [10.1038/nmat3606, 10.1038/NMAT3606]; Lee DW, 2003, J AGR FOOD CHEM, V51, P4819, DOI 10.1021/jf021053y; Goh CH, 2012, CARBOHYD POLYM, V88, P1, DOI 10.1016/j.carbpol.2011.11.012; Wasikiewicz JM, 2005, RADIAT PHYS CHEM, V73, P287, DOI 10.1016/j.radphyschem.2004.09.021; Inoue N, 2006, J BIOMAT SCI-POLYM E, V17, P837, DOI 10.1163/156856206777996835; Campa C, 2004, J CHROMATOGR A, V1026, P271, DOI 10.1016/j.chroma.2003.11.045; Cardoso DA, 2014, MACROMOL BIOSCI, V14, P872, DOI 10.1002/mabi.201300415; Christensen BE, 2007, BIOMACROMOLECULES, V8, P3279, DOI 10.1021/bm078004k; Donati I, 2009, J PHYS CHEM B, V113, P12916, DOI 10.1021/jp905488u; Donati I, 2009, MICROBIOL MONOGR, V13, P1, DOI 10.1007/978-3-540-92679-5_1; Draget Kurt Ingar, 2006, P289; GRASDALEN H, 1983, CARBOHYD RES, V118, P255, DOI 10.1016/0008-6215(83)88053-7; Hara M, 2010, J BIOMAT SCI-POLYM E, V21, P877, DOI 10.1163/156856209X449452; Hsiong SX, 2008, BIOMACROMOLECULES, V9, P1843, DOI 10.1021/bm8000606; Khalil S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128729; Kristiansen KA, 2009, CARBOHYD POLYM, V77, P725, DOI 10.1016/j.carbpol.2009.02.018; Kristiansen KA, 2013, PURE APPL CHEM, V85, P1893, DOI 10.1351/PAC-CON-13-01-05; Morch Y. A., 2009, BIOARTIFICIAL ENDOCR, P51; SCOTT JE, 1976, CARBOHYD RES, V47, P105, DOI 10.1016/S0008-6215(00)83553-3; Sen M, 2010, RADIAT PHYS CHEM, V79, P279, DOI 10.1016/j.radphyschem.2009.08.028; Tanford C., 1961, PHYS CHEM MACROMOLEC; Zegota H, 1999, FOOD HYDROCOLLOID, V13, P51, DOI 10.1016/S0268-005X(98)00069-1	37	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1525-7797	1526-4602		BIOMACROMOLECULES	Biomacromolecules	DEC	2014	15	12					4590	4597		10.1021/bm501386n		8	Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	AW2JR	WOS:000346114400023		
J	Kim, M; Kang, D; Wu, T; Tabatabaei, N; Carruth, RW; Martinez, RV; Whitesides, GM; Nakajima, Y; Tearney, GJ				Kim, Minkyu; Kang, DongKyun; Wu, Tao; Tabatabaei, Nima; Carruth, Robert W.; Martinez, Ramses V.; Whitesides, George M.; Nakajima, Yoshikazu; Tearney, Guillermo J.			Miniature objective lens with variable focus for confocal endomicroscopy	BIOMEDICAL OPTICS EXPRESS			English	Article							OPTICAL COHERENCE TOMOGRAPHY; ELECTRICALLY TUNABLE LENS; MICROSCOPY; CAPSULE; TRACT	Spectrally encoded confocal microscopy (SECM) is a reflectance confocal microscopy technology that can rapidly image large areas of luminal organs at microscopic resolution. One of the main challenges for large-area SECM imaging in vivo is maintaining the same imaging depth within the tissue when patient motion and tissue surface irregularity are present. In this paper, we report the development of a miniature vari-focal objective lens that can be used in an SECM endoscopic probe to conduct adaptive focusing and to maintain the same imaging depth during in vivo imaging. The vari-focal objective lens is composed of an aspheric singlet with an NA of 0.5, a miniature water chamber, and a thin elastic membrane. The water volume within the chamber was changed to control curvature of the elastic membrane, which subsequently altered the position of the SECM focus. The vari-focal objective lens has a diameter of 5 mm and thickness of 4 mm. A vari-focal range of 240 mu m was achieved while maintaining lateral resolution better than 2.6 mu m and axial resolution better than 26 mu m. Volumetric SECM images of swine esophageal tissues were obtained over the vari-focal range of 260 mu m. SECM images clearly visualized cellular features of the swine esophagus at all focal depths, including basal cell nuclei, papillae, and lamina propria. (C) 2014 Optical Society of America	[Kim, Minkyu; Kang, DongKyun; Wu, Tao; Tabatabaei, Nima; Carruth, Robert W.; Tearney, Guillermo J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Kim, Minkyu; Kang, DongKyun; Wu, Tao; Tabatabaei, Nima; Carruth, Robert W.; Tearney, Guillermo J.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Kim, Minkyu; Nakajima, Yoshikazu] Univ Tokyo, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Martinez, Ramses V.; Whitesides, George M.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Whitesides, George M.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Martinez, Ramses V.] Madrid Inst Adv Studies, IMDEA Nanosci, Madrid 28049, Spain; [Tearney, Guillermo J.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Tearney, Guillermo J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02114 USA; [Tearney, Guillermo J.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Kim, M (reprint author), Harvard Univ, Sch Med, 55 Fruit St, Boston, MA 02114 USA.	gtearny@partners.org	Martinez, Ramses/C-5219-2009	Martinez, Ramses/0000-0002-0234-7732	FP7 People program under the project Marie Curie [IOF-275148]; NinePoint Medical, Cambridge, MA	Authors thank Drs. Kengyeh K. Chu, Tim N Ford, Kanwarpal Singh and Manabu Kashiwagi for their assistance in OCT measurement of the lens profile. R. V. M acknowledges funding by the FP7 People program under the project Marie Curie IOF-275148. This research was supported in part through a sponsored research agreement with NinePoint Medical, Cambridge, MA. Dr. Tearney consults for NinePoint Medical. Massachusetts General Hospital has a licensing arrangement with NinePoint Medical. Dr. Tearney has the rights to receive royalty payments as part of this licensing arrangement.	Kang D, 2011, BIOMED OPT EXPRESS, V2, P1412, DOI 10.1364/BOE.2.001412; Tsai FS, 2008, OPT LETT, V33, P291, DOI 10.1364/OL.33.000291; Boudoux C, 2005, OPT EXPRESS, V13, P8214, DOI 10.1364/OPEX.13.008214; Oku H, 2004, OPT EXPRESS, V12, P2138, DOI 10.1364/OPEX.12.002138; Thiberville L, 2009, EUR RESPIR J, V33, P974, DOI 10.1183/09031936.00083708; Polglase AL, 2005, GASTROINTEST ENDOSC, V62, P686, DOI 10.1016/j.gie.2005.05.021; Jabbour JM, 2014, BIOMED OPT EXPRESS, V5, P645, DOI 10.1364/BOE.5.000645; Shaw D, 2007, OPT ENG, V46, DOI 10.1117/1.2821426; Divetia A, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1879096; Douali MG, 2004, OPHTHAL PHYSL OPT, V24, P234, DOI 10.1111/j.1475-1313.2004.00198.x; Yelin D, 2007, OPT LETT, V32, P1102, DOI 10.1364/OL.32.001102; Grewe BF, 2011, BIOMED OPT EXPRESS, V2, P2035, DOI 10.1364/BOE.2.002035; Gora MJ, 2013, NAT MED, V19, P238, DOI 10.1038/nm.3052; Zhang DY, 2003, APPL PHYS LETT, V82, P3171, DOI 10.1063/1.1573337; Liu LB, 2011, NAT MED, V17, P1010, DOI 10.1038/nm.2409; Tabatabaei N, 2014, BIOMED OPT EXPRESS, V5, P197, DOI 10.1364/BOE.5.5.000197; Tearney GJ, 1998, OPT LETT, V23, P1152, DOI 10.1364/OL.23.001152; Kang D, 2013, BIOMED OPT EXPRESS, V4, P1925, DOI 10.1364/BOE.4.001925; Choi ST, 2014, OPT EXPRESS, V22, P6133, DOI 10.1364/OE.22.006133; Gu M., 1996, PRINCIPLES 3 DIMENSI; Kang Dongkyun, 2014, Endosc Int Open, V2, pE135, DOI 10.1055/s-0034-1377177; Shen M, 2008, J MICROMECH MICROENG, V18, DOI 10.1088/0960-1317/18/2/025031; Tsai FS, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3420192; Yang QD, 2008, APPL OPTICS, V47, P3658, DOI 10.1364/AO.47.003658; Yu HB, 2010, OPT EXPRESS, V18, P9945, DOI 10.1364/OE.18.009945	25	2	2	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	DEC 1	2014	5	12					4350	4361		10.1364/BOE.5.004350		12	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	AW1TD	WOS:000346071900022		
J	Kondo, A; Bisaria, VS				Kondo, Akihiko; Bisaria, Virendra S.			Editorial: Asian Congress on Biotechnology 2013	BIOTECHNOLOGY JOURNAL			English	Editorial Material									[Kondo, Akihiko] Kobe Univ, Dept Chem Sci & Engn, Kobe, Hyogo 657, Japan; [Bisaria, Virendra S.] Indian Inst Technol Delhi, Dept Biochem Engn & Biotechnol, New Delhi, India	Kondo, A (reprint author), Kobe Univ, Dept Chem Sci & Engn, Kobe, Hyogo 657, Japan.	akondo@kobe-u.ac.jp; vbisaria@dbeb.iitd.ac.in					Agarwal P, 2014, BIOTECHNOL J, V9, P1480, DOI 10.1002/biot.201400063; Chien HW, 2014, BIOTECHNOL J, V9, P1613, DOI 10.1002/biot.201300433; Park HH, 2014, BIOTECHNOL J, V9, P1582, DOI 10.1002/biot.201400253; Park GW, 2014, BIOTECHNOL J, V9, P1536, DOI 10.1002/biot.201400266; Yang YJ, 2014, BIOTECHNOL J, V9, P1493, DOI 10.1002/biot.201400070; Lee EA, 2014, BIOTECHNOL J, V9, P1604, DOI 10.1002/biot.201400020; Mai NL, 2014, BIOTECHNOL J, V9, P1565, DOI 10.1002/biot.201400099; Hmar RV, 2014, BIOTECHNOL J, V9, P1554, DOI 10.1002/biot.201400215; Grabherr R, 2014, BIOTECHNOL J, V9, P1476, DOI 10.1002/biot.201400409; Ismail KSK, 2014, BIOTECHNOL J, V9, P1519, DOI 10.1002/biot.201300553; Ji YT, 2014, BIOTECHNOL J, V9, P1512, DOI 10.1002/biot.201400165; Ko Y, 2014, BIOTECHNOL J, V9, P1526, DOI 10.1002/biot.201400221; Li T, 2014, BIOTECHNOL J, V9, P1503, DOI 10.1002/biot.201400084; Li Y, 2014, BIOTECHNOL J, V9, P1478, DOI 10.1002/biot.201400472; Menon KR, 2014, BIOTECHNOL J, V9, P1547, DOI 10.1002/biot.201400216; Shembekar N, 2014, BIOTECHNOL J, V9, P1594, DOI 10.1002/biot.201400083; Suzuki R, 2014, BIOTECHNOL J, V9, P1573, DOI 10.1002/biot.201400007; Zhong JJ, 2011, BIOTECHNOL J, V6, P1298, DOI 10.1002/biot.201100445	18	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1860-6768	1860-7314		BIOTECHNOL J	Biotechnol. J.	DEC	2014	9	12					1459	1461		10.1002/biot.201400774		3	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	AW0ZY	WOS:000346021200001		
J	Ismail, KSK; Sakamoto, T; Hasunuma, T; Zhao, XQ; Kondo, A				Ismail, Ku Syahidah Ku; Sakamoto, Takatoshi; Hasunuma, Tomohisa; Zhao, Xin-Qing; Kondo, Akihiko			Zinc, magnesium, and calcium ion supplementation confers tolerance to acetic acid stress in industrial Saccharomyces cerevisiae utilizing xylose	BIOTECHNOLOGY JOURNAL			English	Article						Acetate tolerance; Calcium ions; Magnesium ions; Xylose; Zinc ions	IMPROVES ETHANOL-PRODUCTION; LIGNOCELLULOSIC HYDROLYSATE; FORMIC ACIDS; FERMENTATION; GENE; STRAIN; IDENTIFICATION; YEAST	Lignocellulosic biomass is a potential substrate for ethanol production. However, pretreatment of lignocellulosic materials produces inhibitory compounds such as acetic acid, which negatively affect ethanol production by Saccharomyces cerevisiae. Supplementation of the medium with three metal ions (Zn2+, Mg2+, and Ca2+) increased the tolerance of S. cerevisiae toward acetic acid compared to the absence of the ions. Ethanol production from xylose was most improved (by 34%) when the medium was supplemented with 2 mM Ca2+, followed by supplementation with 3.5 mM Mg2+ (29% improvement), and 180 mu M Zn2+ (26% improvement). Higher ethanol production was linked to high cell viability in the presence of metal ions. Comparative transcriptomics between the supplemented cultures and the control suggested that improved cell viability resulted from the induction of genes controlling the cell wall and membrane. Only one gene, FIT2, was found to be up-regulated in common between the three metal ions. Also up-regulation of HXT1 and TKL1 might enhance xylose consumption in the presence of acetic acid. Thus, the addition of ionic nutrients is a simple and cost-effective method to improve the acetic acid tolerance of S. cerevisiae.	[Ismail, Ku Syahidah Ku; Sakamoto, Takatoshi; Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan; [Ismail, Ku Syahidah Ku] Univ Malaysia Perlis, Sch Bioproc Engn, Perlis, Malaysia; [Hasunuma, Tomohisa] Org Adv Sci & Technol, Kobe, Hyogo, Japan; [Zhao, Xin-Qing] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China	Kondo, A (reprint author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp	Hasunuma, Tomohisa/A-1949-2015	Hasunuma, Tomohisa/0000-0002-8382-2362	Ministry of Economy, Trade, and Industry of Japan [P07015]; National Science Foundation of China (NSFC); Japan Society for the Promotion of Science (JSPS)	This work has been supported through project P07015 by the New Energy and Industrial Technology Development Organization under the sponsorship of the Ministry of Economy, Trade, and Industry of Japan, and through an international collaborative project supported by National Science Foundation of China (NSFC) and Japan Society for the Promotion of Science (JSPS). We are also grateful to the Ministry of Education of Malaysia and University Malaysia Perlis for providing a scholarship to Ku Syahidah Ku Ismail in Kobe University, Japan.	Zhao XQ, 2012, J BIOTECHNOL, V158, P176, DOI 10.1016/j.jbiotec.2011.06.038; Wu YD, 2013, J BIOTECHNOL, V165, P18, DOI 10.1016/j.jbiotec.2013.02.009; Zhao XQ, 2009, J BIOTECHNOL, V139, P55, DOI 10.1016/j.jbiotec.2008.08.013; Almeida JRM, 2011, BIOTECHNOL J, V6, P286, DOI 10.1002/biot.201000301; Hasunuma T, 2014, J BIOSCI BIOENG, V117, P165, DOI 10.1016/j.jbiosc.2013.07.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Protchenko O, 2001, J BIOL CHEM, V276, P49244, DOI 10.1074/jbc.M109220200; Ismail KSK, 2013, J BIOTECHNOL, V163, P50, DOI 10.1016/j.jbiotec.2012.10.017; Sanda T, 2011, BIORESOURCE TECHNOL, V102, P7917, DOI 10.1016/j.biortech.2011.06.028; Li BZ, 2010, APPL MICROBIOL BIOT, V86, P1915, DOI 10.1007/s00253-010-2518-2; Birch RM, 2000, ENZYME MICROB TECH, V26, P678, DOI 10.1016/S0141-0229(00)00159-9; Fujitomi K, 2012, BIORESOURCE TECHNOL, V111, P161, DOI 10.1016/j.biortech.2012.01.161; Haitani Y, 2012, J BIOSCI BIOENG, V114, P648, DOI 10.1016/j.jbiosc.2012.07.002; Lu Y, 2012, J IND MICROBIOL BIOT, V39, P73, DOI 10.1007/s10295-011-1001-0; Mira NP, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-79; NABAIS RC, 1988, APPL ENVIRON MICROB, V54, P2439; Hasunuma T, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-2; Xu G. H., 2012, CIESC J, V63, P1823	18	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1860-6768	1860-7314		BIOTECHNOL J	Biotechnol. J.	DEC	2014	9	12					1519	1525		10.1002/biot.201300553		7	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	AW0ZY	WOS:000346021200012		
J	Suzuki, R; Hirakawa, H; Nagamune, T				Suzuki, Risa; Hirakawa, Hidehiko; Nagamune, Teruyuki			Electron donation to an archaeal cytochrome P450 is enhanced by PCNA-mediated selective complex formation with foreign redox proteins	BIOTECHNOLOGY JOURNAL			English	Article						Artificial protein complex; CYP119; Proliferating cell nuclear antigen; Putidaredoxin; Sulfolobus solfataricus	SULFOLOBUS-SOLFATARICUS; P450CAM MONOOXYGENASE; SYSTEM; CYP119; BIOSYNTHESIS; MUTAGENESIS; PUTIDAREDOXIN; REDUCTASE; PARTNER; FUSION	Cytochrome P450 monooxygenases (P450s) are environmentally friendly biocatalysts that catalyze diverse chemical reactions using molecular oxygen under mild reaction conditions. P450s are activated upon receiving electrons from specific redox partner proteins, although the redox partners for most bacterial/archaeal P450s are not yet identified. Thus, it is important to establish a variety of efficient and versatile electron transfer systems from NAD(P) H to P450s for the design of biocatalysts. Sulfolobus solfataricus possesses a heterotrimeric proliferating cell nuclear antigen (PCNA). Fusion of the PCNA subunits to S. acidocaldarius P450 (CYP119) and the Pseudomonas putida redox proteins, putidaredoxin (PdX) and putidaredoxin reductase (PdR), yielded a selective protein complex containing one molecule each of the three proteins. The PCNA-mediated heterotrimerization of CYP119, PdX, and PdR enhanced the CYP119 activity, likely as a result of high local concentrations of the two redox proteins toward CYP119. Therefore, the PCNA-mediated formation of the complex containing PdX and PdR might be applicable for harnessing the utility of P450s whose redox partners are not yet identified.	[Suzuki, Risa; Nagamune, Teruyuki] Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo 1138656, Japan; [Hirakawa, Hidehiko; Nagamune, Teruyuki] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan	Hirakawa, H (reprint author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	hirakawa@bio.t.u-tokyo.ac.jp; nagamune@bioeng.t.u-tokyo.ac.jp	Hirakawa, Hidehiko/A-3089-2013	Hirakawa, Hidehiko/0000-0003-0623-8573	Ministry of Education, Culture, Sports, Science and Technology [21760633]; Graduate Program for Leaders in Life Innovation	This work is supported by a Grant-in-Aid for Young Scientist (B) from the Ministry of Education, Culture, Sports, Science and Technology (#21760633). We thank Dr. Takiguchi for assistance with LC/MS and Mr. Watanabe for assistance with vector construction. R. S. was supported by a scholarship from Graduate Program for Leaders in Life Innovation.	Saruwatari T, 2014, CHEMBIOCHEM, V15, P656, DOI 10.1002/cbic.201300751; Kimmich N, 2007, J BIOL CHEM, V282, P27006, DOI 10.1074/jbc.M703790200; Munro AW, 2013, TRENDS BIOCHEM SCI, V38, P140, DOI 10.1016/j.tibs.2012.11.006; Sakaki T, 2011, BBA-PROTEINS PROTEOM, V1814, P249, DOI 10.1016/j.bbapap.2010.07.014; Urlacher VB, 2012, TRENDS BIOTECHNOL, V30, P26, DOI 10.1016/j.tibtech.2011.06.012; Koo LS, 2000, J BIOL CHEM, V275, P14112, DOI 10.1074/jbc.275.19.14112; Yang W, 2010, J BIOL CHEM, V285, P27372, DOI 10.1074/jbc.M110.118349; Hirakawa H, 2010, CHEMBIOCHEM, V11, P1517, DOI 10.1002/cbic.201000226; Hirakawa H, 2013, BIOTECHNOL BIOENG, V110, P1858, DOI 10.1002/bit.24861; Sevrioukova IF, 2011, ARCH BIOCHEM BIOPHYS, V507, P66, DOI 10.1016/j.abb.2010.08.022; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Koo LS, 2002, J AM CHEM SOC, V124, P5684, DOI 10.1021/ja017174g; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Rabe KS, 2008, CHEMBIOCHEM, V9, P420, DOI 10.1002/cbic.200700450; Bell SG, 2010, J BIOL INORG CHEM, V15, P315, DOI 10.1007/s00775-009-0604-7; Sevrioukova IF, 2003, J MOL BIOL, V333, P377, DOI 10.1016/j.jmb.2003.08.028; Kang JY, 2014, BIOTECHNOL BIOENG, V111, P1313, DOI 10.1002/bit.25202; Karuzina II, 1999, FREE RADICAL BIO MED, V26, P620, DOI 10.1016/S0891-5849(98)00252-4; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Knights KM, 2013, BRIT J CLIN PHARMACO, V76, P587, DOI 10.1111/bcp.12086; Sibbesen O, 1996, J BIOL CHEM, V271, P22462; McLean MA, 1998, BIOCHEM BIOPH RES CO, V252, P166, DOI 10.1006/bbrc.1998.9584; Dionne I, 2003, MOL CELL, V11, P275, DOI 10.1016/S1097-2765(02)00824-9; Erkelenz M, 2011, J AM CHEM SOC, V133, P16111, DOI 10.1021/ja204993s; Fuhrop J. H., 1975, PORPHYRINS METALLOPO, P804; He K, 1998, BIOCHEMISTRY-US, V37, P17448, DOI 10.1021/bi9808464; Hirakawa H, 2011, METHODS MOL BIOL, V743, P1, DOI 10.1007/978-1-61779-132-1_1; Mandai T, 2009, FEBS J, V276, P2416, DOI 10.1111/j.1742-4658.2009.06974.x; Maves SA, 2001, PROTEIN SCI, V10, P161, DOI 10.1110/ps.17601; Puchkaev AV, 2003, ARCH BIOCHEM BIOPHYS, V409, P52, DOI 10.1016/S0003-9861(02)00402-2; Rabe KS, 2009, CHEMBIOCHEM, V10, P751, DOI 10.1002/cbic.200800750; Sakaki T, 2013, BIOTECHNOL APPL BIOC, V60, P65, DOI 10.1002/bab.1067; Sushko TA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P282, DOI 10.1134/S0006297913030103; Wright RL, 1996, FEBS LETT, V384, P235, DOI 10.1016/0014-5793(96)00322-5; Zhao YJ, 2014, APPL MICROBIOL BIOT, V98, P2371, DOI 10.1007/s00253-013-5496-3	35	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1860-6768	1860-7314		BIOTECHNOL J	Biotechnol. J.	DEC	2014	9	12					1573	1581		10.1002/biot.201400007		9	Biochemical Research Methods; Biotechnology & Applied Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology	AW0ZY	WOS:000346021200018		
J	Takatori, S; Hirai, K; Ozaki, S; Tangsucharit, P; Fukushima-Miyashita, S; Goda, M; Hashikawa-Hobara, N; Ono, N; Kawasaki, H				Takatori, Shingo; Hirai, Kazuhiro; Ozaki, Shuichiro; Tangsucharit, Panot; Fukushima-Miyashita, Satoko; Goda, Mitsuhiro; Hashikawa-Hobara, Narumi; Ono, Nobufumi; Kawasaki, Hiromu			Protons modulate perivascular axo-axonal neurotransmission in the rat mesenteric artery	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							CONTAINING VASODILATOR NERVES; RESISTANCE ARTERIES; CONCISE GUIDE; ADRENERGIC NEUROTRANSMISSION; MEDIATED VASODILATION; ARRIVE GUIDELINES; BLOOD-VESSELS; ION CHANNELS; PHARMACOLOGY; RECEPTORS	Background and PurposePrevious studies have demonstrated that nicotine releases protons from adrenergic nerves via stimulation of nicotinic ACh receptors and activates transient receptor potential vanilloid-1 (TRPV1) receptors located on calcitonin gene-related peptide (CGRP)-containing (CGRPergic) vasodilator nerves, resulting in vasodilatation. The present study investigated whether perivascular nerves release protons, which modulate axon-axonal neurotransmission. Experiment ApproachPerfusion pressure and pH levels of perfusate in rat-perfused mesenteric vascular beds without endothelium were measured with a pressure transducer and a pH meter respectively. Key ResultsPeriarterial nerve stimulation (PNS) initially induced vasoconstriction, which was followed by long-lasting vasodilatation and decreased pH levels in the perfusate. Cold-storage denervation of the preparation abolished the decreased pH and vascular responses to PNS. The adrenergic neuron blocker guanethidine inhibited PNS-induced vasoconstriction and effects on pH, but not PNS-induced vasodilatation. Capsaicin (CGRP depletor), capsazepine and ruthenium red (TRPV1 inhibitors) attenuated the PNS-induced decrease in pH and vasodilatation. In denuded preparations, ACh caused long-lasting vasodilatation and lowered pH; these effects were inhibited by capsaicin pretreatment and atropine, but not by guanethidine or mecamylamine. Capsaicin injection induced vasodilatation and a reduction in pH, which were abolished by ruthenium red. The use of a fluorescent pH indicator demonstrated that application of nicotine, ACh and capsaicin outside small mesenteric arteries reduced perivascular pH levels and these effects were abolished in a Ca2+-free medium. Conclusion and ImplicationThese results suggest that protons are released from perivascular adrenergic and CGRPergic nerves upon PNS and these protons modulate transmission in CGRPergic nerves.	[Takatori, Shingo; Kawasaki, Hiromu] Matsuyama Univ, Coll Pharmaceut Sci, Dept Clin Pharm, Matsuyama, Ehime 7908578, Japan; [Takatori, Shingo; Hirai, Kazuhiro; Ozaki, Shuichiro; Tangsucharit, Panot; Fukushima-Miyashita, Satoko; Goda, Mitsuhiro; Kawasaki, Hiromu] Okayama Univ, Dept Clin Pharmaceut Sci, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Hashikawa-Hobara, Narumi] Okayama Univ Sci, Dept Life Sci, Kita Ku, Okayama, Japan; [Ono, Nobufumi; Kawasaki, Hiromu] Fukuoka Univ, Fac Pharmaceut Sci, Dept Drug Informat, Fukuoka 81401, Japan	Takatori, S (reprint author), Matsuyama Univ, Coll Pharmaceut Sci, Dept Clin Pharm, 4-2 Bunkyo Cho, Matsuyama, Ehime 7908578, Japan.	stakator@cc.matsuyama-u.ac.jp			Smoking Research Foundation; KAKENHI from Ministry of Education, Science and Technology of Japan [13672389, 16390157]	This work was supported by a grant from the Smoking Research Foundation and in part by a Grant-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Science and Technology of Japan (Nos. 13672389 and 16390157).	Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1459, DOI 10.1111/bph.12445; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; KAWASAKI H, 1990, J PHARMACOL EXP THER, V252, P403; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1607, DOI 10.1111/bph.12447; KAWASAKI H, 1988, NATURE, V335, P164, DOI 10.1038/335164a0; Tominaga M, 2005, PFLUG ARCH EUR J PHY, V451, P143, DOI 10.1007/s00424-005-1457-8; Di Giovanni J, 2010, NEURON, V67, P268, DOI 10.1016/j.neuron.2010.06.024; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; KAWASAKI H, 1991, AM J PHYSIOL, V261, pH683; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1582, DOI 10.1111/bph.12446; TAKENAGA M, 1995, CIRC RES, V76, P935; Hatanaka Y, 2006, J PHARMACOL EXP THER, V316, P490, DOI 10.1124/jpet.105.094656; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Eguchi S, 2004, BRIT J PHARMACOL, V142, P1137, DOI 10.1038/sj.bjp.0705773; Eguchi S, 2007, BRIT J PHARMACOL, V151, P1216, DOI 10.1038/sj.bjp.0707331; Hobara N, 2004, PEPTIDES, V25, P589, DOI 10.1016/j.peptides.2004.02.005; KAWASAKI H, 1990, BRAIN RES, V506, P287, DOI 10.1016/0006-8993(90)91263-G; Kawasaki H, 2009, J PHARMACOL EXP THER, V330, P745, DOI 10.1124/jpet.108.149435; Kawasaki H, 2011, ACTA PHYSIOL, V203, P3, DOI 10.1111/j.1748-1716.2010.02197.x; MCGREGOR DD, 1965, J PHYSIOL-LONDON, V177, P21; NUKI C, 1994, J PHARMACOL EXP THER, V268, P59; Shiraki H, 2000, BRIT J PHARMACOL, V130, P1083, DOI 10.1038/sj.bjp.0703376	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	DEC	2014	171	24			SI		5743	5756		10.1111/bph.12878		14	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW0FF	WOS:000345965500019		
J	Narishige, S; Kuwahara, M; Shinozaki, A; Okada, S; Ikeda, Y; Kamagata, M; Tahara, Y; Shibata, S				Narishige, Seira; Kuwahara, Mari; Shinozaki, Ayako; Okada, Satoshi; Ikeda, Yuko; Kamagata, Mayo; Tahara, Yu; Shibata, Shigenobu			Effects of caffeine on circadian phase, amplitude and period evaluated in cells in vitro and peripheral organs in vivo in PER2::LUCIFERASE mice	BRITISH JOURNAL OF PHARMACOLOGY			English	Article							SUPRACHIASMATIC NUCLEUS; ARRIVE GUIDELINES; GENE-EXPRESSION; LIVER CLOCK; RHYTHMS; MOUSE; LIGHT; SHIFTS; SLEEP; LOOP	Background and PurposeCaffeine is one of the most commonly used psychoactive substances. Circadian rhythms consist of the main suprachiasmatic nucleus (SCN) clocks and peripheral clocks. Although caffeine lengthens circadian rhythms and modifies phase changes in SCN-operated rhythms, the effects on caffeine on the phase, period and amplitude of peripheral organ clocks are not known. In addition, the role of cAMP/Ca2+ signalling in effects of caffeine on rhythm has not been fully elucidated. Experimental ApproachWe examined whether chronic or transient application of caffeine affects circadian period/amplitude and phase by evaluating bioluminescence rhythm in PER2::LUCIFERASE knock-in mice. Circadian rhythms were monitored in vitro using fibroblasts and ex vivo and in vivo for monitoring of peripheral clocks. Key ResultsChronic application of caffeine (0.1-10mM) increased period and amplitude in vitro. Transient application of caffeine (10mM) near the bottom of the decreasing phase of bioluminescence rhythm caused phase advance in vitro. Caffeine (0.1%) intake caused a phase delay under light-dark or constant dark conditions, suggesting a period-lengthening effect in vivo. Caffeine (20mgkg(-1)) at daytime or at late night-time caused phase advance or delay in bioluminescence rhythm in the liver and kidney respectively. The complicated roles of cAMP/Ca2+ signalling may be involved in the caffeine-induced increase of period and amplitude in vitro. Conclusions and ImplicationsCaffeine affects circadian rhythm in mice by lengthening the period and causing a phase shift of peripheral clocks. These results suggest that caffeine intake with food/drink may help with food-induced resetting of peripheral circadian clocks.	[Narishige, Seira; Kuwahara, Mari; Shinozaki, Ayako; Okada, Satoshi; Ikeda, Yuko; Kamagata, Mayo; Tahara, Yu; Shibata, Shigenobu] Waseda Univ, Lab Physiol & Pharmacol, Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan	Shibata, S (reprint author), Waseda Univ, Lab Physiol & Pharmacol, Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan.	shibatas@waseda.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23300278, 26220201]	This study was partially supported by a Grant-in-Aid for Scientific Research (B) (23300278) and (S) (26220201) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (S. S.).	Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Kim DY, 2005, EUR J NEUROSCI, V21, P1215, DOI 10.1111/j.1460-9568.2005.03950.x; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; GOODENOUGH JE, 1980, BIOL BULL, V159, P649, DOI 10.2307/1540830; Lundkvist GB, 2005, J NEUROSCI, V25, P7682, DOI 10.1523/JNEUROSCI.2211-05.2005; Vivanco P, 2013, NEUROSCIENCE, V254, P98, DOI 10.1016/j.neuroscience.2013.09.025; Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI 10.1111/j.1476-5381.2010.00872.x; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1797, DOI 10.1111/bph.12451; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; An SW, 2011, J NEUROPHYSIOL, V105, P2289, DOI 10.1152/jn.00966.2010; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Oike H, 2011, BIOCHEM BIOPH RES CO, V410, P654, DOI 10.1016/j.bbrc.2011.06.049; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; FELDMAN JF, 1975, SCIENCE, V190, P789, DOI 10.1126/science.173018; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Ding JM, 1998, NATURE, V394, P381; Ukai H, 2007, NAT CELL BIOL, V9, P1327, DOI 10.1038/ncb1653; Fisone G, 2004, CELL MOL LIFE SCI, V61, P857, DOI 10.1007/s00018-003-3269-3; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Wu MN, 2009, J NEUROSCI, V29, P11029, DOI 10.1523/JNEUROSCI.1653-09.2009; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Lee Y, 2010, J CELL SCI, V123, P3547, DOI 10.1242/jcs.070300; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; McGrath JC, 2010, BRIT J PHARMACOL, V160, P1573, DOI 10.1111/j.1476-5381.2010.00873.x; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; Báez-Ruiz Adrián, 2011, J Circadian Rhythms, V9, P6, DOI 10.1186/1740-3391-9-6; Buhr ED, 2013, HDB EXP PHARM, V217, P3, DOI DOI 10.1007/978-3-642-25950-0_1; Francis S.H., 2011, HDB EXP PHARM, V200, P93; Guerreiro S, 2011, HDB EXP PHARM, V200, P135; Hastings MH, 2008, CURR BIOL, V18, pR805, DOI 10.1016/j.cub.2008.07.021; Hayasaka N, 2007, ENDOCRINOLOGY, V148, P3316, DOI 10.1210/en.2007-0010; Mistlberger RE, 2002, J BIOL RHYTHM, V17, P227, DOI 10.1177/07430402017003006; Muller C.E., 2011, HDB EXP PHARM, V200, P151; O'Neill JS, 2013, HDB EXP PHARM, V217, P67; Ohta H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002601; SHIBATA S, 1984, NEUROSCI LETT, V52, P181, DOI 10.1016/0304-3940(84)90371-9; Shibata S, 2010, ADV DRUG DELIVER REV, V62, P918, DOI 10.1016/j.addr.2010.06.003; Tahara Y, 2011, J BIOL RHYTHM, V26, P230, DOI 10.1177/0748730411405958; Tischkau SA, 2003, J BIOL CHEM, V278, P718, DOI 10.1074/jbc.M209241200; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	48	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1188	1476-5381		BRIT J PHARMACOL	Br. J. Pharmacol.	DEC	2014	171	24			SI		5858	5869		10.1111/bph.12890		12	Pharmacology & Pharmacy	Pharmacology & Pharmacy	AW0FF	WOS:000345965500027		
J	Hiyoshi-Taniguchi, K; Becker, CB; Kinoshita, A				Hiyoshi-Taniguchi, Kazuko; Becker, Carl B.; Kinoshita, Ayae			Social Workers Can Use Sense of Coherence to Predict Burnout of End-of-Life Care-Givers (Research Report from Japan)	BRITISH JOURNAL OF SOCIAL WORK			English	Article						Sense of coherence; burnout; social support; stress; sleep	HEALTH; STABILITY; STRESS; BURDEN; SCALE; DEPRESSION; STROKE; SLEEP; RISK; HOME	Social workers are deeply involved in supporting elder persons' home care-givers, who frequently border on burnout or nervous breakdown. Since social workers cannot fully assist every family caring for frail elders at home, it is valuable to pre-identify those care-givers in greatest need of social work support. Previous research suggests that care-givers' sleep interruption is a major factor in their sense of burden, but this alone proves inadequate to discriminate those in need of extra social work support. We hypothesised that care-givers' Sense of Coherence (SOC) was the major factor in their sense of burden. With co-operation of social workers in rural and urban Japan, we surveyed care-givers' SOC and sense of burden. Our study of 177 family care-givers showed that a high SOC substantially mitigated their sense of burden, while care-givers with low senses of meaning felt more burdened. This suggests that social workers should administer a simple SOC test to home care-givers in order to predict those care-givers most needful of social work assistance during End-of-Life (EOL) home care. Moreover, if social workers could elevate home care-givers' SOC through social support or programmes of exercise or meditation, this might reduce home care-givers' sense of burden, ultimately reducing burnout, neglect and abuse of homebound elderly.	[Hiyoshi-Taniguchi, Kazuko] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto 6068501, Japan; [Becker, Carl B.] Kyoto Univ, Kokoro Res Ctr, Kyoto 6068501, Japan; [Becker, Carl B.] Kyoto Univ, Grad Sch Human & Environm Studies, Kyoto 6068501, Japan; [Kinoshita, Ayae] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan; [Kinoshita, Ayae] Kyoto Univ, Ctr Women Researchers, Kyoto 6068501, Japan	Becker, CB (reprint author), Kyoto Univ, Kokoro Res Ctr, Sakyo Ku, Yoshida Shimo Adachi Cho 46, Kyoto 6068501, Japan.	becker.carlbradley.5e@kyoto-u.ac.jp					Almberg B, 2000, INT J GERIATR PSYCH, V15, P931, DOI 10.1002/1099-1166(200010)15:10<931::AID-GPS219>3.0.CO;2-L; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; Vela-Bueno A, 2008, J PSYCHOSOM RES, V64, P435, DOI 10.1016/j.jpsychores.2007.10.014; MCSHERRY WC, 1994, J CLIN PSYCHOL, V50, P476, DOI 10.1002/1097-4679(199407)50:4<476::AID-JCLP2270500402>3.0.CO;2-9; Pressler SJ, 2009, AM J CRIT CARE, V18, P149, DOI 10.4037/ajcc2009300; Hoge T, 2004, J OCCUP HEALTH PSYCH, V9, P195, DOI 10.1037/1076-8998.9-3-195; Melamed S, 2006, PSYCHOSOM MED, V68, P863, DOI 10.1097/01.psy.0000242860.24009.f0; Togari T, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.056697; Feldt T, 2003, PERS INDIV DIFFER, V35, P1151, DOI 10.1016/S0191-8869(02)00325-2; Torsheim T, 2001, SOC SCI MED, V53, P603, DOI 10.1016/S0277-9536(00)00370-1; Chumbler NR, 2004, INT J GERIATR PSYCH, V19, P944, DOI 10.1002/gps.1187; Sorensen S, 2002, GERONTOLOGIST, V42, P356; SHINN M, 1984, J PERS SOC PSYCHOL, V46, P864, DOI 10.1037/0022-3514.46.4.864; Nilsson I, 2001, SCAND J CARING SCI, V15, P203, DOI 10.1046/j.1471-6712.2001.00008.x; Antonovsky A, 1987, UNRAVELING MYSTERY H; Apples A., 1991, BEHAV MED, V17, P53; Arai Yumiko, 2003, Nihon Ronen Igakkai Zasshi, V40, P497, DOI 10.3143/geriatrics.40.497; Berg A., 1999, PSYCHIAT MENTAL HLTH, V6, P371; Clark M. C., 2009, RES NURSING HLTH, V13, P1; Conaghy M. R., 2005, NURSING HLTH SCI, V7, P81; Cooper C, 2007, INT PSYCHOGERIATR, V19, P175, DOI 10.1017/S1041610206004297; Eriksson M, 2006, J EPIDEMIOL COMMUN H, V60, P376, DOI 10.1136/j.jech.2005.041616; FLANNERY RB, 1990, J CLIN PSYCHOL, V46, P415, DOI 10.1002/1097-4679(199007)46:4<415::AID-JCLP2270460407>3.0.CO;2-A; Greenlass ER, 1990, J HLTH HUMAN RESOURC, V13, P192; Hakanen JJ, 2007, J RES PERS, V41, P602, DOI 10.1016/j.jrp.2006.07.001; Hattori A., 2000, NIPPON RONEN IGAKKAI, V38, P799; Holley P. J., 2005, CONGESTIVE HEART FAI, V11, P303; Hubbell Larry, 2002, J Health Hum Serv Adm, V25, P115; Japan Ministry of Health Labour and Welfare, 2012, STAT HDB JAP 2012; LAHOZ MR, 1989, PSYCHOL REP, V64, P1059; Lewis S L, 1994, ANNA J, V21, P325; LUNDBERG O., 1995, EUROPEAN J PUBLIC HL, V5, P56, DOI 10.1093/eurpub/5.1.56; Makizako Hyuma, 2008, Nihon Ronen Igakkai Zasshi, V45, P59, DOI 10.3143/geriatrics.45.59; McCurry M. S., 2007, SLEEP MED REV, V11, P143; Miyashita M, 2009, J NEUROL SCI, V276, P148, DOI 10.1016/j.jns.2008.09.022; Okabayashi H, 2008, AGING MENT HEALTH, V12, P434, DOI 10.1080/13607860802224318; Quayhagen M., 1997, J MENTAL HLTH AGING, V3, P357; Rhee Y. S., 2009, J CLIN ONCOL, V26, P5890; Rittman M, 2009, J NEUROSCI NURS, V41, P39; Buddeberg-Fischer B, 2001, SOZ PRAVENTIV MED, V46, P404, DOI 10.1007/BF01321667; Schoenmakers B, 2009, EUR J GEN PRACT, V15, P99, DOI 10.1080/13814780903064455; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Schumann A, 2003, BRIT J HEALTH PSYCH, V8, P409, DOI 10.1348/135910703770238275; Tselebis A, 2001, Nurs Health Sci, V3, P69, DOI 10.1046/j.1442-2018.2001.00074.x; Volanen SM, 2007, SCAND J PSYCHOL, V48, P433, DOI 10.1111/j.1467-9450.2007.00598.x; Wiesmann U, 2006, Z GERONTOL GERIATR, V39, P90, DOI 10.1007/s00391-006-0322-5; Miura Hiroko, 2005, Nihon Ronen Igakkai Zasshi, V42, P328; Yamazaki Y., 1999, QUALITY NURSING, V5, P825	48	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0045-3102	1468-263X		BRIT J SOC WORK	Br. J. Soc. Work	DEC	2014	44	8					2360	2374		10.1093/bjsw/bct086		15	Social Work	Social Work	AW1LM	WOS:000346050900018		
J	Wen, YY; Miyake, H; Yen, YT; Irikura, K; Ching, KE				Wen, Yi-Ying; Miyake, Hiroe; Yen, Yin-Tung; Irikura, Kojiro; Ching, Kuo-En			Rupture Directivity Effect and Stress Heterogeneity of the 2013 Nantou Blind-Thrust Earthquakes, Taiwan	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							MOTION GENERATION AREA; 1999 CHI-CHI; STRUCTURAL MATURITY; GROUND MOTIONS; WAVES; INVERSION; SPECTRA; BENEATH	We investigated broadband evidence of the rupture directivity effect and estimated stress drop for the 2013 Nantou blind-thrust earthquakes (the 0327 and 0602 crustal events) from three individual analyses using empirical Green's functions: deconvolution source time function analysis, source spectral ratio analysis, and broadband waveform modeling of a strong-motion generation area. Although these two adjacent events have similar focal mechanisms, the 0327 event shows only up-dip directivity to the west, with an estimated stress drop of 9.0 MPa, and the 0602 event displays significant rupture directivity to the southwest, with an estimated stress drop of 14.2 MPa. The obvious variance in the rupture behavior and stress drop of these two nearby events, which might be related to immature blind faulting, suggests that this region requires additional study of the stress heterogeneity to better assess the seismic hazard.	[Wen, Yi-Ying] Natl Chung Cheng Univ, Dept Earth & Environm, Minhsiung Township 62102, Chia Yi County, Taiwan; [Miyake, Hiroe] Univ Tokyo, Earthquake Res Inst, Tokyo 1130032, Japan; [Yen, Yin-Tung] Sinotech Engn Consultants Inc, Taipei 11494, Taiwan; [Irikura, Kojiro] Aichi Inst Technol, Disaster Prevent Res Ctr, Toyota, Aichi 4700392, Japan; [Ching, Kuo-En] Natl Cheng Kung Univ, Dept Geomat, Tainan 70101, Taiwan	Wen, YY (reprint author), Natl Chung Cheng Univ, Dept Earth & Environm, Minhsiung Township 62102, Chia Yi County, Taiwan.	yiyingwen@ccu.edu.tw			Taiwan Earthquake Center (TEC) [00110]; National Science Council (NSC), Taiwan [NSC102-2116-M-194-013]	We thank Associate Editor Michel Bouchon and an anonymous reviewer for their helpful comments. We thank the Central Weather Bureau (CWB) of Taiwan and Broadband Array in Taiwan for Seismology (BATS) for providing high-quality seismic data. This research was supported by the Taiwan Earthquake Center (TEC) and funded through the National Science Council (NSC), Taiwan, with Grant Number NSC102-2116-M-194-013. The TEC contribution number for this article is 00110.	Aagaard BT, 2004, B SEISMOL SOC AM, V94, P155, DOI 10.1785/0120030053; Ammon J. C., 2005, SCIENCE, V308, P1133; VELASCO AA, 1994, B SEISMOL SOC AM, V84, P735; Miyake H, 2003, B SEISMOL SOC AM, V93, P2531, DOI 10.1785/0120020183; KIKUCHI M, 1982, B SEISMOL SOC AM, V72, P491; Oth A, 2013, EARTH PLANET SC LETT, V377, P132, DOI 10.1016/j.epsl.2013.06.037; MADARIAGA R, 1979, J GEOPHYS RES, V84, P2243, DOI 10.1029/JB084iB05p02243; BRUNE JN, 1971, J GEOPHYS RES, V76, P5002; Baltay A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046698; Carena S, 2002, GEOLOGY, V30, P935, DOI 10.1130/0091-7613(2002)030<0935:ADOTIB>2.0.CO;2; Chuang RY, 2013, GEOPHYS RES LETT, V40, P5080, DOI 10.1002/grl.51005; Kuo-Chen H, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009108; Orefice A, 2013, B SEISMOL SOC AM, V103, P2474, DOI 10.1785/0120120255; BRUNE JN, 1970, J GEOPHYS RES, V75, P4997, DOI 10.1029/JB075i026p04997; Manighetti I, 2007, EARTH PLANET SC LETT, V253, P429, DOI 10.1016/j.epsl.2006.11.004; Chu R, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039494; BOATWRIGHT J, 1988, B SEISMOL SOC AM, V78, P489; BOORE DM, 1978, B SEISMOL SOC AM, V68, P283; Central Geological Survey, 2013, GEOL SURV REP 201303; Central Geological Survey, 2013, GEOL SURV REP 201306; Cheng S.-N., 1999, PHOTOALBUM 10 DISAST; DER ZA, 1991, B SEISMOL SOC AM, V81, P2351; Irikura K., 1994, ANN GEOFIS, VXXXVII, P1721; Irikura K, 1986, P 7 JAP EARTHQ ENG S, p[151, 10]; Lay T, 1995, MODERN GLOBAL SEISMO; Miyake H, 2001, GEOPHYS RES LETT, V28, P2727, DOI 10.1029/2000GL011669; Miyake H, 1999, ZISIN, V51, P431; Radiguet M, 2009, B SEISMOL SOC AM, V99, P2572, DOI 10.1785/0120080340; Somerville P, 1999, SEISMOL RES LETT, V70, P59, DOI DOI 10.1785/GSSRL.70.1.59; Wang YJ, 2010, GEOPHYS J INT, V180, P891, DOI 10.1111/j.1365-246X.2009.04459.x; Wen YY, 2012, GEOPHYS J INT, V190, P379, DOI 10.1111/j.1365-246X.2012.05476.x; WESSEL P, 1998, EOS T AGU, V0079; Wu FT, 2004, GEOL SOC SPEC PUBL, V226, P333, DOI 10.1144/GSL.SP.2004.226.01.18; Yen YT, 2011, B SEISMOL SOC AM, V101, P464, DOI 10.1785/0120100046; Yue LF, 2005, J STRUCT GEOL, V27, P2058, DOI 10.1016/j.jsg.2005.05.020	35	2	2	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	DEC	2014	104	6					2933	2942		10.1785/0120140109		10	Geochemistry & Geophysics	Geochemistry & Geophysics	AW2RP	WOS:000346136800021		
J	Okayama, H; Schetter, AJ; Ishigame, T; Robles, AI; Kohno, T; Yokota, J; Takenoshita, S; Harris, CC				Okayama, Hirokazu; Schetter, Aaron J.; Ishigame, Teruhide; Robles, Ana I.; Kohno, Takashi; Yokota, Jun; Takenoshita, Seiichi; Harris, Curtis C.			The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts	CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION			English	Article							SQUAMOUS-CELL CARCINOMA; ADJUVANT CHEMOTHERAPY; SURVIVAL PREDICTION; CANCER PATIENTS; BREAST-CANCER; SIGNATURES; VALIDATION; METAANALYSES; ASSAY	Background: We previously developed a prognostic classifier using the expression levels of BRCA1, HIF1A, DLC1, and XPO1 that identified stage I lung adenocarcinoma patients with a high risk of relapse. That study evaluated patients in five independent cohorts from various regions of the world. In an attempt to further validate the classifier, we have used a meta-analysis-based approach to study 12 cohorts consisting of 1,069 tumor-node-metastasis stage I lung adenocarcinoma patients from every suitable, publically available dataset. Methods: Cohorts were obtained through a systematic search of public gene expression datasets. These data were used to calculate the risk score using the previously published 4-gene risk model. A fixed effect metaanalysis model was used to generate a pooled estimate for all cohorts. Results: The classifier was associated with prognosis in 10 of the 12 cohorts (P < 0.05). This association was highly consistent regardless of the ethnic diversity or microarray platform. The pooled estimate demonstrated that patients classified as high risk had worse overall survival for all stage I [HR, 2.66; 95% confidence interval (CI), 1.93-3.67; P < 0.0001] patients and in stratified analyses of stage IA (HR, 2.69; 95% CI, 1.66-4.35; P < 0.0001) and stage IB (HR, 2.69; 95% CI, 1.74-4.16; P < 0.0001) patients. Conclusions: The 4-gene classifier provides independent prognostic stratification of stage IA and stage IB patients beyond conventional clinical factors. Impact: Our results suggest that the 4-gene classifier may assist clinicians in decisions about the postoperative management of early-stage lung adenocarcinoma patients. (C) 2014 AACR.	[Okayama, Hirokazu; Schetter, Aaron J.; Ishigame, Teruhide; Robles, Ana I.; Harris, Curtis C.] NCI, Ctr Canc Res, Human Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA; [Kohno, Takashi] Natl Canc Ctr, Res Inst, Div Genome Biol, Tokyo 104, Japan; [Yokota, Jun] Inst Predict & Personalized Med Canc, Genom & Epigenom Canc Predict Program, Barcelona, Spain; [Takenoshita, Seiichi] Fukushima Med Univ, Sch Med, Dept Organ Regulatory Surg, Fukushima, Japan	Harris, CC (reprint author), NCI, Human Carcinogenesis Lab, NIH, 37 Convent Dr MSC4258,Bldg 37,Room 3068A, Bethesda, MD 20892 USA.	Curtis_Harris@nih.gov			Intramural Research Program of the National Cancer Institute, NIH; Department of Defense Congressionally Directed Medical Research Program [PR093793]	This work was supported by the Intramural Research Program of the National Cancer Institute, NIH and Department of Defense Congressionally Directed Medical Research Program Grant PR093793.	Akagi I, 2013, CANCER RES, V73, P3821, DOI 10.1158/0008-5472.CAN-13-0031; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Wilkerson MD, 2010, CLIN CANCER RES, V16, P4864, DOI 10.1158/1078-0432.CCR-10-0199; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Howington JA, 2013, CHEST, V143, pE278, DOI 10.1378/chest.12-2359; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Kratz JR, 2012, LANCET, V379, P823, DOI 10.1016/S0140-6736(11)61941-7; Lau SK, 2007, J CLIN ONCOL, V25, P5562, DOI 10.1200/JCO.2007.12.0352; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Chen DT, 2011, J NATL CANCER I, V103, P1859, DOI 10.1093/jnci/djr420; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Wistuba II, 2013, CLIN CANCER RES, V19, P6261, DOI 10.1158/1078-0432.CCR-13-0596; Zhu CQ, 2010, J CLIN ONCOL, V28, P4417, DOI 10.1200/JCO.2009.26.4325; Raz DJ, 2008, CLIN CANCER RES, V14, P5565, DOI 10.1158/1078-0432.CCR-08-0544; Wang Y, 2013, JPN J CLIN ONCOL, V43, P813, DOI 10.1093/jjco/hyt084; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Bianchi F, 2007, J CLIN INVEST, V117, P3436, DOI 10.1172/JC132007; Butts CA, 2010, J CLIN ONCOL, V28, P29, DOI 10.1200/JCO.2009.24.0333; Subramanian J, 2010, J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Church TR, 2013, NEW ENGL J MED, V368, P1980, DOI 10.1056/NEJMoa1209120; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Goncalves R, 2013, J NATL COMPR CANC NE, V11, P174; Botling J, 2013, CLIN CANCER RES, V19, P194, DOI 10.1158/1078-0432.CCR-12-1139; Tang H, 2013, CLIN CANCER RES, V19, P1577, DOI 10.1158/1078-0432.CCR-12-2321; Nitadori J, 2013, JNCI-J NATL CANCER I, V105, P1212, DOI 10.1093/jnci/djt166; Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; Larsen JE, 2007, CARCINOGENESIS, V28, P760, DOI 10.1093/carcin/bgl207; Matsuyama Y, 2011, MOL CARCINOGEN, V50, P301, DOI 10.1002/mc.20632; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Rousseaux S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005723; Sun ZF, 2008, J CLIN ONCOL, V26, P877, DOI 10.1200/JCO.2007.13.1516; Wilkerson MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036530; Yang M, 2012, EUR J CANCER, V49, P604	44	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1055-9965	1538-7755		CANCER EPIDEM BIOMAR	Cancer Epidemiol. Biomarkers Prev.	DEC	2014	23	12					2884	2894		10.1158/1055-9965.EPI-14-0182		11	Oncology; Public, Environmental & Occupational Health	Oncology; Public, Environmental & Occupational Health	AW0FU	WOS:000345967300030		
J	Yamamoto, N; Suyama, H; Nakazato, H; Yamamoto, N; Koga, Y				Yamamoto, Nobuto; Suyama, Hirofumi; Nakazato, Hiroaki; Yamamoto, Nobuyuki; Koga, Yoshihiko			Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF (Retraction of vol 57, pg 1007, 2008)	CANCER IMMUNOLOGY IMMUNOTHERAPY			English	Correction									[Yamamoto, Nobuto; Yamamoto, Nobuyuki] Socrates Inst Therapeut Immunol, Div Canc Immunol & Mol Immunol, Philadelphia, PA 19126 USA; [Suyama, Hirofumi] Nagasaki Immunotherapy Res Grp, Nagasaki, Japan; [Nakazato, Hiroaki] Yokoyama Gastroenterol Hosp, Nagoya, Aichi, Japan; [Koga, Yoshihiko] Nakagawa Hosp, Fukuoka 8111345, Japan; [Yamamoto, Nobuto] Socrates Inst Therapeut Immunol, Div Canc Immunol & Mol Biol, Philadelphia, PA 19126 USA	Yamamoto, N (reprint author), Socrates Inst Therapeut Immunol, Div Canc Immunol & Mol Biol, 1040,66th Ave, Philadelphia, PA 19126 USA.	nobutoyama@verizon.net					Yamamoto N, 2008, CANCER IMMUNOL IMMUN, V57, P1007, DOI 10.1007/s00262-007-0431-z	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0340-7004	1432-0851		CANCER IMMUNOL IMMUN	Cancer Immunol. Immunother.	DEC	2014	63	12					1349	1349		10.1007/s00262-014-1616-x		1	Oncology; Immunology	Oncology; Immunology	AW0EK	WOS:000345963000012		
J	Tanimine, N; Tanaka, Y; Kobayashi, T; Tashiro, H; Miki, D; Imamura, M; Aikata, H; Tanaka, J; Chayama, K; Ohdan, H				Tanimine, Naoki; Tanaka, Yuka; Kobayashi, Tsuyoshi; Tashiro, Hirotaka; Miki, Daiki; Imamura, Michio; Aikata, Hiroshi; Tanaka, Junko; Chayama, Kazuaki; Ohdan, Hideki			Quantitative Effect of Natural Killer-Cell Licensing on Hepatocellular Carcinoma Recurrence after Curative Hepatectomy	CANCER IMMUNOLOGY RESEARCH			English	Article							TRAIL; LIVER; HLA; RESPONSIVENESS; EDUCATION; ALLELES; FAMILY	Natural killer (NK) cells have a potential role in immune surveillance of hepatocellular carcinoma (HCC). Self-recognition of human leukocyte antigens (HLA) through killer immunoglobulin-like receptors (KIR) confers competence to NK cells-a process termed "licensing." We investigated the effect of NK-cell licensing on the susceptibility of patients to HCC recurrence. A total of 170 Japanese patients with HCC who underwent primary curative hepatectomy between 1996 and 2010 were enrolled in this study. The median follow-up period was 5.4 years. We analyzed their KIR-HLA genotypes with sequence-specific polymorphism-based typing and estimated their susceptibility to HCC recurrence by performing propensity score-matching analyses. The presence of KIR2DL1-C2, KIR2DL2-C1, KIR3DL1-BW4, or KIR3DL2-A3/11, functional compound genotypes that intrinsically license NK cells, did not markedly affect HCC recurrence. However, the multiplicity of those compound KIR-HLA genotypes was significantly associated with the HCC recurrence rate, i.e., the cumulative risk of recurrence in patients with at least three compound genotypes was significantly lower than that in patients with one or two compound genotypes, suggesting that the effect of NK-cell licensing on HCC recurrence is quantitative. Patients at high risk of HCC recurrence after curative hepatectomy could be identified by KIR-HLA genotyping. (C) 2014 AACR.	[Tanimine, Naoki; Tanaka, Yuka; Kobayashi, Tsuyoshi; Tashiro, Hirotaka; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima 7348551, Japan; [Tanimine, Naoki; Tanaka, Yuka; Kobayashi, Tsuyoshi; Tashiro, Hirotaka; Miki, Daiki; Imamura, Michio; Aikata, Hiroshi; Tanaka, Junko; Chayama, Kazuaki; Ohdan, Hideki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima 7348551, Japan; [Miki, Daiki; Chayama, Kazuaki] RIKEN, Ctr Genom Med, Lab Liver Dis, Hiroshima, Japan; [Imamura, Michio; Aikata, Hiroshi; Tanaka, Junko; Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima 7348551, Japan	Ohdan, H (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	hohdan@hiroshima-u.ac.jp			Japanese Ministry of Health, Labor, and Welfare;  [25670581]	This work was supported by a Research on Hepatitis and BSE grant from the Japanese Ministry of Health, Labor, and Welfare, and by a Grant-in-Aid for Challenging Exploratory Research (25670581).	Foley BA, 2008, BLOOD, V112, P435, DOI 10.1182/blood-2008-01-132902; Varchetta S, 2012, HEPATOLOGY, V56, P841, DOI 10.1002/hep.25723; Tian ZG, 2013, HEPATOLOGY, V57, P1654, DOI 10.1002/hep.26115; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Cariani E, 2013, CLIN CANCER RES, V19, P5465, DOI 10.1158/1078-0432.CCR-13-0986; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Tarek N, 2012, J CLIN INVEST, V122, P3260, DOI 10.1172/JCI62749; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Kim S, 2008, P NATL ACAD SCI USA, V105, P3053, DOI 10.1073/pnas.0712229105; Takayama T, 2000, LANCET, V356, P802, DOI 10.1016/S0140-6736(00)02654-4; Leung W, 2011, BRIT J HAEMATOL, V155, P14, DOI 10.1111/j.1365-2141.2011.08823.x; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Ohira M, 2006, TRANSPLANTATION, V82, P1712, DOI 10.1097/01.tp.0000250935.41034.2d; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Ishiyama K, 2006, HEPATOLOGY, V43, P362, DOI 10.1002/hep.21035; Ochi M, 2004, HEPATOLOGY, V39, P1321, DOI 10.1002/hep.20204; Beziat V, 2013, BLOOD, V121, P4703, DOI 10.1182/blood-2012-10-461442; Doskali Marlen, 2011, J Immunother, V34, P129, DOI 10.1097/CJI.0b013e3182048c4e; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Kobayashi T, 2011, J HEPATO-BIL-PAN SCI, V18, P689, DOI 10.1007/s00534-011-0379-4; Ohira M, 2009, J CLIN INVEST, V119, P3226, DOI 10.1172/JCI38374; Thoemmes F., PROPENSITY SCORE MAT; Uhrberg M, 2005, EUR J IMMUNOL, V35, P10, DOI 10.1002/eji.200425743; Vermijlen D, 2002, J LEUKOCYTE BIOL, V72, P668	25	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	2326-6066	2326-6074		CANCER IMMUNOL RES	Cancer Immunol. Res.	DEC	2014	2	12					1142	1147		10.1158/2326-6066.CIR-14-0091		6	Oncology; Immunology	Oncology; Immunology	AW2RE	WOS:000346135500003		
J	Kibe, S; Yutani, S; Motoyama, S; Nomura, T; Tanaka, N; Kawahara, A; Yamaguchi, T; Matsueda, S; Komatsu, N; Miura, M; Hinai, Y; Hattori, S; Yamada, A; Kage, M; Itoh, K; Akagi, Y; Sasada, T				Kibe, Shiro; Yutani, Shigeru; Motoyama, Satoru; Nomura, Takanobu; Tanaka, Natsuki; Kawahara, Akihiko; Yamaguchi, Tomohiko; Matsueda, Satoko; Komatsu, Nobukazu; Miura, Masatomo; Hinai, Yudai; Hattori, Satoshi; Yamada, Akira; Kage, Masayoshi; Itoh, Kyogo; Akagi, Yoshito; Sasada, Tetsuro			Phase II Study of Personalized Peptide Vaccination for Previously Treated Advanced Colorectal Cancer	CANCER IMMUNOLOGY RESEARCH			English	Article							SQUAMOUS-CELL CARCINOMA; CORONARY-HEART-DISEASE; INTERLEUKIN-6 RECEPTOR; GENETIC-POLYMORPHISM; IMMUNOTHERAPY; BLYS; RESPONSES; SURVIVAL; IMMUNITY; TRIALS	The prognosis of advanced colorectal cancer (aCRC) remains poor, and development of new therapeutic approaches, including immunotherapy, is needed urgently. Herein we report on our phase II study of personalized peptide vaccination (PPV) in 60 previously treated patients with aCRC, who had failed at least one regimen of standard chemotherapy and/or targeted therapy. For PPV, a maximum of four HLA-matched peptides were individually selected from a pool of 31 different peptide candidates based on preexisting host immunity, and administered subcutaneously without severe adverse events. Boosting of IgG and cytotoxic T lymphocyte (CTL) responses specific to the administered peptides was observed in 49% and 63%, respectively, of the patients, who completed the first cycles of six vaccinations. Median overall survival (OS) time was 498 days, with 1-and 2-year survival rates of 53% and 22%, respectively. Multivariate Cox regression analysis of prevaccination factors showed that plasma IL6, IP-10, and BAFF levels were significantly prognostic for OS [hazard ratio (HR), 1.508, P = 0.043; HR, 1.579, P = 0.024; HR, 0.509, P = 0.002, respectively]. In addition, increased peptide-specific CTL responses after vaccination were significantly predictive of favorable OS (HR, 0.231; P = 0.021), suggesting a causal relationship between biologic and clinical efficacy of PPV. On the basis of the safety profile and potential clinical efficacy, we believe that clinical trials of PPV would be warranted for previously treated patients with aCRC. (C) 2014 AACR.	[Kibe, Shiro; Tanaka, Natsuki; Akagi, Yoshito] Kurume Univ, Sch Med, Dept Surg, Kurume, Fukuoka 8300011, Japan; [Yutani, Shigeru; Matsueda, Satoko; Itoh, Kyogo; Sasada, Tetsuro] Kurume Univ, Canc Vaccine Ctr, Kurume, Fukuoka 8300011, Japan; [Motoyama, Satoru] Akita Univ, Grad Sch Med, Dept Surg & Comprehens Canc Control, Akita 010, Japan; [Nomura, Takanobu; Hattori, Satoshi] Kurume Univ, Ctr Biostat, Kurume, Fukuoka 8300011, Japan; [Kawahara, Akihiko; Yamaguchi, Tomohiko] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka 8300011, Japan; [Komatsu, Nobukazu; Sasada, Tetsuro] Kurume Univ, Sch Med, Dept Immunol & Immunotherapy, Kurume, Fukuoka 8300011, Japan; [Miura, Masatomo; Hinai, Yudai] Akita Univ Hosp, Dept Pharm, Akita, Japan; [Yamada, Akira; Kage, Masayoshi] Kurume Univ, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 8300011, Japan	Sasada, T (reprint author), Kurume Univ, Sch Med, Dept Immunol & Immunotherapy, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.	tsasada@med.kurume-u.ac.jp			research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan; research program of the Regional Innovation Cluster Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan	This study was supported by a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), Ministry of Education, Culture, Sports, Science and Technology of Japan, and a research program of the Regional Innovation Cluster Program of the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742; Amos SM, 2011, BLOOD, V118, P499, DOI 10.1182/blood-2011-01-325266; Motoyama S, 2013, ANN SURG ONCOL, V20, P1978, DOI 10.1245/s10434-012-2765-9; Disis ML, 2011, CANCER IMMUNOL IMMUN, V60, P433, DOI 10.1007/s00262-010-0960-8; MULLBERG J, 1994, J IMMUNOL, V152, P4958; Hoos A, 2010, J NATL CANCER I, V102, P1388, DOI 10.1093/jnci/djq310; Lopez MN, 2009, J CLIN ONCOL, V27, P945, DOI 10.1200/JCO.2008.18.0794; Yang SH, 2011, ANN SURG ONCOL, V18, P1907, DOI 10.1245/s10434-011-1575-9; Sanchez-Perez L, 2013, CANCER IMMUNOL IMMUN, V62, P983, DOI 10.1007/s00262-013-1405-y; Noguchi M, 2010, CANCER IMMUNOL IMMUN, V59, P1001, DOI 10.1007/s00262-010-0822-4; Terasaki M, 2011, J CLIN ONCOL, V29, P337, DOI 10.1200/JCO.2010.29.7499; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Ognjanovic S, 2010, CANCER CAUSE CONTROL, V21, P1131, DOI 10.1007/s10552-010-9540-7; Noguchi M, 2013, CANCER IMMUNOL IMMUN, V62, P919, DOI 10.1007/s00262-012-1379-1; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Lagmay JP, 2009, CLIN CANCER RES, V15, P5234, DOI 10.1158/1078-0432.CCR-08-2953; Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Dosenovic P, 2012, J IMMUNOL, V188, P6018, DOI 10.4049/jimmunol.1200466; Komatsu N, 2004, SCAND J CLIN LAB INV, V64, P535, DOI 10.1080/00365510410007008; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Cancro MP, 2004, IMMUNOL REV, V202, P237, DOI 10.1111/j.0105-2896.2004.00212.x; Matsueda S, 2013, DEV COMP IMMUNOL, V41, P68, DOI 10.1016/j.dci.2013.04.004; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Sasada T, 2014, CURR MED CHEM, V21, P2332; Koido S, 2013, WORLD J GASTROENTERO, V19, P8531, DOI 10.3748/wjg.v19.i46.8531; Ferreira RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003444; Gor DO, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-9; Hattori T, 2009, CANCER IMMUNOL IMMUN, V58, P1845, DOI 10.1007/s00262-009-0695-6; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Motoyama S, 2012, DIGEST SURG, V29, P194, DOI 10.1159/000336952; Noguchi M, 2011, CANCER BIOL THER, V10, P1266; Sato Y, 2007, CANCER SCI, V98, P1113, DOI 10.1111/j.1349-7006.2007.00498.x; Speetjens FM, 2011, EXPERT REV VACCINES, V10, P899, DOI [10.1586/erv.11.63, 10.1586/ERV.11.63]; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X	35	2	2	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	2326-6066	2326-6074		CANCER IMMUNOL RES	Cancer Immunol. Res.	DEC	2014	2	12					1154	1162		10.1158/2326-6066.CIR-14-0035		9	Oncology; Immunology	Oncology; Immunology	AW2RE	WOS:000346135500005		
J	Mariya, T; Hirohashi, Y; Torigoe, T; Asano, T; Kuroda, T; Yasuda, K; Mizuuchi, M; Sonoda, T; Saito, T; Sato, N				Mariya, Tasuku; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Asano, Takuya; Kuroda, Takafumi; Yasuda, Kazuyo; Mizuuchi, Masahito; Sonoda, Tomoko; Saito, Tsuyoshi; Sato, Noriyuki			Prognostic Impact of Human Leukocyte Antigen Class I Expression and Association of Platinum Resistance with Immunologic Profiles in Epithelial Ovarian Cancer	CANCER IMMUNOLOGY RESEARCH			English	Article							DOWN-REGULATION; T-CELL; FAVORABLE PROGNOSIS; IMMUNE SURVEILLANCE; TUMOR; CARCINOMA; INFILTRATION; MOLECULES; CHEMOTHERAPY; GEMCITABINE	Epithelial ovarian cancer (EOC) is one of the most deadly carcinomas in females. Immune systems can recognize EOCs; however, a defect of human leukocyte antigen (HLA) class I expression is known to be a major mechanism for escape from immune systems, resulting in poor prognosis. The purpose of this study is to identify novel correlations between immunologic responses and other clinical factors. We investigated the expression of immunologic components in 122 cases of EOCs for which surgical operations were performed between 2001 and 2011. We immunohistochemically stained EOC specimens using an anti-pan HLA class I monoclonal antibody (EMR8-5) and anti-CD3, -CD4, and -CD8 antibodies, and we analyzed correlations between immunologic parameters and clinical factors. In multivariate analysis that used the Cox proportional hazards model, independent prognostic factors for overall survival in advanced EOCs included low expression level of HLA class I [risk ratio (RR), 1.97; 95% confidence interval (CI), 1.01-3.83; P = 0.046] and loss of intraepithelial cytotoxic T lymphocyte (CTL) infiltration (RR, 2.11; 95% CI, 1.06-4.20; P = 0.033). Interestingly, almost all platinum-resistant cases showed a significantly low rate of intraepithelial CTL infiltration in the x 2 test (positive vs. negative: 9.0% vs. 97.7%; P < 0.001). Results from a logistic regression model revealed that low CTL infiltration rate was an independent factor of platinum resistance in multivariate analysis (OR, 3.77; 95% CI, 1.08-13.12; P = 0.037). Platinum-resistant EOCs show poor immunologic responses. The immune escape system of EOCs may be one of the mechanisms of platinum resistance. (C) 2014 AACR.	[Mariya, Tasuku; Hirohashi, Yoshihiko; Torigoe, Toshihiko; Asano, Takuya; Kuroda, Takafumi; Yasuda, Kazuyo; Mizuuchi, Masahito; Sato, Noriyuki] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido 0608556, Japan; [Mariya, Tasuku; Asano, Takuya; Kuroda, Takafumi; Mizuuchi, Masahito; Saito, Tsuyoshi] Sapporo Med Univ, Sch Med, Dept Obstet & Gynecol, Sapporo, Hokkaido 0608556, Japan; [Sonoda, Tomoko] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido 0608556, Japan	Mariya, T (reprint author), Sapporo Med Univ, Sch Med, Dept Pathol, Chuo Ku, South 1 West 17, Sapporo, Hokkaido 0608556, Japan.	mariya.tasuku@sapmed.ac.jp; hirohash@sapmed.ac.jp; torigoe@sapmed.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Takeda Science Foundation; Sagawa Foundation for Promotion of Cancer Research; Suharakinenzaidan Co., Ltd.; Kobayashi foundation for cancer research; Northern Advancement Center for Science & Technology of Hokkaido Japan	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N. Sato), program for developing the supporting system for upgrading education and research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to N. Sato) and Takeda Science Foundation (to Y. Hirohashi), Sagawa Foundation for Promotion of Cancer Research (to Y. Hirohashi), Suharakinenzaidan Co., Ltd. (to Y. Hirohashi) and Kobayashi foundation for cancer research (to Y. Hirohashi). This study was supported, in part, by Grants-in-Aid for Regional R&D Proposal-Based Program from Northern Advancement Center for Science & Technology of Hokkaido Japan (to Y. Hirohashi and T. Torigoe).	Algarra I, 2004, CANCER IMMUNOL IMMUN, V53, P904, DOI 10.1007/s00262-004-0517-9; Brabec V, 2005, DRUG RESIST UPDATE, V8, P131, DOI 10.1016/j.drup.2005.04.006; Vitale M, 2005, CLIN CANCER RES, V11, P67; Yamada N, 2010, CANCER IMMUNOL IMMUN, V59, P1543, DOI 10.1007/s00262-010-0881-6; Rolland P, 2007, CLIN CANCER RES, V13, P3591, DOI 10.1158/1078-0432.CCR-06-2087; Mizukami Y, 2008, BRIT J CANCER, V99, P1462, DOI 10.1038/sj.bjc.6604715; Desoize B, 2002, CRIT REV ONCOL HEMAT, V42, P317, DOI 10.1016/S1040-8428(01)00219-0; Bubenik J, 2004, INT J ONCOL, V25, P487; Han LY, 2008, CLIN CANCER RES, V14, P3372, DOI 10.1158/1078-0432.CCR-07-4433; Markman M, 2004, GYNECOL ONCOL, V93, P699, DOI 10.1016/j.ygyno.2004.03.023; Molon B, 2011, J EXP MED, V208, P1949, DOI 10.1084/jem.20101956; Abiko K, 2013, CLIN CANCER RES, V19, P1363, DOI 10.1158/1078-0432.CCR-12-2199; Monk BJ, 2013, ANN ONCOL, V24, P53, DOI 10.1093/annonc/mdt472; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Melero I, 2014, CANCER DISCOV, V4, P522, DOI 10.1158/2159-8290.CD-13-0985; Kikuchi E, 2007, CANCER SCI, V98, P1424, DOI 10.1111/j.1349-7006.2007.00558.x; Suzuki S, 2014, HUM VACC IMMUNOTHER, V10, P338, DOI 10.4161/hv.27217; Kartalou M, 2001, MUTAT RES-FUND MOL M, V478, P23, DOI 10.1016/S0027-5107(01)00141-5; Aptsiauri N, 2007, INT REV CYTOL, V256, P139, DOI 10.1016/S0074-7696(07)56005-5; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Kanaseki T, 2013, J IMMUNOL, V191, P1547, DOI 10.4049/jimmunol.1301043; Hammer GE, 2007, NAT IMMUNOL, V8, P101, DOI 10.1038/ni1409; Hamanishi J, 2007, P NATL ACAD SCI USA, V104, P3360, DOI 10.1073/pnas.0611533104; Tsukahara T, 2006, CANCER SCI, V97, P1374, DOI 10.1111/j.1349-7006.2006.00317.x; Chang CL, 2013, CANCER RES, V73, P119, DOI 10.1158/0008-5472.CAN-12-2225; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Hirohashi Y, 2009, CANCER SCI, V100, P798, DOI 10.1111/j.1349-7006.2009.01137.x; Ishigami S, 2012, CANCER IMMUNOL IMMUN, V61, P1663, DOI 10.1007/s00262-012-1225-5; Katsumata N, 2013, LANCET ONCOL, V14, P1020, DOI 10.1016/S1470-2045(13)70363-2; Marincola F M, 2000, Adv Immunol, V74, P181, DOI 10.1016/S0065-2776(08)60911-6; Niwa Y, 2005, J OBSTET GYNAECOL RE, V31, P452, DOI 10.1111/j.1447-0756.2005.00319.x; Rose PG, 2003, GYNECOL ONCOL, V88, P17, DOI 10.1006/gyno.2002.6850; Sabbatini P, 2007, J CLIN ONCOL, V25, P2884, DOI 10.1200/JCO.2007.11.0775; Safra T, 2014, ANTI-CANCER DRUG, V25, P340, DOI 10.1097/CAD.0000000000000042; Sedletska Yuliya, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P251, DOI 10.2174/1568011053765967; Shehata M, 2009, BRIT J CANCER, V101, P1321, DOI 10.1038/sj.bjc.6605315; Torigoe T, 2012, PATHOL INT, V62, P303, DOI 10.1111/j.1440-1827.2012.02789.x; Yabe H, 2011, J SURG ONCOL, V103, P380, DOI 10.1002/jso.21829	40	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	2326-6066	2326-6074		CANCER IMMUNOL RES	Cancer Immunol. Res.	DEC	2014	2	12					1220	1229		10.1158/2326-6066.CIR-14-0101		10	Oncology; Immunology	Oncology; Immunology	AW2RE	WOS:000346135500011		
J	Hegedus, P; Korkmaz, S; Radovits, T; Schmidt, H; Li, SL; Yoshikawa, Y; Yasui, H; Merkely, B; Karck, M; Szabo, G				Hegedus, Peter; Korkmaz, Sevil; Radovits, Tamas; Schmidt, Harald; Li, Shiliang; Yoshikawa, Yutaka; Yasui, Hiroyuki; Merkely, Bela; Karck, Matthias; Szabo, Gabor			Bis (Aspirinato) Zinc (II) Complex Successfully Inhibits Carotid Arterial Neointima Formation after Balloon-injury in Rats	CARDIOVASCULAR DRUGS AND THERAPY			English	Article						Neointima; Restenosis; Bis (aspirinato) zinc; Balloon-injury	SMOOTH-MUSCLE-CELLS; CORONARY ANGIOPLASTY; PROLIFERATION; HYPERPLASIA; RESTENOSIS; MIGRATION; CYTOKINES; DISEASE; MICE	Neointima formation following angioplasty is a serious consequence of endothelial damage in arteries. Inflammatory mediators and lack of endothelial regulatory mechanisms lead to migration and proliferation of smooth-muscle cells and thus to restenosis. This study examines the effect of the novel bis (aspirinato) zinc (II) complex on neointima formation in a rat model of carotid balloon-injury. Rats underwent balloon-injury of the right common carotid artery, then received PEG400 vehicle (untreated-group), acetylsalicylic-acid (ASA-group), zinc-chloride (Zn-group) and bis (aspirinato) zinc (II) complex (Zn(ASA) (2)-group) orally for 18 consecutive days. From harvested carotid arteries, histology, immunohistochemistry and mRNA expression analysis were performed. Compared to the untreated-group, Zn (ASA) (2)-treatment significantly lowered stenosis ratio (54.0 +/- 5.8 % to 25.5 +/- 3.9 %) and reduced neointima/media ratio (1.5 +/- 0.2 to 0.5 +/- 0.1). Significantly higher alpha smooth muscle actin mRNA and protein expression were measured after Zn (ASA)(2) and Zn-treatment in comparison with the untreated and ASA-groups while the expression of matrix-metalloproteinase-9 was significantly higher in these groups compared to Zn (ASA)(2). The presence of collagen in media was significantly decreased in all treated groups. mRNA expressions of nuclear factor kappa-b, transforming growth-factor-beta and proliferating cell nuclear antigen were significantly down-regulated, whereas a20 was up-regulated by Zn (ASA)(2) treatment compared to the untreated and ASA-groups. This study proves the effectivity of the novel bis (aspirinato) zinc complex in reducing neointima formation and restenosis after balloon-injury and supports the hypothesis that inhibition of smooth-muscle transformation/proliferation plays a key role in the prevention of restenosis.	[Hegedus, Peter; Korkmaz, Sevil; Schmidt, Harald; Li, Shiliang; Karck, Matthias; Szabo, Gabor] Heidelberg Univ, Dept Cardiac Surg, D-69120 Heidelberg, Germany; [Hegedus, Peter; Radovits, Tamas; Merkely, Bela] Semmelweis Univ, Heart & Vasc Ctr, H-1085 Budapest, Hungary; [Yoshikawa, Yutaka; Yasui, Hiroyuki] Kyoto Pharmaceut Univ, Dept Analyt & Bioinorgan Chem, Kyoto 607, Japan	Hegedus, P (reprint author), Heidelberg Univ, Dept Cardiac Surg, INF 326, D-69120 Heidelberg, Germany.	phegedues@gmail.com			Land Baden-Wurttemberg, Germany; Medical Faculty of the University of Heidelberg, Germany; School of PhD Studies, Semmelweis University, Hungary; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	This study was supported by the Land Baden-Wurttemberg, Germany, by the Medical Faculty of the University of Heidelberg, Germany (to S. Korkmaz), by the School of PhD Studies, Semmelweis University, Hungary (to P. Hegedus), and by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences (to T. Radovits).	Hirschberg K, 2009, J THORAC CARDIOV SUR, V137, P1508, DOI 10.1016/j.jtcvs.2008.10.016; Jeremy JY, 1999, CARDIOVASC RES, V43, P580, DOI 10.1016/S0008-6363(99)00171-6; Hirschberg K, 2013, INT J CARDIOL, V167, P470, DOI 10.1016/j.ijcard.2012.01.032; Jugdutt BI, 2007, CIRCULATION, V115, P288, DOI 10.1161/CIRCULATIONAHA.106.675306; Bao B, 2003, AM J PHYSIOL-ENDOC M, V285, pE1095, DOI 10.1152/ajpendo.00545.2002; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Prasad AS, 2004, FREE RADICAL BIO MED, V37, P1182, DOI 10.1016/j.freeradbiomed.2004.07.007; Simon DI, 2012, CIRC J, V76, P1811, DOI 10.1253/circj.CJ-12-0801; Ashino T, 2013, ARTERIOSCL THROM VAS, V33, P760, DOI 10.1161/ATVBAHA.112.300614; Moreno PR, 1996, CIRCULATION, V94, P3098; CLOWES AW, 1983, LAB INVEST, V49, P327; Austin KM, 2013, J BIOL CHEM; Bao B, 2010, AM J CLIN NUTR, V91, P1634, DOI 10.3945/ajcn.2009.28836; Berger M, 2004, ATHEROSCLEROSIS, V175, P229, DOI 10.1016/j.atherosclerosis.2004.03.022; BLOCK PC, 1990, CIRCULATION, V81, P2; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Daniel JM, 2010, ARTERIOSCL THROM VAS, V30, P1890, DOI 10.1161/ATVBAHA.110.209692; Masferrer JL, 2000, P NATL ACAD SCI USA, V97, P12400, DOI 10.1073/pnas.240459597; Mickelson JK, 1996, J AM COLL CARDIOL, V28, P345, DOI 10.1016/0735-1097(96)00164-7; Oinuma T, 1997, J Atheroscler Thromb, V4, P79; Prasad AS, 2011, NUTRITION, V27, P816, DOI 10.1016/j.nut.2010.08.010; Reis ED, 2000, P NATL ACAD SCI USA, V97, P12764, DOI 10.1073/pnas.210394497; SINGLA AK, 1994, INT J PHARM, V108, P173, DOI 10.1016/0378-5173(94)90126-0; Tahir H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066138; Yoshikawa Y, 2011, CHEM PHARM BULL, V59, P972	25	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-3206	1573-7241		CARDIOVASC DRUG THER	Cardiovasc. Drugs Ther.	DEC	2014	28	6					533	539		10.1007/s10557-014-6549-2		7	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	AW3EK	WOS:000346168500005		
J	Fujii, R; Ota, H; Toda, M				Fujii, Ryo; Ota, Hidetoshi; Toda, Mamoru			Genetic and Morphological Assessments of Hybridization Between Two Non-Native Geoemydid Turtles, Mauremys reevesii and Mauremys mutica, in Northcentral Japan	CHELONIAN CONSERVATION AND BIOLOGY			English	Article						interspecific hybridization; allozyme; SINE; introgression; backcross; Mauremys; turtle; Japan	HYBRID ZONES; RARE HYBRIDIZATION; FAMILY GEOEMYDIDAE; CHINESE TURTLES; SPECIATION; ORIGIN; ELECTROPHORESIS; INTROGRESSION; MITOCHONDRIAL; ENVIRONMENT	Interspecific hybridization has been occasionally reported for various combinations of geoemydid turtles, but genetic consequences of such hybridization have rarely been investigated. We surveyed the hybrid status of 40 individuals from a seemingly hybridizing turtle assemblage in a natural pond in northcentral Honshu, Japan. Analysis of mtDNA sequences confirmed that the parental species of this assemblage were Mauremys reevesii (Chinese three-keeled pond turtle) and Mauremys mutica (Asian yellow pond turtle), neither of which is native to the main islands of Japan, although M. reevesii was naturalized in the area before the 19th century. Extensive examination of pure strain samples of the 2 species yielded 10 morphological and 10 genetic diagnostic characters (allozyme and short interspersed repetitive elements) that were used to determine the hybrid status of the turtles in the assemblage. Morphological examination showed that 19 out of 40 individuals were not different from pure M. reevesii individuals, but the remaining 21 individuals exhibited M. mutica states at 1 to 6 characters, indicating interspecific crosses at a moderate to large scale. In the genetic characters, however, only 2 of the 21 individuals possessed marker alleles of M. mutica at a few loci and all others possessed alleles of M. reevesii only; thus neither pure M. mutica nor F1 hybrids were included in the assemblage. These results suggest that iterative backcrosses with pure M. reevesii have occurred. In the analysis using the genetic hybrid index (GHI), which was defined as the number of M. mutica type alleles over the 10 examined loci, the 2 individuals scored 5 and 2, respectively, and all others scored 0. This discrete distribution of GHI scores negates an assumption of a random mating hybrid swarm but suggests that these two individuals emerged by a different hybridization event, independent from that leading to the many other putative hybrids detected by morphological characters only. Our results suggest that even though the hybrid genotypes rarely prevailed in the population, once introgressed genes were diluted by successive backcrosses, they could have been retained over many generations.	[Fujii, Ryo] Univ Ryukyus, Grad Sch Engn & Sci, Nishihara, Okinawa 9030213, Japan; [Ota, Hidetoshi] Univ Hyogo, Inst Nat & Environm Sci, Sanda, Hyogo 6691546, Japan; [Toda, Mamoru] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 9030213, Japan	Toda, M (reprint author), Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa 9030213, Japan.	chinemys@hotmail.com; ota@sci.u-ryukyu.ac.jp; gekko@lab.u-ryukyu.ac.jp			21st Century COE Program at University of the Ryukyus; Japan Ministry of Education, Culture, Sports, Science and Technology [C-24570110]	We would like to express our sincere thanks to Y. Yasukawa and A. Takahashi for their help in morphological examinations of specimens. R.F. is deeply indebted to Professor Y. Hara for his advice and encouragement throughout the study. We also thank the 2 reviewers for their insightful comments on the manuscript. This research was supported by a Grant for Graduate Researches from The 21st Century COE Program at University of the Ryukyus (to R.F.) and a Grant-in-Aid from the Japan Ministry of Education, Culture, Sports, Science and Technology (C-24570110 to HO).	BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Noor MAF, 2006, NAT REV GENET, V7, P851, DOI 10.1038/nrg1968; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; Sasaki T, 2004, MOL BIOL EVOL, V21, P705, DOI 10.1093/molbev/msh069; Shaffer HB, 1997, SYST BIOL, V46, P235, DOI 10.2307/2413622; Spinks PQ, 2004, MOL PHYLOGENET EVOL, V32, P164, DOI 10.1016/j.ympev.2003.12.015; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Fong JJ, 2010, CONSERV GENET, V11, P2061, DOI 10.1007/s10592-010-0066-z; Stuart BL, 2007, CONSERV GENET, V8, P169, DOI 10.1007/s10592-006-9159-0; BARTON NH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P13; BARTH D., 2003, SALAMANDRA, V38, P233; BOYER SH, 1963, SCIENCE, V141, P642, DOI 10.1126/science.141.3581.642; Buskirk James R., 2005, Salamandra, V41, P21; CLAYTON JW, 1972, J FISH RES BOARD CAN, V29, P1169; Coyne J. A., 2004, SPECIATION; ERNST C. H., 2000, TURTLES WORLD; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Fritz U, 2008, J EVOLUTION BIOL, V21, P527, DOI 10.1111/j.1420-9101.2007.01485.x; GIBBONS J.W., 1990, HERPETOL MONOGR, V4, P1, DOI 10.2307/1466966; Goodman SJ, 1999, GENETICS, V152, P355; Haramura Takashi, 2008, Current Herpetology, V27, P101, DOI 10.3105/1881-1019-27.2.101; Harrison R.G., 1993, HYBRID ZONES EVOLUTI; Iverson JB., 1992, REVISED CHECKLIST DI; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; KOBAYASHI R., 2005, B HERPETOLGOICAL SOC, V2005, P150; Lovich J. E., 2011, CHELONIAN RES MONOGR, V5; McCord William P., 1997, Chelonian Conservation and Biology, V2, P555; Murphy Robert W., 1996, P51; OTANI T., 1995, AKAMATA, V11, P25; Parham JF, 2001, ANIM CONSERV, V4, P357; RIDGWAY GJ, 1970, T AM FISH SOC, V99, P147, DOI 10.1577/1548-8659(1970)99<147:PITEOA>2.0.CO;2; Sasaki T, 2006, SYSTEMATIC BIOL, V55, P912, DOI 10.1080/10635150601058014; Shi HT, 2005, AMPHIBIA-REPTILIA, V26, P377, DOI 10.1163/156853805774408487; SHOW C. R., 1970, BIOCH GENET, V4, P297; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Suzuki D, 2011, CHELONIAN CONSERV BI, V10, P237; Tominaga A, 2010, MOL PHYLOGENET EVOL, V54, P910, DOI 10.1016/j.ympev.2009.11.002; Wink Michael, 2001, Zoologische Abhandlungen (Dresden), V51, P41; Yabe Takashi, 1994, Japanese Journal of Herpetology, V15, P131; YASUKAWA Y., 1996, ENCY ANIMALS JAPAN, V5, P59; Yasukawa Y, 1996, ZOOL SCI, V13, P303, DOI 10.2108/zsj.13.303	46	0	0	CHELONIAN RESEARCH FOUNDATION	LUNENBURG	168 GOODRICH ST., LUNENBURG, MA USA	1071-8443	1943-3956		CHELONIAN CONSERV BI	Chelonian Conserv. Biol.	DEC	2014	13	2					191	201				11	Zoology	Zoology	AW2PY	WOS:000346132000008		
J	Kawazu, I; Maeda, K; Koyago, M; Nakada, K; Sawamukai, Y				Kawazu, Isao; Maeda, Konomi; Koyago, Masanori; Nakada, Ken; Sawamukai, Yutaka			Semen Evaluation of Captive Hawksbill Turtles	CHELONIAN CONSERVATION AND BIOLOGY			English	Article							LOGGERHEAD SEA-TURTLES; ARTIFICIAL-INSEMINATION; ERETMOCHELYS-IMBRICATA; CARETTA-CARETTA; SPERM; SPERMATOZOA; MOTILITY; PH; THYROXINE; OVULATION	This study presented information about the semen evaluation of captive male hawksbill sea turtles, Eretmochelys imbricata, based on an extended 15-mo study using the electro-ejaculation technique. In particular, we demonstrated that hawksbill sperm, which is underactive just after ejaculation, was activated by the presence of urine. The findings are useful for developing optimal semen collection techniques for future artificial insemination programs of hawksbill turtles.	[Kawazu, Isao; Maeda, Konomi] Okinawa Churashima Fdn, Motobu, Okinawa 9050206, Japan; [Koyago, Masanori] Livestock Improvement Assoc JAPAN, Morioka, Iwate 0284134, Japan; [Nakada, Ken] Rakuno Gakuen Univ, Ebetsu, Hokkaido 0698501, Japan; [Sawamukai, Yutaka] Yokoo Vet Clin, Nasushiobara, Tochigi 3292801, Japan	Kawazu, I (reprint author), Okinawa Churashima Fdn, 888 Ishikawa, Motobu, Okinawa 9050206, Japan.	I-kawazu@okichura.jp; Ko-maeda@okichura.jp; earth-sh@hb.tp1.jp; kenn@rakuno.ac.jp; yutaka-s@sa2.so-net.ne.jp			Okinawa Churashima Foundation	We express our deep gratitude to Dr. S. Uchida (Director Emeritus) and H. Miyahara (Director) of Okinawa Churaumi Aquarium for providing us with valuable suggestions and comments on this study. We also thank M. Nishimaru of Genetics Hokkaido Association for advice on semen collection techniques of domestic animals and Dr. M. Nakamura of Okinawa Churashima Foundation for advice about preparing this manuscript. We also thank the anonymous reviewers for constructive suggestions that helped us improve the manuscript.	Alavi SMH, 2005, CELL BIOL INT, V29, P101, DOI 10.1016/j.cellbi.2004.11.021; GIST DH, 1989, J MORPHOL, V199, P379, DOI 10.1002/jmor.1051990311; WIBBELS T, 1990, GEN COMP ENDOCR, V79, P154, DOI 10.1016/0016-6480(90)90099-8; PRAKASH BS, 1987, J STEROID BIOCHEM, V28, P623, DOI 10.1016/0022-4731(87)90389-X; Griggers S, 2001, THERIOGENOLOGY, V56, P613, DOI 10.1016/S0093-691X(01)00593-3; Bjorndahl L, 2003, HUM REPROD, V18, P813, DOI 10.1093/humrep/deg199; [Anonymous], 1980, P AM ASS ZOO VET; Jessop TS, 2004, MAR ECOL PROG SER, V276, P281, DOI 10.3354/meps276281; Wood F., 1982, British Journal of Herpetology, V6, P200; Kamel SJ, 2009, J HERPETOL, V43, P367; CHRISTEN R, 1982, J BIOL CHEM, V257, P4881; Cosson J, 2012, SPERM CELL RES 21 CE, P152; Foote R. H., 2002, J ANIM SCI, V80, P1; Gist DH, 2000, J REPROD FERTIL, V119, P271, DOI 10.1530/reprod/119.2.271; HAMANN M., 2003, BIOL SEA TURTLES, VII, P135; IUCN (International Union for Conservation of Nature), 2008, IUCN RED LIST THREAT; Kawazu Isao, 2014, Current Herpetology, V33, P88, DOI 10.5358/hsj.33.88; KOBAYASHI M., 2006, P 3 INT S SEASTAR200, P13; LICHT P, 1985, GEN COMP ENDOCR, V57, P335, DOI 10.1016/0016-6480(85)90212-6; Manire CA, 2008, ZOO BIOL, V27, P213, DOI 10.1002/zoo.20171; Miller JD, 1997, BIOL SEA TURTLES, V1, P51; MIYAKE Y., 2006, THERIOGENOLOGY, P109; MOORE HDM, 1984, J ZOOL, V203, P269; Mortimer JA, 2008, MARINE TURTLE SPECIA; OWENS DW, 1980, AM ZOOL, V20, P549; Owens DW, 2013, P INT S REPR MAR LIF, P23; PLATZ CC, 1978, J REPROD FERTIL, V52, P279; Rodger JC, 2009, THERIOGENOLOGY, V71, P176, DOI 10.1016/j.theriogenology.2008.09.006; Rostal DC, 2005, CHELONIAN CONSERV BI, V4, P788; Rostal DC, 1998, GEN COMP ENDOCR, V109, P232, DOI 10.1006/gcen.1997.7026; Santos I. P., 2011, Animal Reproduction, V8, P73; Shimizu T, 2005, P 2 INT S SEASTAR200, P69; TANASANTI M., 2009, P 4 INT S SEASTAR200, P29; Taya K, 1985, JAPANESE J ANIMAL RE, V31, P186; TSUTSUI T., 2002, NEWEST TEXT THERIOGE, P91; Valente ALS, 2011, VET J, V187, P255, DOI 10.1016/j.tvjl.2009.11.022; Zee YP, 2007, REPROD FERT DEVELOP, V19, P850, DOI 10.1071/RD07084	37	0	0	CHELONIAN RESEARCH FOUNDATION	LUNENBURG	168 GOODRICH ST., LUNENBURG, MA USA	1071-8443	1943-3956		CHELONIAN CONSERV BI	Chelonian Conserv. Biol.	DEC	2014	13	2					271	U186				8	Zoology	Zoology	AW2PY	WOS:000346132000018		
J	Okuyama, J; Kagawa, S; Arai, N				Okuyama, Junichi; Kagawa, Shiro; Arai, Nobuaki			Random Mate Searching: Male Sea Turtle Targets Juvenile for Mating Behavior	CHELONIAN CONSERVATION AND BIOLOGY			English	Article							GREAT-BARRIER-REEF; DERMOCHELYS-CORIACEA; CHELONIA-MYDAS; GREEN TURTLE; REPRODUCTIVE MOVEMENTS; LEATHERBACK TURTLES; DISPLAY BEHAVIOR; COURTSHIP	Here, we report an incidental observation obtained by an animal-borne video logger of courtship behavior by an adult male green turtle (Chelonia mydas) directed toward an immature green turtle. Our result hypothesized that males may select a mating partner mainly using a visual cue based on size, but without high acuity, so that they can distinguish the size of mature females from that of immature turtles. Hence, male turtles may visualize the objects moving underwater that have the similar size to a mature female turtle as a mating partner, and consequently randomly attempt to court turtles including both immature and mature turtles.	[Okuyama, Junichi] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto 6068501, Japan; [Okuyama, Junichi; Arai, Nobuaki] Kyoto Univ, Field Sci Educ & Res Ctr, Kyoto 6068502, Japan; [Kagawa, Shiro] NHK Enterprises Inc, Nat & Sci Programs, Tokyo 1500047, Japan	Okuyama, J (reprint author), Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto 6068501, Japan.	okuyamajunichi@gmail.com; kagawa-sh@nhk-ep.co.jp; arai.nobuaki.8c@kyoto-u.ac.jp					Limpus C, 1997, MAR ECOL PROG SER, V149, P23, DOI 10.3354/meps149023; [Anonymous], 1989, PROCEEDINGS OF 9TH A; KARL SA, 1995, J HERED, V86, P262; Miller Jeffrey D., 2008, P225; Seminoff JA, 2006, MAR ECOL PROG SER, V322, P269, DOI 10.3354/meps322269; Heithaus MR, 2002, J MAR BIOL ASSOC UK, V82, P1049, DOI 10.1017/S0025315402006689; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Reina RD, 2005, J EXP MAR BIOL ECOL, V316, P1, DOI 10.1016/j.jembe.2004.10.002; Auffenberg W., 1965, Copeia, V1965, P335, DOI 10.2307/1440797; AUFFENBERG W, 1977, AM ZOOL, V17, P241; BARTOL S. M., 2003, THE BIOLOGY OF SEA T, VII, P79; BOOTH J, 1972, ANIM BEHAV, V20, P808, DOI 10.1016/S0003-3472(72)80155-6; Bowen Brian W., 2007, Marine Turtle Newsletter, P10; CAGLE F.E., 1950, ECOL MONOGR, V20, P33; DAVIES N.B., 2012, AN INTRODUCTION TO B; DODD C.K., 1988, BIOL REP US FISH WIL, V88, P1; ECKERT KL, 1988, COPEIA, P400, DOI 10.2307/1445880; Ehrhart L. M., 1995, P29; Frick MG, 2000, J HERPETOL, V34, P153, DOI 10.2307/1565255; Green DR, 1999, CARTOGR J, V36, P3; JACKSON CG, 1972, COPEIA, P385; James MC, 2005, MAR BIOL, V147, P845, DOI 10.1007/s00227-005-1581-1; LIMPUS CJ, 1993, WILDLIFE RES, V20, P513, DOI 10.1071/WR9930513; LOHMANN K.J., 2013, THE BIOLOGY OF SEA T, VIII, P59; Narazaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066043; Okuyama J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065783; Plotkin PT, 1996, HERPETOLOGICA, V52, P1; PLUMMER M V, 1977, Journal of Herpetology, V11, P90, DOI 10.2307/1563298; PRITCHARD PCH, 1982, COPEIA, P741; Schofield Gail, 2006, Endangered Species Research, V2, P71, DOI 10.3354/esr002071; SLATER P.J.B., 1983, ANIM BEHAV, P9; WEAVER W G JR, 1970, Bulletin of the Florida State Museum Biological Sciences, V15, P1	32	0	0	CHELONIAN RESEARCH FOUNDATION	LUNENBURG	168 GOODRICH ST., LUNENBURG, MA USA	1071-8443	1943-3956		CHELONIAN CONSERV BI	Chelonian Conserv. Biol.	DEC	2014	13	2					278	281				4	Zoology	Zoology	AW2PY	WOS:000346132000019		
J	Sawant-Dhuri, D; Balasubramanian, VV; Ariga, K; Park, DH; Choy, JH; Cha, WS; Al-deyab, SS; Halligudi, SB; Vinu, A				Sawant-Dhuri, Dhanashri; Balasubramanian, Veerappan V.; Ariga, Katsuhiko; Park, Dae-Hwan; Choy, Jin-Ho; Cha, Wang Soo; Al-deyab, Salem S.; Halligudi, Shivappa B.; Vinu, Ajayan			Titania Nanoparticles Stabilized HPA in SBA-15 for the Intermolecular Hydroamination of Activated Olefins	CHEMCATCHEM			English	Article						heteropoly acids; hydroamination; mesoporous materials; nanocatalysts	SUPPORTED 12-TUNGSTOPHOSPHORIC ACID; MESOPOROUS SILICA SBA-15; HETEROPOLY COMPOUNDS; ALPHA,BETA-ETHYLENIC COMPOUNDS; EXCHANGED MONTMORILLONITE; CATALYZED HYDROAMINATION; UNACTIVATED ALKENES; ALIPHATIC-AMINES; TRANSITION-METAL; IONIC LIQUIDS	A liquid phase hydroamination (HA) of alpha,beta-ethylenic compounds with amines was investigated with TiO2 nanoparticles stabilized 12-tungstophosphoric acid (TPA) in SBA-15. The catalysts were prepared by wet impregnation of TPA/TiO2 nanoparticles into the SBA-15 and calcined at different temperatures. The characterization results reveal that the textural properties and the acidity of the prepared catalysts can be finely controlled with the simple adjustment of the calcination temperature and the structure of the support, decorated with the TiO2 and TPA nanoparticles, was intact even after the modification. The prepared catalysts were investigated for HA of ethyl acrylate with different aromatic and aliphatic amines over a wide range of reaction conditions to optimize the yield and the selectivity of product. It was found that this process is 100% atom efficient and the catalytic performance depended significantly on the loading of TPA over the catalyst and the calcination temperature. Under optimized reaction conditions, the best catalyst, 15 wt% TPA/22.4 wt% TiO2/SBA-15 calcined at 1123 K, offered the highest conversion of p-ethylaniline (70%) with 100% chemo-selectivity to the anti-Markovnikov product, i.e., the mono-addition product. The reaction was heterogeneously catalyzed and no contribution from leached TPA into the reaction was observed.	[Sawant-Dhuri, Dhanashri; Balasubramanian, Veerappan V.; Ariga, Katsuhiko; Vinu, Ajayan] Natl Inst Mat Sci, MANA, WPI, Tsukuba, Ibaraki 3050044, Japan; [Sawant-Dhuri, Dhanashri; Halligudi, Shivappa B.] Natl Chem Lab, Catalysis Div, Pune, Maharashtra, India; [Park, Dae-Hwan; Choy, Jin-Ho; Cha, Wang Soo] Ewha Womans Univ, Dept Chem & Nano Sci, CINBM, Seoul, South Korea; [Choy, Jin-Ho; Cha, Wang Soo; Vinu, Ajayan] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4073, Australia; [Al-deyab, Salem S.] King Saud Univ, Dept Chem, Riyadh 11451, Saudi Arabia	Vinu, A (reprint author), Natl Inst Mat Sci, MANA, WPI, Tsukuba, Ibaraki 3050044, Japan.	a.vinu@uq.edu.au	ARIGA, Katsuhiko/H-2695-2011		NIMS; ARC; University of Queensland; King Saud University	Dhanashri Sawant-Dhuri thanks the NIMS for offering a NIMS postdoctoral researcher award. One of the authors, Ajayan Vinu is grateful to ARC for the award of the future fellowship and the University of Queensland for the start-up grant. The research grant from King Saud University to NIMS was also greatly acknowledged.	Kozhevnikov IV, 2003, APPL CATAL A-GEN, V256, P3, DOI 10.1016/S0926-860X(03)00406-X; Muller TE, 1998, CHEM REV, V98, P675, DOI 10.1021/cr960433d; Yadav JS, 2003, CHEM LETT, V32, P988, DOI 10.1246/cl.2003.988; Seayad J, 2002, ADV SYNTH CATAL, V344, P795, DOI 10.1002/1615-4169(200209)344:8<795::AID-ADSC795>3.0.CO;2-Q; Mizushima E, 2003, ORG LETT, V5, P3349, DOI 10.1021/ol0353159; Ariga K, 2009, SOFT MATTER, V5, P3562, DOI 10.1039/b909397d; Shanbhag GV, 2006, TETRAHEDRON LETT, V47, P141, DOI 10.1016/j.tetlet.2005.11.001; Joseph T, 2006, J MOL CATAL A-CHEM, V250, P210, DOI 10.1016/j.molcata.2006.01.062; Miyahara M, 2006, THIN SOLID FILMS, V499, P13, DOI 10.1016/j.tsf.2005.07.046; ROUNDHILL DM, 1992, CHEM REV, V92, P1, DOI 10.1021/cr00009a001; Michon C, 2010, ADV SYNTH CATAL, V352, P3293, DOI 10.1002/adsc.201000536; Sawant DP, 2004, J MOL CATAL A-CHEM, V217, P211, DOI 10.1016/j.molcata.2004.03.038; Breitenlechner S, 2004, J MOL CATAL A-CHEM, V214, P175, DOI 10.1016/j.molcata.2003.12.032; Izumi Y, 1995, MICROPOROUS MATER, V5, P255, DOI 10.1016/0927-6513(95)00059-3; Yang L, 2008, TETRAHEDRON LETT, V49, P2882, DOI 10.1016/j.tetlet.2008.03.034; Lopez-Salinas E, 2000, APPL CATAL A-GEN, V193, P215, DOI 10.1016/S0926-860X(99)00431-7; Penzien JC, 2004, J CATAL, V221, P302, DOI 10.1016/S0021-9517(03)00283-5; Shanbhag GV, 2004, J MOL CATAL A-CHEM, V222, P223, DOI 10.1016/j.molcata.2004.08.010; Zhao DY, 2000, CHEM MATER, V12, P275, DOI 10.1021/cm9911363; Arredondo VM, 1999, J AM CHEM SOC, V121, P3633, DOI 10.1021/ja984305d; Dorta R, 1997, J AM CHEM SOC, V119, P10857, DOI 10.1021/ja972594k; Ariga K, 2012, CHEM MATER, V24, P728, DOI 10.1021/cm202281m; Devassy B. M., 2005, J CATAL, V229, P576; Fadini L, 2003, CHEM COMMUN, P30, DOI 10.1039/b210680a; Horniakova J, 2005, CATAL LETT, V102, P191, DOI 10.1007/s10562-005-5854-6; Izumi Y., 1992, ZEOLITE CLAY HETEROP; Joseph T, 2003, J MOL CATAL A-CHEM, V206, P13, DOI 10.1016/S1381-1169(03)00452-7; Joseph T, 2005, J MOL CATAL A-CHEM, V236, P139, DOI 10.1016/j.molcata.2005.04.022; Kawatsura M, 2001, ORGANOMETALLICS, V20, P1960, DOI 10.1021/om0009987; Lingaiah N, 2007, CHEM COMMUN, P278, DOI 10.1039/b613013e; Marcsekova K, 2007, SYNTHESIS-STUTTGART, P145, DOI 10.1055/s-2006-958934; MISONO M, 1987, CATAL REV, V29, P269, DOI 10.1080/01614948708078072; Mukai SR, 2001, CHEM ENG SCI, V56, P799, DOI 10.1016/S0009-2509(00)00291-8; Muller T. E., 2002, ENCY CATALYSIS, P492; Neff V, 2002, CHEM COMMUN, P906, DOI 10.1039/b111630d; Okuhara T, 2002, CATAL TODAY, V73, P167, DOI 10.1016/S0920-5861(01)00509-0; Pasha N, 2009, TETRAHEDRON LETT, V50, P239, DOI 10.1016/j.tetlet.2008.10.131; Penzien J, 2001, MICROPOR MESOPOR MAT, V48, P285, DOI 10.1016/S1387-1811(01)00343-2; Sawant DP, 2005, J CATAL, V235, P341, DOI 10.1016/j.jcat.2005.08.010; Sawant DP, 2007, J MOL CATAL A-CHEM, V262, P98, DOI 10.1016/j.molcata.2006.08.027; Sawant DP, 2008, CHEM-EUR J, V14, P3200, DOI 10.1002/chem.200701562; Shaikh NS, 2001, TETRAHEDRON, V57, P9045, DOI 10.1016/S0040-4020(01)00911-5; Shanbhag GV, 2008, J MOL CATAL A-CHEM, V284, P16, DOI 10.1016/j.molcata.2007.12.025; Steinborn D., 1989, J MOL CATAL, V49, P235; Taube R., 1996, APPL HOMOGENEOUS CAT, V1; Xu LW, 2003, SYNLETT, P2425, DOI 10.1055/s-2003-42125; Yadav JS, 2008, LETT ORG CHEM, V5, P651, DOI 10.2174/157017808786857471	47	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1867-3880	1867-3899		CHEMCATCHEM	ChemCatChem	DEC	2014	6	12					3347	3354		10.1002/cctc.201402449		8	Chemistry, Physical	Chemistry	AW0IN	WOS:000345975300012		
J	Dryfe, RAW; Uehara, A; Booth, SG				Dryfe, Robert A. W.; Uehara, Akihiro; Booth, Samuel G.			Metal Deposition at the Liquid-Liquid Interface	CHEMICAL RECORD			English	Article						electrochemistry; gold; interfaces; liquids; nanoparticles	IMMISCIBLE ELECTROLYTE-SOLUTIONS; BRUST-SCHIFFRIN SYNTHESIS; GOLD NANOPARTICLES; LIQUID/LIQUID INTERFACE; WATER/1,2-DICHLOROETHANE INTERFACE; POTENTIAL DIFFERENCE; POLARIZED INTERFACE; SILVER PARTICLES; AU NANOPARTICLES; PD NANOPARTICLES	Metal nanoparticles are readily formed, with a reasonable degree of size and shape control, using solution-based reduction methods under ambient conditions. Despite the large number of reports in this field, much of our knowledge of nanoparticle growth is largely empirical, with the relationship between particle form and growth conditions, for example, still not well understood. Many nanoparticle preparation routes actually depend on not one, but two, solution phases, i.e. the syntheses involve reaction or transfer at the liquid-liquid (organic-water) interface. This interface can be polarised electrochemically, an approach that offers promise as a route to better understanding, and ultimately control, of nanoparticle growth.	[Dryfe, Robert A. W.; Booth, Samuel G.] Univ Manchester, Sch Chem, Manchester M13 9PL, Lancs, England; [Uehara, Akihiro] Kyoto Univ, Inst Res Reactor, Div Nucl Engn Sci, Osaka 5900494, Japan	Dryfe, RAW (reprint author), Univ Manchester, Sch Chem, Oxford Rd, Manchester M13 9PL, Lancs, England.	robert.dryfe@manchester.ac.uk			UK EPSRC [EP/H047786/1]; Kyoto University Foundation	We thank the UK EPSRC (grant reference EP/H047786/1) for financial support and the Kyoto University Foundation, whose support of a sabbatical to A.U. laid the foundations for this manuscript. Constructive discussions with Prof. M. Schlossman (University of Illinois Chicago), Prof. S. Schroeder (University of Manchester), Ms. S.-Y. Chang (University of Manchester) and, particularly, Dr. Y. Grunder (University of Liverpool) are also acknowledged.	Girault HH, 2010, ELECTROANAL CHEM, V23, P1; Mirceski V, 2006, J PHYS CHEM B, V110, P2812, DOI 10.1021/jp056627r; Johans C, 2002, J ELECTROANAL CHEM, V526, P29, DOI 10.1016/S0022-0728(02)00763-5; Flatte ME, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/7/073102; PLIETH WJ, 1985, SURF SCI, V156, P530, DOI 10.1016/0039-6028(85)90615-6; Boker A, 2007, SOFT MATTER, V3, P1231, DOI 10.1039/b706609k; Booth SG, 2014, CHEM COMMUN, V50, P4482, DOI 10.1039/c4cc00359d; Trojanek A, 2007, J ELECTROANAL CHEM, V599, P160, DOI 10.1016/j.jelechem.2005.12.004; Li Y, 2011, J AM CHEM SOC, V133, P2092, DOI 10.1021/ja1105078; Lepkova K, 2008, ELECTROCHIM ACTA, V53, P6273, DOI 10.1016/j.electacta.2008.04.025; Vanysek P, 2008, J CHIL CHEM SOC, V53, P1455; Goulet PJG, 2012, J PHYS CHEM C, V116, P14096, DOI 10.1021/jp304157a; Lohse SE, 2013, CHEM MATER, V25, P1250, DOI 10.1021/cm303708p; Hasse U, 2011, PHYS CHEM CHEM PHYS, V13, P12254, DOI 10.1039/c0cp01469a; Nieminen JJ, 2011, CHEM COMMUN, V47, P5548, DOI 10.1039/c1cc10637f; Su B, 2004, J AM CHEM SOC, V126, P915, DOI 10.1021/ja0386187; Li Y, 2012, J AM CHEM SOC, V134, P1990, DOI 10.1021/ja210359r; Krishna KS, 2013, J AM CHEM SOC, V135, P5450, DOI 10.1021/ja400434c; Grunder Y, 2011, PHYS CHEM CHEM PHYS, V13, P15681, DOI 10.1039/c1cp21536a; Zhu LL, 2013, J PHYS CHEM C, V117, P11399, DOI 10.1021/jp402116x; Sefer B, 2012, J SOLID STATE ELECTR, V16, P2373, DOI 10.1007/s10008-011-1613-3; Sanyal MK, 2008, J PHYS CHEM C, V112, P1739, DOI 10.1021/jp710635e; Johans C, 2002, PHYS CHEM CHEM PHYS, V4, P1067, DOI [10.1039/b110182j, 10.1039/b1100182j]; Reincke F, 2004, ANGEW CHEM INT EDIT, V43, P458, DOI 10.1002/anie.200352339; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104; Li Y, 2011, CHEM COMMUN, V47, P6033, DOI 10.1039/c1cc11642h; Perala SRK, 2013, LANGMUIR, V29, P14756, DOI 10.1021/la403652k; Lin Y, 2003, SCIENCE, V299, P226, DOI 10.1126/science.1078616; Ohyama J, 2011, CHEMPHYSCHEM, V12, P127, DOI 10.1002/cphc.201000731; Perala SRK, 2013, LANGMUIR, V29, P9863, DOI 10.1021/la401604q; Johans C, 2000, J ELECTROANAL CHEM, V488, P99, DOI 10.1016/S0022-0728(00)00185-6; Platt M, 2004, ELECTROCHIM ACTA, V49, P3937, DOI 10.1016/j.electacta.2004.02.050; Hicks JF, 2002, J AM CHEM SOC, V124, P13322, DOI 10.1021/ja027724q; Uehara A, 2014, ELECTROCHIM ACTA, V118, P26, DOI 10.1016/j.electacta.2013.11.162; Samec Z, 2012, ELECTROCHIM ACTA, V84, P21, DOI 10.1016/j.electacta.2012.03.118; Abecassis B, 2010, LANGMUIR, V26, P13847, DOI 10.1021/la1020274; Goulet PJG, 2010, J AM CHEM SOC, V132, P9582, DOI 10.1021/ja104011b; PIERANSKI P, 1980, PHYS REV LETT, V45, P569, DOI 10.1103/PhysRevLett.45.569; Li F, 2009, J PHYS CHEM C, V113, P3553, DOI 10.1021/jp809165t; Trojanek A, 2006, ELECTROCHEM COMMUN, V8, P475, DOI 10.1016/j.elecom.2006.01.004; Binks BP, 2000, LANGMUIR, V16, P8622, DOI 10.1021/la000189s; Laanait N, 2012, P NATL ACAD SCI USA, V109, P20326, DOI 10.1073/pnas.1214204109; Knake R, 2005, LANGMUIR, V21, P1001, DOI 10.1021/la048277q; Dryfe RAW, 2003, J AM CHEM SOC, V125, P13014, DOI 10.1021/ja037599y; Guo JD, 2003, ELECTROCHEM COMMUN, V5, P1005, DOI 10.1016/j.elecom.2003.09.012; Cheng YF, 1996, J CHEM SOC FARADAY T, V92, P3865, DOI 10.1039/ft9969203865; Abid JP, 2007, J PHYS CHEM C, V111, P8849, DOI 10.1021/jp067181x; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; Dryfe RAW, 2009, ADV CHEM PHYS, V141, P153, DOI 10.1002/9780470431917.ch4; YOGEV D, 1988, J PHYS CHEM-US, V92, P5754, DOI 10.1021/j100331a041; Faraday M., 1857, PHILOS T ROY SOC LON, V147, P145, DOI DOI 10.1098/RSTL.1857.0011; Grunder Y, 2013, J PHYS CHEM C, V117, P5765, DOI 10.1021/jp312060f; GUAINAZZI M, 1975, J CHEM SOC CHEM COMM, P200, DOI 10.1039/c39750000200; Izquierdo D, 2012, ANAL CHEM, V84, P5723, DOI 10.1021/ac3009127; Jose D, 2012, J PHYS CHEM LETT, V3, P885, DOI 10.1021/jz201640e; Laanait N, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3428395; Li Y, 2011, LANGMUIR, V27, P7366, DOI 10.1021/la201158v; Martinez A, 2009, ELECTROCHIM ACTA, V54, P5071, DOI 10.1016/j.electacta.2008.12.028; Platt M, 2007, J ELECTROANAL CHEM, V599, P323, DOI 10.1016/j.jelechem.2006.06.002; Platt M, 2003, ELECTROCHIM ACTA, V48, P3037, DOI 10.1016/S0013-4686(03)00373-6; Platt M, 2002, CHEM COMMUN, P2324, DOI 10.1039/b208275f; Rodriguez-Fernandez J, 2005, J PHYS CHEM B, V109, P14257, DOI 10.1021/jp052516g; SAMEC Z, 1979, J ELECTROANAL CHEM, V96, P245, DOI 10.1016/S0022-0728(79)80382-4; Su B, 2005, J PHYS CHEM B, V109, P11427, DOI 10.1021/jp051455j; YOGEV D, 1989, J PHYS CHEM-US, V93, P4174, DOI 10.1021/j100347a056; Zeiri L, 1997, J PHYS CHEM B, V101, P9757, DOI 10.1021/jp9716804; Zeiri L, 1997, J PHYS CHEM B, V101, P9299, DOI 10.1021/jp971772t	67	4	4	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1527-8999	1528-0691		CHEM REC	Chem. Rec.	DEC	2014	14	6					1013	1023		10.1002/tcr.201402027		11	Chemistry, Multidisciplinary	Chemistry	AW0FY	WOS:000345967700001		
J	Kawai, H; Shibata, N				Kawai, Hiroyuki; Shibata, Norio			Asymmetric Synthesis of Agrochemically Attractive Trifluoromethylated Dihydroazoles and Related Compounds under Organocatalysis	CHEMICAL RECORD			English	Article						asymmetric synthesis; fluorine; heterocycles; organocatalysis; trifluoromethylation	HIGHLY ENANTIOSELECTIVE EPOXIDATION; NITRILE OXIDE CYCLOADDITIONS; MICHAEL ADDITION-REACTIONS; QUATERNARY AMMONIUM-SALTS; PHASE-TRANSFER CATALYSTS; ACHIRAL ALLYL ALCOHOL; CONJUGATE ADDITION; ALPHA,BETA-UNSATURATED KETONES; 1,3-DIPOLAR CYCLOADDITION; UNFUNCTIONALIZED OLEFINS	The unique, partially saturated, fluorinated five-membered heterocyclic compounds, trifluoromethylated dihydroazoles, and their derivatives, have emerged as a new class of heterocycles with remarkable biological activities in the 21st century. Despite their small molecular structures, a single sterically demanding tetrasubstituted trifluoromethylated stereogenic carbon center has prevented chemists from achieving the asymmetric synthesis of these compounds. In this account, we describe our recent progress in the catalytic asymmetric synthesis of a series of trifluoromethylated heterocycles, such as isoxazolines and pyrrolines having a stereogenic carbon center, based on organocatalysis. Our protocols have advantages in terms of employing inexpensive reagents and organocatalysts and they would be useful for industrial production.	[Kawai, Hiroyuki; Shibata, Norio] Nagoya Inst Technol, Grad Sch Engn, Dept Nanopharmaceut Sci, Showa Ku, Nagoya, Aichi 4668555, Japan; [Kawai, Hiroyuki; Shibata, Norio] Nagoya Inst Technol, Grad Sch Engn, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan	Kawai, H (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Nanopharmaceut Sci, Showa Ku, Nagoya, Aichi 4668555, Japan.	nozshiba@nitech.ac.jp			MEXT Japan [24105513, 25288045]; ACT-C from JST [25670055]	The authors' research on the review topic was financially supported in part by the Platform for Drug Discovery, Informatics, and Structural Life Science, Grant-in-Aids for Scientific Research on Innovative Areas ("Advanced Molecular Transformations by Organocatalysts", 24105513) and Scientific Research (B) (25288045) from MEXT Japan, and ACT-C from JST, Exploratory Research (25670055).	Akagawa K., 2012, ANGEW CHEM, V124, P12958; ALBERTOLA A, 1988, J CHEM SOC PERK T 1, P791, DOI 10.1039/p19880000791; Allingham MT, 2003, TETRAHEDRON LETT, V44, P8677, DOI 10.1016/j.tetlet.2003.09.162; Kirk KL, 2006, J FLUORINE CHEM, V127, P1013, DOI 10.1016/j.jfluchem.2006.06.007; Tanaka H, 2010, J AM CHEM SOC, V132, P12034, DOI 10.1021/ja104184r; WELCH JT, 1987, TETRAHEDRON, V43, P3123, DOI 10.1016/S0040-4020(01)90286-8; Marrec O, 2010, ADV SYNTH CATAL, V352, P2825, DOI 10.1002/adsc.201000487; DAVIS AP, 1995, TETRAHEDRON-ASYMMETR, V6, P2829, DOI 10.1016/0957-4166(95)00374-X; Mizuta S, 2007, ORG LETT, V9, P3707, DOI 10.1021/ol701791r; Corey EJ, 1999, ORG LETT, V1, P1287, DOI 10.1021/ol990964z; Tanaka Y, 2010, J AM CHEM SOC, V132, P8862, DOI 10.1021/ja1035286; Matoba K, 2010, ANGEW CHEM INT EDIT, V49, P5762, DOI 10.1002/anie.201002065; Hanessian S, 2000, ORG LETT, V2, P2975, DOI 10.1021/ol000170g; Wu XY, 2002, J AM CHEM SOC, V124, P8792, DOI 10.1021/ja020478y; Lu XJ, 2008, J AM CHEM SOC, V130, P8134, DOI 10.1021/ja802982h; Zheng Y, 2012, CHEM COMMUN, V48, P4308, DOI 10.1039/c2cc30949a; SILVESTER MJ, 1994, ADV HETEROCYCL CHEM, V59, P1, DOI 10.1016/S0065-2725(08)60006-9; Zhang JL, 2013, CHEM COMMUN, V49, P9329, DOI 10.1039/c3cc44059a; Wang X, 2008, J AM CHEM SOC, V130, P6070, DOI 10.1021/ja801181u; Kawai H, 2011, ANGEW CHEM INT EDIT, V50, P7803, DOI 10.1002/anie.201102442; Garcia-Reynaga P, 2013, CHEM RES TOXICOL, V26, P514, DOI 10.1021/tx400055p; Porter MJ, 2000, CHEM COMMUN, P1215, DOI 10.1039/b001780i; Wu SX, 2013, ADV SYNTH CATAL, V355, P1917, DOI 10.1002/adsc.201300249; Ishimaru T, 2008, ANGEW CHEM INT EDIT, V47, P4157, DOI 10.1002/anie.200800717; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Purser S, 2008, CHEM SOC REV, V37, P320, DOI 10.1039/b610213c; SAMSEL EG, 1986, INORG CHEM, V25, P2450, DOI 10.1021/ic00234a034; Mazet C, 2008, ANGEW CHEM INT EDIT, V47, P1762, DOI 10.1002/anie.200704461; Suga H, 2009, J ORG CHEM, V74, P1099, DOI 10.1021/jo802392c; Lin P, 2000, TETRAHEDRON, V56, P3635, DOI 10.1016/S0040-4020(00)00158-7; Xia QH, 2005, CHEM REV, V105, P1603, DOI 10.1021/cr0406458; O'Hagan D, 2010, J FLUORINE CHEM, V131, P1071, DOI 10.1016/j.jfluchem.2010.03.003; Vakulya B, 2005, ORG LETT, V7, P1967, DOI 10.1021/ol050431s; Shibata N, 2008, TETRAHEDRON-ASYMMETR, V19, P2633, DOI 10.1016/j.tetasy.2008.11.011; Ogawa S, 2007, ANGEW CHEM INT EDIT, V46, P8666, DOI 10.1002/anie.200703317; Baschieri A, 2009, ANGEW CHEM INT EDIT, V48, P9342, DOI 10.1002/anie.200905018; Kawai H, 2014, CHEMISTRYOPEN, V3, P14, DOI 10.1002/open.201300044; IRIE R, 1990, TETRAHEDRON LETT, V31, P7345, DOI 10.1016/S0040-4039(00)88562-7; Marigo M, 2005, J AM CHEM SOC, V127, P6964, DOI 10.1021/ja051808s; Halland N, 2002, J ORG CHEM, V67, P8331, DOI 10.1021/jo0261449; Kawai H, 2012, ANGEW CHEM INT EDIT, V51, P4959, DOI 10.1002/anie.201201278; Pei QL, 2011, J ORG CHEM, V76, P7849, DOI 10.1021/jo2012779; Adamo MFA, 2005, J ORG CHEM, V70, P8395, DOI 10.1021/jo051181w; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Ooi T, 2004, J AM CHEM SOC, V126, P6844, DOI 10.1021/ja048600b; Kawai H, 2013, ANGEW CHEM INT EDIT, V52, P2221, DOI 10.1002/anie.201209355; Wong OA, 2008, CHEM REV, V108, P3958, DOI 10.1021/cr068367v; Adamo MFA, 2002, TETRAHEDRON LETT, V43, P4157, DOI 10.1016/S0040-4039(02)00765-7; Jeschke P, 2004, CHEMBIOCHEM, V5, P570, DOI 10.1002/cbic.200300833; Suga S, 2010, CHEM LETT, V39, P404, DOI 10.1246/cl.2010.404; Ozoe Y, 2010, BIOCHEM BIOPH RES CO, V391, P744, DOI 10.1016/j.bbrc.2009.11.131; Liu XL, 2013, ORG LETT, V15, P1246, DOI 10.1021/ol400183k; Koya S, 2012, ANGEW CHEM INT EDIT, V51, P8243, DOI 10.1002/anie.201201848; Melo TMVDPE, 2005, CURR ORG CHEM, V9, P925; Zhang W, 2007, J AM CHEM SOC, V129, P286, DOI 10.1021/ja067495y; Shibata N, 2000, J AM CHEM SOC, V122, P10728, DOI 10.1021/ja002732x; Kawai H, 2012, CHEM COMMUN, V48, P4067, DOI 10.1039/c2cc18049a; Prieto A, 2005, ORG LETT, V7, P3897, DOI 10.1021/ol051301m; Nie J, 2011, CHEM REV, V111, P455, DOI 10.1021/cr100166a; KATSUKI T, 1980, J AM CHEM SOC, V102, P5974, DOI 10.1021/ja00538a077; Lahm GP, 2013, BIOORG MED CHEM LETT, V23, P3001, DOI 10.1016/j.bmcl.2013.03.031; Ogawa S, 2010, CHEM-EUR J, V16, P7090, DOI 10.1002/chem.201000911; Sibi MP, 2004, J AM CHEM SOC, V126, P5366, DOI 10.1021/ja0318636; Kim DY, 2001, TETRAHEDRON, V57, P8933, DOI 10.1016/S0040-4020(01)00891-2; Fini F, 2010, ADV SYNTH CATAL, V352, P3163, DOI 10.1002/adsc.201000543; Akagawa K, 2012, ANGEW CHEM INT EDIT, V51, P12786, DOI 10.1002/anie.201206916; Taniguchi T, 2010, ANGEW CHEM INT EDIT, V49, P10154, DOI 10.1002/anie.201005574; Chintareddy VR, 2009, J ORG CHEM, V74, P8118, DOI 10.1021/jo901571y; Yang W, 2010, ORG LETT, V12, P5450, DOI 10.1021/ol102294g; Huang YY, 2010, ORG LETT, V12, P1136, DOI 10.1021/ol100171z; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Ma T, 2011, J AM CHEM SOC, V133, P2828, DOI 10.1021/ja1098353; Vakulya B, 2008, J ORG CHEM, V73, P3475, DOI 10.1021/jo702692a; Shibata N, 2005, ANGEW CHEM INT EDIT, V44, P4204, DOI 10.1002/anie.200501041; Reddy DS, 2008, ANGEW CHEM INT EDIT, V47, P164, DOI 10.1002/anie.200704093; Ma JA, 2008, CHEM REV, V108, pPR1, DOI 10.1021/cr800221v; Kawai H, 2012, CHEM COMMUN, V48, P3632, DOI 10.1039/c2cc18052a; Matsumoto K, 2009, ANGEW CHEM INT EDIT, V48, P7432, DOI 10.1002/anie.200903567; Taylor MS, 2005, J AM CHEM SOC, V127, P1313, DOI 10.1021/ja044999s; AEBI H, 1965, HELV CHIM ACTA, V48, P656, DOI 10.1002/hlca.19650480403; ZHANG W, 1990, J AM CHEM SOC, V112, P2801, DOI 10.1021/ja00163a052; Song JJ, 2007, ORG LETT, V9, P1013, DOI 10.1021/ol0630494; Kawai H, 2013, ANGEW CHEM INT EDIT, V52, P5575, DOI 10.1002/anie.201301123; Bougauchi M, 1997, J AM CHEM SOC, V119, P2329, DOI 10.1021/ja964037o; Theodoridis G, 2006, ADV FLUORINE SCI, V2, P121, DOI 10.1016/S1872-0358(06)02004-5; Bako P, 1997, SYNLETT, P291; BALDWIN JE, 1976, J CHEM SOC CHEM COMM, P734, DOI 10.1039/c39760000734; Banks R. E., 1994, ORGANOFLUORINE CHEMI; BANKS RE, 1979, ORGANOFLUORINE CHEMI; BANSAL RK, 2009, HETEROCYCLIC CHEM; BARTHOLOW M, 2013, PHARMACY TIMES; Baschieri A., 2009, ANGEW CHEM, V121, P9506; Bernardi L, 2008, SYNLETT, P1857, DOI 10.1055/s-2008-1078496; Brinkmann Y, 2007, TETRAHEDRON, V63, P8413, DOI 10.1016/j.tet.2007.06.033; Carlsen L., 1992, HOUBENWEYL METHODS A, VE8a, P45; CASSAYRE J, 2010, Patent No. 2010020522; CASSAYRE JY, 2013, Patent No. 2013026929; COLONNA S, 1978, J CHEM SOC CHEM COMM, P238, DOI 10.1039/c39780000238; Corey EJ, 2000, ORG LETT, V2, P4257, DOI 10.1021/ol0068344; D'Alcontres G.S.:CaristiC., 1976, J CHEM SOC P1, P1694, DOI 10.1039/p19760001694; Davies CD, 2000, TETRAHEDRON LETT, V41, P4229, DOI 10.1016/S0040-4039(00)00571-2; El Qacemi M., 2011, [No title captured], Patent No. [2011154555, WO 2011/154555 A1]; Enders D, 1996, ANGEW CHEM INT EDIT, V35, P1725, DOI 10.1002/anie.199617251; Enders D., 1996, ANGEW CHEM, V108, P1827, DOI 10.1002/ange.19961081530; Erian AW, 2001, J HETEROCYCLIC CHEM, V38, P793; Fiandra C. D., 2012, CHEM COMMUN, V48, P3863; Funabashi K, 1998, TETRAHEDRON LETT, V39, P7557, DOI 10.1016/S0040-4039(98)01644-X; GOERGENS U, 2009, Patent No. 2009097992; Goumont Régis, 2003, Org Biomol Chem, V1, P1741, DOI 10.1039/b302029k; Gouverneur V., 2012, FLUORINE IN PHARMACE; Guesmi N. E., 2008, ORG BIOMOL CHEM, V6, P4041; HENDRICK.JB, 1974, J AM CHEM SOC, V96, P2275, DOI 10.1021/ja00814a061; Hua M., 2010, ANGEW CHEM, V122, P2832; Hua MQ, 2010, ANGEW CHEM INT EDIT, V49, P2772, DOI 10.1002/anie.200906814; Ihara H., 2010, PCT Int. Appl., Patent No. [WO 2010090344, 2010090344]; IHARA H, 2008, Patent No. 2008126665; Ishimaru T., 2008, ANGEW CHEM, V120, P4225, DOI 10.1002/ange.200800717; IWASA T, 2012, Patent No. 2012060317; Jeschke P., 2010, MANAGE SCI, V66, P10; KAISER F, 2012, Patent No. 2012007426; KAMESWARAN V, 1992, Patent No. 481182; Kawai H., 2013, ANGEW CHEM, V125, P2277; Kawai H., 2013, ANGEW CHEM, V125, P5685; Kawai H., 2009, ANGEW CHEM, V121, P6442; Kawai H, 2010, ORG LETT, V12, P5104, DOI 10.1021/ol102189c; Kawai H., 2012, ANGEW CHEM, V124, P5043; Kawai H., 2011, ANGEW CHEM, V123, P7949; Kawai H, 2013, EUR J ORG CHEM, V2013, P6506, DOI 10.1002/ejoc.201301096; Kawai H, 2009, ANGEW CHEM INT EDIT, V48, P6324, DOI 10.1002/anie.200902457; Keller E, 1997, TETRAHEDRON-ASYMMETR, V8, P3403, DOI 10.1016/S0957-4166(97)00432-1; Kirsch P., 2004, MODERN FLUOROORGANIC; Kobayashi S, 2008, ORG LETT, V10, P807, DOI 10.1021/ol702958w; KOSOWER EM, 1971, ACCOUNTS CHEM RES, V4, P193, DOI 10.1021/ar50042a001; Koya S., 2012, ANGEW CHEM, V124, P8368; Kwiatkowski P, 2011, ORG LETT, V13, P3624, DOI 10.1021/ol201275h; Lahm G., PCT Intl. Appl., Patent No. [2007079162, WO 2007/ 079162]; Lai TS, 1998, CHEM COMMUN, P1583, DOI 10.1039/a802009d; Lee CKY, 2006, J ORG CHEM, V71, P3221, DOI 10.1021/jo0602569; Li PF, 2008, CHEM COMMUN, P3302, DOI 10.1039/b804540b; LONG JK, 2009, Patent No. 2009045999; Matoba K., 2010, ANGEW CHEM, V122, P5898; Matoba K., 2009, Patent No. [WO 2009063910, 2009063910]; Matsumoto K., 2009, ANGEW CHEM, V121, P7568; Matsumoto K., 2010, CATALYTIC ASYMMETRIC, P839, DOI 10.1002/9780470584248.ch11; Mazet C., 2008, ANGEW CHEM, V120, P1786, DOI 10.1002/ange.200704461; MCCANN SF, 2007, Patent No. 2007123855; McClendon E, 2009, TETRAHEDRON LETT, V50, P533, DOI 10.1016/j.tetlet.2008.11.053; Mei K, 2009, ORG LETT, V11, P2864, DOI 10.1021/ol9010322; Mita T., 2005, [No title captured], Patent No. [2005272452, JP2005272452]; Mita T., 2004, Patent No. [WO 2004018410, 2004018410]; Mita T., 2009, PCT Int. Appl., Patent No. [WO 2009072621, 2009072621]; Mita T., 2005, [No title captured], Patent No. [WO2005085216, 2005085216, 2005085216 A1]; Mitchell CET, 2005, CHEM COMMUN, P5346, DOI 10.1039/b511441a; MUKAIYAMA T, 1993, CHEM LETT, P327, DOI 10.1246/cl.1993.327; Mulholland N. P., 2011, Patent No. [WO 2011104089 A1, 2011104089]; MURATA T, 2012, Patent No. 2012062267; MURATA T, 2012, Patent No. 2012034957; Murata T., 2009, [No title captured], Patent No. [WO2009112275, 2009112275, WO2009112275A1]; Muzalevskiy VM, 2009, SYNTHESIS-STUTTGART, P3905, DOI 10.1055/s-0029-1217080; NESI R, 1985, J CHEM SOC PERK T 1, P1871, DOI 10.1039/p19850001871; Nguyen Lien Ai, 2006, Int J Biomed Sci, V2, P85; Norman AL, 2008, TETRAHEDRON LETT, V49, P4153, DOI 10.1016/j.tetlet.2008.04.125; Ogawa S., 2007, ANGEW CHEM, V119, P8820, DOI 10.1002/ange.200703317; Ojima I., 2009, FLUORINE IN MEDICINA; PEPINO R, 1982, J ORGANOMET CHEM, V231, P91, DOI 10.1016/S0022-328X(00)81946-4; Petrov V. A., 2009, FLUORINATED HETEROCY; Pohjakallio A, 2009, CHEM-EUR J, V15, P3960, DOI 10.1002/chem.200802684; Quan ML, 1999, J MED CHEM, V42, P2760, DOI 10.1021/jm980406a; Raihan MJ, 2011, J ORG CHEM, V76, P424, DOI 10.1021/jo1018393; Reddy D. S., 2008, ANGEW CHEM, V120, P170, DOI 10.1002/ange.200704093; Ros A, 2005, SYNLETT, P2899, DOI 10.1055/s-2005-921894; Sasaki S, 2011, SYNLETT, P1431, DOI 10.1055/s-0030-1260560; Shaitanova E. N., 2008, TETRAHEDRON LETT, V49, P1184, DOI 10.1016/j.tetlet.2007.12.048; SHEPPARD WA, 1963, J AM CHEM SOC, V85, P1314, DOI 10.1021/ja00892a021; Shibata N., 2005, ANGEW CHEM, V117, P4276, DOI 10.1002/ange.200501041; Shimizu M, 1996, CHEM LETT, P455, DOI 10.1246/cl.1996.455; Soloshonok V.A., 1999, ENANTIOCONTROLLED SY; Sperry JB, 2005, CURR OPIN DRUG DISC, V8, P723; Stinson SC, 2001, CHEM ENG NEWS, V79, P79, DOI 10.1021/cen-v079n040.p079; Stinson SC, 2000, CHEM ENG NEWS, V78, P55, DOI 10.1021/cen-v078n043.p055; Sundararajan G, 2001, ORG LETT, V3, P389, DOI 10.1021/ol006898e; Taniguchi T., 2010, ANGEW CHEM, V122, P10352, DOI 10.1002/ange.201005574; Terrier F, 2005, J AM CHEM SOC, V127, P5563, DOI 10.1021/ja0436291; Thayer AM, 2006, CHEM ENG NEWS, V84, P15, DOI 10.1021/cen-v084n033.p015; Toyama K., 2013, Patent No. [WO 2013069731 A1, 2013069731]; UKAJI Y, 1993, CHEM LETT, P1847, DOI 10.1246/cl.1993.1847; Uneyama K., 2006, ORGANOFLUORINE CHEMI; Wakefield B. J., 2001, SCI SYNTHESIS HOUBEN, V11, P229; Wang LW, 2010, CHEM-EUR J, V16, P7696, DOI 10.1002/chem.201000688; Welch J. T., 1991, FLUORINE IN BIOORGAN; Yagupolskii L. M., 1993, ORGANOFLUORINE COMPO; Zielinska-Blajet M, 2005, TETRAHEDRON, V61, P5235, DOI 10.1016/j.tet.2005.03.085	192	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1527-8999	1528-0691		CHEM REC	Chem. Rec.	DEC	2014	14	6					1024	1040		10.1002/tcr.201402023		17	Chemistry, Multidisciplinary	Chemistry	AW0FY	WOS:000345967700002		
J	Tomishige, K; Tamura, M; Nakagawa, Y				Tomishige, Keiichi; Tamura, Masazumi; Nakagawa, Yoshinao			Role of Re Species and Acid Cocatalyst on Ir-ReOx/SiO2 in the C-O Hydrogenolysis of Biomass-Derived Substrates	CHEMICAL RECORD			English	Article						heterogeneous catalysis; hydrogenolysis; iridium; rhenium; supported catalysts	ION-EXCHANGE-RESIN; GLYCEROL HYDROGENOLYSIS; REACTION-MECHANISM; SUGAR POLYOLS; CATALYST; CONVERSION; 1,3-PROPANEDIOL; HYDROGENATION; CHEMICALS; RH/SIO2	The catalytic performance of ReOx-modified Ir metal catalyst in the hydrogenolysis of C-O bonds is strongly dependent on the choice of solvent. The acidic property of the Re species becomes obvious in the alkane solvent, and the hydrogenolysis reaction proceeds mainly by acid-catalyzed dehydration and the subsequent metal-catalyzed hydrogenation. The acidic property of the Re species is weakened in water; however, the hydrogenolysis reaction proceeds in water via a direct mechanism involving S(N)2-like attack of a hydride species at the interface between Ir and ReOx on the adsorbed Re alkoxide species. This mechanism enabled the selective dissociation of the C-O bond neighboring the CH2OH group.	[Tomishige, Keiichi; Tamura, Masazumi; Nakagawa, Yoshinao] Tohoku Univ, Sch Engn, Dept Appl Chem, Sendai, Miyagi 980, Japan	Tomishige, K (reprint author), Tohoku Univ, Sch Engn, Dept Appl Chem, Sendai, Miyagi 980, Japan.	tomi@erec.che.tohoku.ac.jp			Cabinet Office, Government of Japan through "Funding Program for Next Generation World-Leading Researchers"	This work was supported in part by the Cabinet Office, Government of Japan, through its "Funding Program for Next Generation World-Leading Researchers".	Ruppert AM, 2012, ANGEW CHEM INT EDIT, V51, P2564, DOI 10.1002/anie.201105125; Kusunoki Y, 2005, CATAL COMMUN, V6, P645, DOI 10.1016/j.catcom.2005.06.006; Ebashi T, 2010, J PHYS CHEM C, V114, P6518, DOI 10.1021/jp911908c; Kim YT, 2013, J CATAL, V304, P72, DOI 10.1016/j.jcat.2013.03.022; Chen K, 2012, J CATAL, V294, P171, DOI 10.1016/j.jcat.2012.07.015; Chia M, 2013, J CATAL, V308, P226, DOI 10.1016/j.jcat.2013.08.008; Ciftci A, 2014, GREEN CHEM, V16, P853, DOI 10.1039/c3gc42046a; Amada Y, 2012, CHEMSUSCHEM, V5, P1991, DOI 10.1002/cssc.201200121; Nakagawa Y, 2014, J MATER CHEM A, V2, P6688, DOI 10.1039/c3ta15384c; Shimao A, 2009, CHEM LETT, V38, P540, DOI 10.1246/cl.2009.540; Bozell JJ, 2010, GREEN CHEM, V12, P539, DOI 10.1039/b922014c; Li N, 2010, J CATAL, V270, P48, DOI 10.1016/j.jcat.2009.12.006; Chen KY, 2010, CHEMCATCHEM, V2, P547, DOI 10.1002/cctc.201000018; Shinmi Y, 2010, APPL CATAL B-ENVIRON, V94, P318, DOI 10.1016/j.apcatb.2009.11.021; Koso S, 2012, APPL CATAL B-ENVIRON, V111, P27, DOI 10.1016/j.apcatb.2011.09.015; Ciftci A, 2014, J CATAL, V311, P88, DOI 10.1016/j.jcat.2013.11.011; Miyazawa T, 2007, APPL CATAL A-GEN, V329, P30, DOI 10.1016/j.apcata.2007.06.019; Liu SB, 2014, GREEN CHEM, V16, P617, DOI 10.1039/c3gc41335g; Nakagawa Y, 2013, ACS CATAL, V3, P2655, DOI 10.1021/cs400616p; Nakagawa Y, 2011, CATAL SURV ASIA, V15, P111, DOI 10.1007/s10563-011-9114-z; Nakagawa Y, 2012, APPL CATAL A-GEN, V433, P128, DOI 10.1016/j.apcata.2012.05.009; Zhang Q, 2012, CHEMCATCHEM, V4, P1084, DOI 10.1002/cctc.201100508; Nakagawa Y, 2013, APPL CATAL A-GEN, V468, P418, DOI 10.1016/j.apcata.2013.09.021; Kobayashi H, 2013, GREEN CHEM, V15, P1740, DOI 10.1039/c3gc00060e; Miyazawa T, 2006, J CATAL, V240, P213, DOI 10.1016/j.jcat.2006.03.023; Amada Y, 2010, CHEMSUSCHEM, V3, P728, DOI 10.1002/cssc.201000040; Koso S, 2011, J CATAL, V280, P221, DOI 10.1016/j.jcat.2011.03.018; Koso S, 2009, J CATAL, V267, P89, DOI 10.1016/j.jcat.2009.07.010; Chen KY, 2013, CHEMSUSCHEM, V6, P613, DOI 10.1002/cssc.201200940; Wang ZQ, 2014, CATAL COMMUN, V43, P38, DOI 10.1016/j.catcom.2013.09.007; Nakagawa Y, 2011, CATAL SCI TECHNOL, V1, P179, DOI 10.1039/c0cy00054j; Buntara T, 2011, ANGEW CHEM INT EDIT, V50, P7083, DOI 10.1002/anie.201102156; Fukuoka A, 2009, CHEM REC, V9, P224, DOI 10.1002/tcr.200900004; Miyazawa T, 2007, APPL CATAL A-GEN, V318, P244, DOI 10.1016/j.apcata.2006.11.006; Nakagawa Y, 2010, J CATAL, V272, P191, DOI 10.1016/j.jcat.2010.04.009; Kobayashi H, 2012, CATAL SCI TECHNOL, V2, P869, DOI 10.1039/c2cy00500j; Amada Y, 2011, APPL CATAL B-ENVIRON, V105, P117, DOI 10.1016/j.apcatb.2011.04.001; Tamura M, 2014, J MOL CATAL A-CHEM, V388, P177, DOI 10.1016/j.molcata.2013.09.015; Huber GW, 2004, ANGEW CHEM INT EDIT, V43, P1549, DOI 10.1002/anie.200353050; Ciftci A, 2014, CHEMCATCHEM, V6, P1260, DOI 10.1002/cctc.201301096; Amada Y, 2012, J PHYS CHEM C, V116, P23503, DOI 10.1021/jp308527f; Lange JP, 2012, CHEMSUSCHEM, V5, P150, DOI 10.1002/cssc.201100648; Tamura M, 2013, CHEM COMMUN, V49, P7034, DOI 10.1039/c3cc41526k; Koso S, 2012, J PHYS CHEM C, V116, P3079, DOI 10.1021/jp2114225; Nakagawa Y, 2012, CATAL TODAY, V195, P136, DOI 10.1016/j.cattod.2012.04.048; Furikado I, 2007, GREEN CHEM, V9, P582, DOI 10.1039/b614253b; Nakagawa Y, 2014, GREEN CHEM, V16, P2197, DOI 10.1039/c3gc42322k; Buntara T., 2011, ANGEW CHEM, V123, P7221; Childers KG, 2006, ORG PROCESS RES DEV, V10, P934, DOI 10.1021/op0601058; Huber G. W., 2004, ANGEW CHEM, V116, P1575, DOI 10.1002/ange.200353050; Ishida Y, 2009, CHEM COMMUN, P5308, DOI 10.1039/b907357d; Kobayashi H., 2011, APPL CATAL A-GEN, V409-410, P13; Koso S, 2009, CHEM COMMUN, P2035, DOI 10.1039/b822942b; Muscal M., 2014, ANGEW CHEM INT EDIT, V53, P1854; Muscal M., 2014, ANGEW CHEM, V126, P1885; Sato H, 2014, CHEM LETT, V43, P334, DOI 10.1246/cl.130983; Schlaf M, 2006, DALTON T, P4645, DOI 10.1039/b608007c; Tomishige K., 2014, TOP CURR CHEM, DOI [10.1007/128_2014_538, DOI 10.1007/128_2014_538]; Ueda N, 2010, CHEM LETT, V39, P506, DOI 10.1246/cl.2010.506; vansPutten R.-J., 2013, CHEM REV, V113, P1499; Weinberg K., 2012, ANGEW CHEM, V124, P2614	61	5	5	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1527-8999	1528-0691		CHEM REC	Chem. Rec.	DEC	2014	14	6					1041	1054		10.1002/tcr.201402026		14	Chemistry, Multidisciplinary	Chemistry	AW0FY	WOS:000345967700003		
J	Asanuma, H; Kashida, H; Kamiya, Y				Asanuma, Hiroyuki; Kashida, Hiromu; Kamiya, Yukiko			De Novo Design of Functional Oligonucleotides with Acyclic Scaffolds	CHEMICAL RECORD			English	Article						fluorescent probes; helical structures; nucleic acids; oligonucleotides; photochemistry	INTERCALATING NUCLEIC-ACIDS; STEM MOLECULAR BEACON; DNA FIT-PROBES; QUANTUM DOTS; THERMAL-STABILITY; DUPLEX FORMATION; THREONINOL NUCLEOTIDES; BACKGROUND EMISSION; SIRNA THERAPEUTICS; CHEMICAL ETIOLOGY	In this account, we demonstrate a new methodology for the de novo design of functional oligonucleotides with the acyclic scaffolds threoninol and serinol. Four functional motifswedge, interstrand-wedge, dimer, and clusterhave been prepared from natural DNA or RNA and functional base surrogates prepared from d-threoninol. The following applications of these motifs are described: (1) photoregulation of formation and dissociation of a DNA duplex modified with azobenzene, (2) sequence-specific detection of DNA using a fluorescent probe, (3) formation of fluorophore assemblies that mimic quantum dots, (4) improved strand selectivity of siRNA modified with a base surrogate, and (5) in vivo tracing of the RNAi pathway. Finally, we introduce artificial nucleic acids (XNAs) prepared from d-threoninol and serinol functionalized with each of the four nucleobases, which have unique properties compared with other acyclic XNAs. Functional oligonucleotides designed from acyclic scaffolds will be powerful tools for both DNA nanotechnology and biotechnology.	[Asanuma, Hiroyuki; Kashida, Hiromu; Kamiya, Yukiko] Nagoya Univ, Grad Sch Engn, Dept Mol Design & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Kamiya, Yukiko] Nagoya Univ, EcoTopia Sci Inst, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Asanuma, H (reprint author), Nagoya Univ, Grad Sch Engn, Dept Mol Design & Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	asanuma@nubio.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [25248037, 24750173, 24104005, 26102518]; Naito Foundation Natural Science Scholarship; Canon Foundation	This work was supported by a Grant-in-Aid for Scientific Research (A) (no. 25248037), a Grant-in-Aid for Scientific Research for Young Scientists (B) (no. 24750173), and Grants-in-Aid for Scientific Research on Innovative Areas "Molecular Robotics" (no. 24104005) and "Dynamical Ordering & Integrated Functions" (no. 26102518) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Support from the Naito Foundation Natural Science Scholarship (for H.K.) and the Canon Foundation (for H.A.) is also acknowledged.	Zhang LL, 2005, J AM CHEM SOC, V127, P4174, DOI 10.1021/ja042564z; Bethge L, 2010, ORG BIOMOL CHEM, V8, P2439, DOI 10.1039/c000697a; Eschenmoser A, 1999, SCIENCE, V284, P2118, DOI 10.1126/science.284.5423.2118; Filichev VV, 2005, J AM CHEM SOC, V127, P14849, DOI 10.1021/ja053645d; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Asanuma H, 2003, J AM CHEM SOC, V125, P2217, DOI 10.1021/ja021153k; Obika S, 1998, TETRAHEDRON LETT, V39, P5401, DOI 10.1016/S0040-4039(98)01084-3; Schlegel MK, 2007, CHEMBIOCHEM, V8, P927, DOI 10.1002/cbic.200600435; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Kaur H, 2006, BIOCHEMISTRY-US, V45, P7347, DOI 10.1021/bi060307w; Huber R, 2004, J ORG CHEM, V69, P744, DOI 10.1021/jo0355404; Elkayam E, 2012, CELL, V150, P100, DOI 10.1016/j.cell.2012.05.017; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Asanuma H, 2007, NAT PROTOC, V2, P203, DOI 10.1038/nprot.2006.465; Schoning KU, 2000, SCIENCE, V290, P1347, DOI 10.1126/science.290.5495.1347; Holzhauser C, 2011, ANGEW CHEM INT EDIT, V50, P7268, DOI 10.1002/anie.201101968; Mayer G, 2006, ANGEW CHEM INT EDIT, V45, P4900, DOI 10.1002/anie.200600387; Kuhn H, 2002, J AM CHEM SOC, V124, P1097, DOI 10.1021/ja0041324; WITTUNG P, 1994, NATURE, V368, P561, DOI 10.1038/368561a0; Socher E, 2008, ANGEW CHEM INT EDIT, V47, P9555, DOI 10.1002/anie.200803549; Sahu B, 2011, J ORG CHEM, V76, P5614, DOI 10.1021/jo200482d; Ikeda S, 2009, ANGEW CHEM INT EDIT, V48, P6480, DOI 10.1002/anie.200902000; Brieke C, 2012, ANGEW CHEM INT EDIT, V51, P8446, DOI 10.1002/anie.201202134; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; WEINSTEIN JN, 1977, SCIENCE, V195, P489, DOI 10.1126/science.835007; Liang XG, 2009, SMALL, V5, P1761, DOI 10.1002/smll.200900223; Haner R, 2010, J AM CHEM SOC, V132, P7466, DOI 10.1021/ja102042p; Ehrenschwender T, 2011, J ORG CHEM, V76, P2301, DOI 10.1021/jo102519k; Chou CJ, 2009, ANGEW CHEM INT EDIT, V48, P5950, DOI 10.1002/anie.200901115; Astakhova IV, 2008, BIOCONJUGATE CHEM, V19, P1995, DOI 10.1021/bc800202v; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Baumstark D, 2008, ANGEW CHEM INT EDIT, V47, P2612, DOI 10.1002/anie.200705237; Kamiya Y, 2014, ACCOUNTS CHEM RES, V47, P1663, DOI 10.1021/ar400308f; Asanuma H, 2012, CHEM COMMUN, V48, P1760, DOI 10.1039/c2cc16812j; Gallas A, 2013, CHEM SOC REV, V42, P7983, DOI 10.1039/c3cs35520a; Asanuma H, 2001, ANGEW CHEM INT EDIT, V40, P2671, DOI 10.1002/1521-3773(20010716)40:14<2671::AID-ANIE2671>3.0.CO;2-Z; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Kamiya Y, 2013, CHEM SCI, V4, P4016, DOI 10.1039/c3sc51197a; Fujii T, 2009, CHEM-EUR J, V15, P10092, DOI 10.1002/chem.200900962; Hovelmann F, 2013, J AM CHEM SOC, V135, P19025, DOI 10.1021/ja410674h; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Gao XH, 2005, CURR OPIN BIOTECH, V16, P63, DOI 10.1016/j.copbio.2004.11.003; Nishioka H, 2012, ANGEW CHEM INT EDIT, V51, P1165, DOI 10.1002/anie.201106093; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Kaji N, 2007, ANAL SCI, V23, P21, DOI 10.2116/analsci.23.21; Liang XG, 2003, J AM CHEM SOC, V125, P16408, DOI 10.1021/ja037248j; Asanuma H, 2012, CHEM SCI, V3, P3165, DOI 10.1039/c2sc20732j; Kashida H, 2009, J AM CHEM SOC, V131, P9928, DOI 10.1021/ja9013002; Ito H, 2012, CHEMBIOCHEM, V13, P311, DOI 10.1002/cbic.201100570; Chuzhanova NA, 2003, HUM MUTAT, V21, P28, DOI 10.1002/humu.10146; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Kashida H, 2011, CHEM-EUR J, V17, P2614, DOI 10.1002/chem.201003059; Kashida H, 2008, ORG BIOMOL CHEM, V6, P2892, DOI 10.1039/b806406g; Hovelmann F, 2012, CHEMBIOCHEM, V13, P2072, DOI 10.1002/cbic.201200397; Szymanski W, 2013, CHEM REV, V113, P6114, DOI 10.1021/cr300179f; Mikat V, 2007, RNA, V13, P2341, DOI 10.1261/rna.753407; Kashida H, 2013, J AM CHEM SOC, V135, P7960, DOI 10.1021/ja401835j; ARNOTT S, 1969, ACTA CRYSTALL B-STRU, VB 25, P2192, DOI 10.1107/S0567740869005450; Asanuma H, 2010, J AM CHEM SOC, V132, P14702, DOI 10.1021/ja105539u; Barrois S, 2013, ORG BIOMOL CHEM, V11, P3085, DOI 10.1039/c3ob40435h; Batista A. A., 2006, ISOMERIZATION BIOCH, P295, DOI Weinheim; BIRKS JB, 1975, REP PROG PHYS, V38, P903, DOI 10.1088/0034-4885/38/8/001; Christensen UB, 2002, NUCLEIC ACIDS RES, V30, P4918, DOI 10.1093/nar/gkf624; Filichev VV, 2006, ANGEW CHEM INT EDIT, V45, P5311, DOI 10.1002/anie.200601127; Filichev VV, 2004, TETRAHEDRON LETT, V45, P4907, DOI 10.1016/j.tetlet.2004.04.124; Fujii T, 2012, CHEM-EUR J, V18, P13304, DOI 10.1002/chem.201201956; Fujii T, 2012, CHEM-EUR J, V18, P10865, DOI 10.1002/chem.201201365; Gildea BD, 1998, TETRAHEDRON LETT, V39, P7255, DOI 10.1016/S0040-4039(98)01581-0; Gomes-da-Silva LC, 2014, CELL MOL LIFE SCI, V71, P1417, DOI 10.1007/s00018-013-1502-2; Hara Y, 2010, ANGEW CHEM INT EDIT, V49, P5502, DOI 10.1002/anie.201001459; Hrdlicka PJ, 2005, J AM CHEM SOC, V127, P13293, DOI 10.1021/ja052887a; Huang KW, 2012, ANAL BIOANAL CHEM, V402, P3091, DOI 10.1007/s00216-011-5570-6; Kashida H, 2009, CURR ORG CHEM, V13, P1065; Kashida H, 2011, CHEM COMMUN, V47, P6404, DOI 10.1039/c1cc11041a; Kashida H, 2010, J AM CHEM SOC, V132, P6223, DOI 10.1021/ja101007d; Kashida H, 2011, ANGEW CHEM INT EDIT, V50, P1285, DOI 10.1002/anie.201006498; Kashida H, 2012, RSC BIOMOL SCI, V26, P242, DOI 10.1039/9781849734936-00242; Kashida H, 2009, ANGEW CHEM INT EDIT, V48, P7044, DOI 10.1002/anie.200902367; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leumann CJ, 2002, BIOORGAN MED CHEM, V10, P841, DOI 10.1016/S0968-0896(01)00348-0; Liang X. G., 2012, NAT COMPUT, V13, P311; Liang XG, 2011, LECT NOTES COMPUT SC, V6518, P112; Liang XG, 2010, J MATER CHEM, V20, P575, DOI 10.1039/b915993b; MERLE Y, 1995, INT J BIOL MACROMOL, V17, P239, DOI 10.1016/0141-8130(95)98150-W; Murayama K, 2013, CHEM-EUR J, V19, P14151, DOI 10.1002/chem.201301578; Nishioka H, 2010, CHEM-EUR J, V16, P2054, DOI 10.1002/chem.200902789; Nishioka H, 2007, CHEM COMMUN, P4354, DOI 10.1039/b708952j; Peng L, 1997, HELV CHIM ACTA, V80, P1494, DOI 10.1002/hlca.19970800513; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; STANFIELD CF, 1981, J ORG CHEM, V46, P4799, DOI 10.1021/jo00336a040; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Virta P, 2003, TETRAHEDRON, V59, P5137, DOI 10.1016/S0040-4020(03)00704-X; Zatsepin TS, 2004, IUBMB LIFE, V56, P209, DOI 10.1080/15216540410001710570; Zhang LL, 2006, SYNTHESIS-STUTTGART, P645, DOI 10.1055/s-2006-926313	95	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1527-8999	1528-0691		CHEM REC	Chem. Rec.	DEC	2014	14	6					1055	1069		10.1002/tcr.201402040		15	Chemistry, Multidisciplinary	Chemistry	AW0FY	WOS:000345967700004		
J	Nandi, M; Uyama, H				Nandi, Mahasweta; Uyama, Hiroshi			Exceptional CO2 Adsorbing Materials under Different Conditions	CHEMICAL RECORD			English	Review						carbon storage; metal-organic frameworks; polymers; silicates; zeolites	METAL-ORGANIC FRAMEWORK; CARBON-DIOXIDE CAPTURE; HIGH-SURFACE-AREA; ZEOLITIC IMIDAZOLATE FRAMEWORKS; MESOPOROUS MOLECULAR-SIEVE; POROUS POLYMER NETWORKS; GAS-STORAGE CAPACITIES; SOLID AMINE SORBENT; PORE-SIZE EXPANSION; ACTIVATED CARBON	In this article we discuss those materials that have recorded the highest adsorption capacities for the greenhouse gas CO2 under ambient conditions as well as at different temperatures and pressures. For convenience, the materials have been categorized under four categories, viz., porous carbon, metal-organic, zeolite and mesoporous silica, and porous organic frameworks. It has been found that the gas adsorption property significantly relies on several factors such as high surface area and pore volume and the presence of N-, O- and S-containing moieties. The presence of a microporous structure and strong interaction between the CO2 molecules with the framework through H-bonding or dipole-quadrupole interactions facilitates adsorption of the gas.	[Nandi, Mahasweta] Siksha Bhavana, Dept Integrated Sci Educ & Res, Santini Ketan 731235, W Bengal, India; [Uyama, Hiroshi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan	Nandi, M (reprint author), Siksha Bhavana, Dept Integrated Sci Educ & Res, Santini Ketan 731235, W Bengal, India.	mahasweta.nandi@visva-bharati.ac.in; uyama@chem.eng.osaka-u.ac.jp			Japan Society for the Promotion of Science [21350124]; Project for Creating Start-ups from Advanced Research and Technology, MEXT	M.N. wishes to thank Visva-Bharati, Santiniketan, for providing research funding. H.U. thanks the Japan Society for the Promotion of Science for a Grant-in-Aid for Scientific Research (No. 21350124) and a Project for Creating Start-ups from Advanced Research and Technology, MEXT.	Alessandro D', 2010, ANGEW CHEM, V122, P6194, DOI 10.1002/ange.201000431; Wan S, 2008, ANGEW CHEM INT EDIT, V47, P8826, DOI 10.1002/anie.200803826; Dietzel PDC, 2005, ANGEW CHEM INT EDIT, V44, P6354, DOI 10.1002/anie.200501508; Millward AR, 2005, J AM CHEM SOC, V127, P17998, DOI 10.1021/ja0570032; Couck S, 2009, J AM CHEM SOC, V131, P6326, DOI 10.1021/ja900555r; Jayaramulu K, 2012, INORG CHEM, V51, P7103, DOI 10.1021/ic202601y; Bloch ED, 2010, J AM CHEM SOC, V132, P14382, DOI 10.1021/ja106935d; Dinca M, 2008, ANGEW CHEM INT EDIT, V47, P6766, DOI 10.1002/anie.200801163; Britt D, 2009, P NATL ACAD SCI USA, V106, P20637, DOI 10.1073/pnas.0909718106; Yazaydin AO, 2009, J AM CHEM SOC, V131, P18198, DOI 10.1021/ja9057234; Chaikittisilp W, 2012, CHEM COMMUN, V48, P7259, DOI 10.1039/c2cc33433j; Ben T, 2009, ANGEW CHEM INT EDIT, V48, P9457, DOI 10.1002/anie.200904637; Ma XY, 2014, J MATER CHEM A, V2, P4819, DOI 10.1039/c3ta14684g; Ho MT, 2008, IND ENG CHEM RES, V47, P4883, DOI 10.1021/ie070831e; Xu XC, 2005, IND ENG CHEM RES, V44, P8113, DOI 10.1021/ie050382n; Cooper AI, 2009, ADV MATER, V21, P1291, DOI 10.1002/adma.200801971; Lassig D, 2011, ANGEW CHEM INT EDIT, V50, P10344, DOI 10.1002/anie.201102329; Franchi RS, 2005, IND ENG CHEM RES, V44, P8007, DOI 10.1021/ie0504194; Yuan DQ, 2011, ADV MATER, V23, P3723, DOI 10.1002/adma.201101759; Modak A, 2014, J MATER CHEM A, V2, P11642, DOI 10.1039/c4ta02150a; Li H, 1999, NATURE, V402, P276; Banerjee R, 2009, J AM CHEM SOC, V131, P3875, DOI 10.1021/ja809459e; Lu AH, 2002, ANGEW CHEM INT EDIT, V41, P3489, DOI 10.1002/1521-3773(20020916)41:18<3489::AID-ANIE3489>3.0.CO;2-M; Stoeck U, 2012, CHEM COMMUN, V48, P10841, DOI 10.1039/c2cc34840c; Rabbani MG, 2012, CHEM MATER, V24, P1511, DOI 10.1021/cm300407h; Son WJ, 2008, MICROPOR MESOPOR MAT, V113, P31, DOI 10.1016/j.micromeso.2007.10.049; Nugent P, 2013, NATURE, V495, P80, DOI 10.1038/nature11893; Ding SY, 2013, CHEM SOC REV, V42, P548, DOI 10.1039/c2cs35072f; Furukawa H, 2009, J AM CHEM SOC, V131, P8875, DOI 10.1021/ja9015765; Trewin A, 2010, ANGEW CHEM INT EDIT, V49, P1533, DOI 10.1002/anie.200906827; Fracaroli AM, 2014, J AM CHEM SOC, V136, P8863, DOI 10.1021/ja503296c; Schmidt J, 2009, MACROMOLECULES, V42, P4426, DOI 10.1021/ma9005473; Huang HY, 2003, IND ENG CHEM RES, V42, P2427, DOI 10.1021/ie020440u; Yue MB, 2008, MICROPOR MESOPOR MAT, V114, P74, DOI 10.1016/j.micromeso.2007.12.016; Drese JH, 2009, ADV FUNCT MATER, V19, P3821, DOI 10.1002/adfm.200901461; Rao XT, 2013, CHEM COMMUN, V49, P6719, DOI 10.1039/c3cc41866a; Ma XL, 2009, J AM CHEM SOC, V131, P5777, DOI 10.1021/ja8074105; Liang CD, 2006, J AM CHEM SOC, V128, P5316, DOI 10.1021/ja060242k; Rosi NL, 2005, J AM CHEM SOC, V127, P1504, DOI 10.1021/ja045123o; Hudson MR, 2012, J AM CHEM SOC, V134, P1970, DOI 10.1021/ja210580b; Kruk M, 1999, J PHYS CHEM B, V103, P4590, DOI 10.1021/jp9844258; Zhu YL, 2013, CHEM MATER, V25, P1630, DOI 10.1021/cm400019f; Meng Y, 2005, ANGEW CHEM INT EDIT, V44, P7053, DOI 10.1002/anie.200501561; Dutta A, 2012, CHEM COMMUN, V48, P6738, DOI 10.1039/c2cc32298f; McKeown NB, 2006, ANGEW CHEM INT EDIT, V45, P1804, DOI 10.1002/anie.200504241; Modak A, 2012, CHEM COMMUN, V48, P248, DOI 10.1039/c1cc14275e; Banerjee R, 2008, SCIENCE, V319, P939, DOI 10.1126/science.1152516; Xia YD, 2011, ADV ENERGY MATER, V1, P678, DOI 10.1002/aenm.201100061; DAVIS ME, 1988, NATURE, V331, P698, DOI 10.1038/331698a0; Walspurger S, 2010, CHEM-EUR J, V16, P12694, DOI 10.1002/chem.201000687; Ning GQ, 2012, CHEM COMMUN, V48, P6815, DOI 10.1039/c2cc31785k; Wood CD, 2007, CHEM MATER, V19, P2034, DOI 10.1021/cm070356a; Belmabkhout Y, 2009, ADSORPTION, V15, P318, DOI 10.1007/s10450-009-9185-6; Farha OK, 2012, J AM CHEM SOC, V134, P9860, DOI 10.1021/ja302623w; Choi S, 2009, CHEMSUSCHEM, V2, P796, DOI 10.1002/cssc.200900036; Ben T, 2011, ENERG ENVIRON SCI, V4, P3991, DOI 10.1039/c1ee01222c; Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; Simmons JM, 2011, ENERG ENVIRON SCI, V4, P2177, DOI 10.1039/c0ee00700e; Sevilla M, 2011, ENERG ENVIRON SCI, V4, P1765, DOI 10.1039/c0ee00784f; Rochelle GT, 2009, SCIENCE, V325, P1652, DOI 10.1126/science.1176731; Wei HR, 2012, CHEMSUSCHEM, V5, P2354, DOI 10.1002/cssc.201200570; Arab P, 2014, CHEM MATER, V26, P1385, DOI 10.1021/cm403161e; Jiang JX, 2007, ANGEW CHEM INT EDIT, V46, P8574, DOI 10.1002/anie.200701595; Farha OK, 2009, CHEM MATER, V21, P3033, DOI 10.1021/cm901280w; Okada K, 2011, CHEM COMMUN, V47, P7422, DOI 10.1039/c1cc12402a; Comotti A, 2007, J AM CHEM SOC, V129, P8566, DOI 10.1021/ja071348y; Lin RB, 2012, INORG CHEM, V51, P9950, DOI 10.1021/ic301463z; Xiong SH, 2014, POLYM CHEM-UK, V5, P3424, DOI 10.1039/c3py01471a; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Wahby A, 2010, CHEMSUSCHEM, V3, P974, DOI 10.1002/cssc.201000083; Tian J, 2011, CHEM COMMUN, V47, P7626, DOI 10.1039/c1cc12689j; Zhang JM, 2010, CHEM COMMUN, V46, P9152, DOI 10.1039/c0cc02942d; Morris RE, 2008, ANGEW CHEM INT EDIT, V47, P4966, DOI 10.1002/anie.200703934; Sarawade P, 2013, ACS SUSTAIN CHEM ENG, V1, P66, DOI 10.1021/sc300036p; Dietzel PDC, 2009, J MATER CHEM, V19, P7362, DOI 10.1039/b911242a; Xu XC, 2002, ENERG FUEL, V16, P1463, DOI 10.1021/ef020058u; D'Alessandro DM, 2010, ANGEW CHEM INT EDIT, V49, P6058, DOI 10.1002/anie.201000431; Dutta S, 2014, ENERG ENVIRON SCI, V7, P3574, DOI 10.1039/c4ee01075b; Li LJ, 2014, CHEM COMMUN, V50, P2304, DOI 10.1039/c3cc48275h; Luo XZ, 2013, J AM CHEM SOC, V135, P11684, DOI 10.1021/ja403002m; El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915; Farha OK, 2010, NAT CHEM, V2, P944, DOI [10.1038/nchem.834, 10.1038/NCHEM.834]; Hou L, 2011, CHEM COMMUN, V47, P5464, DOI 10.1039/c1cc10990a; Rabbani MG, 2011, CHEM MATER, V23, P1650, DOI 10.1021/cm200411p; Qi GG, 2011, ENERG ENVIRON SCI, V4, P444, DOI 10.1039/c0ee00213e; Hicks JC, 2008, J AM CHEM SOC, V130, P2902, DOI 10.1021/ja077795v; Khatri RA, 2006, ENERG FUEL, V20, P1514, DOI 10.1021/ef050402y; Zhao JQ, 2012, RSC ADV, V2, P6509, DOI 10.1039/c2ra20149f; Peng Y, 2013, CHEM COMMUN, V49, P2992, DOI 10.1039/c3cc40819a; Lu WG, 2010, CHEM MATER, V22, P5964, DOI 10.1021/cm1021068; Patel HA, 2013, ADV FUNCT MATER, V23, P2270, DOI 10.1002/adfm.201202442; Day A, 2001, J ORG CHEM, V66, P8094, DOI 10.1021/jo015897c; Sayari A, 1998, ADV MATER, V10, P1376; Muniz J, 1998, APPL CATAL B-ENVIRON, V18, P171, DOI 10.1016/S0926-3373(98)00039-3; Sayari A, 2000, ANGEW CHEM INT EDIT, V39, P2920, DOI 10.1002/1521-3773(20000818)39:16<2920::AID-ANIE2920>3.0.CO;2-3; Liu QL, 2010, CHEM COMMUN, V46, P4502, DOI 10.1039/c000900h; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; Patel HA, 2012, J MATER CHEM, V22, P8431, DOI [10.1039/c2jm30761, 10.1039/c2jm30761h]; Nandi M, 2012, CHEM COMMUN, V48, P10283, DOI 10.1039/c2cc35334b; Radosz M, 2008, IND ENG CHEM RES, V47, P3783, DOI 10.1021/ie0707974; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Siriwardane RV, 2001, ENERG FUEL, V15, P279, DOI 10.1021/ef000241s; Vaidhyanathan R, 2010, SCIENCE, V330, P650, DOI 10.1126/science.1194237; Kruk M, 2000, MICROPOR MESOPOR MAT, V35-6, P545, DOI 10.1016/S1387-1811(99)00249-8; Tozawa T, 2009, NAT MATER, V8, P973, DOI [10.1038/nmat2545, 10.1038/NMAT2545]; Xu XC, 2003, MICROPOR MESOPOR MAT, V62, P29, DOI 10.1016/S1387-1811(03)00388-3; Caskey SR, 2008, J AM CHEM SOC, V130, P10870, DOI 10.1021/ja8036096; Llewellyn PL, 2008, LANGMUIR, V24, P7245, DOI 10.1021/la800227x; Debatin F, 2010, ANGEW CHEM INT EDIT, V49, P1258, DOI 10.1002/anie.200906188; Cavenati S, 2004, J CHEM ENG DATA, V49, P1095, DOI 10.1021/je0498917; Kong GQ, 2013, CHEM-EUR J, V19, P14886, DOI 10.1002/chem.201302515; Sevilla M, 2011, ADV FUNCT MATER, V21, P2781, DOI 10.1002/adfm.201100291; Satyapal S, 2001, ENERG FUEL, V15, P250, DOI 10.1021/ef0002391; Yuan DQ, 2010, ANGEW CHEM INT EDIT, V49, P5357, DOI 10.1002/anie.201001009; Sayari A, 1999, J PHYS CHEM B, V103, P3651, DOI 10.1021/jp984504j; Ben T., 2009, ANGEW CHEM, V121, P9621; Chen C, 2012, MATER LETT, V75, P140, DOI 10.1016/j.matlet.2012.02.015; Debatin F., 2010, ANGEW CHEM, V122, P1280; Dietzel P. D. C., 2005, ANGEW CHEM, V117, P6512, DOI 10.1002/ange.200501508; Dietzel PDC, 2006, CHEM COMMUN, P959, DOI 10.1039/b515434k; Dietzel PDC, 2008, CHEM COMMUN, P5125, DOI 10.1039/b810574j; Dinca M., 2008, ANGEW CHEM, V120, P6870, DOI DOI 10.1002/ANGE.200801163; GEDRICH K, 2010, KASKEL ANGEW CHEM IN, V49, P8489; Gedrich K., 2010, ANGEW CHEM, V122, P8667; Jiang J. -X., 2007, ANGEW CHEM, V119, P8728, DOI 10.1002/ange.200701595; Kang D.-Y., 2014, NAT COMMUN, V5, P4342; Kanie O., 2006, ANGEW CHEM, V118, P3935, DOI 10.1002/ange.200600433; Kanie O, 2006, ANGEW CHEM INT EDIT, V45, P3851, DOI 10.1002/anie.200600433; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Kitagawa S., 2004, ANGEW CHEM, V116, DOI 10.1002/ange.200300610; Kruk M, 2002, J PHYS CHEM B, V106, P10096, DOI 10.1021/jp026252z; Lassig D., 2011, ANGEW CHEM, V123, P10528; Liu CY, 2007, CHEM COMMUN, P757, DOI 10.1039/b614199d; Lu A.- H., 2002, ANGEW CHEM, V114, P3639, DOI 10.1002/1521-3757(20020916)114:18<3639::AID-ANGE3639>3.0.CO;2-G; Lu AH, 2004, ANGEW CHEM INT EDIT, V43, P4303, DOI 10.1002/anie.200454222; Lu A.H., 2004, ANGEW CHEM, V116, P4403, DOI 10.1002/ange.200454222; McKeown N. B., 2006, ANGEW CHEM, V118, P1836, DOI 10.1002/ange.200504241; Meng Y., 2005, ANGEW CHEM, V117, P7215, DOI DOI 10.1002/ANGE.200501561; Mohanty P., 2011, NAT COMMUN, V2, P1405; Morris R. E., 2008, ANGEW CHEM, V120, P5044, DOI 10.1002/ange.200703934; Sayari A., 2000, ANGEW CHEM INT EDIT, V112, P3042, DOI 10.1002/1521-3757(20000818)112:16<3042::AID-ANGE3042>3.0.CO;2-T; Shekhah O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5228; Sircar S., 2008, ADSORPTION CARBONS; Trewin A., 2010, ANGEW CHEM, V122, P1575; Wan S., 2008, ANGEW CHEM, V120, P8958, DOI DOI 10.1002/ANGE.200803826; Wang XR, 2011, MICROPOR MESOPOR MAT, V142, P564, DOI 10.1016/j.micromeso.2010.12.047; Yang R. T., 1987, GAS SEPARATION ADSOR; Youn HK, 2011, MATER LETT, V65, P1772, DOI 10.1016/j.matlet.2011.03.039; Yuan D., 2010, ANGEW CHEM, V122, P5485; Zheng B, 2010, J AM CHEM SOC, V133, P748	150	5	5	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1527-8999	1528-0691		CHEM REC	Chem. Rec.	DEC	2014	14	6					1134	1148		10.1002/tcr.201402062		15	Chemistry, Multidisciplinary	Chemistry	AW0FY	WOS:000345967700009		
J	Kamimura, A; Murata, K; Tanaka, Y; Okagawa, T; Matsumoto, H; Kaiso, K; Yoshimoto, M				Kamimura, Akio; Murata, Kengo; Tanaka, Yoshiki; Okagawa, Tomoki; Matsumoto, Hiroshi; Kaiso, Kouji; Yoshimoto, Makoto			Rapid Conversion of Sorbitol to Isosorbide in Hydrophobic Ionic Liquids under Microwave Irradiation	CHEMSUSCHEM			English	Article						biomass; ionic liquids; isosorbide; microwave chemistry; sorbitol	GLUCOSE HYDROGENATION; PHASE DEHYDRATION; CATALYSTS; CELLULOSE; SOLVENTS; DESIGN	Sorbitol was effectively converted to isosorbide by treatment with [TMPA][NTf2] in the presence of catalytic amounts of TsOH under microwave heating at 180 degrees C. The reaction completed within 10 min and isosorbide was isolated to about 60%. Ionic liquids were readily recovered by an extraction treatment and reused several times.	[Kamimura, Akio; Tanaka, Yoshiki; Okagawa, Tomoki; Matsumoto, Hiroshi; Kaiso, Kouji; Yoshimoto, Makoto] Yamaguchi Univ, Dept Appl Mol Biosci, Grad Sch Med, Ube, Yamaguchi 7558611, Japan; [Murata, Kengo] Yamaguchi Univ, Dept Appl Chem, Fac Engn, Ube, Yamaguchi 7558611, Japan; [Matsumoto, Hiroshi; Kaiso, Kouji] Ube Ind Ltd, Ube Lab, Ube, Yamaguchi 7558633, Japan	Kamimura, A (reprint author), Yamaguchi Univ, Dept Appl Mol Biosci, Grad Sch Med, Ube, Yamaguchi 7558611, Japan.	ak10@yamaguchi-u.ac.jp			 [24241023]	This work was partially supported by Grant-in-Aid for Scientific Research (A) (24241023).	Fukuoka A, 2006, ANGEW CHEM INT EDIT, V45, P5161, DOI 10.1002/anie.200601921; Sun P, 2013, CHEMSUSCHEM, V6, P2190, DOI 10.1002/cssc.201300701; Fei ZF, 2006, CHEM-EUR J, V12, P2122, DOI 10.1002/chem.200500581; Yamaguchi A, 2011, GREEN CHEM, V13, P873, DOI 10.1039/c0gc00426j; Fenouillot F, 2010, PROG POLYM SCI, V35, P578, DOI 10.1016/j.progpolymsci.2009.10.001; Onda A, 2008, GREEN CHEM, V10, P1033, DOI 10.1039/b808471h; Gu MG, 2009, CATAL LETT, V133, P214, DOI 10.1007/s10562-009-0142-5; Liang GF, 2011, GREEN CHEM, V13, P839, DOI 10.1039/c1gc15098g; Bozell JJ, 2010, GREEN CHEM, V12, P539, DOI 10.1039/b922014c; Li N, 2010, J CATAL, V270, P48, DOI 10.1016/j.jcat.2009.12.006; Ahmed I, 2013, CHEM ENG SCI, V93, P91, DOI 10.1016/j.ces.2013.01.068; Ohno H, 2009, CHEM LETT, V38, P2, DOI 10.1246/cl.2009.2; Hallett JP, 2011, CHEM REV, V111, P3508, DOI 10.1021/cr1003248; Jain N, 2005, TETRAHEDRON, V61, P1015, DOI 10.1016/j.tet.2004.10.070; Miao WS, 2006, ACCOUNTS CHEM RES, V39, P897, DOI 10.1021/ar030252f; Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m; Li JR, 2013, CATAL SCI TECHNOL, V3, P1540, DOI 10.1039/c3cy20809e; Polaert I, 2013, CHEM ENG J, V222, P228, DOI 10.1016/j.cej.2013.02.043; Palkovits R, 2010, GREEN CHEM, V12, P972, DOI 10.1039/c000075b; Vallin KSA, 2002, J ORG CHEM, V67, P6243, DOI 10.1021/jo025942w; Xia JJ, 2011, CATAL COMMUN, V12, P544, DOI 10.1016/j.catcom.2010.12.002; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Wasserscheid P, 2000, ANGEW CHEM INT EDIT, V39, P3772, DOI 10.1002/1521-3773(20001103)39:21<3772::AID-ANIE3772>3.0.CO;2-5; Hoffmann J, 2003, GREEN CHEM, V5, P296, DOI 10.1039/b212533a; Astruc D, 2005, ANGEW CHEM INT EDIT, V44, P7852, DOI 10.1002/anie.200500766; Davda RR, 2004, CHEM COMMUN, P36, DOI 10.1039/b310152e; Khan NA, 2011, RES CHEM INTERMEDIAT, V37, P1231, DOI 10.1007/s11164-011-0389-5; Baudequin C, 2005, TETRAHEDRON-ASYMMETR, V16, P3921, DOI 10.1016/j.tetasy.2005.10.026; Rose M, 2012, CHEMSUSCHEM, V5, P167, DOI 10.1002/cssc.201100580; Gallezot P, 1998, J CATAL, V180, P51, DOI 10.1006/jcat.1998.2261; Astruc D., 2005, ANGEW CHEM, V117, P8062, DOI 10.1002/ange.200500766; Dabbawala AA, 2013, CATAL COMMUN, V42, P1, DOI 10.1016/j.catcom.2013.07.020; Dharman MM, 2009, J MOL CATAL A-CHEM, V303, P96, DOI 10.1016/j.molcata.2009.01.004; Dhepe L., 2007, CATAL SURV ASIA, V11, P186; Fukuoka A., 2006, ANGEW CHEM, V118, P5285, DOI 10.1002/ange.200601921; Harmer MA, 2009, CHEM COMMUN, P6610, DOI 10.1039/b916048e; Kamimura A, 2011, CHEMSUSCHEM, V4, P644, DOI 10.1002/cssc.201000430; Kamimura A., 2014, [No title captured], Patent No. [JP 2014101327, 2014101327]; Kamimura A, 2012, GREEN CHEM, V14, P2816, DOI 10.1039/c2gc35811e; Kim B. J., 2012, [No title captured], Patent No. [KR 2012129558, 2012129558]; Leadbeater NE, 2002, J ORG CHEM, V67, P3145, DOI 10.1021/jo016297g; Li HX, 2000, J CATAL, V191, P257, DOI 10.1006/jcat.1999.2792; Wasserscheid P., 2000, ANGEW CHEM, V112, P3926, DOI DOI 10.1002/1521-3773(20001103)39:21<3772::AID-ANIE3772>3.0.CO;2-5; Winterle S, 2010, CHEM-ING-TECH, V82, P1211	44	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1864-5631	1864-564X		CHEMSUSCHEM	ChemSusChem	DEC	2014	7	12					3257	3259		10.1002/cssc.201402655		3	Chemistry, Multidisciplinary	Chemistry	AW0IU	WOS:000345976200007		
J	Sato, K; Yagi, S; Zaitsu, S; Kitayama, G; Kayada, Y; Teramura, K; Takita, Y; Nagaoka, K				Sato, Katsutoshi; Yagi, Sho; Zaitsu, Shuhei; Kitayama, Godai; Kayada, Yuto; Teramura, Kentaro; Takita, Yusaku; Nagaoka, Katsutoshi			Inhibition of Ammonia Poisoning by Addition of Platinum to Ru/alpha-Al2O3 for Preferential CO Oxidation in Fuel Cells	CHEMSUSCHEM			English	Article						fuel cells; heterogeneous catalysis; hydrogen; natural gas; X-ray absorption spectroscopy	SELECTIVE CATALYTIC-OXIDATION; SUPPORTED RUTHENIUM CATALYST; DEACTIVATION; REMOVAL; METHANE; NH3	In polymer electrolyte fuel cell (PEFC) systems, small amounts of ammonia (NH3) present in the reformate gas deactivate the supported ruthenium catalysts used for preferential oxidation (PROX) of carbon monoxide (CO). In this study, we investigated how the addition of a small amount of platinum to a Ru/alpha-Al2O3 catalyst (Pt/Ru=1:9 w/w) affected the catalyst's PROX activity in both the absence and the presence of NH3 (130 ppm) under conditions mimicking the reformate conditions during steam reforming of natural gas. The activity of undoped Ru/alpha-Al2O3 decreased sharply upon addition of NH3, whereas Pt/Ru/alpha-Al2O3 exhibited excellent PROX activity even in the presence of NH3. Ruthenium K-edge X-ray absorption near-edge structure (XANES) spectra indicated that in the presence of NH3, some of the ruthenium in the undoped catalyst was oxidized in the presence of NH3, whereas ruthenium oxidation was not observed with Pt/Ru/alpha-Al2O3. These results suggest that ruthenium oxidation is retarded by the platinum, so that the catalyst shows high activity even in the presence of NH3.	[Sato, Katsutoshi; Teramura, Kentaro; Nagaoka, Katsutoshi] Kyoto Univ, Elements Strategy Initiat Catalysts & Batteries, Nishikyo Ku, Kyoto 6158245, Japan; [Sato, Katsutoshi; Yagi, Sho; Zaitsu, Shuhei; Kitayama, Godai; Kayada, Yuto; Takita, Yusaku; Nagaoka, Katsutoshi] Oita Univ, Dept Appl Chem, Fac Engn, Oita 8701192, Japan; [Teramura, Kentaro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Teramura, Kentaro] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan	Sato, K (reprint author), Kyoto Univ, Elements Strategy Initiat Catalysts & Batteries, Nishikyo Ku, 1-30 Goryo Ohara, Kyoto 6158245, Japan.	nagaoka@oita-u.ac.jp			Elements Strategy Initiative for Catalysts and Batteries (ESICB); Ministry of Education, Culture, Sports, Science and Technology, Japan	A part of this work was performed under the auspices of the Elements Strategy Initiative for Catalysts and Batteries (ESICB) supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors thank Dr. S. Hosokawa (Kyoto University), Mr. S. Iguchi (Kyoto University), and Mr. Y. Wada (Oita University) for assistance with the XANES measurements. The XANES measurements conducted at SPring-8 were approved by the Japan Synchrotron Radiation Research Institute (proposal no. 2013B1771).	AIKA K, 1992, J CATAL, V136, P126, DOI 10.1016/0021-9517(92)90112-U; Wang Z, 2012, APPL CATAL A-GEN, V411, P131, DOI 10.1016/j.apcata.2011.10.030; Pajonk GM, 2000, APPL CATAL A-GEN, V202, P157, DOI 10.1016/S0926-860X(00)00522-6; OH SH, 1993, J CATAL, V142, P254, DOI 10.1006/jcat.1993.1205; Carabineiro SAC, 2004, SURF SCI, V555, P83, DOI 10.1016/j.susc.2004.02.022; Chin SY, 2006, J CATAL, V243, P329, DOI 10.1016/j.jcat.2006.08.004; Echigo M, 2004, CATAL TODAY, V90, P269, DOI 10.1016/j.cattod.2004.04.036; Kim YH, 2009, APPL CATAL A-GEN, V366, P363, DOI 10.1016/j.apcata.2009.07.030; Li D, 2008, APPL CATAL A-GEN, V350, P225, DOI 10.1016/j.apcata.2008.08.017; Liu K., 2010, HYDROGEN SYNGAS PROD; Nurunnabi M, 2006, APPL CATAL A-GEN, V299, P145, DOI 10.1016/j.apcata.2005.10.020; O'Hayre R. P., 2008, FUEL CELL FUNDAMENTA, V2nd; SCHRIBER TJ, 1967, CHEM ENG SCI, V22, P1067, DOI 10.1016/0009-2509(67)80171-4; Wakita H, 2007, J PHYS CHEM C, V111, P2205, DOI 10.1021/jp065497z; Wakita H, 2006, CHEM LETT, V35, P734, DOI 10.1246/cl.2006.734	15	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1864-5631	1864-564X		CHEMSUSCHEM	ChemSusChem	DEC	2014	7	12					3264	3267		10.1002/cssc.201402583		4	Chemistry, Multidisciplinary	Chemistry	AW0IU	WOS:000345976200009		
J	Du, HW; Yang, N				Du Hai-Wei; Yang Nan			Theoretical Investigation on THz Generation from Optical Rectification with Tilted-Pulse-Front Excitation	CHINESE PHYSICS LETTERS			English	Article							LITHIUM-NIOBATE; TERAHERTZ SPECTROSCOPY; ABSORPTION; LASERS; RANGE	The generation of THz pulses from stoichiometric LiNbO3 (sLN) crystal with tilted-pulse-front excitation is studied. In this scheme, THz absorption by sLN is obtained by numerical interpolation based on the measured data. It shows that THz generation can be enhanced by decreasing the temperature of sLN. The refractive indices of the laser from visible to mid-infrared regime are calculated from the Sellmeier dispersion equation. Then the THz generation law pumped by visible and mid-infrared laser pulses is calculated. It is found that the THz amplitude and energy increase in the near-infrared regime and then tread to a constant value when the wavelength of the laser pulses increases.	[Du Hai-Wei] RIKEN, Ctr Adv Photon, Terahertz Sensing & Imaging Team, Sendai, Miyagi 9800845, Japan; [Yang Nan] Shanghai Jiao Tong Univ, Lab Laser Plasma, Minist Educ, Shanghai 200240, Peoples R China; [Yang Nan] Shanghai Jiao Tong Univ, Dept Phys & Astron, Shanghai 200240, Peoples R China	Du, HW (reprint author), RIKEN, Ctr Adv Photon, Terahertz Sensing & Imaging Team, Sendai, Miyagi 9800845, Japan.	haiweidu@yahoo.com			Foreign Postdoctoral Researcher Program of RIKEN of Japan	Supported by the Foreign Postdoctoral Researcher Program of RIKEN of Japan.	Yeh KL, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734374; Zelmon DE, 1997, J OPT SOC AM B, V14, P3319, DOI 10.1364/JOSAB.14.003319; Fulop JA, 2010, OPT EXPRESS, V18, P12311, DOI 10.1364/OE.18.012311; Ferguson B, 2002, NAT MATER, V1, P26, DOI 10.1038/nmat708; Chan WL, 2007, REP PROG PHYS, V70, P1325, DOI 10.1088/0034-4885/70/8/R02; Huang SW, 2013, OPT LETT, V38, P796, DOI 10.1364/OL.38.000796; Hebling J, 2002, OPT EXPRESS, V10, P1161, DOI 10.1364/OE.10.001161; Hirori H, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3560062; Clerici M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.253901; Nahata A, 1996, APPL PHYS LETT, V69, P2321, DOI 10.1063/1.117511; Keller U, 2003, NATURE, V424, P831, DOI 10.1038/nature01938; Ulbricht R, 2011, REV MOD PHYS, V83, P543, DOI 10.1103/RevModPhys.83.543; Palfalvi L, 2005, J APPL PHYS, V97, DOI 10.1063/1.1929859; Hebling J, 2008, IEEE J SEL TOP QUANT, V14, P345, DOI 10.1109/JSTQE.2007.914602; Dai JM, 2011, IEEE J SEL TOP QUANT, V17, P183, DOI 10.1109/JSTQE.2010.2047007; Popmintchev T, 2012, SCIENCE, V336, P1287, DOI 10.1126/science.1218497; Hebling J, 2004, APPL PHYS B-LASERS O, V78, P593, DOI 10.1007/s00340-004-1469-7; Hoffmann MC, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/8/083001; Yao JP, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.051802; Zhang M, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/10/104208; Zuo ZG, 2013, CHINESE PHYS B, V22, DOI 10.1088/1674-1056/22/10/107802	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0256-307X	1741-3540		CHINESE PHYS LETT	Chin. Phys. Lett.	DEC	2014	31	12							124201	10.1088/0256-307X/31/12/124201		3	Physics, Multidisciplinary	Physics	AW3AQ	WOS:000346158200012		
J	Izumi, K; Zhang, Z; Kaur, M; Krantz, ID				Izumi, Kosuke; Zhang, Zhe; Kaur, Maninder; Krantz, Ian D.			12p microRNA expression in fibroblast cell lines from probands with Pallister-Killian syndrome	CHROMOSOME RESEARCH			English	Article						miR-1244; MEIS2; UQCRB; Isochromosome 12p; Cleft palate	AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; MUTATIONS; DELETION; HUMANS; GROWTH	Pallister-Killian syndrome is a multisystem sporadic genetic diagnosis characterized by facial dysmorphia, variable developmental delay and intellectual impairment, hypotonia, seizures, diaphragmatic hernia, and other systemic abnormalities. Pallister-Killian syndrome is typically caused by the presence of a supernumerary isochromosome that is always present in a tissue limited mosaic pattern, resulting in tetrasomy 12p due to the two extra copies of 12p. We evaluated the potential contribution of microRNAs located on 12p to the pathogenesis of Pallister-Killian syndrome phenotype. Using skin fibroblast cell lines from 13 probands with Pallister-Killian syndrome and 5 normal matched controls, the expression level of 5 microRNAs located on 12p and their target gene mRNA levels were measured. All measured micro RNAs located on 12p were overexpressed in Pallister-Killian syndrome fibroblasts, although the fold difference of the expression level was lower than copy number differences. Among the five microRNAs, miR-1244 had the highest fold difference. Many of computer-predicted target genes of miR-1244 were downregulated in Pallister-Killian syndrome skin fibroblasts. In particular, expression levels of MEIS2 and UQCRB were significantly decreased in Pallister-Killian syndrome samples, and an inverse linear correlation was seen between the level of miR-1244 and MEIS2 and UQCRB expression levels. Since many of computer-predicted miR-1244 target genes play roles in transcriptional regulation, overexpression of miR-1244 due to tetrasomy 12p may contribute to the pleiotropic phenotype of Pallister-Killian syndrome by modulating its downstream target genes including MEIS2 and UQCRB.	[Izumi, Kosuke; Kaur, Maninder; Krantz, Ian D.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Izumi, Kosuke] Univ Tokyo, Res Ctr Epigenet Dis, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1138654, Japan; [Zhang, Zhe] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Krantz, Ian D.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	Izumi, K (reprint author), Univ Tokyo, Res Ctr Epigenet Dis, Inst Mol & Cellular Biosci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138654, Japan.	kosukeizumi@iam.u-tokyo.ac.jp					Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Ackerman KG, 2005, PLOS GENET, V1, P58, DOI 10.1317/journal.pgen.00100010; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Sankaran VG, 2011, P NATL ACAD SCI USA, V108, P1519, DOI 10.1073/pnas.1018384108; Hausser J, 2009, NUCLEIC ACIDS RES, V37, pW266, DOI 10.1093/nar/gkp412; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Paige SL, 2012, CELL, V151, P221, DOI 10.1016/j.cell.2012.08.027; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; de Pontual L, 2011, NAT GENET, V43, P1026, DOI 10.1038/ng.915; Crowley MA, 2010, AM J MED GENET A, V152A, P1326, DOI 10.1002/ajmg.a.33375; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Avnit-Sagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005033; Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0; Izumi K, 2012, AM J MED GENET A, V158A, P3033, DOI 10.1002/ajmg.a.35500; Kaur M, 2010, 60 ANN M AM SOC HUM; Malaney S, 1996, CYTOGENET CELL GENET, V73, P297, DOI 10.1159/000134360; Mathieu M, 1997, ANN GENET-PARIS, V40, P45; Pallister P D, 1977, Birth Defects Orig Artic Ser, V13, P103; PELTOMAKI P, 1987, CLIN GENET, V31, P399; Teschler-Nicola M, 1981, SYND IDENT, V7, P6; TSl Elton, 2010, RNA BIOL, V7, P540; Wilkens A, 2012, AM J MED GENET A, V158A, P3002, DOI 10.1002/ajmg.a.35722	26	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0967-3849	1573-6849		CHROMOSOME RES	Chromosome Res.	DEC	2014	22	4					453	461		10.1007/s10577-014-9431-y		9	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	AW0GA	WOS:000345967900002		
J	Inamasu, J; Hayashi, T; Oheda, M; Yamashiro, K; Tateyama, S; Kogame, H; Yamada, Y; Sugimoto, K; Watanabe, E; Kato, Y; Hirose, Y				Inamasu, Joji; Hayashi, Takuro; Oheda, Motoki; Yamashiro, Kei; Tateyama, Shinichiro; Kogame, Hirotaka; Yamada, Yasuhiro; Sugimoto, Keiko; Watanabe, Eiichi; Kato, Yoko; Hirose, Yuichi			Cardiac wall motion abnormality after bleeding from vertebral artery aneurysms	CLINICAL AUTONOMIC RESEARCH			English	Article						Aneurysm; Catecholamine; Hydrocephalus; Subarachnoid hemorrhage; Vertebral artery; Wall motion abnormality	NEUROGENIC STUNNED MYOCARDIUM; SUBARACHNOID HEMORRHAGE; PULMONARY-EDEMA; NOREPINEPHRINE; CARDIOMYOPATHY; HYDROCEPHALUS	Lesions in the medulla oblongata may be causally associated with cardiac wall motion abnormality (WMA). Although subarachnoid hemorrhage (SAH) patients occasionally develop WMA, the relationship between aneurysmal locations and the frequency of WMA has rarely been investigated. The objective of this study was to evaluate whether the frequency of WMA was higher after the rupture of vertebral artery (VA) aneurysms than that of non-VA aneurysms. We performed a retrospective chart analysis of 244 SAH patients who underwent transthoracic echocardiography and plasma catecholamine measurements. The frequencies of WMA and electrocardiographic (ECG) abnormalities were compared among patients classified by the location of aneurysms. Multivariate regression analysis was conducted to identify variables correlated with WMA. Furthermore, the relationship between plasma catecholamine levels and aneurysmal locations was evaluated. The frequency of WMA was significantly higher in patients with VA aneurysms than in those with non-VA aneurysms (45 vs. 22 %, p = 0.01). However, there was no significant difference in the frequency of ECG abnormalities. Multivariate regression analysis showed that VA aneurysms (OR, 3.317; 95 % CI, 1.129-9.745), poor-grade SAH (OR, 2.733; 95 % CI, 1.320-5.658) and concomitant hydrocephalus (OR, 3.658; 95 % CI, 1.690-7.917) correlated with WMA. There were no significant intergroup differences in plasma catecholamine levels. VA aneurysms are close to several medullary nuclei that integrate autonomic inputs. A transient deformation and ischemia of the medulla oblongata caused by the mechanical stress related to the rupture of a VA aneurysm and/or a concomitant hydrocephalus may be responsible for the disproportionately high frequency of WMA.	[Inamasu, Joji; Hayashi, Takuro; Oheda, Motoki; Yamashiro, Kei; Tateyama, Shinichiro; Kogame, Hirotaka; Yamada, Yasuhiro; Kato, Yoko; Hirose, Yuichi] Fujita Hlth Univ Hosp, Dept Neurosurg, Toyoake, Aichi 4701192, Japan; [Sugimoto, Keiko] Fujita Hlth Univ Hosp, Dept Lab Med, Toyoake, Aichi 4701192, Japan; [Watanabe, Eiichi] Fujita Hlth Univ Hosp, Dept Cardiol, Toyoake, Aichi 4701192, Japan	Inamasu, J (reprint author), Fujita Hlth Univ Hosp, Dept Neurosurg, 1-98 Kutsukake, Toyoake, Aichi 4701192, Japan.	namasu@fujita-hu.ac.jp					Robertson SD, 2013, NAT NEUROSCI, V16, P1016, DOI 10.1038/nn.3458; Sugimoto K, 2012, STROKE, V43, P1897, DOI 10.1161/STROKEAHA.111.646893; Johnson J, 2010, J NEUROSURG-PEDIATR, V5, P428, DOI 10.3171/2009.11.PEDS09341; Naredi S, 2000, STROKE, V31, P901; Berganzo K, 2011, CLIN AUTON RES, V21, P65, DOI 10.1007/s10286-010-0088-0; Inamasu J, 2012, NEUROL MED-CHIR, V52, P49; MAYER SA, 1995, J NEUROSURG, V83, P889, DOI 10.3171/jns.1995.83.5.0889; BROUWERS PJAM, 1995, J NEUROL NEUROSUR PS, V58, P614, DOI 10.1136/jnnp.58.5.614; DILRAJ A, 1992, NEUROSURGERY, V31, P42; Im So-Hyang, 2007, Int J Cardiol, V114, pe120, DOI 10.1016/j.ijcard.2006.07.028; Inamasu J, 2003, CEREBROVASC DIS, V16, P306, DOI 10.1159/000071135; Jain R, 2004, AM J NEURORADIOL, V25, P126; Jarquin-Valdivia AA, 2005, CLIN NEUROL NEUROSUR, V107, P361, DOI 10.1016/j.clineuro.2004.09.012; Khush K, 2005, J AM SOC ECHOCARDIOG, V18, P168, DOI 10.1016/j.echo.2004.08.045; Ochiai H, 2001, NEUROL MED-CHIR, V41, P529, DOI 10.2176/nmc.41.529; WEINTRAU.BM, 1974, STROKE, V5, P384; Yokota H, 2011, NEUROL MED-CHIR, V51, P842	17	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0959-9851	1619-1560		CLIN AUTON RES	Clin. Auton. Res.	DEC	2014	24	6					259	264		10.1007/s10286-014-0256-8		6	Clinical Neurology; Neurosciences	Neurosciences & Neurology	AW1AA	WOS:000346021400005		
J	Kitamura, T; Otsuki, M; Tamada, D; Tabuchi, Y; Mukai, K; Morita, S; Kasayama, S; Bando, Y; Shimomura, I; Koga, M				Kitamura, Tetsuhiro; Otsuki, Michio; Tamada, Daisuke; Tabuchi, Yukiko; Mukai, Kosuke; Morita, Shinya; Kasayama, Soji; Bando, Yukihiro; Shimomura, Iichiro; Koga, Masafumi			Serum albumin-adjusted glycated albumin is an adequate indicator of glycemic control in patients with Cushing's syndrome	CLINICAL BIOCHEMISTRY			English	Article						Cushing's syndrome; Glucocorticoid; Glycated albumin; HbA1c; Albumin	NEONATAL DIABETES-MELLITUS; PLASMA-GLUCOSE; HEMOGLOBIN; DISEASE; COMPLICATIONS; PREDNISOLONE; DIAGNOSIS; AGE	Objectives: We recently reported that glycated albumin (GA) in patients with Cushing's syndrome is low. In the present study, we examined whether serum albumin (SA)-adjusted GA (SAaGA) is an adequate indicator of glycemic control in patients with Cushing's syndrome. Design and methods: We studied 26 patients with Cushing's syndrome (13 patients without diabetes and 13 patients with diabetes). Twenty six non-diabetic subjects and 26 patients with type 2 diabetes mellitus matched for age, sex and BMI were used as the controls. SAaGA was calculated using the regression formula between SA and GA in non-diabetic patients with Cushing's syndrome and non-diabetic subjects. Results: SA showed a significant correlation with GA in non-diabetic patients with Cushing's syndrome and non-diabetic subjects. GA, but not SAaGA, in non-diabetic patients with Cushing's syndrome was significantly lower than that in the non-diabetic controls. Furthermore, the GA/HbA1c ratio, but not the SAaGA/HbA1c ratio, in diabetic patients with Cushing's syndrome was significantly lower than that in the diabetic controls. The measured GA in the patients with Cushing's syndrome was significantly lower than the estimated GA, but there was no difference between SAaGA and the estimated GA. Conclusions: The present findings suggest that SAaGA is an adequate indicator of the glycemic control in patients with Cushing's syndrome. (C) 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Kitamura, Tetsuhiro; Otsuki, Michio; Tamada, Daisuke; Tabuchi, Yukiko; Mukai, Kosuke; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka 565, Japan; [Morita, Shinya; Kasayama, Soji] Nissay Hosp, Dept Med, Suita, Osaka, Japan; [Bando, Yukihiro] Fukui Ken Saiseikai Hosp, Dept Internal Med, Fukui, Japan; [Koga, Masafumi] Kawanishi City Hosp, Dept Internal Med, Kawanishi, Hyogo 6600195, Japan	Koga, M (reprint author), Kawanishi City Hosp, Dept Internal Med, 5-21-1 Higashi Uneno, Kawanishi, Hyogo 6600195, Japan.	m-koga@kawanishi-city-hospital.com					Koga M, 2014, CLIN CHIM ACTA, V433, P96, DOI 10.1016/j.cca.2014.03.001; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Okada T, 2011, INTERNAL MED, V50, P23, DOI 10.2169/internalmedicine.50.4129; Kitamura T, 2013, CLIN CHIM ACTA, V424, P164, DOI 10.1016/j.cca.2013.06.011; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Jeffcoate SL, 2004, DIABETIC MED, V21, P657, DOI 10.1046/j.1464-5491.2003.01065.x; Arnaldi G, 2003, J CLIN ENDOCR METAB, V88, P5593, DOI 10.1210/jc.2003-030871; Koga M, 2009, DIABETES RES CLIN PR, V84, P163, DOI 10.1016/j.diabres.2009.01.013; Suzuki S, 2013, PEDIATR DIABETES, V14, P25, DOI 10.1111/j.1399-5448.2012.00895.x; Bando Y, 2009, ANN CLIN BIOCHEM, V46, P368, DOI 10.1258/acb.2009.008231; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; ETXABE J, 1994, CLIN ENDOCRINOL, V40, P479, DOI 10.1111/j.1365-2265.1994.tb02486.x; Suzuki S, 2011, DIABETOLOGIA, V54, P2247, DOI 10.1007/s00125-011-2211-8; Koga M, 2008, DIABETES RES CLIN PR, V81, P258, DOI 10.1016/j.diabres.2008.04.012; Suzuki S, 2012, HORM RES PAEDIAT, V77, P273, DOI 10.1159/000337914; BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569; Kouzuma T, 2002, CLIN CHIM ACTA, V324, P61, DOI 10.1016/S0009-8981(02)00207-3; Bry L, 2001, CLIN CHEM, V47, P153; Burt MG, 2007, AM J PHYSIOL-ENDOC M, V292, pE1426, DOI 10.1152/ajpendo.00524.2006; Burt MG, 2011, J CLIN ENDOCR METAB, V96, P1789, DOI 10.1210/jc.2010-2729; Burt MG, 2012, RHEUMATOLOGY, V51, P1112, DOI 10.1093/rheumatology/kes003; Cohen M P, 1988, J Diabet Complications, V2, P214, DOI 10.1016/S0891-6632(88)80012-6; Committee on the Standardization of Diabetes Mellitus-Related Laboratory Testing of Japan Diabetes Society, 2012, DIABETOL INT, V3, P8; GRIFFIN P, 1988, EXPERIENTIA, V44, P242, DOI 10.1007/BF01941722; Hirata T, 2013, J GENET SYNDR GENE T, V4, P168; Kim KJ, 2004, AM J PHYSIOL-LUNG C, V287, pL616, DOI 10.1152/ajplung.00121.2004; Koga M, 2014, ADV CLIN CHEM, V64, P269, DOI 10.1016/B978-0-12-800263-6.00007-0; Mancini T, 2004, CLIN ENDOCRINOL, V61, P768, DOI 10.1111/j.1365-2265.2004.02168.x; Putignano P, 2000, J CLIN ENDOCR METAB, V85, P3309, DOI 10.1210/jc.85.9.3309; SIMMONS PS, 1984, J CLIN INVEST, V73, P412, DOI 10.1172/JCI111227; Suzuki S, 2014, ANN CLIN BIOCHEM, V51, P602, DOI 10.1177/0004563213512617; Tsutsumi C, 2013, DIABETOL INT, V4, P156; Yamanouchi T, 1998, EUR J PHARMACOL, V341, P257, DOI 10.1016/S0014-2999(97)01460-X	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	DEC	2014	47	18					279	282		10.1016/j.clinbiochem.2014.09.007		4	Medical Laboratory Technology	Medical Laboratory Technology	AW2NO	WOS:000346125500006		
J	Ishige, T; Itoga, S; Sato, K; Kitamura, K; Nishimura, M; Sawai, S; Matsushita, K; Suzuki, K; Ota, S; Miyauchi, H; Matsubara, H; Nakatani, Y; Nomura, F				Ishige, Takayuki; Itoga, Sakae; Sato, Kenichi; Kitamura, Kouichi; Nishimura, Motoi; Sawai, Setsu; Matsushita, Kazuyuki; Suzuki, Kazufumi; Ota, Satoshi; Miyauchi, Hideaki; Matsubara, Hisahiro; Nakatani, Yukio; Nomura, Fumio			High-throughput screening of extended RAS mutations based on high-resolution melting analysis for prediction of anti-EGFR treatment efficacy in colorectal carcinoma	CLINICAL BIOCHEMISTRY			English	Article						Colorectal carcinoma; Anti-EGFR treatment; Extended RAS; High-resolution melting	WILD-TYPE KRAS; CANCER; PANITUMUMAB; FLUOROURACIL; LEUCOVORIN; CETUXIMAB	Objectives: Recent studies have demonstrated that, in advanced colorectal carcinoma (CRC) patients, extended RAS (in KRAS exons 2-4 and NRAS exons 2-4) and BRAF mutations are negative predictors for anti-EGFR treatment efficacy and negative prognostic factor, respectively. Thus, high-throughput and cost-effective methods for identification of the mutation status are required. Design and methods: We developed a PCR-high-resolution melting (HRM)-based method for screening extended RAS and BRAF mutations, and relative frequency of mutations in formalin-fixed paraffin-embedded samples of CRC was analyzed. Results: Among 93 CRC samples, 29 harbored mutations in KRAS exon 2, and 9 harbored mutations in BRAF exon 15. Analysis of 55 KRAS exon 2 and BRAF exon 15 wild-type CRC samples identified the following mutations: 1/55 in exon 3 and 2/55 in exon 4 of KRAS; 1/55 in exon 2, 3/55 in exon 3, and 0/55 in exon 4 of NRAS. Conclusions: Our PCR-HRM method will enable rapid determination of the extended RAS and BRAF mutation status prior to anti-EGFR treatment in the clinical setting. (C) 2014 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.	[Ishige, Takayuki; Kitamura, Kouichi; Nishimura, Motoi; Sawai, Setsu; Matsushita, Kazuyuki; Nomura, Fumio] Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba 2608670, Japan; [Ishige, Takayuki; Itoga, Sakae; Kitamura, Kouichi; Nishimura, Motoi; Sawai, Setsu; Matsushita, Kazuyuki; Nomura, Fumio] Chiba Univ Hosp, Div Lab Med & Clin Genet, Chiba, Japan; [Sato, Kenichi] Int Univ Hlth & Welf, Dept Med Technol & Sci, Fukuoka, Japan; [Suzuki, Kazufumi; Miyauchi, Hideaki; Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba 2608670, Japan; [Ota, Satoshi; Nakatani, Yukio] Chiba Univ, Grad Sch Med, Dept Diagnost Pathol, Chiba 2608670, Japan; [Ota, Satoshi; Nakatani, Yukio] Chiba Univ Hosp, Dept Pathol, Chiba, Japan	Ishige, T (reprint author), Chiba Univ, Grad Sch Med, Dept Mol Diag, 1-8-1 Inohana, Chiba 2608670, Japan.	ishige.t@chiba-u.jp		Matsushita, Kazuyuki/0000-0001-6742-0761			Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Dahabreh IJ, 2011, ANN INTERN MED, V154, P37, DOI 10.7326/0003-4819-154-1-201101040-00006; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; Vaughn CP, 2011, GENE CHROMOSOME CANC, V50, P307, DOI 10.1002/gcc.20854; Schwartzberg LS, 2014, J CLIN ONCOL, V32, P2240, DOI 10.1200/JCO.2013.53.2473; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Pichler M, 2009, J MOL DIAGN, V11, P140, DOI 10.2353/jmoldx.2009.080100; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Peeters M, 2013, CLIN CANCER RES, V19, P1902, DOI 10.1158/1078-0432.CCR-12-1913; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Krypuy M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-295; Shackelford Rodney E, 2012, Genes Cancer, V3, P459, DOI 10.1177/1947601912460547	15	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0009-9120	1873-2933		CLIN BIOCHEM	Clin. Biochem.	DEC	2014	47	18					340	343		10.1016/j.clinbiochem.2014.09.013		4	Medical Laboratory Technology	Medical Laboratory Technology	AW2NO	WOS:000346125500018		
J	Hirai, H; Fujishita, T; Kurimoto, K; Miyachi, H; Kitano, S; Inamoto, S; Itatani, Y; Saitou, M; Maekawa, T; Taketo, MM				Hirai, Hideyo; Fujishita, Teruaki; Kurimoto, Kazuki; Miyachi, Hitoshi; Kitano, Satsuki; Inamoto, Susumu; Itatani, Yoshiro; Saitou, Mitinori; Maekawa, Taira; Taketo, M. Mark			CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis	CLINICAL & EXPERIMENTAL METASTASIS			English	Article						Colon cancer; Liver metastasis; CCR1; Neutrophils; Fibrocytes; MMP9; MMP2	CIRCULATING FIBROCYTES; EMERGENCY GRANULOPOIESIS; TUMOR MICROENVIRONMENT; HUMAN NEUTROPHILS; C/EBP-BETA; RECEPTOR 1; FIBROBLASTS; INFLAMMATION; PROGRESSION; MACROPHAGE	To understand colon cancer metastasis, we earlier analyzed a mouse model that developed liver metastasis of cancer cells disseminated from the spleen. We suggested that CCR1(+) bone marrow (BM)-derived cells are recruited to the microenvironment of disseminated colon cancer cells, and produce metalloproteinases MMP9 and MMP2, helping metastatic colonization. In the present study, we have examined these myeloid cells expressing CCR1 and/or MMPs in detail. To this end, we have established bacterial artificial chromosome (BAC)-based transgenic mouse lines in which membrane-targeted Venus fluorescent protein (mVenus) was expressed under the control of Ccr1 gene promoter. Then, myeloid cells obtained from the BM and liver metastatic foci were analyzed by the combination of flow cytometry and cytology/immunohistochemistry, in situ RNA hybridization, or quantitative RT-PCR. We have found four distinct types of myeloid cells recruited to the metastatic foci; neutrophils, eosinophils, monocytes and fibrocytes. These cell types exhibited distinct expression patterns for CCR1, MMP2 and MMP9. Namely, neutrophils found in the early phase of cancer cell dissemination expressed CCR1 exclusively and MMP9 preferentially, whereas fibrocytes accumulated in later phase expressed MMP2 exclusively. Either genetic inactivation of Ccr1 or antibody-mediated neutrophil depletion reduced subsequent recruitment of fibrocytes. The recruitment of CCR1(+) neutrophils in early phase of colon cancer dissemination appears to cause that of fibrocytes in late phase. These results implicate the key role of CCR1 in colon cancer metastasis in this mouse model, and explain why both MMP9 and MMP2 are essential as genetically demonstrated previously. The results also suggest relevant mechanisms in humans.	[Hirai, Hideyo; Maekawa, Taira] Kyoto Univ, Grad Sch Med, Dept Transfus Med & Cell Therapy, Kyoto 6068501, Japan; [Fujishita, Teruaki; Kurimoto, Kazuki; Itatani, Yoshiro; Saitou, Mitinori; Taketo, M. Mark] Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan; [Miyachi, Hitoshi; Kitano, Satsuki] Kyoto Univ, Inst Virus Res, Reprod Engn Team, Kyoto 6068501, Japan; [Inamoto, Susumu; Itatani, Yoshiro; Taketo, M. Mark] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto 6068501, Japan; [Saitou, Mitinori] JST, ERATO, Kyoto, Japan; [Saitou, Mitinori] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068501, Japan; [Saitou, Mitinori] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan	Taketo, MM (reprint author), Kyoto Univ, Grad Sch Med, Kyoto 6068501, Japan.	taketo@mfour.med.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan	This work has been supported by Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan to MMT.	Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; Jensen HK, 2009, J CLIN ONCOL, V27, P4709, DOI 10.1200/JCO.2008.18.9498; Weinberg RA, 2014, CELL, V157, P267, DOI 10.1016/j.cell.2014.03.004; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Smith HA, 2013, J MOL MED, V91, P411, DOI 10.1007/s00109-013-1021-5; Bonecchi R, 1999, J IMMUNOL, V162, P474; Kitamura T, 2007, NAT GENET, V39, P467, DOI 10.1038/ng1997; Galligan CL, 2013, J LEUKOCYTE BIOL, V93, P45, DOI 10.1189/jlb.0712365; Nagaraj S, 2008, CANCER RES, V68, P2561, DOI 10.1158/0008-5472.CAN-07-6229; Ogawa M, 2006, BLOOD, V108, P2893, DOI 10.1182/blood-2006-04-016600; Kitamura T, 2010, P NATL ACAD SCI USA, V107, P13063, DOI 10.1073/pnas.1002372107; Dumitru CA, 2013, SEMIN CANCER BIOL, V23, P141, DOI 10.1016/j.semcancer.2013.02.005; Itatani Y, 2013, GASTROENTEROLOGY, V145, P1064, DOI 10.1053/j.gastro.2013.07.033; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Busuttil RA, 2014, CLIN CANCER RES, V20, P2761, DOI 10.1158/1078-0432.CCR-13-3049; van Deventer HW, 2013, J IMMUNOL, V190, P4861, DOI 10.4049/jimmunol.1202857; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Miyoshi H, 2002, CANCER RES, V62, P2261; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Khaled YS, 2014, J IMMUNOL RES, DOI 10.1155/2014/879897; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; BUCALA R, 1994, MOL MED, V1, P71; Satake S, 2012, J IMMUNOL, V189, P4546, DOI 10.4049/jimmunol.1103007; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Zhang H, 2013, BLOOD, V122, P1105, DOI 10.1182/blood-2012-08-449413; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Xing F, 2010, FRONT BIOSCI, V15, P166, DOI 10.2741/3613; Carus A, 2013, BRIT J CANCER, V108, P2116, DOI 10.1038/bjc.2013.167; Cheng SS, 2001, J IMMUNOL, V166, P1178; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; McDonald LT, 2012, INT J CLIN EXP PATHO, V5, P863; Taketo MM, 2012, J BIOCHEM, V151, P477, DOI 10.1093/jb/mvs035	37	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0262-0898	1573-7276		CLIN EXP METASTAS	Clin. Exp. Metastasis	DEC	2014	31	8					977	989		10.1007/s10585-014-9684-z		13	Oncology	Oncology	AW0ZW	WOS:000346020900009		
J	Sumioka, H; Nishio, S; Minato, T; Yamazaki, R; Ishiguro, H				Sumioka, Hidenobu; Nishio, Shuichi; Minato, Takashi; Yamazaki, Ryuji; Ishiguro, Hiroshi			Minimal Human Design Approach for sonzai-kan Media: Investigation of a Feeling of Human Presence	COGNITIVE COMPUTATION			English	Article						Human-robot Interaction; Minimal design; Elderly care; Android science	SOCIAL RELATIONSHIPS; ROBOTS; ANTHROPOMORPHISM; COMMUNICATION; RECOGNITION; INFORMATION; COPRESENCE; SENSES; HEALTH; MIND	Even though human-like robotic media give the feeling of being with others and positively affect our physical and mental health, scant research has addressed how much information about a person should be reproduced to enhance the feeling of a human presence. We call this feeling sonzai-kan, which is a Japanese phrase that means the feeling of a presence. We propose a minimal design approach for exploring the requirements to enhance this feeling and hypothesize that it is enhanced if information is presented from at least two different modalities. In this approach, the exploration is conducted by designing sonzai-kan media through exploratory research with the media, their evaluations, and the development of their systems. In this paper, we give an overview of our current work with Telenoid, a teleoperated android designed with our approach, to illustrate how we explore the requirements and how such media impact our quality of life. We discuss the potential advantages of our approach for forging positive social relationships and designing an autonomous agent with minimal cognitive architecture.	[Sumioka, Hidenobu; Nishio, Shuichi; Minato, Takashi; Yamazaki, Ryuji; Ishiguro, Hiroshi] Adv Telecommun Res Inst Int, Hiroshi Ishiguro Lab, Keihanna Sci City, Kyoto 6190288, Japan; [Ishiguro, Hiroshi] Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Toyonaka, Osaka 5608531, Japan	Sumioka, H (reprint author), Adv Telecommun Res Inst Int, Hiroshi Ishiguro Lab, 2-2-2 Hikaridai, Keihanna Sci City, Kyoto 6190288, Japan.	sumioka@atr.jp	Ahirwal, Ashish/B-8886-2015	Ahirwal, Ashish/0000-0002-8247-9793	JST CREST (Core Research of Evolutional Science and Technology)	We are grateful to the three anonymous reviewers. This work has been supported by JST CREST (Core Research of Evolutional Science and Technology) research promotion program "Creation of Human-Harmonized Information Technology for Convivial Society'' Research Area.	Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; Mori M, 2012, IEEE ROBOT AUTOM MAG, V19, P98, DOI 10.1109/MRA.2012.2192811; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Nowak KL, 2003, PRESENCE-TELEOP VIRT, V12, P481, DOI 10.1162/105474603322761289; McPherson M, 2006, AM SOCIOL REV, V71, P353; Kanda T, 2004, P IEEE, V92, P1839, DOI 10.1109/JPROC.2004.835359; Vogeley K, 2010, NEURAL NETWORKS, V23, P1077, DOI 10.1016/j.neunet.2010.06.003; Zhao SY, 2003, PRESENCE-TELEOP VIRT, V12, P445, DOI 10.1162/105474603322761261; Duffy BR, 2003, ROBOT AUTON SYST, V42, P177, DOI 10.1016/S0921-8890(02)00374-3; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Dautenhahn K, 2007, PHILOS T R SOC B, V362, P679, DOI 10.1098/rstb.2006.2004; Rilling JK, 2004, NEUROIMAGE, V22, P1694, DOI 10.1016/j.neuroimage.2004.04.015; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1126/science.3399889; Fong T, 2003, ROBOT AUTON SYST, V42, P143, DOI 10.1016/S0921-8890(02)00372-X; Ishiguro H, 2006, CONNECT SCI, V18, P319, DOI 10.1080/09540090600873953; von der Putten AM, 2010, COMPUT HUM BEHAV, V26, P1641, DOI 10.1016/j.chb.2010.06.012; Yee N, 2007, HUM COMMUN RES, V33, P271, DOI 10.1111/j.1468-2958.2007.00299.x; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; Cohen S, 2004, AM PSYCHOL, V59, P676, DOI 10.1037/0003-066X.59.8.676; Beer J. M., 2011, Proceedings of the 2011 6th ACM/IEEE International Conference on Human-Robot Interaction (HRI 2011), DOI 10.1145/1957656.1957665; Dogu, 2012, DOG A COSM; Froese T, 2012, COGN COMPUT, V4, P365, DOI 10.1007/s12559-012-9153-4; Fujie Y, 2013, P HRI2013 WORKSH DES, P19; Goetz J., 2003, Proceedings. RO-Man 2003. The 12th IEEE International Workshop on Robot and Human Interactive Communication (IEEE Cat. No. 03TH8711); Goffman E., 1963, BEHAV PUBLIC PLACE; Gough H. G., 1983, ADJECTIVE CHECK LIST; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Ishi CT, 2011, P INT C AUD VIS SPEE, P131; Kaner S, 2009, POWER DOGU CERAMIC F; Kashiwabara T, 2012, P ACM SIGCHI C HUM F, P2001; Kendon A., 1994, RES LANG SOC INTERAC, V27, P175, DOI DOI 10.1207/S15327973R1SI2703_2; Kiesler S, 1996, J PERS SOC PSYCHOL, V70, P47, DOI 10.1037/0022-3514.70.1.47; Kuwamura K, 2013, INT S ROB HUM INT CO, P70; Kuwamura K, 2012, P RO MAN 12, P49; Lee M.K., 2011, P CHI 11, P33; Lindblom J, 2006, CONNECT SCI, V18, P333, DOI 10.1080/09540090600868888; Liu C, 2013, INT J HUM ROBOT, V10; Matsumoto N, 2006, J AROB, V10, P49; Mehrabian A., 1980, SILENT MESSAGES IMPL; Minato T, 2012, P INT C HUM ROB INT; Minato T, 2012, P ROMAN WS SOC ROB T, P15; Minsky M., 1980, OMNI, V2, P45; Nakanishi J, 2013, 1 INT C HUM AG INT I; Nishio S., 2007, HUMANOID ROBOTS NEW, P343; Nishio S, 2012, P INT S ROB HUM INT, P809; Nowak K, 2001, 2001 4 ANN INT WORKS; Nowak K. L., 2005, J COMPUT-MEDIAT COMM, V11, P153, DOI DOI 10.1111/J.1083-6101.2006.TB00308.X; Ogata M, 2012, P AS PAC C COMP HUM, P85; Ogawa K, 2011, J ADV COMPUT INTELL, V15, P592; Osawa H, 2007, J ADV COMP INTELL IN, V11, P1007; Paulos E., 1998, P ACM C HUM FACT COM, P296, DOI 10.1145/274644.274686; Pfeifer R., 2001, UNDERSTANDING INTELL; Plutchik R., 1980, EMOTION PSYCHOEVOLUT; Reeves B., 1996, MEDIA EQUATION PEOPL; Sakai K, 2013, INT J INNOV IN PRESS, V9; Sakamoto D., 2007, P ACM IEEE INT C HUM, P193, DOI 10.1145/1228716.1228743; Shams L, 2010, PHYS LIFE REV, V7, P269, DOI 10.1016/j.plrev.2010.04.006; Shimada M, 2008, P ANN C COG SCI SOC, P2468; Short J., 1976, SOCIAL PSYCHOL TELEC; Straub I, 2010, 2010 IEEE RO-MAN, P119, DOI 10.1109/ROMAN.2010.5598695; Sumioka H, 2013, P INT S ROB HUM INT, P726; Sumioka H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03034; Tanaka K, 2013, INTERACTION, P125; Thacker PD, 2005, JAMA-J AM MED ASSOC, V293, P150, DOI 10.1001/jama.293.2.150; Tsumaki Y, 2002, IEEE ROMAN 2002, PROCEEDINGS, P35, DOI 10.1109/ROMAN.2002.1045594; Wada S, 1996, JPN J PSYCHOL, V67, P61; Yamazaki R, 2012, P C HUM FACT COMP SY, P351; Yamazaki R., 2012, P INT C SOC ROB ICSR, P428; Yamazaki R, 2012, PROC RO MAN12, P1066	71	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-9956	1866-9964		COGN COMPUT	Cogn. Comput.	DEC	2014	6	4			SI		760	774		10.1007/s12559-014-9270-3		15	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	AW0PJ	WOS:000345994900012		
J	Yamaguchi, S; Coelho, PG; Thompson, VP; Tovar, N; Yamauchi, J; Imazato, S				Yamaguchi, Satoshi; Coelho, Paulo G.; Thompson, Van P.; Tovar, Nick; Yamauchi, Junpei; Imazato, Satoshi			Dynamic finite element analysis and moving particle simulation of human enamel on a microscale	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Dental enamel; Finite element analysis; Computer simulation; Moving particle simulation; In silico	FRACTURE; MODELS; COMPOSITES; STIFFNESS; BEHAVIOR; DENTIN	Background: The study of biomechanics of deformation and fracture of hard biological tissues involving organic matrix remains a challenge as variations in mechanical properties and fracture mode may have time-dependency. Finite element analysis (FEA) has been widely used but the shortcomings of PEA such as the long computation time owing to re-meshing in simulating fracture mechanics have warranted the development of alternative computational methods with higher throughput. The aim of this study was to compare dynamic two-dimensional PEA and moving particle simulation (MPS) when assuming a plane strain condition in the modeling of human enamel on a reduced scale. Methods: Two-dimensional models with the same geometry were developed for MPS and FEA and tested in tension generated with a single step of displacement. The displacement, velocity, pressure, and stress levels were compared and Spearman's rank-correlation coefficients R were calculated (p < 0.001). Results: The MPS and FEA were significantly correlated for displacement, velocity, pressure, and Y-stress. Conclusions: The MPS may be further developed as an alternative approach without mesh generation to simulate deformation and fracture phenomena of dental and potentially other hard tissues with complex microstructure. (C) 2014 Elsevier Ltd. All rights reserved.	[Yamaguchi, Satoshi; Yamauchi, Junpei; Imazato, Satoshi] Osaka Univ, Grad Sch Dent, Dept Biomat Sci, Suita, Osaka 5650871, Japan; [Coelho, Paulo G.; Tovar, Nick] NYU, Coll Dent, Dept Biomat & Biomimet, New York, NY 10010 USA; [Thompson, Van P.] Kings Coll London, Guys Hosp, Inst Dent, Dept Biomat Biomimet & Biophoton, London SE1 9RT, England	Yamaguchi, S (reprint author), Osaka Univ, Grad Sch Dent, Dept Biomat Sci, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	yamagu@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science, Japan [24592955]	This study was supported by a Grant-in-Aid for Scientific Research (No. 24592955) from the Japan Society for the Promotion of Science, Japan. The authors thank Prof. Seiichi Koshizuka and Prof. Kazuya Shibata at Tokyo University for advice of the implementation of MPS.	Adachi T, 2001, J BIOMECH ENG-T ASME, V123, P403, DOI 10.1115/1.1392315; Anderson PSL, 2011, J MORPHOL, V272, P50, DOI 10.1002/jmor.10896; Ghorayeb SR, 1998, J DENT RES, V77, P39; TURNER MJ, 1956, J AERONAUT SCI, V23, P805; Suzuki Y, 2008, INT J NUMER METH ENG, V74, P1344, DOI 10.1002/nme.2222; Magne P, 2010, J PROSTHET DENT, V103, P343, DOI 10.1016/S0022-3913(10)60074-1; Miller K, 2012, J BIOMECH, V45, P2698, DOI 10.1016/j.jbiomech.2012.07.031; Horton A, 2010, INT J NUMER METH BIO, V26, P977, DOI 10.1002/cnm.1374; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; He LH, 2008, J MECH BEHAV BIOMED, V1, P18, DOI 10.1016/j.jmbbm.2007.05.001; Ryou H, 2011, J DENT RES, V90, P1122, DOI 10.1177/0022034511414059; Schileo E, 2008, J BIOMECH, V41, P356, DOI 10.1016/j.jbiomech.2007.09.009; Kinney JH, 2003, CRIT REV ORAL BIOL M, V14, P13; White SN, 2000, J AM CERAM SOC, V83, P238, DOI 10.1111/j.1151-2916.2000.tb01181.x; Koshizuka S, 1996, NUCL SCI ENG, V123, P421; Lam RHW, 2012, INTEGR BIOL-UK, V4, P1289, DOI 10.1039/c2ib20134h; Hori C, 2011, COMPUT FLUIDS, V51, P174, DOI 10.1016/j.compfluid.2011.08.004; Fagan MJ, 2007, J MORPHOL, V268, P1071; He LH, 2009, J BIOMED MATER RES A, V91A, P352, DOI 10.1002/jbm.a.32223; Mishnaevsky LL, 2005, MAT SCI ENG A-STRUCT, V407, P11, DOI 10.1016/j.msea.2005.06.047; Myoung S, 2009, J BIOMECH, V42, P1947, DOI 10.1016/j.jbiomech.2009.05.013; Nakabayashi N, 1992, Proc Finn Dent Soc, V88 Suppl 1, P321; Slomka N, 2010, J BIOMECH, V43, P1806, DOI 10.1016/j.jbiomech.2010.02.011; Stolk J, 2003, J BIOMECH, V36, P861, DOI 10.1016/S0021-9290(03)00003-4; Zheng QH, 2013, J MECH BEHAV BIOMED, V26, P148, DOI 10.1016/j.jmbbm.2013.04.025; Zienkiewicz C, 2004, INT J NUMER METH ENG, V60, P3, DOI 10.1002/nme.951	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	DEC 1	2014	55						53	60		10.1016/j.compbiomed.2014.10.005		8	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	AW4CI	WOS:000346228600008		
J	Yamaguchi, S; Satake, K; Yamaji, Y; Chen, YW; Tanaka, HT				Yamaguchi, Satoshi; Satake, Koji; Yamaji, Yoshio; Chen, Yen-Wei; Tanaka, Hiromi T.			Three-dimensional semiautomatic liver segmentation method for non-contrast computed tomography based on a correlation map of locoregional histogram and probabilistic atlas	COMPUTERS IN BIOLOGY AND MEDICINE			English	Article						Liver/AH; Computed tomography; Probabilistic models; Region-growing methodology; Liver segmentation	STATISTICAL SHAPE MODEL; AIDED DIAGNOSIS; CT IMAGES; INCREASE	Background: We sought to evaluate a new regional segmentation method for use with three-dimensional (3D) non-contrast abdominal CT images and to report the preliminary results. Methods: The proposed method was evaluated in ten cases. Manually segmented areas were used as the gold standard for evaluation. To compare the standard and the extracted liver regions, the degree of coincidence R% was redefined by transforming a volumetric overlap error. We also evaluated the influence of varying the density window size in terms of setting the starting points. Results: We confirmed in ten cases that our method could segment the liver region more precisely than the conventional method. A size of window 15 voxels was optimal as the starting point in all cases. Conclusions: We demonstrated the accuracy of a 3D semiautomatic liver segmentation method for noncontrast CT. This method promises to offer radiologists a time-efficient segmentation aid. (C) 2014 Elsevier Ltd. All rights	[Yamaguchi, Satoshi] Osaka Univ, Grad Sch Dent, Dept Biomat Sci, Suita, Osaka 5650871, Japan; [Satake, Koji; Yamaji, Yoshio; Chen, Yen-Wei; Tanaka, Hiromi T.] Ritsumeikan Univ, Coll Informat Sci & Engn, Kusatsu, Shiga 5258577, Japan	Yamaguchi, S (reprint author), Osaka Univ, Grad Sch Dent, Dept Biomat Sci, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	yamagu@dent.osaka-u.ac.jp			Japan Society for the Promotion of Science, Japan [21240017, 24592955]	This work was supported by Grants-in-Aid for Scientific Research nos. 21240017 and 24592955 from the Japan Society for the Promotion of Science, Japan.	Alomari RS, 2010, INT J COMPUT ASS RAD, V5, P287, DOI 10.1007/s11548-009-0396-9; Park H, 2003, IEEE T MED IMAGING, V22, P483, DOI 10.1109/TMI.2003.809139; Shiraishi J, 2011, SEMIN NUCL MED, V41, P449, DOI 10.1053/j.semnuclmed.2011.06.004; Wormanns D, 2002, EUR RADIOL, V12, P1052, DOI 10.1007/s003300101126; Boykov Y, 2006, INT J COMPUT VISION, V70, P109, DOI 10.1007/s11263-006-7934-5; SANDOR T, 1991, INT J BIOMED COMPUT, V29, P133, DOI 10.1016/0020-7101(91)90004-X; Li H, 2008, ACAD RADIOL, V15, P1437, DOI 10.1016/j.acra.2008.05.004; Lee J, 2007, COMPUT METH PROG BIO, V88, P26, DOI 10.1016/j.cmpb.2007.07.005; Rusko L, 2009, MED IMAGE ANAL, V13, P871, DOI 10.1016/j.media.2009.07.009; Tomoshige S, 2014, MED IMAGE ANAL, V18, P130, DOI 10.1016/j.media.2013.10.003; El-Serag H, 2003, ANN INTERN MED, V139, P817; Okada T, 2008, ACAD RADIOL, V15, P1390, DOI 10.1016/j.acra.2008.07.008; Heimann T, 2009, IEEE T MED IMAGING, V28, P1251, DOI 10.1109/TMI.2009.2013851; Chen YF, 2012, BIOMED SIGNAL PROCES, V7, P591, DOI 10.1016/j.bspc.2012.04.005; Chen H, 2010, ACAD RADIOL, V17, P595, DOI 10.1016/j.acra.2009.12.009; Bookstein F.L., 1989, IEEE T PATTERN ANAL, V11, P567; Buhmann S, 2007, ACAD RADIOL, V14, P651, DOI 10.1016/j.acra.2007.02.007; Goggin Leigh S, 2007, Otolaryngol Head Neck Surg, V136, pS21, DOI 10.1016/j.otohns.2007.01.028; Gottlieb S, 1999, BRIT MED J, V318, P755; Kiszka Kinga, 2009, Przegl Lek, V66, P437; Smeets D, 2010, MED IMAGE ANAL, V14, P13, DOI 10.1016/j.media.2009.09.002	21	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0010-4825	1879-0534		COMPUT BIOL MED	Comput. Biol. Med.	DEC 1	2014	55						79	85		10.1016/j.compbiomed.2014.10.003		7	Biology; Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Computer Science; Engineering; Mathematical & Computational Biology	AW4CI	WOS:000346228600011		
J	Ueda, K; Oguni, M; Asaji, T				Ueda, Kouhei; Oguni, Masaharu; Asaji, Tetsuo			Halogen Bond as Controlling the Crystal Structure of 4-Amino-3,5-Dihalogenobenzoic Acid and Its Effect on the Positional Ordering/Disordering of Acid Protons	CRYSTAL GROWTH & DESIGN			English	Article							TEMPERATURE-DEPENDENCE; ROOM-TEMPERATURE; HYDROGEN-BONDS; COMPLEXES; RECOGNITION; ENVIRONMENT; DISORDER; IODINE; DIMER; CL	Crystal structures and thermal behaviors of 4-amino-3,5-dihalogenobenzoic acid (AXBA: X = Cl and I) were studied by single-crystal X-ray diffractometry and differential scanning calorimetry. It was found that all the crystal structures of AClBA and AIBA as well as ABrBA at room temperature belong to the same space group with two crystallographically distinguishable dimer units. The dimer was located in a highly symmetric circumstance; for example, its C=O and C-O bonds were indistinguishable due to the presence of 2-fold rotational and mirror symmetry elements so that two hydrogen bonds should be equivalent within each dimer. Such symmetric dimer structures are very rare among carboxylic acid crystals. Stabilization of such a symmetric dimer structure is attributed probably to notably strong and angular-dependent interdimer interactions: halogen bonds and NH center dot center dot center dot O hydrogen bonds. The strength of the halogen bond, among different halogens, was in the order of I > Br > Cl from the interhalogen-atomic length as compared with its ordinary van der Waals diameter. AIBA revealed no phase transition even down to 110 K, while AClBA revealed it at around 140 K. The difference in the thermal behaviors perhaps originates from the different strengths of halogen bonds in the AIBA and AClBA crystals.	[Ueda, Kouhei; Oguni, Masaharu] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Chem, Meguro Ku, Tokyo 1528551, Japan; [Asaji, Tetsuo] Nihon Univ, Dept Chem, Coll Humanities & Sci, Setagaya Ku, Tokyo 1568550, Japan	Ueda, K (reprint author), RIKEN, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	ueda.kohei@riken.jp					Aakeroy CB, 2007, J AM CHEM SOC, V129, P13772, DOI 10.1021/ja073201c; Metrangolo P, 2005, ACCOUNTS CHEM RES, V38, P386, DOI 10.1021/ar0400995; Riley KE, 2007, J PHYS CHEM A, V111, P1688, DOI 10.1021/jp066745u; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Riley KE, 2011, J MOL MODEL, V17, P3309, DOI 10.1007/s00894-011-1015-6; PANT AK, 1965, ACTA CRYSTALLOGR, V19, P440, DOI 10.1107/S0365110X65003572; Wilcken R, 2013, J MED CHEM, V56, P1363, DOI 10.1021/jm3012068; LARSEN DW, 1965, J PHYS CHEM-US, V69, P2400, DOI 10.1021/j100891a049; [Anonymous], 2009, J MED CHEM; Fox DB, 2004, J FLUORINE CHEM, V125, P271, DOI 10.1016/j.jfluchem.2003.07.020; ALTOMARE A, 1994, J APPL CRYSTALLOGR, V27, P435, DOI 10.1107/S002188989400021X; Farina A, 1999, ANGEW CHEM INT EDIT, V38, P2433, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2433::AID-ANIE2433>3.0.CO;2-D; Shields ZP, 2010, INT J QUANTUM CHEM, V110, P2823, DOI 10.1002/qua.22787; Politzer P, 2007, INT J QUANTUM CHEM, V107, P3046, DOI 10.1002/qua.21419; Wilson CC, 1996, CHEM PHYS LETT, V253, P103, DOI 10.1016/0009-2614(96)00217-5; LAI TF, 1967, ACTA CRYSTALLOGR, V22, P885, DOI 10.1107/S0365110X67001720; Corradi E, 2000, ANGEW CHEM INT EDIT, V39, P1782, DOI 10.1002/(SICI)1521-3773(20000515)39:10<1782::AID-ANIE1782>3.0.CO;2-5; [Anonymous], 2011, CHEM SOC REV, V40, P2267; LARSEN DW, 1965, J AM CHEM SOC, V87, P1216, DOI 10.1021/ja01084a013; Athimoolam S, 2007, ACTA CRYSTALLOGR C, V63, pO514, DOI 10.1107/S0108270107022469; BAUGHMAN RG, 1984, ACTA CRYSTALLOGR C, V40, P204, DOI 10.1107/S0108270184003607; BRUNO G, 1980, ACTA CRYSTALLOGR B, V36, P1711, DOI 10.1107/S0567740880007030; Hassel O., 1954, J ACTA CHEM SCAND, V8, P873; Hassel O, 1970, SCIENCE, V170, P497; ICHIKAWA M, 1979, J CRYST MOL STRUCT, V9, P87, DOI 10.1007/BF01387561; Jones AOF, 2013, CRYST GROWTH DES, V13, P497, DOI 10.1021/cg300906j; OHKURA K, 1972, B CHEM SOC JPN, V45, P2651, DOI 10.1246/bcsj.45.2651; Parkin A, 2007, CRYST GROWTH DES, V7, P531, DOI 10.1021/cg060777p; Pinkus AG, 2003, J CHEM CRYSTALLOGR, V33, P181, DOI 10.1023/A:1023597409468; PROUT K, 1988, J CHEM SOC PERK T 2, P265, DOI 10.1039/p29880000265; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Thomas LH, 2010, CRYST GROWTH DES, V10, P2770, DOI 10.1021/cg100315u; Wang SA, 2010, J MOL STRUC-THEOCHEM, V952, P115, DOI 10.1016/j.theochem.2010.05.005; Wilson CC, 2006, NEW J CHEM, V30, P979, DOI 10.1039/b601123c	34	6	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	DEC	2014	14	12					6189	6196		10.1021/cg501479p		8	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	AU9AJ	WOS:000345884000005		
J	Araki, Y; Tsukamoto, K; Takagi, R; Miyashita, T; Oyabu, N; Kobayashi, K; Yamada, H				Araki, Yuki; Tsukamoto, Katsuo; Takagi, Ryosuke; Miyashita, Tomoyuki; Oyabu, Noriaki; Kobayashi, Kei; Yamada, Hirofumi			Direct Observation of the Influence of Additives on Calcite Hydration by Frequency Modulation Atomic Force Microscopy	CRYSTAL GROWTH & DESIGN			English	Article							AQUEOUS-SOLUTION; CRYSTAL-GROWTH; FREE-ENERGY; WATER; SURFACE; CARBONATE; MAGNESIUM; CRYSTALLIZATION; INTERFACE; IONS	The effects of inorganic and organic additives on the hydration structure on the crystal surface have been discussed in X-ray reflectivity studies and in molecular dynamics simulations. We now demonstrate their effects on the hydration structure by conducting in situ observations of the hydration structure at a growing calcite surface by frequency modulation atomic force microscopy (FM-AFM). We show the atomic scale change of the hydration structure on the calcite surface in a supersaturated solution of CaCO3 by the addition of magnesium ions and a hydrophilic polypeptide. The FM-AFM images of the hydration structure revealed that magnesium ions increase the number of hydration layers on the terrace of the calcite surface from two to four layers. On the other hand, the hydrophilic polypeptide was ineffective for the hydration of the calcite surface. When both the magnesium ions and the hydrophilic polypeptide were added to the CaCO3 solution, the number of hydration layers increased and the magnitude of the oscillation hydration force as well as the long-range electrostatic force became larger than in the case when they were individually added. This is a noteworthy effect on the hydration structure on the calcite surface by cooperation of the magnesium ions and the polypeptide.	[Araki, Yuki; Tsukamoto, Katsuo] Tohoku Univ, Grad Sch Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Takagi, Ryosuke; Miyashita, Tomoyuki] Kinki Univ, Dept Genet Engn, Fac Biol Oriented Sci & Technol, Wakayama 6496493, Japan; [Oyabu, Noriaki; Kobayashi, Kei; Yamada, Hirofumi] Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Kobayashi, Kei] Kyoto Univ, Hakubi Ctr Adv Res, Nishikyo Ku, Kyoto 6158520, Japan	Araki, Y (reprint author), Tohoku Univ, Grad Sch Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.				Japan Society for the Promotion of Science	The use of FM-AFM was enabled by the Kyoto-Advanced Nanotechnology Network. The authors acknowledge the Matsushige Laboratory, Kyoto University, for the technical support. Financial support was provided by a Grant-in-Aid of Research from Challenging Exploratory Research for K.T. and by a Research Fellowship from the Japan Society for the Promotion of Science for Y. A.	Heberling F, 2011, J COLLOID INTERF SCI, V354, P843, DOI 10.1016/j.jcis.2010.10.047; Watkins M, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4800770; VEKILOV PG, 1992, J CRYST GROWTH, V121, P643, DOI 10.1016/0022-0248(92)90571-Y; REDDY MM, 1976, J CRYST GROWTH, V35, P33, DOI 10.1016/0022-0248(76)90240-2; Davis KJ, 2000, SCIENCE, V290, P1134, DOI 10.1126/science.290.5494.1134; MUCCI A, 1983, GEOCHIM COSMOCHIM AC, V47, P217, DOI 10.1016/0016-7037(83)90135-7; Elhadj S, 2006, CRYST GROWTH DES, V6, P197, DOI 10.1021/cg050288+; Kimura K, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3408289; Elhadj S, 2006, P NATL ACAD SCI USA, V103, P19237, DOI 10.1073/pnas.0605748103; Reischl B, 2013, J CHEM THEORY COMPUT, V9, P600, DOI 10.1021/ct3008342; Imada H, 2013, LANGMUIR, V29, P10744, DOI 10.1021/la402090w; Watkins M, 2011, PHYS CHEM CHEM PHYS, V13, P12584, DOI 10.1039/c1cp21021a; Maruyama M, 2009, CRYST GROWTH DES, V9, P127, DOI 10.1021/cg701219h; Kerisit S, 2003, J PHYS CHEM B, V107, P7676, DOI 10.1021/jp034201b; NOYES RM, 1962, J AM CHEM SOC, V84, P513, DOI 10.1021/ja00863a002; Harada M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.035414; Fenter P, 2012, GEOCHIM COSMOCHIM AC, V97, P58, DOI 10.1016/j.gca.2012.08.021; Fukuma T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.016101; Kobayashi K, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4803742; Walters DA, 1997, BIOPHYS J, V72, P1425; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hiasa T, 2010, J PHYS CHEM C, V114, P21423, DOI 10.1021/jp1057447; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Rode S, 2009, LANGMUIR, V25, P2850, DOI 10.1021/la803448v; Suzuki K, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.125102; REDDY MM, 1980, J CRYST GROWTH, V50, P470, DOI 10.1016/0022-0248(80)90095-0; Astilleros JM, 2003, SURF SCI, V545, pL767, DOI 10.1016/j.susc.2003.08.031; Bennema P., 1967, Journal of Crystal Growth, V1, DOI 10.1016/0022-0248(67)90034-6; Bennema P., 1967, Journal of Crystal Growth, V1, DOI 10.1016/0022-0248(67)90035-8; BERNER RA, 1966, SCIENCE, V153, P188, DOI 10.1126/science.153.3732.188; Cabrera N., 1958, GROWTH PERFECTION CR; Chemov A. A, 1961, SOV PHYS USP, V4, P116, DOI 10.1070/PU1961v004n01ABEH003328; DEGROOT K, 1966, NATURE, V212, P183, DOI 10.1038/212183a0; Fukuma T, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2149004; Geissbuhler P, 2004, SURF SCI, V573, P191, DOI 10.1016/j.susc.2004.09.036; Gricar M, 2008, ACTA CHIM SLOV, V55, P575; Hiasa T, 2012, PHYS CHEM CHEM PHYS, V14, P8419, DOI 10.1039/c2cp40252a; Hiasa T, 2012, J PHYS CHEM C, V116, P26475, DOI 10.1021/jp310203s; Kerisit S, 2004, CHEM COMMUN, P52, DOI 10.1039/b311928a; Kim W., 2006, CRYST GROWTH DES, V6, P5; Kolodynska D, 2011, EXPANDING ISSUES DES, P346; Magdans U, 2007, LANGMUIR, V23, P4999, DOI 10.1021/la0636659; Magdans U, 2006, EUR J MINERAL, V18, P83, DOI 10.1127/0935-1221/2006/0018-0083; MARRA J, 1986, BIOPHYS J, V50, P815; Moller P., 1975, MAR CHEM, V3, P63, DOI 10.1016/0304-4203(75)90027-4; Nishioka R, 2013, J PHYS CHEM C, V117, P2939, DOI 10.1021/jp3117424; Rahe P, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/8/084006; Reddy M. M., 1986, STUDIES DIAGENESIS; Spijker P, 2014, J PHYS CHEM C, V118, P2058, DOI 10.1021/jp4106647; Takagi R, 2010, ZOOL SCI, V27, P416, DOI 10.2108/zsj.27.416; Watkins M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.196101	52	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	DEC	2014	14	12					6254	6260		10.1021/cg500891j		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	AU9AJ	WOS:000345884000012		
J	Suzuki, M; Maeda, Y; Akita, M; Teramae, H; Kobayashi, K				Suzuki, Mitsuaki; Maeda, Yutaka; Akita, Motoko; Teramae, Hiroyuki; Kobayashi, Keiji			Polymorphs Related by an Enantiotropic Phase Transition but Having Only Order-Disorder-Level Conformational Differences in a Spiro-Conjugated Imidazolidine Ring Compound	CRYSTAL GROWTH & DESIGN			English	Article							MOLECULAR-CRYSTALS; ORGANIC-CRYSTALS; 1,2,3-TRICARBONYL COMPOUNDS; INTERMOLECULAR INTERACTIONS; HAMILTONIAN ALGORITHM; THERMODYNAMIC RULES; DYNAMIC DISORDER; METHYL PARABEN; STATES; SPIROCONJUGATION	Variable-temperature single-crystal X-ray diffraction analyses of 1,3-diethyl-spiro[imidazolidine-2,2'-[2H]indene]-1',3'-dione (1) were performed at low temperatures. The temperature dependence of the cell parameters exhibited a discontinuous change between 158 and 153 K, indicating the existence of a phase transition and hence the occurrence of two polymorphs, I and II, which was also confirmed by DSC analysis: reversible exothermic and endothermic peaks with Delta H = 2.1 kJ mol(-1) were observed in the cooling and heating processes, respectively. The molecular packing in I and II at 200 and 90 K, respectively, remained essentially unchanged, retaining the space group Pnma. I and II are conformationally isomorphic crystals, including two crystallographically independent molecules, A and B, with different conformations in a 1:2 ratio. Upon the phase transition from I to II with decreasing temperature, the dynamic disorder of the imidazolidine ring of A in I, which interconverts between quasi-half-chair conformations, is frozen to settle in an envelope conformation, whereas B is retained in a half-chair conformation in both I and II. The close intermolecular contacts in I and II were compared on the basis of Hirshfeld surface analysis. DFT calculations at the B3LYP/6-311G(d,p) level show that the half-chair structure is more stable than the envelope conformer by 2.6 kJ mol-1 in the gas phase. The quasi-half-chair conformation was not obtained as an energy-minimum geometry on the potential energy surface. Temperature-dependent IR spectroscopy along with theoretical calculation using the QST method gave assignments of the carbonyl stretching bands for each conformation. Compound 1 provides a unique example of the isostructural polymorphs in which the structural differences are small, being only at the order-disorder level in the ring conformation; nevertheless, the existence of the enantiotropic phase transition clearly indicates that they are polymorphs.	[Suzuki, Mitsuaki; Maeda, Yutaka] Tokyo Gakugei Univ, Dept Chem, Tokyo 1848501, Japan; [Akita, Motoko; Teramae, Hiroyuki; Kobayashi, Keiji] Josai Univ, Grad Sch Mat Sci, Sakado, Saitama 3500295, Japan	Kobayashi, K (reprint author), Josai Univ, Grad Sch Mat Sci, Sakado, Saitama 3500295, Japan.	kobayak@josai.ac.jp					SCHONBERG A, 1978, CHEM BER-RECL, V111, P3058, DOI 10.1002/cber.19781110906; Katrusiak A, 2000, ACTA CRYSTALLOGR B, V56, P872, DOI 10.1107/S0108768100005905; Spackman MA, 2009, CRYSTENGCOMM, V11, P19, DOI 10.1039/b818330a; Howard JAK, 2008, CRYSTENGCOMM, V10, P502, DOI 10.1039/b715349j; CHRISTY AG, 1995, ACTA CRYSTALLOGR B, V51, P753, DOI 10.1107/S0108768195001728; SAITO K, 1994, SOLID STATE COMMUN, V92, P495, DOI 10.1016/0038-1098(94)90485-5; THRELFALL TL, 1995, ANALYST, V120, P2435, DOI 10.1039/an9952002435; Setaka W, 2013, J AM CHEM SOC, V135, P14560, DOI 10.1021/ja408405f; Dikundwar AG, 2012, CRYST GROWTH DES, V12, P4530, DOI 10.1021/cg300699r; Ye Q, 2011, CRYST GROWTH DES, V11, P4175, DOI 10.1021/cg2007556; Copley RCB, 2008, CRYST GROWTH DES, V8, P3474, DOI 10.1021/cg800517h; Cruz-Cabeza AJ, 2014, CHEM REV, V114, P2170, DOI 10.1021/cr400249d; Zhang W, 2010, ANGEW CHEM INT EDIT, V49, P6608, DOI 10.1002/anie.201001208; Kumar VSS, 2002, ANGEW CHEM INT EDIT, V41, P3848, DOI 10.1002/1521-3773(20021018)41:20<3848::AID-ANIE3848>3.0.CO;2-L; Saragi TPI, 2007, CHEM REV, V107, P1011, DOI 10.1021/cr0501341; Harada J, 2004, J AM CHEM SOC, V126, P3539, DOI 10.1021/ja0382031; PENG CY, 1993, ISRAEL J CHEM, V33, P449; Chopra D, 2008, CRYST GROWTH DES, V8, P848, DOI 10.1021/cg070350y; Spackman MA, 2013, PHYS SCRIPTA, V87, DOI 10.1088/0031-8949/87/04/048103; de Castro RAE, 2007, CRYST GROWTH DES, V7, P496, DOI 10.1021/cg0601857; Scott AP, 1996, J PHYS CHEM-US, V100, P16502, DOI 10.1021/jp960976r; Minkin VI, 2004, CHEM REV, V104, P2751, DOI 10.1021/cr020088u; Facey GA, 1996, CAN J CHEM, V74, P1844, DOI 10.1139/v96-206; Threlfall TL, 2007, CRYST GROWTH DES, V7, P2297, DOI 10.1021/cg0700871; Li SG, 2013, CRYST GROWTH DES, V13, P2675, DOI 10.1021/cg4004565; GIRON D, 1995, THERMOCHIM ACTA, V248, P1, DOI 10.1016/0040-6031(94)01953-E; Peng CY, 1996, J COMPUT CHEM, V17, P49, DOI 10.1002/(SICI)1096-987X(19960115)17:1<49::AID-JCC5>3.0.CO;2-0; Cairns AB, 2013, CHEM SOC REV, V42, P4881, DOI 10.1039/c3cs35524a; Bernstein J., 2002, POLYMORPHISM IN MOLE; Bilton C, 1999, CHEM COMMUN, P1675, DOI 10.1039/a905025f; Bis JA, 2006, CRYST GROWTH DES, V6, P1048, DOI 10.1021/cg0680024; Blundell S. J., 2008, CONCEPTS IN THERMAL; Borodi G, 2012, CRYST GROWTH DES, V12, P5846, DOI 10.1021/cg300943b; Brittain HG, 1999, DRUGS PHARM SCI, V95, P227; Budzianowski A, 2002, ACTA CRYSTALLOGR B, V58, P125, DOI 10.1107/S0108768101017955; BURGER A, 1979, MIKROCHIM ACTA, V2, P273; BURGER A, 1979, MIKROCHIM ACTA, V2, P259; Cai WZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5337; Delaney SP, 2012, CRYST GROWTH DES, V12, P5017, DOI 10.1021/cg300977e; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fu D. W., 2001, J AM CHEM SOC, V133, P12780; Harada J, 2001, J AM CHEM SOC, V123, P10884, DOI 10.1021/ja011197d; Harada J, 2009, CRYSTENGCOMM, V11, P638, DOI 10.1039/b815869j; LENSTRA ATH, 1994, ACTA CRYSTALLOGR B, V50, P96, DOI 10.1107/S0108768193007931; Maria TMR, 2010, CRYST GROWTH DES, V10, P1194, DOI 10.1021/cg901160v; MASLAK P, 1994, ADV MATER, V6, P405, DOI 10.1002/adma.19940060515; Maslak P, 1996, J AM CHEM SOC, V118, P1471, DOI 10.1021/ja9533003; McKinnon JJ, 2007, CHEM COMMUN, P3814, DOI 10.1039/b704980c; Molcanov K, 2011, J MOL STRUCT, V987, P174, DOI 10.1016/j.molstruc.2010.12.011; Murugan N. A., 2004, J CHEM PHYS, V123; Nangia A, 2008, ACCOUNTS CHEM RES, V41, P595, DOI 10.1021/ar700203k; Ohtawara K, 2004, CHEM PHYS LETT, V390, P84, DOI 10.1016/j.cplett.2004.03.088; SCHONBERG A, 1975, TETRAHEDRON LETT, P3217; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SHELDRICK WS, 1982, ACTA CRYSTALLOGR B, V38, P1355, DOI 10.1107/S0567740882005792; SIMMONS HE, 1967, J AM CHEM SOC, V89, P5208, DOI 10.1021/ja00996a022; Skorepova E, 2013, CRYST GROWTH DES, V13, P5193, DOI 10.1021/cg4007394; Spackman MA, 2002, CRYSTENGCOMM, V4, P378, DOI 10.1039/b203191b; Stilinovic V, 2013, CRYST GROWTH DES, V13, P1703, DOI 10.1021/cg400016z; Teramae H, 2008, B CHEM SOC JPN, V81, P1094, DOI 10.1246/bcsj.81.1094; Teramae H, 2011, THEOR CHEM ACC, V130, P671, DOI 10.1007/s00214-011-1010-0; Vujovic D, 2006, CRYST GROWTH DES, V6, P1595, DOI 10.1021/cg050639k; Wolak JE, 2003, J PHYS CHEM B, V107, P13293, DOI 10.1021/jp036527q; Wolff S. K., 2012, CRYSTALEXPLORER; Yasuda N, 2003, J MOL STRUCT, V647, P217, DOI 10.1016/S0022-2860(02)00527-6; Yoshii Y, 2012, CRYSTENGCOMM, V14, P7458, DOI 10.1039/c2ce25945a	66	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	DEC	2014	14	12					6302	6310		10.1021/cg501060w		9	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	AU9AJ	WOS:000345884000017		
J	Aso, R; Kan, D; Fujiyoshi, Y; Shimakawa, Y; Kurata, H				Aso, Ryotaro; Kan, Daisuke; Fujiyoshi, Yoshifumi; Shimakawa, Yuichi; Kurata, Hiroki			Strong Dependence of Oxygen Octahedral Distortions in SrRuO3 Films on Types of Substrate-Induced Epitaxial Strain	CRYSTAL GROWTH & DESIGN			English	Article							SINGLE-CRYSTAL; THIN-FILMS; MAGNETIC-PROPERTIES; ELECTRON-GAS; OXIDE; SUPERLATTICES; HETEROINTERFACE; ENHANCEMENT; TRANSITION	This work investigates the effects of types of epitaxial strain on the structural and magneto-transport properties of SrRuO3 (SRO) thin films grown on (110)(ortho) NdGaO3 (NGO) and (110)ortho SmScO3 (SSO) substrates that result in a -1.66% compressive strain and a +1.63% tensile strain, respectively. Although the epitaxial strains induced by the NGO and SSO substrates are almost equal in magnitude, the film properties were found to be strongly dependent on the type of strain. High-resolution scanning transmission electron microscopy revealed that the compressively strained SRO films possess a tetragonal structure with no octahedral tilts, while the tensilely strained SRO films undergo a thickness-dependent transition from a monoclinic structure with octahedral tilts to a tetragonal structure with small tilts. These findings indicate that octahedral tilt propagation from the substrate into the film is preferentially induced under tensile rather than compressive strain. We further found that the magneto-transport properties of SRO films exhibit a significant dependence on the type of the epitaxial strain, demonstrating the close correlation between strain-induced octahedral distortions and magnetic anisotropy. These results highlight the important role of the type of the epitaxial strain on the structural and physical properties of epitaxial thin films.	[Aso, Ryotaro; Kan, Daisuke; Fujiyoshi, Yoshifumi; Shimakawa, Yuichi; Kurata, Hiroki] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Aso, Ryotaro] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Shimakawa, Yuichi; Kurata, Hiroki] Japan Sci & Technol Agcy, CREST, Kyoto 6110011, Japan	Kan, D (reprint author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	dkan@scl.kyoto-u.ac.jp; kurata@eels.kuicr.kyoto-u.ac.jp	Kan, Daisuke/G-3550-2010		Ministry of Education, Culture, Sports, Science and Technology of Japan [24760009]; Japan Science and Technology Agency, CREST	This work was partially supported by a Grant-in-Aid for Scientific Research (Grant No. 24760009) and a Joint Project of Chemical Synthesis Core Research Institutions grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The work was also supported by the Japan Science and Technology Agency, CREST.	Lee HN, 2005, NATURE, V433, P395, DOI 10.1038/nature03261; Cantoni C, 2012, ADV MATER, V24, P3952, DOI 10.1002/adma.201200667; Kan D, 2013, ADV FUNCT MATER, V23, P1129, DOI 10.1002/adfm.201202402; Ziese M, 2012, NANO LETT, V12, P4276, DOI 10.1021/nl301963a; Lu H, 2012, ADV MATER, V24, P1209, DOI 10.1002/adma.201104398; Ishizuka K, 2002, ULTRAMICROSCOPY, V90, P71, DOI 10.1016/S0304-3991(01)00145-0; Cao G, 1997, PHYS REV B, V56, P321, DOI 10.1103/PhysRevB.56.321; Ohtomo A, 2004, NATURE, V427, P423, DOI 10.1038/nature02308; Grutter AJ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.134429; Boris AV, 2011, SCIENCE, V332, P937, DOI 10.1126/science.1202647; Rondinelli JM, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.235502; Rondinelli JM, 2011, ADV MATER, V23, P3363, DOI 10.1002/adma.201101152; Hwang HY, 2012, NAT MATER, V11, P103, DOI [10.1038/nmat3223, 10.1038/NMAT3223]; Bousquet E, 2008, NATURE, V452, P732, DOI 10.1038/nature06817; Rondinelli JM, 2012, MRS BULL, V37, P261, DOI 10.1557/mrs.2012.49; He J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.227203; Galindo PL, 2007, ULTRAMICROSCOPY, V107, P1186, DOI 10.1016/j.ultramic.2007.01.019; Aso R, 2014, ADV FUNCT MATER, V24, P5177, DOI 10.1002/adfm.201303521; Aso R, 2014, CRYST GROWTH DES, V14, P2128, DOI 10.1021/cg500285m; Aso R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02214; Biegalski MD, 2005, J MATER RES, V20, P952, DOI 10.1557/JMR.2005.0126; Galindo P., 2009, MICROSC ANAL, V23, P23; GLAZER AM, 1972, ACTA CRYSTALLOGR B, VB 28, P3384, DOI 10.1107/S0567740872007976; Kan D, 2013, J APPL PHYS, V113, DOI 10.1063/1.4803869; Kan D, 2014, J APPL PHYS, V115, DOI 10.1063/1.4875839; Kan D, 2011, CRYST GROWTH DES, V11, P5483, DOI 10.1021/cg201070n; KANBAYASI A, 1976, J PHYS SOC JPN, V41, P1876, DOI 10.1143/JPSJ.41.1876; KANBAYASI A, 1978, J PHYS SOC JPN, V44, P89, DOI 10.1143/JPSJ.44.89; Kats Y, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.100403; Rondinelli JM, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.113402; Schultz M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125444; Zayak AT, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.094104	32	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	DEC	2014	14	12					6478	6485		10.1021/cg501340e		8	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	AU9AJ	WOS:000345884000038		
J	Matsumoto, K; Kimura, F; Song, GJ; Yamane, S; Kikuchi, H; Tanaka, T; Higuchi, S; Kitamura, N; Kimura, T				Matsumoto, Kenji; Kimura, Fumiko; Song, Guangjie; Yamane, Shuhei; Kikuchi, Hiroaki; Tanaka, Tatsuya; Higuchi, Shingo; Kitamura, Naoyuki; Kimura, Tsunehisa			Crystal System Determination from X-ray Diffraction of Magnetically Oriented Microcrystal Suspensions	CRYSTAL GROWTH & DESIGN			English	Article							POWDER; FIELDS; OPPORTUNITIES; ORIENTATION; PATTERNS	A procedure for determining the crystal system of a microcrystalline powder is described. In this procedure, in situ X-ray diffraction measurements are performed on a microcrystal suspension oriented uniaxially under static and rotating magnetic fields. This is followed by the classification of the obtained diffraction images using a flowchart proposed in this study. To demonstrate the validity of this procedure, diffraction images were recorded for microcrystalline suspensions prepared from known crystal systems including triclinic (D-arabitol), monoclinic (cellobiose), orthorhombic (L-alanine), tetragonal (urea), trigonal (bismuth, calcite), hexagonal (zinc), and cubic (sodium chloride) systems. The crystals were classified into their respective crystal systems following the proposed procedure. The determined crystal systems for biaxial crystals were consistent with the reported crystal systems of the microcrystalline powders investigated. Herein, determination of the lattice parameters and space groups for the crystal systems is also discussed.	[Matsumoto, Kenji; Kimura, Fumiko; Song, Guangjie; Yamane, Shuhei; Kikuchi, Hiroaki; Tanaka, Tatsuya; Higuchi, Shingo; Kimura, Tsunehisa] Kyoto Univ, Div Forest & Biomat Sci, Sakyo Ku, Kyoto 6068502, Japan; [Kitamura, Naoyuki] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan	Kimura, T (reprint author), Kyoto Univ, Div Forest & Biomat Sci, Sakyo Ku, Kyoto 6068502, Japan.	tkimura@kais.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24350119]	This research was partially supported by the Ministry of Education, Culture, Sports, Science and Technology (24350119).	Akiyama J, 2005, MATER TRANS, V46, P203, DOI 10.2320/matertrans.46.203; Harris KDM, 2001, ANGEW CHEM INT EDIT, V40, P1626, DOI 10.1002/1521-3773(20010504)40:9<1626::AID-ANIE16260>3.0.CO;2-7; David WIF, 2008, ACTA CRYSTALLOGR A, V64, P52, DOI 10.1107/S0108767307064252; Coelho AA, 2003, J APPL CRYSTALLOGR, V36, P86, DOI 10.1107/S0021889802019878; Blakeley MP, 2008, CURR OPIN STRUC BIOL, V18, P593, DOI 10.1016/j.sbi.2008.06.009; Kimura T, 2003, POLYM J, V35, P823, DOI 10.1295/polymj.35.823; GRAF DL, 1961, AM MINERAL, V46, P1283; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; SWAMINATHAN S, 1984, ACTA CRYSTALLOGR B, V40, P300, DOI 10.1107/S0108768184002135; WERNER PE, 1985, J APPL CRYSTALLOGR, V18, P367, DOI 10.1107/S0021889885010512; VISSER JW, 1969, J APPL CRYSTALLOGR, V2, P89, DOI 10.1107/S0021889869006649; Harris KDM, 2004, CHEM SOC REV, V33, P526, DOI 10.1039/b409059b; BOULTIF A, 1991, J APPL CRYSTALLOGR, V24, P987, DOI 10.1107/S0021889891006441; Brochard F., 1975, J PHYS C FRANCE, V36, pC1, DOI 10.1051/jphyscol:1975139; David W. I. F., 2002, IUCR MONOGRAPHS CRYS, V13; Fujiwara M, 1999, J PHYS CHEM B, V103, P2627, DOI 10.1021/jp983432t; Gupta R. R., 1986, LANDOLT BORNSTEIN, V11; ITO T, 1949, NATURE, V164, P755, DOI 10.1038/164755a0; Kalenius E, 2008, CHEM-EUR J, V14, P5220, DOI 10.1002/chem.200800075; Kimura F, 2014, CRYSTENGCOMM, V16, P6630, DOI 10.1039/c4ce00839a; Kimura T, 2004, LANGMUIR, V20, P5669, DOI 10.1021/la049347w; Kimura T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.020217; Kimura T, 2013, CRYST GROWTH DES, V13, P1815, DOI 10.1021/cg4002225; Kitamura N, 2013, PROC SPIE, V8621, DOI 10.1117/12.2001953; KOPF J, 1991, CARBOHYD RES, V218, P9, DOI 10.1016/0008-6215(91)84082-P; Maret G., 1985, TOP APPL PHYS, V57; Matsumoto K, 2011, CRYST GROWTH DES, V11, P945, DOI 10.1021/cg200090u; Nishiyama Y., 1997, MACROMOLECULES, V30, P6395; Nye J. F., 1985, PHYS PROPERTIES CRYS; Rajkumar G, 2007, J APPL CRYSTALLOGR, V40, P178, DOI 10.1107/S0021889806048643; SCHIFERL D, 1969, J APPL CRYSTALLOGR, V2, P30, DOI 10.1107/S0021889869006443; Shirley R. R., 2003, IUCR COMPUTING COMMI, P48; SIMPSON HJ, 1966, ACTA CRYSTALLOGR, V20, P550, DOI 10.1107/S0365110X66001221; Singer L. S., 1973, 11TH BIENN C CARB GA, P207; Song GJ, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.060203; Stout GH, 1989, XRAY STRUCTURE DETER; WYCKOFF RWG, 1963, CRYSTAL STRUCTURES, V0001	37	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	DEC	2014	14	12					6486	6491		10.1021/cg501357b		6	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	AU9AJ	WOS:000345884000039		
J	Moon, H; Xuan, QP; Kim, D; Kim, Y; Park, JW; Lee, CH; Kim, HJ; Kawamata, A; Park, SY; Ahn, KH				Moon, Hyunsoo; Xuan, Qui Pham; Kim, Dokyoung; Kim, Yonghwi; Park, Jae Woo; Lee, Chong Han; Kim, Hyeong-Ju; Kawamata, Ayano; Park, Soo Young; Ahn, Kyo Han			Molecular-Shape-Dependent Luminescent Behavior of Dye Aggregates: Bent versus Linear Benzocoumarins	CRYSTAL GROWTH & DESIGN			English	Article							INTRAMOLECULAR CHARGE-TRANSFER; LIGHT-EMITTING-DIODES; FLUORESCENT-PROBES; ENHANCED EMISSION; SOLID-STATE; PHOTOLUMINESCENCE; FLUOROPHORES; CONSTRUCTION; TRANSPORT	Aggregation patterns of dye molecules can govern their photophysical properties in the solid state. The linear and bent shaped dipolar benzocoumarins showed contrasting luminescence behavior in solution and in the solid state. Single crystal structures of both compounds showed pi-stacking patterns with eclipsing but opposite dipole moments when viewed orthogonal to the stacking plane. Although the bent molecules are stacked in parallel in the solid state, they behave as independent molecules owing to the unfavorable excited state resonance interaction and hence emit strong fluorescence because each dipolar molecule now is in a hydrophobic environment surrounded by other molecules. This is an unusual example where the shape-dependent stacking governs the solid-state luminescence of dyes, being suggested here as a nonresonant pi-stacking system.	[Moon, Hyunsoo; Xuan, Qui Pham; Kim, Dokyoung; Kim, Yonghwi; Park, Jae Woo; Ahn, Kyo Han] POSTECH, Dept Chem, Pohang 790784, Gyungbuk, South Korea; [Moon, Hyunsoo; Xuan, Qui Pham; Kim, Dokyoung; Ahn, Kyo Han] POSTECH, Ctr Electrophoto Behav Adv Mol Syst, Pohang 790784, Gyungbuk, South Korea; [Lee, Chong Han; Kim, Hyeong-Ju; Park, Soo Young] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151744, South Korea; [Kawamata, Ayano] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Organ Chem, Aoba Ku, Sendai, Miyagi 9808578, Japan	Kim, D (reprint author), POSTECH, Dept Chem, 77 Cheongam Ro, Pohang 790784, Gyungbuk, South Korea.	kimdk@postech.ac.kr; ahn@postech.ac.kr	Park, Soo Young/G-1080-2012		EPB Center through National Research Foundation [R11-2008-052-01001]; Ministry of Health Welfare, Korea [HI13C1378]	This work was supported by grants from the EPB Center (No. R11-2008-052-01001) through the National Research Foundation and Ministry of Health & Welfare (No. HI13C1378), Korea.	Yoon SJ, 2011, J MATER CHEM, V21, P8338, DOI 10.1039/c0jm03711g; Peng T, 2010, ORG LETT, V12, P496, DOI 10.1021/ol902706b; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; An BK, 2002, J AM CHEM SOC, V124, P14410, DOI 10.1021/ja0269082; Rosch U, 2006, ANGEW CHEM INT EDIT, V45, P7026, DOI 10.1002/anie.200602286; Grabowski ZR, 2003, CHEM REV, V103, P3899, DOI 10.1021/cr940745l; Kim D, 2012, CHEM COMMUN, V48, P10243, DOI 10.1039/c2cc35668f; Walzer K, 2007, CHEM REV, V107, P1233, DOI 10.1021/cr050156n; Kim I, 2012, ASIAN J ORG CHEM, V1, P60, DOI 10.1002/ajoc.201200034; Lim CK, 2009, CHEM MATER, V21, P5819, DOI 10.1021/cm902379x; Shimizu M, 2010, CHEM-ASIAN J, V5, P1516, DOI 10.1002/asia.200900727; Gierschner J, 2013, J MATER CHEM C, V1, P5818, DOI 10.1039/c3tc31062k; Li D, 2013, CHEM SOC REV, V42, P8416, DOI 10.1039/c3cs60170f; An BK, 2009, J AM CHEM SOC, V131, P3950, DOI 10.1021/ja806162h; Santra M, 2012, CHEM-EUR J, V18, P9886, DOI 10.1002/chem.201200726; Shi W, 2012, CHEM COMMUN, V48, P8732, DOI 10.1039/c2cc33366j; Yuan WZ, 2010, ADV MATER, V22, P2159, DOI 10.1002/adma.200904056; Kim HM, 2007, J ORG CHEM, V72, P2088, DOI 10.1021/jo062341m; Hong YN, 2011, CHEM SOC REV, V40, P5361, DOI 10.1039/c1cs15113d; Wurthner F, 2011, ANGEW CHEM INT EDIT, V50, P3376, DOI 10.1002/anie.201002307; Zhao ZJ, 2012, J MATER CHEM, V22, P23726, DOI 10.1039/c2jm31949g; Imahori H, 2009, ACCOUNTS CHEM RES, V42, P1809, DOI 10.1021/ar900034t; An BK, 2012, ACCOUNTS CHEM RES, V45, P544, DOI 10.1021/ar2001952; Ding D, 2013, ACCOUNTS CHEM RES, V46, P2441, DOI 10.1021/ar3003464; Yang YM, 2013, CHEM REV, V113, P192, DOI 10.1021/cr2004103; Jun ME, 2011, CHEM COMMUN, V47, P7583, DOI 10.1039/c1cc00014d; Li D, 2012, J MATER CHEM, V22, P4319, DOI 10.1039/c1jm14606h; Bucherer HT, 1904, J PRAKTISCHE CHEMIE, V69, P49, DOI 10.1002/prac.19040690105; Fleisher AJ, 2013, J PHYS CHEM B, V117, P4231, DOI 10.1021/jp3041296; Frank C. S., 2010, ACCOUNTS CHEM RES, V43, P429; Kasha M., 1965, Eighth European Congress on Molecular Spectroscopy, DOI 10.1351/pac196511030371; Katz H. E., 2001, ACCOUNTS CHEM RES, V34, P349; Kim D, 2012, CHEM COMMUN, V48, P6833, DOI 10.1039/c2cc32424e; Kim D, 2014, ASIAN J ORG CHEM, V3, P1089, DOI 10.1002/ajoc.201402107; Rhee YM, 2009, J CHEM THEORY COMPUT, V5, P1224, DOI 10.1021/ct800509z; Spano FC, 2006, ANNU REV PHYS CHEM, V57, P217, DOI 10.1146/annurev.physchem.57.032905.104557	36	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	DEC	2014	14	12					6613	6619		10.1021/cg501567s		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	AU9AJ	WOS:000345884000055		
J	Uchida, S; Ogasawara, Y; Maruichi, T; Kumamoto, A; Ikuhara, Y; Yamada, T; Kitagawa, H; Mizuno, N				Uchida, Sayaka; Ogasawara, Yoshiyuki; Maruichi, Toshiaki; Kumamoto, Akihito; Ikuhara, Yuichi; Yamada, Teppei; Kitagawa, Hiroshi; Mizuno, Noritaka			Morphology-Controlled Synthesis of Cubic Cesium Hydrogen Silicododecatungstate Crystals	CRYSTAL GROWTH & DESIGN			English	Article							HETEROPOLY COMPOUNDS; NANOCRYSTALS; NANOSTRUCTURES; CATALYSIS; CHEMISTRY	Cubic particles of cesium hydrogen silicododecatungstate crystals are obtained for the first time by the use of spherical seed crystals and control of the Cs+ to SiW12O404- (Cs/POM) ratio in the synthetic solution. The morphology of the particles is controlled between rhombic dodecahedra faceted with {110} planes (thermodynamically stable morphology) and cubes faceted with {100} planes. Scanning transmission electron microscopy-energy-dispersive X-ray spectroscopy analysis of the cross-section shows that the cubes possess a core-shell structure, and the Cs/POM ratio of the shell (ave. 3.24) is larger than that of the core (ave. 2.76), suggesting the existence of anion (POM) vacancies in the shell. Solid state magic angle spinning NMR spectroscopy, nitrogen adsorption, and water vapor sorption measurements of the cubes show that the porous core is covered by the dense shell, and only water molecules can diffuse through the dense shell via the anion vacancies. Despite the small amounts of acidic protons, the cubes exhibit moderate proton conductivity (2.5 x 10(-4) S cm(-1)) at room temperature under water vapor (298 K, P/P-0 = 0.95), suggesting that mobile water molecules in the anion vacancies contribute to the proton conduction.	[Uchida, Sayaka] Univ Tokyo, Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan; [Ogasawara, Yoshiyuki; Maruichi, Toshiaki; Mizuno, Noritaka] Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; [Uchida, Sayaka] JST PRESTO, Kawaguchi, Saitama 3320012, Japan; [Kumamoto, Akihito; Ikuhara, Yuichi] Univ Tokyo, Inst Engn Innovat, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; [Yamada, Teppei] Kyushu Univ, Sch Engn, Dept Chem & Biochem, Nishi Ku, Fukuoka 8190395, Japan; [Kitagawa, Hiroshi] Kyoto Univ, Grad Sch Sci, Div Chem, Sakyo Ku, Kyoto 6068502, Japan	Mizuno, N (reprint author), Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	tmizuno@mail.ecc.u-tokyo.ac.jp	Ikuhara, Yuichi/N-1001-2015; Ikuhara, Yuichi/F-3066-2010	Ikuhara, Yuichi/0000-0003-3886-005X; 	JST-PRESTO; JSPS through "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [12024046]; MEXT [2107, 24108079]	This work was supported by JST-PRESTO, JSPS through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), "Nanotechnology Platform" (Project No. 12024046) of the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), and Scientific Research on Innovative Areas ("Coordination Programming" Area 2107, No. 24108079) from MEXT. Dr. Ryo Ishikawa (Univ. of Tokyo) is acknowledged for advices on STEM-EDS measurements.	Hill CL, 1998, CHEM REV, V98, P1, DOI 10.1021/cr960395y; Deori K, 2013, ACS APPL MATER INTER, V5, P10665, DOI 10.1021/am4027482; Long DL, 2007, CHEM SOC REV, V36, P105, DOI 10.1039/b502666k; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Okuhara T, 2000, CHEM MATER, V12, P2230, DOI 10.1021/cm9907561; Xu Y, 2011, J PHYS CHEM C, V115, P15288, DOI 10.1021/jp204982q; POPE MT, 1991, ANGEW CHEM INT EDIT, V30, P34, DOI 10.1002/anie.199100341; Tao A, 2006, ANGEW CHEM INT EDIT, V45, P4597, DOI 10.1002/anie.200601277; Okamoto K, 2007, J AM CHEM SOC, V129, P7378, DOI 10.1021/ja070694c; SPENCER ND, 1981, NATURE, V294, P643, DOI 10.1038/294643a0; Yang JH, 2010, CRYST GROWTH DES, V10, P1233, DOI 10.1021/cg9012284; Okuhara T, 1996, ADV CATAL, V41, P113, DOI 10.1016/S0360-0564(08)60041-3; Sanchez-Sanchez M, 2002, J AM CHEM SOC, V124, P3443, DOI 10.1021/ja011912j; Gregg SJ, 1982, ADSORPTION SURFACE A; Huheey J.E., 1983, INORGANIC CHEM PRINC; Ito T, 2001, CHEM LETT, P1272; Kwak M., 2005, J CRYST GROWTH, V275, P1655; Li J.R., 2009, CHEM SOC REV, V28, P1477; Neumann R, 2006, CHEM COMMUN, P2529, DOI 10.1039/b600711m; Ogasawara Y, 2013, CHEM MATER, V25, P905, DOI 10.1021/cm3039448; Paetero L., 2012, CRYST GROWTH DES, V12, P2306; UKSHE EA, 1989, SOLID STATE IONICS, V36, P219, DOI 10.1016/0167-2738(89)90176-8	23	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1528-7483	1528-7505		CRYST GROWTH DES	Cryst. Growth Des.	DEC	2014	14	12					6620	6626		10.1021/cg501575x		7	Chemistry, Multidisciplinary; Crystallography; Materials Science, Multidisciplinary	Chemistry; Crystallography; Materials Science	AU9AJ	WOS:000345884000056		
J	Komatsu, K; Abe, Y; Yoshioka, T; Ishimura, H; Ebihara, A; Suda, H				Komatsu, K.; Abe, Y.; Yoshioka, T.; Ishimura, H.; Ebihara, A.; Suda, H.			Differential diagnosis of vertical root fractures using reconstructed three-dimensional models of bone defects	DENTOMAXILLOFACIAL RADIOLOGY			English	Article						cone beam computed tomography; tooth fracture; periapical periodontitis; three-dimensional imaging	BEAM COMPUTED-TOMOGRAPHY; ENDODONTICALLY TREATED TEETH; PERIAPICAL RADIOGRAPHY; LESIONS; CT	Objectives: The purpose of this study was to evaluate the accuracy of diagnosing vertical root fractures (VRFs) by comparing the volume of bone defects in VRFs with those in non-VRFs on reconstructed three-dimensional (3D) models (TDMs) using CBCT. Methods: 32 maxillary pre-molars and anterior teeth with radiolucent areas were evaluated on pre-operative CBCT images. Of the 32 teeth, 16 had a fractured root (VRF group) and 16 had a non-fractured root (non-VRF group). The radiolucent area of each tooth was traced in each dimension [mesiodistal, buccolingual and horizontal (the apicoincisal aspect)] by two observers, and 3D images were reconstructed with the Amira(R) software (Visage Imaging Inc., Richmond, Australia). The volume, V, of the TDM was divided into the coronal side and the periapical side at the horizontal slice through the apical foramen, and v was defined as the volume of the coronal side. The values of v/V were calculated for all cases. The Mann-Whitney U test was used to compare values between the VRF group and the non-VRF group (p < 0.05). A receiver operating characteristic (ROC) curve was constructed to select the optimal cut-point. Results: There was a statistically significant difference in the value of v/V between the two groups (p < 0.05). With a cut-point derived from the ROC curve, and the sensitivity, specificity and accuracy of predicting the VRFs were 1.00, 0.75 and 0.88, respectively. Conclusions: Lesions resulting from VRFs can be distinguished from those of non-VRFs on 3D CBCT images with a high degree of accuracy, based on their different 3D shapes.	[Komatsu, K.; Abe, Y.; Yoshioka, T.; Ishimura, H.; Ebihara, A.; Suda, H.] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pulp Biol & Endodont, Div Oral Hlth Sci Med & Dent Sci Track, Tokyo, Japan	Ebihara, A (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Pulp Biol & Endodont, Div Oral Hlth Sci Med & Dent Sci Track, Tokyo, Japan.	a.ebihara.endo@tmd.ac.jp			Japan Society for the Promotion of Science, the Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Medical and Dental Sciences Track, Graduate School of Medical and Dental Sciences, Tokyo Medical and the Dental University, Japan [19209059, 25293385-00]	This work was supported by Grants-in-Aid for Scientific Research (A; grant number 19209059) and (B; grant number 25293385-00) from the Japan Society for the Promotion of Science, the Department of Pulp Biology and Endodontics, Division of Oral Health Sciences, Medical and Dental Sciences Track, Graduate School of Medical and Dental Sciences, Tokyo Medical and the Dental University, Japan.	BENDER IB, 1961, J AM DENT ASSOC, V62, P152; Estrela C, 2008, J ENDODONT, V34, P273, DOI 10.1016/j.joen.2007.11.023; Youssefzadeh S, 1999, RADIOLOGY, V210, P545; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; Liang YH, 2013, J ENDODONT, V39, P1218, DOI 10.1016/j.joen.2013.06.024; Riddle DL, 1999, PHYS THER, V79, P939; Edlund M, 2011, J ENDODONT, V37, P768, DOI 10.1016/j.joen.2011.02.034; Kositbowornchai S, 2001, DENTOMAXILLOFAC RAD, V30, P106, DOI 10.1038/sj.dmfr.4600587; Lofthag-Hansen S, 2007, ORAL SURG ORAL MED O, V103, P114, DOI 10.1016/j.tripleo.2006.01.001; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Bernardes RA, 2009, ORAL SURG ORAL MED O, V108, P270, DOI 10.1016/j.tripleo.2009.01.017; Bornstein MM, 2011, J ENDODONT, V37, P151, DOI 10.1016/j.joen.2010.11.014; Fuss Z, 1999, INT ENDOD J, V32, P283, DOI 10.1046/j.1365-2591.1999.00208.x; VIRE DE, 1991, J ENDODONT, V17, P338; Hassan B, 2009, J ENDODONT, V35, P719, DOI 10.1016/j.joen.2009.01.022; Bechara B, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20120404; Bechara B, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20120245; Christiansen R, 2009, DENTOMAXILLOFAC RAD, V38, P531, DOI 10.1259/dmfr/63019695; Culjat MO, 2005, DENTOMAXILLOFAC RAD, V34, P80, DOI 10.1259/dmfr/12901010; Estrela Carlos, 2008, Braz Dent J, V19, P114, DOI 10.1590/S0103-64402008000200005; Grondahl HG, 2004, ENDOD TOPICS, V1, P55, DOI 10.1111/j.1601-1546.2004.00082.x; Hagiya Y, 2008, JPN J CONSERV DENT, V51, P344; Jakobson SJM, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20130287; Kamburoglu K, 2010, ORAL SURG ORAL MED O, V109, pE74, DOI 10.1016/j.tripleo.2009.09.005; Kawamura-Hagiya Y, 2008, DENTOMAXILLOFAC RAD, V37, P28, DOI 10.1259/dmfr/25198672; Melo SLS, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20120459; MORFIS AS, 1990, ORAL SURG ORAL MED O, V69, P631, DOI 10.1016/0030-4220(90)90248-Q; Rud J, 1970, Scand J Dent Res, V78, P397; SJOGREN U, 1990, J ENDODONT, V16, P498; TAMSE A, 1988, ENDOD DENT TRAUMATOL, V4, P190; van der Borden WG, 2013, J ENDODONT, V39, P1245, DOI 10.1016/j.joen.2013.07.001	31	1	1	BRITISH INST RADIOLOGY	LONDON	36 PORTLAND PLACE, LONDON W1N 4AT, ENGLAND	0250-832X	1476-542X		DENTOMAXILLOFAC RAD	Dentomaxillofac. Radiol.	DEC	2014	43	8							20140256	10.1259/dmfr.20140256		9	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	Dentistry, Oral Surgery & Medicine; Radiology, Nuclear Medicine & Medical Imaging	AW4DL	WOS:000346231400001		
J	Rahmani, W; Abbasi, S; Hagner, A; Raharjo, E; Kumar, R; Hotta, A; Magness, S; Metzger, D; Biernaskie, J				Rahmani, Waleed; Abbasi, Sepideh; Hagner, Andrew; Raharjo, Eko; Kumar, Ranjan; Hotta, Akitsu; Magness, Scott; Metzger, Daniel; Biernaskie, Jeff			Hair Follicle Dermal Stem Cells Regenerate the Dermal Sheath, Repopulate the Dermal Papilla, and Modulate Hair Type	DEVELOPMENTAL CELL			English	Article							ADULT; GROWTH; NICHE; POPULATIONS; REGRESSION; APOPTOSIS; CATAGEN; MARKER; NUMBER; MATRIX	The dermal papilla (DP) provide instructive signals required to activate epithelial progenitors and initiate hair follicle regeneration. DP cell numbers fluctuate over the hair cycle, and hair loss is associated with gradual depletion/atrophy of DP cells. How DP cell numbers are maintained in healthy follicles remains unclear. We performed in vivo fate mapping of adult hair follicle dermal sheath (DS) cells to determine their lineage relationship with DP and found that a subset of DS cells are retained following each hair cycle, exhibit self-renewal, and repopulate the DS and the DP with new cells. Ablating these hair follicle dermal stem cells and their progeny retarded hair regrowth and altered hair type specification, suggesting that they function to modulate normal DP function. This work identifies a bipotent stem cell within the adult hair follicle mesenchyme and has important implications toward restoration of hair growth after injury, disease, and aging.	[Rahmani, Waleed; Abbasi, Sepideh; Hagner, Andrew; Raharjo, Eko; Biernaskie, Jeff] Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4N1, Canada; [Biernaskie, Jeff] Univ Calgary, Fac Med, Dept Surg, Calgary, AB T2N 4N1, Canada; [Biernaskie, Jeff] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB T2N 4N1, Canada; [Kumar, Ranjan; Biernaskie, Jeff] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Hotta, Akitsu] Kyoto Univ, CiRA, Kyoto 6068507, Japan; [Magness, Scott] Univ N Carolina, Chapel Hill, NC 27599 USA; [Metzger, Daniel] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, INSERM, U964,CNRS,UMR 7104, Illkirch Graffenstaden, France	Biernaskie, J (reprint author), Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4N1, Canada.	jeff.biernaskie@ucalgary.ca			AIHS MD-PhD; ACHRI/CIHR; UCVM Dean's Excellence Award; CIHR [MOP 106646]; Calgary Firefighters Burn Treatment Society; Stem Cell Network Global Impact Grant	We thank Min Cheng, Morgan Stykel, and Sarthak Sinha for technical assistance and Molly Chisholm and Martha Hurtatis for outstanding animal care. W.R. was supported by the AIHS MD-PhD and ACHRI/CIHR studentships and SA received a UCVM Dean's Excellence Award. J.B. is a CIHR New Investigator and this work was funded by a CIHR operating grant (MOP 106646) to J.B., a Stem Cell Network Global Impact Grant, and the Calgary Firefighters Burn Treatment Society.	ALCARAZ MV, 1993, J CUTAN PATHOL, V20, P344, DOI 10.1111/j.1600-0560.1993.tb01273.x; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; VANSCOTT EJ, 1958, J INVEST DERMATOL, V31, P281, DOI 10.1038/jid.1958.121; Elliott K, 1999, J INVEST DERMATOL, V113, P873, DOI 10.1046/j.1523-1747.1999.00797.x; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; McElwee KJ, 2003, J INVEST DERMATOL, V121, P1267, DOI 10.1111/j.1523-1747.2003.12568.x; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Wendling O, 2009, GENESIS, V47, P14, DOI 10.1002/dvg.20448; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Lindner G, 1997, AM J PATHOL, V151, P1601; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x; Chi WY, 2010, J INVEST DERMATOL, V130, P2664, DOI 10.1038/jid.2010.176; JAHODA CAB, 1991, J CELL SCI, V99, P627; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; Randall VA, 2008, DERMATOL THER, V21, P314, DOI 10.1111/j.1529-8019.2008.00214.x; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Clavel C, 2012, DEV CELL, V23, P981, DOI 10.1016/j.devcel.2012.10.013; Chi W, 2013, DEVELOPMENT, V140, P1676, DOI 10.1242/dev.090662; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Tobin DJ, 2003, J INVEST DERMATOL, V120, P895, DOI 10.1046/j.1523-1747.2003.12237.x; Biernaskie J, 2009, CELL STEM CELL, V5, P610, DOI 10.1016/j.stem.2009.10.019; Capla JM, 2006, PLAST RECONSTR SURG, V117, P836, DOI 10.1097/01.prs.0000201459.91559.7f; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Enshell-Seijffers D, 2010, P NATL ACAD SCI USA, V107, P21564, DOI 10.1073/pnas.1007326107; Jahoda CAB, 2003, J INVEST DERMATOL, V121, pIX, DOI 10.1111/j.1523-1747.2003.12585.x; Matsuo Shinji, 2007, J Med Invest, V54, P267, DOI 10.2152/jmi.54.267; WEEDON D, 1981, ACTA DERM-VENEREOL, V61, P335	27	6	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1534-5807	1878-1551		DEV CELL	Dev. Cell	DEC	2014	31	5					543	558		10.1016/j.devcel.2014.10.022		16	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	AW2JB	WOS:000346112800007		
J	Toyoda, M; Yokoyama, H; Abe, K; Nakamura, S; Suzuki, D				Toyoda, Masao; Yokoyama, Hiroki; Abe, Katsushige; Nakamura, Shuji; Suzuki, Daisuke			Predictors of response to liraglutide in Japanese type 2 diabetes	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Human GLP-1 analog; Type 2 diabetes; BMI	GLUCAGON-LIKE PEPTIDE-1; IMPAIRED GLUCOSE-METABOLISM; ANALOG LIRAGLUTIDE; INSULIN; EFFICACY; SAFETY; GLIBENCLAMIDE; SULFONYLUREA; MONOTHERAPY; MELLITUS	Aim: In Japan, liraglutide is approved for use alone or in combination with sulfonylureas, and the approved maximum dosage is 0.9 mg/day. This restriction could limit the glucose-lowering effect of liraglutide in Japanese patients with type 2 diabetes mellitus (T2DM). This study was designed to identify predictors of response to liraglutide therapy at the approved dosage. Methods: This observational retrospective study included 380 patients with T2DM who were treated with liraglutide alone or in combination with sulfonylureas at Diabetes Centers located in four geographically different areas of Japan. Binary logistic regression analysis was used to identify patient characteristics associated with discontinuation of liraglutide, while multiple regression and decision tree analyses were used to identify predictors of response to liraglutide therapy. Results: Factors associated with discontinuation of liraglutide included high BMI, long duration of diabetes, and prior insulin therapy. Predictors of response to liraglutide therapy in patients who did not use insulin previously included previous use of few oral glucose-lowering agents and high baseline HbA1c level. Conclusion: The results suggest greater efficacy of liraglutide monotherapy or liraglutide-sulfonylurea combination therapy in patients with short duration of diabetes, non-insulin therapy, and low BMI and high HbA1c level at baseline. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Toyoda, Masao] Tokai Univ, Sch Med, Dept Internal Med, Div Nephrol Endocrinol & Metab, Isehara, Kanagawa 2591193, Japan; [Yokoyama, Hiroki] Jiyugaoka Med Clin Internal Med, Obihiro, Hokkaido 0800016, Japan; [Abe, Katsushige] Abe Diabet Clin, Oita 8700039, Japan; [Nakamura, Shuji] Heiwadai Hosp, Miyazaki 8800034, Japan; [Suzuki, Daisuke] Suzuki Diabet Clin, Atsugi, Kanagawa 2430035, Japan	Toyoda, M (reprint author), Tokai Univ, Sch Med, Dept Internal Med, Div Nephrol Endocrinol & Metab, Isehara, Kanagawa 2591193, Japan.	m-toyoda@is.icc.u-tokai.ac.jp			Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Japan [12F188139]	This study was sponsored by the Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine (Grant No. 12F188139), Tokai University School of Medicine, Japan.	Kaku K, 2011, J DIABETES INVEST, V2, P441, DOI 10.1111/j.2040-1124.2011.00128.x; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Hojberg PV, 2009, DIABETOLOGIA, V52, P199, DOI 10.1007/s00125-008-1195-5; Usui R, 2013, J DIABETES INVEST, V4, P585, DOI 10.1111/jdi.12111; Larsen J, 2001, DIABETES CARE, V24, P1416, DOI 10.2337/diacare.24.8.1416; Kaku K, 2010, DIABETES OBES METAB, V12, P341, DOI 10.1111/j.1463-1326.2009.01194.x; RITZEL R, 1995, DIABETOLOGIA, V38, P720, DOI 10.1007/s001250050344; Seino Y, 2010, CURR MED RES OPIN, V26, P1013, DOI 10.1185/03007991003672551; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; GUTNIAK M, 1992, NEW ENGL J MED, V326, P1316, DOI 10.1056/NEJM199205143262003; Kozawa J, 2012, J DIABETES INVEST, V3, P294, DOI 10.1111/j.2040-1124.2011.00168.x; Seino Y, 2011, J DIABETES INVEST, V2, P280, DOI 10.1111/j.2040-1124.2011.00103.x; BELL GI, 1983, NATURE, V302, P716, DOI 10.1038/302716a0; Hische M, 2010, EUR J ENDOCRINOL, V163, P565, DOI 10.1530/EJE-10-0649; Iwao T, 2013, J DIABETES COMPLICAT, V27, P87, DOI 10.1016/j.jdiacomp.2012.07.001; Mohlig M, 2006, DIABETOLOGIA, V49, P2572, DOI 10.1007/s00125-006-0395-0; Nambu T, 2013, J DIABETES INVEST, V4, P69, DOI 10.1111/j.2040-1124.2012.00242.x; Worachartcheewan Apilak, 2010, Diabetes Res Clin Pract, V90, pe15, DOI 10.1016/j.diabres.2010.06.009	18	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	DEC	2014	106	3					451	457		10.1016/j.diabres.2014.09.052		7	Endocrinology & Metabolism	Endocrinology & Metabolism	AW1PF	WOS:000346060800020		
J	Sanke, H; Mita, T; Yoshii, H; Yokota, A; Yamashiro, K; Ingaki, N; Onuma, T; Someya, Y; Komiya, K; Tamura, Y; Shimizu, T; Ohmura, C; Kanazawa, A; Fujitani, Y; Watada, H				Sanke, Haruna; Mita, Tomoya; Yoshii, Hidenori; Yokota, Ayako; Yamashiro, Keiko; Ingaki, Noriko; Onuma, Tomio; Someya, Yuki; Komiya, Koji; Tamura, Yoshifumi; Shimizu, Tomoaki; Ohmura, Chie; Kanazawa, Akio; Fujitani, Yoshio; Watada, Hirotaka			Relationship between olfactory dysfunction and cognitive impairment in elderly patients with type 2 diabetes mellitus	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Olfactory function; Cognitive impairment; Type 2 diabetes mellitus; Elderly patients	MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; ODOR IDENTIFICATION; OLDER-ADULTS; FOLLOW-UP; DEMENTIA; POPULATION; DEFICITS; DECLINE; MEMORY	Aims: Recent clinical studies identified the relation between olfactory dysfunction and cognitive impairment in the elderly without type 2 diabetes mellitus. The aim of the present study was to define the relation between olfactory function and cognition in elderly patients with type 2 diabetes mellitus. Methods: The study participants comprised 250 elderly (age, 68-77, median 72) Japanese outpatient with type 2 diabetes mellitus free of clinically-evident cognitive impairment. Olfactory and cognitive functions were evaluated by the Open Essence (OE) test and Minimental State Examination (MMSE), respectively. Results: Based on the MMSE score, 62.0%, 24.4%, and 13.6% of the participants were considered to have no impairment, possible cognitive impairment and probable dementia, respectively. The OE test score of the probable dementia group was significantly lower than other groups. Furthermore, age and serum uric acid were significantly higher in the probable dementia group than other groups. Simple correlation analysis showed positive correlation between the MMSE score and diastolic blood pressure, education, OE test score, total cholesterol, LDL cholesterol, folic acid, and negative correlation with age, HbA(1c), aspartate aminotransferase, serum adiponectin and urinary albumin excretion. Multivariate regression analysis showed that OE test score correlated significantly and independently with MMSE score (standardized coefficients beta = 0.542, R-2 = 0.478, P < 0.01), in addition to education level, HbA1c and serum adiponectin. Conclusions: The results suggested the association of olfactory dysfunction with cognitive impairment in elderly patients with type 2 diabetes mellitus. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Sanke, Haruna; Mita, Tomoya; Someya, Yuki; Komiya, Koji; Tamura, Yoshifumi; Shimizu, Tomoaki; Ohmura, Chie; Kanazawa, Akio; Fujitani, Yoshio; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Dept Endocrinol & Metab, Bunkyo Ku, Tokyo 1138421, Japan; [Yoshii, Hidenori; Yokota, Ayako; Yamashiro, Keiko; Ingaki, Noriko; Onuma, Tomio] Juntendo Tokyo Koto Geriatr Med Ctr, Dept Med Diabetol & Endocrinol, Koto Ku, Tokyo 1360075, Japan; [Kanazawa, Akio; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Ctr Therapeut Innovat Diabet, Bunkyo Ku, Tokyo 1138421, Japan; [Mita, Tomoya; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Ctr Mol Diabetol, Bunkyo Ku, Tokyo 1138421, Japan; [Tamura, Yoshifumi; Watada, Hirotaka] Juntendo Univ, Grad Sch Med, Sportol Ctr, Bunkyo Ku, Tokyo 1138421, Japan	Mita, T (reprint author), Juntendo Univ, Grad Sch Med, Dept Endocrinol & Metab, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	tom-m@juntendo.ac.jp			Ministry of Education, Sports and Culture of Japan [23500858]	This clinical trial was funded by a grant from the Ministry of Education, Sports and Culture of Japan (number 23500858) to CO.	Aime P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051227; Eibenstein A, 2005, NEUROL SCI, V26, P147, DOI 10.1007/s10072-005-0452-3; Murphy C, 1998, ANN NY ACAD SCI, V855, P744, DOI 10.1111/j.1749-6632.1998.tb10654.x; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; Bruce DG, 2008, DIABETOLOGIA, V51, P241, DOI 10.1007/s00125-007-0894-7; WEINSTOCK RS, 1993, PHYSIOL BEHAV, V53, P17, DOI 10.1016/0031-9384(93)90005-Z; SERBY M, 1991, AM J PSYCHIAT, V148, P357; Marioni RE, 2010, DIABETES, V59, P710, DOI 10.2337/db09-1163; Devanand DP, 2000, AM J PSYCHIAT, V157, P1399, DOI 10.1176/appi.ajp.157.9.1399; Marks DR, 2009, J NEUROSCI, V29, P6734, DOI 10.1523/JNEUROSCI.1350-09.2009; Mesholam RI, 1998, ARCH NEUROL-CHICAGO, V55, P84, DOI 10.1001/archneur.55.1.84; Wilson RS, 2007, J NEUROL NEUROSUR PS, V78, P30, DOI 10.1136/jnnp.2006.099721; Une K, 2011, EUR J NEUROL, V18, P1006, DOI 10.1111/j.1468-1331.2010.03194.x; Umegaki H, 2013, GERIATR GERONTOL INT, V13, P28, DOI 10.1111/j.1447-0594.2012.00922.x; Umegaki H, 2012, GERIATR GERONTOL INT, V12, P103, DOI 10.1111/j.1447-0594.2011.00817.x; Wilson RS, 2006, NEUROEPIDEMIOLOGY, V26, P61, DOI 10.1159/000090250; Sharma R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013463; Schiffman SS, 2002, NEUROBIOL AGING, V23, P397, DOI 10.1016/S0197-4580(01)00337-2; Schubert CR, 2008, J AM GERIATR SOC, V56, P1517, DOI 10.1111/j.1532-5415.2008.01826.x; [Anonymous], 1998, LANCET, V352, P837; Feil DG, 2009, INT J PSYCHIAT MED, V39, P199, DOI 10.2190/PM.39.2.h; Ebady SA, 2008, DIABETES RES CLIN PR, V82, P305, DOI 10.1016/j.diabres.2008.08.020; LEFLOCH JP, 1993, DIABETES CARE, V16, P934, DOI 10.2337/diacare.16.6.934; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Rosen CS, 2002, ALZ DIS ASSOC DIS, V16, P15, DOI 10.1097/00002093-200201000-00003; Anstey KJ, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-62; Beck A. T., 1996, MANUAL BECK DEPRESSI; Cerf-Ducastel B, 2006, NEUROIMAGE, V31, P386, DOI 10.1016/j.neuroimage.2005.11.009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORSELL Y, 1992, ACTA PSYCHIAT SCAND, V86, P49, DOI 10.1111/j.1600-0447.1992.tb03225.x; Fujio H, 2012, ANN OTO RHINOL LARYN, V121, P413; Haan MN, 1996, ANN EPIDEMIOL, V6, P392, DOI 10.1016/S1047-2797(96)00062-2; Lojkowska W, 2011, CURR ALZHEIMER RES, V8, P689; Makizako M, 2014, CHEM SENSES, V39, P39, DOI 10.1093/chemse/bjt052; PATTERSO.DS, 1966, NATURE, V209, P625, DOI 10.1038/209625a0; Riedel G, 2001, PROG NEURO-PSYCHOPH, V25, P835, DOI 10.1016/S0278-5846(01)00153-1; Sohrabi HR, 2009, J ALZHEIMERS DIS, V17, P135, DOI 10.3233/JAD-2009-1020; Swan GE, 2002, NEUROEPIDEMIOLOGY, V21, P58, DOI 10.1159/000048618; Yamazaki Y, 2011, ENDOCR J, V58, P109, DOI 10.1507/endocrj.K10E-388	39	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	DEC	2014	106	3					465	473		10.1016/j.diabres.2014.09.039		9	Endocrinology & Metabolism	Endocrinology & Metabolism	AW1PF	WOS:000346060800022		
J	Tanaka, M; Sekioka, R; Nishimura, T; Ichihara, A; Itoh, H				Tanaka, Masami; Sekioka, Risa; Nishimura, Takeshi; Ichihara, Atsuhiro; Itoh, Hiroshi			Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: Association with BNP and aldosterone levels	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Cilnidipine; Diabetes mellitus; Hypertension; Renin-angiotensin-aldosterone system; Sympathetic nervous system	CALCIUM-CHANNEL BLOCKER; URINE PROTEIN EXCRETION; L/N-TYPE; TRANSPLANT PATIENTS; CREATININE RATIO; SYSTEM; CATECHOLAMINES; ANTAGONIST; PEPTIDE; DISEASE	Aims: Hypertension stimulates the sympathetic nervous system and this phenomenon is exacerbated by diabetes mellitus. We investigated the effects of cilnidipine, an N/L-type calcium channel blocker, on aspects of this system in patients with type 2 diabetes mellitus. Methods: In 33 hypertensive patients with type 2 diabetes mellitus treated with a calcium channel blocker other than cilnidipine, we evaluated the influence of switching to cilnidipine on blood pressure, heart rate, catecholamine, plasma renin and aldosterone concentration, brain natriuretic peptide, urine liver-type fatty acid binding protein, and urinary albumin excretion ratio in the same patients by a cross-over design. Other biochemical parameters were also evaluated. Results: Switching to cilnidipine did not change blood pressure but caused reduction in catecholamine concentrations in blood and urine and plasma aldosterone concentration, accompanied by significant reduction in brain natriuretic peptide, urine liver-type fatty acid binding protein, and albumin excretion ratio. These parameters other than brain natriuretic peptide were significantly increased after cilnidipine was changed to the original calcium channel blocker. Conclusions: In 33 hypertensive patients with type 2 diabetes mellitus, compared to other calcium channel blockers, cilnidipine suppressed sympathetic nerve activity and aldosterone, and significantly improved markers of cardiorenal disorders. Therefore, cilnidipine may be an important calcium channel blocker for use in combination with renin-angiotensin- aldosterone system inhibitors when dealing with hypertension complicated with diabetes mellitus. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Tanaka, Masami; Sekioka, Risa; Nishimura, Takeshi; Itoh, Hiroshi] Keio Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Nephrol, Tokyo, Japan; [Ichihara, Atsuhiro] Tokyo Womens Med Univ, Dept Endocrinol & Hypertens, Tokyo, Japan	Tanaka, M (reprint author), Keio Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Nephrol, Tokyo, Japan.	tana176k@a7.keio.jp					Mancia G, 2006, J HYPERTENS, V24, pS51, DOI 10.1097/01.hjh.0000220407.84363.fb; Elmasry A, 2002, EUR RESPIR J, V19, P511, DOI 10.1183/09031936.02.00106402; Katayama K, 2006, KIDNEY INT, V70, P151, DOI 10.1038/sj.ki.5000349; Voulgari C, 2013, METABOLISM, V62, P609, DOI 10.1016/j.metabol.2012.09.005; Yokoyama T, 2009, AM J PATHOL, V174, P2096, DOI 10.2353/ajpath.2009.080780; Sciarretta S, 2009, CLIN SCI, V116, P467, DOI 10.1042/CS20080390; Konoshita T, 2010, J HYPERTENS, V28, P2156, DOI 10.1097/HJH.0b013e32833d01dd; Takahara A, 2009, CARDIOVASC THER, V27, P124, DOI 10.1111/j.1755-5922.2009.00079.x; Grassi G, 2006, HYPERTENS RES, V29, P839, DOI 10.1291/hypres.29.839; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Aritomi S, 2011, HYPERTENS RES, V34, P193, DOI 10.1038/hr.2010.191; FERNANDEZ PG, 1988, CAN J CARDIOL, V4, P169; Fujita T, 2007, KIDNEY INT, V72, P1543, DOI 10.1038/sj.ki.5002623; Iimura O, 1996, Hypertens Res, V19 Suppl 1, pS1, DOI 10.1291/hypres.19.SupplementI_S1; Kamijo-Ikemori A, 2011, DIABETES CARE, V34, P691, DOI 10.2337/dc10-1392; KANNEL WB, 1989, J CARDIOVASC PHARM, V13, pS4, DOI 10.1097/00005344-198900131-00003; Konda T, 2005, NEPHRON PHYSIOL, V101, pp1; Konda T, 2006, BIOL PHARM BULL, V29, P933, DOI 10.1248/bpb.29.933; Konda T, 2009, AM J NEPHROL, V30, P155, DOI 10.1159/000210396; Konno Y, 2008, INT HEART J, V49, P723, DOI 10.1536/ihj.49.723; Kyuma M, 2004, J NUCL MED, V45, P155; Perkins JM, 2008, CURR OPIN ENDOCRINOL, V15, P147, DOI 10.1097/MED.0b013e3282f7026f; Rafiq K, 2011, J PHARMACOL SCI, V115, P1, DOI 10.1254/jphs.10R07CR; Shidham G, 2006, AM J KIDNEY DIS, V47, P8, DOI 10.1053/j.ajkd.2005.10.013; STEINHAUSLIN F, 1995, CLIN NEPHROL, V43, P110; Takeda S, 1999, DIABETES RES CLIN PR, V44, P197, DOI 10.1016/S0168-8227(99)00053-4; Tanaka M, 2010, J INT MED RES, V38, P602; Torng S, 2001, TRANSPLANTATION, V72, P1453, DOI 10.1097/00007890-200110270-00021	28	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	DEC	2014	106	3					504	510		10.1016/j.diabres.2014.09.056		7	Endocrinology & Metabolism	Endocrinology & Metabolism	AW1PF	WOS:000346060800028		
J	Mise, K; Hoshino, J; Ueno, T; Sumida, K; Hiramatsu, R; Hasegawa, E; Yamanouchi, M; Hayami, N; Suwabe, T; Sawa, N; Fujii, T; Hara, S; Ohashi, K; Takaichi, K; Ubara, Y				Mise, Koki; Hoshino, Junichi; Ueno, Toshiharu; Sumida, Keiichi; Hiramatsu, Rikako; Hasegawa, Eiko; Yamanouchi, Masayuki; Hayami, Noriko; Suwabe, Tatsuya; Sawa, Naoki; Fujii, Takeshi; Hara, Shigeko; Ohashi, Kenichi; Takaichi, Kenmei; Ubara, Yoshifumi			Clinical implications of linear immunofluorescent staining for immunoglobulin G in patients with diabetic nephropathy	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Diabetic nephropathy; Pathology; Renal biopsy; Linear immunofluorescent IgG staining; Renal prognosis	CHARGE-SELECTIVITY; OBSERVER AGREEMENT; RENAL PROGNOSIS; GLOMERULAR SIZE; MELLITUS; CLASSIFICATION; PROTEINURIA; MICROSCOPY; BIOPSY	Aims: The kidneys of patients with diabetes mellitus usually exhibit a characteristic pattern of linear immunofluorescent staining for immunoglobulin G (IgG) along the glomerular and tubular basement membranes. However, the association between linear IgG staining and the renal prognosis remains unclear. Methods: Among 223 patients with diabetes who underwent renal biopsy from 1985 to 2010 and were confirmed to have pure diabetic nephropathy according to the classification of Tervaert et al., 165 patients (glomerular classes I to III) were enrolled in this study. Immunofluorescent staining was classified into three categories according to its intensity (0 = none, 1 = weakly positive, and 2 = positive). Cox proportional hazards regression analysis was used to calculate the hazard ratio (HR) and 95% confidence interval (CI) for death-censored renal death, with each regression analysis employing four levels of multivariate adjustment. Results: After adjustment for important clinical factors at the time of renal biopsy, the HR for death-censored renal death in patients with an IgG staining score of 1 or 2 was, respectively, 3.01 (95% CI: 1.05-8.68) and 4.68 (1.67-13.1) compared with patients who had a staining score of 0. Even after adjustment for clinical variables and pathological findings, the HR for IgG score of 1 or 2 was higher than that for an IgG score of 0, and it was, respectively, 2.22 (0.71-7.00) and 3.76 (1.27-11.2). Conclusions: More intense linear IgG staining is associated with a higher HR for renal death, which suggests that linear immunofluorescent staining for IgG may be a prognostic indicator in patients with diabetic nephropathy. (C) 2014 The Authors. Published by Elsevier Ireland Ltd.	[Mise, Koki; Hoshino, Junichi; Ueno, Toshiharu; Sumida, Keiichi; Hiramatsu, Rikako; Hasegawa, Eiko; Yamanouchi, Masayuki; Hayami, Noriko; Suwabe, Tatsuya; Sawa, Naoki; Hara, Shigeko; Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan; [Fujii, Takeshi; Ohashi, Kenichi] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan; [Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Tokyo, Japan; [Ohashi, Kenichi] Yokohama City Univ, Grad Sch Med, Dept Pathol, Yokohama, Kanagawa 232, Japan	Mise, K (reprint author), Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan.	kokims-frz@umin.ac.jp			Okinaka Memorial Institute for Medical Research	This work was supported by a grant from Okinaka Memorial Institute for Medical Research. We are grateful to Drs. Shogi Kawatsu (The Institute for Adult Diseases, Asahi Life Foundation), Ayako Hakura, Masafumi Yokota, Yukio Maruyama, Tomio Onuma, and Ai Terai for providing data and for treatment after renal biopsy. We are also grateful to Dr Chizuru Watanabe for her helpful comment.	Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Raats CJI, 2000, KIDNEY INT, V57, P385, DOI 10.1046/j.1523-1755.2000.00858.x; Horio M, 2010, AM J KIDNEY DIS, V56, P32, DOI 10.1053/j.ajkd.2010.02.344; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Haas M, 2006, ARCH PATHOL LAB MED, V130, P699; Sharma SG, 2013, CLIN J AM SOC NEPHRO, V8, P1718, DOI 10.2215/CJN.02510213; Najafian B, 2011, CONTRIB NEPHROL, V170, P36, DOI 10.1159/000324942; Bellur SS, 2011, NEPHROL DIAL TRANSPL, V26, P2533, DOI 10.1093/ndt/gfq812; AINSWORTH SK, 1982, HUM PATHOL, V13, P470, DOI 10.1016/S0046-8177(82)80030-0; BERNS AW, 1962, J LAB CLIN MED, V60, P535; Dalla Vestra M, 2000, DIABETES METAB, V26, P8; DECKERT T, 1988, KIDNEY INT, V33, P100, DOI 10.1038/ki.1988.16; FARRANT PC, 1965, DIABETES, V14, P274; GALL MA, 1994, DIABETOLOGIA, V37, P195, DOI 10.1007/s001250050093; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; MILLER K, 1976, DIABETES, V25, P701, DOI 10.2337/diabetes.25.8.701; Mise K, 2014, NEPHROL DIAL TRANSPL, V29, P109, DOI 10.1093/ndt/gft349; MORANO S, 1993, ACTA DIABETOL, V30, P138; Nossent H, 2000, LUPUS, V9, P504, DOI 10.1177/096120330000900705; Oh SW, 2012, DIABETES RES CLIN PR, V97, P418, DOI 10.1016/j.diabres.2012.03.016; Okada T, 2012, NEPHROLOGY, V17, P68, DOI 10.1111/j.1440-1797.2011.01525.x; PARVING HH, 1981, DIABETOLOGIA, V20, P457; Wada T, 2013, CLIN EXP NEPHROL, V17, P3, DOI 10.1007/s10157-012-0711-6; WESTBERG NG, 1972, DIABETES, V21, P163	25	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	DEC	2014	106	3					522	530		10.1016/j.diabres.2014.09.051		9	Endocrinology & Metabolism	Endocrinology & Metabolism	AW1PF	WOS:000346060800030		
J	Daido, H; Horikawa, Y; Takeda, J				Daido, Hisashi; Horikawa, Yukio; Takeda, Jun			The effects of pitavastatin on glucose metabolism in patients with type 2 diabetes with hypercholesterolemia	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Statin; Glucose metabolism; Insulin resistance; Insulin secretion; Dyslipidemia	IMPAIRED FASTING GLUCOSE; PLACEBO-CONTROLLED TRIAL; CARDIOVASCULAR-DISEASE; INSULIN-SECRETION; CHOLESTEROL; PREVENTION; ATORVASTATIN; RISK; ROSUVASTATIN; PRAVASTATIN	Background: Although there have been several reports that statins cause insulin resistance that leads to the occurrence of type 2 diabetes in Caucasians, there has been no Japanese prospective studies investigating the effects of statins on the glucose metabolism system. Materials and methods: Our subjects were 86 Japanese patients with type 2 diabetes with hypercholesterolemia. Pitavastatin 2 mg/day was administered for 12 months and the lipid-related values, glucose metabolism values, and the presence/absence of side effects were investigated. Results: None of these factors was found to differ between before and after administration of pitavastatin in overall analysis of all subjects. In subgroup analysis, fasting blood glucose showed a decrease in the BMI >= 25 group and there was a significant difference between the BMI < 25 and BMI >= 25 groups (P-values: 0.021 and 0.0036). Although HbA1c showed an increase both in the group switched to pitavastatin and the BMI < 25 group (P-values: 0.035 and 0.033) and HOMA-beta showed a decrease in the BMI < 25 group (P-values: 0.044), there were no significant differences in changes between each divided group and their counterparts. Conclusion: In the Japanese obese group with BMI >= 25, pitavastatin elicited a significant decrease in fasting blood glucose. It is not clear whether or not this is due to improved insulin resistance as a direct effect of pitavastatin, but in contrast to findings in Caucasians pitavastatin does not worsen insulin resistance in Japanese patients with type 2 diabetes complicated by hypercholesterolemia. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Daido, Hisashi] Hashima City Hosp, Gifu, Japan; [Daido, Hisashi; Horikawa, Yukio; Takeda, Jun] Gifu Univ, Grad Sch Med, Dept Endocrinol & Diabet, Gifu 5011194, Japan	Horikawa, Y (reprint author), Gifu Univ, Grad Sch Med, Dept Endocrinol & Diabet, 1-1 Yanagido, Gifu 5011194, Japan.	yhorikaw@gifu-u.ac.jp					Keech A, 2003, DIABETES CARE, V26, P2713, DOI 10.2337/diacare.26.10.2713; Kostapanos MS, 2009, INT J CLIN PRACT, V63, P1308, DOI 10.1111/j.1742-1241.2009.02101.x; Collins R, 2003, LANCET, V361, P2005; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Schaefer EJ, 2010, CURR OPIN LIPIDOL, V21, P289, DOI 10.1097/MOL.0b013e32833c1ef6; Waters DD, 2011, J AM COLL CARDIOL, V57, P1535, DOI 10.1016/j.jacc.2010.10.047; Freeman DJ, 2001, CIRCULATION, V103, P357; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Teramoto T, 2007, J ATHEROSCLER THROMB, V14, P45; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Gaede P, 2003, NEW ENGL J MED, V348, P383; Brunham LR, 2008, J CLIN INVEST, V118, P403, DOI 10.1172/JCI33296; Waters DD, 2013, J AM COLL CARDIOL, V61, P148, DOI 10.1016/j.jacc.2012.09.042; Kruit JK, 2010, DIABETOLOGIA, V53, P1110, DOI 10.1007/s00125-010-1691-2; Bardini Gianluca, 2012, Rev Diabet Stud, V9, P82, DOI 10.1900/RDS.2012.9.82; Carter AA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2610; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Koseki M, 2009, J ATHEROSCLER THROMB, V16, P292; Odawara M, 2013, 73 AM DIAB ASS ANN M; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Teramoto T, 2009, J ATHEROSCLER THROMB, V16, P654; Yamakawa Tadashi, 2008, J Atheroscler Thromb, V15, P269	22	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	DEC	2014	106	3					531	537		10.1016/j.diabres.2014.09.048		7	Endocrinology & Metabolism	Endocrinology & Metabolism	AW1PF	WOS:000346060800031		
J	Mikada, A; Narita, T; Yokoyama, H; Yamashita, R; Horikawa, Y; Tsukiyama, K; Yamada, Y				Mikada, Atsushi; Narita, Takuma; Yokoyama, Hiroki; Yamashita, Risa; Horikawa, Yohei; Tsukiyama, Katsushi; Yamada, Yuichiro			Effects of miglitol, sitagliptin, and initial combination therapy with both on plasma incretin responses to a mixed meal and visceral fat in over-weight Japanese patients with type 2 diabetes. "The MASTER randomized, controlled trial''	DIABETES RESEARCH AND CLINICAL PRACTICE			English	Article						Gastiric inhibitory polypeptide; Obesity; Alpha-glucosidase inhibitor; Dipeptidyl peptidase-4 inhibitor; Adiponectin	GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; ALPHA-GLUCOSIDASE INHIBITOR; BETA-CELL FUNCTION; INSULIN-RESISTANCE; METABOLIC SYNDROME; BLOOD-GLUCOSE; 7-36 AMIDE; POSTPRANDIAL GLYCEMIA; DOUBLE-BLIND	Aim: To assess changes in circulating incretin levels and body fat compositions with initial combination therapy with alpha-glucosidase inhibitor and dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetes (T2D). Methods: In this multicenter open-label 24-week trial, Japanese over-weight (BMI >= 25 kg/m(2)) patients with T2D not taking medication or taking metformin and/or sulfonylurea were randomly assigned to receive either 50 mg of miglitol three times a day (M, n = 14), 50 mg of sitagliptin once a day (S, n = 14), or a combination of both (M + S, n = 13). Changes in plasma incretin levels during a meal tolerance test (MTT) and body fat composition with impedance method were evaluated. Results: During MTT, postprandial plasma glucose levels decreased more after M + S than after M or S, and postprandial serum insulin levels decreased significantly after M and M + S whereas they increased after S. After M, active gastric inhibitory polypeptide (aGIP) decreased significantly at 30 min despite a significant increase at 120 min. After S, aGIP levels increased significantly throughout the MTT. After M + S, aGIP increased significantly at 0 and 120 min despite of significant decrease at 30 min. M + S further enhanced postprandial active glucagon-like peptide-1 levels during MTT than S did. Total body fat mass decreased significantly after M and M + S. Visceral fat mass decreased significantly only after M + S. Serum adiponectin increased significantly only after M + S. Conclusions: In over-weight patients with T2D, M + S may have a beneficial effect on adiposity with relation to these different effects on two incretins. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Mikada, Atsushi; Narita, Takuma; Yamada, Yuichiro] Akita Univ, Grad Sch Med, Dept Endocrinol Diabet & Geriatr Med, Akita 010, Japan; [Mikada, Atsushi; Horikawa, Yohei; Tsukiyama, Katsushi] Hiraka Gen Hosp, Gastroenterol & Diabet Unit, Yokote, Japan; [Yokoyama, Hiroki; Yamashita, Risa] Jiyugaoka Med Clin, Obihiro, Hokkaido, Japan; [Tsukiyama, Katsushi] Akita Univ, Sch Med Metab & Clin Nutr, Akita 010, Japan	Narita, T (reprint author), Akita Univ, Grad Sch Med, Dept Endocrinol Diabet & Geriatr Med, Akita 010, Japan.	narita@med.akita-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology; Japanese Ministry of Health, Labour and Welfare	The study was supported in part by Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology and from the Japanese Ministry of Health, Labour and Welfare.	Kaku H, 2012, HORM METAB RES, V44, P312, DOI 10.1055/s-0032-1304563; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Nonaka K, 2008, DIABETES RES CLIN PR, V79, P291, DOI 10.1016/j.diabres.2007.08.021; Seino Y, 2013, J DIABETES INVEST, V4, P108, DOI 10.1111/jdi.12065; Seifarth C, 1998, DIABETIC MED, V15, P485, DOI 10.1002/(SICI)1096-9136(199806)15:6<485::AID-DIA610>3.0.CO;2-Y; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Yabe D, 2012, J DIABETES INVEST, V3, P70, DOI 10.1111/j.2040-1124.2011.00141.x; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Derosa G, 2010, METABOLISM, V59, P887, DOI [10.1016/j.metabol.2009.10.007, 10.1016/j.metabo1.2009.10.007]; Tajiri Y, 2012, ENDOCR J, V59, P197; Rosenstock J, 2008, DIABETES CARE, V31, P30, DOI 10.2337/dc07-1616; GOKE B, 1995, DIGESTION, V56, P493; Lamers D, 2011, DIABETES, V60, P1917, DOI 10.2337/db10-1707; Herman GA, 2006, J CLIN ENDOCR METAB, V91, P4612, DOI 10.1210/jc.2006-1009; Iwamoto Y, 2010, DIABETES OBES METAB, V12, P700, DOI 10.1111/j.1463-1326.2010.01222.x; Narita T, 2009, DIABETIC MED, V26, P187, DOI 10.1111/j.1464-5491.2008.02651.x; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Derosa G, 2012, DIABETES RES CLIN PR, V98, P51, DOI 10.1016/j.diabres.2012.05.022; Meier JJ, 2010, DIABETES, V59, P1117, DOI 10.2337/db09-1899; Narita T, 2012, DIABETES OBES METAB, V14, P283, DOI 10.1111/j.1463-1326.2011.01526.x; McClean PL, 2007, AM J PHYSIOL-ENDOC M, V293, pE1746, DOI 10.1152/ajpendo.00460.2007; Lee A, 2002, DIABETES OBES METAB, V4, P329, DOI 10.1046/j.1463-1326.2002.00219.x; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Kusunoki Y, 2013, ENDOCR J, V60, P431; Lorenz M, 2013, REGUL PEPTIDES, V185, P1, DOI 10.1016/j.regpep.2013.04.001; Aoki K, 2010, ENDOCR J, V57, P667; NAUCK MA, 1993, J CLIN INVEST, V91, P301, DOI 10.1172/JCI116186; Enc FY, 2001, AM J PHYSIOL-GASTR L, V281, P752; Hojberg PV, 2008, DIABETOLOGIA, V51, P632, DOI 10.1007/s00125-008-0943-x; Hojberg PV, 2008, DIABETIC MED, V25, P1268, DOI 10.1111/j.1464-5491.2008.02579.x; Imai C, 2014, METABOLISM, V63, P746, DOI 10.1016/j.metabol.2013.12.014; Iwamoto Y, 2010, DIABETES OBES METAB, V12, P613, DOI 10.1111/j.1463-1326.2010.01197.x; Kashiwagi A, 2012, DIABETOL INT, V3, P8, DOI DOI 10.1007/S13340-012-0069-8; Matsuda M, 2014, REV ENDOCR METAB DIS, V15, P1, DOI 10.1007/s11154-013-9271-7; Miyachi A, 2013, J PROTEOME RES, V12, P2690, DOI 10.1021/pr400069f; Ouaghlidi AE, 2007, J CLIN ENDOCR METAB, V92, P4165; WIESENFELD P, 1993, P SOC EXP BIOL MED, V202, P338; Yamada C, 2007, BIOCHEM BIOPH RES CO, V364, P175, DOI 10.1016/j.bbrc.2007.09.128; Yamaguchi M, 2013, INT J CLIN PHARM TH, V51, P641, DOI 10.5414/CP201902; Yokoyama H, 2007, METABOLISM, V56, P1458, DOI 10.1016/j.metabol.2007.06.010	41	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0168-8227	1872-8227		DIABETES RES CLIN PR	Diabetes Res. Clin. Pract.	DEC	2014	106	3					538	547		10.1016/j.diabres.2014.09.040		10	Endocrinology & Metabolism	Endocrinology & Metabolism	AW1PF	WOS:000346060800032		
J	Kito, Y; Saigo, C; Atsushi, K; Mutsuo, F; Tamotsu, T				Kito, Yusuke; Saigo, Chiemi; Atsushi, Kurabayashi; Mutsuo, Furihata; Tamotsu, Takeuchi			Transgenic mouse model of cutaneous adnexal tumors	DISEASE MODELS & MECHANISMS			English	Article						Cutaneous adnexal tumor; Mouse model; TMEM207	BROOKE-SPIEGLER-SYNDROME; INTESTINAL TREFOIL FACTOR; CELL-CARCINOMA; SUPPRESSOR GENE; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; IDENTIFY; LESIONS	TMEM207 was first characterized as being an important molecule for the invasion activity of gastric signet-ring cell carcinoma cells. In order to unravel the pathological properties of TMEM207, we generated several transgenic mouse lines, designated C57BL/6-Tg (ITF-TMEM207), in which murine TMEM207 was ectopically expressed under a truncated (by similar to 200 bp) proximal promoter of the murine intestinal trefoil factor (ITF) gene (also known as Tff3). Unexpectedly, a C57BL/6-Tg (ITF-TMEM207) mouse line exhibited a high incidence of spontaneous intradermal tumors with histopathological features that resembled those of various human cutaneous adnexal tumors. These tumors were found in similar to 14% female and 13% of male 6- to 12-month-old mice. TMEM207 immunoreactivity was found in hair follicle bulge cells in non-tumorous skin, as well as in cutaneous adnexal tumors of the transgenic mouse. The ITF-TMEM207 construct in this line appeared to be inserted to a major satellite repeat sequence at chromosome 2, in which no definite coding molecule was found. In addition, we also observed cutaneous adnexal tumors in three other C57BL/6-Tg (ITF-TMEM207) transgenic mouse lines. We believe that the C57BL/6-Tg (ITF-TMEM207) mouse might be a useful model to understand human cutaneous adnexal tumors.	[Kito, Yusuke; Saigo, Chiemi; Tamotsu, Takeuchi] Gifu Univ, Grad Sch Med, Dept Pathol & Translat Res, Gifu 5011194, Japan; [Atsushi, Kurabayashi; Mutsuo, Furihata] Kochi Med Sch, Dept Pathol, Nankoku, Kochi 7838505, Japan	Tamotsu, T (reprint author), Gifu Univ, Grad Sch Med, Dept Pathol & Translat Res, Yanagido 1-1, Gifu 5011194, Japan.	takeutit08@gmail.com			Ministry of Education of Japan [KAKEN 24590384]	This study was supported by grants from the Ministry of Education of Japan [ grant number KAKEN 24590384].	Ostler DA, 2010, MODERN PATHOL, V23, P567, DOI 10.1038/modpathol.2010.1; Sellheyer K, 2011, J CUTAN PATHOL, V38, P460, DOI 10.1111/j.1600-0560.2010.01671.x; Harwood CA, 2003, J AM ACAD DERMATOL, V48, P401, DOI 10.1067/mjd.2003.97; Takeuchi T, 2012, CARCINOGENESIS, V33, P548, DOI 10.1093/carcin/bgs001; Blake PW, 2010, ARCH DERMATOL, V146, P625, DOI 10.1001/archdermatol.2010.105; Bignell GR, 2000, NAT GENET, V25, P160; Crowson AN, 2006, MODERN PATHOL, V19, pS93, DOI 10.1038/modpathol.3800511; Zhang XJ, 2004, J INVEST DERMATOL, V122, P658, DOI 10.1111/j.0022-202X.2004.22321.x; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Emanuel P, 2005, MODERN PATHOL, V18, P645, DOI 10.1038/modpathol.3800329; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Takeuchi T, 2000, J NEUROCHEM, V74, P1489, DOI 10.1046/j.1471-4159.2000.0741489.x; Ponti G, 2012, J CUTAN PATHOL, V39, P366, DOI 10.1111/j.1600-0560.2011.01813.x; Bai JC, 2014, ARCH DERMATOL RES, V306, P399, DOI 10.1007/s00403-014-1442-1; Brooke HG, 1892, BRIT J DERMATOL, V4, P269; Itoh H, 1999, BIOCHEM J, V341, P461, DOI 10.1042/0264-6021:3410461; Iwakiri D, 2001, AM J PHYSIOL-GASTR L, V280, pG1114; Kazakov DV, 2005, AM J DERMATOPATH, V27, P27, DOI 10.1097/01.dad.0000138049.86662.3e; Sima R, 2010, DIAGN MOL PATHOL, V19, P83, DOI 10.1097/PDM.0b013e3181ba2d96; Spiegler H., 1899, ARCH DERM SYPHILOL, V50, P163; Takeuchi T, 1997, J IMMUNOL, V159, P726	21	1	1	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	1754-8403	1754-8411		DIS MODEL MECH	Dis. Model. Mech.	DEC	2014	7	12					1379	1383		10.1242/dmm.017574		5	Cell Biology; Pathology	Cell Biology; Pathology	AW2AL	WOS:000346090500007		
J	Yamanaka, K; Sekine, S; Uenoyama, T; Wada, M; Ikeuchi, T; Saito, M; Yamaguchi, Y; Tamiya, E				Yamanaka, Keiichiro; Sekine, Shinichi; Uenoyama, Takahiro; Wada, Masahiro; Ikeuchi, Tomohiko; Saito, Masato; Yamaguchi, Yoshinori; Tamiya, Eiichi			Quantitative Detection for Porphyromonas gingivalis in Tooth Pocket and Saliva by Portable Electrochemical DNA Sensor Linked with PCR	ELECTROANALYSIS			English	Article						Electrochemistry; Polymerase chain reaction; Periodontal microorganism; Saliva; Screen-printed electrode	MEDIATED ISOTHERMAL AMPLIFICATION; POLYMERASE CHAIN-REACTION; HUMAN PERIODONTAL-DISEASE; SUBGINGIVAL PLAQUE; ESCHERICHIA-COLI; HOECHST-33258; PATHOGENS; ETIOLOGY; RNA	Here, a quantitative electrochemical analysis of periodontal bacteria in gingival crevicular fluid (GCF) and saliva by direct polymerase chain reaction (PCR) is presented. The electrochemical measurement was performed by mixing with PCR products and electrochemical indicator (bisbenzimidazole trihydrochloride). The peak current of indicator is reduced due to slower diffusion when the dye intercalates into the amplified DNA, and the degree of reduction in the peak current is correlates with the quantity of amplified DNA. Therefore, a quantitative analysis is possible by using our electrochemical method at the end point of PCR. In the GCF testing, The number of Porphyromonas gingivalis (Pg) detected by our electrochemical method at the end point of PCR were almost same compared with that were calculated by the conventional method of quantitative real-time PCR. In the saliva testing, the relationship between number of Pg in saliva and average pocket depth, and age-dependence were also clearly observed. Since the saliva sample is obtained in a non-invasive manner, this method is useful for the primary screening of periodontal disease. Moreover, our detection method is simple and uses a hand-held potentiostat making it suitable for development of an on-site periodontal diagnosis system.	[Yamanaka, Keiichiro; Tamiya, Eiichi] Osaka Univ, Grad Sch Engn, PARC, Suita, Osaka 5650871, Japan; [Sekine, Shinichi] Osaka Univ, Grad Sch Dent, Dept Prevent Dent, Suita, Osaka 5650871, Japan; [Yamanaka, Keiichiro; Uenoyama, Takahiro; Ikeuchi, Tomohiko; Saito, Masato; Yamaguchi, Yoshinori; Tamiya, Eiichi] Osaka Univ, Grad Sch Engn, Dept Appl Phys, Suita, Osaka 5650871, Japan; [Wada, Masahiro] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka 5650871, Japan	Tamiya, E (reprint author), Osaka Univ, Grad Sch Engn, PARC, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	tamiya@ap.eng.osaka-u.ac.jp					Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Ashimoto A, 1996, ORAL MICROBIOL IMMUN, V11, P266, DOI 10.1111/j.1399-302X.1996.tb00180.x; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Kobayashi M, 2004, ELECTROCHEM COMMUN, V6, P337, DOI 10.1016/j.elecom.2004.01.012; Yamanaka K, 2011, ANALYST, V136, P2064, DOI 10.1039/c1an15066a; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Ahmed MU, 2010, FOOD CONTROL, V21, P599, DOI 10.1016/j.foodcont.2009.09.001; Amano A, 1999, J CLIN MICROBIOL, V37, P1426; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244; HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x; Yamanaka K, 2012, ELECTROCHIM ACTA, V82, P132, DOI 10.1016/j.electacta.2012.03.032; Tran SD, 1996, J CLIN MICROBIOL, V34, P2674; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; Tonetti MS, 2007, NEW ENGL J MED, V356, P911, DOI 10.1056/NEJMoa063186; NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x; Ahmed MU, 2009, ANALYST, V134, P966, DOI 10.1039/b812569d; Ahmed MU, 2007, ANALYST, V132, P431, DOI 10.1039/b615242b; CIANCIOLA LJ, 1977, NATURE, V265, P445, DOI 10.1038/265445a0; Nagatani N, 2011, ANALYST, V136, P5143, DOI 10.1039/c1an15638a; PAGE RC, 1991, J PERIODONTAL RES, V26, P230, DOI 10.1111/j.1600-0765.1991.tb01649.x; Petersen P. E., 2000, PERIODONTOLOGY, V60, P15; Saito M, 2004, J BIOCHEM, V136, P813, DOI 10.1093/jp/mvh191; SARIS PEJ, 1990, J MICROBIOL METH, V11, P121, DOI 10.1016/0167-7012(90)90012-U; Shet UK, 2013, J PERIODONTAL IMPLAN, V43, P183, DOI 10.5051/jpis.2013.43.4.183; SOCRANSK.SS, 1970, J DENT RES, V49, P203, DOI 10.1177/00220345700490020401; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322	28	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1040-0397	1521-4109		ELECTROANAL	Electroanalysis	DEC	2014	26	12					2686	2692		10.1002/elan.201400447		7	Chemistry, Analytical; Electrochemistry	Chemistry; Electrochemistry	AW0JL	WOS:000345978300017		
J	Liu, XZ; Li, D; Li, HQ; Iyo, A; Hanada, N; Ishida, M; Zhou, HS				Liu, Xizheng; Li, De; Li, Huiqiao; Iyo, Akira; Hanada, Nobuko; Ishida, Masayoshi; Zhou, Haoshen			Study on the capacity fading of pristine and FePO4 coated LiNi1/3Co1/3Mn1/3O2 by Electrochemical and Magnetical techniques	ELECTROCHIMICA ACTA			English	Article						capacity fading; surface coating; Li/Ni disorder; electrochemical; magnetic	LITHIUM-ION BATTERIES; CATHODE MATERIALS; PERFORMANCE; PERSPECTIVE; LAYER	Capacity fading mechanism of pristine and FePO4-coated LiNi1/3Co1/3Mn1/3O2 has been studied by electrochemical and magnetic methods. Along with cycles, significant increase of cell polarization and charger transfer resistance (R-ct), which mainly cause the capacity fading at the initial charge/discharge cycles, have been observed according to the cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) analysis. In comparison, the existence of FePO4 coating layer can effectively suppress the deterioration of surface polarization and increase of Rct at the interface of electrode/electrolyte. The coated sample suppress the decrease of Li+ diffusion coefficient with prolonged cycles according to the galvanostatic intermittent titration technique (GITT) tests. It also shows larger Weiss constants (fitting above 130 K) and lower blocking temperatures, which indicate the surface coating can suppress the deterioration of Li/Ni disorder upon repeated cycles. This study may give the researchers some light on understanding the capacity fading mechanism of LiNi1/3Co1/3Mn1/3O2 and the effects of surface coating layer, and thus, give help to the future designing of superior coating layers for layered cathode materials in Li-ion batteries. (C) 2014 Elsevier Ltd. All rights reserved.	[Liu, Xizheng; Li, De; Li, Huiqiao; Zhou, Haoshen] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Liu, Xizheng; Hanada, Nobuko; Ishida, Masayoshi; Zhou, Haoshen] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan; [Iyo, Akira] Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki 3058568, Japan	Zhou, HS (reprint author), Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Umezono 1-1-1, Tsukuba, Ibaraki 3058568, Japan.	hs.zhou@aist.go.jp			MEXT Japan	X. Z. Liu would like to thank Scholarship from MEXT Japan, and Dr. Liang Liu in The University of Tokyo for valuable discussion and suggestions about the magnetic properties.	Yu HJ, 2014, ENERG ENVIRON SCI, V7, P1068, DOI 10.1039/c3ee42398k; WEPPNER W, 1977, J ELECTROCHEM SOC, V124, P1569, DOI 10.1149/1.2133112; Xiao J, 2008, CHEM MATER, V20, P7454, DOI 10.1021/cm802316d; Sinha NN, 2009, ACS APPL MATER INTER, V1, P1241, DOI 10.1021/am900120s; Lee KT, 2013, ACCOUNTS CHEM RES, V46, P1161, DOI 10.1021/ar200224h; Zhang XY, 2010, J POWER SOURCES, V195, P1292, DOI 10.1016/j.jpowsour.2009.09.029; Liu XZ, 2013, J POWER SOURCES, V243, P374, DOI 10.1016/j.jpowsour.2013.06.037; Hong JS, 2000, J ELECTROCHEM SOC, V147, P3190, DOI 10.1149/1.1393882; Goodenough JB, 2007, J POWER SOURCES, V174, P996, DOI 10.1016/j.jpowsour.2007.06.217; Liu XZ, 2013, J ALLOY COMPD, V552, P76, DOI 10.1016/j.jallcom.2012.10.090; Shaju KM, 2004, J ELECTROCHEM SOC, V151, pA1324, DOI 10.1149/1.1775218; Shaju KM, 2003, J MATER CHEM, V13, P106, DOI 10.1039/b207407a; Hashem AMA, 2011, J POWER SOURCES, V196, P8632, DOI 10.1016/j.jpowsour.2011.06.039; Wang M, 2009, SCI CHINA SER E, V52, P2737, DOI 10.1007/s11431-008-0306-3; Dunn B, 2011, SCIENCE, V334, P928, DOI 10.1126/science.1212741; Zhang XY, 2010, ELECTROCHIM ACTA, V55, P6440, DOI 10.1016/j.electacta.2010.06.040; Liu XZ, 2012, ELECTROCHIM ACTA, V83, P253, DOI 10.1016/j.electacta.2012.07.111; Sun YK, 2007, J ELECTROCHEM SOC, V154, pA168, DOI 10.1149/1.2422890; Goodenough JB, 2013, J AM CHEM SOC, V135, P1167, DOI 10.1021/ja3091438; Bie XF, 2013, ELECTROCHIM ACTA, V97, P357, DOI 10.1016/j.electacta.2013.02.131; Chernova Natasha A, 2007, Chemistry of Materials, V19, DOI 10.1021/cm0708867; Ghany A.A., 2007, ELECTROCHIM ACTA, V52, P4092; Goodenough J. B., 1963, MAGNETISM CHEM BOND; Hu S.K., 2013, J POWER SOURCES, V188, P564; Lee K.S., 2009, J POWER SOURCES, V196, P6974; Oh Y.P. Cho, 2013, NANO LETT, V13, P1145; Ohzuku T, 2001, CHEM LETT, P642; Riley L.A., 2013, J POWER SOURCES, V196, P3317; Shivashankaraiah H., 2012, J SOLID STATE ELECTR, V16, P1279; Sun S.H., 2009, J POWER SOURCES, V195, P6108	30	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	DEC 1	2014	148						26	32		10.1016/j.electacta.2014.10.018		7	Electrochemistry	Electrochemistry	AW3JC	WOS:000346181600004		
J	Kitta, M; Kuratani, K; Tabuchi, M; Takeichi, N; Akita, T; Kiyobayashi, T; Kohyama, M				Kitta, Mitsunori; Kuratani, Kentaro; Tabuchi, Mitsuharu; Takeichi, Nobuhiko; Akita, Tomoki; Kiyobayashi, Tetsu; Kohyama, Masanori			Irreversible structural change of a spinel Li4Ti5O12 particle via Na insertion-extraction cycles of a sodium-ion battery	ELECTROCHIMICA ACTA			English	Article						Sodium-ion battery; Anode material; Spinel lithium titanate; Reaction mechanism; Analytical Transmission Electron; Microscopy	ANODE; ELECTRODES; MECHANISM; OXIDE	We investigate the structural changes of spinel lithium titanate (LTO; Li4Ti5O12) via the electrochemical Na insertion-extraction cycles, using X-ray diffraction (XRD) and analytical transmission electron microscopy (A-TEM). The XRD reveals that an extra phase with an about 4-5% larger unit cell volume is generated in pristine LTO during the first cycle. The A-TEM reveals that the extra phase co-exists with Li4Ti5O12 in a single particle and is identified as a Na-substituted LTO phase (Na-LTO; Li4-xNaxTi5O12, 0 < x < 3). The reversible electrochemical capacity of the electrode (155 mA h g (1)) is more than 90% of the theoretical one, suggesting that both LTO and Na-LTO are involved in the charge-discharge reactions. (C) 2014 Elsevier Ltd. All rights reserved.	[Kitta, Mitsunori; Kuratani, Kentaro; Tabuchi, Mitsuharu; Takeichi, Nobuhiko; Akita, Tomoki; Kiyobayashi, Tetsu; Kohyama, Masanori] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan	Kitta, M (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	m-kitta@aist.go.jp	KURATANI, kentaro/O-6349-2015		JSPS KAKENHI Grant [22360279, 26790053]	The author thanks Dr. Masaru Yao and Dr. Riki Kataoka for EIS experiment and valuable discussion. This work was supported by JSPS KAKENHI Grant Number 22360279 and 26790053.	Zhao L, 2012, CHINESE PHYS B, V21, DOI 10.1088/1674-1056/21/2/028201; Xiong H, 2011, J PHYS CHEM LETT, V2, P2560, DOI 10.1021/jz2012066; Alcantara R, 2002, J ELECTROCHEM SOC, V149, pA201, DOI 10.1149/1.1431963; Komaba S, 2012, ELECTROCHEM COMMUN, V21, P65, DOI 10.1016/j.elecom.2012.05.017; Yabuuchi N, 2012, NAT MATER, V11, P512, DOI [10.1038/nmat3309, 10.1038/NMAT3309]; Stevens DA, 2000, J ELECTROCHEM SOC, V147, P1271, DOI 10.1149/1.1393348; Wang W, 2013, RSC ADV, V3, P1041, DOI 10.1039/c2ra22050d; Senguttuvan P, 2011, CHEM MATER, V23, P4109, DOI 10.1021/cm202076g; DOEFF MM, 1994, J ELECTROCHEM SOC, V141, pL145, DOI 10.1149/1.2059323; Sauvage F, 2007, INORG CHEM, V46, P3289, DOI 10.1021/ic0700250; TAKEDA Y, 1994, MATER RES BULL, V29, P659, DOI 10.1016/0025-5408(94)90122-8; Komaba S, 2011, ADV FUNCT MATER, V21, P3859, DOI 10.1002/adfm.201100854; Kitta M, 2013, J POWER SOURCES, V237, P26, DOI 10.1016/j.jpowsour.2013.03.022; COLBOW KM, 1989, J POWER SOURCES, V26, P397, DOI 10.1016/0378-7753(89)80152-1; OHZUKU T, 1995, J ELECTROCHEM SOC, V142, P1431, DOI 10.1149/1.2048592; Okada S., 2009, LITHIUM ION RECHARGE, P53, DOI 10.1002/9783527629022.ch4; Sun Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2878; Takami N, 2009, J ELECTROCHEM SOC, V156, pA128, DOI 10.1149/1.3043441; Tanaka S, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/49/494004	19	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	DEC 1	2014	148						175	179		10.1016/j.electacta.2014.10.050		5	Electrochemistry	Electrochemistry	AW3JC	WOS:000346181600022		
J	Komiya, N; Okada, M; Hoshino, M; Le, NHT; Naota, T				Komiya, Naruyoshi; Okada, Minoru; Hoshino, Makoto; Ngoc Ha-Thu Le; Naota, Takeshi			Controlled Linker Dependence of Solution- and Solid-State Emission of Vaulted trans-Bis(salicylaldiminato)-platinum(II) Complexes with Amino Functionalities	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						Platinum; Salicylaldiminato complexes; Solid-state structures; Solid-state emission; Acid-induced emission enhancement; Luminescence	CATALYTIC ASYMMETRIC-SYNTHESIS; EFFECTIVE CORE POTENTIALS; PENTAMETHYLENE SPACERS; MOLECULAR CALCULATIONS; COPPER(II) COMPLEXES; EXCITATION-ENERGIES; QUANTUM EFFICIENCY; METAL-COMPLEXES; LIGANDS; PORPHYRINS	The synthesis, structures, and emission properties of vaulted trans-bis(salicylaldiminato)platinum(II) complexes 1 with diethylamino functionalities are described and compared with the non-substituted analogues. The amino substitution provides an improvement of the linker dependence both for the color change of the trans-bis(salicylaldiminato)platinum(II) platform in the glass state and for the acid-induced emission enhancement in the solution state. The linker dependence of the crystalline-state emission intensity changes with the amino functionality, which leads to intense emission of the vaulted crystals with low structural dependence. Single-crystal X-ray diffraction studies and DFT calculations revealed that the unique photophysical properties arising from the amino functionality are attributable to enhanced planarity and self-constraint of the coordination platform, which is due to their strong contribution to d-pi conjugation and intermolecular hydrogen bonding.	[Komiya, Naruyoshi; Okada, Minoru; Hoshino, Makoto; Ngoc Ha-Thu Le; Naota, Takeshi] Osaka Univ, Grad Sch Engn, Dept Chem, Toyonaka, Osaka 5608531, Japan	Naota, T (reprint author), Osaka Univ, Grad Sch Engn, Dept Chem, Machikaneyama, Toyonaka, Osaka 5608531, Japan.	naota@chem.es.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by a Grant-in-Aid for Scientific Research, from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Komiya N, 2011, J AM CHEM SOC, V133, P6493, DOI 10.1021/ja110398p; Komiya N, 2013, CHEM-EUR J, V19, P4798, DOI 10.1002/chem.201203669; Skopek K, 2007, COORDIN CHEM REV, V251, P1723, DOI 10.1016/j.ccr.2006.12.015; HAY PJ, 1985, J CHEM PHYS, V82, P299, DOI 10.1063/1.448975; Komiya N, 2011, J AM CHEM SOC, V133, P16054, DOI 10.1021/ja2039369; Stratmann RE, 1998, J CHEM PHYS, V109, P8218, DOI 10.1063/1.477483; Komiya N, 2013, CHEM-EUR J, V19, P9497, DOI 10.1002/chem.201301087; Komiya N, 2013, TRANSIT METAL CHEM, V38, P659, DOI 10.1007/s11243-013-9734-4; Naito M, 2014, CHEM-EUR J, V20, P6991, DOI 10.1002/chem.201305054; Jung MS, 2012, POLYHEDRON, V40, P168, DOI 10.1016/j.poly.2012.04.006; COLLMAN JP, 1990, J AM CHEM SOC, V112, P5356, DOI 10.1021/ja00169a056; FRANCL MM, 1982, J CHEM PHYS, V77, P3654, DOI 10.1063/1.444267; Ikai M, 2006, ADV FUNCT MATER, V16, P515, DOI 10.1002/adfm.200500492; NARUTA Y, 1991, J AM CHEM SOC, V113, P6865, DOI 10.1021/ja00018a024; Casida ME, 1998, J CHEM PHYS, V108, P4439, DOI 10.1063/1.475855; Wong KMC, 2005, INORG CHEM, V44, P1492, DOI 10.1021/ic049079p; TAKEUCHI KJ, 1983, J AM CHEM SOC, V105, P4261, DOI 10.1021/ja00351a025; LEXA D, 1986, J AM CHEM SOC, V108, P6937, DOI 10.1021/ja00282a018; Zhang XQ, 2009, ORGANOMETALLICS, V28, P3093, DOI 10.1021/om8011695; Komiya N, 2013, INORG CHEM COMMUN, V27, P122, DOI 10.1016/j.inoche.2012.10.036; Naota T, 2005, J AM CHEM SOC, V127, P9324, DOI 10.1021/ja050809h; Komiya N, 2013, ACTA CRYSTALLOGR C, V69, P503, DOI 10.1107/S0108270113004484; Kawamura Y, 2004, JPN J APPL PHYS 1, V43, P7729, DOI 10.1143/JJAP.43.7729; Khandar AA, 2010, INORG CHIM ACTA, V363, P4080, DOI 10.1016/j.ica.2010.08.019; Goto H, 2012, INORG CHEM, V51, P4134, DOI 10.1021/ic2024742; BAILEY NA, 1984, J CHEM SOC DALTON, P2741, DOI 10.1039/dt9840002741; Becke A.D., 1995, MODERN ELECT STRUC 2; Boschi T., 1994, METALLOPORPHYRINS CA, P239; Burnett M.N., 1996, ORNL6895; FANIZZI FP, 1990, J CHEM SOC DALTON, P199, DOI 10.1039/dt9900000199; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Groves J. T., 1989, J AM CHEM SOC, V111, P8537; Han X, 2007, CHEM-EUR J, V13, P1231, DOI 10.1002/chem.200600769; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; HENDRICKSON AR, 1979, J CHEM SOC DALTON, P1497, DOI 10.1039/dt9790001497; Ito Y, 1999, PHOSPHORUS SULFUR, V144, P469, DOI 10.1080/10426509908546283; Ji ZQ, 2009, J ORGANOMET CHEM, V694, P4140, DOI 10.1016/j.jorganchem.2009.09.015; Rose E., 2005, CHEM SOC REV, V34, P573; SAWAMURA M, 1992, J AM CHEM SOC, V114, P8295, DOI 10.1021/ja00047a053; Spek S. L., 2003, APPL CRYSTALLOGR, V36, P7; HAY PJ, 1985, J CHEM PHYS, V82, P270, DOI 10.1063/1.448799	41	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	DEC	2014		35					6085	6096		10.1002/ejic.201402712		12	Chemistry, Inorganic & Nuclear	Chemistry	AW1RA	WOS:000346065900011		
J	Nagaya, Y; Aoyama, M; Tamura, T; Kakita, H; Kato, S; Hida, H; Saitoh, S; Asai, K				Nagaya, Yoshiaki; Aoyama, Mineyoshi; Tamura, Tetsuya; Kakita, Hiroki; Kato, Shin; Hida, Hideki; Saitoh, Shinji; Asai, Kiyofumi			Inflammatory cytokine tumor necrosis factor a suppresses neuroprotective endogenous erythropoietin from astrocytes mediated by hypoxia-inducible factor-2 alpha	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						erythropoietin (EPO); hypoxia-inducible factor (HIF)-2; neuroprotection; nuclear factor-kappa B (NF-B); tumor necrosis factor (TNF)	CEREBRAL-ISCHEMIA; AUTOIMMUNE ENCEPHALOMYELITIS; TRANSCRIPTION FACTOR; CORTICAL ASTROCYTES; NEURONAL APOPTOSIS; O-2 HOMEOSTASIS; IN-VITRO; KAPPA-B; EXPRESSION; BRAIN	Interest in erythropoietin (EPO) as a neuroprotective mediator has grown since it was found that systemically administered EPO is protective in several animal models of disease. However, given that the blood-brain barrier limits EPO entry into the brain, alternative approaches that induce endogenous EPO production in the brain may be more effective clinically and associated with fewer untoward side-effects. Astrocytes are the main source of EPO in the central nervous system. In the present study we investigated the effect of the inflammatory cytokine tumor necrosis factor (TNF) on hypoxia-induced upregulation of EPO in rat brain. Hypoxia significantly increased EPO mRNA expression in the brain and kidney, and this increase was suppressed by TNF in vivo. In cultured astrocytes exposed to hypoxic conditions for 6 and 12h, TNF suppressed the hypoxia-induced increase in EPO mRNA expression in a concentration-dependent manner. TNF inhibition of hypoxia-induced EPO expression was mediated primarily by hypoxia-inducible factor (HIF)-2 rather than HIF-1. The effects of TNF in reducing hypoxia-induced upregulation of EPO mRNA expression probably involve destabilization of HIF-2, which is regulated by the nuclear factor (NF)-B signaling pathway. TNF treatment attenuated the protective effects of astrocytes on neurons under hypoxic conditions via EPO signaling. The effective blockade of TNF signaling may contribute to the maintenance of the neuroprotective effects of EPO even under hypoxic conditions with an inflammatory response.	[Nagaya, Yoshiaki; Aoyama, Mineyoshi; Tamura, Tetsuya; Kakita, Hiroki; Kato, Shin; Asai, Kiyofumi] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Neurobiol, Mizuho Ku, Nagoya, Aichi 4678601, Japan; [Nagaya, Yoshiaki; Kakita, Hiroki; Kato, Shin; Saitoh, Shinji] Nagoya City Univ, Grad Sch Med Sci, Dept Pediat & Neonatol, Nagoya, Aichi 4678601, Japan; [Tamura, Tetsuya] Nagoya City Univ, Grad Sch Med Sci, Dept Anesthesiol & Med Crisis Management, Nagoya, Aichi 4678601, Japan; [Hida, Hideki] Nagoya City Univ, Grad Sch Med Sci, Dept Neurophysiol & Brain Sci, Nagoya, Aichi 4678601, Japan	Aoyama, M (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Mol Neurobiol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	ao.mine@med.nagoya-cu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported, in part, by Grants-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ryou MG, 2012, STROKE, V43, P1101, DOI 10.1161/STROKEAHA.111.620088; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Liu J, 2005, STROKE, V36, P1264, DOI 10.1161/01.STR.0000166180.91042.02; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Jiang BH, 1996, J BIOL CHEM, V271, P17771; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; MAXWELL PH, 1993, P NATL ACAD SCI USA, V90, P2423, DOI 10.1073/pnas.90.6.2423; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Fandrey J, 2004, AM J PHYSIOL-REG I, V286, pR977, DOI 10.1152/ajpregu.00577.2003; Chavez JC, 2000, J APPL PHYSIOL, V89, P1937; Kato S, 2011, J NEUROSCI RES, V89, P1566, DOI 10.1002/jnr.22702; Savino C, 2006, J NEUROIMMUNOL, V172, P27, DOI 10.1016/j.jneuroim.2005.10.016; Ruscher K, 2002, J NEUROSCI, V22, P10291; MASUDA S, 1994, J BIOL CHEM, V269, P19488; Prass K, 2003, STROKE, V34, P1981, DOI 10.1161/01.STR.0000080381.76409.B2; Stroka DM, 2001, FASEB J, V15, P2445; Bunn HF, 1998, J EXP BIOL, V201, P1197; Diaz Z, 2005, J NEUROCHEM, V93, P392, DOI 10.1111/j.1471-4159.2005.03028.x; Hoke A, 2005, ANN NY ACAD SCI, V1053, P491, DOI 10.1196/annals.1344.043; Huang XS, 2010, BLOOD CELL MOL DIS, V44, P1, DOI 10.1016/j.bcmd.2009.09.007; Ikuta K, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3811; Kim TS, 2008, J NEUROSCI RES, V86, P2353, DOI 10.1002/jnr.21687; Mengozzi M, 2008, MOL MED, V14, P682, DOI 10.2119/2008-00086.Mengozzi; Miyachi T, 2001, NEUROSCI RES, V40, P53, DOI 10.1016/S0168-0102(01)00208-5; Mizuno K, 2008, NEONATOLOGY, V94, P255, DOI 10.1159/000151644; Prass K, 2002, J CEREBR BLOOD F MET, V22, P520; Semenza G L, 2000, Respir Res, V1, P159, DOI 10.1186/rr27; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123	36	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	DEC	2014	40	11					3620	3626		10.1111/ejn.12747		7	Neurosciences	Neurosciences & Neurology	AW1MO	WOS:000346053700004		
J	Toya, S; Takatsuru, Y; Kokubo, M; Amano, I; Shimokawa, N; Koibuchi, N				Toya, Syutaro; Takatsuru, Yusuke; Kokubo, Michifumi; Amano, Izuki; Shimokawa, Noriaki; Koibuchi, Noriyuki			Early-life-stress affects the homeostasis of glutamatergic synapses	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						AMPA receptor; early-life stress; in vivo microdialysis; NMDA receptor	PREFRONTAL CORTEX; MATERNAL SEPARATION; MOOD DISORDERS; HIPPOCAMPAL; PLASTICITY; INCREASES; DEPRESSION; RESPONSES; NEURONS; IMPACT	Early-life stress induces several neuropsychological disorders in adulthood, including depression. Such disorders may be induced by functional alteration of the glutamatergic system. However, their underlying mechanisms have not yet been fully clarified. Furthermore, the involvement of glucocorticoids, which are representative stress hormones, has not yet been fully clarified. In this study, we used maternal deprivation (MD) mice as an early-life-stress model, and studied the changes in the glutamatergic system in adulthood. The glutamate concentration and neuronal activity in the somatosensory cortex (SSC) increased under basal conditions in MD mice. Stressful physical stimulation (SPS) increased the concentration of corticosterone, but not of glutamate, in the control mouse SSC. On the other hand, in the MD mice, although the basal concentration of corticosterone in the SSC increased, no SPS-induced increase was observed. In contrast, the concentration of glutamate increased greatly during SPS. It was significantly high for 30min after stimulation. The expression level of -amino-3-hydroxy-5-methylisoxazole-4-propionic acid/N-methyl-d-aspartate receptors in the MD mice was also changed compared with that in the control mice after stimulation. These findings indicate that early-life stress disrupts the homeostasis of glutamatergic synapses.	[Toya, Syutaro; Takatsuru, Yusuke; Kokubo, Michifumi; Amano, Izuki; Shimokawa, Noriaki; Koibuchi, Noriyuki] Gunma Univ Grad Sch Med, Dept Integrat Physiol, Maebashi, Gunma 3718511, Japan	Takatsuru, Y (reprint author), Gunma Univ Grad Sch Med, Dept Integrat Physiol, Maebashi, Gunma 3718511, Japan.	takatsur@gunma-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23111504]; Japan Society for the Scientific of Sciences (JSPS) [21390065]	This work was supported by a Grants-in-Aid for Scientific Research on Innovative Areas (23111504) from Ministry of Education, Culture, Sports, Science and Technology (MEXT) to Y.T. and a Grant-in-Aid for Scientific Research (B) (21390065) from the Japan Society for the Scientific of Sciences (JSPS) to N.K.	LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; Reznikov LR, 2007, EUR J NEUROSCI, V25, P3109, DOI 10.1111/j.1460-9568.2007.05560.x; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Wigger A, 1999, PHYSIOL BEHAV, V66, P293, DOI 10.1016/S0031-9384(98)00300-X; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Francis DD, 2002, J NEUROSCI, V22, P7840; Vyas A, 2002, J NEUROSCI, V22, P6810; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Martisova E, 2012, NEUROPHARMACOLOGY, V62, P1944, DOI 10.1016/j.neuropharm.2011.12.019; Sanacora G, 2012, NEUROPHARMACOLOGY, V62, P63, DOI 10.1016/j.neuropharm.2011.07.036; Bock J, 2005, CEREB CORTEX, V15, P802, DOI 10.1093/cercor/bhh181; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; Romeo RD, 2006, ANN NY ACAD SCI, V1094, P202, DOI 10.1196/annals.1376.022; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; Crawford M. A., 1993, Nutrition and Health (Bicester), V9, P81; Gershon A, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0352-9; MOGHADDAM B, 1993, J NEUROCHEM, V60, P1650, DOI 10.1111/j.1471-4159.1993.tb13387.x; Musazzi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008566; Ovtscharoff W, 2001, NEUROSCIENCE, V104, P33, DOI 10.1016/S0306-4522(01)00059-8; Parfitt DB, 2004, BRAIN RES, V1016, P111, DOI 10.1016/j.brainres.2004.04.077; Popoli M, 2011, NAT REV NEUROSCI, V13, P22, DOI [10.1038/nrn3138, DOI 10.1038/NRN3138]; Shair HN, 2007, BEHAV BRAIN RES, V182, P180, DOI 10.1016/j.bbr.2007.02.016; Takatsuru Y, 2013, J NEUROSCI, V33, P4683, DOI 10.1523/JNEUROSCI.2657-12.2013; Takatsuru Y, 2009, BRAIN RES, V1294, P45, DOI 10.1016/j.brainres.2009.07.092	31	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	DEC	2014	40	11					3627	3634		10.1111/ejn.12728		8	Neurosciences	Neurosciences & Neurology	AW1MO	WOS:000346053700005		
J	Tadano, S; Kondo, T; Watanabe, M; Takayashiki, N; Shiozawa, T; Ohara, G; Kagohashi, K; Kurishima, K; Satoh, H				Tadano, Sosuke; Kondo, Tadashi; Watanabe, Muneaki; Takayashiki, Norio; Shiozawa, Toshihiro; Ohara, Gen; Kagohashi, Kastunori; Kurishima, Koichi; Satoh, Hiroaki			Incidental esophageal submucosal tumor detection by chest radiography: A case report	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						esophageal submucosal tumor; esophageal leiomyoma; mass-screening; chest radiograph	STROMAL TUMORS; LUNG-CANCER; PREFECTURE; LEIOMYOMA; DIAGNOSIS; JAPAN	Esophageal submucosal tumors are occasionally detected incidentally during a gastrointestinal survey. In the present study, a case of esophageal leiomyoma is reported, which was incidentally detected by chest radiography during an annual survey of mass-screening for lung cancer. The patient underwent a laparoscopic lower esophagectomy, a proximal gastrectomy and a gastric tube reconstruction. Macroscopic examination revealed a 50x40x28-mm mass, while microscopic examination identified submucosal smooth muscle tissue without mitotic activity or necrosis. The tumor was diagnosed as an esophageal leiomyoma. The patient was asymptomatic during the three-month follow-up period. However, when a mass lesion adjacent to the gastrointestinal tract is detected during chest radiography, the possibility of a rare disease should be considered. Therefore, further investigation with upper gastrointestinal radiography and gastroendoscopy should be performed.	[Tadano, Sosuke; Kondo, Tadashi; Watanabe, Muneaki] Univ Tsukuba, Mito Med Ctr, Div Surg, Mito, Ibaraki 3100015, Japan; [Takayashiki, Norio] Univ Tsukuba, Mito Med Ctr, Div Pathol, Mito, Ibaraki 3100015, Japan; [Shiozawa, Toshihiro; Ohara, Gen; Kagohashi, Kastunori; Kurishima, Koichi; Satoh, Hiroaki] Univ Tsukuba, Mito Med Ctr, Div Resp Med, Mito, Ibaraki 3100015, Japan	Satoh, H (reprint author), Univ Tsukuba, Mito Med Ctr, Div Resp Med, Miya Machi 3-2-7, Mito, Ibaraki 3100015, Japan.	hirosato@md.tsukuba.ac.jp					Miettinen M, 2001, VIRCHOWS ARCH, V438, P1, DOI 10.1007/s004280000338; Shim CS, 2003, J KOREAN MED SCI, V18, P120; Miettinen M, 2000, AM J SURG PATHOL, V24, P211, DOI 10.1097/00000478-200002000-00007; Aurea P, 2002, EUR J CARDIO-THORAC, V22, P1008, DOI 10.1016/S1010-7940(02)00569-9; De Rezende L, 2007, DIS ESOPHAGUS, V20, P436, DOI 10.1111/j.1442-2050.2007.00692.x; Dohba S, 2000, Kyobu Geka, V53, P1129; Hatch GF, 2000, WORLD J SURG, V24, P401; Jang KM, 2002, KOREAN J RADIOL, V3, P199; Kanashiki M, 2012, ONCOL LETT, V4, P513, DOI 10.3892/ol;2012.780; Kobayashi N, 2000, SURG TODAY, V30, P526; Masuda M, 2001, REV POPULATION SOCIA, V10, P37; Mizutani E, 2011, SURG TODAY, V41, P846, DOI 10.1007/s00595-010-4356-3; MONTESI A, 1983, GASTROINTEST RADIOL, V8, P207, DOI 10.1007/BF01948121; Nishii K, 2001, LUNG CANCER-J IASLC, V34, P325, DOI 10.1016/S0169-5002(01)00270-7; Peters JH, 2005, SCHWARTZS PRINCIPLES, P906; Priego P, 2006, REV ESP ENFERM DIG, V98, P350, DOI 10.4321/s1130-01082006000500005; Punpale Ajay, 2007, Ann Thorac Cardiovasc Surg, V13, P78; Tsukada H, 2001, BRIT J CANCER, V85, P1326, DOI 10.1054/bjoc.2001.2060; Yamashita R, 1989, Nihon Kyobu Geka Gakkai Zasshi, V37, P2001	19	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	DEC	2014	8	6					1831	1834		10.3892/etm.2014.2008		4	Medicine, Research & Experimental	Research & Experimental Medicine	AU9YN	WOS:000345948000028		
J	Kagohashi, K; Ohara, G; Shiozawa, T; Tamura, T; Miyazaki, K; Kurishima, K; Satoh, H; Hizawa, N				Kagohashi, Katsunori; Ohara, Gen; Shiozawa, Toshihiro; Tamura, Tomohiro; Miyazaki, Kunihiko; Kurishima, Koichi; Satoh, Hiroaki; Hizawa, Nobuyuki			Blood-patch pleurodesis for pneumothorax in lung fibrosis due to progressive systemic sclerosis: A case report	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						blood-patch pleurodesis; pneumothorax; lung fibrosis; progressive systemic sclerosis	PERSISTENT AIR LEAK	Pneumothorax in patients with progressive systemic sclerosis (PSS) often presents as a difficult-to-treat disease. Autologous blood-patch pleurodesis has previously been used for the treatment of pneumothorax. Blood outside its own environment is an irritant; therefore, chest physicians must watch closely for an allergic reaction. The injection is simple, painless, causes no side effects, is an inexpensive treatment for pneumothorax and is available not only in patients with persistent air leak but also in those with residual air space. A case is reported here of blood-patch pleurodesis for pneumothorax in lung fibrosis due to PSS. As an alternative therapy for difficult-to-treat pneumothorax in patients with PSS with persistent air leak and residual air space, autologous blood-patch pleurodesis would be one of the treatment options.	[Kagohashi, Katsunori; Ohara, Gen; Kurishima, Koichi; Satoh, Hiroaki] Univ Tsukuba, Mito Med Ctr, Div Resp Med, Mito, Ibaraki 3100015, Japan; [Shiozawa, Toshihiro; Tamura, Tomohiro; Miyazaki, Kunihiko; Hizawa, Nobuyuki] Univ Tsukuba, Fac Med, Div Resp Med, Mito, Ibaraki 3100015, Japan	Satoh, H (reprint author), Univ Tsukuba, Mito Med Ctr, Div Resp Med, Miya Machi 3-2-7, Mito, Ibaraki 3100015, Japan.	hirosato@md.tsukuba.ac.jp					Light RW, 1997, LUNG, V175, P213, DOI 10.1007/PL00007568; Cagirici U, 1998, SCAND CARDIOVASC J, V32, P75; DUMIRE R, 1992, CHEST, V101, P64, DOI 10.1378/chest.101.1.64; Le Pavec J, 2011, CLIN REV ALLERG IMMU, V40, P104, DOI 10.1007/s12016-009-8194-2; Mallen J K, 1993, Chest, V103, P326, DOI 10.1378/chest.103.1.326-a; Manley K, 2012, CURR OPIN PULM MED, V18, P333, DOI 10.1097/MCP.0b013e32835358ca; Ramos-Izquierdo R, 2010, SURG ENDOSC, V24, P984, DOI 10.1007/s00464-009-0707-9; Rodriguez-Panadero F, 2012, RESPIRATION, V83, P91, DOI 10.1159/000335419; Shaikhrezai K, 2011, EUR J CARDIO-THORAC, V40, P120, DOI 10.1016/j.ejcts.2010.10.012; Sripavatakul Kwanreuthai, 2011, J Med Case Rep, V5, P309, DOI 10.1186/1752-1947-5-309	10	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	DEC	2014	8	6					1919	1921		10.3892/etm.2014.1993		3	Medicine, Research & Experimental	Research & Experimental Medicine	AU9YN	WOS:000345948000044		
J	Ohtake, K; Saito, N; Shibuya, S; Kobayashi, W; Amano, R; Hirai, T; Sasaki, S; Nakano, C; Hoshino, T				Ohtake, Kana; Saito, Naoki; Shibuya, Satoshi; Kobayashi, Wakako; Amano, Ryosuke; Hirai, Takumi; Sasaki, Shinji; Nakano, Chiaki; Hoshino, Tsutomu			Biochemical characterization of the water-soluble squalene synthase from Methylococcus capsulatus and the functional analyses of its two DXXD(E)D motifs and the highly conserved aromatic amino acid residues	FEBS JOURNAL			English	Article						farnesyl diphosphate; Methylococcus capsulatus; NADPH; squalene; squalene synthase	CATION-PI INTERACTIONS; HUMAN OXIDOSQUALENE CYCLASE; DEHYDROSQUALENE SYNTHASE; CHOLESTEROL-BIOSYNTHESIS; KINETIC CHARACTERIZATION; PRESQUALENE DIPHOSPHATE; STAPHYLOCOCCUS-AUREUS; TRYPANOSOMA-CRUZI; CRYSTAL-STRUCTURE; ZARAGOZIC ACID	Information regarding squalene synthases (SQSs) from prokaryotes is scarce. We aimed to characterize the SQS from Methylococcus capsulatus. We studied its reaction mechanism by kinetic analysis and evaluated the structure of the substrate/inhibitor-binding sites via homology modeling. The cloned M.capsulatus SQS was expressed in Escherichiacoli and purified by nickel-nitrilotriacetic acid column chromatography. Interestingly, M.capsulatus SQS was water-soluble and did not require any detergent for its higher activity, unlike other SQSs studied previously; supplementation of any type of detergent inhibited enzyme activity. The specific activity and the kinetic values (K-m and k(cat)) for the substrate farnesyl diphosphate and NADPH are reported. The substrate analog farnesyl methylenediphosphonate showed potent inhibition toward the enzyme. We prepared the site-specific mutants directed at potential active-site residues (DXXED)-D-58-E-61-D-62 (S1 site) and (DXXDD)-D-213-D-216-D-217 (S2 site), which were assumed to be involved in the binding of the substrate farnesyl diphosphate through the Mg2+ ion. We first demonstrated that the S1 site and the two basic residues (R55 and K212) were responsible for the binding of farnesyl diphosphate. Furthermore, we examined the catalytic roles of the highly conserved aromatic residues and demonstrated that the Y164 residue abstracts the proton of cation 5, which is produced during the first half-reaction (Scheme1), to afford presqualene diphosphate, and that the W224 residue stabilizes the intermediary cation 5 via the cation- interaction. Furthermore, we confirm for the first time that the F32 and the Y51 residues also stabilize the carbocation intermediate(s) generated during the second half-reaction.	Niigata Univ, Dept Appl Biol Chem, Fac Agr, Niigata 9502181, Japan; Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan	Hoshino, T (reprint author), Niigata Univ, Dept Appl Biol Chem, Fac Agr, Nishi Ku, Ikarashi 2-8050, Niigata 9502181, Japan.	hoshitsu@agr.niigata-u.ac.jp			Japan Society for the Promotion of Science [25450150]	This work was supported in part by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (No. 25450150).	LOGRASSO PV, 1993, ARCH BIOCHEM BIOPHYS, V307, P193, DOI 10.1006/abbi.1993.1578; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Blagg BSJ, 2002, J AM CHEM SOC, V124, P8846, DOI 10.1021/ja020411a; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Pelz A, 2005, J BIOL CHEM, V280, P32493, DOI 10.1074/jbc.M505070200; Thoma R, 2004, NATURE, V432, P118, DOI 10.1038/nature02993; Gu PD, 1998, J BIOL CHEM, V273, P12515, DOI 10.1074/jbc.273.20.12515; Gupta N, 2012, MOL BIOL REP, V39, P8803, DOI 10.1007/s11033-012-1743-4; Ruf A, 2004, BIOCHEM BIOPH RES CO, V315, P247, DOI 10.1016/j.bbrc.2004.01.052; Morikubo N, 2006, J AM CHEM SOC, V128, P13184, DOI 10.1021/ja063358p; Thompson JF, 1998, ARCH BIOCHEM BIOPHYS, V350, P283, DOI 10.1006/abbi.1997.0502; BOUVIER P, 1976, BIOCHEM J, V159, P267; JENNINGS SM, 1991, P NATL ACAD SCI USA, V88, P6038, DOI 10.1073/pnas.88.14.6038; Liu CI, 2012, J BIOL CHEM, V287, P18750, DOI 10.1074/jbc.M112.351254; ZHANG DL, 1993, ARCH BIOCHEM BIOPHYS, V304, P133, DOI 10.1006/abbi.1993.1331; Faraldos JA, 2011, J AM CHEM SOC, V133, P13906, DOI 10.1021/ja205927u; Govaert J, 2012, J BIOL CHEM, V287, P1970, DOI 10.1074/jbc.M111.242818; Sealey-Cardona M, 2007, ANTIMICROB AGENTS CH, V51, P2123, DOI 10.1128/AAC.01454-06; Lee S, 2008, J BACTERIOL, V190, P3808, DOI 10.1128/JB.01939-07; Ito R, 2013, FEBS J, V280, P1267, DOI 10.1111/febs.12119; Urbina JA, 2002, MOL BIOCHEM PARASIT, V125, P35, DOI 10.1016/S0166-6851(02)00206-2; BIRD CW, 1971, NATURE, V230, P473, DOI 10.1038/230473a0; Mecozzi S, 1996, P NATL ACAD SCI USA, V93, P10566, DOI 10.1073/pnas.93.20.10566; Pandit J, 2000, J BIOL CHEM, V275, P30610, DOI 10.1074/jbc.M004132200; BELINGHERI L, 1991, FEBS LETT, V292, P34, DOI 10.1016/0014-5793(91)80827-P; Bhargava P, 2010, FEMS MICROBIOL LETT, V311, P82, DOI 10.1111/j.1574-6968.2010.02071.x; BILLER SA, 1988, J MED CHEM, V31, P1869, DOI 10.1021/jm00118a001; Dougherty DA, 2013, ACCOUNTS CHEM RES, V46, P885, DOI 10.1021/ar300265y; Jarstfer MB, 1996, J AM CHEM SOC, V118, P13089, DOI 10.1021/ja963308s; Lehhart A, 2002, CHEM BIOL, V9, P639; Lin FY, 2010, P NATL ACAD SCI USA, V107, P21337, DOI 10.1073/pnas.1010907107; LINDSEY S, 1995, J BIOL CHEM, V270, P9083; Michaux C, 2008, FEBS J, V275, P1687, DOI 10.1111/j.1742-4658.2008.06324.x; Nakano C, 2007, BIOSCI BIOTECH BIOCH, V71, P2543, DOI 10.1271/bbb.70331; Radsky ES, 2000, BIOCHEMISTRY-US, V39, P1748; Schechter I, 1992, J BIOL CHEM, V267, P8628; Tippelt A, 1998, BBA-LIPID LIPID MET, V1391, P223, DOI 10.1016/S0005-2760(97)00212-9; Troutman JM, 2004, BIOORG MED CHEM LETT, V14, P4979, DOI 10.1016/j.bmcl.2004.07.017	39	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	DEC	2014	281	24					5479	5497		10.1111/febs.13090		19	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AW1SD	WOS:000346069200009		
J	Esaki, K; Yoshinaga, S; Tsuji, T; Toda, E; Terashima, Y; Saitoh, T; Kohda, D; Kohno, T; Osawa, M; Ueda, T; Shimada, I; Matsushima, K; Terasawa, H				Esaki, Kaori; Yoshinaga, Sosuke; Tsuji, Tatsuichiro; Toda, Etsuko; Terashima, Yuya; Saitoh, Takashi; Kohda, Daisuke; Kohno, Toshiyuki; Osawa, Masanori; Ueda, Takumi; Shimada, Ichio; Matsushima, Kouji; Terasawa, Hiroaki			Structural basis for the binding of the membrane-proximal C-terminal region of chemokine receptor CCR2 with the cytosolic regulator FROUNT	FEBS JOURNAL			English	Article						cross-saturation; GPCR; NMR; Pro-C; transferred cross-saturation	PROTEIN-COUPLED RECEPTOR; TORSION ANGLE DYNAMICS; MELANOCORTIN-4 RECEPTOR; CRYSTAL-STRUCTURE; DODECYLPHOSPHOCHOLINE MICELLES; NMR; ACTIVATION; COMPLEX; SEQUENCE; GPCR	The membrane-proximal C-terminal region (Pro-C) is important for the regulation of G-protein-coupled receptors (GPCRs), but the binding of the Pro-C region to a cytosolic regulator has not been structurally analyzed. The chemokine receptor CCR2 is a member of the GPCR superfamily, and the Pro-C region of CCR2 binds to the cytosolic regulator FROUNT. Studying the interaction between CCR2 Pro-C and FROUNT at an atomic level provides a basis for understanding the signal transduction mechanism via GPCRs. NOE-based NMR experiments showed that, when bound to FROUNT, CCR2 Pro-C adopted a helical conformation, as well as when embedded in dodecylphosphocholine micelles. A comparison of two types of cross-saturation-based NMR experiments, applied to a three-component mixture of Pro-C, FROUNT and micelles or a two-component mixture of Pro-C and micelles, revealed that the hydrophobic binding surface on Pro-C for FROUNT mostly overlapped with the binding site for micelles, suggesting competitive binding of Pro-C between FROUNT and micelles. Leu316 was important for both FROUNT and micelle binding. Phe319 was newly identified to be crucial for FROUNT binding, by NMR and mutational analyses. The association and dissociation rates of CCR2 Pro-C for lipid bilayer biomembranes were faster than those for FROUNT. We previously reported that FROUNT binding to CCR2 is detectable even in unstimulated cells and increases in response to chemokine stimulation. Taken together, these results support a model of CCR2 equilibrium: chemokine binding changes the conformational equilibrium of CCR2 toward the active state, and Pro-C switches its binding partner from the membrane to FROUNT.	[Esaki, Kaori; Yoshinaga, Sosuke; Tsuji, Tatsuichiro; Terasawa, Hiroaki] Kumamoto Univ, Dept Struct BioImaging, Fac Life Sci, Kumamoto 8620973, Japan; [Toda, Etsuko; Terashima, Yuya; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Tokyo, Japan; [Saitoh, Takashi; Kohda, Daisuke] Kyushu Univ, Med Inst Bioregulat, Div Struct Biol, Fukuoka 812, Japan; [Kohno, Toshiyuki] Kitasato Univ, Sch Med, Dept Biochem, Aomori, Kanagawa, Japan; [Osawa, Masanori; Ueda, Takumi; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Div Phys Chem, Tokyo, Japan	Terasawa, H (reprint author), Kumamoto Univ, Dept Struct BioImaging, Fac Life Sci, Chuo Ku, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	terasawa@structbiol.com			Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); MEXT; Sasakawa Scientific Research Grant from the Japan Science Society; Global COE Program-Cell Fate Regulation Research and Education Unit from Japan Society for the Promotion of Science (JSPS); Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University	We gratefully acknowledge Dr Hiroshi Morioka for SPR measurements, Masashi Yokochi and Dr Fuyuhiko Inagaki for NMR analyses, and Miyuki Honda for DNA preparation. This work was supported in part by a Grant-in-Aid from the Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), by a Grant-in-Aid for Young Scientists (B) from MEXT, by a Sasakawa Scientific Research Grant from the Japan Science Society, by the Global COE Program-Cell Fate Regulation Research and Education Unit from Japan Society for the Promotion of Science (JSPS), and by the Cooperative Research Project Program of the Medical Institute of Bioregulation, Kyushu University.	Kohno T, 1998, J BIOMOL NMR, V12, P109, DOI 10.1023/A:1008254603368; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Hekman M, 2002, J BIOL CHEM, V277, P24090, DOI 10.1074/jbc.M200576200; Yan JL, 2003, J MAGN RESON, V163, P270, DOI 10.1016/S1090-7807(03)00106-X; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; CLORE GM, 1983, J MAGN RESON, V53, P423, DOI 10.1016/0022-2364(83)90215-9; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Panchal SC, 2003, NAT STRUCT BIOL, V10, P591, DOI 10.1038/nsb952; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Huynh J, 2009, MOL CELL ENDOCRINOL, V302, P118, DOI 10.1016/j.mce.2009.01.002; Hinney A, 1999, J CLIN ENDOCR METAB, V84, P1483, DOI 10.1210/jc.84.4.1483; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kraft K, 2001, J BIOL CHEM, V276, P34408, DOI 10.1074/jbc.M102782200; Gassner GT, 1999, BIOCHEMISTRY-US, V38, P12768, DOI 10.1021/bi990841m; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Prioleau C, 2002, J BIOL CHEM, V277, P36577, DOI 10.1074/jbc.M206223200; VOLD RL, 1968, J CHEM PHYS, V48, P3831, DOI 10.1063/1.1669699; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; CLORE GM, 1982, J MAGN RESON, V48, P402, DOI 10.1016/0022-2364(82)90073-7; Sai JQ, 2006, J BIOL CHEM, V281, P35931, DOI 10.1074/jbc.M605883200; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Hanson MA, 2012, SCIENCE, V335, P851, DOI 10.1126/science.1215904; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; VanLeeuwen D, 2003, J BIOL CHEM, V278, P15935, DOI 10.1074/jbc.M211546200; Arai H, 1997, J BIOL CHEM, V272, P25037, DOI 10.1074/jbc.272.40.25037; Beswick V, 1998, EUR BIOPHYS J BIOPHY, V28, P48, DOI 10.1007/s002490050182; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chou YT, 2005, J BIOL CHEM, V280, P32753, DOI 10.1074/jbc.M507532200; Eglen RM, 2007, ASSAY DRUG DEV TECHN, V5, P425, DOI 10.1089/adt.2007.062; Esaki K, 2011, PROTEIN EXPRES PURIF, V77, P86, DOI 10.1016/j.pep.2010.12.012; Kenakin TP, 2008, BRIT J PHARMACOL, V153, P432, DOI 10.1038/sj.bjp.0707407; Matsuo H, 1999, J AM CHEM SOC, V121, P9903, DOI 10.1021/ja991881g; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; Park TJ, 2011, BIOPHYS J, V101, P1193, DOI 10.1016/j.bpj.2011.06.067; Strosberg AD, 2007, BIOCHEM SOC T, V35, P23; Sugiki T, 2010, ANAL BIOCHEM, V399, P162, DOI 10.1016/j.ab.2009.12.031; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Terashima Y, 2005, NAT IMMUNOL, V6, P827, DOI 10.1038/ni1222; Toda E, 2009, J IMMUNOL, V183, P6387, DOI [10.4049/jimmunol.0803469, 10.4049/jimmuno1.0803469]; Toda E, 2014, BIOCHEM J, V457, P313, DOI 10.1042/BJ20130827; Walters KJ, 1999, P NATL ACAD SCI USA, V96, P7877, DOI 10.1073/pnas.96.14.7877; Xie XQ, 2005, J BIOL CHEM, V280, P3605, DOI 10.1074/jbc.M410294200	55	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	DEC	2014	281	24					5552	5566		10.1111/febs.13096		15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AW1SD	WOS:000346069200013		
J	Obase, K; Douhan, GW; Matsuda, Y; Smith, ME				Obase, Keisuke; Douhan, Greg W.; Matsuda, Yosuke; Smith, Matthew E.			Culturable fungal assemblages growing within Cenococcum sclerotia in forest soils	FEMS MICROBIOLOGY ECOLOGY			English	Article						Cenococcum geophilum; decomposition; mycoparasite; root endophyte; pathogen	ECTOMYCORRHIZAL FUNGI; OIDIODENDRON-MAIUS; CONIOTHYRIUM-MINITANS; MYCORRHIZAL FUNGI; RIBOSOMAL DNA; CELL-WALL; GEOPHILUM; IDENTIFICATION; GERMINATION; DIVERSITY	The ectomycorrhizal fungus Cenococcum geophilum (Ascomycota, Dothideomycetes) forms black, round to irregular sclerotia in forest soils. Fungi that colonize the sclerotia appear to affect sclerotia viability and may play an important role in the life history of Cenococcum. Some of the fungi could also affect nutrient cycling by decomposing Cenococcum sclerotia, which are melanized and recalcitrant to decay. We used a culture-based method to document the fungal communities growing inside surface-sterilized sclerotia that were collected from forest soils. Cenococcum was successfully isolated from 297 of 971 sclerotia whereas 427 sclerotia hosted fungi other than Cenococcum. DNA barcoding of the internal transcribed spacer rDNA followed by grouping at 97% sequence similarity yielded 85 operational taxonomic units (OTUs) that consisted primarily of Ascomycota (e.g. Chaetothyriales, Eurotiales, Helotiales, Pleosporales) and a few Basidiomycota and Mucoromycotina. Although most fungal OTUs were infrequently cultured, several OTUs such as members of Asterostroma, Cladophialophora, Oidiodendron, and Pleosporales were common and found across many sites. Our results suggest that Cenococcum sclerotia act as a substrate for diverse fungi. The occurrence of several OTUs in sclerotia across many sites suggests that these fungi may be active parasites of Cenococcum sclerotia or may preferentially use sclerotia as a nutrient source.	[Obase, Keisuke; Smith, Matthew E.] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Douhan, Greg W.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Matsuda, Yosuke] Mie Univ, Grad Sch Bioresources, Lab Forest Pathol & Mycol, Tsu, Mie 514, Japan	Obase, K (reprint author), Univ Florida, Dept Plant Pathol, 2523 Fifield Hall, Gainesville, FL 32611 USA.	oba-suke@hotmail.co.jp	Smith, Matthew/A-8115-2012	Smith, Matthew/0000-0002-0878-0932	University of Florida Institute for Food and Agricultural Sciences (IFAS)	This study was supported by Grant-in-Aid for JSPS Post-doctoral Fellow for Research Abroad (to K.O.) with additional funding from the University of Florida Institute for Food and Agricultural Sciences (IFAS) (to M.E.S.). We thank Interdisciplinary Center for Biotechnology Research (ICBR) at the University of Florida for performing DNA sequencing and collaborators at the Smith Mycology Lab at the University of Florida for their assistance in collecting samples. The authors would like to thank University of Florida's Ordway-Swisher Biological Station and Austin Cary Forest for access to forest sites.	ALEXANDER BJR, 1994, SOIL BIOL BIOCHEM, V26, P1323, DOI 10.1016/0038-0717(94)90213-5; Fernandez CW, 2013, SOIL BIOL BIOCHEM, V65, P141, DOI 10.1016/j.soilbio.2013.05.022; Jany JL, 2002, NEW PHYTOL, V154, P651, DOI 10.1046/j.1469-8137.2002.00408.x; Fernandez-Toiran LM, 2007, MYCOTAXON, V100, P109; Berbee ML, 1999, MYCOLOGIA, V91, P964, DOI 10.2307/3761627; Singh J, 1999, INDOOR BUILT ENVIRON, V8, P3, DOI 10.1159/000024606; Douhan GW, 2007, MYCOLOGIA, V99, P812, DOI 10.3852/mycologia.99.6.812; Kernaghan G, 2011, MICROB ECOL, V62, P460, DOI 10.1007/s00248-011-9851-6; MASSICOTTE HB, 1992, CAN J BOT, V70, P125; Douhan GW, 2005, NEW PHYTOL, V166, P263, DOI 10.1111/j.1469-8137.2004.01305.x; Obase Keisuke, 2010, Mycobiology, V38, P225, DOI 10.4489/MYCO.2010.38.3.225; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Park MJ, 2011, MYCOTAXON, V116, P449, DOI 10.5248/116.449; WHIPPS JM, 1992, MYCOL RES, V96, P897; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; MARX DH, 1969, PHYTOPATHOLOGY, V59, P153; VILGALYS R, 1990, J BACTERIOL, V172, P4238; RAUP DM, 1979, J PALEONTOL, V53, P1213; WILLETTS HJ, 1971, BIOL REV, V46, P387, DOI 10.1111/j.1469-185X.1971.tb01050.x; ZAZZERINI A, 1985, PLANT PATHOL, V34, P415, DOI 10.1111/j.1365-3059.1985.tb01381.x; ELAD Y, 1984, SOIL BIOL BIOCHEM, V16, P381, DOI 10.1016/0038-0717(84)90037-3; Prenafeta-Boldu FX, 2002, APPL ENVIRON MICROB, V68, P2660, DOI 10.1128/AEM.68.6.2660-2665.2002; LOBUGLIO KF, 1991, CAN J BOT, V69, P2331; Dahlberg A, 1997, CAN J BOT, V75, P1323; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Koide RT, 2005, NEW PHYTOL, V165, P305, DOI 10.1111/j.1469-8137.2004.01216.x; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tsuneda A, 2001, CAN J BOT, V79, P93, DOI 10.1139/cjb-79-1-93; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; BULLOCK S, 1980, PROTOPLASMA, V104, P333, DOI 10.1007/BF01279777; BURTON RJ, 1985, T BRIT MYCOL SOC, V85, P447; COLEYSMI.JR, 1971, ANNU REV PHYTOPATHOL, V9, P65, DOI 10.1146/annurev.py.09.090171.000433; Colwell R.K., 2013, ESTIMATES STAT ESTIM; Duong TA, 2012, MYCOLOGIA, V104, P715, DOI 10.3852/11-109; FOGEL R, 1979, CAN J FOREST RES, V9, P245, DOI 10.1139/x79-041; Frisvad JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094857; GLADDERS P, 1980, T BRIT MYCOL SOC, V74, P579; Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025; HUANG HC, 1976, CAN J BOT, V54, P406; HUANG HC, 1985, PHYTOPATHOLOGY, V75, P433, DOI 10.1094/Phyto-75-433; HURST HM, 1969, SOIL SCI SOC AM PRO, V33, P707; LoBuglio KF, 1996, MOL PHYLOGENET EVOL, V6, P287, DOI 10.1006/mpev.1996.0077; LoBuglio KF, 1999, CENOCOCCUM, P287; MAKKONEN RAUHA, 1960, ACTA AGRIC SCAND, V10, P105; MALIK KA, 1982, SOIL BIOL BIOCHEM, V14, P457, DOI 10.1016/0038-0717(82)90104-3; Midgley DJ, 2004, PLANT SOIL, V259, P137, DOI 10.1023/B:PLSO.0000020947.13655.9f; MILLER SL, 1994, MYCOLOGIA, V86, P89, DOI 10.2307/3760722; NAIKI T, 1975, SOIL BIOL BIOCHEM, V7, P301, DOI 10.1016/0038-0717(75)90071-1; Obase K, MYCORRHIZA IN PRESS, DOI [10.1007/s00572-014-0584-5, DOI 10.1007/S00572-014-0584-5]; Pickles BJ, 2012, MOL ECOL, V21, P5110, DOI 10.1111/j.1365-294X.2012.05739.x; Rice AV, 2002, MYCOL RES, V106, P1463, DOI 10.1017/S0953756202006767; SCHROEDER D. B., 1964, CANADIAN JOUR BOT, V42, P205; SHAW CG, 1983, CAN J FOREST RES, V13, P9, DOI 10.1139/x83-002; SHAW TM, 1995, MYCOL RES, V99, P159; Sigler L, 2005, STUD MYCOL, P63; Trappe J.M., 1962, THESIS U WASHINGTON; TRAPPE JM, 1969, CAN J BOTANY, V47, P1389; Tu JC, 1984, J PHYTOPATHOL, V109, P261, DOI 10.1111/j.1439-0434.1984.tb00716.x; VOGT KA, 1981, OECOLOGIA, V50, P170, DOI 10.1007/BF00348033; Watanabe M, 2001, SOIL SCI PLANT NUTR, V47, P411; Watanabe M, 2007, EUR J SOIL SCI, V58, P786, DOI 10.1111/j.1365-2389.2006.00868.x; White TJ, 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1139/B07-071; WICKLOW DT, 1982, CAN J BOT, V60, P525; WILLETTS HJ, 1980, BOT REV, V46, P101, DOI 10.1007/BF02860868	65	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0168-6496	1574-6941		FEMS MICROBIOL ECOL	FEMS Microbiol. Ecol.	DEC	2014	90	3					708	717		10.1111/1574-6941.12428		10	Microbiology	Microbiology	AW1OE	WOS:000346057900015		
J	Kodama, Y; Fujishima, M				Kodama, Yuuki; Fujishima, Masahiro			Symbiotic Chlorella variabilis incubated under constant dark conditions for 24 hours loses the ability to avoid digestion by host lysosomal enzymes in digestive vacuoles of host ciliate Paramecium bursaria	FEMS MICROBIOLOGY ECOLOGY			English	Article						Chlorella spp.; digestion; endosymbiosis; lysosome; Paramecium bursaria; photosynthesis	EARLY INFECTION PROCESS; METABOLIC INTERACTIONS; ENDOSYMBIOTIC CHLORELLAE; PHOTOSYNTHETIC PRODUCTS; ALGAE; VULGARIS; MEMBRANE; SPEC; CAUDATUM; NITROGEN	Endosymbiosis between symbiotic Chlorella and alga-free Paramecium bursaria cells can be induced by mixing them. To establish the endosymbiosis, algae must acquire temporary resistance to the host lysosomal enzymes in the digestive vacuoles (DVs). When symbiotic algae isolated from the alga-bearing paramecia are kept under a constant dark conditions for 24 h before mixing with the alga-free paramecia, almost all algae are digested in the host DVs. To examine the cause of algal acquisition to the host lysosomal enzymes, the isolated algae were kept under a constant light conditions with or without a photosynthesis inhibitor 3-(3,4-dichlorophenyl)-1,1-dimethylurea for 24 h, and were mixed with alga-free paramecia. Unexpectedly, most of the algae were not digested in the DVs irrespective of the presence of the inhibitor. Addition of 1 mM maltose, a main photosynthetic product of the symbiotic algae or of a supernatant of the isolated algae kept for 24 h under a constant light conditions, did not rescue the algal digestion in the DVs. These observations reveal that unknown factors induced by light are a prerequisite for algal resistance to the host lysosomal enzymes.	[Kodama, Yuuki] Shimane Univ, Fac Life & Environm Sci, Dept Biol Sci, Matsue, Shimane 6908504, Japan; [Fujishima, Masahiro] Yamaguchi Univ, Grad Sch Sci & Engn, Dept Environm Sci & Engn, Yamaguchi, Japan	Kodama, Y (reprint author), Shimane Univ, Fac Life & Environm Sci, Dept Biol Sci, 1060 Nishikawatsu Cho, Matsue, Shimane 6908504, Japan.	kodama@life.shimane-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24770228, 26840119]; JSPS [22370082, 26291073]	This work was supported by a Grant-in-Aid for Young Scientists (B) (No. 24770228 and 26840119) from the Japan Society for the Promotion of Science (JSPS) to Y.K. and by a Grant-in-Aid for Scientific Research (B) (No. 22370082 and 26291073) from the JSPS to M.F. The authors declare no conflict of interest.	ALBERS D, 1985, ENDOCYT CELL RES, V2, P55; Tanaka M, 1996, ZOOL SCI, V13, P685; Nowack ECM, 2010, PHILOS T R SOC B, V365, P699, DOI 10.1098/rstb.2009.0188; Kodama Y, 2005, PROTOPLASMA, V225, P191, DOI 10.1007/s00709-005-0087-5; Yamada T, 2006, ADV VIRUS RES, V66, P293, DOI 10.1016/S0065-3527(06)66006-5; Swanson SJ, 1998, PLANT CELL, V10, P685; Summerer M, 2009, PROTIST, V160, P233, DOI 10.1016/j.protis.2008.11.005; Fujishima M, 2009, MICROBIOL MONOGR, V12, P201, DOI 10.1007/978-3-540-92677-1_8; Araoye PA, 2009, INT J PHYS SCI, V4, P271; ALBERS D, 1982, PLANT SCI LETT, V25, P85, DOI 10.1016/0304-4211(82)90210-3; Kerney R, 2011, P NATL ACAD SCI USA, V108, P6497, DOI 10.1073/pnas.1018259108; Hortnagl PH, 2007, PHOTOCH PHOTOBIO SCI, V6, P842, DOI 10.1039/b703119j; GORTZ HD, 1982, J CELL SCI, V58, P445; Miwa I, 2009, MICROBIOL MONOGR, V12, P83, DOI 10.1007/978-3-540-92677-1_4; Yu SM, 1999, PLANT PHYSIOL, V121, P687, DOI 10.1104/pp.121.3.687; Thomas TH, 1997, PLANT GROWTH REGUL, V23, P105, DOI 10.1023/A:1005906609158; ATKINSON AW, 1974, PROTOPLASMA, V81, P77, DOI 10.1007/BF02055775; BROWN JA, 1974, J PROTOZOOL, V21, P569, DOI 10.1111/j.1550-7408.1974.tb03702.x; DRYL S, 1959, J PROTOZOOL, V6, P25; FUJISHIMA M, 1990, ZOOL SCI, V7, P849; Gomori G, 1952, MICROSCOPIC HISTOCHE; Gu FK, 2002, EUR J PROTISTOL, V38, P267, DOI 10.1078/0932-4739-00875; Jayabaskaran C, 1998, PLANT SCI, V131, P115, DOI 10.1016/S0168-9452(97)00246-X; Kamako S, 2006, J EUKARYOT MICROBIOL, V53, P136, DOI 10.1111/j.1550-7408.2005.00084.x; Karakashian M. W, 1975, Symposia Soc exp Biol, VNo. 29, P145; KARAKASH.MW, 1973, EXP CELL RES, V81, P111, DOI 10.1016/0014-4827(73)90117-1; KARAKASHIAN STEPHEN J., 1963, PHYSIOL ZOOL, V36, P52; KARAKASH.SJ, 1968, J PROTOZOOL, V15, P113, DOI 10.1111/j.1550-7408.1968.tb02095.x; Kato Y, 2009, MICROBIOL MONOGR, V12, P57, DOI 10.1007/978-3-540-92677-1_3; KAWAKAMI H, 1978, J PROTOZOOL, V25, P217, DOI 10.1111/j.1550-7408.1978.tb04399.x; Kleinig H, 1986, ZELLBIOLOGIE; Kodama Y, 2013, SYMBIOSIS, V60, P25, DOI 10.1007/s13199-013-0233-3; Kodama Y, 2011, PROTOPLASMA, V248, P325, DOI 10.1007/s00709-010-0175-z; Kodama Y, 2012, PROTIST, V163, P658, DOI 10.1016/j.protis.2011.10.004; Kodama Y, 2011, PROTIST, V162, P288, DOI 10.1016/j.protis.2010.06.005; Kodama Y, 2007, PROTOPLASMA, V231, P55, DOI 10.1007/s00709-006-0241-8; Kodama Y, 2009, PROTIST, V160, P65, DOI 10.1016/j.protis.2008.06.001; Kodama Y, 2012, ENVIRON MICROBIOL, V14, P2800, DOI 10.1111/j.1462-2920.2012.02793.x; Kodama Y, 2010, INT REV CEL MOL BIO, V279, P33, DOI 10.1016/S1937-6448(10)79002-X; Kodama Y, 2008, PROTIST, V159, P483, DOI 10.1016/j.protis.2008.02.005; Kodama Y, 2013, PROTIST, V164, P660, DOI 10.1016/j.protis.2013.07.001; Kodama Y, 2009, PROTIST, V160, P319, DOI 10.1016/j.protis.2008.11.003; Kodama Y, 2007, PROTOPLASMA, V230, P61, DOI 10.1007/s00709-006-0193-z; KUCHITSU K, 1987, ARCH MICROBIOL, V148, P83, DOI 10.1007/BF00425353; Muscatine L, 1975, Symposia Soc exp Biol, VNo. 29, P175; Piotrowska A, 2009, ACTA PHYSIOL PLANT, V31, P573, DOI 10.1007/s11738-008-0267-y; Reisser W, 1986, ENDOSYMBIOTIC ASS FR; REISSER W, 1988, ARCH HYDROBIOL, V111, P575; REISSER W, 1976, ARCH MICROBIOL, V111, P161, DOI 10.1007/BF00446564; REISSER W, 1976, ARCH MICROBIOL, V107, P357, DOI 10.1007/BF00425352; REISSER W, 1980, ARCH MICROBIOL, V125, P291, DOI 10.1007/BF00446890; SIEGEL RW, 1959, ANAT REC, V134, P639; Tanaka M, 2000, ZOOL SCI, V17, P735, DOI 10.2108/zsj.17.735; TSUKII Y, 1995, J EUKARYOT MICROBIOL, V42, P109, DOI 10.1111/j.1550-7408.1995.tb01550.x; VANETTEN JL, 1991, MICROBIOL REV, V55, P586; ZIESENISZ E, 1981, PLANTA, V153, P481, DOI 10.1007/BF00394991	56	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0168-6496	1574-6941		FEMS MICROBIOL ECOL	FEMS Microbiol. Ecol.	DEC	2014	90	3					946	955		10.1111/1574-6941.12448		10	Microbiology	Microbiology	AW1OE	WOS:000346057900034		
J	Sakamoto, A; Terui, Y; Horie, C; Fukui, T; Masuzawa, T; Sugawara, S; Shigeta, K; Shigeta, T; Igarashi, K; Kashiwagi, K				Sakamoto, Akihiko; Terui, Yusuke; Horie, Chihiro; Fukui, Takashi; Masuzawa, Toshiyuki; Sugawara, Shintaro; Shigeta, Kaku; Shigeta, Tatsuo; Igarashi, Kazuei; Kashiwagi, Keiko			Antibacterial effects of protruding and recessed shark skin micropatterned surfaces of polyacrylate plate with a shallow groove	FEMS MICROBIOLOGY LETTERS			English	Article						bacterial attachment; catheters; environmental pollution; infection; medicine	BIOFILM FORMATION; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; ATTACHMENT; INHIBITION; RESISTANCE; IRON	Antibacterial effects in terms of biofilm formation and swarming motility were studied using polyacrylate plates having protruding or recessed shark skin micropatterned surfaces with a shallow groove (2 mu m pattern width and spacing, 0.4 mu m pattern height). It was found that biofilm formation and swarming motility of Pseudomonas aeruginosa were strongly inhibited by the shark skin pattern plates with a shallow (0.4 mu m) pattern height. Biofilm formation of Staphylococcus aureus was also strongly inhibited. Live bacteria were located on the pattern rather than in the spacing. When the shape of pattern was a linear ridge instead of shark skin, the antibacterial effects were weaker than seen with the shark skin pattern. The results indicate that the pattern of shark skin is important for decreasing bacterial infection even with a shallow feature height.	[Sakamoto, Akihiko; Terui, Yusuke; Horie, Chihiro; Fukui, Takashi; Masuzawa, Toshiyuki; Kashiwagi, Keiko] Chiba Inst Sci, Fac Pharm, Choshi, Chiba 2880025, Japan; [Sugawara, Shintaro; Shigeta, Kaku; Shigeta, Tatsuo] Think Lab Co Ltd, Kashiwa, Chiba, Japan; [Igarashi, Kazuei] Amine Pharma Res Inst, Chiba, Japan	Kashiwagi, K (reprint author), Chiba Inst Sci, Fac Pharm, 15-8 Shiomi Cho, Choshi, Chiba 2880025, Japan.	kkashiwagi@cis.ac.jp					HASSETT DJ, 1995, J BACTERIOL, V177, P6330; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122; Reddy ST, 2011, J ENDOUROL, V25, P1547, DOI 10.1089/end.2010.0611; Tran PL, 2012, ANTIMICROB AGENTS CH, V56, P972, DOI 10.1128/AAC.05680-11; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12; Schumacher JF, 2008, LANGMUIR, V24, P4931, DOI 10.1021/la703421v; Long CJ, 2010, BIOFOULING, V26, P411, DOI 10.1080/08927011003628849; Chung KK, 2007, BIOINTERPHASES, V2, P89, DOI 10.1116/1.2751405; Hinsa SM, 2003, MOL MICROBIOL, V49, P905, DOI 10.1046/j.1365-2958.2003.03615.x; Banin E, 2005, P NATL ACAD SCI USA, V102, P11076, DOI 10.1073/pnas.0504266102; Sakamoto A, 2012, INT J BIOCHEM CELL B, V44, P1877, DOI 10.1016/j.biocel.2012.07.010; Long CJ, 2009, LANGMUIR, V25, P12982, DOI 10.1021/la901836w; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Hannig M, 2007, J NANOSCI NANOTECHNO, V7, P4642, DOI 10.1166/jnn.2007.005; Lamppa JW, 2013, ANTIMICROB AGENTS CH, V57, P137, DOI [10.1128/AAC.01789-12, 10.1128/AAC.01789]; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0378-1097	1574-6968		FEMS MICROBIOL LETT	FEMS Microbiol. Lett.	DEC	2014	361	1					10	16		10.1111/1574-6968.12604		7	Microbiology	Microbiology	AW1OR	WOS:000346059400003		
J	Hori, T; Akuzawa, M; Haruta, S; Ueno, Y; Ogata, A; Ishii, M; Igarashi, Y				Hori, Tomoyuki; Akuzawa, Masateru; Haruta, Shin; Ueno, Yoshiyuki; Ogata, Atsushi; Ishii, Masaharu; Igarashi, Yasuo			Involvement of a novel fermentative bacterium in acidification in a thermophilic anaerobic digester	FEMS MICROBIOLOGY LETTERS			English	Article						stable isotope probing; acidification; thermophilic anaerobic digester	WASTE-WATER TREATMENT; RICE FIELD SOIL; RIBOSOMAL-RNA; COMMUNITY STRUCTURE; GRADIENT	Acidification results from the excessive accumulation of volatile fatty acids and the breakthrough of buffering capacity in anaerobic digesters. However, little is known about the identity of the acidogenic bacteria involved. Here, we identified an active fermentative bacterium during acidification in a thermophilic anaerobic digester by sequencing and phylogenetic analysis of isotopically labeled rRNA. The digestion sludge retrieved from the beginning of pH drop in the laboratory-scale anaerobic digester was incubated anaerobically at 55 degrees C for 4 h during which C-13-labeled glucose was supplemented repeatedly. (CH4)-C-13 and (CO2)-C-13 were produced after substrate addition. RNA extracts from the incubated sludge was density-separated by ultracentrifugation, and then bacterial communities in the density fractions were screened by terminal restriction fragment length polymorphism and clone library analyses based on 16S rRNA transcripts. Remarkably, a novel lineage within the genus Thermoanaerobacterium became abundant with increasing the buoyant density and predominated in the heaviest fraction of RNA. The results in this study indicate that a thermoacidophilic bacterium exclusively fermented the simple carbohydrate glucose, thereby playing key roles in acidification in the thermophilic anaerobic digester.	[Hori, Tomoyuki; Akuzawa, Masateru; Haruta, Shin; Ishii, Masaharu; Igarashi, Yasuo] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo, Japan; [Hori, Tomoyuki; Ogata, Atsushi] Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Tsukuba, Ibaraki, Japan; [Haruta, Shin] Tokyo Metropolitan Univ, Dept Biol Sci, Grad Sch Sci & Engn, Hachioji, Tokyo, Japan; [Ueno, Yoshiyuki] Kajima Tech Res Inst, Chofu, Tokyo, Japan; [Igarashi, Yasuo] Southwest Univ, Res Ctr Bioenergy & Bioremediat, Chongqing, Peoples R China	Hori, T (reprint author), Onogawa 16-1, Tsukuba, Ibaraki 3058569, Japan.	hori-tomo@aist.go.jp					Hori T, 2007, APPL ENVIRON MICROB, V73, P101, DOI 10.1128/AEM.01676-06; Akuzawa M, 2011, MICROB ECOL, V61, P595, DOI 10.1007/s00248-010-9788-1; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846; Hori T, 2011, MICROBIOL-SGM, V157, P1980, DOI 10.1099/mic.0.049189-0; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; LETTINGA G, 1995, ANTON LEEUW INT J G, V67, P3, DOI 10.1007/BF00872193; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Steinberg LM, 2011, BIORESOURCE TECHNOL, V102, P8790, DOI 10.1016/j.biortech.2011.07.017; Qiu YL, 2006, ARCH MICROBIOL, V185, P172, DOI 10.1007/s00203-005-0081-5; Dumont MG, 2005, NAT REV MICROBIOL, V3, P499, DOI 10.1038/nrmicro1162; Hori T, 2006, APPL ENVIRON MICROB, V72, P1623, DOI 10.1128/AEM.72.2.1623-1630.2006; Neufeld JD, 2007, ISME J, V1, P103, DOI 10.1038/ismej.2007.30; Narihiro T, 2007, CURR OPIN BIOTECH, V18, P273, DOI 10.1016/j.copbio.2007.04.003; Noll M, 2005, ENVIRON MICROBIOL, V7, P382, DOI 10.1111/j.1462-2920.2004.00700.x; Lueders T, 2004, ENVIRON MICROBIOL, V6, P60, DOI 10.1046/j.1462-2920.2003.00535.x; Taconi KA, 2008, BIORESOURCE TECHNOL, V99, P8075, DOI 10.1016/j.biortech.2008.03.068; Hori T, 2006, J MICROBIOL METH, V66, P165, DOI 10.1016/j.mimet.2005.11.007; Kublanov IV, 2007, INT J SYST EVOL MICR, V57, P260, DOI 10.1099/ijs.0.64633-0; Sasaki D, 2011, J BIOSCI BIOENG, V111, P41, DOI 10.1016/j.jbiosc.2010.08.011; Speece R. E., 1996, ANAEROBIC BIOTECHNOL	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0378-1097	1574-6968		FEMS MICROBIOL LETT	FEMS Microbiol. Lett.	DEC	2014	361	1					62	67		10.1111/1574-6968.12611		6	Microbiology	Microbiology	AW1OR	WOS:000346059400009		
J	Ikeda, R; Ichikawa, T; Miyazaki, Y; Shimizu, N; Ryoke, T; Haru, K; Sugita, T; Takashima, M				Ikeda, Reiko; Ichikawa, Tomoe; Miyazaki, Yusuke; Shimizu, Nanaho; Ryoke, Tomomi; Haru, Kunihiko; Sugita, Takashi; Takashima, Masako			Detection and characterization of plasminogen receptors on clinical isolates of Trichosporon asahii	FEMS YEAST RESEARCH			English	Article						Trichosporon asahii; plasminogen; heparinase; thioredoxin-dependent peroxide reductase	CRYPTOCOCCUS-NEOFORMANS; EXTRACELLULAR-MATRIX; BREAKTHROUGH TRICHOSPORONOSIS; INVASION; SULFATE; MALIGNANCIES; PROTEINS; PATHOGEN; DISEASE; REGIONS	Trichosporon asahii is the major causative agent of deep-seated trichosporonosis. The virulence factors of this yeast pathogen remain uncharacterized. To investigate the pathogenicity of T. asahii, we focused on the interactions between surface molecules of the yeast and host biomolecules. We examined the ability of surface molecules to bind human plasminogen using clinical isolates of T. asahii. Living T. asahii cells accelerated the conversion of plasminogen to plasmin in a dose-dependent manner in the presence of tissue plasminogen activator. Extracts from cells using lithium chloride contained plasminogen-binding molecules based on surface plasmon resonance (SPR) analyses. In all strains tested, several of the fractions obtained using DEAE column chromatography bound and accelerated the conversion of plasminogen to plasmin. Based on far-Western blotting analyses, a common protein was identified within the four strains, which was identified as a hypothetical protein from genome analyses of T. asahii. BLAST searches suggested the protein might be heparinase, and heparinase activity was detected in the T. asahii extract. Furthermore, affinity chromatography using plasminogen as a ligand detected one protein band by SDS-PAGE, which was identified as thioredoxin-dependent peroxide reductase. SPR analyses suggested the presence of molecules on T. asahii cells that could bind plasminogen with differing affinities.	[Ikeda, Reiko; Ichikawa, Tomoe; Miyazaki, Yusuke; Shimizu, Nanaho; Ryoke, Tomomi; Haru, Kunihiko] Meiji Pharmaceut Univ, Dept Microbial Sci & Host Def, Tokyo 2048588, Japan; [Sugita, Takashi] Meiji Pharmaceut Univ, Dept Microbiol, Tokyo 2048588, Japan; [Takashima, Masako] RIKEN BioResource Ctr, Japan Collect Microorganisms, Ibaraki, Japan	Ikeda, R (reprint author), Meiji Pharmaceut Univ, Dept Microbial Sci & Host Def, 2-522-1 Noshio, Tokyo 2048588, Japan.	ikeda@my-pharm.ac.jp			JSPS KAKENHI [23590155]	This work was supported by JSPS KAKENHI Grant Number 23590155. The authors declare no conflict of interest associated with this manuscript.	Sugita T, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P2015, DOI 10.1016/B978-0-444-52149-1.00161-0; Di Bonaventura G, 2006, ANTIMICROB AGENTS CH, V50, P3269, DOI 10.1128/AAC.00556-06; Andreasen PA, 2000, CELL MOL LIFE SCI, V57, P25, DOI 10.1007/s000180050497; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Sugita T, 2002, J CLIN MICROBIOL, V40, P1826, DOI 10.1128/JCM.40.5.1826-1830.2002; Sugita T, 1999, J CLIN MICROBIOL, V37, P1985; Godier A, 2013, J THROMB HAEMOST, V11, P26, DOI 10.1111/jth.12064; Erer B, 2000, BONE MARROW TRANSPL, V25, P745, DOI 10.1038/sj.bmt.1702231; Furuya H, 2011, MICROBIOL IMMUNOL, V55, P855, DOI 10.1111/j.1348-0421.2011.00392.x; Chitasombat MN, 2012, J INFECTION, V64, P68, DOI 10.1016/j.jinf.2011.11.002; Toriumi Y, 2002, MICROBIOL IMMUNOL, V46, P89; SUGITA T, 1995, J CLIN MICROBIOL, V33, P1368; Singh B, 2012, FEMS MICROBIOL REV, V36, P1122, DOI 10.1111/j.1574-6976.2012.00340.x; Matsue K, 2006, CLIN INFECT DIS, V42, P753, DOI 10.1086/500323; Ichikawa T, 2004, MICROBIOL IMMUNOL, V48, P237; Bhattacharya S., 2012, J BIOMED BIOTECHNOL, V2012, DOI [10.1155/2012/482096, DOI 10.1155/2012/482096]; Bochenek T, 2012, THROMB HAEMOSTASIS, V107, P699, DOI 10.1160/TH11-08-0565; Conti S, 2003, PATHOPHYSIOL HAEMO T, V33, P197, DOI 10.1159/000081508; Fatoux-Ardore M, 2014, INFECT IMMUN, V82, P594, DOI 10.1128/IAI.01146-13; Stie J, 2012, MICROBIOL-SGM, V158, P240, DOI 10.1099/mic.0.051524-0; Fulde M, 2013, MBIO, V4; Goodman D, 2002, CLIN INFECT DIS, V35, pE35, DOI 10.1086/341305; Hyun YJ, 2010, J APPL MICROBIOL, V108, P226, DOI 10.1111/j.1365-2672.2009.04418.x; Ikeda R, 2014, FEMS YEAST RES, V14, P445, DOI 10.1111/1567-1364.12131; Kalkanci A, 2008, MICROBIOL IMMUNOL, V52, P435, DOI 10.1111/j.1348-0421.2008.00056.x; Liu J, 2007, APPL MICROBIOL BIOT, V74, P263, DOI 10.1007/s00253-006-0722-x; Magalhaes V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063244; Mekha N, 2010, MYCOPATHOLOGIA, V169, P67, DOI 10.1007/s11046-009-9225-5; Plow EF, 2012, J BIOMED BIOTECHNOL, V2012; Sanderson-Smith ML, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/272148; Stie J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005780; Sugita T, 2001, J CLIN MICROBIOL, V39, P2405, DOI 10.1128/JCM.39.7.2405-2411.2001; Tang XD, 2014, CANCER SCI, V105, P9, DOI 10.1111/cas.12308; Tripathi CKM, 2012, APPL MICROBIOL BIOT, V94, P307, DOI 10.1007/s00253-012-3967-6	34	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1567-1356	1567-1364		FEMS YEAST RES	FEMS Yeast Res.	DEC	2014	14	8					1186	1195		10.1111/1567-1364.12215		10	Biotechnology & Applied Microbiology; Microbiology; Mycology	Biotechnology & Applied Microbiology; Microbiology; Mycology	AW1OJ	WOS:000346058500005		
J	Kanagawa, Y; Akahane, M; Hasegawa, A; Yamaguchi, K; Onitake, K; Takaya, S; Yamamoto, S; Imamura, T				Kanagawa, Yoshiyuki; Akahane, Manabu; Hasegawa, Atsushi; Yamaguchi, Kentaro; Onitake, Kazuo; Takaya, Satoshi; Yamamoto, Shigeki; Imamura, Tomoaki			Developing a National Food Defense Guideline Based on a Vulnerability Assessment of Intentional Food Contamination in Japanese Food Factories Using the CARVER+Shock Vulnerability Assessment Tool	FOODBORNE PATHOGENS AND DISEASE			English	Article							IMPLEMENTATION; HACCP; CHEESE	The awareness of food terrorism has increased following the September 11, 2001 terrorist attacks in New York City, United States, and many measures and policies dealing with this issue have been established worldwide. Suspected deliberate food-poisoning crimes have occurred in Japan, although they are not regarded as acts of food terrorism. One area of concern is that the small- to medium-sized companies that dominate Japan's food industry are extremely vulnerable to deliberate food poisoning. We conducted a literature research on food defense measures undertaken by the World Health Organization and in the United States and Europe. Using the Carver+Shock vulnerability assessment tool, eight food factories and related facilities in Japan were evaluated and we found the level of awareness of food defense to be low and the measures inappropriate. On the basis of this evaluation, we developed a set of guidelines that Japanese food companies can use to help develop their food defense strategies and to serve as a reference in considering specific measures.	[Kanagawa, Yoshiyuki; Akahane, Manabu; Imamura, Tomoaki] Nara Med Univ, Dept Publ Hlth Hlth Management & Policy, Kashihara, Nara 6348521, Japan; [Hasegawa, Atsushi; Yamaguchi, Kentaro] Mitsubishi Res Inst Inc, Tokyo, Japan; [Onitake, Kazuo] Japanese Consumers Cooperat Union, Tokyo, Japan; [Takaya, Satoshi] Japan Food Hyg Assoc, Tokyo, Japan; [Yamamoto, Shigeki] Natl Inst Hlth Sci, Div Biomed Food Res, Tokyo, Japan	Kanagawa, Y (reprint author), Nara Med Univ, Dept Publ Hlth Hlth Management & Policy, 840 Shijyocho, Kashihara, Nara 6348521, Japan.	kanagawa-tky@umin.ac.jp					Amoa-Awua WK, 2007, FOOD CONTROL, V18, P1449, DOI 10.1016/j.foodcont.2006.10.009; Dias MAC, 2012, FOOD CONTROL, V24, P199, DOI 10.1016/j.foodcont.2011.09.028; Cusato S, 2013, FOODBORNE PATHOG DIS, V10, P6, DOI 10.1089/fpd.2012.1286; Michino H, 2000, J VET MED SCI, V62, P557, DOI 10.1292/jvms.62.557; [Anonymous], 2005, 22000 ISO; Celaya C, 2007, FOOD CONTROL, V18, P1314, DOI 10.1016/j.foodcont.2006.09.006; Domenech E, 2013, FOODBORNE PATHOG DIS, V10, P222, DOI 10.1089/fpd.2012.1305; British Standards Institution, 2013, PRER PROGR FOOD SAF; Dioguardi L, 2010, FOOD CONTROL, V21, P1187, DOI 10.1016/j.foodcont.2010.02.005; FDA, 2007, CARV PLUS SHOCK METH; FDA, 2005, STRAT PARTN PROGR AG; [FDA] U.S. Food and Drug Administration, 2003, GUID IND FOOD PROC P; International Organization for Standardization, 2009, 2200212009 ISOTS; Japanese Consumer Co-operative Union, 2008, FIN REP VER COMM 3 V; MHLW and Osaka City, 2000, CAUS FOOD POIS TYP E; [MHLW] Ministry of Health Labour and Welfare Department of Food Security, 2008, CAS SUBST INT CAUS C; National Police Agency, 2000, WHIT PAP POL 2000 SE; Rodrigues KRM, 2012, FOOD CONTROL, V25, P767, DOI 10.1016/j.foodcont.2011.11.020; Satomura K, 2007, ANN M JAP SOC PUBLC, P626; Soon JM, 2012, EXPERT SYST APPL, V39, P8325, DOI 10.1016/j.eswa.2012.01.189; Soon JM, 2013, FOOD CHEM, V136, P1603, DOI 10.1016/j.foodchem.2012.01.029; Taylor Mary Kay, 2008, Medical Reference Services Quarterly, V27, P81, DOI 10.1300/J115v27n01_06; USDA. Food Safety and Inspection Service, 2007, DEV FOOD DEF PLAN ME; USDA. Food Safety and Inspection Service, 2008, GUID DEV FOOD DEF PL; [USDA] U.S. Department of Agriculture Food Safety and Inspection Service, 2008, GUID DEV FOOD DEF PL; [WHO] World Health Organization, 2003, TERR THREATS FOOD GU; World Health Organization, 2008, TERR THREATS FOOD GU	27	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1535-3141	1556-7125		FOODBORNE PATHOG DIS	Foodborne Pathog. Dis.	DEC 1	2014	11	12					953	959		10.1089/fpd.2014.1767		7	Food Science & Technology	Food Science & Technology	AW4LZ	WOS:000346253800006		
J	Matsui, T; Komoto, M; Muroyama, H; Eguchi, K				Matsui, T.; Komoto, M.; Muroyama, H.; Eguchi, K.			Interfacial Stability between Air Electrode and Ceria-Based Electrolyte under Cathodic Polarization in Solid Oxide Fuel Cells	FUEL CELLS			English	Article						Cathode/Electrolyte interface; Microstuctural Change; Polarization; SOFCs	LA0.9SR0.1MNO3-X/YTTRIA-STABILIZED ZIRCONIA INTERFACE; ION MASS-SPECTROMETRY; SR-DOPED LAMNO3; OXYGEN REDUCTION; (LA,SR)MNO3 ELECTRODES; DISCHARGE OPERATION; O-2 REDUCTION; ACTIVATION; MICROSTRUCTURE; BEHAVIOR	The stability of interfacial structure between air electrode and ceria-based electrolyte (Sm2O3-CeO2, SDC) was evaluated under various polarization conditions at 1,000 degrees C. This is because the structural change at the interface is strongly related to the diffusion of constituent elements and has the potential to affect the long term stability. In this study, (La,Sr)MnO3 (LSM) and (La,Sr)(Co,Fe)O-3 (LSCF) were applied as air electrodes. The cell with LSM/SDC interface showed the performance enhancement after cathodic polarization for 5 h, accompanied with the change in interfacial structure. The magnitude of the microstructural change as well as activation was dependent on the current density and the oxygen partial pressure. However, the active triple phase boundary (TPB)-length decreased at every condition studied. On the other hand, no appreciable change in interfacial structure was confirmed for the LSCF/SDC system regardless of polarization conditions. In response to this phenomenon, the total TPB-length was almost identical to the active one. The difference in morphological evolution at the interface depending on the electrode material was discussed.	[Matsui, T.; Komoto, M.; Muroyama, H.; Eguchi, K.] Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Kyoto 6158510, Japan	Matsui, T (reprint author), Kyoto Univ, Grad Sch Engn, Dept Energy & Hydrocarbon Chem, Nishikyo Ku, Kyoto 6158510, Japan.	matsui@elech.kuic.kyoto-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO), Japan.	Wang W, 2006, SOLID STATE IONICS, V177, P1361, DOI 10.1016/j.ssi.2006.05.022; Jiang Y, 1998, J ELECTROCHEM SOC, V145, P373, DOI 10.1149/1.1838271; Jiang SP, 2007, J SOLID STATE ELECTR, V11, P93, DOI 10.1007/s10008-005-0076-9; Adler SB, 2004, CHEM REV, V104, P4791, DOI 10.1021/cr020724o; Jiang SP, 2008, J MATER SCI, V43, P6799, DOI 10.1007/s10853-008-2966-6; Murakami K, 2010, J ELECTROCHEM SOC, V157, pB880, DOI 10.1149/1.3374407; Haider MA, 2009, J ELECTROCHEM SOC, V156, pB1369, DOI 10.1149/1.3231500; Kim JD, 2001, SOLID STATE IONICS, V143, P379, DOI 10.1016/S0167-2738(01)00877-3; Suzuki M, 2013, ECS TRANSACTIONS, V57, P309, DOI 10.1149/05701.0309ecst; Matsui T, 2010, J ELECTROCHEM SOC, V157, pB1790, DOI 10.1149/1.3499357; Horita T, 2000, SOLID STATE IONICS, V127, P55, DOI 10.1016/S0167-2738(99)00276-3; Horita T, 1998, J ELECTROCHEM SOC, V145, P3196, DOI 10.1149/1.1838786; Iwai H, 2010, J POWER SOURCES, V195, P955, DOI 10.1016/j.jpowsour.2009.09.005; Horiuchi K, 2013, ECS TRANSACTIONS, V57, P3, DOI 10.1149/05701.0003ecst; Mineshige A, 2005, SOLID STATE IONICS, V176, P1145, DOI 10.1016/j.ssi.2004.11.021; Wang W, 2004, J SOLID STATE ELECTR, V8, P914, DOI 10.1007/s10008-004-0515-z; Matsui T, 2005, SOLID STATE IONICS, V176, P647, DOI [10.1016/j.ssi.2004.10.011, 10.1016/J.SSI.2004.10.011]; Jiang SP, 2001, SOLID STATE IONICS, V138, P183, DOI 10.1016/S0167-2738(00)00806-7; Jiang SP, 2003, SOLID STATE IONICS, V158, P45, DOI 10.1016/S0167-2738(02)00760-9; Chen XJ, 2003, J POWER SOURCES, V123, P17, DOI 10.1016/S0378-7753(03)00436-1; Chen XJ, 2004, ELECTROCHEM SOLID ST, V7, pA144, DOI 10.1149/1.1701584; Chen XJ, 2004, SOLID STATE IONICS, V167, P379, DOI 10.1016/j.ssi.2003.08.049; Horita T, 2002, J POWER SOURCES, V106, P224, DOI 10.1016/S0378-7753(01)01017-5; Koch S, 2006, FUEL CELLS, V6, P117, DOI 10.1002/fuce.200500111; Matsui T, 2010, J ELECTROCHEM SOC, V157, pB776, DOI 10.1149/1.3336830; Matsui T, 2013, J POWER SOURCES, V242, P790, DOI 10.1016/j.jpowsour.2013.05.162; Stevenson J. W., 1996, J ELECTROCHEM SOC, V143, P2728; Tsukuda H, 1997, J CERAM SOC JPN, V105, P862, DOI 10.2109/jcersj.105.862; Vance AA, 2008, J ELECTROCHEM SOC, V155, pB1, DOI 10.1149/1.2799061; vanHeuveln FH, 1997, J ELECTROCHEM SOC, V144, P134, DOI 10.1149/1.1837375; Yang J, 2012, J POWER SOURCES, V204, P25, DOI 10.1016/j.jpowsour.2011.12.049; Yasumoto K, 2001, J ELECTROCHEM SOC, V148, pA105, DOI 10.1149/1.1344524; Yasumoto K, 2002, J ELECTROCHEM SOC, V149, pA531, DOI 10.1149/1.1463400; Yokokawa H, 2013, ECS TRANSACTIONS, V57, P299, DOI 10.1149/05701.0299ecst	34	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-6846	1615-6854		FUEL CELLS	Fuel Cells	DEC	2014	14	6					1022	1027		10.1002/fuce.201400043		6	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	AW0ZL	WOS:000346019800029		
J	Kobayashi, Y; Kosaka, K; Tomida, K; Matake, N; Ito, K; Sasaki, K				Kobayashi, Y.; Kosaka, K.; Tomida, K.; Matake, N.; Ito, K.; Sasaki, K.			Start-Up Characteristics of Segmented-In-Series Tubular SOFC Power Modules Improved by Catalytic Combustion at Cathodes	FUEL CELLS			English	Article						Dynamic Performance; Gas Turbine Combined Cycle System; Micro Gas Turbine Hybrid System; Numerical Analysis; Solid Oxide Fuel Cells; Start-Up Procedure	COMBINED-CYCLE SYSTEM; METHANE COMBUSTION; PEROVSKITES	For large-scale SOFC power generation systems, a shorter start-up time of SOFC cell stacks with relatively large heat capacity is one of the most important technological issues to determine the flexibility in SOFC system operation. In this study, start-up procedures have been examined to shorten the start-up time period. The conventional healing procedure using pre-heated hot air and self-heating by SOFC operation at low temperatures had a difficulty to shorten the start-up time period because of the limitation in power generation at lower temperatures. In this study, as an alternative start-up procedure, catalytic combustion at the SOFC cathodes is, for the first time, demonstrated to be useful on the system level. The applicability of the catalytic combustion to shorten the start-up time period has been verified numerically as well as experimentally by using a large-scale cell stack cartridge. This unique start-up procedure enables to operate SOFC-based large-scale power generation systems.	[Kobayashi, Y.] Mitsubishi Heavy Ind Co Ltd, Energy & Environm, Power Syst Div,Nishi Ku, Fuel Cell Business Dept,New Prod SOFC Strateg Bus, Yokohama, Kanagawa 2208401, Japan; [Kosaka, K.; Matake, N.] Mitsubishi Heavy Ind Co Ltd, Nagasaki Res & Dev Ctr, Nagasaki 8510301, Japan; [Tomida, K.] Mitsubishi Heavy Ind Co Ltd, Power Syst Div Energy & Enviroment, Fuel Cell Business Dept, Dev Design Grp, Nagasaki 8508610, Japan; [Ito, K.; Sasaki, K.] Kyushu Univ, Next Generat Fuel Cell Res Ctr NEXT FC, Nishi Ku, Fukuoka 8190395, Japan; [Ito, K.; Sasaki, K.] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPH2CNER, Nishi Ku, Fukuoka 8190395, Japan	Kobayashi, Y (reprint author), Mitsubishi Heavy Ind Co Ltd, Energy & Environm, Power Syst Div,Nishi Ku, Fuel Cell Business Dept,New Prod SOFC Strateg Bus, 3-3-1 Minatomirai, Yokohama, Kanagawa 2208401, Japan.	yoshinori_kobayashi@mhps.com			New Energy and Industrial Technology Development Organization (NEDO)	The authors would like to thank New Energy and Industrial Technology Development Organization (NEDO) for supporting this study.	ARAI H, 1986, APPL CATAL, V26, P265, DOI 10.1016/S0166-9834(00)82556-7; Lin PH, 2006, J POWER SOURCES, V160, P1230, DOI 10.1016/j.jpowsour.2006.02.030; Forzatti P, 2003, CATAL TODAY, V83, P3, DOI 10.1016/S0920-5861(03)00211-6; Marchetti L, 1998, APPL CATAL B-ENVIRON, V15, P179, DOI 10.1016/S0926-3373(97)00045-3; Nishiura M, 2007, ECS TRANSACTIONS, V7, P155, DOI 10.1149/1.2729085; Cimino S, 2000, CATAL TODAY, V59, P19, DOI 10.1016/S0920-5861(00)00269-8; Batis NH, 2005, APPL CATAL A-GEN, V282, P173, DOI 10.1016/j.apcata.2004.12.009; Betta R. A. D., 1997, CATAL TODAY, V35, P129; Hisatome N., 2000, TECHNICAL REV, V37, P30; Jeffs E, 2008, WOODHEAD PUBL SER EN, P1, DOI 10.1533/9781845694548; Kawakami K., 2009, TECHNICAL REV, V46, P31; Kehlhofer R., 2009, COMBINED CYCLE GAS S; Kobayashi Y., 2012, J GAS TURBINE SOC JP, V40, P89; Kobayashi Y., 2011, THERM NUCL POWER J, V662, P54; McCarty J.G., 1990, CATAL TODAY, V8, P231, DOI 10.1016/0920-5861(90)87020-4; Ono H, 2005, KAGAKU KOGAKU RONBUN, V31, P421, DOI 10.1252/kakoronbunshu.31.421; Takahashi S., 2005, 12 FCDIC FUEL CELL S, P201; Yoshida S, 2011, ECS TRANSACTIONS, V35, P105, DOI 10.1149/1.3569984	18	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-6846	1615-6854		FUEL CELLS	Fuel Cells	DEC	2014	14	6					1028	1035		10.1002/fuce.201400014		8	Electrochemistry; Energy & Fuels	Electrochemistry; Energy & Fuels	AW0ZL	WOS:000346019800030		
J	Maeda, T; Higashimoto, K; Jozaki, K; Yatsuki, H; Nakabayashi, K; Makita, Y; Tonoki, H; Okamoto, N; Takada, F; Ohashi, H; Migita, M; Kosaki, R; Matsubara, K; Ogata, T; Matsuo, M; Hamasaki, Y; Ohtsuka, Y; Nishioka, K; Joh, K; Mukai, T; Hata, K; Soejima, H				Maeda, Toshiyuki; Higashimoto, Ken; Jozaki, Kosuke; Yatsuki, Hitomi; Nakabayashi, Kazuhiko; Makita, Yoshio; Tonoki, Hidefumi; Okamoto, Nobuhiko; Takada, Fumio; Ohashi, Hirofumi; Migita, Makoto; Kosaki, Rika; Matsubara, Keiko; Ogata, Tsutomu; Matsuo, Muneaki; Hamasaki, Yuhei; Ohtsuka, Yasufumi; Nishioka, Kenichi; Joh, Keiichiro; Mukai, Tsunehiro; Hata, Kenichiro; Soejima, Hidenobu			Comprehensive and quantitative multilocus methylation analysis reveals the susceptibility of specific imprinted differentially methylated regions to aberrant methylation in Beckwith-Wiedemann syndrome with epimutations	GENETICS IN MEDICINE			English	Article						Beckwith-Wiedemann syndrome; DNA methylation; differentially methylated region; genomic imprinting; multiple methylation defects	ASSISTED REPRODUCTIVE TECHNOLOGY; FETAL-GROWTH DISORDERS; DNA-METHYLATION; HYPOMETHYLATION; CANCER; LOCI; MUTATIONS; DEFECTS; DISEASE; COHORT	Purpose: Expression of imprinted genes is regulated by DNA methylation of differentially methylated regions (DMRs). Beckwith-Wiedemann syndrome is an imprinting disorder caused by epimutations of DMRs at 11p15.5. To date, multiple methylation defects have been reported in Beckwith-Wiedemann syndrome patients with epimutations; however, limited numbers of DMRs have been analyzed. The susceptibility of DMRs to aberrant methylation, alteration of gene expression due to aberrant methylation, and causative factors for multiple methylation defects remain undetermined. Methods: Comprehensive methylation analysis with two quantitative methods, matrix-assisted laser desorption/ionization mass spectrometry and bisulfite pyrosequencing, was conducted across 29 DMRs in 54 Beckwith-Wiedemann syndrome patients with epimutations. Allelic expressions of three genes with aberrant methylation were analyzed. All DMRs with aberrant methylation were sequenced. Results: Thirty-four percent of KvDMR1-loss of methylation patients and 30% of H19DMR-gain of methylation patients showed multiple methylation defects. Maternally methylated DMRs were susceptible to aberrant hypomethylation in KvDMR1-loss of methylation patients. Biallelic expression of the genes was associated with aberrant methylation. Cis-acting pathological variations were not found in any aberrantly methylated DMR. Conclusion: Maternally methylated DMRs may be vulnerable to DNA demethylation during the preimplantation stage, when hypomethylation of KvDMR1 occurs, and aberrant methylation of DMRs affects imprinted gene expression. Cis-acting variations of the DMRs are not involved in the multiple methylation defects.	[Maeda, Toshiyuki; Higashimoto, Ken; Jozaki, Kosuke; Yatsuki, Hitomi; Nishioka, Kenichi; Joh, Keiichiro; Soejima, Hidenobu] Saga Univ, Fac Med, Dept Biomol Sci, Div Mol Genet & Epigenet, Saga 840, Japan; [Maeda, Toshiyuki; Matsuo, Muneaki; Hamasaki, Yuhei; Ohtsuka, Yasufumi] Saga Univ, Fac Med, Dept Pediat, Saga 840, Japan; [Nakabayashi, Kazuhiko; Hata, Kenichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan; [Makita, Yoshio] Asahikawa Med Univ, Educ Ctr, Asahikawa, Hokkaido, Japan; [Tonoki, Hidefumi] Tenshi Hosp, Maternal Perinatal & Child Med Ctr, Dept Pediat, Sapporo, Hokkaido, Japan; [Okamoto, Nobuhiko] Osaka Med Ctr, Dept Med Genet, Izumi, Japan; [Okamoto, Nobuhiko] Res Inst Maternal & Child Hlth, Izumi, Japan; [Takada, Fumio] Kitasato Univ, Grad Sch Med Sci, Dept Med Genet, Yokohama, Kanagawa, Japan; [Ohashi, Hirofumi] Saitama Childrens Med Ctr, Div Med Genet, Saitama, Japan; [Migita, Makoto] Nippon Med Sch, Dept Pediat, Tokyo 113, Japan; [Kosaki, Rika] Natl Ctr Child Hlth & Dev, Div Med Genet, Tokyo, Japan; [Matsubara, Keiko] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo, Japan; [Ogata, Tsutomu] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan; [Mukai, Tsunehiro] Nishikyushu Univ, Saga, Japan	Soejima, H (reprint author), Saga Univ, Fac Med, Dept Biomol Sci, Div Mol Genet & Epigenet, Saga 840, Japan.	soejimah@cc.saga-u.ac.jp			Grant for Research on Intractable Diseases from the Ministry of Health, Labor, and Welfare; Grant for Child Health and Development from the National Center for Child Health and Development; Japan Society for the Promotion of Science	We thank all the participants and their families who provided samples and all the doctors who referred patients to us. This study was supported, in part, by a Grant for Research on Intractable Diseases from the Ministry of Health, Labor, and Welfare; a Grant for Child Health and Development from the National Center for Child Health and Development; a Grant-in-Aid for Challenging Exploratory Research; and a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science.	Tost J, 2003, BIOTECHNIQUES, V35, P152; Mackay DJG, 2008, NAT GENET, V40, P949, DOI 10.1038/ng.187; Soejima H, 2013, J HUM GENET, V58, P402, DOI 10.1038/jhg.2013.51; Nakabayashi K, 2011, HUM MOL GENET, V20, P3188, DOI 10.1093/hmg/ddr224; DeBaun MR, 1998, J PEDIATR-US, V132, P398, DOI 10.1016/S0022-3476(98)70008-3; Cui HM, 2002, CANCER RES, V62, P6442; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Mackay DJG, 2006, HUM GENET, V120, P262, DOI 10.1007/s00439-006-0205-2; Weksberg R, 2010, EUR J HUM GENET, V18, P8, DOI 10.1038/ejhg.2009.106; Lim D, 2009, HUM REPROD, V24, P741, DOI 10.1093/humrep/den406; Tomizawa S, 2012, J HUM GENET, V57, P84, DOI 10.1038/jhg.2011.151; Choufani S, 2010, AM J MED GENET C, V154C, P343, DOI 10.1002/ajmg.c.30267; Abramowitz LK, 2012, CURR OPIN GENET DEV, V22, P72, DOI 10.1016/j.gde.2011.12.001; Rossignol S, 2006, J MED GENET, V43, P902, DOI 10.1136/jmg.2006.042135; Poole RL, 2013, AM J MED GENET A, V161, P2174, DOI 10.1002/ajmg.a.36049; Lorthongpanich C, 2013, SCIENCE, V341, P1110, DOI 10.1126/science.1240617; Court F, 2013, HUM MUTAT, V34, P595, DOI 10.1002/humu.22276; Demars J, 2010, HUM MOL GENET, V19, P803, DOI 10.1093/hmg/ddp549; Bliek J, 2009, EUR J HUM GENET, V17, P611, DOI 10.1038/ejhg.2008.233; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Azzi S, 2009, HUM MOL GENET, V18, P4724, DOI 10.1093/hmg/ddp435; Lopes S, 2003, HUM MOL GENET, V12, P295, DOI 10.1093/hmg/ddg022; Claus R, 2012, EPIGENETICS-US, V7, P772, DOI 10.4161/epi.20299; Higashimoto K, 2013, CLIN GENET; Higashimoto K, 2012, AM J MED GENET A, V158A, P1670, DOI 10.1002/ajmg.a.35335; Kobayashi H, 2009, GENOMICS, V93, P461, DOI 10.1016/j.ygeno.2008.12.012; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Reik W, 1997, TRENDS GENET, V13, P330, DOI 10.1016/S0168-9525(97)01200-6; Meyer E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000423; Murrell A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001849; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Rumbajan JM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-608; Soejima H, 2004, ONCOGENE, V23, P4380, DOI 10.1038/sj.onc.1207576; Sparago A, 2007, HUM MOL GENET, V16, P254, DOI 10.1093/hmg/ddl448; Tee L, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-23; Weksberg R, 2002, HUM MOL GENET, V11, P1317, DOI 10.1093/hmg/11.11.1317; Woodfine K, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-1; Yatsuki H, 2013, GENES GENOM, V35, P141, DOI 10.1007/s13258-013-0079-3	38	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1098-3600	1530-0366		GENET MED	Genet. Med.	DEC	2014	16	12					903	912		10.1038/gim.2014.46		10	Genetics & Heredity	Genetics & Heredity	AW1HN	WOS:000346040900008		
J	Kobayashi, K; Ezaki, K; Nozawa, I				Kobayashi, Kazuhiro; Ezaki, Kosuke; Nozawa, Ippei			Synthesis of 2-Substituted 3-Alkylidene-2,3-dihydro-1H-isoindol-1-imines through Cyclization of [1-(2-Cyanophenyl)alkylidene]aminide Intermediates Generated from the Reaction of 2-(1-Azidoalkyl)benzonitriles with NaH	HELVETICA CHIMICA ACTA			English	Article							DERIVATIVES	A convenient sequence for the preparation of 3-alkylidene-2,3-dihydro-1H-isoindol-1-imine derivatives 6 has been developed. Thus, 2-(1-azidoalkyl) benzonitriles 2, readily accessible from 2-alkylbenzonitriles, are allowed to react with NaH in DMF at 0 degrees to room temperature to generate [1-(2-cyanophenyl) alkylidene] aminide intermediates 3, of which cyclization and the subsequent rearrangement, followed by alkylation with alkyl halides, affords 2-substituted 1-alkylidene-2,3-dihydro-1H-isoindol- 2-imines 6 in generally moderate yields.	[Kobayashi, Kazuhiro; Ezaki, Kosuke; Nozawa, Ippei] Tottori Univ, Div Appl Chem, Dept Chem & Biotechnol, Grad Sch Engn, Tottori 6808552, Japan	Kobayashi, K (reprint author), Tottori Univ, Div Appl Chem, Dept Chem & Biotechnol, Grad Sch Engn, 4-101 Koyama Minami, Tottori 6808552, Japan.	kkoba@chem.tottori-u.ac.jp			JSPS KAKENHI Grant [26410051]	This work was supported in part by JSPS KAKENHI Grant No. 26410051. Assistance in recording mass spectra and performing combustion analyses by Mrs. Miyuki Tanmatsu of our university is gratefully acknowledged.	Ezaki K, 2014, HELV CHIM ACTA, V97, P822, DOI 10.1002/hlca.201300431; Kobayashi K, 1997, J ORG CHEM, V62, P664, DOI 10.1021/jo961744r; LABBE G, 1993, J CHEM SOC PERK T 1, P27, DOI 10.1039/p19930000027; Lu H., 2011, CHEM ABSTR, V155; Lu H., 2011, PCT Int. Appl., Patent No. 2011140936; Miao HM, 2011, HELV CHIM ACTA, V94, P1981, DOI 10.1002/hlca.201100128; NOYCE SJ, 1985, TETRAHEDRON LETT, V26, P941, DOI 10.1016/S0040-4039(00)61970-6; Shen SD, 2012, SYNTHESIS-STUTTGART, V44, P3543, DOI 10.1055/s-0032-1317472; STEWART JM, 1960, J ORG CHEM, V25, P913, DOI 10.1021/jo01076a010; Zhang H, 2011, CHEM ABSTR, Patent No. 20110105490; Zhang H.-C., 2011, U.S. Pat. Appl. Publ., Patent No. 201101054390	11	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0018-019X	1522-2675		HELV CHIM ACTA	Helv. Chim. Acta	DEC	2014	97	12					1624	1629		10.1002/hlca.201400261		6	Chemistry, Multidisciplinary	Chemistry	AW2CK	WOS:000346095600003		
J	Egawa, H; Ueda, Y; Kawagishi, N; Yagi, T; Kimura, H; Ichida, T				Egawa, Hiroto; Ueda, Yoshihide; Kawagishi, Naoki; Yagi, Takahito; Kimura, Hiroyuki; Ichida, Takafumi			Significance of pretransplant abstinence on harmful alcohol relapse after liver transplantation for alcoholic cirrhosis in Japan	HEPATOLOGY RESEARCH			English	Article						harmful relapse; high-risk alcohol relapse score; living donor liver transplantation; pretransplant abstinence; recidivism	DISEASE	AimAlcoholic liver cirrhosis (ALC) is an established indication for liver transplantation (LT). Although the importance of preoperative abstinence is accepted, the optimal period of pretransplant abstinence is unclear. Our previous report in a Japanese cohort revealed a significant negative impact of recidivism on patient survival but failed to show significance of the length of pretransplant abstinence. The aim of this study was to evaluate the optimal period of pretransplant abstinence. MethodsSubjects underwent LT for ALC (n=195: 187 living donor liver transplantations, five deceased donor liver transplantations and three domino LT) in Japan from November 1997 to December 2011. Risk factors and the impact on outcome of alcohol relapse were analyzed in 140 patients, after excluding 26 patients with in-hospital mortality and 29 patients without information about alcohol relapse. ResultsThe incidence of alcohol consumption after LT was 22.9% (32/140). The relapse time was within 18 months after LT in 24 patients, after 18 months in two patients and unknown in six patients. Alcohol-related damage occurred in 18 of the 24 patients with recidivism within 18 months. The patient survival rate of patients with harmful relapse was significantly lower than that of abstinent patients and patients with non-harmful relapse (P=0.019). Preoperative abstinence shorter than 18 months was a significant indicator of the risk of harmful relapse (P=0.009). High-risk alcohol relapse scores had no impact on the incidence. ConclusionPreoperative abstinence was an important predictor of post-transplant harmful relapse leading to inferior outcomes.	[Egawa, Hiroto] Tokyo Womens Med Univ, Dept Surg, Tokyo 1628666, Japan; [Ueda, Yoshihide] Kyoto Univ, Grad Sch Med, Dept Gastroenterol, Kyoto, Japan; [Kawagishi, Naoki] Tohoku Univ Hosp, Div Transplantat Reconstruct & Endoscop Surg, Sendai, Miyagi, Japan; [Yagi, Takahito] Okayama Univ, Grad Sch Med, Dept Surg, Okayama 7008530, Japan; [Kimura, Hiroyuki] Nagoya Univ, Grad Sch Med, Dept Psychiat, Nagoya, Aichi 4648601, Japan; [Ichida, Takafumi] Juntendo Univ, Shizuoka Hosp, Dept Gastroenterol, Izunokuni, Japan	Egawa, H (reprint author), Tokyo Womens Med Univ, Dept Surg, Inst Gastroenterol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	egawa@ige.twmu.ac.jp					Gish RG, 2001, LIVER TRANSPLANT, V7, P581, DOI 10.1053/jlts.2001.25455; Kelly M, 2006, ALCOHOL ALCOHOLISM, V41, P278, DOI 10.1093/alcalc/agh257; Cuadrado A, 2005, LIVER TRANSPLANT, V11, P420, DOI 10.1002/lt20386; De Gottardi A, 2007, ARCH INTERN MED, V167, P1183, DOI 10.1001/archinte.167.11.1183; Tandon P, 2009, AM J GASTROENTEROL, V104, P1700, DOI 10.1038/ajg.2009.226; Webb K, 2006, LIVER TRANSPLANT, V12, P301, DOI 10.1002/it.20681; YATES WR, 1993, J STUD ALCOHOL, V54, P645; Egawa H, 2013, LIVER TRANSPLANT, V20, P298; Kawaguchi Y, 2013, HEPATOL RES, V43, P1169, DOI 10.1111/hepr.12065; Paegeaux GP, 2003, J HEPATOLO, V38, P629; Shmeding M, 2011, DIGEST DIS SCI, V56, P236; The Japanese Liver Transplant Society, 2013, ISHOKU, V48, P362	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E428	E436		10.1111/hepr.12334		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200012		
J	Enkhbold, C; Utsunomiya, T; Morine, Y; Imura, S; Ikemoto, T; Arakawa, Y; Kanamoto, M; Iwahashi, S; Saito, Y; Ishikawa, D; Shimada, M				Enkhbold, Chinbold; Utsunomiya, Tohru; Morine, Yuji; Imura, Satoru; Ikemoto, Tetsuya; Arakawa, Yusuke; Kanamoto, Mami; Iwahashi, Shuichi; Saito, Yu; Ishikawa, Daichi; Shimada, Mitsuo			Loss of FBXW7 expression is associated with poor prognosis in intrahepatic cholangiocarcinoma	HEPATOLOGY RESEARCH			English	Article						clinicopathological variables; FBXW7; intrahepatic cholangiocarcinoma	GASTRIC-CANCER; C-MYC; TUMOR-SUPPRESSOR; CYCLIN-E; PATHOGENESIS; DEGRADATION; DIAGNOSIS; FBW7	AimFBXW7 acts as a tumor suppressor gene by targeting several oncogenic regulators of proliferation, growth and apoptosis for proteasomal degradation. However, the significance of this protein is not yet well understood in intrahepatic cholangiocarcinoma (IHCC). In this study, we aimed to investigate the correlation between FBXW7 expression and clinicopathological variables in IHCC patients. MethodsThirty-one patients with IHCC who underwent hepatic resection were enrolled. FBXW7 expression in tumor tissue was determined by immunohistochemistry and patients were divided into two groups, the FBXW7 high expression group (n=11) and the FBXW7 low expression group (n=20). We then compared clinicopathological variables including prognosis between the high and low expression groups in tumor tissue. ResultsFBXW7 expression was significantly correlated with staging (P=0.006), and tended to correlate with lymph node metastasis. The FBXW7 low expression group had significantly poorer prognosis compared with the FBXW7 high expression group (P=0.020); 3-year survival rates were 29.4% and 72.7%, respectively. Furthermore, the disease-free survival rate in the FBXW7 low expression group was significantly worse than in the FBXW7 high expression group (P=0.022). On multivariate analysis, intrahepatic metastasis (P=0.006) was a significant independent prognostic factor for disease-free survival, and FBXW7 low expression tended to be an independent prognostic factor for both overall (P=0.067) and disease-free survival (P=0.083). ConclusionOur results confirmed that low expression of FBXW7 in IHCC correlates with tumor progression and poor prognosis in IHCC.	[Enkhbold, Chinbold; Utsunomiya, Tohru; Morine, Yuji; Imura, Satoru; Ikemoto, Tetsuya; Arakawa, Yusuke; Kanamoto, Mami; Iwahashi, Shuichi; Saito, Yu; Ishikawa, Daichi; Shimada, Mitsuo] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Surg, Tokushima 7708503, Japan	Shimada, M (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Surg, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	mitsuo.shimada@tokushima-u.ac.jp			Japan Society for the Promotion of Science [24592003, 23390324]	THIS WORK WAS supported in part by Grants-in-Aid for Scientific Research (C) (24592003) and Scientific Research (B) (23390324), Japan Society for the Promotion of Science.	Spruck CH, 2002, CANCER RES, V62, P4535; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Yokobori T, 2009, CANCER RES, V69, P3788, DOI 10.1158/0008-5472.CAN-08-2846; Babaei-Jadidi R, 2011, J EXP MED, V208, P295, DOI 10.1084/jem.20100830; Kubben FJGM, 2006, BRIT J CANCER, V94, P1035, DOI 10.1038/sj.bjc.6603041; Tu KS, 2012, HEPATOL RES, V42, P904, DOI 10.1111/j.1872-034X.2012.01005.x; Khan SA, 2008, HPB, V10, P77, DOI 10.1080/13651820801992641; Takeishi S, 2013, CANCER CELL, V23, P347, DOI 10.1016/j.ccr.2013.01.026; Ibusuki M, 2011, CANCER SCI, V102, P439, DOI 10.1111/j.1349-7006.2010.01801.x; Pelengaris S, 2003, ARCH BIOCHEM BIOPHYS, V416, P129, DOI 10.1016/S0003-9861(03)00294-7; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Patel T, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-10; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; Choi SB, 2009, ANN SURG ONCOL, V16, P3048, DOI 10.1245/s10434-009-0631-1; Shaib YH, 2004, J HEPATOL, V40, P472, DOI 10.1016/j.jhep.2003.11.030; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Chang KY, 2009, J NATL COMPR CANC NE, V7, P423; Izumi N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041116; Khan SA, 2002, GUT, V51, P1; Liver Cancer Study Group of Japan, 1997, CLASS PRIM LIV CANC; Calcagno DQ, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-141; Ohtsuka Masayuki, 2003, J Hepatobiliary Pancreat Surg, V10, P259, DOI 10.1007/s00534-002-0724-8; Shimada K, 2007, J SURG ONCOL, V96, P160, DOI 10.1002/jso.20792; Shwartz AL, 2009, ANN REV PHARM TOXICO, V49, P73; Yamamoto M, 1999, J Hepatobiliary Pancreat Surg, V6, P117, DOI 10.1007/s005340050093	29	3	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E346	E352		10.1111/hepr.12314		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200003		
J	Imai, K; Beppu, T; Chikamoto, A; Mima, K; Okabe, H; Hayashi, H; Nitta, H; Ishiko, T; Baba, H				Imai, Katsunori; Beppu, Toru; Chikamoto, Akira; Mima, Kosuke; Okabe, Hirohisa; Hayashi, Hiromitsu; Nitta, Hidetoshi; Ishiko, Takatoshi; Baba, Hideo			Salvage treatment for local recurrence of hepatocellular carcinoma after local ablation therapy	HEPATOLOGY RESEARCH			English	Article						hepatocellular carcinoma; local ablation therapy; local recurrence; radiofrequency ablation; salvage treatment	PERCUTANEOUS ETHANOL INJECTION; RADIOFREQUENCY THERMAL ABLATION; PROGNOSTIC-FACTORS; RISK-FACTORS; LIVER-TUMORS; HEPATIC RESECTION; SINGLE SESSION; COMPLICATIONS; CIRRHOSIS; COAGULATION	AimLocal recurrence of hepatocellular carcinoma (HCC) after local ablation therapy (LAT) is a serious problem; however, the optimal treatment strategy remains unclear. MethodsA retrospective analysis was conducted of 50 patients with local recurrence of HCC after LAT that underwent either salvage hepatectomy (n=23) or radiofrequency ablation (RFA; n=27). Their background characteristics, intraoperative data, and postoperative short- and long-term outcome were analyzed. ResultsThe RFA group was found to be significantly associated with an impaired liver functional reserve, smaller number and size of tumors. The hepatectomy group showed a significantly longer operation time, greater intraoperative blood loss and more frequent red blood cell transfusion. In-hospital stay mortality and morbidity rate did not significantly differ. The disease-free and overall survival showed no significant difference between the groups. Although local recurrence after salvage treatment was found in zero (0%) for hepatectomy and in seven (25.9%) for RFA, that did not affect the overall survival. The tumor size at the prior LAT was identified as an independent prognostic factor for disease-free survival and serum albumin for overall survival. ConclusionWhereas salvage hepatectomy for local recurrent HCC is recommended for selected patients in terms of its good local control effect, salvage RFA is also acceptable because it is less invasive and also has a reasonable long-term outcome.	[Imai, Katsunori; Beppu, Toru; Chikamoto, Akira; Mima, Kosuke; Okabe, Hirohisa; Hayashi, Hiromitsu; Nitta, Hidetoshi; Ishiko, Takatoshi; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto 8608556, Japan; [Beppu, Toru] Kumamoto Univ Hosp, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto, Japan	Baba, H (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	hdobaba@kumamoto-u.ac.jp					Shiina S, 2012, LIVER INT, V32, P1434, DOI 10.1111/j.1478-3231.2012.02838.x; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Itoh S, 2011, ANN SURG ONCOL, V18, P3650, DOI 10.1245/s10434-011-1831-z; Mima K, 2013, J HEPATO-BIL-PAN SCI, V20, P429, DOI 10.1007/s00534-012-0580-0; Lau WY, 2009, ANN SURG, V249, P20, DOI 10.1097/SLA.0b013e31818eec29; Lin SM, 2005, GUT, V54, P1151, DOI 10.1136/gut.2004.045203; Abu-Hilal M, 2008, J GASTROINTEST SURG, V12, P1521, DOI 10.1007/s11605-008-0553-4; Masuda T, 2008, J HEPATO-BILIARY-PAN, V15, P589, DOI 10.1007/s00534-007-1288-4; Takami Y, 2013, J HEPATO-BIL-PAN SCI, V20, P332, DOI 10.1007/s00534-012-0527-5; Lam VWT, 2008, ANN SURG ONCOL, V15, P782, DOI 10.1245/s10434-007-9733-9; Lam VWT, 2008, J AM COLL SURGEONS, V207, P20, DOI 10.1016/j.jamcollsurg.2008.01.020; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Xu KC, 2009, WORLD J GASTROENTERO, V15, P3664, DOI 10.3748/wjg.15.3664; Mulier S, 2005, ANN SURG, V242, P158, DOI 10.1097/01.sla.0000171032.99149.fe; [Anonymous], 1994, CANCER, V74, P2772; Yamanaka Y, 2005, WORLD J GASTROENTERO, V11, P2174; Befeler AS, 2005, GASTROENTEROLOGY, V128, P1752, DOI 10.1053/j.gastro.2005.03.033; N'Kontchou G, 2009, HEPATOLOGY, V50, P1475, DOI 10.1002/hep.23181; Mulier S, 2002, BRIT J SURG, V89, P1206, DOI 10.1046/j.1365-2168.2002.02168.x; Borie F, 2008, J SURG ONCOL, V98, P505, DOI 10.1002/jso.21159; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; Lu DSK, 2003, J VASC INTERV RADIOL, V14, P1267, DOI 10.1097/01.RVI.0000092666.72261.6B; Koda M, 2012, HEPATOL RES, V42, P1058, DOI 10.1111/j.1872-034X.2012.01025.x; Hori T, 2003, J GASTROENTEROL, V38, P977, DOI 10.1007/s00535-003-1181-0; Komorizono Y, 2003, CANCER, V97, P1253, DOI 10.1002/cncr.11168; LIVRAGHI T, 1995, RADIOLOGY, V197, P101; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440; Ishiko T, 2008, SURG LAPARO ENDO PER, V18, P272, DOI 10.1097/SLE.0b013e31816a24bf; Kei SK, 2008, AM J ROENTGENOL, V190, P1544, DOI 10.2214/AJR.07.2798; Ikai I, 2007, HEPATOL RES, V37, P676, DOI 10.1111/j.1872-034X.2007.00119.x; Lencioni RA, 2003, RADIOLOGY, V228, P235, DOI 10.1148/radiol.2281020718; Ishii H, 1996, CANCER, V77, P1792; Patterson EJ, 1998, ANN SURG, V227, P559, DOI 10.1097/00000658-199804000-00018; Hong SN, 2005, J CLIN GASTROENTEROL, V39, P247, DOI 10.1097/01.mcg.0000152746.72149.31; Imai K, 2009, J SURG ONCOL, V100, P121, DOI 10.1002/jso.21302; Imai K, 2013, HEPATOL RES, V43, P853, DOI 10.1111/hepr.12035; Koda M, 2003, HEPATOL RES, V27, P163, DOI 10.1016/S1386-6346(03)00207-9; Kong J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037266; Lee SM, 2011, CLIN RADIOL, V66, P752, DOI 10.1016/j.crad.2011.02.015; Lencioni Riccardo, 2004, Liver Transpl, V10, pS91, DOI 10.1002/lt.20043; Ohmoto K, 2009, J GASTROEN HEPATOL, V24, P223, DOI 10.1111/j.1440-1746.2008.05596.x; Omata M, 2004, GASTROENTEROLOGY, V127, pS159, DOI 10.1053/j.gastro.2004.09.030; Sato M, 2012, J GASTROENTEROL, V47, P1125, DOI 10.1007/s00535-012-0569-0; Sugo H, 2012, ANN SURG ONCOL, V19, P2238, DOI 10.1245/s10434-012-2220-y; Torzilli G, 2007, BRIT J SURG, V94, P208, DOI 10.1002/bjs.5603; Tzeng CW, 2013, HPB OXFORD; Zhou YM, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-78	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E335	E345		10.1111/hepr.12313		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200002		
J	Itaba, N; Wairagu, PM; Aramaki, N; Yasui, T; Matsumi, Y; Kono, Y; Phan, ANH; Otsu, M; Kunisada, T; Nakamura, Y; Okano, H; Jeong, Y; Shiota, G				Itaba, Noriko; Wairagu, Peninah M.; Aramaki, Natsumi; Yasui, Toshihiro; Matsumi, Yoshiaki; Kono, Yohei; Phan, Ai N. H.; Otsu, Makoto; Kunisada, Takahiro; Nakamura, Yukio; Okano, Hideyuki; Jeong, Yangsik; Shiota, Goshi			Nuclear receptor gene alteration in human induced pluripotent stem cells with hepatic differentiation propensity	HEPATOLOGY RESEARCH			English	Article						hepatic differentiation propensity; hepatic differentiation; human induced pluripotent stem cells; nuclear receptor	HEPATOCYTE-LIKE CELLS; EFFICIENT DIFFERENTIATION; FUNCTIONAL HEPATOCYTES; DEFINITIVE ENDODERM; GENERATION; EXPRESSION; MEMORY; REPRESSION; ALPHA; GCNF	AimHuman induced pluripotent stem (hiPS) cells are an alternative cell source of regenerative medicine for liver disease. Because variations in hepatic differentiation efficacy among hiPS cells exist, it is important to select a hiPS cell line with hepatic differentiation propensity. In addition, nuclear receptors (NR) regulate essential biological processes including differentiation and development. In this study, we identified the hiPS cell line with hepatic differentiation propensity and examined expression levels of 48 NR during this process. MethodsWe screened 28 hiPS cell lines, which are established from various tissues of healthy persons with various reprogramming methods, using a three-step differentiation method, and examined expression levels of 48 NR by quantitative real-time polymerase chain reaction during the differentiation process in the selected cells. ResultshiPS-RIKEN-2B and hiPS-RIKEN-2F cells have hepatic differentiation propensity. Differentiation propensity towards endoderm was affected by donor origin but not by reprogramming methods or cell type of origins. Expression levels of NR were closely associated with those of hepatic differentiation markers. Furthermore, expression patterns of NR were categorized as five patterns. In particular, seven NR such as chicken ovalbumin upstream promoter transcription factor 1, retinoic acid receptor , peroxisome proliferator-activated receptor-, progesterone receptor, photoreceptor cell-specific nuclear receptor, tailless homolog orphan receptor and glucocorticoid receptor were identified as the genes of which expression gradually goes up with differentiation. ConclusionThese findings will be useful for not only elucidating mechanisms of hepatic differentiation of hiPS cells but also cell-based therapy for liver diseases.	[Itaba, Noriko; Aramaki, Natsumi; Yasui, Toshihiro; Matsumi, Yoshiaki; Kono, Yohei; Shiota, Goshi] Tottori Univ, Grad Sch Med, Div Mol & Genet Med, Yonago, Tottori 6838504, Japan; [Otsu, Makoto] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Stem Cell Bank, Tokyo, Japan; [Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Kunisada, Takahiro] Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev Regenerat & Adv Med Sci, Gifu, Japan; [Nakamura, Yukio] RIKEN BioResource Ctr, Cell Engn Div, Ibaraki, Japan; [Wairagu, Peninah M.; Phan, Ai N. H.; Jeong, Yangsik] Yonsei Univ, Inst Lifestyle Med, Dept Biochem, Wonju, South Korea; [Wairagu, Peninah M.; Phan, Ai N. H.; Jeong, Yangsik] Yonsei Univ, Wonju Coll Med, Nucl Receptor Res Consortium, Wonju, South Korea	Shiota, G (reprint author), Tottori Univ, Grad Sch Med, Div Mol & Genet Med, 36-1 Nishi Machi, Yonago, Tottori 6838504, Japan.	yjeong@yonsei.ac.kr; gshiota@med.tottori-u.ac.jp	Okano, Hideyuki/J-5973-2013; 	Kunisada, Takahiro/0000-0003-1651-2716; Kono, Yohei/0000-0001-8264-9417	Intractable Hepato-Biliary Disease Study Group of Health, Labor and Welfare of Japan; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2013R1A1A1A05005075]	THIS WORK WAS mainly supported by the Intractable Hepato-Biliary Disease Study Group of Health, Labor and Welfare of Japan (to G. S.), and was supported in part by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A1A05005075 to Y. J.).	DeLaForest A, 2011, DEVELOPMENT, V138, P4143, DOI 10.1242/dev.062547; Wagner M, 2011, HEPATOLOGY, V53, P1023, DOI 10.1002/hep.24148; Agarwal S, 2008, STEM CELLS, V26, P1117, DOI 10.1634/stemcells.2007-1102; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Gu PL, 2005, MOL CELL BIOL, V25, P8507, DOI 10.1128/MCB.25.19.8507-8519.2005; Takayama K, 2012, MOL THER, V20, P127, DOI 10.1038/mt.2011.234; Trauner M, 2011, GASTROENTEROLOGY, V140, P1120, DOI 10.1053/j.gastro.2011.02.044; Ahfeldt T, 2012, NAT CELL BIOL, V14, P209, DOI 10.1038/ncb2411; Hay DC, 2008, STEM CELLS, V26, P894, DOI 10.1634/stemcells.2007-0718; Kajiwara M, 2012, P NATL ACAD SCI USA, V109, P12538, DOI 10.1073/pnas.1209979109; Lee SB, 2012, STEM CELLS, V30, P997, DOI 10.1002/stem.1074; Wu JY, 2013, NEUROCHEM INT, V62, P92, DOI 10.1016/j.neuint.2012.09.016; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Tremblay GB, 2001, GENE DEV, V15, P833, DOI 10.1101/gad.873401; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Liu H, 2010, HEPATOLOGY, V51, P1810, DOI 10.1002/hep.23626; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Ding X, 2006, J BIOL CHEM, V281, P26540, DOI 10.1074/jbc.M600931200; Zhang YQ, 2008, FEBS LETT, V582, P10, DOI 10.1016/j.febslet.2007.11.015; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Chen YF, 2012, HEPATOLOGY, V55, P1193, DOI 10.1002/hep.24790; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; Bonala S, 2012, J BIOL CHEM, V287, P12935, DOI 10.1074/jbc.M111.319145; Drosos GK, 2013, STEM CELL REV, V9, P668; Funakoshi N, 2011, STEM CELL REV REP, V7, P518, DOI 10.1007/s12015-010-9225-3; Gu PL, 2006, MOL CELL BIOL, V26, P9471, DOI 10.1128/MCB.00898-06; Hang J, 2009, LIVER INT, V29, P1569; He YW, 2002, J LEUKOCYTE BIOL, V72, P440; Jeong Y, 2009, EXP MOL MED, V41, P525, DOI 10.3858/emm.2009.41.8.091; Nasu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053771; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Park CH, 2012, DEVELOPMENT, V139, P2447, DOI 10.1242/dev.075978; Park SJ, 2013, BIOMED RES INT, DOI 10.1155/2013/375076; Wang Q, 2013, ADV EXP MED BIOL, V786, P287, DOI 10.1007/978-94-007-6621-1_16; Xie CQ, 2009, MOL ENDOCRINOL, V23, P724, DOI 10.1210/me.2008-0465; Zhuang Y, 2008, DIFFERENTIATION, V76, P760, DOI 10.1111/j.1432-0436.2007.00258.x	45	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E408	E419		10.1111/hepr.12329		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200010		
J	Kan, H; Kimura, Y; Hyogo, H; Fukuhara, T; Fujino, H; Naeshiro, N; Honda, Y; Kawaoka, T; Tsuge, M; Hiramatsu, A; Imamura, M; Kawakami, Y; Aikata, H; Ochi, H; Arihiro, K; Chayama, K				Kan, Hiromi; Kimura, Yuki; Hyogo, Hideyuki; Fukuhara, Takayuki; Fujino, Hatsue; Naeshiro, Noriaki; Honda, Yohji; Kawaoka, Tomokazu; Tsuge, Masataka; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiku; Aikata, Hiroshi; Ochi, Hidenori; Arihiro, Koji; Chayama, Kazuaki			Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease	HEPATOLOGY RESEARCH			English	Article						liver to spleen ratio; non-alcoholic fatty liver disease; non-invasive assessment; steatotic grade	COMPUTED-TOMOGRAPHY; INSULIN-RESISTANCE; STEATOHEPATITIS; PREVALENCE; UTILITY; DONORS; COMMON; JAPAN; CT	AimThe diagnosis of non-alcoholic fatty liver disease (NAFLD) is based on the histological findings. Further, there may be interobserver differences. Liver to spleen (L/S) ratio on computed tomography (CT) is employed to detect or even quantify the fat content of the liver. The objective of this study was to accurately diagnose fatty liver by evaluating the relationship between L/S ratio and histological findings. MethodsSixty-seven biopsy-proven NAFLD patients were enrolled. L/S ratio on CT was calculated. The area of steatosis in liver specimens was measured by BIOREVO BZ-9000 microscope, and the percentage of steatosis was calculated using Dynamic cell count BZ-H1C software. ResultsSteatotic grade assessed by pathologist was significantly correlated with the percentage of steatosis and L/S ratio. Factors associated with steatosis were L/S ratio, aspartate aminotransferase and Homeostasis Model of Assessment - Insulin Resistance as determined by multivariate analysis. L/S ratios were: S0, 1.160.20 (mean +/- standard deviation); S1, 0.88 +/- 0.28; S2, 0.76 +/- 0.20; and S3, 0.40 +/- 0.18, respectively. The optimal cut-off value of L/S ratio to exclude steatosis was 1.1, and the area under the receiver-operator curve for the diagnosis of steatosis was 0.886. ConclusionOur study suggests that while 0% of steatosis showed 1.296 L/S ratio, the cut-off value of L/S ratio would be 1.1 at least to exclude clinically important liver steatosis.	[Kan, Hiromi; Hyogo, Hideyuki; Fukuhara, Takayuki; Fujino, Hatsue; Naeshiro, Noriaki; Honda, Yohji; Kawaoka, Tomokazu; Tsuge, Masataka; Hiramatsu, Akira; Imamura, Michio; Kawakami, Yoshiiku; Aikata, Hiroshi; Ochi, Hidenori; Chayama, Kazuaki] Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Hiroshima 7348551, Japan; [Arihiro, Koji] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima 7348551, Japan; [Kimura, Yuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Epidemiol Infect Dis Control & Preven, Hiroshima, Japan	Hyogo, H (reprint author), Hiroshima Univ Hosp, Dept Gastroenterol & Metab, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	hidehyogo@hiroshima-u.ac.jp					Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Iwamoto K, 2008, J GASTROENTEROL, V43, P298, DOI 10.1007/s00535-007-2152-7; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Hamaguchi M, 2005, ANN INTERN MED, V143, P722; Amarapurkar DN, 2007, J GASTROEN HEPATOL, V22, P788, DOI 10.1111/j.1440-1746.2007.05042.x; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; James O, 1999, LANCET, V353, P1634; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Teli MR, 1995, HEPATOLOGY, V22, P1714, DOI 10.1016/0270-9139(95)90196-5; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Iwasaki M, 2004, TRANSPLANTATION, V78, P1501, DOI 10.1097/01.TP.0000140499.23683.0D; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Schwenzer NF, 2009, J HEPATOL, V51, P433, DOI 10.1016/j.jhep.2009.05.023; Goldaracena N, 2012, TRANSPL P, V44, P2219, DOI 10.1016/j.transproceed.2012.07.113; Park SH, 2006, RADIOLOGY, V239, P105, DOI 10.1148/radiol.2391050361; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Charatcharoenwitthaya Phunchai, 2007, Clin Liver Dis, V11, P37, DOI 10.1016/j.cld.2007.02.014; Farrell GC, 2006, HEPATOLOGY, V43, P99; Hyogo H, 2007, J GASTROEN HEPATOL, V22, P1114; Masaki K, 2013, HEPATOL RES, V43, P1182, DOI 10.1111/hepr.12094; Negro F, 2009, J VIRAL HEPATITIS, V16, P681, DOI 10.1111/j.1365-2893.2009.01186.x; Ohnishi M, 2012, J GASTROENTEROL, V47, P834, DOI 10.1007/s00535-012-0550-y; Okanoue T, 2011, J GASTROEN HEPATOL, V26, P153, DOI 10.1111/j.1440-1746.2010.06547.x; Oliva MR, 2006, J COMPUT ASSIST TOMO, V30, P37, DOI 10.1097/01.rct.0000193818.31749.84; PIEKARSKI J, 1980, RADIOLOGY, V137, P727; Ricci C, 1997, J HEPATOL, V27, P108, DOI 10.1016/S0168-8278(97)80288-7; The World Medical Association Inc, 2008, DECL HELS ETH PRINC	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E420	E427		10.1111/hepr.12330		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200011		
J	Katayama, K; Ohkawa, K; Imanaka, K; Sakakibara, M; Miyazaki, M; Kimura, H; Ishihara, A; Matsunaga, T; Murata, M; Nakazawa, T; Nakanishi, K				Katayama, Kazuhiro; Ohkawa, Kazuyoshi; Imanaka, Kazuho; Sakakibara, Mitsuru; Miyazaki, Masanori; Kimura, Haruki; Ishihara, Akio; Matsunaga, Takashi; Murata, Masayuki; Nakazawa, Tetsuro; Nakanishi, Katsuyuki			Computed tomography during hepatic arteriography pattern may predict hepatocellular carcinoma recurrence following transarterial chemoembolization	HEPATOLOGY RESEARCH			English	Article						computed tomography during hepatic arteriography; hepatocellular carcinoma; imaging; metastasis; morphology; transarterial chemoembolization	TRANSCATHETER OILY CHEMOEMBOLIZATION; RANDOMIZED CONTROLLED TRIAL; ARTERIAL PORTOGRAPHY; LIPIODOL CHEMOEMBOLIZATION; MICROVASCULAR INVASION; GROSS CLASSIFICATION; GENE-EXPRESSION; HELICAL CT; CLIP SCORE; SORAFENIB	AimThis study aimed to determine the role of morphological patterns seen on imaging in predicting hepatocellular carcinoma recurrence following transarterial chemoembolization therapy. MethodsForty-seven patients from a single center who underwent transarterial chemoembolization to treat unresectable hepatocellular carcinomas between January 2011 and June 2012 were included in this study. We investigated whether the two pretreatment findings on computed tomography during hepatic arteriography (pattern 1, the single nodule pattern; pattern 2, at least one nodule showing the contiguous multinodular pattern) and other factors (age, sex, etiology, serum total bilirubin, serum albumin, prothrombin time, platelet count, serum level of protein induced by vitamin K absence/antagonist-II, serum -fetoprotein, number of previous treatments for hepatocellular carcinoma, tumor number and maximum tumor size, presence of hypovascular lesions) could predict post-treatment recurrence. ResultsIn a univariate analysis using Cox's proportional hazards model, serum total bilirubin, the serum level of protein induced by vitamin K absence/antagonist-II (100 vs 101mAU/mL), tumor morphology (pattern 1 vs 2) and tumor number (3 vs 4) showed statistical significance (0.05). In a multivariate analysis of these factors, morphology and tumor number showed significance. According to Kaplan-Meier estimation, the cumulative disease-free survival rates were significantly lower in patients with four or more lesions than in those with three or less lesions and in patients showing pattern 2 than in those showing pattern 1. ConclusionPatients with pattern 2 hepatocellular carcinoma and/or four or more lesions may have a relatively high recurrence rate after transarterial chemoembolization.	[Katayama, Kazuhiro; Ohkawa, Kazuyoshi; Imanaka, Kazuho; Sakakibara, Mitsuru; Miyazaki, Masanori; Kimura, Haruki; Ishihara, Akio] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Osaka 5378511, Japan; [Matsunaga, Takashi] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Med Informat, Osaka 5378511, Japan; [Murata, Masayuki; Nakazawa, Tetsuro; Nakanishi, Katsuyuki] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiat Oncol, Osaka 5378511, Japan	Katayama, K (reprint author), Osaka Med Ctr Canc & Cardiovasc Dis, Dept Hepatobiliary & Pancreat Oncol, Higashinari Ku, 1-3-3 Nakamichi, Osaka 5378511, Japan.	katayama-ka@mc.pref.osaka.jp					American Cancer Society, 2011, GLOB CANC FACTS FIG; Hyodo T, 2013, RADIOLOGY, V266, P480, DOI 10.1148/radiol.12112677; Inayoshi J, 2003, J GASTROEN HEPATOL, V18, P673, DOI 10.1046/j.1440-1746.2003.03021.x; Kudo M, 2011, EUR J CANCER, V47, P2117, DOI 10.1016/j.ejca.2011.05.007; Desmet VJ, 2009, HEPATOLOGY, V49, P355, DOI 10.1002/hep.22681; MATSUI O, 1983, RADIOLOGY, V146, P721; Kudo M, 2004, HEPATOLOGY, V40, P1396, DOI 10.1002/hep.20486; Chung YH, 2013, INT J CANCER, V132, P2448, DOI 10.1002/ijc.27925; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; Murakata A, 2011, ANN SURG, V253, P94, DOI 10.1097/SLA.0b013e3181f9bc00; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Yang LY, 2009, ANN SURG, V249, P118, DOI 10.1097/SLA.0b013e3181904988; Shimada M, 2001, AM J SURG, V182, P177, DOI 10.1016/S0002-9610(01)00682-1; KANAI T, 1987, CANCER, V60, P810, DOI 10.1002/1097-0142(19870815)60:4<810::AID-CNCR2820600417>3.0.CO;2-1; Murakami T, 1997, AM J ROENTGENOL, V169, P131; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Sansonno D, 2012, ONCOLOGIST, V17, P359, DOI 10.1634/theoncologist.2011-0313; Perrone F, 2000, HEPATOLOGY, V31, P840; Pawlik TM, 2011, J CLIN ONCOL, V29, P3960, DOI 10.1200/JCO.2011.37.1021; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Choi GH, 2009, AM J SURG, V198, P693, DOI 10.1016/j.amjsurg.2008.09.019; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hui AM, 2000, J HEPATOL, V33, P975, DOI 10.1016/S0168-8278(00)80131-2; OBERTI F, 1995, NEW ENGL J MED, V332, P1256; HASHIMOTO T, 1995, CARDIOVASC INTER RAD, V18, P82, DOI 10.1007/BF02807227; HEIKEN JP, 1989, RADIOLOGY, V171, P47; Kanematsu M, 1997, AM J ROENTGENOL, V169, P1507; Katoh H, 2007, GASTROENTEROLOGY, V133, P1475, DOI 10.1053/j.gastro.2007.08.038; Kawaguchi T, 2012, HEPATO-GASTROENTEROL, V59, P219, DOI 10.5754/hge11258; Kawamura Y, 2011, AM J ROENTGENOL, V197, pW665, DOI 10.2214/AJR.11.6843; Kawamura Y, 2010, HEPATOL RES, V40, P1006, DOI 10.1111/j.1872-034X.2010.00703.x; Liver Cancer Study Group of Japan, 2003, GEN RUL CLIN PATH ST; Muto Y, 1996, NEW ENGL J MED, V334, P1561, DOI 10.1056/NEJM199606133342402; Nagano Y, 2008, WORLD J SURG, V32, P2218, DOI 10.1007/s00268-008-9585-x; NAKAMURA H, 1993, HEPATO-GASTROENTEROL, V40, P6; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Takai K, 2005, INTERVIROLOGY, V48, P39, DOI 10.1159/000082093	40	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E455	E463		10.1111/hepr.12337		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200015		
J	Kudo, A; Matsumura, S; Ban, D; Irie, T; Ochiai, T; Tanaka, S; Arii, S; Tanabe, M				Kudo, Atsushi; Matsumura, Satoshi; Ban, Daisuke; Irie, Takumi; Ochiai, Takanori; Tanaka, Shinji; Arii, Shigeki; Tanabe, Minoru			Does the preoperative alpha-fetoprotein predict the recurrence and mortality after hepatectomy for hepatocellular carcinoma without macrovascular invasion in patients with normal liver function?	HEPATOLOGY RESEARCH			English	Article						alpha-fetoprotein; liver function; microvascular invasion; normal liver function; prognosis	GAMMA-CARBOXY PROTHROMBIN; MICROVASCULAR INVASION; ANATOMIC RESECTION; PROGNOSTIC VALUE; MILAN CRITERIA; TUMOR-MARKERS; TRANSPLANTATION; SURVIVAL; CIRRHOSIS; IMPROVES	AimIt has been highly controversial whether elevated serum -fetoprotein (AFP) level before hepatectomy predicts recurrence and mortality of patients with hepatocellular carcinoma (HCC) or not. This study is to identify whether the index predicts recurrence and mortality after hepatectomy in HCC. MethodsOf 568 consecutive patients, 342 with normal liver function (Child-Pugh score, 5) and no macrovascular invasion were enrolled between April 2000 and March 2013. Multivariate analysis was performed to identify risk factors for disease-free survival (DFS) and overall survival (OS). ResultsIn multivariate analysis, the elevated serum AFP level was an independent risk factor for DFS (hazard ratio [HR], 1.9; P<0.0001) and OS (HR, 2.0; P<0.0001). Histological hepatic venous tumor thrombus was also an independent risk factor for DFS (HR, 2.6; P<0.0001) and OS (HR, 2.5; P=0.001). Anatomical resection decreases the risk factor for recurrence after hepatectomy (HR, 0.6; P=0.003), though it did not decrease the risk for OS (P=0.3). At 5 years, DFS rates were 42% and 21% (P<0.0001) and OS rates were 75% and 46% among patients with low and high AFP levels, respectively (P<0.0001). The area under the receiver-operator curves (AUROC) of serum AFP and des--carboxy prothrombin were 0.65 and 0.58 for DFS and 0.65 and 0.57 for OS, respectively. Tumor size was the best predictor of microvascular invasion (AUROC, 0.70, P<0.0001). ConclusionSerum AFP was a highly reliable index for DFS and OS.	[Kudo, Atsushi; Matsumura, Satoshi; Ban, Daisuke; Irie, Takumi; Ochiai, Takanori; Tanaka, Shinji; Arii, Shigeki; Tanabe, Minoru] Tokyo Med & Dent Univ, Dept Hepatobiliary Pancreat Surg, Tokyo 1138519, Japan	Kudo, A (reprint author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Hepatobiliary Pancreat Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	kudomsrg@tmd.ac.jp		Ban, Daisuke/0000-0003-0868-8519			Trevisani F, 2001, J HEPATOL, V34, P570, DOI 10.1016/S0168-8278(00)00053-2; Bertino G, 2011, MINERVA MED, V102, P363; Muscari F, 2012, WORLD J SURG, V36, P1824, DOI 10.1007/s00268-012-1587-z; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Shindoh J, 2013, HPB, V15, P31, DOI 10.1111/j.1477-2574.2012.00552.x; Kim HS, 2009, J CLIN GASTROENTEROL, V43, P482, DOI 10.1097/MCG.0b013e318182015a; Murakata A, 2011, ANN SURG, V253, P94, DOI 10.1097/SLA.0b013e3181f9bc00; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; Schiodt FV, 2006, LIVER TRANSPLANT, V12, P1776, DOI 10.1002/lt.20886; Kiriyama S, 2011, ANN SURG, V254, P984, DOI 10.1097/SLA.0b013e3182215016; Lim KC, 2011, ANN SURG, V254, P108, DOI 10.1097/SLA.0b013e31821ad884; Duvoux C, 2012, GASTROENTEROLOGY, V143, P986, DOI 10.1053/j.gastro.2012.05.052; Wang CC, 2009, ANN SURG ONCOL, V16, P1832, DOI 10.1245/s10434-009-0448-y; Bhangui P, 2011, HEPATOLOGY, V53, P1570, DOI 10.1002/hep.24231; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yamashita Y, 2007, J AM COLL SURGEONS, V205, P19, DOI 10.1016/j.jamcollsurg.2007.01.069; Lauwers GY, 2002, AM J SURG PATHOL, V26, P25, DOI 10.1097/00000478-200201000-00003; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Fujiki M, 2009, AM J TRANSPLANT, V9, P2362, DOI 10.1111/j.1600-6143.2009.02783.x; Todo S, 2007, LIVER TRANSPLANT, V13, pS48, DOI 10.1002/lt.21334; Aragon Robert J, 2012, J Gastrointest Oncol, V3, P28, DOI 10.3978/j.issn.2078-6891.2012.006; Chan SC, 2011, HEPATOL INT; Chen JG, 2011, DIGEST DIS SCI, V56, P1626, DOI 10.1007/s10620-010-1482-0; Cucchetti A, 2012, ANN SURG ONCOL, V19, P3697, DOI 10.1245/s10434-012-2450-z; Gotoh M, 2003, JPN J CLIN ONCOL, V33, P522, DOI 10.1093/jjco/hyg096; Kudo A, 2014, AM J SURG, V207, P863, DOI 10.1016/j.amjsurg.2013.06.009; Kudo A, 2013, J GASTROENTEROL; Lee YH, 2012, J GASTROINTEST SURG, V17, P730; Mailey B, 2011, ARCH SURG-CHICAGO, V146, P26, DOI 10.1001/archsurg.2010.295; Mazzoferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mitsunori Y, 2012, J HEPATOBILIARY PANC, V20, P234; Okuda H, 1999, CANCER, V85, P812, DOI 10.1002/(SICI)1097-0142(19990215)85:4<812::AID-CNCR8>3.0.CO;2-O; Regimbeau JM, 2002, SURGERY, V131, P311, DOI 10.1067/msy.2002.121892; Rodriguez-Peralvarez M, 2013, ANN SURG ONCOL, V20, P325, DOI 10.1245/s10434-012-2513-1; Sato K, 2012, HEPATOLOGY, V57, P1436; Shi M, 2004, WORLD J SURG, V28, P376, DOI 10.1007/s00268-003-7308-x; Shim JH, 2012, ANN SURG ONCOL, V19, P3687, DOI 10.1245/s10434-012-2416-1; Sumie S, 2008, ANN SURG ONCOL, V15, P1375, DOI 10.1245/s10434-008-9846-9; Toyoda H, 2008, J HEPATOL, V49, P223, DOI 10.1016/j.jhep.2008.04.013; Wakai T, 2007, ANN SURG ONCOL, V14, P1356, DOI 10.1245/s10434-006-9318-z; Yin JJ, 2014, STAT MED, V33, P985, DOI 10.1002/sim.5992; Zhou YM, 2011, LANGENBECK ARCH SURG, V396, P1109, DOI 10.1007/s00423-011-0784-9	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E437	E446		10.1111/hepr.12335		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200013		
J	Masuya, M; Shiraki, K; Sugimoto, K; Yamamoto, N; Yoneda, M; Kanayama, K; Nishikawa, K; Ino, K; Tawara, I; Ohishi, K; Sakurai, H; Usui, M; Shiraishi, T; Isaji, S; Takei, Y; Katayama, N				Masuya, Masahiro; Shiraki, Katsuya; Sugimoto, Kazushi; Yamamoto, Norihiko; Yoneda, Misao; Kanayama, Kazuki; Nishikawa, Kenichiro; Ino, Kazuko; Tawara, Isao; Ohishi, Kohshi; Sakurai, Hiroyuki; Usui, Masanobu; Shiraishi, Taizo; Isaji, Shuji; Takei, Yoshiyuki; Katayama, Naoyuki			Splenectomy increases the number of circulating hematopoietic stem/progenitor cells in patients with hepatitis C virus-associated liver cirrhosis	HEPATOLOGY RESEARCH			English	Article						hematopoietic stem; progenitor cells; hepatitis C virus; liver cirrhosis; splenectomy	BONE-MARROW; PERIPHERAL-BLOOD; STEM-CELL; PROGENITOR CELLS; CD34(+) CELLS; MYOCARDIAL-INFARCTION; CXCR4-POSITIVE CELLS; ENDOTHELIAL-CELLS; FACTOR-I; MOBILIZATION	AimThe spleen is not believed to contribute to hematopoiesis in healthy adults. However, several reports have demonstrated that the spleen in adults contains a large number of hematopoietic stem/progenitor cells (HSC). Although splenectomy increases platelet and leukocyte counts, the effects of splenectomy on circulating HSC have not been elucidated. In this study, we evaluated the association between the number of circulating HSC and splenectomy in patients with hepatitis C virus (HCV)-associated liver cirrhosis (LC). MethodsIn 48 patients with various stages of HCV-associated chronic liver disease and seven patients with LC who underwent splenectomy, and 10 healthy volunteers, we determined the numbers of circulating CD34(+) cells and colony-forming unit culture by flow cytometry and methylcellulose culture, respectively. Plasma stromal cell-derived factor-1 (SDF-1) concentrations were measured using an enzyme-linked immunosorbent assay. ResultsThe numbers of circulating CD34(+) cells and colony-forming unit culture decreased but the plasma SDF-1 concentration increased with the progression of liver disease. There was an inverse correlation between the number of circulating HSC and the plasma SDF-1 concentration. The numbers of circulating HSC and platelets were determined before and after splenectomy in seven patients with LC. In these patients, the numbers of circulating HSC and platelets increased significantly after splenectomy and the enhancing effect persisted for a long time. ConclusionOur data suggest that the spleen plays an important role in modulating HSC dynamics in patients with HCV-associated chronic liver disease. Our results also imply that splenectomy may improve liver function in patients with LC.	[Masuya, Masahiro; Nishikawa, Kenichiro; Ino, Kazuko; Tawara, Isao; Ohishi, Kohshi; Katayama, Naoyuki] Mie Univ, Grad Sch Med, Dept Hematol & Oncol, Tsu, Mie 5148507, Japan; [Shiraki, Katsuya; Sugimoto, Kazushi; Yamamoto, Norihiko; Takei, Yoshiyuki] Mie Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Tsu, Mie 5148507, Japan; [Kanayama, Kazuki; Shiraishi, Taizo] Mie Univ, Grad Sch Med, Dept Oncol Pathol, Tsu, Mie 5148507, Japan; [Sakurai, Hiroyuki; Usui, Masanobu; Isaji, Shuji] Mie Univ, Grad Sch Med, Dept Transplantat & Hepatobiliary Pancreat Surg, Tsu, Mie 5148507, Japan; [Yoneda, Misao] Suzuka Univ Med Sci, Dept Clin Nutr, Suzuka, Japan	Masuya, M (reprint author), Mie Univ, Grad Sch Med, Dept Hematol & Oncol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	mmasuya@clin.medic.mie-u.ac.jp			Japan Society for the Promotion of Science [18591055]	THIS WORK WAS supported in part by Grants-in-Aid for Scientific Research (C) for 2006-2007 (to M. M., grant no. 18591055) from the Japan Society for the Promotion of Science.	Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Idilman R, 2004, TRANSPLANTATION, V78, P1647, DOI 10.1097/01.TP.0000144055.78462.4F; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; MURRAY L, 1995, BLOOD, V85, P368; Peichev M, 2000, BLOOD, V95, P952; FREEDMAN MH, 1981, AM J HEMATOL, V11, P271, DOI 10.1002/ajh.2830110307; Kim JK, 2010, CELL TRANSPLANT, V19, P1237, DOI 10.3727/096368910X506863; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132; Wright LM, 2005, BONE, V36, P840, DOI 10.1016/j.bone.2005.01.021; Tavor S, 2004, CANCER RES, V64, P2817, DOI 10.1158/0008-5472.CAN-03-3693; Carlo-Stella C, 2004, BLOOD, V103, P3287, DOI 10.1182/blood-2003-07-2428; Gehling UM, 2010, WORLD J GASTROENTERO, V16, P217, DOI 10.3748/wjg.v16.i2.217; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Terada R, 2003, LAB INVEST, V83, P665, DOI 10.1097/01.LAB.0000067498.89585.06; MCBRIDE JA, 1968, BRIT J HAEMATOL, V14, P225, DOI 10.1111/j.1365-2141.1968.tb01489.x; Si Y, 2010, J CLIN INVEST, V120, P1192, DOI 10.1172/JCI40310; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Paczkowska E, 2005, EUR J HAEMATOL, V75, P461, DOI 10.1111/j.1600-0609.2005.00536.x; Wald O, 2004, EUR J IMMUNOL, V34, P1164, DOI 10.1002/eji.200324441; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Kucia M, 2004, CIRC RES, V95, P1191, DOI 10.1161/01.RES.0000150856.47324.5b; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Bashour FN, 2000, AM J GASTROENTEROL, V95, P2936, DOI 10.1016/S0002-9270(00)01117-5; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; BARR RD, 1975, SCIENCE, V190, P284, DOI 10.1126/science.1179209; BENDER JG, 1991, BLOOD, V77, P2591; BERMAN L, 1949, BLOOD, V4, P511; Bidus MA, 2006, INT J GYNECOL CANCER, V16, P1957, DOI 10.1111/j.1525-1438.2006.00725.x; Brunner S, 2007, AM J PHYSIOL-ENDOC M, V293, pE1670, DOI 10.1152/ajpendo.00287.2007; D'Arena G, 1998, HAEMATOLOGICA, V83, P587; Di Campli C, 2005, TRANSPLANT P, V37, P2563, DOI 10.1016/j.transproceed.2005.06.072; Dor FJMF, 2006, EXP HEMATOL, V34, P1573, DOI 10.1016/j.exphem.2006.06.016; Ghanem LY, 2012, J DIGEST DIS, V13, P571, DOI 10.1111/j.1751-2980.2012.00634.x; Hamada T, 1998, J EXP MED, V188, P539, DOI 10.1084/jem.188.3.539; Iwamoto T, 2012, J GASTROENTEROL, V47, P300, DOI 10.1007/s00535-011-0486-7; Kantele JM, 2000, J IMMUNOL, V164, P5035; Klco JM, 2010, AM J HEMATOL, V85, P106, DOI 10.1002/ajh.21600; Mirzania M, 2010, BONE MARROW TRANSPL, V45, P694, DOI 10.1038/bmt.2009.229; Okubo M, 2000, CLIN SCI, V99, P207, DOI 10.1042/CS20000023; Shenoy GN, 2012, J IMMUNOL, V189, P521, DOI 10.4049/jimmunol.1102814; Soderdahl G, 1998, BONE MARROW TRANSPL, V21, P79, DOI 10.1038/sj.bmt.1701039; TO LB, 1994, BLOOD, V84, P2930; Wulf GG, 2003, HAEMATOLOGICA, V88, P368; Yoshida D, 2012, HEPATOL INT, V6, P657, DOI 10.1007/s12072-011-9315-6	47	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E376	E385		10.1111/hepr.12319		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200007		
J	Miura, M; Maekawa, S; Sato, M; Komatsu, N; Tatsumi, A; Takano, S; Amemiya, F; Nakayama, Y; Inoue, T; Sakamoto, M; Enomoto, N				Miura, Mika; Maekawa, Shinya; Sato, Mitsuaki; Komatsu, Nobutoshi; Tatsumi, Akihisa; Takano, Shinichi; Amemiya, Fumitake; Nakayama, Yasuhiro; Inoue, Taisuke; Sakamoto, Minoru; Enomoto, Nobuyuki			Deep sequencing analysis of variants resistant to the non-structural 5A inhibitor daclatasvir in patients with genotype 1b hepatitis C virus infection	HEPATOLOGY RESEARCH			English	Article						deep sequencing; hepatitis C virus; NS5A inhibitor; resistance	COMBINATION THERAPY; RIBAVIRIN THERAPY; ANTIVIRAL AGENTS; REPLICON SYSTEM; NULL RESPONDERS; IN-VITRO; INTERFERON; PROTEIN; ASSOCIATION; ASUNAPREVIR	AimDaclatasvir, a non-structural (NS)5A replication complex inhibitor, is a potent and promising direct antiviral agent (DAA) for hepatitis C virus (HCV), being most effective in genotype 1b infection. Although it is known that genotype 1b viruses with Y93H and/or L31M/V/F mutations have strong resistance to daclatasvir, it is not known whether there are some clinical background conditions that favor the occurrence of HCV carrying those NS5A mutations. MethodsIn this study, we carried out deep sequencing analysis of stored sera to determine the presence and significance of daclatasvir-resistant mutants in 110 genotype 1b HCV-infected patients with no previous daclatasvir treatment. ResultsDeep sequencing analysis revealed that the NS5A L31M/V/F and Y93H mutations were present in 13 (11.8%) and 34 (30.9%) of the 110 patients, respectively, and significantly more frequently than in the control plasmid. Simultaneous L31M/V/F and Y93H mutations were detected in four of the 110 patients (3.6%). When the clinical relevance of NS5A resistance was investigated, Y93H was significantly correlated with the IL28B major (TT) genotype of the host (P=0.042). ConclusionY93H was detected frequently by deep sequencing in daclatasvir treatment-naive patients. Importantly, it seems that the IL28B status of the patients may influence the presence of Y93H mutations, resulting in different treatment responses to daclatasvir.	[Miura, Mika; Maekawa, Shinya; Sato, Mitsuaki; Komatsu, Nobutoshi; Tatsumi, Akihisa; Takano, Shinichi; Amemiya, Fumitake; Nakayama, Yasuhiro; Inoue, Taisuke; Sakamoto, Minoru; Enomoto, Nobuyuki] Univ Yamanashi, Fac Med, Dept Internal Med 1, Chuo Ku, Yamanashi 4093898, Japan	Maekawa, S (reprint author), Univ Yamanashi, Fac Med, Dept Internal Med 1, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	maekawa@yamanashi.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [23390195, 23791404, 24590964, 24590965]; Ministry of Health, Labor and Welfare of Japan [H23-kanen-001, H23-kanen-004, H23-kanen-006, H24-kanen-002, H24-kanen-004, H25-kanen-006]	This study was supported in part by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan (23390195, 23791404, 24590964 and 24590965), and in part by a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan (H23-kanen-001, H23-kanen-004, H23-kanen-006, H24-kanen-002, H24-kanen-004 and H25-kanen-006).	Akuta N, 2013, J MED VIROL, V85, P1028, DOI 10.1002/jmv.23579; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; McPhee F, 2013, HEPATOLOGY, V58, P902, DOI 10.1002/hep.26388; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Scheel TKH, 2011, GASTROENTEROLOGY, V140, P1032, DOI 10.1053/j.gastro.2010.11.036; Fridell RA, 2011, HEPATOLOGY, V54, P1924, DOI 10.1002/hep.24594; Kurosaki M, 2011, J HEPATOL, V54, P439, DOI 10.1016/j.jhep.2010.07.037; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Pol S, 2012, LANCET INFECT DIS, V12, P671, DOI 10.1016/S1473-3099(12)70138-X; Karino Y, 2013, J HEPATOL, V58, P646, DOI 10.1016/j.jhep.2012.11.012; Hiraga N, 2011, HEPATOLOGY, V54, P781, DOI 10.1002/hep.24460; Suzuki F, 2012, J CLIN VIROL, V54, P352, DOI 10.1016/j.jcv.2012.04.024; El-Shamy A, 2008, HEPATOLOGY, V48, P38, DOI 10.1002/hep.22339; Miura M, 2013, J VIROL, V87, P12541, DOI 10.1128/JVI.00826-13; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Fridell RA, 2010, ANTIMICROB AGENTS CH, V54, P3641, DOI 10.1128/AAC.00556-10; Suzuki Y, 2013, J HEPATOL, V58, P655, DOI 10.1016/j.jhep.2012.09.037; Friborg J, 2013, ANTIMICROB AGENTS CH, V57, P1312, DOI 10.1128/AAC.02239-12; Gates AT, 2004, VIRUS RES, V100, P213, DOI 10.1016/j.virusres.2003.12.039; Londono MC, 2013, J HEPATOL, V58, P643, DOI 10.1016/j.jhep.2013.01.007; Maekawa S, 2012, HEPATOLOGY, V56, P1611, DOI 10.1002/hep.25826; Miura M, 2012, HEPATOL INT, V6, P386, DOI 10.1007/s12072-011-9307-6; Nagayama K, 1999, VIROLOGY, V263, P244, DOI 10.1006/viro.1999.9924	28	7	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E360	E367		10.1111/hepr.12316		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200005		
J	Morimoto, Y; Nouso, K; Wada, N; Takeuchi, Y; Kinugasa, H; Miyahara, K; Yasunaka, T; Kuwaki, K; Onishi, H; Ikeda, F; Miyake, Y; Nakamura, S; Shiraha, H; Takaki, A; Yamamoto, K				Morimoto, Yuki; Nouso, Kazuhiro; Wada, Nozomu; Takeuchi, Yasuto; Kinugasa, Hideaki; Miyahara, Koji; Yasunaka, Tetsuya; Kuwaki, Kenji; Onishi, Hideki; Ikeda, Fusao; Miyake, Yasuhiro; Nakamura, Shinichiro; Shiraha, Hidenori; Takaki, Akinobu; Yamamoto, Kazuhide			Involvement of platelets in extrahepatic metastasis of hepatocellular carcinoma	HEPATOLOGY RESEARCH			English	Article						extrahepatic metastasis; hepatocellular carcinoma; platelet counts; prognosis	RENAL-CELL CARCINOMA; TUMOR-METASTASIS; THROMBOCYTOSIS; COUNT; SURVIVAL; CANCER; JAPAN; LUNG	AimRecently, a relationship between platelets and cancer metastasis has been reported. The aim of this study is to elucidate the risk factors for extrahepatic metastasis (EHM), with emphasis on association with platelets in patients, with hepatocellular carcinoma (HCC). MethodsWe examined risk factors for EHM in 1613 consecutive, newly diagnosed HCC patients by logistic regression analysis (case-control study). We also examined the factors by Cox proportional hazard model in a retrospective cohort fashion in 803 patients who received non-curative treatment for HCC. ResultsIn the case-control study, multivariate analysis revealed that high platelet counts (odds ratio [OR]=4.84; 95% confidence interval [CI]=1.29-29.54; P=0.01), high tumor number and the presence of macroscopic vascular invasion were significantly associated with EHM. In the cohort study, EHM was diagnosed in 71 patients during the study period (mean observation time=23.3 months). On multivariate analysis, high tumor number, high des--carboxyprothrombin (DCP) and Child-Pugh class A were significantly correlated with EHM, and the patients with high platelet counts tended to develop EHM (OR=1.73; 95% CI=0.99-3.14; P=0.055). ConclusionHCC patients with high platelet counts, as well as large numbers of tumors, high serum DCP and Child-Pugh class A, are at risk for EHM.	[Morimoto, Yuki; Nouso, Kazuhiro; Wada, Nozomu; Takeuchi, Yasuto; Kinugasa, Hideaki; Miyahara, Koji; Yasunaka, Tetsuya; Kuwaki, Kenji; Onishi, Hideki; Ikeda, Fusao; Miyake, Yasuhiro; Nakamura, Shinichiro; Shiraha, Hidenori; Takaki, Akinobu; Yamamoto, Kazuhide] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Okayama 7008558, Japan	Nouso, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol & Hepatol, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	nouso@cc.okayama-u.ac.jp			Japan Society for the Promotion of Science [KAKENHI 23590976]	THIS WORK WAS supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (KAKENHI 23590976).	Adams PC, 2004, HEPATOLOGY, V39, P1204, DOI 10.1002/hep.20169; Addario L, 2011, DIGEST LIVER DIS, V43, P319, DOI 10.1016/j.dld.2010.09.003; Bolondi L, 2003, J HEPATOL, V39, P1076, DOI 10.1016/S0168-8278(03)00349-0; Ayhan A, 2006, GYNECOL ONCOL, V103, P902, DOI 10.1016/j.ygyno.2006.05.034; Jain S, 2009, J THROMB HAEMOST, V7, P1713, DOI 10.1111/j.1538-7836.2009.03559.x; Laubli H, 2010, SEMIN CANCER BIOL, V20, P169, DOI 10.1016/j.semcancer.2010.04.005; Ikai I, 2010, HEPATOL RES, V40, P1043, DOI 10.1111/j.1872-034X.2010.00731.x; Kanda M, 2008, LIVER INT, V28, P1256, DOI 10.1111/j.1478-3231.2008.01864.x; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Malaguarnera G, 2010, DIGEST DIS SCI, V55, P2744, DOI 10.1007/s10620-010-1184-7; Suzuki M, 2005, J BIOL CHEM, V280, P6409, DOI 10.1074/jbc.M406714200; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Gay LJ, 2011, NAT REV CANCER, V11, P123, DOI 10.1038/nrc3004; Nouso K, 2010, ALIMENT PHARM THER, V31, P407, DOI 10.1111/j.1365-2036.2009.04179.x; Camerer E, 2004, BLOOD, V104, P397, DOI 10.1182/blood-2004-02-0434; Guiu B, 2010, CLIN GASTROENTEROL H, V8, P986, DOI 10.1016/j.cgh.2010.07.018; Bensalah K, 2006, J UROLOGY, V175, P859, DOI 10.1016/S0022-5347(05)00526-4; Brockmann MA, 2007, NEURO-ONCOLOGY, V9, P335, DOI 10.1215/15228517-2007-013; Brown K, 2005, PSYCHOLOGIST, V18, P3; COSTANTINI V, 1990, THROMB HAEMOSTASIS, V64, P501; desNoronha R, 1991, CLIN LAB HAEMATOL, V13, P127; Erdemir F, 2007, UROL INT, V79, P111, DOI 10.1159/000106322; Mitsunobu M, 1996, CLIN EXP METASTAS, V14, P520, DOI 10.1007/BF00115112; Palumbo JS, 2007, THROMB RES, V120, pS22, DOI 10.1016/S0049-3848(07)70127-5; Taucher S, 2003, THROMB HAEMOSTASIS, V89, P1098	25	6	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E353	E359		10.1111/hepr.12315		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200004		
J	Nagaoki, Y; Imamura, M; Kawakami, Y; Kan, H; Fujino, H; Fukuhara, T; Kobayashi, T; Ono, A; Nakahara, T; Naeshiro, N; Urabe, A; Yokoyama, S; Miyaki, D; Murakami, E; Kawaoka, T; Tsuge, M; Hiramatsu, A; Aikata, H; Takahashi, S; Hayes, CN; Ochi, H; Chayama, K				Nagaoki, Yuko; Imamura, Michio; Kawakami, Yoshiiku; Kan, Hiromi; Fujino, Hatsue; Fukuhara, Takayuki; Kobayashi, Tomoki; Ono, Atsushi; Nakahara, Takashi; Naeshiro, Noriaki; Urabe, Ayako; Yokoyama, Satoe; Miyaki, Daisuke; Murakami, Eisuke; Kawaoka, Tomokazu; Tsuge, Masataka; Hiramatsu, Akira; Aikata, Hiroshi; Takahashi, Shoichi; Hayes, C. Nelson; Ochi, Hidenori; Chayama, Kazuaki		Hiroshima Liver Study Grp	Interferon lambda 4 polymorphism affects on outcome of telaprevir, pegylated interferon and ribavirin combination therapy for chronic hepatitis C	HEPATOLOGY RESEARCH			English	Article						chronic hepatitis C; inteferon lambda 4; rapid virological response; sustained virological response; telaprevir	GENOME-WIDE ASSOCIATION; GENOTYPE 1 INFECTION; HEPATOCELLULAR-CARCINOMA; ITPA POLYMORPHISM; GENETIC-VARIATION; VIRAL RESPONSE; IL28B; HCV; PEGINTERFERON; VIRUS	AimThe predictive value of the recently identified interferon- (IFNL)4 polymorphism on the outcome of telaprevir (TVR), pegylated interferon (PEG IFN) plus ribavirin (RBV) combination therapy for chronic hepatitis C is unknown. MethodsWe assessed predictive factors for sustained virological response (SVR) for TVR, PEG IFN plus RBV combination therapy in 283 genotype 1 chronic hepatitis C patients. IFNL4 polymorphism ss469415590 was analyzed by Invader assay. ResultsSVR rates for patients with IFNL4 TT/TT genotype were significantly higher than for those with the IFNL4 TT/G or G/G genotypes (93% and 59%, respectively, P<0.0001). In a multivariate regression analysis, prior treatment history (treatment-naive patients or patients who relapsed during prior treatment) (odds ratio [OR], 2.385; P=0.028), rapid virological response (OR, 6.800; P<0.0001) and ss469415590 TT/TT genotype (OR, 8.064; P<0.0001) were identified as significant independent predictors for SVR. In patients with IFNL4 TT/G or G/G genotypes, SVR rates for non-RVR patients were significantly lower than RVR patients (22% and 75%, respectively, P<0.0001). ConclusionAnalysis of IFNL4 polymorphism is a valuable predictor in patients receiving TVR triple therapy.	[Nagaoki, Yuko; Imamura, Michio; Kawakami, Yoshiiku; Kan, Hiromi; Fujino, Hatsue; Fukuhara, Takayuki; Kobayashi, Tomoki; Ono, Atsushi; Nakahara, Takashi; Naeshiro, Noriaki; Urabe, Ayako; Yokoyama, Satoe; Miyaki, Daisuke; Murakami, Eisuke; Kawaoka, Tomokazu; Tsuge, Masataka; Hiramatsu, Akira; Aikata, Hiroshi; Takahashi, Shoichi; Hayes, C. Nelson; Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima 7348551, Japan; [Ochi, Hidenori; Chayama, Kazuaki] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Lab Digest Dis, Hiroshima, Japan	Chayama, K (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	chayama@hiroshima-u.ac.jp			Ministry of Health, Labor and Welfare; Ministry of Education Culture Sports Science and Technology, Government of Japan	This work was supported by Grants-in-Aid for scientific research and development from the Ministry of Health, Labor and Welfare and Ministry of Education Culture Sports Science and Technology, Government of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Akuta N, 2006, J MED VIROL, V78, P83, DOI 10.1002/jmv.20507; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Chayama K, 2011, J INFECT DIS, V204, P84, DOI 10.1093/infdis/jir210; Ochi H, 2010, GASTROENTEROLOGY, V139, P1190, DOI 10.1053/j.gastro.2010.06.071; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Akuta N, 2010, HEPATOLOGY, V52, P421, DOI 10.1002/hep.23690; SHIRATORI Y, 1995, HEPATOLOGY, V22, P1027, DOI 10.1016/0270-9139(95)90605-3; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Suzuki F, 2011, HEPATOLOGY, V53, P415, DOI 10.1002/hep.24058; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Hayashi N, 2012, J VIRAL HEPATITIS, V19, pE134, DOI 10.1111/j.1365-2893.2011.01528.x; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; TAKANO S, 1995, HEPATOLOGY, V21, P650; Kawakami Y, 2013, ANTIVIR THER; Motomura T, 2012, HEPATOL RES, V42, P288, DOI 10.1111/j.1872-034X.2011.00927.x; Nozawa Y, 2014, TISSUE ANTIGENS, V83, P45, DOI 10.1111/tan.12264; Saito H, 2012, HEPATOL RES, V42, P958, DOI 10.1111/j.1872-034X.2012.01013.x; Suzuki F, 2013, HEPATOL RES, V43, P691, DOI 10.1111/hepr.12009; Tsukada H, 2009, GASTROENTEROLOGY, V136, P1796, DOI 10.1053/j.gastro.2009.01.061; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501	28	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E447	E454		10.1111/hepr.12336		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200014		
J	Nishikawa, H; Enomoto, H; Nasu, A; Aizawa, N; Saito, M; Tamori, A; Kawada, N; Kimura, T; Osaki, Y; Nishiguchi, S				Nishikawa, Hiroki; Enomoto, Hirayuki; Nasu, Akihiro; Aizawa, Nobuhiro; Saito, Masaki; Tamori, Akihiro; Kawada, Norifumi; Kimura, Toru; Osaki, Yukio; Nishiguchi, Shuhei			Clinical significance of pretreatment serum interferon-gamma-inducible protein 10 concentrations in chronic hepatitis C patients treated with telaprevir-based triple therapy	HEPATOLOGY RESEARCH			English	Article						chronic hepatitis C; histology; IL28B; interferon-gamma-inducible protein-10; telaprevir; treatment response	SUSTAINED VIROLOGICAL RESPONSE; AMINO-ACID SUBSTITUTION; CHRONIC HCV INFECTION; VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; ELDERLY-PATIENTS; VIRAL RESPONSE; RIBAVIRIN THERAPY; GENOTYPE; PEGINTERFERON	AimWe aimed to determine whether pretreatment serum interferon--inducible protein (IP)-10 concentration can predict response to telaprevir (TVR)-based triple therapy in patients with genotype 1 chronic hepatitis C (CHC), and to examine the effects of IP-10 concentration on liver histology. MethodsBaseline IP-10 concentrations were measured in 97 patients with genotype 1 CHC treated with TVR-based triple therapy, and the associations between baseline IP-10 and treatment outcome were assessed by univariate and multivariate analyses. Associations between baseline serum IP-10 concentration and laboratory data and liver histological findings were also investigated. ResultsMedian IP-10 concentration in these patients was 461.83pg/mL (range, 151.35-4297.62). Multivariate analysis showed that IL28B genotype (P=0.025) and IP-10 level (P=0.004) were factors significantly predictive of rapid virological response (RVR), whereas in pretreatment factors only, IL28B genotype (P=0.001) and liver fibrosis (P=0.035) were independent predictors of sustained virological response. Using a cut-off IP-10 concentration of 460pg/mL, patients with IL28B risk allele and low IP-10 had a significantly higher RVR rate than those with high IP-10 (P=0.005). IP-10 concentration was significantly correlated with liver fibrosis (P=0.001) and inflammation activity (P=0.006) and had the highest areas under the curve for liver histological findings. ConclusionBaseline serum IP-10 level is a useful predictor of virological response in patients with genotype 1 CHC treated with TVR-based triple therapy, especially in patients with IL28B risk allele. IP-10 was well correlated with liver fibrosis and inflammation.	[Nishikawa, Hiroki; Nasu, Akihiro; Kimura, Toru; Osaki, Yukio] Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Osaka 5430027, Japan; [Tamori, Akihiro; Kawada, Norifumi] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 558, Japan; [Enomoto, Hirayuki; Aizawa, Nobuhiro; Saito, Masaki; Nishiguchi, Shuhei] Hyogo Coll Med, Dept Internal Med, Div Hepatobiliary & Pancreat Dis, Kobe, Hyogo, Japan	Nishikawa, H (reprint author), Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Tennoji Ku, 5-30 Fudegasaki Cho, Osaka 5430027, Japan.	h-nishikawa@osaka-med.jrc.or.jp			Chugai Pharmaceutical; MSD; Dainippon Sumitomo Pharma; Ajinomoto Pharma; Otsuka Pharmaceutical	In the past year, S. N. has received financial support from Chugai Pharmaceutical, MSD, Dainippon Sumitomo Pharma, Ajinomoto Pharma and Otsuka Pharmaceutical. In the past year, A. T. has received research funding from MSD, and N. K. has consulted for and has received research funding from MSD. The remaining authors declare that they have no conflicts of interest.	Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Grebely J, 2013, HEPATOLOGY, V57, P2124, DOI 10.1002/hep.26263; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Darling JM, 2011, HEPATOLOGY, V53, P14, DOI 10.1002/hep.24056; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Askarieh G, 2010, HEPATOLOGY, V51, P1523, DOI [10.1002/hep.23509, 10.1002/hep.22773]; Chen JM, 2013, GASTROENTEROLOGY, V144, P1450, DOI 10.1053/j.gastro.2013.02.039; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Pearlman BL, 2012, LANCET INFECT DIS, V12, P717, DOI 10.1016/S1473-3099(12)70060-9; Furusyo N, 2013, J HEPATOL, V59, P205, DOI 10.1016/j.jhep.2013.03.020; Nishikawa H, 2013, J CANCER, V4, P635, DOI 10.7150/jca.7279; Imai Y, 2010, J VIRAL HEPATITIS, V17, P185, DOI 10.1111/j.1365-2893.2009.01163.x; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Zeremski M, 2009, J INFECT DIS, V200, P1774, DOI 10.1086/646614; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Akuta N, 2010, HEPATOLOGY, V52, P421, DOI 10.1002/hep.23690; [Anonymous], 2010, HEPATOLOGY S, V52, p320A; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Romero AI, 2006, J INFECT DIS, V194, P895, DOI 10.1086/507307; Fattovich G, 2011, ALIMENT PHARM THER, V33, P1162, DOI 10.1111/j.1365-2036.2011.04635.x; Lagging M, 2006, HEPATOLOGY, V44, P1617, DOI 10.1002/hep.21407; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; Arase Y, 2007, INTERVIROLOGY, V50, P16, DOI 10.1159/000096308; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Diago M, 2006, GUT, V55, P374, DOI 10.1136/gut.2005.074062; Han H, 2013, J HEPATOL, V59, P957, DOI 10.1016/j.jhep.2013.07.004; Hara T, 2013, J MED VIROL, V85, P1746, DOI 10.1002/jmv.23673; Kurelac I, 2012, J INTERF CYTOK RES, V32, P386, DOI 10.1089/jir.2012.0006; Lagging M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017232; Matsuura K, 2013, HEPATOL RES; National Institutes of Health, 2002, HEPATOLOGY, V36, pS3, DOI DOI 10.1053/JHEP.2002.37117	36	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E397	E407		10.1111/hepr.12326		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200009		
J	Shimada, N; Tsubota, A; Atsukawa, M; Abe, H; Ide, T; Takaguchi, K; Chuganji, Y; Toyoda, H; Yoshizawa, K; Ika, M; Sato, Y; Kato, K; Kumada, T; Sakamoto, C; Aizawa, Y; Sata, M				Shimada, Noritomo; Tsubota, Akihito; Atsukawa, Masanori; Abe, Hiroshi; Ide, Tatsuya; Takaguchi, Koichi; Chuganji, Yoshimichi; Toyoda, Hidenori; Yoshizawa, Kai; Ika, Makiko; Sato, Yoshiyuki; Kato, Keizo; Kumada, Takashi; Sakamoto, Choitsu; Aizawa, Yoshio; Sata, Michio			A 48-week telaprevir-based triple combination therapy improves sustained virological response rate in previous non-responders to peginterferon and ribavirin with genotype 1b chronic hepatitis C: A multicenter study	HEPATOLOGY RESEARCH			English	Article						48-week therapy; chronic hepatitis C; non-responders; telaprevir	AMINO-ACID SUBSTITUTION; CHRONIC HCV INFECTION; PEGYLATED INTERFERON; VIRUS-INFECTION; PLUS RIBAVIRIN; TREATMENT FAILURE; GENETIC-VARIATION; IL28B; ASSOCIATION; RETREATMENT	AimThe sustained virological response (SVR) rate of non-responders to peginterferon and ribavirin therapy (PR) is low for 24-week telaprevir-based triple combination therapy (T12PR24), compared to that of treatment-naive patients or previous-treatment relapsers. This study investigated which characteristics of non-responders were associated with a better SVR rate to 48-week therapy (T12PR48). MethodsA total of 103 Japanese non-responders with genotype 1b chronic hepatitis C received telaprevir-based therapy. Among them, 81 patients (50 partial and 31 null responders) received T12PR24 and 22 (seven partial and 15 null responders) who agreed to the extended therapy received T12PR48. ResultsMultivariate logistic regression analysis for SVR identified the interleukin-28B (IL28B) rs8099917 TT genotype (P=0.0005, odds ratio [OR]=10.38), extended rapid virological response (P=0.0008, OR=7.02), T12PR48 regimen (P=0.0016, OR=9.31) and previous partial responders (P=0.0022, OR=5.89). Among partial responders, the SVR rate did not differ significantly between T12PR48 (85.7%) and T12PR24 (70.0%). Among null responders, the SVR rate was significantly higher with T12PR48 than T12PR24 (66.7% vs 22.6%, P=0.0037). Among patients with the IL28B non-TT genotype, the SVR rate was significantly higher with T12PR48 than T12PR24 (68.8% vs 37.7%, P=0.0288). Moreover, among null responders with the non-TT genotype, the SVR rate was significantly higher with T12PR48 than T12PR24 (66.7% vs 9.1%, P=0.0009). ConclusionT12PR48 improves the SVR rate in null responders, patients with the non-TT genotype, and null responders with a non-TT genotype.	[Shimada, Noritomo; Ika, Makiko; Sato, Yoshiyuki; Kato, Keizo] Shinmatsudo Cent Gen Hosp, Div Gastroenterol & Hepatol, Matsudo, Chiba 2700034, Japan; [Tsubota, Akihito] Jikei Univ, Sch Med, Inst Clin Med & Res, Kashiwa, Chiba, Japan; [Atsukawa, Masanori] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Internal Med, Div Gastroenterol, Chiba, Japan; [Abe, Hiroshi; Aizawa, Yoshio] Jikei Univ, Sch Med, Katsushika Med Ctr, Div Gastroenterol & Hepatol,Dept Internal Med, Tokyo, Japan; [Chuganji, Yoshimichi] Tokyo Metropolitan Bokutoh Hosp, Dept Gastroenterol, Tokyo, Japan; [Yoshizawa, Kai] Machida Municipal Hosp, Dept Gastroenterol, Tokyo, Japan; [Sakamoto, Choitsu] Nippon Med Sch, Dept Internal Med, Div Gastroenterol, Tokyo 113, Japan; [Ide, Tatsuya; Sata, Michio] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Kurume, Fukuoka 830, Japan; [Takaguchi, Koichi] Kagawa Prefectural Cent Hosp, Dept Hepatol, Takamatsu, Kagawa, Japan; [Toyoda, Hidenori; Kumada, Takashi] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Japan	Shimada, N (reprint author), Shinmatsudo Cent Gen Hosp, Div Gastroenterol & Hepatol, 1-380 Shinmatsudo, Matsudo, Chiba 2700034, Japan.	noritomos@jcom.home.ne.jp					Akuta N, 2012, J MED VIROL, V84, P1097, DOI 10.1002/jmv.23262; Akuta N, 2013, J CLIN MICROBIOL, V51, P2862, DOI 10.1128/JCM.01129-13; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Akuta N, 2005, INTERVIROLOGY, V48, P372, DOI 10.1159/000086064; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Enomoto N, 1996, NEW ENGL J MED, V334, P77, DOI 10.1056/NEJM199601113340203; Furusyo N, 2013, J HEPATOL, V59, P205, DOI 10.1016/j.jhep.2013.03.020; Yoshizawa K, 2013, J MED VIROL, V85, P1180, DOI 10.1002/jmv.23597; Chayama K, 2013, J GASTROENTEROL, V48, P1, DOI 10.1007/s00535-012-0714-9; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Chayama K, 2011, J INFECT DIS, V204, P84, DOI 10.1093/infdis/jir210; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Ogawa E, 2013, ALIMENT PHARM THER, V38, P1076, DOI 10.1111/apt.12494; Kurosaki M, 2011, J HEPATOL, V54, P439, DOI 10.1016/j.jhep.2010.07.037; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; Akuta N, 2010, HEPATOLOGY, V52, P421, DOI 10.1002/hep.23690; Simmonds P, 1996, J GEN VIROL, V77, P3013, DOI 10.1099/0022-1317-77-12-3013; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Tsubota A, 2014, J GASTROEN HEPATOL, V29, P144, DOI 10.1111/jgh.12402; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Pol S, 2013, J HEPATOL, V58, P883, DOI 10.1016/j.jhep.2012.12.023; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Hayashi N, 2012, J VIRAL HEPATITIS, V19, pE134, DOI 10.1111/j.1365-2893.2011.01528.x; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Drafting Committee for Hepatitis Management. Guidelines the Japan Society of Hepatology, 2014, HEPATOL RES S1, V44, P59; Editors of the Drafting Committee for Hepatitis Management Guidelines: the Japan Society of Hepatology, 2013, HEPATOL RES, V43, P1; Muir AJ, 2011, HEPATOLOGY, V54, P1538, DOI 10.1002/hep.24549; Muir AJ, 2013, J CLIN GASTROENTEROL, V47, P222, DOI 10.1097/MCG.0b013e3182680221; Shimada N, 2013, J GASTROENTEROL; Shimada N, 2014, J MED VIROL, V86, P461, DOI 10.1002/jmv.23824; The French METAVIR Cooperative Study Group, 1994, HEPATOLOGY, V20, P15, DOI DOI 10.1002/HEP.1840200104.PUBMED:8020885; Toyoda H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-324; Tsubota A, 2012, LIVER INT, V32, P826, DOI 10.1111/j.1478-3231.2011.02727.x; Zeuzem S, 2014, GASTROENTEROLOGY, V146, P430, DOI 10.1053/j.gastro.2013.10.058	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E386	E396		10.1111/hepr.12323		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200008		
J	Soejima, Y; Inoue, M; Takahashi, Y; Uozaki, H; Sawabe, M; Fukusato, T				Soejima, Yurie; Inoue, Masafumi; Takahashi, Yoshihisa; Uozaki, Hiroshi; Sawabe, Motoji; Fukusato, Toshio			Integrins alpha v beta 6, alpha 6 beta 4 and alpha 3 beta 1 are down-regulated in cholangiolocellular carcinoma but not cholangiocarcinoma	HEPATOLOGY RESEARCH			English	Article						cholangiocarcinoma; cholangiolocellular carcinoma; hepatocellular carcinoma; integrin; laminin; stem cell features	HEPATOCELLULAR-CARCINOMA; INTRAHEPATIC CHOLANGIOCARCINOMA; TUMOR INVASION; CELL-LINE; LIVER; EXPRESSION; MATRIX; CANCER; FIBRONECTIN; ACTIVATION	AimThe aim of this study was to evaluate integrin expression and immunolocalization of the extracellular matrix proteins in cholangiolocellular carcinoma (CoCC). MethodsTissue specimens of 23 CoCC, 28 cholangiocarcinomas (CCC), 42 hepatocellular carcinomas (HCC) and 11 classical type combined hepatocellular cholangiocarcinomas (CHC) were immunostained for 6, 4 and 3 integrins, fibronectin and laminin. ITGB6, B4 and A3mRNA levels in six HCC cell lines, five CCC cell lines and two CHC cell lines were quantified by quantitative reverse transcription polymerase chain reaction. ResultsLittle or no positivity for 6, 4 and 3 integrins was shown in 91%, 91% and 52% of CoCC and 100%, 98% and 81% of HCC, respectively, according to immunostaining, whereas intense positive staining for these integrins was demonstrated in 64%, 96% and 75% of CCC, respectively. There was a close correlation between 4 and 3 integrin expression and intracytoplasmic laminin in CoCC, CCC and HCC, but not between 6 expression and its ligand, fibronectin. Integrin mRNA levels were increased in four of five CCC cell lines, but nearly undetectable in five of six HCC cell lines and one CHC cell line. Tubular differentiation of a CHC cell line cultured in collagen gel matrix induced upregulation of these integrins. ConclusionOur results first indicated downregulation of v6, 64 and 31 integrins in CoCC, in contrast to its high expression in CCC, suggesting a diagnostic value of integrins in the differential diagnosis of CoCC and CCC, as well as a useful inducible marker of the intermediate features of CoCC.	[Soejima, Yurie; Takahashi, Yoshihisa; Uozaki, Hiroshi; Fukusato, Toshio] Teikyo Univ, Sch Med, Dept Pathol, Tokyo 1738605, Japan; [Inoue, Masafumi] Toranomon Gen Hosp, Dept Pathol, Tokyo, Japan; [Soejima, Yurie; Sawabe, Motoji] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Mol Pathol, Tokyo, Japan	Fukusato, T (reprint author), Teikyo Univ, Sch Med, Dept Pathol, Itabashi Ku, 2-11-1 Kaga, Tokyo 1738605, Japan.	fukusato@med.teikyo-u.ac.jp					Aishima S, 2004, MODERN PATHOL, V17, P938, DOI 10.1038/modpathol.3800143; Al-Hazmi N, 2007, EUR J ORAL SCI, V115, P454, DOI 10.1111/j.1600-0722.2007.00481.x; Yano H, 1996, J HEPATOL, V24, P413, DOI 10.1016/S0168-8278(96)80161-9; Brafman DA, 2013, CELL DEATH DIFFER, V20, P369, DOI 10.1038/cdd.2012.138; Patsenker E, 2010, J HEPATOL, V52, P362, DOI 10.1016/j.jhep.2009.12.006; Missan DS, 2012, CRIT REV EUKAR GENE, V22, P309; MURAKAMI T, 1987, HEPATOLOGY, V7, P551, DOI 10.1002/hep.1840070322; Sempoux C, 2011, SEMIN LIVER DIS, V31, P104, DOI 10.1055/s-0031-1272838; Thomas GJ, 2006, J ORAL PATHOL MED, V35, P1, DOI 10.1111/j.1600-0714.2005.00374.x; Chaturvedi P, 2007, MOL CANCER RES, V5, P309, DOI 10.1158/1541-7786.MCR-06-0353; Komuta M, 2008, HEPATOLOGY, V47, P1544, DOI 10.1002/hep.22238; Giancotti FG, 2007, TRENDS PHARMACOL SCI, V28, P506, DOI 10.1016/j.tips.2007.08.004; Engbring JA, 2003, J PATHOL, V200, P465, DOI 10.1002/path.1396; Iwahashi S, 2013, SURG TODAY, V43, P654, DOI 10.1007/s00595-012-0437-9; Torbenson M, 2002, MODERN PATHOL, V15, P826, DOI 10.1097/01.MP.0000024257.83046.7C; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Patsenker E, 2008, GASTROENTEROLOGY, V135, P660, DOI 10.1053/j.gastro.2008.04.009; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Bandyopadhyay A, 2009, CURR DRUG TARGETS, V10, P645; Shiota K, 2001, ONCOL REP, V8, P263; Tanimizu N, 2012, J BIOL CHEM, V287, P28586, DOI 10.1074/jbc.M112.350488; STEINER PE, 1959, CANCER, V12, P753, DOI 10.1002/1097-0142(195907/08)12:4<753::AID-CNCR2820120420>3.0.CO;2-L; Baker EL, 2010, J BIOMECH, V43, P38, DOI 10.1016/j.jbiomech.2009.09.007; Beaulieu Jean-François, 2010, World J Gastrointest Pathophysiol, V1, P3, DOI 10.4291/wjgp.v1.i1.3; Couvelard A, 1998, HEPATOLOGY, V27, P839, DOI 10.1002/hep.510270328; Ding YB, 2013, DIGEST DIS SCI, V58, P1627, DOI 10.1007/s10620-012-2524-6; Giannelli G, 2002, CLIN EXP METASTAS, V19, P217, DOI 10.1023/A:1015579204607; Kumagai A, 2013, HEPATOL RES, V43, P959, DOI 10.1111/hepr.12047; Labat-Robert J, 2012, PATHOL BIOL, V60, P15, DOI 10.1016/j.patbio.2011.10.003; Liu S, 2013, HEAD NECK ONCOL, V5, P7; Liver Cancer Study Group of Japan, 2010, GEN RUL CLIN PATH ST; Nejjari M, 2002, HEPATOLOGY, V36, P418, DOI 10.1053/jhep.2002.34611; Nejjari M, 2001, J PATHOL, V195, P473, DOI 10.1002/path.964; Shiojiri N, 2004, HEPATOLOGY, V40, P346, DOI 10.1002/hep.20303; Theise ND, 2010, WHO CLASSIFICATION T, P225; VOLPES R, 1991, GASTROENTEROLOGY, V101, P200; VOLPES R, 1993, AM J PATHOL, V142, P1483	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E320	E334		10.1111/hepr.12312		15	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200001		
J	Tsuboi, H; Ohira, H; Asashima, H; Tsuzuki, S; Iizuka, M; Matsuo, N; Kondo, Y; Matsumoto, I; Sumida, T				Tsuboi, Hiroto; Ohira, Hiromasa; Asashima, Hiromitsu; Tsuzuki, Sayaka; Iizuka, Mana; Matsuo, Naomi; Kondo, Yuya; Matsumoto, Isao; Sumida, Takayuki			Anti-M3 muscarinic acetylcholine receptor antibodies in patients with primary biliary cirrhosis	HEPATOLOGY RESEARCH			English	Article						autoantibodies; M3 muscarinic acetylcholine receptor; primary biliary cirrhosis		AimM3 muscarinic acetylcholine receptor (M3R) is expressed in biliary tracts as well as in exocrine glands. It is reported that some patients with primary biliary cirrhosis (PBC) carry autoantibodies against M3R. The aim of this study is to clarify the presence, potential use as diagnostic marker and clinical roles of anti-M3R antibodies in PBC. MethodsWe synthesized peptides encoding the extracellular domains of human-M3R, including the N-terminal region, the first, second and third extracellular loops. Antibodies against these regions were examined by peptide-based enzyme-linked immunoassay in sera of 90 patients with PBC and 40 with chronic hepatitis C (CHC), 21 with non-alcoholic steatohepatitis (NASH), 10 with primary sclerosing cholangitis (PSC), 14 with obstructive jaundice, 10 with drug-induced liver injury and 42 healthy controls. ResultsAntibodies to the N-terminal, first, second and third loop were detected in 90.0% (81/90), 73.3% (66/90), 76.7% (69/90) and 66.7% (60/90) of PBC, in 67.5% (27/40), 10.0% (4/40), 67.5% (27/40) and 27.5% (11/40) of CHC, in 85.7% (18/21), 9.5% (2/21), 4.8% (1/21) and 57.1% (12/21) of NASH, in 60.0% (6/10), 20.0% (2/10), 60.0% (6/10) and 60.0% (6/10) of PSC, in 100.0% (14/14), 0% (0/14), 64.3% (9/14) and 78.6% (11/14) of obstructive jaundice, in 100.0% (10/10), 0% (0/10), 30.0% (3/10) and 10.0% (1/10) of drug-induced liver injury, and in 4.8% (2/42), 7.1% (3/42), 2.4% (1/42) and 2.4% (1/42) of the controls, respectively. ConclusionA high frequency of PBC carried anti-M3R antibodies. Anti-M3R antibodies against the first loop of M3R are a potentially useful diagnostic marker for PBC.	[Tsuboi, Hiroto; Asashima, Hiromitsu; Tsuzuki, Sayaka; Iizuka, Mana; Matsuo, Naomi; Kondo, Yuya; Matsumoto, Isao; Sumida, Takayuki] Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki 3058575, Japan; [Ohira, Hiromasa] Fukushima Med Univ, Sch Med, Dept Gastroenterol & Rheumatol, Fukushima, Japan	Sumida, T (reprint author), Univ Tsukuba, Fac Med, Dept Internal Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	tsumida@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science	This work was supported in part by Grants-in-Aid for Scientific Research (Grant-in-Aid for Young Scientists [B]) from the Ministry of Education, Culture, Sports, Science and Technology and Japan Society for the Promotion of Science.		0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E471	E479		10.1111/hepr.12346		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200017		
J	Yamagiwa, S; Tamura, Y; Takamura, M; Genda, T; Ichida, T; Ishikawa, T; Kamimura, T; Takahashi, T; Suda, T; Matsuda, Y; Nomoto, M; Aoyagi, Y				Yamagiwa, Satoshi; Tamura, Yasushi; Takamura, Masaaki; Genda, Takuya; Ichida, Takafumi; Ishikawa, Toru; Kamimura, Tomoteru; Takahashi, Toru; Suda, Takeshi; Matsuda, Yasunobu; Nomoto, Minoru; Aoyagi, Yutaka			Increase of fucosylated alpha-fetoprotein fraction at the onset of autoimmune hepatitis and acute liver failure	HEPATOLOGY RESEARCH			English	Article						acute liver failure; alpha-fetoprotein; autoimmune hepatitis; Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein	EARLY HEPATOCELLULAR-CARCINOMA; HEPATOMA-CELL LINES; ON-CHIP; CLINICAL-SIGNIFICANCE; MARKER; IMMUNOASSAY; SEPARATION; PROGNOSIS; SERUM; ELECTROPHORESIS	AimIncreased serum -fetoprotein (AFP) has been associated with a good prognosis following acute liver failure (ALF), but the levels of the fucosylated fraction of AFP (Lens culinaris agglutinin-reactive fraction of AFP [AFP-L3]) following acute liver injury remain unknown. The aim of the present study was to investigate the clinical significance of AFP and AFP-L3 in patients with acute liver injury. MethodsWe investigated the serum levels of AFP and highly sensitive AFP-L3% in 27 patients with acute-onset autoimmune hepatitis (AIH), 28 patients with acute hepatitis (AH) and 22 patients with ALF at the onset using a highly sensitive immunoassay (micro-total analysis system). ResultsThe serum AFP levels were increased in patients with AIH, AH and ALF, but the levels did not significantly differ among them. However, the mean AFP-L3% level was significantly higher in patients with AIH than in patients with AH (P=0.0039). Moreover, significantly more patients with AIH demonstrated AFP-L3 positivity (10%) when compared with patients with AH (P=0.014). Although the percentage of AFP-L3 positivity increased with AFP levels, at low serum AFP levels (<10ng/mL), significantly more patients with AIH demonstrated AFP-L3 positivity than did patients with AH (P=0.024) or ALF (P=0.038). ConclusionWe demonstrated for the first time that highly sensitive AFP-L3% levels were increased at the onset of AIH. The mechanism underlying the increase in AFP-L3 remains to be elucidated, but this finding may reflect an alteration of the glycosylation such as hyperfucosylation, which can influence the modifications of self-antigens in hepatocytes.	[Yamagiwa, Satoshi; Tamura, Yasushi; Takamura, Masaaki; Suda, Takeshi; Nomoto, Minoru; Aoyagi, Yutaka] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata 9518510, Japan; [Ishikawa, Toru; Kamimura, Tomoteru] Saiseikai Niigata Daini Hosp, Dept Gastroenterol & Hepatol, Niigata, Japan; [Matsuda, Yasunobu] Niigata Univ, Fac Med, Sch Hlth Sci, Dept Med Technol, Niigata 9518510, Japan; [Genda, Takuya; Ichida, Takafumi] Juntendo Univ, Shizuoka Hosp, Dept Gastroenterol & Hepatol, Izunokuni, Japan; [Takahashi, Toru] Uonuma Hosp, Dept Internal Med, Ojiya, Japan	Yamagiwa, S (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	syamagi@med.niigata-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24590963]; Ministry of Health, Labor and Welfare of Japan	THIS WORK WAS supported in part by Grants-in-Aid for Scientific Research (C) (24590963 to S. Y.) from Japan Society for the Promotion of Science (JSPS), and Grants-in Aid from the Ministry of Health, Labor and Welfare of Japan to the Study Group of Intractable Hepatobiliary Diseases.	Alvarez F., 1999, Journal of Hepatology, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Mochida S, 2011, HEPATOL RES, V41, P805, DOI 10.1111/j.1872-034X.2011.00860.x; Stravitz RT, 2011, HEPATOLOGY, V53, P517, DOI 10.1002/hep.24080; Nakagawa T, 2008, J PROTEOME RES, V7, P2222, DOI 10.1021/pr700841q; BREBOROWICZ J, 1981, SCAND J IMMUNOL, V14, P15, DOI 10.1111/j.1365-3083.1981.tb00179.x; Czaja AJ, 2010, GASTROENTEROLOGY, V139, P58, DOI 10.1053/j.gastro.2010.04.053; Tamura Y, 2010, DIGEST DIS SCI, V55, P3576, DOI 10.1007/s10620-010-1222-5; Mizejewski GJ, 2001, EXP BIOL MED, V226, P377; Schiodt FV, 2006, LIVER TRANSPLANT, V12, P1776, DOI 10.1002/lt.20886; Noda K, 1998, HEPATOLOGY, V28, P944, DOI 10.1002/hep.510280408; Hu KQ, 2004, AM J GASTROENTEROL, V99, P860, DOI 10.1111/j.1572-0241.04152.x; Yang SS, 2002, J GASTROENTEROL, V37, P626, DOI 10.1007/s005350200099; Nakagawa T, 2006, J BIOL CHEM, V281, P29797, DOI 10.1074/jbc.M605697200; Schmidt LE, 2005, HEPATOLOGY, V41, P26, DOI 10.1002/hep.20511; Blomme B, 2009, J HEPATOL, V50, P592, DOI 10.1016/j.jhep.2008.12.010; AOYAGI Y, 1985, LANCET, V2, P1353; Kumada T, 2014, J GASTROENTEROL, V49, P555, DOI 10.1007/s00535-013-0883-1; Hanaoka T, 2011, J GASTROEN HEPATOL, V26, P739, DOI 10.1111/j.1440-1746.2010.06585.x; Manns MP, 2010, HEPATOLOGY, V51, P2193, DOI 10.1002/hep.23584; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Noda K, 2003, CANCER RES, V63, P6282; Kagebayashi C, 2009, ANAL BIOCHEM, V388, P306, DOI 10.1016/j.ab.2009.02.030; Toyoda H, 2012, J HEPATOL, V57, P1251, DOI 10.1016/j.jhep.2012.07.018; Takikawa Y, 2002, J GASTROENTEROL, V37, P681, DOI 10.1007/s005350200111; Nakagawa T, 2012, J PROTEOME RES, V11, P2798, DOI 10.1021/pr201154k; AOYAGI Y, 1986, LANCET, V1, P210; KARVOUNT.GG, 1974, ANN INTERN MED, V80, P156; Kawabata T, 2008, ELECTROPHORESIS, V29, P1399, DOI 10.1002/elps.200700898; Manns MP, 2001, GASTROENTEROLOGY, V120, P1502, DOI 10.1053/gast.2001.24227; Mizejewski GJ, 2003, OBSTET GYNECOL SURV, V58, P804, DOI 10.1097/01.OGX.0000099770.97668.18; Moriya S, 2013, ANTICANCER RES, V33, P997; Nakamura K, 1998, ANAL CHEM, V70, P954, DOI 10.1021/ac9711495; Nakao K, 2013, HEPATOL RES, V43, P820, DOI 10.1111/hepr.12052; Onji M, 2011, HEPATOL RES, V41, P497, DOI 10.1111/j.1872-034X.2011.00810.x; Purcell AW, 2008, IMMUNOL CELL BIOL, V86, P574, DOI 10.1038/icb.2008.48; Sakurai T, 2003, HEPATOL RES, V26, P98, DOI 10.1016/S1386-6346(03)00013-5; Tamura Y, 2013, DIGEST DIS SCI, V58, P2406, DOI 10.1007/s10620-013-2661-6; YAMASAKI H, 1995, LIVER, V15, P219	39	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E368	E375		10.1111/hepr.12318		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200006		
J	Yoneda, M; Thomas, E; Sumida, Y; Imajo, K; Eguchi, Y; Hyogo, H; Fujii, H; Ono, M; Kawaguchi, T; Schiff, ER				Yoneda, Masato; Thomas, Emmanuel; Sumida, Yoshio; Imajo, Kento; Eguchi, Yuichiro; Hyogo, Hideyuki; Fujii, Hideki; Ono, Masafumi; Kawaguchi, Takumi; Schiff, Eugene R.			Clinical usage of serum ferritin to assess liver fibrosis in patients with non-alcoholic fatty liver disease: Proceed with caution	HEPATOLOGY RESEARCH			English	Article						fibrosis; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; serum ferritin	SCORING SYSTEM; STEATOHEPATITIS; INSULIN	Serum ferritin was recently reported to have low diagnostic accuracy for the detection of advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). To corroborate these findings, we investigated the diagnostic accuracy of serum ferritin levels for detecting liver fibrosis in NAFLD patients utilizing a large Japanese cohort database. A total 1201 biopsy-proven NAFLD patients, seen between 2001 and 2013, were enrolled into the Japan Study Group of NAFLD. Analysis was performed on data from this cohort comparing between serum ferritin levels and hepatic histology. Serum ferritin increased with increasing histological grade of steatosis, lobular inflammation and ballooning. Multivariate analyses revealed that sex differences, steatotic grade and fibrotic stage were independently associated with serum ferritin levels (P<0.0001, <0.0001, 0.0248, respectively). However, statistical analyses performed using serum ferritin levels demonstrated that the area under the receiver-operator curve for detecting fibrosis was not adequate for rigorous prediction. Several factors including sex differences, steatosis and fibrosis were found to correlate with serum ferritin levels. Therefore, serum ferritin may have low diagnostic accuracy for specifically detecting liver fibrosis in NAFLD patients due to the involvement of multiple hepatocellular processes.	[Yoneda, Masato; Thomas, Emmanuel; Schiff, Eugene R.] Univ Miami, Miller Sch Med, Schiff Ctr Liver Dis, Miami, FL 33136 USA; [Sumida, Yoshio] Kyoto Prefectural Univ Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Yoneda, Masato; Imajo, Kento] Yokohama City Univ, Grad Sch Med, Div Gastroenterol, Yokohama, Kanagawa 232, Japan; [Eguchi, Yuichiro] Saga Med Sch, Liver Ctr, Saga, Japan; [Hyogo, Hideyuki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci, Hiroshima, Japan; [Fujii, Hideki] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 558, Japan; [Ono, Masafumi] Kochi Med Sch, Dept Gastroenterol & Hepatol, Kochi, Japan; [Kawaguchi, Takumi] Kurume Univ, Sch Med, Dept Med & Digest Dis Informat & Res, Div Gastroenterol, Kurume, Fukuoka 830, Japan	Yoneda, M (reprint author), Univ Miami, Miller Sch Med, Schiff Ctr Liver Dis, 1500 NW 12th Ave,Suite 1101, Miami, FL 33136 USA.	m.yoneda1@med.miami.edu					Angulo P, 2013, CLIN GASTROENTEROL H; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1056/NEJMra011775; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Iwasaki T, 2005, DIABETES CARE, V28, P2486, DOI 10.2337/diacare.28.10.2486; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; Liou I, 2006, J CLIN GASTROENTEROL, V40, pS11; Sumida Y, 2011, J GASTROENTEROL, V46, P257, DOI 10.1007/s00535-010-0305-6; George DK, 1998, GASTROENTEROLOGY, V114, P311, DOI 10.1016/S0016-5085(98)70482-2; Kowdley KV, 2012, HEPATOLOGY, V55, P77, DOI 10.1002/hep.24706; Yoneda M, 2011, J GASTROENTEROL, V46, P1300, DOI 10.1007/s00535-011-0436-4; Yoneda M, 2010, DIGEST DIS SCI, V55, P808, DOI 10.1007/s10620-009-0771-y	12	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1386-6346	1872-034X		HEPATOL RES	Hepatol. Res.	DEC	2014	44	14					E499	E502		10.1111/hepr.12327		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW7FD	WOS:000346429200019		
J	Shimodaira, M; Niwa, T; Nakajima, K; Kobayashi, M; Hanyu, N; Nakayama, T				Shimodaira, M.; Niwa, T.; Nakajima, K.; Kobayashi, M.; Hanyu, N.; Nakayama, T.			The Relationship Between Serum Uric Acid Levels and beta-Cell Functions in Nondiabetic Subjects	HORMONE AND METABOLIC RESEARCH			English	Article						diabetes; disposition index; hyperuricemia; insulin secretion	IMPAIRED FASTING GLUCOSE; INSULIN-RESISTANCE; METABOLIC SYNDROME; DIABETES-MELLITUS; RISK; TOLERANCE; HYPERTENSION; INDIVIDUALS; ASSOCIATION	High serum uric acid (UA) levels are believed to be an independent risk factor for the development of diabetes. We aimed to investigate the relationship between serum UA concentrations and early-phase insulin secretion following a 75g oral glucose tolerance test (OGTT) in nondiabetic subjects. We enrolled 570 Japanese subjects (354 males and 216 females, aged 50.5 +/- 8.9 years and 52.6 +/- 7.3 years, respectively), who underwent the 75g OGTT during their annual health examination. The OGTT confirmed their nondiabetic status. Insulin secretion was estimated by the disposition index (DI) [( insulin/ glucose (0-30min)x(1/HOMA-IR)], which is an adjusted measure of -cell function relative to variations in insulin sensitivity. Simple linear regression analysis showed negative correlations between serum UA levels and DI, when examined in the whole study population and female subjects only (r=-0.209, p<0.001 and r=-0.232, p<0.001, respectively). However, in male subjects, UA levels did not correlate with DI. In females, multivariate linear regression analysis revealed that serum UA levels were the major predictors of DI, explaining 16.4% of its variation (p<0.001). Serum UA levels significantly correlate with early-phase insulin secretion in nondiabetic Japanese women. It may be an independent risk factor for predicting -cell function in women.	[Shimodaira, M.; Niwa, T.; Nakajima, K.; Kobayashi, M.; Hanyu, N.] Iida Municipal Hosp, Dept Internal Med, Iida, Nagano 3958502, Japan; [Shimodaira, M.; Nakayama, T.] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Lab Med, Tokyo, Japan	Shimodaira, M (reprint author), Iida Municipal Hosp, Dept Internal Med, 438 Yawata Machi, Iida, Nagano 3958502, Japan.	masanori19810813@yahoo.co.jp					Jensen CC, 2002, DIABETES, V51, P2170, DOI 10.2337/diabetes.51.7.2170; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nakanishi N, 2003, EUR J EPIDEMIOL, V18, P523; Krishnan E, 2012, AM J EPIDEMIOL, V176, P108, DOI 10.1093/aje/kws002; [Anonymous], 2011, DIABETES CARE S1, V34, pS11; Le May C, 2006, P NATL ACAD SCI USA, V103, P9232, DOI 10.1073/pnas.0602956103; Wang TG, 2011, ENDOCRINE, V40, P109, DOI 10.1007/s12020-011-9449-2; Rocic B, 2005, BIOORG MED CHEM LETT, V15, P1181, DOI 10.1016/j.bmcl.2004.12.003; So A, 2010, J CLIN INVEST, V120, P1791, DOI 10.1172/JCI42344; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26; Bergman RN, 2002, DIABETES, V51, pS212, DOI 10.2337/diabetes.51.2007.S212; Zhang YN, 2013, MOL CELL ENDOCRINOL, V375, P89, DOI 10.1016/j.mce.2013.04.027; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; GORDON T, 1983, ARCH INTERN MED, V143, P1366, DOI 10.1001/archinte.143.7.1366; Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Perticone F, 2012, DIABETES CARE, V35, P153, DOI [10.2337/dc11-1727, 10.2337/dc11.-1727]; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337/dc08-1478; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Evans SA, 2009, ENDOCRINOLOGY, V150, P5302, DOI 10.1210/en.2009-0747; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; Hodge AM, 2001, INT J OBESITY, V25, P126, DOI 10.1038/sj.ijo.0801522; Jia L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078284; Kawamoto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065886; Kramer CK, 2009, DIABETES CARE, V32, P1272, DOI 10.2337/dc09-0275; Lyngdoh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019901; Meisinger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037180; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20	31	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0018-5043	1439-4286		HORM METAB RES	Horm. Metab. Res.	DEC	2014	46	13					950	954		10.1055/s-0034-1389996		5	Endocrinology & Metabolism	Endocrinology & Metabolism	AW0JT	WOS:000345979200008		
J	Tanaka, Y; Ohira, M; Tashiro, H; Imamura, M; Chayama, K; Ohdan, H				Tanaka, Yuka; Ohira, Masahiro; Tashiro, Hirotaka; Imamura, Michio; Chayama, Kazuaki; Ohdan, Hideki			Impact of alloimmune T cell responses on hepatitis C virus replication in liver transplant recipients	HUMAN IMMUNOLOGY			English	Article						Alloimmune responses; Hepatitis C; Living donor liver transplantation	EARLY RECURRENCE; REJECTION; KINETICS; IDENTIFICATION; REINFECTION; INHIBITION; INTERFERON; ALPHA; ASSAY	We investigated the influence of alloimmune T cell responses on hepatitis C virus (HCV) replication in HCV-infected patients after liver transplantation (LT). To monitor the immune-status in 27 HCV-infected LT recipients, we routinely performed mixed lymphocyte reaction (MLR) assays within 4 weeks after LT. HCV RNA titers in most patients fluctuated in inverse proportion to the stimulation index (SI) of anti-donor reactive T cells early after LT. Two weeks after LT, recipients with high HCV RNA titers (>1000 KIU/mL) displayed a significantly lower SI for anti-donor reactive T cells than recipients with low HCV RNA titers did (<1000 KIU/mL). An in vitro transwell assay mimicking the anatomical features of the interaction between HCV-infected hepatocytes and alloreactive T cells in allograft livers demonstrated that interferon (IFN)-gamma was necessary to suppress HCV replication. This study proves the significant impact of alloimmune T cell responses on HCV replication in HCV-infected LT recipients. (C) 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.	[Tanaka, Yuka; Ohira, Masahiro; Tashiro, Hirotaka; Imamura, Michio; Chayama, Kazuaki; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima 7348551, Japan; [Tanaka, Yuka; Ohira, Masahiro; Tashiro, Hirotaka; Imamura, Michio; Chayama, Kazuaki; Ohdan, Hideki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima 7348551, Japan	Ohdan, H (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	hohdan@hiroshima-u.ac.jp			Japanese Ministry of Health, Labor, and Welfare	This work was supported by a Research on Hepatitis and BSE grant from the Japanese Ministry of Health, Labor, and Welfare. The authors thank Drs. Nobuhiko Hiraga, Takashi Onoe, Kentaro Ide, and Kohei Ishiyama for their advice and encouragement, and Mrs. Midori Kiyokawa for her expert technical assistance.	Neumann UP, 2004, TRANSPLANTATION, V77, P226, DOI 10.1097/01.TP.0000101738.27552.9D; Ballardini G, 2002, LIVER TRANSPLANT, V8, P10, DOI 10.1053/jlts.2002.30141; Schiano TD, 2005, HEPATOLOGY, V42, P1420, DOI 10.1002/hep.20947; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Powers KA, 2006, LIVER TRANSPLANT, V12, P207, DOI 10.1002/lt.20572; Gane EJ, 1996, GASTROENTEROLOGY, V110, P167, DOI 10.1053/gast.1996.v110.pm8536853; Rosen HR, 2004, J IMMUNOL, V173, P5355; Yokota T, 2003, EMBO REP, V4, P602, DOI 10.1038/sj.embor.embor840; Tanaka Y, 2012, TRANSPL P, V44, P555, DOI 10.1016/j.transproceed.2012.01.038; Belli LS, 2000, HEPATOLOGY, V31, P1345, DOI 10.1053/jhep.2000.7879; Berenguer M, 1999, GUT, V45, P159; Brillanti S, 2002, LIVER TRANSPLANT, V8, P884, DOI 10.1053/jlts.2002.34640; Cotler SJ, 1998, TISSUE ANTIGENS, V52, P435, DOI 10.1111/j.1399-0039.1998.tb03070.x; Demetris AJ, 2004, AM J SURG PATHOL, V28, P658, DOI 10.1097/00000478-200405000-00015; Doskali Marlen, 2011, J Immunother, V34, P129, DOI 10.1097/CJI.0b013e3182048c4e; Fukumoto T, 1996, HEPATOLOGY, V24, P1351, DOI 10.1002/hep.510240606; Garcia-Retortillo M, 2002, HEPATOLOGY, V35, P680, DOI 10.1053/jhep.2002.31773; Langrehr JM, 2006, LIVER TRANSPLANT, V12, P644, DOI 10.1002/lt.20648; MANEZ R, 1995, TRANSPLANTATION, V59, P640; MANEZ R, 1993, TRANSPLANTATION, V55, P1067; Ohira M, 2009, J CLIN INVEST, V119, P3226, DOI 10.1172/JCI38374; Rosen Hugo R, 2003, Clin Liver Dis, V7, P107, DOI 10.1016/S1089-3261(02)00073-9; SHEINER PA, 1995, HEPATOLOGY, V21, P30, DOI 10.1016/0270-9139(95)90404-2; Tambur AR, 2005, HUM IMMUNOL, V66, P21, DOI 10.1016/j.humimm.2004.08.180; Tanabe Y, 2004, J INFECT DIS, V189, P1129, DOI 10.1086/382595; Tanaka Y, 2004, IMMUNOL INVEST, V33, P309, DOI 10.1081/IMM-120038079; Tanaka Y, 2005, TRANSPLANTATION, V79, P1262, DOI 10.1097/01.TP.0000161667.99145.20	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0198-8859	1879-1166		HUM IMMUNOL	Hum. Immunol.	DEC	2014	75	12					1259	1267		10.1016/j.humimm.2014.09.006		9	Immunology	Immunology	AW1HP	WOS:000346041100019		
J	Takeshita, T; Oda, K; Mawatari, H				Takeshita, T.; Oda, K.; Mawatari, H.			Interior Degradation Analysis of Distributed Feedback Laser Using Optical-Beam-Induced Current	IEEE TRANSACTIONS ON DEVICE AND MATERIALS RELIABILITY			English	Article						Aging; distributed feedback lasers; failure analysis; laser reliability; photon beams; quantum well lasers; semiconductor lasers	OBIC MONITOR; DFB LASER	We propose a novel optical-beam-induced current (OBIC) measurement technique to detect the degradation of the interior of a laser waveguide. OBIC topographies were obtained with incident transverse-magnetic-mode light, such that OBIC became sensitive to interior degradation. We additionally used transverse-magnetic-mode and transverse-electric-mode lights to confirm that the degradation region of t(0.5) deterioration is mainly located in the active layer, not in the vicinity of the antireflection facet.	[Takeshita, T.; Oda, K.] Kyushu Sangyo Univ, Fac Engn, Dept Elect Engn & Informat Technol, Fukuoka 8138503, Japan; [Mawatari, H.] NTT Corp, Nippon Telegraph & Tel NTT Photon Labs, Atsugi, Kanagawa 2430198, Japan	Takeshita, T (reprint author), Kyushu Sangyo Univ, Fac Engn, Dept Elect Engn & Informat Technol, Fukuoka 8138503, Japan.	takeshita@te.kyusan-u.ac.jp; oda@ip.kyusan-u.ac.jp; mawatari.hiroyasu@lab.ntt.co.jp					CHUANG SL, 1991, PHYS REV B, V43, P9649, DOI 10.1103/PhysRevB.43.9649; KOGELNIK H, 1972, J APPL PHYS, V43, P2327, DOI 10.1063/1.1661499; BAJAJ J, 1987, J VAC SCI TECHNOL A, V5, P3186, DOI 10.1116/1.574834; Cramer R. M., 1998, MICROELECTRON RELIAB, V38, P936; Fukano H, 1996, IEEE J QUANTUM ELECT, V32, P1959, DOI 10.1109/3.541682; Fukuda M., 1991, RELIABILITY DEGRADAT; Fukuda M., 1998, OPTICAL SEMICONDUCTO; Henley F. J., 1984, P INT REL PHYS S, P69; Kressel H., 1977, SEMICONDUCTOR LASERS; NIKAWA K, 1995, JPN J APPL PHYS 1, V34, P2260, DOI 10.1143/JJAP.34.2260; Sim S. P., 1988, P 14 EUR C OPT COMM, P396; Sze S. M., 1969, PHYSICS SEMICONDUCTO; Takeshita T, 2007, IEEE T ELECTRON DEV, V54, P456, DOI 10.1109/TED.2006.890367; Takeshita T., 2009, MATER RES SOC S P, V1195, pB01; Takeshita T, 2006, IEEE T ELECTRON DEV, V53, P211, DOI 10.1109/TED.2005.862238; Takeshita T, 2007, MICROELECTRON RELIAB, V47, P2135, DOI 10.1016/j.microrel.2007.01.001; Takeshita T, 2007, IEEE T ELECTRON DEV, V54, P1852, DOI 10.1109/TED.2007.900975; Ueda O., 1996, RELIABILITY DEGRADAT; Ueda O., 2013, MAT RELIABILITY HDB, P55; Wills . S., 1990, PARALLELS CELL CELL, P21	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1530-4388	1558-2574		IEEE T DEVICE MAT RE	IEEE Trans. Device Mater. Reliab.	DEC	2014	14	4					1074	1079		10.1109/TDMR.2014.2369420		6	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	AW0LT	WOS:000345984600020		
J	Wu, JS; Hsu, CC; Chu, JP; Teii, K				Wu, Jong-Shinn; Hsu, Cheng-Che (Jerry); Chu, Jinn P.; Teii, Kungen			Introduction to the Special Issue on the APSPT 2013	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Editorial Material									[Wu, Jong-Shinn] Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan; [Hsu, Cheng-Che (Jerry)] Natl Taiwan Univ, Dept Chem Engn, Taipei 10764, Taiwan; [Chu, Jinn P.] Natl Taiwan Univ Sci & Technol, Dept Mat Sci & Engn, Taipei, Taiwan; [Teii, Kungen] Kyushu Univ, Dept Elect & Mat Sci, Fukuoka 812, Japan	Wu, JS (reprint author), Natl Chiao Tung Univ, Dept Mech Engn, Hsinchu, Taiwan.							0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	DEC	2014	42	12	1		SI		3654	3655		10.1109/TPS.2014.2368058		2	Physics, Fluids & Plasmas	Physics	AW1TL	WOS:000346072900001		
J	Nishida, Y; Cheng, CZ; Iwasaki, K				Nishida, Yasushi; Cheng, Chio-Zong; Iwasaki, Kenichi			Hydrogen Production From Hydrocarbons With Use of Plasma Discharges Under High Pressure Condition	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Corona discharge; COx free H-2 production on the moving vehicle; dielectric barrier discharge (DBD); fuel cell; plasma system with catalysts	NONTHERMAL PLASMA; CORONA DISCHARGE; ETHANOL; METHANE	New H-2 production system from hydrocarbons is under development that uses plasma discharges working in high pressure condition over 1.5 atm. Here methane and propane are tried at present. This system is objected to be installed on the moving vehicles and the produced H-2 gas is directly supplied to the fuel cell on the vehicle. The hydrocarbons can be easily compressed into liquid state for storing in the conveyable tank, while H-2 gas requires a lot of extra energy for compression. For those purposes three kinds of plasma discharge methods are tried: 1) corona discharge plasma system; 2) dielectric barrier discharge nonthermal plasma system; and 3) nonthermal plasma reactor filled with dielectric pellet catalysts. Clear decompositions of hydrocarbons to produce H-2 gas have been observed without COx. Decomposed carbon powder is attached fully on the electrodes and no contamination on the chamber wall is observed.	[Nishida, Yasushi; Cheng, Chio-Zong] Natl Cheng Kung Univ, Inst Space & Plasma Sci, Plasma & Space Sci Ctr, Tainan 70101, Taiwan; [Nishida, Yasushi; Cheng, Chio-Zong] Natl Cheng Kung Univ, Res Ctr Energy Technol & Strategy, Tainan 70101, Taiwan; [Nishida, Yasushi; Iwasaki, Kenichi] Daikoh Shoji Co Ltd, Osaka, Tochigi 3200075, Japan	Nishida, Y (reprint author), Natl Cheng Kung Univ, Inst Space & Plasma Sci, Plasma & Space Sci Ctr, Tainan 70101, Taiwan.	nishiday_1@ybb.ne.jp; frankcheng@plasma.pssc.ncku.edu.tw; k-iwasaki@daikoh.net	Cheng, Chio/K-1005-2014		Top-University Fund, Research Center for Energy Technology and Strategy, National Cheng Kung University (NCKU), Tainan, Taiwan; Plasma and Space Science Center, NCKU	This work was supported in part by the Top-University Fund, Research Center for Energy Technology and Strategy, National Cheng Kung University (NCKU), Tainan, Taiwan, and in part by the Plasma and Space Science Center, NCKU.	Aleknaviciute I., 2013, Journal of Clean Energy Technologies, V1, DOI 10.7763/JOCET.2013.V1.25; Oda T, 2003, J ELECTROSTAT, V57, P293, DOI 10.1016/S0304-3886(02)00179-1; Haryanto A, 2005, ENERG FUEL, V19, P2098, DOI 10.1021/ef0500538; Ni M, 2007, INT J HYDROGEN ENERG, V32, P3238, DOI 10.1016/j.ijhydene.2007.04.038; Chang JS, 2002, INT J HYDROGEN ENERG, V27, P1167, DOI 10.1016/S0360-3199(02)00130-1; Liu CM, 2011, IEEE T PLASMA SCI, V39, P717, DOI 10.1109/TPS.2010.2096434; [Anonymous], 2012, FCX CLAR; Brown LF, 2001, INT J HYDROGEN ENERG, V26, P381; Zhou LM, 1998, ENERG FUEL, V12, P1191, DOI 10.1021/ef980044h; CHANG JS, 1991, IEEE T PLASMA SCI, V19, P1152, DOI 10.1109/27.125038; Patel N, 2008, INT J HYDROGEN ENERG, V33, P287, DOI 10.1016/j.ijhydene.2007.07.018; Mishra LN, 2004, IEEE T PLASMA SCI, V32, P1727, DOI 10.1109/TPS.2004.831591; Holladay JD, 2009, CATAL TODAY, V139, P244, DOI 10.1016/j.cattod.2008.08.039; Paulmier T, 2005, CHEM ENG J, V106, P59, DOI 10.1016/j.cej.2004.09.005; HUANG J, 1993, J PHYS CHEM-US, V97, P9403, DOI 10.1021/j100139a025; Kabashima H, 2003, IEEE T IND APPL, V39, P340, DOI 10.1109/TIA.2003.808968; Kittel P., 1996, ADV CRYOGEN ENG, V41, P1020; Mishra LN, 2004, J NAT GAS CHEM, V13, P82; Nishida Y., 2012, P 7 AS PAC INT S BAS; Nishida Y., 2014, Taiwan Patent, Patent No. [100 129 597, 100129597]; Nishida Y., 2012, P 18 INT C ADV OX TE; The Chemical Society of Japan, 1969, CHEM HDB, V1	22	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	DEC	2014	42	12	1		SI		3674	3680		10.1109/TPS.2014.2337351		7	Physics, Fluids & Plasmas	Physics	AW1TL	WOS:000346072900004		
J	Mitsugi, F; Ohshima, T; Kawasaki, H; Kawasaki, T; Aoqui, SI; Baba, T; Kinouchi, S				Mitsugi, Fumiaki; Ohshima, Tamiko; Kawasaki, Hiroharu; Kawasaki, Toshiyuki; Aoqui, Shin-Ichi; Baba, Tetsuro; Kinouchi, Shigeru			Gas Flow Dependence on Dynamic Behavior of Serpentine Plasma in Gliding Arc Discharge System	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Gliding arc discharge; photoelectric effect; reconnection; serpentine plasma; ultraviolet (UV)-assisted gliding arc system	WATER-SPRAY; TEMPERATURE DISTRIBUTION; ATMOSPHERIC-PRESSURE; SURFACE MODIFICATION; REACTOR; DECOMPOSITION; METHANE; INACTIVATION	Gliding arc discharge systems have been used in various applications. However, the power of conventional gliding arc plasmas is relatively high and the system requires an additional discharge for its ignition and a resistor for current protection, which causes further total energy consumption. We have proposed ultraviolet (UV)-assisted gliding arc discharge systems supported by time-resolved understanding for electrical characteristics and dynamic behavior of serpentine plasmas. In this paper, we report on gas flow dependence on dynamic behavior of serpentine plasmas in a gliding arc discharge system with the irradiation of a low-pressure mercury lamp. Time-resolved evaluation was carried out using the results of synchronized measurement for serpentine plasmas with a high-speed camera, a high-voltage probe, and a current sensor. Waveforms and mean values of the applied voltage, current, power, impedance, and energy for serpentine plasmas in the UV-assisted gliding arc discharge system were studied. The power and impedance per unit plasma length were also evaluated.	[Mitsugi, Fumiaki] Kumamoto Univ, Kumamoto 8600862, Japan; [Ohshima, Tamiko; Kawasaki, Hiroharu] Sasebo Natl Coll Technol, Sasebo 8571193, Japan; [Kawasaki, Toshiyuki] Nippon Bunri Univ, Oita 8700397, Japan; [Aoqui, Shin-Ichi] Sojo Univ, Kumamoto 8600082, Japan; [Baba, Tetsuro] VIC Int Inc, Tokyo 1901232, Japan; [Kinouchi, Shigeru] Ditect Co Ltd, Tokyo 1500031, Japan	Mitsugi, F (reprint author), Kumamoto Univ, Kumamoto 8600862, Japan.	mitsugi@cs.kumamoto-u.ac.jp; ohshima@post.cc.sasebo.ac.jp; h-kawasa@sasebo.ac.jp; kawasaki@nbu.ac.jp; aoqui@cis.sojo-u.ac.jp; baba@vic-int.co.jp; s-kinouchi@ditect.co.jp					Mlotek M, 2009, APPL CATAL A-GEN, V366, P232, DOI 10.1016/j.apcata.2009.06.043; Burlica R, 2010, IND ENG CHEM RES, V49, P6342, DOI 10.1021/ie100038g; Tu X, 2011, IEEE T PLASMA SCI, V39, P2900, DOI 10.1109/TPS.2011.2150247; Bo Z, 2008, INT J HYDROGEN ENERG, V33, P5545, DOI 10.1016/j.ijhydene.2008.05.101; Burlica R, 2008, IEEE T IND APPL, V44, P482, DOI 10.1109/TIA.2008.916603; Krawczyk K, 2009, PLASMA CHEM PLASMA P, V29, P27, DOI 10.1007/s11090-008-9159-6; Acayanka E, 2013, PLASMA CHEM PLASMA P, V33, P725, DOI 10.1007/s11090-013-9455-7; Fridman A, 1999, PROG ENERG COMBUST, V25, P211; Kim HS, 2013, SEP PURIF TECHNOL, V120, P423, DOI 10.1016/j.seppur.2013.09.041; Ghezzar MR, 2009, J HAZARD MATER, V164, P1266, DOI 10.1016/j.jhazmat.2008.09.060; Burlica R, 2006, J ELECTROSTAT, V64, P35, DOI 10.1016/j.elstat.2004.12.007; Bo Z, 2009, J HAZARD MATER, V166, P1210, DOI 10.1016/j.jhazmat.2008.12.030; Bo Z, 2007, PLASMA CHEM PLASMA P, V27, P691, DOI 10.1007/s11090-007-9102-2; Burlica R, 2010, PLASMA PROCESS POLYM, V7, P640, DOI 10.1002/ppap.200900183; Diatczyk J, 2008, PRZ ELEKTROTECHNICZN, V84, P309; Diatczyk J, 2010, PRZ ELEKTROTECHNICZN, V86, P298; Diatczyk J, 2006, J ADV OXID TECHNOL, V9, P174; Djowe AT, 2013, PLASMA CHEM PLASMA P, V33, P707, DOI 10.1007/s11090-013-9454-8; Iya-Sou D, 2013, PLASMA CHEM PLASMA P, V33, P97, DOI 10.1007/s11090-012-9423-7; Krawczyk K, 2007, CATAL TODAY, V119, P239, DOI 10.1016/j.cattod.2006.08.020; Liu SX, 2013, PLASMA CHEM PLASMA P, V33, P827, DOI 10.1007/s11090-013-9470-8; Locke BR, 2009, IEEE T PLASMA SCI, V37, P494, DOI 10.1109/TPS.2008.2011797; Luo Z, 2013, J APPL POLYM SCI, V127, P4756, DOI 10.1002/app.37986; Mitsugi F., JPN J APPL IN PRESS; Mitsugi F, 2013, EUR PHYS J-APPL PHYS, V61, DOI 10.1051/epjap/2012120408; Mitsugi F, 2012, PRZ ELEKTROTECHNICZN, V88, P105; Mitsugi F., 2013, P 21 INT S PLASM CHE, V66, P1; Sagas JC, 2011, IEEE T PLASMA SCI, V39, P775, DOI 10.1109/TPS.2010.2096481; Schmidt-Szalowski K, 2007, PLASMA PROCESS POLYM, V4, P728, DOI 10.1002/ppap.200700052; Selerowicz W, 2011, IEEE T PLASMA SCI, V39, P2866, DOI 10.1109/TPS.2011.2160565; Stryczewska Henryka Danuta, 2008, Przeglad Elektrotechniczny, V84; Stryczewska HD, 2011, J ADV OXID TECHNOL, V14, P276; Yu L, 2010, J PHYS CHEM A, V114, P360, DOI 10.1021/jp905082s	33	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	DEC	2014	42	12	1		SI		3681	3686		10.1109/TPS.2014.2363653		6	Physics, Fluids & Plasmas	Physics	AW1TL	WOS:000346072900005		
J	Akatsuka, H; Hatcho, M; Matsuura, H				Akatsuka, Hiroshi; Hatcho, Masahiko; Matsuura, Haruaki			Spectroscopic Characteristics of Supersonically Expanding Nitrogen Arc-Jet Plume-Strong Atomic Lines and Weak Molecular Band Spectra	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Arc jet; atomic nitrogen lines; nitrogen plasma; recombining plasma; spectroscopic characteristics	STATIONARY-POPULATION INVERSION; HELIUM PLASMA-JET	We generate recombining nitrogen plasma plume by expansion of nitrogen arc into lower pressure vessel with a weak longitudinal magnetic field in a steady state. Spectroscopic observation reveals that the plasma has almost no component of molecular band spectra. Meanwhile, atomic nitrogen lines are observed with considerable intensity. The reason for this spectroscopic peculiarity is discussed in terms of chemical thermodynamics of the nitrogen thermal arc plasma and of nonequilibrium characteristics.	[Akatsuka, Hiroshi; Matsuura, Haruaki] Tokyo Inst Technol, Nucl Reactors Res Lab, Tokyo 1528550, Japan; [Hatcho, Masahiko] IC Brains Co Ltd, Tokyo 1058001, Japan	Akatsuka, H (reprint author), Tokyo Inst Technol, Nucl Reactors Res Lab, Tokyo 1528550, Japan.	hakatsuk@nr.titech.ac.jp	Akatsuka, Hiroshi/G-3776-2014	Akatsuka, Hiroshi/0000-0002-3567-3833			Akatsuka H., 1994, J PLASMA FUSION RES, V70, P1196; AKATSUKA H, 1995, PLASMA SOURCES SCI T, V4, P125, DOI 10.1088/0963-0252/4/1/013; AKATSUKA H, 1993, REV SCI INSTRUM, V64, P1734, DOI 10.1063/1.1144001; AKATSUKA H, 1994, PHYS REV E, V49, P1534, DOI 10.1103/PhysRevE.49.1534; Ando Y., 1999, J JPN THERMAL SPRAY, V36, P38; Ichikawa Y, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.106101; CHANTRY PJ, 1987, J APPL PHYS, V62, P1141, DOI 10.1063/1.339662; Dresvin S. V., 1972, FISICA TEKHNIKA NIZI; Fujimoto T. J., 2004, PLASMA SPECTROSCOPY; Kano K, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.056404; Kobori H, 2004, THIN SOLID FILMS, V457, P69, DOI 10.1016/j.tsf.2003.12.016; Krivonosova O. E., 1991, REV PLASMA CHEM, V1, P9; Kuriki K., 2003, INTRO ELECT PROPULSI; Nagahara Y, 2013, IEEE T PLASMA SCI, V41, P1869, DOI 10.1109/TPS.2013.2260180; Rouffet B, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/18/185203; Yoshida K, 2009, IEEE T PLASMA SCI, V37, P1414, DOI 10.1109/TPS.2009.2021422; Yoshida K., 2009, J PLASMA FUSION RES, V8, P923; Yoshida K, 2009, IEEJ T ELECTR ELECTR, V4, P416, DOI 10.1002/tee.20425	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	DEC	2014	42	12	1		SI		3691	3697		10.1109/TPS.2014.2330840		7	Physics, Fluids & Plasmas	Physics	AW1TL	WOS:000346072900007		
J	Mitsugi, F; Nagatomo, T; Takigawa, K; Sakai, T; Ikegami, T; Nagahama, K; Ebihara, K; Sung, T; Teii, S				Mitsugi, Fumiaki; Nagatomo, Takuya; Takigawa, Keisuke; Sakai, Takamasa; Ikegami, Tomoaki; Nagahama, Kazuhiro; Ebihara, Kenji; Sung, Talun; Teii, Shinriki			Properties of Soil Treated With Ozone Generated by Surface Discharge	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Bacteria; DNA; nitrification; nitrogen nutrient; ozone treatment; soil; sterilization	AGRICULTURAL SOIL; STERILIZATION; STRESS	Chemical contamination in plants, soil, and ground water has become serious by overuse of pesticides and nitrogen fertilizers in agriculture. We propose the use of ozone generated by atmospheric pressure plasma for soil disinfection as one of the plasma applications into agriculture. Because ozone has strong oxidation potential to decompose organic substances in soil, it is considered to be one of the candidates as potential alternative to both pesticide and nitrogen fertilizer. In this paper, fundamental studies on changes in acidity and amounts of nitrogen nutrients, bacteria, mold, and soil DNA remained in soil after ozone treatment were carried out with a system using a quartz chamber. Surface barrier discharge that operates in atmospheric oxygen was used in the system as the ozone generator. In addition, growth of radishes that seeded on soils in pots that were treated by ozone diffusion method was also evaluated.	[Mitsugi, Fumiaki; Nagatomo, Takuya; Takigawa, Keisuke; Sakai, Takamasa; Ikegami, Tomoaki] Kumamoto Univ, Kumamoto 8608555, Japan; [Nagahama, Kazuhiro] Sojo Univ, Kumamoto 8600082, Japan; [Ebihara, Kenji] Environm & Energy Lab, Fukuoka 8100074, Japan; [Sung, Talun; Teii, Shinriki] Lunghwa Univ Sci & Technol, Taoyuan 33306, Taiwan	Mitsugi, F (reprint author), Kumamoto Univ, Kumamoto 8608555, Japan.	mitsugi@cs.kumamoto-u.ac.jp; kazuhiro@bio.sojo-u.ac.jp; ikegami@cs.kumamoto-u.ac.jp					Gomez-Alvarez M, 2012, J ENVIRON MANAGE, V113, P545, DOI 10.1016/j.jenvman.2012.03.017; Ahsan N, 2010, PROTEOMICS, V10, P2605, DOI 10.1002/pmic.201000180; Ikeura H, 2011, J FOOD ENG, V103, P345, DOI 10.1016/j.jfoodeng.2010.11.002; McDonough MX, 2011, J STORED PROD RES, V47, P306, DOI 10.1016/j.jspr.2011.04.003; Park DP, 2013, CURR APPL PHYS, V13, pS19, DOI 10.1016/j.cap.2012.12.019; Ikeura H, 2011, J HAZARD MATER, V186, P956, DOI 10.1016/j.jhazmat.2010.11.094; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Olmez H, 2009, J FOOD ENG, V90, P487, DOI 10.1016/j.jfoodeng.2008.07.026; Wigginton KR, 2012, CURR OPIN VIROL, V2, P84, DOI 10.1016/j.coviro.2011.11.003; Bao XL, 2014, ECOTOXICOLOGY, V23, P11, DOI 10.1007/s10646-013-1146-x; Cui XC, 2013, J AGR SCI TECH-IRAN, V15, P1043; Ebihara K, 2012, PRZ ELEKTROTECHNICZN, V88, P92; Ebihara K, 2011, PRZ ELEKTROTECHNICZN, V87, P148; Ebihara K, 2009, PRZ ELEKTROTECHNICZN, V85, P113; Ebihara K., 2013, EUR PHYS J-APPL PHYS, V61; Hashizume H, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.010209; Ito M, 2012, J KOREAN PHYS SOC, V60, P937, DOI 10.3938/jkps.60.937; Kitazaki S, 2014, CURR APPL PHYS, V14, pS149, DOI 10.1016/j.cap.2013.11.056; Kitazaki S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.11PJ02; Mitsugi F., JPN J APPL IN PRESS; Msayleb N, 2011, PHYSCS PROC, V21, DOI 10.1016/j.phpro.2011.10.028; Nagatomo T, 2013, 2013 SECOND IIAI INTERNATIONAL CONFERENCE ON ADVANCED APPLIED INFORMATICS (IIAI-AAI 2013), P121, DOI 10.1109/IIAI-AAI.2013.64; Rodoni L, 2010, J AGR FOOD CHEM, V58, P594, DOI 10.1021/jf9029145; Saitanis CJ, 2002, J AGRON CROP SCI, V188, P51, DOI 10.1046/j.1439-037x.2002.00539.x; Wang J, 2012, J SOIL SEDIMENT, V12, P117, DOI 10.1007/s11368-011-0439-z; Yendrek CR, 2013, GLOBAL CHANGE BIOL, V19, P3155, DOI 10.1111/gcb.12237; Zambre SS, 2010, J FOOD ENG, V96, P463, DOI 10.1016/j.jfoodeng.2009.08.027	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	DEC	2014	42	12	1		SI		3706	3711		10.1109/TPS.2014.2350533		6	Physics, Fluids & Plasmas	Physics	AW1TL	WOS:000346072900010		
J	Tsuno, S; Nakahagi, T; Yamashiro, R; Nezu, A; Matsuura, H; Akatsuka, H				Tsuno, Satoshi; Nakahagi, Takeshi; Yamashiro, Ryutaro; Nezu, Atsushi; Matsuura, Haruaki; Akatsuka, Hiroshi			Numerical Study on Acceleration and Deceleration Mechanism of Weakly Ionized Plasma Flowing Supersonically Through Open Field Line	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Diverging magnetic field; hybrid simulation; ion slip; potential drop; rarefied flow; supersonic plasma flow; weakly ionized plasma	APPLIED MAGNETIC-FIELDS; RAREFIED-GAS DYNAMICS; ARC-JET PLASMA; DIRECT SIMULATION; ISOTOPE-SEPARATION; DC DISCHARGE; NOBLE-GASES; COLLISIONS; THRUSTER; PERFORMANCE	We study supersonic flow of rarefied weakly ionized plasma at diverging magnetic field. While the flows of ions and neutral are treated by particle-based direct simulation Monte Carlo method, the electron is treated as a fluid, i.e., we carried out hybrid simulation. We calculate number density, velocity, temperature, and electric potential of charged particles and neutrals when the arc plasma flows out of the uniform magnetic field into lower pressure region in a steady state. We find the velocity increase just after passing the open magnetic field line, followed by deceleration due to collisions with residual molecules. We also find the temperature increase during the deceleration. In this acceleration/deceleration phenomena, the velocity difference between the neutrals and charged species are found, which also changes the electric potential. We discuss the mechanisms of potential formation along the plasma flow mainly by the pressure difference and the friction force between the charged particles and neutral species. The numerical results are, at least qualitatively, consistent with our previous experimental results.	[Tsuno, Satoshi] Toshiba Co Ltd, Tokyo 1058001, Japan; [Nakahagi, Takeshi] Mitsubishi Electr Corp, Tokyo 1000005, Japan; [Yamashiro, Ryutaro] Mitsui OSK Lines Ltd, Tokyo 1058688, Japan; [Nezu, Atsushi; Matsuura, Haruaki; Akatsuka, Hiroshi] Tokyo Inst Technol, Res Lab Nucl Reactors, Tokyo 1528550, Japan	Tsuno, S (reprint author), Toshiba Co Ltd, Tokyo 1058001, Japan.	hakatsuk@nr.titech.ac.jp	Akatsuka, Hiroshi/G-3776-2014	Akatsuka, Hiroshi/0000-0002-3567-3833			AKATSUKA H, 1993, REV SCI INSTRUM, V64, P1734, DOI 10.1063/1.1144001; Ando Y., 1999, J JPN THERMAL SPRAY, V36, P38; RIECHELMANN D, 1993, PHYS FLUIDS A-FLUID, V5, P2585, DOI 10.1063/1.858775; BIRDSALL CK, 1991, IEEE T PLASMA SCI, V19, P65, DOI 10.1109/27.106800; Russell CT, 2000, IEEE T PLASMA SCI, V28, P1818, DOI 10.1109/27.902211; NANBU K, 1980, J PHYS SOC JPN, V49, P2042, DOI 10.1143/JPSJ.49.2042; Swift DW, 1996, J COMPUT PHYS, V126, P109, DOI 10.1006/jcph.1996.0124; Akatsuka H, 2000, J PHYS D APPL PHYS, V33, P948, DOI 10.1088/0022-3727/33/8/311; Nanbu K, 2000, IEEE T PLASMA SCI, V28, P971, DOI 10.1109/27.887765; IVANOV MS, 1988, SOV J NUMER ANAL MAT, V3, P453; Winske D, 2003, LECT NOTES PHYS, V615, P136, DOI 10.1007/3-540-36530-3_8; MATTHEWS AP, 1994, J COMPUT PHYS, V112, P102, DOI 10.1006/jcph.1994.1084; Asami M, 2002, J VAC SCI TECHNOL A, V20, P1303, DOI 10.1116/1.1481046; BRACE LH, 1981, J ATMOS TERR PHYS, V43, P1317, DOI 10.1016/0021-9169(81)90157-4; Cheng S, 2004, COMPUT PHYS COMMUN, V164, P73, DOI 10.1016/j.cpc.2004.06.010; Eletskii A. V., 1976, FIZICHESIE VELICHNY, P375; Garrigues L, 2002, J APPL PHYS, V91, P9521, DOI 10.1063/1.1480480; Hagelaar GJM, 2002, J APPL PHYS, V91, P5592, DOI 10.1063/1.1465125; HAYASHI M, 1982, J PHYS D APPL PHYS, V15, P1411, DOI 10.1088/0022-3727/15/8/012; Ichiki T., 2009, J PLASMA FUSION RES, V8, P768; Kanuma T, 2005, AIP CONF PROC, V762, P385; Lai MC, 2001, NUMER METH PART D E, V17, P199, DOI 10.1002/num.1; Nagahara Y, 2013, IEEE T PLASMA SCI, V41, P1869, DOI 10.1109/TPS.2013.2260180; Nishihara H., 1979, DENJIKIGAKU TAIYO; Sasoh A., 2012, P 48 AIAA ASME SAE A; Shibata T., 2001, Q J JPN WELDING SOC, V19, P465; Suwa Yoshihide, 2012, Earozoru Kenkyu, V27; SUZUKI M, 1990, KAGAKU KOGAKU RONBUN, V16, P614; Suzuki S., 2006, J PLASMA FUSION RES, V82, P699; TAHARA H, 1995, J PROPUL POWER, V11, P337, DOI 10.2514/3.51430; Tahara H., 2007, P 30 INT ELECT PROPU; Tahara H, 1997, J PROPUL POWER, V13, P651, DOI 10.2514/2.5216; Yoshida K, 2009, IEEE T PLASMA SCI, V37, P1414, DOI 10.1109/TPS.2009.2021422; Yoshida K., 2009, J PLASMA FUSION RES, V8, P923; Yoshida K, 2009, IEEJ T ELECTR ELECTR, V4, P416, DOI 10.1002/tee.20425	35	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	DEC	2014	42	12	1		SI		3732	3741		10.1109/TPS.2014.2336254		10	Physics, Fluids & Plasmas	Physics	AW1TL	WOS:000346072900015		
J	Tanaka, H; Mizuno, M; Ishikawa, K; Takeda, K; Nakamura, K; Utsumi, F; Kajiyama, H; Kano, H; Okazaki, Y; Toyokuni, S; Maruyama, S; Kikkawa, F; Hori, M				Tanaka, Hiromasa; Mizuno, Masaaki; Ishikawa, Kenji; Takeda, Keigo; Nakamura, Kae; Utsumi, Fumi; Kajiyama, Hiroaki; Kano, Hiroyuki; Okazaki, Yasumasa; Toyokuni, Shinnya; Maruyama, Shoichi; Kikkawa, Fumitaka; Hori, Masaru			Plasma Medical Science for Cancer Therapy: Toward Cancer Therapy Using Nonthermal Atmospheric Pressure Plasma	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Cancer therapy; non-thermal atmospheric pressure plasma; and plasma-activated medium	GLIDING ELECTRIC-DISCHARGES; MELANOMA-CELLS; IN-VIVO; APOPTOSIS; STRATEGY; WATER	We have been developing novel ultrahigh density atmospheric pressure plasma sources and succeeded in the selective killing ovarian cancer cells against normal ones. Furthermore, we have found out the plasma- activated medium (PAM) also killed glioblastoma brain tumor cells selectively against normal ones and the chemical products in the PAM have long lifetime healing effects. To clarify the mechanism, interactions of plasma with the organism and the medium where the organism belongs were investigated on the viewpoint of intracellular molecular mechanism.	[Tanaka, Hiromasa; Mizuno, Masaaki; Ishikawa, Kenji; Takeda, Keigo; Toyokuni, Shinnya; Maruyama, Shoichi; Kikkawa, Fumitaka; Hori, Masaru] Nagoya Univ, Plasma Med Sci Global Innovat Ctr, Nagoya, Aichi 4648603, Japan; [Mizuno, Masaaki] Nagoya Univ, Ctr Adv Med & Clin Res, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Nakamura, Kae; Utsumi, Fumi; Kajiyama, Hiroaki; Kikkawa, Fumitaka] Nagoya Univ, Dept Obstet & Gynecol, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Kano, Hiroyuki] NU Ecoengn Co Ltd, Nagoya, Aichi 4700201, Japan; [Okazaki, Yasumasa; Toyokuni, Shinnya] Nagoya Univ, Dept Pathol & Biol Responses, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Maruyama, Shoichi] Nagoya Univ, Dept Nephrol, Grad Sch Med, Nagoya, Aichi 4668550, Japan	Tanaka, H (reprint author), Nagoya Univ, Plasma Med Sci Global Innovat Ctr, Nagoya, Aichi 4648603, Japan.	htanaka@plasma.engg.nagoya-u.ac.jp; mmizuno@med.nagoya-u.ac.jp; ishikawa@plasma.engg.nagoya-u.ac.jp; ktakeda@nuee.nagoya-u.ac.jp; k-naka@med.nagoya-u.ac.jp; fufumifu@med.nagoya-u.ac.jp; nu-eco@hm7.aitai.ne.jp; okazsamasuya@med.nagoya-u.ac.jp; toyokuni@med.nagoya-u.ac.jp; marus@med.nagoya-u.ac.jp; kikkawaf@med.nagoya-u.ac.jp; hori@nuee.nagoya-u.ac.jp	Toyokuni, Shinya/C-1358-2010; Ishikawa, Kenji /C-9919-2009; Ishikawa, Kenji/I-6758-2014; Okazaki, Yasumasa/E-7895-2010	Toyokuni, Shinya/0000-0002-5757-1109; Ishikawa, Kenji /0000-0002-8288-6620; Ishikawa, Kenji/0000-0002-8288-6620; Okazaki, Yasumasa/0000-0003-1054-9403	Knowledge Cluster Initiative Second Stage-Tokai Region Nanotechnology Manufacturing Cluster;  [24108002];  [24108008]	This work was supported in part by the Knowledge Cluster Initiative Second Stage-Tokai Region Nanotechnology Manufacturing Cluster and in part by a Grant-in-Aid for Scientific Research on Innovative Areas Plasma Medical Innovation under Grant 24108002 and Grant 24108008.	Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; von Woedtke T, 2013, PHYS REP, V530, P291, DOI 10.1016/j.physrep.2013.05.005; Oehmigen K, 2010, PLASMA PROCESS POLYM, V7, P250, DOI 10.1002/ppap.200900077; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Lee HJ, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115026; Kamgang-Youbi G, 2007, APPL ENVIRON MICROB, V73, P4791, DOI 10.1128/AEM.00120-07; Kieft IE, 2004, BIOELECTROMAGNETICS, V25, P362, DOI 10.1002/bem.20005; Shashurin A, 2010, PLASMA PROCESS POLYM, V7, P294, DOI 10.1002/ppap.200900086; Sato T, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/37/372001; Takeda K, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/46/464006; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kamgang-Youbi G, 2009, LETT APPL MICROBIOL, V48, P13, DOI 10.1111/j.1472-765X.2008.02476.x; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Jia FD, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.026101; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Bruggeman P, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/053001; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Huang J, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3666819; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Winter JN, 2011, AM J PHYSIOL-CELL PH, V300, pC1172, DOI 10.1152/ajpcell.00504.2010; Keidar M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801516; Kim SJ, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3462293; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Isbary G, 2013, EXPERT REV MED DEVIC, V10, P367, DOI [10.1586/erd.13.4, 10.1586/ERD.13.4]; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Arndt S, 2013, EXP DERMATOL, V22, P284, DOI 10.1111/exd.12127; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Weltmann KD, 2011, IEEE T PLASMA SCI, V39, P1015, DOI 10.1109/TPS.2011.2112674; Stoffels E, 2006, PLASMA SOURCES SCI T, V15, pS169, DOI 10.1088/0963-0252/15/4/S03; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Han X, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4809830; Yan X, 2012, PLASMA PROCESS POLYM, V9, P59, DOI 10.1002/ppap.201100031; Stoffels E, 2008, IEEE T PLASMA SCI, V36, P1441, DOI 10.1109/TPS.2008.2001084; Calugaru Ana, 2005, Roum Arch Microbiol Immunol, V64, P57; GWEON B, 2010, APPL PHYS LETT, V96; HAANEN C, 1995, MEDIAT INFLAMM, V4, P5, DOI 10.1155/S0962935195000020; ISEKI S, 2010, APPL PHYS LETT, V96; ISEKI S, 2012, APPL PHYS LETT, V100; IWASAKI M, 2008, APPL PHYS LETT, V92, P3; Joh HM, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4742742; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kaushik NK, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3687172; Kim JY, 2011, IEEE T PLASMA SCI, V39, P2974, DOI 10.1109/TPS.2011.2134111; KIM K, 2011, APPL PHYS LETT, V98, P3; Morfill GE, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115011; Partecke LI, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-473; Satoh K, 2007, JPN J APPL PHYS 1, V46, P1137, DOI 10.1143/JJAP.46.1137; Tanaka H, 2011, PLASMA MED, V1, P265; TANAKA H, 2012, PLASMA MED, V2, P207; Utsumi F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081576; Volotskova O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00636; Weltmann KD, 2011, EUR PHYS J-APPL PHYS, V55, DOI 10.1051/epjap/2011100452	52	3	3	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	DEC	2014	42	12	1		SI		3760	3764		10.1109/TPS.2014.2353659		5	Physics, Fluids & Plasmas	Physics	AW1TL	WOS:000346072900020		
J	Hsiao, RC; Sung, TL; Liu, CM; Teii, S; Chan, TC; Ono, S; Teii, K; Yang, CC; Zeng, SC				Hsiao, Ruey-Chang; Sung, Ta-Lun; Liu, Chung-Ming; Teii, Shinriki; Chan, Tu-Cheng; Ono, Shigeru; Teii, Kungen; Yang, Chao-Chen; Zeng, Shi-Chao			Hydrophilic Stability of Plastic Surfaces Treated in Low- and Atmospheric-Pressure Radio-Frequency Plasmas	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Acrylonitrile butadiene styrene (ABS); contact angle; corona torch; polycarbonate (PC); radio frequency (RF); surface treatment; wettability	WETTABILITY; FILMS	An atmospheric-pressure radio-frequency (RF) corona torch plasma and a low-pressure parallel-plate RF plasma are employed to increase hydrophilicity of polycarbonate and acrylonitrile butadiene styrene surfaces. The contact angle of water for the plastic surfaces is decreased by Ar plasma treatment in any condition, while the surface roughness is decreased, too, unexpectedly. The rate of decrease in contact angle versus treatment time in the atmospheric pressure plasma is about an order of magnitude higher than that in the low-pressure plasma. During postexposure of the plastic surfaces to ambient air, the contact angle is recovered gradually and saturated at a certain value depending on plasma treatment time. A longer plasma treatment time causes less recovery in contact angle. The results indicate that surface roughening as well as surface functionalization is responsible for improving the recovery characteristic and, hence, the hydrophilic stability.	[Hsiao, Ruey-Chang; Sung, Ta-Lun; Liu, Chung-Ming; Teii, Shinriki] Lunghwa Univ Sci & Technol, Dept Chem & Mat Engn, Taoyuan 33306, Taiwan; [Teii, Shinriki] Musashi Inst Technol, Tokyo 1588557, Japan; [Chan, Tu-Cheng] Ming Tong Enterprise Co Ltd, Taoyuan 22248, Taiwan; [Ono, Shigeru] Tokyo City Univ, Dept Elect & Elect Engn, Tokyo 1588557, Japan; [Teii, Kungen] Kyushu Univ, Dept Appl Sci Elect & Mat, Fukuoka 8168580, Japan; [Yang, Chao-Chen; Zeng, Shi-Chao] Natl Yunlin Univ Sci & Technol, Dept Chem & Mat Engn, Yunlin 64002, Taiwan	Hsiao, RC (reprint author), Lunghwa Univ Sci & Technol, Dept Chem & Mat Engn, Taoyuan 33306, Taiwan.	hrc@mail.lhu.edu.tw; tlsung@mail.lhu.edu.tw; liuc@mail.lhu.edu.tw					Prysiazhnyi V, 2014, THIN SOLID FILMS, V550, P373, DOI 10.1016/j.tsf.2013.10.176; Beake BD, 1998, J MATER CHEM, V8, P2845, DOI 10.1039/a807261b; Yang JHC, 2012, THIN SOLID FILMS, V520, P6566, DOI 10.1016/j.tsf.2012.06.041; Duca MD, 1998, POLYM DEGRAD STABIL, V61, P65, DOI 10.1016/S0141-3910(97)00130-4; Lee JL, 2005, J ADV OXID TECHNOL, V8, P71; Matsuda S., 1994, IEEE T IND APPL, V30, P377; Park YW, 2002, J APPL POLYM SCI, V83, P1258, DOI 10.1002/app.2293; Sung TL, 2011, THIN SOLID FILMS, V519, P6688, DOI 10.1016/j.tsf.2011.04.075; Sung TL, 2011, CURR APPL PHYS, V11, pS26, DOI 10.1016/j.cap.2011.06.008; Sung TL, 2012, IEEE T PLASMA SCI, V40, P1837, DOI 10.1109/TPS.2012.2196057; Takayama S., 2002, Transactions of the Institute of Electrical Engineers of Japan, Part A, V122-A; YAMAMOTO T, 1995, IEEE T IND APPL, V31, P494, DOI 10.1109/28.382108; Yamamoto T., 2000, P 4 ESA IEJ JOINT S; Yang JHC, 2012, DIAM RELAT MATER, V24, P54, DOI 10.1016/j.diamond.2011.10.023	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	DEC	2014	42	12	1		SI		3837	3841		10.1109/TPS.2014.2329895		5	Physics, Fluids & Plasmas	Physics	AW1TL	WOS:000346072900030		
J	Sung, TL; Hsiao, RC; Liu, CM; Teii, S; Jhou, HP; Teii, K; Ono, S; Ebihara, K; Mitsugi, F				Sung, Ta-Lun; Hsiao, Ruey-Chang; Liu, Chung-Ming; Teii, Shinriki; Jhou, Huei-Ping; Teii, Kungen; Ono, Shigeru; Ebihara, Kenji; Mitsugi, Fumiaki			Direct Measurement of Metal Surface Temperature During Catalytic Dissociation of Ozone for Sensor Application	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Catalyst; catalytic probe; dielectric barrier discharge; dissociation; microplasma; ozone; ozonizer; platinum; sensor; stainless steel; thermocouple	DIELECTRIC-BARRIER-DISCHARGE; OZONIZER; PLASMA; STERILIZATION	Temperature variation of a catalytic metal surface exposed to ozone produced in an atmospheric-pressure dielectric barrier discharge is examined by using a very thin thermocouple. The metal sheet is heated initially to a certain temperature (T-1) using a resistive heater and, then, the ozone concentration is increased with the heater current unchanged. When T-1 is room temperature, the temperature of the metal sheet remains almost constant independent of ozone concentration. When T-1 is increased up to 80 degrees C, the temperature of the metal sheet decreases clearly with increasing ozone concentration due to enhanced catalytic dissociation of ozone at the metal surface. The rate of decrease in temperature for a stainless steel sheet is increased from nearly 0% to similar to 5.7% with increasing T-1 from room temperature to 80 degrees C, while that for a platinum sheet is increased further to similar to 17.5% at 80 degrees C due to stronger catalytic activity of platinum. The results confirm that the sensitivity for ozone is improved with a stronger catalytic metal heated to a higher temperature as the sensor body.	[Sung, Ta-Lun; Hsiao, Ruey-Chang; Liu, Chung-Ming; Teii, Shinriki; Jhou, Huei-Ping] Lunghwa Univ Sci & Technol, Dept Chem & Mat Engn, Taoyuan 33306, Taiwan; [Teii, Shinriki] Musashi Inst Technol, Tokyo 1580087, Japan; [Teii, Kungen] Kyushu Univ, Dept Appl Sci Elect & Mat, Fukuoka 8168581, Japan; [Ono, Shigeru] Tokyo City Univ, Dept Elect & Elect Engn, Tokyo 1588557, Japan; [Ebihara, Kenji] Environm & Energy Lab, Fukuoka 8100074, Japan; [Ebihara, Kenji] Kumamoto Univ, Kumamoto 8600862, Japan; [Mitsugi, Fumiaki] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8600862, Japan	Sung, TL (reprint author), Lunghwa Univ Sci & Technol, Dept Chem & Mat Engn, Taoyuan 33306, Taiwan.	tlsung@mail.lhu.edu.tw; hrc@mail.lhu.edu.tw					Takayama M, 2006, THIN SOLID FILMS, V506, P396, DOI 10.1016/j.tsf.2005.08.332; McDonough MX, 2011, J STORED PROD RES, V47, P249, DOI 10.1016/j.jspr.2011.04.001; Santana MHP, 2009, J HAZARD MATER, V164, P10, DOI 10.1016/j.jhazmat.2008.07.108; Akbas MY, 2008, FOOD MICROBIOL, V25, P386, DOI 10.1016/j.fm.2007.09.007; Takaki K, 2008, VACUUM, V83, P128, DOI 10.1016/j.vacuum.2008.03.047; John S, 2009, CHEM ENG SCI, V64, P4826, DOI 10.1016/j.ces.2009.07.034; Kuraica MM, 2004, VACUUM, V73, P705, DOI 10.1016/j.vacuum.2003.12.093; Choi JH, 2006, J ELECTROSTAT, V64, P17, DOI 10.1016/j.elstat.2005.04.001; Babic D, 2001, REV SCI INSTRUM, V72, P4110, DOI 10.1063/1.1409567; Crowe KM, 2012, FOOD CONTROL, V25, P464, DOI 10.1016/j.foodcont.2011.11.021; Hsiao RC, 2014, VACUUM, V101, P345, DOI 10.1016/j.vacuum.2013.10.008; Itoh H, 2011, OZONE-SCI ENG, V33, P106, DOI 10.1080/01919512.2011.548295; Kaneda S, 2004, VACUUM, V73, P567, DOI 10.1016/j.vacuum.2003.12.088; Oda T, 2006, THIN SOLID FILMS, V506, P669, DOI 10.1016/j.tsf.2005.08.266; Ono S, 2009, THIN SOLID FILMS, V518, P981, DOI 10.1016/j.tsf.2009.07.175; Sung TL, 2012, IEEE T PLASMA SCI, V40, P2751, DOI 10.1109/TPS.2012.2210447; Sung TL, 2013, VACUUM, V90, P65, DOI 10.1016/j.vacuum.2012.10.003	17	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	DEC	2014	42	12	1		SI		3842	3846		10.1109/TPS.2014.2350000		5	Physics, Fluids & Plasmas	Physics	AW1TL	WOS:000346072900031		
J	Harigai, T; Iwasa, K; Furuta, H; Hatta, A				Harigai, Toru; Iwasa, Koyo; Furuta, Hiroshi; Hatta, Akimitsu			Hydrophilic DLC Surface Induced by Nanostructures Formed by RF O-2 Plasma Etching With Metal Micromasks	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Article						Amorphous carbon; diamond-like carbon (DLC); nanostructures; plasma etching	DIAMOND-LIKE CARBON; FILMS	Long pillar- and tip-shaped nanostructures were formed on diamond-like carbon (DLC) surfaces by RF O-2 plasma etching after deposition of a small amount of metal as a micromask by the dc magnetron sputtering method. Ni, Pt, Fe, Au, and Cu were examined as metal micromasks for deposition on the DLC surface. During the initial etching stage, nanostructures appeared on all of the DLC surfaces with each of the metal micromasks. The initial nanostructures were induced by anisotropic etching with the micromasks of aggregated metal. As the etching duration was increased, the nanostructures grown with Ni and Fe micromasks appeared to be lengthened, while the nanostructures induced by Pt, Au, and Cu completely disappeared. O-2 plasma etching for 5 min after deposition of a 0.15-nm thick Ni layer resulted in complete coverage of the DLC surface with fine nanostructures around 30 nm in diameter, 60 nm in height, and an areal number density of 1500 mu m(-2). The resultant surface had hydrophilic characteristics with a small water contact angle of 13 degrees.	[Harigai, Toru; Iwasa, Koyo; Furuta, Hiroshi; Hatta, Akimitsu] Kochi Univ Technol, Dept Elect & Photon Syst Engn, Kochi 7828502, Japan; [Furuta, Hiroshi; Hatta, Akimitsu] Kochi Univ Technol, Inst Nanotechnol, Kochi 7828502, Japan	Harigai, T (reprint author), Kochi Univ Technol, Dept Elect & Photon Syst Engn, Kochi 7828502, Japan.	166006m@gs.kochi-tech.ac.jp; 130020k@ugs.kochi-tech.ac.jp; furuta.hiroshi@kochi-tech.ac.jp; hatta.akimitsu@kochi-tech.ac.jp	Furuta, Hiroshi/A-8202-2010	Furuta, Hiroshi/0000-0002-3129-0894	Ministry of Education, Culture, Sports, Science and Technology of Japan [22110515, 24110719]; Ministry of Education, Culture, Sports, Science and Technology of Japanthrough the Scientific Research on Innovative Areas Frontier Science of Interactions between Plasmas and Nanointerfaces; Japan Society for the Promotion of Science Fellows [24.9423]	This work was supported in part by the Grants-in-Aid for Scientific Research, Ministry of Education, Culture, Sports, Science and Technology of Japan, under Grant 22110515 and Grant 24110719, through the Scientific Research on Innovative Areas Frontier Science of Interactions between Plasmas and Nanointerfaces, and in part by the Grant-in-Aid through the Japan Society for the Promotion of Science Fellows under 24.9423.	Anil M, 2010, DIAM RELAT MATER, V19, P300, DOI 10.1016/j.diamond.2009.12.001; Kwok SCH, 2005, DIAM RELAT MATER, V14, P78, DOI 10.1016/j.diamond.2004.07.019; Zhang S, 2002, INT J MOD PHYS B, V16, P1080, DOI 10.1142/S0217979202010890; Koji H, 2013, DIAM RELAT MATER, V36, P1, DOI 10.1016/j.diamond.2013.02.002; Endrino JL, 2008, APPL SURF SCI, V254, P5323, DOI 10.1016/j.apsusc.2008.02.065; Robertson J, 2002, MAT SCI ENG R, V37, P129, DOI 10.1016/S0927-796X(02)00005-0; Harigai T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.08JF12; Hosono E, 2009, J CERAM SOC JPN, V117, P299, DOI 10.2109/jcersj2.117.299; Kusumoto Y., 2014, J VAC TECHNOL A, V32; Mundo R. D., 2009, APPL SURF SCI, V255, P5461; Mundo Rosa Di, 2008, Langmuir, V24, P5044, DOI 10.1021/la800059a; Mundo R. D., 2009, LANGMUIR, V26, P5196; Nagashima S, 2010, DIAM RELAT MATER, V19, P861, DOI 10.1016/j.diamond.2010.02.003; Nakatani T, 2007, NEW DIAM FRONT C TEC, V17, P289; Peter NJ, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4768808	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	DEC	2014	42	12	1		SI		3858	3861		10.1109/TPS.2014.2338352		4	Physics, Fluids & Plasmas	Physics	AW1TL	WOS:000346072900033		
J	Teii, K				Teii, Kungen			Plasma Deposition of Diamond at Low Pressures: A Review	IEEE TRANSACTIONS ON PLASMA SCIENCE			English	Review						Amorphous carbon; chemical vapor deposition (CVD); diamond-like carbon (DLC); epitaxy; hydrogen; ion bombardment; nanocrystalline diamond; nanodiamond; physical vapor deposition (PVD); plasma diagnostics; subplantation	CHEMICAL-VAPOR-DEPOSITION; INDUCTIVELY-COUPLED PLASMA; CYCLOTRON-RESONANCE PLASMA; CUBIC BORON-NITRIDE; P-N-JUNCTION; MICROWAVE PLASMA; CARBON-FILMS; THIN-FILMS; MICROCRYSTALLINE DIAMOND; NANOCRYSTALLINE DIAMOND	Plasma deposition techniques of nanocrystalline and microcrystalline diamond and related mechanisms at pressures below 0.1 torr are reviewed. The mechanism of nucleation and growth of diamond in low-pressure conditions is discussed theoretically and experimentally along with the role of radicals and ions in two different ion-energy ranges. For ion impact energies below 20-30 eV, diamond deposition occurs on a surface. The growth process is limited by the substrate temperature and the flux of hydrogen radicals when the ion energy is reduced enough to several eV as shown by a kinetic rate analysis for radical species. The nucleation process is limited mainly by the degree of carbon saturation and, hence, the flux of carbon-containing species. For ion impact energies above 20-30 eV, diamond deposition occurs beneath a surface. Renucleation hinders the growth and diamond nanocrystals are embedded in an amorphous carbon matrix. The nucleation process depends strongly upon the ion energy, ion-to-depositing flux ratio, and substrate temperature as shown by the film density increment based on the subplantation model.	Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Dept Appl Sci Elect & Mat, Fukuoka 8168580, Japan	Teii, K (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Dept Appl Sci Elect & Mat, Fukuoka 8168580, Japan.	teii@asem.kyushu-u.ac.jp			Japan Society for the Promotion of Science	This paper was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	AMARATUNGA G, 1989, APPL PHYS LETT, V55, P634, DOI 10.1063/1.101808; LIFSHITZ Y, 1994, PHYS REV LETT, V72, P2753, DOI 10.1103/PhysRevLett.72.2753; Teii K, 2013, J APPL PHYS, V114, DOI 10.1063/1.4819385; Isberg J, 2002, SCIENCE, V297, P1670, DOI 10.1126/science.1074374; KAMO M, 1983, J CRYST GROWTH, V62, P642, DOI 10.1016/0022-0248(83)90411-6; Wesolowski P, 1997, APPL PHYS LETT, V71, P1948, DOI 10.1063/1.119990; Lyutovich Y, 1999, APPL PHYS LETT, V74, P659, DOI 10.1063/1.122978; YUGO S, 1991, APPL PHYS LETT, V58, P1036, DOI 10.1063/1.104415; FALLON PJ, 1993, PHYS REV B, V48, P4777, DOI 10.1103/PhysRevB.48.4777; COBURN JW, 1972, J APPL PHYS, V43, P4965, DOI 10.1063/1.1661054; Yoshimoto M, 1999, NATURE, V399, P340, DOI 10.1038/20653; STONER BR, 1992, APPL PHYS LETT, V60, P698, DOI 10.1063/1.106541; Kim J, 2010, PLASMA SOURCES SCI T, V19, DOI 10.1088/0963-0252/19/1/015003; Teii K, 1999, J APPL PHYS, V85, P1864, DOI 10.1063/1.369311; Okada K, 2000, J APPL PHYS, V88, P1674, DOI 10.1063/1.373870; ANGUS JC, 1988, SCIENCE, V241, P913, DOI 10.1126/science.241.4868.913; JACKMAN RB, 1995, APPL PHYS LETT, V66, P1018, DOI 10.1063/1.113591; LIFSHITZ Y, 1989, PHYS REV LETT, V62, P1290, DOI 10.1103/PhysRevLett.62.1290; Teii K, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2830006; Ohtsuka K, 1996, JPN J APPL PHYS 2, V35, pL1072; ROBERTSON J, 1994, DIAM RELAT MATER, V3, P361, DOI 10.1016/0925-9635(94)90186-4; LANDSTRASS MI, 1989, APPL PHYS LETT, V55, P975, DOI 10.1063/1.101694; Koizumi S, 2001, SCIENCE, V292, P1899, DOI 10.1126/science.1060258; Zarrabian M, 1997, APPL PHYS LETT, V70, P2535, DOI 10.1063/1.118912; Krauss AR, 2001, J APPL PHYS, V89, P2958, DOI 10.1063/1.1320009; AGER JW, 1991, PHYS REV B, V43, P6491, DOI 10.1103/PhysRevB.43.6491; Williams OA, 2004, APPL PHYS LETT, V85, P1680, DOI 10.1063/1.1785288; Gsell S, 2004, APPL PHYS LETT, V84, P4541, DOI 10.1063/1.1758780; Chapman B., 1980, GLOW DISCHARGE PROCE; EDDY CR, 1991, SURF COAT TECH, V48, P69, DOI 10.1016/0257-8972(91)90129-K; Gamarnik MY, 1996, NANOSTRUCT MATER, V7, P651, DOI 10.1016/0965-9773(96)00034-7; Grotjohn TA, 2000, DIAM RELAT MATER, V9, P322, DOI 10.1016/S0925-9635(99)00211-3; HATTA A, 1995, APPL PHYS LETT, V66, P1602, DOI 10.1063/1.113865; HIRAKI A, 1990, SURF COAT TECH, V43-4, P10, DOI 10.1016/0257-8972(90)90055-H; Hiramatsu M, 1998, THIN SOLID FILMS, V332, P136, DOI 10.1016/S0040-6090(98)01022-0; Ikeda M, 1997, J APPL PHYS, V82, P4055, DOI 10.1063/1.365715; Ikeda M, 1996, JPN J APPL PHYS 1, V35, P4826, DOI 10.1143/JJAP.35.4826; Ikeda T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3115767; Ikeda T, 2008, J APPL PHYS, V104, DOI 10.1063/1.2990061; Ikeda T, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3082045; KADONO M, 1993, JPN J APPL PHYS 1, V32, P3231, DOI 10.1143/JJAP.32.3231; Kim J, 2007, J APPL PHYS, V101, DOI 10.1063/1.2409761; KOIZUMI S, 1990, J CRYST GROWTH, V99, P1188, DOI 10.1016/S0022-0248(08)80105-4; KOMORI M, 1993, APPL PHYS LETT, V62, P582, DOI 10.1063/1.108862; Kouzuma Y, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.064104; Lee J, 1997, APPL PHYS LETT, V70, P1527, DOI 10.1063/1.118607; Lee ST, 1997, PHYS REV B, V55, P15937, DOI 10.1103/PhysRevB.55.15937; Lifshitz Y, 2002, SCIENCE, V297, P1531, DOI 10.1126/science.1074551; Loh KP, 1996, DIAM RELAT MATER, V5, P231, DOI 10.1016/0925-9635(95)00421-1; Makino T, 2006, DIAM RELAT MATER, V15, P513, DOI 10.1016/j.diamond.2005.11.021; Makino T, 2005, JPN J APPL PHYS 2, V44, pL1190, DOI 10.1143/JJAP.44.L1190; Matsumoto S., 1982, JPN J APPL PHYS, V21, P183; Mitsuda Y, 1997, DIAM RELAT MATER, V6, P468, DOI 10.1016/S0925-9635(96)00618-8; NAMBA Y, 1989, J VAC SCI TECHNOL A, V7, P36, DOI 10.1116/1.575764; Okada K, 1999, J MATER RES, V14, P578, DOI 10.1557/JMR.1999.0082; Okushi H, 2001, DIAM RELAT MATER, V10, P281, DOI 10.1016/S0925-9635(00)00399-X; Piazza F, 2007, DIAM RELAT MATER, V16, P1950, DOI 10.1016/j.diamond.2007.08.038; Prelas M. A., 1998, HDB IND DIAMONDS DIA; Ravi S, 1996, APPL PHYS LETT, V69, P491, DOI 10.1063/1.117763; Robertson J, 1996, DIAM RELAT MATER, V5, P519, DOI 10.1016/0925-9635(96)80071-9; Sattel S, 1996, APPL PHYS LETT, V69, P497, DOI 10.1063/1.117765; SILVA SRP, 1994, DIAM RELAT MATER, V3, P1048, DOI 10.1016/0925-9635(94)90117-1; Spear K. E., 1994, SYNTHETIC DIAMOND EM; SPENCER EG, 1976, APPL PHYS LETT, V29, P118, DOI 10.1063/1.88963; SPITSYN BV, 1981, J CRYST GROWTH, V52, P219, DOI 10.1016/0022-0248(81)90197-4; Sun C, 1999, DIAM RELAT MATER, V8, P1410, DOI 10.1016/S0925-9635(99)00011-4; SUZUKI JI, 1989, JPN J APPL PHYS 2, V28, pL281, DOI 10.1143/JJAP.28.L281; Teii K, 2000, J APPL PHYS, V87, P4572, DOI 10.1063/1.373104; Teii K, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.125327; Teii K, 2007, J APPL PHYS, V101, DOI 10.1063/1.2431401; Teii K, 2004, J APPL PHYS, V95, P4463, DOI 10.1063/1.1686900; Teii K, 2003, J APPL PHYS, V93, P5888, DOI 10.1063/1.1568158; Teii K, 1998, THIN SOLID FILMS, V316, P24, DOI 10.1016/S0040-6090(98)00382-4; Teii K, 2012, ACS APPL MATER INTER, V4, P5249, DOI 10.1021/am301133d; WEILER M, 1994, APPL PHYS LETT, V64, P2797, DOI 10.1063/1.111428; Wolden CA, 1996, DIAM RELAT MATER, V5, P1503, DOI 10.1016/S0925-9635(96)00574-2; Yang JHC, 2012, DIAM RELAT MATER, V24, P54, DOI 10.1016/j.diamond.2011.10.023; Yeh WY, 2001, J VAC SCI TECHNOL A, V19, P2835, DOI 10.1116/1.1409378; YOUCHISON DL, 1993, J VAC SCI TECHNOL A, V11, P103, DOI 10.1116/1.578275; Zhang WJ, 2000, PHYS REV B, V61, P5579, DOI 10.1103/PhysRevB.61.5579	80	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0093-3813	1939-9375		IEEE T PLASMA SCI	IEEE Trans. Plasma Sci.	DEC	2014	42	12	1		SI		3862	3869		10.1109/TPS.2014.2333772		8	Physics, Fluids & Plasmas	Physics	AW1TL	WOS:000346072900034		
J	Yano, Y; Goka, S				Yano, Yuichiro; Goka, Shigeyoshi			High-Contrast Coherent Population Trapping Based on Crossed Polarizers Method	IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROL			English	Article							FREQUENCY REFERENCES/; RESONANCES; CLOCKS; ATOMS	A method based on crossed polarizers to observe high-contrast coherent population trapping (CPT) resonance has been developed. Because crossed polarizers have a simple optical system, our method is suitable for chip-scale atomic clocks (CSACs). In CPT, the Faraday rotation in a linearly polarized light field (lin parallel to lin) was calculated using two pairs of Lambda-system models; the spectrum of the Faraday rotation is also estimated. After measuring the contrast and linewidth with the crossed-polarizer method, a comparison of the theoretical model and experimental data showed they were in good agreement. Moreover, the experimental results showed that a high contrast (88.4%) and narrow linewidth (1.15 kHz) resonance could be observed using a Cs gas cell and D-1-line vertical-cavity surface-emitting laser (VCSEL).	[Yano, Yuichiro; Goka, Shigeyoshi] Tokyo Metropolitan Univ, Dept Elect & Elect Engn, Tokyo 158, Japan	Yano, Y (reprint author), Tokyo Metropolitan Univ, Dept Elect & Elect Engn, Tokyo 158, Japan.	yano-yuichiro@ed.tmu.ac.jp					Budker D, 2002, REV MOD PHYS, V74, P1153, DOI 10.1103/RevModPhys.74.1153; Zibrov SA, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.013833; Knappe S, 2004, APPL PHYS LETT, V85, P1460, DOI 10.1063/1.1787942; Lin JD, 2012, OPT LETT, V37, P5036, DOI 10.1364/OL.37.005036; Budker D., 2004, ATOMIC PHYS EXPLORAT; DICK B, 1988, CHEM PHYS LETT, V143, P186, DOI 10.1016/0009-2614(88)87035-0; Jau YY, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.160802; Kitching J, 2001, J OPT SOC AM B, V18, P1676, DOI 10.1364/JOSAB.18.001676; Knappe S, 2001, J OPT SOC AM B, V18, P1545, DOI 10.1364/JOSAB.18.001545; Lutwak R., 2004, P PTTI, P467; Pradhan S., 2012, APPL PHYS LETT, V100; VIG JR, 1993, IEEE T ULTRASON FERR, V40, P522, DOI 10.1109/58.238104; Watabe K, 2009, APPL OPTICS, V48, P1098, DOI 10.1364/AO.48.001098; Zanon T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.193002	14	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-3010	1525-8955		IEEE T ULTRASON FERR	IEEE Trans. Ultrason. Ferroelectr. Freq. Control	DEC	2014	61	12					1953	1960		10.1109/TUFFC.2014.006623		8	Acoustics; Engineering, Electrical & Electronic	Acoustics; Engineering	AU9XF	WOS:000345944300003		
J	Saeki, M				Saeki, M.			Data-driven loop-shaping design of PID controllers for stable plants	INTERNATIONAL JOURNAL OF ADAPTIVE CONTROL AND SIGNAL PROCESSING			English	Article						PID control; robust stability; linear programming; transient response	CONVEX-OPTIMIZATION; MODELS	In this paper, a loop-shaping design method of PID controllers is proposed for stable plants under the condition that the plant is linear time invariant and a finite-time plant response is available. The integral gain of the PID controller is maximized subject to a stability margin constraint, and the optimal solution can be found by linear programming. A filter bank is used for extracting useful information from the finite-time response data. Numerical examples show that this method is applicable to a wide range of plants including non-minimum phase and/or time-delay plants. Copyright (c) 2013 John Wiley & Sons, Ltd.	Hiroshima Univ, Dept Mech Syst Engn, Higashihiroshima 7398527, Japan	Saeki, M (reprint author), Hiroshima Univ, Dept Mech Syst Engn, Higashihiroshima 7398527, Japan.	saeki@hiroshima-u.ac.jp					Campi MC, 2002, AUTOMATICA, V38, P1337, DOI 10.1016/S0005-1098(02)00032-8; Campestrini L, 2011, AUTOMATICA, V47, P1778, DOI 10.1016/j.automatica.2011.04.002; Shamsuzzoha M, 2010, J PROCESS CONTR, V20, P1220, DOI 10.1016/j.jprocont.2010.08.003; Panagopoulos H, 2002, IEE P-CONTR THEOR AP, V149, P32, DOI 10.1049/ip-cta:20020102; Safonov MG, 1997, IEEE T AUTOMAT CONTR, V42, P843, DOI 10.1109/9.587340; Galdos G, 2010, J PROCESS CONTR, V20, P1175, DOI 10.1016/j.jprocont.2010.07.006; Hara S, 2006, IEEE CONTR SYST MAG, V26, P80, DOI 10.1109/MCS.2006.1580156; Hjalmarssons H, 1999, IEEE CONTROL SYSTEMS, V42, P843; Kaneko O., 2005, T I SYSTEMS CONTROL, V18, P400; Karimi A, 2010, AUTOMATICA, V46, P1388, DOI 10.1016/j.automatica.2010.05.019; Karimi A, 2004, INT J ADAPT CONTROL, V18, P645, DOI 10.1002/acs.825; Karimi A, 2007, CONTROL ENG PRACT, V15, P197, DOI 10.1016/j.conengprac.2006.06.002; Kessler C., 1960, Regelungstechnik, V8; Kitamori T., 1979, Transactions of the Society of Instrument and Control Engineers, V15; Ljungs L., 1999, SYSTEM IDENTIFICATIO, V2nd; Saeki M, 2000, INT J ROBUST NONLIN, V10, P83, DOI 10.1002/(SICI)1099-1239(200002)10:2<83::AID-RNC464>3.0.CO;2-L; Saeki M, 2006, AUTOMATICA, V42, P93, DOI 10.1016/j.automatica.2005.07.006; Saekis M, 2008, P 17 WORLD IFAC C, P4958; Saeki M, 2010, INT J ROBUST NONLIN, V20, P323, DOI 10.1002/rnc.1434; Skogestads S, 1996, MULTIVARIABLE FEEDBA; stroms K, 2006, ADV PID CONTROL; stroms K, 1998, AUTOMATICA, V34, P585, DOI DOI 10.1016/S0005-1098(98)00011-9; Sudas N, 1992, PID CONTROL; vans Helvoorts J, 2007, AUTOMATICA, V43, P2034; Vidyasagars M, 1993, NONLINEAR SYSTEMS AN	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0890-6327	1099-1115		INT J ADAPT CONTROL	Int. J. Adapt. Control Signal Process.	DEC	2014	28	12					1325	1340		10.1002/acs.2444		16	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	AW1FJ	WOS:000346035500002		
J	Liu, Y; Tanaka, M; Choi, S; Watanabe, T				Liu, Yaping; Tanaka, Manabu; Choi, Sooseok; Watanabe, Takayuki			Investigation of In-Flight Glass Melting by Controlling the High-Temperature Region of Multiphase AC Arc Plasma	INTERNATIONAL JOURNAL OF APPLIED GLASS SCIENCE			English	Article							INDUCTION THERMAL PLASMAS; DISCHARGE; BEHAVIOR; POWDERS	A large volume discharge produced by a stable 12-phase alternating current (AC) arc plasma is preferable to melt the granulated glass materials for time and energy saving. The discharge behavior and the high-temperature region of the plasma system can be controlled by the electrode configurations. In this study, the spatial characteristics of the arc discharge were examined by image analysis with a high-speed camera. The melting characteristics of alkali-free glass particles were investigated by microscope and X-ray diffractometry. This is the first time to investigate the relationship between spatial characteristics of plasma and glass particle property. Results show the arc existence area is strongly related to the electrode configuration. Distributions of in-flight powders and the spatial characteristics of arc are important factors when using multiphase AC arc for in-flight melting. This study provides information of efficient particle treatment according to the electrode configuration.	[Liu, Yaping; Tanaka, Manabu; Choi, Sooseok; Watanabe, Takayuki] Tokyo Inst Technol, Dept Environm Chem & Engn, Yokohama, Kanagawa 2268502, Japan; [Watanabe, Takayuki] Kyushu Univ, Dept Chem Engn, Fukuoka 8190395, Japan	Watanabe, T (reprint author), Tokyo Inst Technol, Dept Environm Chem & Engn, Yokohama, Kanagawa 2268502, Japan.	watanabe@chem-eng.kyushu-u.ac.jp			Strategic Development of Energy Conservation Technology Project of NEDO (New Energy and Industry Technology Development Organization, Japan)	The financial support provided by the Strategic Development of Energy Conservation Technology Project of NEDO (New Energy and Industry Technology Development Organization, Japan) is gratefully acknowledged.	Matsuura T, 2007, THIN SOLID FILMS, V515, P4240, DOI 10.1016/j.tsf.2006.02.086; Gonterman J. R., 2006, DOE US DEP EN; Hossain MM, 2009, IEEJ T ELECTR ELECTR, V4, P504, DOI 10.1002/tee.20436; Liu YP, 2011, THIN SOLID FILMS, V519, P7005, DOI 10.1016/j.tsf.2010.11.056; Liu YP, 2013, J CHEM ENG JPN, V46, P672, DOI 10.1252/jcej.13we098; Ross C. P., 2010, KANCH, V3, P5; Tanaka M, 2012, THIN SOLID FILMS, V523, P67, DOI 10.1016/j.tsf.2012.07.064; Watanabe T, 2010, PURE APPL CHEM, V82, P1337, DOI 10.1351/PAC-CON-09-09-19; Yao Y., 2008, SCI TECHNOL ADV MAT, V9, P1; Yao Y, 2008, CHEM ENG J, V139, P390, DOI 10.1016/j.cej.2007.11.016; Yao Y, 2008, THIN SOLID FILMS, V516, P6622, DOI 10.1016/j.tsf.2007.11.084; Yao YC, 2008, CHEM ENG J, V144, P317, DOI 10.1016/j.cej.2008.06.039	12	0	0	WILEY PERIODICALS, INC	SAN FRANCISCO	ONE MONTGOMERY ST, SUITE 1200, SAN FRANCISCO, CA 94104 USA	2041-1286	2041-1294		INT J APPL GLASS SCI	Int. J. Appl. Glass Sci.	DEC	2014	5	4			SI		443	451		10.1111/ijag.12081		9	Materials Science, Ceramics	Materials Science	AW0MY	WOS:000345987800014		
J	Toda, H; Qu, PC; Ito, S; Shimizu, K; Uesugi, K; Takeuchi, A; Suzuki, Y; Kobayashi, M				Toda, H.; Qu, P. C.; Ito, S.; Shimizu, K.; Uesugi, K.; Takeuchi, A.; Suzuki, Y.; Kobayashi, M.			Formation behaviour of blister in cast aluminium alloy	INTERNATIONAL JOURNAL OF CAST METALS RESEARCH			English	Article						Blister; Aluminium alloy; Micropore; Heat treatment; X-ray tomography; Image based simulation	HYDROGEN; STEEL	The formation behaviour of a blister in a die cast aluminium alloy was observed by employing a combined methodology of in situ three-dimensional observation using X-ray microtomography and image based simulation. It has been revealed, via a reverse approach based on the simulation, that nitrogen and carbon dioxide gases fill the blister nucleus. Spontaneous growth of the blister nucleus occurs through creep deformation of the surrounding aluminium due to the blister nucleus' high internal gas pressure. This internal gas pressure also induces hydrogen precipitation in the form of micropores, which undergo steady growth in a spherical shell region around the blister nucleus. The selective growth of the micropores is attributable to the elevation of hydrostatic stress in directions parallel to the casting surface, thereby promoting the expansion of the blister, also parallel to the casting surface, through the absorption of surrounding micropores into the blister nucleus.	[Toda, H.] Kyushu Univ, Dept Mech Engn, Nishi Ward, Fukuoka 8190395, Japan; [Qu, P. C.; Ito, S.; Shimizu, K.; Kobayashi, M.] Toyohashi Univ Technol, Dept Mech Engn, Tempaku Ku, Toyohashi, Aichi 4418580, Japan; [Uesugi, K.; Takeuchi, A.; Suzuki, Y.] Japan Synchrotron Radiat Res Inst, Mikazuki, Hyogo 6795198, Japan	Toda, H (reprint author), Kyushu Univ, Dept Mech Engn, Nishi Ward, 744 Motooka, Fukuoka 8190395, Japan.	toda@mech.kyushu-u.ac.jp			Light Metal Educational Foundation	The synchrotron radiation experiments were performed with the approval of JASRI through proposal nos. 2007B1078 and 2010A1299. The authors wish to thank Mr S. Aoyama, Mr S. Orii and Mr S. Ueda, of Ahresty Corp., for providing the die cast materials. The support provided to HT by the Light Metal Educational Foundation is also gratefully acknowledged.	Akaike J, 1998, J JPN I MET, V62, P56; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Ren XC, 2008, METALL MATER TRANS A, V39A, P87, DOI 10.1007/s11661-007-9391-3; Baba Y., 1968, P ICSMA S, V9, P356; Izumi T, 2011, MATER TRANS, V52, P130, DOI 10.2320/matertrans.L-M2010825; Kaufman J. G., 1999, PROPERTIES ALUMINUM, P264; Kobayashi M, 2008, ACTA MATER, V56, P2167, DOI 10.1016/j.actamat.2007.12.058; Lorensen E., 1987, COMPUTER GRAPHICS, V21, P163; Nishida K., 1976, SEISANKENKYU, V28, P464; SCHUYLER RL, 1979, MATER PERFORMANCE, V18, P9; TALBOT DEJ, 1964, J I MET, V92, P290; Talbot D. E. J., 1975, International Metallurgical Reviews, V20; Toda H, 2009, ACTA MATER, V57, P2277, DOI 10.1016/j.actamat.2009.01.026; Tomita K., 1981, J JILM, V31, P186; Verran GO, 2006, J MATER PROCESS TECH, V179, P190, DOI 10.1016/j.jmatprotec.2006.03.089; Yano Ken'ichi, 2008, INT J AUTOMATION TEC, V2, P259; Yen SK, 2003, MATER CHEM PHYS, V80, P662, DOI 10.1016/S0254-0584(03)00084-1	17	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	1364-0461	1743-1336		INT J CAST METAL RES	Int. J. Cast. Metals Res.	DEC	2014	27	6					369	377		10.1179/1743133614Y.0000000123		9	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	AW2UC	WOS:000346143500008		
J	Takane, Y; Kusaka, H; Kondo, H				Takane, Yuya; Kusaka, Hiroyuki; Kondo, Hiroaki			Climatological study on mesoscale extreme high temperature events in the inland of the Tokyo Metropolitan Area, Japan, during the past 22 years	INTERNATIONAL JOURNAL OF CLIMATOLOGY			English	Article						consecutive preceding clear-sky days; extreme high temperature; foehn wind; pressure pattern; statistical analysis; urban area	SURFACE AIR-TEMPERATURE; EXTENDED SEA-BREEZE; URBAN HEAT-ISLAND; NUMERICAL EXPERIMENT; FUTURE CLIMATE; URBANIZATION; SUMMER; IMPACT; CHINA; MODEL	Over the past 22 years (1990-2011), the inland part of the Tokyo metropolitan area has had 75 days with an extreme high temperature (EHT) higher than 37.2 degrees C in Kumagaya, Saitama Prefecture. To determine the synoptic-scale and mesoscale conditions for such EHT events, a statistical analysis was conducted using observational and objective analysis data. The results show that all the EHT events satisfy the conditions of a daily minimum surface air temperature above 21.4 degrees C on Kumagaya and an air temperature at 850 hPa above 18.8 degrees C on Tsukuba. The EHT days satisfying these conditions were categorized into 27 types according to different combinations of synoptic-pressure patterns, surface wind patterns, and the number of consecutive preceding clear-sky days. The most frequent type occurred eight times (10.7% of days) and was the WHALE' (tail of a whale) pressure pattern with a southeast (SE) surface wind, with at least four (4+) consecutive preceding clear-sky days. However, the type with the highest average maximum surface air temperature had a different wind direction, which was WHALE with a northwest (NW) surface wind and 4+ consecutive preceding clear-sky days. This type appeared only twice but produced the average maximum temperature of 39.7 degrees C.	[Takane, Yuya; Kondo, Hiroaki] Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, Tsukuba, Ibaraki 3058569, Japan; [Kusaka, Hiroyuki] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 305, Japan	Takane, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Environm Management Technol, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	takane.yuya@aist.go.jp	Takane, Yuya/A-9880-2014		Ministry of the Environment, Japan [S-8]; Research Program on Climate Change Adaptation (RECCA)	We thank three anonymous reviewers for providing valuable comments that helped us to improve the manuscript. We thank Dr. Asuka Suzuki-Parker of the University of Tsukuba, who helped to improve the manuscript. This research was supported by the Environment Research and Technology Development Fund (S-8) of the Ministry of the Environment, Japan. The present study was also partially supported by the Research Program on Climate Change Adaptation (RECCA). The datasets used for this study are provided from the cooperative research project of the JRA-25 long-term reanalysis by the Japan Meteorological Agency (JMA) and the Central Research Institute of Electric Power Industry (CREPI). The free software package Generic Mapping Tools (GMT) was used in drawing the figures.	Adachi SA, 2012, J APPL METEOROL CLIM, V51, P1441, DOI 10.1175/JAMC-D-11-0137.1; Lau NC, 2012, J CLIMATE, V25, P4761, DOI 10.1175/JCLI-D-11-00575.1; Gershunov A, 2009, J CLIMATE, V22, P6181, DOI 10.1175/2009JCLI2465.1; Kusaka H, 2012, J METEOROL SOC JPN, V90B, P47, DOI 10.2151/jmsj.2012-B04; YOSHIKADO H, 1989, BOUND-LAY METEOROL, V48, P389, DOI 10.1007/BF00123061; YOSHIKADO H, 1992, J APPL METEOROL, V31, P1146; Fujibe F, 2009, INT J CLIMATOL, V29, P1811, DOI 10.1002/joc.1822; KONDO H, 1990, J METEOROL SOC JPN, V68, P435; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Ren GY, 2008, J CLIMATE, V21, P1333, DOI 10.1175/2007JCLI1348.1; Li Q, 2004, THEOR APPL CLIMATOL, V79, P165, DOI 10.1007/s00704-004-0065-4; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Kusaka H, 2000, J METEOROL SOC JPN, V78, P405; Basara JB, 2010, ADV METEOROL, DOI 10.1155/2010/230365; Black E., 2004, WEATHER, V59, P217, DOI DOI 10.1256/WEA.74.04; Chung U, 2004, CLIMATIC CHANGE, V66, P127, DOI 10.1023/B:CLIM.0000043136.58100.ce; De Bono A, 2004, UNEP DEWA GRID EUR E, V2, P1; Fink A. H., 2004, WEATHER, V59, P209, DOI DOI 10.1256/WEA.73.04; Fujibe F, 1996, J METEOROL SOC JPN, V74, P259; Fujibe F., 1999, TENKI, V46, P501; Fujibe F., 2004, GEOGRAPHICAL REV JAP, V77, P119; Fujibe F., 1998, TENKI, V45, P643; Grossman-Clarke S, 2010, J APPL METEOROL CLIM, V49, P1649, DOI 10.1175/2010JAMC2362.1; HULME M, 1994, INT J CLIMATOL, V14, P637, DOI 10.1002/joc.3370140604; Ishizaki N, 2009, SOLA, V5, P129, DOI 10.2151/sola.2009-033; KONDO H, 1990, J METEOROL SOC JPN, V68, P419; Kusunoki S., 2012, METEOROL RES NOTES, V225, P1; Meteorological Society of Japan, 1998, ENC MET ATM SCI; Meteorological Society of Japan, 2011, ABN HEAT GEN CIRC 20; Nagasawa Y., 1992, 26 SEMINAR TXB SUMME; Sakurai M, 2009, TENKI, V56, P248; Shimamura M, 1996, JPN METEOROL AGENCY, V118, P165; Shinohara Y, 2009, TENKI, V56, P543; Skamarock W., 2008, NCARTN475STR, P113; Takane Y, 2011, J APPL METEOROL CLIM, V50, P1827, DOI 10.1175/JAMC-D-10-05032.1; Takane Y, 2013, J APPL METEOROL CLIM, V52, P1764, DOI 10.1175/JAMC-D-12-0116.1; Takane Y, 2012, J HEAT ISL I INT, V7, P18; United Nations, 2010, ESAPWP224 UN; Yasunari T, 1997, METEOROL RES NOTES, V189, P290; YOSHIKADO H, 1990, J APPL METEOROL, V29, P878, DOI 10.1175/1520-0450(1990)029<0878:VSOTSB>2.0.CO;2	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-8418	1097-0088		INT J CLIMATOL	Int. J. Climatol.	DEC	2014	34	15					3926	3938		10.1002/joc.3951		13	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AW0PX	WOS:000345996500008		
J	Tsuji, T; Yamasaki, H; Hirano, T; Toyozumi, Y; Arima, N; Tsuda, H				Tsuji, Takahiro; Yamasaki, Hiroshi; Hirano, Taichi; Toyozumi, Yasuo; Arima, Nobuyuki; Tsuda, Hiroyuki			Crystal-storing histiocytosis complicating marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Editorial Material									[Tsuji, Takahiro; Yamasaki, Hiroshi; Hirano, Taichi; Tsuda, Hiroyuki] Kumamoto City Hosp, Div Hematol Oncol, Kumamoto 8628505, Japan; [Toyozumi, Yasuo; Arima, Nobuyuki] Kumamoto City Hosp, Div Clin Pathol, Kumamoto 8628505, Japan	Tsuji, T (reprint author), Kumamoto City Hosp, Div Hematol Oncol, Kumamoto 8628505, Japan.	tsuji.takahiro@cityhosp-kumamoto.jp					Dorgan S, 2012, HEAD NECK PATHOL, V6, P111; Tan LHC, 2004, ANN ACAD MED SINGAP, V33, P15	2	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2014	100	6					519	520		10.1007/s12185-014-1669-9		2	Hematology	Hematology	AW0QG	WOS:000345997600001		
J	Nakano-Akamatsu, S; Takahashi, R; Nishimura, S; Arai, I; Hosokawa, Y; Inaba, T				Nakano-Akamatsu, Sonoko; Takahashi, Ryoichi; Nishimura, Seiji; Arai, Ikuko; Hosokawa, Yohei; Inaba, Tohru			Azurophilic granular and rod-like inclusion bodies in mature B-cell neoplasm	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Editorial Material						Granular inclusion body; Rod-like inclusion body; Mature B-cell neoplasm			[Nakano-Akamatsu, Sonoko; Takahashi, Ryoichi] Omihachiman Community Med Ctr, Dept Hematol, Omihachiman, Shiga 5230082, Japan; [Nishimura, Seiji] Omihachiman Community Med Ctr, Fac Transfus, Omihachiman, Shiga 5230082, Japan; [Arai, Ikuko; Hosokawa, Yohei] Omihachiman Community Med Ctr, Fac Clin Lab, Omihachiman, Shiga 5230082, Japan; [Inaba, Tohru] Kyoto Prefectural Univ Med, Dept Infect Control & Lab Med, Kamigyo Ku, Kyoto 6028566, Japan	Nakano-Akamatsu, S (reprint author), Omihachiman Community Med Ctr, Dept Hematol, Tsuchida Cho 1379, Omihachiman, Shiga 5230082, Japan.	so.akamatsu@gmail.com					Hristov AC, 2010, ANN DIAGN PATHOL, V14, P292, DOI 10.1016/j.anndiagpath.2009.07.005; LAGIOS MD, 1974, AM J CLIN PATHOL, V62, P342; Meriņo Anna, 2006, Br J Haematol, V133, P354, DOI 10.1111/j.1365-2141.2006.06039.x	3	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2014	100	6					523	524		10.1007/s12185-014-1687-7		2	Hematology	Hematology	AW0QG	WOS:000345997600003		
J	Yamamoto, T; Nozaki, Y; Mitsui, H; Koshiishi, M; Sueki, Y; Kawashima, I; Nakajima, K; Mitsumori, T; Shimada, S; Kirito, K				Yamamoto, Takeo; Nozaki, Yumi; Mitsui, Hiroshi; Koshiishi, Megumi; Sueki, Yuki; Kawashima, Ichiro; Nakajima, Kei; Mitsumori, Toru; Shimada, Shinji; Kirito, Keita			Cutaneous invasion of leukemia cells during blastic transformation in a post polycythemia vera myelofibrosis patient	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Editorial Material									[Yamamoto, Takeo; Nozaki, Yumi; Koshiishi, Megumi; Sueki, Yuki; Kawashima, Ichiro; Nakajima, Kei; Mitsumori, Toru; Kirito, Keita] Univ Yamanashi, Dept Hematol & Oncol, Kofu, Yamanashi, Japan; [Mitsui, Hiroshi; Shimada, Shinji] Univ Yamanashi, Fac Med, Dept Dermatol, Kofu, Yamanashi, Japan	Kirito, K (reprint author), Univ Yamanashi, Dept Hematol & Oncol, Kofu, Yamanashi, Japan.	kirito@yamanashi.ac.jp					Pecci A, 2014, AM J HEMATOL, V89, P448, DOI 10.1002/ajh.23539; Takahashi H, 2012, INT J HEMATOL, V96, P136, DOI 10.1007/s12185-012-1111-0	2	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2014	100	6					525	526		10.1007/s12185-014-1689-5		2	Hematology	Hematology	AW0QG	WOS:000345997600004		
J	Hayashi, T; Ikeda, H; Igarashi, T; Maruyama, Y; Aoki, Y; Nojima, M; Ishida, T; Shinomura, Y				Hayashi, Toshiaki; Ikeda, Hiroshi; Igarashi, Tetsuyuki; Maruyama, Yumiko; Aoki, Yuka; Nojima, Masanori; Ishida, Tadao; Shinomura, Yasuhisa			Autologous stem cell transplantation for AL amyloidosis: adjustment of melphalan dose by factors including BNP	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						B-type natriuretic peptide (BNP); Immunoglobulin light chain (AL) amyloidosis; Autologous stem cell transplantation (ASCT); Dose-adjusted melphalan	LIGHT-CHAIN AMYLOIDOSIS; CARDIAC BIOMARKERS; THERAPY; TRIAL; SURVIVAL	High-dose melphalan with autologous stem cell transplantation (HDM/ASCT) is a promising treatment option for eligible patients with systemic immunoglobulin light chain (AL) amyloidosis. We present the results of ASCT following risk-adapted melphalan conditioning on the basis of criteria proposed by our group, including B-type natriuretic peptide (BNP). Ten patients with primary systemic AL amyloidosis treated at our institute were evaluated. A full dose of melphalan (200 mg/m(2)) was administered to patients who met all the following: performance status, 0 or 1; number of organs involved, 2 or less; serum creatinine, 1.5 mg/dL or less; EF 50 % or more and BNP 200 pg/mL or less; otherwise 140 mg/m(2). The hematologic complete response was achieved in four and organ response was seen in two patients. The median event-free survival (EFS) of all patients was 21.5 months, and median overall survival (OS) was 47.0 months. EFS and OS were significantly longer for patients who received 200 mg/m(2) of melphalan than for those who received lower dose (EFS: not reached vs. 13.9 months, P = 0.0217; OS: not reached vs. 13.8 months, P = 0.0186). No treatment-related mortality within 100 days from ASCT was observed. Evaluation of cardiac diastolic function may contribute to safer HDM/ASCT and improve outcome of AL amyloidosis.	[Hayashi, Toshiaki; Ikeda, Hiroshi; Igarashi, Tetsuyuki; Maruyama, Yumiko; Aoki, Yuka; Ishida, Tadao; Shinomura, Yasuhisa] Sapporo Med Univ, Sch Med, Dept Gastroenterol Rheumatol & Clin Immunol, Chuou Ku, Sapporo, Hokkaido, Japan; [Nojima, Masanori] Univ Tokyo, Inst Med Sci Hosp, Tokyo, Japan	Hayashi, T (reprint author), Sapporo Med Univ, Sch Med, Dept Gastroenterol Rheumatol & Clin Immunol, Chuou Ku, South 1,West 16, Sapporo, Hokkaido, Japan.	haya@sapmed.ac.jp					Gertz MA, 2013, BONE MARROW TRANSPL, V48, P557, DOI 10.1038/bmt.2012.170; Gertz MA, 2004, BONE MARROW TRANSPL, V34, P1025, DOI 10.1038/sj.bmt.1704691; Skinner M, 2004, ANN INTERN MED, V140, P85; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Cibeira MT, 2011, BLOOD, V118, P4346, DOI 10.1182/blood-2011-01-330738; Kumar S, 2012, J CLIN ONCOL, V30, P989, DOI 10.1200/JCO.2011.38.5724; Gertz MA, 2005, AM J HEMATOL, V79, P319, DOI 10.1002/ajh.20381; Dispenzieri A, 2004, BLOOD, V103, P3960, DOI 10.1182/blood-2003-12-4192; Huang XH, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-2; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kyle RA, 1997, NEW ENGL J MED, V336, P1202, DOI 10.1056/NEJM199704243361702; Moreau P, 1998, BRIT J HAEMATOL, V101, P766, DOI 10.1046/j.1365-2141.1998.00772.x; Palladini G, 2012, AM J HEMATOL, V87, P465, DOI 10.1002/ajh.23141; Perfetti V, 2006, HAEMATOL-HEMATOL J, V91, P1635; Saito Mayuko, 2007, Rinsho Ketsueki, V48, P1478; Sanchorawala V, 2004, BONE MARROW TRANSPL, V33, P381, DOI 10.1038/sj.bmt.1704346; Scott EC, 2014, CLIN LYMPHO IN PRESS	17	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2014	100	6					554	558		10.1007/s12185-014-1680-1		5	Hematology	Hematology	AW0QG	WOS:000345997600009		
J	Sakai, T; Kohda, K; Konuma, Y; Hiraoka, Y; Ichikawa, Y; Ono, K; Horiguchi, H; Tatekoshi, A; Takada, K; Iyama, S; Kato, J				Sakai, Toshiro; Kohda, Kyuhei; Konuma, Yuichi; Hiraoka, Yasuko; Ichikawa, Yukari; Ono, Kaoru; Horiguchi, Hiroto; Tatekoshi, Ayumi; Takada, Kouichi; Iyama, Satoshi; Kato, Junji			A role for peripherally inserted central venous catheters in the prevention of catheter-related blood stream infections in patients with hematological malignancies	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Peripherally inserted central venous catheter; Hematological malignancy; Catheter-related blood stream infection	INDUCTION CHEMOTHERAPY; HOSPITALIZED-PATIENTS; CANCER; ACCESS; COMPLICATIONS; GUIDELINES; MANAGEMENT; NUTRITION; LEUKEMIA; DISEASES	Central venous catheter-related blood stream infections (CR-BSIs) are a serious complication in patients with hematological malignancies. However, it remains unclear whether there is a difference in the rate of CR-BSI associated with the conventional type of central venous catheters (cCVCs) and peripherally inserted CVCs (PICCs) in such patients. To address this question, we retrospectively investigated the incidence of CR-BSIs associated with PICCs versus cCVCs in patients with hematological malignancies. We used PICCs in all consecutive patients requiring CVC placement between February 2009 and February 2013. We compared the CR-BSI rate in patients with PICCs with that in patients with cCVCs treated between September 2006 and January 2009 (control group). Eighty-four patients received PICCs and 85 received cCVCs. The most common reason for removal due to catheter-related complications was CR-BSI. The CR-BSI rate in the PICC group was significantly lower than that in the cCVC group (PICCs: 1.23/1000 catheter days; cCVCs: 5.30/1000 catheter days; P < 0.01). Catheter-related complications other than CR-BSIs occurred at an extremely low rate in the PICC group. The median catheter-related complication-free survival duration was significantly longer in the PICC group than in the cCVC group. Our study shows that PICCs are useful in patients with hematological malignancies.	[Sakai, Toshiro; Kohda, Kyuhei; Konuma, Yuichi] Asahikawa Red Cross Hosp, Dept Hematol & Oncol, Asahikawa, Hokkaido, Japan; [Hiraoka, Yasuko; Ichikawa, Yukari] Asahikawa Red Cross Hosp, Dept Infect Control & Prevent, Asahikawa, Hokkaido, Japan; [Ono, Kaoru; Horiguchi, Hiroto; Tatekoshi, Ayumi; Takada, Kouichi; Iyama, Satoshi; Kato, Junji] Sapporo Med Univ, Dept Med Oncol & Hematol, Sapporo, Hokkaido, Japan	Sakai, T (reprint author), Asahikawa Red Cross Hosp, Dept Hematol & Oncol, 1-1 Akebono Cho, Asahikawa, Hokkaido, Japan.	to-sa0627@asahikawa-rch.gr.jp					Bellesi S, 2013, SUPPORT CARE CANCER, V21, P531, DOI 10.1007/s00520-012-1554-0; Moureau N, 2002, J VASC INTERV RADIOL, V13, P1009, DOI 10.1016/S1051-0443(07)61865-X; Hatakeyama N, 2011, INT J HEMATOL, V94, P372, DOI 10.1007/s12185-011-0928-2; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Chaberny IF, 2009, ANN HEMATOL, V88, P907, DOI 10.1007/s00277-008-0687-1; Skaff ER, 2012, LEUKEMIA LYMPHOMA, V53, P1090, DOI 10.3109/10428194.2011.639879; BOTTINO J, 1979, CANCER, V43, P1937, DOI 10.1002/1097-0142(197905)43:5<1937::AID-CNCR2820430554>3.0.CO;2-T; Safdar N, 2005, CHEST, V128, P489, DOI 10.1378/chest.128.2.489; Gunst M, 2011, SURG INFECT, V12, P279, DOI 10.1089/sur.2008.058; O'Grady NP, 2002, INFECT CONT HOSP EP, V23, P759, DOI 10.1086/502007; Abedin S, 2008, PEDIATR BLOOD CANCER, V51, P251, DOI 10.1002/pbc.21344; Allen AW, 2000, J VASC INTERV RADIOL, V11, P1309, DOI 10.1016/S1051-0443(07)61307-4; Lim MY, 2013, LEUKEMIA LYMPHOMA, V54, P1263, DOI 10.3109/10428194.2012.742520; Mollee P, 2011, J HOSP INFECT, V78, P26, DOI 10.1016/j.jhin.2011.01.018; Worth LJ, 2009, SUPPORT CARE CANCER, V17, P811, DOI 10.1007/s00520-008-0561-7; Cowl CT, 2000, CLIN NUTR, V19, P237, DOI 10.1054/clnu.2000.0103; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441; HOSHAL VL, 1975, ARCH SURG-CHICAGO, V110, P644; NOBLE WC, 1984, J MED MICROBIOL, V17, P1; Skiest DJ, 2000, CLIN INFECT DIS, V30, P949, DOI 10.1086/313822; Tomlinson D, 2011, CLIN INFECT DIS, V53, P697, DOI 10.1093/cid/cir523	21	0	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2014	100	6					592	598		10.1007/s12185-014-1677-9		7	Hematology	Hematology	AW0QG	WOS:000345997600014		
J	Ishihara, Y; Kanda, J; Tanaka, K; Nakano, H; Ugai, T; Wada, H; Yamasaki, R; Kawamura, K; Sakamoto, K; Ashizawa, M; Sato, M; Terasako-Saito, K; Kimura, S; Kikuchi, M; Nakasone, H; Yamazaki, R; Kako, S; Nishida, J; Watanabe, K; Kanda, Y				Ishihara, Yuko; Kanda, Junya; Tanaka, Kaori; Nakano, Hirofumi; Ugai, Tomotaka; Wada, Hidenori; Yamasaki, Ryoko; Kawamura, Koji; Sakamoto, Kana; Ashizawa, Masahiro; Sato, Miki; Terasako-Saito, Kiriko; Kimura, Shun-ichi; Kikuchi, Misato; Nakasone, Hideki; Yamazaki, Rie; Kako, Shinichi; Nishida, Junji; Watanabe, Kunitomo; Kanda, Yoshinobu			Severe oral infection due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Lactobacillus rhamnosus; Oral infection; Neutropenic fever; Acute myeloid leukemia	ANTIMICROBIAL SUSCEPTIBILITY; BACTEREMIA; GG; IDENTIFICATION; PROBIOTICS; STRAINS; SAFETY	We report a case of severe oral infection with a high fever due to Lactobacillus rhamnosus during induction chemotherapy for acute myeloid leukemia. The patient did not improve on treatment with meropenem, clindamycin, or vancomycin until neutrophil recovery. Since L. rhamnosus GG is used in dairy products, and the patient ingested dairy products daily before starting chemotherapy, we suspected an association between the ingestion of dairy products and the development of infection. Pulsed-field gel electrophoresis using two different restriction enzymes showed that the strain isolated from the patient was identical to the L. rhamnosus GG strain isolated from dairy products and ATCC #53103. This was confirmed by a PCR assay with species-specific L. rhamnosus GG primers. Since Lactobacillus infection, particularly L. rhamnosus infection, can be fatal in immunocompromised hosts, we should consider Lactobacillus as a causative organism when Gram-positive rods are detected during treatment with broad-spectrum antibiotics and vancomycin. The causal association between the ingestion of dairy products containing Lactobacillus and Lactobacillus infection in immunocompromised hosts warrants further study.	[Ishihara, Yuko; Kanda, Junya; Nakano, Hirofumi; Ugai, Tomotaka; Wada, Hidenori; Yamasaki, Ryoko; Kawamura, Koji; Sakamoto, Kana; Ashizawa, Masahiro; Sato, Miki; Terasako-Saito, Kiriko; Kimura, Shun-ichi; Kikuchi, Misato; Nakasone, Hideki; Yamazaki, Rie; Kako, Shinichi; Nishida, Junji; Kanda, Yoshinobu] Jichi Med Univ, Saitama Med Ctr, Div Hematol, Omiya Ku, Saitama 3308503, Japan; [Tanaka, Kaori; Watanabe, Kunitomo] Gifu Univ, Life Sci Res Ctr, Div Anaerobe Res, Gifu, Japan	Kanda, Y (reprint author), Jichi Med Univ, Saitama Med Ctr, Div Hematol, Omiya Ku, 1-847 Amanuma Cho, Saitama 3308503, Japan.	ycanda-tky@umin.ac.jp					Allen SJ, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003048.pub2, DOI 10.1002/14651858.CD003048.PUB2]; Lebeer S, 2007, APPL ENVIRON MICROB, V73, P6768, DOI 10.1128/AEM.01393-07; Salminen MK, 2004, CLIN INFECT DIS, V38, P62, DOI 10.1086/380455; Salminen MK, 2002, CLIN INFECT DIS, V35, P1155, DOI 10.1086/342912; Borriello SP, 2003, CLIN INFECT DIS, V36, P775, DOI 10.1086/368080; Rautio M, 1999, CLIN INFECT DIS, V28, P1159, DOI 10.1086/514766; Coudeyras S, 2008, APPL ENVIRON MICROB, V74, P2679, DOI 10.1128/AEM.02286-07; Salminen MK, 2006, CLIN INFECT DIS, V42, pE35, DOI 10.1086/500214; Cannon JP, 2005, EUR J CLIN MICROBIOL, V24, P31, DOI 10.1007/s10096-004-1253-y; Miyawaki S, 2012, INT J HEMATOL, V96, P171, DOI 10.1007/s12185-012-1150-6; Hammerman C, 2006, BRIT MED J, V333, P1006, DOI 10.1136/bmj.39010.630799.BE; Brandt K, 2003, INT J FOOD MICROBIOL, V84, P189, DOI 10.1016/S0168-1605(02)00419-1; Danielsen M, 2007, EUR J CLIN MICROBIOL, V26, P287, DOI 10.1007/s10096-007-0274-8; Mackay A.D., 1999, CLIN MICROBIOL INFEC, V5, P290, DOI 10.1111/j.1469-0691.1999.tb00144.x; MURRAY PR, 1990, DIAGN MICR INFEC DIS, V13, P57, DOI 10.1016/0732-8893(90)90055-Z; Robin F, 2010, J CLIN MICROBIOL, V48, P4317, DOI 10.1128/JCM.00250-10; Schlegel L, 1998, EUR J CLIN MICROBIOL, V17, P887, DOI 10.1007/s100960050216	17	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2014	100	6					607	610		10.1007/s12185-014-1650-7		4	Hematology	Hematology	AW0QG	WOS:000345997600017		
J	Yoshimura, M; Kojima, K; Tomimasu, R; Fukushima, N; Hayashi, S; Sueoka, E; Kimura, S				Yoshimura, Mariko; Kojima, Kensuke; Tomimasu, Rika; Fukushima, Noriyasu; Hayashi, Shinichiro; Sueoka, Eisaburo; Kimura, Shinya			ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						Chronic myeloid leukemia; Imatinib; Nilotinib; Dasatinib; Pulmonary alveolar proteinosis	COLONY-STIMULATING FACTOR; CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC-PHASE; IMATINIB; DASATINIB; THERAPY; MANAGEMENT; SECRETION; PATIENT	Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by the accumulation of eosinophilic periodic acid Schiff-positive material in the intra-alveolar and bronchiolar spaces. Tyrosine kinase inhibitors, including imatinib, nilotinib, and dasatinib, have shown excellent efficacy in the treatment of chronic myeloid leukemia (CML). We report a case of acquired PAP in a patient with CML receiving tyrosine kinase inhibitors. A 67-year-old man with CML presented with progressive back pain 5 months after starting imatinib treatment. Acquired PAP was diagnosed based on physical, radiographic, and histopathological findings. The presence of granulocyte-macrophage colony-stimulating autoantibodies suggested that autoimmune mechanisms were involved in the pathogenesis. Interestingly, PAP developed in association with imatinib and dasatinib administration, but not with nilotinib treatment. The patient died of refractory leukemia in lymphoid blast crisis with a newly emerged T315I mutation. Although the incidence is very rare, imatinib and dasatinib associated with PAP development has been reported. Meanwhile, PAP in nilotinib-treated patients has not been reported. Our observation in one patient receiving multiple TKIs suggests that nilotinib may be safer than imatinib or dasatinib in avoiding the development or exacerbation of PAP.	[Yoshimura, Mariko; Kojima, Kensuke; Tomimasu, Rika; Fukushima, Noriyasu; Hayashi, Shinichiro; Sueoka, Eisaburo; Kimura, Shinya] Saga Univ, Div Hematol Resp Med & Oncol, Dept Internal Med, Fac Med, Saga 8498501, Japan	Kojima, K (reprint author), Saga Univ, Div Hematol Resp Med & Oncol, Dept Internal Med, Fac Med, 5-1-1 Nabeshima, Saga 8498501, Japan.	kkojima@cc.saga-u.ac.jp			Bristol-Myers Squibb; Novartis Pharmaceuticals	Shinya Kimura received research grants and lecture fees from Bristol-Myers Squibb and Novartis Pharmaceuticals.	Wang Y, 2007, BLOOD, V109, P2147, DOI 10.1182/blood-2006-08-040022; Kimura S, 2014, INT J CLIN ONCOL, V19, P3, DOI 10.1007/s10147-013-0641-7; Tazawa R, 2010, AM J RESP CRIT CARE, V181, P1345, DOI 10.1164/rccm.200906-0978OC; Carey B, 2010, CLIN IMMUNOL, V135, P223, DOI 10.1016/j.clim.2010.02.017; Venkateshiah SB, 2006, CHEST, V130, P227, DOI 10.1378/chest.130.1.227; Ben-Dov I, 2014, AUTOIMMUN REV, V13, P513, DOI 10.1016/j.autrev.2014.01.046; Ito Y, 2013, INT J HEMATOL, V97, P135, DOI 10.1007/s12185-012-1222-7; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Quintas-Cardama A, 2007, J CLIN ONCOL, V25, P3908, DOI 10.1200/JCO.2007.12.0329; Breccia M, 2008, LEUKEMIA RES, V32, P353, DOI 10.1016/j.leukres.2007.07.023; Al Sobhi E, 2007, HEMATOLOGY, V12, P49, DOI 10.1080/10245330600937929; Khan A, 2011, RESP CARE, V56, P1016, DOI 10.4187/respcare.01125; Dewar AL, 2005, IMMUNOL CELL BIOL, V83, P48, DOI 10.1111/j.1440-1711.2004.01296.x; Leth S, 2013, RESPIROLOGY, V18, P82, DOI 10.1111/j.1440-1843.2012.02274.x; Bunda S, 2013, CANCER RES, V73, P2540, DOI 10.1158/0008-5472.CAN-12-3425; Borie R, 2009, EUR RESPIR J, V33, P1503, DOI 10.1183/09031936.00160908; Seymour JF, 2001, AM J RESP CRIT CARE, V163, P524; Rea D, 2008, LANCET, V372, P713, DOI 10.1016/S0140-6736(08)61295-7; BALLEARI E, 1994, HAEMATOLOGICA, V79, P7; Chung JH, 2009, J THORAC IMAG, V24, P115, DOI 10.1097/RTI.0b013e3181930ed6; Harbaum L, 2014, INT J HEMATOL, V99, P91, DOI 10.1007/s12185-013-1474-x; ITO K, 1994, INTERNAL MED, V33, P710, DOI 10.2169/internalmedicine.33.710; Jabbour EJ, 2013, EXPERT REV ANTICANC, V13, P1433, DOI 10.1586/14737140.2013.859074; Kelly K, 2009, TARGET ONCOL, V4, P99, DOI 10.1007/s11523-009-0110-4; Latagliata R, 2013, HEMATOL ONCOL, V31, P363, DOI 10.1002/hon.2020; Ohashi K, 2012, EUR RESPIR J, V39, P777, DOI 10.1183/09031936.00076711; Ohmachi Ken, 2008, Tokai J Exp Clin Med, V33, P146; Sakagami T, 2010, AM J RESP CRIT CARE, V182, P49, DOI 10.1164/rccm.201001-0008OC; Trask PC, 2012, INT J HEMATOL, V95, P535, DOI 10.1007/s12185-012-1043-8; Wagner U, 2003, AM J MED, V115, P674, DOI 10.1016/S0002-9343(03)00445-5	30	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0925-5710	1865-3774		INT J HEMATOL	Int. J. Hematol.	DEC	2014	100	6					611	614		10.1007/s12185-014-1666-z		4	Hematology	Hematology	AW0QG	WOS:000345997600018		
J	Yamashita, T; Yoshino, K; Kaneko, A				Yamashita, Takahiro; Yoshino, Kensaku; Kaneko, Arata			Micro/nano-mechanical structure fabricated by transfer printing	INTERNATIONAL JOURNAL OF PRECISION ENGINEERING AND MANUFACTURING			English	Article						Mechanical structure; Transfer printing; MEMS; Thin-film	THIN-FILM	A fabrication of micro-electro-mechanical systems (MEMS) generally involves complicated conventional semiconductor processes. Simply micro/nano-structuring process is a technical issue on further wide range of MEMS application. This study proposes to apply transfer printing to fabricate a mechanical structure for MEMS elements. Some metals (Au, Cu and Ni) are previously deposited to be thin-films on a micro-ridged poly-dimethyl-siloxane (PDMS) stamp, while a micro-grooved SU-8 is prepared as a substrate. Contact-and-release process allows the metal thin-film to be locally transferred from the micro-ridges of stamp to the micro-grooved substrate. The transferred Au and Ni thin-films successfully form to be an ultra-thin fixed beam, "cross-linked structure", of which the thickness is less than 100 nm. The fabricated structure is applicable to a nano-scale mechanical oscillator. The production yield of fixed beam increases with thin-film thickness and highly-dense of thin-film. The micro-roughness and hydrophobicity of stamp enhance the production yield of ultrathin fixed beam. These experimental results clearly indicate that the proposed process is dominated by an adhesion force between the stamp and the thin-film as well as the mechanical strength of the thin-film. Nevertheless, it is confirmed the transfer printing process is effective for a fabrication of MEMS element.	[Yamashita, Takahiro; Yoshino, Kensaku; Kaneko, Arata] Tokyo Metropolitan Univ, Grad Sch Syst Design, Tokyo 1910065, Japan	Kaneko, A (reprint author), Tokyo Metropolitan Univ, Grad Sch Syst Design, 6-6 Asahigaoka, Tokyo 1910065, Japan.	kaneko-arata@tmu.ac.jp			KEIRIN RACE [22560130, 25-114]	The authors wish to thank Ms. Omata of ELIONIX INC for SEM works. Fruitful discussions with Mr. Murakami and Mr. Miyazaki of Tokyo Metropolitan University are greatly appreciated. This work was supported by the Japanese Grant-in-Aid for Scientific Research (C) (22560130) and JKA promotion funds from KEIRIN RACE (25-114).	Hur SH, 2004, APPL PHYS LETT, V85, P5730, DOI 10.1063/1.1829774; Kang MG, 2010, SOL ENERG MAT SOL C, V94, P1179, DOI 10.1016/j.solmat.2010.02.039; Someya T, 2009, PROCEDIA CHEM, V1, P9, DOI 10.1016/j.proche.2009.07.003; Lee TW, 2005, ADV FUNCT MATER, V15, P1683, DOI 10.1002/adfm.200400295; Read DT, 2004, MICROELECTRON ENG, V75, P63, DOI 10.1016/j.mee.2003.09.012; Ge LJ, 2012, MICROELECTRON ENG, V97, P289, DOI 10.1016/j.mee.2012.04.031; Son D, 2003, THIN SOLID FILMS, V437, P182, DOI 10.1016/S0040-6090(03)00645-X; Unno N, 2010, MICROELECTRON ENG, V87, P1019, DOI 10.1016/j.mee.2009.11.102; Kim JW, 2008, APPL SURF SCI, V254, P5607, DOI 10.1016/j.apsusc.2008.03.046; Huang YH, 2011, MICROELECTRON ENG, V88, P849, DOI 10.1016/j.mee.2010.08.006; Law JBK, 2011, APPL SURF SCI, V258, P748, DOI 10.1016/j.apsusc.2011.08.065; Yang DY, 2011, INT J PLASTICITY, V27, P1527, DOI 10.1016/j.ijplas.2010.09.006	12	0	0	KOREAN SOC PRECISION ENG	SEOUL	RM 306, KWANGMYUNG BLDG, 5-4 NONHYUN-DONG, KANGNAM-GU, SEOUL, 135-010, SOUTH KOREA	2234-7593	2005-4602		INT J PRECIS ENG MAN	Int. J. Precis. Eng. Manuf.	DEC	2014	15	12					2581	2587		10.1007/s12541-014-0630-4		7	Engineering, Manufacturing; Engineering, Mechanical	Engineering	AW3DW	WOS:000346166800013		
J	Ando, K; Koike, S; Ohmachi, Y; Ando, Y; Kobashi, G				Ando, Koichi; Koike, Sachiko; Ohmachi, Yasushi; Ando, Yutaka; Kobashi, Gen			Tumor induction in mice after local irradiation with single doses of either carbon-ion beams or gamma rays	INTERNATIONAL JOURNAL OF RADIATION BIOLOGY			English	Article						High Linear Energy Transfer (LET); radiation-induced tumors; relative biological effectiveness (RBE)	HIGH-LET RADIATION; CELL-TRANSFORMATION; CHARGED-PARTICLES; CARCINOGENESIS; RISK	Purpose : To determine the dose-dependent relative biological effectiveness (RBE) for tumor prevalence in mice receiving single localized doses to their right leg of either carbon ions (15, 45 or 75 keV/mu m) or 137Cs gamma rays. Methods and materials : A total of 1647 female C3H mice were irradiated to their hind legs with a localized dose of either reference gamma rays or 15, 45 or 75 keV/mu m carbon-ion beams. Irradiated mice were evaluated for tumors twice a month during their three-year life span, and the dimensions of any tumors found were measured with a caliper. The tumor induction frequency was calculated by Kaplan-Meier analysis. Results : The incidence of tumors from 50 Gy of 45 keV/mu m carbon ions was marginally higher than those from 50 Gy of gamma rays. However, 60 Gy of 15 keV/mu m carbon ions induced significantly fewer tumors than did gamma rays. RBE values of 0.87 +/- 0.12, 1.29 +/- 0.08 or 2.06 +/- 0.39 for lifetime tumorigenesis were calculated for 15, 45 or 75 keV/mu m carbon-ion beams, respectively. Fibrosarcoma predominated, with no Linear Energy Transfer (LET)-dependent differences in the tumor histology. Experiments measuring the late effect of leg skin shrinkage suggested that the carcinogenic damage of 15 keV/mu m carbon ions would be less than that of gamma rays. Conclusions : We conclude that patients receiving radiation doses to their normal tissues would face less risk of secondary tumor induction by carbon ions of intermediate LET values compared to equivalent doses of photons.	[Ando, Koichi] Gunma Univ, Heavy Ion Med Ctr, Maebashi, Gunma 3718511, Japan; [Koike, Sachiko; Ando, Yutaka] Natl Inst Radiol Sci, Res Ctr Charged Particle Therapy, Chiba 260, Japan; [Ohmachi, Yasushi] Natl Inst Radiol Sci, Res Ctr Radiat Emergency Med, Chiba 260, Japan; [Kobashi, Gen] Natl Inst Radiol Sci, Planning & Management Dept, Chiba 260, Japan	Ando, K (reprint author), Gunma Univ, Heavy Ion Med Ctr, Showa Machi 3-39-22, Maebashi, Gunma 3718511, Japan.	kando3@air.email.ne.jp			Special Coordination Funds for Research Project; Heavy Ions at the National Institute of Radiological Sciences-Heavy-ion Medical Accelerator in Chiba (NIRS-HIMAC)	This report was partly supported by the Special Coordination Funds for Research Project with Heavy Ions at the National Institute of Radiological Sciences-Heavy-ion Medical Accelerator in Chiba (NIRS-HIMAC). We are grateful to Ms Akiko Uzawa, Dr Ryoichi Hirayama, Dr Yoshitaka Matsumoto and Dr Yoshiya Furusawa for their help to conduct experiments, and to Dr Tatsuaki Kanai and Dr Donald Chapman for their helpful discussion and English edit. The animals involved in these studies were procured, maintained and used in accordance with the Recommendations for Handling of Laboratory Animals for Biomedical Research, compiled by the Committee on the Safety and Handling Regulations for Laboratory Animal Experiments, NIRS, Japan.	ALPEN EL, 1993, RADIAT RES, V136, P382, DOI 10.2307/3578551; Ando K, 2005, J RADIAT RES, V46, P185, DOI 10.1269/jrr.46.185; Weiss JF, 1997, ENVIRON HEALTH PERSP, V105, P1473, DOI 10.2307/3433654; Suit H, 2007, RADIAT RES, V167, P12, DOI 10.1667/RR0527.1; Newhauser WD, 2011, NAT REV CANCER, V11, P438, DOI 10.1038/nrc3069; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; FRY RJM, 1985, RADIAT RES, V104, pS188, DOI 10.2307/3576646; Han ZB, 1998, J RADIAT RES, V39, P193, DOI 10.1269/jrr.39.193; Suit H, 2010, RADIOTHER ONCOL, V95, P3, DOI 10.1016/j.radonc.2010.01.015; Weil MM, 2009, RADIAT RES, V172, P213, DOI 10.1667/RR1648.1; Bettega D, 2009, INT J RADIAT ONCOL, V73, P861, DOI 10.1016/j.ijrobp.2008.07.067; Bettega D, 2004, RADIOTHER ONCOL, V73, pS155, DOI 10.1016/S0167-8140(04)80039-2; Chadwick K H, 1981, MOL THEORY RAD BIOL; COVELLI V, 1991, J RADIAT RES, V32, P110, DOI 10.1269/jrr.32.SUPPLEMENT2_110; Giaccia AJ, 2006, RADIOBIOLOGY RADIOLO; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; MASUDA K, 1980, INT J RADIAT ONCOL, V6, P1539; Matsushita S, 1994, INT J RADIAT ONCOL, V15, P867; Particle Therapy Co-operative Group, 2012, STAT PAT TREAT HADR; Scott BR, 1997, RADIAT PROT DOSIM, V72, P105; TURNER JE, 1994, RADIAT PROT DOSIM, V52, P189; WATANABE M, 1984, RADIAT RES, V98, P274, DOI 10.2307/3576235; YANG TCH, 1985, RADIAT RES, V104, pS177, DOI 10.2307/3576645	23	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0955-3002	1362-3095		INT J RADIAT BIOL	Int. J. Radiat. Biol.	DEC	2014	90	12					1119	1124		10.3109/09553002.2014.932030		6	Biology; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	AW0RS	WOS:000346001600001		
J	Takahashi, M; Hirakawa, H; Yajima, H; Izumi-Nakajima, N; Okayasu, R; Fujimori, A				Takahashi, Momoko; Hirakawa, Hirokazu; Yajima, Hirohiko; Izumi-Nakajima, Nakako; Okayasu, Ryuichi; Fujimori, Akira			Carbon ion beam is more effective to induce cell death in sphere-type A172 human glioblastoma cells compared with X-rays	INTERNATIONAL JOURNAL OF RADIATION BIOLOGY			English	Article						Glioblastoma cells; radiosensitivity; stem cells	CANCER STEM-CELLS; CLUSTERED DNA-DAMAGE; DOUBLE-STRAND BREAKS; SERUM-FREE CULTURE; IN-VITRO; RADIATION; APOPTOSIS; THERAPY; BRAIN; SOX2	Purpose: To obtain human glioblastoma cells A172 expressing stem cell-related protein and comparison of radiosensitivity in these cells with X-rays and carbon beam. Methods: Human monolayer-type A172 glioblastoma cells were maintained in normal medium with 10% bovine serum. In order to obtain sphere-type A172 cells the medium was replaced with serum-free medium supplemented with growth factors. Both types of A172 cells were irradiated with either X-rays or carbon ion beams and their radiosensitivity was evaluated. Results: Serum-free medium induced expression of stem cell-related proteins in A172 cells along with the neurosphere-like appearance. These sphere-type cells were found resistant to both X-rays and carbon ion beams. Phosphorylation of histone H2A family member X persisted for a longer period in the cells exposed to carbon ion beams than in those exposed to X-rays and it disappeared quicker in the sphere type than in the monolayer type. Relative radioresistance of the sphere type cells was smaller for carbon ion beams than for X-rays. Conclusions: We demonstrated that glioblastoma A172 cells with induced stem cell-related proteins turned resistant to irradiation. Accelerated heavy ion particles may have advantage over X-rays in overcoming the tumor resistance due to cell stemness.	[Takahashi, Momoko] Fukushima Med Univ, Translat Res Ctr, Fukushima, Japan; [Hirakawa, Hirokazu; Yajima, Hirohiko; Izumi-Nakajima, Nakako; Fujimori, Akira] Res Ctr Charged Particle Therapy, Res Program Applicat Heavy Ions Med Sci, Cellular & Mol Biol Res Team, Chiba, Japan; [Okayasu, Ryuichi; Fujimori, Akira] Natl Inst Radiol Sci, Int Open Lab, Particle Therapy Mol Target Res Unit, Chiba 2638555, Japan	Fujimori, A (reprint author), Natl Inst Radiol Sci, Ctr Charged Particle Therapy, Cellular & Mol Biol Res Team, Res Program Applicat Heavy Ions Med Sci,Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	fujimora@nirs.go.jp			Ministry of Education, Culture, Sports, Science and Technology [21791235]	The work was supported by a research grant from the Ministry of Education, Culture, Sports, Science and Technology: Grants-in-Aid for Young Scientists (B) 21791235 (Dr Momoko Takahashi).	AHMED Z, 1983, J NEUROSCI, V3, P2448; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Shikazono N, 2009, J RADIAT RES, V50, P27, DOI 10.1269/jrr.08086; Cui X, 2011, CANCER RES, V71, P3676, DOI 10.1158/0008-5472.CAN-10-2926; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Balajee AS, 2004, EXP CELL RES, V300, P320, DOI 10.1016/j.yexcr.2004.07.022; Oonishi K, 2012, RADIOTHER ONCOL, V105, P258, DOI 10.1016/j.radonc.2012.08.009; Hamada N, 2010, J RADIAT RES, V51, P365, DOI 10.1269/jrr.09137; Rich JN, 2007, CANCER RES, V67, P8980, DOI 10.1158/0008-5472.CAN-07-0895; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Ishiwata T, 2011, WORLD J GASTROENTERO, V17, P409, DOI 10.3748/wjg.v17.i4.409; Carpenter MK, 1999, EXP NEUROL, V158, P265, DOI 10.1006/exnr.1999.7098; Tysnes BB, 2010, NEOPLASIA, V12, P506, DOI 10.1593/neo.10290; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Hada M, 2008, J RADIAT RES, V49, P203, DOI 10.1269/jrr.07123; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Sakakibara S, 1996, DEV BIOL, V176, P230, DOI 10.1006/dbio.1996.0130; Ghods AJ, 2007, STEM CELLS, V25, P1645, DOI 10.1634/stemcells.2006-0624; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Yajima H, 2013, DNA REPAIR, V12, P936, DOI 10.1016/j.dnarep.2013.08.009; Badie B, 1999, CANCER GENE THER, V6, P155, DOI 10.1038/sj.cgt.7700009; Debeb BG, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-180; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Guo W, 2006, PEDIATR RES, V59, p59R, DOI 10.1203/01.pdr.0000203592.04530.06; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Nakajima NI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070107; Rubel A, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-6; WALSH C, 1990, EXPERIENTIA, V46, P940, DOI 10.1007/BF01939387	30	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0955-3002	1362-3095		INT J RADIAT BIOL	Int. J. Radiat. Biol.	DEC	2014	90	12					1125	1132		10.3109/09553002.2014.927933		8	Biology; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	AW0RS	WOS:000346001600002		
J	Ushiyama, A; Ohtani, S; Suzuki, Y; Wada, K; Kunugita, N; Ohkubo, C				Ushiyama, Akira; Ohtani, Shin; Suzuki, Yukihisa; Wada, Keiji; Kunugita, Naoki; Ohkubo, Chiyoji			Effects of 21-kHz intermediate frequency magnetic fields on blood properties and immune systems of juvenile rats	INTERNATIONAL JOURNAL OF RADIATION BIOLOGY			English	Article						Intermediate frequency magnetic fields; immune effect; juvenile rat	VIDEO-DISPLAY TERMINALS; CYTOTOXIC T-LYMPHOCYTE; HEATING IH COOKTOP; SPONTANEOUS-ABORTION; IN-VITRO; GENE-EXPRESSION; ASTROGLIA CELLS; NATURAL-KILLER; CYTO-TOXICITY; BIRTH-WEIGHT	Purpose : Due to a lack of science-based evidence, we explored the effects of exposure to intermediate frequency magnetic fields (IF-MF) on experimental animals. We assessed several immunological parameters to determine the effect of exposure of the whole body to IF-MF. Materials and methods: Male Sprague-Dawley rats (4-5 weeks old) were divided into three groups: Cage-control, sham, and 3.8-mT (rms) exposure groups. The animals were exposed to IF-MF at 21 kHz under fixed conditions in an acrylic holder. Exposure was performed for 1 h/day for 14 consecutive days. On the 15th day following the exposure, biochemical and hematological parameters in blood were analyzed. The effects of the exposure on immunological functions such as the cytotoxic activity of lymphocytes, chemotactic and phagocytic activity of granulocytes, and T (cluster of differentiation 4 [CD4] and cluster of differentiation 8 [CD8])-cell frequency were also examined. Results : Hematological parameters were not affected by IF-MF exposure. Other immune functions such as the cytotoxic activity and phagocytic activity were not affected. Populations of T cells after exposure also did not show any significant differences. In blood biochemistry, there was significant difference in inorganic phosphorus level between sham and exposure group. However, this will not induce any pathophysiological status, because they were still within physiological range. Overall, no significant effect by exposure of IF-MF was observed under our experimental conditions. Conclusions : Our results suggest that exposure to 21-kHz sinusoidal IF-MF at 3.8 mT for 1 h/day for 14 days did not affect immune function in juvenile rats.	[Ushiyama, Akira; Ohtani, Shin; Kunugita, Naoki] Natl Inst Publ Hlth, Dept Environm Hlth, Wako, Saitama 3510197, Japan; [Ohtani, Shin] Meiji Pharmaceut Univ, Dept Hyg Chem, Kiyose, Tokyo, Japan; [Suzuki, Yukihisa; Wada, Keiji] Tokyo Metropolitan Univ, Grad Sch Social Sci, Hachioji, Tokyo, Japan; [Ohkubo, Chiyoji] Japan EMF Informat Ctr, Minato Ku, Tokyo, Japan	Ushiyama, A (reprint author), Natl Inst Publ Hlth, Dept Environm Hlth, Wako, Saitama 3510197, Japan.	ushiyama@niph.go.jp		Kunugita, Naoki/0000-0002-6516-8379	Health Labour Science Research Grant, The Ministry of Health Labour and Welfare, Japan	This work was supported by the Health Labour Science Research Grant, The Ministry of Health Labour and Welfare, Japan. The authors would like to thank Dr. Aiko Unno, Mrs. Masako Ohsawa, Mrs. Kasumi Yamanaka and Ms. Machiko Maeda for their helpful assistances. The authors also would like to thank Enago (www.enago.jp) for the English language review.	Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Nakasono S, 2008, MUTAT RES-GEN TOX EN, V649, P187, DOI 10.1016/j.mrgentox.2007.09.003; YUAN Y, 1990, MICROVASC RES, V40, P218, DOI 10.1016/0026-2862(90)90021-I; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Miyakoshi J, 2007, BIOELECTROMAGNETICS, V28, P529, DOI 10.1002/bem.20334; Yamazaki K, 2004, IEEE T ELECTROMAGN C, V46, P115, DOI 10.1109/TEMC.2004.823621; Acero J, 2010, IEEE IND APPL MAG, V16, P39, DOI 10.1109/MIAS.2009.935495; Sakurai T, 2009, INT J RADIAT BIOL, V85, P883, DOI 10.3109/09553000903184358; Aly AA, 2008, IEEE T BIO-MED ENG, V55, P795, DOI 10.1109/TBME.2007.912636; Grajewski B, 1997, AM J IND MED, V32, P681, DOI 10.1002/(SICI)1097-0274(199712)32:6<681::AID-AJIM16>3.3.CO;2-A; Nitta N, 2007, J IMMUNOL METHODS, V320, P155, DOI 10.1016/j.jim.2006.12.010; LINDBOHM ML, 1992, AM J EPIDEMIOL, V136, P1041; BEATTIE D, 1978, LIFE SCI, V23, P2307, DOI 10.1016/0024-3205(78)90196-0; Dasdag S, 2001, ELECTRO MAGNETOBIOL, V20, P177, DOI 10.1081/JBC-100104141; FROLEN H, 1993, BIOELECTROMAGNETICS, V14, P197, DOI 10.1002/bem.2250140303; Fujita A, 2007, BIOELECTROMAGNETICS, V28, P538, DOI 10.1002/bem.20339; HUUSKONEN H, 1993, BIOELECTROMAGNETICS, V14, P205, DOI 10.1002/bem.2250140304; Ikehata M, 2010, 32 ANN M BIOEL SOC 2, P429; International Commission on Non-Ionizing Radiation Protection (ICNIRP), 2010, HEALTH PHYS, V99, P818, DOI DOI 10.1097/HP.0B013E3181F06C86; Juutilainen J, 1997, BIOELECTROMAGNETICS, V18, P410, DOI 10.1002/(SICI)1521-186X(1997)18:6<410::AID-BEM2>3.0.CO;2-5; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Li Q, 2002, TOXICOLOGY, V172, P181, DOI 10.1016/S0300-483X(02)00004-5; Li Q, 1998, TOXICOLOGY, V127, P223, DOI 10.1016/S0300-483X(98)00027-4; Nishimura I, 2009, BIOELECTROMAGNETICS; Nishimura I, 2011, BIRTH DEFECTS RES B, V92, P469, DOI 10.1002/bdrb.20316; Nishimura I, 2009, BIOELECTROMAGNETICS, V30, P573, DOI 10.1002/bem.20513; Nishimura I, 2012, REGUL TOXICOL PHARM, V64, P394, DOI 10.1016/j.yrtph.2012.10.005; Nishimura I, 2013, CONGENIT ANOM, V53, P115, DOI 10.1111/cga.12018; Ohtani S, 2011, 10 INT C EUR BIOEL A; Sakurai T, 2013, J RADIAT RES, V54, P1005, DOI 10.1093/jrr/rrt063; Sakurai T, 2012, BIOELECTROMAGNETICS, V33, P662, DOI 10.1002/bem.21734; SCHNORR TM, 1991, NEW ENGL J MED, V324, P727, DOI 10.1056/NEJM199103143241104; Smialowicz RJ, 1983, BIOELECTROMAGNETICS, V4, P371; STUCHLY MA, 1988, TERATOLOGY, V38, P461, DOI 10.1002/tera.1420380509; SZUCS S, 1994, J IMMUNOL METHODS, V167, P245, DOI 10.1016/0022-1759(94)90093-0; Wada K, 2010, 32 ANN M BIOEL SOC 2, P455; WHO, 2007, EXTR LOW FREQ FIELDS; WINDHAM GC, 1990, AM J IND MED, V18, P675, DOI 10.1002/ajim.4700180606; Win-Shwe TT, 2013, J TOXICOL SCI, V38, P169	39	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0955-3002	1362-3095		INT J RADIAT BIOL	Int. J. Radiat. Biol.	DEC	2014	90	12					1211	1217		10.3109/09553002.2014.930538		7	Biology; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	Life Sciences & Biomedicine - Other Topics; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging	AW0RS	WOS:000346001600012		
J	Tabata, R; Tabata, C; Nagai, T; Yasumizu, R; Kojima, M				Tabata, Rie; Tabata, Chiharu; Nagai, Tomoko; Yasumizu, Ryoji; Kojima, Masaru			Richter Syndrome With Follicular Colonization of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Cells Mimicking Follicular Lymphoma	INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY			English	Article						Richter syndrome; chronic lymphocytic leukemia; follicular colonization; CD5; diffuse large B cell lymphoma; bcl-2	NON-HODGKIN-LYMPHOMA; MARGINAL-ZONE; GASTROINTESTINAL-TRACT; EXPRESSION; CD10; COEXPRESSION; SPECTRUM	Follicular colonization is occasionally observed in marginal zone lymphoma. In rare cases, it has also been associated with mantle cell lymphoma. Chronic lymphocytic leukemia typically involves nodal or extranodal tissues as diffuse proliferation by complete effacement of the normal architecture. The involvement of chronic lymphocytic leukemia may be less frequently limited to the interfollicular areas. Here, we report a case of Richter syndrome of the small intestine that was initially diagnosed as follicular lymphoma of the gastrointestinal tract because of a partial follicular growth pattern in addition to a mainly diffuse proliferation pattern. The follicular pattern mimicking follicular lymphoma was shown to be composed of reactive follicles with follicular colonization of the original chronic lymphocytic leukemia cells. As the prognoses of Richter syndrome and follicular lymphoma of gastrointestinal tract are quite different, clinicians must carefully diagnose these conditions to avoid a misdiagnosis.	[Tabata, Rie; Nagai, Tomoko; Yasumizu, Ryoji] Hyogo Prefectural Tsukaguchi Hosp, Amagasaki, Hyogo 6610012, Japan; [Tabata, Chiharu] Hyogo Coll Med, Nishinomiya, Hyogo, Japan; [Kojima, Masaru] Dokkyo Med Univ Sch Med, Mibu, Tochigi, Japan	Tabata, R (reprint author), Hyogo Prefectural Tsukaguchi Hosp, Dept Hematol & Oncol, 6-8-17 Minamitsukaguchi, Amagasaki, Hyogo 6610012, Japan.	rtabata@hp.pref.hyogo.jp					Gupta D, 2000, MODERN PATHOL, V13, P1161, DOI 10.1038/modpathol.3880214; Bahler DW, 2000, AM J PATHOL, V157, P1063, DOI 10.1016/S0002-9440(10)64620-2; Shia J, 2002, AM J SURG PATHOL, V26, P216, DOI 10.1097/00000478-200202000-00008; MATOLCSY A, 1995, AM J PATHOL, V147, P207; Dong HY, 2003, AM J CLIN PATHOL, V119, P218, DOI 10.1309/U98ADVKUC26R2RJA; Naresh KN, 2008, HISTOPATHOLOGY, V52, P331, DOI 10.1111/j.1365-2559.2007.02951.x; Rossi D, 2011, BLOOD, V117, P3391, DOI 10.1182/blood-2010-09-302174; Yamaguchi M, 2008, HAEMATOL-HEMATOL J, V93, P1195, DOI 10.3324/haematol.12810; Gualco G, 2010, APPL IMMUNOHISTO M M, V18, P103, DOI 10.1097/PAI.0b013e3181bb9edf; Lai R, 1999, AM J CLIN PATHOL, V111, P488; Tsimberidou AM, 2005, CANCER, V103, P216, DOI 10.1002/cncr.20773; Mao ZR, 2007, AM J SURG PATHOL, V31, P1605; Damaj G, 2003, ANN ONCOL, V14, P623, DOI 10.1093/annonc/mdg168; Barrans SL, 2002, BLOOD, V99, P1136, DOI 10.1182/blood.V99.4.1136; CHEREPAKHIN V, 1993, BLOOD, V82, P3141; ISAACSON PG, 1991, AM J SURG PATHOL, V15, P819, DOI 10.1097/00000478-199109000-00001; Kim SJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-321; King BE, 2000, MODERN PATHOL, V13, P1219, DOI 10.1038/modpathol.3880226; Kojima M, 2005, INT J SURG PATHOL, V13, P73, DOI 10.1177/106689690501300110; Molica S, 2010, LEUKEMIA LYMPHOMA, V51, P415, DOI 10.3109/10428190903515192; Nakamura N, 2003, PATHOL INT, V53, P195, DOI 10.1046/j.1320-5463.2003.01455.x; Parrens M, 2001, MODERN PATHOL, V14, P452, DOI 10.1038/modpathol.3880333; Ree HJ, 2001, HUM PATHOL, V32, P954, DOI 10.1053/hupa.2001.27118; Ross D, 2009, HEMATOL ONCOL, V27, P1, DOI 10.1002/hon.880; Swerdlow SH, 1996, AM J SURG PATHOL, V20, P627, DOI 10.1097/00000478-199605000-00009; Wang GB, 2011, WORLD J GASTROENTERO, V17, P4625, DOI 10.3748/wjg.v17.i41.4625; Yatabe Y, 2001, PATHOL INT, V51, P747, DOI 10.1046/j.1440-1827.2001.01277.x	27	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1066-8969	1940-2465		INT J SURG PATHOL	Int. J. Surg. Pathol.	DEC	2014	22	8					736	743		10.1177/1066896913509011		8	Pathology; Surgery	Pathology; Surgery	AW1YJ	WOS:000346084400012		
J	Nakamura, Y; Shimizu, M; Fujisawa, Y; Taguchi, S; Nakamura, Y; Teramoto, Y; Sato, S; Yamamoto, A				Nakamura, Yasuhiro; Shimizu, Michio; Fujisawa, Yasuhiro; Taguchi, Shijima; Nakamura, Yoshiyuki; Teramoto, Yukiko; Sato, Sayuri; Yamamoto, Akifumi			Pedunculated dermatofibrosarcoma protuberans: an unusual presentation	JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT			English	Letter							SINGLE INSTITUTION		[Nakamura, Yasuhiro; Teramoto, Yukiko; Sato, Sayuri; Yamamoto, Akifumi] Saitama Med Univ, Int Med Ctr, Dept Skin Oncol Dermatol, Hidaka, Saitama 3501298, Japan; [Shimizu, Michio] Saitama Med Univ, Int Med Ctr, Dept Pathol, Hidaka, Saitama 3501298, Japan; [Fujisawa, Yasuhiro; Nakamura, Yoshiyuki] Univ Tsukuba, Fac Med, Dept Dermatol, Tsukuba, Ibaraki, Japan; [Taguchi, Shijima] Mito Kyodo Gen Hosp, Dept Dermatol, Mito, Ibaraki, Japan	Nakamura, Y (reprint author), Saitama Med Univ, Int Med Ctr, Dept Skin Oncol Dermatol, 1397-1 Yamane, Hidaka, Saitama 3501298, Japan.	ynakamur@saitama-med.ac.jp					Fiore M, 2005, J CLIN ONCOL, V23, P7669, DOI 10.1200/JCO.2005.02.5122; ZELGER B, 1994, AM J SURG PATHOL, V18, P677, DOI 10.1097/00000478-199407000-00003; Archontaki M, 2010, ANTICANCER RES, V30, P3775; Oliveira-Soares R, 2002, J EUR ACAD DERMATOL, V16, P441, DOI 10.1046/j.1468-3083.2002.00558.x; Resnik KS, 2003, J AM ACAD DERMATOL, V49, P1139, DOI 10.1016/S0190-9622(03)00439-0; Sigel JE, 2000, J CUTAN PATHOL, V27, P159, DOI 10.1034/j.1600-0560.2000.027004159.x	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1610-0379	1610-0387		J DTSCH DERMATOL GES	J. Dtsch. Dermatol. Ges.	DEC	2014	12	12					1132	1134		10.1111/ddg.12416		3	Dermatology	Dermatology	AW1ML	WOS:000346053400066		
J	Zou, WQ; Mizokami, S				Zou, Wenqian; Mizokami, Shoshi			Incentive subsidy scheme design with elastic transport demand	JOURNAL OF ADVANCED TRANSPORTATION			English	Review						bus services; incentive subsidy scheme; Laffont-Tirole's model; frequency elasticity	BUS; PERFORMANCE	Huge public transport subsidies caused by deficits have become a heavy financial burden on some local governments due to the decline of bus passenger numbers. It is essential to apply the performance-based contract to bus services considering maximization of social welfare. This paper constructs an incentive subsidy contract considering the decision-making powers of the service level and calculating the proper frequency elasticity aiming at two problems of performance-based contracts. Meanwhile, we consider a role of bus operators ignored by most researchers. Under the scheme, the decision-making power of the service level is discussed based on five assumptions, and meanwhile, bus operators are motivated to reduce cost and improve service level in the scheme. The case of the bus service of Arao city indicates that the optimal frequency equals to zero when bus operators decide frequency. If bus operators determine efforts, the optimal effort also equals to zero with the goal of maximizing the profit. Also, bus operators can play their roles in lessening cost and improving service level to help bus operators and the local government achieve a win-win situation, which maximizes the social benefit in this subsidy scheme when all factors are decided by the government. Copyright (c) 2013 John Wiley & Sons, Ltd.	[Zou, Wenqian; Mizokami, Shoshi] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto, Japan	Mizokami, S (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto, Japan.	smizo@gpo.kumamoto-u.ac.jp					Simoes P, 2012, J CLEAN PROD, V29-30, P214, DOI 10.1016/j.jclepro.2012.01.027; Gonzalez-Diaz M, 2011, TRANSPORT POLICY, V18, P299, DOI 10.1016/j.tranpol.2010.09.001; Hensher DA, 2008, TRANSPORT RES A-POL, V42, P1143, DOI 10.1016/j.tra.2008.05.004; Currie G, 2008, J TRANSP GEOGR, V16, P419, DOI 10.1016/j.jtrangeo.2008.04.007; Cheungs YHF, 1985, P SEM J PTRC SUMM AN, P97; da Cruz NF, 2014, J MANAGE ENG, V30, DOI 10.1061/(ASCE)ME.1943-5479.0000224; Gargetts A, 1995, 4 INT C COMP OWN LAN; Henshers DA, 2002, TRANSPORT RES A-POL, V37, P519; Laffont J. J., 1993, THEORY INCENTIVES PR, P53; Matthewss B, 2001, 7 INT C COMP OWN LAN; Paulleys N, 2004, P EUR TRANSP C STRAS; PUCHER J, 1983, J TRANSP ECON POLICY, V17, P155; Radbones I., 1997, 5 INT C COMP OWN LAN; SAVAGE I, 1993, J REGUL ECON, V5, P143, DOI 10.1007/BF01065363; Stackelbergs H, 1934, MARKETFORM GLEICHGEW; Suwardo Napiahs M, 2010, J CIVIL ENV ENG, V10, P1; WORCMAN N, 1993, TECHNOL REV, V96, P12; Zous W, 2011, 11 INT C AS PLANN SC	18	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0197-6729	2042-3195		J ADV TRANSPORT	J. Adv. Transp.	DEC	2014	48	8					927	941		10.1002/atr.1253		15	Engineering, Civil; Transportation Science & Technology	Engineering; Transportation	AW0RG	WOS:000346000300001		
J	Garcia, JC; Machimura, T; Matsui, T; Miyauchi, T				Garcia M, Juan C.; Machimura, Takashi; Matsui, Takanori; Miyauchi, Tatsuya			Estimating the potential and planning of bioethanol production from agro-residues based on a model-predicted NPP under climate change in Ecuador	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Article						Agro-residue; Bioethanol; Biome-BGC; LCA; NPP	AIR CO2 ENRICHMENT; TEMPERATURE; NITROGEN; FORESTS; BIOMASS; RICE; SENSITIVITY; HUMIDITY; BUDGETS; IMPACT	It is known that bioethanol is an alternative for fossil fuels for reducing GHG emissions, and agro-residues offer potentially significant advantages over other feedstock because of reduced conflict with food production. In this study, which aims to assess biomass energy potential and GHG reduction effects in Ecuador in the present and under climate change, NPP predicted by an ecosystem process model was utilized with a life-cycle GHG assessment and optimization of a biomass energy system. First, the NPP of rice, banana, sugarcane, and corn in the present and under climate change was predicted by Biome-BGC. Next, productivity of each of the four crops was formulated by NPP using government crop statistics and the model-predicted NPP, where the difference in technological and management standards among provinces was considered. Then, based on estimated crop production and geographical distribution of croplands and consumption, a nation-wide bioethanol production plan was proposed. Applying a life-cycle assessment to account for GHGs, crop selection for feedstock and product-delivery allocation, were optimized to maximize GHG reduction. Under the most-severe climate change case, total GHG emission reduction was decreased by 7% of the present condition, caused by decreased crop productivity, longer feedstock transportation, and the use of less-efficient crops.	[Garcia M, Juan C.; Machimura, Takashi; Matsui, Takanori; Miyauchi, Tatsuya] Osaka Univ, Grad Sch Engn, Dept Sustainable Energy & Environm, Suita, Osaka 5650871, Japan	Garcia, JC (reprint author), Osaka Univ, Grad Sch Engn, Dept Sustainable Energy & Environm, 2-1 Yamadaoka, Suita, Osaka 5650871, Japan.	juan-carlos-garcia@ge.see.eng.osaka-u.ac.jp			Environment Research and Technology Development Fund (Ministry of Environment Japan) [K113022]	This study was supported by the Environment Research and Technology Development Fund K113022 (Ministry of Environment Japan).	Vuille M, 2000, J CLIMATE, V13, P2520, DOI 10.1175/1520-0442(2000)013<2520:CVITAO>2.0.CO;2; Borbor-Cordova MJ, 2006, BIOGEOCHEMISTRY, V79, P135, DOI 10.1007/s10533-006-9009-7; Aggarwal PK, 2006, AGR SYST, V89, P1, DOI 10.1016/j.agsy.2005.08.001; [Anonymous], 1985, J AGROMETEOROL; Long HL, 2013, RENEW SUST ENERG REV, V26, P344, DOI 10.1016/j.rser.2013.05.035; Tatarinov FA, 2006, FOREST ECOL MANAG, V237, P267, DOI 10.1016/j.foreco.2006.09.085; Hemming D, 2013, AGR FOREST METEOROL, V170, P79, DOI 10.1016/j.agrformet.2011.10.016; Kang YH, 2009, PROG NAT SCI-MATER, V19, P1665, DOI 10.1016/j.pnsc.2009.08.001; Thornton PE, 2000, AGR FOREST METEOROL, V104, P255, DOI 10.1016/S0168-1923(00)00170-2; Cherubini F, 2009, RESOUR CONSERV RECY, V53, P434, DOI 10.1016/j.resconrec.2009.03.013; Stahl K, 1998, BIOMASS BIOENERG, V15, P205, DOI 10.1016/S0961-9534(98)00025-7; Zhou GS, 2002, FOREST ECOL MANAG, V169, P149, DOI 10.1016/S0378-1127(02)00305-5; Kim S, 2004, BIOMASS BIOENERG, V26, P361, DOI 10.1016/j.biombioe.2003.08.002; Kimball JS, 1997, AGR FOREST METEOROL, V85, P87, DOI 10.1016/S0168-1923(96)02366-0; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Gnansounou E, 2009, BIORESOURCE TECHNOL, V100, P4919, DOI 10.1016/j.biortech.2009.05.067; Sakai H, 2006, NEW PHYTOL, V170, P321, DOI 10.1111/j.1469-8137.2006.01688.x; Yang LX, 2007, FIELD CROP RES, V102, P128, DOI 10.1016/j.fcr.2007.03.006; Blanc E., 2012, CLIMATIC CHANGE, V117, P873; Blottnitz H.V., 2007, J CLEAN PROD, V15, P607, DOI [10.1016/j.jclepro.2006.03.002, DOI 10.1016/J.JCLEPRO.2006.03.002]; Garcia M, 2013, ENERGY PROCEDIA, V34, P57; Garcia M. J. C., 2012, Waste and Biomass Valorization, V3, P435, DOI 10.1007/s12649-012-9138-2; IEA, 2013, WORLD EN OUTL SPEC R; IEA, 2012, CO2 EM FUEL COMB HIG; Instituto Nacional de Meteorologia e Hidrologia (INAMHI), CLIM AN; Intergovernmental Panel on Climate Change (IPCC), 2007, 4 ASS REP CLIM CHANG, P847; Intergovernmental Panel on Climate Change (IPCC) Data Distribution Center, CARB DIOX PROJ EM CO; Lieth H, 1977, PRIMARY PRODUCTIVITY, P237; Machimura T., 2007, TRANSITION RESOURCE, P111; Ministerio de Agricultura Ganaderia Acuacultura y Pesca in Ecuador (MAGAP), EST SPR; Ministerio de Agricultura Ganaderia Acuacultura y Pesca in Ecuador (MAGAP), GEOP AGR EC INV REC; Padgitt M., 2000, STAT B, V969; USEIA, 2009, INT EN OUTL 2009; Velasquez-Arredondo H. I., 2010, ENERGY, V35, P3082; Walsh M. E., 2004, OAK RIDGE NATL LAB E, V1, P237; Xie H., 2003, WORLD WAT ENV RES C, P1; Xiong W, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044014; Yoshimoto M, 2005, AGR FOREST METEOROL, V133, P226, DOI 10.1016/j.agrformet.2005.09.010	38	0	0	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	DEC	2014	70	4					171	185		10.2480/agrmet.D-13-00027		15	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	AW3YB	WOS:000346217900001		
J	Kanda, E; Kanno, H; Okubo, S; Shimada, T; Yoshida, R; Kobayashi, T; Iwasaki, T				Kanda, Eiji; Kanno, Hiromitsu; Okubo, Sayuri; Shimada, Teruhisa; Yoshida, Ryuhei; Kobayashi, Takashi; Iwasaki, Toshiki			Estimation of cool summer damage in the Tohoku region based on the MRI AGCM	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Article						Cooling degree by average temperature; Cool summer damage; Global warming; MRI AGCM; Standardized yield	NORTHERN JAPAN; NORTHEASTERN JAPAN; CLIMATE-CHANGE; RICE; TEMPERATURE; WEATHER; MODEL	We analyzed the impact of climate change due to global warming on the risk of cool summer damage to paddy rice in the Tohoku region of Japan. We downscaled the atmospheric general circulation model of the Meteorological Research Institute (MRI AGCM) to 10 km, and we used monthly average temperatures and their standard deviations to correct the bias of the simulated temperatures. We did not use daily averaged temperatures to determine the risk of cool summer damage. Instead, we used the cooling degree calculated from the average daily temperature over a period of time (CDAT). We also used the standardized yield calculated from temperatures during the month preceding heading. An examination of the reproducibility of cooling damage occurring under the current climate was based on bias-corrected data which revealed that although the simulated risk of cool summer damage slightly underestimated both the CDAT and the standardized yield, the areal distributions of risk were similar to those in years of cool summer damage. We assumed that the heading stage occurred 15.6 days earlier than current climate because of the impact of temperature increase under the future climate and therefore calculated the CDAT and standardized yield by advancing the critical period by half a month. During the second- and third-coolest summers under the future climate scenario, the risk of cool summer damage decreased in the southern Tohoku region facing the Pacific Ocean and in Aomori Prefecture on the Japan Sea side, but the risk of cool summer damage was almost the same as during the observed cool summer of 1980. In summary, our results revealed that under a future climate, simulated by the MRI AGCM, the risk of cool summer damage will persist in the Tohoku region; risk management for cool summer damage will therefore be essential, even though global temperatures rise.	[Kanda, Eiji] NARO Agr Res Ctr, Tsukuba, Ibaraki 3058666, Japan; [Kanno, Hiromitsu; Okubo, Sayuri] NARO Tohoku Agr Res Ctr, Morioka, Iwate 0200198, Japan; [Shimada, Teruhisa; Yoshida, Ryuhei; Iwasaki, Toshiki] Tohoku Univ, Grad Sch Sci, Sendai, Miyagi 9808579, Japan; [Kobayashi, Takashi] Yamagata Univ, Fac Agr, Tsuruoka, Yamagata 9978555, Japan	Kanda, E (reprint author), Kagoshima Univ, Fac Agr, Kagoshima 890, Japan.	kanda@agri.kagoshima-u.ac.jp	Shimada, Teruhisa/L-5974-2013		MAFF (Ministry of Agriculture, Forestry and Fisheries, Japan) project, "Development of Mitigation and Adaptation Techniques for Global Warming in the Sectors of Agriculture, Forestry and Fisheries"; MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan) project, "Research Program on Climate Change Adaptation (RECCA)"	This research was partly supported by a MAFF (Ministry of Agriculture, Forestry and Fisheries, Japan) project, "Development of Mitigation and Adaptation Techniques for Global Warming in the Sectors of Agriculture, Forestry and Fisheries," and MEXT (Ministry of Education, Culture, Sports, Science and Technology, Japan) project, "Research Program on Climate Change Adaptation (RECCA)." The downscaling was performed using the supercomputer system SX-9 of the Cyberscience Center, Tohoku University.	Iizumi T, 2011, CLIMATIC CHANGE, V107, P391, DOI 10.1007/s10584-010-9990-7; Mizuta R, 2012, J METEOROL SOC JPN, V90A, P233, DOI 10.2151/jmsj.2012-A12; Iizumi Toshichika, 2007, Journal of Agricultural Meteorology, V63, P11, DOI 10.2480/agrmet.63.11; Shimono H, 2007, FIELD CROP RES, V101, P221, DOI 10.1016/j.fcr.2006.11.010; Endo H, 2012, J METEOROL SOC JPN, V90A, P123, DOI 10.2151/jmsj.2012-A06; Hayase H. T., 1969, P CROP SCI SOC JPN, V38, P706, DOI DOI 10.1626/JCS.38.706; Hayashi Y., 2001, GLOBAL ENV RES, V6, P141; HORIE T, 1990, JPN J CROP SCI, V59, P687; Horie T., 1995, MODELING IMPACT CLIM, P143; Iizumi Toshichika, 2010, Journal of Agricultural Meteorology, V66, P131, DOI 10.2480/agrmet.66.2.5; Kanda E, 2002, JPN J CROP SCI, V71, P394; Kanno H, 2004, J METEOROL SOC JPN, V82, P711, DOI 10.2151/jmsj.2004.711; Kanno H, 1997, J METEOROL SOC JPN, V75, P1053; Kanno H, 2013, J AGRIC METEOROL, V69, P117; Kudoh T., 1984, TENKI, V31, P411; MAFF, 2013, PADD UPL RIC CROP AR; Okada M., 2005, J AGROMETEOROL, V60, P589; Satake T., 1976, RES B HOKKAIDO NATL, V113, P1; Shimono H, 2008, JAPANESE J CROP SCI, V14, P489; Shimono H, 2011, AGR ECOSYST ENVIRON, V144, P201, DOI 10.1016/j.agee.2011.08.006; Shimono H, 2008, GLOBAL CHANGE BIOL, V14, P276, DOI 10.1111/j.1365-2486.2007.01498.x; Takezawa K., 2007, NONPARAMETRIC REGRES, V2, P331; Uchijima T, 1976, J AGROMETEOROL, V31, P199; Yokozawa Masayuki, 2003, Journal of Agricultural Meteorology, V59, P117, DOI 10.2480/agrmet.59.117	24	1	1	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	DEC	2014	70	4					187	198		10.2480/agrmet.D-14-00004		12	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	AW3YB	WOS:000346217900002		
J	Maki, T; Morita, O; Suzuki, Y; Wakimizu, K; Nishiyama, K				Maki, Taichi; Morita, Osamu; Suzuki, Yoshinori; Wakimizu, Kenji; Nishiyama, Koji			Artificial rainfall experiment by seeding liquid carbon dioxide above the Izu Islands of Tokyo on March 14 in 2013	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Article						Artificial rainfall; Aircraft seeding; Convective cloud; Liquid carbon dioxide (LCD); Miyake and Milcura Islands	CLOUD	Experiments of cloud seeding using liquid carbon dioxide (LCD) were carried out on March 14, 2013 near Miyake Island and Mikura Island in the Izu Islands, Tokyo, Japan. Convective clouds near the islands developed 0.5 to 1 h after the seeding. Artificial convective clouds accompanied by rain stream, i.e., virga, were observed, and rain was seen around the islands. Photos from aircraft and satellite images revealed trails and holes of disappeared clouds about 1 h and 2 h later, respectively. Within 1 h, the amount of precipitation was presumed to be about 0.1 million tons, with the precipitation intensity of 1 mm/h, based on a disappeared area 2 km x 50 km, constituting the first direct effect. Within 2 h, the total amount of precipitation from the disappeared cloud was presumed to be 1.8 million tons, based on a disappeared cloud area of diameter 50 km, constituting the secondary indirect effect. The main objective is whether the experiment of artificial rain is a success or not in a meteorological condition. Other objectives were shown successfully by photos taken of virga and the disappeared cloud, and by a satellite image based on the combination of convective cloud and the air temperature inversion layer. We found that LCD seeding at about 5 g/s within convective clouds near their bases is feasible when the air temperature is below 0 degrees C, i.e., suitable around -5 degrees C. The excellence of LCD seeding technique is supported by the results of this study, and we believe this technique will spread worldwide.	[Maki, Taichi] Japan Int Res Ctr Agr Sci, Tsukuba, Ibaraki 3058686, Japan; [Morita, Osamu] Fukuoka Univ, Off Sustainable Future, Jonan Ku, Fukuoka 8140180, Japan; [Maki, Taichi; Suzuki, Yoshinori] Kyushu Univ, Higashi Ku, Fukuoka 8128581, Japan; [Wakimizu, Kenji] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 8128581, Japan; [Nishiyama, Koji] Kyushu Univ, Fac Engn, Nishi Ku, Fukuoka 8190395, Japan	Maki, T (reprint author), Japan Int Res Ctr Agr Sci, 1-1 Ohwashi, Tsukuba, Ibaraki 3058686, Japan.	maki@affrc.go.jp					Seto J, 2011, J APPL METEOROL CLIM, V50, P1417, DOI 10.1175/2011JAMC2592.1; Wakimizu K, 2002, HYDROL PROCESS, V16, P2239, DOI 10.1002/hyp.1153; Maki T, 2013, J AGRIC METEOROL, V69, P147; Fukuta N, 2000, ATMOS RES, V55, P271, DOI 10.1016/S0169-8095(00)00065-X; Fukuta N., 1988, P 12 INT C NUCL ATM, P504; Fukuta N., 1988, METEOROLOGICAL RES N; Maki T., 2011, ENCY WIND, P134; Maki T., 2014, AGR HORTICULTURE, V89, P9; Maki T., 2013, Journal of Developments in Sustainable Agriculture, V8, P13; Maki T., 2012, ARTIFICIAL RAINFALL; Maki T., 2008, PROMOTION ARTIFICIAL; Nagata M., 2005, J AGR METEOROL, V60, P901; Nishiyama K., 2005, J AGR METEOROL, V60, P721; Ota Y., 2005, J AGR METEOROL, V60, P905	14	2	2	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	DEC	2014	70	4					199	211		10.2480/agrmet.D-14-00007		13	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	AW3YB	WOS:000346217900003		
J	Na-Ngern, P; Chutteang, C; Aoki, M; Takemasa, F; Ge, ZR; Chaichana, N; Pakoktom, T				Na-Ngern, Prathomrak; Chutteang, Cattleya; Aoki, Masatoshi; Takemasa, Fumiaki; Ge Zhenrui; Chaichana, Nongpat; Pakoktom, Tiwa			Effects of peroxides and ozone on visible foliar injury and physiological responses of two Thai and two Japanese rice cultivars	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Article						Ozone; Peroxides; Photosynthetic rate; Rice; Visible leaf injury	ORYZA-SATIVA L.; OPEN-TOP CHAMBERS; HYDROGEN-PEROXIDE; HYDROXYMETHYL HYDROPEROXIDE; TROPOSPHERIC OZONE; ELEVATED OZONE; CARBON-DIOXIDE; AIR-POLLUTION; GRAIN-YIELD; AMBIENT AIR	Air pollutant concentrations such as ozone (O-3) and peroxides have been increasing in the world, and may cause many negative impacts on crop production. The objectives of the present study are to investigate the effects of peroxides and O-3 on visible foliar injury and physiological responses, and to compare the sensitivities among two Thai rice cultivars, RD 31 and Chainat 1, and two Japanese rice cultivars, Nipponbare and Nourin 52, under exposure to single O-3 and combined O-3 and peroxides. Four treatment plots were prepared, namely control plot (O-3 2-3 ppbv and free peroxides), O-3 50 ppbv plot and free peroxides, O-3 50 ppbv and peroxides 3 ppbv plot and O-3 50 ppbv and peroxides 5 ppbv plot. The results showed that combined O-3 and several ppbv peroxides plots caused severe damage on visible leaf injury, increase in Malondialdehyde (MDA) concentration, and decrease in total chlorophyll content and a net photosynthetic rate much higher than single O-3 plot. According to the O-3 dose response analysis, we found that, in combined O-3 (50 ppbv) and peroxides (3 ppbv and 5 ppbv) exposure, in case of visible foliar injury, Chainat 1 was seriously damaged rice cultivar while Nipponbare was a less damaged rice cultivar.	[Na-Ngern, Prathomrak; Chutteang, Cattleya; Aoki, Masatoshi; Takemasa, Fumiaki; Ge Zhenrui; Chaichana, Nongpat] Tokyo Univ Agr & Technol, Fuchu, Tokyo 1838509, Japan; [Pakoktom, Tiwa] Kasetsart Univ, Fac Agr Kamphaeng Saen, Dept Agron, Kamphaeng Saen 73140, Nakhon Pathom, Thailand	Na-Ngern, P (reprint author), Petr Author Thailand Publ Co Ltd, Sustainabil Management Project, Bangkok, Thailand.	prathomrak.n@pttplc.com			Japanese Government; Education Program for Field-Oriented Leaders in Environmental Sectors in Asia and Africa, Tokyo University of Agriculture and Technology; S8-project of the Ministry of the Environment	P. Na-ngern and C. Chutteang are grateful to the Japanese Government and the Education Program for Field-Oriented Leaders in Environmental Sectors in Asia and Africa, Tokyo University of Agriculture and Technology for awarding the scholarship. We are thankful to Horticulture Laboratory, Plant Nutrition Laboratory and Pesticide Fate and Transport Laboratory, Tokyo University of Agriculture and Technology for technical and equipment support. The present study is financially supported partly by the S8-project of the Ministry of the Environment in 2010 and 2011.	HATAKEYAMA S, 1993, CHEM LETT, P1287, DOI 10.1246/cl.1993.1287; Vollenweider P, 2003, ENVIRON POLLUT, V124, P101, DOI 10.1016/S0269-7491(02)00412-8; Yamaji K, 2006, ATMOS ENVIRON, V40, P1856, DOI 10.1016/j.atmosenv.2005.10.067; Cho K, 2011, REV ENVIRON CONTAM T, V212, P61, DOI 10.1007/978-1-4419-8453-1_3; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Fiscus EL, 2005, PLANT CELL ENVIRON, V28, P997, DOI 10.1111/j.1365-3040.2005.01349.x; Potvin C, 1988, FUNCT ECOL, V2, P123, DOI 10.2307/2389472; Calatayud A, 2001, ENVIRON POLLUT, V115, P283, DOI 10.1016/S0269-7491(01)00101-4; Fuhrer J, 2003, ENVIRON INT, V29, P141, DOI 10.1016/S0160-4120(02)00157-5; Aoki M., 2011, P PLANT FUNCT CHANG, P89; Ariyaphanphitak W, 2005, WATER AIR SOIL POLL, V167, P179, DOI 10.1007/s11270-005-8650-4; Chen X, 2010, ENVIRON POLLUT, V158, P1675, DOI 10.1016/j.envpol.2009.12.002; Chen X., 2008, J ATMOS CHEM, V60, P39; Chen X., 2005, J AGR METEOROL, V60, P953; Chutteang C., 2011, P CIGR INT S SUST BI, P7; Chutteang Cattleya, 2012, Journal of Agricultural Meteorology, V68, P45, DOI 10.2480/agrmet.68.1.6; Chutteang C, 2013, J AGRIC METEOROL, V69, P135; Das M, 1999, J GEOPHYS RES-ATMOS, V104, P21367, DOI 10.1029/1999JD900284; Dizengremel P, 2001, PLANT PHYSIOL BIOCH, V39, P729, DOI 10.1016/S0981-9428(01)01291-8; Frei M, 2008, J EXP BOT, V59, P3741, DOI 10.1093/jxb/ern222; Hossain M., 1995, Geojournal, V35, P286, DOI 10.1007/BF00989136; Imai K, 2008, PHOTOSYNTHETICA, V46, P387, DOI 10.1007/s11099-008-0070-4; Jackson AV, 1996, ATMOS ENVIRON, V30, P819, DOI 10.1016/1352-2310(95)00348-7; Jiang G. M., 2004, ENV STRESS PLANT RES, P175; Kang CM, 2002, ATMOS ENVIRON, V36, P5509, DOI 10.1016/S1352-2310(02)00667-2; KOBAYASHI K, 1995, AGR ECOSYST ENVIRON, V53, P109, DOI 10.1016/0167-8809(94)00564-U; KOBAYASHI K, 1995, AGR ECOSYST ENVIRON, V53, P1, DOI 10.1016/0167-8809(94)00560-2; Lin DI, 2001, PLANT GROWTH REGUL, V35, P295, DOI 10.1023/A:1014427505353; Maggs R, 1998, ENVIRON POLLUT, V103, P159, DOI 10.1016/S0269-7491(98)00129-8; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; Ostromsky T, 2001, LECT NOTES COMPUT SC, V1988, P636; OSullivan DW, 1996, J PHYS CHEM-US, V100, P3241, DOI 10.1021/jp951168n; Pang J, 2009, AGR ECOSYST ENVIRON, V132, P203, DOI 10.1016/j.agee.2009.03.012; Pleijel H, 1999, AGR ECOSYST ENVIRON, V72, P265, DOI 10.1016/S0167-8809(98)00185-6; Rai R, 2008, SCI TOTAL ENVIRON, V407, P679, DOI 10.1016/j.scitotenv.2008.09.010; Ren Y, 2009, ATMOS ENVIRON, V43, P1702, DOI 10.1016/j.atmosenv.2008.12.020; Sawada H, 2009, PLANT BIOLOGY, V11, P70, DOI 10.1111/j.1438-8677.2009.00233.x; Smith C. W., 2003, RICE ORIGIN HIST TEC; Taiz L., 2010, PLANT PHYSL; Takami A, 2003, ATMOS ENVIRON, V37, P3861, DOI 10.1016/S1352-2310(03)00454-0; WAHID A, 1995, ENVIRON POLLUT, V90, P323, DOI 10.1016/0269-7491(95)00024-L; Watanabe K, 1995, J METEOROL SOC JPN, V73, P1153; Yang C. K., 2000, J AGRON ASS CHINA, V1, P159; ZHOU XL, 1992, J PHYS CHEM-US, V96, P265, DOI 10.1021/j100180a051	44	0	0	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	DEC	2014	70	4					213	222		10.2480/agrmet.D-12-00007		10	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	AW3YB	WOS:000346217900004		
J	Marpaung, F; Hirano, T				Marpaung, Fiolenta; Hirano, Takashi			Environmental dependence and seasonal variation of diffuse solar radiation in tropical peatland	JOURNAL OF AGRICULTURAL METEOROLOGY			English	Article						Aerosol; Clearness index; El Nino drought; Peat fire; Smoke	GLOBAL RADIATION; SWAMP FORESTS; EMISSIONS; KALIMANTAN; INDONESIA; FIRE; PARTICLES; COMPONENT; BALANCE; CLOUDS	Changes in cloud cover and atmospheric aerosol loading strongly affect the diffuse proportion of solar radiation (R-d/R-g). It has been reported that plant photosynthesis is more efficient under diffuse light conditions, but diffuse radiation (R-d) regimes in tropical peatland frequently subjected to large-scale fires are poorly described, and there are few or no site-based datasets to date. Therefore, we continuously measured R-d for more than three years at a burnt ex-forest on tropical peatland in Central Kalimantan, Indonesia. Daily R-d/R-g was significantly related to the clearness index (R-g/R-o) with a linear threshold model. The model parameters showed that R-d/R-g under a clear sky is larger in tropical peatland with a humid climate than in Australia. Using the model, long-term variation in R-d/R-g for more than 12 years was estimated from R-g measured above a nearby forest. As a result, R-d/R-g showed a seasonal variation with its minimum of 0.51 in June (the transition between the wet and dry seasons) and its maximum of 0.68 in October (the late dry season) on a monthly basis. The decreasing pattern from the late wet season to the early dry season corresponded to decreasing precipitation due to fewer clouds. In contrast, the increasing pattern through the latter half of the dry season was due to shading by smoke emitted through burning biomass and peat fires. In particular, during the El Nino droughts in 2002, 2006 and 2009, the monthly mean R-d/R-g rose above 0.72, because the ground was densely covered with smoke from large-scale fires.	[Marpaung, Fiolenta] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan; [Hirano, Takashi] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan	Marpaung, F (reprint author), Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan.	fiolenta@env.agr.hokudai.ac.jp	Hirano, Takashi/A-4557-2012		JSPS Core University Program; JSPS KAKENHI [13375011, 15255001, 18403001, 21255001, 25257401]; JST-JICA Project (SATREPS) (Wild Fire and Carbon Management in Peat-Forest in Indonesia)	This work was supported by JSPS Core University Program, JSPS KAKENHI (Nos. 13375011,15255001, 18403001, 21255001, and 25257401) and the JST-JICA Project (SATREPS) (Wild Fire and Carbon Management in Peat-Forest in Indonesia). We thank Dr. Suwido Limin and Mr. Kitso Kusin at CIMTRP, University of Palangkaraya for supporting fieldwork and site management.	Aldrian A., 2003, INT J CLIMATOLOGY, V23, P1435; Kaufman YJ, 1997, SCIENCE, V277, P1636, DOI 10.1126/science.277.5332.1636; Hirano T, 2012, GLOBAL CHANGE BIOL, V18, P3410, DOI 10.1111/j.1365-2486.2012.02793.x; SPITTERS CJT, 1986, AGR FOREST METEOROL, V38, P217, DOI 10.1016/0168-1923(86)90060-2; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Fan XH, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014650; Knohl A, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000663; Oliphant AJ, 2011, AGR FOREST METEOROL, V151, P781, DOI 10.1016/j.agrformet.2011.01.005; Couwenberg J, 2010, GLOBAL CHANGE BIOL, V16, P1715, DOI 10.1111/j.1365-2486.2009.02016.x; Page SE, 2011, GLOBAL CHANGE BIOL, V17, P798, DOI 10.1111/j.1365-2486.2010.02279.x; Hooijer A, 2010, BIOGEOSCIENCES, V7, P1505, DOI 10.5194/bg-7-1505-2010; Hirano T, 2007, GLOBAL CHANGE BIOL, V13, P412, DOI 10.1111/j.1365-2486.2006.01301.x; Langner A, 2009, GLOBAL CHANGE BIOL, V15, P48, DOI 10.1111/j.1365-2486.2008.01828.x; van der Werf GR, 2008, P NATL ACAD SCI USA, V105, P20350, DOI 10.1073/pnas.0803375105; Oliveira PHF, 2007, TELLUS B, V59, P338, DOI [10.1111/j.1600-0889.2007.00270.x, 10.1111/J.1600-0889.2007.00270.x]; Butt N, 2010, AGR FOREST METEOROL, V150, P361, DOI 10.1016/j.agrformet.2009.12.004; Ramanathan V, 2001, J GEOPHYS RES-ATMOS, V106, P28371, DOI 10.1029/2001JD900133; Ballhorn U, 2009, P NATL ACAD SCI USA, V106, P21213, DOI 10.1073/pnas.0906457106; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; GU LH, 2002, J GEOPHYS RES-ATMOS, V107, DOI DOI 10.1029/2001JD0; Heil A., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P113; Hirano T, 2014, GLOBAL CHANGE BIOL, V20, P555, DOI 10.1111/gcb.12296; Ikegami M, 2001, ATMOS ENVIRON, V35, P4237, DOI 10.1016/S1352-2310(01)00247-3; Khan B. H., 2009, NONCONVENTIONAL ENER, P82; Matsui T, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009658; Murdiyarso D., 2007, Mitigation and Adaptation Strategies for Global Change, V12, P101; Oldeman L. R., 1980, AGROCLIMATIC MAPS KA, P1; Putra E. I., 2008, J DISASTER RES, V3, P334; Putra E. I., 2011, TROPICS, V19, P145; Roderick ML, 1999, AGR FOREST METEOROL, V95, P169, DOI 10.1016/S0168-1923(99)00028-3; Still CJ, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2007JG000675; Suzaki T., 2003, J FOR RES, V8, P283, DOI 10.1007/s10310-003-0038-y; Toriyama J, 2014, FOREST ECOL MANAG, V314, P1, DOI 10.1016/j.foreco.2013.11.034; Tosca M. G., 2011, J GEOPHYS RES, V116, pD0827; Yulianti N., 2012, GLOBAL ENV RES, V16, P105	36	0	0	SOC AGRICULTURAL METEOROLOGY JAPAN	TSUKUBA	C/O SADANORI SASE, MANAGING EDITOR, LAB OF ENVIRONMENTAL CONTROL IN AGRICULTURAL BUILDINGS, NATIONA, TSUKUBA, IBARAKI, 305-8609 00000, JAPAN	0021-8588	1881-0136		J AGRIC METEOROL	J. Agric. Meteorol.	DEC	2014	70	4					223	232		10.2480/agrmet.D-14-00028		10	Agriculture, Multidisciplinary; Meteorology & Atmospheric Sciences	Agriculture; Meteorology & Atmospheric Sciences	AW3YB	WOS:000346217900005		
J	Oishi-Tomiyasu, R				Oishi-Tomiyasu, R.			Method to generate all the geometrical ambiguities of powder indexing solutions	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article							BINARY QUADRATIC FORM; INTEGER POINTS; DIFFRACTION; VALUES	A new algorithm is reported that returns all the lattices with the same set of d spacings as that of a given lattice. The algorithm is useful for quickly checking lattice parameters obtained for a considered powder diffraction pattern and assessing the reliability of the results of powder indexing. The proposed algorithm was implemented as a new function in the powder indexing software Conograph (http://sourceforge.jp/projects/conograph/; http://research.kek.jp/people/rtomi/ConographGUI/web_page.html). Examples of real cases are reported to explain how the algorithm can be used.	High Energy Accelerator Res Org, Tsukuba, Ibaraki, Japan	Oishi-Tomiyasu, R (reprint author), High Energy Accelerator Res Org, Tsukuba, Ibaraki, Japan.	ryoko.tomiyasu@kek.jp			JSPS KAKENHI, JST PRESTO [22740077]; Ibaraki Prefecture [J-PARC-23D06]	This research was partly supported by a JSPS KAKENHI grant (No. 22740077), JST PRESTO, and by Ibaraki Prefecture (J-PARC-23D06).	WATSON GL, 1979, MATHEMATIKA, V26, P72; Oikawa K, 2000, J SOLID STATE CHEM, V154, P524, DOI 10.1006/jssc.2000.8873; DEWOLFF PM, 1968, J APPL CRYSTALLOGR, V1, P108, DOI 10.1107/S002188986800508X; Bhargava M., 2005, INVENT MATH UNPUB; Cassels J. W. S., 1978, RATIONAL QUADRATIC F; Kroll H, 2011, J APPL CRYSTALLOGR, V44, P812, DOI 10.1107/S0021889811019650; Mighell AD, 2004, J RES NATL INST STAN, V109, P569, DOI 10.6028/jres.109.043; MIGHELL AD, 1975, J APPL CRYSTALLOGR, V8, P372, DOI 10.1107/S0021889875010710; Mori K, 1999, J PHYS CHEM SOLIDS, V60, P1443, DOI 10.1016/S0022-3697(99)00158-4; Oishi-Tomiyasu R, 2013, J APPL CRYSTALLOGR, V46, P1277, DOI 10.1107/S0021889813018773; Oishi-Tomiyasu R, 2012, ACTA CRYSTALLOGR A, V68, P525, DOI 10.1107/S0108767312024579; Oishi-Tomiyasu R, 2014, J APPL CRYSTALLOGR, V47, P593, DOI 10.1107/S1600576714000922; SANTORO A, 1980, ACTA CRYSTALLOGR A, V36, P796, DOI 10.1107/S0567739480001593; Shirley R., 1980, NBS US SPEC PUBL, V567, P361; VANDERWAERDEN BL, 1956, ACTA MATH-DJURSHOLM, V96, P265; WATSON GL, 1980, MATHEMATIKA, V27, P188; Wuernisha T, 2006, PHYSICA B, V385, P116, DOI 10.1016/j.physb.2006.05.178	17	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-8898	1600-5767		J APPL CRYSTALLOGR	J. Appl. Crystallogr.	DEC	2014	47		6				2055	2059		10.1107/S1600576714023620		5	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	AU8XY	WOS:000345877900029		
J	Wu, SY; Saito, I; Isoyama, T; Inoue, Y; Sato, M; Hara, S; Li, XY; Yurimoto, T; Murakami, H; Kawase, Y; Ono, T; Abe, Y				Wu, Sheng-Yuan; Saito, Itsuro; Isoyama, Takashi; Inoue, Yusuke; Sato, Masami; Hara, Shintaro; Li, Xin-Yang; Yurimoto, Terumi; Murakami, Haruka; Kawase, Yukino; Ono, Toshiya; Abe, Yusuke			Concept of left atrial pressure estimation using its pulsatile amplitude in the helical flow total artificial heart	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Total artificial heart; Atrial pressure; Estimation; Compliance; Sensor	PUMP	The total artificial heart (TAH) requires physiological control to respond to the metabolic demand of the body. To date, 1/R control is a single physiological control method that can control venous pressure. To realize an implantable 1/R control system, we are developing a new pressure measuring method using absolute pressure sensor. To find a method for absolute pressure sensor, which went well without calibration, concept of left atrial pressure (LAP) estimation using its pulsatile amplitude was proposed. Its possibility was investigated with two long-term survived goats whose hearts were replaced with the helical flow TAHs. In manual control condition, there existed a positive relation between mean LAP (mLAP) and normalized pulsatile amplitude (NPA). Percent systole revealed not to affect the relationship between mLAP and NPA. Dispersion was observed between different pulse rates. As for cardiac output difference (QLD) that is the difference of flow rate between systolic and diastolic phases, similar results were obtained except in low QLDs. In the 1/R control condition, relatively high correlation between mLAP and NPA could be obtained. In estimation of mLAP using the correlating function of individual goat, fairly good correlation was obtained between measured mLAP and estimated mLAP. Despite that further studies are necessary, it was demonstrated that the concept of the LAP estimation could be possible.	[Wu, Sheng-Yuan; Saito, Itsuro; Isoyama, Takashi; Sato, Masami; Hara, Shintaro; Li, Xin-Yang; Yurimoto, Terumi; Murakami, Haruka; Ono, Toshiya; Abe, Yusuke] Univ Tokyo, Grad Sch Med, Dept Biomed Engn, Bunkyo Ku, Tokyo 1130033, Japan; [Inoue, Yusuke] Univ Tokyo, Grad Sch Engn, Dept Elect Engn & Informat Syst, Tokyo 1130033, Japan; [Kawase, Yukino] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan	Saito, I (reprint author), Univ Tokyo, Grad Sch Med, Dept Biomed Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	saito@bme.gr.jp; abe@bme.gr.jp			JSPS KAKENHI [22249053, 22240054]	The study was supported in part by the JSPS KAKENHI (22249053) and (22240054).	Abe Y, 1998, J APPL PHYSIOL, V84, P868; Abe Y, 2012, J ARTIF ORGANS, V15, P331, DOI 10.1007/s10047-012-0659-z; Abe Y, 1998, HEART REPLACEMENT AR, V6, P34; Abe Yusuke, 2013, Conf Proc IEEE Eng Med Biol Soc, V2013, P2720, DOI 10.1109/EMBC.2013.6610102; Snyder A J, 1992, ASAIO J, V38, pM707, DOI 10.1097/00002480-199207000-00130; Yoshizawa M, 2002, ASAIO J, V48, P443, DOI 10.1097/00002480-200207000-00020; Auhero TX, 1987, ASAIO T, V33, P157; HENNIG E, 1978, T AM SOC ART INT ORG, V24, P616; HILLER KW, 1962, T AM SOC ART INT ORG, V8, P125; PIERCE WS, 1976, T AM SOC ART INT ORG, V22, P347; Saito I, 2008, IFMBE PROC, V19, P62; Shi W, 2011, J ARTIF ORGANS, V14, P81, DOI 10.1007/s10047-011-0556-x; TAKATANI S, 1982, T AM SOC ART INT ORG, V28, P148; Vasku J, 1992, HEART REPLACEMENT AR, V4, P161	14	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2014	17	4					301	307		10.1007/s10047-014-0788-7		7	Engineering, Biomedical; Transplantation	Engineering; Transplantation	AW0FK	WOS:000345966200002		
J	Yoshioka, D; Matsumiya, G; Toda, K; Sakaguchi, T; Yoshikawa, Y; Saito, S; Matsuda, H; Sawa, Y				Yoshioka, Daisuke; Matsumiya, Goro; Toda, Koichi; Sakaguchi, Taichi; Yoshikawa, Yasushi; Saito, Shunsuke; Matsuda, Hikaru; Sawa, Yoshiki			Clinical results with Jarvik 2000 axial flow left ventricular assist device: Osaka University Experience	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Left ventricular assist device; Jarvik 2000; Heart failure	HEART-FAILURE; IMPLANTATION; SYSTEM; BRIDGE	The aim of this study was to evaluate our clinical experience with the Jarvik 2000 axial flow pump (Jarvik Heart, Inc, New York, NY, USA), a miniature axial flow left ventricular assist device (LVAD). The clinical results of eight patients, who underwent LVAD implantation with the Jarvik 2000 (median age 55.0 years; six men) between 2005 and 2010, including two who participated in a multicenter clinical trial in Japan, were reviewed. Two patients underwent LVAD implantation as destination therapy. Four patients underwent Jarvik 2000 implantation via median sternotomy, while the other four underwent implantation via left thoracotomy. There were no major complications during surgery. Four patients were supported for more than 2 years. The longest support duration was 1,618 days. Six patients successfully bridged to heart transplantation after a median 725 days of support. One patient on destination therapy died of a cerebral infarction. The other patient on destination therapy had had the LVAD for 1,618 days. The overall survival rates at 1, 2, and 3 years were 100, 86, and 86 %, respectively. The median postoperative serum lactate dehydrogenase level was 860.5 U/L at 1 month, 735 U/L at 6 months, and 692 U/L at 1 year. There were no fatal device-related infections. We found that the Jarvik 2000 with pin bearing could support patients with end-stage heart failure with acceptable mortality and morbidity rates. Further evaluations of the prevalence of thromboembolic and hemolytic events in patients with the new conical-bearing Jarvik 2000 are required.	[Yoshioka, Daisuke; Matsumiya, Goro; Toda, Koichi; Sakaguchi, Taichi; Yoshikawa, Yasushi; Saito, Shunsuke; Matsuda, Hikaru; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan	Yoshioka, D (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, 2-2 Yamadaoka, Suita, Osaka, Japan.	yoshioka@surg1.med.osaka-u.ac.jp			Century Medical Inc.	Matsumiya Goro received a research grant from Century Medical Inc. All other authors have no conflict of interest.	Saito S, 2011, J HEART LUNG TRANSPL, V30, P845, DOI 10.1016/j.healun.2011.02.004; Frazier OH, 2002, CIRCULATION, V105, P2855, DOI 10.1161/01.CIR.0000018167.47314.AF; Kato TS, 2012, J HEART LUNG TRANSPL, V31, P1, DOI 10.1016/j.healun.2011.08.014; Saito S, 2013, J ARTIF ORGANS, V16, P105, DOI 10.1007/s10047-012-0669-x; Lalonde SD, 2013, J CARDIAC SURG, V28, P604, DOI 10.1111/jocs.12158; Komoda T, 2013, EUR J CARDIO-THORAC, V43, P1036, DOI 10.1093/ejcts/ezs483; Sakaguchi T, 2013, CIRC J, V77, P1736, DOI 10.1253/circj.CJ-12-1410; Cabrera AG, 2013, J HEART LUNG TRANSPL, V32, P1107, DOI 10.1016/j.healun.2013.07.012; Frazier OH, 2003, ANN SURG, V237, P631, DOI 10.1097/00000658-200305000-00005; Haj-Yahia S, 2007, J THORAC CARDIOV SUR, V134, P199, DOI 10.1016/j.jtvcs.2007.01.002; Kainuma S, 2012, J ARTIF ORGANS, V15, P83, DOI 10.1007/s10047-011-0602-8; Kamata S, 2010, J ARTIF ORGANS, V13, P170, DOI 10.1007/s10047-010-0512-1; Loffler C, 2009, J THORAC CARDIOV SUR, V137, P736, DOI 10.1016/j.jtcvs.2008.09.019; Siegenthaler MP, 2002, J AM COLL CARDIOL, V39, P1764, DOI 10.1016/S0735-1097(02)01855-7; Siegenthaler MP, 2006, ANN THORAC SURG, V81, P1752, DOI 10.1016/j.athoracsur.2005.12.013; Sorensen EN, 2012, ANN THORAC SURG, V93, P133, DOI 10.1016/j.athoracsur.2011.09.021; Uriel N, 2013, J HEART LUNG TRANSPL, VS1053- 2498	17	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2014	17	4					308	314		10.1007/s10047-014-0783-z		7	Engineering, Biomedical; Transplantation	Engineering; Transplantation	AW0FK	WOS:000345966200003		
J	Hoashi, T; Kagisaki, K; Nishigaki, T; Yoshida, K; Hayashi, T; Ichikawa, H				Hoashi, Takaya; Kagisaki, Koji; Nishigaki, Takayuki; Yoshida, Kotaro; Hayashi, Teruyuki; Ichikawa, Hajime			Efficacy of new pediatric extra-corporeal life support system (Endumo 2000) for postoperative management after Norwood operation	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Extra-corporeal life support; Membrane oxygenation; Endumo; Norwood	MEMBRANE-OXYGENATION; PALLIATION; PERFUSION; SURVIVAL; PUMP	This study aimed to assess the efficacy of a new pediatric extra-corporeal life support (ECLS) system (Endumo 2000, Heiwa Bussan, Tokyo, Japan) for postoperative management after the Norwood operation. Thirty-three consecutive patients with hypoplastic left heart syndrome or its variant undergoing the Norwood operation between August 2007 and December 2013 were divided into two groups according to available ECLS devices. Before November 2009, pediatric Emersave (TERUMO, Saitama, Japan) was employed as the ECLS device, and 14 patients were operated on during this period (Emersave era: 7 boys; 2.9 kg). After December 2009, Endumo 2000 was employed and 19 patients were operated on (Endumo era: 8 boys, 3.1 kg). The demographic characteristics of both groups showed no significant differences. ECLS was initiated in 7 of 14 patients (50 %) during the Emersave era and 7 of 19 patients (37 %) during the Endumo era (p = 0.45). Chest reentry for hemostasis during ECLS support was more frequently needed in patients supported by Emersave (5/7) than Endumo (1/7) (p = 0.03). The first ECLS circuit durability of Endumo was significantly longer than that of Emersave (p = 0.01). The survival at discharge rate in patients required ECLS was 0 % (0/7) when supported by Emersave, but 57 % (4/7) by Endumo (p = 0.02). As a result, the survival at discharge rate was 43 % (6/14) in the Emersave era and 79 % (14/19) in the Endumo era (p = 0.03). Longer durability and superior antithrombogenicity of the Endumo 2000 contributed to the improvement of surgical outcomes after the Norwood operation.	[Hoashi, Takaya; Kagisaki, Koji; Ichikawa, Hajime] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, Suita, Osaka 5658565, Japan; [Nishigaki, Takayuki; Yoshida, Kotaro; Hayashi, Teruyuki] Natl Cerebral & Cardiovasc Ctr, Dept Clin Engn, Suita, Osaka 5658565, Japan	Hoashi, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiovasc Surg, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	thoashi@surg1.med.osaka-u.ac.jp; ichikawa@hsp.ncvc.co.jp					Alsoufi Bahaaldin, 2014, World J Pediatr Congenit Heart Surg, V5, P7, DOI 10.1177/2150135113507292; Nishinaka T, 2007, J ARTIF ORGANS, V10, P240, DOI 10.1007/s10047-007-0390-3; Kashiwa K, 2012, J ARTIF ORGANS, V15, P207, DOI 10.1007/s10047-012-0632-x; Nishinaka T, 2002, ARTIF ORGANS, V26, P548, DOI 10.1046/j.1525-1594.2002.06886_3.x; Hoashi T, 2013, J ARTIF ORGANS, V16, P267, DOI 10.1007/s10047-013-0713-5; Friedland-Little JM, 2014, J THORAC CARDIOV SUR, V148, P266, DOI 10.1016/j.jtcvs.2013.08.051; Friedland-Little JM, 2014, ANN THORAC SURG, V97, P659, DOI 10.1016/j.athoracsur.2013.10.066; MENDLER N, 1995, ARTIF ORGANS, V19, P620, DOI 10.1111/j.1525-1594.1995.tb02391.x; Sherwin ED, 2012, J THORAC CARDIOV SUR, V144, P1337, DOI 10.1016/j.jtcvs.2012.03.035; Ungerleider RM, 2004, ANN THORAC SURG, V77, P18, DOI 10.1016/S0003-4975(03)01365-1	10	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2014	17	4					315	320		10.1007/s10047-014-0786-9		6	Engineering, Biomedical; Transplantation	Engineering; Transplantation	AW0FK	WOS:000345966200004		
J	Ehashi, T; Kakinoki, S; Yamaoka, T				Ehashi, Tomo; Kakinoki, Sachiro; Yamaoka, Tetsuji			Water absorbing and quick degradable PLLA/PEG multiblock copolymers reduce the encapsulation and inflammatory cytokine production	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Biomaterials; Biodegradable; Water absorbing; Inflammation; Wound healing	PERIPHERAL-NERVE REGENERATION; IN-VIVO EVALUATION; POLY(L-LACTIC ACID); ADHESION PREVENTION; SURFACE-CHEMISTRY; POLY(ETHYLENE GLYCOL); ABDOMINAL ADHESIONS; BIOMATERIALS; RESPONSES; MODEL	Biomaterials that contact with soft tissues such as postoperative adhesion prevention membrane or tissue-regenerative scaffolds should possess specific features such as hydrophilicity, mild to no immunogenicity, and quick degradability. The inflammation reaction to multiblock copolymers of poly(l-lactic acid) (PLLA) and poly(ethylene glycol), named as Multi, which we developed as a good adhesion prevention materials with a very high degradation rate were investigated and compared with usual PLLA, non-degradable polyethylene (PE), and acellular collagenous tissue (COL). Tissue encapsulation, inflammatory cell recruitment, and expression of four cytokines (IL-1 beta, IL-6, IL-10, and TGF beta) affecting the promotion or inhibition of inflammation and wound healing were evaluated. The thick encapsulation for PE might have related to high expression of TGF beta, and it was largely reduced in the cases of PLLA and Multi. The cytokine expression pattern in PE was dominantly alternatively activated macrophage (M2) type, while expression patterns to Multi were classically activated macrophage (M1)-type dominant, as with the COL specimen. Thus, multi is a tissue compatible material in spite of the large degradability. By introducing low molecular weight PEG into PLLA as multiblock-type sequence, we successfully prepared biocompatible PLLA derivatives with high molecular weight, large degradation rate, and mild tissue responses.	[Ehashi, Tomo; Kakinoki, Sachiro; Yamaoka, Tetsuji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, Suita, Osaka 5658565, Japan; [Ehashi, Tomo; Kakinoki, Sachiro; Yamaoka, Tetsuji] Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol, Chiyoda Ku, Tokyo 1020076, Japan	Yamaoka, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Biomed Engn, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	yamtet@ri.ncvc.go.jp			Ministry of Health, Labour and Welfare of Japan; CREST-JST grant	This work was financially supported by a Grant-in-Aid for Young Scientists (B), a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare of Japan, and a CREST-JST grant.	Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066; Sandor M, 2008, TISSUE ENG PT A, V14, P2021, DOI 10.1089/ten.tea.2007.0317; Boland GM, 2006, J SURG RES, V132, P3, DOI 10.1016/j.jss.2005.12.002; Schutte RJ, 2009, J BIOMED MATER RES A, V88A, P128, DOI 10.1002/jbm.a.31863; Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048; Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425; Gretzer C, 2006, J BIOMAT SCI-POLYM E, V17, P669, DOI 10.1163/156856206777346340; LAM KH, 1995, J BIOMED MATER RES, V29, P929, DOI 10.1002/jbm.820290804; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/nmat2442, 10.1038/NMAT2442]; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; Schnuriger B, 2011, AM J SURG, V201, P111, DOI 10.1016/j.amjsurg.2010.02.008; Kamath S, 2008, J BIOMED MATER RES A, V86A, P617, DOI 10.1002/jbm.a.31649; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mitragotri S, 2009, NAT MATER, V8, P15, DOI [10.1038/nmat2344, 10.1038/NMAT2344]; Rodriguez A, 2009, J BIOMED MATER RES A, V89A, P152, DOI 10.1002/jbm.a.31939; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; Mills CD, 2000, J IMMUNOL, V164, P6166; Zong XH, 2004, ANN SURG, V240, P910, DOI 10.1097/0l.sla.0000143302.48223.7e; Wilshaw SP, 2008, TISSUE ENG PT A, V14, P463, DOI 10.1089/tea.2007.0145; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; Chujo S, 2009, J CELL PHYSIOL, V220, P189, DOI 10.1002/jcp.21750; Debusscher F, 2009, EUR SPINE J, V18, P1314, DOI 10.1007/s00586-009-1062-1; Ehashi T, 2011, J BIOMAT SCI-POLYM E, V22, P627, DOI 10.1163/092050610X488250; Evans GRD, 1999, BIOMATERIALS, V20, P1109, DOI 10.1016/S0142-9612(99)00010-1; Fujisato T, 2005, CARDIOVASCULAR REGENERATION THERAPIES USING TISSUE ENGINEERING APPROACHES, P83, DOI 10.1007/4-431-27378-6_7; Hunt JA, 2008, KNEE SURG SPORT TR A, V16, P655, DOI 10.1007/s00167-008-0528-8; Kakinoki S, 2011, POLYMERS-BASEL, V3, P820, DOI 10.3390/polym3020820; Kakinoki S, 2010, ACTA BIOMATER, V6, P1925, DOI 10.1016/j.actbio.2009.12.001; Kakinoki S, 2013, J BIOMATER APPL, V28, P544, DOI 10.1177/0885328212462260; Li JM, 2008, J BIOMED MATER RES A, V87A, P392, DOI 10.1002/jbm.a.31814; Lips PAM, 2006, J BIOMED MATER RES A, V76A, P699, DOI 10.1002/jbm.a.30530; Martinez FO, 2008, FRONT BIOSCI, V13, P543; Yamaoka T, 2001, J BIOMED MATER RES, V54, P470, DOI 10.1002/1097-4636(20010315)54:4<470::AID-JBM20>3.0.CO;2-X; Yamaoka T, 2013, POLYM DEGRAD STABIL, V98, P2168, DOI 10.1016/j.polymdegradstab.2013.08.026; Yamaoka T, 1999, INT J BIOL MACROMOL, V25, P265, DOI 10.1016/S0141-8130(99)00041-0; Yamaoka T, 1999, J POLYM SCI POL CHEM, V37, P1513, DOI 10.1002/(SICI)1099-0518(19990515)37:10<1513::AID-POLA13>3.0.CO;2-9; YAMAOKA T, 1995, J PHARM SCI, V84, P349, DOI 10.1002/jps.2600840316; YAMAOKA T, 1994, J PHARM SCI, V83, P601, DOI 10.1002/jps.2600830432; Yeo Y, 2007, BIOMATERIALS, V28, P3704, DOI 10.1016/j.biomaterials.2007.04.033	39	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2014	17	4					321	328		10.1007/s10047-014-0791-z		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	AW0FK	WOS:000345966200005		
J	Choi, SJ; Liu, IL; Yamamoto, K; Honnami, M; Ohba, S; Echigo, R; Sakai, T; Igawa, K; Suzuki, S; Nishimura, R; Chung, UI; Sasaki, N; Mochizuki, M				Choi, Sungjin; Liu, I-Li; Yamamoto, Kenichi; Honnami, Muneki; Ohba, Shinsuke; Echigo, Ryosuke; Sakai, Takamasa; Igawa, Kazuyo; Suzuki, Shigeki; Nishimura, Ryouhei; Chung, Ung-il; Sasaki, Nobuo; Mochizuki, Manabu			Comparison of the long-term effects on rabbit bone defects between Tetrabone(A (R)) and beta-tricalcium phosphate granules implantation	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Artificial bones; OCP; Rabbit; Tetrabone (R); beta-TCP granules	SYNTHETIC OCTACALCIUM PHOSPHATE; ALPHA-TRICALCIUM; HYDROXYAPATITE; TCP; OSTEOCONDUCTIVITY; REGENERATION; DEGRADATION; PARTICLES; MARROW; MODEL	Tetrabone(A (R)) is a newly developed granular artificial bone. The 1-mm Tetrabone(A (R)) has a four-legged structure. In this study, the long-term effect of implanting Tetrabone(A (R)) or beta-TCP granules in rabbit femoral cylindrical defects was evaluated. The rabbits were euthanized at 4, 13, and 26 weeks after implantation. Micro-CT was conducted to evaluate the residual material volume and the non-osseous tissue volume. New bone tissue areas were measured by histological analysis. Micro-CT imaging showed that the residual material volume in the beta-TCP group had decreased significantly at 4 weeks after implantation (P < 0.05) and that the beta-TCP granules had nearly disappeared at 26 weeks after implantation. In the Tetrabone(A (R)) group, it did not significantly change until 13 weeks after implantation; it then continued to decrease slightly until 26 weeks after implantation. The non-osseous volume increased in the beta-TCP group, whereas that of the Tetrabone(A (R)) group decreased (P < 0.05). Histological examination showed that the new bone areas were significantly greater in the Tetrabone(A (R)) group than in the beta-TCP group at 13 and 26 weeks. In conclusion, resorption of beta-TCP granules occurs before sufficient bone formation, thereby allowing non-osseous tissue invasion. Tetrabone(A (R)) resorption progressed slowly while the new bone tissues were formed, thus allowing better healing. Tetrabone(A (R)) showed better osteoconductivity, whereas the beta-TCP granules lost their function over a long duration. These results may be caused by the differences in the absorption rate of the granules, intergranular pore structure, and crystallinity of each granule.	[Choi, Sungjin; Liu, I-Li; Honnami, Muneki; Echigo, Ryosuke; Nishimura, Ryouhei; Sasaki, Nobuo; Mochizuki, Manabu] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Surg, Bunkyo Ku, Tokyo 1138657, Japan; [Choi, Sungjin; Yamamoto, Kenichi; Ohba, Shinsuke; Chung, Ung-il] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 1130033, Japan; [Honnami, Muneki; Sakai, Takamasa; Igawa, Kazuyo; Chung, Ung-il] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1130033, Japan; [Suzuki, Shigeki] NEXT21 KK, Bunkyo Ku, Tokyo 1130033, Japan	Mochizuki, M (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Surg, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	amm@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS); Japan Society for the Promotion of Science (JSPS) through the Center for Medical System Innovation (CMSI); Japan Society for the Promotion of Science (JSPS) through the International Core Research Center for Nanobio, Core-to-Core Program; Japan Society for the Promotion of Science (JSPS) through the A. Advanced Research Networks; Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) through the Center for NanoBio Integration (CNBI); Japan Science and Technology Agency (JST); New Energy and Industrial Technology Development Organization (NEDO)	This work was supported by the Japan Society for the Promotion of Science (JSPS) through the Grants-in-Aid for Scientific Research, the Center for Medical System Innovation (CMSI), the Graduate Program for Leaders in Life Innovation (GPLLI), the International Core Research Center for Nanobio, Core-to-Core Program, A. Advanced Research Networks and the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program); the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) through the Center for NanoBio Integration (CNBI); and the Japan Science and Technology Agency (JST) through the S-innovation program and Research and Development Programs for 3-D Complex Organ Structures and for Autonomous Regeneration Device from the New Energy and Industrial Technology Development Organization (NEDO).	Chai YC, 2012, BIOMATERIALS, V33, P4044, DOI 10.1016/j.biomaterials.2012.02.026; Field JR, 2009, VET COMP ORTHOPAED, V22, P87, DOI 10.3415/VCOT-08-02-0019; Weijs WLJ, 2010, INT J ORAL MAX SURG, V39, P424, DOI 10.1016/j.ijom.2010.02.004; Walsh WR, 2008, BIOMATERIALS, V29, P266, DOI 10.1016/j.biomaterials.2007.09.035; Paul W, 1999, J MATER SCI-MATER M, V10, P383, DOI 10.1023/A:1008918412198; BROWN WE, 1962, NATURE, V196, P1050, DOI 10.1038/1961050a0; Chazono M, 2004, J BIOMED MATER RES A, V70A, P542, DOI 10.1002/jbm.a.30094; Suzuki O, 2006, J BIOMED MATER RES B, V77B, P201, DOI 10.1002/jbm.b.30407; Imaizumi H, 2006, CALCIFIED TISSUE INT, V78, P45, DOI 10.1007/s00223-005-0170-0; Zerbo IR, 2005, BIOMATERIALS, V26, P1445, DOI 10.1016/j.biomaterials.2004.05.003; Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259; Suzuki O, 2006, BIOMATERIALS, V27, P2671, DOI 10.1016/j.boimaterials.2005.12.004; Kamakura S, 2007, J BIOMED MATER RES A, V83A, P725, DOI 10.1002/jbm.a.31332; Meleo D, 2012, ANN I SUPER SANITA, V48, P59, DOI 10.4415/ANN_12_01_10; Oonishi H, 1999, J BIOMED MATER RES, V44, P31, DOI 10.1002/(SICI)1097-4636(199901)44:1<31::AID-JBM4>3.0.CO;2-9; [Anonymous], 2002, CLIN ORFHOP REL RES, DOI DOI 10.1097/00003086-200202000-00009; Rojbani H, 2011, J BIOMED MATER RES A, V98A, P488, DOI 10.1002/jbm.a.33117; Kihara H, 2006, J BIOMED MATER RES B, V79B, P284, DOI 10.1002/jbm.b.30540; Kurashina K, 2002, BIOMATERIALS, V23, P407, DOI 10.1016/S0142-9612(01)00119-3; Wiltfang J, 2002, J BIOMED MATER RES, V63, P115, DOI 10.1002/jbm.10084; Chawla K, 2011, QUINTESSENCE INT, V42, P291; Choi S, 2012, ACTA BIOMATER, V8, P2340, DOI 10.1016/j.actbio.2012.02.019; De Groot K, 1988, Ann N Y Acad Sci, V523, P227; Garrido C. A., 2011, INT J BIOMATER, V2011; Hirota M, 2009, DENT MATER J, V28, P153; Kamakura S, 2002, J BIOMED MATER RES, V59, P29, DOI 10.1002/jbm.1213.abs; Kamakura S, 2001, ORAL DIS, V7, P259, DOI 10.1034/j.1601-0825.2001.70410.x; Kikawa T, 2009, ACTA BIOMATER, V5, P1756, DOI 10.1016/j.actbio.2008.12.008; Kondo N, 2005, BIOMATERIALS, V26, P5600, DOI 10.1016/j.biomaterials.2005.02.026; Merten HA, 2001, J CRANIOFAC SURG, V12, P59, DOI 10.1097/00001665-200101000-00010; Miyatake N, 2009, BIOMATERIALS, V30, P1005, DOI 10.1016/j.biomaterials.2008.10.058; Shelton RM, 2006, BIOMATERIALS, V27, P2874, DOI 10.1016/j.biomaterials.2005.12.031; Wu CC, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/3/035009	33	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2014	17	4					344	351		10.1007/s10047-014-0778-9		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	AW0FK	WOS:000345966200008		
J	Morimoto, N; Kakudo, N; Notodihardjo, PV; Suzuki, S; Kusumoto, K				Morimoto, Naoki; Kakudo, Natsuko; Notodihardjo, Priscilla Valentin; Suzuki, Shigehiko; Kusumoto, Kenji			Comparison of neovascularization in dermal substitutes seeded with autologous fibroblasts or impregnated with bFGF applied to diabetic foot ulcers using laser Doppler imaging	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Artificial dermis; Fibroblasts; Basic fibroblast growth factor; Laser Doppler imaging	GROWTH-FACTOR; ARTIFICIAL-DERMIS; SUSTAINED-RELEASE; CLINICAL-TRIAL; SKIN ULCERS; EFFICACY; LEG; RECONSTRUCTION; SCAFFOLD; SAFETY	A bilayered artificial dermis (AD) composed of an upper silicone sheet and a lower collagen sponge has been widely applied for skin defects. After application, fibroblasts and capillaries infiltrate the AD and the collagen sponge is replaced by host dermal tissue within a few weeks. However, this delay and the high incidence of infection are concerns regarding the use of AD in the treatment of chronic ulcers. In this study, we compared the neovascularization of conventional AD seeded with autologous fibroblasts (cultured dermis: CD) and collagen/gelatin sponge (CGS), which is a novel artificial dermis capable of sustained release of basic fibroblast growth factor (bFGF) after application using laser Doppler imaging (LDI). CD (n = 5) and CGS impregnated with bFGF (n = 6) were applied to diabetic foot ulcers after debridement. Perfusion units (PUs) were measured just after, and 1, 2 and 3 weeks after application, and complete healing rates within 16 weeks were compared. No significant differences in PUs were seen 1, 2 and 3 weeks after application and in healing rates within 16 weeks between the two groups. This study suggested that CD and CGS treatments were effective, but there were no significant differences between them in the treatment of diabetic ulcers .	[Morimoto, Naoki; Kakudo, Natsuko; Notodihardjo, Priscilla Valentin; Kusumoto, Kenji] Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka 5731010, Japan; [Suzuki, Shigehiko] Kyoto Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kyoto, Japan	Morimoto, N (reprint author), Kansai Med Univ, Dept Plast & Reconstruct Surg, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan.	morimotn@hirakata.kmu.ac.jp; kakudon@hirakata.kmu.ac.jp					Monstrey SM, 2011, BURNS, V37, P249, DOI 10.1016/j.burns.2010.08.013; Momoh AO, 2009, ANN PLAS SURG, V62, P656, DOI 10.1097/SAP.0b013e318180c913; Uchi H, 2009, EUR J DERMATOL, V19, P461, DOI 10.1684/ejd.2009.0750; Vuorisalo S, 2009, J CARDIOVASC SURG, V50, P275; Yannas IV, 2013, BIOMATERIALS, V34, P321, DOI 10.1016/j.biomaterials.2012.10.006; Takemoto S, 2008, TISSUE ENG PT A, V14, P1629, DOI 10.1089/ten.tea.2007.0215; Morimoto N, 2013, TISSUE ENG PT A, V19, P1931, DOI [10.1089/ten.TEA.2012.0634, 10.1089/ten.tea.2012.0634]; Ito K, 2005, PLAST RECONSTR SURG, V115, P567, DOI 10.1097/01.PRS.0000149485.60638.30; Senet P, 2011, ARCH DERMATOL, V147, P926, DOI 10.1001/archdermatol.2011.84; Langer A, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-115; Riordan CL, 2003, J BURN CARE REHABIL, V24, P177, DOI 10.1097/01.BCR.0000075966.50533.B0; Marston WA, 2003, DIABETES CARE, V26, P1701, DOI 10.2337/diacare.26.6.1701; Singh N, 2005, JAMA-J AM MED ASSOC, V293, P217, DOI 10.1001/jama.293.2.217; Ehrenreich M, 2006, TISSUE ENG, V12, P2407, DOI 10.1089/ten.2006.12.2407; Cavorsi J, 2006, WOUND REPAIR REGEN, V14, P102, DOI 10.1111/j.1743-6109.2006.00098.x; Dinh TL, 2006, PLAST RECONSTR SURG, V117, p152S, DOI 10.1097/01.prs.0000222534.79915.d3; Kanda N, 2014, J TISSUE ENG REGEN M, V8, P29, DOI 10.1002/term.1492; Morimoto N, 2014, ANN PLAS SURG, V72, P84, DOI 10.1097/SAP.0b013e3182590948; Morimoto N, 2014, INT WOUND J, V11, P183, DOI 10.1111/j.1742-481X.2012.01064.x; Morimoto N, 2011, J SURG RES, V171, P339, DOI 10.1016/j.jss.2009.11.724; Suzuki S, 1996, Tissue Eng, V2, P267, DOI 10.1089/ten.1996.2.267; Tuyet Hoa Le, 2009, Int Wound J, V6, P159, DOI 10.1111/j.1742-481X.2009.00594.x; Yamada N, 2008, J ARTIF ORGANS, V11, P100, DOI 10.1007/s10047-008-0406-7	23	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2014	17	4					352	357		10.1007/s10047-014-0782-0		6	Engineering, Biomedical; Transplantation	Engineering; Transplantation	AW0FK	WOS:000345966200009		
J	Nakahara, I; Takao, M; Bandoh, S; Sugano, N				Nakahara, Ichiro; Takao, Masaki; Bandoh, Shunichi; Sugano, Nobuhiko			Fixation strength of taper connection at head-neck junction in retrieved carbon fiber-reinforced PEEK hip stems	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Carbon-fiber-reinforced PEEK; Hip stem; Ceramic head; Head-neck taper junction; Pull-off strength	ORTHOPEDIC IMPLANTS; PROSTHESIS DESIGN; FEMORAL COMPONENT; METAL; ARTHROPLASTY; COMPOSITE; INTERFACE; CORROSION; POLYETHERETHERKETONE; BIOCOMPATIBILITY	Carbon fiber-reinforced polyetheretherketone (CFR-PEEK) hip prostheses possess numerous advantages over metal prostheses; however, the security of the taper connection between the CFR-PEEK stem and the modular femoral head in vivo has not been verified. Therefore, we mechanically examined the taper connection of retrieved in vivo loaded CFR-PEEK stems in comparison with in vivo loaded titanium alloy stems. CFR-PEEK and titanium alloy femoral stems with a 12/14 taper trunnion were implanted in ovine hips. A 22-mm ceramic head was intraoperatively impacted to the stem. Retrieved specimens were obtained following weight-bearing conditions for up to 39 postoperative weeks and taper junction pull-off tests were conducted. Postoperative retrieved CFR-PEEK stem pull-off strength was significantly greater than that at time zero. Postoperative retrieved CFR-PEEK stem pull-off strength was also significantly higher than that of postoperative retrieved titanium alloy stem. Microscopic findings of the taper surface revealed no obvious damage in the retrieved CFR-PEEK stems, whereas fretting and corrosion were observed in the retrieved titanium alloy stems. The present findings suggest that the taper connection between the ceramic head and the 12/14 CFR-PEEK stem trunnion is more secure than that between the ceramic head and the titanium alloy trunnion.	[Nakahara, Ichiro] Osaka Natl Hosp, Dept Orthopaed Surg, Chuo Ku, Osaka 5400006, Japan; [Takao, Masaki; Sugano, Nobuhiko] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka 5650871, Japan; [Bandoh, Shunichi] BITEC Co Ltd, Kakamigahara, Japan; [Sugano, Nobuhiko] Osaka Univ, Grad Sch Med, Dept Orthopaed Med Engn, Suita, Osaka 5650871, Japan	Nakahara, I (reprint author), Osaka Natl Hosp, Dept Orthopaed Surg, Chuo Ku, 2-1-14 Hoenzaka, Osaka 5400006, Japan.	ichiro-n@umin.net; n-sugano@umin.net					Rehmer A, 2012, CLIN BIOMECH, V27, P77, DOI 10.1016/j.clinbiomech.2011.08.002; BURSTEIN AH, 1985, J BONE JOINT SURG AM, V67A, P497; MORRISON C, 1995, BIOMATERIALS, V16, P987, DOI 10.1016/0142-9612(95)94906-2; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P1011, DOI 10.1302/0301-620X.93B8.26040; Pandit H, 2008, J BONE JOINT SURG BR, V90B, P847, DOI 10.1302/0301-620X.90B7.20213; Yildiz H, 1998, J BIOMED MATER RES, V39, P92, DOI 10.1002/(SICI)1097-4636(199801)39:1<92::AID-JBM12>3.0.CO;2-Q; Goldberg JR, 2002, CLIN ORTHOP RELAT R, P149; WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207; Cooper HJ, 2012, J BONE JOINT SURG AM, V94A, P1655, DOI 10.2106/JBJS.K.01352; LIEBERMAN JR, 1994, CLIN ORTHOP RELAT R, P162; Yildiz H, 1998, J BIOMED MATER RES, V39, P102, DOI 10.1002/(SICI)1097-4636(199801)39:1<102::AID-JBM13>3.0.CO;2-H; Heiney JP, 2009, ARCH ORTHOP TRAUM SU, V129, P793, DOI 10.1007/s00402-008-0660-4; GILBERT JL, 1994, J BONE JOINT SURG AM, V76A, P110; McCarthy JC, 1997, CLIN ORTHOP RELAT R, P162; Willert HG, 2005, J BONE JOINT SURG AM, V87A, P28, DOI 10.2106/JBJS.A.02039pp; Hennessy DW, 2009, CLIN ORTHOP RELAT R, V467, P2290, DOI 10.1007/s11999-009-0831-9; Cook RB, 2013, J ARTHROPLASTY, V28, P1430, DOI 10.1016/j.arth.2013.02.009; Nassutt R, 2006, BIOMED TECH, V51, P103, DOI 10.1515/BMT.2006.018; [Anonymous], 2003, 720610 ISO; Thyssen JP, 2009, ACTA ORTHOP, V80, P646, DOI 10.3109/17453670903487008; BARRACK RL, 1993, J BONE JOINT SURG BR, V75, P688; Cales B, 1998, J BIOMED MATER RES, V43, P62, DOI 10.1002/(SICI)1097-4636(199821)43:1<62::AID-JBM7>3.0.CO;2-K; COLLIER JP, 1991, CLIN ORTHOP RELAT R, P305; COLLIER JP, 1995, CLIN ORTHOP RELAT R, P91; Gotze C, 2006, ARCH ORTHOP TRAUM SU, V126, P28, DOI 10.1007/s00402-005-0064-7; Kishida Y, 2002, J ARTHROPLASTY, V17, P1021, DOI 10.1054/arth.2002.35822; Krüger T, 1998, Aktuelle Radiol, V8, P81; MAHARAJ G, 1994, BIO-MED MATER ENG, V4, P193; PELLICCI PM, 1990, J BONE JOINT SURG AM, V72A, P619; Pennock AT, 2002, J ARTHROPLASTY, V17, P773, DOI 10.1054/arth.2002.33565; Ramirez MA, 2007, J BONE JOINT SURG AM, V89A, P742, DOI 10.2106/JBJS.F.00570; SKINNER HB, 1988, CLIN ORTHOP RELAT R, P224; WOOLSON ST, 1990, J BONE JOINT SURG AM, V72A, P624; Zhang GG, 1996, BIOMATERIALS, V17, P781, DOI 10.1016/0142-9612(96)81415-3	34	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2014	17	4					358	363		10.1007/s10047-014-0789-6		6	Engineering, Biomedical; Transplantation	Engineering; Transplantation	AW0FK	WOS:000345966200010		
J	Kashiyama, N; Toda, K; Miyagawa, S; Nishi, H; Yoshikawa, Y; Fukushima, S; Yoshioka, D; Saito, T; Sawa, Y				Kashiyama, Noriyuki; Toda, Koichi; Miyagawa, Shigeru; Nishi, Hiroyuki; Yoshikawa, Yasushi; Fukushima, Satsuki; Yoshioka, Daisuke; Saito, Tetsuya; Sawa, Yoshiki			Initial experience of EVAHEART explantation after continuous-flow LVAD off test with percutaneous occlusion balloon	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Left ventricular assist device; LVAD off test; Explantation; EVAHEART	VENTRICULAR ASSIST DEVICE; MYOCARDIAL RECOVERY	In contrast to a pulsatile-flow left ventricular assist device (LVAD), an LVAD off test for evaluation of cardiac recovery with a continuous-flow device is difficult because of intra-circuit backflow from the outflow graft when a device is stopped. We report a case of reliable evaluation of cardiac recovery using balloon occlusion of the outflow graft, followed by successful removal of a continuous-flow EVAHEART LVAD using a minimally invasive approach.	[Kashiyama, Noriyuki; Toda, Koichi; Miyagawa, Shigeru; Nishi, Hiroyuki; Yoshikawa, Yasushi; Fukushima, Satsuki; Yoshioka, Daisuke; Saito, Tetsuya; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka 5650087, Japan	Sawa, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Yamadaoka 2-2, Suita, Osaka 5650087, Japan.	kashiyama0614@gmail.com; sawa-p@surg-1.med.osaka-u.ac.jp					Ando M, 2011, J ARTIF ORGANS, V14, P70, DOI 10.1007/s10047-010-0543-7; Kato TS, 2011, CIRC-HEART FAIL, V4, P546, DOI 10.1161/CIRCHEARTFAILURE.111.962142; Haj-Yahia S, 2008, J THORAC CARDIOV SUR, V135, P453, DOI 10.1016/j.jtcvs.2007.10.012; Potapov EV, 2011, J HEART LUNG TRANSPL, V30, P1300, DOI 10.1016/j.healun.2011.07.007; Yoshioka D, 2013, J ARTIF ORGANS, V16, P386, DOI 10.1007/s10047-013-0704-6	5	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2014	17	4					366	369		10.1007/s10047-014-0784-y		4	Engineering, Biomedical; Transplantation	Engineering; Transplantation	AW0FK	WOS:000345966200012		
J	Kishimoto, S; Date, K; Arakawa, M; Takewa, Y; Nishimura, T; Tsukiya, T; Mizuno, T; Katagiri, N; Kakuta, Y; Ogawa, D; Nishimura, M; Tatsumi, E				Kishimoto, Satoru; Date, Kazuma; Arakawa, Mamoru; Takewa, Yoshiaki; Nishimura, Takashi; Tsukiya, Tomonori; Mizuno, Toshihide; Katagiri, Nobumasa; Kakuta, Yukihide; Ogawa, Daisuke; Nishimura, Motonobu; Tatsumi, Eisuke			Influence of a novel electrocardiogram-synchronized rotational-speed-change system of an implantable continuous-flow left ventricular assist device (EVAHEART) on hemolytic performance	JOURNAL OF ARTIFICIAL ORGANS			English	Article						Hemolytic performance; Implantable left ventricular assist devices; Pulsatile flow; EVAHEART; Electrocardiogram-synchronized rotational-speed-change system	CENTRIFUGAL PUMP; PULSATILE MODE	We developed a novel controller for a continuous-flow left ventricular assist device (EVAHEART) that can change the pump's rotational speed (RS) in synchronization with a patient's myocardial electrocardiogram (ECG) with the aim of facilitating cardiac recovery. We previously presented various applications of this system in animal models, but there remained a concern that the repeated acceleration and deceleration of the impeller may induce additional hemolysis. In this study, we evaluated the blood trauma and motor power consumption induced by our system in a mock circulation. We evaluated our system with a 60-bpm pulse frequency and a variance between the high and low RSs of 500 rpm (EVA-P; n = 4). The continuous modes of EVAHEART (EVA-C; n = 4) and ROTAFLOW (n = 4) were used as controls. The pumps were examined at a mean flow rate of 5.0 +/- A 0.2 L/min against a mean pressure head of 100 +/- A 3 mmHg for a 4-h period. As a result, the normalized indexes of the hemolysis levels of EVA-P and EVA-C were 0.0023 +/- A 0.0019 and 0.0023 +/- A 0.0025, respectively, and their difference was not significant. The estimated mean motor power consumptions of EVA-C and EVA-P were 6.24 +/- A 0.33 and 7.19 +/- A 0.93 W, respectively. When a novel ECG-synchronized RS-change system was applied to EVAHEART, the periodic RS change with a 500-rpm RS variance did not affect the hemolysis at a 60-bpm pulse frequency.	[Kishimoto, Satoru; Date, Kazuma; Takewa, Yoshiaki; Tsukiya, Tomonori; Mizuno, Toshihide; Katagiri, Nobumasa; Kakuta, Yukihide; Tatsumi, Eisuke] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Artificial Organs, Suita, Osaka 5658565, Japan; [Kishimoto, Satoru; Nishimura, Motonobu] Tottori Univ, Div Surg, Dept Organ Regenerat Surg, Tottori 680, Japan; [Arakawa, Mamoru] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Saitama, Japan; [Nishimura, Takashi] Tokyo Metropolitan Geriatr Hosp, Dept Cardiovasc Surg, Tokyo 173, Japan; [Ogawa, Daisuke] Sun Med Technol Res Corp, Nagano, Japan	Kishimoto, S (reprint author), Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Artificial Organs, 5-7-1 Fujishiro Dai, Suita, Osaka 5658565, Japan.	kishimoto.satoru.ri@mail.ncvc.go.jp					Ando M, 2012, J THORAC CARDIOV SUR, V143, P1176, DOI 10.1016/j.jtcvs.2011.07.065; Ando M, 2011, J ARTIF ORGANS, V14, P185, DOI 10.1007/s10047-011-0573-9; Ando M, 2011, J ARTIF ORGANS, V14, P74, DOI 10.1007/s10047-010-0544-6; Ando M, 2011, ARTIF ORGANS, V35, P941, DOI 10.1111/j.1525-1594.2011.01205.x; Arakawa M, 2014, J THORAC CARDIOVASC, DOI [10.1016/j.jtcvs.2013.12.049, DOI 10.1016/J.JTCVS.2013.12.049.(EPUB]; Araki K., 1994, Japanese Journal of Artificial Organs, V23, P898; ASTM, 2005, F184191 ASTM; Kishimoto Y, 2013, J ARTIF ORGANS, V16, P129, DOI 10.1007/s10047-012-0685-x; Kono S, 1997, ASAIO J, V43, pM580; Sobieski MA, 2012, ARTIF ORGANS, V36, P677, DOI 10.1111/j.1525-1594.2012.01514.x; Tayama E, 1997, ARTIF ORGANS, V21, P657; Tayama E, 1997, ARTIF ORGANS, V21, P1284; Umeki A, 2012, J ARTIF ORGANS, V15, P128, DOI 10.1007/s10047-011-0615-3; Umeki A, 2013, CIRC J, V77, P995, DOI 10.1253/circj.CJ-12-0676; Yamazaki Kenji, 2002, Jpn J Thorac Cardiovasc Surg, V50, P461, DOI 10.1007/BF02919636	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1434-7229	1619-0904		J ARTIF ORGANS	J. Artif. Organs	DEC	2014	17	4					373	377		10.1007/s10047-014-0787-8		5	Engineering, Biomedical; Transplantation	Engineering; Transplantation	AW0FK	WOS:000345966200014		
J	Yang, QY; Santosh, M; Tsunogae, T				Yang, Qiong-Yan; Santosh, M.; Tsunogae, Toshiaki			Ultrahigh-temperature metamorphism under isobaric heating: New evidence from the North China Craton	JOURNAL OF ASIAN EARTH SCIENCES			English	Article						Ultrahigh-temperature metamorphism; Petrology; Zircon geochronology; Hf isotope; North China Craton	EXTREME CRUSTAL METAMORPHISM; PLASMA-MASS SPECTROMETRY; PB ZIRCON GEOCHRONOLOGY; PLUS QUARTZ ASSEMBLAGE; MONGOLIA SUTURE ZONE; U-PB; KHONDALITE BELT; WESTERN BLOCK; INNER-MONGOLIA; ICP-MS	The Khondalite Belt within Inner Mongolia Suture Zone (IMSZ) in the North China Craton (NCC) preserves evidence for extreme crustal metamorphism under ultra-high temperature (UHT) conditions at ca. 1.92 Ga, associated with the subduction-collision tectonics between the Yinshan and Ordos Blocks. Here we report a new locality in Hongsigou where cordierite- and spinel-bearing granulites record UHT metamorphism. The prograde, peak, and retrograde mineral assemblages in these pelitic granulites have been identified based on petrography and mineral chemistry as: Bt(1) + Grt(1) + Sil(1) + Kfs(1) + Pl(1) + Ilm + Grt(1) + Sil(2) + Kfs(2) + Pl(2) + Spl + Ilm + Qtz(2) + Liq, and Crd + Grt(2) + Sil(3) + Kfs(2) + Pl(2) + Ilm + Qtz(2) respectively. The peak metamorphic conditions of the pelitic granulite were estimated as 930-1050 degrees C and 6.5-7.5 kbar based on pseudosection analysis in the system NCKFMASHTO, suggesting extreme thermal metamorphism. We report LA-ICPMS zircon U-Pb data from the granulite which show weighted mean Pb-207/Pb-206 age of 1881 +/- 6.6 Ma, marking the timing of UHT metamorphism. Lu-Hf analyses of the zircons show epsilon(Hf)(t) values within a restricted range of -4.2 to 0.3 and together with Hf model ages, a Paleoproterozoic arc magmatic source is inferred for the detrital zircons. The estimated P-T path for the UHT granulite suggests isobaric heating followed by cooling and decompression along a clockwise trajectory, different from the anti-clockwise P-T paths defined in earlier studies for the 1.92 Ga UHT rocks from the IMSZ. The younger age and the isobaric heating trajectory suggest that the Hongsigou UHT rocks are related to heat input from underplated mafic magmas following continental collision. (C) 2014 Elsevier Ltd. All rights reserved.	[Yang, Qiong-Yan; Santosh, M.] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Santosh, M.] Kochi Univ, Fac Sci, Kochi 7808520, Japan; [Tsunogae, Toshiaki] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058572, Japan; [Tsunogae, Toshiaki] Univ Johannesburg, Dept Geol, Auckland 2006, New Zealand	Yang, QY (reprint author), China Univ Geosci, Sch Earth Sci & Resources, 29 Xueyuan Rd, Beijing 100083, Peoples R China.	qyyang1004@126.com	Santosh, M/B-2563-2012		Chinese Government; Japan Society for the Promotion of Science (JSPS) [22403017]	We thank Prof. Sanghoon Kwon, Guest Editor, and two referees for constructive comments which greatly helped in improving our work. This work forms part of the PhD research of Q.Y. Yang at the China University of Geosciences Beijing. This study also contributes to the Talent Award to M. Santosh under the 1000 Talents Plan of the Chinese Government. Partial funding for this project was provided by a Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science (JSPS) to Tsunogae (No. 22403017).	Zhao GC, 2002, EARTH-SCI REV, V59, P125, DOI 10.1016/S0012-8252(02)00073-9; Santosh M, 2007, GONDWANA RES, V11, P263, DOI 10.1016/j.gr.2006.10.009; Griffin WL, 2002, LITHOS, V61, P237, DOI 10.1016/S0024-4937(02)00082-8; HOLLAND TJB, 1990, J METAMORPH GEOL, V8, P89, DOI 10.1111/j.1525-1314.1990.tb00458.x; Wu FY, 2007, ACTA PETROL SIN, V23, P185; Jiao SJ, 2013, J PETROL, V54, P1725, DOI 10.1093/petrology/egt029; Harley SL, 1998, GEOL SOC SPEC PUBL, V138, P81, DOI 10.1144/GSL.SP.1996.138.01.06; Vervoort JD, 1996, GEOCHIM COSMOCHIM AC, V60, P3717, DOI 10.1016/0016-7037(96)00201-3; Santosh M, 2007, PRECAMBRIAN RES, V159, P178, DOI 10.1016/j.precamres.2007.06.006; Santosh M, 2008, GONDWANA RES, V13, P86, DOI 10.1016/j.gr.2007.07.003; Maruyama S, 2010, GONDWANA RES, V18, P106, DOI 10.1016/j.gr.2010.03.007; Zhao GC, 2009, ACTA PETROL SIN, V25, P1772; Xia XP, 2006, PRECAMBRIAN RES, V144, P199, DOI 10.1016/j.precamres.2005.11.004; Santosh M, 2009, J GEOL, V117, P429, DOI 10.1086/598949; Santosh M, 2009, LITHOS, V110, P140, DOI 10.1016/j.lithos.2008.12.010; Santosh M, 2012, PRECAMBRIAN RES, V222, P77, DOI 10.1016/j.precamres.2011.05.003; Harley SL, 2008, J METAMORPH GEOL, V26, P125, DOI 10.1111/j.1525-1314.2008.00765.x; Jiao SJ, 2011, AM MINERAL, V96, P250, DOI 10.2138/am.2011.3500; Rogers JJW, 2009, GONDWANA RES, V15, P373, DOI 10.1016/j.gr.2008.06.008; Morimoto T, 2004, J MINER PETROL SCI, V99, P257, DOI 10.2465/jmps.99.257; Holland T, 2003, CONTRIB MINERAL PETR, V145, P492, DOI 10.1007/s00410-003-0464-z; Wu CH, 2006, ACTA PETROL SIN, V22, P2639; Chu NC, 2002, J ANAL ATOM SPECTROM, V17, P1567, DOI 10.1039/b206707b; Andersen T, 2002, CHEM GEOL, V192, P59, DOI 10.1016/S0009-2541(02)00195-X; Hoskin PWO, 2003, REV MINERAL GEOCHEM, V53, P27, DOI 10.2113/0530027; Woodhead J, 2004, CHEM GEOL, V209, P121, DOI 10.1016/j.chemgeo.2004.04.026; Geng YS, 2012, GONDWANA RES, V21, P517, DOI 10.1016/j.gr.2011.07.006; Santosh M, 2013, PRECAMBRIAN RES, V227, P29, DOI 10.1016/j.precamres.2011.11.004; Liu S, 2011, GEOL J, V46, P263, DOI 10.1002/gj.1247; Zhang HF, 2013, GONDWANA RES, V23, P95, DOI 10.1016/j.gr.2011.12.006; Wan YS, 2006, PRECAMBRIAN RES, V149, P249, DOI 10.1016/j.precamres.2006.06.006; Amelin Y, 2000, GEOCHIM COSMOCHIM AC, V64, P4205, DOI 10.1016/S0016-7037(00)00493-2; NICHOLS GT, 1992, CONTRIB MINERAL PETR, V111, P362, DOI 10.1007/BF00311197; Yuan HL, 2004, GEOSTAND GEOANAL RES, V28, P353, DOI 10.1111/j.1751-908X.2004.tb00755.x; Shimizu H, 2013, GEOL J, V48, P456, DOI 10.1002/gj.2504; Yuan HL, 2008, CHEM GEOL, V247, P100, DOI 10.1016/j.chemgeo.2007.10.003; Liu SJ, 2010, CONTRIB MINERAL PETR, V159, P225, DOI 10.1007/s00410-009-0425-2; White RW, 2007, J METAMORPH GEOL, V25, P511, DOI 10.1111/j.1525-1314.2007.00711.x; Gerya T, 2014, GONDWANA RES, V25, P439, DOI 10.1016/j.gr.2013.08.006; Sajeev K, 2006, LITHOS, V92, P465, DOI 10.1016/j.lithos.2006.03.059; Jiao SJ, 2011, CONTRIB MINERAL PETR, V162, P379, DOI 10.1007/s00410-010-0602-3; Powell R, 1999, AM MINERAL, V84, P1; Black LP, 2003, CHEM GEOL, V200, P155, DOI 10.1016/S0009-2541(03)00165-7; Song BA, 1996, PRECAMBRIAN RES, V78, P79, DOI 10.1016/0301-9268(95)00070-4; Zhai MG, 2011, GONDWANA RES, V20, P6, DOI 10.1016/j.gr.2011.02.005; Santosh M, 2006, GONDWANA RES, V10, P256, DOI 10.1016/j.gr.2006.06.005; Xia XP, 2008, AM J SCI, V308, P304, DOI 10.2475/03.2008.05; Griffin WL, 2000, GEOCHIM COSMOCHIM AC, V64, P133, DOI 10.1016/S0016-7037(99)00343-9; Tsunogae T, 2011, GONDWANA RES, V20, P36, DOI 10.1016/j.gr.2011.03.001; Yin CQ, 2009, PRECAMBRIAN RES, V174, P78, DOI 10.1016/j.precamres.2009.06.008; Yin CQ, 2011, LITHOS, V122, P25, DOI 10.1016/j.lithos.2010.11.010; Kelsey DE, 2008, GONDWANA RES, V13, P1, DOI 10.1016/j.gr.2007.06.001; Santosh M, 2008, EARTH PLANET SC LETT, V266, P149, DOI 10.1016/j.epsl.2007.10.058; Xia XP, 2006, EARTH PLANET SC LETT, V241, P581, DOI 10.1016/j.epsl.2005.11.024; BlichertToft J, 1997, EARTH PLANET SC LETT, V148, P243, DOI 10.1016/S0012-821X(97)00040-X; LIU DY, 1992, GEOLOGY, V20, P339, DOI 10.1130/0091-7613(1992)020<0339:ROMCIT>2.3.CO;2; Zhang HF, 2012, GONDWANA RES, V22, P73, DOI 10.1016/j.gr.2011.08.011; Harley SL, 2004, J MINER PETROL SCI, V99, P140, DOI 10.2465/jmps.99.140; White RW, 2003, J PETROL, V44, P1937, DOI 10.1093/petrology/egg065; Scherer E, 2001, SCIENCE, V293, P683, DOI 10.1126/science.1061372; Santosh M, 2010, PRECAMBRIAN RES, V178, P149, DOI 10.1016/j.precamres.2010.02.003; White RW, 2000, J METAMORPH GEOL, V18, P497; Zhao GC, 2005, PRECAMBRIAN RES, V136, P177, DOI 10.1016/j.precamres.2004.10.002; Liu SJ, 2012, LITHOS, V148, P54, DOI 10.1016/j.lithos.2012.05.024; Brown M, 2007, EARTH SCI FRONTIERS, V14, P1, DOI DOI 10.1016/S1872-5791(07)60001-3; Cutts KA, 2013, GONDWANA RES, V23, P617, DOI 10.1016/j.gr.2012.04.009; DeBievre P., 1993, J MASS SPECTROM, P123; Guo J.H., 2011, INT C CRAT FORM DEST, P36; Guo J.H., 2006, ABSTRACT VOLUME PETR, P215; Liu JZ, 2000, ACTA PETROL SIN, V16, P245; Nutman A.P., 2013, GEOSCI FRONT; POWELL R, 1988, J METAMORPH GEOL, V6, P173, DOI 10.1111/j.1525-1314.1988.tb00415.x; Sajeev K, 2006, LITHOS, V92, pV, DOI 10.1016/j.lithos.2006.03.048; Shimizu H, 2009, J ASIAN EARTH SCI, V36, P209, DOI 10.1016/j.jseaes.2009.06.005; Shimizu S., 2013, GEOSCI FRONT, V4, P655; Spear F., 1993, METAMORPHIC PHASE EQ; Tsunogae T, 2011, GEOL J, V46, P183, DOI 10.1002/gj.1244; Tsunogae T, 2002, CONTRIB MINERAL PETR, V143, P279, DOI 10.1007/s00410-001-0343-4; Zhang H.-F., 2011, GONDWANA RES; Zhang H.T., 2012, GEOSCIENCE FRONTIERS, V3, P603	80	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1367-9120	1878-5786		J ASIAN EARTH SCI	J. Asian Earth Sci.	DEC 1	2014	95				SI		2	16		10.1016/j.jseaes.2014.01.018		15	Geosciences, Multidisciplinary	Geology	AW6SJ	WOS:000346398400002		
J	Koizumi, T; Tsunogae, T; Santosh, M; Tsutsumi, Y; Chetty, TRK; Saitoh, Y				Koizumi, Tatsuya; Tsunogae, Toshiaki; Santosh, M.; Tsutsumi, Yukiyasu; Chetty, T. R. K.; Saitoh, Yohsuke			Petrology and zircon U-Pb geochronology of metagabbros from a mafic-ultramafic suite at Aniyapuram: Neoarchean to Early Paleoproterozoic convergent margin magmatism and Middle Neoproterozoic high-grade metamorphism in southern India	JOURNAL OF ASIAN EARTH SCIENCES			English	Article						Aniyapuram Ophiolite Complex; Metamorphic history; Clockwise P-T path; Pseudosection; Zircon geochronology; Tectonics	CAUVERY SHEAR ZONE; ULTRAHIGH-TEMPERATURE METAMORPHISM; PLAGIOCLASE-QUARTZ GEOBAROMETERS; COEXISTING GARNET; HIGH-PRESSURE; CRUSTAL EVOLUTION; MASS-SPECTROMETRY; GONDWANA SUTURE; SALEM BLOCK; ICP-MS	Several mafic-ultramafic complexes occur within the Palghat-Cauvery Suture Zone (PCSZ) in southern India. The PCSZ is regarded in recent models as the zone along which crustal blocks were amalgamated during the Late Neoproterozoic-Cambrian (550-530 Ma) Gondwana assembly. Here we report petrologic and zircon U-Pb geochronologic data from gabbros associated with the Aniyapuram mafic-ultramafic suite in the central domain of the PCSZ. Geothermobarometry and pseudosection approach in the system NCFMASHTO for the metagabbro (Grt + Cpx + Opx + Hbl + Pl + Qtz + Ilm + Rt) yield peak P-T condition of 9.8-10.6 kbar and 730-790 degrees C, which was followed by decompression to 6.5-8.0 kbar and ca. 750 degrees C as inferred from the formation of Opx + Pl symplectite around garnet, probably along a clockwise P-T path. Zircon U-Pb data analyzed by LA-ICP-MS plot along a well-defined discordia with upper and lower intercepts in the concordia at 2436 +/- 22 Ma and 731 +/- 11 Ma respectively, suggesting Neoarchean-Early Paleoproterozoic magmatic emplacement of the protolith and progressive Pb loss related to the Middle Neoproterozoic (Cryogenian) thermal event (or high-grade metamorphism). These results closely compare with the available Neoarchean magmatic ages of mafic-ultramafic complexes (e.g., Sittampundi, Devanur, Agali Hills, and Kanja Malai) and Middle Neoproterozoic magmatic event (e.g., Manamedu and Kadavur) in the PCSZ and adjacent granulite blocks. The 650 Ma concordia ages obtained from unzoned zircons might indicate the timing of high-grade metamorphism or post-peak hydration event. The P-T conditions obtained from Aniyapuram are significantly lower than the high-pressure and ultra-high-temperature conditions of the 550-530 Ma final collisional event (P > 14 kbar and T > 950 degrees C). The Middle Neoproterozoic (ca. 730 Ma or 650 Ma) high-grade metamorphism in Aniyapuram reported for the first time from the PCSZ is possibly associated with magmatism in arc tectonic setting. (C) 2014 Elsevier Ltd. All rights reserved.	[Koizumi, Tatsuya; Tsunogae, Toshiaki; Saitoh, Yohsuke] Univ Tsukuba, Fac Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan; [Tsunogae, Toshiaki] Univ Johannesburg, Dept Geol, Auckland 2006, New Zealand; [Santosh, M.] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Santosh, M.] Kochi Univ, Fac Sci, Kochi 7808520, Japan; [Tsutsumi, Yukiyasu] Natl Museum Nat & Sci, Dept Geol & Paleontol, Tsukuba, Ibaraki 3050005, Japan; [Chetty, T. R. K.] Natl Geophys Res Inst, CSIR, Hyderabad 500007, Andhra Pradesh, India	Tsunogae, T (reprint author), Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058572, Japan.	tsunogae@geol.tsukuba.ac.jp	Santosh, M/B-2563-2012		National Museum of Nature and Science; Japan Society for the Promotion of Science (JSPS) [22403017, 26302009]; Chinese Government	We thank Dr. Vinod O. Samuel and an anonymous reviewer for their constructive review comments, and Professors Sanghoon Kwon and Bor-ming Jahn for editorial handling. We also thank National Museum of Nature and Science for analytical facilities and support. This work was partly supported by a Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science (JSPS) to Tsunogae (Nos. 22403017 and 26302009). This study also contributes to the Talent Award to M. Santosh under the 1000 Talents Plan from the Chinese Government.	Santosh M, 2012, PRECAMBRIAN RES, V192-95, P190, DOI 10.1016/j.precamres.2011.10.025; ELLIS DJ, 1979, CONTRIB MINERAL PETR, V71, P13, DOI 10.1007/BF00371878; KRETZ R, 1983, AM MINERAL, V68, P277; Santosh M, 2013, PRECAMBRIAN RES, V231, P301, DOI 10.1016/j.precamres.2013.04.003; Chetty TRK, 2006, GONDWANA RES, V10, P77, DOI 10.1016/j.gr.2005.11.017; STACEY JS, 1975, EARTH PLANET SC LETT, V26, P207, DOI 10.1016/0012-821X(75)90088-6; Clark C, 2009, GONDWANA RES, V16, P27, DOI 10.1016/j.gr.2008.11.001; Clark C, 2009, PRECAMBRIAN RES, V174, P129, DOI 10.1016/j.precamres.2009.07.003; Holland T, 2003, CONTRIB MINERAL PETR, V145, P492, DOI 10.1007/s00410-003-0464-z; Santosh M, 2006, GONDWANA RES, V9, P261, DOI 10.1016/j.gr.2005.11.003; Yellappa T, 2010, J GEODYN, V50, P268, DOI 10.1016/j.jog.2009.12.004; Sajeev K, 2009, PRECAMBRIAN RES, V171, P23, DOI 10.1016/j.precamres.2009.03.001; Ganguly J, 1996, CONTRIB MINERAL PETR, V126, P137, DOI 10.1007/s004100050240; Sato K, 2011, J MINER PETROL SCI, V106, P1, DOI 10.2465/jmps.091222; PACES JB, 1993, J GEOPHYS RES-SOL EA, V98, P13997, DOI 10.1029/93JB01159; Chetty TRK, 2011, J ASIAN EARTH SCI, V42, P176, DOI 10.1016/j.jseaes.2011.02.009; Green E, 2007, AM MINERAL, V92, P1181, DOI 10.2138/am.2007.2401; White RW, 2007, J METAMORPH GEOL, V25, P511, DOI 10.1111/j.1525-1314.2007.00711.x; Santosh M, 2009, GONDWANA RES, V16, P321, DOI 10.1016/j.gr.2008.12.012; Leake BE, 1997, AM MINERAL, V82, P1019; Diener JFA, 2007, J METAMORPH GEOL, V25, P631, DOI 10.1111/j.1525-1314.2007.00720.x; Santosh M, 2003, GONDWANA RES, V6, P29, DOI 10.1016/S1342-937X(05)70643-2; DRURY SA, 1984, J GEOL, V92, P3; Ghosh JG, 2004, TECTONICS, V23, DOI 10.1029/2002TC001444; Yellappa T, 2012, GONDWANA RES, V21, P246, DOI 10.1016/j.gr.2011.05.003; Rubatto D, 2002, CHEM GEOL, V184, P123, DOI 10.1016/S0009-2541(01)00355-2; Nishimiya Y, 2010, LITHOS, V114, P490, DOI 10.1016/j.lithos.2009.10.012; Powell R, 1999, AM MINERAL, V84, P1; Collins AS, 2014, GONDWANA RES, V25, P190, DOI 10.1016/j.gr.2013.01.002; Saitoh Y, 2011, J ASIAN EARTH SCI, V42, P268, DOI 10.1016/j.jseaes.2010.11.015; Eggins SM, 1998, APPL SURF SCI, V127, P278, DOI 10.1016/S0169-4332(97)00643-0; Shimpo M, 2006, EARTH PLANET SC LETT, V242, P111, DOI 10.1016/j.epsl.2005.11.042; Mohan MR, 2013, GONDWANA RES, V23, P539, DOI 10.1016/j.gr.2012.04.004; ECKERT JO, 1991, AM MINERAL, V76, P148; Santosh M, 2006, GONDWANA RES, V10, P128, DOI 10.1016/j.gr.2005.12.005; Santosh M, 2010, TERRA NOVA, V22, P35, DOI 10.1111/j.1365-3121.2009.00914.x; Collins AS, 2007, PRECAMBRIAN RES, V155, P125, DOI 10.1016/j.precamres.2007.01.006; Collins AS, 2007, TERRA NOVA, V19, P141, DOI 10.1111/j.1365-3121.2007.00729.x; White RW, 2000, J METAMORPH GEOL, V18, P497; MOECHER DP, 1988, CONTRIB MINERAL PETR, V100, P92, DOI 10.1007/BF00399441; Teale W, 2011, J ASIAN EARTH SCI, V42, P223, DOI 10.1016/j.jseaes.2011.04.006; Sato K, 2011, J ASIAN EARTH SCI, V40, P162, DOI 10.1016/j.jseaes.2010.08.008; DAHL PS, 1980, AM MINERAL, V65, P854; GSI (Geological Survey of India), 1995, GEOL MIN MAP TAM NAD; Koshimoto S, 2004, J MINER PETROL SCI, V99, P298, DOI 10.2465/jmps.99.298; Ludwig K. R., 2003, BERKELEY GEOCHRONOLO; Nishimiya Y, 2008, J MINER PETROL SCI, V103, P354, DOI 10.2465/jmps.080617; PERKINS D, 1981, NATURE, V292, P144, DOI 10.1038/292144a0; POWELL R, 1985, J METAMORPH GEOL, V3, P231, DOI 10.1111/j.1525-1314.1985.tb00319.x; POWELL R, 1988, J METAMORPH GEOL, V6, P173, DOI 10.1111/j.1525-1314.1988.tb00415.x; Praveen M.N., 2013, GONDWANA RES; RAHEIM A, 1974, CONTRIB MINERAL PETR, V48, P179, DOI 10.1007/BF00383355; SANTOSH M., 2013, GONDWANA RES; Santosh M, 2010, CONTRIB MINERAL PETR, V159, P349, DOI 10.1007/s00410-009-0431-4; Tsutsumi Y., 2012, B NATL MUSEUM NATU C, V38, P15; Williams I. S., 1998, REV EC GEOLOGY, V7, P1; Yellappa T., 2014, J ASIAN EARTH SCI, V10	57	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1367-9120	1878-5786		J ASIAN EARTH SCI	J. Asian Earth Sci.	DEC 1	2014	95				SI		51	64		10.1016/j.jseaes.2014.04.013		14	Geosciences, Multidisciplinary	Geology	AW6SJ	WOS:000346398400005		
J	Yellappa, T; Venkatasivappa, V; Koizumi, T; Chetty, TRK; Santosh, M; Tsunogae, T				Yellappa, T.; Venkatasivappa, V.; Koizumi, T.; Chetty, T. R. K.; Santosh, M.; Tsunogae, T.			The mafic-ultramafic complex of Aniyapuram, Cauvery Suture Zone, southern India: Petrological and geochemical constraints for Neoarchean suprasubduction zone tectonics	JOURNAL OF ASIAN EARTH SCIENCES			English	Article						Aniyapuram Mafic-Ultramafic Complex; Cauvery Sutures Zone; Southern Granulite Terrain; Island arc magmatism; Suprasubduction zone ophiolite	U-PB GEOCHRONOLOGY; PODIFORM CHROMITE DEPOSITS; ISUA SUPRACRUSTAL BELT; NORTH CHINA CRATON; VOLCANIC-ROCKS; SHEAR ZONE; ARC MAGMATISM; CRUSTAL EVOLUTION; GRANULITE TERRANE; OPHIOLITE COMPLEX	Several Precambrian mafic-ultramafic complexes occur along the Cauvery Suture Zone (CSZ) in Southern Granulite Terrain, India. Their origin, magmatic evolution and relationship with the associated high-grade rocks have not been resolved. The Aniyapuram Mafic-Ultramafic Complex (AMUC), the focus of the present study in southern part of the CSZ, is dominantly composed of peridotites, pyroxenites, gabbros, metagabbros/mafic granulites, hornblendites, amphibolites, plagiogranites, felsic granulites and ferruginous cherts. The rock types in the AMUC are structurally emplaced within hornblende gneiss (TTG) basement rocks and are highly deformed. The geochemical signature of the amphibolites indicates tholeiitic affinity for the protolith with magma generation in island arc-setting. N-MORB normalized pattern of the amphibolites show depletion in HFS-elements (P, Zr, Sm, Ti, and Y) and enrichment of LIL-elements (Rb, Ba, Th, Sr) with negative Nb anomalies suggesting involvement of subduction component in the depleted mantle source and formation in a supra-subduction zone tectonic setting. Our new results when correlated with the available age data suggest that the lithological association of AMUC represent the remnants of the Neoarchean oceanic lithosphere. (C) 2014 Elsevier Ltd. All rights reserved.	[Yellappa, T.; Venkatasivappa, V.; Chetty, T. R. K.] CSIR Natl Geophys Res Inst, Hyderabad 500007, Andhra Pradesh, India; [Koizumi, T.; Tsunogae, T.] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki, Japan; [Santosh, M.] China Univ Geosci, Sch Earth Sci & Resources, Beijing, Peoples R China	Yellappa, T (reprint author), CSIR Natl Geophys Res Inst, Hyderabad 500007, Andhra Pradesh, India.	yellappa_thoti@yahoo.co.uk	Santosh, M/B-2563-2012		Chinese Government; CSIR-INDEX project work program [W.P.2.1]	We thank the handling guest editor and two anonymous referees for their constructive and helpful comments. The authors are grateful to Director, CSIR-NGRI, Hyderabad for providing facilities, encouragement and permission to publish this paper. We are thankful to our colleagues Dr. A. Keshav Krishna, Dr. M. Satyanarayanan and Dr. S.S. Savanth for their help in geochemical analysis. This work forms part of our international collaborative programs of AISRF-DST and CSIR-INDEX project work program (W.P.2.1). This work also contributes to the 1000 Talent Award to M. Santosh from the Chinese Government.	Pearce J, 1996, EPISODES, V19, P120; Santosh M, 2012, PRECAMBRIAN RES, V192-95, P190, DOI 10.1016/j.precamres.2011.10.025; BARKER F, 1976, GEOLOGY, V4, P596, DOI 10.1130/0091-7613(1976)4<596:GOTLAA>2.0.CO;2; Auge T, 2003, PRECAMBRIAN RES, V121, P85, DOI 10.1016/S0301-9268(02)00202-4; Santosh M, 2013, PRECAMBRIAN RES, V231, P301, DOI 10.1016/j.precamres.2013.04.003; Chetty TRK, 2006, GONDWANA RES, V10, P77, DOI 10.1016/j.gr.2005.11.017; PEARCE JA, 1979, CONTRIB MINERAL PETR, V69, P33, DOI 10.1007/BF00375192; Clark C, 2009, GONDWANA RES, V16, P27, DOI 10.1016/j.gr.2008.11.001; Noack NM, 2013, PRECAMBRIAN RES, V233, P206, DOI 10.1016/j.precamres.2013.04.018; PEARCE TH, 1977, EARTH PLANET SC LETT, V36, P121, DOI 10.1016/0012-821X(77)90193-5; Zhou MF, 2014, GONDWANA RES, V26, P262, DOI 10.1016/j.gr.2013.12.011; Samuel VO, 2014, PRECAMBRIAN RES, V245, P146, DOI 10.1016/j.precamres.2014.02.002; Chetty TRK, 2013, J ASIAN EARTH SCI, V78, P39, DOI 10.1016/j.jseaes.2013.02.021; PEARCE JA, 1984, J PETROL, V25, P956; Yellappa T, 2010, J GEODYN, V50, P268, DOI 10.1016/j.jog.2009.12.004; ALABASTER T, 1982, CONTRIB MINERAL PETR, V81, P168, DOI 10.1007/BF00371294; Sato K, 2011, J MINER PETROL SCI, V106, P1, DOI 10.2465/jmps.091222; ALDISS DT, 1981, NATURE, V289, P577, DOI 10.1038/289577a0; Chetty TRK, 2011, J ASIAN EARTH SCI, V42, P176, DOI 10.1016/j.jseaes.2011.02.009; [Anonymous], 1985, OFIOLITI; Santosh M, 2009, GONDWANA RES, V16, P321, DOI 10.1016/j.gr.2008.12.012; Ghosh JG, 2004, TECTONICS, V23, DOI 10.1029/2002TC001444; Yellappa T, 2012, GONDWANA RES, V21, P246, DOI 10.1016/j.gr.2011.05.003; Kusky TM, 2001, SCIENCE, V292, P1142, DOI 10.1126/science.1059426; Polat A, 2011, GONDWANA RES, V20, P255, DOI 10.1016/j.gr.2011.01.007; [Anonymous], 1997, GREENSTONE BELTS; Dilek Y, 2011, GEOL SOC AM BULL, V123, P387, DOI 10.1130/B30446.1; Regelous M, 2003, J PETROL, V44, P113, DOI 10.1093/petrology/44.1.113; COLEMAN RG, 1975, J GEOPHYS RES, V80, P1099, DOI 10.1029/JB080i008p01099; Zhang Q, 2008, J ASIAN EARTH SCI, V32, P308, DOI 10.1016/j.jseaes.2007.11.012; Kusky TM, 2013, GONDWANA RES, V24, P501, DOI 10.1016/j.gr.2013.01.004; Mohan MR, 2013, GONDWANA RES, V23, P539, DOI 10.1016/j.gr.2012.04.004; NUTMAN AP, 1984, PRECAMBRIAN RES, V25, P365, DOI 10.1016/0301-9268(84)90010-X; Chetty TRK, 2006, J ASIAN EARTH SCI, V28, P46, DOI 10.1016/j.jseaes.2005.05.010; IRVINE TN, 1971, CAN J EARTH SCI, V8, P523, DOI 10.1139/e71-055; Teale W, 2011, J ASIAN EARTH SCI, V42, P223, DOI 10.1016/j.jseaes.2011.04.006; Sato K, 2011, J ASIAN EARTH SCI, V40, P162, DOI 10.1016/j.jseaes.2010.08.008; PECCERILLO A, 1976, CONTRIB MINERAL PETR, V58, P63, DOI 10.1007/BF00384745; [Anonymous], 2012, GEOSCI FRONT, DOI DOI 10.1016/j.gsf.2012.04.003; Su BX, 2011, GONDWANA RES, V20, P516, DOI 10.1016/j.gr.2010.11.015; Brandt S, 2014, PRECAMBRIAN RES, V246, P91, DOI 10.1016/j.precamres.2014.01.007; BECCALUVA L, 1979, CAN J EARTH SCI, V16, P1874, DOI 10.1139/e79-172; Bonev N, 2009, GEOL MAG, V146, P72, DOI 10.1017/S0016756808005396; Chetty TRK, 1998, J GEOL SOC INDIA, V52, P443; Chetty TRK, 2006, J STRUCT GEOL, V28, P713, DOI 10.1016/j.jsg.2006.01.007; Coleman RG, 1979, TRONDHJEMITES DACITE, P149; Collins A.S., 2007, TERRA NOVA, V19, P41; DEWEY JF, 1977, TECTONOPHYSICS, V40, P53, DOI 10.1016/0040-1951(77)90029-4; Dilek Y., 2003, 373 GEOL SOC AM; Dilek Y., 2003, GEOLOGICAL SOC LONDO, V218; Dutta D., 2011, ORE GEOL REV, V40, P90; Floyd PA, 1998, LITHOS, V42, P225, DOI 10.1016/S0024-4937(97)00044-3; Fumes H., 2007, SCIENCE, V315, P1704, DOI DOI 10.1126/SCIENCE.1139170; Fumes H., 2013, GONDWANA RES; Furnes H, 2009, LITHOS, V113, P115, DOI 10.1016/j.lithos.2009.03.043; Gopalakrishnan K., 1994, OVERVIEW SO GRANULIT, P1003; GSI, 2005, GEOL MIN RES MAP NAM; GSI, 2006, GEOL MIN RES STAT IN, V30; Jafari S.H., 1995, J GEOL SOC LONDON, V152, P681; Jaques A.L., 1980, J PETROL, V22, P1; KANARISSOTIRIOU R, 1989, J GEOL SOC LONDON, V146, P607, DOI 10.1144/gsjgs.146.4.0607; KOIZUMI T, 2014, J ASIAN EARTH SCI; Kusky T.M., 2004, DEV PRECAMBRIAN GEOL, V13; Kusky TM, 2010, J EARTH SCI-CHINA, V21, P744, DOI 10.1007/s12583-010-0119-8; KUTTY TRN, 1986, J GEOL SOC INDIA, V28, P449; Le Maitre R. W., 1989, CLASSIFICATION IGNEO; Luchitskaya M., 2005, GEOPHYS RES, V7; Moores EM, 2002, GEOL SOC AM BULL, V114, P80, DOI 10.1130/0016-7606(2002)114<0080:PGPROT>2.0.CO;2; Moses B.V.C., 1999, J GEOSCI-OSAKA CITY, V42, P215; MULLEN ED, 1983, EARTH PLANET SC LETT, V62, P53, DOI 10.1016/0012-821X(83)90070-5; Murphy JB, 2007, GEOSCI CAN, V34, P7; Murthy S.R.N., 1979, REC GEOL SURV INDIA, V112, P15; O'Connor J. T., 1965, US GEOLOGICAL SURV B, V525, pB79; Pasqua Della F.N., 1995, MINER PETROL, V53, P1; Pearce J. A., 1980, OPHIOLITES, P261; Pearce J. A., 1984, GEOLOGICAL SOC LONDO, V16, P77, DOI DOI 10.1144/GSL.SP.1984.016.01.06; Pearce J.A, 1982, ANDESITES, P525; PEDERSEN RB, 1984, CONTRIB MINERAL PETR, V88, P36, DOI 10.1007/BF00371410; Praveen M.N., 2014, GONDWANA RES; Rao YJB, 1996, CONTRIB MINERAL PETR, V125, P237, DOI 10.1007/s004100050219; REDDY BM, 1995, J GEOL SOC INDIA, V45, P251; SANTOSH M., 2013, GONDWANA RES; SHERVAIS JW, 1982, EARTH PLANET SC LETT, V59, P101, DOI 10.1016/0012-821X(82)90120-0; Shervais J. W., 2001, GEOCHEM GEOPHY GEOSY, V2, DOI DOI 10.1029/2000GC000080; Shi RD, 2012, GONDWANA RES, V21, P194, DOI 10.1016/j.gr.2011.05.011; SUBRAMANIAM AP, 1956, GEOL SOC AM BULL, V67, P317, DOI 10.1130/0016-7606(1956)67[317:MAPOTS]2.0.CO;2; Sun S. S., 1989, GEOL SOC SPEC PUBL, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19	87	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1367-9120	1878-5786		J ASIAN EARTH SCI	J. Asian Earth Sci.	DEC 1	2014	95				SI		81	98		10.1016/j.jseaes.2014.04.023		18	Geosciences, Multidisciplinary	Geology	AW6SJ	WOS:000346398400007		
J	Cheng, ZG; Zhang, ZC; Santosh, M; Hou, T; Zhang, DY				Cheng, Zhiguo; Zhang, Zhaochong; Santosh, M.; Hou, Tong; Zhang, Dongyang			Carbonate- and silicate-rich globules in the kimberlitic rocks of northwestern Tarim large igneous province, NW China: Evidence for carbonated mantle source	JOURNAL OF ASIAN EARTH SCIENCES			English	Article						Kimberlite; Andradite; Globule; Skarn system; Tarim large igneous province	PLUME-LITHOSPHERE INTERACTION; SPINEL PERIDOTITE XENOLITHS; OCEANIC UPPER-MANTLE; LIQUID IMMISCIBILITY; GEOCHEMICAL CHARACTERISTICS; HYPABYSSAL KIMBERLITE; SOUTH-AFRICA; CONTINENTAL COLLISION; MINERAL CHEMISTRY; KAAPVAAL CRATON	We report carbonate- and silicate-rich globules and andradite from the Wajilitage kimberlitic rocks in the northwestern Tarim large igneous province, NW China. The carbonate-rich globules vary in size from 1 to 3 mm, and most have ellipsoidal or round shape, and are composed of nearly pure calcite. The silicate-rich globules are elliptical to round in shape and are typically larger than the carbonate-rich globules ranging from 2 to several centimeters in diameter. They are characterized by clear reaction rims and contain several silicate minerals such as garnet, diopside and phlogopite. The silicate-rich globules, reported here for the first time, are suggested to be related to the origin of andradite within the kimberlitic rocks. Our results show that calcite in the carbonate-rich globules has a high X-Ca (>0.97) and is characterized by extremely high concentrations of the total rare earth elements (up to 1500 ppm), enrichment in Sr (8521-10,645 ppm) and LREE, and remarkable depletion in Nd, Ta, Zr, Hf and Ti. The calcite in the silicate-rich globules is geochemically similar to those in the carbonate-rich globules except the lower trace element contents. Garnet is dominantly andradite (And(59.56-92.32)Grs(5.67-36.03)Pyr(0.36-4.61)Spe(0-0.33)) and is enriched in light rare earth elements (LREEs) and relatively depleted in Rb, Ba, Th, Pb, Sr, Zr and Hf. Phlogopite in the silicate-rich globules has a high Mg# ranging from 0.93 to 0.97. The composition of the diopside is Wo(45.82-51.39)En(39.81-49.09)Fs(0.88-0.95) with a high Mg# ranging from 0.88 to 0.95. Diopside in the silicate-rich globules has low total rare earth element (REE) contents (14-31 ppm) and shows middle REE- (Eu to Gd), slight light REE- and heavy REE-enrichment with elevated Zr, Hf and Sr contents and a negative Nb anomaly in the normalized diagram. The matrix of the kimberlitic rocks are silica undersaturated (27.92-29.31 wt.% SiO2) with low Al2O3 (4.51-5.15 wt.%) and high CaO (17.29-17.77 wt.%) contents. The samples are characterized by incompatible element enrichment with high (La/Yb)(N) values (41-58) and remarkable negative anomalies in HFSEs (e.g. Ta, Zr, Hf). Our new data suggest that the carbonate-rich globule most likely crystallized at high-temperature and does not represent immiscible liquids, whereas the silicate-rich globules are related to carbonate-rich deuteric hydrothermal fluids during the later-stage of melt evolution. The fluids reacted with the surrounding silicate melts resulting in the formation of skarn minerals such as phlogopite, diopside and andradite. The presence of the carbonate-bearing globules indicates that the Wajilitage kimberlitic rocks are carbonate-rich and most likely derived from an enriched mantle with abundant carbonate. We correlate the carbonated mantle to metasomatism by the migration of deep-seated fluids (carbonate-rich) in response to the impingement of the early Permian mantle plume. (C) 2014 Elsevier Ltd. All rights reserved.	[Cheng, Zhiguo; Zhang, Zhaochong; Santosh, M.; Hou, Tong; Zhang, Dongyang] China Univ Geosci, State Key Lab Geol Proc & Mineral Resources, Beijing 100083, Peoples R China; [Santosh, M.] Kochi Univ, Div Interdisciplinary Sci, Kochi 7808520, Japan	Zhang, ZC (reprint author), China Univ Geosci, State Key Lab Geol Proc & Mineral Resources, Beijing 100083, Peoples R China.	zczhang@cugb.edu.cn	Hou, houtong0707@126.com/B-7467-2013; Santosh, M/B-2563-2012	Hou, houtong0707@126.com/0000-0002-8847-3018; 	State Science and Technology Program of China [2011BAB06B0204]; National Natural Science Foundation of China [41390442]; Chinese Government	We thank Dr. Zhenyu Chen and Mingyue Hu for technical support and Dr. He Huang and Yuan Ma for field research. This work is supported by the 305 Project of the State Science and Technology Program of China (2011BAB06B0204) and National Natural Science Foundation of China (41390442). This study also contributes to the 1000 Talents Award to M. Santosh from the Chinese Government.	Agashev AM, 2008, CHEM GEOL, V255, P317, DOI 10.1016/j.chemgeo.2008.07.003; Ahmed Z, 2006, CHEM ERDE-GEOCHEM, V66, P187, DOI 10.1016/j.chemer.2004.10.001; Moine BN, 2004, LITHOS, V75, P239, DOI 10.1016/j.lithos.2003.12.019; Brooker RA, 2011, J PETROL, V52, P1281, DOI 10.1093/petrology/egq081; Tian W, 2010, CONTRIB MINERAL PETR, V160, P407, DOI 10.1007/s00410-009-0485-3; HOAL KEO, 1994, EARTH PLANET SC LETT, V126, P303, DOI 10.1016/0012-821X(94)90114-7; Wiechert U, 1997, CONTRIB MINERAL PETR, V126, P345, DOI 10.1007/s004100050255; Pirajno F, 2009, ORE GEOL REV, V35, P114, DOI 10.1016/j.oregeorev.2008.10.003; Seifert W, 1995, CHEM ERDE-GEOCHEM, V55, P263; van Achterbergh E, 2004, LITHOS, V76, P461, DOI 10.1016/j.lithos.2004.04.007; Stachel T, 1998, EARTH PLANET SC LETT, V159, P1, DOI 10.1016/S0012-821X(98)00064-8; Haggerty SE, 2006, AM MINERAL, V91, P1461, DOI 10.2138/am.2006.2194; Sparks RSJ, 2006, J VOLCANOL GEOTH RES, V155, P18, DOI 10.1016/j.jvolgeores.2006.02.010; Armstrong JP, 2004, LITHOS, V76, P415, DOI 10.1016/j.lithos.2004.03.025; Ionov D, 2002, EARTH PLANET SC LETT, V198, P495, DOI 10.1016/S0012-821X(02)00532-0; FOLEY S, 1992, LITHOS, V28, P187, DOI 10.1016/0024-4937(92)90006-K; Zhou LG, 2011, LITHOS, V127, P101, DOI 10.1016/j.lithos.2011.08.010; Francis D, 2009, LITHOS, V109, P72, DOI 10.1016/j.lithos.2008.05.007; Zhou MF, 2004, CHEM GEOL, V209, P233, DOI 10.1016/j.chemgeo.2004.05.005; Ma XX, 2013, PRECAMBRIAN RES, V228, P1, DOI 10.1016/j.precamres.2013.01.009; Sparks RSJ, 2009, LITHOS, V112, P429, DOI 10.1016/j.lithos.2009.05.032; Li ZL, 2011, J ASIAN EARTH SCI, V42, P917, DOI 10.1016/j.jseaes.2011.05.009; Ciobanu CL, 2004, ORE GEOL REV, V24, P315, DOI 10.1016/j.oregeorev.2003.04.002; RUDNICK RL, 1993, EARTH PLANET SC LETT, V114, P463, DOI 10.1016/0012-821X(93)90076-L; GREEN DH, 1988, NATURE, V336, P459; Zangana NA, 1997, CONTRIB MINERAL PETR, V127, P187, DOI 10.1007/s004100050275; Tappe S, 2009, LITHOS, V112, P385, DOI 10.1016/j.lithos.2009.03.002; Li ZL, 2012, J ASIAN EARTH SCI, V49, P191, DOI 10.1016/j.jseaes.2011.11.021; Long XP, 2010, PRECAMBRIAN RES, V180, P272, DOI 10.1016/j.precamres.2010.05.001; Guo ZJ, 2005, J ASIAN EARTH SCI, V25, P45, DOI 10.1016/j.jseaes.2004.01.016; Ionov DA, 2005, CHEM GEOL, V217, P41, DOI 10.1016/j.chemgeo.2004.12.001; Veksler IV, 2012, GEOCHIM COSMOCHIM AC, V79, P20, DOI 10.1016/j.gca.2011.11.035; Hetman CM, 2004, LITHOS, V76, P51, DOI 10.1016/j.lithos.2004.03.051; Zhang DY, 2013, EARTH PLANET SC LETT, V361, P238, DOI 10.1016/j.epsl.2012.10.034; Chowdhury S, 2011, J GEOCHEM EXPLOR, V108, P39, DOI 10.1016/j.gexplo.2010.07.005; Zhang CL, 2010, LITHOS, V119, P537, DOI 10.1016/j.lithos.2010.08.007; JONES JH, 1995, GEOCHIM COSMOCHIM AC, V59, P1307, DOI 10.1016/0016-7037(95)00045-2; Orhan A, 2011, J ASIAN EARTH SCI, V40, P550, DOI 10.1016/j.jseaes.2010.10.009; Zhang CL, 2008, J GEOL, V116, P269, DOI 10.1086/587726; Gaspar M, 2008, GEOCHIM COSMOCHIM AC, V72, P185, DOI 10.1016/j.gca.2007.09.033; KJARSGAARD B, 1991, MINER PETROL, V43, P293, DOI 10.1007/BF01164532; Lee WJ, 1996, J PETROL, V37, P1125, DOI 10.1093/petrology/37.5.1125; Zhang CL, 2013, GONDWANA RES, V23, P1306, DOI 10.1016/j.gr.2012.05.009; Jiang CY, 2004, ACTA PETROL SIN, V20, P1433; Schulze DJ, 2003, LITHOS, V71, P195, DOI 10.1016/S0024-4937(03)00113-0; Rao NVC, 2011, CONTRIB MINERAL PETR, V161, P721, DOI 10.1007/s00410-010-0559-2; Yang SF, 2007, GONDWANA RES, V12, P113, DOI 10.1016/j.gr.2006.10.018; Nowell GM, 2004, J PETROL, V45, P1583, DOI 10.1093/petrology/egh024; Zhou MF, 2009, LITHOS, V113, P583, DOI 10.1016/j.lithos.2009.06.027; Lu SN, 2008, PRECAMBRIAN RES, V160, P94, DOI 10.1016/j.precamres.2007.04.025; Lee WJ, 1998, J PETROL, V39, P2005, DOI 10.1093/petrology/39.11.2005; Scully KR, 2004, CHEM GEOL, V207, P189, DOI 10.1016/j.chemgeo.2004.03.001; Klaudius J, 2006, LITHOS, V91, P173, DOI 10.1016/j.lithos.2006.03.017; Coe N, 2008, CONTRIB MINERAL PETR, V156, P627, DOI 10.1007/s00410-008-0305-1; Kopylova MG, 2007, GEOCHIM COSMOCHIM AC, V71, P3616, DOI 10.1016/j.gca.2007.05.009; D'Orazio M, 2007, LITHOS, V98, P313, DOI 10.1016/j.lithos.2007.05.004; Nowicki T, 2004, LITHOS, V76, P1, DOI 10.1016/j.lithos.2004.03.020; Veksler IV, 1998, J PETROL, V39, P2095, DOI 10.1093/petrology/39.11.2095; Simon NSC, 2007, J PETROL, V48, P589, DOI 10.1093/petrology/egl074; [包广萍 Bao Guangping], 2013, [矿物学报, Acta Mineralogica Sinica], V33, P681; BAO PS, 2009, DIZHI XUEBAO, V83, P1276; Boyd FR, 2004, LITHOS, V77, P573, DOI 10.1016/j.lithos.2004.03.010; Brod JA, 2013, J S AM EARTH SCI, V41, P41, DOI 10.1016/j.jsames.2012.04.013; Buhn B, 2001, J AFR EARTH SCI, V32, P1, DOI 10.1016/S0899-5362(01)90015-6; Calagari AA, 2006, J ASIAN EARTH SCI, V28, P423, DOI 10.1016/j.jseaes.2005.11.009; Canet C, 2011, ORE GEOL REV, V39, P277, DOI 10.1016/j.oregeorev.2011.03.007; Chang L. L. Y, 1965, J GEOL, V73, P346; [程志国 Cheng Zhiguo], 2013, [地质学报, Acta Geologica Sinica], V87, P1104; Clarke D.B., 1975, PHYS CHEM EARTH, V9, P123, DOI 10.1016/0079-1946(75)90012-9; Clement C. R, 1975, PHYS CHEM EARTH, V9, P51, DOI DOI 10.1016/0079-1946(75)90006-3; Clement C.R., 1979, KIMB S 2 CAMBR; Clement C.R., 1982, THESIS U CAPE TOWN, P728; Downes PJ, 2007, LITHOS, V93, P175, DOI 10.1016/j.lithos.2006.06.005; Du P.L., 1983, XINJIANG GEOLOGY, V1, P55; Foster MD, 1960, US GEOLOGICAL SURV B, V354B, P11; Frantz G.W., 1967, ULTRAMAFIC RELATED R, P323; FREZZOTTI ML, 1994, EUR J MINERAL, V6, P805; Gaspar M., 2005, THESIS WASHINGTON ST; Gazel E, 2011, LITHOS, V125, P393, DOI 10.1016/j.lithos.2011.02.021; Gittins J., 1989, CARBONATITES GENESIS, P580; GREEN DH, 1973, EARTH PLANET SC LETT, V17, P456, DOI 10.1016/0012-821X(73)90214-8; Hamilton D.L., 1989, CARBONATITES GENESIS, P405; Hayman PC, 2009, LITHOS, V112, P473, DOI 10.1016/j.lithos.2009.06.025; Hogarth D.D., 1989, CARBONATITES GENESIS, P105; Howarth GH, 2011, LITHOS, V125, P795, DOI 10.1016/j.lithos.2011.05.001; Hu MY, 2008, CHINESE J ANAL CHEM, V36, P947; [黄智龙 Huang Zhilong], 2003, [矿床地质, Mineral Deposits], V22, P199; Ionov D, 1998, J PETROL, V39, P1931; Jia C, 1997, TECTONIC CHARACTERIS; Kamenetsky V.S., 2012, CHEM GEOL, V353, P96, DOI DOI 10.1016/J.CHEMGE0.2012.09.022; Konrad S.M., 2008, EARTH PLANET SC LETT, V272, P488; Laurora A, 2001, J PETROL, V42, P69, DOI 10.1093/petrology/42.1.69; Lazarov M, 2009, EARTH PLANET SC LETT, V279, P1, DOI 10.1016/j.epsl.2008.12.015; Lee WJ, 1997, J PETROL, V38, P1113, DOI 10.1093/petrology/38.9.1113; Lee W.J., 1994, INT GEOL REV, V36, P797; [刘楚雄 Liu Chuxiong], 2004, [新疆地质, Xinjiang Geology], V22, P43; Ma XX., 2013, GONDWANA RES; McDonough W.F., 1995, CHEM GEOL, V120, P2523; Mitchell RH, 2009, LITHOS, V112, P452, DOI 10.1016/j.lithos.2009.06.018; Mitchell R.H., 1994, P 5 INT KIMB C KIMB, P115; Mitchell R.H., 1986, KIMBERLITES MINERALO, P442; MITCHELL RH, 1975, CAN J EARTH SCI, V12, P757, DOI 10.1139/e75-066; MITCHELL RH, 1979, AM J SCI, V279, P570; Rao NVC, 2011, EARTH-SCI REV, V107, P315, DOI 10.1016/j.earscirev.2011.04.003; [任涛 Ren Tao], 2010, [地学前缘, Earth Science Frontiers], V17, P348; Rosatelli G, 2010, CONTRIB MINERAL PETR, V160, P645, DOI 10.1007/s00410-010-0499-x; SCHIANO P, 1994, EARTH PLANET SC LETT, V123, P167, DOI 10.1016/0012-821X(94)90265-8; Shuang Y., 2006, MINER PETROL, V26, P57; Smith CB, 2013, LITHOS, V182, P102, DOI 10.1016/j.lithos2013.10.006; Steenfelt A, 2009, LITHOS, V112, P116, DOI 10.1016/j.lithos.2009.03.022; Stoppa F, 2005, LITHOS, V85, P26, DOI 10.1016/j.lithos.2005.03.026; Su L, 1991, B XIAN I GEOL MIN RE, V32, P15; Sun S. S., 1989, GEOL SOC SPEC PUBL, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Twyman JD, 1987, GEOLOGICAL SOC SPECI, V30, P85, DOI 10.1144/GSL.SP.1987.030.01.06; Wang Y.S., 1987, B XIAN I GEOLOGY MIN, V15, P47; WATKINSO.DH, 1971, J PETROL, V12, P357; Wilson MR, 2007, CHEM GEOL, V242, P435, DOI 10.1016/j.chemgeo.2007.05.002; WulffPedersen E, 1996, CONTRIB MINERAL PETR, V125, P113, DOI 10.1007/s004100050210; WYLLIE PJ, 1987, EARTH PLANET SC LETT, V82, P391, DOI 10.1016/0012-821X(87)90213-5; Xia L.Q, 2012, GEOSCIENCE FRONTIERS, V3, P445, DOI [10.1016/j.gsf.2011.12.011, DOI 10.1016/J.GSF.2011.12.011]; Xia QX, 2012, LITHOS, V136, P73, DOI 10.1016/j.lithos.2011.10.004; Xu X.Y., 2005, NW GEOLOGY, V38, P1; [杨树锋 YANG Shufeng], 2005, [高校地质学报, Geological journal of China universities], V11, P504; Zhang HF, 2003, EARTH PLANET SC LETT, V216, P329, DOI 10.1016/S0012-821X(03)00487-4; Zhang YT, 2010, GONDWANA RES, V18, P596, DOI 10.1016/j.gr.2010.03.006	125	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1367-9120	1878-5786		J ASIAN EARTH SCI	J. Asian Earth Sci.	DEC 1	2014	95				SI		114	135		10.1016/j.jseaes.2014.04.018		22	Geosciences, Multidisciplinary	Geology	AW6SJ	WOS:000346398400009		
J	Ashley, NT; Ubuka, T; Schwabl, I; Goymann, W; Salli, BM; Bentley, GE; Buck, CL				Ashley, Noah T.; Ubuka, Takayoshi; Schwabl, Ingrid; Goymann, Wolfgang; Salli, Brady M.; Bentley, George E.; Buck, C. Loren			Revealing a Circadian Clock in Captive Arctic-Breeding Songbirds, Lapland Longspurs (Calcarius lapponicus), under Constant Illumination	JOURNAL OF BIOLOGICAL RHYTHMS			English	Article						circadian rhythm; clock genes; Lapland longspur; melatonin; Per2	GONADOTROPIN-INHIBITORY HORMONE; LAGOPUS-MUTUS-HYPERBOREUS; GENE-EXPRESSION; JAPANESE-QUAIL; SUPRACHIASMATIC NUCLEUS; PLASMA MELATONIN; HOUSE SPARROW; CONTINUOUS DAYLIGHT; PASSER-DOMESTICUS; LIGHT-INTENSITY	Most organisms in temperate or tropic regions employ the light-dark (LD) cycle as the primary Zeitgeber to synchronize circadian rhythms. At higher latitudes (>66 degrees 33), continuous illumination during the summer presents a significant time-keeping dilemma for polar-adapted species. Lapland longspurs (Calcarius lapponicus), arctic-breeding migratory songbirds, are one of the few recorded species maintaining an intact diel rhythm in activity and plasma melatonin titers during polar summer. However, it is unknown whether rhythms are endogenous and entrain to low-amplitude polar Zeitgeber signals, such as daily variations in light intensity and the spectral composition of the sun (as measured by color temperature). Wild-caught male and female longspurs were brought into captivity, and locomotor activity was assessed using infrared detection. To examine if rhythms were endogenous, birds were exposed to constant bright light (LL; 1300 lux) or constant darkness (DD; 0.1 lux). All birds exhibited free-running activity rhythms in LL and DD, suggesting the presence of a functional circadian clock. Mean periods in LL (22.86 h) were significantly shorter than those in DD (23.5 h), in accordance with Aschoff's rule. No birds entrained to diel changes in light intensity, color temperature, or both. To examine endogenous molecular clock function, the Per2 gene was partially cloned in longspurs (llPer2) and transcripts were measured in hypothalamic tissue punches, eye, and liver using competitive polymerase chain reaction. Ocular llPer2 gene expression was periodic in LL and elevated at ZT24 (CT24) for LD or constant conditions (LL and DD), but llPer2 rhythmicity was not detected in hypothalamus or liver. Plasma melatonin was significantly lower in LL compared with LD or DD. In conclusion, rhythmic ocular Per2 expression and melatonin secretion may maintain the circadian activity rhythm across the polar day.	[Ashley, Noah T.] Western Kentucky Univ, Dept Biol, Bowling Green, KY 42101 USA; [Ubuka, Takayoshi] Waseda Univ, Dept Biol, Shinjuku Ku, Tokyo, Japan; [Schwabl, Ingrid; Goymann, Wolfgang] Max Planck Inst Ornithol, Abt Verhaltensneurobiol, Seewiesen, Germany; [Salli, Brady M.; Buck, C. Loren] Univ Alaska Anchorage, Dept Biol Sci, Anchorage, AK USA; [Bentley, George E.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Integrat Biol, Berkeley, CA 94720 USA	Ashley, NT (reprint author), Western Kentucky Univ, Dept Biol, 1906 Coll Hts Blvd,11080, Bowling Green, KY 42101 USA.	noah.ashley@wku.edu	Goymann, Wolfgang/E-4854-2010	Goymann, Wolfgang/0000-0002-7553-5910	University of Alaska Fairbanks Center for Global Change; University of Alaska Fairbanks Arctic Systems Research Award; University of Alaska Anchorage Fran Ulmer Transformative Research Award; Institutional Development Award (IDeA) from National Institute of General Medical Sciences of the National Institutes of Health [5P20GM103436-13]; National Science Foundation [OPP 0817635]	We thank Katie Akpik, Luke George, and Vera Simmonds for field assistance and the staffs at Barrow Arctic Science Consortium and CH2MHill Polar Services for logistical support. We are indebted to the Ukpeagivk Inupiat Corporation for permitting us to conduct fieldwork on their tribal lands. B.M.S. was supported by a University of Alaska Fairbanks Center for Global Change and Arctic Systems Research Award and the University of Alaska Anchorage Fran Ulmer Transformative Research Award. N.T.A. was supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant 5P20GM103436-13. We thank 2 anonymous reviewers and Dr. William Schwartz for providing helpful feedback that improved the manuscript. This research was funded by the National Science Foundation (grant OPP 0817635).	Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11; Lopes PC, 2013, NEUROIMMUNOMODULAT, V20, P348, DOI 10.1159/000353779; Abraham U, 2002, EUR J NEUROSCI, V16, P429, DOI 10.1046/j.1460-9568.2002.02102.x; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Ubuka T, 2003, J ENDOCRINOL, V178, P311, DOI 10.1677/joe.0.1780311; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Doi M, 2001, P NATL ACAD SCI USA, V98, P8089, DOI 10.1073/pnas.141090998; OISHI T, 1973, AM J PHYSIOL, V225, P880; CASSONE VM, 1987, J COMP NEUROL, V266, P171, DOI 10.1002/cne.902660204; Goymann W, 2008, J BIOL RHYTHM, V23, P274, DOI 10.1177/0748730408316349; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7; Abraham U, 2003, CHRONOBIOL INT, V20, P657, DOI 10.1081/CBI-120022414; Hau M, 2002, GEN COMP ENDOCR, V126, P101, DOI 10.1006/gcen.2002.7776; Reierth E, 1998, CAN J ZOOL, V76, P2031, DOI 10.1139/cjz-76-11-2031; Yasuo S, 2003, ENDOCRINOLOGY, V144, P3742, DOI 10.1210/en.2003-0435; ASCHOFF J, 1989, ANIM BEHAV, V37, P881, DOI 10.1016/0003-3472(89)90132-2; ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; COCKREM JF, 1991, J PINEAL RES, V10, P2, DOI 10.1111/j.1600-079X.1991.tb00002.x; MICHE F, 1991, GEN COMP ENDOCR, V84, P249, DOI 10.1016/0016-6480(91)90048-B; Helm B, 2010, P ROY SOC B-BIOL SCI, V277, P3335, DOI 10.1098/rspb.2010.0871; Hart NS, 2001, PROG RETIN EYE RES, V20, P675, DOI 10.1016/S1350-9462(01)00009-X; Zheng BH, 1999, NATURE, V400, P169; Long RA, 2005, J MAMMAL, V86, P314, DOI 10.1644/BRG-224.1; Calisi RM, 2009, HORM BEHAV, V56, P1, DOI 10.1016/j.yhbeh.2009.02.010; Ubuka T, 2005, P NATL ACAD SCI USA, V102, P3052, DOI 10.1073/pnas.0403840102; Silverin B, 2009, HORM BEHAV, V56, P163, DOI 10.1016/j.yhbeh.2009.04.002; Bentley GE, 2001, MICROSC RES TECHNIQ, V53, P63, DOI 10.1002/jemt.1069; Ashley NT, 2013, J EXP ZOOL PART A, V319A, P10, DOI 10.1002/jez.1768; Gwinner E, 1997, BRAIN RES BULL, V44, P439, DOI 10.1016/S0361-9230(97)00224-4; Brandstatter R, 2003, J NEUROENDOCRINOL, V15, P398, DOI 10.1046/j.1365-2826.2003.01003.x; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Gwinner E, 2001, PHILOS T ROY SOC B, V356, P1801, DOI 10.1098/rstb.2001.0959; Helfer G, 2006, CHRONOBIOL INT, V23, P113, DOI 10.1080/07420520500521871; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; van Oort BEH, 2005, NATURE, V438, P1095, DOI 10.1038/4381095a; Yasuo S, 2004, ENDOCRINOLOGY, V145, P1612, DOI 10.1210/en.2003-1285; Singh D, 2013, CHRONOBIOL INT, V30, P1208, DOI 10.3109/07420528.2013.810632; Cassone VM, 2008, J BIOL RHYTHM, V23, P49, DOI 10.1177/0748730407311110; Yasuo S, 2002, EUR J NEUROSCI, V16, P1541, DOI 10.1046/j.1460-9568.2002.02222.x; Rani S, 2009, CHRONOBIOL INT, V26, P653, DOI 10.1080/07420520902926009; Arendt J, 2012, CHRONOBIOL INT, V29, P379, DOI 10.3109/07420528.2012.668997; Aschoff J., 1981, HDB BEHAVIOURAL NEUR, V4, P81; ASCHOFF J, 1989, J BIOL RHYTHM, V4, P29, DOI 10.1177/074873048900400102; BARRELL GK, 1989, J ENDOCRINOL, V122, P445, DOI 10.1677/joe.0.1220445; Bloch G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0019; Brandstatter R, 2001, NEUROREPORT, V12, P1167, DOI 10.1097/00001756-200105080-00023; Buhr ED, 2013, HDB EXP PHARM, V217, P3, DOI DOI 10.1007/978-3-642-25950-0_1; Cassone VM, 2014, FRONT NEUROENDOCRIN, V35, P76, DOI 10.1016/j.yfrne.2013.10.002; ELORANTA E, 1995, AM ZOOL, V35, P203; Hussell DJT, 2002, BIRDS N AM, V656; KRULL F, 1976, OECOLOGIA, V24, P141, DOI 10.1007/BF00572755; KRULL F, 1976, OECOLOGIA, V24, P149, DOI 10.1007/BF00572756; KRULL F, 1985, NATURWISSENSCHAFTEN, V72, P197, DOI 10.1007/BF01195761; KRULL F, 1976, OECOLOGIA, V25, P301, DOI 10.1007/BF00345602; Kumar V, 2000, J COMP PHYSIOL A, V186, P205, DOI 10.1007/s003590050020; Kumar V, 2007, NATURWISSENSCHAFTEN, V94, P693, DOI 10.1007/s00114-007-0243-1; Pandey RK, 2011, CHRONOBIOL INT, V28, P758, DOI 10.3109/07420528.2011.603873; Perfito N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034997; Pielou E.C., 1994, NATURALISTS GUIDE AR; Pittendrigh CS, 1981, HDB BEHAVIORAL NEURO, P57; Pohl H, 1999, PHYSIOL BEHAV, V67, P327, DOI 10.1016/S0031-9384(99)00070-0; POHL H, 1992, NATURWISSENSCHAFTEN, V79, P227, DOI 10.1007/BF01227134; Refinetti R, 2006, CIRADIAN PHYSL; Reierth E, 1999, J BIOL RHYTHM, V14, P314, DOI 10.1177/074873099129000731; REITER RJ, 1991, MOL CELL ENDOCRINOL, V79, pC153, DOI 10.1016/0303-7207(91)90087-9; Steiger SS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1016; Steinmeyer C, 2012, GENETICA, V140, P219, DOI 10.1007/s10709-012-9673-6; Stelzer RJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-93; STOKKAN KA, 1994, CAN J ZOOL, V72, P904; SWADE RH, 1967, AM NAT, V101, P431, DOI 10.1086/282510; Williams CT, 2012, BIOL LETTERS, V8, P31, DOI 10.1098/rsbl.2011.0435; YAMADA H, 1988, J COMP PHYSIOL A, V163, P459, DOI 10.1007/BF00604900; Yasuo S, 2004, BRAIN RES, V1005, P193, DOI 10.1016/j.brainres.2004.01.031; Yoshimura T, 2001, AM J PHYSIOL-REG I, V280, pR1185; Zheng B, 1999, CELL, V105, P683	77	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0748-7304	1552-4531		J BIOL RHYTHM	J. Biol. Rhythms	DEC	2014	29	6					456	469		10.1177/0748730414552323		14	Biology; Physiology	Life Sciences & Biomedicine - Other Topics; Physiology	AW3KA	WOS:000346184100006		
J	Okada, M; Imai, T; Yaegaki, K; Ishkitiev, N; Tanaka, T				Okada, Mio; Imai, Toshio; Yaegaki, Ken; Ishkitiev, Nikolay; Tanaka, Tomoko			Regeneration of insulin-producing pancreatic cells using a volatile bioactive compound and human teeth	JOURNAL OF BREATH RESEARCH			English	Article						tooth; stem cell; insulin; pancreas	STEM-CELLS; HYDROGEN-SULFIDE; BETA-CELL; SIGNALING MOLECULE; ADIPOSE-TISSUE; BONE-MARROW; IN-VITRO; DIFFERENTIATION; MICE; PROLIFERATION	Transplantation of insulin (INS)-secreting cells differentiated in vitro from stem cells promises a safer and easier treatment of severe diabetes mellitus. A volatile bioactive compound, hydrogen sulfide (H2S), promotes cell differentiation; human tooth-pulp stem cells undergo hepatic differentiation. The aim of this study is to develop a novel protocol using H2S to enhance pancreatic differentiation from the CD117(+) cell fraction of human tooth pulp. During the differentiation, the cells were exposed to 0.1 ng ml(-1) H2S. Immunocytochemistry, RT-PCR, determination of INS c-peptide content and flow cytometry of pancreatically related markers were carried out. Expression of WNT and the PI3K/AKT signaling pathway were also determined by PCR array. After differentiation, INS, glucagon (GCG), somatostatin (SST) and pancreatic polypeptide (PPY) were positive when examined by immunofluorescence. INS and GCG were also determined flow-cytometrically. Only the cells expressing INS increased after H2S exposure. The number of cells expressing GCG was significantly decreased. Genes involved in canonical WNT and the WNT/calcium pathways were highly expressed after H2S exposure. H2S accelerated INS synthesis and secretion by regenerated INS-producing cells from human teeth. All signaling pathway functions of the PI3K-AKT pathway were extremely activated by H2S exposure. The matured INS-producing cells originating in human teeth were increased by H2S in order to control blood-glucose level.	[Okada, Mio; Imai, Toshio; Yaegaki, Ken; Ishkitiev, Nikolay; Tanaka, Tomoko] Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Oral Hlth, Tokyo 1028159, Japan	Okada, M (reprint author), Nippon Dent Univ Tokyo, Sch Life Dent Tokyo, Dept Oral Hlth, 1-9-20 Chiyoda Ku, Tokyo 1028159, Japan.	yaegaki-k@tky.ndu.ac.jp	Ishkitiev, Nikolay/I-4654-2012; Lauritano, Dorina/H-1373-2011	Ishkitiev, Nikolay/0000-0002-4351-5579; 	Japanese Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan [25670898]	The authors thank Dr H Ishikawa, Invited Professor, Nippon Dental University, for his kind gift of embryo-trophic factors. This study was fully supported by Grant-In-Aid No. 25670898 from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan.	Abiola M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008509; Shahjalal HM, 2014, J MOL CELL BIOL, V6, P394, DOI 10.1093/jmcb/mju029; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Fiorucci S, 2006, GASTROENTEROLOGY, V131, P259, DOI 10.1053/j.gastro.2006.02.033; Chandra V, 2009, STEM CELLS, V27, P1941, DOI 10.1002/stem.117; Kimura H, 2014, NITRIC OXIDE-BIOL CH, V41, P4, DOI 10.1016/j.niox.2014.01.002; Vriesendorp TM, 2008, CURR OPIN CRIT CARE, V14, P397, DOI 10.1097/MCC.0b013e328306c7b1; Govindasamy V, 2011, J DENT RES, V90, P646, DOI 10.1177/0022034510396879; Bouwens L, 2013, NAT REV ENDOCRINOL, V9, P598, DOI 10.1038/nrendo.2013.145; Fong CY, 2010, J CELL BIOCHEM, V111, P769, DOI 10.1002/jcb.22775; Lorber D, 2014, DIABETES CARE, V37, pS97, DOI 10.2337/dc14-S097; Kaneko Y, 2006, DIABETES, V55, P1391, DOI 10.2337/db05-1082; Orlic D, 2003, PEDIATR TRANSPLANT, V7, P86, DOI 10.1034/j.1399-3046.7.s3.13.x; Ii H, 2010, J PERIODONTOL, V81, P1691, DOI 10.1902/jop.2010.100116; Polhemus DJ, 2014, CIRC RES, V114, P730, DOI 10.1161/CIRCRESAHA.114.300505; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Imai T, 2009, J PERIODONTOL, V80, P2028, DOI 10.1902/jop.2009.090208; Hancock JT, 2014, PLANT PHYSIOL BIOCH, V78, P37, DOI 10.1016/j.plaphy.2014.02.012; Robertson JA, 2001, NAT REV GENET, V2, P74, DOI 10.1038/35047594; Ishkitiev N, 2012, J ENDODONT, V38, P475, DOI 10.1016/j.joen.2011.12.011; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kohn AD, 1996, J BIOL CHEM, V271, P31372; Segev H, 2004, STEM CELLS, V22, P265, DOI 10.1634/stemcells.22-3-265; Pei YX, 2012, DEVELOPMENT, V139, P1724, DOI 10.1242/dev.050104; Blyszczuk P, 2004, J BIOTECHNOL, V113, P3, DOI 10.1016/j.jbiotec.2004.03.023; Hua XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102198; Huang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097315; Ishiwata I, 2000, Hum Cell, V13, P185; Ishkitiev N, 2013, REGEN MED, V8, P597, DOI 10.2217/rme.13.42; Ishkitiev N, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/1/017103; KLEINBERG I, 1990, Critical Reviews in Oral Biology and Medicine, V1, P247; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Lee J, 2013, ELIFE, V2, DOI 10.7554/eLife.00940; Lo B, 2010, CELL STEM CELL, V6, P16, DOI 10.1016/j.stem.2009.12.004; McCluskey JT, 2011, J BIOL CHEM, V286, P21982, DOI 10.1074/jbc.M111.226795; Milanesi A, 2011, J ENDOCRINOL, V209, P193, DOI 10.1530/JOE-10-0344; Okada M, 2014, INT ENDOD J, V47, P1142, DOI 10.1111/iej.12262; Vorobeychik M, 2008, J MOL HISTOL, V39, P463, DOI 10.1007/s10735-008-9185-y	38	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1752-7155	1752-7163		J BREATH RES	J. Breath Res.	DEC	2014	8	4							046004	10.1088/1752-7155/8/4/046004		10	Biochemical Research Methods; Respiratory System	Biochemistry & Molecular Biology; Respiratory System	AW2SC	WOS:000346138100005		
J	Tanda, N; Hinokio, Y; Washio, J; Takahashi, N; Koseki, T				Tanda, Naoko; Hinokio, Yoshinori; Washio, Jumpei; Takahashi, Nobuhiro; Koseki, Takeyoshi			Analysis of ketone bodies in exhaled breath and blood of ten healthy Japanese at OGTT using a portable gas chromatograph	JOURNAL OF BREATH RESEARCH			English	Article						acetone; acetoacetate; beta-hydroxybutyrate; plasma glucose; oral glucose tolerance test; type 2 diabetes mellitus; portable gas chromatograph	TUBE MASS-SPECTROMETRY; DIABETIC-KETOACIDOSIS; BETA-HYDROXYBUTYRATE; ACETONE METABOLISM; CLINICAL-PRACTICE; PLASMA-GLUCOSE; ORAL MALODOR	Ketone bodies including acetone are disease biomarkers for diabetes that sometimes causes severe ketoacidosis. The present study was undertaken to clarify the significance of exhaled acetone and plasma ketone bodies at bedside in a clinical setting. The oral glucose tolerance test (OGTT) was performed in 10 healthy Japanese volunteers (five females and five males). Exhaled breath acetone and volatile sulfide compounds (VSCs) in mouth air were measured simultaneously with blood sampling during the OGTT using a portable gas chromatograph equipped with an In2O3 thick-film type gas sensor and a VSC monitor. Acetone, beta-hydroxybutyrate (beta-OHB) and acetoacetate (AcAc) in blood plasma as well as glucose and insulin were examined. Oral conditions were examined based on the Community Periodontal Index (CPI) by one dentist. In addition, the same type of analysis was applied to two uncontrolled type 2 diabetes mellitus patients hospitalized at Tohoku University Hospital. Exhaled acetone was measured at the same time as blood withdrawal in the morning before breakfast and at night before bed at the beginning, the middle, and the end of hospitalization. All volunteers showed normal OGTT patterns with no ketonuria and periodontitis; however, there were significant correlations between breath acetone and plasma beta-OHB and between breath acetone and plasma AcAc under fasting conditions. Breath acetone of the type 2 diabetes mellitus patients showed positive correlations with plasma glucose when the level of plasma glucose tended to decrease during hospitalization. In spite of a very limited number of cases, our results support the idea that exhaled breath acetone may be related to plasma beta-OHB and AcAc, which reflect glucose metabolism in the body.	[Tanda, Naoko] Tohoku Univ Hosp, Dept Prevent Dent, Sendai, Miyagi, Japan; [Hinokio, Yoshinori] Sendai City Hosp, Dept Diabet & Metab, Sendai, Miyagi, Japan; [Washio, Jumpei; Takahashi, Nobuhiro] Tohoku Univ, Grad Sch Dent Oral Ecol & Biochem, Sendai, Miyagi 980, Japan; [Koseki, Takeyoshi] Tohoku Univ, Grad Sch Dent Prevent Dent, Sendai, Miyagi 980, Japan	Tanda, N (reprint author), Tohoku Univ Hosp, Dept Prevent Dent, Sendai, Miyagi, Japan.	ntanda@mail.tains.tohoku.ac.jp			Japan Society for the Promotion of Science [20592447]	We would like to thank Mr Kengo Suzuki (New Cosmos Electric Co, Ltd, Japan) for helpful advice about the structure of Gas Analyzer XG-100 V. This work was supported in part by a Grant-in-Aid for Scientific Research (20592447) from the Japan Society for the Promotion of Science.	Delanghe G, 1997, LANCET, V350, P187, DOI 10.1016/S0140-6736(05)62354-9; Righettoni M, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/037110; Krespi YP, 2006, OTOLARYNG HEAD NECK, V135, P671, DOI 10.1016/j.otohns.2005.09.036; MILES JM, 1983, J CLIN INVEST, V71, P1554, DOI 10.1172/JCI110911; Smith D, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/2/022001; Wang ZN, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/037109; TONZETICH J, 1977, J PERIODONTOL, V48, P13, DOI 10.1902/jop.1977.48.1.13; Turner C, 2006, PHYSIOL MEAS, V27, P321, DOI 10.1088/0967-3334/27/4/001; Kitabchi AE, 2009, DIABETES CARE, V32, P1335, DOI 10.2337/dc09-9032; AINAMO J, 1982, INT DENT J, V32, P281; Minh TDC, 2011, AM J PHYSIOL-ENDOC M, V300, pE1166, DOI 10.1152/ajpendo.00634.2010; REICHARD GA, 1979, J CLIN INVEST, V63, P619, DOI 10.1172/JCI109344; Mochalski P, 2013, ANALYST, V138, P1405, DOI 10.1039/c2an36193k; Turner C, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/4/046004; Wallace TM, 2001, DIABETIC MED, V18, P640, DOI 10.1046/j.1464-5491.2001.00550.x; Casey DE, 2004, J CLIN PSYCHIAT, V65, P4; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Sheikh-Ali M, 2008, DIABETES CARE, V31, P643, DOI 10.2337/dc07-1683; Choi YH, 2011, DIABETES CARE, V34, P381, DOI 10.2337/dc10-1354; Turner C, 2008, RAPID COMMUN MASS SP, V22, P526, DOI 10.1002/rcm.3402; Arora Sanjay, 2012, Hosp Pract (1995), V40, P73, DOI 10.3810/hp.2012.04.972; Galassetti Pietro R, 2005, Diabetes Technol Ther, V7, P115, DOI 10.1089/dia.2005.7.115; Halbritter S, 2012, DIABETES TECHNOL THE, V14, P917, DOI 10.1089/dia.2012.0076; Kanda K, 2004, P IEEE SENSORS, V3, P1187; King BR, 2012, PEDIATR DIABETES, V13, P647, DOI 10.1111/j.1399-5448.2012.00896.x; Lee J, 2009, J APPL PHYSIOL, V107, P155, DOI 10.1152/japplphysiol.91657.2008; Lourenço Célia, 2014, Metabolites, V4, P465, DOI 10.3390/metabo4020465; Meas T, 2005, DIABETES METAB, V31, P299, DOI 10.1016/S1262-3636(07)70198-2; Morita I, 2012, J DENT RES, V91, P161, DOI 10.1177/0022034511431583; OWEN OE, 1982, DIABETES, V31, P242, DOI 10.2337/diabetes.31.3.242; Pysanenko A, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/4/046004; Rosenberg M, 1996, J AM DENT ASSOC, V127, P475; SMITH DW, 2007, ROUTL PHILOS, P1; Storer M, 2011, J BREATH RES, V5, DOI 10.1088/1752-7155/5/4/046011; Tanda N, 2007, J DENT, V35, P552, DOI 10.1016/j.jdent.2007.03.003; Turner C, 2011, EXPERT REV MOL DIAGN, V11, P497, DOI 10.1586/ERM.11.31; Wang TS, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037013; Yaegaki K, 2012, J BREATH RES, V6, DOI 10.1088/1752-7155/6/1/017101	38	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1752-7155	1752-7163		J BREATH RES	J. Breath Res.	DEC	2014	8	4							046008	10.1088/1752-7155/8/4/046008		9	Biochemical Research Methods; Respiratory System	Biochemistry & Molecular Biology; Respiratory System	AW2SC	WOS:000346138100009		
J	Talib, AK; Sato, N; Kawabata, N; Sugiyama, E; Sakamoto, N; Tanabe, Y; Fujino, T; Takeuchi, T; Saijo, Y; Akasaka, K; Kawamura, Y; Hasebe, N				Talib, Ahmed Karim; Sato, Nobuyuki; Kawabata, Naoko; Sugiyama, Eitaro; Sakamoto, Naka; Tanabe, Yasuko; Fujino, Takayuki; Takeuchi, Toshiharu; Saijo, Yasuaki; Akasaka, Kazumi; Kawamura, Yuichiro; Hasebe, Naoyuki			Repolarization Characteristics in Early Repolarization and Brugada Syndromes: Insight into an Overlapping Mechanism of Lethal Arrhythmias	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Article						Brugada syndrome; early repolarization syndrome; QT dynamics; QT interval; sudden death	SHORT-QT SYNDROME; MODULATES SPONTANEOUS AUGMENTATION; SUDDEN CARDIAC DEATH; J WAVE SYNDROMES; VENTRICULAR-FIBRILLATION; CIRCADIAN VARIATION; TRANSMURAL DISPERSION; ELEVATION; ARRHYTHMOGENESIS; ISOPROTERENOL	Repolarization Indices in ER and Brugada Syndromes. Introduction: We reported impaired QT-rate dependence in early repolarization syndrome (ERS); however, contemporary data have shown peak incidence of sudden cardiac death (SCD) in ERS and Brugada syndrome (BrS) at mid-night and early morning. Taken together, we analyzed the nocturnal QT-rate dependence in both syndromes. Methods and Results: A total of 172 subjects were enrolled: 11 ERS, 11 BrS patients, 50 subjects with an uneventful ER pattern (ERP), and 100 non-J-wave control subjects. Ambulatory ECG-derived parameters (QT, QTc, and QT/RR slope) and day-night QT difference were analyzed and compared. Among the groups, there was no significant difference in the average QT or QTc; however, the 24-hour QT/RR slope was significantly smaller in ERS and BrS patients (0.103 +/- 0.01 and 0.106 +/- 0.01, respectively) than in the control group (0.156 +/- 0.03, P < 0.001). Detailed analysis showed a lower day-night QT difference in ERS and BrS patients (19 +/- 18.7 and 24 +/- 14 milliseconds, respectively) than in the controls (40 +/- 22 milliseconds, P = 0.007) with the lowest QT/RR slopes seen in the ERS and BrS groups from 0 to 3: 00 am (QT/RR; 0.076 +/- 0.02 vs. 0.092 +/- 0.04 vs. 0.117 +/- 0.04, for the ERS, BrS, and controls, respectively, P = 0.004) and from 3 to 6 am (QT/RR 0.074 +/- 0.03 vs. 0.079 +/- 0.02 vs. 0.118 +/- 0.04, P < 0.001). Conclusion: In a large population of age-and gender-matched groups, both ERS and BrS patients showed attenuated QT-rate dependence and impaired QT day-night modulation that may provide a baseline reentrant substrate. Importantly, QT/RR maladaptation was most evident at mid-night and early morning, which may explain the propensity of such patients to develop SCD during this critical period.	[Talib, Ahmed Karim; Sato, Nobuyuki; Kawabata, Naoko; Sugiyama, Eitaro; Sakamoto, Naka; Tanabe, Yasuko; Fujino, Takayuki; Takeuchi, Toshiharu; Kawamura, Yuichiro; Hasebe, Naoyuki] Asahikawa Med Univ, Dept Cardiol, Asahikawa, Hokkaido 0788510, Japan; [Saijo, Yasuaki] Asahikawa Med Univ, Dept Hlth Sci, Div Community Med & Epidemiol, Asahikawa, Hokkaido 0788510, Japan; [Akasaka, Kazumi] Asahikawa Med Univ, Dept Lab Med, Asahikawa, Hokkaido 0788510, Japan	Talib, AK (reprint author), Asahikawa Med Univ, Dept Cardiol, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	ahmed@asahikawa-med.ac.jp					Mizumaki K, 2012, HEART RHYTHM, V9, P249, DOI 10.1016/j.hrthm.2011.09.055; Mazzanti A, 2014, J AM COLL CARDIOL, V63, P1300, DOI 10.1016/j.jacc.2013.09.078; Antzelevitch C, 2010, HEART RHYTHM, V7, P549, DOI 10.1016/j.hrthm.2009.12.006; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Haissaguerre M, 2009, J AM COLL CARDIOL, V53, P612, DOI 10.1016/j.jacc.2008.10.044; Charbit B, 2009, AM J CARDIOL, V103, P887, DOI 10.1016/j.amjcard.2008.11.041; MERRI M, 1992, CIRCULATION, V85, P1816; Jongman JY, 2007, NETH HEART J, V15, P151; Mizumaki K, 2004, J CARDIOVASC ELECTR, V15, P667, DOI 10.1046/j.1540-8167.2004.03601.x; Wolpert C, 2005, J CARDIOVASC ELECTR, V16, P54, DOI 10.1046/j.1540-8167.2005.04470.x; MULLER JE, 1987, CIRCULATION, V75, P131; Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; Zareba W, 2005, ANN NONINVAS ELECTRO, V10, P256, DOI 10.1111/j.1542-474X.2005.10205.x; Bun SS, 2012, J CARDIOVASC ELECTR, V23, P1028, DOI 10.1111/j.1540-8167.2012.02295.x; Takigawa M, 2008, HEART RHYTHM, V5, P1523, DOI 10.1016/j.hrthm.2008.08.022; Talib AK, 2012, J CARDIOVASC ELECTR, V23, P1109, DOI 10.1111/j.1540-8167.2012.02363.x; Tikkanen JT, 2011, CIRCULATION, V123, P2666, DOI 10.1161/CIRCULATIONAHA.110.014068; Extramiana F, 2004, CIRCULATION, V110, P3661, DOI 10.1161/01.CIR.0000143078.48699.0C; Rosso R, 2008, J AM COLL CARDIOL, V52, P1231, DOI 10.1016/j.jacc.2008.07.010; BROWNE KF, 1983, AM J CARDIOL, V52, P55, DOI 10.1016/0002-9149(83)90068-1; Batchvarov VN, 2002, AM J PHYSIOL-HEART C, V282, pH2356, DOI 10.1152/ajpheart.00860.2001; Kim SH, 2012, J CARDIOVASC ELECTR, V23, P757, DOI 10.1111/j.1540-8167.2011.02287.x; Haissaguerre M, 2008, NEW ENGL J MED, V358, P2016, DOI 10.1056/NEJMoa071968; Benito B, 2010, J AM COLL CARDIOL, V56, P1177, DOI 10.1016/j.jacc.2010.05.037; Bjerregaard P, 2009, ELECT DIS HEART GENE, P555; Castro HJ, 2006, J AM COLL CARDIOL, V47, P1828; Chevalier P, 2003, J CARDIOVASC ELECTR, V14, P227; KONG TQ, 1995, CIRCULATION, V92, P1507; Mayuga KA, 2010, ANN NONINVAS ELECTRO, V15, P3, DOI 10.1111/j.1542-474X.2009.00333.x; MURAKAWA Y, 1992, AM J CARDIOL, V69, P339, DOI 10.1016/0002-9149(92)90230-V; Shimizu W, 2007, J CARDIOVASC ELECTR, V18, P415, DOI 10.1111/j.1540-8167.2006.00743.x; Talib AK, 2013, J CARDIOVASC ELECTR, V24, P556, DOI 10.1111/jce.12074; Watanabe H, 2010, HEART RHYTHM, V7, P647, DOI 10.1016/j.hrthm.2010.01.012; Yamashita T, 2003, CIRCULATION, V107, P1917, DOI 10.1161/01.CIR.0000058752.79734.F0	34	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	DEC	2014	25	12					1376	1384		10.1111/jce.12566		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AW0ZU	WOS:000346020800017		
J	Miyazaki, S; Kinjo, T; Iesaka, Y				Miyazaki, Shinsuke; Kinjo, Tsunemichi; Iesaka, Yoshito			Atrioventricular Reentrant Tachycardia with Intraatrial Conduction Block	JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY			English	Editorial Material									[Miyazaki, Shinsuke; Kinjo, Tsunemichi; Iesaka, Yoshito] Tsuchiura Kyodo Gen Hosp, Tsuchiura, Ibaraki 3000053, Japan; [Miyazaki, Shinsuke; Kinjo, Tsunemichi; Iesaka, Yoshito] Hokushin Gen Hosp, Nagano, Japan	Miyazaki, S (reprint author), Tsuchiura Kyodo Gen Hosp, Div Cardiol, Cardiovasc Ctr, 11-7 Manabeshin Machi, Tsuchiura, Ibaraki 3000053, Japan.	mshinsuke@k3.dion.ne.jp						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1045-3873	1540-8167		J CARDIOVASC ELECTR	J. Cardiovasc. Electrophysiol.	DEC	2014	25	12					1407	1407		10.1111/jce.12531		1	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AW0ZU	WOS:000346020800021		
J	Hirota, N; Takayabu, YN; Watanabe, M; Kimoto, M; Chikira, M				Hirota, Nagio; Takayabu, Yukari N.; Watanabe, Masahiro; Kimoto, Masahide; Chikira, Minoru			Role of Convective Entrainment in Spatial Distributions of and Temporal Variations in Precipitation over Tropical Oceans	JOURNAL OF CLIMATE			English	Article							GENERAL-CIRCULATION MODELS; HIGH-RESOLUTION SIMULATION; PACIFIC DOUBLE ITCZ; LARGE-SCALE MODELS; MASS-FLUX SCHEME; CLOUD-TOP HEIGHT; CUMULUS PARAMETERIZATION; PART II; INTRASEASONAL VARIABILITY; CLIMATE MODELS	The authors demonstrate that an appropriate treatment of convective entrainment is essential for determining spatial distributions of and temporal variations in precipitation. Four numerical experiments are performed using atmospheric models with different entrainment characteristics: a control experiment (Ctl), a no-entrainment experiment (NoEnt), an original Arakawa-Schubert experiment (AS), and an AS experiment with a simple empirical suppression of convection depending on cloud-layer humidity (ASRH). The fractional entrainment rates of AS and ASRH are constant for each cloud type and are very small in the lower troposphere compared with those in the Ctl, in which half of the buoyancy-generated energy is consumed by entrainment. Spatial and temporal variations in the observed precipitation are satisfactorily reproduced in the Ctl, but their amplitudes are underestimated with a so-called double intertropical convergence zone bias in the NoEnt and AS. The spatial variation is larger in the Ctl because convection is more active over humid ascending regions and more suppressed over dry subsidence regions. Feedback processes involving convection, the large-scale circulation, free tropospheric moistening by congestus, and radiation enhance the variations. The temporal evolution of precipitation events is also more realistic in the Ctl, because congestus moistens the midtroposphere, and large precipitation events occur once sufficient moisture is available. The large entrainment in the lower troposphere, increasing free tropospheric moistening by congestus and enhancing the coupling of convection to free tropospheric humidity, is suggested to be important for the realistic spatial and temporal variations.	[Hirota, Nagio] Univ Tokyo, Natl Inst Polar Res, Tokyo, Japan; [Hirota, Nagio; Takayabu, Yukari N.; Watanabe, Masahiro; Kimoto, Masahide] Univ Tokyo, Atmosphere & Ocean Res Inst, Tokyo, Japan; [Chikira, Minoru] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa, Japan	Hirota, N (reprint author), Natl Inst Polar Res, 10-3 Midoricho, Tachikawa, Tokyo 1908518, Japan.	nagio@aori.u-tokyo.ac.jp			Green Network of Excellence Program of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [2A-1201]	This study was supported by the Green Network of Excellence Program of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan, and by the Environment Research and Technology Development Fund (2A-1201) of the Ministry of the Environment, Japan. We also acknowledge the Program for Risk Information on Climate Change from MEXT. The Grid Analysis and Display System was used to plot the figures.	Chikira M, 2014, J ATMOS SCI, V71, P615, DOI 10.1175/JAS-D-13-038.1; Hirota N, 2011, J CLIMATE, V24, P4859, DOI 10.1175/2011JCLI4156.1; Jensen MP, 2006, J CLIMATE, V19, P2105, DOI 10.1175/JCLI3722.1; Nakanishi M, 2004, BOUND-LAY METEOROL, V112, P1, DOI 10.1023/B:BOUN.0000020164.04146.98; Kim D, 2012, J CLIMATE, V25, P4641, DOI 10.1175/JCLI-D-11-00447.1; Derbyshire SH, 2004, Q J ROY METEOR SOC, V130, P3055, DOI 10.1256/qj.03.130; ARAKAWA A, 1974, J ATMOS SCI, V31, P674, DOI 10.1175/1520-0469(1974)031<0674:IOACCE>2.0.CO;2; SIEBESMA AP, 1995, J ATMOS SCI, V52, P650, DOI 10.1175/1520-0469(1995)052<0650:EOPAFS>2.0.CO;2; MELLOR GL, 1982, REV GEOPHYS, V20, P851, DOI 10.1029/RG020i004p00851; de Rooy WC, 2013, Q J ROY METEOR SOC, V139, P1, DOI 10.1002/qj.1959; Mobis B, 2012, J ADV MODEL EARTH SY, V4, DOI 10.1029/2012MS000199; Khairoutdinov M, 2006, J ATMOS SCI, V63, P3421, DOI 10.1175/JAS3810.1; Song XL, 2009, J CLIMATE, V22, P4299, DOI 10.1175/2009JCLI2642.1; Bechtold P, 2014, J ATMOS SCI, V71, P734, DOI 10.1175/JAS-D-13-0163.1; Holloway CE, 2009, J ATMOS SCI, V66, P1665, DOI 10.1175/2008JAS2806.1; Takemura T, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005029; [Anonymous], 2012, ARCH REV, V10, P3, DOI DOI 10.2151/JMSJ.2012-A16; Chikira M, 2010, J ATMOS SCI, V67, P2194, DOI 10.1175/2010JAS3317.1; Del Genio AD, 2010, J CLIMATE, V23, P2722, DOI 10.1175/2009JCLI3340.1; Sekiguchi M, 2008, J QUANT SPECTROSC RA, V109, P2779, DOI 10.1016/j.jqsrt.2008.07.013; TOKIOKA T, 1988, J METEOROL SOC JPN, V66, P883; Takata K, 2003, GLOBAL PLANET CHANGE, V38, P209, DOI 10.1016/S0921-8181(03)00030-4; Kim D, 2011, J CLIMATE, V24, P5506, DOI 10.1175/2011JCLI4177.1; Zhang GJ, 2010, J CLIMATE, V23, P800, DOI 10.1175/2009JCLI3109.1; Hirons LC, 2013, Q J ROY METEOR SOC, V139, P1427, DOI 10.1002/qj.2059; Dai A, 2006, J CLIMATE, V19, P4605, DOI 10.1175/JCLI3884.1; Grant ALM, 1999, Q J ROY METEOR SOC, V125, P1913, DOI 10.1256/smsqj.55801; Pan DM, 1998, Q J ROY METEOR SOC, V124, P949, DOI 10.1256/smsqj.54713; De Szoeke SP, 2008, J CLIMATE, V21, P2573, DOI 10.1175/2007JCLI1975.1; Takemi T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020225; Xie SP, 2007, J CLIMATE, V20, P1504, DOI 10.1175/JCLI4080.1; Chikira M, 2010, J ATMOS SCI, V67, P2171, DOI 10.1175/2010JAS3316.1; Redelsperger JL, 2002, J ATMOS SCI, V59, P2438, DOI 10.1175/1520-0469(2002)059<2438:RPAFLC>2.0.CO;2; Johnson RH, 1999, J CLIMATE, V12, P2397, DOI 10.1175/1520-0442(1999)012<2397:TCOTC>2.0.CO;2; Hirota N, 2012, CLIM DYNAM, V39, P2219, DOI 10.1007/s00382-012-1416-y; Bellucci A, 2010, J CLIMATE, V23, P1127, DOI 10.1175/2009JCLI3002.1; Watanabe M, 2011, J CLIMATE, V24, P543, DOI 10.1175/2010JCLI3878.1; Watanabe M, 2009, CLIM DYNAM, V33, P795, DOI 10.1007/s00382-008-0489-0; Meehl GA, 2005, B AM METEOROL SOC, V86, P89, DOI 10.1175/BAMS-86-1-89; Lin JL, 2006, J CLIMATE, V19, P2665, DOI 10.1175/JCLI3735.1; TIEDTKE M, 1989, MON WEATHER REV, V117, P1779, DOI 10.1175/1520-0493(1989)117<1779:ACMFSF>2.0.CO;2; Wheeler M, 1999, J ATMOS SCI, V56, P374, DOI 10.1175/1520-0469(1999)056<0374:CCEWAO>2.0.CO;2; Bechtold P, 2008, Q J ROY METEOR SOC, V134, P1337, DOI 10.1002/qj.289; Arakawa A, 2004, J CLIMATE, V17, P2493, DOI 10.1175/1520-0442(2004)017<2493:RATCPP>2.0.CO;2; Philander SGH, 1996, J CLIMATE, V9, P2958, DOI 10.1175/1520-0442(1996)009<2958:WTIIMN>2.0.CO;2; Maloney ED, 2001, J CLIMATE, V14, P2015, DOI 10.1175/1520-0442(2001)014<2015:TSOIVI>2.0.CO;2; Takayabu YN, 2010, J CLIMATE, V23, P2030, DOI 10.1175/2009JCLI3110.1; Wang YQ, 2007, MON WEATHER REV, V135, P567, DOI 10.1175/MWR3308.1; Del Genio AD, 2012, J CLIMATE, V25, P3755, DOI 10.1175/JCLI-D-11-00384.1; Kuang ZM, 2006, J ATMOS SCI, V63, P1895, DOI 10.1175/JAS3723.1; [Anonymous], 2010, SHARING, V19, P5, DOI DOI 10.1175/2010JCLI3679.1; SIMPSON J, 1969, MON WEATHER REV, V97, P471, DOI 10.1175/1520-0493(1969)097<0471:MOPCT>2.3.CO;2; Gregory D, 2001, Q J ROY METEOR SOC, V127, P53, DOI 10.1256/smsqj.57103; Chikira M, 2013, J ATMOS SCI, V70, P3920, DOI 10.1175/JAS-D-13-034.1; Emori S, 2001, J METEOROL SOC JPN, V79, P939, DOI 10.2151/jmsj.79.939; ESBENSEN S, 1978, J ATMOS SCI, V35, P826, DOI 10.1175/1520-0469(1978)035<0826:BTEAPO>2.0.CO;2; Hirota N, 2013, CLIM DYNAM, V41, P2909, DOI 10.1007/s00382-013-1839-0; Lin CC, 1999, J ATMOS SCI, V56, P3736, DOI 10.1175/1520-0469(1999)056<3736:SBPOCE>2.0.CO;2; Lin YL, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017018; Manabe S., 1965, MON WEA REV, V93, P769, DOI [10.1175/1520-0493(1965)093<lessthan>0769:SCOAGC<greaterthan>2.3.CO;2, DOI 10.1175/1520-0493(1965)093<0769:SCOAGC>2.3.CO;2]; MECHOSO CR, 1995, MON WEATHER REV, V123, P2825, DOI 10.1175/1520-0493(1995)123<2825:TSCOTT>2.0.CO;2; Miura H, 2012, SOLA, V8, P165, DOI 10.2151/sola.2012-040; Oueslati B, 2013, J CLIMATE, V26, P2931, DOI 10.1175/JCLI-D-12-00314.1; Zipser E. J., 2003, METEOROL MONOGR, V29, P49, DOI [10.1175/0065-9401(2003)029<0049:CSVOHT>2.0.CO;2, DOI 10.1175/0065-9401(2003)029<0049:CSVOHT>2.0.CO;2]	64	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	DEC	2014	27	23					8707	8723		10.1175/JCLI-D-13-00701.1		17	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AW1NC	WOS:000346055100007		
J	Hsu, PC; Li, T; Murakami, H				Hsu, Pang-Chi; Li, Tim; Murakami, Hiroyuki			Moisture Asymmetry and MJO Eastward Propagation in an Aquaplanet General Circulation Model	JOURNAL OF CLIMATE			English	Article							MADDEN-JULIAN OSCILLATION; TROPICAL INTRASEASONAL OSCILLATION; SEA-SURFACE TEMPERATURE; STATIC ENERGY BUDGET; VERTICAL STRUCTURE; LIFE-CYCLE; DYNAMICS; PARAMETERIZATION; SIMULATIONS; VARIABILITY	The role of zonal moisture asymmetry in the eastward propagation of the Madden-Julian oscillation (MJO) is investigated through a set of aquaplanet atmospheric general circulation model (AGCM) experiments with a zonally symmetric sea surface temperature distribution. In the control experiment, the model produces eastward-propagating MJO-like perturbations with a dominant period of 30-90 days. The model MJO exhibits a clear zonal asymmetry in the lower-tropospheric specific humidity field, with a positive (negative) anomaly appearing to the east (west) of the MJO convection. A diagnosis of the lower-tropospheric moisture budget indicates that the asymmetry primarily arises from vertical moisture advection associated with boundary layer convergence, while horizontal moisture advection has the opposite effect. In a sensitivity experiment, the lower-tropospheric specific humidity field is relaxed toward a zonal-mean basic state derived from the control simulation. In this case, the model's mean state remains the same, but its intraseasonal mode becomes quasi-stationary. The numerical model experiments clearly demonstrate the importance of the zonal moisture asymmetry in MJO eastward propagation.	[Hsu, Pang-Chi; Li, Tim] Nanjing Univ Informat Sci & Technol, Int Lab Climate & Environm Change, CDRC ESMC, Nanjing, Jiangsu, Peoples R China; [Hsu, Pang-Chi; Li, Tim; Murakami, Hiroyuki] Univ Hawaii Manoa, SOEST, IPRC, Honolulu, HI 96822 USA; [Murakami, Hiroyuki] Meteorol Res Inst, Climate Res Dept, Tsukuba, Ibaraki 305, Japan	Li, T (reprint author), Univ Hawaii Manoa, SOEST, IPRC, 1680 East West Rd,Post Bldg 401, Honolulu, HI 96822 USA.	timli@hawaii.edu	Murakami, Hiroyuki/L-5745-2015		China National 973 Project [2015CB453200]; NSFC [41375100, 41475084]; Natural Science Foundation of Jiangsu Province [BK20140046]; Research Project of Chinese Ministry of Education [213014A]; NSF [AGS-1106536]; ONR [N00014-1210450]; International Pacific Research Center	This work was supported by China National 973 Project 2015CB453200, NSFC Grants 41375100 and 41475084, Natural Science Foundation of Jiangsu Province (BK20140046), Research Project of Chinese Ministry of Education (213014A), NSF Grant AGS-1106536, ONR Grant N00014-1210450, and by the International Pacific Research Center. Comments from three anonymous reviewers are greatly appreciated. The authors thank the modeling groups at the MRI for their help on model experiments. The numerical simulations were performed on the Earth Simulator.	Andersen JA, 2012, J CLIMATE, V25, P2782, DOI 10.1175/JCLI-D-11-00168.1; Yoshimura H, 2015, MON WEATHER REV, V143, P597, DOI 10.1175/MWR-D-14-00068.1; WANG B, 1990, J ATMOS SCI, V47, P397, DOI 10.1175/1520-0469(1990)047<0397:DOTCMK>2.0.CO;2; Kiranmayi L, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016031; YANAI M, 1973, J ATMOS SCI, V30, P611, DOI 10.1175/1520-0469(1973)030<0611:DOBPOT>2.0.CO;2; Maloney ED, 1998, J CLIMATE, V11, P2387, DOI 10.1175/1520-0442(1998)011<2387:FMCIAC>2.0.CO;2; Raymond DJ, 2001, J ATMOS SCI, V58, P2807, DOI 10.1175/1520-0469(2001)058<2807:ANMOTM>2.0.CO;2; ARAKAWA A, 1974, J ATMOS SCI, V31, P674, DOI 10.1175/1520-0469(1974)031<0674:IOACCE>2.0.CO;2; EMANUEL KA, 1987, J ATMOS SCI, V44, P2324, DOI 10.1175/1520-0469(1987)044<2324:AASIMO>2.0.CO;2; NEELIN JD, 1987, J ATMOS SCI, V44, P2341, DOI 10.1175/1520-0469(1987)044<2341:EWFALF>2.0.CO;2; Benedict JJ, 2007, J ATMOS SCI, V64, P2332, DOI 10.1175/JAS3968.1; HAYASHI YY, 1986, J METEOROL SOC JPN, V64, P451; Mizuta R, 2012, J METEOROL SOC JPN, V90A, P233, DOI 10.2151/jmsj.2012-A12; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Sobel A, 2013, J ATMOS SCI, V70, P187, DOI 10.1175/JAS-D-12-0189.1; SALBY ML, 1994, J ATMOS SCI, V51, P2344, DOI 10.1175/1520-0469(1994)051<2344:PSCITP>2.0.CO;2; Sperber KR, 2003, MON WEATHER REV, V131, P3018, DOI 10.1175/1520-0493(2003)131<3018:PATVSO>2.0.CO;2; Kemball-Cook SR, 2001, J CLIMATE, V14, P780, DOI 10.1175/1520-0442(2001)014<0780:TOOCIT>2.0.CO;2; Hsu PC, 2012, J CLIMATE, V25, P4914, DOI 10.1175/JCLI-D-11-00310.1; WANG B, 1994, J ATMOS SCI, V51, P1386, DOI 10.1175/1520-0469(1994)051<1386:CIWBLD>2.0.CO;2; LI TM, 1994, MON WEATHER REV, V122, P2349, DOI 10.1175/1520-0493(1994)122<2349:TIOSST>2.0.CO;2; Maloney ED, 2009, J CLIMATE, V22, P711, DOI 10.1175/2008JCLI2542.1; HENDON HH, 1994, J ATMOS SCI, V51, P2225, DOI 10.1175/1520-0469(1994)051<2225:TLCOTM>2.0.CO;2; Li T, 2014, J METEOROL RES-PRC, V28, P1, DOI 10.1007/s13351-014-3087-6; Kiladis GN, 2005, J ATMOS SCI, V62, P2790, DOI 10.1175/JAS3520.1; MADDEN RA, 1972, J ATMOS SCI, V29, P1109, DOI 10.1175/1520-0469(1972)029<1109:DOGSCC>2.0.CO;2; TIEDTKE M, 1989, MON WEATHER REV, V117, P1779, DOI 10.1175/1520-0493(1989)117<1779:ACMFSF>2.0.CO;2; MADDEN RA, 1971, J ATMOS SCI, V28, P702, DOI 10.1175/1520-0469(1971)028<0702:DOADOI>2.0.CO;2; Li T, 2009, J ATMOS SCI, V66, P2429, DOI 10.1175/2009JAS2968.1; Lee MI, 2003, J METEOROL SOC JPN, V81, P963, DOI 10.2151/jmsj.81.963; Maloney ED, 2010, J ADV MODEL EARTH SY, V2, DOI 10.3894/JAMES.2010.2.5; NAKAZAWA T, 1988, J METEOROL SOC JPN, V66, P823	32	3	3	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	DEC	2014	27	23					8747	8760		10.1175/JCLI-D-14-00148.1		14	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AW1NC	WOS:000346055100010		
J	Nakanowatari, T; Sato, K; Inoue, J				Nakanowatari, Takuya; Sato, Kazutoshi; Inoue, Jun			Predictability of the Barents Sea Ice in Early Winter: Remote Effects of Oceanic and Atmospheric Thermal Conditions from the North Atlantic	JOURNAL OF CLIMATE			English	Article							CANONICAL CORRELATION-ANALYSIS; NORDIC SEAS; ARCTIC AMPLIFICATION; GULF-STREAM; SURFACE TEMPERATURE; CROSS-VALIDATION; FORECAST SKILL; VARIABILITY; CIRCULATION; EXTENT	Predictability of sea ice concentrations (SICs) in the Barents Sea in early winter (November-December) is studied using canonical correlation analysis with atmospheric and ocean anomalies from the NCEP Climate Forecast System Reanalysis (CFSR) data. It is found that the highest prediction skill for a single-predictor model is obtained from the 13-month lead subsurface temperature at 200-m depth (T200) and the in-phase meridional surface wind (V-sfc). T200 skillfully predicts SIC variability in 35% of the Barents Sea, mainly in the eastern side. The T200 for negative sea ice anomalies exhibits warm anomalies in the subsurface ocean temperature downstream of the Norwegian Atlantic Slope Current (NwASC) on a decadal time scale. The diagnostic analysis of NCEP CFSR data suggests that the subsurface temperature anomaly stored below the thermocline during summer reemerges in late autumn by atmospheric cooling and affects the sea ice. The subsurface temperature anomaly of the NwASC is advected from the North Atlantic subpolar gyre over; similar to 3 years. Also, V-sfc skillfully predicts SIC variability in 32% of the Barents Sea, mainly in the western side. The V-sfc for the negative sea ice anomalies exhibits southerly wind anomalies; V-sfc is related to the large-scale atmospheric circulation patterns from the subtropical North Atlantic to the Eurasian continent. This study suggests that both atmospheric and oceanic remote effects have a potential impact on the forecasting accuracy of SIC.	[Nakanowatari, Takuya] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan; [Sato, Kazutoshi; Inoue, Jun] Grad Univ Adv Studies, Tachikawa, Tokyo, Japan; [Sato, Kazutoshi; Inoue, Jun] JAMSTEC, Res & Dev Ctr Global Change, Yokosuka, Kanagawa, Japan; [Inoue, Jun] Natl Inst Polar Res, Tachikawa, Tokyo, Japan	Nakanowatari, T (reprint author), Japan Agcy Marine Earth Sci & Technol, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	nakanow@jamstec.go.jp			 [24241009];  [22221001];  [13J10583]	The hydrographic data in the Kola section were provided by the Polar Research Institute of Marine Fisheries and Oceanography (http://www.pinro.ru), Murmansk, Russia. The hydrographic data in the BSO were provided by the Institute of Marine Research (http://www.imr.no/en), Bergen, Norway. We wish to thank three anonymous reviewers for their constructive comments. Some figures were produced with the GrADS package developed by B. Doty. This work was supported by funding from a Grant-in-Aid for Scientific Research (24241009, 22221001), for Scientific Research on Innovative Areas, and for JSPS fellows (13J10583).	Koenigk T, 2014, CLIM DYNAM, V42, P3101, DOI 10.1007/s00382-013-1821-x; Minobe S, 2010, J CLIMATE, V23, P3699, DOI 10.1175/2010JCLI3359.1; Koenigk T, 2009, CLIM DYNAM, V32, P1119, DOI 10.1007/s00382-008-0450-2; Deser C, 2000, J CLIMATE, V13, P617, DOI 10.1175/1520-0442(2000)013<0617:ASIVIT>2.0.CO;2; Vihma T, 2014, SURV GEOPHYS, V35, P1175, DOI 10.1007/s10712-014-9284-0; Cohen J, 2014, NAT GEOSCI, V7, P627, DOI [10.1038/ngeo2234, 10.1038/NGEO2234]; Arthun M, 2010, J MARINE SYST, V83, P88, DOI 10.1016/j.jmarsys.2010.07.003; ELSNER JB, 1994, WEATHER FORECAST, V9, P619, DOI 10.1175/1520-0434(1994)009<0619:AFSTCV>2.0.CO;2; Hughes SL, 2009, ICES J MAR SCI, V66, P1467, DOI 10.1093/icesjms/fsp041; Screen JA, 2014, NAT CLIM CHANGE, V4, P704, DOI 10.1038/nclimate2271; Serreze MC, 2006, CLIMATIC CHANGE, V76, P241, DOI 10.1007/s10584-005-9017-y; Minobe S, 2008, NATURE, V452, P206, DOI 10.1038/nature06690; Smedsrud LH, 2013, REV GEOPHYS, V51, P415, DOI 10.1002/rog.20017; Livezey RE, 1999, J CLIMATE, V12, P303, DOI 10.1175/1520-0442-12.1.303; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Arthun M, 2012, J CLIMATE, V25, P4736, DOI 10.1175/JCLI-D-11-00466.1; OLENIC EA, 1988, MON WEATHER REV, V116, P1682, DOI 10.1175/1520-0493(1988)116<1682:PCITUO>2.0.CO;2; Sato K, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/084009; Frankignoul C, 2001, J PHYS OCEANOGR, V31, P3516, DOI 10.1175/1520-0485(2002)031<3516:GSVAOA>2.0.CO;2; Bengtsson L, 2007, B AM METEOROL SOC, V88, P495, DOI 10.1175/BAMS-88-4-495; Sorteberg A, 2006, J CLIMATE, V19, P4772, DOI 10.1175/JCLI3885.1; Kwok R, 2009, J CLIMATE, V22, P2438, DOI 10.1175/2008JCLI2819.1; Chevallier M, 2013, J CLIMATE, V26, P6092, DOI 10.1175/JCLI-D-12-00612.1; Zwiers FW, 2004, INT J CLIMATOL, V24, P665, DOI 10.1002/joc.1027; Zhang XD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035607; BARNSTON AG, 1994, J CLIMATE, V7, P1513, DOI 10.1175/1520-0442(1994)007<1513:LSSTCP>2.0.CO;2; Wang WQ, 2011, CLIM DYNAM, V37, P1601, DOI 10.1007/s00382-010-0935-7; Inoue J, 2012, J CLIMATE, V25, P2561, DOI 10.1175/JCLI-D-11-00449.1; Hatun H, 2005, SCIENCE, V309, P1841, DOI 10.1126/science.1114777; Polyakov IV, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023740; WALLACE JM, 1981, MON WEATHER REV, V109, P784, DOI 10.1175/1520-0493(1981)109<0784:TITGHF>2.0.CO;2; BRETHERTON CS, 1992, J CLIMATE, V5, P541, DOI 10.1175/1520-0442(1992)005<0541:AIOMFF>2.0.CO;2; Screen JA, 2014, NAT CLIM CHANGE, V4, P577, DOI [10.1038/nclimate2268, 10.1038/NCLIMATE2268]; BARNETT TP, 1987, MON WEATHER REV, V115, P1825, DOI 10.1175/1520-0493(1987)115<1825:OALOMA>2.0.CO;2; Hakkinen S, 2004, SCIENCE, V304, P555, DOI 10.1126/science.1094917; Yang ST, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053338; Joyce TM, 2000, J CLIMATE, V13, P2550, DOI 10.1175/1520-0442(2000)013<2550:TRBDVO>2.0.CO;2; Peings Y, 2014, J CLIMATE, V27, P244, DOI 10.1175/JCLI-D-13-00272.1; BLINDHEIM J, 1981, Fiskeridirektoratets Skrifter Serie Havundersokelser, V17, P161; Cavalieri D J, 1996, SEA ICE CONCENTRATIO; Cavalieri D. J., 1994, 104559 NASA; Chassignet E. P., 2008, GEOPHYS MONOGR SER, V177, P39; Conkright M. E., 1999, 14 NAT OC DAT CTR; Divine DV, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002851; Francis JA, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051000; Francis JA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030995; Glass L., 1995, UNDERSTANDING NONLIN; Grumbine R. W., 1996, 120 NCEP OMB; Hilmer M., 1998, Geophysical Research Letters, V25, DOI 10.1029/98GL52360; Honda M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037079; Kauker F, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001573; Kimura N, 2001, J GEOPHYS RES-OCEANS, V106, P31319, DOI 10.1029/2000JC000739; Maslanik J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028269; MICHAELSEN J, 1987, J CLIM APPL METEOROL, V26, P1589, DOI 10.1175/1520-0450(1987)026<1589:CVISCF>2.0.CO;2; Parkinson CL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004558; Petoukhov V, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013568; Roemmich D., 2001, OBSERVING OCEANS 21, P248; Sando AB, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005884; Schlichtholz P, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2009JC005944; Schlichtholz P, 2013, J CLIMATE, V26, P2957, DOI 10.1175/JCLI-D-11-00594.1; Schlichtholz P, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045894; Serreze MC, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008230; Shapiro I, 2003, POLAR RES, V22, P5, DOI 10.1111/j.1751-8369.2003.tb00089.x; Simmonds I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039810; Simonsen K, 1996, J GEOPHYS RES-OCEANS, V101, P6553, DOI 10.1029/95JC03305; Skagseth O., 2008, ARCTIC SUBARCTIC OCE, P45, DOI DOI 10.1007/978-1-4020-6774-7_3; Deser C, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032023; Tivy A, 2011, J CLIMATE, V24, P1378, DOI 10.1175/2010JCLI3527.1; Vinje T, 2001, J CLIMATE, V14, P255, DOI 10.1175/1520-0442(2001)014<0255:AATOSI>2.0.CO;2; Von Storch H., 1999, STAT ANAL CLIMATE RE; Wang W., 2013, J CLIMATE, V141, P1375, DOI [10.1175/MWR-D-12-00057.1, DOI 10.1175/MWR-D-12-00057.1]; Xue Y, 2011, CLIM DYNAM, V37, P2511, DOI 10.1007/s00382-010-0954-4	73	3	3	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	DEC	2014	27	23					8884	8901		10.1175/JCLI-D-14-00125.1		18	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AW1NC	WOS:000346055100018		
J	Horn, M; Walsh, K; Zhao, M; Camargo, SJ; Scoccimarro, E; Murakami, H; Wang, H; Ballinger, A; Kumar, A; Shaevitz, DA; Jonas, JA; Oouchi, K				Horn, Michael; Walsh, Kevin; Zhao, Ming; Camargo, Suzana J.; Scoccimarro, Enrico; Murakami, Hiroyuki; Wang, Hui; Ballinger, Andrew; Kumar, Arun; Shaevitz, Daniel A.; Jonas, Jeffrey A.; Oouchi, Kazuyoshi			Tracking Scheme Dependence of Simulated Tropical Cyclone Response to Idealized Climate Simulations	JOURNAL OF CLIMATE			English	Article							RESOLUTION; MODELS; ARCHIVE	Future tropical cyclone activity is a topic of great scientific and societal interest. In the absence of a climate theory of tropical cyclogenesis, general circulation models are the primary tool available for investigating the issue. However, the identification of tropical cyclones in model data at moderate resolution is complex, and numerous schemes have been developed for their detection. The influence of different tracking schemes on detected tropical cyclone activity and responses in the Hurricane Working Group experiments is examined herein. These are idealized atmospheric general circulation model experiments aimed at determining and distinguishing the effects of increased sea surface temperature and other increased CO2 effects on tropical cyclone activity. Two tracking schemes are applied to these data and the tracks provided by each modeling group are analyzed. The results herein indicate moderate agreement between the different tracking methods, with some models and experiments showing better agreement across schemes than others. When comparing responses between experiments, it is found that much of the disagreement between schemes is due to differences in duration, wind speed, and formation-latitude thresholds. After homogenization in these thresholds, agreement between different tracking methods is improved. However, much disagreement remains, accountable for by more fundamental differences between the tracking schemes. The results indicate that sensitivity testing and selection of objective thresholds are the key factors in obtaining meaningful, reproducible results when tracking tropical cyclones in climate model data at these resolutions, but that more fundamental differences between tracking methods can also have a significant impact on the responses in activity detected.	[Horn, Michael; Walsh, Kevin] Univ Melbourne, Sch Earth Sci, Melbourne, Vic, Australia; [Zhao, Ming] NOAA GFDL, Princeton, NJ USA; [Camargo, Suzana J.; Shaevitz, Daniel A.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Scoccimarro, Enrico; Jonas, Jeffrey A.] Ist Nazl Geofis & Vulcanol, Bologna, Italy; [Scoccimarro, Enrico; Jonas, Jeffrey A.] Centro Euro Mediterraneo Cambiamenti Climat, Bologna, Italy; [Murakami, Hiroyuki] IPRC MRI, Tsukuba, Ibaraki, Japan; [Wang, Hui; Kumar, Arun] NOAA NWS NCEP Climate Predict Ctr, College Pk, MD USA; [Ballinger, Andrew] Princeton Univ, Program Atmospher & Ocean Sci, Princeton, NJ 08544 USA; Columbia Univ, Dept Appl Phys & Appl Math, New York, NY USA; Columbia Univ, Ctr Climate Syst Res, New York, NY USA; NASA Goddard Inst Space Studies, New York, NY USA; [Oouchi, Kazuyoshi] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa, Japan	Horn, M (reprint author), Univ Melbourne, Sch Earth Sci, Corner Swanston & Elgin St, Parkville, Vic 3010, Australia.	mjhorn@student.unimelb.edu.au	Camargo, Suzana/C-6106-2009; Murakami, Hiroyuki/L-5745-2015; Zhao, Ming/C-6928-2014	Camargo, Suzana/0000-0002-0802-5160; 	NSF [AGS 1143959]; NASA [NNX09AK34G]; Italian Ministry of Education, University and Research; Italian Ministry of Environment, Land and Sea	The authors thank the U.S. Climate Variability and Predictability Program, the Australian Research Council Centre of Excellence for Climate System Science, and their respective institutions for supporting this work. Suzana Camargo, Dan Shaevitz, and Kevin Walsh are supported by NSF Grant AGS 1143959. Suzana Camargo is supported by NASA Grant NNX09AK34G. Enrico Scoccimarro acknowledges support from the Italian Ministry of Education, University and Research and the Italian Ministry of Environment, Land and Sea under the GEMINA project. Thanks also to Sally Lavender of CSIRO for help with plotting software. We acknowledge also the support provided by Naomi Henderson, who compiled the HWG model output archive.	Camargo SJ, 2013, J CLIMATE, V26, P9880, DOI 10.1175/JCLI-D-12-00549.1; Zhao M, 2009, J CLIMATE, V22, P6653, DOI 10.1175/2009JCLI3049.1; Walsh KJE, 2007, J CLIMATE, V20, P2307, DOI 10.1175/JCLI4074.1; Landsea CW, 2010, J CLIMATE, V23, P2508, DOI 10.1175/2009JCLI3034.1; Murakami H, 2012, J CLIMATE, V25, P3237, DOI 10.1175/JCLI-D-11-00415.1; Mizuta R, 2012, J METEOROL SOC JPN, V90A, P233, DOI 10.2151/jmsj.2012-A12; Held IM, 2011, J CLIMATE, V24, P5353, DOI 10.1175/JCLI-D-11-00050.1; Stowasser M, 2007, J CLIMATE, V20, P2378, DOI 10.1175/JCLI4126.1; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Saha S, 2014, J CLIMATE, V27, P2185, DOI 10.1175/JCLI-D-12-00823.1; Camargo SJ, 2002, WEATHER FORECAST, V17, P1152, DOI 10.1175/1520-0434(2002)017<1152:ITDATO>2.0.CO;2; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Schmidt GA, 2014, J ADV MODEL EARTH SY, V6, P141, DOI 10.1002/2013MS000265; Strachan J, 2013, J CLIMATE, V26, P133, DOI 10.1175/JCLI-D-12-00012.1; Walsh K, 2013, CLIM DYNAM, V40, P585, DOI 10.1007/s00382-012-1298-z; Vecchi GA, 2013, J CLIMATE, V26, P3877, DOI 10.1175/JCLI-D-12-00503.1; Tory KJ, 2013, J CLIMATE, V26, P9946, DOI 10.1175/JCLI-D-13-00010.1; Bengtsson L, 2007, TELLUS A, V59, P539, DOI 10.1111/j.1600-0870.2007.00251.x; Horn M., 2013, P US CLIVAR HURR WOR; Li FY, 2013, J ADV MODEL EARTH SY, V5, P134, DOI 10.1002/jame.20020; Roeckner E., 2003, 349 M PLANCK I MET, V349, P127; SHAPIRO MA, 1990, EXTRATROPICAL CYCLONES, P167; Walsh K, 2014, CLIM DYNAM, V42, P1053, DOI 10.1007/s00382-013-1723-y	23	6	6	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	DEC	2014	27	24					9197	9213		10.1175/JCLI-D-14-00200.1		17	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AW1NK	WOS:000346055900012		
J	Shoji, T; Kanno, Y; Iwasaki, T; Takaya, K				Shoji, Takamichi; Kanno, Yuki; Iwasaki, Toshiki; Takaya, Koutarou			An Isentropic Analysis of the Temporal Evolution of East Asian Cold Air Outbreaks	JOURNAL OF CLIMATE			English	Article							NORTHERN HEMISPHERIC WINTER; HYBRID VERTICAL COORDINATE; INTRASEASONAL AMPLIFICATION; INTERANNUAL VARIATION; ARCTIC OSCILLATION; MONSOON; SURGES; CIRCULATION; MASS; PRESSURE	The equatorward cold airmass flux below potential temperature theta(T) = 280K across 45 degrees N integrated from 90 degrees E to 180 degrees is used as an index to quantitatively measure cold air outbreaks (CAOs) in the East Asian winter monsoon. Intermittent CAOs over East Asia significantly contribute to the global equatorward cold airmass flux. An autocorrelation analysis indicates that CAO events persist for approximately 5 days. The geographical distributions of lagged correlations/regressions with the CAO index (CAOI) clarify the temporal evolution of synoptic conditions associated with CAOs. The developing Siberian high located northwest of Lake Baikal (65 degrees N, 100 degrees E) on day -4 slowly moves southeastward, reaches maximum intensity over Siberia (50 degrees N, 110 degrees E) on day 0, and then decays while moving rapidly southward. By contrast, the Aleutian low is almost stagnant and maintains a strong intensity. The eastward pressure gradient geostrophically induces the equatorward cold airmass flux. After day -2, the cold air mass significantly decreases over Siberia, but increases over East Asia and the western North Pacific Ocean. The cold air mass continues to migrate southward while spreading eastward, and disappears mainly over the ocean. The leading edge of the high pressure anomaly moves southward at 13 ms(-1) and reaches the equator simultaneously with the equatorward wind anomaly on about day 14. An additional analysis of separating the equatorward flux into 90 degrees-135 degrees E and 135 degrees E-180 degrees suggests that CAOs are, to some extent, caused by the Siberian high and the Aleutian low acting separately.	[Shoji, Takamichi; Kanno, Yuki; Iwasaki, Toshiki] Tohoku Univ, Grad Sch Sci, Dept Geophys, Sendai, Miyagi 9808578, Japan; [Takaya, Koutarou] Kyoto Sangyo Univ, Dept Phys, Dept Phys, Kyoto 603, Japan	Iwasaki, T (reprint author), Tohoku Univ, Grad Sch Sci, Aoba Ku, 6-3 Aoba, Sendai, Miyagi 9808578, Japan.	iwasaki@wind.gp.tohoku.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology	We would like to express sincere thanks to anonymous reviewers for their informative comments. This study is supported in part by the Japanese Ministry of Education, Culture, Sports, Science and Technology through a Grant-in-Aid for Scientific Research in Innovative AREAS 2205 and Research Program on Climate Change Adaptation (RECCA).	Huang RH, 2012, ADV ATMOS SCI, V29, P910, DOI 10.1007/s00376-012-2015-x; Chen TC, 2004, J CLIMATE, V17, P401, DOI 10.1175/1520-0442(2004)017<0401:IVOTEA>2.0.CO;2; Iwasaki T, 2014, J ATMOS SCI, V71, P2230, DOI 10.1175/JAS-D-13-058.1; Park TW, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014794; CHANG CP, 1979, MON WEATHER REV, V107, P812, DOI 10.1175/1520-0493(1979)107<0812:NCSANE>2.0.CO;2; [Anonymous], 1987, STADSNIEUWS, V31, P2, DOI DOI 10.1175/1520-0493(1987)115; Zhang Y, 1997, MON WEATHER REV, V125, P2605, DOI 10.1175/1520-0493(1997)125<2605:CAIVOT>2.0.CO;2; Gong DY, 2001, GEOPHYS RES LETT, V28, P2073, DOI 10.1029/2000GL012311; Compo GP, 1999, Q J ROY METEOR SOC, V125, P29, DOI 10.1256/smsqj.55302; Li YQ, 2010, J CLIMATE, V23, P4255, DOI 10.1175/2010JCLI3375.1; Takaya K, 2005, J ATMOS SCI, V62, P4441, DOI 10.1175/JAS3628.1; Wang L, 2010, ADV ATMOS SCI, V27, P855, DOI 10.1007/s00376-009-9094-3; CHANG CP, 1982, MON WEATHER REV, V110, P933, DOI 10.1175/1520-0493(1982)110<0933:STPSIO>2.0.CO;2; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Juckes M, 2001, Q J ROY METEOR SOC, V127, P147, DOI 10.1256/smsqj.57108; Garreaud RD, 2001, INT J CLIMATOL, V21, P1181, DOI 10.1002/joc.687; Takaya K, 2005, J ATMOS SCI, V62, P4423, DOI 10.1175/JAS3629.1; Wang L, 2014, J CLIMATE, V27, P2361, DOI 10.1175/JCLI-D-13-00086.1; Jhun JG, 2004, J CLIMATE, V17, P711, DOI 10.1175/1520-0442(2004)017<0711:ANEAWM>2.0.CO;2; IWASAKI T, 1989, J METEOROL SOC JPN, V67, P293; Wu BY, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015373; Jeong JH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023024; Wang L, 2009, J CLIMATE, V22, P600, DOI 10.1175/2008JCLI2295.1; DING YH, 1990, METEOROL ATMOS PHYS, V44, P281; Iwasaki T, 2012, SOLA, V8, DOI 10.2151/sola.2012-029; IWASAKI T, 1992, J METEOROL SOC JPN, V70, P673; JUCKES MN, 1994, Q J ROY METEOR SOC, V120, P1017, DOI 10.1002/qj.49712051811; LAU NC, 1984, MON WEATHER REV, V112, P1309, DOI 10.1175/1520-0493(1984)112<1309:TSAEOM>2.0.CO;2; MURAKAMI T, 1983, J METEOROL SOC JPN, V61, P547; Ryoo SB, 2005, ADV ATMOS SCI, V22, P509, DOI 10.1007/BF02918484; SUMI A, 1985, J METEOROL SOC JPN, V63, P377; Tanaka D, 2004, J ATMOS SCI, V61, P2370, DOI 10.1175/1520-0469(2004)061<2370:EFDBOI>2.0.CO;2; TOWNSEND RD, 1985, J ATMOS SCI, V42, P1565, DOI 10.1175/1520-0469(1985)042<1565:ADSOTI>2.0.CO;2; WU MC, 1995, MON WEATHER REV, V123, P662, DOI 10.1175/1520-0493(1995)123<0662:SFOWMS>2.0.CO;2; Yoshikane T, 2008, J METEOROL SOC JPN, V86, P773, DOI 10.2151/jmsj.86.773	35	4	4	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	DEC	2014	27	24					9337	9348		10.1175/JCLI-D-14-00307.1		12	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AW1NK	WOS:000346055900020		
J	Sugimoto, S				Sugimoto, Shusaku			Influence of SST Anomalies on Winter Turbulent Heat Fluxes in the Eastern Kuroshio-Oyashio Confluence Region	JOURNAL OF CLIMATE			English	Article							SEA-SURFACE TEMPERATURE; NORTH PACIFIC; ATMOSPHERIC MODEL; VARIABILITY; OCEAN; EXTENSION; REANALYSIS; ROTATION; EXCHANGES; FEEDBACK	Variations in the turbulent heat flux (THF; the sum of the sensible and latent heat fluxes) in the eastern Kuroshio-Oyashio confluence region (EKOCR; 36 degrees-40 degrees N, 155 degrees-160 degrees E) were investigated over a period of 27 consecutive winters (December-February) from 1985/86 to 2011/12. The THF was calculated from a bulk formula using daily variables [surface wind speed, surface air specific humidity, surface air temperature, and sea surface temperature (SST)] of the objectively analyzed air-sea fluxes (OAFlux) dataset and bulk coefficients based on the Tropical Ocean and Global Atmosphere Coupled Ocean-Atmosphere Response Experiment (TOGA COARE) bulk flux algorithm 3.0. The winter THF over the EKOCR showed low-frequency variations, with larger THF values in the early 2000s and smaller values in the late 1990s and late 2000s. The heat release in the early 2000s was up to; similar to 40% greater than that in the late 1990s and late 2000s. By performing experiments using combinations of daily raw data values and daily climatological data, the relative contributions of SST, surface air specific humidity, surface air temperature, and surface wind speed were quantitatively assessed in determining the THF over the EKOCR. Results showed that SST predominantly determines the THF: large amounts of heat are released during times of positive SST anomalies. By using Argo float (temperature-salinity) profiles of 2003-12 and a satellite altimetry dataset of 1992-2012, it was found that the warm-salty water transported by an occurrence of the Kuroshio bifurcation was responsible for the generation of positive SST anomalies in the EKOCR.	[Sugimoto, Shusaku] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808578, Japan	Sugimoto, S (reprint author), Tohoku Univ, Grad Sch Sci, Dept Geophys, Aoba Ku, 6-3 Aramaki Aza Aoba, Sendai, Miyagi 9808578, Japan.	sugimoto@pol.gp.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [23106501]; Japan Society for the Promotion of Science [23740348]	The authors thank the members of the Physical Oceanography Group at Tohoku University for useful discussions. Three anonymous reviewers provided useful and constructive comments that helped improve the manuscript. This work was partly supported by a Grant-in-Aid for Scientific Research on Innovative Areas (23106501, "A 'hot spot' in the climate system: Extra-tropical air-sea interaction under the East Asian monsoon system'') from the Ministry of Education, Culture, Sports, Science and Technology and a Grant-in-Aid for Young Scientists (B) (23740348) from the Japan Society for the Promotion of Science.	KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Oka E, 2007, J OCEANOGR, V63, P293, DOI 10.1007/s10872-007-0029-2; Kushnir Y, 2002, J CLIMATE, V15, P2233, DOI 10.1175/1520-0442(2002)015<2233:AGRTES>2.0.CO;2; Nakamura M, 2010, J CLIMATE, V23, P6445, DOI 10.1175/2010JCLI3017.1; DAVIS RE, 1976, J PHYS OCEANOGR, V6, P249, DOI 10.1175/1520-0485(1976)006<0249:POSSTA>2.0.CO;2; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Sugimoto S, 2011, J CLIMATE, V24, P6551, DOI 10.1175/2011JCLI4023.1; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/Bams-83-11-1631, 10.1175/BAMS-83-11-1631]; Qiu B, 2005, J PHYS OCEANOGR, V35, P2090, DOI 10.1175/JPO2807.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Joyce TM, 2009, J CLIMATE, V22, P3177, DOI 10.1175/2008JCLI2690.1; Seo Y, 2014, J CLIMATE, V27, P5929, DOI 10.1175/JCLI-D-13-00641.1; Fairall CW, 2003, J CLIMATE, V16, P571, DOI 10.1175/1520-0442(2003)016<0571:BPOASF>2.0.CO;2; Frankignoul C, 2002, CLIM DYNAM, V19, P633, DOI 10.1007/s00382-002-0252-x; Nonaka M, 2009, J CLIMATE, V22, P6515, DOI 10.1175/2009JCLI2960.1; Itoh S, 2010, J PHYS OCEANOGR, V40, P1018, DOI 10.1175/2009JPO4265.1; Qiu B, 2002, J OCEANOGR, V58, P57, DOI 10.1023/A:1015824717293; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; LAU NC, 1994, J CLIMATE, V7, P1184, DOI 10.1175/1520-0442(1994)007<1184:AMSOTR>2.0.CO;2; Taguchi B, 2012, J CLIMATE, V25, P111, DOI 10.1175/JCLI-D-11-00046.1; AKIMA H, 1970, J ACM, V17, P589, DOI 10.1145/321607.321609; Tokinaga H, 2009, J CLIMATE, V22, P4241, DOI 10.1175/2009JCLI2763.1; Taguchi B, 2009, J CLIMATE, V22, P6536, DOI 10.1175/2009JCLI2910.1; Oka E, 2012, J OCEANOGR, V68, P355, DOI 10.1007/s10872-011-0098-0; Nakamura H, 1997, B AM METEOROL SOC, V78, P2215, DOI 10.1175/1520-0477(1997)078<2215:DCVITN>2.0.CO;2; Tanimoto Y, 2011, J CLIMATE, V24, P4419, DOI 10.1175/2011JCLI4062.1; Ducet N., 2000, J GEOPHYS RES, V105, P19, DOI DOI 10.1029/2000JC900063; Favorite F, 1976, INT N PACIFIC FISHER, V33; FRANKIGNOUL C, 1985, REV GEOPHYS, V23, P357, DOI 10.1029/RG023i004p00357; HANAWA K, 1995, J METEOROL SOC JPN, V73, P757; IWASAKA N, 1987, J METEOROL SOC JPN, V65, P103; KAISER HF, 1959, EDUC PSYCHOL MEAS, V19, P413, DOI 10.1177/001316445901900314; Kawai H, 1972, KUROSHIO ITS PHYSICA, P235; KLEEMAN R, 1995, J PHYS OCEANOGR, V25, P92, DOI 10.1175/1520-0485(1995)025<0092:ASAMOS>2.0.CO;2; NAKAMURA H, 2004, EATHS CLIMATE OCEAN, V147, P329; Qiu B, 2010, DEEP-SEA RES PT II, V57, P1098, DOI 10.1016/j.dsr2.2008.11.036; RICHMAN MB, 1986, J CLIMATOL, V6, P293; Tanimoto Y, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001750; Wallace JM, 1987, ATMOSPHERIC OCEANIC, P17; Yu L, 2008, OA200801 WOODS HOL O; Zhang YS, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003779	41	1	1	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755	1520-0442		J CLIMATE	J. Clim.	DEC	2014	27	24					9349	9358		10.1175/JCLI-D-14-00195.1		10	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AW1NK	WOS:000346055900021		
J	Rejab, MRM; Ushijima, K; Cantwell, WJ				Rejab, M. R. M.; Ushijima, K.; Cantwell, W. J.			The shear response of lightweight corrugated core structures	JOURNAL OF COMPOSITE MATERIALS			English	Article						Corrugated core; Arcan test; strength; failure criterion	COMPOSITE SANDWICH STRUCTURES; LOW-VELOCITY IMPACT; MECHANICAL-PROPERTIES; HONEYCOMB-CORES; BEHAVIOR; FOAM; PANELS; COMPRESSION; STRENGTH; LOADS	A combination of experimental, analytical and numerical techniques is used to characterise the shear response of lightweight corrugations based on glass fibre and carbon fibre reinforced epoxy resins. The corrugations were manufactured via a compression moulding procedure in which composite prepregs are cured between two serrated mould halves. The properties of the composite corrugations are compared with those offered by a similar aluminium system. Subsequent mechanical testing was undertaken using an Arcan rig capable of generating a range of loading conditions between pure shear and pure compression. As a result of difficulties in accurately measuring the displacement of the cores under mixed-loading conditions, an analytical model was used to predict the stiffness characteristics of the cores as a function of loading angle. The accuracy of the model was assessed using a finite element analysis. The final part of this investigation focused on fitting the measured values of maximum strength to an appropriate failure criterion. An examination of the corrugated structures during combined compression-shear loading indicated that the composite samples failed as a result of buckling in the strands and in certain cases, delamination between the composite plies. Both the analytical model and the finite element analysis indicated that the stiffness of composite and aluminium cores did not vary significantly with loading angle. An analysis of the strength characteristics of the corrugated cores showed that the aluminium corrugations could be accurately represented using a two-dimensional quadratic failure criterion. In contrast, due to the initiation of delamination within the composite struts, an additional component in the failure criterion was required to accurately capture the response of the composite corrugations.	[Rejab, M. R. M.] Univ Liverpool, Sch Engn, Liverpool L69 3GH, Merseyside, England; [Rejab, M. R. M.] Univ Malaysia Pahang, Fac Mech Engn, Pahang, Malaysia; [Ushijima, K.] Kyushu Sangyo Univ, Dept Mech Engn, Fukuoka, Japan; [Cantwell, W. J.] KUSTAR, Dept Aerosp Engn, Abu Dhabi, U Arab Emirates	Rejab, MRM (reprint author), Univ Liverpool, Sch Engn, Brownlow Hill, Liverpool L69 3GH, Merseyside, England.	ruzaimi@liv.ac.uk	Rejab, M.R.M./F-2884-2015	Rejab, M.R.M./0000-0002-4030-6085	Government of Malaysia; Universiti Malaysia Pahang	The authors are grateful to the Government of Malaysia and the Universiti Malaysia Pahang for funding this study.	Heimbs S, 2007, APPL COMPOS MATER, V14, P363, DOI 10.1007/s10443-008-9051-9; Petras A, 2000, COMPOS STRUCT, V50, P311, DOI 10.1016/S0263-8223(00)00122-7; Zhang ZH, 2011, THIN WALL STRUCT, V49, P1071, DOI 10.1016/j.tws.2011.03.017; Kintscher M, 2007, COMPOS PART A-APPL S, V38, P1288, DOI 10.1016/j.compositesa.2006.11.008; Li QM, 2000, INT J SOLIDS STRUCT, V37, P6321, DOI 10.1016/S0020-7683(99)00277-2; Yokozeki T, 2006, COMPOS PART A-APPL S, V37, P1578, DOI 10.1016/j.compositesa.2005.10.015; Malcom AJ, 2013, COMPOS PART A-APPL S, V54, P88, DOI 10.1016/j.compositesa.2013.07.007; Aminanda Y, 2005, APPL COMPOS MATER, V12, P213, DOI 10.1007/s10443-005-1125-3; Rejab MRM, 2013, COMPOS PART B-ENG, V47, P267, DOI 10.1016/j.compositesb.2012.10.031; Heimbs S, 2010, COMPOS STRUCT, V92, P1485, DOI 10.1016/j.compstruct.2009.11.001; Besant T, 2001, COMPOS PART A-APPL S, V32, P1189, DOI 10.1016/S1359-835X(01)00084-7; Kazemahvazi S, 2009, COMPOS SCI TECHNOL, V69, P920, DOI 10.1016/j.compscitech.2008.11.035; Cote F, 2006, INT J SOLIDS STRUCT, V43, P6220, DOI 10.1016/j.ijsolstr.2005.07.045; Kazemahvazi S, 2009, COMPOS SCI TECHNOL, V69, P913, DOI 10.1016/j.compscitech.2008.11.030; Vaidya UK, 2000, COMPOS PART A-APPL S, V31, P761, DOI 10.1016/S1359-835X(00)00025-7; Benderly D, 2004, POLYM TEST, V23, P51, DOI [10.1016/S0142-9418(03)00061-8, 10.1016/S01421-9418(03)00061-8]; Charca S, 2011, J SANDW STRUCT MATER, V13, P97, DOI 10.1177/1099636209344131; Chawla A, 2003, INT J CRASHWORTHINES, V8, P229, DOI 10.1533/ijcr.2003.0227; de Moura MFSF, 2006, INT J ADHES ADHES, V26, P464, DOI 10.1016/j.ijadhadh.2005.06.010; Fan X, 2009, J SANDW STRUCT MATER, V11, P179, DOI 10.1177/1099636208098219; Foo CC, 2007, COMPOS STRUCT, V80, P588, DOI 10.1016/j.compstruct.2006.07.010; Herrmann AS, 2005, P 7 INT C SANDW STRU, P3; Klaus M, 2012, INT J IMPACT ENG, V44, P50, DOI 10.1016/j.ijimpeng.2012.01.001; Lamb AJ, 2011, STRAIN, V47, P2, DOI 10.1111/j.1475-1305.2008.00575.x; Li GQ, 2010, COMPOS PART A-APPL S, V41, P177, DOI 10.1016/j.compositesa.2009.10.007; MINES RAW, 1995, COMPOSITES, V26, P803, DOI 10.1016/0010-4361(95)90874-Y; Mohr D, 2002, J COMPOS MATER, V36, P2538; Pan SD, 2006, COMPOS STRUCT, V72, P42, DOI 10.1016/j.compstruct.2004.10.011; Seibert HF, 2006, REINF PLAST, V50, P44, DOI 10.1016/S0034-3617(06)70873-6; Sharma N, 2006, J SANDW STRUCT MATER, V8, P263, DOI 10.1177/1099636206063337	30	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0021-9983	1530-793X		J COMPOS MATER	J. Compos Mater.	DEC	2014	48	30					3785	3798		10.1177/0021998313514086		14	Materials Science, Composites	Materials Science	AU9ET	WOS:000345895300008		
J	Cai, JJ; Lou, BD; Zhou, ML				Cai, Jingjing; Lou, Bendong; Zhou, Maolin			Asymptotic Behavior of Solutions of a Reaction Diffusion Equation with Free Boundary Conditions	JOURNAL OF DYNAMICS AND DIFFERENTIAL EQUATIONS			English	Article						Nonlinear diffusion equation; Free boundary problem; Asymptotic behavior; Monostable; Bistable; Combustion	FISHER-KPP EQUATION; MODEL	We study a nonlinear diffusion equation of the form with free boundary conditions and for some . Such problems may be used to describe the spreading of a biological or chemical species, with the free boundaries representing the expanding fronts. When , the problem was recently investigated by Du and Lin (SIAM J Math Anal 42:377-405, 2010) and Du and Lou (J Euro Math Soc arXiv:1301.5373. In this paper we consider the case . In this case shrinking (i.e. ) may happen, which is quite different from the case . Moreover, we show that, under certain conditions on , shrinking is equivalent to vanishing (i.e. ), both of them happen as tends to some finite time. On the other hand, every bounded and positive time-global solution converges to a nonzero stationary solution as . As applications, we consider monostable, bistable and combustion types of nonlinearities, and obtain a complete description on the asymptotic behavior of the solutions.	[Cai, Jingjing] Shanghai Univ Elect Power, Sch Math & Phys, Shanghai 200090, Peoples R China; [Lou, Bendong] Tongji Univ, Dept Math, Shanghai 200092, Peoples R China; [Zhou, Maolin] Univ Tokyo, Grad Sch Math Sci, Tokyo 1538914, Japan	Lou, BD (reprint author), Tongji Univ, Dept Math, 1239 Siping Rd, Shanghai 200092, Peoples R China.	cjjing1983@163.com; blou@tongji.edu.cn; zhouml@ms.u-tokyo.ac.jp			NSFC [11271285]; Shanghai Natural Science Foundation [13ZR1454900]	This research was partly supported by NSFC (No. 11271285) and by Shanghai Natural Science Foundation (No. 13ZR1454900).	Du YH, 2014, ARCH RATION MECH AN, V212, P957, DOI 10.1007/s00205-013-0710-0; ARONSON DG, 1978, ADV MATH, V30, P33, DOI 10.1016/0001-8708(78)90130-5; ANGENENT S, 1988, J REINE ANGEW MATH, V390, P79; Du YH, 2010, SIAM J MATH ANAL, V42, P377, DOI 10.1137/090771089; Du YH, 2010, J EUR MATH SOC, V12, P279, DOI 10.4171/JEMS/198; Bunting G, 2012, NETW HETEROG MEDIA, V7, P583, DOI 10.3934/nhm.2012.7.583; Du YH, 2014, SIAM J MATH ANAL, V46, P375, DOI 10.1137/130908063; Fernandez FJ, 2003, COMMUN PART DIFF EQ, V28, P1597, DOI 10.1081/PDE-120024523; Du YH, 2012, J DIFFER EQUATIONS, V253, P996, DOI 10.1016/j.jde.2012.04.014; Aronson D G, 1975, LECT NOTES MATH, V446, P5; Cai JJ, 2014, NONLINEAR ANAL-REAL, V16, P170, DOI 10.1016/j.nonrwa.2013.09.016; Du Y., J EUR MATH SOC	12	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1040-7294	1572-9222		J DYN DIFFER EQU	J. Dyn. Differ. Equ.	DEC	2014	26	4					1007	1028		10.1007/s10884-014-9404-z		22	Mathematics, Applied; Mathematics	Mathematics	AW3FO	WOS:000346171800008		
J	Lee, CC; Neoh, KB; Lee, CY				Lee, Ching-Chen; Neoh, Kok-Boon; Lee, Chow-Yang			Colony Size Affects the Efficacy of Bait Containing Chlorfluazuron Against the Fungus-Growing Termite Macrotermes gilvus (Blattodea: Termitidae)	JOURNAL OF ECONOMIC ENTOMOLOGY			English	Article						fungus-growing termite; Macrotermes gilvus; termite baiting; chlorfluazuron; colony size	COPTOTERMES-FORMOSANUS ISOPTERA; ACINACIFORMIS FROGGATT ISOPTERA; CHITIN SYNTHESIS INHIBITORS; SUBTERRANEAN TERMITES; FIELD-EVALUATION; CURVIGNATHUS ISOPTERA; HEXAFLUMURON BAITS; MATURE NESTS; RHINOTERMITIDAE; BISTRIFLURON	The efficacy of chitin synthesis inhibitors (CSIs) against fungus-growing termites is known to vary. In this study, 0.1% chlorfluazuron (CFZ) cellulose bait was tested against medium and large field colonies of Macrotermes gilvus (Hagen). The termite mounds were dissected to determine the health of the colony. Individual termites (i.e., workers and larvae) and fungus combs were subjected to gas chromatography-mass spectrometry (GC-MS) analysis to detect the presence of CFZ. In this study, 540.0 +/- 25.8 g (or equivalent to 540.0 +/- 25.8 mg active ingredient) and 680.0 +/- 49.0 g (680.0 +/- 49.0 mg active ingredient) of bait matrix were removed by the medium-and large-sized colonies, respectively, after baiting. All treated medium-sized colonies were moribund. The dead termites were scattered in the mound, larvae were absent, population size had decreased by 90%, and the queens appeared unhealthy. In contrast, no or limited effects were found in large-sized colonies. Only trace amounts of CFZ were detected in workers, larvae, and fungus combs, and the population of large-sized colonies had declined by only up to 40%. This might be owing to the presence of large amount of basidiomycete fungus and a drastic decrease of CFZ content per unit fungus comb (a main food source of larvae) in the large-sized colonies, and hence reduced the toxic effect and longer time is required to accumulate the lethal dose in larvae. Nevertheless, we do not deny the possibility of CSI bait eliminating or suppressing the higher termite if the test colonies could pick up adequate lethal dose by installing more bait stations and prolonging the baiting period.	[Lee, Ching-Chen] Univ Sains Malaysia, Sch Biol Sci, Vector Control Res Unit, Urban Entomol Lab, George Town 11800, Malaysia; [Neoh, Kok-Boon] Kyoto Univ, Ctr Southeast Asian Studies, Sakyo Ku, Kyoto 6068501, Japan		chowyang@usm.my	Neoh, Kok-Boon/A-4070-2011; Lee, Chow-Yang/C-7129-2009	Neoh, Kok-Boon/0000-0002-8462-6662; Lee, Chow-Yang/0000-0001-8279-4104	USM; Agricultural Crop Trust; "Southeast Asian Studies for Sustainable Humanosphere," Kyoto University; Bayer CropScience (Singapore)	We thank the staff of the National Poison Centre, Universiti Sains Malaysia (USM), for their technical support. C.-C.L. was supported under a Ph.D. fellowship from USM and a scholarship provided by the Agricultural Crop Trust. K.-B.N. was supported by a postdoctoral fellowship from "Southeast Asian Studies for Sustainable Humanosphere," Kyoto University. We thank Bayer CropScience (Singapore) for supporting this study.	Aanen DK, 2005, CURR BIOL, V15, P851, DOI 10.1016/j.cub.2005.03.043; Rust MK, 2012, ANNU REV ENTOMOL, V57, P355, DOI 10.1146/annurev-ento-120710-100634; Bending GD, 2002, FEMS MICROBIOL LETT, V212, P59, DOI 10.1016/S0378-1097(02)00710-3; Haagsma KA, 2005, PEST MANAG SCI, V61, P517, DOI 10.1002/ps.1003; SU NY, 1994, J ECON ENTOMOL, V87, P389; BADERTSCHER S, 1983, BEHAV ECOL SOCIOBIOL, V12, P115, DOI 10.1007/BF00343201; Gao DW, 2010, CRIT REV BIOTECHNOL, V30, P70, DOI 10.3109/07388550903427272; Grace JK, 1996, SOCIOBIOLOGY, V28, P511; Broadbent S, 2011, URBAN PEST MANAGEMENT: AN ENVIRONMENTAL PERSPECTIVE, P145, DOI 10.1079/9781845938031.0145; Cabrera BJ, 2006, FLA ENTOMOL, V89, P20, DOI 10.1653/0015-4040(2006)89[20:VOBCNF]2.0.CO;2; Darlington Johanna P. E. C., 1994, P105; DARLINGTON JPEC, 1987, INSECT SOC, V34, P165, DOI 10.1007/BF02224082; DARLINGTON JPEC, 1986, INSECT SOC, V33, P168, DOI 10.1007/BF02224596; DARLINGTON JPEC, 1991, INSECT SOC, V38, P251, DOI 10.1007/BF01314911; Dhang P., 2011, Insects, V2, P486, DOI 10.3390/insects2040486; Duncan Frances D., 1997, Insect Science and its Application, V17, P221; Evans TA, 2010, J ECON ENTOMOL, V103, P423, DOI 10.1603/EC09067; Haverty MI, 2010, J ECON ENTOMOL, V103, P770, DOI 10.1603/EC09088; Hinze B, 2002, INSECT SOC, V49, P31, DOI 10.1007/s00040-002-8275-1; Huang QY, 2006, J ECON ENTOMOL, V99, P455; Karr LL, 2004, J ECON ENTOMOL, V97, P593, DOI 10.1603/0022-0493-97.2.593; Kubota S, 2009, SOCIOBIOLOGY, V53, P707; Kubota S, 2008, J PESTIC SCI, V33, P243, DOI 10.1584/jpestics.G08-09; Lee CC, 2013, J PESTIC SCI, V38, P208, DOI 10.1584/jpestics.D13-036; Lee CC, 2012, ANN ENTOMOL SOC AM, V105, P427, DOI 10.1603/AN11174; Lee CY, 2002, SOCIOBIOLOGY, V40, P3; Lee CY, 2002, SOCIOBIOLOGY, V39, P411; Lee CY, 2007, SOCIOBIOLOGY, V50, P213; Messenger MT, 2005, J ECON ENTOMOL, V98, P916; Mougin C, 1996, PESTIC SCI, V47, P51; Neoh KB, 2009, ANN ENTOMOL SOC AM, V102, P1091; Neoh KB, 2011, J ECON ENTOMOL, V104, P607, DOI 10.1603/EC10161; Peppuy A, 1998, PESTIC SCI, V54, P22, DOI 10.1002/(SICI)1096-9063(199809)54:1<22::AID-PS785>3.0.CO;2-I; Peters B. C., 2008, P 6 INT C URB PESTS, P379; Peters BC, 2005, P 5 INT C URB PESTS, P229; Peters BC, 2003, J ECON ENTOMOL, V96, P1828, DOI 10.1603/0022-0493-96.6.1828; Peters BC, 1999, SOCIOBIOLOGY, V33, P227; ROHRMANN GF, 1980, PEDOBIOLOGIA, V20, P61; Roisin Y, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P95; Rojas MG, 2004, J ECON ENTOMOL, V97, P2015; Rojas MG, 2001, J ECON ENTOMOL, V94, P506, DOI 10.1603/0022-0493-94.2.506; Sajap AS, 2000, J ECON ENTOMOL, V93, P429; Stansly PA, 2001, CROP PROT, V20, P199, DOI 10.1016/S0261-2194(00)00127-7; Su NY, 2000, J ECON ENTOMOL, V93, P415; Su NY, 2000, STUD CONSERV, V45, P30, DOI 10.2307/1506681; SU NY, 1995, J ECON ENTOMOL, V88, P932; Su NY, 1997, J ECON ENTOMOL, V90, P809; Sukartana P, 2009, J TROP FOR SCI, V21, P13; Tsunoda K., 2005, JPN J ENV ENTOMOL ZO, V16, P125; Wood T.G., 1989, P69; Yu SJ, 2008, TOXICOLOGY BIOCH INS	51	1	1	ENTOMOLOGICAL SOC AMER	ANNAPOLIS	3 PARK PLACE, STE 307, ANNAPOLIS, MD 21401-3722 USA	0022-0493	1938-291X		J ECON ENTOMOL	J. Econ. Entomol.	DEC	2014	107	6					2154	2162		10.1603/EC14193		9	Entomology	Entomology	AW0EM	WOS:000345963300018		
J	Katoh, K; Kobayashi, Y; Chujo, T; Wang, JS; Li, ES; Li, CB; Kobayashi, H				Katoh, Kentaroh; Kobayashi, Yutaro; Chujo, Takeshi; Wang, Junshan; Li, Ensi; Li, Conbing; Kobayashi, Haruo			A Small Chip Area Stochastic Calibration for TDC Using Ring Oscillator	JOURNAL OF ELECTRONIC TESTING-THEORY AND APPLICATIONS			English	Article						TDC; Stochastic calibration; Self compensation; Self Test; FPGA		This paper proposes a small chip area stochastic calibration for TDC linearity and input range, and analyzes it with FPGA. The proposed calibration estimates the absolute values of the delay of the buffers and the range of measurement statistically. The hardware implementation of the proposed calibration requires single counter to construct the histogram, so that the extra area for the proposed calibration is smaller. Because the implementation is fully digital, it is easily implemented on digital LSIs such as FPGA, micro-processor, and SoC. Experiments with Xilinx Virtex-5 LX FPGA ML501 reveal that both the periods of the external clock and the ring oscillator are preferred as short as possible under more than twice of the range of measurement of TDC when the oscillation period of the ring oscillator is wider than that of the external clock for fast convergence. The required time for the proposed calibration is 0.08 ms, and the required hardware resources LUTs and FFs for the implementation on FPGA are 24.1% and 22.2% of the conventional implementation, respectively.	[Katoh, Kentaroh] Tsuruoka Coll, Natl Inst Technol, Tsuruoka, Yamagata 9978511, Japan; [Kobayashi, Yutaro; Chujo, Takeshi; Wang, Junshan; Li, Ensi; Li, Conbing; Kobayashi, Haruo] Gunma Univ, Fac Sci & Technol, Div Elect & Informat, Kiryu, Gunma 3768515, Japan	Katoh, K (reprint author), Tsuruoka Coll, Natl Inst Technol, Tsuruoka, Yamagata 9978511, Japan.	k-katoh@tsuruoka-nct.ac.jp; t10306028@gunma-u.ac.jp; t10306054@gunma-u.ac.jp; t10306902@gunma-u.ac.jp; t13801499@gunma-u.ac.jp; t13802483@gunma-u.ac.jp; k_haruo@el.gunma-u.ac.jp			Semiconductor Technology Academic Research Center (STARC)	This work is supported by the Semiconductor Technology Academic Research Center (STARC). The authors acknowledge Prof. Nobukazu Takai who gave us the variable suggestions.	Kratyuk V, 2009, IEEE T CIRCUITS-I, V56, P1612, DOI 10.1109/TCSI.2008.2010109; Chang Y.-C., 2011, P IEEE EUR WIR APR, P1; Chujyo T, 2014, P IEE EL CIRC RES M, P1; Hirabayashi D, 2012, P IEE EL CIRC RES M, P1; Ito S, 2010, P 4 INT C ADV MICR E, P1; Katoh K, 2010, Proceedings 2010 19th Asian Test Symposium (ATS 2010), DOI 10.1109/ATS.2010.65; Kobayashi H, 2014, IEICE ELECTROEXPRESS, V11, P1; Komuro T., 2007, IEICE T ELECTRON, VJ90-C, P125; Rivoir J, 2006, ASIAN TEST SYMPOSIUM, P45; Rivoir J., 2006, P IEEE INT TEST C OC, P1; S Verma, 2003, IEEE J SOLID-ST CIRC, V38, P1504; TSAI MC, 2008, P 26 IEEE VLSI TEST, P249, DOI DOI 10.1109/VTS.2008.25; Xilinx, 2007, VIRT 5 CMT CHAR REP; Xilinx, 2012, VIRT 5 US GUID; Xilinx, 2009, ML501 EV PLATF US GU	15	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0923-8174	1573-0727		J ELECTRON TEST	J. Electron. Test.-Theory Appl.	DEC	2014	30	6					653	663		10.1007/s10836-014-5486-0		11	Engineering, Electrical & Electronic	Engineering	AU8LP	WOS:000345848300003		
J	Ueno, M; Morii, Y; Uramoto, K; Oyamada, H; Mori, Y; Kobayashi, S				Ueno, Masaharu; Morii, Yasuharu; Uramoto, Kiyoko; Oyamada, Hidekazu; Mori, Yuichiro; Kobayashi, Shu			Catalytic Flow Hydrogenation of Aromatic Nitro Compounds Using Polysilane-Supported Palladium	JOURNAL OF FLOW CHEMISTRY			English	Article						hydrogenation; catalytic flow; palladium; polysilane; supported catalyst; nitro compound; amino compound	CHIRAL HETEROGENEOUS CATALYSTS; CARBON BOND FORMATION; MICROCHANNEL REACTORS; ORGANIC-REACTIONS; HYBRID CATALYSTS; CHEMISTRY; OXIDATION; ALCOHOLS; SYSTEMS; GAS	Continuous-flow hydrogenation of aromatic nitro compounds was successfully performed by using polysilane-supported palladium catalysts to afford the corresponding amino compounds in high yields. Productivity was high, and a wide variety of nitro compounds were applicable under the continuous-flow conditions. It is noted that no leaching of palladium was observed by inductively coupled plasma analysis.	[Ueno, Masaharu; Morii, Yasuharu; Uramoto, Kiyoko; Oyamada, Hidekazu; Mori, Yuichiro; Kobayashi, Shu] Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Kobayashi, S (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.	shu_kobayashi@chem.s.u-tokyo.ac.jp	Kobayashi, Shu/E-9214-2012; UENO, Masaharu/M-1609-2013				Ahao D., 2013, ACS CATAL, V3, P928; Harris KDM, 2009, CHEMCATCHEM, V1, P223, DOI 10.1002/cctc.200900181; Tsubogo T, 2013, ANGEW CHEM INT EDIT, V52, P6590, DOI 10.1002/anie.201210066; Chan N, 2013, J POLYM SCI POL CHEM, V51, P3081, DOI 10.1002/pola.26711; McQuade DT, 2013, J ORG CHEM, V78, P6384, DOI 10.1021/jo400583m; Solodenko W, 2004, EUR J ORG CHEM, P3601, DOI 10.1002/ejoc.200400194; Kobayashi J, 2004, SCIENCE, V304, P1305, DOI 10.1126/science.1096956; Kaizuka K, 2012, J FLOW CHEM, V2, P1, DOI 10.1556/jfchem.2011.00014; Anderson EB, 2012, CHEMCATCHEM, V4, P30, DOI 10.1002/cctc.201100086; O'Brien M, 2011, CHEM SCI, V2, P1250, DOI 10.1039/c1sc00055a; Noel T, 2011, CHEM SOC REV, V40, P5010, DOI 10.1039/c1cs15075h; Wang NW, 2009, ANGEW CHEM INT EDIT, V48, P4744, DOI 10.1002/anie.200900565; Jones RV, 2006, J COMB CHEM, V8, P110, DOI 10.1021/cc050107o; Shuit SH, 2013, RSC ADV, V3, P9070, DOI 10.1039/c3ra22945a; Miyamura H, 2014, ACCOUNTS CHEM RES, V47, P1054, DOI 10.1021/ar400224f; Oyamada H, 2011, BEILSTEIN J ORG CHEM, V7, P735, DOI 10.3762/bjoc.7.83; Itabaiana I, 2013, J MOL CATAL B-ENZYM, V85-86, P1, DOI 10.1016/j.molcatb.2012.08.008; Aijaz A, 2014, J PHYS CHEM LETT, V5, P1400, DOI 10.1021/jz5004044; Kobayashi S, 2005, J AM CHEM SOC, V127, P9251, DOI 10.1021/ja051246c; Matsumoto T, 2008, CHEM-ASIAN J, V3, P196, DOI 10.1002/asia.200700359; Puglisi A, 2013, GREEN CHEM, V15, P1790, DOI 10.1039/c3gc40195b; Kreutzer MT, 2005, CATAL TODAY, V105, P421, DOI 10.1016/j.cattod.2005.06.028; Rebrov EV, 2011, CHEM ENG SCI, V66, P1374, DOI 10.1016/j.ces.2010.05.044; Wegner J, 2011, CHEM COMMUN, V47, P4583, DOI 10.1039/c0cc05060a; Hartman RL, 2012, ORG PROCESS RES DEV, V16, P870, DOI 10.1021/op200348t; Hessel V, 2012, CHEM ENG TECHNOL, V35, P1184, DOI 10.1002/ceat.201200038; Oyamada H, 2008, ORG BIOMOL CHEM, V6, P61, DOI 10.1039/b715220e; Wegner J, 2012, ADV SYNTH CATAL, V354, P17, DOI 10.1002/adsc.201100584; Baumann M, 2010, SYNLETT, P749, DOI 10.1055/s-0029-1219344; Chen J., ORG PROCESS RES DEV; HATZIANTONIOU V, 1986, IND ENG CHEM PROC DD, V25, P964, DOI 10.1021/i200035a021; Javaid R, 2013, BEILSTEIN J ORG CHEM, V9, P1156, DOI 10.3762/bjoc.9.129; Kobayashi J, 2005, ADV SYNTH CATAL, V347, P1889, DOI 10.1002/adsc.200505265; Kobayashi J, 2005, CHEM COMMUN, P2567, DOI 10.1039/b501169h; Mawatari K., 2011, J FLOW CHEM, V1, P3; McPake CB, 2012, ORG PROCESS RES DEV, V16, P844, DOI 10.1021/op200331s; Oelgemoller M, 2012, CHEM ENG TECHNOL, V35, P1144, DOI 10.1002/ceat.201200009; Oyamada H, 2006, CHEM COMMUN, P4297, DOI 10.1039/b610241g; Sahoo S, 2011, CATAL SURV ASIA, V15, P200, DOI 10.1007/s10563-011-9122-z; Tsubogo T, 2014, TOP CATAL, V57, P935, DOI 10.1007/s11244-014-0254-z; Tsubogo T, 2012, CHEM-EUR J, V18, P13624, DOI 10.1002/chem.201202896; Ueno M, 2008, CHEM COMMUN, P1647, DOI 10.1039/b715259k	42	1	1	AKADEMIAI KIADO RT	BUDAPEST	PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY	2062-249X	2060-5587		J FLOW CHEM	J. Flow Chem.	DEC	2014	4	4					160	163		10.1556/JFC-D-14-00024		4	Chemistry, Multidisciplinary	Chemistry	AW2QS	WOS:000346134300002		
J	Nagaki, A; Akahori, K; Takahashi, Y; Yoshida, J				Nagaki, Aiichiro; Akahori, Kana; Takahashi, Yusuke; Yoshida, Jun-ichi			Flow Microreactor Synthesis of Fluorine-Containing Block Copolymers	JOURNAL OF FLOW CHEMISTRY			English	Article						flow microreactor; fluorine-containing polymer	LIVING ANIONIC-POLYMERIZATION; CONTAINING VINYL MONOMERS; CONTINUOUS TUBULAR REACTOR; RADICAL POLYMERIZATION; ORGANIC-SYNTHESIS; MICROFLOW-SYSTEM; FLASH CHEMISTRY; FLUOROALKYL ACRYLATES; MICROSTRUCTURED REACTORS; TRIBLOCK COPOLYMERS	Living anionic polymerization of perfluoroalkyl methacrylates initiated by 1,1-diphenylhexyllithium was conducted without adding lithium chloride in an integrated flow microreactor system. The high degree of polydispersity index (PID) control was achieved at 0 degrees C (2-(nonafluorobutyl) ethyl and 2-(tridecafluorohexyl) ethyl methacrylates) or -40 degrees C (2,2,2-trifluoroethyl methacrylate). The subsequent reaction of a reactive polymer chain end with alkyl methacrylates or tert-butyl acrylate led to the formation of fluorine-containing block copolymers with narrow PDI.	[Nagaki, Aiichiro; Akahori, Kana; Takahashi, Yusuke; Yoshida, Jun-ichi] Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan	Yoshida, J (reprint author), Kyoto Univ, Dept Synthet Chem & Biol Chem, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.	yoshida@sbchem.kyoto-u.ac.jp	yoshida, junichi/E-8786-2010		 [2105]	This work is partially supported by the Grant-in-Aid for Scientific Research on Innovative Areas "Reaction Integration" (No. 2105).	Ameduri B, 2004, WELL ARCHITECTURED F; Hornung CH, 2011, ORG PROCESS RES DEV, V15, P593, DOI 10.1021/op1003314; McMullen JP, 2010, ANNU REV ANAL CHEM, V3, P19, DOI 10.1146/annurev.anchem.111808.073718; Nagaki A, 2011, CHEM ENG J, V167, P548, DOI 10.1016/j.cej.2010.07.073; Wu T, 2004, J AM CHEM SOC, V126, P9880, DOI 10.1021/ja048432n; Hadjichristidis N, 2001, CHEM REV, V101, P3747, DOI 10.1021/cr9901337; McQuade DT, 2013, J ORG CHEM, V78, P6384, DOI 10.1021/jo400583m; Vandenbergh J, 2013, J POLYM SCI POL CHEM, V51, P2366, DOI 10.1002/pola.26593; Battilocchio C, 2013, ORG LETT, V15, P2278, DOI 10.1021/ol400856g; Tonhauser C, 2012, MACROMOLECULES, V45, P9551, DOI 10.1021/ma301671x; Asano K, 2013, ORG LETT, V15, P2398, DOI 10.1021/ol4008519; Serra C, 2005, LAB CHIP, V5, P966, DOI 10.1039/b500440c; Hong KL, 1999, CURR OPIN SOLID ST M, V4, P531, DOI 10.1016/S1359-0286(00)00011-5; Shu W, 2012, ANGEW CHEM INT EDIT, V51, P5355, DOI 10.1002/anie.201202221; Bruno A, 2010, MACROMOLECULES, V43, P10163, DOI 10.1021/ma1019297; Yoshida JI, 2010, CHEM REC, V10, P332, DOI 10.1002/tcr.201000020; Nagaki A, 2004, J AM CHEM SOC, V126, P14702, DOI 10.1021/ja044879k; Cortese B, 2012, MACROMOL REACT ENG, V6, P507, DOI 10.1002/mren.201200027; Enright TE, 2010, MACROMOL REACT ENG, V4, P186, DOI 10.1002/mren.200900060; Pastre JC, 2013, CHEM SOC REV, V42, P8849, DOI 10.1039/c3cs60246j; Shen YQ, 2002, AICHE J, V48, P2609, DOI 10.1002/aic.690481119; Elvira KS, 2013, NAT CHEM, V5, P905, DOI [10.1038/nchem.1753, 10.1038/NCHEM.1753]; Nagaki A, 2012, CHEM COMMUN, V48, P11211, DOI 10.1039/c2cc36197c; Yoshida JI, 2008, CHEM-EUR J, V14, P7450, DOI 10.1002/chem.200800582; Rosenfeld C, 2007, CHEM ENG SCI, V62, P5245, DOI 10.1016/j.ces.2006.12.074; Yoshida JI, 2011, CHEMSUSCHEM, V4, P331, DOI 10.1002/cssc.201000271; Hessel V, 2005, CHEM-ING-TECH, V77, P1693, DOI 10.1002/cite.200500142; Yoshida J, 2013, CHEM COMMUN, V49, P9896, DOI 10.1039/c3cc44709j; Nagaki A, 2008, MACROMOLECULES, V41, P6322, DOI 10.1021/ma800769n; Wurm F, 2008, MACROMOL CHEM PHYS, V209, P1106, DOI 10.1002/macp.200700613; Hornung CH, 2013, AUST J CHEM, V66, P192, DOI 10.1071/CH12479; Kobayashi J, 2006, CHEM-ASIAN J, V1, P22, DOI 10.1002/asia.200600058; Jahnisch K, 2004, ANGEW CHEM INT EDIT, V43, P406, DOI 10.1002/anie.200300577; SZWARC M, 1956, NATURE, V178, P1168, DOI 10.1038/1781168a0; Hornung CH, 2012, MACROMOL REACT ENG, V6, P458, DOI 10.1002/mren.201200029; Cantillo D, 2012, ANGEW CHEM INT EDIT, V51, P10190, DOI 10.1002/anie.201205792; Nagaki A, 2008, CHEM-ASIAN J, V3, P1558, DOI 10.1002/asia.200800081; Wilms D, 2008, MACROMOL CHEM PHYS, V209, P343, DOI 10.1002/macp.200700588; Song H, 2006, ANGEW CHEM INT EDIT, V45, P7336, DOI 10.1002/anie.200601554; Watts P, 2005, CHEM SOC REV, V34, P235, DOI 10.1039/b313866f; Geyer K, 2006, CHEM-EUR J, V12, P8434, DOI 10.1002/chem.200600596; Steinbacher JL, 2006, J POLYM SCI POL CHEM, V44, P6505, DOI 10.1002/pola.21630; Bally F, 2011, MACROMOL RAPID COMM, V32, P1820, DOI 10.1002/marc.201100429; deMello AJ, 2006, NATURE, V442, P394, DOI 10.1038/nature05062; Iida K, 2009, LAB CHIP, V9, P339, DOI 10.1039/b810006c; Hartman RL, 2009, LAB CHIP, V9, P2495, DOI 10.1039/b906343a; Basavaraju KC, 2013, ANGEW CHEM INT EDIT, V52, P6735, DOI 10.1002/anie.201301124; Shen YQ, 2000, MACROMOL RAPID COMM, V21, P956, DOI 10.1002/1521-3927(20000901)21:14<956::AID-MARC956>3.0.CO;2-3; Nguyen JD, 2013, CHEM COMMUN, V49, P4352, DOI 10.1039/c2cc37206a; Iwasaki T, 2006, ORG PROCESS RES DEV, V10, P1126, DOI 10.1021/op060127u; Kleinke AS, 2013, ORG LETT, V15, P710, DOI 10.1021/ol400051n; Rosenfeld C, 2008, LAB CHIP, V8, P1682, DOI 10.1039/b803885f; Yoshida J, 2005, CHEM ENG TECHNOL, V28, P259, DOI 10.1002/ceat.200407127; Tonhauser C, 2010, MACROMOLECULES, V43, P5582, DOI 10.1021/ma902849r; Doku GN, 2005, TETRAHEDRON, V61, P2733, DOI 10.1016/j.tet.2005.01.028; Guetzoyan L, 2013, CHEM SCI, V4, P764, DOI 10.1039/c2sc21850j; Ahmed-Omer B, 2007, ORG BIOMOL CHEM, V5, P733, DOI 10.1039/b615072a; Russum JP, 2005, IND ENG CHEM RES, V44, P2484, DOI 10.1021/ie040136w; Levesque F, 2012, ANGEW CHEM INT EDIT, V51, P1706, DOI 10.1002/anie.201107446; Fuse S, 2014, ANGEW CHEM INT EDIT, V53, P851, DOI 10.1002/anie.201307987; Brancour C, 2013, ORG LETT, V15, P2794, DOI 10.1021/ol401092a; Patil Y, 2013, PROG POLYM SCI, V38, P703, DOI 10.1016/j.progpolymsci.2012.09.005; Nagaki A, 2013, CHEM COMMUN, V49, P3242, DOI 10.1039/c3cc40392k; Brivio M, 2006, LAB CHIP, V6, P329, DOI 10.1039/b510856j; Iwasaki T, 2005, MACROMOLECULES, V38, P1159, DOI 10.1021/ma048369m; Wiles C, 2012, GREEN CHEM, V14, P38, DOI 10.1039/c1gc16022b; Nagaki A, 2009, MACROMOLECULES, V42, P4384, DOI 10.1021/ma900551a; Mason BP, 2007, CHEM REV, V107, P2300, DOI 10.1021/cr050944c; Baxendale IR, 2013, J CHEM TECHNOL BIOT, V88, P519, DOI 10.1002/jctb.4012; Ehrfeld W., 2000, MICROREACTORS; Enright TE, 2005, MACROMOL RAPID COMM, V26, P221, DOI 10.1002/marc.200400531; Fukuyama T, 2008, SYNLETT, P151, DOI 10.1055/s-2007-1000884; Hessel V., 2009, MICROPROCESS ENG; Hessel V., 2004, CHEM MICROPROCESS EN; Hsieh H. L., 1996, ANIONIC POLYM PRINCI; Ishizone T, 1999, POLYM J, V31, P983, DOI 10.1295/polymj.31.983; Iwasaki T, 2007, CHEM COMMUN, P1263, DOI 10.1039/b615159k; Jagur-Grodzinski J, 2002, J POLYM SCI POL CHEM, V40, P2116, DOI 10.1002/pola.10291; Kirschning A, 2012, CHEM LETT, V41, P562, DOI 10.1246/cl.2012.562; Nagaki A, 2010, MACROMOLECULES, V43, P8424, DOI 10.1021/ma101663x; Nagaki A, 2012, MACROMOL REACT ENG, V6, P467, DOI 10.1002/mren.201200051; NARITA T, 1985, MAKROMOL CHEM-RAPID, V6, P5; Narita T, 2000, MACROMOL RAPID COMM, V21, P613, DOI 10.1002/1521-3927(20000601)21:10<613::AID-MARC613>3.0.CO;2-D; Narita T, 1999, PROG POLYM SCI, V24, P1095, DOI 10.1016/S0079-6700(99)00021-0; NARITA T, 1987, MAKROMOL CHEM, V188, P273; NARITA T, 1986, MAKROMOL CHEM, V187, P739; Pittman A. G., 1977, FLUOROPOLYMERS; SANDBERG CL, 1955, J POLYM SCI, V15, P553, DOI 10.1002/pol.1955.120158022; Scheirs J., 1997, MODERN FLUOROPOLYMER; Smid J, 2002, J POLYM SCI POL CHEM, V40, P2101, DOI 10.1002/pola.10286; Vandenbergh J, 2012, POLYM CHEM-UK, V3, P2739, DOI 10.1039/c2py20423a; Watts P, 2007, CHEM COMMUN, P443, DOI 10.1039/b609428g; Wilms D, 2007, CHEM ENG TECHNOL, V30, P1519, DOI 10.1002/ceat.200700277; Xu C, 2005, MACROMOLECULES, V38, P6, DOI 10.1021/ma048208i; Yoshida J, 2005, CHEM COMMUN, P4509, DOI 10.1039/b508341a; Yoshida J., 2008, FLASH CHEM FAST ORGA	96	2	2	AKADEMIAI KIADO RT	BUDAPEST	PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY	2062-249X	2060-5587		J FLOW CHEM	J. Flow Chem.	DEC	2014	4	4					168	172		10.1556/JFC-D-14-00017		5	Chemistry, Multidisciplinary	Chemistry	AW2QS	WOS:000346134300004		
J	Mifune, Y; Fuse, S; Tanaka, H				Mifune, Yuto; Fuse, Shinichiro; Tanaka, Hiroshi			Synthesis of N-Allyloxycarbonyl 3,5-Dihydroxyphenylglycine via Photochemical Wolff Rearrangement-Nucleophilic Addition Sequence in a Micro-Flow Reactor	JOURNAL OF FLOW CHEMISTRY			English	Article						photoreaction; microfluidic; Wolff rearrangement; Arndt-Eistert homologation; phenylglycine	PEPTIDE ANTIBIOTIC FEGLYMYCIN; ARNDT-EISTERT REACTION; CARBOXYLIC-ACIDS; ASYMMETRIC-SYNTHESIS; ORGANIC-SYNTHESIS; AMINO-ACIDS; STEREOSELECTIVE-SYNTHESIS; VANCOMYCIN BIOSYNTHESIS; STRUCTURE ELUCIDATION; CHEMISTRY	In this study, two practical and scalable procedures were developed for the synthesis of N-arylacetyl oxazolidinone, which is an intermediate for the preparation of N-allyloxylcarbonyl 3,5-dihydroxyphenylglycine. The key sequence in the developed procedures was a photochemical Wolff rearrangement-nucleophilic addition in a micro-flow reactor. A power-saving, inexpensive, and readily available light source (4-W portable ultraviolet [UV] lamp) along with a fluorinated ethylene propylene copolymer (FEP) tube was employed in the developed procedures. The first-generation procedure afforded the desired N-arylacetyl oxazolidinone in the highest yield. The yield was lower in the second-generation procedure, but it afforded pure N-arylacetyl oxazolidinone without column chromatographic purification. The use of the two parallel channel tube reactors enabled the gram-scale preparation of N-arylacetyl oxazolidinone. N-Allyloxylcarbonyl 3,5-dihydroxyphenylglycine was successfully prepared via the second-generation procedure.	[Mifune, Yuto; Fuse, Shinichiro; Tanaka, Hiroshi] Tokyo Inst Technol, Dept Appl Chem, Meguro Ku, Tokyo 1528552, Japan	Fuse, S (reprint author), Tokyo Inst Technol, Dept Appl Chem, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	sfuse@apc.titech.ac.jp	Fuse, Shinichiro/B-9396-2015; Tanaka, Hiroshi/I-2402-2012	Fuse, Shinichiro/0000-0002-6836-4180; 			Knowles JP, 2012, BEILSTEIN J ORG CHEM, V8, P2025, DOI 10.3762/bjoc.8.229; Fuse S, 2012, ORG BIOMOL CHEM, V10, P5205, DOI 10.1039/c2ob25511a; Willumstad TP, 2013, J ORG CHEM, V78, P11450, DOI 10.1021/jo402010b; Fuse S, 2013, BEILSTEIN J ORG CHEM, V9, P2336, DOI 10.3762/bjoc.9.268; Dettner F, 2009, ANGEW CHEM INT EDIT, V48, P1856, DOI 10.1002/anie.200804130; Boger DL, 2001, MED RES REV, V21, P356, DOI 10.1002/med.1014; Li DB, 2005, ORG BIOMOL CHEM, V3, P1233; Pastre JC, 2013, CHEM SOC REV, V42, P8849, DOI 10.1039/c3cs60246j; Nicolaou KC, 1999, ANGEW CHEM INT EDIT, V38, P2096, DOI 10.1002/(SICI)1521-3773(19990802)38:15<2096::AID-ANIE2096>3.0.CO;2-F; Garbarino S, 2014, J ORG CHEM, V79, P3615, DOI 10.1021/jo500535f; Protasova LN, 2013, ORG PROCESS RES DEV, V17, P760, DOI 10.1021/op4000169; Yoshida JI, 2011, CHEMSUSCHEM, V4, P331, DOI 10.1002/cssc.201000271; Winum JY, 1996, TETRAHEDRON LETT, V37, P1781, DOI 10.1016/0040-4039(96)00130-X; NEWMAN MS, 1950, J AM CHEM SOC, V72, P5163, DOI 10.1021/ja01167a101; Kirmse W, 2002, EUR J ORG CHEM, P2193; Fuse S, 2011, CHEM COMMUN, V47, P12661, DOI 10.1039/c1cc15662d; SKELTON NJ, 1990, J ORG CHEM, V55, P3718, DOI 10.1021/jo00299a008; Oelgemoller M, 2011, MOLECULES, V16, P7522, DOI 10.3390/molecules16097522; AOYAMA T, 1980, TETRAHEDRON LETT, V21, P4461, DOI 10.1016/S0040-4039(00)92200-7; Levesque F, 2012, ANGEW CHEM INT EDIT, V51, P1706, DOI 10.1002/anie.201107446; Fuse S, 2014, ANGEW CHEM INT EDIT, V53, P851, DOI 10.1002/anie.201307987; Wisniewski K, 2002, CNS DRUG REV, V8, P101; Wegner J, 2011, CHEM COMMUN, V47, P4583, DOI 10.1039/c0cc05060a; Hessel V, 2013, CHEMSUSCHEM, V6, P746, DOI 10.1002/cssc.201200766; EVANS DA, 1990, J AM CHEM SOC, V112, P4011, DOI 10.1021/ja00166a045; Anderson NG, 2012, ORG PROCESS RES DEV, V16, P852, DOI 10.1021/op200347k; Wegner J, 2012, ADV SYNTH CATAL, V354, P17, DOI 10.1002/adsc.201100584; ASANO T, 1994, J ANTIBIOT, V47, P557; Baumann M., 2001, MOL DIVERS, V15, P613; Baxendale I. R., 2012, AUST J CHEM, V66, P131, DOI 10.1071/CH12365; Candeias NR, 2009, CURR ORG CHEM, V13, P763; EVANS DA, 1992, TETRAHEDRON LETT, V33, P1189, DOI 10.1016/S0040-4039(00)91892-6; Ferir G, 2012, VIROLOGY, V433, P308, DOI 10.1016/j.virol.2012.08.007; Freund E, 2000, HELV CHIM ACTA, V83, P2572, DOI 10.1002/1522-2675(20000906)83:9<2572::AID-HLCA2572>3.0.CO;2-X; Fuse S., 2012, NEW STRATEGIES CHEM; Fuse S, 2010, CHEM COMMUN, V46, P8722, DOI 10.1039/c0cc02239j; Hanchen A, 2013, CHEMBIOCHEM, V14, P625, DOI 10.1002/cbic.201300032; Jones EP, 2011, ORG LETT, V13, P1012, DOI 10.1021/ol1030469; Katritzky AR, 2001, J ORG CHEM, V66, P5606, DOI 10.1021/jo0017640; Maiese K, 2008, OXID MED CELL LONGEV, V1, P1; Oelgemoller M, 2012, CHEM ENG TECHNOL, V35, P1144, DOI 10.1002/ceat.201200009; PEARSON AJ, 1989, J CHEM SOC CHEM COMM, P659, DOI 10.1039/c39890000659; Rausch S, 2011, CHEMBIOCHEM, V12, P1171, DOI 10.1002/cbic.201100120; Reddy KL, 1998, J AM CHEM SOC, V120, P1207, DOI 10.1021/ja9728177; SCHOLLKOPF U, 1983, TOP CURR CHEM, V109, P65; Terao K, 2014, J FLOW CHEM, V4, P35, DOI 10.1556/JFC-D-13-00035; Vaske YSM, 2010, J AM CHEM SOC, V132, P11379, DOI 10.1021/ja1050023; Vertesy L, 1999, J ANTIBIOT, V52, P374; WILLIAMS RM, 1992, CHEM REV, V92, P889, DOI 10.1021/cr00013a007; Hutchings MJ, 2013, MICROREACTORS IN ORGANIC CHEMISTRY AND CATALYSIS, 2ND EDITION, P197	50	2	2	AKADEMIAI KIADO RT	BUDAPEST	PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY	2062-249X	2060-5587		J FLOW CHEM	J. Flow Chem.	DEC	2014	4	4					173	179		10.1556/JFC-D-14-00015		7	Chemistry, Multidisciplinary	Chemistry	AW2QS	WOS:000346134300005		
J	Yoshiiwa, T; Umezu, S; Tokeshi, M; Baba, Y; Shindo, M				Yoshiiwa, Toshiya; Umezu, Satoshi; Tokeshi, Manabu; Baba, Yoshinobu; Shindo, Mitsuru			Synthesis and Reactions of Ynolates via a Stop-Flow Method with a Flow Microreactor	JOURNAL OF FLOW CHEMISTRY			English	Article						flow microreactor; lithium-halogen exchange; stop-flow method; ynolate	CYCLOADDITION-DIECKMANN CONDENSATION; Z-SELECTIVE OLEFINATION; STEREOSELECTIVE OLEFINATION; TORQUOSELECTIVE OLEFINATION; TETRASUBSTITUTED ALKENES; ORGANOLITHIUM REAGENTS; CARBONYL-COMPOUNDS; SPACE INTEGRATION; MICROFLOW SYSTEMS; ORGANIC-SYNTHESIS	We report a method for the generation and subsequent reaction of ynolates in a flow microreactor via a stop-flow process. This procedure allowed for the synthesis of ynolates at ambient temperature within 11 min via a Li-Br exchange reaction with sec-butyllithium, whereas the corresponding batch process generally requires low temperature control and extended reaction times of up to 1 h. The stop-flow method is especially useful for optimizing the reaction time without having to use various microtube lengths. The resulting ynolates were applied to the olefination of carbonyl compounds and to pyrrole synthesis. These results indicate the practical utility of the ynolate reaction and should contribute to progress in flash chemistry.	[Yoshiiwa, Toshiya; Umezu, Satoshi] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka 8168580, Japan; [Shindo, Mitsuru] Kyushu Univ, Inst Mat Chem & Engn, Kasuga, Fukuoka 8168580, Japan; [Tokeshi, Manabu] Hokkaido Univ, Fac Engn, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Baba, Yoshinobu] Nagoya Univ, Grad Sch Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Shindo, M (reprint author), Kyushu Univ, Inst Mat Chem & Engn, 6-1 Kasuga Koen, Kasuga, Fukuoka 8168580, Japan.	shindo@cm.kyushu-u.ac.jp	Tokeshi, Manabu/B-6257-2012		Program for Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; Japan Society for the Promotion of Science (JSPS) [24106731, 22390002]	This work was supported by the Program for Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry and by the Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant Nos. 24106731 and 22390002).	Usutani H, 2007, J AM CHEM SOC, V129, P3046, DOI 10.1021/ja068330s; Ley SV, 2012, CHEM REC, V12, P378, DOI 10.1002/tcr.201100041; Nagaki A, 2009, ANGEW CHEM INT EDIT, V48, P8063, DOI 10.1002/anie.200904316; Shindo M, 2000, J ORG CHEM, V65, P5443, DOI 10.1021/jo000650l; Yoshida JI, 2008, CHEM-EUR J, V14, P7450, DOI 10.1002/chem.200800582; Nagaki A, 2010, ANGEW CHEM INT EDIT, V49, P7543, DOI 10.1002/anie.201002763; Nagaki A, 2007, CHEM-ASIAN J, V2, P1513, DOI 10.1002/asia.200700231; Nagaki A, 2012, ANGEW CHEM INT EDIT, V51, P3245, DOI 10.1002/anie.201108932; Suga S, 2010, CHEM LETT, V39, P404, DOI 10.1246/cl.2010.404; Nagaki A, 2008, ANGEW CHEM INT EDIT, V47, P7833, DOI 10.1002/anie.200803205; Shindo M, 2007, ORG LETT, V9, P1963, DOI 10.1021/ol0705200; Shindo M, 2006, J AM CHEM SOC, V128, P1062, DOI 10.1021/ja0561082; Wegner J, 2011, CHEM COMMUN, V47, P4583, DOI 10.1039/c0cc05060a; Nagaki A, 2013, CHEM COMMUN, V49, P3242, DOI 10.1039/c3cc40392k; Nagaki A, 2010, ORG BIOMOL CHEM, V8, P1212, DOI 10.1039/b919325c; Shindo M, 2007, TETRAHEDRON, V63, P10, DOI 10.1016/j.tet.2006.09.013; Wegner J, 2012, ADV SYNTH CATAL, V354, P17, DOI 10.1002/adsc.201100584; Asai T, 2011, CHEM LETT, V40, P393, DOI 10.1246/cl.2011.393; BATES RB, 1972, J ORG CHEM, V37, P560, DOI 10.1021/jo00969a007; Fukuyama T, 2008, SYNLETT, P151, DOI 10.1055/s-2007-1000884; Geyer K, 2009, SYNLETT, P2382, DOI 10.1055/s-0029-1217828; Goto S, 2008, SYNLETT, P1361, DOI 10.1055/s-2008-1072771; HANER R, 1985, J AM CHEM SOC, V107, P5396; Kim H., 2011, NATURE COMMUN, V2; Mori S, 2004, ORG LETT, V6, P3945, DOI 10.1021/ol048499f; Nagaki A, 2013, J SYN ORG CHEM JPN, V71, P1002; Nagaki A, 2011, GREEN CHEM, V13, P1110, DOI 10.1039/c0gc00852d; Nagaki A, 2009, J AM CHEM SOC, V131, P1654, DOI 10.1021/ja809325a; Nagaki A, 2012, J FLOW CHEM, V2, P70, DOI 10.1556/JFC-D-12-00004; Nagaki A, 2013, CHEM-ASIAN J, V8, P705, DOI 10.1002/asia.201201191; Shindo M, 1998, TETRAHEDRON, V54, P2411, DOI 10.1016/S0040-4020(98)00006-4; Shindo M, 1999, J AM CHEM SOC, V121, P6507, DOI 10.1021/ja990656w; Shindo M, 2001, J ORG CHEM, V66, P7818, DOI 10.1021/jo015929w; Shindo M, 2008, SYNLETT, P2231, DOI 10.1055/s-2008-1077971; Shindo M., 2009, CHEM METAL ENOLATES, P739; Shindo M., 2007, ORG SYNTH, V84, P11; Shindo M, 2006, CHEM-EUR J, V12, P524, DOI 10.1002/chem.200500574; Shindo M, 2001, ORG LETT, V3, P2029, DOI 10.1021/ol0159928; Shindo M, 2012, TOP CURR CHEM, V327, P1, DOI 10.1007/128_2012_313; Shindo M, 2002, J AM CHEM SOC, V124, P6840, DOI 10.1021/ja026275r; Shindo M, 2004, J ORG CHEM, V69, P3912, DOI 10.1021/jo0497813; Tomida Y, 2009, ORG LETT, V11, P3614, DOI 10.1021/ol901352t; TOMIOKA K, 1990, J ORG CHEM, V55, P2276, DOI 10.1021/jo00295a005; Umezu S, 2013, TETRAHEDRON LETT, V54, P6871, DOI 10.1016/j.tetlet.2013.10.027; Umezu S, 2014, TETRAHEDRON LETT, V55, P1822, DOI 10.1016/j.tetlet.2014.01.147; Yoshikawa T, 2009, J AM CHEM SOC, V131, P2092, DOI 10.1021/ja809592q	46	0	0	AKADEMIAI KIADO RT	BUDAPEST	PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY	2062-249X	2060-5587		J FLOW CHEM	J. Flow Chem.	DEC	2014	4	4					180	184		10.1556/JFC-D-14-00008		5	Chemistry, Multidisciplinary	Chemistry	AW2QS	WOS:000346134300006		
J	Nishiyama, Y; Mori, R; Nishida, K; Tanimoto, H; Morimoto, T; Kakiuchi, K				Nishiyama, Yasuhiro; Mori, Ryota; Nishida, Kosei; Tanimoto, Hiroki; Morimoto, Tsumoru; Kakiuchi, Kiyomi			Diastereodifferentiating [2+2] Photocycloaddition of a Chiral Cyclohexenone with Cyclopentene in Supercritical Carbon Dioxide Using a Flow Microreactor	JOURNAL OF FLOW CHEMISTRY			English	Article						diastereoselective reaction; [2+2] photocycloaddition; flow microreactor; supercritical carbon dioxide	ORGANIC-SYNTHESIS; CONTINUOUS PHOTOOXIDATION; CYCLOBUTANE DERIVATIVES; PHOTOCHEMICAL-REACTIONS; MICROCAPILLARY REACTOR; CHEMICAL-SYNTHESIS; SINGLET OXYGEN; PHOTOADDITION; CHEMISTRY; CATALYSIS	The diastereodifferentiating [2+2] photocycloaddition of a chiral cyclohexenone with cyclopentene was performed in supercritical carbon dioxide (scCO(2)) using a flow microreactor. In all cases examined, the microreactor gave higher conversions than the batch system because of the very short path length of the microreactor. Additionally, by using the microreactor, accurate temperature control produced higher diastereoselectivity. These distinguished findings can be attributed to the synergistic effect of superior light penetration in the microreactor and the unique solvent property (clustering effect) of scCO(2).	[Nishiyama, Yasuhiro; Mori, Ryota; Nishida, Kosei; Tanimoto, Hiroki; Morimoto, Tsumoru; Kakiuchi, Kiyomi] Nara Inst Sci & Technol NAIST, Grad Sch Mat Sci, Nara 6300101, Japan	Nishiyama, Y (reprint author), Nara Inst Sci & Technol NAIST, Grad Sch Mat Sci, 8916-5 Takayama Cho, Nara 6300101, Japan.	y-west@ms.naist.jp; kakiuchi@ms.naist.jp			Japan Society for the Promotion of Science (JSPS) [25870437, 24310101]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24106729]	We thank Dr. M. Matsumoto and Mr. M. Nagasawa (Syn Corporation) for setting up of the microflow reactor using scCO<INF>2</INF>. This work was supported in part by a Grant-in-Aid for Young Scientists (B) (No. 25870437), a Grant-in-Aid for Scientific Research (B) (No. 24310101) from the Japan Society for the Promotion of Science (JSPS), and a Grant- in-Aid for Scientific Research on Innovative Areas (No. 24106729) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). Furthermore, NAIST under the project for " Green Photonics Research" supported this work.	McMullen JP, 2010, ANNU REV ANAL CHEM, V3, P19, DOI 10.1146/annurev.anchem.111808.073718; Hall JFB, 2012, CHEM COMMUN, V48, P3073, DOI 10.1039/c2cc17429d; Knowles JP, 2012, BEILSTEIN J ORG CHEM, V8, P2025, DOI 10.3762/bjoc.8.229; McQuade DT, 2013, J ORG CHEM, V78, P6384, DOI 10.1021/jo400583m; Lee-Ruff E, 2003, CHEM REV, V103, P1449, DOI 10.1021/cr010013a; Namyslo JC, 2003, CHEM REV, V103, P1485, DOI 10.1021/cr010010y; Ciana CL, 2007, CHIMIA, V61, P650, DOI 10.2533/chimia.2007.650; Oelgemoller M, 2006, GREEN CHEM, V8, P831, DOI 10.1039/b605906f; Coyle EE, 2008, PHOTOCH PHOTOBIO SCI, V7, P1313, DOI 10.1039/b808778d; Baiker A, 1999, CHEM REV, V99, P453, DOI 10.1021/cr970090z; Han X, 2011, CHEM SCI, V2, P1059, DOI 10.1039/c0sc00641f; Coote SC, 2013, J AM CHEM SOC, V135, P14948, DOI 10.1021/ja408167r; Pastre JC, 2013, CHEM SOC REV, V42, P8849, DOI 10.1039/c3cs60246j; Lu P, 2012, ANGEW CHEM INT EDIT, V51, P1261, DOI 10.1002/anie.201106889; Kawanami Y, 2013, J ORG CHEM, V78, P3073, DOI 10.1021/jo302818w; Yoshida JI, 2008, CHEM-EUR J, V14, P7450, DOI 10.1002/chem.200800582; Yoshida JI, 2011, CHEMSUSCHEM, V4, P331, DOI 10.1002/cssc.201000271; Tsutsumi K, 2010, CHEM-EUR J, V16, P7448, DOI 10.1002/chem.201000429; Tucker SC, 1999, CHEM REV, V99, P391, DOI 10.1021/cr9700437; Tan HB, 2011, ORG LETT, V13, P2192, DOI 10.1021/ol200418e; Nishiyama Y, 2007, CHEM LETT, V36, P1488, DOI 10.1246/cl.2007.1488; Suga S, 2010, CHEM LETT, V39, P404, DOI 10.1246/cl.2010.404; Matsushita Y, 2007, PURE APPL CHEM, V79, P1959, DOI 10.1351/pac200779111959; Terao K, 2012, J PHOTOCH PHOTOBIO A, V242, P13, DOI 10.1016/j.jphotochem.2012.05.021; Sakamoto M, 2006, J PHOTOCH PHOTOBIO C, V7, P183, DOI 10.1016/j.jphotochemrev.2006.11.002; Nishijima M, 2013, CHEM COMMUN, V49, P8916, DOI 10.1039/c3cc44235g; Bourne RA, 2009, ANGEW CHEM INT EDIT, V48, P5322, DOI 10.1002/anie.200901731; Muller C, 2008, AUST J CHEM, V61, P557, DOI 10.1071/CH08195; Brimioulle R, 2013, SCIENCE, V342, P840, DOI 10.1126/science.1244809; Razzaq T, 2010, CHEM-ASIAN J, V5, P1274, DOI 10.1002/asia.201000010; Tsutsumi K, 2010, CHEM LETT, V39, P828, DOI 10.1246/cl.2010.828; Bach T, 2011, ANGEW CHEM INT EDIT, V50, P1000, DOI 10.1002/anie.201002845; Brennecke JF, 1999, CHEM REV, V99, P433, DOI 10.1021/cr970035q; Dell CP, 1998, J CHEM SOC PERK T 1, P3873; Fukuyama T, 2008, SYNLETT, P151, DOI 10.1055/s-2007-1000884; Hofmann N, 2008, CHEM REV, V108, P1052; Inhulsen I, 2013, TETRAHEDRON, V69, P782, DOI 10.1016/j.tet.2012.10.074; Inoue Y., 2004, CHIRAL PHOTOCHEMISTR; Jayaraman S, 2000, TETRAHEDRON LETT, V41, P8231, DOI 10.1016/S0040-4039(00)01459-3; Liu CE, 2013, TETRAHEDRON LETT, V54, P541, DOI 10.1016/j.tetlet.2012.11.077; Ma M., 2013, TETRAHEDRON, V68, P8875; Mayr F., 2004, CHEM COMMUN, V50, P3353; Nicolaou KC, 2011, ANGEW CHEM INT EDIT, V50, P5149, DOI 10.1002/anie.201101360; Nishiyama Y, 2013, J ORG CHEM, V78, P7186, DOI 10.1021/jo401126p; Nishiyama Y, 2012, J ORG CHEM, V77, P5681, DOI 10.1021/jo300816w; Nishiyama Y, 2004, J AM CHEM SOC, V126, P6568, DOI 10.1021/ja0494609; Oelgemoller M, 2012, CHEM ENG TECHNOL, V35, P1144, DOI 10.1002/ceat.201200009; Ramamurthy V., 2011, SUPRAMOLECULAR PHOTO; Shimada Y., 2003, TETRAHEDRON LETT, V44, P1301; Terao K, 2012, J FLOW CHEM, V2, P73, DOI 10.1556/JFC-D-12-00005; Terao K, 2014, J FLOW CHEM, V4, P35, DOI 10.1556/JFC-D-13-00035; Yoshida J., 2008, FLASH CHEM FAST ORGA; Yoshida J, 2011, SYNLETT, P1189, DOI 10.1055/s-0030-1259946; Zhao GL, 2012, ORG LETT, V14, P776, DOI 10.1021/ol203314y	54	1	1	AKADEMIAI KIADO RT	BUDAPEST	PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY	2062-249X	2060-5587		J FLOW CHEM	J. Flow Chem.	DEC	2014	4	4					185	189		10.1556/JFC-D-14-00012		5	Chemistry, Multidisciplinary	Chemistry	AW2QS	WOS:000346134300007		
J	Ouchi, A; Hyugano, T; Kaneda, M; Suzuki, T; Liu, CX				Ouchi, Akihiko; Hyugano, Takeshi; Kaneda, Masayuki; Suzuki, Toshiaki; Liu, Chuanxiang			Two-Step Laser Photolysis of Flavone and NaBH4 at Organic-Aqueous Liquid Interface Using a Microchannel Reactor: A Method to Avoid Secondary Thermal Side Reactions	JOURNAL OF FLOW CHEMISTRY			English	Article						laser; flavone; photoreduction; photocleavage; microreactor; interface	LIGHT PHOTOREDOX CATALYSIS; CONTINUOUS-FLOW; MICROFLOW PHOTOCHEMISTRY; 2+2 PHOTOCYCLOADDITION; PHOTOCATALYTIC MICROREACTOR; HETEROAROMATIC-COMPOUNDS; MICROCAPILLARY REACTOR; CHIRAL CYCLOHEXENONE; METHYLENE-BLUE; POLYMER BEADS	A microchannel reactor was used for suppressing undesirable side reactions in a photochemical reaction. A two-step photolysis, flavone (1). flavanone (2). salicylic acid (3b), was conducted in a microchannel reactor using a two-phase photolysis, that is, 1 and NaBH4 were dissolved in immiscible H2O and hexane, respectively, and photolyses were conducted at their interface. The two-step photolysis product 3b was obtained as a major product. In contrast, photolysis in homogeneous EtOH solution gave flavanol (4) as a major product. The thermal side reaction 2 -> 4 was suppressed completely by the interface photolysis, and a greater than 25-fold increase was observed in the selectivity of 3b.	[Ouchi, Akihiko; Hyugano, Takeshi; Kaneda, Masayuki; Suzuki, Toshiaki; Liu, Chuanxiang] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Ouchi, A (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan.	ouchi.akihiko@aist.go.jp					Yavorskyy A, 2012, ORG LETT, V14, P4342, DOI 10.1021/ol301773r; Belluau V, 2010, TETRAHEDRON LETT, V51, P4738, DOI 10.1016/j.tetlet.2010.07.017; Willumstad TP, 2013, J ORG CHEM, V78, P11450, DOI 10.1021/jo402010b; Zhang Q, 2013, J HAZARD MATER, V254, P318, DOI 10.1016/j.jhazmat.2013.04.012; Asano K, 2013, ORG LETT, V15, P2398, DOI 10.1021/ol4008519; Ehrich H, 2002, CHIMIA, V56, P647, DOI 10.2533/000942902777680063; Liao HH, 2013, CHEM COMMUN, V49, P7953, DOI 10.1039/c3cc43996h; Maeda H, 2013, RES CHEM INTERMEDIAT, V39, P301, DOI 10.1007/s11164-012-0650-6; Wang N, 2012, LAB CHIP, V12, P3983, DOI 10.1039/c2lc40428a; Neumann M, 2012, ORG LETT, V14, P2658, DOI 10.1021/ol3005529; Lu H, 2001, LAB CHIP, V1, P22, DOI 10.1039/b104037p; Aida S, 2012, TETRAHEDRON LETT, V53, P5578, DOI 10.1016/j.tetlet.2012.07.143; Wang X, 2013, ANGEW CHEM INT EDIT, V52, P7860, DOI 10.1002/anie.201303483; Kopetzki D, 2013, CHEM-EUR J, V19, P5450, DOI 10.1002/chem.201204558; Matsushita Y, 2006, CHEM LETT, V35, P410, DOI 10.1246/cl.2006.410; Meng ZX, 2013, NANOSCALE, V5, P4687, DOI 10.1039/c3nr00775h; Shvydkiv O, 2010, ORG LETT, V12, P5170, DOI 10.1021/ol102184u; Zourob M, 2006, LAB CHIP, V6, P296, DOI 10.1039/b513195b; Han ZT, 2013, MICROELECTRON ENG, V111, P199, DOI 10.1016/j.mee.2013.03.154; Fukuyama T, 2011, J FLOW CHEM, V1, P40, DOI 10.1556/jfchem.2011.00007; Bouquey M, 2008, CHEM ENG J, V135, pS93, DOI 10.1016/j.cej.2007.07.043; Ueno K, 2002, LAB CHIP, V2, P231, DOI 10.1039/b207991g; Nguyen JD, 2013, CHEM COMMUN, V49, P4352, DOI 10.1039/c2cc37206a; Tsuchiya N, 2012, PHYS CHEM CHEM PHYS, V14, P4734, DOI 10.1039/c2cp23979e; Terao K, 2012, J PHOTOCH PHOTOBIO A, V242, P13, DOI 10.1016/j.jphotochem.2012.05.021; Oelgemoller M, 2011, MOLECULES, V16, P7522, DOI 10.3390/molecules16097522; Wootton RCR, 2002, ORG PROCESS RES DEV, V6, P187, DOI 10.1021/op0155155; Kreis LM, 2013, ORG LETT, V15, P1634, DOI 10.1021/ol400410m; Aillet T, 2013, CHEM ENG PROCESS, V64, P38, DOI 10.1016/j.cep.2012.10.017; Maeda H, 2005, CHEM LETT, V34, P66, DOI 10.1246/cl.2005.66; Dubinsky S, 2008, MACROMOLECULES, V41, P3555, DOI 10.1021/ma800300d; Chen DU, 2005, BIOORG MED CHEM LETT, V15, P2665, DOI 10.1016/j.bmcl.2005.03.005; Shvydkiv O, 2011, PHOTOCH PHOTOBIO SCI, V10, P1399, DOI 10.1039/c1pp05024a; Fukuyama T, 2004, CHEM LETT, V33, P1430, DOI 10.1246/cl.2004.1430; ASHERSON JL, 1980, J CHEM SOC PERK T 1, P522, DOI 10.1039/p19800000522; Bachollet S, 2013, BEILSTEIN J ORG CHEM, V9, P2015, DOI 10.3762/bjoc.9.237; Bremus-Kobberling E, 2012, BEILSTEIN J ORG CHEM, V8, P1213, DOI 10.3762/bjoc.8.135; Chen AH, 2003, J CHIN CHEM SOC-TAIP, V50, P123; Drhova M., 2012, PROCEDIA ENG, V42, P1365; Kawata H, 1996, J PHOTOCH PHOTOBIO A, V101, P201, DOI 10.1016/S1010-6030(96)04419-X; Krivec M, 2013, ACS APPL MATER INTER, V5, P9088, DOI 10.1021/am402389t; MACK POL, 1972, J CHEM SOC CHEM COMM, P451, DOI 10.1039/c39720000451; MATSUSHIMA R, 1986, J CHEM SOC PERK T 2, P1217, DOI 10.1039/p29860001217; Matsushita Y, 2009, CHEM LETT, V38, P846, DOI 10.1246/cl.2009.846; Matsushita Y, 2008, CATAL TODAY, V132, P153, DOI 10.1016/j.cattod.2007.12.078; Montero-Ocampo C, 2012, ENVIRON SCI POLLUT R, V19, P3751, DOI 10.1007/s11356-012-0771-x; Nekkanti V, 2010, J APPL POLYM SCI, V116, P1940, DOI 10.1002/app.31685; Nishiyama Y, 2012, CHIRALITY, V24, P400, DOI 10.1002/chir.22004; Oelgemoller M, 2012, CHEM ENG TECHNOL, V35, P1144, DOI 10.1002/ceat.201200009; Ouchi A, 2008, J PHOTOCH PHOTOBIO A, V199, P261, DOI 10.1016/j.jphotochem.2008.05.024; Pimparkar K, 2011, J FLOW CHEM, V1, P53, DOI 10.1556/jfchem.2011.00006; Sakai M, 2013, APPL SURF SCI, V265, P925, DOI 10.1016/j.apsusc.2012.11.043; Sakeda K, 2007, J PHOTOCH PHOTOBIO A, V192, P166, DOI 10.1016/j.jphotochem.2007.05.019; Shvydkiv O., 2012, HDB ORGANIC PHOTOCHE, V1, P49; Sugimoto A, 2009, TETRAHEDRON, V65, P1593, DOI 10.1016/j.tet.2008.12.063; Sugimoto A, 2006, TETRAHEDRON LETT, V47, P6197, DOI 10.1016/j.tetlet.2006.06.153; Takei G, 2005, CATAL COMMUN, V6, P357, DOI 10.1016/j.catcom.2005.02.010; Tan SB, 2010, SYNLETT, P2240, DOI 10.1055/s-0030-1258032; Terao K, 2012, J FLOW CHEM, V2, P73, DOI 10.1556/JFC-D-12-00005; Vesborg PCK, 2010, CHEM ENG J, V160, P738, DOI 10.1016/j.cej.2010.03.083; Yamashita T, 2013, RES CHEM INTERMEDIAT, V39, P111, DOI 10.1007/s11164-012-0636-4; Yeh CH, 2009, MICROFLUID NANOFLUID, V6, P277, DOI 10.1007/s10404-008-0333-1; Yoon TH, 2011, CHEM ENG J, V167, P666, DOI 10.1016/j.cej.2010.08.090; Yu WB, 2012, J CHEM RES, P258, DOI 10.3184/174751912X13333614619977	64	1	1	AKADEMIAI KIADO RT	BUDAPEST	PRIELLE K U 19, PO BOX 245,, H-1117 BUDAPEST, HUNGARY	2062-249X	2060-5587		J FLOW CHEM	J. Flow Chem.	DEC	2014	4	4					190	194		10.1556/JFC-D-14-00025		5	Chemistry, Multidisciplinary	Chemistry	AW2QS	WOS:000346134300008		
J	Nagai, T; Suzuki, N; Kai, N; Tanoue, Y				Nagai, Takeshi; Suzuki, Nobutaka; Kai, Norihisa; Tanoue, Yasuhiro			Functional properties of autolysate and enzymatic hydrolysates from yam tsukuneimo (Dioscorea opposita Thunb.) tuber mucilage tororo: antioxidative activity and antihypertensive activity	JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE			English	Article						Yam tsukuneimo tuber mucilage tororo; Enzymatic hydrolysis; Antioxidant activity; Free radical scavenging activity; Antihypertensive activity	PROTEIN HYDROLYSATE; GLYCOSIDES; EXTRACTS; RHIZOMES; STORAGE; RATS	Yam tsukuneimo tuber mucilage tororo hydrolysates were prepared by autolysis and three different peptic enzymes. Except for pepsin hydrolysate, tororo was perfectly digested. Each hydrolysate for 100 mg/ml significantly prolonged the induction period of auto-oxidation of linoleic acid, which was similar to 5 mM ascorbic acid. These hydrolysates also possessed high scavenging activities such as superoxide anion radicals, hydroxyl radicals, and DPPH radicals. Moreover, high antihypertensive activities were detected in these hydrolysates except for autolysate, which were similar to various fermented foods such as miso, natto, sake, cheese, and so on. Present findings suggest that yam tsukuneimo tuber mucilage tororo may be useful for preventing diseases associated with reactive oxygen species and blood pressure in the body system and it can fully absorb the useful components from it to digest using the gastrointestinal enzymes.	[Nagai, Takeshi] Yamagata Univ, Grad Sch Agr Sci, Yamagata 9978555, Japan; [Nagai, Takeshi] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Nagai, Takeshi] Songkla Univ, Grad Sch Prince, Hat Yai 90112, Songkhla, Thailand; [Suzuki, Nobutaka] Nagoya Res Inst, Toyoake, Aichi 4701131, Japan; [Kai, Norihisa; Tanoue, Yasuhiro] Natl Fisheries Univ, Yamaguchi 7596595, Japan	Nagai, T (reprint author), Yamagata Univ, Grad Sch Agr Sci, Yamagata 9978555, Japan.	nandemofreefree@yahoo.co.jp					Yin J, 2003, J NAT PROD, V66, P646, DOI 10.1021/np0205957; Hu K, 2002, PLANTA MED, V68, P297, DOI 10.1055/s-2002-26743; Zhou KQ, 2004, LEBENSM-WISS TECHNOL, V37, P717, DOI 10.1016/j.lwt.2004.02.008; Sachindra NM, 2010, J FOOD SCI TECH MYS, V47, P94, DOI 10.1007/s13197-010-0022-4; OKAMOTO A, 1995, BIOSCI BIOTECH BIOCH, V59, P1147; Chen HX, 2012, J FOOD SCI TECH MYS, V49, P356, DOI 10.1007/s13197-011-0291-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ardestani A, 2007, FOOD CHEM, V104, P21, DOI 10.1016/j.foodchem.2006.10.066; Thiansilakul Y, 2007, J FOOD BIOCHEM, V31, P266, DOI 10.1111/j.1745-4514.2007.00111.x; Kosanic M, 2011, J FOOD SCI TECH MYS, V48, P584, DOI 10.1007/s13197-010-0174-2; Kitts DD, 2003, CURR PHARM DESIGN, V9, P1309, DOI 10.2174/1381612033454883; OZO ON, 1984, PHYTOCHEMISTRY, V23, P329, DOI 10.1016/S0031-9422(00)80327-1; SLINKARD K, 1977, AM J ENOL VITICULT, V28, P49; Klompong V, 2007, FOOD CHEM, V102, P1317, DOI 10.1016/j.foodchem.2006.07.016; Je JY, 2005, FOOD RES INT, V38, P45, DOI 10.1016/j.foodres.2004.07.005; Manso MA, 2008, FOOD CHEM, V109, P361, DOI 10.1016/j.foodchem.2007.12.049; Atindehou KK, 2002, PHYTOTHER RES, V16, P497, DOI 10.1002/ptr.970; Je JY, 2007, PROCESS BIOCHEM, V42, P840, DOI 10.1016/j.procbio.2007.02.006; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Butterfield DA, 2002, J NUTR BIOCHEM, V13, P444, DOI 10.1016/S0955-2863(02)00205-X; Kanatt SR, 2007, FOOD CHEM, V100, P451, DOI 10.1016/j.foodchem.2005.09.066; Araghinikam Mohsen, 1996, Life Sciences, V59, P147; Bhandari MR, 2003, FOOD CHEM, V82, P619, DOI 10.1016/S0308-8146(03)00019-0; Box HC, 1997, NUTRITION, V13, P920, DOI 10.1016/S0899-9007(97)00260-8; Hou WC, 1999, J AGR FOOD CHEM, V47, P2168, DOI 10.1021/jf980738o; Hou WC, 2002, PLANTA MED, V68, P1072, DOI 10.1055/s-2002-36356; Hu K, 1996, PLANTA MED, V62, P573, DOI 10.1055/s-2006-957978; Indu Sasidharan, 2011, Journal of Food Science and Technology, V48, P366; Kagawa Y, 2012, STANDARD TABLES FOOD; Krishna DS, 2011, J FOOD SCI TECHNOL, V48, P510; Lee SC, 2002, ACTA PHARMACOL SIN, V23, P503; Liu S.Y., 1995, J CHIN MED, V6, P111; Ma Hai-ying, 2002, Zhongguo Zhongyao Zazhi, V27, P528; Marijana K, 2011, J FOOD SCI TECHNOL, V48, P584; Nagai T, 2006, Z NATURFORSCH C, V61, P792; Nasirullah, 2009, J FOOD SCI TECH MYS, V46, P66; Omonigho SE, 2000, FOOD CHEM, V71, P215, DOI 10.1016/S0308-8146(00)00158-8; Qian Sun, 2011, Journal of Food Science and Technology, V48, DOI 10.1007/s13197-010-0115-0; Ramakrishnan Kaushik, 2010, Journal of Food Science and Technology, V47, P27; Rekha CR, 2010, J FOOD SCI TECH MYS, V47, P387, DOI 10.1007/s13197-010-0064-7; Sarala M, 2012, J FOOD SCI TECH MYS, V49, P119, DOI 10.1007/s13197-011-0364-6; Seema MN, 2008, J FOOD SCI TECHNOL, V45, P349; Singh UAK, 2009, J FOOD SCI TECHNOL, V46, P595; Suma PF, 2012, J FOOD SCI TECH MYS, V49, P500, DOI 10.1007/s13197-011-0300-9	44	0	0	SPRINGER INDIA	NEW DELHI	7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001, INDIA	0022-1155	0975-8402		J FOOD SCI TECH MYS	J. Food Sci. Technol.-Mysore	DEC	2014	51	12					3838	3845		10.1007/s13197-012-0910-x		8	Food Science & Technology	Food Science & Technology	AU9ME	WOS:000345916400030		
J	Mukai, A; Iijima, H; Hiyama, S; Fujii, H; Shinzaki, S; Inoue, T; Shiraishi, E; Kawai, S; Araki, M; Hayashi, Y; Kondo, J; Mizushima, T; Kanto, T; Egawa, S; Nishida, T; Tsujii, M; Takehara, T				Mukai, Akira; Iijima, Hideki; Hiyama, Satoshi; Fujii, Hironobu; Shinzaki, Shinichiro; Inoue, Takahiro; Shiraishi, Eri; Kawai, Shoichiro; Araki, Manabu; Hayashi, Yoshito; Kondo, Jumpei; Mizushima, Tsunekazu; Kanto, Tatsuya; Egawa, Satoshi; Nishida, Tsutomu; Tsujii, Masahiko; Takehara, Tetsuo			Regulation of anergy-related ubiquitin E3 ligase, GRAIL, in murine models of colitis and patients with Crohn's disease	JOURNAL OF GASTROENTEROLOGY			English	Article						Inflammatory bowel disease; MicroRNA; GRAIL; Regulatory T cells	INFLAMMATORY-BOWEL-DISEASE; T-CELL ANERGY; ULCERATIVE-COLITIS; ORAL TOLERANCE; MICE	Abrogating tolerance is a critical step in the pathogenesis of Crohn's disease (CD). T cell-anergy is one of the main mechanisms of tolerance and is regulated by the gene related to anergy in lymphocytes (GRAIL). This study investigated the expressions and regulation of GRAIL in CD and murine colitis models. Expressions of GRAIL mRNA and protein in CD4(+) T cells were investigated in the peripheral blood and mucosal tissues of patients with CD, mice with dextran sodium salt (DSS)-induced colitis, and Il-10-deficient mice. MicroRNAs responsible for the regulation of GRAIL were examined by miRNA microarray. GRAIL-overexpressing T cells were intravenously injected in mice with DSS-induced colitis. The GRAIL expression was higher in the lamina propria (LP) CD4(+) T cells of CD patients than of the control subjects, while it was lower in the peripheral blood CD4(+) T cells of the CD patients than of the control subjects. The GRAIL mRNA expression was lower, but the GRAIL protein expression was higher in the LP of colitic mice than that of non-colitic mice. The miRNA microarray identified miR-290-5p as an miRNA that inhibits expression of the GRAIL protein and that is highly expressed in the LP of non-colitic mice. GRAIL-expressing T cells expressed regulatory T cell markers and showed suppressive effects in murine DSS-induced colitis. Our results show that expression of GRAIL is uniquely regulated by the specific miRNA in the intestinal mucosa, and suggest that GRAIL may associate with the pathophysiology of CD.	[Mukai, Akira; Iijima, Hideki; Hiyama, Satoshi; Fujii, Hironobu; Shinzaki, Shinichiro; Inoue, Takahiro; Shiraishi, Eri; Kawai, Shoichiro; Araki, Manabu; Hayashi, Yoshito; Kondo, Jumpei; Nishida, Tsutomu; Tsujii, Masahiko; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan; [Fujii, Hironobu] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka 5650871, Japan; [Mizushima, Tsunekazu] Osaka Univ, Grad Sch Med, Dept Surg Clin Applicat, Suita, Osaka 5650871, Japan; [Kanto, Tatsuya] Osaka Univ, Grad Sch Med, Dept Dendrit Cell Biol & Clin Applicat, Suita, Osaka 5650871, Japan; [Egawa, Satoshi] Kansai Rosai Hosp, Dept Gastroenterol, Amagasaki, Hyogo 6608611, Japan	Iijima, H (reprint author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, 2-2 K1 Yamadaoka, Suita, Osaka 5650871, Japan.	hiijima@gh.med.osaka-u.ac.jp		Nishida, Tsutomu/0000-0003-4037-9003	Japan Society for the Promotion of Science [23590941]	We thank Drs. Takatoshi Nawa, Satoshi Shimizu (Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine), and Hiroaki Yamanaka, Ph.D. (Pattern Formation Group, Osaka University Graduate School of Frontier Bioscience) for technical advice about generating plasmid vectors and AcGFP fusion protein. This work was supported by a Grant in Aid from the Japan Society for the Promotion of Science (Grant No. 23590941).	Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Lin JT, 2009, J IMMUNOL, V182, P5919, DOI 10.4049/jimmunol.0803986; MacKenzie DA, 2007, J BIOL CHEM, V282, P9696, DOI 10.1074/jbc.M604192200; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Whiting CC, 2011, FEBS J, V278, P47, DOI 10.1111/j.1742-4658.2010.07922.x; Nurieva RI, 2010, IMMUNITY, V32, P670, DOI 10.1016/j.immuni.2010.05.002; Kraus TA, 2004, GASTROENTEROLOGY, V126, P1771, DOI 10.1053/j.gastro.2004.03.076; Corthay A, 2009, SCAND J IMMUNOL, V70, P326, DOI 10.1111/j.1365-3083.2009.02308.x; Mueller DL, 2004, NAT IMMUNOL, V5, P883, DOI 10.1038/ni1106; Su LL, 2009, J IMMUNOL, V183, P438, DOI 10.4049/jimmunol.0900204; Arimura Y, 2014, J GASTROENTEROL, V49, P1217, DOI 10.1007/s00535-013-0866-2; Leone V, 2013, J GASTROENTEROL, V48, P315, DOI 10.1007/s00535-013-0777-2; Iweala OI, 2006, IMMUNOL REV, V213, P82, DOI 10.1111/j.1600-065X.2006.00431.x; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Dohi T, 2005, GASTROENTEROLOGY, V128, P411, DOI 10.1053/j.gastro.2004.11.063; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Soares L, 2004, NAT IMMUNOL, V5, P45, DOI 10.1038/ni1017; Schartner JM, 2009, CLIN EXP IMMUNOL, V155, P348, DOI 10.1111/j.1365-2249.2008.03827.x; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; Takahashi I, 1997, GASTROENTEROLOGY, V112, P1876, DOI 10.1053/gast.1997.v112.pm9178680; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Lennard-Jones J E, 1989, Scand J Gastroenterol Suppl, V170, P2; Dalal Sushila R, 2010, Gastroenterol Hepatol (N Y), V6, P714; Egawa S, 2008, AM J PHYSIOL-GASTR L, V295, pG163, DOI 10.1152/ajpgi.90242.2008; FUJIHASHI K, 1992, J EXP MED, V175, P695, DOI 10.1084/jem.175.3.695; Hamilton MJ, 2012, J GASTROENTEROL, V47, P1, DOI 10.1007/s00535-011-0521-8; Lineberry NB, 2008, J IMMUNOL, V181, P1622; PODOLSKY DK, 1991, NEW ENGL J MED, V325, P928, DOI 10.1056/NEJM199109263251306; Sturm A, 2004, GUT, V53, P1624, DOI 10.1136/gut.2003.033613; Sudo H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031397	30	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	DEC	2014	49	12					1524	1535		10.1007/s00535-013-0923-x		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW1PA	WOS:000346060200002		
J	Nagahara, A; Suzuki, T; Nagata, N; Sugai, N; Takeuchi, Y; Sakurai, K; Miyamoto, M; Inoue, K; Akiyama, J; Mabe, K; Konuma, I; Kamada, T; Haruma, K				Nagahara, Akihito; Suzuki, Tsuyoshi; Nagata, Naoyoshi; Sugai, Nozomu; Takeuchi, Yoshiaki; Sakurai, Kouichi; Miyamoto, Masaki; Inoue, Kazuhiko; Akiyama, Junichi; Mabe, Katsuhiro; Konuma, Ichiro; Kamada, Tomoari; Haruma, Ken			A multicentre randomised trial to compare the efficacy of omeprazole versus rabeprazole in early symptom relief in patients with reflux esophagitis	JOURNAL OF GASTROENTEROLOGY			English	Article						Omeprazole; Rabeprazole; Proton pump inhibitor; Reflux esophagitis; Symptom relief	QUALITY-OF-LIFE; CYP2C19 EXTENSIVE METABOLIZERS; PROTON PUMP INHIBITORS; INTRAGASTRIC PH; GENERAL-POPULATION; DISEASE; LANSOPRAZOLE; ESOMEPRAZOLE; DYSPEPSIA; COMMUNITY	Proton pump inhibitors (PPIs) are affected by cytochrome P450 2C19 (CYP2C19) polymorphisms. This study compared the effect of two PPIs on early symptom relief in Japanese patients with reflux esophagitis, classified by the CYP2C19 phenotype. Patients with reflux esophagitis were randomised to treatment with omeprazole 20 mg or rabeprazole 10 mg once daily. The CYP2C19 phenotype [homozygous extensive metaboliser (homoEM), heterozygous extensive metaboliser (heteroEM) or poor metaboliser (PM)] of each patient was determined. The primary efficacy endpoint was early, sufficient (Global Overall Symptom scale score 1 or 2), sustained (maintained for a parts per thousand yen7 days) reflux symptom relief. Of the 199 patients included in this analysis, the proportion achieving sufficient, sustained reflux symptom relief was higher with omeprazole than with rabeprazole on day 1 (35.6 vs. 22.4 %; p = 0.041) and day 2 (43.6 vs. 28.6 %; p = 0.028); there was no significant difference between the two groups on days 3-7. Among patients with the CYP2C19 PM phenotype, sufficient, sustained reflux symptom relief was higher with omeprazole than with rabeprazole on days 4-7 (62.5-66.9 vs 31.6 %; p a parts per thousand currency sign 0.03); differences were not significant on days 1-3, or among those with the homoEM or heteroEM phenotypes on days 1-7. In Japanese patients with reflux esophagitis, omeprazole 20 mg is more effective than rabeprazole 10 mg at achieving early, sufficient, sustained reflux symptom relief in individuals with the CYP2C19 PM phenotype, and is similarly effective to rabeprazole 10 mg in those with heteroEM or homoEM phenotypes.	[Nagahara, Akihito] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 113, Japan; [Suzuki, Tsuyoshi] Tokyo Metropolitan Police Hosp, Dept Gastroenterol, Tokyo, Japan; [Nagata, Naoyoshi; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Sugai, Nozomu] KKR Sapporo Med Ctr, Dept Gastroenterol, Sapporo, Hokkaido, Japan; [Takeuchi, Yoshiaki] Showa Univ, Sch Med, Dept Gastroenterol, Tokyo 142, Japan; [Sakurai, Kouichi] Kumamoto Univ, Dept Gastroenterol & Hepatol, Kumamoto, Japan	Nagahara, A (reprint author), Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 113, Japan.	nagahara@juntendo.ac.jp					Furuta K, 2010, J INT MED RES, V38, P1473; Stedman CAM, 2000, ALIMENT PHARM THERAP, V14, P963, DOI 10.1046/j.1365-2036.2000.00788.x; Furuta T, 1999, CLIN PHARMACOL THER, V65, P552, DOI 10.1016/S0009-9236(99)70075-5; Vakil N, 2006, AM J GASTROENTEROL, V101, P1900, DOI 10.1111/j.1572-0241.2006.00630.x; Kulig M, 2003, ALIMENT PHARM THERAP, V18, P767, DOI 10.1046/j.1365-2036.2003.01770.x; Shirai N, 2001, ALIMENT PHARM THER, V15, P1929, DOI 10.1046/j.1365-2036.2001.01108.x; Fock KM, 2005, WORLD J GASTROENTERO, V11, P3091; Saitoh T, 2002, ALIMENT PHARM THERAP, V16, P1811, DOI 10.1046/j.0269-2813.2002.01348.x; Furuta T, 2007, PHARMACOGENOMICS, V8, P1199, DOI 10.2217/14622416.8.9.1199; Kinoshita Y, 2011, J GASTROENTEROL, V46, P1092, DOI 10.1007/s00535-011-0429-3; Ronkainen J, 2011, AM J GASTROENTEROL, V106, P1946, DOI 10.1038/ajg.2011.326; Tominaga K, 2012, J GASTROENTEROL, V47, P284, DOI 10.1007/s00535-011-0488-5; Archimandritis AJ, 2005, CURR MED RES OPIN, V21, P603, DOI 10.1185/030079905X41444; Bytzer P, 2006, SCAND J GASTROENTERO, V41, P1132, DOI 10.1080/00365520600615781; Dewan B, 2011, GASTROENT RES PRACT, DOI 10.1155/2011/640685; Donnellan C, 2005, COCHRANE DB SYST REV, V2; Galmiche JP, 2001, ALIMENT PHARM THERAP, V15, P1343, DOI 10.1046/j.1365-2036.2001.01030.x; Khan M, 2007, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003244.PUB2; Matsuki N, 2013, J GASTROENTEROL, V48, P340, DOI 10.1007/s00535-012-0649-1; Mee AS, 1996, ALIMENT PHARM THERAP, V10, P757, DOI 10.1046/j.1365-2036.1996.56198000.x; Pace F, 2005, ALIMENT PHARM THERAP, V22, P349, DOI 10.1111/j.1365-2036.2005.02558.x; Ronkainen J, 2006, ALIMENT PHARM THERAP, V23, P1725, DOI 10.1111/j.1365-2036.2006.02952.x; Sakurai K, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-42; VAKIL N, 2011, GUT, V60, pA154; VANPINXTEREN B, 2004, COCHRANE DB SYST REV, V4, P2095; Van Zanten SJOV, 2006, ALIMENT PHARM THERAP, V23, P521, DOI 10.1111/j.1365-2036.2006.02774.x; van Zanten SV, 2006, AM J GASTROENTEROL, V101, P2096, DOI 10.1111/j.1572-0241.2006.00751.x; Wahlqvist P, 2007, VALUE HEALTH, V10, pA149, DOI 10.1016/S1098-3015(10)68993-0; Wahlqvist P, 2006, ALIMENT PHARM THERAP, V24, P259, DOI 10.1111/j.1365-2036.2006.02996.x; Wiklund I, 2006, AM J GASTROENTEROL, V101, P18, DOI 10.1111/j.1572-0241.2006.00343.x; Yamagishi H, 2008, WORLD J GASTROENTERO, V14, P2049, DOI 10.3748/wjg.14.2049	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	DEC	2014	49	12					1536	1547		10.1007/s00535-013-0925-8		12	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW1PA	WOS:000346060200003		
J	Fujino, H; Imamura, M; Nagaoki, Y; Kawakami, Y; Abe, H; Hayes, CN; Kan, H; Fukuhara, T; Kobayashi, T; Masaki, K; Ono, A; Nakahara, T; Honda, Y; Naeshiro, N; Urabe, A; Yokoyama, S; Miyaki, D; Murakami, E; Kawaoka, T; Hiraga, N; Tsuge, M; Hiramatsu, A; Hyogo, H; Aikata, H; Takahashi, S; Miki, D; Ochi, H; Ohishi, W; Chayama, K				Fujino, Hatsue; Imamura, Michio; Nagaoki, Yuko; Kawakami, Yoshiiku; Abe, Hiromi; Hayes, C. Nelson; Kan, Hiromi; Fukuhara, Takayuki; Kobayashi, Tomoki; Masaki, Keiichi; Ono, Atsushi; Nakahara, Takashi; Honda, Youji; Naeshiro, Noriaki; Urabe, Ayako; Yokoyama, Satoe; Miyaki, Daisuke; Murakami, Eisuke; Kawaoka, Tomokazu; Hiraga, Nobuhiko; Tsuge, Masataka; Hiramatsu, Akira; Hyogo, Hideyuki; Aikata, Hiroshi; Takahashi, Shoichi; Miki, Daiki; Ochi, Hidenori; Ohishi, Waka; Chayama, Kazuaki		Hiroshima Liver Study Grp	Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C	JOURNAL OF GASTROENTEROLOGY			English	Article						Hepatitis C virus; Telaprevir; Older patients; IFNL4; RVR	GENOME-WIDE ASSOCIATION; COMBINATION THERAPY; PEGYLATED INTERFERON; PLUS RIBAVIRIN; HEPATOCELLULAR-CARCINOMA; ITPA POLYMORPHISM; GENETIC-VARIATION; VIRAL RESPONSE; CORE REGION; VIRUS	Older patients with chronic hepatitis C have a lower virological response to interferon (IFN) treatment compared to younger patients. The efficacy of telaprevir (TVR) and PEG-IFN plus ribavirin combination therapy and the predictive value of recently identified IFN lambda (IFNL) 4 polymorphisms on the outcome of therapy for older patients have not been addressed. We assessed predictive factors for sustained virological response (SVR) to triple therapy in 226 younger (a parts per thousand currency sign65 years) and 87 older (> 65 years) Japanese patients with chronic genotype 1 hepatitis C. IFNL4 polymorphism ss469415590 was analyzed by Invader assay. The SVR rate for older patients was slightly lower than for younger patients (69 vs. 82 %, P = 0.043). In the older group, the SVR rate for patients with the IFNL4 TT/TT genotype was significantly higher than patients with TT/Delta G or Delta G/Delta G genotypes (81.8 and 42.9 %, P = 0.003). In multivariate regression analysis, rapid virological response (OR 36.601, P = 0.002) and IFNL4 TT/TT genotype (OR 19.502, P = 0.009) were identified as significant independent predictors for SVR in older patients. Treatment-related decreases in hemoglobin and increases in serum creatinine were higher in older patients than younger patients. Reduction of initial TVR dose to 1,500 mg per day alleviated these adverse events without compromising SVR rate in older patients. Analysis of IFNL4 polymorphisms is a valuable predictor in older patients receiving TVR triple therapy. 1,500 mg per day is a suitable initial TVR dose for older Japanese patients.	[Fujino, Hatsue; Imamura, Michio; Nagaoki, Yuko; Kawakami, Yoshiiku; Abe, Hiromi; Hayes, C. Nelson; Kan, Hiromi; Fukuhara, Takayuki; Kobayashi, Tomoki; Masaki, Keiichi; Ono, Atsushi; Nakahara, Takashi; Naeshiro, Noriaki; Urabe, Ayako; Miyaki, Daisuke; Murakami, Eisuke; Kawaoka, Tomokazu; Hiraga, Nobuhiko; Tsuge, Masataka; Hiramatsu, Akira; Hyogo, Hideyuki; Aikata, Hiroshi; Takahashi, Shoichi; Chayama, Kazuaki] Hiroshima Univ, Dept Gastroenterol & Metab, Appl Life Sci, Inst Biomed & Hlth Sci,Minami Ku, Hiroshima 7348551, Japan; [Miki, Daiki; Ochi, Hidenori; Chayama, Kazuaki] Inst Phys & Chem Res RIKEN, Lab Digest Dis, Ctr Genom Med, Hiroshima, Japan; [Ohishi, Waka] Radiat Effects Res Fdn, Dept Clin Studies, Hiroshima, Japan	Chayama, K (reprint author), Hiroshima Univ, Dept Gastroenterol & Metab, Appl Life Sci, Inst Biomed & Hlth Sci,Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	chayama@hiroshima-u.ac.jp			Ministry of Health, Labor and Welfare; Ministry of Education, Culture, Sports, Science, and Technology, Government of Japan	This work was supported by Grants-in-Aid for scientific research and development from the Ministry of Health, Labor and Welfare and the Ministry of Education, Culture, Sports, Science, and Technology, Government of Japan. The funders had no role in the study's design, data collection and analysis, the decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Kainuma M, 2010, WORLD J GASTROENTERO, V16, P4400, DOI 10.3748/wjg.v16.i35.4400; Akuta N, 2006, J MED VIROL, V78, P83, DOI 10.1002/jmv.20507; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P15584, DOI 10.1073/pnas.242608099; Huang CF, 2010, J INFECT DIS, V201, P751, DOI 10.1086/650470; Zeuzem S, 2004, ANN INTERN MED, V140, P370; Furusyo N, 2013, J HEPATOL, V59, P205, DOI 10.1016/j.jhep.2013.03.020; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Nishiguchi S, 2014, J GASTROENTEROL, V49, P492, DOI 10.1007/s00535-013-0785-2; Chayama K, 2013, J GASTROENTEROL, V48, P1, DOI 10.1007/s00535-012-0714-9; Chayama K, 2011, J INFECT DIS, V204, P84, DOI 10.1093/infdis/jir210; Ochi H, 2010, GASTROENTEROLOGY, V139, P1190, DOI 10.1053/j.gastro.2010.06.071; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; SEEFF LB, 1992, NEW ENGL J MED, V327, P1906, DOI 10.1056/NEJM199212313272703; Akuta N, 2010, HEPATOLOGY, V52, P421, DOI 10.1002/hep.23690; Ogawa E, 2013, J HEPATOL, V58, P495, DOI 10.1016/j.jhep.2012.10.017; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Suzuki F, 2011, HEPATOLOGY, V53, P415, DOI 10.1002/hep.24058; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Akuta N, 2007, J HEPATOL, V46, P403, DOI 10.1016/j.jhep.2006.09.019; Honda T, 2010, LIVER INT, V30, P527, DOI 10.1111/j.1478-3231.2009.02064.x; Iwasaki Y, 2006, HEPATOLOGY, V43, P54, DOI 10.1002/hep.20984; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Hayashi N, 2012, J VIRAL HEPATITIS, V19, pE134, DOI 10.1111/j.1365-2893.2011.01528.x; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Arase Y, 2007, INTERVIROLOGY, V50, P16, DOI 10.1159/000096308; Hiramatsu N, 2006, HEPATOL RES, V35, P185, DOI 10.1016/j.hepres.2006.03.008; Lee SS, 2002, J HEPATOL, V37, P500, DOI 10.1016/S0168-8278(02)00211-8; NIH, 2002, GASTROENTEROLOGY, V123, P2082, DOI DOI 10.1053/GAST.2002.1232082; Suzuki F, 2013, HEPATOL RES, V43, P691, DOI 10.1111/hepr.12009	34	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	DEC	2014	49	12					1548	1556		10.1007/s00535-013-0924-9		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW1PA	WOS:000346060200004		
J	Wang, T; Takikawa, Y; Watanabe, A; Kakisaka, K; Oigawa, K; Miyamoto, Y; Suzuki, K				Wang, Ting; Takikawa, Yasuhiro; Watanabe, Asako; Kakisaka, Keisuke; Oigawa, Kanta; Miyamoto, Yasuhiro; Suzuki, Kazuyuki			Proliferation of mouse liver stem/progenitor cells induced by plasma from patients with acute liver failure is modulated by P2Y(2) receptor-mediated JNK activation	JOURNAL OF GASTROENTEROLOGY			English	Article						ALF-P; JNK; OCs; P2Y; TNF alpha	FULMINANT HEPATIC-FAILURE; NECROSIS-FACTOR-ALPHA; C-JUN; NUCLEOTIDE RECEPTORS; PURINERGIC RECEPTORS; HEPATOCYTE DEATH; PROTEIN-KINASE; STEM-CELLS; REGENERATION; SERUM	We recently reported that acute liver failure plasma (ALF-P) promotes the proliferation of mouse liver oval cells (OCs) through c-jun N-terminal kinase (JNK) activation. The aim of this study was to investigate the mechanism by which ALF-P induces JNK activation and OC proliferation. OCs and primary hepatocytes were exposed to ALF-P or normal control plasma (NC-P). Cell proliferation and activation of JNK and other JNK signaling molecules were detected subsequently. Next, we determined the effects of extracellular adenosine triphosphate (ATP) and ATP receptors on ALF-P-stimulated cell growth. Finally, the relationship between the tumor necrosis factor alpha (TNF alpha) and ATP receptor pathways was investigated. Cell proliferation accompanied by JNK activation was only observed in ALF-P-stimulated OCs. ALF-P stimulated the activation of SEK1/MKK4 and ATF2, but not c-Jun. Both PPADS (pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid) treatment and P2Y(2) (G-protein-coupled) small interfering RNA (siRNA) transfection blocked the effects of ALF-P on cell proliferation and JNK activation. However, ATP levels in ALF-P were significantly lower than that in NC-P, and ATP did not stimulate the proliferation of OCs. On the other hand, TNF alpha stimulated JNK activation and proliferation of OCs. TNF alpha receptor antagonist partly inhibited the ALF-P-stimulated proliferation of OCs. Moreover, PPADS significantly inhibited TNF alpha-stimulated cell proliferation, induced apoptosis, and inhibited the activation of JNK. However, our data showed no significant difference in plasma TNF alpha levels between the NC-P and ALF-P samples. JNK activation induced by P2Y(2) receptor crosstalk with the TNF alpha signaling pathway is important in mediating the effects of ALF-P on the proliferation and survival of OCs.	[Wang, Ting; Takikawa, Yasuhiro; Watanabe, Asako; Kakisaka, Keisuke; Oigawa, Kanta; Miyamoto, Yasuhiro; Suzuki, Kazuyuki] Iwate Med Univ, Div Hepatol, Dept Internal Med, Morioka, Iwate 020, Japan	Wang, T (reprint author), Iwate Med Univ, Div Hepatol, Dept Internal Med, Morioka, Iwate 020, Japan.	tingwang@iwate-med.ac.jp; ytakikaw@iwate-med.ac.jp			Ministry of Health, Labour and Welfare of Japan	The study was supported in part by Grants-in-Aid from the Ministry of Health, Labour and Welfare of Japan to the of Intractable Hepatobiliary Diseases study Group.	Akdogan M, 2006, J CLIN APHERESIS, V21, P96, DOI 10.1002/jca.20064; Vaughn BP, 2012, J HEPATOL, V57, P916, DOI 10.1016/j.jhep.2012.06.008; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Hayato R, 2007, J PHYSIOL-LONDON, V584, P473, DOI 10.1113/jphysiol.2007.138370; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Emmett DS, 2008, HEPATOLOGY, V47, P698, DOI 10.1002/hep.22035; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Dixon CJ, 2005, J PHARMACOL EXP THER, V313, P1305, DOI 10.1124/jpet.104.082743; Polson J, 2005, HEPATOLOGY, V41, P1179, DOI 10.1002/hep.20703; Behrens A, 2002, EMBO J, V21, P1782, DOI 10.1093/emboj/21.7.1782; Katoonizadeh A, 2006, LIVER INT, V26, P1225, DOI 10.1111/j.1478-3231.2006.01377.x; Vlahopoulos SA, 2008, BIOESSAYS, V30, P314, DOI 10.1002/bies.20734; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Di Virgilio F, 2001, BLOOD, V97, P587, DOI 10.1182/blood.V97.3.587; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Besirli CG, 2003, J BIOL CHEM, V278, P22357, DOI 10.1074/jbc.M300742200; Streetz K, 2000, GASTROENTEROLOGY, V119, P446, DOI 10.1053/gast.2000.9364; Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Malhi H, 2010, PHYSIOL REV, V90, P1165, DOI 10.1152/physrev.00061.2009; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; Thevananther S, 2004, HEPATOLOGY, V39, P393, DOI 10.1002/hep.20075; Nagaki M, 2000, J INFECT DIS, V182, P1103, DOI 10.1086/315826; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; O'Grady JG, 2005, POSTGRAD MED J, V81, P148, DOI 10.1136/pgmj.2004.026005; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Ayata CK, 2012, GASTROENTEROLOGY, V143, P1620, DOI 10.1053/j.gastro.2012.08.049; Duncan AW, 2009, GASTROENTEROLOGY, V137, P466, DOI 10.1053/j.gastro.2009.05.044; BRODNIEWICZPROBA T, 1991, BLOOD REV, V5, P245, DOI 10.1016/0268-960X(91)90016-6; Chastre A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049670; Dezső Katalin, 2012, Hepatology, V56, P1457, DOI 10.1002/hep.25713; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Fujioka H, 1997, TRANSPLANT P, V29, P3495, DOI 10.1016/S0041-1345(97)00994-9; GOVE CD, 1982, BRIT J EXP PATHOL, V63, P547; GREGUS Z, 1988, DRUG METAB DISPOS, V16, P527; Harada H, 2000, KIDNEY INT, V57, P949, DOI 10.1046/j.1523-1755.2000.00911.x; HARRINGTON WN, 1980, P NATL ACAD SCI-BIOL, V77, P423, DOI 10.1073/pnas.77.1.423; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; HUGHES RD, 1976, BRIT J EXP PATHOL, V57, P348; Iimuro Y, 2010, GASTROENTEROL RES PR, V2010; Kakisaka K, 2009, J IWATE MED ASS, V61, P259; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; Muscella A, 2004, J CELL PHYSIOL, V200, P428, DOI 10.1002/jcp.20033; Nagaki M, 2005, LIVER INT, V25, P1010, DOI 10.1111/j.1478-3231.2005.01127.x; Neufeld D S, 1997, Methods Mol Biol, V75, P145; Newsome PN, 2004, HEPATOLOGY, V40, P636, DOI 10.1002/hep.20359; O'Neil D, 2012, BLOOD COMPONENTS; Saich R, 2012, TOXIC MOLECULES LIVE; SANCHEZ I, 1994, NATURE, V372, P794; Stuyver LJ, 2003, J VIROL, V77, P10689, DOI 10.1128/JVI.77.19.10689-10694.2003	52	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	DEC	2014	49	12					1557	1566		10.1007/s00535-013-0927-6		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW1PA	WOS:000346060200005		
J	Tokunaga, M; Uto, H; Oda, K; Tokunaga, M; Mawatari, S; Kumagai, K; Haraguchi, K; Oketani, M; Ido, A; Ohnou, N; Utsunomiya, A; Tsubouchi, H				Tokunaga, Mayumi; Uto, Hirofumi; Oda, Kohei; Tokunaga, Masahito; Mawatari, Seiichi; Kumagai, Kotaro; Haraguchi, Kouichi; Oketani, Makoto; Ido, Akio; Ohnou, Nobuhito; Utsunomiya, Atae; Tsubouchi, Hirohito			Influence of human T-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis C virus infection	JOURNAL OF GASTROENTEROLOGY			English	Article						HTLV-1; Risk factor; Hepatitis C virus; Hepatocellular carcinoma; Coinfection	HUMAN-IMMUNODEFICIENCY-VIRUS; CELL LEUKEMIA-VIRUS; PLASMACYTOID DENDRITIC CELLS; HTLV-I INFECTION; SOUTHWESTERN JAPAN; VIRAL-HEPATITIS; NATURAL-HISTORY; LIVER-CANCER; RISK; CIRRHOSIS	Human T-lymphotropic virus type 1 (HTLV-1) may worsen the clinical course of hepatitis C virus (HCV) infection. The aim of this study was to investigate whether HTLV-1 coinfection influences the clinical characteristics of patients with HCV infection. This retrospective study included 523 consecutive patients from January 2001 to December 2010 with chronic liver disease due to HCV infection, in whom serum anti-HTLV-1 antibodies were examined. Among these patients, 265 were diagnosed with hepatocellular carcinoma (HCC). The seroprevalence of anti-HTLV-1 antibodies was significantly higher in patients with HCC (21.1 %) than those without HCC (10.5 %, P = 0.001). This significant difference was observed in female patients (29.5 vs. 8.5 %, P < 0.001), but not in male patients (16.5 vs. 12.9 %, P = 0.501). In multivariate analysis, anti-HTLV-1 antibody positivity was independently associated with HCC in female patients [odds ratio (OR), 5.029; 95 % confidence interval (95 % CI), 1.760-14.369; P = 0.003], in addition to age (a parts per thousand yen65 years; OR, 10.297; 95 % CI, 4.322-24.533; P < 0.001), platelet count (< 15 x 10(4)/mu L; OR, 2.715; 95 % CI, 1.050-7.017; P = 0.039), total bilirubin (a parts per thousand yen1 mg/dL; OR, 3.155; 95 % CI, 1.365-7.292; P = 0.007), and total cholesterol (a parts per thousand currency sign160 mg/dL; OR, 2.916; 95 % CI, 1.341-6.342; P = 0.007). In contrast, HTLV-1 coinfection was not associated with HCC in male patients, although age, alcohol consumption, platelet count, and albumin were independently associated with HCC. HTLV-1 coinfection may contribute to the development of HCC in patients with chronic HCV infection, especially in females.	[Tokunaga, Mayumi; Uto, Hirofumi; Oda, Kohei; Tokunaga, Masahito; Mawatari, Seiichi; Kumagai, Kotaro; Haraguchi, Kouichi; Oketani, Makoto; Ido, Akio] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Kagoshima 8908544, Japan; [Tokunaga, Mayumi; Tokunaga, Masahito; Utsunomiya, Atae] Imamura Bun Hosp, Dept Hematol, Kagoshima 8900064, Japan; [Haraguchi, Kouichi] Kagoshima Med Ctr, Natl Hosp Org, Dept Hematol, Kagoshima 8920853, Japan; [Ohnou, Nobuhito] Ikeda Hosp, Dept Hematol, Kanoya 8930024, Japan; [Tsubouchi, Hirohito] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept HGF Tissue Repair & Regenerat Med, Kagoshima 8908544, Japan	Uto, H (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	hirouto@m2.kufm.kagoshima-u.ac.jp			Eisai Co., Ltd.	H. Tsubouchi holds endowed faculty positions in research for HGF tissue repair and regenerative medicine, and has received funds from Eisai Co., Ltd. The other authors declare that they have no conflict of interest.	El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Arisawa K, 2000, INT J CANCER, V85, P319, DOI 10.1002/(SICI)1097-0215(20000201)85:3<319::AID-IJC4>3.0.CO;2-B; Kishihara Y, 2001, J INFECT DIS, V184, P1114, DOI 10.1086/323890; Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131; Gordon SC, 1998, HEPATOLOGY, V28, P562, DOI 10.1002/hep.510280238; Seeff LB, 2002, HEPATOLOGY, V36, pS1, DOI 10.1053/jhep.2002.36992; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Uto H, 2009, HEPATOLOGY, V50, P393, DOI 10.1002/hep.23002; OSAME M, 1986, LANCET, V1, P1031; YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534; Takahashi M, 2013, BLOOD, V122, P715, DOI 10.1182/blood-2013-03-493718; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Kobayashi M, 2012, J GASTROENTEROL, V47, P596, DOI 10.1007/s00535-012-0531-1; Akuta N, 2012, HEPATOLOGY, V56, P2134, DOI 10.1002/hep.25949; Yonkers NL, 2007, J IMMUNOL, V178, P4436; Suruki R, 2006, INT J CANCER, V119, P192, DOI 10.1002/ijc.21796; Chuang SC, 2010, CANCER EPIDEM BIOMAR, V19, P1261, DOI 10.1158/1055-9965.EPI-09-1297; Ioannou GN, 2013, HEPATOLOGY, V57, P249, DOI 10.1002/hep.25800; Strader DB, 1996, EUR J GASTROEN HEPAT, V8, P324, DOI 10.1097/00042737-199604000-00006; Boschi-Pinto C, 2000, J INFECT DIS, V181, P35, DOI 10.1086/315177; Karp DR, 2001, J BIOL CHEM, V276, P3798, DOI 10.1074/jbc.M008484200; GESSAIN A, 1985, LANCET, V2, P407; Takeda S, 2004, INT J CANCER, V109, P559, DOI 10.1002/ijc.20007; Nagai M, 2001, BLOOD, V98, P1858, DOI 10.1182/blood.V98.6.1858; Hishizawa M, 2004, BRIT J HAEMATOL, V125, P568, DOI 10.1111/j.1365-2141.2004.04956.x; Ikeda K, 1998, J HEPATOL, V28, P930, DOI 10.1016/S0168-8278(98)80339-5; Walter SR, 2011, J GASTROEN HEPATOL, V26, P1757, DOI 10.1111/j.1440-1746.2011.06785.x; Fattovich G, 1997, GASTROENTEROLOGY, V112, P463, DOI 10.1053/gast.1997.v112.pm9024300; Arisawa K, 2006, CANCER SCI, V97, P535, DOI 10.1111/j.1349-7006.2006.00212.x; Hanaoka M, 2012, J OBSTET GYNAECOL RE, V38, P793, DOI 10.1111/j.1447-0756.2011.01786.x; Hayashi K, 2000, HAEMOPHILIA, V6, P677, DOI 10.1046/j.1365-2516.2000.00444.x; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; KONDO T, 1989, INT J CANCER, V43, P1061, DOI 10.1002/ijc.2910430618; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; MEYTES D, 1990, LANCET, V336, P1533, DOI 10.1016/0140-6736(90)93308-C; MOCHIZUKI M, 1994, BRIT J OPHTHALMOL, V78, P149, DOI 10.1136/bjo.78.2.149; Mueller N, 1996, J ACQUIR IMMUNO DEFI, V13, P2; Nakashima K, 1994, J EPIDEMIOL, V4, P17; OKAYAMA A, 1995, JPN J CANCER RES, V86, P1; Sauleda S, 2001, HEPATOLOGY, V34, P1035, DOI 10.1053/jhep.2001.29130; Serfaty L, 1998, HEPATOLOGY, V27, P1435, DOI 10.1002/hep.510270535; Shembade Noula, 2010, World J Biol Chem, V1, P13, DOI 10.4331/wjbc.v1.i1.13; Soguero C, 2002, J VIROL, V76, P9345, DOI 10.1128/JVI.76.18.9345-9354.2002; STUVER SO, 1993, J INFECT DIS, V167, P57; Stuver SO, 1996, INT J CANCER, V67, P35, DOI 10.1002/(SICI)1097-0215(19960703)67:1<35::AID-IJC8>3.0.CO;2-0; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; TOKUDOME S, 1989, CANCER RES, V49, P226; WELLES SL, 1994, INT J CANCER, V56, P337, DOI 10.1002/ijc.2910560307; YAMAGUCHI K, 1994, LANCET, V343, P213, DOI 10.1016/S0140-6736(94)90994-6; Zhang J, 2007, VIROLOGY, V369, P198, DOI 10.1016/j.virol.2007.07.032	51	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	DEC	2014	49	12					1567	1577		10.1007/s00535-013-0928-5		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW1PA	WOS:000346060200006		
J	Arizumi, T; Ueshima, K; Takeda, H; Osaki, Y; Takita, M; Inoue, T; Kitai, S; Yada, N; Hagiwara, S; Minami, Y; Sakurai, T; Nishida, N; Kudo, M				Arizumi, Tadaaki; Ueshima, Kazuomi; Takeda, Haruhiko; Osaki, Yukio; Takita, Masahiro; Inoue, Tatsuo; Kitai, Satoshi; Yada, Norihisa; Hagiwara, Satoru; Minami, Yasunori; Sakurai, Toshiharu; Nishida, Naoshi; Kudo, Masatoshi			Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma	JOURNAL OF GASTROENTEROLOGY			English	Article						Hypervascular lesion; Liver cirrhosis; Response evaluation criteria in solid tumors; Response evaluation criteria in cancer of the liver; Tumor viability	INHIBITOR	To test the hypothesis that use of the response evaluation criteria in cancer of the liver (RECICL), an improved evaluation system designed to address the limitations of the response evaluation criteria in solid tumors 1.1 (RECIST1.1) and modified RECIST (mRECIST), provides for more accurate evaluation of response of patients with hepatocellular carcinoma (HCC) to treatment with sorafenib, a molecularly targeted agent, as assessed by overall survival (OS). The therapeutic response of 156 patients with advanced HCC who had been treated with sorafenib therapy for more than 1 month was evaluated using the RECIST1.1, mRECIST, and RECICL. After categorization as showing progressive disease (PD), stable disease (SD), or objective response, the association between OS and categorization was examined using the Kaplan-Meier method to develop survival curves. The 141 cases categorized as PD or SD by the RECIST1.1, but objective response by the mRECIST and RECICL, were further analyzed for determination of the association between OS and categorization. Only categorization using the RECICL was found to be significantly correlated with OS (p = 0.0033). Among the patients categorized as SD or PD by the RECIST1.1, reclassification by the RECICL but not the mRECIST was found to be significantly associated with OS and allowed for precise prediction of prognosis (p = 0.0066). Only the use of the RECICL allowed for identification of a subgroup of HCC patients treated with sorafenib with improved prognosis. The RECICL should, therefore, be considered a superior system for assessment of therapeutic response.	[Arizumi, Tadaaki; Ueshima, Kazuomi; Takita, Masahiro; Inoue, Tatsuo; Kitai, Satoshi; Yada, Norihisa; Hagiwara, Satoru; Minami, Yasunori; Sakurai, Toshiharu; Nishida, Naoshi; Kudo, Masatoshi] Kinki Univ, Fac Med, Dept Gastroenterol & Hepatol, Osakasayama, Osaka 5898511, Japan; [Takeda, Haruhiko; Osaki, Yukio] Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Tennoji Ku, Osaka 5438555, Japan	Kudo, M (reprint author), Kinki Univ, Fac Med, Dept Gastroenterol & Hepatol, 377-2 Ohno Higashi, Osakasayama, Osaka 5898511, Japan.	m-kudo@med.kindai.ac.jp			Health Labor Sciences Research Grant from the Ministry of Health Labour and Welfare of Japan [H22-Clinical Oncology-General-015]	This work was supported by a Health Labor Sciences Research Grant from the Ministry of Health Labour and Welfare of Japan (H22-Clinical Oncology-General-015).	Kano MR, 2009, CANCER SCI, V100, P173, DOI 10.1111/j.1349-7006.2008.01003.x; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Tanaka S, 2009, CANCER SCI, V100, P1, DOI 10.1111/j.1349-7006.2008.01006.x; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Llovet JM, 2008, J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Ebied OM, 2003, CANCER, V97, P1042, DOI 10.1002/cncr.11109; Rini BI, 2006, EXPERT OPIN PHARMACO, V7, P453, DOI 10.1517/14656566.7.4.453; Sakurai T, 2011, ONCOLOGY-BASEL, V81, P24, DOI 10.1159/000333256; The Liver Cancer Study Group of Japan, 2009, GEN RUL CLIN PATH ST; Wu HC, 2008, J CANC MOL, V4, P37	15	4	4	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	DEC	2014	49	12					1578	1587		10.1007/s00535-014-0936-0		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW1PA	WOS:000346060200007		
J	Wang, T; Takikawa, Y; Watanabe, A; Kakisaka, K; Oikawa, K; Miyamoto, Y; Suzuki, K				Wang, Ting; Takikawa, Yasuhiro; Watanabe, Asako; Kakisaka, Keisuke; Oikawa, Kanta; Miyamoto, Yasuhiro; Suzuki, Kazuyuki			Proliferation of mouse liver stem/progenitor cells induced by plasma from patients with acute liver failure is modulated by P2Y(2) receptor-mediated JNK activation (vol 49, pg 1557, 2014)	JOURNAL OF GASTROENTEROLOGY			English	Correction									[Wang, Ting; Takikawa, Yasuhiro; Watanabe, Asako; Kakisaka, Keisuke; Oikawa, Kanta; Miyamoto, Yasuhiro; Suzuki, Kazuyuki] Iwate Med Univ, Div Hepatol, Dept Internal Med, Morioka, Iwate 020, Japan	Wang, T (reprint author), Iwate Med Univ, Div Hepatol, Dept Internal Med, Morioka, Iwate 020, Japan.	tingwang@iwate-med.ac.jp; ytakikaw@iwate-med.ac.jp					Wang T, 2014, J GASTROENTEROL, V49, P1557, DOI 10.1007/s00535-013-0927-6	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	0944-1174	1435-5922		J GASTROENTEROL	J. Gastroenterol.	DEC	2014	49	12					1588	1588		10.1007/s00535-014-0939-x		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW1PA	WOS:000346060200008		
J	Sakoda, M; Ueno, S; Iino, S; Hiwatashi, K; Minami, K; Kawasaki, Y; Kurahara, H; Mataki, Y; Maemura, K; Uenosono, Y; Shinchi, H; Natsugoe, S				Sakoda, Masahiko; Ueno, Shinichi; Iino, Satoshi; Hiwatashi, Kiyokazu; Minami, Koji; Kawasaki, Yota; Kurahara, Hiroshi; Mataki, Yukou; Maemura, Kousei; Uenosono, Yoshikazu; Shinchi, Hiroyuki; Natsugoe, Shoji			Anatomical Laparoscopic Hepatectomy for Hepatocellular Carcinoma Using Indocyanine Green Fluorescence Imaging	JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES			English	Article							HEPATIC RESECTION; NAVIGATION SYSTEM; LIVER; SURGERY; SUBSEGMENTECTOMY; ULTRASONOGRAPHY; IDENTIFICATION; ULTRASOUND	Purpose: It is important to minimize surgical invasiveness in the therapy of patients with hepatocellular carcinoma (HCC), and consequently laparoscopic hepatic resection is widely performed. However, most anatomical resections, except left lateral sectionectomy, remain difficult technically, and laparoscopy-assisted procedures have been introduced as an alternative approach because of the safety and curative success of the operation. We reported previously pure laparoscopic subsegmentectomy of the liver using puncture of the portal branch under percutaneous ultrasound (US) with artificial ascites. Herein, we describe pure anatomical laparoscopic segmentectomy using the puncture method with indocyanine green (ICG) injection under laparoscopic US. Patients and Methods: Pure laparoscopic segmentectomy was planned for 2 patients with HCC of the liver. Identification of the segment was performed by ICG injection for optical imaging using near-infrared fluorescence under laparoscopic US guidance. Results: The procedures were completed successfully, and the postoperative courses were uneventful. Conclusions: Pure laparoscopic segmentectomy for HCC with a conventional puncture technique by ICG injection under laparoscopic US is considered to be a useful procedure featuring both low invasiveness and curative success.	[Sakoda, Masahiko; Iino, Satoshi; Hiwatashi, Kiyokazu; Minami, Koji; Kawasaki, Yota; Kurahara, Hiroshi; Mataki, Yukou; Maemura, Kousei; Uenosono, Yoshikazu; Shinchi, Hiroyuki; Natsugoe, Shoji] Kagoshima Univ, Sch Med, Dept Digest Surg Breast & Thyroid Surg, Kagoshima 8908520, Japan; [Ueno, Shinichi] Kagoshima Univ, Sch Med, Dept Clin Oncol, Kagoshima 8908520, Japan	Sakoda, M (reprint author), Kagoshima Univ, Sch Med, Dept Digest Surg Breast & Thyroid Surg, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	sakoda@m.kufm.kagoshima-u.ac.jp					Gotoh K, 2009, J SURG ONCOL, V100, P75, DOI 10.1002/jso.21272; Aoki T, 2010, J HEPATO-BIL-PAN SCI, V17, P590, DOI 10.1007/s00534-009-0197-0; MAKUUCHI M, 1985, SURG GYNECOL OBSTET, V161, P346; Kusano M, 2008, DIGEST SURG, V25, P103, DOI 10.1159/000121905; Uchiyama K, 2011, LANGENBECK ARCH SURG, V396, P1101, DOI 10.1007/s00423-011-0778-7; RIFKIN MD, 1987, ANN SURG, V205, P466, DOI 10.1097/00000658-198705000-00004; Ishizawa T, 2012, ARCH SURG-CHICAGO, V147, P393, DOI 10.1001/archsurg.2012.59; Kudo H, 2014, SURG ENDOSC, V28, P2504, DOI 10.1007/s00464-014-3468-z; Ishizawa T, 2009, CANCER, V115, P2491, DOI 10.1002/cncr.24291; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Kaneko H, 2008, HPB, V10, P219, DOI 10.1080/13651820802166831; Nitta H, 2010, ANN SURG, V251, P450, DOI 10.1097/SLA.0b013e3181cf87da; Kaneko H, 2009, J HEPATO-BILIARY-PAN, V16, P433, DOI 10.1007/s00534-009-0123-5; KOSUGE T, 1993, HEPATO-GASTROENTEROL, V40, P328; Marano A, 2013, WORLD J SURG, V37, P2800, DOI 10.1007/s00268-013-2066-x; Ueno S, 2008, J HEPATO-BILIARY-PAN, V15, P493, DOI 10.1007/s00534-007-1312-8; Wakabayashi G, 2009, J HEPATO-BILIARY-PAN, V16, P439, DOI 10.1007/s00534-009-0122-6; Aoki T, 2008, WORLD J SURG, V32, P1763, DOI 10.1007/s00268-008-9620-y; Kitai Toshiyuki, 2005, Breast Cancer, V12, P211, DOI 10.2325/jbcs.12.211; Kokudo N, 1996, SURGERY, V119, P634, DOI 10.1016/S0039-6060(96)80187-5; Sakoda M, 2013, SURG LAPARO ENDO PER, V23, pE45, DOI 10.1097/SLE.0b013e31826f9598; Takasaki K, 1998, J Hepatobiliary Pancreat Surg, V5, P286, DOI 10.1007/s005340050047; TAKAYAMA T, 1991, SURGERY, V109, P226; Ueno S, 2010, HEPATO-GASTROENTEROL, V57, P807; Yamamoto M, 2001, SURGERY, V130, P443, DOI 10.1067/msy.2001.116406	25	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1092-6429	1557-9034		J LAPAROENDOSC ADV S	J. Laparoendosc. Adv. Surg. Tech.	DEC 1	2014	24	12					878	882		10.1089/lap.2014.0243		5	Surgery	Surgery	AW4LP	WOS:000346252900011		
J	Tanaka, Y; Uchida, H; Kawashima, H; Masuko, T; Takazawa, S; Deie, K; Amano, H; Iwanaka, T				Tanaka, Yujiro; Uchida, Hiroo; Kawashima, Hiroshi; Masuko, Takayuki; Takazawa, Shinya; Deie, Kyoichi; Amano, Hizuru; Iwanaka, Tadashi			Laparoscopic Partial Nephrectomy for the Treatment of Large Cystic Nephroma in Children	JOURNAL OF LAPAROENDOSCOPIC & ADVANCED SURGICAL TECHNIQUES			English	Article							PARTIALLY DIFFERENTIATED NEPHROBLASTOMA; MULTILOCULAR CYST; COMPUTED-TOMOGRAPHY; KIDNEY; SURGERY	Background: Cystic nephroma (CN) is a rare benign renal neoplasm. The differential diagnosis of cystic partially differentiated nephroblastoma is only possible with pathological findings. Therefore, surgical resection is necessary to diagnose suspected CN lesions. Because CN is usually well demarcated and has a good prognosis, partial nephrectomy is recommended for its treatment. However, to our knowledge, laparoscopic treatment of CN has not been reported. We describe 2 cases of large CNs successfully treated: Case 1 was a 9-month-old boy with a lower polar mass in the right kidney, which occupied two-thirds of the kidney, and Case 2 was a 9-month-old boy with an upper polar mass in the left kidney, which occupied three-fourths of the kidney. Materials and Methods: Using the transperitoneal approach, the lesion was detected by a laparoscopic ultrasound probe, and vessels in the affected region were dissected. After the renal artery was clamped with bulldog clips, the parenchyma of the affected region was divided with an ultrasonically activated scalpel. The partly cut pelvis was closed by suturing, and the resected stump was coated with hemostatic agents and covered with the pediculate peritoneum. Results: The lesion was not exposed during surgery, and the microscopic features were consistent with CN in both cases. Residual renal function was good, and no residual tumor was found in both cases for over a year. Conclusions: Laparoscopic partial nephrectomy is a feasible approach to treat large CNs. When it is difficult to close the resection stump by parenchymal suturing, covering the stump with hemostatic agents and pediculate peritoneum is feasible.	[Tanaka, Yujiro; Uchida, Hiroo; Kawashima, Hiroshi; Masuko, Takayuki; Takazawa, Shinya; Deie, Kyoichi; Amano, Hizuru] Saitama Childrens Med Ctr, Dept Pediat Surg, Iwatsuki, Saitama 3398551, Japan; [Uchida, Hiroo] Nagoya Univ, Dept Pediat Surg, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Takazawa, Shinya; Iwanaka, Tadashi] Tokyo Univ Hosp, Dept Pediat Surg, Tokyo 113, Japan	Tanaka, Y (reprint author), Saitama Childrens Med Ctr, Dept Pediat Surg, 2100 Magome, Iwatsuki, Saitama 3398551, Japan.	tanaka.yujiro@pref.saitama.lg.jp	UCHIDA, Hiroo/E-4437-2015	UCHIDA, Hiroo/0000-0002-1818-6697			Abou-Elela Ashraf, 2009, Surg Technol Int, V18, P75; CASTILLO OA, 1991, UROLOGY, V37, P156, DOI 10.1016/0090-4295(91)80214-R; Gong EM, 2008, UROLOGY, V72, P843, DOI 10.1016/j.urology.2008.05.020; PARIENTY RA, 1981, RADIOLOGY, V140, P135; Fuchs J, 2009, J UROLOGY, V182, P1561, DOI 10.1016/j.juro.2009.06.063; Dingemann C, 2013, J LAPAROENDOSC ADV S, V23, P889, DOI 10.1089/lap.2013.0194; Shao PF, 2012, EUR UROL, V62, P1001, DOI 10.1016/j.eururo.2012.05.056; JORDAN GH, 1993, J UROLOGY, V150, P940; Robinson BC, 2003, J UROLOGY, V169, P638, DOI 10.1097/01.ju.0000040332.77090.d2; GALLO GE, 1977, CANCER, V39, P1322, DOI 10.1002/1097-0142(197703)39:3<1322::AID-CNCR2820390346>3.0.CO;2-L; Breda A, 2007, EUR UROL, V52, P798, DOI 10.1016/j.eururo.2007.02.035; Nguyen MM, 2008, J UROLOGY, V179, P627, DOI 10.1016/j.juro.2007.09.086; Schneider A, 2010, J PEDIATR UROL, V6, P166, DOI 10.1016/j.jpurol.2009.06.012; Eble JN, 1998, SEMIN DIAGN PATHOL, V15, P2; Blakely ML, 2003, J PEDIATR SURG, V38, P897, DOI 10.1016/S0022-3468(03)00118-0; Boybeyi O, 2008, J PEDIATR SURG, V43, P1985, DOI 10.1016/j.jpedsurg.2008.04.006; Chertin B, 2007, PEDIATR SURG INT, V23, P1233, DOI 10.1007/s00383-007-2005-8; FERRER FA, 1994, J UROLOGY, V151, P1358; Galanakis I, 2011, Rev Urol, V13, P131; GERVAIS DA, 1993, AM J ROENTGENOL, V161, P600; Joshi V V, 1979, Perspect Pediatr Pathol, V5, P217; Luithle T, 2007, J UROLOGY, V177, P294, DOI 10.1016/j.juro.2006.09.011; Matsuda Tadashi, 2013, Asian J Endosc Surg, V6, P68, DOI 10.1111/ases.12032; Okada T, 2003, J PEDIATR SURG, V38, P1689, DOI 10.1016/S0022-3468(0-3)00589-X; POWELL T, 1951, Br J Urol, V23, P142, DOI 10.1111/j.1464-410X.1951.tb02576.x; Streif W, 1997, MED PEDIATR ONCOL, V28; van den Hoek J, 2009, UROL INT, V82, P65, DOI 10.1159/000176028	27	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1092-6429	1557-9034		J LAPAROENDOSC ADV S	J. Laparoendosc. Adv. Surg. Tech.	DEC 1	2014	24	12					901	906		10.1089/lap.2014.0222		6	Surgery	Surgery	AW4LP	WOS:000346252900016		
J	Gelpi, E; Chaurand, P; Linscheid, M; Nakamura, T; Wada, Y; Korfmacher, W; Turecek, F; Eberlin, MN; Vekey, K				Gelpi, Emilio; Chaurand, Pierre; Linscheid, Michael; Nakamura, Takemichi; Wada, Yoshinao; Korfmacher, Walter; Turecek, Frank; Eberlin, Marcos N.; Vekey, Karoly			Congratulations Professor Caprioli!	JOURNAL OF MASS SPECTROMETRY			English	Editorial Material									[Gelpi, Emilio] Spanish Res Council CSIC, Madrid, Spain; [Chaurand, Pierre] Univ Montreal, Montreal, PQ H3C 3J7, Canada; [Linscheid, Michael] Humboldt Univ, Berlin, Germany; [Nakamura, Takemichi] RIKEN, Wako, Saitama, Japan; [Wada, Yoshinao] Osaka Med Ctr, Osaka, Japan; [Turecek, Frank] Univ Washington, Seattle, WA 98195 USA; [Eberlin, Marcos N.] Univ Estadual Campinas, Campinas, SP, Brazil; [Vekey, Karoly] Hungarian Acad Sci, H-1051 Budapest, Hungary	Gelpi, E (reprint author), Spanish Res Council CSIC, Madrid, Spain.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1076-5174	1096-9888		J MASS SPECTROM	J. Mass Spectrom.	DEC	2014	49	12					1203	1204		10.1002/jms.3470		2	Biochemical Research Methods; Chemistry, Analytical; Spectroscopy	Biochemistry & Molecular Biology; Chemistry; Spectroscopy	AW0QR	WOS:000345998800001		
J	Iwakuni, K; Sera, H; Abe, M; Sasada, H				Iwakuni, Kana; Sera, Hideyuki; Abe, Masashi; Sasada, Hiroyuki			Hyperfine-resolved transition frequency list of fundamental vibration bands of (HCl)-Cl-35 and (HCl)-Cl-37	JOURNAL OF MOLECULAR SPECTROSCOPY			English	Article						HCl; Mid-infrared; Hyperfine structure; Sub-Doppler resolution; Optical frequency comb; DFG	SUBMILLIMETER-WAVE SPECTRA; INFRARED-SPECTROSCOPY; HCL; PARAMETERS; REGION; STATES; DCL; HF	Sub-Doppler resolution spectroscopy of the fundamental vibration bands of (HCl)-Cl-35 and (HCl)-Cl-37 has been carried out from 87.1 to 89.9 THz. We have determined the absolute transition frequencies of the hyperfine-resolved R(0) to R(4) transitions with a typical uncertainty of 10 kHz. We have also yielded six molecular constants for each isotopomer in the vibrational excited state, which reproduce the determined frequencies with a standard deviation of about 10 kHz. (C) 2014 Elsevier Inc. All rights reserved.	[Iwakuni, Kana; Sera, Hideyuki; Abe, Masashi; Sasada, Hiroyuki] Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Iwakuni, K (reprint author), Keio Univ, Fac Sci & Technol, Dept Phys, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	k.iwakuni@z7.keio.jp			JSPS KAKENHI [23244084]; Photon Frontier Network Program of the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work is supported by JSPS KAKENHI Grant No. 23244084, and the Photon Frontier Network Program of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Villanueva GL, 2013, ICARUS, V223, P11, DOI 10.1016/j.icarus.2012.11.013; DeNatale P, 1997, CHEM PHYS LETT, V273, P253, DOI 10.1016/S0009-2614(97)00602-7; Rothman LS, 2013, J QUANT SPECTROSC RA, V130, P4, DOI 10.1016/j.jqsrt.2013.07.002; Krasnopolsky VA, 2013, ICARUS, V224, P57, DOI 10.1016/j.icarus.2013.02.010; NOLT IG, 1987, J MOL SPECTROSC, V125, P274, DOI 10.1016/0022-2852(87)90099-3; Hurtmans D, 2009, J MOL SPECTROSC, V254, P126, DOI 10.1016/j.jms.2009.01.015; Cazzoli G, 2004, J MOL SPECTROSC, V226, P161, DOI 10.1016/j.jms.2004.03.020; CODE RF, 1968, J CHEM PHYS, V49, P1895, DOI 10.1063/1.1670322; Coxon JA, 2000, J MOL SPECTROSC, V203, P49, DOI 10.1006/jmsp.2000.8155; de Leeuw F. H., 1973, Journal of Molecular Spectroscopy, V48, DOI 10.1016/0022-2852(73)90107-0; DELUCIA FC, 1971, PHYS REV A-GEN PHYS, V3, P1849, DOI 10.1103/PhysRevA.3.1849; Jones A, 2012, ATMOS CHEM PHYS, V12, P5207, DOI 10.5194/acp-12-5207-2012; JONES G, 1964, PHYS REV A-GEN PHYS, V136, P1229; KAISER EW, 1970, J CHEM PHYS, V53, P53, DOI 10.1063/1.1673831; Klaus T, 1998, J MOL SPECTROSC, V187, P109, DOI 10.1006/jmsp.1997.7465; Kreyling D., 2013, J GEOPHYS RES-ATMOS, V118, P11888; lwakuni K., 2013, OPT EXPRESS, V21, P14832; Odashima H, 1999, J MOL SPECTROSC, V194, P283, DOI 10.1006/jmsp.1998.7790; RINSLAND CP, 1993, J MOL SPECTROSC, V159, P274, DOI 10.1006/jmsp.1993.1124	19	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2852	1096-083X		J MOL SPECTROSC	J. Mol. Spectrosc.	DEC	2014	306						19	25		10.1016/j.jms.2014.09.013		7	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	AW2JS	WOS:000346114500004		
J	Nakamura, Y; Izumi, H; Fukushige, R; Shimizu, T; Watanabe, K; Morioka, N; Hama, A; Takamatsu, H; Nakata, Y				Nakamura, Yoki; Izumi, Hiroki; Fukushige, Ryo; Shimizu, Takumi; Watanabe, Kyohei; Morioka, Norimitsu; Hama, Aldric; Takamatsu, Hiroyuki; Nakata, Yoshihiro			Continuous infusion of substance P into rat striatum alleviates nociceptive behavior via phosphorylation of extracellular signal-regulated kinase 1/2	JOURNAL OF NEUROCHEMISTRY			English	Article						anti-nociception; ERK1; 2; reverse microdialysis; striatum; substance P; volume transmission	ROSTRAL VENTROMEDIAL MEDULLA; TUMOR-NECROSIS-FACTOR; PARKINSONS-DISEASE; NEUROKININ-1 RECEPTOR; MAP-KINASE; VOLUME TRANSMISSION; EXPRESSING NEURONS; INFLAMMATORY PAIN; GLOBUS-PALLIDUS; CAUDATE-PUTAMEN	Intraplantar injection of 0.4% formalin into the rat hind paw leads to a biphasic nociceptive response; an acute' phase (0-15min) and tonic' phase (16-120min), which is accompanied by significant phosphorylation of extracellular signal-regulated kinase (ERK)1/2 in the contralateral striatum at 120min post-formalin injection. To uncover a possible relationship between the slow-onset substance P (SP) release and increased ERK1/2 phosphorylation in the striatum, continuous infusion of SP into the striatum by reverse microdialysis (0.4g/mL in microdialysis fiber, 1L/min) was performed to mimic volume neurotransmission of SP. Continuous infusion for 3h of SP reduced the duration of tonic' phase nociception, and this SP effect was mediated by neurokinin 1 (NK1) receptors since pre-treatment with NK1 receptor antagonist CP96345 (10M) blocked the effect of SP infusion. However, formalin-induced tonic' phase nociception was significantly prolonged following acute injection of the MAP/ERK kinase 1/2 inhibitor PD0325901 (100pmol) by microinjection. The coinfusion of SP and PD0325901 significantly increased the tonic' phase of nociception. These data demonstrate that volume transmission of striatal SP triggered by peripheral nociceptive stimulation does not lead to pain facilitation but a significant decrease of tonic nociception by the activation of the SP-NK1 receptor-ERK1/2 system.	[Nakamura, Yoki; Izumi, Hiroki; Fukushige, Ryo; Shimizu, Takumi; Watanabe, Kyohei; Morioka, Norimitsu; Nakata, Yoshihiro] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacol, Hiroshima 7348553, Japan; [Hama, Aldric; Takamatsu, Hiroyuki] Hamamatsu Pharma Res Inc, Kita Ku, Hamamatsu, Shizuoka, Japan	Nakata, Y (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmacol, Minami Ku, Kasumi 1-2-3, Hiroshima 7348553, Japan.	ynakata@hiroshima-u.ac.jp			Hiroshima University	Experiments were carried out using equipment at the Analysis Center of Life Science, Hiroshima University and the Research Center for Molecular Medicine, Faculty of Medicine, Hiroshima University. This work was funded by Hiroshima University. The authors declare no competing financial interests.	Amadoro G, 2007, NEUROPHARMACOLOGY, V52, P1366, DOI 10.1016/j.neuropharm.2007.01.020; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Urban MO, 1999, P NATL ACAD SCI USA, V96, P7687, DOI 10.1073/pnas.96.14.7687; Gear RW, 2009, NEUROSCI LETT, V464, P170, DOI 10.1016/j.neulet.2009.08.036; Morioka N, 2009, NEUROCHEM INT, V55, P226, DOI 10.1016/j.neuint.2009.03.004; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Cassinelli G, 2013, CURR MED CHEM, V20, P1923; Ji RR, 2002, J NEUROSCI, V22, P478; Choi JIL, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-4; Parenti C, 2012, PEPTIDES, V34, P412, DOI 10.1016/j.peptides.2012.01.016; Goto T, 2008, PAIN, V140, P509, DOI 10.1016/j.pain.2008.10.009; Beiske AG, 2009, PAIN, V141, P173, DOI 10.1016/j.pain.2008.12.004; Steinhoff MS, 2014, PHYSIOL REV, V94, P265, DOI 10.1152/physrev.00031.2013; Tepper JM, 2007, PROG BRAIN RES, V160, P3, DOI 10.1016/S0079-6123(06)60001-0; Fuxe K, 2007, BRAIN RES REV, V55, P17, DOI 10.1016/j.brainresrev.2007.02.009; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Beutler AS, 2009, GENE THER, V16, P461, DOI 10.1038/gt.2009.23; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Perez-Aso M, 2013, BBA-MOL CELL RES, V1833, P2322, DOI 10.1016/j.bbamcr.2013.06.013; CHUDLER EH, 1993, J NEUROPHYSIOL, V69, P1890; Arai T, 2003, NEUROLOGY, V61, P1625; Jarcho JM, 2013, PAIN, V154, P987, DOI 10.1016/j.pain.2013.02.026; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Magnusson JE, 2000, BRAIN RES, V855, P260, DOI 10.1016/S0006-8993(99)02396-3; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Xu QH, 2011, J NEUROSCI, V31, P2113, DOI 10.1523/JNEUROSCI.2139-10.2011; Yang PF, 2011, PAIN, V152, P194, DOI 10.1016/j.pain.2010.10.027; Stambolic V, 2006, TRENDS CELL BIOL, V16, P461, DOI 10.1016/j.tcb.2006.07.001; Wei F, 2010, J NEUROSCI, V30, P8624, DOI 10.1523/JNEUROSCI.5389-09.2010; Morioka N, 2010, J PHARMACOL SCI, V113, P234, DOI 10.1254/jphs.10031FP; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Zhang FF, 2013, J NEUROSCI RES, V91, P745, DOI 10.1002/jnr.23213; Quartara L, 1997, NEUROPEPTIDES, V31, P537, DOI 10.1016/S0143-4179(97)90001-9; Barcelo AC, 2010, J NEURAL TRANSM, V117, P171, DOI 10.1007/s00702-009-0348-0; Barcelo AC, 2012, CELL MOL NEUROBIOL, V32, P1, DOI 10.1007/s10571-011-9737-7; Boivie J, 2009, PAIN, V141, P2, DOI 10.1016/j.pain.2008.09.021; Brink TS, 2012, J NEUROPHYSIOL, V107, P1210, DOI 10.1152/jn.00678.2011; Bugnicourt JM, 2011, J NEUROL, V258, P1150, DOI 10.1007/s00415-010-5899-3; Caioli S, 2011, NEUROBIOL DIS, V44, P92, DOI 10.1016/j.nbd.2011.06.008; Castro-Obregon S, 2004, J BIOL CHEM, V279, P17543, DOI 10.1074/jbc.M312363200; Chudler EH, 1998, BRAIN RES, V812, P283, DOI 10.1016/S0006-8993(98)00971-8; dasRocha J T., 2013, BIOL TRACE ELEM RES, V154, P372; Durieux PF, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00040; Edelmayer RM, 2014, BIOCHEM PHARMACOL, V87, P390, DOI 10.1016/j.bcp.2013.11.019; FERNANDEZ A, 1992, NEUROSCI LETT, V145, P171, DOI 10.1016/0304-3940(92)90014-X; AGNATI LF, 1986, ACTA PHYSIOL SCAND, V128, P201, DOI 10.1111/j.1748-1716.1986.tb07967.x; Ford B, 2009, NAT REV NEUROL, V5, P242, DOI 10.1038/nrneurol.2009.50; HERRERO MT, 1995, NEUROSCIENCE, V68, P1189, DOI 10.1016/0306-4522(95)00120-8; Kim J, 2008, ACT NEUR S, V101, P99; Koh YH, 2012, J CELL MOL MED, V16, P1582, DOI 10.1111/j.1582-4934.2011.01475.x; Lai JP, 2008, P NATL ACAD SCI USA, V105, P12605, DOI 10.1073/pnas.0806632105; Letro GH, 2009, ARQ NEURO-PSIQUIAT, V67, P591; Li CM, 2014, NEUROREPORT, V25, P164, DOI 10.1097/WNR.0000000000000051; Lineberry C G, 1975, Brain Res, V98, P119, DOI 10.1016/0006-8993(75)90513-2; MAO JR, 1993, J NEUROSCI, V13, P2689; Min MY, 2009, MOL CELL NEUROSCI, V42, P56, DOI 10.1016/j.mcn.2009.05.006; Min MY, 2008, NEUROSCIENCE, V153, P1020, DOI 10.1016/j.neuroscience.2008.03.011; Nakamura Y, 2013, J PHARMACOL SCI, V121, P257, DOI 10.1254/jphs.12218FP; Ojala DS, 2015, NEUROSCIENTIST, V21, P84, DOI 10.1177/1073858414521870; Ossipov MH, 2012, SCIENTIFICA CAIRO, V2012; Pacharinsak C, 2008, PAIN, V139, P34, DOI 10.1016/j.pain.2008.02.032; Paxinos G., 1997, RAT BRAIN STEREOTAXI; PEZZOLI G, 1984, NEUROLOGY, V34, P516; Polgar E, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-4; Rosen A, 2004, BRAIN RES, V1001, P87, DOI 10.1016/j.brainres.2003.11.060; Rossi F., 2013, J NEUROPHYSIOL, V111, P2196; Sanoja R., 2010, EUR J PAIN, V14; Shih YYI, 2008, MED ENG PHYS, V30, P953, DOI 10.1016/j.medengphy.2007.12.004	68	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	DEC	2014	131	6					755	766		10.1111/jnc.12938		12	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AW2ZX	WOS:000346156200006		
J	Kurokawa, K; Mizuno, K; Ohkuma, S				Kurokawa, Kazuhiro; Mizuno, Koji; Ohkuma, Seitaro			Sensitization of ethanol-induced place preference as a result of up-regulation of type 1 inositol 1,4,5-trispphate retcepters in mouse nucleus accumbens	JOURNAL OF NEUROCHEMISTRY			English	Article						2-APB; conditioned place preference; ethanol; FK506; nucleus accumbens; type 1 inositol 1,4,5-trisphosphate receptors	VENTRAL TEGMENTAL AREA; RYANODINE RECEPTOR EXPRESSION; PHYSICAL-DEPENDENCE; DOPAMINE D1; BEHAVIORAL SENSITIZATION; CALCIUM-RELEASE; ADDICTION; MICE; WITHDRAWAL; NEURONS	This study involved mice that received 4days of ethanol (EtOH) vapor inhalation and then were assessed for type 1 inositol 1,4,5-trisphosphate receptor (IP(3)Rs-1) expression and the development of EtOH-induced place preference at various time points in withdrawal. IP3R-1 protein was found to be significantly increased in the nucleus accumbens (NAcc) of mice immediately after 4-day EtOH vapor inhalation, while it significantly reduced to the control level during the next 3days of withdrawal from EtOH inhalation. EtOH (2g/kg, i.p.)-induced place preference after 3days of withdrawal from EtOH vapor inhalation increased dose dependently for 4days, which was significantly inhibited by 2-aminophenoxyethane-borate, an antagonist for IP(3)Rs. EtOH conditioning significantly increased, compared to alcohol-naive control mice, both IP3R-1 protein and the release of dopamine in the NAcc of mice after 3days of withdrawal from EtOH vapor inhaled for 4days, and this increase of IP3R-1 protein was completely abolished by intracerebroventricular injection of FK506, an inhibitor for calcineurin. These results indicate that the sensitization of EtOH-induced place preference is due to up-regulated IP3R-1 via calcineurin-mediated pathway after enhanced release of dopamine in the NAcc on EtOH administration during EtOH conditioning.	[Kurokawa, Kazuhiro; Mizuno, Koji; Ohkuma, Seitaro] Kawasaki Med Univ, Dept Pharmacol, Kurashiki, Okayama 7010192, Japan	Ohkuma, S (reprint author), Kawasaki Med Univ, Dept Pharmacol, Matsushima 577, Kurashiki, Okayama 7010192, Japan.	sohkuma@bcc.kawasaki-m.ac.jp			Japan Society for the Promotion of Science (from the Ministry of Education, Culture, Sports, Science, and Technology of Japan); Kawasaki Medical School [25-B7]	This work was supported, in part, by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (from the Ministry of Education, Culture, Sports, Science, and Technology of Japan) and by a Research Project Grant from Kawasaki Medical School (No. 25-B7). All authors declare that they have no conflicts of interest in this study.	Ahn KC, 2010, J NEUROSCI, V30, P6689, DOI 10.1523/JNEUROSCI.4453-09.2010; Lack AK, 2007, J NEUROPHYSIOL, V98, P3185, DOI 10.1152/jn.00189.2007; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Foddai M, 2004, NEUROPSYCHOPHARMACOL, V29, P530, DOI 10.1038/sj.npp.1300326; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Gonzales RA, 2004, PHARMACOL THERAPEUT, V103, P121, DOI 10.1016/j.pharmthera.2004.06.002; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Bernier BE, 2011, J NEUROSCI, V31, P5205, DOI 10.1523/JNEUROSCI.5282-10.2011; Biala G, 1999, ALCOHOL ALCOHOLISM, V34, P175, DOI 10.1093/alcalc/34.2.175; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Mizuno K, 2013, NEUROPHARMACOLOGY, V71, P264, DOI 10.1016/j.neuropharm.2013.03.036; Nestler EJ, 2002, NEUROBIOL LEARN MEM, V78, P637, DOI 10.1006/nlme.2002.4084; Shibasaki M, 2012, ALCOHOL CLIN EXP RES, V36, P1385, DOI 10.1111/j.1530-0277.2012.01747.x; Narita M, 2008, NEUROPSYCHOPHARMACOL, V33, P1097, DOI 10.1038/sj.npp.1301471; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; Spanagel R, 2009, PHYSIOL REV, V89, P649, DOI 10.1152/physrev.00013.2008; Verkhratsky A, 1996, CELL CALCIUM, V19, P1, DOI 10.1016/S0143-4160(96)90009-3; HALEY TJ, 1957, BRIT J PHARM CHEMOTH, V12, P12; Kelm MK, 2011, BRAIN RES REV, V65, P113, DOI 10.1016/j.brainresrev.2010.09.003; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Balino P, 2012, EXP NEUROL, V234, P446, DOI 10.1016/j.expneurol.2012.01.016; CAMPBELL AD, 1995, PHARMACOL BIOCHEM BE, V51, P835, DOI 10.1016/0091-3057(95)00050-7; GOLDSTEI.DB, 1972, J PHARMACOL EXP THER, V180, P203; Griffin Iii W. C., 2014, NEUROPSYCHOPHARMACOL, V39, P707, DOI [10.1038/npp.2013.256, DOI 10.1038/NPP.2013.256]; Katsura M, 2005, BRAIN RES, V1039, P211, DOI 10.1016/j.brainres.2005.01.074; Kim JA, 2004, P NATL ACAD SCI USA, V101, P5664, DOI 10.1073/pnas.0401373101; KURIYAMA K, 1990, ALCOHOL ALCOHOLISM, V25, P239; Kurokawa K, 2012, SYNAPSE, V66, P180, DOI 10.1002/syn.20997; Kurokawa K, 2013, ALCOHOL CLIN EXP RES, V37, P771, DOI 10.1111/acer.12036; Kurokawa K, 2011, J PHARMACOL SCI, V117, P87, DOI 10.1254/jphs.11106FP; Kurokawa K, 2012, NEUROSCIENCE, V227, P22, DOI 10.1016/j.neuroscience.2012.09.029; Mikoshiba K, 1997, CURR OPIN NEUROBIOL, V7, P339, DOI 10.1016/S0959-4388(97)80061-X; Mizuno K, 2012, J NEUROCHEM, V122, P702, DOI 10.1111/j.1471-4159.2012.07827.x; Mizuno K, 2013, SYNAPSE, V67, P51, DOI 10.1002/syn.21610; Paxinos G, 2001, MOUSE BRAIN STEREOTA; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Shibasaki M, 2011, SYNAPSE, V65, P1244, DOI 10.1002/syn.20947; Shibasaki M, 2010, J PHARMACOL SCI, V114, P234, DOI 10.1254/jphs.10146SC; Tarragon E, 2012, BEHAV BRAIN RES, V233, P554, DOI 10.1016/j.bbr.2012.05.046; YOSHIMOTO K, 1992, ALCOHOL, V9, P17, DOI 10.1016/0741-8329(92)90004-T	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	DEC	2014	131	6					836	847		10.1111/jnc.12945		12	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	AW2ZX	WOS:000346156200013		
J	Hara, Y; Gardner, JL				Hara, Yuko; Gardner, Justin L.			Encoding of graded changes in spatial specificity of prior cues in human visual cortex	JOURNAL OF NEUROPHYSIOLOGY			English	Article						vision; attention; contrast; efficient-selection; gating	CONTRAST RESPONSE FUNCTIONS; RAT SOMATOSENSORY CORTEX; CEREBRAL-BLOOD-FLOW; MACAQUE AREA V4; NEURONAL-ACTIVITY; WORKING-MEMORY; STIMULUS CONTRAST; HEMODYNAMIC-RESPONSES; PERCEPTUAL DECISIONS; ATTENTION MECHANISMS	Prior information about the relevance of spatial locations can vary in specificity; a single location, a subset of locations, or all locations may be of potential importance. Using a contrast-discrimination task with four possible targets, we asked whether performance benefits are graded with the spatial specificity of a prior cue and whether we could quantitatively account for behavioral performance with cortical activity changes measured by blood oxygenation level-dependent (BOLD) imaging. Thus we changed the prior probability that each location contained the target from 100 to 50 to 25% by cueing in advance 1, 2, or 4 of the possible locations. We found that behavioral performance (discrimination thresholds) improved in a graded fashion with spatial specificity. However, concurrently measured cortical responses from retinotopically defined visual areas were not strictly graded; response magnitude decreased when all 4 locations were cued (25% prior probability) relative to the 100 and 50% prior probability conditions, but no significant difference in response magnitude was found between the 100 and 50% prior probability conditions for either cued or uncued locations. Also, although cueing locations increased responses relative to noncueing, this cue sensitivity was not graded with prior probability. Furthermore, contrast sensitivity of cortical responses, which could improve contrast discrimination performance, was not graded. Instead, an efficient-selection model showed that even if sensory responses do not strictly scale with prior probability, selection of sensory responses by weighting larger responses more can result in graded behavioral performance benefits with increasing spatial specificity of prior information.	[Hara, Yuko; Gardner, Justin L.] RIKEN, Brain Sci Inst, Lab Human Syst Neurosci, Wako, Saitama 3510198, Japan	Gardner, JL (reprint author), RIKEN, Brain Sci Inst, Lab Human Syst Neurosci, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	justin@brain.riken.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24300146]	This work was supported in part by Grants-in-Aid for Scientific Research 24300146 (to J. L. Gardner) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Alvarez GA, 2012, J VISION, V12, DOI 10.1167/12.5.9; Anderson DE, 2013, J NEUROSCI, V33, P9273, DOI 10.1523/JNEUROSCI.0239-13.2013; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Zhou M, 2014, NAT NEUROSCI, V17, P841, DOI 10.1038/nn.3701; Purushothaman G, 2005, NAT NEUROSCI, V8, P99, DOI 10.1038/nn1373; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Muller NG, 2003, J NEUROSCI, V23, P3561; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Kok P, 2012, NEURON, V75, P265, DOI 10.1016/j.neuron.2012.04.034; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Dosher BA, 2000, VISION RES, V40, P1269, DOI 10.1016/S0042-6989(00)00019-5; Abrams J, 2012, VISION RES, V52, P70, DOI 10.1016/j.visres.2011.10.016; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0; FOLEY JM, 1981, VISION RES, V21, P1041, DOI 10.1016/0042-6989(81)90009-2; CASTIELLO U, 1992, J EXP PSYCHOL HUMAN, V18, P837, DOI 10.1037/0096-1523.18.3.837; Scolari M, 2009, J NEUROSCI, V29, P11933, DOI 10.1523/JNEUROSCI.5642-08.2009; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; LEGGE GE, 1980, J OPT SOC AM, V70, P1458, DOI 10.1364/JOSA.70.001458; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037//0096-3445.109.2.160; NACHMIAS J, 1974, VISION RES, V14, P1039, DOI 10.1016/0042-6989(74)90175-8; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Scolari M, 2010, J NEUROPHYSIOL, V104, P2266, DOI 10.1152/jn.00273.2010; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; SCLAR G, 1990, VISION RES, V30, P1, DOI 10.1016/0042-6989(90)90123-3; Eckstein MP, 2009, VISION RES, V49, P1097, DOI 10.1016/j.visres.2008.12.008; Jehee JFM, 2011, J NEUROSCI, V31, P8210, DOI 10.1523/JNEUROSCI.6153-09.2011; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; Dorris MC, 1998, J NEUROSCI, V18, P7015; Chen YZ, 2012, NEURON, V74, P557, DOI 10.1016/j.neuron.2012.03.033; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Lee DK, 1999, NAT NEUROSCI, V2, P375; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Thiele A, 2009, CEREB CORTEX, V19, P2970, DOI 10.1093/cercor/bhp070; McAdams CJ, 1999, J NEUROSCI, V19, P431; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009; Pestilli F, 2005, VISION RES, V45, P1867, DOI 10.1016/j.visres.2005.01.019; Gardner JL, 2005, NEURON, V47, P607, DOI 10.1016/j.neuron.2005.07.016; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P11026, DOI 10.1073/pnas.97.20.11026; Liang CL, 2013, NEUROIMAGE, V64, P104, DOI 10.1016/j.neuroimage.2012.08.077; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Ngai AC, 1999, BRAIN RES, V837, P221, DOI 10.1016/S0006-8993(99)01649-2; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Kiani R, 2008, J NEUROSCI, V28, P3017, DOI 10.1523/JNEUROSCI.4761-07.2008; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Awh E, 2000, J EXP PSYCHOL HUMAN, V26, P834, DOI 10.1037/0096-1523.26.2.834; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Pestilli F, 2011, NEURON, V72, P832, DOI 10.1016/j.neuron.2011.09.025; Briggs F, 2013, NATURE, V499, P476, DOI 10.1038/nature12276; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; SPERLING G, 1978, SCIENCE, V202, P315, DOI 10.1126/science.694536; Zenger-Landolt B, 2003, J NEUROSCI, V23, P6884; Gardner JL, 2008, J NEUROSCI, V28, P3988, DOI 10.1523/JNEUROSCI.5476-07.2008; Muller MM, 2003, NATURE, V424, P309, DOI 10.1038/nature01812; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Dhruv NT, 2014, NEURON, V81, P529, DOI 10.1016/j.neuron.2013.11.025; Moradi F, 2012, NEUROIMAGE, V59, P601, DOI 10.1016/j.neuroimage.2011.07.078; Fukuda K, 2010, CURR OPIN NEUROBIOL, V20, P177, DOI 10.1016/j.conb.2010.03.005; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24; Williford T, 2006, J NEUROPHYSIOL, V96, P40, DOI 10.1152/jn.01207.2005; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/j.neuron.2009.01.002; Boynton GM, 1999, VISION RES, V39, P257, DOI 10.1016/S0042-6989(98)00113-8; Boynton GM, 1996, J NEUROSCI, V16, P4207; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Uncapher MR, 2009, J NEUROSCI, V29, P8270, DOI 10.1523/JNEUROSCI.1043-09.2009; McMains SA, 2005, J NEUROSCI, V25, P9444, DOI 10.1523/JNEUROSCI.2647-05.2005; Palmer J, 2000, VISION RES, V40, P1227, DOI 10.1016/j.visres.2008.02.022; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Alvarez GA, 2005, PSYCHOL SCI, V16, P637, DOI 10.1111/j.1467-9280.2005.01587.x; Verghese P, 2001, NEURON, V31, P523, DOI 10.1016/S0896-6273(01)00392-0; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; McMains SA, 2004, NEURON, V42, P677, DOI 10.1016/S0896-6273(04)00263-6; Li X, 2008, P NATL ACAD SCI USA, V105, P6202, DOI 10.1073/pnas.0801390105; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; PELLI DG, 1985, J OPT SOC AM A, V2, P1508, DOI 10.1364/JOSAA.2.001508; Dhruv NT, 2011, J NEUROSCI, V31, P15016, DOI 10.1523/JNEUROSCI.0890-11.2011; Pooresmaeili A, 2010, J NEUROSCI, V30, P12701, DOI 10.1523/JNEUROSCI.1388-10.2010; Jazayeri M, 2007, NATURE, V446, P912, DOI 10.1038/nature05739; Ma WJ, 2011, NAT NEUROSCI, V14, P783, DOI 10.1038/nn.2814; Buracas GT, 2007, J NEUROSCI, V27, P93, DOI 10.1523/JNEUROSCI.3162-06.2007; Cardoso MMB, 2012, NAT NEUROSCI, V15, P1298, DOI 10.1038/nn.3170; Arthurs OJ, 2000, NEUROSCIENCE, V101, P803, DOI 10.1016/S0306-4522(00)00511-X; Boynton G. M., 2011, J VISION, V11, P1; Ciaramitaro VM, 2001, VISION RES, V41, P57, DOI 10.1016/S0042-6989(00)00203-0; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; Eckstein MP, 2011, J VISION, V11, DOI 10.1167/11.5.14; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; Fischer J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2054; Green DM, 1966, SIGNAL DETECTION THE; Hara Y, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00012; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Jones M, 2004, NEUROIMAGE, V22, P956, DOI 10.1016/j.neuroimage.2004.02.007; Lee J, 2010, J NEUROPHYSIOL, V104, P960, DOI 10.1152/jn.01019.2009; Li B, 2007, J NEUROSCI, V27, P10223, DOI 10.1523/JNEUROSCI.1505-07.2007; Martinez-Trujillo JC, 2002, NEURON, V35, P365; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037//0033-295X.101.2.343; Morawetz C, 2007, VISUAL NEUROSCI, V24, P817, DOI 10.1017/S0952523807070745; Morrone MC, 2002, CURR BIOL, V12, P1134, DOI 10.1016/S0960-9822(02)00921-1; Murray SO, 2008, J VIS, V8; Nemoto M, 2004, J NEUROSCI, V24, P3850, DOI 10.1523/JNEUROSCI.4870-03.2004; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Offenhauser N, 2005, J PHYSIOL-LONDON, V565, P279, DOI 10.1113/jphysiol.2005.082776; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Pashler HE, 1998, PSYCHOL ATTENTION; Scolari M, 2012, J NEUROSCI, V32, P7723, DOI 10.1523/JNEUROSCI.5558-11.2012; Sergent C, 2011, J COGNITIVE NEUROSCI, V23, P1921, DOI 10.1162/jocn.2010.21553; SHAW ML, 1984, ATTENTION PERFORM, V10, P109; SHAW ML, 1977, J EXP PSYCHOL HUMAN, V3, P201, DOI 10.1037//0096-1523.3.2.201; Verghese P, 2012, J NEUROSCI, V32, P16379, DOI 10.1523/JNEUROSCI.1174-12.2012; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293	130	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	DEC 1	2014	112	11					2834	2849		10.1152/jn.00729.2013		16	Neurosciences; Physiology	Neurosciences & Neurology; Physiology	AW1AN	WOS:000346023000015		
J	Kobayashi, S; Asakura, K; Suga, H; Sasaki, S				Kobayashi, S.; Asakura, K.; Suga, H.; Sasaki, S.		Three Generation Study Women Diets	Inverse association between dietary habits with high total antioxidant capacity and prevalence of frailty among elderly Japanese women: A multicenter cross-sectional study	JOURNAL OF NUTRITION HEALTH & AGING			English	Article						Frailty; dietary total antioxidant capacity; brief-type self-administered diet history questionnaire; elderly Japanese women	FOOD-FREQUENCY QUESTIONNAIRE; SF-36 HEALTH SURVEY; C-REACTIVE PROTEIN; OLDER-ADULTS; HISTORY QUESTIONNAIRES; ABDOMINAL OBESITY; OXIDATIVE STRESS; PREDICT FRAILTY; REDOX STATUS; AGED 65	To examine the association of dietary habits with high total antioxidant capacity (TAC) with frailty among elderly Japanese women. Cross-sectional multicenter study. Thirty-five of 47 prefectures in Japan. 2121 grandmothers or acquaintances of dietetic students aged 65 and older. Dietary TAC and food intakes were calculated using a validated brief-type self-administered diet history questionnaire. The TAC value of each food was assigned using four different assays, ferric reducing ability of plasma (FRAP), oxygen radical absorbance capacity (ORAC), Trolox equivalent antioxidant capacity (TEAC), and total radical-trapping antioxidant parameter (TRAP). Frailty was defined as the presence three or more of the following four components: slowness and weakness (two points), exhaustion, low physical activity, and unintentional weight loss. The number of subjects with frailty was 486 (23%). Multivariate adjusted ORs (95% CI) for frailty in the highest compared to the lowest quintile were 0.35 (0.24, 0.53) for FRAP, 0.35 (0.23, 0.52) for ORAC, 0.40 (0.27, 0.60) for TEAC, and 0.41 (0.28, 0.62) for TRAP. The intakes of green tea, coffee, vegetables, and fruits which contribute to dietary TAC were also associated with lower odds of frailty (the range of multivariate adjusted OR: 0.47 for vegetables to 0.77 for green tea), although the odds ratios were less marked than those of dietary TAC. Dietary habits with high TAC showed a stronger inverse association with frailty in elderly Japanese women than the individual foods examined.	[Kobayashi, S.; Suga, H.; Sasaki, S.] Univ Tokyo, Dept Social & Prevent Epidemiol, Grad Sch Med, Tokyo 1130033, Japan; [Asakura, K.; Sasaki, S.] Univ Tokyo, Dept Social & Prevent Epidemiol, Sch Publ Hlth, Tokyo 1130033, Japan; [Asakura, K.] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo, Japan	Sasaki, S (reprint author), Univ Tokyo, Dept Social & Prevent Epidemiol, Sch Publ Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	stssasak@m.u-tokyo.ac.jp			JSPS KAKENHI Grant from the Japan Society for the Promotion of Science [22240077]	This study was funded by JSPS KAKENHI Grant Number 22240077 from the Japan Society for the Promotion of Science. We thank the members of the Three-generation Study of Women on Diets and Health Study Group (in addition to the authors; Supplementary Material 3).	Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Doba N, 2012, EXP GERONTOL, V47, P638, DOI 10.1016/j.exger.2012.05.016; Carlsen MH, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-3; La Vecchia C, 2013, INT J CANCER, V133, P1447, DOI 10.1002/ijc.28133; Woods NF, 2005, J AM GERIATR SOC, V53, P1321, DOI 10.1111/j.1532-5415.2005.53405.x; Bollwein J, 2013, J GERONTOL A-BIOL, V68, P483, DOI 10.1093/gerona/gls204; Ble A, 2006, J GERONTOL A-BIOL, V61, P278; Ghiselli A, 2000, FREE RADICAL BIO MED, V29, P1106, DOI 10.1016/S0891-5849(00)00394-4; Hsiao PY, 2013, J NUTR HEALTH AGING, V17, P19, DOI 10.1007/s12603-012-0082-4; Talegawkar SA, 2012, J NUTR, V142, P2161, DOI 10.3945/jn.112.165498; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Lakey SL, 2012, J AM GERIATR SOC, V60, P854, DOI 10.1111/j.1532-5415.2012.03940.x; Pellegrini N, 2003, J NUTR, V133, P2812; Mulero J, 2011, J NUTR HEALTH AGING, V15, P756, DOI 10.1007/s12603-011-0130-5; Semba RD, 2006, J GERONTOL A-BIOL, V61, P594; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146; Hubbard RE, 2010, J GERONTOL A-BIOL, V65, P377, DOI 10.1093/gerona/glp186; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Takebayashi J, 2010, BIOSCI BIOTECH BIOCH, V74, P2137, DOI 10.1271/bbb.100430; Raji MA, 2010, J GERONTOL A-BIOL, V65, P1228, DOI 10.1093/gerona/glq121; Wada K, 2007, AM J IND MED, V50, P8, DOI 10.1002/ajim.20403; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bartali B, 2006, J GERONTOL A-BIOL, V61, P589; Kolomvotsou AI, 2013, EUR J NUTR, V52, P37, DOI 10.1007/s00394-011-0283-3; Michelon E, 2006, J GERONTOL A-BIOL, V61, P600; Serafini M, 2004, REDOX REP, V9, P145, DOI 10.1179/135100004225004814; Chen XL, 2010, J CLIN ONCOL, V28, P991, DOI 10.1200/JCO.2009.23.0565; Valtuena S, 2008, AM J CLIN NUTR, V87, P1290; Niu KJ, 2009, AM J CLIN NUTR, V90, P1615, DOI 10.3945/ajcn.2009.28216; Dent E, 2012, J NUTR HEALTH AGING, V16, P764, DOI 10.1007/s12603-012-0405-5; Stanner SA, 2004, PUBLIC HEALTH NUTR, V7, P407, DOI 10.1079/PHN2003543; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI [10.2188/jeaJE20110075, 10.2188/jea.JE20110075]; Brighenti F, 2005, BRIT J NUTR, V93, P619, DOI 10.1079/BJN20051400; Chan DCD, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-58; Detopoulou P, 2010, EUR J CLIN NUTR, V64, P161, DOI 10.1038/ejcn.2009.130; Devore EE, 2010, AM J CLIN NUTR, V92, P1157, DOI 10.3945/ajcn.2010.29634; Fukuhara S, 2004, MANUAL SF 36V2 JAPAN; Hermsdorff HHM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-42; Kaiser MJ, 2009, AGING MALE, V12, P87, DOI 10.3109/13685530903296706; Kobayashi S, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-91; Lee PH, 2012, J CLIN GERIATR GERON, V3, P47; Ministry of Education Culture Sports and Technology, 2012, GEN SURV SCH; Ministry of Health. Labour and welfare, 2009, DIET REF INT JAP 201; Murayama H, 2012, J EPIDEMIOL, V22, P551, DOI 10.2188/jea.JE20120015; Nemoto M, 2012, ARCH GERONTOL GERIAT, V55, P385, DOI 10.1016/j.archger.2011.10.004; Pellegrini N, 2007, J NUTR, V137, P93; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rautiainen S, 2008, AM J CLIN NUTR, V87, P1247; Science and Technology Agency, 2010, STAND TABL FOOD COMP	51	3	3	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	1279-7707	1760-4788		J NUTR HEALTH AGING	J. Nutr. Health Aging	DEC	2014	18	9					827	836		10.1007/s12603-014-0556-7		10	Geriatrics & Gerontology; Nutrition & Dietetics	Geriatrics & Gerontology; Nutrition & Dietetics	AW3LE	WOS:000346187400008		
J	Hamada, Y; Nagasaki, H; Fujiya, A; Seino, Y; Shang, QL; Suzuki, T; Hashimoto, H; Oiso, Y				Hamada, Yoji; Nagasaki, Hiroshi; Fujiya, Atsushi; Seino, Yusuke; Shang, Qing-Long; Suzuki, Takeshi; Hashimoto, Hiroyuki; Oiso, Yutaka			Involvement of de novo ceramide synthesis in pro-inflammatory adipokine secretion and adipocyte-macrophage interaction	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Article						Ceramide; Palmitate; Adipocytes; Macrophages; Cytokines; Serine-palmitoyl transferase	INDUCED INSULIN-RESISTANCE; FREE FATTY-ACID; SKELETAL-MUSCLE CELLS; KAPPA-B; SPHINGOLIPID METABOLISM; 3T3-L1 ADIPOCYTES; PALMITATE; EXPRESSION; KINASE; PLASMA	Interaction between adipocytes and macrophages has been suggested to play a central role in the pathogenesis of obesity. Ceramide, a sphingolipid de novo synthesized from palmitate, is known to stimulate pro-inflammatory cytokine secretion from multiple types of cells. To clarify whether de novo synthesized ceramide contributes to cytokine dysregulation in adipocytes and macrophages, we observed cytokine secretion in mature 3T3-L1 adipocytes (L1) and RAW264.7 macrophages (RAW) cultured alone or co-cultured under the suppression of de novo ceramide synthesis. Palmitate enhanced ceramide accumulation and stimulated the expression and secretion of interleukin-6 (IL-6) and monocyte chemoattractant protein-1 (MCP-1) in L1. The suppression of serine-palmitoyl transferase, a rate-limiting enzyme of de novo ceramide synthesis, by myriocin or siRNA attenuated those palmitate-induced alterations, and a ceramide synthase inhibitor fumonisin B1 showed similar results. In contrast, the inhibitor of sphingosine kinase or a membrane-permeable ceramide analogue augmented the cytokine secretion. Myriocin effects on the palmitate-induced changes were not abrogated by toll-like receptor-4 blockade. Although palmitate stimulated RAW to secrete tumor necrosis factor-alpha (TNF-alpha), it did not significantly increase ceramide content, and neither myriocin nor fumonisin B1 attenuated the TNF-alpha hypersecretion. The co-culture of L1 with RAW markedly augmented IL-6 and MCP-1 levels in media. Myriocin or fumonisin B1 significantly lowered these cytokine levels and suppressed the gene expression of TNF-alpha and MCP-1 in RAW and of IL-6 and MCP-1 in L1. In conclusion, de nova synthesized ceramide partially mediates the palmitate effects on pro-inflammatory adipokines and is possibly involved in the interaction with macrophages. (C) 2014 Elsevier Inc. All rights reserved.	[Hamada, Yoji; Nagasaki, Hiroshi; Seino, Yusuke] Nagoya Univ, Grad Sch Med, Dept Metab Med, Showa Ku, Nagoya, Aichi 4668550, Japan; [Nagasaki, Hiroshi] Fujita Hlth Univ, Sch Med, Dept Physiol 1, Aichi 4701192, Japan; [Fujiya, Atsushi; Oiso, Yutaka] Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Showa Ku, Nagoya, Aichi 4668550, Japan; [Shang, Qing-Long; Suzuki, Takeshi; Hashimoto, Hiroyuki] Sanwa Kagaku Kenkyusho Co Ltd, Pharmaceut Res Labs, Inabe 5110406, Japan; [Shang, Qing-Long] Harbin Med Univ, Dept Microbiol, Harbin 150086, Peoples R China	Hamada, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Metab Med, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	yhama@med.nagoya-u.ac.jp			Ministry of Health and Welfare of Japan; Mitsui Life Social Welfare Foundation; Aichi D.R.G. Foundation	Grants: This study was supported by research grants from the Ministry of Health and Welfare of Japan, Mitsui Life Social Welfare Foundation and Aichi D.R.G. Foundation.	Busch AK, 2002, DIABETES, V51, P977, DOI 10.2337/diabetes.51.4.977; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Suzuki J, 2011, NEUROSCIENCE, V176, P188, DOI 10.1016/j.neuroscience.2010.11.035; Fujiya A, 2014, OBESITY, V22, P371, DOI 10.1002/oby.20532; Fischer H, 2007, CELL MICROBIOL, V9, P1239, DOI 10.1111/j.1462-5822.2006.00867.x; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Thrush AB, 2008, AM J PHYSIOL-REG I, V294, pR1205, DOI 10.1152/ajpregu.00909.2007; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Teruel T, 2001, DIABETES, V50, P2563, DOI 10.2337/diabetes.50.11.2563; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Ghosh N, 2007, ENDOCRINOLOGY, V148, P1359, DOI 10.1210/en.2006-0750; Boon J, 2013, DIABETES, V62, P401, DOI 10.2337/db12-0686; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; SJOHOLM A, 1995, FEBS LETT, V367, P283; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Igoillo-Esteve M, 2010, DIABETOLOGIA, V53, P1395, DOI 10.1007/s00125-010-1707-y; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Straczkowski M, 2004, DIABETES, V53, P1215, DOI 10.2337/diabetes.53.5.1215; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Lee JY, 1996, J BIOL CHEM, V271, P13169; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Schilling JD, 2013, J BIOL CHEM, V288, P2923, DOI 10.1074/jbc.M112.419978; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Ajuwon KM, 2005, J NUTR, V135, P1841; Wilding JPH, 2007, DIABETIC MED, V24, P934, DOI 10.1111/j.1464-5491.2007.02186.x; Staiger H, 2004, DIABETES, V53, P3209, DOI 10.2337/diabetes.53.12.3209; Han CY, 2010, DIABETES, V59, P386, DOI 10.2337/db09-0925; Basu A, 2001, AM J PHYSIOL-ENDOC M, V280, pE1000; Bektas M, 2003, ANAL BIOCHEM, V320, P259, DOI 10.1016/S0003-2697(03)00388-9; Isley WL, 2006, METABOLISM, V55, P758, DOI 10.1016/j.metabol.2006.01.013; LAULEDERKIND SJF, 1995, J EXP MED, V182, P599, DOI 10.1084/jem.182.2.599; Mittendorfer B, 2003, DIABETES, V52, P1641, DOI 10.2337/diabetes.52.7.1641; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Takahashi K, 2008, AM J PHYSIOL-ENDOC M, V294, pE898, DOI 10.1152/ajpendo.00131.2007	40	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	DEC	2014	25	12					1309	1316		10.1016/j.jnutbio.2014.07.008		8	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	AW2JF	WOS:000346113200008		
J	Morita, T; Tamura, K; Kusajima, E; Sakai, S; Kawa, M; Imura, C; Ichihara, K; Miyashita, M; Yamaguchi, T; Uchitomi, Y				Morita, Tatsuya; Tamura, Keiko; Kusajima, Etsuko; Sakai, Sayuri; Kawa, Masako; Imura, Chizuru; Ichihara, Kaori; Miyashita, Mitsunori; Yamaguchi, Takuhiro; Uchitomi, Yosuke			Nurse Education Program on Meaninglessness in Terminally Ill Cancer Patients: A Randomized Controlled Study of a Novel Two-Day Workshop	JOURNAL OF PALLIATIVE MEDICINE			English	Article							PALLIATIVE CARE; COMMUNICATION-SKILLS; FUNCTIONAL ASSESSMENT; TRAINING-PROGRAM; SPIRITUAL CARE; FACIT-SP; VALIDATION; TRIAL; LIFE; END	Background: Fostering patients' sense of meaning is an essential task for palliative care clinicians. Few studies have reported the effects on nurses of a short-term training program aimed at improving skills to relieve feelings of meaninglessness in terminally ill cancer patients. Objective: The primary aim of this study was to determine the impact on nurses of a novel two-day education program focusing on care that addresses patients' feelings of meaninglessness. Measured were impacts on nurses' confidence, self-reported practice, attitudes toward caring for such patients, burnout, meaning of life, and knowledge. Methods: This study was a randomized controlled trial using the waiting list control. Intervention consisted of a two-day interactive education program. A total of 76 nurses randomly allocated to two groups completed the study. Outcome measures included confidence scale; self-reported practice scale; scales of nursing attitudes toward caring for patients who experience feelings of meaningless (willingness to help, positive appraisal, helplessness, nurse-perceived value of being, and nurse-perceived value of patients' inner power); Maslach burnout scale, Functional Assessment of Chronic Illness Therapy-Spiritual, and knowledge scale. Results: There were significant intervention effects in nurse-reported confidence and nurse-perceived value of patients' inner power. Nurse-reported helplessness showed marginally significant improvement after intervention (p=0.067). No significant intervention effects were observed in the self-reported practice scale; attitudes toward caring for patients (willingness to help, positive appraisal, and nurse-perceived value of being); burnout scale, meaning of life; and knowledge score. The percentages of nurses who evaluated this program as useful or very useful were 95% (understanding the conceptual framework) and 85% (helping to learn how to provide care for patients feeling meaninglessness in clinical practice). Conclusion: This short-term educational intervention had a significant beneficial effect on nurses' confidence and modest effects on attitudes.	[Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Dept Palliat & Support Care, Hamamatsu, Shizuoka 4338558, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Seirei Hosp, Hamamatsu, Shizuoka 4338558, Japan; [Tamura, Keiko] Kyoto Univ Grad Sch Med, Sch Human Hlth Sci, Dept Palliat Gerontol Nursing, Kyoto, Japan; [Kusajima, Etsuko] Peace House Hosp, Tokyo, Japan; [Sakai, Sayuri] Niigata Univ, Div Nursing, Sch Hlth Sci, Niigata, Japan; [Kawa, Masako] Palliat Care Support Grp NPO, Higashikurume, Japan; [Imura, Chizuru] Seirei Mikatahara Gen Hosp, Hamamatsu Canc Support Ctr, Hamamatsu, Shizuoka 4338558, Japan; [Ichihara, Kaori] Yodogawa Christians Hosp, Ctr Canc, Osaka, Japan; [Miyashita, Mitsunori] Tohoku Univ Grad Sch Med, Dept Palliat Nursing, Sendai, Miyagi, Japan; [Yamaguchi, Takuhiro] Tohoku Univ Grad Sch Med, Div Biostat, Sendai, Miyagi, Japan; [Uchitomi, Yosuke] Okayama Univ Grad Sch Med, Dept Neuropsychiat, Okayama, Japan	Morita, T (reprint author), Seirei Mikatahara Gen Hosp, Dept Palliat & Support Care, 3453 Mikatahara Cho, Hamamatsu, Shizuoka 4338558, Japan.	tmorita@sis.seirei.or.jp			Third Term Comprehensive Control Research for Cancer Health and Labor Sciences research grants in Japan	This study was funded by the Third Term Comprehensive Control Research for Cancer Health and Labor Sciences research grants in Japan.	Bowles N, 2001, J ADV NURS, V36, P347, DOI 10.1046/j.1365-2648.2001.01979.x; RAZAVI D, 1993, EUR J CANCER, V29A, P1858, DOI 10.1016/0959-8049(93)90538-Q; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Morita T, 2009, J PAIN SYMPTOM MANAG, V37, P649, DOI 10.1016/j.jpainsymman.2008.04.017; Vachon M, 2009, J PALLIAT MED, V12, P53, DOI 10.1089/jpm.2008.0189; Kissane DW, 2001, J PALLIATIVE CARE, V17, P12; Gijsberts MJHE, 2011, J PALLIAT MED, V14, P852, DOI 10.1089/jpm.2010.0356; Breitbart W, 2012, J CLIN ONCOL, V30, P1304, DOI 10.1200/JCO.2011.36.2517; Chochinov HM, 2002, JAMA-J AM MED ASSOC, V287, P2253, DOI 10.1001/jama.287.17.2253; Morita T, 2004, J PAIN SYMPTOM MANAG, V27, P44, DOI 10.1016/j.jpainsymman.2003.05.001; Peterman AH, 2002, ANN BEHAV MED, V24, P49, DOI 10.1207/S15324796ABM2401_06; Morita T, 2004, SUPPORT CARE CANCER, V12, P137, DOI 10.1007/s00520-003-0561-6; Arranz P, 2005, PATIENT EDUC COUNS, V56, P233, DOI 10.1016/j.pec.2004.02.017; Borneman T, 2001, TXB PALLIATIVE NURSI; Dalvaux N, 2004, BRIT J CANCER, V90, P106; Fillion Lise, 2006, Palliat Support Care, V4, P333; Frommelt Katherine H Murray, 2003, Am J Hosp Palliat Care, V20, P13, DOI 10.1177/104990910302000108; Higashiguchi K, 1998, Nihon Eiseigaku Zasshi, V53, P447; Morita T, 2007, J PAIN SYMPTOM MANAG, V34, P160, DOI 10.1016/j.jpainsymman.2006.10.021; Murata Hisayuki, 2006, Palliat Support Care, V4, P279; Nakai Y., 2006, JPN J CANC NURS, V11, P723; Noguchi W, 2004, SUPPORT CARE CANCER, V12, P240, DOI 10.1007/s00520-003-0582-1; Shih F J, 1999, Intensive Crit Care Nurs, V15, P83, DOI 10.1016/S0964-3397(99)80004-4; Shih FJ, 2001, J ADV NURS, V36, P333, DOI 10.1046/j.1365-2648.2001.01978.x; Tamura Keiko, 2006, Palliat Support Care, V4, P179; Tamura K, 2012, SPIRITUAL CARE HDB N; Wasner M, 2005, PALLIATIVE MED, V19, P99, DOI 10.1191/0269216305pm995oa; Wilkinson S, 1998, PALLIATIVE MED, V12, P13, DOI 10.1191/026921698675034697	28	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-6218	1557-7740		J PALLIAT MED	J. Palliat. Med.	DEC 1	2014	17	12					1298	1305		10.1089/jpm.2013.0559		8	Health Care Sciences & Services	Health Care Sciences & Services	AW5TH	WOS:000346336200005		
J	Miyano, T				Miyano, Takeshi			History of the Pacific Association of Pediatric Surgeons (PAPS) 1984-1998	JOURNAL OF PEDIATRIC SURGERY			English	Article						Pacific Association of Pediatric Surgeons (PAPS); History	CONGENITAL DIAPHRAGMATIC-HERNIA; IN-UTERO; LUNG	This is a history of the second 15 years of the Pacific Association of Pediatric Surgeons (PAPS) from 1984 to 1998. (C) 2014 Published by Elsevier Inc.	Juntendo Univ, Nerima Hosp, Nerima Ku, Tokyo 1178521, Japan	Miyano, T (reprint author), Juntendo Univ, Nerima Hosp, Nerima Ku, 3-1-10 Takanodai, Tokyo 1178521, Japan.	takeshi@juntendo.ac.jp					ADZICK NS, 1993, J PEDIATR SURG, V28, P806; PENA A, 1992, J PEDIATR SURG, V27, P681, DOI 10.1016/S0022-3468(05)80090-9; Lipshutz GS, 1997, J PEDIATR SURG, V32, P1634, DOI 10.1016/S0022-3468(97)90471-1; Harrison MR, 1997, J PEDIATR SURG, V32, P1637, DOI 10.1016/S0022-3468(97)90472-3; HEDRICK MH, 1994, J PEDIATR SURG, V29, P612; Campbell JR, 2007, J PEDIATR SURG, V42, P1977, DOI 10.1016/j.jpedsurg.2007.08.013; Clark RH, 1998, J PEDIATR SURG, V33, P1004, DOI 10.1016/S0022-3468(98)90522-X; MartinezFrontanilla LA, 1996, J PEDIATR SURG, V31, P275, DOI 10.1016/S0022-3468(96)90014-7; PENA A, 1982, J PEDIATR SURG, V17, P796, DOI 10.1016/S0022-3468(82)80448-X	9	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	DEC	2014	49	12					1707	1711		10.1016/j.jpedsurg.2014.09.006		5	Pediatrics; Surgery	Pediatrics; Surgery	AW0FA	WOS:000345965000002		
J	Kawahara, H; Tazuke, Y; Soh, H; Yoneda, A; Fukuzawa, M				Kawahara, Hisayoshi; Tazuke, Yuko; Soh, Hideki; Yoneda, Akihiro; Fukuzawa, Masahiro			Does laparoscopy-aided gastrostomy placement improve or worsen gastroesophageal reflux in patients with neurological impairment?	JOURNAL OF PEDIATRIC SURGERY			English	Article						Gastrostomy; Gastroesophageal reflux; pH-multichannel intraluminal impedance; Gastric emptying	ENDOSCOPIC GASTROSTOMY; BREATH TEST; CHILDREN; ACID; IMPEDANCE	Background/purpose: The purpose of this study was to retrospectively investigate whether laparoscopy-aided gastrostomy placement (LGP) improved or worsened gastroesophageal reflux (GER) in neurological impairment (NI) patients. Methods: Subjects included 26 NI patients nourished via nasogastric tubes (age, 1-17 years; median, 6 years). They were divided into groups based on the percentage of time with an esophageal pH <4.0 (reflux index: RI) before LGP: Group 1 (GI, n = 13), RI <5.0%; Group II (GH, n = 13), RI >= 5.0%. Acid/nonacid reflux episodes (RE) were evaluated using combined pH-multichannel intraluminal impedance (pH-MII) monitoring, and gastric emptying was measured with the C breath test before and after LGP. Results: RI and number of RE evaluated with pH analyses and number of total/acid distal and proximal bolus RE with pH-MH increased significantly in GI. RI and acid clearance time with pH analyses and number of total bolus RE with pH-MII decreased significantly in GH. Gastric emptying parameters did not change significantly in GI, whereas the half-gastric emptying time and gastric emptying coefficient improved significantly in GH. Conclusion: LGP reduces GER in NI patients with pathological GER by improving gastric emptying, although it has a paradoxical influence on those without pathological GER. (C) 2014 Elsevier Inc. All rights reserved.	[Kawahara, Hisayoshi] Hamamatsu Univ, Dept Pediat Surg, Sch Med, Hamamatsu, Shizuoka 4313192, Japan; [Tazuke, Yuko; Soh, Hideki; Yoneda, Akihiro; Fukuzawa, Masahiro] Osaka Med Ctr, Dept Pediat Surg, Izumi Ku, Osaka, Japan; [Tazuke, Yuko; Soh, Hideki; Yoneda, Akihiro; Fukuzawa, Masahiro] Res Inst Maternal & Child Hlth, Izumi Ku, Izumi, Osaka, Japan	Kawahara, H (reprint author), Hamamatsu Univ, Dept Pediat Surg, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	kawahara.hisayoshi@gmail.com			Health and Labour Sciences Research Grants from the Ministry of Health, Labour, and Welfare of Japan [26462706]	This study was supported in part by Health and Labour Sciences Research Grants for research on pediatric military disorders from the Ministry of Health, Labour, and Welfare of Japan to HK (26462706).	Thomson M, 2011, WORLD J GASTROENTERO, V17, P191, DOI 10.3748/wjg.v17.i2.191; Plantin I, 2006, PEDIATR SURG INT, V22, P581, DOI 10.1007/s00383-006-1707-7; Kawahara H, 2007, PEDIATR SURG INT, V23, P1001, DOI 10.1007/s00383-007-1986-7; Gatti C, 2000, J PEDIATR SURG, V35, P62, DOI 10.1016/S0022-3468(00)80078-0; Sifrim D, 2004, GUT, V53, P1024, DOI 10.1136/gut.2003.033290; Wilson GJP, 2006, J PEDIATR SURG, V41, P1441, DOI 10.1016/j.jpedsurg.2006.04.021; Kawahara H, 2009, PEDIATR SURG INT, V25, P987, DOI 10.1007/s00383-009-2453-4; van Wijk MP, 2009, J PEDIATR GASTR NUTR, V48, P2, DOI 10.1097/MPG.0b013e31818f0902; GHOOS YF, 1993, GASTROENTEROLOGY, V104, P1640; Francavilla R, 2010, J PEDIATR GASTR NUTR, V50, P154, DOI 10.1097/MPG.0b013e3181a4c1d8; JOLLEY SG, 1985, ANN SURG, V201, P736, DOI 10.1097/00000658-198506000-00010; Kawahara H, 2006, J PEDIATR SURG, V41, P2076, DOI 10.1016/j.jpedsurg.2006.08.010; Kawahara H, 2010, J PEDIATR SURG, V45, P2373, DOI 10.1016/j.jpedsurg.2010.08.034; Lysy J, 2006, NEUROGASTROENT MOTIL, V18, P433, DOI 10.1111/j.1365-2982.2006.00800.x; Salvatore S, 2010, J PEDIATR-US, V157, P949, DOI 10.1016/j.jpeds.2010.07.029; Vicente Y, 2002, J PEDIATR GASTR NUTR, V35, P173, DOI 10.1097/01.MPG.0000018761.86415.19	16	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	DEC	2014	49	12					1742	1745		10.1016/j.jpedsurg.2014.09.008		4	Pediatrics; Surgery	Pediatrics; Surgery	AW0FA	WOS:000345965000011		
J	Sakai, K; Kimura, O; Furukawa, T; Fumino, S; Higuchi, K; Wakao, J; Kimura, K; Aoi, S; Masumoto, K; Tajiri, T				Sakai, Kohei; Kimura, Osamu; Furukawa, Taizo; Fumino, Shigehisa; Higuchi, Koji; Wakao, Junko; Kimura, Koseki; Aoi, Shigeyoshi; Masumoto, Kouji; Tajiri, Tatsuro			Prenatal administration of neuropeptide bombesin promotes lung development in a rat model of nitrofen-induced congenital diaphragmatic hernia	JOURNAL OF PEDIATRIC SURGERY			English	Article						Bombesin; Congenital diaphragmatic hernia; Nitrofen; Lung hypoplasia; Fetal therapy	SMALL-BOWEL TRANSPLANTATION; MATURATION INUTERO; HYPOPLASTIC LUNG; FETAL LUNG; GROWTH; IMMUNOSUPPRESSION; MODULATION; ALLOGRAFT; PEPTIDE; TISSUE	Background/purpose: Fetal medical treatment to improve lung hypoplasia in congenital diaphragmatic hernia (CDH) has yet to be established. The neuropeptide bombesin (BBS) might play an important role in lung development. The present study aims to determine whether prenatally administered BBS could be useful to promote fetal lung development in a rat model of nitrofen-induced CDH. Methods: Pregnant rats were administered with nitrofen (100 mg) on gestation day 9.5 (E9.5). BBS (50 mg/kg/day) was then daily infused intraperitoneally from E14, and fetal lungs were harvested on E21. The expression of PCNA was assessed by both immunohistochemical staining and RT-PCR to determine the amount of cell proliferation. Lung maturity was assessed as the expression of TTF-1, a marker of alveolar epithelial cell type II. Results: The lung-body-weight ratio was significantly increased in CDH/BBS(+) compared with CDH/BBS(-) (p < 0.05). The number of cells stained positive for PCNA and TTF-1 was significantly decreased in CDH/BBS (+) compared with CDH/BBS(-) (p < 0.01). The TTF-1 mRNA expression levels were significantly decreased in CDH/BBS(+) compared with CDH/BBS(-) (p < 0.05). Conclusions: Prenatally administered BBS promotes lung development in a rat model of nitrofen-induced CDH. Neuropeptide BBS could help to rescue lung hypoplasia in fetal CDH. (C) 2014 Elsevier Inc. All rights reserved.	[Sakai, Kohei; Kimura, Osamu; Furukawa, Taizo; Fumino, Shigehisa; Higuchi, Koji; Wakao, Junko; Kimura, Koseki; Aoi, Shigeyoshi; Tajiri, Tatsuro] Kyoto Prefectural Univ Med, Dept Pediat Surg, Grad Sch Med Sci, Kyoto 6028566, Japan; [Masumoto, Kouji] Univ Tsukuba, Fac Med, Dept Pediat Surg, Tsukuba, Ibaraki, Japan	Sakai, K (reprint author), Kyoto Prefectural Univ Med, Dept Pediat Surg, Grad Sch Med Sci, Kamigyo Ku, 465 Kawaramachi Hirokoji, Kyoto 6028566, Japan.	kohei-sk@koto.kpu-m.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT KAKENHI) [22659318]	This work was supported by Grant-in-Aid for Exploratory Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT KAKENHI grant number 22659318).	Lally KP, 2006, J PEDIATR SURG, V41, P668, DOI 10.1016/j.jpedsurg.2005.12.007; MCDONALD TJ, 1979, BIOCHEM BIOPH RES CO, V90, P227, DOI 10.1016/0006-291X(79)91614-0; SUNDAY ME, 1990, AM J RESP CELL MOL, V3, P199; SUNDAY ME, 1993, ANAT REC, V236, P25, DOI 10.1002/ar.1092360107; WHARTON J, 1978, NATURE, V273, P769, DOI 10.1038/273769a0; Harrison MR, 2003, NEW ENGL J MED, V349, P1916, DOI 10.1056/NEJMoa035005; Fujino N, 2011, LAB INVEST, V91, P363, DOI 10.1038/labinvest.2010.187; Doi T, 2010, PEDIATR SURG INT, V26, P1011, DOI 10.1007/s00383-010-2654-x; Doyle NM, 2004, SEMIN PERINATOL, V28, P174, DOI 10.1053/j.semperi.2004.03.009; ERSPAMER V, 1983, TRENDS NEUROSCI, V6, P200, DOI 10.1016/0166-2236(83)90091-7; Furukawa T, 2003, J PEDIATR SURG, V38, P83, DOI 10.1053/jpsu.2003.50016; Gonzalez-Reyes S, 2006, J PEDIATR SURG, V41, P1446, DOI 10.1016/j.jpedsurg.2006.04.022; Higuchi K, 2006, J PEDIATR SURG, V41, P1957, DOI 10.1016/j.jpedsurg.2006.08.016; Higuchi K, 2009, J PEDIATR SURG, V44, P541, DOI 10.1016/j.jpedsurg.2008.06.044; Kimura O, 2013, PEDIATR SURG INT, V29, P335, DOI 10.1007/s00383-012-3242-z; Kimura O, 2006, TRANSPLANT P, V38, P1825, DOI 10.1016/j.transproceed.2006.05.012; Kinoshita H, 2005, J PEDIATR SURG, V40, P1877, DOI 10.1016/j.jpedsurg.2005.08.035; Kubota Y, 2000, EUR J PEDIATR SURG, V10, P248, DOI 10.1055/s-2008-1072368; Montedonico S, 2008, J PEDIATR SURG, V43, P500, DOI 10.1016/j.jpedsurg.2007.10.030; Morikawa Y, 1999, J VET MED SCI, V61, P1229, DOI 10.1292/jvms.61.1229; Ruttenstock E, 2011, BIRTH DEFECTS RES B, V92, P148, DOI 10.1002/bdrb.20293; Ruttenstock EM, 2011, PEDIATR SURG INT, V27, P125, DOI 10.1007/s00383-010-2783-2; SUEN HC, 1994, PEDIATR RES, V35, P523, DOI 10.1203/00006450-199405000-00002; SUNDAY ME, 1992, J CLIN INVEST, V90, P2517, DOI 10.1172/JCI116145; Takayasu H, 2007, PEDIATR SURG INT, V23, P405, DOI 10.1007/s00383-006-1853-y	25	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	DEC	2014	49	12					1749	1752		10.1016/j.jpedsurg.2014.09.015		4	Pediatrics; Surgery	Pediatrics; Surgery	AW0FA	WOS:000345965000013		
J	Muto, M; Matsufuji, H; Tomomasa, T; Nakajima, A; Kawahara, H; Ida, S; Ushijima, K; Kubota, A; Mushiake, S; Taguchi, T				Muto, Mitsuru; Matsufuji, Hiroshi; Tomomasa, Takeshi; Nakajima, Atsushi; Kawahara, Hisayoshi; Ida, Shinobu; Ushijima, Kosuke; Kubota, Akio; Mushiake, Sotaro; Taguchi, Tomoaki		Japanese Study Grp Allied Disorder	Pediatric chronic intestinal pseudo-obstruction is a rare, serious, and intractable disease: A report of a nationwide survey in Japan	JOURNAL OF PEDIATRIC SURGERY			English	Article						Chronic intestinal pseudo-obstruction; CIPO; Children; Nationwide survey; Idiopathic	NATURAL-HISTORY; CHILDREN	Background/Purpose: A nationwide survey was conducted to identify the clinical presentation of pediatric chronic intestinal pseudo-obstruction (CIPO) in Japan. Methods: Data were collected via a questionnaire, ensuring patient anonymity, from facilities that treat pediatric gastrointestinal diseases in Japan. Results: Ninety-two responses were collected from forty-seven facilities. Sixty-two patients (28 males, 34 females) met formal diagnostic criteria for CIPO. The estimated pediatric prevalence was 3.7 in 1 million individuals. More than half the children (56.5%) developed CIPO in the neonatal period. Full-thickness intestinal specimens were available for histopathology assessment in forty-five patients (72.6%). Forty-one (91.1%) had no pathological abnormalities and were considered to be idiopathic. Patients were treated according to the local protocol of each facility. Forty-one patients (66.1%) had restricted oral intake of ordinary diets, and twenty-nine (46.8%) depended on parenteral nutrition. No therapeutic intervention, including medication and surgery, successfully improved oral food intake or obstructive symptoms. Only three patients (4.8%) died from enteritis or sepsis. Conclusions: In Japan, pediatric CIPO is a rare, serious, and intractable disease. The prognosis with respect to survival is good, but unsatisfactory because of the need for prolonged parenteral nutrition and associated potential for restricted quality of life. (C) 2014 Elsevier Inc. All rights reserved.	[Muto, Mitsuru; Matsufuji, Hiroshi] Kagoshima Univ, Dept Pediat Surg, Kagoshima 8908520, Japan; [Tomomasa, Takeshi] PAL Childrens Clin, Gunma, Japan; [Nakajima, Atsushi] Yokohama City Univ, Sch Med, Div Gastroenterol, Yokohama, Kanagawa, Japan; [Kawahara, Hisayoshi] Hamamatsu Univ Sch Med, Dept Pediat Surg, Hamamatsu, Shizuoka, Japan; [Ida, Shinobu] Osaka Med Ctr, Dept Pediat Gastroenterol Nutr & Endocrinol, Osaka, Japan; [Ida, Shinobu] Res Inst Maternal & Child Hlth, Tokyo, Japan; [Ushijima, Kosuke] Kurume Univ, Med Ctr, Kurume, Fukuoka, Japan; [Kubota, Akio] Wakayama Med Univ, Dept Surg 2, Wakayama, Japan; [Mushiake, Sotaro] Kinki Univ, Nara Hosp, Dept Pediat, Higashiosaka, Osaka 577, Japan; [Taguchi, Tomoaki] Kyushu Univ, Dept Pediat Surg, Fukuoka 812, Japan	Muto, M (reprint author), Kagoshima Univ, Dept Pediat Surg, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	mitsuru@m3.kufm.kagoshima-u.ac.jp			Ministry of Health, Labor and Welfare of Japan	Pediatric CIPO, Research Group for "Comprehensive Study and Seamless Guidelines" on rare and intractable gastrointestinal disease from childhood, supported by the Ministry of Health, Labor and Welfare of Japan.	Rudolph CD, 1997, J PEDIATR GASTR NUTR, V24, P102, DOI 10.1097/00005176-199701000-00021; Stanghellini V, 2005, CLIN GASTROENTEROL H, V3, P449, DOI 10.1053/S1.542-3565(04)00675-5; Masaki T, 2012, SURG TODAY, V42, P264, DOI 10.1007/s00595-011-0115-3; Mousa H, 2002, DIGEST DIS SCI, V47, P2298, DOI 10.1023/A:1020199614102; VARGAS JH, 1988, J PEDIATR GASTR NUTR, V7, P323, DOI 10.1097/00005176-198805000-00003; Stanghellini V, 2007, NEUROGASTROENT MOTIL, V19, P440, DOI 10.1111/j.1365-2982.2007.00902.x; Goulet O, 1999, EUR J PEDIATR SURG, V9, P83, DOI 10.1055/s-2008-1072218; Amiot A, 2009, AM J SURG PATHOL, V33, P749, DOI 10.1097/PAS.0b013e31819b381a; Lindberg G, 2009, GUT, V58, P1084, DOI 10.1136/gut.2008.148296; Faure C, 1999, DIGEST DIS SCI, V44, P953, DOI 10.1023/A:1026656513463; DUDLEY H A, 1958, J R Coll Surg Edinb, V3, P206; FAULK DL, 1978, GASTROENTEROLOGY, V74, P922; Goulet O, 2005, J PEDIATR GASTR NUTR, V41, pS66, DOI 10.1097/01.scs.0000180312.55417.8e; Nakajima A, 2012, CHRONIC INTESTINAL P; Ohkubo H, 2012, DIGESTION, V86, P12, DOI 10.1159/000337528; Research Group for the Survey of the Actual Conditions of the Epidemiology Diagnosis and Treatment of CIIP in Japan Research Project for Overcoming Intractable Diseases Health Labour Sciences Research Grant, NAK GROUP RES REP FI	16	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	DEC	2014	49	12					1799	1803		10.1016/j.jpedsurg.2014.09.025		5	Pediatrics; Surgery	Pediatrics; Surgery	AW0FA	WOS:000345965000024		
J	Koga, H; Ochi, T; Okawada, M; Doi, T; Lane, GJ; Yamataka, A				Koga, Hiroyuki; Ochi, Takanori; Okawada, Manabu; Doi, Takashi; Lane, Geoffrey J.; Yamataka, Atsuyuki			Comparison of outcomes between laparoscopy-assisted and posterior sagittal anorectoplasties for male imperforate anus with recto-bulbar fistula	JOURNAL OF PEDIATRIC SURGERY			English	Article						Laparoscopy-assisted anorectoplasty; Posterior sagittal anorectoplasty; Imperforate anus; Recto-bulbar fistula	ANORECTAL PULL-THROUGH; RECTOURETHRAL FISTULA; MALFORMATIONS; SURGERY; PREVENTION; REPAIR	Purpose: All reports comparing laparoscopy-assisted anorectoplasty (LAARP) with posterior sagittal anorectoplasty (PSARP) in male high-type imperforate anus include a mix of recto-vesical, recto-prostatic, recto-bulbar, and absent fistula cases without focusing on recto-bulbar fistula (RBF), the most challenging type to treat laparoscopically. We compared LAARP with PSARP for treating only RBF. Method: We used our fecal continence evaluation questionnaire (FCE; maximumscore = 10), scoring of magnetic resonance imaging (MRI) findings (MRI scores), and the angle between the rectum and the anal canal (RAA) to assess 20 RBF cases (LAARP = 12, PSARP = 8) treated from 2000 to 2013 prospectively. Results: Mean ages at surgery, MRI scores, mean RAA, and duration of raised C-reactive protein (6.6 vs. 6.7 days; p = NS) were similar. In all cases, postoperative MRI showed no residual fistula and normal urination. LAARP had consistently higher FCE (7.9 vs. 7.8 at 3 years; 8.6 vs. 8.3 at 5 years; 8.9 vs 8.6 at 7 years; p = NS, respectively), less wound infections (0 vs. 37.5%; p < 0.05), higher incidence of rectalmucosal prolapse (50.0 vs. 0%; p < 0.05), and required less analgesia (p < 0.05). Conclusion: Although LAARP and PSARP are comparable for treating RBF, LAARP is associated with less wound infections and higher incidence of rectal mucosal prolapse. (C) 2014 Elsevier Inc. All rights reserved.	[Koga, Hiroyuki; Ochi, Takanori; Okawada, Manabu; Doi, Takashi; Lane, Geoffrey J.; Yamataka, Atsuyuki] Juntendo Univ, Sch Med, Dept Pediat Gen & Urogenital Surg, Tokyo 1138421, Japan	Koga, H (reprint author), Juntendo Univ, Sch Med, Dept Pediat Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	h-koga@juntendo.ac.jp					McGrath P, 1996, PAIN, V64, P435, DOI 10.1016/0304-3959(95)00171-9; Georgeson KE, 2000, J PEDIATR SURG, V35, P927, DOI 10.1053/jpsu.2000.6925; Levitt MA, 2010, J PEDIATR SURG, V45, P1228, DOI 10.1016/j.jpedsurg.2010.02.096; Bischoff A, 2011, J PEDIATR SURG, V46, P1609, DOI 10.1016/j.jpedsurg.2011.03.068; DEVRIES PA, 1982, J PEDIATR SURG, V17, P638, DOI 10.1016/S0022-3468(82)80126-7; Ichijo C, 2008, J PEDIATR SURG, V43, P158, DOI 10.1016/j.jpedsurg.2007.09.037; Koga H, 2010, J PEDIATR SURG, V45, P397, DOI 10.1016/j.jpedsurg.2009.10.085; Koga H, 2005, PEDIATR SURG INT, V21, P58, DOI 10.1007/s00383-004-1265-9; Koga H, 2010, J PEDIATR SURG, V45, P2394, DOI 10.1016/j.jpedsurg.2010.08.041; Kudou S, 2005, J PEDIATR SURG, V40, P1923, DOI 10.1016/j.jpedsurg.2005.08.008; Peña A, 2003, Tech Coloproctol, V7, P35, DOI 10.1007/s101510300006; PENA A, 1993, J PEDIATR SURG, V28, P773, DOI 10.1016/0022-3468(93)90323-D; Podevin G, 2009, J LAPAROENDOSC ADV S, V19, pS233, DOI 10.1089/lap.2008.0137; Tong QS, 2011, J PEDIATR SURG, V46, P1578, DOI 10.1016/j.jpedsurg.2011.04.059; Wong KKY, 2011, J PEDIATR SURG, V46, P2313, DOI 10.1016/j.jpedsurg.2011.09.021; Yamataka A, 2013, PEDIATR SURG INT, V29, P1007, DOI 10.1007/s00383-013-3391-8; Yamataka A, 2001, J PEDIATR SURG, V36, P1659, DOI 10.1053/jpsu.2001.27944; Yamataka A, 2002, J PEDIATR SURG, V37, P1657, DOI 10.1053/jpsu.2002.36683; Yang JX, 2009, J PEDIATR SURG, V44, P2380, DOI 10.1016/j.jpedsurg.2009.07.064	19	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	DEC	2014	49	12					1815	1817		10.1016/j.jpedsurg.2014.09.028		3	Pediatrics; Surgery	Pediatrics; Surgery	AW0FA	WOS:000345965000027		
J	Tanaka, K; Manabe, S; Ooyama, K; Seki, Y; Nagae, H; Takagi, M; Koike, J; Zuccollo, J; Pringle, KC; Kitagawa, H				Tanaka, Kunihide; Manabe, Shutaro; Ooyama, Kei; Seki, Yasuji; Nagae, Hideki; Takagi, Masayuki; Koike, Junki; Zuccollo, Jane; Pringle, Kevin C.; Kitagawa, Hiroaki			Can a pressure-limited V-A shunt for obstructive uropathy really protect the kidney?	JOURNAL OF PEDIATRIC SURGERY			English	Article						Obstructive uropathy; Vesicoamniotic shunt; Fetal surgery; Vacuolated degeneration	URINARY-TRACT OBSTRUCTION; VESICOAMNIOTIC SHUNT; FETAL SURGERY; BLADDER; INTERVENTION; VESICOSTOMY; CHILDREN; DISEASE; LAMB; TUBE	Background: In our fetal lamb model of lower urinary tract obstruction, a valved shunt preserves bladder function. This study investigates the effects on renal histology. Methods: We created obstructive uropathy (OU) in 60-day gestation fetal lambs, ligating the urethra and urachus, and delivering them at term (130-145 days). We compared renal histology in 4 groups: group A-OU without shunt, group B-low-pressure shunt (15-54 mmH(2)O),group C-high-pressure shunt (95-150 mmH(2)O). Shunts were inserted 3 weeks post-obstruction. Group D were normal controls. Results: We delivered 32 fetuses from 23 ewes: 13 fetuses in group A (9 survived), 6 fetuses in group B (5 survived), 7 fetuses in group C (5 survived), and 6 fetuses in group D. Histologically, we found renal tubular distention, vacuolated degeneration of tubular epithelial cells in 7 lambs, and cyst formation in 4 lambs in group A. There was renal tubular distention in two lambs, and cyst formation in one lamb in both groups B and C, with vacuolated degeneration of tubular epithelial cells observed in all but 1 lamb in each group. Conclusions: V-A shunting prevents multicystic dysplastic kidney (MCDK). Some lambs have renal tubular distention and vacuolated degeneration of renal tubular epithelial cells. (C) 2014 Elsevier Inc. All rights reserved.	[Tanaka, Kunihide; Manabe, Shutaro; Ooyama, Kei; Seki, Yasuji; Nagae, Hideki; Kitagawa, Hiroaki] St Marianna Univ, Sch Med, Dept Pediat Surg, Kawasaki, Kanagawa, Japan; [Zuccollo, Jane; Pringle, Kevin C.] Univ Otago, Sch Med & Hlth Sci, Dept Obstet & Gynecol, Wellington, New Zealand; [Takagi, Masayuki; Koike, Junki] St Marianna Univ, Sch Med, Dept Pathol, Kawasaki, Kanagawa, Japan	Kitagawa, H (reprint author), St Marianna Univ, Sch Med, Div Pediat Surg, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa, Japan.	h2kita@marianna-u.ac.jp			"Phil & Teds" through the Wellington Surgical Research Trust	This study was supported by the Japanese Society for Grant-in-aid of Scientific Research (C) and by a grant from "Phil & Teds" through the Wellington Surgical Research Trust. Suture materials were supplied by COVIDIEN Japan. All animals were consistently bred to a timing of 24 hours by the late Doug Jensen in Wairarapa, New Zealand. Management of the animals in the laboratory is supervised by Katherine Wright. The authors thank Shigeko Ohnuma and the other staff in the Department of Pathology in St. Marianna University school of Medicine for assistance in processing the histology.	Ruano R, 2011, PRENATAL DIAG, V31, P667, DOI 10.1002/pd.2736; HARRISON MR, 1982, NEW ENGL J MED, V306, P591, DOI 10.1056/NEJM198203113061006; Freedman AL, 1999, LANCET, V354, P374, DOI 10.1016/S0140-6736(98)11006-1; Biard JM, 2005, OBSTET GYNECOL, V106, P503, DOI 10.1097/01.AOG.0000171117.38929.eb; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; RYFFEL B, 1983, ARCH TOXICOL, V53, P107; Kitagawa H, 2006, J PEDIATR SURG, V41, P394, DOI 10.1016/j.jpedsurg.2005.11.035; Morris RK, 2011, EARLY HUM DEV, V87, P607, DOI 10.1016/j.earlhumdev.2011.07.004; Lissauer D, 2007, SEMIN FETAL NEONAT M, V12, P464, DOI 10.1016/j.siny.2007.06.005; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Anumba DO, 2005, PRENATAL DIAG, V25, P7, DOI 10.1002/pd.1074; GOLBUS MS, 1982, AM J OBSTET GYNECOL, V142, P383; Aoba T, 2008, J PEDIATR SURG, V43, P2250, DOI 10.1016/j.jpedsurg.2008.08.058; Kitagawa H, 2005, PEDIATR SURG INT, V21, P25, DOI 10.1007/s00383-004-1257-9; Kitagawa H, 1999, J PEDIATR SURG, V34, P1678, DOI 10.1016/S0022-3468(99)90643-7; Kitagawa H, 2000, J PEDIATR SURG, V35, P1651, DOI 10.1053/jpsu.2000.18344; Kitagawa H, 2013, PEDIATR SURG INT, V29, P381, DOI 10.1007/s00383-012-3249-5; Kitagawa H, 2007, J PEDIATR SURG, V42, P2002, DOI 10.1016/j.jpedsurg.2007.08.019; MERSKI JA, 1985, FOOD CHEM TOXICOL, V23, P923, DOI 10.1016/0278-6915(85)90109-7; MOREAU JF, 1975, RADIOLOGY, V115, P329; Morris RK, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17590; Nagae H, 2006, J PEDIATR SURG, V41, P2086, DOI 10.1016/j.jpedsurg.2006.08.012; Pringle KC, 1984, ANIMAL MODELS FETAL, P109; Sato Y, 2004, J PEDIATR SURG, V39, P1849, DOI 10.1016/j.jpedsurg.2004.08.023	24	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	DEC	2014	49	12					1831	1834		10.1016/j.jpedsurg.2014.09.030		4	Pediatrics; Surgery	Pediatrics; Surgery	AW0FA	WOS:000345965000031		
J	Kurihara, S; Hiyama, E; Onitake, Y; Yamaoka, E; Hiyama, K				Kurihara, Sho; Hiyama, Eiso; Onitake, Yoshiyuki; Yamaoka, Emi; Hiyama, Keiko			Clinical features of ATRX or DAXX mutated neuroblastoma	JOURNAL OF PEDIATRIC SURGERY			English	Article						ATRX; DAXX; Neuroblastoma; Mutation; Telomere; ALT; Prognosis	SINGLE-STRAND OVERHANG; TELOMERASE ACTIVITY; MUTATIONS; LENGTH; ASSOCIATION; DIAGNOSIS; THERAPY; CANCER; CELLS; GENE	Purpose: Previously, we reported that alternative lengthening of telomere (ALT) may be a biomarker for chemosensitivity and late recurrence in neuroblastoma (NBL). In this study, alterations of ATRX or DAXX, which both encode chromatin remodeling proteins in telomeric region, and their relationship to ALT were examined in NBLs. Methods: Our previous report on 121 NBLs revealed 11 NBLs with elongated telomeres by ALT. In these NBLs, ATRX or DAXX gene alterations were identified using next-generation sequencing and compared to clinical and other biological factors. Results: In 11 ALT cases, DAXX mutations were detected in one case, and ATRX alterations were detected in 10 cases. Except for one case, no DAXX or ATRX alterations were detected in 110 tumors with normal or shortened telomeres. MYCN amplification was not detected in ATRX altered tumors. In ALT cases, three infants showed ATRX deletions, and all seven cases detected after 18 months of age showed poor prognosis. Conclusions: In NBLs, ALT was caused by ATRX or DAXX alterations. ATRX altered cases without MYCN amplification detected at greater than 18 months showed poor prognosis, suggesting that ATRX or DAXX alterations are a particular NBL subtype. Since these tumors showed chemo-resistance and late recurrence, complete resection in a surgical approach should be performed to improve patient prognosis. (C) 2014 Elsevier Inc. All rights reserved.	[Kurihara, Sho; Hiyama, Eiso; Onitake, Yoshiyuki] Hiroshima Univ, Grad Sch Biomed Sci & Hlth, Hiroshima 7348551, Japan; [Kurihara, Sho; Hiyama, Eiso; Onitake, Yoshiyuki] Hiroshima Univ Hosp, Dept Pediat Surg, Hiroshima 7348551, Japan; [Hiyama, Eiso; Yamaoka, Emi; Hiyama, Keiko] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev N BARD, Hiroshima 7348551, Japan	Hiyama, E (reprint author), Hiroshima Univ, Nat Sci Ctr Basic Res, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	eiso@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [13313631, 13370806]; Ministry of Health, Labor, and Welfare of the Government of Japan [13801449]	This research was partially supported by Grant-in-Aids for Scientific Research (A) (No. 13313631 and 13370806) from the Ministry of Education, Culture, Sports, Science, and Technology and for Cancer Research by that (13801449) from the Ministry of Health, Labor, and Welfare of the Government of Japan.	Hiyama E, 2001, NEOPLASIA, V3, P17, DOI 10.1038/sj.neo.7900134; Sridhar S, 2013, MOL DIAGN THER, V17, P63, DOI 10.1007/s40291-013-0019-6; HIYAMA E, 1992, JPN J CANCER RES, V83, P159; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Hiyama E, 2008, LANCET, V371, P1173, DOI 10.1016/S0140-6736(08)60523-1; Shimada H, 1999, CANCER, V86, P364, DOI 10.1002/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7; Heaphy CM, 2011, SCIENCE, V333, P425, DOI 10.1126/science.1207313; Bower K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050062; BRODEUR GM, 1984, SCIENCE, V224, P1121, DOI 10.1126/science.6719137; Deyell RJ, 2011, CANCER GENET-NY, V204, P113, DOI 10.1016/j.cancergen.2011.03.001; Hashimoto M, 2005, FEBS LETT, V579, P2959, DOI 10.1016/j.febslet.2005.04.021; Hiyama E, 2005, CURR GENOMICS, V6, P319, DOI 10.2174/1389202054750202; HIYAMA E, 1995, INT J ONCOL, V6, P13; Hiyama E, 2007, PEDIATR SURG INT, V23, P1051, DOI 10.1007/s00383-007-1998-3; Hiyama E, 2009, DIAGNOSTIC PROGNOSIT, P135; HIYAMA E, 1995, NAT MED, V1, P249, DOI 10.1038/nm0395-249; Hiyama E, 1997, EUR J CANCER, V33, P1932, DOI 10.1016/S0959-8049(97)00226-8; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Ogura T, 2012, J PEDIATR SURG, V47, P1789, DOI 10.1016/j.jpedsurg.2012.05.007; Onitake Y, 2009, J PEDIATR SURG, V44, P2258, DOI 10.1016/j.jpedsurg.2009.07.046; Piatyszek Mieczyslaw A., 1995, Methods in Cell Science, V17, P1, DOI 10.1007/BF00981880; Reynolds C. P., 1996, Proceedings of the American Association for Cancer Research Annual Meeting, V37, P199; SAWAGUCHI S, 1990, CANCER, V66, P1879, DOI 10.1002/1097-0142(19901101)66:9<1879::AID-CNCR2820660905>3.0.CO;2-L; Wylie L, 2012, PEDIATR BLOOD CANCER, V58, P649, DOI 10.1002/pbc.23329; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739	32	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0022-3468	1531-5037		J PEDIATR SURG	J. Pediatr. Surg.	DEC	2014	49	12					1835	1838		10.1016/j.jpedsurg.2014.09.029		4	Pediatrics; Surgery	Pediatrics; Surgery	AW0FA	WOS:000345965000032		
J	Fukushima, S; Haugh, M				Fukushima, Saeko; Haugh, Michael			The role of emic understandings in theorizing im/politeness: The metapragmatics of attentiveness, empathy and anticipatory inference in Japanese and Chinese	JOURNAL OF PRAGMATICS			English	Article						Politeness; Impoliteness; Metapragmatics; Metalanguage; Emic understandings; Attentiveness	POLITENESS; FACE; CONCEPTUALIZATIONS; (IM)POLITENESS; SYMPATHY; APOLOGY; ENGLISH; BRITISH	While the notion of face has continued to play a key role in many accounts of im/politeness, there have increasingly been calls for im/politeness to be theorized in its own right, drawing from the emic understandings of members in relation to im/politeness. In this paper, we make a contribution to this latter agenda by comparing emic understandings of attentiveness, and the related notions of empathy and anticipatory inference in Japanese and Taiwanese Mandarin Chinese. Drawing from metapragmatic interviews with Japanese and Taiwanese participants from two different generations, we suggest that there are both similarities and differences in the ways in which these notions are conceptualized among speakers of Japanese and Mandarin Chinese spoken in Taiwan. It was found that while the participants evaluated these practices positively, and in some cases linked them to politeness concerns, in other instances they evaluated them negatively. Intracultural variability also emerged in the course of our cross-generational-cultural comparison. We conclude that further work investigating the metapragmatics of interpersonal notions such as attentiveness, empathy and anticipatory inference is necessary if we are to better understand the moral grounds on which evaluations of im/politeness are made across different languages and cultures. (C) 2014 Elsevier B.V. All rights reserved.	[Fukushima, Saeko] Tsuru Univ, Dept English, Tsuru, Yamanashi 4028555, Japan; [Haugh, Michael] Griffith Univ, Sch Languages & Linguist, Nathan, Qld 4111, Australia	Fukushima, S (reprint author), Tsuru Univ, Dept English, 3-8-1 Tahara, Tsuru, Yamanashi 4028555, Japan.	saeko@tsuru.ac.jp; m.haugh@griffith.edu.au					Spencer-Oatey H, 2002, J PRAGMATICS, V34, P529, DOI 10.1016/S0378-2166(01)00039-X; MAO LR, 1994, J PRAGMATICS, V21, P451, DOI 10.1016/0378-2166(94)90025-6; Chang WLM, 2011, INTERCULT PRAGMAT, V8, P411, DOI 10.1515/IPRG.2011.019; GU YG, 1990, J PRAGMATICS, V14, P237, DOI 10.1016/0378-2166(90)90082-O; Haugh M, 2007, J PRAGMATICS, V39, P657, DOI 10.1016/j.pragma.2006.12.005; Terkourafi M, 2011, J POLITENESS RES-LAN, V7, P159, DOI 10.1515/JPLR.2011.009; Fukushima S, 2013, PRAGMATICS, V23, P275; Chang WLM, 2011, J PRAGMATICS, V43, P2948, DOI 10.1016/j.pragma.2011.05.009; Fukushima S, 2011, PRAGMATICS, V21, P549; Fukushima S, 2009, PRAGMATICS, V19, P501; Intachakra S, 2012, J PRAGMATICS, V44, P619, DOI 10.1016/j.pragma.2011.07.016; Bousfield Derek, 2008, IMPOLITENESS INTERAC; Brown P., 1987, POLITENESS SOME UNIV; Burdelski M, 2013, PRAGMAT SOC, V4, P54, DOI 10.1075/ps.4.1.03bur; Burdelski M, 2010, J PRAGMATICS, V42, P1606, DOI 10.1016/j.pragma.2009.11.007; Burdelski M, 2010, LANG SOC, V39, P65, DOI 10.1017/S0047404509990650; Chang Wei-Lin Melody, FACE FACE P IN PRESS; Clancy P., 1986, LANGUAGE SOCIALIZATI, P213; Dunn CD, 2013, MULTILINGUA, V32, P225, DOI 10.1515/multi-2013-0011; Eelen Gino, 2001, CRITIQUE POLITENESS; FUKUSHIMA S, 2013, TSURU U GRADUATE SCH, V17, P19; Fukushima Saeko, 2004, MULTILINGUA, V23, P365, DOI 10.1515/mult.2004.23.4.365; Fukushima Saeko, 2000, REQUESTS CULTURE POL; Gao G., 1998, COMMUNICATING EFFECT; Garfinkel H., 1967, STUDIES ETHNOMETHODO; Gladkova A, 2010, CULT PSYCHOL, V16, P267, DOI 10.1177/1354067X10361396; HAMANO K, 1987, PSYCHOLOGIA, V30, P101; Hara Kazuya, 2006, INTERCULTURAL COMMUN, V15, P24; Haugh M, 2007, J PRAGMATICS, V39, P84, DOI 10.1016/j.pragma.2006.07.004; Haugh Michael, 2014, IMPOLITENESS IMPLICA; Haugh Michael, 2013, ENCY APPL LINGUISTIC, P2658; Haugh Michael, 2004, MULTILINGUA, V23, P85, DOI 10.1515/mult.2004.009; Haugh Michael, 2005, INTERCULT PRAGMAT, V2, P41, DOI 10.1515/iprg.2005.2.1.41; Haugh M, 2007, J POLITENESS RES-LAN, V3, P295, DOI 10.1515/PR.2007.013; Haugh Michael, 2010, 5 INT S POL U BAS 30; Haugh M, 2013, J PRAGMATICS, V58, P52, DOI 10.1016/j.pragma.2013.07.003; Haugh Michael, 2013, SOCIOCULTURAL PRAGMA, V1, P46; Haugh Michael, 2011, POLITENESS E ASIA, P147; Haugh Michael, 2010, PRAGMATICS LANGUAGES, P139; Ide Sachiko, 1992, POLITENESS LANGUAGE, P299; Ide Sachiko, 1989, MULTILINGUA, V8, P223, DOI 10.1515/mult.1989.8.2-3.223; Ishii Satoshi, 1984, CROSS CURRENTS, V11, P49; Kadar DZ, 2013, UNDERSTANDING POLITENESS, P1; Kaganoi Shuichi, 1999, LINE, V4, P12; Krippendorff K., 2013, CONTENT ANAL INTRO I; Lebra T., 1976, JAPANESE PATTERNS BE; Lebra Takie, 2004, JAPANESE SELF CULTUR; Marui Ichiro, 1996, CONTRASTIVE SOCIOLIN, P385; Matsumoto Yoshiko, 1989, MULTILINGUA, V8, P207, DOI 10.1515/mult.1989.8.2-3.207; Miike Yoshitaka, 2003, KEIO COMMUNICATION R, V25, P93; Mills Sara, 2003, GENDER POLITENESS; Miyake Kazuko, 2011, NIHONGO TAIJINKANKEI; Obana Yasuko, 1994, JAPANESE STUDIES B, V14, P37, DOI 10.1080/10371399408727576; Ohashi Jun, 2013, THANKING POLITENESS; Okabe R., 1983, INTERCULTURAL COMMUN, P21; Pan Yulin, 2000, POLITENESS CHINESE F; Pan Yuling, 2011, POLITENESS HIST CONT; Pizziconi B, 2007, J POLITENESS RES-LAN, V3, P207, DOI 10.1515/PR.2007.010; Potter J, 2005, QUALITATIVE RES PSYC, V2, P281, DOI DOI 10.1191/1478088705QP045OA; Pudlinski C, 2005, DISCOURSE STUD, V7, P267, DOI 10.1177/1461445605052177; Shinmura I., 2008, KOJIEN; Sifianou M., 1992, POLITENESS PHENOMENA; Sifianou M, 2010, INTERCULT PRAGMAT, V7, P661, DOI 10.1515/IPRG.2010.029; Spencer-Oatey Helen, 2005, J POLITENESS RES-LAN, V1, P95, DOI 10.1515/jplr.2005.1.1.95; Spencer-Oatey Helen, 2000, CULTURALLY SPEAKING, P11; Takada A, 2013, LANG COMMUN, V33, P420, DOI 10.1016/j.langcom.2013.03.012; Tracy Karen, 2010, COMMUNICATION METHOD, V4, P177, DOI DOI 10.1080/19312458.2010.505501; TRAVIS C, 1998, SPEAKING EMOTIONS CO, V10, P55; Travis Catherine, 1997, LEXICOS, V7, P130; Uchida Y, 2001, JPN J PSYCHOL, V72, P275; Watanabe T., 2003, KENKYUSHAS NEW JAPAN; Watts Richard, 2003, POLITENESS; Watts Richard J., 2005, J POLITENESS RES-LAN, V1, P9, DOI DOI 10.1515/JPLR.2005.1.1.9; Wierzbicka Anna, 1997, UNDERSTANDING CULTUR; Yamada Haru, 1997, DIFFERENT GAMES DIFF; Ye Zhengdao, 2004, INTERCULT PRAGMAT, V1, P211, DOI 10.1515/iprg.2004.1.2.211	76	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-2166	1879-1387		J PRAGMATICS	J. Pragmat.	DEC	2014	74						165	179		10.1016/j.pragma.2014.08.004		15	Linguistics; Language & Linguistics	Linguistics	AW3WL	WOS:000346213900012		
J	Kanazawa, M; Iwaki, M; Minakuchi, S; Nomura, N				Kanazawa, Manabu; Iwaki, Maiko; Minakuchi, Shunsuke; Nomura, Naoyuki			FABRICATION OF TITANIUM ALLOY FRAMEWORKS FOR COMPLETE DENTURES BY SELECTIVE LASER MELTING	JOURNAL OF PROSTHETIC DENTISTRY			English	Article							BIOMEDICAL APPLICATIONS; BEHAVIOR; MICROSTRUCTURE; EVOLUTION; TI	Statement of problem. Casting difficulties have led to the limited use of titanium in dental prostheses. The selective laser melting system was recently developed to fabricate biomedical components from titanium alloys. However, the fabrication of a titanium alloy framework for a maxillary complete denture by selective laser melting has not yet been investigated. Purpose. The purpose of the study was to fabricate thin titanium alloy frameworks for a maxillary complete denture with a selective laser melting system and to evaluate their hardness and microstructure. Material and methods. A cast of an edentulous maxilla was scanned with a dental 3-dimensional cone-beam computed tomography system, and standard triangulation language data were produced with the DICOM Viewer (Digital Imaging and Communications in Medicine). Two types of metal frameworks for complete dentures were designed with 3-dimensional computer-aided design software. Two titanium alloy frameworks, SLM-1 and SLM-2, were fabricated from these designs with the selective laser melting system. Plate-shaped specimens were cut from the central flat region of SLM-1, SLM-2, and as-cast Ti-6Al-4V (As-cast). Vickers hardness testing, optical microscopy, and x-ray diffraction measurements were performed. Results. Thin titanium alloy frameworks for maxillary complete dentures could be fabricated by selective laser melting. The hardness values for SLM-1 and SLM-2 were higher than that for the as-cast specimen. Optical microscopy images of the SLM-1 and SLM-2 microstructure showed that the specimens did not exhibit pores, indicating that dense frameworks were successfully obtained with the selective laser melting process. In the x-ray diffraction patterns, only peaks associated with the a phase were observed for SLM-1 and SLM-2. In addition, the lattice parameters for SLM-1 and SLM-2 were slightly larger than those for the as-cast specimen. Conclusions. The mechanical properties and microstructure of the denture frameworks prepared by selective laser melting indicate that these dentures are appropriate for clinical use.	[Kanazawa, Manabu; Iwaki, Maiko; Minakuchi, Shunsuke] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Gerontol & Gerodontol, Tokyo, Japan; [Nomura, Naoyuki] Tokyo Med & Dent Univ, Inst Biomaterials & Bioengn, Tokyo, Japan	Kanazawa, M (reprint author), 1-5-45 Yushima,Bunkyo ku, Tokyo 1138549, Japan.	m.kanazawa.gerd@tmd.ac.jp					ADA Council on Scientific Affairs, 2003, J AM DENT ASSOC, V134, P347; Kanazawa M, 2011, DENT MATER J, V30, P93, DOI 10.4012/dmj.2010-112; Gu DD, 2012, ACTA MATER, V60, P3849, DOI 10.1016/j.actamat.2012.04.006; PAWLEY GS, 1981, J APPL CRYSTALLOGR, V14, P357, DOI 10.1107/S0021889881009618; Murr LE, 2009, J MECH BEHAV BIOMED, V2, P20, DOI 10.1016/j.jmbbm.2008.05.004; van Noort R, 2012, DENT MATER, V28, P3, DOI 10.1016/j.dental.2011.10.014; Mullen L, 2009, J BIOMED MATER RES B, V89B, P325, DOI 10.1002/jbm.b.31219; Yadroitsev I, 2014, J ALLOY COMPD, V583, P404, DOI 10.1016/j.jallcom.2013.08.183; Boberick KG, 1998, J PROSTHET DENT, V79, P399, DOI 10.1016/S0022-3913(98)70152-0; Bridgeman JT, 1997, J PROSTHET DENT, V78, P187, DOI 10.1016/S0022-3913(97)70124-0; Colling EW, 2003, MAT PROPERTIES HDB T, V23, P149; Cubberly WH, 1980, AMS HDB COMMITTEE, V3, P361; EOS Electra Optical Systems, 2010, PROD INF; Gil FJ, 2012, J MATER SCI-MATER M, V23, P885, DOI 10.1007/s10856-012-4572-z; Gonda Y, 1986, J JAPAN PROSTHODONT, V30, P853; HAMANAKA H, 1989, J DENT RES, V68, P1529, DOI 10.1177/00220345890680111201; Hasegawa K, 1976, J JAPAN PROSTHODONT, V20, P423; Ida K, 1982, Dent Mater J, V1, P8; Kaiba Yoshinori, 2006, Journal of Medical and Dental Sciences, V53, P1; King A W, 1994, Int J Prosthodont, V7, P532; Leong D, 1994, Int J Prosthodont, V7, P440; Miyakawa O, 1993, Dent Mater J, V12, P171; Nakajima H, 1996, Dent Mater J, V15, P77; Oluwajana F, 2012, BRIT DENT J, V213, P123, DOI 10.1038/sj.bdj.2012.667; Serra-Prat J, 2014, J PROSTHET DENT, V112, P249; Suyalatu, 2012, ACTA BIOMATER, V7, P4259; Takahashi J, 1993, Dent Mater J, V12, P245; Takamata T, 1989, Int J Prosthodont, V2, P555; Wakabayashi N, 1996, INT J PROSTHODONT, V9, P520; Wang R R, 1996, Quintessence Int, V27, P401; Wu L, 2014, J PROSTHET DENT, V111, P51, DOI 10.1016/j.prosdent.2013.09.011; Yamada T, 1979, J JAPAN PROSTHODONT, V23, P288; Zarb GA, 2004, PROSTHODONTIC TREATM, P190	33	4	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3913	1097-6841		J PROSTHET DENT	J. Prosthet. Dent.	DEC	2014	112	6					1441	1447				7	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AW0BR	WOS:000345955900020		
J	Saito, M; Kanazawa, M; Takahashi, H; Uo, M; Minakuchi, S				Saito, Marie; Kanazawa, Manabu; Takahashi, Hidekazu; Uo, Motohiro; Minakuchi, Shunsuke			TREND OF CHANGE IN RETENTIVE FORCE FOR BAR ATTACHMENTS WITH DIFFERENT MATERIALS	JOURNAL OF PROSTHETIC DENTISTRY			English	Article							PATIENT SATISFACTION; IMPLANT OVERDENTURES; CLINICAL-TRIAL; BALL; MAINTENANCE; MAGNET; 5-YEAR; CLIP; WEAR	Statement of problem. Attachment wear can decrease the retentive force of 2-implant overdentures (2-IODs). Purpose. The purpose of this in vitro study was to investigate the trend of change in retentive force for 6 different bar attachments during dislodgement. Material and methods. Round and Dolder bars were made of platinum-added gold alloy (PGA), cobalt chromium alloy (Co-Cr), and commercially pure titanium grade IV (Ti). Clips were made of PGA. Retentive force was measured during 7200 dislodging cycles. Simple linear regression analysis was performed in order to investigate the relationship between number of cycles and retentive force (P<.05). Subsequently, wear debris was analyzed, and the surface of the attachments was observed. Results. The retentive force of the Co-Cr round bar attachment (CoCr-R) increased from 57.5 N to 68.3 N and the Ti round bar attachment (Ti-R) from 54.8 N to 59.7 N. However, the retentive force of the PGA round bar attachment (PGA-R) decreased from 69.3 N to 64.0 N. A positive relationship was found between the number of cycles and the retentive force of both CoCr-R and Ti-R. The composition of the wear debris was almost the same as for PGA. For the Dolder bar attachment, no changes were seen in retentive force (between 7.0 N to 12.0 N). Conclusions. For the round bar attachment, the PGA clip and PGA bar showed wear. The retentive force of PGA-R slightly decreased. The retentive force of CoCr-R and Ti-R tended to increase. For the Dolder bar attachment, all 3 types of bar attachment showed no wear.	[Saito, Marie; Kanazawa, Manabu; Uo, Motohiro; Minakuchi, Shunsuke] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Tokyo, Japan; [Takahashi, Hidekazu] Tokyo Med & Dent Univ, Sch Oral Hlth Care Sci Course Oral Hlth Engn, Tokyo, Japan	Kanazawa, M (reprint author), 1-5-45 Yushima, Tokyo 1138549, Japan.	m.kanazawa.gerd@tmd.ac.jp			JSPS KAKENHI [23792211]	This work was supported by a Grant-in-Aid for Young Scientists (B) (Grant 23792211) from JSPS KAKENHI.	Cune M, 2005, INT J PROSTHODONT, V18, P99; Federick DR, 1996, J PROSTHET DENT, V76, P624, DOI 10.1016/S0022-3913(96)90441-2; Duyck J, 1999, Clin Oral Investig, V3, P201, DOI 10.1007/s007840050102; Ekfeldt A, 1997, INT J PROSTHODONT, V10, P366; Feine J S, 2002, Gerodontology, V19, P3; Gotfredsen K, 2000, INT J PROSTHODONT, V13, P125; MericskeStern R, 1996, CLIN ORAL IMPLAN RES, V7, P387, DOI 10.1034/j.1600-0501.1996.070413.x; Misch CH, 2008, CONT IMPLANT DENT, P297; Naert I, 1999, J ORAL REHABIL, V26, P195, DOI 10.1046/j.1365-2842.1999.00369.x; Payne AGT, 2000, INT J PROSTHODONT, V13, P246; Phillips K, 2001, COMPEND CONTIN ED DE, V22, P522; Phillips K, 2001, COMPEND CONTIN ED DE, V22, P520; Phillips K, 2001, Compend Contin Educ Dent, V22, P516; Sakai Y, 2011, DENT MATER J, V30, P635, DOI 10.4012/dmj.2011-006; SARNAT AE, 1983, J DENT, V11, P324, DOI 10.1016/0300-5712(83)90117-3; Setz I, 1998, J Prosthet Dent, V80, P323; Setz J, 1989, Int J Oral Maxillofac Implants, V4, P107; SINCLAIR PM, 1983, AM J ORTHOD DENTOFAC, V83, P114, DOI 10.1016/S0002-9416(83)90296-8; van Kampen F, 2003, CLIN ORAL IMPLAN RES, V14, P720, DOI 10.1046/j.0905-7161.2003.00961.x; WALTON JN, 1995, J PROSTHET DENT, V74, P482, DOI 10.1016/S0022-3913(05)80349-X; Wichmann MG, 1999, INT J PROSTHODONT, V12, P409; Wolf K, 2009, QUINTESSENCE INT, V40, P405; Zarb G, 2003, PROSTHODONTIC TREATM, P417	23	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3913	1097-6841		J PROSTHET DENT	J. Prosthet. Dent.	DEC	2014	112	6					1545	1552				8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AW0BR	WOS:000345955900032		
J	Fehniger, TE; Boja, ES; Rodriguez, H; Baker, MS; Marko-Varga, G				Fehniger, Thomas E.; Boja, Emily S.; Rodriguez, Henry; Baker, Mark S.; Marko-Varga, Gyorgy			Four Areas of Engagement Requiring Strengthening in Modern Proteomics Today	JOURNAL OF PROTEOME RESEARCH			English	Editorial Material						proteomics; biobank; mass spectrometry; biomarker; FDA; patient integrity; CEBMMS	ACCESS DATA COROLLARY; DATA QUALITY METRICS; MASS-SPECTROMETRY; AMSTERDAM PRINCIPLES; RECOMMENDATIONS; PROTEINS; PLASMA; STANDARDIZATION; VERIFICATION	The global human proteomics community in 2014 is fully engaged in projects that aim to create a better understanding of human biology and its complexities and to provide products from this new knowledge that will in some way benefit humanity. Human proteomics, like any other scientific enterprise, needs to identify areas of direction and development, both for the near future in completing current research projects and into the long-term for the engagement with even more complex challenges. In this Editorial we highlight and discuss four important areas that we collectively believe require attention and demand a collective response going forward. These four areas are: (1) Provide high-quality standardized, sensitive, specific, quantitative, and readily accessible protein, peptide, or other biomarkers of health, disease, response to therapy into the approval processes of regulatory agencies (e.g., U.S. Food and Drug Administration; FDA), and obtaining approval from the relevant agencies for their use in a clinical or other testing settings. (2) Implement standard processes for collecting, processing, and storing human clinical samples in biorepositories and enforcement of measures to ensure subject integrity including informed consent for the downstream use of samples and in registrations of subject identities within study databases. (3) Test and validate mass spectrometry technology platforms that hold much promise for creating opportunities for obtaining new important knowledge at levels of detection previously not achievable. (4) Organize clinical discovery operations and activities in an intuitive manner to meet the challenges of increased interests in the science we provide and diminishing levels of centrally financed resource and infrastructure support.	[Fehniger, Thomas E.; Marko-Varga, Gyorgy] Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry, S-22100 Lund, Sweden; [Fehniger, Thomas E.; Marko-Varga, Gyorgy] Lund Univ, Dept Biomed Engn, Biomed Ctr, S-22184 Lund, Sweden; [Boja, Emily S.; Rodriguez, Henry] NCI, Off Canc Clin Prote Res, Ctr Strateg Sci Initiat, NIH, Bethesda, MD 20892 USA; [Baker, Mark S.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Marko-Varga, Gyorgy] Tokyo Med Univ, Dept Surg 1, Shinjiku Ku, Tokyo 1600023, Japan	Marko-Varga, G (reprint author), Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry, BMC D13,Klin Gatan 32, S-22100 Lund, Sweden.	thomas.fehniger@bme.lth.se; bojae@nhlbi.nih.gov; rodriguezh@mail.nih.gov; mark.baker@mq.edu.au; gyorgymarkovarga@bme.lth.se		Baker, Mark/0000-0001-5858-4035			Sevy AM, 2013, J THROMB HAEMOST, V11, P2128, DOI 10.1111/jth.12433; Hebert AS, 2014, MOL CELL PROTEOMICS, V13, P339, DOI 10.1074/mcp.M113.034769; Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Rodriguez H, 2010, PROTEOM CLIN APPL, V4, P904, DOI 10.1002/prca.201000057; Rodriguez H, 2009, J PROTEOME RES, V8, P3689, DOI 10.1021/pr900023z; Paik YK, 2012, NAT BIOTECHNOL, V30, P221, DOI 10.1038/nbt.2152; Anderson NL, 2010, CLIN CHEM, V56, P177, DOI 10.1373/clinchem.2009.126706; Bianconi E, 2013, ANN HUM BIOL, V40, P463, DOI 10.3109/03014460.2013.807878; Malm J, 2013, J PROTEOMICS, V95, P38, DOI 10.1016/j.jprot.2013.06.035; Skates SJ, 2013, J PROTEOME RES, V12, P5383, DOI 10.1021/pr400132j; Hermjakob H, 2004, NAT BIOTECHNOL, V22, P177, DOI 10.1038/nbt926; LaBaer J, 2005, J PROTEOME RES, V4, P1053, DOI 10.1021/pr01259; LaBaer J, 2012, J PROTEOME RES, V11, P5592, DOI 10.1021/pr300796m; Senko MW, 2013, ANAL CHEM, V85, P11710, DOI 10.1021/ac403115c; Marko-Varga G, 2012, J PROTEOME RES, V11, P5124, DOI 10.1021/pr300185k; Boja ES, 2014, J PROTEOME RES, V13, P5325, DOI 10.1021/pr500753r; Carr SA, 2014, MOL CELL PROTEOMICS, V13, P907, DOI 10.1074/mcp.M113.036095; Kinsinger C., 2011, MOL CELL PROTEOMICS, V10; Kinsinger CR, 2012, PROTEOMICS, V12, P11, DOI 10.1002/pmic.201100562; Kinsinger CR, 2011, PROTEOM CLIN APPL, V5, P580, DOI 10.1002/prca.201100097; Malm J, 2013, J PROTEOME RES, V12, P3087, DOI 10.1021/pr400131r; Marko-Varga G, 2014, J PROTEOME RES, V13, P5319, DOI 10.1021/pr500475q; Martinez-Bartolome S, 2014, METHODS MOL BIOL, V1072, P765, DOI 10.1007/978-1-62703-631-3_53; Thomson B, 2012, GENETIC ENG BIOTECHN	24	1	1	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	DEC	2014	13	12					5310	5318		10.1021/pr500472d		9	Biochemical Research Methods	Biochemistry & Molecular Biology	AW1GY	WOS:000346039400003		
J	Marko-Varga, G; Baker, MS; Boja, ES; Rodriguez, H; Fehniger, TE				Marko-Varga, Gyorgy; Baker, Mark S.; Boja, Emily S.; Rodriguez, Henry; Fehniger, Thomas E.			Biorepository Regulatory Frameworks: Building Parallel Resources That Both Promote Scientific Investigation and Protect Human Subjects	JOURNAL OF PROTEOME RESEARCH			English	Editorial Material						biobank; regulatory; ethics; LIMS	PERSONALIZED MEDICINE; DRUG DEVELOPMENT; HUMAN-DISEASE; LARGE-SCALE; BIOBANKING; STANDARDIZATION; BIOMARKERS; CANCER; BLOOD	Clinical samples contained in biorepositories represent an important resource for investigating the many factors that drive human biology. The biological and chemical markers contained in clinical samples provide important measures of health and disease that when combined with such medical evaluation data can aid in decision making by physicians. Nearly all disciplines in medicine and every omic depend upon the readouts obtained from such samples, whether the measured analyte is a gene, a protein, a lipid, or a metabolite. There are many steps in sample processing, storage, and management that need to understood by the researchers who utilize biorepositories in their own work. These include not only the preservation of the desired analytes in the sample but also good understanding of the moral and legal framework required for subject protection irrespective of where the samples have been collected. Today there is a great deal of effort in the community to align and standardize both the methodology of sample collection and storage performed in different locations and the necessary frameworks of subject protection including informed consent and institutional review of the studies being performed. There is a growing trend in developing biorepositories around the focus of large population-based studies that address both active and silent nonsymptomatic disease. Logistically these studies generate large numbers of clinical samples and practically place increasing demand upon health care systems to provide uniform sample handling, processing, storage, and documentation of both the sample and the subject as well to ensure that safeguards exist to protect the rights of the study subjects for deciding upon the fates of their samples. Currently the authority to regulate the entire scope of biorepository usage exists as national practice in law in only a few countries. Such legal protection is a necessary component within the framework of biorepositories, both now and in the future. In this brief overview, we provide practical information to the potential users of biorepositories about some of the current developments in both the methodology of sample acquisition and in the regulatory environment governing their use.	[Marko-Varga, Gyorgy; Fehniger, Thomas E.] Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry, S-22100 Lund, Sweden; [Marko-Varga, Gyorgy; Fehniger, Thomas E.] Lund Univ, Dept Biomed Engn, Biomed Ctr, S-22184 Lund, Sweden; [Marko-Varga, Gyorgy] Tokyo Med Univ, Dept Surg 1, Shinjiku Ku, Tokyo 1600023, Japan; [Baker, Mark S.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Boja, Emily S.; Rodriguez, Henry] NCI, Off Canc Clin Prote Res, Ctr Strateg Sci Initiat, NIH, Bethesda, MD 20892 USA	Marko-Varga, G (reprint author), Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry, BMC D13,Klin Gatan 32, S-22100 Lund, Sweden.			Baker, Mark/0000-0001-5858-4035			Marko-Varga G, 2007, J PROTEOME RES, V6, P2925, DOI 10.1021/pr070046s; Malm J, 2012, J PROTEOMICS, V76, P116, DOI 10.1016/j.jprot.2012.05.003; Khleif SN, 2010, CLIN CANCER RES, V16, P3299, DOI 10.1158/1078-0432.CCR-10-0880; Dewey FE, 2014, JAMA-J AM MED ASSOC, V311, P1035, DOI 10.1001/jama.2014.1717; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Karsdal MA, 2009, BIOMARKERS, V14, P181, DOI 10.1080/13547500902777608; Riegman PHJ, 2008, MOL ONCOL, V2, P213, DOI 10.1016/j.molonc.2008.07.004; Malm J, 2013, J PROTEOMICS, V95, P38, DOI 10.1016/j.jprot.2013.06.035; Hewitt RE, 2011, CURR OPIN ONCOL, V23, P112, DOI 10.1097/CCO.0b013e32834161b8; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Marko-Varga G, 2012, J PROTEOME RES, V11, P5124, DOI 10.1021/pr300185k; Baker M, NATURE, V486, P141; Daly MJ, 1998, JAMA-J AM MED ASSOC, V280, P652, DOI 10.1001/jama.280.7.652; Eiseman E, 2003, CASE STUDIES EXISTIN; *ENCODE PROJ CONS, 2011, PLOS BIOL, V0009; Hao DP, 2014, EUR J HUM GENET, V22, P1260, DOI 10.1038/ejhg.2013.309; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Lasso R. O., 2010, JAMA-J AM MED ASSOC, V304, P908; Malm J, 2013, J PROTEOME RES, V12, P3087, DOI 10.1021/pr400131r; Margaret A., 2010, NEW ENGL J MED, V363, P301; Park A., 2009, TIME MAGAZINE; Simeon-Dubach D, 2011, NATURE, V475, P454, DOI 10.1038/475454d; Vegvari A, 2011, 2011 SIN S CLIN TRAN, P36; Welinder Charlotte, 2013, Clin Transl Med, V2, P7, DOI 10.1186/2001-1326-2-7	24	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	DEC	2014	13	12					5319	5324		10.1021/pr500475q		6	Biochemical Research Methods	Biochemistry & Molecular Biology	AW1GY	WOS:000346039400004		
J	Boja, ES; Fehniger, TE; Baker, MS; Marko-Varga, G; Rodriguez, H				Boja, Emily S.; Fehniger, Thomas E.; Baker, Mark S.; Marko-Varga, Gyorgy; Rodriguez, Henry			Analytical Validation Considerations of Multiplex Mass-Spectrometry-Based Proteomic Platforms for Measuring Protein Biomarkers	JOURNAL OF PROTEOME RESEARCH			English	Editorial Material						quantitative fidgeted proteomics; protein biomarker; multiplex proteomics assays; MRM-MS; immunoassays	PEPTIDE IMMUNOAFFINITY ENRICHMENT; C-REACTIVE PROTEIN; ABSOLUTE QUANTIFICATION; TARGETED PROTEOMICS; ASSAY DEVELOPMENT; PLASMA; DISCOVERY; SERUM; STANDARDS; VERIFICATION	Protein biomarker discovery and validation in current omics era are vital for healthcare professionals to improve diagnosis, detect cancers at an early stage, identify the likelihood of cancer recurrence, stratify stages with differential survival outcomes, and monitor therapeutic responses. The success of such biomarkers would have a huge impact on how we improve the diagnosis and treatment of patients and alleviate the financial burden of healthcare systems. In the past, the genomics community (mostly through large-scale, deep genomic sequencing technologies) has been steadily improving our understanding of the molecular basis of disease, with a number of biomarker panels already authorized by the U.S. Food and Drug Administration (FDA) for clinical use (e.g., MammaPrint, two recently cleared devices using next-generation sequencing platforms to detect DNA changes in the cystic fibrosis transmembrane conductance regulator (CFTR) gene). Clinical proteomics, on the other hand, albeit its ability to delineate the functional units of a cell, more likely driving the phenotypic differences of a disease (i.e., proteins and protein-protein interaction networks and signaling pathways underlying the disease), staggers to make a significant impact with only an average similar to 1.5 protein biomarkers per year approved by the FDA over the past 15-20 years. This statistic itself raises the concern that major roadblocks have been impeding an efficient transition of protein marker candidates in biomarker development despite major technological advances in proteomics in recent years.	[Boja, Emily S.; Rodriguez, Henry] NCI, Off Canc Clin Prote Res, Ctr Strateg Sci Initiat, NIH, Bethesda, MD 20892 USA; [Fehniger, Thomas E.; Marko-Varga, Gyorgy] Lund Univ, Ctr Excellence Biol & Med Mass Spectrometry, S-22100 Lund, Sweden; [Fehniger, Thomas E.; Marko-Varga, Gyorgy] Lund Univ, Dept Biomed Engn, Biomed Ctr, S-22184 Lund, Sweden; [Baker, Mark S.] Macquarie Univ, Australian Sch Adv Med, Sydney, NSW 2109, Australia; [Marko-Varga, Gyorgy] Tokyo Med Univ, Dept Surg 1, Shinjiku Ku, Tokyo 1600023, Japan	Rodriguez, H (reprint author), NCI, Off Canc Clin Prote Res, Ctr Strateg Sci Initiat, NIH, 31 Ctr Dr,MS 2580, Bethesda, MD 20892 USA.	rodriguezh@mail.nih.gov		Baker, Mark/0000-0001-5858-4035			An HJ, 2010, METHODS MOL BIOL, V600, P199, DOI 10.1007/978-1-60761-454-8_14; Williams DK, 2009, J PROTEOME RES, V8, P1085, DOI 10.1021/pr800922p; Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Neubert H, 2010, CLIN CHEM, V56, P1413, DOI 10.1373/clinchem.2010.144576; Rodriguez H, 2009, J PROTEOME RES, V8, P3689, DOI 10.1021/pr900023z; Boja ES, 2011, KOREAN J LAB MED, V31, P61, DOI 10.3343/kjlm.2011.31.2.61; Anderson NL, 2010, CLIN CHEM, V56, P177, DOI 10.1373/clinchem.2009.126706; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Whiteaker JR, 2007, J PROTEOME RES, V6, P828, DOI 10.1021/pr0604920; Mansfield E, 2005, J MOL DIAGN, V7, P2, DOI 10.1016/S1525-1578(10)60002-5; Whiteaker JR, 2011, NAT BIOTECHNOL, V29, P625, DOI 10.1038/nbt.1900; Geiger T, 2010, NAT METHODS, V7, P383, DOI 10.1038/nmeth.1446; Boja ES, 2011, CLIN CHEM, V57, P560, DOI 10.1373/clinchem.2010.156034; Kuhn E, 2009, CLIN CHEM, V55, P1108, DOI 10.1373/clinchem.2009.123935; Regnier FE, 2010, CLIN CHEM, V56, P165, DOI 10.1373/clinchem.2009.140087; Gloriam DE, 2010, MOL CELL PROTEOMICS, V9, P1, DOI 10.1074/mcp.M900185-MCP200; Reid JD, 2010, J AM SOC MASS SPECTR, V21, P1680, DOI 10.1016/j.jasms.2010.01.024; Ernoult E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/927917; Skates SJ, 2013, J PROTEOME RES, V12, P5383, DOI 10.1021/pr400132j; Wang P, 2009, CANCER BIOL THER, V8, P1083, DOI 10.4161/cbt.8.12.8634; Xu X, 2007, ANAL CHEM, V79, P7813, DOI 10.1021/ac070494j; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Kushnir MM, 2013, CLIN CHEM, V59, P982, DOI 10.1373/clinchem.2012.195594; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; Kuhn E, 2004, PROTEOMICS, V4, P1175, DOI 10.1002/pmic.200300670; Ciccimaro E, 2009, ANAL CHEM, V81, P3304, DOI 10.1021/ac900204f; Stergachis AB, 2011, NAT METHODS, V8, P1041, DOI [10.1038/nmeth.1770, 10.1038/NMETH.1770]; Anderson KS, 2011, J PROTEOME RES, V10, P85, DOI 10.1021/pr100686b; Krishhan VV, 2009, CRIT REV BIOTECHNOL, V29, P29, DOI 10.1080/07388550802688847; Paulovich AG, 2010, MOL CELL PROTEOMICS, V9, P242, DOI 10.1074/mcp.M900222-MCP200; Carr SA, 2014, MOL CELL PROTEOMICS, V13, P907, DOI 10.1074/mcp.M113.036095; García-Foncillas Jesús, 2006, Clin Transl Oncol, V8, P250, DOI 10.1007/BF02664935; Grebe Stefan Kg, 2011, Clin Biochem Rev, V32, P5; Hoofnagle AN, 2010, CLIN CHEM, V56, P1515, DOI 10.1373/clinchem.2010.152181; Jiang J, 2007, ANAL CHIM ACTA, V605, P70, DOI 10.1016/j.aca.2007.10.02S; Kiyonami R, 2011, MOL CELL PROTEOMICS, DOI DOI 10.1074/MCP.M110.002931-1; Wiener MC, 2004, ANAL CHEM, V76, P6085, DOI 10.1021/ac0493875; Xu X, 2004, RAPID COMMUN MASS SP, V18, P2299, DOI 10.1002/rcm.1625	38	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	DEC	2014	13	12					5325	5332		10.1021/pr500753r		8	Biochemical Research Methods	Biochemistry & Molecular Biology	AW1GY	WOS:000346039400005		
J	Adachi, J; Kishida, M; Watanabe, S; Hashimoto, Y; Fukamizu, K; Tomonaga, T				Adachi, Jun; Kishida, Marina; Watanabe, Shio; Hashimoto, Yuuki; Fukamizu, Kazuna; Tomonaga, Takeshi			Proteome-Wide Discovery of Unknown ATP-Binding Proteins and Kinase Inhibitor Target Proteins Using an ATP Probe	JOURNAL OF PROTEOME RESEARCH			English	Article						Chemical proteomics; ATP-binding proteins; ATP-competitive kinase inhibitor	QUANTITATIVE PROTEOMICS; MASS-SPECTROMETRY; SELECTIVITY; AFFINITY; KINOME; IDENTIFICATION; PHOSPHOPROTEOMICS; MECHANISMS; EXPRESSION; ENRICHMENT	ATP-binding proteins, including protein kinases, play essential roles in many biological and pathological processes and thus these proteins are attractive as drug targets. Acyl-ATP probes have been developed as efficient probes for kinase enrichment, and these probes have also been used to enrich other ATP-binding proteins. However, a robust method to identify ATP-binding proteins with systematic elimination of nonspecific binding proteins has yet to be established. Here, we describe an ATP competition assay that permitted establishment of a rigorous ATP-binding protein list with virtual elimination of nonspecific proteins. A total of 539 ATP-binding protein candidates were identified, including 178 novel candidates. In informatics analysis, ribosomal proteins were overrepresented in the list of novel candidates. We also found multiple ATP-competitive sites for several kinases, including epidermal growth factor receptor, serine/threonine-protein kinase PRP4 homologue, cyclin-dependent kinase 12, eukaryotic elongation factor 2 kinase, ribosomal protein S6 kinase alpha-1, and SRSF protein kinase 1. Using our cataloged ATP-binding protein list, a selectivity profiling method that covers the kinome and ATPome was established to identify off-target binding sites of ATP-competitive kinase inhibitors, staurosporine and crizotinib.	[Adachi, Jun; Kishida, Marina; Watanabe, Shio; Hashimoto, Yuuki; Fukamizu, Kazuna; Tomonaga, Takeshi] Natl Inst Biomed Innovat, Lab Proteome Res, Osaka 5670085, Japan	Adachi, J (reprint author), Natl Inst Biomed Innovat, Lab Proteome Res, Osaka 5670085, Japan.	jun_adachi@nibio.go.jp; tomonaga@nibio.go.jp			Ministry of Health, Labour, and Welfare of Japan [H20-0005]; Ministry of Education, Science, Sports, and Culture of Japan [25290054, 24681009, 26640098]	This work was supported by Grants-in-Aid, Research on Biological Markers for New Drug Development H20-0005 to K.Y., from the Ministry of Health, Labour, and Welfare of Japan. This work was supported by Grants-in-Aid 25290054 to T.T. and 24681009 and 26640098 to J.A. from the Ministry of Education, Science, Sports, and Culture of Japan. We thank Daisuke Higo for advice on mass spectrum analysis.	Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; McAllister FE, 2013, ANAL CHEM, V85, P4666, DOI 10.1021/ac303478g; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; Patricelli MP, 2011, CHEM BIOL, V18, P699, DOI 10.1016/j.chembiol.2011.04.011; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Nagaraj N, 2010, J PROTEOME RES, V9, P6786, DOI 10.1021/pr100637q; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Geiger T, 2010, NAT METHODS, V7, P383, DOI 10.1038/nmeth.1446; Graves PR, 2002, MOL PHARMACOL, V62, P1364, DOI 10.1124/mol.62.6.1364; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Gallien S, 2012, MOL CELL PROTEOMICS, V11, P1709, DOI 10.1074/mcp.O112.019802; Ito J, 2006, J PROTEOME RES, V5, P3459, DOI 10.1021/pr060403j; Lemeer S, 2013, J PROTEOME RES, V12, P1723, DOI 10.1021/pr301073j; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163; WALKER JE, 1982, EMBO J, V1, P945; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Murphy JM, 2014, BIOCHEM J, V457, P369, DOI 10.1042/BJ20131270; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Wolfe LM, 2013, MOL CELL PROTEOMICS, V12, P1644, DOI 10.1074/mcp.M112.025635; BERGLUND O, 1972, FEBS J, V28, P492; Bilodeau MT, 2004, J MED CHEM, V47, P6363, DOI 10.1021/jm049697f; Chene P, 2002, NAT REV DRUG DISCOV, V1, P665, DOI 10.1038/nrd894; Fujii Y, 1999, J BIOL CHEM, V274, P38251, DOI 10.1074/jbc.274.53.38251; Geiger T, 2012, MOL CELL PROTEOMICS, V11, pM111, DOI DOI 10.1074/MCP.M111.014050; Kuhn M, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.10; Qiu HB, 2007, ANAL CHEM, V79, P5547, DOI 10.1021/ac0622375; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Villamor JG, 2013, MOL CELL PROTEOMICS, V12, P2481, DOI 10.1074/mcp.M112.026278; Xiao YS, 2013, ANAL CHEM, V85, P3198, DOI 10.1021/ac303383c; Xiao YS, 2014, MOL CELL PROTEOMICS, V13, P1065, DOI 10.1074/mcp.M113.036905; Xiao YS, 2013, ANAL CHEM, V85, P7478, DOI 10.1021/ac401415z	39	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	DEC	2014	13	12					5461	5470		10.1021/pr500845u		10	Biochemical Research Methods	Biochemistry & Molecular Biology	AW1GY	WOS:000346039400016		
J	Yin, XJ; Sakata, K; Komatsu, S				Yin, Xiaojian; Sakata, Katsumi; Komatsu, Setsuko			Phosphoproteomics Reveals the Effect of Ethylene in Soybean Root under Flooding Stress	JOURNAL OF PROTEOME RESEARCH			English	Article						soybean; flooding stress; root tip; phosphoproteomics	UDP-GLUCOSE DEHYDROGENASES; SUCROSE-PHOSPHATE SYNTHASE; MAIZE SEEDLING ROOTS; RNA CAP-BINDING; PROTEOMIC ANALYSIS; PHOSPHORYLATION; PROTEIN; ARABIDOPSIS; TOLERANCE; STAGE	Flooding has severe negative effects on soybean growth. To explore the flooding-responsive mechanisms in early-stage soybean, a phosphoproteomic approach was used. Two-day-old soybean plants were treated without or with flooding for 3, 6, 12, and 24 h, and root tip proteins were then extracted and analyzed at each time point. After 3 h of flooding exposure, the fresh weight of soybeans increased, whereas the ATP content of soybean root tips decreased. Using a gel-free proteomic technique, a total of 114 phosphoproteins were identified in the root tip samples, and 34 of the phosphoproteins were significantly changed with respect to phosphorylation status after 3 h of flooding stress. Among these phosphoproteins, eukaryotic translation initiation factors were dephosphorylated, whereas several protein synthesis-related proteins were phosphorylated. The mRNA expression levels of sucrose phosphate synthase 1F and eukaryotic translation initiation factor 4G were down-regulated, whereas UDP-glucose 6-dehydrogenase mRNA expression was up-regulated during growth but down-regulated under flooding stress. Furthermore, bioinformatic protein interaction analysis of flooding-responsive proteins based on temporal phosphorylation patterns indicated that eukaryotic translation initiation factor 4G was located in the center of the network during flooding. Soybean eukaryotic translation initiation factor 4G has homology to programmed cell death 4 protein and is implicated in ethylene signaling. The weight of soybeans was increased with treatment by an ethylene-releasing agent under flooding condition, but it was decreased when plants were exposed to an ethylene receptor antagonist. These results suggest that the ethylene signaling pathway plays an important role, via the protein phosphorylation, in mechanismsof plant tolerance to the initial stages of flooding stress in soybean root tips.	[Yin, Xiaojian; Komatsu, Setsuko] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Yin, Xiaojian; Komatsu, Setsuko] Natl Agr & Food Res Org, Natl Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan; [Sakata, Katsumi] Maebashi Inst Technol, Maebashi, Gumma 3710816, Japan	Komatsu, S (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	skomatsu@affrc.go.jp			Chinese Scholarship Council	The authors thank Dr. Yohei Nanjo, Dr. Susumu Hiraga, and Dr. Keito Nishizawa of the National Institute of Crop Science for useful discussions. This study was partially supported by a scholarship from the Chinese Scholarship Council to X.Y.	Setter TL, 2003, PLANT SOIL, V253, P1, DOI 10.1023/A:1024573305997; Nanjo Y, 2010, J PROTEOME RES, V9, P3989, DOI 10.1021/pr100179f; Subbaiah CC, 2001, PLANT PHYSIOL, V125, P585, DOI 10.1104/pp.125.2.585; Githiri SM, 2006, PLANT BREEDING, V125, P613, DOI 10.1111/j.1439-0523.2006.01291.x; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Rajjou L, 2004, PLANT PHYSIOL, V134, P1598, DOI 10.1104/pp.103.036293; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; SCHARF KD, 1982, CELL, V30, P427, DOI 10.1016/0092-8674(82)90240-9; BAILEYSERRES J, 1990, PLANT PHYSIOL, V94, P1237, DOI 10.1104/pp.94.3.1237; Komatsu S, 2010, AMINO ACIDS, V39, P1435, DOI 10.1007/s00726-010-0608-1; Gibbs J, 2003, FUNCT PLANT BIOL, V30, P353, DOI 10.1071/PP98095_ER; Komatsu S, 2009, J PROTEOME RES, V8, P4766, DOI 10.1021/pr900460x; Karkonen A, 2005, BIOCHEM J, V391, P409, DOI 10.1042/BJ20050800; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Tanaka N, 2005, MOL CELL PROTEOMICS, V4, P796, DOI 10.1074/mcp.M400211-MCP200; Chen SL, 2010, P NATL ACAD SCI USA, V107, P17188, DOI 10.1073/pnas.1012348107; Mijakovic I, 2003, EMBO J, V22, P4709, DOI 10.1093/emboj/cdg458; Sima C, 2009, CURR GENOMICS, V10, P416, DOI 10.2174/138920209789177610; Lei G, 2011, PLANT CELL ENVIRON, V34, P1678, DOI 10.1111/j.1365-3040.2011.02363.x; STONE JM, 1995, PLANT PHYSIOL, V108, P451, DOI 10.1104/pp.108.2.451; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Hashiguchi A, 2009, J PROTEOME RES, V8, P2058, DOI 10.1021/pr801051m; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; BaileySerres J, 1997, PLANT PHYSIOL, V114, P1293, DOI 10.1104/pp.114.4.1293; Komatsu S, 2013, J PROTEOMICS, V79, P231, DOI 10.1016/j.jprot.2012.12.023; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Komatsu S, 2011, J PROTEOME RES, V10, P3993, DOI 10.1021/pr2001918; Armstrong W., 1979, Advances in Botanical Research, V7, P225; Banga M, 1996, PLANT PHYSIOL, V112, P229; Cheng SJ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-199; GALTIER N, 1995, J EXP BOT, V46, P1335; Khan MA, 2004, BIOCHEMISTRY-US, V43, P9092, DOI 10.1021/bi049602b; Lewandowska-Gnatowska E, 2011, MOL CELL BIOCHEM, V356, P241, DOI 10.1007/s11010-011-0952-9; Manjunath S, 1999, PLANT J, V19, P21, DOI 10.1046/j.1365-313X.1999.00489.x; MCMICHAEL RW, 1993, ARCH BIOCHEM BIOPHYS, V307, P248, DOI 10.1006/abbi.1993.1586; Millenaar FF, 2005, PLANT PHYSIOL, V137, P998, DOI 10.1104/pp.104.053967; Nakayama N., 2004, JPN J CROP SCI, V74, P325, DOI DOI 10.1626/JCS.74.325; Nanjo Y, 2011, J PROTEOME RES, V11, P372, DOI DOI 10.1021/PR200701Y; Patz A., 2008, AM J PREV MED, V35, P451; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Voit E. O., 2000, COMPUTATIONAL ANAL B; Yin X. J., 2014, J PROTEOMICS, V13, P1	43	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	DEC	2014	13	12					5618	5634		10.1021/pr500621c		17	Biochemical Research Methods	Biochemistry & Molecular Biology	AW1GY	WOS:000346039400029		
J	Khan, MN; Sakata, K; Hiraga, S; Komatsu, S				Khan, Mudassar Nawaz; Sakata, Katsumi; Hiraga, Susumu; Komatsu, Setsuko			Quantitative Proteomics Reveals That Peroxidases Play Key Roles in Post-flooding Recovery in Soybean Roots	JOURNAL OF PROTEOME RESEARCH			English	Article						soybean; root; flooding; proteomics; recovery stage	ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; DIRIGENT PROTEINS; DE-SUBMERGENCE; STRESS; SEEDLINGS; TOLERANCE; RICE; PLANTS; GROWTH	Soybean is an important legume crop that exhibits markedly reduced growth and yields under flooding conditions. To unravel the mechanisms involved in recovery after flooding in soybean root, gel-free proteomic analysis was performed. Morphological analysis revealed that growth suppression was more severe with increased flooding duration. Out of a total of 1645 and 1707 identified proteins, 73 and 21 proteins were changed significantly during the recovery stage following 2 and 4 days flooding, respectively. Based on the proteomic, clustering, and in silico protein-protein interaction analyses, six key enzymes were analyzed at the mRNA level. Lipoxygenase 1, which was increased at the protein level during the recovery period, was steadily down-regulated at the mRNA level. The peroxidase superfamily protein continuously increased in abundance during the course of recovery and was up-regulated at the mRNA level. HAD acid phosphatase was decreased at the protein level and down-regulated at the transcript level, while isoflavone reductase and an unknown protein were increased at both the protein and mRNA levels. Consistent with these findings, the enzymatic activity of peroxidase was decreased under flooding stress but increased significantly during the recovery sage. These results suggest that peroxidases might play key roles in post-flooding recovery in soybean roots through the scavenging of toxic radicals.	[Khan, Mudassar Nawaz; Komatsu, Setsuko] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Khan, Mudassar Nawaz; Hiraga, Susumu; Komatsu, Setsuko] Natl Agr & Food Res Org, Natl Inst Crop Sci, Tsukuba, Ibaraki 3058518, Japan; [Sakata, Katsumi] Maebashi Inst Technol, Maebashi, Gumma 3710816, Japan	Komatsu, S (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	skomatsu@affrc.go.jp	Khan, Mudassar/D-7592-2015	Khan, Mudassar/0000-0002-4682-5089			An SH, 2008, PLANTA, V228, P61, DOI 10.1007/s00425-008-0719-z; Branco-Price C, 2008, PLANT J, V56, P743, DOI 10.1111/j.1365-313X.2008.03642.x; Day A, 2009, PLANT PHYSIOL BIOCH, V47, P9, DOI 10.1016/j.plaphy.2008.09.011; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Nanjo Y, 2010, J PROTEOME RES, V9, P3989, DOI 10.1021/pr100179f; Ralph SG, 2007, PHYTOCHEMISTRY, V68, P1975, DOI 10.1016/j.phytochem.2007.04.042; Herrero J, 2013, PLANT PHYSIOL BIOCH, V67, P77, DOI 10.1016/j.plaphy.2013.02.019; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Luo FL, 2011, ANN BOT-LONDON, V107, P49, DOI 10.1093/aob/mcq212; Sarkar RK, 2006, CURR SCI INDIA, V91, P899; Burlat V, 2001, PHYTOCHEMISTRY, V57, P883, DOI 10.1016/S0031-9422(01)00117-0; Navrot N, 2006, PLANT PHYSIOL, V142, P1364, DOI 10.1104/pp.106.089458; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Tsukuda S, 2006, PLANT MOL BIOL, V60, P125, DOI 10.1007/s11103-005-2941-4; Zhang Y, 2009, ANAL CHEM, V81, P6317, DOI 10.1021/ac9004887; Gibbs J, 2003, FUNCT PLANT BIOL, V30, P1, DOI 10.1071/PP98095; Ismail AM, 2009, ANN BOT-LONDON, V103, P197, DOI 10.1093/aob/mcn211; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Tewari RK, 2002, PLANT SCI, V162, P381, DOI 10.1016/S0168-9452(01)00578-7; Do CT, 2007, PLANTA, V226, P1117, DOI 10.1007/s00425-007-0558-3; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Sun L, 2007, B ENVIRON CONTAM TOX, V79, P514, DOI 10.1007/s00128-007-9274-8; Khatoon A, 2012, J PROTEOMICS, V75, P5706, DOI 10.1016/j.jprot.2012.07.031; Tanaka N, 2005, MOL CELL PROTEOMICS, V4, P796, DOI 10.1074/mcp.M400211-MCP200; Yu XQ, 2012, J PLANT PHYSIOL, V169, P1040, DOI 10.1016/j.jplph.2012.03.001; Salavati A, 2012, J PROTEOMICS, V75, P878, DOI 10.1016/j.jprot.2011.10.002; Nanjo Y, 2013, J PROTEOME RES, V12, P4785, DOI 10.1021/pr4002349; Kausar R, 2012, MOL BIOL REP, V39, P10573, DOI 10.1007/s11033-012-1945-9; BORS W, 1990, METHOD ENZYMOL, V186, P343; Justino GC, 2013, J PLANT PHYSIOL, V170, P235, DOI 10.1016/j.jplph.2012.10.006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Kim SG, 2010, PHYSIOL PLANTARUM, V138, P1, DOI 10.1111/j.1399-3054.2009.01290.x; Komatsu S, 2011, J PROTEOME RES, V10, P3993, DOI 10.1021/pr2001918; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Nanjo Y, 2012, J PROTEOME RES, V11, P372, DOI 10.1021/pr200701y; Armstrong W., 1979, Advances in Botanical Research, V7, P225; AXELROD B, 1981, METHOD ENZYMOL, V71, P441, DOI DOI 10.1016/0076-6879(81)71055-3; Jackson MB, 2005, ANN BOT-LONDON, V96, P501, DOI 10.1093/aob/mci205; Joshi C. P., 1998, PLANT MOL BIOL, V37, P5663; Junghans TG, 2004, PESQUI AGROPECU BRAS, V39, P625, DOI 10.1590/S0100-204X2004000700002; Komatsu S, 2012, J PROTEOME RES, V11, P68, DOI 10.1021/pr2008863; Komatsu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065301; Komatsu S., 2010, AMINO ACIDS, V39, P14335; Michalcova D, 2011, PLANT ECOL, V212, P879, DOI 10.1007/s11258-010-9871-1; Passardi F, 2004, PHYTOCHEMISTRY, V65, P1879, DOI 10.1016/j.phytochem.2004.06.023; Soares NC, 2009, J PROTEOME RES, V8, P2298, DOI 10.1021/pr8009353; Untergasser A., 2007, NUCLEIC ACIDS RES, V35, P71; Vizcaino J. A., 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI DOI 10.1093/NAR/GKS1262(PUBMED; Voit E. O., 2000, COMPUTATIONAL ANAL B	50	4	4	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	DEC	2014	13	12					5812	5828		10.1021/pr5007476		17	Biochemical Research Methods	Biochemistry & Molecular Biology	AW1GY	WOS:000346039400046		
J	Inoue, K; Tanada, C; Nishikawa, H; Matsuda, S; Tada, A; Ito, Y; Min, JZ; Todoroki, K; Sugimoto, N; Toyo'oka, T; Akiyama, H				Inoue, Koichi; Tanada, Chihiro; Nishikawa, Hiroaki; Matsuda, Satoru; Tada, Atsuko; Ito, Yusai; Min, Jun Zhe; Todoroki, Kenichiro; Sugimoto, Naoki; Toyo'oka, Toshimasa; Akiyama, Hiroshi			Evaluation of gardenia yellow using crocetin from alkaline hydrolysis based on ultra high performance liquid chromatography and high-speed countercurrent chromatography	JOURNAL OF SEPARATION SCIENCE			English	Article						Crocetin; Gardenia Yellow; High-speed countercurrent chromatography	PREPARATIVE SEPARATION; JASMINOIDES ELLIS; GENIPOSIDE; PURIFICATION; SAFFRON; FRUITS; EXTRACTION; CROCIN; CANCER	Gardenia yellow is globally the most valuable spice and food color. It is generally a mixture of water-soluble carotenoid glycosyl esters which consist of crocetin bis(gentiobiosyl) ester as the main component. Crocetin is a natural carotenoid dicarboxylic acid that may be a candidate drug for pharmaceutical development, however, it is either present in trace amounts or is absent in natural gardenia yellow products. We here propose that crocetin produced by alkaline hydrolysis can be used to qualitatively evaluate gardenia yellow products using an ultra high performance liquid chromatographic assay. A useful and efficient isolation technique for isolating high-purity crocetin from gardenia yellow using high-speed countercurrent chromatography is described. High-speed countercurrent chromatographic fractionation followed by an ultra high performance liquid chromatographic assay showed that trans-crocetin is easily converted to about 15% cis-crocetin (85% trans-crocetin). Crocetin in gardenia yellow was quantitatively evaluated. Our approach is based on the hydrolysis process for converting crocetin glycosyl esters to crocetin before evaluation and isolation using the ultra high performance liquid chromatographic and high-speed countercurrent chromatographic methods. The combination of hydrolysis and chromatographic methods allows evaluation of the purity and quantity of crocetin in gardenia yellow.	[Inoue, Koichi; Tanada, Chihiro; Nishikawa, Hiroaki; Min, Jun Zhe; Todoroki, Kenichiro; Sugimoto, Naoki; Toyo'oka, Toshimasa] Univ Shizuoka, Sch Pharmaceut Sci, Lab Analyt & Bioanalyt Chem, Shizuoka 4228526, Japan; [Matsuda, Satoru; Tada, Atsuko; Ito, Yusai; Akiyama, Hiroshi] Natl Inst Hlth Sci, Tokyo 1588501, Japan; [Ito, Yusai] Kyoritsu Womens Univ, Fac Home Econ, Dept Food Sci & Nutr, Tokyo, Japan	Akiyama, H (reprint author), Natl Inst Hlth Sci, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	akiyama@nihs.go.jp	Todoroki, Kenichiro/D-6152-2011		Ministry of Health, Labour and Welfare of Japan; Japan Food Chemical Research Foundation	We are grateful to San-Ei Gen F.F.I. and RIKEN VITAMIN for providing us with gardenia yellow colorant products. This work was supported by Grant-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare of Japan and by a Grant from the Japan Food Chemical Research Foundation.	Ahn JH, 2011, BIOCHEM BIOPH RES CO, V414, P79, DOI 10.1016/j.bbrc.2011.09.025; Chen JF, 2012, J CHROMATOGR B, V893, P43, DOI 10.1016/j.jchromb.2012.02.032; Skalicka-Wozniak K, 2013, J SEP SCI, V36, P2611, DOI 10.1002/jssc.201300407; Chryssanthi DG, 2011, J PHARMACEUT BIOMED, V55, P563, DOI 10.1016/j.jpba.2011.02.018; Alavizadeh SH, 2014, FOOD CHEM TOXICOL, V64, P65, DOI 10.1016/j.fct.2013.11.016; Fang L, 2011, J SEP SCI, V34, P2545, DOI 10.1002/jssc.201000857; Carmona M, 2006, J AGR FOOD CHEM, V54, P973, DOI 10.1021/jf052297w; Zhang M, 2007, J CHROMATOGR B, V858, P220, DOI 10.1016/j.jchromb.2007.08.041; Hou YC, 2008, FOOD CHEM TOXICOL, V46, P2764, DOI 10.1016/j.fct.2008.04.033; Ozaki A, 2002, FOOD CHEM TOXICOL, V40, P1603, DOI 10.1016/S0278-6915(02)00118-7; Mohajeri SA, 2010, J SEP SCI, V33, P2302, DOI 10.1002/jssc.201000183; Zhou TT, 2005, J CHROMATOGR A, V1100, P76, DOI 10.1016/j.chroma.2005.09.026; Chen P, 2013, J SEP SCI, V36, P3660, DOI 10.1002/jssc.201300917; Gutheil WG, 2012, CURR PHARM BIOTECHNO, V13, P173; Li CY, 2012, ASIAN PAC J CANCER P, V13, P3757, DOI 10.7314/APJCP.2012.13.8.3757; Chen Y, 2010, FITOTERAPIA, V81, P269, DOI 10.1016/j.fitote.2009.09.011; Feng JY, 2014, J SEP SCI, V37, P314, DOI 10.1002/jssc.201300601; Kim CY, 2007, PHYTOCHEM ANALYSIS, V18, P115, DOI 10.1002/pca.958; Kong Y, 2014, CNS NEUROL DISORD-DR, V13, P1627; Lech K, 2009, J MASS SPECTROM, V44, P1661, DOI 10.1002/jms.1631; Costa FD, 2010, J SEP SCI, V33, P336, DOI 10.1002/jssc.200900632; Mohammadpour AH, 2013, IRAN J BASIC MED SCI, V16, P47; Oka H., 1995, ACS SYM SER, P92; Pan IH, 2002, J CHROMATOGR A, V977, P239, DOI 10.1016/S0021-9673(02)01385-7; Sun YS, 2014, J SEP SCI, V37, P1703, DOI 10.1002/jssc.201400153; The Ministry of Health Labour and Welfare of Japan, 2010, JAP SPEC STAND FOOD, pD479	26	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1615-9306	1615-9314		J SEP SCI	J. Sep. Sci.	DEC	2014	37	24					3619	3624		10.1002/jssc.201400793		6	Chemistry, Analytical	Chemistry	AW1NN	WOS:000346056200004		
J	Hasmady, S; Fushinobu, K				Hasmady, Saiful; Fushinobu, Kazuyoshi			Inclusion of surface heterogeneity in bridging PEM fuel cell electrode contamination kinetics and transport via a competitive Langmuir-Freundlich isotherm	JOURNAL OF SOLID STATE ELECTROCHEMISTRY			English	Article						Fuel cell; Electrochemical transport; Adsorption and desorption; Computational methods; CO contamination; Langmuir-Freundlich isotherm	HYDROGEN OXIDATION REACTION; GAS-DIFFUSION LAYER; CARBON-MONOXIDE; ELECTROCHEMICAL OXIDATION; WATER TRANSPORT; MODEL; CO; PLATINUM; CATHODE; REFORMATE	This paper reports the development of mathematical model that bridges PEMFC transport phenomena with surface reaction kinetics in rough and heterogeneous electrodes, in which specifically the anode is modeled under carbon monoxide contamination. The mathematical bridging is done by converting surface concentration of reactants and contaminant into surface coverage of relevant adsorbates using the Langmuir-Freundlich isotherm to statistically include heterogeneity in binding site energetics. Thermodynamically optimized kinetic rate and equilibrium constants are calculated using coverage-dependent activation energies and provided as input to the HOR, ORR, and a kinetic-based limiting current model developed to solve for the distribution of activation overpotential. A novel model for a closed-form calculation of activation overpotential is proposed to allow numerical investigation via a galvanostatic approach. The kinetic reaction models are highly coupled with three-dimensional transport equations and solved iteratively under single-phase and steady-state conditions. Comparison is done with respect to two sets of available literature data in order to test the kinetic model validity under variation of CO concentrations and cell operating temperatures, in which good agreement is found. The results confirm that a Langmuir-Freundlich isotherm could be a more suitable isotherm compared to the extensively used Langmuir-specific isotherm for rough heterogeneous surfaces physically found in PEMFC catalysts. Results from the model show that rate of HOR is higher under the ribs of the cell since most of the active sites under channel are blocked with CO, with the effect exacerbated at lower temperatures.	[Hasmady, Saiful; Fushinobu, Kazuyoshi] Tokyo Inst Technol, Dept Mech & Control Engn, Meguro Ku, Tokyo 1528552, Japan	Hasmady, S (reprint author), Tokyo Inst Technol, Dept Mech & Control Engn, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	saiful.h.ab@m.titech.ac.jp			MEXT/JSPS	Part of this work was supported by the Grant-in-Aid for Scientific Research from MEXT/JSPS.	DEBECDELIEVRE AM, 1990, J ELECTROANAL CHEM, V294, P97, DOI 10.1016/0022-0728(90)87138-A; Springer TE, 2001, J ELECTROCHEM SOC, V148, pA11, DOI 10.1149/1.1344516; Bhatia KK, 2004, ELECTROCHIM ACTA, V49, P2333, DOI 10.1016/j.electacta.2004.01.014; Umpleby RJ, 2001, ANAL CHEM, V73, P4584, DOI 10.1021/ac0105686; Lum KW, 2005, J POWER SOURCES, V143, P103, DOI 10.1016/j.jpowsour.2004.11.032; Baschuk JJ, 2003, INT J ENERG RES, V27, P1095, DOI 10.1002/er.934; Weber AZ, 2004, CHEM REV, V104, P4679, DOI 10.1021/cr020729l; Nguyen PT, 2004, J POWER SOURCES, V130, P149, DOI 10.1016/j.jpowsour.2003.12.027; SIPS R, 1948, J CHEM PHYS, V16, P490, DOI 10.1063/1.1746922; Nitta I, 2007, J POWER SOURCES, V171, P26, DOI 10.1016/j.jpowsour.2006.11.018; Balasubramanian S, 2011, ELECTROCHIM ACTA, V58, P723, DOI 10.1016/j.electacta.2011.10.020; Oetjen HF, 1996, J ELECTROCHEM SOC, V143, P3838, DOI 10.1149/1.1837305; Lee SJ, 1999, ELECTROCHIM ACTA, V44, P3283, DOI 10.1016/S0013-4686(99)00052-3; Wang CY, 2004, CHEM REV, V104, P4727, DOI 10.1021/cr020718s; Siegel C, 2008, ENERGY, V33, P1331, DOI 10.1016/j.energy.2008.04.015; SPRINGER TE, 1991, J ELECTROCHEM SOC, V138, P2334, DOI 10.1149/1.2085971; Ralph TR, 2002, PLATIN MET REV, V46, P117; Hartnig C, 2002, J ELECTROANAL CHEM, V532, P165, DOI 10.1016/S0022-0728(02)00970-1; Gurau V, 1998, AICHE J, V44, P2410, DOI 10.1002/aic.690441109; Berning T, 2003, J ELECTROCHEM SOC, V150, pA1589, DOI 10.1149/1.1621412; GOTTESFELD S, 1988, J ELECTROCHEM SOC, V135, P2651, DOI 10.1149/1.2095401; Ju H, 2005, INT J HEAT MASS TRAN, V48, P1303, DOI 10.1016/j.ijheatmasstransfer.2004.10.004; Koper MTM, 1998, J CHEM PHYS, V109, P6051, DOI 10.1063/1.477230; Shah AA, 2011, ELECTROCHIM ACTA, V56, P3731, DOI 10.1016/j.electacta.2010.10.046; Zhdanov VP, 2006, ELECTROCHEM COMMUN, V8, P1132, DOI 10.1016/j.elecom.2006.05.003; Benziger J, 2011, AICHE J, V57, P2505, DOI 10.1002/aic.12455; Bird R.B., 2002, TRANSPORT PHENOMENA; Breiter MW, 2003, ELECTROCATALYSIS, V2; Camara GA, 2002, J ELECTROCHEM SOC, V149, pA748, DOI 10.1149/1.1473775; Franco AA, 2006, J ELECTROCHEM SOC, V153, pA1053, DOI 10.1149/1.2188353; Gasteiger H.A., 2003, FUEL CELLS, V3, P593; GILMAN S, 1964, J PHYS CHEM-US, V68, P70, DOI 10.1021/j100783a013; Gurau B, ELAT GAS DIFFUSION L; Hasmady S., 2009, THERMAL SCI ENG, V17, P147; Hauptmann W, 2011, APPL CATAL A-GEN, V397, P174, DOI 10.1016/j.apcata.2011.02.031; Hirschfielder JO, 1954, MOL THEORY GASES LIQ; Hwang JJ, 2006, J ELECTROCHEM SOC, V153, pA216, DOI 10.1149/1.2137652; Japan Society of Mechanical Engineers, 1986, JSME DAT BOOK HEAT T; Ju H, 2008, J MECH SCI TECHNOL, V22, P991, DOI 10.1007/s12206-008-0207-1; Kee R. J., 2003, CHEM REACTING FLOW T; Khajeh-Hosseini-Dalasm N, 2010, J ELECTROCHEM SOC, V157, pB1358, DOI 10.1149/1.3467794; LAMPINEN MJ, 1993, J ELECTROCHEM SOC, V140, P3537, DOI 10.1149/1.2221123; Li X., 2006, PRINCIPLES FUEL CELL, VTaylor and Francis; Markovic NM, 1999, J PHYS CHEM B, V103, P487, DOI 10.1021/jp983177c; Masuda M., 2003, THESIS TOKYO I TECHN; Mazumder S, 2003, J ELECTROCHEM SOC, V150, pA1503, DOI 10.1149/1.1615608; Pasaogullari U, 2007, J ELECTROCHEM SOC, V154, pB823, DOI 10.1149/1.2745714; Reid R., 1958, PROPERTIES GASES LIQ; Somorjai G. A., 2010, INTRO SURFACE CHEM C; Taylor R., 1993, MULTICOMPONENT MASS; Wei ZD, 2006, ELECTROCHIM ACTA, V51, P3091, DOI 10.1016/j.electacta.2005.08.048; Yi JS, 1999, J ELECTROCHEM SOC, V146, P38, DOI 10.1149/1.1391561; Zamel N, 2011, THESIS U WATERLOO ON; Zhou TH, 2004, J POWER SOURCES, V138, P101, DOI 10.1016/j.jpowsour.2004.06.033	54	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1432-8488	1433-0768		J SOLID STATE ELECTR	J. Solid State Electrochem.	DEC	2014	18	12			SI		3387	3405		10.1007/s10008-014-2521-0		19	Electrochemistry	Electrochemistry	AW3GH	WOS:000346173900018		
J	Van Hirtum, A; Fujiso, Y; Nozaki, K				Van Hirtum, Annemie; Fujiso, Yo; Nozaki, Kazunori			The role of initial flow conditions for sibilant fricative production (L)	JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA			English	Article								Sibilant fricative sound production depends on the geometric and flow properties of the production system. Nevertheless, few studies deal with the potential impact of flow properties other than the inlet volume flow rate on the noise produced. In this work, an experimental study is presented using a replica based on a reconstructed oral cavity for the phoneme /s/. Initial flow conditions upstream from the sibilant groove are altered by varying the method of air supply. Statistical moments of the initial velocity distribution are characterized using hot-film anemometry and related to spectral features of the radiated acoustic pressure. Discrepancies in the dynamic amplitude (<= 25%) and negative spectral slope (<= 35%) observed at a constant Reynolds number but different initial upstream flow conditions are of the same order of magnitude as those previously reported in humans. This suggests that consideration of the upstream flow conditions is important in the study of sibilant fricative sound production. (C) 2014 Acoustical Society of America.	[Van Hirtum, Annemie; Fujiso, Yo] Grenoble Univ, UMR CNRS 5216, GIPSA Lab, F-38402 Grenoble, France; [Nozaki, Kazunori] Osaka Univ, Dent Hosp, Suita, Osaka 5650871, Japan	Van Hirtum, A (reprint author), Grenoble Univ, UMR CNRS 5216, GIPSA Lab, 11 Rue Math BP46, F-38402 Grenoble, France.	annemie.vanhirtum@grenoble-inp.fr			JST-ANR grant [PETAFLOW ANR-09-BLAN-0376-01]; EU-FET grant [EUNISON 308874]	This research was partly supported by JST-ANR grant (PETAFLOW ANR-09-BLAN-0376-01) and by EU-FET grant (EUNISON 308874).	Van Hirtum A, 2012, APPL ACOUST, V73, P72, DOI 10.1016/j.apacoust.2011.06.014; Jesus LMT, 2002, J PHONETICS, V30, P437, DOI 10.1006/yjpho.2002.0169; Cisonni J., 2013, FLUID DYN RES, V45, P1; Grandchamp X., 2010, MEAS SCI TECHNOL, V21, P1; Howe MS, 2005, P ROY SOC A-MATH PHY, V461, P1005, DOI 10.1098/rspa.2004.1405; NARAYANAN SS, 1995, J ACOUST SOC AM, V98, P1325, DOI 10.1121/1.413469; Nozaki K., 2010, HIGH PERFORMANCE COM, P137, DOI 10.1007/978-3-642-11851-7_10; Nozaki K, 2012, J COMPUT SCI-NETH, V3, P298, DOI 10.1016/j.jocs.2011.06.004; Pope S.P., 2005, TURBULENT FLOWS; Shadle C., 1985, THESIS MIT CAMBRIDGE; Van Hirtum A, 2011, J ACOUST SOC AM, V130, P2128, DOI 10.1121/1.3631631	11	1	1	ACOUSTICAL SOC AMER AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0001-4966	1520-8524		J ACOUST SOC AM	J. Acoust. Soc. Am.	DEC	2014	136	6					2922	2925		10.1121/1.4900595		4	Acoustics; Audiology & Speech-Language Pathology	Acoustics; Audiology & Speech-Language Pathology	AW0IX	WOS:000345976500008		
J	Sommer, DE; Tokuda, IT; Peterson, SD; Sakakibara, KI; Imagawa, H; Yamauchi, A; Nito, T; Yamasoba, T; Tayama, N				Sommer, David E.; Tokuda, Isao T.; Peterson, Sean D.; Sakakibara, Ken-Ichi; Imagawa, Hiroshi; Yamauchi, Akihito; Nito, Takaharu; Yamasoba, Tatsuya; Tayama, Niro			Estimation of inferior-superior vocal fold kinematics from high-speed stereo endoscopic data in vivo	JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA			English	Article							MEDIAL SURFACE DYNAMICS; VIBRATION; PHONATION; WAVE	Despite being an indispensable tool for both researchers and clinicians, traditional endoscopic imaging of the human vocal folds is limited in that it cannot capture their inferior-superior motion. A three-dimensional reconstruction technique using high-speed video imaging of the vocal folds in stereo is explored in an effort to estimate the inferior-superior motion of the medial-most edge of the vocal folds under normal muscle activation in vivo. Traditional stereo-matching algorithms from the field of computer vision are considered and modified to suit the specific challenges of the in vivo application. Inferior-superior motion of the medial vocal fold surface of three healthy speakers is reconstructed over one glottal cycle. The inferior-superior amplitude of the mucosal wave is found to be approximately 13 mm for normal modal voice, reducing to approximately 3 mm for strained falsetto voice, with uncertainty estimated at sigma approximate to 2 mm and sigma approximate to 1 mm, respectively. Sources of error, and their relative effects on the estimation of the inferior-superior motion, are considered and recommendations are made to improve the technique. (C) 2014 Acoustical Society of America.	[Sommer, David E.; Peterson, Sean D.] Univ Waterloo, Dept Mech & Mechatron Engn, Waterloo, ON N2L 3G1, Canada; [Tokuda, Isao T.] Ritsumeikan Univ, Dept Mech Engn, Kusatsu, Shiga 5258577, Japan; [Sakakibara, Ken-Ichi] Hlth Sci Univ Hokkaido, Dept Commun Disorders, Sapporo, Hokkaido 0028072, Japan; [Imagawa, Hiroshi; Yamauchi, Akihito; Nito, Takaharu; Yamasoba, Tatsuya] Tokyo Univ Hosp, Dept Otolaryngol, Tokyo 1138655, Japan; [Tayama, Niro] Natl Ctr Global Hlth & Med Hosp, Dept Otolaryngol Head & Neck Surg, Tokyo 1628655, Japan	Tokuda, IT (reprint author), Ritsumeikan Univ, Dept Mech Engn, 1-1-1 Nojihigashi, Kusatsu, Shiga 5258577, Japan.	isao@fc.ritsumei.ac.jp			CGS-MSFSS exchange program of the Canadian Natural Sciences and Engineering Research Council (NSERC); Japan Society for the Promotion of Science (JSPS) [25540074, 23300071, 25861530]	This work was partially supported by the CGS-MSFSS exchange program of the Canadian Natural Sciences and Engineering Research Council (NSERC) and Grant-in-Aid for Scientific Research (No. 25540074, No. 23300071, No. 25861530) from Japan Society for the Promotion of Science (JSPS).	Adachi S, 2005, J ACOUST SOC AM, V117, P3213, DOI 10.1121/1.1861592; KANADE T, 1994, IEEE T PATTERN ANAL, V16, P920, DOI 10.1109/34.310690; Yu LF, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3268442; Mittal R, 2013, ANNU REV FLUID MECH, V45, P437, DOI 10.1146/annurev-fluid-011212-140636; Thomson SL, 2005, J ACOUST SOC AM, V118, P1689, DOI 10.1121/1.2000787; Tang SS, 2013, J ACOUST SOC AM, V134, P528, DOI 10.1121/1.4807652; Luegmair G, 2010, IEEE T MED IMAGING, V29, P1979, DOI 10.1109/TMI.2010.2055578; George NA, 2008, PHYS MED BIOL, V53, P2667, DOI 10.1088/0031-9155/53/10/015; Doellinger M, 2006, J VOICE, V20, P401, DOI 10.1016/j.jvoice.2005.08.003; Svec JG, 1996, J VOICE, V10, P201, DOI 10.1016/S0892-1997(96)80047-6; Dollinger M, 2005, J ACOUST SOC AM, V117, P3174, DOI 10.1121/1.1871772; Wurzbacher T, 2008, MED IMAGE ANAL, V12, P300, DOI 10.1016/j.media.2007.12.007; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; FUJIMURA O, 1979, J ACOUST SOC AM, V65, P478, DOI 10.1121/1.382347; Boessenecker A, 2007, ACTA ACUST UNITED AC, V93, P815; BAER T, 1983, J ACOUST SOC AM, V73, P1304, DOI 10.1121/1.389279; Ballard D. H., 1982, COMPUTER VISION, P1; Berry DA, 2001, J ACOUST SOC AM, V110, P2539, DOI 10.1121/1.1408947; Bless D M, 1987, Ear Nose Throat J, V66, P289; Chan A, 2013, J ACOUST SOC AM, V133, P1667, DOI 10.1121/1.4789937; Chang EW, 2011, SCI REP-UK, V1, DOI 10.1038/srep00048; Henrich N, 2005, J ACOUST SOC AM, V117, P1417, DOI 10.1121/1.1850031; Hirano M, 1993, VIDEOSTROBOSCOPIC EX; HIROSE H, 1988, ACTA OTO-LARYNGOL, P151; HOLLIEN H., 1974, J PHONETICS, V2, P125; Joint Committee for Guides in Metrology, 2008, EV MEAS DAT GUID EXP, V100; Larsson Hans, 2004, Logoped Phoniatr Vocol, V29, P154, DOI 10.1080/14015430410024353; Levine M., 1973, COMPUT GRAPH IMAGE P, V2, P131, DOI 10.1016/0146-664X(73)90024-5; MILLER RL, 1959, J ACOUST SOC AM, V31, P667, DOI 10.1121/1.1907771; Saito S., 1985, VOCAL FOLD PHYSL, P169; Sawashima M., 1983, VOCAL FOLD PHYSL, P264; Sawashima M., 1974, ANN B RES I LOG PHON, V8, P7; Schuster M, 2005, EUR ARCH OTO-RHINO-L, V262, P477, DOI 10.1007/s00405-004-0862-5; Szeliski R, 2011, TEXTS COMPUT SCI, P181, DOI 10.1007/978-1-84882-935-0_4; Titze I. R., 2006, MYOELASTIC AERODYNAM; TITZE IR, 1988, J ACOUST SOC AM, V83, P1536, DOI 10.1121/1.395910; Tokuda I. T., 2013, ACOUST SCI TECH, V34, P374; WENDLER J, 1992, J VOICE, V6, P149, DOI 10.1016/S0892-1997(05)80129-8	38	1	1	ACOUSTICAL SOC AMER AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0001-4966	1520-8524		J ACOUST SOC AM	J. Acoust. Soc. Am.	DEC	2014	136	6					3290	3300		10.1121/1.4900572		11	Acoustics; Audiology & Speech-Language Pathology	Acoustics; Audiology & Speech-Language Pathology	AW0IX	WOS:000345976500042		
J	Li, JF; Xia, RS; Ying, DW; Yan, YH; Akagi, M				Li, Junfeng; Xia, Risheng; Ying, Dongwen; Yan, Yonghong; Akagi, Masato			Investigation of objective measures for intelligibility prediction of noise-reduced speech for Chinese, Japanese, and English	JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA			English	Article							REDUCTION ALGORITHMS; ENHANCEMENT; RECOGNITION; QUALITY; INDEX; CUES; AUDITORIA; ENVELOPE	Many objective measures have been reported to predict speech intelligibility in noise, most of which were designed and evaluated with English speech corpora. Given the different perceptual cues used by native listeners of different languages, examining whether there is any language effect when the same objective measure is used to predict speech intelligibility in different languages is of great interest, particularly when non-linear noise-reduction processing is involved. In the present study, an extensive evaluation is taken of objective measures for speech intelligibility prediction of noisy speech processed by noise-reduction algorithms in Chinese, Japanese, and English. Of all the objective measures tested, the short-time objective intelligibility (STOI) measure produced the most accurate results in speech intelligibility prediction for Chinese, while the normalized covariance metric (NCM) and middle-level coherence speech intelligibility index (CSIIm) incorporating the signal-dependent band-importance functions (BIFs) produced the most accurate results for Japanese and English, respectively. The objective measures that performed best in predicting the effect of non-linear noise-reduction processing in speech intelligibility were found to be the BIF-modified NCM measure for Chinese, the STOI measure for Japanese, and the BIF-modified CSIIm measure for English. Most of the objective measures examined performed differently even under the same conditions for different languages. (C) 2014 Acoustical Society of America.	[Li, Junfeng; Xia, Risheng; Ying, Dongwen; Yan, Yonghong] Chinese Acad Sci, Inst Acoust, Beijing 100190, Peoples R China; [Akagi, Masato] Japan Adv Inst Sci & Technol, Sch Informat Sci, Nomi, Ishikawa 9231292, Japan	Li, JF (reprint author), Chinese Acad Sci, Inst Acoust, Beijing 100190, Peoples R China.	junfeng.li.1979@gmail.com			National 973 Program [2013CB329302]; National Natural Science Foundation of China [11461141004]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA06030100, XDA06030500]; National 863 Program [2012AA012503]	The authors thank Professor Y. Hu and Professor P. C. Loizou for their valuable discussions on this research and sharing the subjective intelligibility evaluation data for English. This work was partially supported by the National 973 Program (Grant No. 2013CB329302), the National Natural Science Foundation of China (Grant No. 11461141004), the Strategic Priority Research Program of the Chinese Academy of Sciences (Grant Nos. XDA06030100, XDA06030500), and the National 863 Program (Grant No. 2012AA012503).	Amano S, 2009, SPEECH COMMUN, V51, P76, DOI 10.1016/j.specom.2008.07.002; Hu Y, 2003, IEEE T SPEECH AUDI P, V11, P334, DOI 10.1109/TSA.2003.814458; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Banziger T, 2005, SPEECH COMMUN, V46, P252, DOI 10.1016/j.specom.2005.02.016; FRENCH NR, 1947, J ACOUST SOC AM, V19, P90, DOI 10.1121/1.1916407; Ma JF, 2009, J ACOUST SOC AM, V125, P3387, DOI 10.1121/1.3097493; Goldsworthy RL, 2004, J ACOUST SOC AM, V116, P3679, DOI 10.1121/1.1804628; Fu QJ, 1998, J ACOUST SOC AM, V104, P505, DOI 10.1121/1.423251; HOUTGAST T, 1985, J ACOUST SOC AM, V77, P1069, DOI 10.1121/1.392224; Kates JM, 2005, J ACOUST SOC AM, V117, P2224, DOI 10.1121/1.1862575; Cohen I, 2001, SIGNAL PROCESS, V81, P2403, DOI 10.1016/S0165-1684(01)00128-1; HOUTGAST T, 1984, ACUSTICA, V54, P185; Liu WM, 2006, INT CONF ACOUST SPEE, P1225; Brown CA, 2010, HEARING RES, V266, P52, DOI 10.1016/j.heares.2009.08.011; STEENEKEN HJM, 1980, J ACOUST SOC AM, V67, P318, DOI 10.1121/1.384464; Scalart P, 1996, INT CONF ACOUST SPEE, P629, DOI 10.1109/ICASSP.1996.543199; KRYTER KD, 1962, J ACOUST SOC AM, V34, P1698, DOI 10.1121/1.1909096; ANSI, 1997, METH CALC SPEECH INT; Arai T, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P2490, DOI 10.1109/ICSLP.1996.607318; Arehart KH, 2007, J ACOUST SOC AM, V122, P1150, DOI 10.1121/1.2754061; Boldt J., 2009, EUR SIGN PROC C, P1849; Chen F, 2012, J ACOUST SOC AM, V131, P4104, DOI 10.1121/1.3695401; DRULLMAN R, 1995, J ACOUST SOC AM, V97, P585, DOI 10.1121/1.413112; EPHRAIM Y, 1985, IEEE T ACOUST SPEECH, V33, P443, DOI 10.1109/TASSP.1985.1164550; FURUI S, 1986, J ACOUST SOC AM, V80, P1016, DOI 10.1121/1.393842; Havelock D., 2009, HDB SIGNAL PROCESS 2, P197; Hisch H., 2000, ISCA TUT RES WORKSH, P29; Hollube I., 1996, J ACOUST SOC AM, V100, P1703; Hu Y, 2007, J ACOUST SOC AM, V122, P1777, DOI 10.1121/1.2766778; IEEE, 1969, IEEE T AUDIO ELECTRO, V17, P225, DOI DOI 10.1109/TAU.1969.1162058; Kamath S, 2002, INT CONF ACOUST SPEE, P4164; Li JF, 2011, J ACOUST SOC AM, V129, P3291, DOI 10.1121/1.3571422; Liu C, 2014, J ACOUST SOC AM, V135, P428, DOI 10.1121/1.4837255; Loizou P, 2007, SPEECH ENHANCEMENT T; Luo X, 2006, J ACOUST SOC AM, V120, P2260, DOI 10.1121/1.2336990; Ma D., 2004, ACOUSTIC MANUAL; Taal CH, 2011, IEEE T AUDIO SPEECH, V19, P2125, DOI 10.1109/TASL.2011.2114881; Trask R, 1998, KEY CONCEPTS LANGUAG, P15; Wang D. L., 2006, COMPUTATIONAL AUDITO; Yamada T, 2006, INTERSPEECH 2006 AND 9TH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, VOLS 1-5, P169	40	0	0	ACOUSTICAL SOC AMER AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0001-4966	1520-8524		J ACOUST SOC AM	J. Acoust. Soc. Am.	DEC	2014	136	6					3301	3312		10.1121/1.4901079		12	Acoustics; Audiology & Speech-Language Pathology	Acoustics; Audiology & Speech-Language Pathology	AW0IX	WOS:000345976500043		
J	Fujioka, E; Aihara, I; Watanabe, S; Sumiya, M; Hiryu, S; Simmons, JA; Riquimaroux, H; Watanabe, Y				Fujioka, Emyo; Aihara, Ikkyu; Watanabe, Shotaro; Sumiya, Miwa; Hiryu, Shizuko; Simmons, James A.; Riquimaroux, Hiroshi; Watanabe, Yoshiaki			Rapid shifts of sonar attention by Pipistrellus abramus during natural hunting for multiple prey	JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA			English	Article							BIG BROWN BATS; ECHOLOCATING BATS; TELEMETRY MICROPHONE; EPTESICUS-FUSCUS; FLIGHT; STRATEGY; BEHAVIOR; CAPTURE; SIGNALS; SYSTEM	Flight paths of echolocating Japanese house bats, Pipistrellus abramus, were tracked during insect hunting in a natural setting using a 32-microphone array. The array surrounded the foraging area, locating each bat, and determined the directional aim of the sonar beam. Successive interceptions, indicated by feeding "buzzes" and post-buzz pauses, occurred singly at intervals from over 20 s down to multiple interceptions at 2-3 s intervals. Bats flew on looping, curved paths. Turning radius tightened as rate of interceptions increased, keeping the bat in a smaller area of higher capture density. Broadcast beams shifted direction during search, often alternating between the direction of flight and another direction where, moments later, the next interception would occur. Broadcasts also shifted direction between the current target and the next target. Bats time-share biosonar attention between objects by alternating acoustic gaze. During search, most interpulse intervals (IPIs) were 70-120 ms, but bats interspersed long IPIs up to 200 ms when the rate of interception was low and flight paths followed broad curves. Mathematical modeling of search paths demonstrated that circular flight-paths with occasional long IPIs would be more effective for target search than either random, correlated random, or linear flights. (C) 2014 Acoustical Society of America.	[Fujioka, Emyo; Watanabe, Shotaro; Sumiya, Miwa] Doshisha Univ, Fac Life & Med Sci, Kyoto 6100321, Japan; [Aihara, Ikkyu] RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; [Hiryu, Shizuko; Riquimaroux, Hiroshi; Watanabe, Yoshiaki] Doshisha Univ, Bionav Res Ctr, Fac Life & Med Sci, Kyoto 6100321, Japan; [Simmons, James A.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Simmons, JA (reprint author), Doshisha Univ, Neurosensing & Bionav Res Ctr, 1-3 Tatara Miyakotani Kyotanabe, Kyoto 6100321, Japan.	james_simmons@brown.edu			Japan Society for the Promotion of Science (JSPS) [20200055, 21760318]; U.S. Office of Naval Research [N00014-07-1-0858, N00014-09-1-0691]; U.S. National Science Foundation [IOS 0843522]; RIKEN's Special Postdoctoral Researcher Program; Aihara Project; FIRST program from JSPS; Council for Science and Technology Policy	Our research was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (Grant No. 20200055), a Grant-in-Aid for Young Scientists (B) (Grant No. 21760318) of Japan Society for the Promotion of Science (JSPS), U.S. Office of Naval Research Grant Nos. N00014-07-1-0858 and N00014-09-1-0691, and U.S. National Science Foundation Grant No. IOS 0843522, RIKEN's Special Postdoctoral Researcher Program, and Aihara Project, the FIRST program from JSPS, initiated by Council for Science and Technology Policy. We thank A. M. Simmons for extensive editorial contributions on the manuscript.	Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; SCHNITZLER HU, 1987, J COMP PHYSIOL A, V161, P267, DOI 10.1007/BF00615246; Simmons JA, 2005, ACOUST RES LETT ONL, V6, P238, DOI 10.1121/1.1985957; Yovel Y, 2010, SCIENCE, V327, P701, DOI 10.1126/science.1183310; Fujioka E, 2011, J ACOUST SOC AM, V129, P1081, DOI 10.1121/1.3523300; Jensen ME, 1999, BEHAV ECOL SOCIOBIOL, V47, P60, DOI 10.1007/s002650050650; Hiryu S, 2007, J ACOUST SOC AM, V121, P1749, DOI 10.1121/1.2431337; Blumstein DT, 2011, J APPL ECOL, V48, P758, DOI 10.1111/j.1365-2664.2011.01993.x; Au WWL, 2003, J ACOUST SOC AM, V113, P598, DOI 10.1121/1.1518980; Ghose K, 2003, J ACOUST SOC AM, V114, P1120, DOI 10.1121/1.1589754; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; LAWRENCE BD, 1982, J ACOUST SOC AM, V71, P585, DOI 10.1121/1.387529; KALKO EKV, 1995, ANIM BEHAV, V50, P861, DOI 10.1016/0003-3472(95)80090-5; Conradt L, 2003, AM NAT, V161, P905, DOI 10.1086/375298; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Matsuta N, 2013, J EXP BIOL, V216, P1210, DOI 10.1242/jeb.081398; Ghose K, 2006, J NEUROSCI, V26, P1704, DOI 10.1523/JNEUROSCI.4315-05.2006; Hiryu S, 2005, J ACOUST SOC AM, V118, P3927, DOI 10.1121/1.2130940; Surlykke A, 2009, J EXP BIOL, V212, P1011, DOI 10.1242/jeb.024620; Holderied MW, 2005, J EXP BIOL, V208, P1321, DOI 10.1242/jeb.01528; Holderied MW, 2003, P ROY SOC B-BIOL SCI, V270, P2293, DOI 10.1098/rspb.2003.2487; Britton ARC, 1999, J EXP BIOL, V202, P1793; Hirai Toshiaki, 2004, Japanese Journal of Ecology (Otsu), V54, P159; Hiryu S, 2008, J ACOUST SOC AM, V124, pEL51, DOI 10.1121/1.2947629; Ghose K, 2006, PLOS BIOL, V4, P865, DOI 10.1371/journal.pbio.0040108; KALKO EKV, 1993, BEHAV ECOL SOCIOBIOL, V33, P415; Surlykke A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002036	28	0	0	ACOUSTICAL SOC AMER AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0001-4966	1520-8524		J ACOUST SOC AM	J. Acoust. Soc. Am.	DEC	2014	136	6					3389	3400		10.1121/1.4898428		12	Acoustics; Audiology & Speech-Language Pathology	Acoustics; Audiology & Speech-Language Pathology	AW0IX	WOS:000345976500051		
J	You, Y; Ohtsuka, M; Miyake, H; Fukuyama, H				You, Yu; Ohtsuka, Makoto; Miyake, Hideto; Fukuyama, Hiroyuki			Growth of AlN Crystals on SiC Substrates by Thermal Nitridation of Al2O3	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							PHASE-EPITAXY; AIN; SAPPHIRE	The growth of AlN crystals on c-plane 6H-SiC substrates by thermal nitridation of Al2O3 pellets in the presence of graphite and ZrO2 was demonstrated. Addition of graphite and ZrO2 effectively accelerated the evaporation of Al2O3, yielding c-axis oriented AlN films on SiC substrates. The SiC substrate was severely deteriorated at 2173K, which produced a porous interface between the AlN film and substrate, resulting in low-quality AlN crystals. The deterioration of SiC was successfully suppressed by introducing a pre-deposited homo-buffer layer, allowing two-dimensional-like growth of AlN. The buffer layer promoted the formation of a high-quality AlN film. At 2173K, the full-width at half maximum of the X-ray rocking curves of the (0002) and (10-10) planes of the AlN film was 360 and 425arcsec, respectively.	[You, Yu; Ohtsuka, Makoto; Fukuyama, Hiroyuki] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Miyake, Hideto] Mie Univ, Dept Elect & Elect Engn, Tsu, Mie 5148507, Japan	Fukuyama, H (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	fukuyama@tagen.tohoku.ac.jp			Cabinet Office, Government of Japan	This research was funded by the Cabinet Office, Government of Japan, through its Funding Program for Next Generation World-Leading Researchers.	Adachi M, 2011, PHYS STATUS SOLIDI A, V208, P1494, DOI 10.1002/pssa.201001014; Herro ZG, 2010, J CRYST GROWTH, V312, P2519, DOI 10.1016/j.jcrysgro.2010.04.005; SLACK GA, 1977, J CRYST GROWTH, V42, P560, DOI 10.1016/0022-0248(77)90246-9; Chen Z, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988323; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; SLACK GA, 1976, J CRYST GROWTH, V34, P263, DOI 10.1016/0022-0248(76)90139-1; Eriguchi K, 2008, J CRYST GROWTH, V310, P4016, DOI 10.1016/j.jcrysgro.2008.06.033; Benaissa M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2399940; Dalmau R., 2010, SPRINGER HDB CRYSTAL, P821, DOI 10.1007/978-3-540-74761-1_24; Filip O, 2011, J CRYST GROWTH, V318, P427, DOI 10.1016/j.jcrysgro.2010.10.198; Hartmann C, 2012, J CRYST GROWTH, V344, P19, DOI 10.1016/j.jcrysgro.2012.01.045; Hironaka K, 2010, J CRYST GROWTH, V312, P2527, DOI 10.1016/j.jcrysgro.2010.04.007; Isobe H, 2005, JPN J APPL PHYS 2, V44, pL488, DOI 10.1143/JJAP.44.L488; Jaime Jr A. F., 2010, J PHYS D, V43; Nomura T, 2012, J CRYST GROWTH, V350, P69, DOI 10.1016/j.jcrysgro.2011.12.025; Tanaka Y, 2000, J CRYST GROWTH, V209, P410, DOI 10.1016/S0022-0248(99)00581-3; Yao ZQ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2948854; You Y, 2013, J AM CERAM SOC, V96, P3054, DOI 10.1111/jace.12545; You Y, 2013, J CRYST GROWTH, V365, P1, DOI 10.1016/j.jcrysgro.2012.12.034	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	DEC	2014	97	12					3781	3786		10.1111/jace.13183		6	Materials Science, Ceramics	Materials Science	AW2EA	WOS:000346099800013		
J	Hirano, M; Minagawa, K				Hirano, Masanori; Minagawa, Kosuke			Solid Solution Nanocrystals in the CeO2-Y3NbO7 System: Hydrothermal Formation and Control of Crystallite Growth of Ceria	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							CERIUM(IV) OXIDE POWDERS; RARE-EARTH NIOBATE; PHASE-STABILITY; PHOTOCATALYTIC ACTIVITY; MAGNETIC-PROPERTIES; THERMAL HYDROLYSIS; CEO2 NANORODS; FINE POWDERS; NANOPARTICLES; LUMINESCENCE	New solid solution nanocrystals with fluorite-type cubic structure in the ceria (CeO2)-yttrium niobate (1/4Y(3)NbO(7)) system were directly formed at 120 degrees C-240 degrees C from the precursor solution mixtures of (NH4)Ce(NO3)(6), YCl(3)6H(2)O, and NbCl5 under mild hydrothermal conditions in the presence of aqueous ammonia. The hydrothermal formation of cubic solid solution nanocrystals in the wide composition range of CeO2 (mol%) = 10-100 in the CeO2-1/4Y(3)NbO(7) system was effectively achieved via the assistance of the presence of CeO2 component more than 10mol% as a promoter with the same fluorite-type structure. The optical band gap of the solid solutions gradually decreased with increased CeO2 component. The high phase stability of the solid solutions in the CeO2-1/4Y(3)NbO(7) system was confirmed, i.e., the single cubic phase of the solid solutions was maintained after heat treatment at 600 degrees C-1500 degrees C for 1h in air. The presence of Y3NbO7 as an inhibitor and the substitutional incorporation of Y3NbO7 into the lattice, CeO2 effectively controlled the crystallite growth of CeO2, and nano-sized cubic solid solutions with high specific surface areas were maintained after heat treatment up to 800 degrees C-1000 degrees C for 1h air.	[Hirano, Masanori; Minagawa, Kosuke] Aichi Inst Technol, Fac Engn, Dept Appl Chem, Toyota 4700392, Japan	Hirano, M (reprint author), Aichi Inst Technol, Fac Engn, Dept Appl Chem, Toyota 4700392, Japan.	hirano@aitech.ac.jp					Hirano M, 2011, J AM CERAM SOC, V94, P3319, DOI 10.1111/j.1551-2916.2011.04598.x; CHEN PL, 1993, J AM CERAM SOC, V76, P1577, DOI 10.1111/j.1151-2916.1993.tb03942.x; Taniguchi T, 2011, CRYST GROWTH DES, V11, P3754, DOI 10.1021/cg101585b; Talapin DV, 2010, CHEM REV, V110, P389, DOI 10.1021/cr900137k; Steele BCH, 2000, SOLID STATE IONICS, V129, P95, DOI 10.1016/S0167-2738(99)00319-7; Downing E, 1996, SCIENCE, V273, P1185, DOI 10.1126/science.273.5279.1185; Byrappa K, 2007, PROG CRYST GROWTH CH, V53, P117, DOI 10.1016/j.pcrysgrow.2007.04.001; Purohit RD, 2001, MATER RES BULL, V36, P2711, DOI 10.1016/S0025-5408(01)00762-0; Yang SW, 2006, J AM CHEM SOC, V128, P9330, DOI 10.1021/ja063359h; Sun CW, 2005, NANOTECHNOLOGY, V16, P1454, DOI 10.1088/0957-4484/16/9/006; Christie GM, 1996, SOLID STATE IONICS, V83, P17, DOI 10.1016/0167-2738(95)00155-7; Abe R, 2006, J PHYS CHEM B, V110, P2219, DOI 10.1021/jp0552933; Rodriguez JA, 2003, J CHEM PHYS, V119, P5659, DOI 10.1063/1.1601595; Cushing BL, 2004, CHEM REV, V104, P3893, DOI 10.1021/cr030027b; Mogensen M, 2000, SOLID STATE IONICS, V129, P63, DOI 10.1016/S0167-2738(99)00318-5; Hirano M, 2013, J AM CERAM SOC, V96, P3389, DOI 10.1111/jace.12595; Hirano M, 2014, MATER CHEM PHYS, V143, P860, DOI 10.1016/j.matchemphys.2013.10.025; Hirano M, 2002, J AM CERAM SOC, V85, P1915; Liyanage AD, 2014, ACS CATAL, V4, P577, DOI 10.1021/cs400889y; Hirano M, 2000, J MATER CHEM, V10, P473, DOI 10.1039/a907510k; LUCHE JL, 1978, J AM CHEM SOC, V100, P2226, DOI 10.1021/ja00475a040; Yu TY, 2005, ANGEW CHEM INT EDIT, V44, P7411, DOI 10.1002/anie.200500992; Walasek A, 2007, OPT MATER, V30, P188, DOI 10.1016/j.optmat.2006.11.024; Wakeshima M, 2004, J PHYS-CONDENS MAT, V16, P4103, DOI [10.1088/0953-8984/16/23/025, 10.1088/0953-8984/16/213/025]; Hirano M, 1999, J AM CERAM SOC, V82, P786; Yabe S, 2003, J SOLID STATE CHEM, V171, P7, DOI 10.1016/S0022-4596(02)00139-1; ALLPRESS JG, 1979, J SOLID STATE CHEM, V27, P105, DOI 10.1016/0022-4596(79)90149-X; Coey JMD, 1999, ADV PHYS, V48, P167, DOI 10.1080/000187399243455; Xie AR, 2014, RSC ADV, V4, P11357, DOI 10.1039/c3ra46292g; Doi Y, 2009, J SOLID STATE CHEM, V182, P709, DOI 10.1016/j.jssc.2008.12.012; Norberg ST, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/21/215401; DAWSON WJ, 1988, AM CERAM SOC BULL, V67, P1673; Hirano M, 1996, J CERAM SOC JPN, V104, P958, DOI 10.2109/jcersj.104.958; Hirano M, 2003, J AM CERAM SOC, V86, P2209; Hirano M, 2001, J CERAM SOC JPN, V109, P401, DOI 10.2109/jcersj.109.1269_401; Hirano M, 2001, J AM CERAM SOC, V84, P1728; HIRANO M, 1991, NIPPON SERAM KYO GAK, V99, P23; HIRANO M, 1991, J AM CERAM SOC, V74, P606, DOI 10.1111/j.1151-2916.1991.tb04067.x; Hirano M, 2013, J AM CERAM SOC, V96, P3394, DOI 10.1111/jace.12593; Hirano M, 2004, J AM CERAM SOC, V87, P1567; KIRK TJ, 1993, J ELECTROCHEM SOC, V140, P3494, DOI 10.1149/1.2221117; Kovyazina SA, 2003, J STRUCT CHEM+, V44, P975, DOI 10.1023/B:JORY.0000034803.89136.ba; Kubelka P., 1931, Zeitschrift fur Technische Physik, V12; Lee E. Y., 2009, J KOREAN ELECTROCHEM, V12, P234; Lee JH, 1999, SOLID STATE IONICS, V124, P185, DOI 10.1016/S0167-2738(99)00144-7; Masui T, 2006, CATAL TODAY, V117, P187, DOI 10.1016/j.cattod.2006.05.015; Okubo T, 1997, J ALLOY COMPD, V256, P151, DOI 10.1016/S0925-8388(96)02986-6; Paranthaman M, 2005, J MATER RES, V20, P6, DOI 10.1557/JMR.2005.0011; Sugiura N., 2005, B CHEM SOC JPN, V78, P752; Suphantharida P, 2004, J ELECTROCHEM SOC, V151, pG658, DOI 10.1149/1.1785793; TSUKUMA K, 1985, J MATER SCI, V20, P1178, DOI 10.1007/BF01026311; YASHIMA M, 1994, J AM CERAM SOC, V77, P1067, DOI 10.1111/j.1151-2916.1994.tb07270.x	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	DEC	2014	97	12					3800	3806		10.1111/jace.13215		7	Materials Science, Ceramics	Materials Science	AW2EA	WOS:000346099800016		
J	Dong, YC; Hayashi, K; Nozoe, H; Shinoda, Y; Hosono, H				Dong, Yingchao; Hayashi, Katsuro; Nozoe, Hiroki; Shinoda, Yutaka; Hosono, Hideo			Chloride-Ion-Stabilized Strontium Mayenite: Expansion of Versatile Material Family	JOURNAL OF THE AMERICAN CERAMIC SOCIETY			English	Article							DOT 7AL(2)O(3) ELECTRIDE; LUMINESCENCE PROPERTIES; CRYSTAL-STRUCTURE; 12CAO-CENTER-DOT-7AL(2)O(3); SYSTEM; CONDUCTIVITY; 12CAO.7AL2O3; CA12AL14O33; SRO-AL2O3; ANIONS	Sr-mayenite (S(12)A(7)) incorporating Cl- ions in its crystallographic cages up to the theoretical maximum occupancy, Sr12Al14O32Cl2, is reported in our study. The addition of a stoichiometric amount of SrCl2 to the starting mixture is effective for the formation of Sr12Al14O32Cl2 with high phase purity. Almost 100% densification is achieved using spark plasma sintering (SPS). Evaporation of SrCl2 from Sr12Al14O32Cl2, which becomes significant at sintering temperatures above similar to 1300 degrees C, degrades the phase purity. However, SrCl2 effusion is significantly suppressed in the samples fully densified by SPS, impeding the decomposition of Sr12Al14O32Cl2 up to temperature as high as similar to 1400 degrees C. The crystal structure of Sr12Al14O32Cl2 was investigated by Rietveld analysis of the X-ray diffraction pattern. It is found that the Cl- ion is incorporated in the center of the inner cage with nearly theoretical maximum occupancy, which is responsible for the phase stability. Porous Sr12Al14O32Cl2 exhibits humidity-sensitive surface protonic conductivity. Dense Sr12Al14O32Cl2 prepared under reducing conditions such as SPS exhibits electronic conductivity. Sr-mayenite has various potential applications derived from its multifunctionalities.	[Dong, Yingchao; Hayashi, Katsuro; Nozoe, Hiroki; Shinoda, Yutaka; Hosono, Hideo] Tokyo Inst Technol, Ctr Secure Mat, Mat & Struct Lab, Yokohama, Kanagawa 2268503, Japan	Hayashi, K (reprint author), Kyushu Univ, Dept Appl Chem, West 3,744 Motooka, Fukuoka 8910395, Japan.	k.hayashi@cstf.kyushu-u.ac.jp	Hosono, Hideo/J-3489-2013; Dong, Yingchao/E-9151-2011; Shinoda, Yutaka/F-7502-2014	Hosono, Hideo/0000-0001-9260-6728; 	Elements Strategy Project; Elements Strategy Initiative Project; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Society for the Promotion of Science (JSPS)	This work was supported by a Grant-in-Aid from the Elements Strategy Project, and Elements Strategy Initiative Project to Form Core Research Center, the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. Y. D. and K. H. wish to thank the Japan Society for the Promotion of Science (JSPS) for financial support through a Postdoctoral Fellowship for Foreign Researchers.	Kim SW, 2012, PHILOS MAG, V92, P2596, DOI 10.1080/14786435.2012.685770; Munir ZA, 2006, J MATER SCI, V41, P763, DOI 10.1007/s10853-006-6555-2; Iwata T, 2008, J SOLID STATE CHEM, V181, P51, DOI 10.1016/j.jssc.2007.11.002; FENG QL, 1988, ACTA CRYSTALLOGR C, V44, P589, DOI 10.1107/S0108270187012046; Boysen H, 2007, ACTA CRYSTALLOGR B, V63, P675, DOI 10.1107/S0108768107030005; Hayashi K, 2008, CHEM MATER, V20, P5987, DOI 10.1021/cm800666p; Lee DK, 2009, PHYS CHEM CHEM PHYS, V11, P3105, DOI 10.1039/b818474g; Kitano M, 2012, NAT CHEM, V4, P934, DOI [10.1038/nchem.1476, 10.1038/NCHEM.1476]; Jiang ZQ, 2013, J ALLOY COMPD, V577, P683, DOI 10.1016/j.jallcom.2013.06.140; Bertoni MI, 2005, J APPL PHYS, V97, DOI 10.1063/1.1899246; Blois M. S., 1961, S FREE RAD BIOL SYST, P117; CHATTERJ.AK, 1972, J MATER SCI, V7, P93, DOI 10.1007/BF00549555; Chung JH, 2011, ELECTROCHEM SOLID ST, V14, pE41, DOI 10.1149/2.021112esl; Hayashi K, 2009, ELECTROCHEM SOLID ST, V12, pJ11, DOI 10.1149/1.3032908; Hayashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4515; Hayashi K, 2007, B CHEM SOC JPN, V80, P872, DOI 10.1246/bcsj.80.872; HENDERSON B, 1980, CRC CR REV SOL STATE, V9, P1, DOI 10.1080/10408438008243569; IRVINE JTS, 1990, SOLID STATE IONICS, V40-1, P896, DOI 10.1016/0167-2738(90)90147-J; Izumi F, 2000, MATER SCI FORUM, V321-3, P198; JEEVARATNAM J, 1964, J AM CERAM SOC, V47, P105, DOI 10.1111/j.1151-2916.1964.tb15669.x; Li CS, 2013, J RENEW SUSTAIN ENER, V5, DOI 10.1063/1.4811803; Li J, 2012, ELECTROCHEM COMMUN, V17, P52, DOI 10.1016/j.elecom.2012.01.024; Miyakawa M., 2007, J CERAM SOC JPN, V115, P568; Murphy DM, 1999, J PHYS CHEM B, V103, P1944, DOI 10.1021/jp984132e; Nomura T, 2007, CHEM LETT, V36, P902, DOI 10.1246/cl.2007.902; Palacios L, 2008, PHYS STATUS SOLIDI B, V245, P666, DOI 10.1002/pssb.200743425; Palacios L, 2008, INORG CHEM, V47, P2661, DOI 10.1021/ic7021193; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sushko PV, 2011, P ROY SOC A-MATH PHY, V467, P2066, DOI 10.1098/rspa.2010.0560; WILLIAMS PP, 1973, ACTA CRYSTALLOGR B, VB 29, P1550, DOI 10.1107/S0567740873004942; YAMAGUCHI O, 1986, J AM CERAM SOC, V69, pC36; Ye XY, 2007, J PHASE EQUILIB DIFF, V28, P362, DOI 10.1007/s11669-007-9086-x; Yoshizumi T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.015802	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7820	1551-2916		J AM CERAM SOC	J. Am. Ceram. Soc.	DEC	2014	97	12					4037	4044		10.1111/jace.13194		8	Materials Science, Ceramics	Materials Science	AW2EA	WOS:000346099800048		
J	Nakanishi, M; Shibuya, R; Ito, J; Niino, H				Nakanishi, Mikio; Shibuya, Ryosuke; Ito, Junshi; Niino, Hiroshi			Large-Eddy Simulation of a Residual Layer: Low-Level Jet, Convective Rolls, and Kelvin-Helmholtz Instability	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							ATMOSPHERIC BOUNDARY-LAYER; ORTHOGONAL FUNCTION-ANALYSIS; EVOLUTION; CASES-99	Diurnal variations of an atmospheric boundary layer from 0900 LST on day 33 to 0600 LST on day 34 of the Wangara experiment are studied using a large-eddy simulation (LES) model that includes longwave radiation and baroclinicity. The present study directs its particular attention to phenomena in a residual layer (RL). As the surface heat flux decreases, an inertial oscillation is initiated and is accompanied by a low-level jet (LLJ) at a height of approximately 200 m. The maximum wind speed of the LLJ exceeds 12 m s(-1) at 0300 LST on day 34. After 2100 EST on day 33, the horizontal advection due to the LLJ under a large-scale horizontal gradient of temperature destabilizes the RL and consequently induces horizontal convective rolls, parallel to a vertical wind shear (VWS) vector, between heights of 400 and 1400 m. The VWS in the layer between the bottom of the convective rolls and the gradually growing LLJ maximum is intensified after midnight, and the gradient Richardson number falls below its critical value of 0.25 at a height of 400 m at 0130 LST on day 34. An empirical orthogonal function analysis demonstrates that Kelvin-Helmholtz (KH) vortices appear below the convective rolls and are coupled with them. This study suggests that horizontal convective rolls can occur in an RL because an LLJ often advects warmer air to the lower layer according to a large-scale gradient of temperature and that the rolls may coexist with KH vortices in a stable boundary layer because the LLJ gradually increases a VVVS.	[Nakanishi, Mikio] Natl Def Acad, Yokosuka, Kanagawa 2398686, Japan; [Nakanishi, Mikio] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa, Japan; [Shibuya, Ryosuke] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo, Japan; [Ito, Junshi; Niino, Hiroshi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan	Nakanishi, M (reprint author), Natl Def Acad, Dept Earth & Ocean Sci, Yokosuka, Kanagawa 2398686, Japan.	naka@nda.ac.jp			MEXT of the Japanese Government; Strategic Programs for Innovative Research of the MEXT of the Japanese Government	The authors thank four anonymous reviewers and an editor for their valuable suggestions to improve the manuscript. This work was partly supported by Strategic Programs for Innovative Research of the MEXT of the Japanese Government. The computation was carried out using the computer facilities at JAMSTEC. A source program of our LES model is available online (at http://www.nda.ac.jp/similar to naka/LES/).	ANDRE JC, 1978, J ATMOS SCI, V35, P1861, DOI 10.1175/1520-0469(1978)035<1861:MTHEOT>2.0.CO;2; YAMADA T, 1975, J ATMOS SCI, V32, P2309, DOI 10.1175/1520-0469(1975)032<2309:ASOTWA>2.0.CO;2; Blumen W, 2001, DYNAM ATMOS OCEANS, V34, P189, DOI 10.1016/S0377-0265(01)00067-7; Weckwerth TM, 1997, MON WEATHER REV, V125, P505, DOI 10.1175/1520-0493(1997)125<0505:HCRDTE>2.0.CO;2; Sun JL, 2002, BOUND-LAY METEOROL, V105, P199, DOI 10.1023/A:1019969131774; Cuxart J, 2000, BOUND-LAY METEOROL, V96, P337, DOI 10.1023/A:1002609509707; Nakanishi M, 2000, BOUND-LAY METEOROL, V94, P461, DOI 10.1023/A:1002490423389; Ha KJ, 2003, TELLUS A, V55, P317, DOI 10.1034/j.1600-0870.2003.00031.x; SULLIVAN PP, 1994, BOUND-LAY METEOROL, V71, P247, DOI 10.1007/BF00713741; Van de Wiel BJH, 2010, J ATMOS SCI, V67, P2679, DOI 10.1175/2010JAS3289.1; Newsom RK, 2003, J ATMOS SCI, V60, P16, DOI 10.1175/1520-0469(2003)060<0016:SFIITS>2.0.CO;2; DAVIS PA, 1976, J ATMOS SCI, V33, P1287, DOI 10.1175/1520-0469(1976)033<1287:RPSIIT>2.0.CO;2; SCHMIDT H, 1989, J FLUID MECH, V200, P511, DOI 10.1017/S0022112089000753; Banta RM, 2006, J ATMOS SCI, V63, P2700, DOI 10.1175/JAS3776.1; Shibuya R, 2014, J ATMOS SCI, V71, P767, DOI 10.1175/JAS-D-13-0124.1; Baas P, 2009, J APPL METEOROL CLIM, V48, P1627, DOI 10.1175/2009JAMC1965.1; Poulos GS, 2002, B AM METEOROL SOC, V83, P555, DOI 10.1175/1520-0477(2002)083<0555:CACIOT>2.3.CO;2; Asai T., 1972, J METEOROL SOC JAP, V50, P525; Asai T., 1970, J METEOR SOC JAPAN, V48, P18; Basu S, 2008, J APPL METEOROL CLIM, V47, P1156, DOI 10.1175/2007JAMC1677.1; Blackadar A. K., 1957, B AM METEOROL SOC, V38, P283; CAUGHEY SJ, 1979, Q J ROY METEOR SOC, V105, P811, DOI 10.1002/qj.49710544606; Clarke R. H., 1971, 19 CSIRO DIV MET PHY; Deardorff J. W., 1974, Boundary-Layer Meteorology, V7; Dyer A. J., 1974, Boundary-Layer Meteorology, V7, DOI 10.1007/BF00240838; Garratt J. R., 1992, ATMOSPHERIC BOUNDARY; Hicks B. B, 1981, ARL104 NOAA ERL; HICKS BB, 1976, Q J ROY METEOR SOC, V102, P535, DOI 10.1002/qj.49710243304; Katayama A., 1972, 6 U CAL; KLAASSEN GP, 1985, J ATMOS SCI, V42, P1321, DOI 10.1175/1520-0469(1985)042<1321:EOFAKB>2.0.CO;2; Lilly D. K., 1966, APPL EDDY VISC UNPUB, V123; MAHRT L, 1979, BOUND-LAY METEOROL, V17, P247, DOI 10.1007/BF00117983; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.C0;2, 10.1175/1520-0493(1963)091&LT;0099:GCEWTP&GT;2.3.CO;2(1963)]; Sorbjan Z, 2004, BOUND-LAY METEOROL, V112, P57, DOI 10.1023/B:BOUN.0000020161.99887.b3; Stull R. B., 1988, INTRO BOUNDARY LAYER; Wilson DK, 1996, J ATMOS SCI, V53, P824; Wilson DK, 1996, J ATMOS SCI, V53, P801	37	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	DEC	2014	71	12					79	97		10.1175/JAS-D-13-0402.1		19	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AU9BF	WOS:000345886100006		
J	Khamrin, P; Thongprachum, A; Okitsu, S; Maneekarn, N; Hayakawa, S; Ushijima, H				Khamrin, Pattara; Thongprachum, Aksara; Okitsu, Shoko; Maneekarn, Niwat; Hayakawa, Satoshi; Ushijima, Hiroshi			Comparison of Three Rapid Tests for Detection of Norovirus in Stool Samples of Acute Gastroenteritis Pediatric Patients	JOURNAL OF TROPICAL PEDIATRICS			English	Letter							MULTIPLEX PCR; ENTEROVIRUSES; ASTROVIRUS; GII		[Khamrin, Pattara; Maneekarn, Niwat] Chiang Mai Univ, Fac Med, Dept Microbiol, Chiang Mai 50000, Thailand; [Khamrin, Pattara; Thongprachum, Aksara; Okitsu, Shoko; Ushijima, Hiroshi] Univ Tokyo, Grad Sch Med, Inst Int Hlth, Dept Dev Med Sci, Tokyo, Japan; [Khamrin, Pattara; Thongprachum, Aksara; Okitsu, Shoko; Hayakawa, Satoshi; Ushijima, Hiroshi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo 1738610, Japan	Ushijima, H (reprint author), Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol,Itabashi Ku, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan.	ushijima-hiroshi@jcom.home.ne.jp					Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Bitler EJ, 2013, EPIDEMIOL INFECT, V141, P1563, DOI 10.1017/S095026881300006X; Donaldson EF, 2008, IMMUNOL REV, V225, P190, DOI 10.1111/j.1600-065X.2008.00680.x; Khamrin P, 2010, J TROP PEDIATRICS, V56, P129, DOI 10.1093/tropej/fmp055; Khamrin P, 2011, J TROP PEDIATRICS, V57, P375, DOI 10.1093/tropej/fmq101; Khamrin P, 2010, J TROP PEDIATRICS, V56, P368, DOI 10.1093/tropej/fmp134; Pham NTK, 2010, J VIROL METHODS, V169, P193, DOI 10.1016/j.jviromet.2010.07.038; Yan Hainian, 2004, Kansenshogaku Zasshi, V78, P699	9	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	DEC	2014	60	6					481	483		10.1093/tropej/fmu046		4	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	AW1FN	WOS:000346035900015		
J	Sakurai, M; Kunimoto, H; Watanabe, N; Fukuchi, Y; Yuasa, S; Yamazaki, S; Nishimura, T; Sadahira, K; Fukuda, K; Okano, H; Nakauchi, H; Morita, Y; Matsumura, I; Kudo, K; Ito, E; Ebihara, Y; Tsuji, K; Harada, Y; Harada, H; Okamoto, S; Nakajima, H				Sakurai, M.; Kunimoto, H.; Watanabe, N.; Fukuchi, Y.; Yuasa, S.; Yamazaki, S.; Nishimura, T.; Sadahira, K.; Fukuda, K.; Okano, H.; Nakauchi, H.; Morita, Y.; Matsumura, I.; Kudo, K.; Ito, E.; Ebihara, Y.; Tsuji, K.; Harada, Y.; Harada, H.; Okamoto, S.; Nakajima, H.			Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients	LEUKEMIA			English	Article							HUMAN PRIMITIVE HEMATOPOIESIS; AML1/RUNX1 POINT MUTATIONS; ACUTE MYELOGENOUS LEUKEMIA; ACUTE MYELOID-LEUKEMIA; DEFINITIVE HEMATOPOIESIS; MYELODYSPLASTIC SYNDROME; IN-VITRO; MYELOMONOCYTIC LEUKEMIA; SOMATIC MUTATIONS; AML1 GENE	Somatic mutation of RUNX1 is implicated in various hematological malignancies, including myelodysplastic syndrome and acute myeloid leukemia (AML), and previous studies using mouse models disclosed its critical roles in hematopoiesis. However, the role of RUNX1 in human hematopoiesis has never been tested in experimental settings. Familial platelet disorder (FPD)/AML is an autosomal dominant disorder caused by germline mutation of RUNX1, marked by thrombocytopenia and propensity to acute leukemia. To investigate the physiological function of RUNX1 in human hematopoiesis and pathophysiology of FPD/AML, we derived induced pluripotent stem cells (iPSCs) from three distinct FPD/AML pedigrees (FPD-iPSCs) and examined their defects in hematopoietic differentiation. By in vitro differentiation assays, FPD-iPSCs were clearly defective in the emergence of hematopoietic progenitors and differentiation of megakaryocytes, and overexpression of wild-type (WT)-RUNX1 reversed most of these phenotypes. We further demonstrated that overexpression of mutant-RUNX1 in WT-iPSCs did not recapitulate the phenotype of FPD-iPSCs, showing that the mutations were of loss-of-function type. Taken together, this study demonstrated that haploinsufficient RUNX1 allele imposed cell-intrinsic defects on hematopoietic differentiation in human experimental settings and revealed differential impacts of RUNX1 dosage on human and murine megakaryopoiesis. FPD-iPSCs will be a useful tool to investigate mutant RUNX1-mediated molecular processes in hematopoiesis and leukemogenesis.	[Sakurai, M.; Kunimoto, H.; Fukuchi, Y.; Sadahira, K.; Okamoto, S.; Nakajima, H.] Keio Univ, Sch Med, Dept Internal Med, Div Hematol, Tokyo 1608582, Japan; [Watanabe, N.] Keio Univ, Sch Med, Dept Transfus Med & Cell Therapy, Tokyo 1608582, Japan; [Yuasa, S.; Fukuda, K.] Keio Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo 1608582, Japan; [Yamazaki, S.; Nakauchi, H.] Japan Sci & Technol Agcy, ERATO, Tokyo, Japan; [Nishimura, T.; Nakauchi, H.] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy, Tokyo, Japan; [Okano, H.] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Morita, Y.; Matsumura, I.] Keio Univ, Fac Med, Dept Internal Med, Div Hematol & Rheumatol, Tokyo 1608582, Japan; [Kudo, K.; Ito, E.] Hirosaki Univ, Grad Sch Med, Dept Pediat, Aomori, Japan; [Ebihara, Y.; Tsuji, K.] Univ Tokyo, Inst Med Sci, Dept Pediat Hematol Oncol, Tokyo, Japan; [Tsuji, K.] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Proc, Tokyo, Japan; [Harada, Y.; Harada, H.] Hiroshima Univ, Res Inst Radiat Biol & Med, Div Clin Res, Dept Hematol & Oncol, Hiroshima, Japan	Nakajima, H (reprint author), Keio Univ, Sch Med, Dept Internal Med, Div Hematol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hnakajim@z2.keio.jp	Okano, Hideyuki/J-5973-2013		Ministry of Education, Culture, Sports, Science and Technology of Japan	We thank excellent technical assistance by J Kawakita. We also thank S Suzuki (FACS Core Laboratory, Keio University School of Medicine) for FACS sorting, W Akamatsu and M Sato (Department of Physiology, Keio University School of Medicine) and H Nakata (Division of Cardiology, Keio University School of Medicine) for cell culture or establishment of iPSCs. This work was supported in part by a grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Harada H, 2003, BLOOD, V101, P673, DOI 10.1182/blood-2002-04-1010; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Kuo MC, 2009, LEUKEMIA, V23, P1426, DOI 10.1038/leu.2009.48; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Seki T, 2012, NAT PROTOC, V7, P718, DOI 10.1038/nprot.2012.015; Takayama N, 2008, BLOOD, V111, P5298, DOI 10.1182/blood-2007-10-117622; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Harada Y, 2009, J CELL PHYSIOL, V220, P16, DOI 10.1002/jcp.21769; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Zharlyganova D, 2008, J RADIAT RES, V49, P549, DOI 10.1269/jrr.08040; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Chang CJ, 2012, BLOOD, V120, P3906, DOI 10.1182/blood-2012-03-420703; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Kumano K, 2012, BLOOD, V119, P6234, DOI 10.1182/blood-2011-07-367441; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Jacob B, 2010, BLOOD, V115, P1610, DOI 10.1182/blood-2009-07-232249; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1172482; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Ran D, 2013, BLOOD, V121, P2882, DOI 10.1182/blood-2012-08-451641; Ernst T, 2010, HAEMATOL-HEMATOL J, V95, P1473, DOI 10.3324/haematol.2010.021808; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Matheny CJ, 2007, EMBO J, V26, P1163, DOI 10.1038/sj.emboj.7601568; Imai Y, 2000, BLOOD, V96, P3154; Chou ST, 2012, P NATL ACAD SCI USA, V109, P17573, DOI 10.1073/pnas.1211175109; Harada H, 2004, BLOOD, V103, P2316, DOI 10.1182/blood-2003-09-3074; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Ma F, 2008, P NATL ACAD SCI USA, V105, P13087, DOI 10.1073/pnas.0802220105; Carette JE, 2010, BLOOD, V115, P4039, DOI 10.1182/blood-2009-07-231845; North T, 1999, DEVELOPMENT, V126, P2563; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Michaud J, 2002, BLOOD, V99, P1364, DOI 10.1182/blood.V99.4.1364; Song WJ, 1999, NAT GENET, V23, P166; Nakajima H, 2010, BLOOD, V116, P4474, DOI 10.1182/blood-2010-01-266528; Motoda L, 2007, STEM CELLS, V25, P2976, DOI 10.1634/stemcells.2007; Dowdy CR, 2010, HUM MOL GENET, V19, P1048, DOI 10.1093/hmg/ddp568; Gandre-Babbe S, 2013, BLOOD, V121, P4925, DOI 10.1182/blood-2013-01-478412; MacLean GA, 2012, P NATL ACAD SCI USA, V109, P17567, DOI 10.1073/pnas.1215468109; Christiansen DH, 2004, BLOOD, V104, P1474, DOI 10.1182/blood-2004-02-0754; Fukuchi Y, 2006, EMBO J, V25, P3398, DOI 10.1038/sj.emboj.7601199; Hiramoto T, 2013, P NATL ACAD SCI USA, V110, P3023, DOI 10.1073/pnas.1217039110; Ma F, 2007, INT J HEMATOL, V85, P371, DOI 10.1532/IJH97.06203; Xu MJ, 1998, BLOOD, V92, P2032	45	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0887-6924	1476-5551		LEUKEMIA	Leukemia	DEC	2014	28	12					2344	2354		10.1038/leu.2014.136		11	Oncology; Hematology	Oncology; Hematology	AW3HP	WOS:000346177500011		
J	Dzik, W; Jarvinen, J; Kondo, M				Dzik, Wojciech; Jarvinen, Jouni; Kondo, Michiro			Characterizing intermediate tense logics in terms of Galois connections	LOGIC JOURNAL OF THE IGPL			English	Article						Galois connection; intuitionistic modal logic; intermediate tense logics; representation theorem	MODAL LOGIC; SEMANTICS; OPERATORS; LATTICES	We propose a uniform way of defining for every logic L intermediate between intuitionistic and classical logics, the corresponding intermediate tense logic LKt. This is done by building the fusion of two copies of intermediate logic with a Galois connection LGC, and then interlinking their operators by two Fischer Servi axioms. The resulting system is called L2GC+FS. In the cases of intuitionistic logic Int and classical logic Cl, it is noted that Int2GC+FS is syntactically equivalent to intuitionistic tense logic IKt by W. B. Ewald and Cl2GC+FS equals classical tense logic Kt. This justifies calling L2GC+FS the L-tense logic LKt for any intermediate logic L. We define H2GC+FS-algebras as expansions of HK1-algebras, introduced by E. Orlowska and I. Rewitzky. For each intermediate logic L, we show algebraic completeness of L2GC+FS and its conservativeness over L. We prove relational completeness of Int2GC+FS with respect to the models defined on IK-frames introduced by G. Fischer Servi. We also prove a representation theorem stating that every H2GC+FS-algebra can be embedded into the complex algebra of its canonical IK-frame.	[Dzik, Wojciech] Univ Silesia, Inst Math, PL-40007 Katowice, Poland; [Kondo, Michiro] Tokyo Denki Univ, Sch Informat Environm, Inzai 2701382, Japan	Dzik, W (reprint author), Univ Silesia, Inst Math, Ul Bankowa 12, PL-40007 Katowice, Poland.	wojciech.dzik@us.edu.pl; Jouni.Kalervo.Jarvinen@gmail.com; mkondo@mail.dendai.ac.jp					Alechina N., 2001, LECT NOTES COMPUTER, V2142, P292; EWALD WB, 1986, J SYMBOLIC LOGIC, V51, P166, DOI 10.2307/2273953; ERNE M, 1993, ANN NY ACAD SCI, V704, P103, DOI 10.1111/j.1749-6632.1993.tb52513.x; Belohlavek R, 1999, MATH LOGIC QUART, V45, P497, DOI 10.1002/malq.19990450408; Caicedo X, 2010, STUD LOGICA, V94, P189, DOI 10.1007/s11225-010-9230-1; Georgescu G, 2004, ARCH MATH LOGIC, V43, P1009, DOI 10.1007/s00153-004-0240-4; Balbes R., 1974, DISTRIBUTIVE LATTICE; Benton P. N., 1994, MIXED LINEAR NONLINE; Bierman G. M., 2000, Studia Logica, V65, DOI 10.1023/A:1005291931660; Blok W., 1989, MEMOIRS AMS, V77; Burris S., 1981, GRADUATE TEXTS MATH, V78; Caicedo X., 2013, LECT NOTES COMPUT SC, V8071, P226; Caicedo X, 2015, J LOGIC COMPUT, V25, P37, DOI 10.1093/logcom/exs036; Chagrov A., 1997, MODAL LOGIC; Chajda I, 2011, CENT EUR J MATH, V9, P1185, DOI 10.2478/s11533-011-0063-6; Davoren JM, 2007, LECT NOTES COMPUT SC, V4514, P162, DOI 10.1007/978-3-540-72734-7_12; Dunn J.M., 1995, STUDIA LOGICA, V55, P301, DOI 10.1007/BF01061239; Dzik W, 2014, INT J APPROX REASON, V55, P427, DOI [10.1016/j.ijar.2013.07.005, 10.1016/j.ijar.13.07.005]; Dzik W, 2010, LOG J IGPL, V18, P837, DOI 10.1093/jigpal/jzp057; Dzik W., 2012, ARXIV12082971MATHLO; Dzik W, 2013, LOG J IGPL, V21, P199, DOI 10.1093/jigpal/jzs016; Figallo A. V., 2012, B SECTION LOGIC U LO, V41, P71; Figallo Aldo Victorio, 2012, [Communications of the KMS, 대한수학회논문집], V27, P47; Fischer Servi G., 1984, REND SEM MAT U POLIT, V42, P179; Garcia-Pardo F, 2013, LECT NOTES COMPUT SC, V7903, P224; Ghilardi S., 1999, STUDIA LOGICA, V63, P353, DOI 10.1023/A:1005203020752; Gratzer G., 1998, GEN LATTICE THEORY; Jarvinen J, 2007, FUND INFORM, V76, P129; Jarvinen J, 2008, INT J APPROX REASON, V49, P595, DOI 10.1016/j.ijar.2008.06.003; Jonsson B., 1951, AM J MATH, V73, P891, DOI 10.2307/2372123; Kurucz A, 2007, STUD LOGIC PRACT REA, V3, P869; Menni M, 2014, J PHILOS LOGIC, V43, P365, DOI 10.1007/s10992-012-9266-y; Ore O, 1944, T AM MATH SOC, V55, P493, DOI 10.2307/1990305; Orlowska E, 2007, FUND INFORM, V81, P275; Orlowska E., 2013, DISCRETE DUALI UNPUB; Rasiowa H., 1968, MATH METAMATHEMATICS, V41; Reyes G. E., 1993, STUDIA LOGICA, V52, P595, DOI 10.1007/BF01053262; REYES GE, 1991, LECT NOTES MATH, V1488, P359; Sadrzadeh M, 2010, REV SYMB LOG, V3, P351, DOI 10.1017/S1755020310000134; Simpson A. K., 1994, THESIS U EDINBURGH E; Venema Y, 2007, STUD LOGIC PRACT REA, V3, P331; Von Karger B., 1998, Mathematical Structures in Computer Science, V8, DOI 10.1017/S0960129598002540	42	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-0751	1368-9894		LOG J IGPL	Log. J. IGPL	DEC	2014	22	6					992	1018		10.1093/jigpal/jzu024		27	Mathematics, Applied; Mathematics; Logic	Mathematics; Science & Technology - Other Topics	AW1EZ	WOS:000346034500010		
J	Garnaev, A; Kikuta, K				Garnaev, Andrey; Kikuta, Kensaku			Screening and hiding versus search	MATHEMATICAL METHODS OF OPERATIONS RESEARCH			English	Article						Search game; Zero-sum game; Resource allocation	IMMOBILE HIDER; GAME	In this paper we suggest a new class of search games, namely, screening and hiding versus search games. This new class of search games is motivated by the book Search and Screening by Koopman who is the founder of the modern search theory. In our game a hider is not just trying to find the best places to hide resources from a searcher, but also it applies efforts to screen their allocations making it more difficult for the searcher to find them. This hiding and screening strategy of the hider versus search strategy of the searcher makes the plot more real-world relative comparing to widely investigated in literature just hiding versus search games. For the suggested game we found the equilibrium strategies of both players as well as we proved uniqueness of the equilibrium.	[Garnaev, Andrey] St Petersburg State Univ, Fac Appl Math & Control Proc, St Petersburg 198504, Russia; [Kikuta, Kensaku] Univ Nyogo, Sch Business Adm, Nishi Ku, Kobe, Hyogo 6512197, Japan	Garnaev, A (reprint author), St Petersburg State Univ, Fac Appl Math & Control Proc, Univ Skii Prospekt 35, St Petersburg 198504, Russia.	agarnaev@rambler.ru					ANDERSON EJ, 1990, NETWORKS, V20, P817, DOI 10.1002/net.3230200703; Baston VJ, 2000, NAV RES LOG, V47, P85, DOI 10.1002/(SICI)1520-6750(200003)47:2<85::AID-NAV1>3.3.CO;2-3; CROUCHER JS, 1975, NAV RES LOG, V22, P197, DOI 10.1002/nav.3800220117; Danskin J. M., 1967, THEORY MAX MIN; GAL S, 1979, SIAM J CONTROL OPTIM, V17, P99, DOI 10.1137/0317009; Gal S., 2003, THEORY SEARCH GAMES; Garnaev A, 2013, ASIA PAC J OPER RES, V30, pN2; GARNAEV AY, 1991, J OPTIMIZ THEORY APP, V69, P531, DOI 10.1007/BF00940687; Garnaev A, 2007, NAV RES LOG, V54, P109, DOI 10.1002/nav.20196; Hohzaki R, 2006, EUR J OPER RES, V172, P101, DOI 10.1016/j.ejor.2004.10.003; IIDA K, 1994, J OPER RES SOC JPN, V37, P287; KIKUTA K, 1994, NAV RES LOG, V41, P821, DOI 10.1002/1520-6750(199410)41:6<821::AID-NAV3220410610>3.0.CO;2-Y; Koopman B. O., 1980, SEARCH SCREENING GEN; Koopman BO, 1946, 56 CTR NAV AN OP RES; LALLEY S, 1988, PROBAB THEORY REL, V77, P99, DOI 10.1007/BF01848133; Zoroa M, 1993, NAV RES LOG, V40, P525	16	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1432-2994	1432-5217		MATH METHOD OPER RES	Math. Method Oper. Res.	DEC	2014	80	3					255	265		10.1007/s00186-014-0479-4		11	Operations Research & Management Science; Mathematics, Applied	Operations Research & Management Science; Mathematics	AW0GP	WOS:000345969500002		
J	Ozawa, T; Hiroyasu, S; Tsuruta, D				Ozawa, Toshiyuki; Hiroyasu, Sho; Tsuruta, Daisuke			The role of hemidesmosomes and focal contacts in the skin visualized by dual-color live cell imaging	MEDICAL MOLECULAR MORPHOLOGY			English	Review						Live cell imaging; Keratinocyte; Hemidesmosome; Focal contact; BP180	BULLOUS-PEMPHIGOID ANTIGEN; GREEN-FLUORESCENT PROTEIN; ENDOTHELIAL-CELLS; BLISTER FORMATION; KERATINOCYTES; DYNAMICS; INTEGRIN; ADHESION; INTERNALIZATION; ALPHA-6-BETA-4	Live cell imaging is a powerful tool to elucidate dynamics of protein(s). Our group has concentrated on dynamics of two major cell-matrix adhesion devices, hemidesmosome and focal contact in the keratinocytes. Firstly, we observed the fate of hemidesmosome protein or focal contact protein by single-color live cell imaging in the physiological setting of keratinocytes. Both hemidesmosome proteins and focal contact proteins were highly dynamic. Next, in order to observe the interaction between hemidesmosome protein and focal contact protein, we observed the fate of these proteins at the same time by dual-color live cell imaging in physiological setting and in wound setting of keratinocytes. These hemidesmosome proteins and focal contact proteins showed individual dynamics with minimal overlap expressions in physiological settings. In sharp contrast, both proteins showed highly regulated interaction in wound setting of keratinocytes. Finally, we observed the fate of BP180 protein, which is a major target of autoimmune bullous disease, bullous pemphigoid, and component of hemidesmosome, under the existence of anti-BP180 autoantibody. In results, under such a circumstance, BP180 molecules were internalized and thus keratinocyte showed weakened adhesion to the cell matrix. Our work has elucidated dynamic aspects of cell-matrix adhesion devices under both physiological and pathological conditions.	[Ozawa, Toshiyuki; Hiroyasu, Sho; Tsuruta, Daisuke] Osaka City Univ, Grad Sch Med, Dept Dermatol, Abeno Ku, Osaka 5458585, Japan	Tsuruta, D (reprint author), Osaka City Univ, Grad Sch Med, Dept Dermatol, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	dtsuruta@med.osaka-cu.ac.jp			Japanese Dermatological Association Shiseido [23-13]; Ministry of Education, Culture, Sports, Science and Technology of Japan [J112640081]	We thank Drs. Yasuo Kitajima, Takashi Hashimoto, Yumi Aoyama and Jonathan C.R. Jones for helpful discussion. This work was supported in part by the Japanese Dermatological Association Shiseido Award 23-13 and the Ministry of Education, Culture, Sports, Science and Technology of Japan Grants-in-Aid for Science Research and Strategic Research Basis Formation Supporting Project J112640081. Statement of all funding sources for this work; none.	LIU Z, 1995, J CLIN INVEST, V95, P1539, DOI 10.1172/JCI117826; Tsuruta D, 2003, J CELL SCI, V116, P4977, DOI 10.1242/jcs.00823; Tsuruta D, 2011, J DERMATOL SCI, V62, P1, DOI 10.1016/j.jdermsci.2011.01.005; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; CARTER WG, 1990, J CELL BIOL, V110, P1387, DOI 10.1083/jcb.110.4.1387; LIU Z, 1993, J CLIN INVEST, V92, P2480, DOI 10.1172/JCI116856; Liu Z, 1997, J CLIN INVEST, V100, P1256, DOI 10.1172/JCI119639; Chen RY, 2001, J CLIN INVEST, V108, P1151; Tsuruta D, 2008, CURR MED CHEM, V15, P1968, DOI 10.2174/092986708785132834; Sugawara K, 2008, EXP DERMATOL, V17, P473, DOI 10.1111/j.1600-0625.2008.00721.x; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Chen RY, 2002, J IMMUNOL, V169, P3987; Lai-Cheong JE, 2009, BRIT J DERMATOL, V160, P233, DOI 10.1111/j.1365-2133.2008.08976.x; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iwata H, 2009, J INVEST DERMATOL, V129, P919, DOI 10.1038/jid.2008.305; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; Geuijen CAW, 2002, MOL BIOL CELL, V13, P3845, DOI 10.1091/mbc.02-01-0601; Hiroyasu S, 2013, AM J PATHOL, V182, P828, DOI 10.1016/j.ajpath.2012.11.029; JORDON RE, 1967, J AMER MED ASSOC, V200, P751, DOI 10.1001/jama.200.9.751; Kitajima Y, 1998, BRIT J DERMATOL, V138, P71; LABIB RS, 1986, J IMMUNOL, V136, P1231; Nelson KC, 2006, J CLIN INVEST, V116, P2892, DOI 10.1172/JCI17891; Ozawa T, 2011, MED MOL MORPHOL, V44, P27, DOI 10.1007/s00795-010-0502-7; Ozawa T, 2010, J INVEST DERMATOL, V130, P1624, DOI 10.1038/jid.2009.439; Shimomura O, 2009, ANGEW CHEM INT EDIT, V48, P5590, DOI 10.1002/anie.200902240; STANLEY JR, 1988, J CLIN INVEST, V82, P1864, DOI 10.1172/JCI113803; Tsuruta D, 2003, CELL MOTIL CYTOSKEL, V54, P122, DOI 10.1002/cm.10089; Tsuruta D, 2002, FASEB J, V16, P866, DOI 10.1096/fj.01-0878fje	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2014	47	4					185	188		10.1007/s00795-014-0078-8		4	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	AW3KO	WOS:000346185800001		
J	Prechapanich, J; Kajihara, T; Fujita, K; Sato, K; Uchino, S; Tanaka, K; Matsumoto, S; Akita, M; Nagashima, M; Brosens, JJ; Ishihara, O				Prechapanich, Japarath; Kajihara, Takeshi; Fujita, Keiko; Sato, Kazuko; Uchino, Satomi; Tanaka, Kayoko; Matsumoto, Sachiko; Akita, Masumi; Nagashima, Masabumi; Brosens, Jan J.; Ishihara, Osamu			Effect of a dienogest for an experimental three-dimensional endometrial culture model for endometriosis	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Endometriosis; Three-dimensional culture model; Ultrastructure; Dienogest; Apoptosis	INDUCED INTERLEUKIN-8 PRODUCTION; IN-VITRO MODEL; STROMAL CELLS; EPITHELIAL-CELLS; GROWTH; ACETATE; CYCLOOXYGENASE-2; MULTICENTER; RECURRENCE; EXPRESSION	The pathogenesis of endometriosis remains poorly understood at least in part because early stages of the disease process are difficult to investigate. Previous studies have proposed a three-dimensional fibrin matrix culture model to study human endometriosis. We examined the ultrastructural features of the endometriosis in this model and assessed the effect of a progestin on endometrial outgrowth and apoptosis in this culture system. Endometrial explants were placed in three-dimensional fibrin matrix culture and treated with and without various concentrations of the progestin dienogest. By the second week, endometrial gland-like formation was established in outgrowths both attached to and at a distance from the explants. These cells formed a combination of clumps and tubular monolayers surrounding a central cavity. Electron microscopy demonstrated that these cells are polarized with microvilli on the apical surface, desmosome-like structures, and basement membrane; features consistent with glandular epithelial cells. Outgrowth of endometrial stromal cells and glandular formation was impaired in response to dienogest in a dose-dependent manner. Our study shows that the human endometrial explants cultured in three-dimensional fibrin matrix establish outgrowths that ultrastructurally resemble ectopic endometrial implants. This model may provide insight into the cellular processes leading to endometriosis formation and enables screening of therapeutic compounds.	[Prechapanich, Japarath; Kajihara, Takeshi; Sato, Kazuko; Uchino, Satomi; Ishihara, Osamu] Saitama Med Univ, Fac Med, Dept Obstet & Gynecol, Moroyama, Saitama, Japan; [Fujita, Keiko; Nagashima, Masabumi] Saitama Med Univ, Fac Med, Dept Anat, Moroyama, Saitama, Japan; [Tanaka, Kayoko; Matsumoto, Sachiko; Akita, Masumi] Saitama Med Univ, Fac Med, Div Morphol Sci, Biomed Res Ctr, Moroyama, Saitama, Japan; [Brosens, Jan J.] Univ Hosp, Clin Sci Res Labs, Warwick Med Sch, Div Reprod Hlth, Coventry CV2 2DX, W Midlands, England	Kajihara, T (reprint author), Saitama Med Univ, Fac Med, Dept Obstet & Gynecol, 38 Morohongo, Moroyama, Saitama, Japan.	Kajihara@saitama-med.ac.jp		Brosens, Jan/0000-0003-0116-9329	Ministry of Education, Science, and Culture, Japan [23592412]	T.K. received grant-in-aid from Scientific Research from the Ministry of Education, Science, and Culture, Japan (no. 23592412). J.J.B. was supported by the Biomedical Research Unit in Reproductive Health, a joint initiative between the University Hospitals Coventry and Warwickshire National Health Service Trust and Warwick Medical School.	Sulaiman H, 2002, BIOCHEM SOC T, V30, P126; Strowitzki T, 2010, HUM REPROD, V25, P633, DOI 10.1093/humrep/dep469; Fourquet J, 2011, FERTIL STERIL, V96, P107, DOI 10.1016/j.fertnstert.2011.04.095; JACQUOT J, 1994, J CELL PHYSIOL, V161, P407, DOI 10.1002/jcp.1041610303; Fu L, 2008, FERTIL STERIL, V89, P1344, DOI 10.1016/j.fertnstert.2007.03.042; Okada H, 2001, MOL HUM REPROD, V7, P341, DOI 10.1093/molehr/7.4.341; Yamanaka K, 2012, FERTIL STERIL, V97, P477, DOI 10.1016/j.fertnstert.2011.11.005; GORDON M, 1975, INT REV CYTOL, V42, P127, DOI 10.1016/S0074-7696(08)60980-8; Foster RH, 1998, DRUGS, V56, P825, DOI 10.2165/00003495-199856050-00007; Horie S, 2005, FERTIL STERIL, V83, P1530, DOI 10.1016/j.fertnstert.2004.11.042; Banu SK, 2008, ENDOCRINOLOGY, V149, P1180, DOI 10.1210/en.2007-1168; SCHWEPPE KW, 1981, OBSTET GYNECOL, V58, P465; Okada H, 2011, FERTIL STERIL, V96, P786, DOI 10.1016/j.fertnstert.2011.06.048; Witz CA, 1999, FERTIL STERIL, V71, P56, DOI 10.1016/S0015-0282(98)00400-2; Holoch KJ, 2010, CLIN OBSTET GYNECOL, V53, P429, DOI 10.1097/GRF.0b013e3181db7d71; Lee DY, 2010, HUM REPROD, V25, P3050, DOI 10.1093/humrep/deq279; Braundmeier AG, 2009, MOL HUM REPROD, V15, P577, DOI 10.1093/molehr/gap057; Harada T, 2009, FERTIL STERIL, V91, P675, DOI 10.1016/j.fertnstert.2007.12.080; Boxberger HJ, 1997, IN VITRO CELL DEV-AN, V33, P536; BUNGE RP, 1973, BRAIN RES, V57, P261, DOI 10.1016/0006-8993(73)90135-2; Coccia ME, 2011, EUR J OBSTET GYN R B, V157, P78, DOI 10.1016/j.ejogrb.2011.02.008; Esfandiari N, 2007, FERTIL STERIL, V87, P257, DOI 10.1016/j.fertnstert.2006.06.040; Esfandiari N, 2007, AM J REPROD IMMUNOL, V57, P49, DOI 10.1111/j.1600-0897.2006.00445.x; Fasciani A, 2003, FERTIL STERIL, V80, P1137, DOI 10.1016/S0015-0282(03)02164-2; Hever A, 2006, MOL HUM REPROD, V12, P737, DOI 10.1093/molehr/gal076; Kuhl H, 1996, DRUGS, V51, P188, DOI 10.2165/00003495-199651020-00002; Mattioli F, 2004, MUTAT RES-GEN TOX EN, V564, P21, DOI 10.1016/j.mrgentox.2004.07.006; Ohama Y, 2008, FERTIL STERIL, V89, P311, DOI 10.1016/j.fertnstert.2007.03.061; Porpora MG, 2010, FERTIL STERIL, V93, P716, DOI 10.1016/j.fertnstert.2008.10.018; Sasagawa S, 2008, J ENDOCRINOL INVEST, V31, P636; SCHWEPPE KW, 1984, AM J OBSTET GYNECOL, V148, P1024; Witz CA, 2002, ANN NY ACAD SCI, V955, P296	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2014	47	4					189	195		10.1007/s00795-013-0059-3		7	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	AW3KO	WOS:000346185800002		
J	Hirano, H; Maeda, H; Takeuchi, Y; Susaki, Y; Kobayashi, R; Hayashi, A; Ose, N; Nakazawa, Y; Yamaguchi, T; Yokota, S; Mori, M				Hirano, Hiroshi; Maeda, Hajime; Takeuchi, Yukiyasu; Susaki, Yoshiyuki; Kobayashi, Ryoji; Hayashi, Akio; Ose, Naoko; Nakazawa, Yukie; Yamaguchi, Toshihiko; Yokota, Soichiro; Mori, Masahide			Association of cigarette smoking with the expression of nuclear survivin in pathological Stage IA lung adenocarcinomas	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Lung; Adenocarcinoma; Survivin; Nuclear expression		Survivin is expressed in the cytoplasm and/or nucleus of various types of malignant tumor cells. Cytoplasmic survivin functions as an apoptosis inhibitor, while nuclear survivin is indispensable for complete mitosis completion. To investigate the effect of cigarette smoking on the survivin expression in lung adenocarcinomas at the early developmental stage, we examined the expression of nuclear and cytoplasmic survivin in pathological Stage IA lung adenocarcinomas resected from 38 non-smokers and 44 smokers (current smokers and ex-smokers) using an immunohistochemical method. Labeling indices of nuclear survivin in tumors of smokers were significantly greater than those of non-smokers. The labeling index of nuclear survivin was above 3 % in only 1 (2.6 %) of the 38 tumors of the non-smokers, while the labeling indices in 19 (43.2 %) of 44 tumors of the smokers were above 3 % with a significantly greater frequency. There was no significant difference in the labeling index of nuclear survivin between current smokers and ex-smokers. There was no significant difference in the labeling index of cytoplasmic survivin between tumors of the non-smokers and the smokers. The present results show that cigarette smoking is associated with the higher nuclear surviving expression in lung adenocarcinomas at the early stage, suggesting that cigarette smoking affects the nuclear survivin expression in lung adenocarcinomas at the early developmental stage.	[Hirano, Hiroshi] Toneyama Natl Hosp, Dept Pathol, Toyonaka, Osaka 5608552, Japan; [Hirano, Hiroshi] Toneyama Natl Hosp, Dept Lab Med, Toyonaka, Osaka 5608552, Japan; [Maeda, Hajime; Takeuchi, Yukiyasu; Susaki, Yoshiyuki; Kobayashi, Ryoji; Hayashi, Akio; Ose, Naoko] Toneyama Natl Hosp, Dept Surg, Toyonaka, Osaka 5608552, Japan; [Nakazawa, Yukie; Yamaguchi, Toshihiko; Yokota, Soichiro; Mori, Masahide] Toneyama Natl Hosp, Dept Internal Med, Toyonaka, Osaka 5608552, Japan	Hirano, H (reprint author), Toneyama Natl Hosp, Dept Lab Med, 1-1,Toneyama 5 Chome, Toyonaka, Osaka 5608552, Japan.	hihirano@toneyama.go.jp					Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Stauber RH, 2007, CANCER RES, V67, P5999, DOI 10.1158/0008-5472.CAN-07-0494; Shinohara ET, 2005, CANCER-AM CANCER SOC, V103, P1685, DOI 10.1002/cncr.20951; Devesa SS, 2005, INT J CANCER, V117, P294, DOI 10.1002/ijc.21183; Li FZ, 2005, INT J CANCER, V114, P509, DOI 10.1002/ijc.20768; Jin Q, 2008, CARCINOGENESIS, V29, P1614, DOI 10.1093/carcin/bgm234; Khuder SA, 2001, LUNG CANCER, V31, P39; Li FZ, 2006, J CELL PHYSIOL, V208, P476, DOI 10.1002/jcp.20634; Maeda R, 2012, ANN THORAC SURG, V93, P1626, DOI 10.1016/j.athoracsur.2012.01.005	10	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2014	47	4					196	200		10.1007/s00795-013-0061-9		5	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	AW3KO	WOS:000346185800003		
J	Hoshi, O				Hoshi, Osamu			Observation of collagen fibrils produced by osteosarcoma cells using atomic force microscopy	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Collagen fibril assembly; Osteosarcoma; Cell culture; Atomic force microscopy; Scanning electron microscopy	FIBRILLOGENESIS IN-SITU; EXTRACELLULAR-MATRIX; ELECTRON-MICROSCOPY; HUMAN FIBROBLASTS; SKIN FIBROBLASTS; ASCORBIC-ACID; FEG-SEM; SEGMENTS; GROWTH; CULTURE	The present study examined the three-dimensional process of collagen fibril formation in the human osteosarcoma cell line NOS-1 by conventional scanning electron microscopy (SEM) and atomic force microscopy (AFM). SEM images showed collagen fibril formation on the bottom of culture dishes after 1 week of culture. The collagen fibrils had diameters of 30-100 nm. The surfaces of individual fibrils had characteristic grooves and ridges with periodicities of 60-70 nm. AFM images showed that the newly formed collagen fibrils were 30-300 nm in diameter and possessed characteristic grooves and ridges with periodicities of 60-70 nm. The thicker collagen fibrils contained thinner (approximately 30 nm thick) subfibrils that ran in a helical direction along the long axis of the thicker fibrils. Furthermore, twisted structures of collagen fibrils, which possessed a characteristic rope-like structure, were also identified. The ultrastructure of the collagen fibrils was clearly imaged in liquid medium by AFM, and the process of collagen fibril assembly was successfully analyzed under conditions much closer to the physiological state than those afforded by transmission electron microscopy or SEM. AFM also provided a precise morphological measurement, particularly of the vertical distance, of collagen fibrils with nanometer-scale resolution in liquid conditions.	Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Tokyo 1138519, Japan	Hoshi, O (reprint author), Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Tokyo 1138519, Japan.	o-hoshi.aps@tmd.ac.jp			Japan Society for the Promotion of Science [20590186]	The author is very grateful to Professor T. Ushiki (Niigata University Graduate School of Medical and Dental Sciences) for his continuous support and encouragement. This study was supported in part by a Grant-in-Aid for Scientific Research (No. 20590186 to O.H.) from the Japan Society for the Promotion of Science.	Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Raspanti M, 1996, MICROSC RES TECHNIQ, V35, P87; BIRK DE, 1989, P NATL ACAD SCI USA, V86, P4549, DOI 10.1073/pnas.86.12.4549; Bozec L, 2007, BIOPHYS J, V92, P70, DOI 10.1529/biophysj.106.085704; LAYMAN DL, 1971, P NATL ACAD SCI USA, V68, P454, DOI 10.1073/pnas.68.2.454; Cisneros DA, 2006, J STRUCT BIOL, V154, P232, DOI 10.1016/j.jsb.2006.02.006; DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794; BIRK DE, 1995, DEV DYNAM, V202, P229; GUIDRY C, 1985, J CELL SCI, V79, P67; Kadler KE, 1996, BIOCHEM J, V316, P1; HOTTA T, 1992, ACTA PATHOL JAPON, V42, P595; MARCHINI M, 1986, CONNECT TISSUE RES, V15, P269, DOI 10.3109/03008208609001985; BARD JBL, 1993, J CELL SCI, V105, P1045; Birk DE, 1997, DEV DYNAM, V208, P291; Franz CM, 2011, METHODS MOL BIOL, V736, P97, DOI 10.1007/978-1-61779-105-5_7; GRINNELL F, 1989, EXP CELL RES, V181, P483, DOI 10.1016/0014-4827(89)90105-5; Hashizume H, 1999, ARCH HISTOL CYTOL, V62, P327, DOI 10.1679/aohc.62.327; HATA RI, 1989, J CELL PHYSIOL, V138, P8, DOI 10.1002/jcp.1041380103; Hazeki N, 1998, J BIOCHEM-TOKYO, V123, P587; KADLER KE, 1993, INT J EXP PATHOL, V74, P319; LAMANDE SR, 1993, MATRIX, V13, P323; Liang ZH, 2010, SCANNING, V32, P104, DOI 10.1002/sca.20189; OGOSE A, 1995, VIRCHOWS ARCH, V426, P117; RASPANTI M, 1990, J ANAT, V172, P157; Raspanti M, 2006, MICRON, V37, P81, DOI 10.1016/j.micron.2005.06.002; Tilley JMR, 2011, MICRON, V42, P531, DOI 10.1016/j.micron.2011.01.001; Yamamoto S, 1997, ARCH HISTOL CYTOL, V60, P371, DOI 10.1679/aohc.60.371	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2014	47	4					201	206		10.1007/s00795-013-0063-7		6	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	AW3KO	WOS:000346185800004		
J	Shibayama, M; Serrano-Luna, J; Sohda, T; Kawashima, M; Yamauchi, E; Tanaka, T; Ueda, S; Morihara, D; Anan, A; Takeyama, Y; Irie, M; Iwata, K; Shakado, S; Sakisaka, S				Shibayama, Mineko; Serrano-Luna, Jesus; Sohda, Tetsuro; Kawashima, Motoko; Yamauchi, Eri; Tanaka, Takashi; Ueda, Shu-ichi; Morihara, Daisuke; Anan, Akira; Takeyama, Yasuaki; Irie, Makoto; Iwata, Kaoru; Shakado, Satoshi; Sakisaka, Shotaro			Restoration of albumin production by nucleoside analogue therapy in patients with chronic hepatitis B	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Chronic hepatitis B; Nucleotide analogues; Albumin; Hepatocyte growth factor; In situ hybridization	HEPATOCYTE GROWTH-FACTOR; ACUTE-PHASE PROTEINS; MESSENGER-RNA; LAMIVUDINE THERAPY; RAT HEPATOCYTES; DNA-SYNTHESIS; GENES; LIVER	The clinical course of patients with chronic hepatitis B (CH-B) was greatly changed by the introduction of nucleoside analogues. We often encounter patients where the serum level of albumin recovers quickly following the treatment. In this study, we focused carefully on the changes in serum albumin level noted during nucleoside analogue therapy, in an effort to clarify the mechanism behind the restoration of albumin production. We observed changes in serum albumin levels during nucleoside analogue therapy in 12 patients with CH-B and studied the mechanism behind the restoration of albumin production following the therapy. The serum level of albumin was significantly increased very soon after the treatment was started. Prior to treatment with nucleoside analogues, the albumin signal for mRNA was only slightly seen in the peri-portal area, whereas 12 months after the treatment, the liver tissue presented an obvious signal of albumin mRNA. Serum levels of hepatocyte growth factor (HGF) were significantly decreased 12 months after the treatment. In this study, we demonstrated that nucleoside analogues decrease HGF through the suppression of hepatocyte damage, leading to the restoration of albumin production in patients with CH-B.	[Shibayama, Mineko] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Mexico City, DF, Mexico; [Serrano-Luna, Jesus] Natl Polytech Inst, Ctr Res & Adv Studies, Dept Cell Biol, Mexico City, DF, Mexico; [Sohda, Tetsuro; Kawashima, Motoko; Yamauchi, Eri; Tanaka, Takashi; Ueda, Shu-ichi; Morihara, Daisuke; Anan, Akira; Takeyama, Yasuaki; Irie, Makoto; Iwata, Kaoru; Shakado, Satoshi; Sakisaka, Shotaro] Fukuoka Univ, Fac Med, Dept Gastroenterol, Jonan Ku, Fukuoka 8140108, Japan	Sohda, T (reprint author), Fukuoka Univ, Fac Med, Dept Gastroenterol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140108, Japan.	tetsuro@fukuoka-u.ac.jp			Japan Society for the Promotion of Science (JSPS)	A part of this study was supported by the Japan Society for the Promotion of Science (JSPS).	MACKIEWICZ A, 1990, P NATL ACAD SCI USA, V87, P1491, DOI 10.1073/pnas.87.4.1491; DUGAICZYK A, 1982, P NATL ACAD SCI-BIOL, V79, P71, DOI 10.1073/pnas.79.1.71; Yuen MF, 2005, ALIMENT PHARM THERAP, V21, P841, DOI 10.1111/j.1365-2036.2005.02410.x; Guillen MI, 1996, HEPATOLOGY, V23, P1345, DOI 10.1002/hep.510230609; Chang TT, 2010, HEPATOLOGY, V52, P886, DOI 10.1002/hep.23785; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; HUANG Y, 1995, ARCH BIOCHEM BIOPHYS, V320, P203, DOI 10.1016/0003-9861(95)90001-2; BEAUCHAMP RD, 1992, ANN SURG, V216, P300, DOI 10.1097/00000658-199209000-00009; Flisiak R, 2004, WORLD J GASTROENTERO, V10, P2661; Hadziyannis SJ, 2007, EXPERT OPIN INV DRUG, V16, P777, DOI 10.1517/13543784.16.6.777; Krishna M, 1997, AM J SURG PATHOL, V21, P147, DOI 10.1097/00000478-199702000-00003; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; MURRAY GI, 1992, J CLIN PATHOL, V45, P21, DOI 10.1136/jcp.45.1.21; TAKEHARA T, 1992, J BIOCHEM-TOKYO, V112, P330; Yamaoka M, 1998, LIVER, V18, P52	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2014	47	4					207	212		10.1007/s00795-013-0065-5		6	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	AW3KO	WOS:000346185800005		
J	Adachi, T; Sugiyama, N; Yagita, H; Yokoyama, T				Adachi, Takaomi; Sugiyama, Noriyuki; Yagita, Hideo; Yokoyama, Takahiko			Renal atrophy after ischemia-reperfusion injury depends on massive tubular apoptosis induced by TNF alpha in the later phase	MEDICAL MOLECULAR MORPHOLOGY			English	Article						TNF alpha; Apoptosis; Atrophy; Ischemia-reperfusion injury	ACUTE KIDNEY INJURY; NECROSIS-FACTOR-ALPHA; EPITHELIAL-CELLS; FAS LIGAND; FAILURE; INVOLVEMENT; RECEPTOR-1; EXPRESSION; PATHWAYS; PROTECTS	Recent studies have suggested that acute kidney injury (AKI) develops into chronic kidney disease (CKD). However, a mechanism for disease progression from AKI to CKD has not been established. We developed two ischemia-reperfusion injury (IRI) mouse models, a repaired kidney model and an atrophic kidney model, and studied the mechanisms of renal atrophy after IRI by comparing the two models. We found that renal atrophy after IRI depended on tubular apoptosis at 14 days after IRI. Moreover, we found that Tnf alpha and FasL mRNA were synchronously expressed at the time of tubular apoptosis. To elucidate the relationship between tubular apoptosis and apoptotic ligands, we administered TNF alpha and FasL neutralizing antibodies according to the time of tubular apoptosis. TNF alpha blockade significantly repressed tubular apoptosis, resulting in the prevention of renal atrophy. FasL blockade could not repress tubular apoptosis, resulting in renal atrophy. We also found that TNF receptors were expressed in the kidney at 14 days after IRI, but Fas receptor was not. We concluded that renal atrophy after IRI depends on tubular apoptosis induced by the TNF alpha signaling pathway in the later phase of renal IRI, and that TNF alpha blockade could be a potential new therapeutic approach for improving renal prognosis after AKI.	[Adachi, Takaomi; Sugiyama, Noriyuki; Yokoyama, Takahiko] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Anat & Dev Biol, Kyoto, Japan; [Adachi, Takaomi] Kyoto Prefectural Univ Med, Dept Med, Div Nephrol, Kyoto, Japan; [Sugiyama, Noriyuki] Osaka Med Coll, Dept Anat & Cell Biol, Div Life Sci, Takatsuki, Osaka 5698686, Japan; [Yagita, Hideo] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan	Sugiyama, N (reprint author), Osaka Med Coll, Dept Anat & Cell Biol, Div Life Sci, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	an1027@art.osaka-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23591197]	This work was supported by a Grant-in-Aid for Scientific Research (C, 23591197) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Ramesh G, 2003, AM J PHYSIOL-RENAL, V285, pF610, DOI 10.1152/ajprenal.00101.2003; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Al-Lamki RS, 2005, FASEB J, V19, P1637, DOI 10.1096/fj.05-3841com; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Linkermann A, 2012, KIDNEY INT, V81, P751, DOI 10.1038/ki.2011.450; Lo LJ, 2009, KIDNEY INT, V76, P893, DOI 10.1038/ki.2009.289; Bonegio R, 2002, CURR OPIN NEPHROL HY, V11, P301, DOI 10.1097/00041552-200205000-00006; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Misseri R, 2005, AM J PHYSIOL-RENAL, V288, pF406, DOI 10.1152/ajprenal.00099.2004; Hotta K, 2011, KIDNEY INT, V79, P179, DOI 10.1038/ki.2010.379; Conlon PJ, 1999, NEPHROL DIAL TRANSPL, V14, P1158, DOI 10.1093/ndt/14.5.1158; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM, V48, P2122, DOI 10.1002/art.11137; Silva LCR, 2010, IMMUNOTHERAPY-UK, V2, P817, DOI [10.2217/imt.10.67, 10.2217/IMT.10.67]; Donnahoo KK, 2001, IMMUNOLOGY, V102, P53, DOI 10.1046/j.1365-2567.2001.01141.x; Siew ED, 2012, J AM SOC NEPHROL, V23, P305, DOI 10.1681/ASN.2011030315; Ko GJ, 2011, J AM SOC NEPHROL, V22, P732, DOI 10.1681/ASN.2010010121; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Vielhauer V, 2005, J CLIN INVEST, V115, P1199, DOI 10.1172/JCI200523348; Al-Lamki RS, 2001, LAB INVEST, V81, P1503; FINN WF, 1980, CIRC RES, V46, P440; Guo GJ, 1999, AM J PHYSIOL-RENAL, V277, pF766; Aten J, 2000, J AM SOC NEPHROL, V11, P1426; Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Lu F, 2001, CELL RES, V11, P217, DOI 10.1038/sj.cr.7290089; Hamar P, 2004, P NATL ACAD SCI USA, V101, P14883, DOI 10.1073/pnas.040621101; Daemen MARC, 1999, TRANSPLANTATION, V67, P792, DOI 10.1097/00007890-199903270-00003; Du C, 2006, AM J TRANSPLANT, V6, P2256, DOI 10.1111/j.1600-6143.2006.01478.x; Gwinner W, 2008, AM J TRANSPLANT, V8, P1684, DOI 10.1111/j.1600-6143.2008.02293.x; Himmelfarb J, 2007, KIDNEY INT, V71, P971, DOI 10.1038/sj.ki.5002224; Linkermann A, 2011, KIDNEY INT, V79, P169, DOI 10.1038/ki.2010.317; Nogae S, 1998, J AM SOC NEPHROL, V9, P620; Ortiz A, 2003, BIOCHEM PHARMACOL, V66, P1589, DOI 10.1016/S0006-2952(03)00515-X; Saikumar P, 2003, SEMIN NEPHROL, V23, P511, DOI 10.1053/S0270-9295(03)00130-X; SHIMIZU A, 1993, VIRCHOWS ARCH B, V64, P171, DOI 10.1007/BF02915110; Sugiyama N, 2006, GENES CELLS, V11, P1213, DOI 10.1111/j.1365-2443.2006.01011.x; Tsuruya K, 2003, KIDNEY INT, V63, P72, DOI 10.1046/j.1523-1755.2003.00709.x; Zhang XS, 2006, TRANSPLANTATION, V82, P1728, DOI 10.1097/01.tp.0000250764.17636.ba	37	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2014	47	4					213	223		10.1007/s00795-013-0067-3		11	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	AW3KO	WOS:000346185800006		
J	Wu, H; Nakano, T; Matsuzaki, Y; Ooi, Y; Kohno, T; Ishihara, S; Sano, K				Wu, Hong; Nakano, Takashi; Matsuzaki, Yuji; Ooi, Yukimasa; Kohno, Takehiro; Ishihara, Sonoko; Sano, Kouichi			A new type of intrabacterial nanotransportation system for VacA in Helicobacter pylori	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Acidic pH; Helicobacter pylori; Immunoelectron microscopy; Localization; Intrabacterial nanotransportation system; VacA	VIBRIO-CHOLERAE; VACUOLATING CYTOTOXIN; H-2-RECEPTOR ANTAGONISTS; GASTRIC EPITHELIUM; GENE-EXPRESSION; UREA CHANNEL; TOXIN; PH; VIRULENCE; AUTOTRANSPORTER	Helicobacter pylori possesses intrabacterial nanotransportation systems (ibNoTSs) for CagA and urease. Both systems are UreI-dependent and urea-independent, and activated by extrabacterial acid. The activation occurs/appears within 15 min after exposure to extrabacterial acid stimulation. Although it has been clarified that VacA is secreted via the type-V secretion machinery, it remains unclear how this toxin is transported toward the machinery. To clarify the intrabacterial nanotransportation system for H. pylori VacA, immunoelectron microscopic analysis was performed in this study. VacA shifted to the periphery of the bacterial cytoplasm at 30 min after the extracellular pH change, whereas CagA and urease did so within 15 min. Studies using an ureI-deletion mutant revealed that unlike CagA and urease transport, VacA transport was not UreI-dependent. VacA secretion was accelerated without an increase in the production of VacA 30 min after the exposure to extrabacterial acid. These findings indicated that H. pylori possesses a novel type of ibNoTS for VacA, which is different from that for CagA or urease, in response time and dependency of UreI.	[Wu, Hong; Nakano, Takashi; Matsuzaki, Yuji; Ooi, Yukimasa; Kohno, Takehiro; Ishihara, Sonoko; Sano, Kouichi] Osaka Med Coll, Dept Microbiol & Infect Control, Takatsuki, Osaka 5698686, Japan	Wu, H (reprint author), Osaka Med Coll, Dept Microbiol & Infect Control, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	wuhong@art.osaka-med.ac.jp					Alexandre G, 2008, J BACTERIOL, V190, P3095, DOI 10.1128/JB.00253-08; Wu H, 2005, J MED MICROBIOL, V54, P1117, DOI 10.1099/jmm.0.46158-0; Behari J, 2001, J BACTERIOL, V183, P178, DOI 10.1128/JB.183.1.178-188.2001; Rassow J, 2012, MICROBES INFECT, V14, P1026, DOI 10.1016/j.micinf.2012.07.002; Gschwantler M, 1998, EUR J GASTROEN HEPAT, V10, P579, DOI 10.1097/00042737-199807000-00010; Kim N, 2002, J BACTERIOL, V184, P6155, DOI 10.1128/JB.184.22.6155-6162.2002; Guruge JL, 1998, P NATL ACAD SCI USA, V95, P3925, DOI 10.1073/pnas.95.7.3925; Aoki H, 2009, MED MOL MORPHOL, V42, P40, DOI 10.1007/s00795-008-0431-x; Budde PP, 2007, J BACTERIOL, V189, P491, DOI 10.1128/JB.00909-06; Weeks DL, 2000, SCIENCE, V287, P482, DOI 10.1126/science.287.5452.482; Graham DY, 2004, HELICOBACTER, V9, P17, DOI 10.1111/j.1083-4389.2004.00191.x; Hatakeyama M, 2006, HELICOBACTER, V11, P14, DOI 10.1111/j.1478-405X.2006.00424.x; Pal RR, 2012, J BACTERIOL, V194, P5638, DOI 10.1128/JB.00518-12; Covacci A, 1999, SCIENCE, V284, P1328, DOI 10.1126/science.284.5418.1328; Boquet P, 2012, TRENDS MICROBIOL, V20, P165, DOI 10.1016/j.tim.2012.01.008; Hong W, 2003, J MED MICROBIOL, V52, P211, DOI 10.1099/jmm.0.05072-0; Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C; Fischer W, 2001, INFECT IMMUN, V69, P6769, DOI 10.1128/IAI.69.11.6769-6775.2001; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; Scott DR, 2007, P NATL ACAD SCI USA, V104, P7235, DOI 10.1073/pnas.0702300104; Hong W, 2000, J MICROBIOL METH, V42, P121, DOI 10.1016/S0167-7012(00)00165-2; Backert S, 2010, TOXINS, V2, P69, DOI 10.3390/toxins2010069; Cerda O, 2003, FEMS MICROBIOL LETT, V224, P175, DOI 10.1016/S0378-1097(03)00423-3; Gray LR, 2011, BIOCHEMISTRY-US, V50, P8656, DOI 10.1021/bi200887a; Hirst BH, 1989, HDB PHYSL, P279; Karita M, 1996, INFECT IMMUN, V64, P4501; Lamers CBHW, 1996, EUR J GASTROEN HEPAT, V8, pS3, DOI 10.1097/00042737-199610001-00002; Letley DP, 2006, MICROBIOL-SGM, V152, P1319, DOI 10.1099/mic.0.28548-0; Oka S, 2000, INFECT IMMUN, V68, P2863, DOI 10.1128/IAI.68.5.2863-2869.2000; PHADNIS SH, 1994, INFECT IMMUN, V62, P1557; Sachs George, 2011, Curr Gastroenterol Rep, V13, P540, DOI 10.1007/s11894-011-0226-4; Sanchez J, 2004, J BACTERIOL, V186, P1355, DOI 10.1128/JB.186.5.1355-1361.2004; Scott DR, 2010, J BACTERIOL, V192, P94, DOI 10.1128/JB.00848-09; Tuo BG, 2004, DIGEST DIS SCI, V49, P1845, DOI 10.1007/s10620-004-9582-3; WADSTROM T, 1995, CURR OPIN GASTROEN, V11, P69, DOI 10.1097/00001574-199501000-00014; WARREN JR, 1983, LANCET, V1, P1273	36	3	3	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2014	47	4					224	232		10.1007/s00795-013-0068-2		9	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	AW3KO	WOS:000346185800007		
J	Yoshimura, A; Yamaguchi, T; Kawazato, H; Takahashi, N; Shimada, T				Yoshimura, Akira; Yamaguchi, Takeshi; Kawazato, Hiroaki; Takahashi, Naohiko; Shimada, Tatsuo			Immuno-histochemistry and three-dimensional architecture of the intermediate filaments in Purkinje cells in mammalian hearts	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Intermediate filaments; Desmin antibody; Purkinje cells; Mammalian heart; Imuno-histochemistry; Electron microscopy; Cytoskeleton; Desmin	CONDUCTION SYSTEM; IDENTIFICATION; MYOCARDIUM	In mammalian hearts, Purkinje cells varied greatly in morphological appearance in different species, and were divided into three groups. Bovine Purkinje cells corresponding to group I were a large size, and had a few myofibrils and abundant intermediate filaments throughout the cytoplasm. The aim of the present study was to clarify the more detailed distribution and three-dimensional architecture of intermediate filaments in Purkinje cells. The hearts in various mammals including humans were investigated by both immuno-histochemistry and scanning electron microscopy (SEM).Immuno-histochemical studies demonstrated that sheep Purkinje cells in group I had a great number of intermediate filaments of 10 nm positive for desmin antibody. Purkinje cells in group II (humans, monkeys and dogs) and group III (mice) were somewhat larger or smaller in size than myocardial cells, but also showed a strong positive reaction for desmin antibody. The saponin or NaOH treatment of cardiac tissues in sheep and humans enabled us to view intermediate filaments by SEM three-dimensionally. Intermediate filaments in sheep Purkinje cells formed a considerably delicate network, and were distributed throughout the cytoplasm. In contrast, those in human Purkinje cells were lower in density, and were present around the nucleus and between myofibrils. It was concluded that a delicate network of intermediate filaments in Purkinje cells of mammalian hearts acted as the cytoskeleton to maintain intercellular stability.	[Yoshimura, Akira; Takahashi, Naohiko] Oita Univ, Dept Internal Med, Oita 8795591, Japan; [Yamaguchi, Takeshi] Kanazawa Univ, Dept Anat & Neuroembryol, Kanazawa Ku, Kanazawa, Ishikawa 9200934, Japan; [Kawazato, Hiroaki] Oita Univ, Res Promot Project, Oita 8795591, Japan; [Shimada, Tatsuo] Oita Univ, Sch Med, Oita 8795591, Japan; [Shimada, Tatsuo] Oita Coll Judo Therapy & Acupuncture Moxibust, Oita 8708658, Japan	Shimada, T (reprint author), Oita Coll Judo Therapy & Acupuncture Moxibust, 1-1 Chiyo Machi, Oita 8708658, Japan.	tshimada@oita-u.ac-jp					Anderson RH, 2009, CLIN ANAT, V22, P99, DOI 10.1002/ca.20700; Rappaport L, 1998, MOL CELL BIOCHEM, V184, P101, DOI 10.1023/A:1006843113166; Shimada T, 2004, ANAT REC PART A, V280A, P940, DOI 10.1002/ar.a.20109; Pak HN, 2008, CIRC J, V72, P1185, DOI 10.1253/circj.72.1185; Ono N, 2009, ARCH HISTOL CYTOL, V72, P139; Canale ED, 1986, HDB MICROSCOPIC ANAT, VII/7, P60; ERIKSSON A, 1979, J CELL BIOL, V80, P231, DOI 10.1083/jcb.80.2.231; HARA T, 1967, Archivum Histologicum Japonicum, V28, P227; Kitamura H, 1991, ACTA HISTOCHEM CYTOC, V24, P521; NAGAO K, 1981, AM J CARDIOL, V48, P864, DOI 10.1016/0002-9149(81)90351-9; Ohkawa S, 2008, J ARRHYTHMIA, V24, P177; SUGI Y, 1989, J ELECTRON MICROSC, V38, P126; SUGI Y, 1986, CELL TISSUE RES, V245, P273; Tawara T, 1906, REIZLEITUNGSSYSTEM S; Tornell LE, 1981, AM J PHYSIOL, V241, P291; TOYOSHIMA H, 1982, AM J CARDIOL, V49, P1938, DOI 10.1016/0002-9149(82)90213-2; Viragh S, 1973, ULTRASTRUCTURE MAMMA, P43; Yamaguchi T, 2009, J ARRHYTHMIA, V25, P24	18	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2014	47	4					233	239		10.1007/s00795-014-0069-9		7	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	AW3KO	WOS:000346185800008		
J	Kusafuka, K; Onitsuka, T; Miki, T; Murai, C; Suda, T; Fuke, T; Kamijo, T; Iida, Y; Nakajima, T				Kusafuka, Kimihide; Onitsuka, Tetsuro; Miki, Tomoko; Murai, Chika; Suda, Toshihito; Fuke, Tomohito; Kamijo, Tomoyuki; Iida, Yoshiyuki; Nakajima, Takashi			Squamous cell carcinoma with rhabdoid features of the gingiva: a case report with unusual histology	MEDICAL MOLECULAR MORPHOLOGY			English	Article						Squamous cell carcinoma; Rhabdoid cells; Gingiva; Acantholysis; Immunohistochemistry	OF-THE-LITERATURE; ORAL-CAVITY; MUCOSA; LIP	Squamous cell carcinoma (SCC) with rhabdoid features (SCCRF) is extremely rare in the oral cavity. We report herein a case of oral SCCRF. The patient was a 69-year-old Japanese woman who had been suffering from a mass in the right lower gingiva. Right hemi-mandibulectomy was performed. The gingival tumor was composed of pleomorphic, non-cohesive ovoid tumor cells with abundant cytoplasm and eccentric nuclei, which were positive for both pan-cytokeratin and vimentin. In another portion, moderately differentiated SCC and carcinoma in situ were also seen. A transition zone existed between the components. Finally, we diagnosed SCCRF. Four months after the operation, multiple bone metastases, lung and skin metastases and marked hypercalcemia were found. SCCRF, therefore, might be more aggressive than the usual type of oral SCC.	[Kusafuka, Kimihide; Miki, Tomoko; Nakajima, Takashi] Shizuoka Canc Ctr, Div Pathol, Nagaizumi, Shizuoka 4118777, Japan; [Onitsuka, Tetsuro; Suda, Toshihito; Fuke, Tomohito; Kamijo, Tomoyuki; Iida, Yoshiyuki] Shizuoka Canc Ctr, Div Head & Neck Surg, Nagaizumi, Shizuoka 4118777, Japan; [Murai, Chika] Shizuoka Canc Ctr, Div Dent & Oral Surg, Nagaizumi, Shizuoka 4118777, Japan	Kusafuka, K (reprint author), Shizuoka Canc Ctr, Div Pathol, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	k.kusafuka@scchr.jp					AIHARA M, 1995, CANCER, V75, P522, DOI 10.1002/1097-0142(19950115)75:2<522::AID-CNCR2820750215>3.0.CO;2-W; Fukumura Y, 2009, PATHOL INT, V59, P322, DOI 10.1111/j.1440-1827.2009.02373.x; Remo A, 2012, INT J SURG PATHOL, V20, P185, DOI 10.1177/1066896911415405; PARHAM DM, 1994, AM J SURG PATHOL, V18, P1010, DOI 10.1097/00000478-199410000-00005; UEYAMA T, 1993, AM J SURG PATHOL, V17, P813, DOI 10.1097/00000478-199308000-00006; Tamboli P, 2004, HUM PATHOL, V35, P8, DOI 10.1016/j.humpath.2003.07.019; Aoyagi S, 2009, J CUTAN PATHOL, V36, P919, DOI 10.1111/j.1600-0560.2009.01192.x; Bayer-Garner IB, 1999, J CUTAN PATHOL, V26, P386, DOI 10.1111/j.1600-0560.1999.tb01862.x; Blackburn TK, 1999, J ORAL MAXIL SURG, V57, P612, DOI 10.1016/S0278-2391(99)90086-1; Driemel Oliver, 2008, Head Face Med, V4, P17, DOI 10.1186/1746-160X-4-17; GOLDMAN RL, 1977, ARCH OTOLARYNGOL, V103, P496; JACOWAY JR, 1971, ORAL SURG ORAL MED O, V32, P444, DOI 10.1016/0030-4220(71)90205-2; Johnson N, 2005, TUMOURS SALIVARY GLA, P168; Jones AC, 1933, J ORAL MAXILLOFAC SU, V51, P676; Kerawala CJ, 2009, BRIT J ORAL MAX SURG, V47, P123, DOI 10.1016/j.bjoms.2008.04.018; Kuroda N, 2007, MED MOL MORPHOL, V40, P168, DOI 10.1007/s00795-006-0349-0; Kusafuka K, 2006, PATHOL INT, V56, P78, DOI 10.1111/j.1440-1827.2006.01927.x; Kusafuka K, 2014, HEAD NECK-J SCI SPEC, V36, pE28, DOI 10.1002/hed.23466; Leboit PE, 2006, WHO CLASSIFICATION T; Nanadyala P-A, 2013, DIAG CYTOL, V41, P159; Papadopoulou E, 2010, ORAL SURG ORAL MED O, V109, pE67, DOI 10.1016/j.tripleo.2010.01.019; TAKAGI M, 1977, CANCER, V40, P2250, DOI 10.1002/1097-0142(197711)40:5<2250::AID-CNCR2820400535>3.0.CO;2-M; Terada T, 2012, INT J CLIN EXP PATHO, V5, P442; TOMICH CE, 1972, J ORAL SURG, V30, P592; Urdiales-Viedma Mariano, 2002, Ann Diagn Pathol, V6, P381, DOI 10.1053/adpa.2002.36654; Weitzer S, 1973, ORAL SURG ORAL MED O, V37, P589; ZAATARI GS, 1986, ARCH PATHOL LAB MED, V110, P542; Zidar N, 2006, J CLIN PATHOL, V59, P1206, DOI 10.1136/jcp.2005.029553	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1860-1480	1860-1499		MED MOL MORPHOL	Med. Mol. Morphol.	DEC	2014	47	4					240	245		10.1007/s00795-013-0066-4		6	Biology; Microscopy; Pathology	Life Sciences & Biomedicine - Other Topics; Microscopy; Pathology	AW3KO	WOS:000346185800009		
J	Melnikov, DE; Watanabe, T; Matsugase, T; Ueno, I; Shevtsova, V				Melnikov, D. E.; Watanabe, T.; Matsugase, T.; Ueno, I.; Shevtsova, V.			Experimental Study on Formation of Particle Accumulation Structures by a Thermocapillary Flow in a Deformable Liquid Column	MICROGRAVITY SCIENCE AND TECHNOLOGY			English	Article						Marangoni convection; Thermocapillary flow; Liquid bridge; Dynamics of particles; Coherent structures; PAS	OSCILLATORY MARANGONI-CONVECTION; TIME-SERIES; BRIDGE; INSTABILITY; ZONE; NUMBER; TEMPERATURE; GRAVITY; MOTION; ONSET	A series of experiments has been performed under earth's gravity to study formation of particle accumulation structures (PAS) in a supercritical flow driven by the combined effects of buoyancy and thermocapillary forces. The test flow was created in a non-isothermal cylindrical column (liquid bridge) made of n-decane and heated from above. The objective of the experiment was to answer two major questions: (1) how strong is the influence of the shape of the interface on the process of formation of PAS; (2) what temperature of the ambient air fits better for PAS to occur. Considering these questions, we developed a method based on changing both the volume of the liquid bridge and temperature at the external walls of the experimental chamber to set and to keep constant the shape of the interface and the temperature inside the setup, respectively. The experimental observations are presented in the form of diagrams in the parameters' space showing ranges of the PAS formation. The findings show that a liquid bridge with an interface as close to the straight cylindrical as possible and surrounded by air at low temperature is the best terrain for PAS formation. The results of the chaos analysis of the recorded temperature time series and their correlation with the obtained diagrams allow for showing that accumulation of particles in coherent structures is possible only in a periodic oscillatory flow characterized by a small value of the translation error not exceeding 0.01. It is demonstrated that presence of either any spectral noise or of several modes with incommensurate frequencies makes formation of a PAS impossible.	[Melnikov, D. E.; Shevtsova, V.] Univ Libre Bruxelles, MRC, B-1050 Brussels, Belgium; [Watanabe, T.; Matsugase, T.; Ueno, I.] Tokyo Univ Sci, Noda, Chiba 278, Japan	Melnikov, DE (reprint author), Univ Libre Bruxelles, MRC, CP 165-62,50 Ave FD Roosevelt, B-1050 Brussels, Belgium.	dmelniko@ulb.ac.be; a7508151@rs.tus.ac.jp; a7509104@rs.tus.ac.jp; ich@rs.tus.ac.jp; vshev@ulb.ac.be			Japan Society for the Promotion of Science (JSPS) [21360101, 24360078]; Center for Promotion of Internationalization, Tokyo University of Science; Belgian Science Policy Office, ESA-PRODEX program; Japanese-European Research Experiment on Marangoni Instability (JEREMI)	The authors greatly appreciate the financial supports from the Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research (B) (the project # : 21360101, 24360078). The author Takumi Watanabe would like to thank the Center for Promotion of Internationalization, Tokyo University of Science for the financial support of the international activities which allowed him to travel and to stay at the MRC, ULB. We would like to gratefully acknowledge the Belgian Science Policy Office, ESA-PRODEX program for supporting the Japanese-European Research Experiment on Marangoni Instability (JEREMI) for supporting the scientific collaboration between Japan and the European Union and for making it possible for students from Japan to come to Universite Libre de Bruxelles to perform their joint projects.	Melnikov DE, 2014, INT J HEAT MASS TRAN, V74, P185, DOI 10.1016/j.ijheatmasstransfer.2014.02.058; WAYLAND R, 1993, PHYS REV LETT, V70, P580, DOI 10.1103/PhysRevLett.70.580; Shinbrot T, 2001, PHYS REV LETT, V86, P1207, DOI 10.1103/PhysRevLett.86.1207; Di Carlo D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.094503; Cao LY, 1997, PHYSICA D, V110, P43, DOI 10.1016/S0167-2789(97)00118-8; CHUN CH, 1979, ACTA ASTRONAUT, V6, P1073, DOI 10.1016/0094-5765(79)90056-0; Hofmann E., 2011, PHYS FLUIDS, V23; Irikura M, 2005, MICROGRAVITY SCI TEC, V16, P176, DOI 10.1007/BF02945971; Kuhlmann H.C., 2012, PHYS REV E, V85; Kuhlmann HC, 2011, EUR PHYS J-SPEC TOP, V192, P3, DOI 10.1140/epjst/e2011-01355-9; Kuhlmann H.C., 2014, FLUID DYN MAT PROCES, V10, P1; Lappa M., 2013, PHYS FLUIDS, V25; Lappa M, 2013, J FLUID MECH, V726, P160, DOI 10.1017/jfm.2013.203; Lappa M., 2014, PHYS FLUIDS, V26; Lappa M., 2013, CHAOS, V23; Leypoldt J, 2000, J FLUID MECH, V414, P285, DOI 10.1017/S0022112000008570; Melnikov D., 2012, J JPN SOC MICROGRAVI, V29, P77; Melnikov D, 2013, MICROGRAVITY SCI TEC, V25, P1, DOI 10.1007/s12217-012-9319-4; Melnikov D, 2011, EUR PHYS J-SPEC TOP, V192, P29, DOI 10.1140/epjst/e2011-01357-7; Melnikov DE, 2004, PHYS FLUIDS, V16, P1746, DOI 10.1063/1.1699135; Melnikov DE, 2005, ADV SPACE RES, V36, P43, DOI 10.1016/j.asr.2005.02.078; Melnikov DE, 2006, MICROGRAVITY SCI TEC, V18, P128; Muehlner KA, 1997, PHYS FLUIDS, V9, P1850, DOI 10.1063/1.869304; Mukin RV, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.053016; Muldoon FH, 2013, PHYSICA D, V253, P40, DOI 10.1016/j.physd.2013.02.010; Pushkin DO, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.234501; Schwabe D, 2006, MICROGRAVITY SCI TEC, V18, P117, DOI 10.1007/BF02870393; Schwabe D., 2007, PHYS FLUIDS, V19; SCHWABE D, 1979, J CRYST GROWTH, V46, P125, DOI 10.1016/0022-0248(79)90119-2; Schwabe D, 1996, MICROGRAVITY SCI TEC, V9, P163; Shevtsova V, 2005, J CRYST GROWTH, V280, P632, DOI 10.1016/j.jcrysgro.2005.03.092; Shevtsova VM, 2003, ADV SPACE RES, V32, P155, DOI 10.1016/S0273-1177(03)00378-8; Shevtsova VM, 1998, PHYS FLUIDS, V10, P1621, DOI 10.1063/1.869681; Shevtsova VM, 2003, LECT NOTES PHYS, V628, P241; Shevtsova VM, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066311; Shevtsova VM, 2001, PHYS FLUIDS, V13, P2851, DOI 10.1063/1.1396669; Takens F., 1981, LECT NOTES MATH, V898, P366, DOI DOI 10.1007/BFB0091924; Tanaka S., 2006, PHYS FLUIDS, V18; Tirumkudulu M, 1999, PHYS FLUIDS, V11, P507, DOI 10.1063/1.869923; Ueno I, 2008, ADV SPACE RES, V41, P2145, DOI 10.1016/j.asr.2007.08.039; Ueno I, 2003, PHYS FLUIDS, V15, P408, DOI 10.1063/1.1531993; WANSCHURA M, 1995, PHYS FLUIDS, V7, P912, DOI 10.1063/1.868567; Watanabe T, 2014, MICROGRAVITY SCI TEC, V26, P17, DOI 10.1007/s12217-014-9367-z; Yasnou V, 2012, MICROGRAVITY SCI TEC, V24, P411, DOI 10.1007/s12217-012-9314-9	44	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-0108	1875-0494		MICROGRAVITY SCI TEC	Microgravity Sci. Technol.	DEC	2014	26	6					365	374		10.1007/s12217-014-9405-x		10	Engineering, Aerospace; Thermodynamics; Mechanics	Engineering; Thermodynamics; Mechanics	AW3KP	WOS:000346185900002		
J	Xu, Q; Xu, N; Xu, H; Tang, L; Liu, J; Sun, J; Wang, JY				Xu, Quan; Xu, Na; Xu, Hai; Tang, Liang; Liu, Jin; Sun, Jian; Wang, Jiayu			Breeding value estimation of the application of IPA1 and DEP1 to improvement of Oryza sativa L. ssp japonica in early hybrid generations	MOLECULAR BREEDING			English	Article						IPA1; DEP1; Yield components; Gene combination; High-yield breeding	PLANT ARCHITECTURE; NATURAL VARIATION; GREEN-REVOLUTION; GRAIN WIDTH; MAJOR QTL; RICE; YIELD; IDENTIFICATION; OSSPL14; PROTEIN	Rice (Oryza sativa L.) is a major food component of over half of the world's population, and increased grain yield is a major goal of rice production. Two important yield-related genes are DEP1, regulating inflorescence internode length, and IPA1, involved in plant architecture. The dep1 allele gives rise to a dense, erect panicle shape, while the ipa1 allele leads to a reduced number of tillers and an increased number of grains per panicle. In this study, we focused on the breeding effects of dep1 and ipa1 using two F2 populations derived from cultivars carrying these alleles. Analysis of yield components in the F2 populations revealed that dep1 and ipa1 have contradictory effects, with the exception of number of panicles and spikelet density. The two dep1 and ipa1 alleles can offset each other's negative advantage for some traits. The performance of yield components is consistent with the requirements of ideal plant type in northeast China once the individuals are heterozygous at two loci. By considering genetic analysis data and previous studies, we speculate that DEP1 and IPA1 loci make genetic contributions of additive, dominance and epistasis effects to yield components. Our results should provide a valuable reference for developing hybrid japonica rice by direct application of F1 plants heterozygous at the two loci and for shortening the breeding period for conventional japonica rice by rapidly fixing superior genotype combinations in early hybrid generations.	[Xu, Quan; Xu, Na; Xu, Hai; Tang, Liang; Liu, Jin; Wang, Jiayu] Shenyang Agr Univ, Key Lab Northern Japon Rice Genet & Breeding, Key Lab Northeast Rice Biol & Genet & Breeding, Rice Res Inst,Minist Educ & Liaoning Prov,Minist, Shenyang 110866, Peoples R China; [Sun, Jian] Natl Inst Agrobiol Sci NIAS, Rice Appl Genom Res Unit, Agrogen Res Ctr, Tsukuba, Ibaraki 3058602, Japan	Wang, JY (reprint author), Shenyang Agr Univ, Key Lab Northern Japon Rice Genet & Breeding, Key Lab Northeast Rice Biol & Genet & Breeding, Rice Res Inst,Minist Educ & Liaoning Prov,Minist, Shenyang 110866, Peoples R China.	sunjian@affrc.go.jp; ricewjy@126.com			'Major Science and Technology Projects for New GMO Breeding' program [2011ZX08001-004, 2014ZX08001-004]	This work was supported by Grants from the 'Major Science and Technology Projects for New GMO Breeding' program (2011ZX08001-004 and 2014ZX08001-004).	Zhou Y, 2009, GENETICS, V183, P315, DOI 10.1534/genetics.109.102681; Khush GS, 1999, GENOME, V42, P646, DOI 10.1139/gen-42-4-646; Miura K, 2010, NAT GENET, V42, P545, DOI 10.1038/ng.592; Lu ZF, 2013, PLANT CELL, V25, P3743, DOI 10.1105/tpc.113.113639; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; Oikawa T, 2009, PLANT CELL, V21, P1095, DOI 10.1105/tpc.108.065425; Huang XZ, 2009, NAT GENET, V41, P494, DOI 10.1038/ng.352; Shomura A, 2008, NAT GENET, V40, P1023, DOI 10.1038/ng.169; Yan CJ, 2007, THEOR APPL GENET, V115, P1093, DOI 10.1007/s00122-007-0635-9; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Doyle J. J., 1991, NATO ASI SERIES H, V57, P283, DOI DOI 10.1007/978-3-642-83962-7_; Jianlin W, 2004, CHIN AGR SCI B, V5, P040; Sun J, 2012, THEOR APPL GENET, V125, P1149, DOI 10.1007/s00122-012-1901-z; VIRMANI SS, 1982, THEOR APPL GENET, V63, P373, DOI 10.1007/BF00303911; Wang JY, 2009, THEOR APPL GENET, V119, P85, DOI 10.1007/s00122-009-1019-0; Yuan LP, 1998, 31 IPRI, P10; Yuan LP, 1998, ADV HYBRID RICE TECH, P27; Zhu J, 1999, J ZHEJIANG U AGR LIF, V26, P1	23	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-3743	1572-9788		MOL BREEDING	Mol. Breed.	DEC	2014	34	4					1933	1942		10.1007/s11032-014-0150-z		10	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	AW0GU	WOS:000345970200031		
J	Park, YJ; Nishikawa, T; Matsushima, K; Minami, M; Tomooka, N; Nemoto, K				Park, Young-Jun; Nishikawa, Tomotaro; Matsushima, Kenichi; Minami, Mineo; Tomooka, Norihiko; Nemoto, Kazuhiro			Molecular characterization and genetic diversity of the starch branching enzyme (SBE) gene from Amaranthus: the evolutionary origin of grain amaranths	MOLECULAR BREEDING			English	Article						Amaranthus; Nuclear gene; Phylogenetic; Starch branching enzyme	PHYLOGENETIC UTILITY; RAPD ANALYSIS; ALLOZYME VARIATION; WILD; SYNTHASE; IDENTIFICATION; ORGANIZATION; PROTEINS; PLANTS; L.	Full-length genomic DNA clones encoding starch branching enzymes (SBEs) from three cultivated grain amaranths were isolated and characterized. A sequence analysis showed that the SBE genes from Amaranthus caudatus, A. cruentus, and A. hypochondriacus, viz. SBE-ca, SBE-cr, and SBE-hy, respectively, contained the same exon and intron structure and consisted of 961 amino acids with molecular weights of approximately 108.4 kDa. The lengths of the genes were 7,446 (SBE-ca), 7,453 (SBE-cr), and 7,443 bp (SBE-hy), and they are highly homologous. We also tested, for the first time, the potential use of SBE from diverse genetic sources to answer long-standing questions on the origin of grain amaranths. The maximum parsimony tree based on the SBE sequence data suggests that A. hybridus is the progenitor wild species of grain amaranths. The results could be summarized as follows: (1) the A. hybridus species comprise all grain amaranths, which can then be divided into two subgroups; (2) A. caudatus and A. hypochondriacus and/or A. caudatus and A. quitensis appear to be closely related to each other; (3) A. powellii was the most distantly related to the other five species in the A. hybridus complex. These results indicate that A. hybridus is the ancestor species in at least two separate domestication events, lending support to the theory of three separate, rather than one, domestication events involving A. hybridus as the common ancestor. A new approach to investigating the genetic diversity in Amaranthus using the nuclear gene SBE provided useful information on the evolutionary origin of three cultivated species.	[Park, Young-Jun; Nishikawa, Tomotaro; Tomooka, Norihiko] Natl Inst Agrobiol Sci, Genet Resources Ctr, Ibaraki 3058602, Japan	Nemoto, K (reprint author), Shinshu Univ, Grad Sch Agr, 8304 Minami Minowa, Nagano 3994598, Japan.	knemoto@shinshu-u.ac.jp					Lanoue KZ, 1996, THEOR APPL GENET, V93, P722, DOI 10.1007/BF00224068; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Costea M, 2006, GENET RESOUR CROP EV, V53, P1625, DOI 10.1007/s10722-005-2288-3; GUPTA VK, 1991, EUPHYTICA, V52, P33; ALDRICH PR, 1992, THEOR APPL GENET, V85, P451, DOI 10.1007/BF00222327; HAUPTLI H, 1984, THEOR APPL GENET, V69, P153, DOI 10.1007/BF00272889; Kim KN, 1998, GENE, V216, P233, DOI 10.1016/S0378-1119(98)00339-4; Han Y, 2007, MOL PHYLOGENET EVOL, V43, P852, DOI 10.1016/j.ympev.2006.09.001; Xu FX, 2001, MOL PHYLOGENET EVOL, V21, P372, DOI 10.1006/mpev.2001.1016; Chan KF, 1997, THEOR APPL GENET, V95, P865, DOI 10.1007/s001220050637; Bailey CD, 1999, MOL PHYLOGENET EVOL, V13, P20, DOI 10.1006/mpev.1999.0627; Ray T, 2009, J HERED, V100, P338, DOI 10.1093/jhered/esn102; TRANSUE DK, 1994, CROP SCI, V34, P1385; Zheleznov AV, 1997, EUPHYTICA, V97, P177, DOI 10.1023/A:1003073804203; KAWASAKI T, 1993, GENE, V129, P183, DOI 10.1016/0378-1119(93)90267-7; Das S, 2012, GENET RESOUR CROP EV, V59, P289, DOI 10.1007/s10722-011-9684-7; CAMPBELL WH, 1990, PLANT PHYSIOL, V92, P1, DOI 10.1104/pp.92.1.1; Costea Mihai, 2001, SIDA Contributions to Botany, V19, P931; Emshwiller E, 1999, MOL PHYLOGENET EVOL, V12, P310, DOI 10.1006/mpev.1999.0613; Kietlinski KD, 2014, CROP SCI, V54, P220, DOI 10.2135/cropsci2013.03.0173; Lewis CE, 2001, MOL PHYLOGENET EVOL, V19, P409, DOI 10.1006/mpev.2001.0932; Lu B, 2006, THESIS U HONG KONG H; Mason-Gamer RJ, 1998, MOL BIOL EVOL, V15, P1658; Ohnishi O, 1999, GENET RESOUR CROP EV, V46, P389, DOI 10.1023/A:1008640522979; Pal M., 1974, Evolutionary Studies in World Crops., P129; Peralta IE, 2001, AM J BOT, V88, P1888, DOI 10.2307/3558365; Rahman S, 1999, THEOR APPL GENET, V98, P156, DOI 10.1007/s001220051052; SAUER JONATHAN D., 1967, ANN MO BOT GARD, V54, P103, DOI 10.2307/2394998; Saunders R. M., 1984, Advances in Cereal Science and Technology, V6, P357; Smith A. M., 1997, Annual Review of Plant Physiology and Plant Molecular Biology, V48, P67, DOI 10.1146/annurev.arplant.48.1.67; Swofford D, 1988, PAUP PHYLOGENETIC AN	32	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-3743	1572-9788		MOL BREEDING	Mol. Breed.	DEC	2014	34	4					1975	1985		10.1007/s11032-014-0156-6		11	Agronomy; Plant Sciences; Genetics & Heredity; Horticulture	Agriculture; Plant Sciences; Genetics & Heredity	AW0GU	WOS:000345970200035		
J	Ibuki, N; Ghaffari, M; Reuveni, H; Pandey, M; Fazli, L; Azuma, H; Gleave, ME; Levitzki, A; Cox, ME				Ibuki, Naokazu; Ghaffari, Mazyar; Reuveni, Hadas; Pandey, Mitali; Fazli, Ladan; Azuma, Haruhito; Gleave, Martin E.; Levitzki, Alexander; Cox, Michael E.			The Tyrphostin NT157 Suppresses Insulin Receptor Substrates and Augments Therapeutic Response of Prostate Cancer	MOLECULAR CANCER THERAPEUTICS			English	Article							FACTOR-I RECEPTOR; GROWTH-FACTOR RECEPTOR; IRS PROTEINS; CELL-LINE; IGF-I; EXPRESSION; CHEMOTHERAPY; PROGRESSION; COMPONENTS; INHIBITORS	Insulin-like growth factor (IGF) signaling is associated with castrate-resistant prostate cancer (CRPC) progression. Insulin receptor substrates 1 and 2 (IRS1/2) mediate mitogenic and antiapoptotic signaling from IGF1 receptor (IGF1R), insulin receptor, and other oncoproteins. This study demonstrates that IRS1/2 expression is increased in prostate cancer, and persists in CRPC. Furthermore, this study assesses the anticancer activity of NT157, a small molecule tyrphostin targeting IRS proteins, using androgen-responsive (LNCaP) and -independent (PC3) prostate cancer cells in vitro and in vivo. NT157 treatment resulted in dose-dependent inhibition of IGF1R activation, suppression of IRS protein expression, inhibition of IGF1-induced AKT activation, but increased ERK activation in NT157-treated cells in vitro. These effects were correlated with decreased proliferation and increasing apoptosis of LNCaP cells and increasing G(2)-M arrest in PC3 cells. NT157 also suppressed androgen-responsive growth, delayed CRPC progression of LNCaP xenografts, and suppressed PC3 tumor growth alone and in combination with docetaxel. This study reports the first preclinical proof-of-principle data that this novel small molecule tyrosine kinase inhibitor suppresses IRS1/2 expression, delays CRPC progression, and suppresses growth of CRPC tumors in vitro and in vivo. Demonstration that IRS expression can be increased in response to a variety of stressors that may lead to resistance or reduced effect of the therapies indicate that NT157-mediated IRS1/2 downregulation is a novel therapeutic approach for management of advanced prostate cancer. (C) 2014 AACR.	[Ibuki, Naokazu; Ghaffari, Mazyar; Pandey, Mitali; Fazli, Ladan; Gleave, Martin E.; Cox, Michael E.] Vancouver Gen Hosp, Vancouver Prostate Ctr, Vancouver, BC, Canada; [Ibuki, Naokazu; Azuma, Haruhito] Osaka Med Coll, Dept Urol, Osaka, Japan; [Ghaffari, Mazyar] Univ British Columbia, Dept Med, Vancouver, BC V5Z 1M9, Canada; [Reuveni, Hadas] TyrNovo Ltd, Herzliyya, Israel; [Reuveni, Hadas; Levitzki, Alexander] Hebrew Univ Jerusalem, Dept Biol Chem, Unit Cellular Signaling, Jerusalem, Israel; [Gleave, Martin E.; Cox, Michael E.] Univ British Columbia, Dept Urol Sci, Vancouver, BC, Canada	Cox, ME (reprint author), Vancouver Gen Hosp, Vancouver Prostate Ctr, 2660 Oak St, Vancouver, BC, Canada.	mcox@prostatecentre.com			Canadian Cancer Society; Canadian Institute for Health Research Doctoral Fellowship	This study was supported by operating grant funding from the Canadian Cancer Society to M.E. Cox and a Canadian Institute for Health Research Doctoral Fellowship to M. Ghaffari.	Sachdev D, 2004, J BIOL CHEM, V279, P5017, DOI 10.1074/jbc.M305403200; Ozkan EE, 2011, MOL CELL ENDOCRINOL, V344, P1, DOI 10.1016/j.mce.2011.07.002; Boura-Halfon S, 2009, VITAM HORM, V80, P313, DOI 10.1016/S0083-6729(08)00612-2; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Reuveni H, 2013, CANCER RES, V73, P4383, DOI 10.1158/0008-5472.CAN-12-3385; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203; Pollak M, 2000, EUR J CANCER, V36, P1224, DOI 10.1016/S0959-8049(00)00102-7; Liao YD, 2005, HUM PATHOL, V36, P1186, DOI 10.1016/j.humpath.2005.07.023; Antonarakis ES, 2010, CANCER LETT, V291, P1, DOI 10.1016/j.canlet.2009.08.012; Papatsoris AG, 2005, TRENDS MOL MED, V11, P52, DOI 10.1016/j.molmed.2004.12.005; Patterson SG, 2006, ONCOGENE, V25, P6113, DOI 10.1038/sj.onc.1209632; SUN XJ, 1991, NATURE, V352, P73, DOI 10.1038/352073a0; Buck E, 2008, CANCER RES, V68, P8322, DOI 10.1158/0008-5472.CAN-07-6720; Hellawell GO, 2002, CANCER RES, V62, P2942; Sowery RD, 2008, BJU INT, V102, P389, DOI 10.1111/j.1464-410X.2008.07618.x; White MF, 1998, CURR TOP MICROBIOL, V228, P179; Shaw LM, 2011, CELL CYCLE, V10, P1750, DOI 10.4161/cc.10.11.15824; Tanaka S, 1996, CANCER RES, V56, P3391; Szabolcs M, 2009, AM J PATHOL, V174, P276, DOI 10.2353/ajpath.2009.080086; Leung SYL, 2000, PROSTATE, V44, P156, DOI 10.1002/1097-0045(20000701)44:2<156::AID-PROS8>3.0.CO;2-8; Cui XJ, 2006, CANCER RES, V66, P5304, DOI 10.1158/0008-5472.CAN-05-2858; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; Chan JM, 2002, J NATL CANCER I, V94, P1099; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Attard G, 2006, BRIT J CANCER, V95, P767, DOI 10.1038/sj.bjc.6603223; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Fritsche L, 2011, AM J PHYSIOL-ENDOC M, V300, P23; Furukawa J, 2010, PROSTATE, V70, P206, DOI 10.1002/pros.21054; Geck P, 2000, P NATL ACAD SCI USA, V97, P10185, DOI 10.1073/pnas.97.18.10185; Gleave ME, 2010, DRUG MANAGEMENT OF PROSTATE CANCER, P1, DOI 10.1007/978-1-60327-829-4_1; Heni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050953; Huang SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041219; Jansen B, 1998, NAT MED, V4, P232, DOI 10.1038/nm0298-232; Krueckl SL, 2004, CANCER RES, V64, P8620, DOI 10.1158/0008-5472.CAN-04-2446; Lubik AA, 2011, CANCER RES, V71, P5754, DOI 10.1158/0008-5472.CAN-10-2470; Mardilovich K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-14; Moreau JP, 2006, CLIN THER, V28, P1485, DOI 10.1016/j.clinthera.2006.10.018; Mulholland DJ, 2004, PROSTATE, V59, P115, DOI 10.1002/pros.20059; Porter HA, 2012, EXP CELL RES, V318, P1745, DOI 10.1016/j.yexcr.2012.04.020; Reiss K, 2000, ONCOGENE, V19, P2687, DOI 10.1038/sj.onc.1203587; Ryan CJ, 2007, UROL ONCOL-SEMIN ORI, V25, P134, DOI 10.1016/j.urolonc.2006.07.019; Schayek H, 2010, EXP CELL RES, V316, P1479, DOI 10.1016/j.yexcr.2010.03.007; Takahara K, 2013, PROSTATE CANCER P D, V16, P239, DOI 10.1038/pcan.2013.14; Takahara K, 2011, PROSTATE, V71, P525, DOI 10.1002/pros.21268; Yamauchi T, 1998, J BIOL CHEM, V273, P15719, DOI 10.1074/jbc.273.25.15719	45	2	2	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	DEC	2014	13	12					2827	2839		10.1158/1535-7163.MCT-13-0842		13	Oncology	Oncology	AW2QH	WOS:000346132900006		
J	Kodama, T; Tsukaguchi, T; Satoh, Y; Yoshida, M; Watanabe, Y; Kondoh, O; Sakamoto, H				Kodama, Tatsushi; Tsukaguchi, Toshiyuki; Satoh, Yasuko; Yoshida, Miyuki; Watanabe, Yoshiaki; Kondoh, Osamu; Sakamoto, Hiroshi			Alectinib Shows Potent Antitumor Activity against RET-Rearranged Non-Small Cell Lung Cancer	MOLECULAR CANCER THERAPEUTICS			English	Article							MEDULLARY-THYROID CANCER; TYROSINE KINASE INHIBITOR; IN-VIVO; CCDC6-RET FUSION; GENE FUSIONS; ALK; MUTATION; ADENOCARCINOMA; IDENTIFICATION; CABOZANTINIB	Alectinib/CH5424802 is a known inhibitor of anaplastic lymphoma kinase (ALK) and is being evaluated in clinical trials for the treatment of ALK fusion-positive non-small cell lung cancer (NSCLC). Recently, some RET and ROS1 fusion genes have been implicated as driver oncogenes in NSCLC and have become molecular targets for antitumor agents. This study aims to explore additional target indications of alectinib by testing its ability to inhibit the activity of kinases other than ALK. We newly verified that alectinib inhibited RET kinase activity and the growth of RET fusion-positive cells by suppressing RET phosphorylation. In contrast, alectinib hardly inhibited ROS1 kinase activity unlike other ALK/ROS1 inhibitors such as crizotinib and LDK378. It also showed antitumor activity in mouse models of tumors driven by the RET fusion. In addition, alectinib showed kinase inhibitory activity against RET gatekeeper mutations (RET V804L and V804M) and blocked cell growth driven by the KIF5B-RET V804L and V804M. Our results suggest that alectinib is effective against RET fusion-positive tumors. Thus, alectinib might be a therapeutic option for patients with RET fusion-positive NSCLC. (C)2014 AACR.	[Kodama, Tatsushi; Tsukaguchi, Toshiyuki; Satoh, Yasuko; Yoshida, Miyuki; Watanabe, Yoshiaki; Kondoh, Osamu; Sakamoto, Hiroshi] Chugai Pharmaceut Co Ltd, Div Res, Kamakura, Kanagawa 2478530, Japan	Sakamoto, H (reprint author), Chugai Pharmaceut Co Ltd, Div Res, 200 Kajiwara, Kamakura, Kanagawa 2478530, Japan.	sakamotohrs@chugai-pharm.co.jp					Albert L, 2003, J CELL PHYSIOL, V195, P168, DOI 10.1002/jcp.10252; Chu YF, 1996, J BIOL CHEM, V271, P6497; Bentzien F, 2013, THYROID, V23, P1569, DOI 10.1089/thy.2013.0137; Trudel S, 2005, BLOOD, V105, P2941, DOI 10.1182/blood-2004-10-3913; Wells SA, 2010, J CLIN ONCOL, V28, P767, DOI 10.1200/JCO.2009.23.6604; Houvras Y, 2012, J CLIN ONCOL, V30, P200, DOI 10.1200/JCO.2011.38.7639; Suzuki M, 2013, CANCER SCI, V104, P896, DOI 10.1111/cas.12175; Lovly CM, 2011, CANCER RES, V71, P4920, DOI 10.1158/0008-5472.CAN-10-3879; Seto T, 2013, LANCET ONCOL, V14, P590, DOI 10.1016/S1470-2045(13)70142-6; Schulte KM, 2010, J CLIN ENDOCR METAB, V95, pE92, DOI 10.1210/jc.2010-0375; Hart CD, 2013, ONCOTARGETS THER, V6, P1, DOI 10.2147/OTT.S27671; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Drilon A, 2013, CANCER DISCOV, V3, P630, DOI 10.1158/2159-8290.CD-13-0035; Cortes J, 2007, BLOOD, V110, P4005, DOI 10.1182/blood-2007-03-080838; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Okamoto K, 2010, CANCER RES, V70, P10402, DOI 10.1158/0008-5472.CAN-10-2438; Friboulet L, 2014, CANCER DISCOV, V4, P662, DOI 10.1158/2159-8290.CD-13-0846; Robinson ES, 2010, CLIN J AM SOC NEPHRO, V5, P477, DOI 10.2215/CJN.08111109; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155; Ou SHI, 2011, DRUG DES DEV THER, V5, P471, DOI 10.2147/DDDT.S19045; Sakamoto H, 2011, CANCER CELL, V19, P679, DOI 10.1016/j.ccr.2011.04.004; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Bongarzone I, 1998, CLIN CANCER RES, V4, P223; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Chen JY, 2013, J MED CHEM, V56, P5673, DOI 10.1021/jm401005u; Matsui J, 2008, INT J CANCER, V122, P664, DOI 10.1002/ijc.23131; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Gild ML, 2011, NAT REV ENDOCRINOL, V7, P617, DOI 10.1038/nrendo.2011.141; Yasuda H, 2012, J THORAC ONCOL, V7, P1086, DOI 10.1097/JTO.0b013e3182570919; Matsubara D, 2012, J THORAC ONCOL, V7, P1872, DOI 10.1097/JTO.0b013e3182721ed1; Arkell RS, 2008, CELL SIGNAL, V20, P836, DOI 10.1016/j.cellsig.2007.12.014; Ben-Ami I, 2009, HUM REPROD, V24, P176, DOI 10.1093/humrep/den359; CARLOMAGNO F, 1995, BIOCHEM BIOPH RES CO, V207, P1022, DOI 10.1006/bbrc.1995.1287; Elisei R, 2004, J CLIN ENDOCR METAB, V89, P3579, DOI 10.1210/jc.2003-031898; Gozgit JM, 2013, CANC RES S, V73; Guo T, 2007, CLIN CANCER RES, V13, P4874, DOI 10.1158/1078-0432.CCR-07-0484; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lovly CM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003728; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Solomon B, 2013, CLIN PHARMACOL THER, V95, P15, DOI DOI 10.1038/CLPT.2013.200	42	11	11	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	DEC	2014	13	12					2910	2918		10.1158/1535-7163.MCT-14-0274		9	Oncology	Oncology	AW2QH	WOS:000346132900013		
J	Gao, R; Shah, N; Lee, JS; Katiyar, SP; Li, L; Oh, E; Sundar, D; Yun, CO; Wadhwa, R; Kaul, SC				Gao, Ran; Shah, Navjot; Lee, Jung-Sun; Katiyar, Shashank P.; Li, Ling; Oh, Eonju; Sundar, Durai; Yun, Chae-Ok; Wadhwa, Renu; Kaul, Sunil C.			Withanone-Rich Combination of Ashwagandha Withanolides Restricts Metastasis and Angiogenesis through hnRNP-K	MOLECULAR CANCER THERAPEUTICS			English	Article							NUCLEAR RIBONUCLEOPROTEIN K; BREAST-CANCER CELLS; GROWTH-FACTOR VEGF; MATRIX METALLOPROTEINASES; MOLECULAR-DYNAMICS; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; LEAF EXTRACT; WITHAFERIN; ACTIVATION	Ashwagandha is an important herb used in the Indian system of traditional home medicine, Ayurveda. Alcoholic extract (i-Extract) from its leaves and its component, withanone, were previously shown to possess anticancer activity. In the present study, we developed a combination of withanone and withaferin A, major withanolides in the i-Extract, that retained the selective cancer cell killing activity and found that it also has significant antimigratory, -invasive, and -angiogenic activities, in both in vitro and in vivo assays. Using bioinformatics and biochemical approaches, we demonstrate that these phytochemicals caused downregulation of migration-promoting proteins hnRNP-K, VEGF, and metalloproteases and hence are candidate natural drugs for metastatic cancer therapy. (C)2014 AACR.	[Gao, Ran; Shah, Navjot; Li, Ling; Wadhwa, Renu; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, AIST, Cell Proliferat Res Grp, Tsukuba, Ibaraki 3058562, Japan; [Gao, Ran; Shah, Navjot; Li, Ling; Wadhwa, Renu; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, AIST, DBT, Int Lab Adv Biomed, Tsukuba, Ibaraki 3058562, Japan; [Lee, Jung-Sun; Oh, Eonju; Yun, Chae-Ok] Hanyang Univ, Coll Engn, Dept Bioengn, Seoul 133791, South Korea; [Katiyar, Shashank P.; Sundar, Durai] Indian Inst Technol, Dept Biochem Engn & Biotechnol, New Delhi, India	Wadhwa, R (reprint author), Natl Inst Adv Ind Sci & Technol, AIST, Cent 4,1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.	renu-wadhwa@aist.go.jp; chaeok@hanyang.ac.kr	Sundar, Durai/F-7671-2012; Yun, Chae-Ok/P-3698-2015		Ministry of Knowledge Economy, Korea [10030051]; Korea Science and Engineering Foundation [2013K1A1A2A02050188, 2013M3A9D3045879, 2010-0029220]; AIST, Japan Special Budget	This work was partly supported by grants from the Ministry of Knowledge Economy, Korea (10030051) and the Korea Science and Engineering Foundation (2013K1A1A2A02050188, 2013M3A9D3045879, 2010-0029220) to C.-O. Yun and AIST, Japan Special Budget to S. C. Kaul and R. Wadhwa.	Sataranatarajan K, 2008, CELL SIGNAL, V20, P969, DOI 10.1016/j.cellsig.2008.01.016; Gao R, 2013, J BIOL CHEM, V288, P15046, DOI 10.1074/jbc.M113.466136; Westermarck J, 1999, FASEB J, V13, P781; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Yu YL, 2004, NAT MED, V10, P175, DOI 10.1038/nm966; Sinha P, 2013, CANCER IMMUNOL IMMUN, V62, P1663, DOI 10.1007/s00262-013-1470-2; Ndlovu MN, 2009, MOL CELL BIOL, V29, P5488, DOI 10.1128/MCB.01657-08; Roy RV, 2013, J NAT PROD, V76, P1909, DOI 10.1021/np400441f; Bachmeier BE, 2005, EXPERT REV ANTICANC, V5, P149, DOI 10.1586/14737140.5.1.149; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Belotti D, 2003, CANCER RES, V63, P5224; Narasimhan P, 2009, STROKE, V40, P1467, DOI 10.1161/STROKEAHA.108.534644; Wei YC, 2009, MODERN PATHOL, V22, P1351, DOI 10.1038/modpathol.2009.107; Deocaris CC, 2013, CURR PHARM DESIGN, V19, P418; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Lu WJ, 2011, INT J CANCER, V129, P1806, DOI 10.1002/ijc.25857; Yang ES, 2011, CHEM-BIOL INTERACT, V190, P9, DOI 10.1016/j.cbi.2011.01.015; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Lee J, 2012, BREAST CANCER RES TR, V136, P45, DOI 10.1007/s10549-012-2239-6; Oh J, 2008, APOPTOSIS, V13, P1494, DOI 10.1007/s10495-008-0273-y; Uribe DJ, 2011, BIOCHEMISTRY-US, V50, P3796, DOI 10.1021/bi101633b; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Case D., 2012, AMBER 12; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Grover A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030890; Grover A, 2011, INT J BIOCHEM CELL B, V44, P496, DOI DOI 10.1016/J.BIOCEL.2011.11.021; Hahm ER, 2012, CANC LETT, V334, P101; Hahm ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023354; Konstantinovsky S, 2012, CLIN EXP METASTAS, V29, P527, DOI 10.1007/s10585-012-9468-2; Lee CC, 2006, J BIOMED SCI, V13, P143, DOI 10.1007/s11373-005-9037-7; Lee DH, 2013, ONCOL REP, V30, P933, DOI 10.3892/or.2013.2487; Lee J, 2010, CARCINOGENESIS, V31, P1991, DOI 10.1093/carcin/bgq175; Li JJ, 2010, ONCOL REP, V24, P965, DOI 10.3892/or_00000943; Meng YX, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-61; Mohan Royce, 2004, Angiogenesis, V7, P115, DOI 10.1007/s10456-004-1026-3; Rah B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044039; Salven P, 1998, INT J CANCER, V79, P144, DOI 10.1002/(SICI)1097-0215(19980417)79:2<144::AID-IJC8>3.3.CO;2-M; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Um Hee Jung, 2012, Biochem Biophys Res Commun, V427, P24, DOI 10.1016/j.bbrc.2012.08.133; Vaishnavi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044419; Wang FQ, 2006, INT J CANCER, V118, P879, DOI 10.1002/ijc.21421; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Yang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075069	47	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	DEC	2014	13	12					2930	2940		10.1158/1535-7163.MCT-14-0324		11	Oncology	Oncology	AW2QH	WOS:000346132900015		
J	Aoyama, A; Katayama, R; Oh-hara, T; Sato, S; Okuno, Y; Fujita, N				Aoyama, Aki; Katayama, Ryohei; Oh-hara, Tomoko; Sato, Shigeo; Okuno, Yasushi; Fujita, Naoya p			Tivantinib (ARQ 197) Exhibits Antitumor Activity by Directly Interacting with Tubulin and Overcomes ABC Transporter-Mediated Drug Resistance	MOLECULAR CANCER THERAPEUTICS			English	Article							DISPLAYS CYTOTOXIC ACTIVITY; TYROSINE KINASE INHIBITOR; HUMAN TUMOR-CELLS; LUNG-CANCER; BIND MET; MULTIDRUG-RESISTANCE; SELECTIVE INHIBITOR; DOSE-ESCALATION; BETA-TUBULIN; IN-VITRO	Tivantinib (ARQ197) was first reported as a highly selective inhibitor of c-MET and is currently being investigated in a phase III clinical trial. However, as recently reported by us and another group, tivantinib showed cytotoxic activity independent of cellular c-MET status and also disrupted microtubule dynamics. To investigate if tivantinib exerts its cytotoxic activity by disrupting microtubules, we quantified polymerized tubulin in cells and xenograft tumors after tivantinib treatment. Consistent with our previous report, tivantinib reduced tubulin polymerization in cells and in mouse xenograft tumors in vivo. To determine if tivantinib directly binds to tubulin, we performed an in vitro competition assay. Tivantinib competitively inhibited colchicine but not vincristine or vinblastine binding to purified tubulin. These results imply that tivantinib directly binds to the colchicine binding site of tubulin. To predict the binding mode of tivantinib with tubulin, we performed computer simulation of the docking pose of tivantinib with tubulin using GOLD docking program. Computer simulation predicts tivantinib fitted into the colchicine binding pocket of tubulin without steric hindrance. Furthermore, tivantinib showed similar IC50 values against parental and multidrug-resistant cells. In contrast, other microtubule-targeting drugs, such as vincristine, paclitaxel, and colchicine, could not suppress the growth of cells overexpressing ABC transporters. Moreover, the expression level of ABC transporters did not correlate with the apoptosis-inducing ability of tivantinib different from other microtubule inhibitor. These results suggest that tivantinib can overcome ABC transporter-mediated multidrug-resistant tumor cells and is potentially useful against various tumors. (C) 2014 AACR.	[Aoyama, Aki; Katayama, Ryohei; Oh-hara, Tomoko; Sato, Shigeo; Fujita, Naoya p] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Tokyo 1358550, Japan; [Aoyama, Aki; Fujita, Naoya p] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Okuno, Yasushi] Kyoto Univ, Grad Sch Med, Kyoto, Japan	Fujita, N (reprint author), Japanese Fdn Canc Res, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	naoya.fujita@jfcr.or.jp			Japan Society for the Promotion of Science KAKENHI [24300344, 22112008, 25710015]; research grant of the Princess Takamatsu Cancer Research Fund	The study was supported in part by Japan Society for the Promotion of Science KAKENHI grant numbers 24300344 and 22112008 (to N. Fujita) and 25710015 (to R. Katayama) and a research grant of the Princess Takamatsu Cancer Research Fund (to N. Fujita).	Loganzo F, 2003, CANCER RES, V63, P1838; Vahdat L, 2008, ONCOLOGIST, V13, P214, DOI 10.1634/theoncologist.2007-0167; Huang SM, 2002, CANCER RES, V62, P4300; Mozzetti S, 2005, CLIN CANCER RES, V11, P298; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Rimassa L, 2013, CLIN CANCER RES, V19, P4290, DOI 10.1158/1078-0432.CCR-13-1321; Munshi N, 2010, MOL CANCER THER, V9, P1544, DOI 10.1158/1535-7163.MCT-09-1173; Rosen LS, 2011, CLIN CANCER RES, V17, P7754, DOI 10.1158/1078-0432.CCR-11-1002; Eathiraj S, 2011, J BIOL CHEM, V286, P20666, DOI 10.1074/jbc.M110.213801; Ling YH, 2007, MOL PHARMACOL, V72, P248, DOI 10.1124/mol.107.034827; Dumontet C, 2010, NAT REV DRUG DISCOV, V9, P790, DOI 10.1038/nrd3253; TSURUO T, 1983, CANCER RES, V43, P2267; Jordan MA, 2005, MOL CANCER THER, V4, P1086, DOI 10.1158/1535-7163.MCT-04-0345; Katayama R, 2013, CANCER RES, V73, P3087, DOI 10.1158/0008-5472.CAN-12-3256; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Chang JY, 2004, MOL PHARMACOL, V65, P77, DOI 10.1124/mol.65.1.77; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; Wagner AJ, 2012, CANCER-AM CANCER SOC, V118, P5894, DOI 10.1002/cncr.27582; [Anonymous], 2014, HEPATIC ONCOL; Michieli P, 2013, NAT REV CLIN ONCOL, V10, P372, DOI 10.1038/nrclinonc.2013.86; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Basilico C, 2013, CLIN CANCER RES, V19, P2381, DOI 10.1158/1078-0432.CCR-12-3459; Yap TA, 2011, J CLIN ONCOL, V29, P1271, DOI 10.1200/JCO.2010.31.0367; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; Hari M, 2003, MOL CANCER THER, V2, P597; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; BECK WT, 1979, CANCER RES, V39, P2070; Yasuda H, 2012, J THORAC ONCOL, V7, P1086, DOI 10.1097/JTO.0b013e3182570919; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nr1317; Katayama R, 2009, CANCER SCI, V100, P2060, DOI 10.1111/j.1349-7006.2009.01288.x; BLAGOSKLONNY MV, 1995, CANCER RES, V55, P4623; Etievant C, 2001, CANCER CHEMOTH PHARM, V48, P62, DOI 10.1007/s002800100275; Goldman JW, 2012, CANCER-AM CANCER SOC, V118, P5903, DOI 10.1002/cncr.27575; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Loe DW, 1998, CANCER RES, V58, P5130; Michieli P, 2013, CLIN CANCER RES, V19, P4291, DOI 10.1158/1078-0432.CCR-13-1534; Ngan VK, 2000, CANCER RES, V60, P5045; Remsing Rix LL, 2013, ACS CHEM BIOL, V9, P353; Scagliotti G, 2013, EUR J CANCER, P49; Schutz FAB, 2011, EXPERT OPIN DRUG SAF, V10, P645, DOI 10.1517/14740338.2011.581660; Tahir SK, 2000, BIOTECHNIQUES, V29, P156	44	5	5	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	DEC	2014	13	12					2978	2990		10.1158/1535-7163.MCT-14-0462		13	Oncology	Oncology	AW2QH	WOS:000346132900019		
J	Saito, N; Sakakibara, K; Sato, T; Friedman, JM; Kufe, DW; VonHoff, DD; Kawabe, T				Saito, Naoya; Sakakibara, Keiichi; Sato, Takuji; Friedman, Jonathan M.; Kufe, Donald W.; VonHoff, Daniel D.; Kawabe, Takumi			CBS9106-Induced CRM1 Degradation Is Mediated by Cullin Ring Ligase Activity and the Neddylation Pathway	MOLECULAR CANCER THERAPEUTICS			English	Article							UBIQUITIN-PROTEASOME SYSTEM; ORDER CHROMOSOME STRUCTURE; MLN4924 INDUCES AUTOPHAGY; NUCLEAR EXPORT; NEDD8-ACTIVATING ENZYME; COP9 SIGNALOSOME; LEPTOMYCIN-B; CANCER-THERAPY; FISSION YEAST; IN-VIVO	Chromosome region maintenance 1 (CRM1) mediates the nuclear export of proteins and mRNAs, and is overexpressed in various cancers. Recent studies have also reported that CRM1 protein expression is a negative prognostic factor in patients with cancer. Therefore, CRM1 is considered a potential target for anticancer therapy. Our previous study demonstrated that CBS9106, a synthetic small-molecular inhibitor of CRM1, decreases CRM1 protein through proteasomal degradation without affecting CRM1 mRNA levels. However, the mechanism by which CRM1 is degraded is not well understood. Here, we demonstrate a novel signaling pathway that plays an important role in CBS9106-induced CRM1 degradation. We found that MLN4924, a selective inhibitor of NEDD8-activating enzyme (NAE), effectively inhibits cullin neddylation and attenuates CBS9106-induced CRM1 degradation in a time- and dose-dependent manner. MLN4924 also attenuated CBS9106-induced nuclear accumulation of Ran-binding protein 1 (RanBP1), cell growth inhibition, and apoptosis. Furthermore, RNAi-mediated knockdown of neddylation pathway proteins (NEDD8 and UBA3) or cullin ring ligase (CRL) component protein (Rbx1) attenuated CRM1 protein degradation and G1 phase cell-cycle arrest by CBS9106. Knockdown of CSN5 or CAND1 also partially inhibited CBS9106-induced CRM1 degradation. These findings demonstrate that CBS9106-induced CRM1 degradation is conferred by CRL activity involving the neddylation pathway, and that this response to CBS9106 leads to cell growth inhibition and apoptosis. (C) 2014 AACR.	[Saito, Naoya; Sakakibara, Keiichi; Sato, Takuji; Friedman, Jonathan M.; Kawabe, Takumi] CanBas Co Ltd, Numazu, Shizuoka 4100801, Japan; [Kufe, Donald W.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [VonHoff, Daniel D.] Translat Genom Res Inst TGen, Phoenix, AZ USA	Kawabe, T (reprint author), CanBas Co Ltd, 2-2-1 Ote Machi, Numazu, Shizuoka 4100801, Japan.	takumi@canbas.co.jp					ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Zhao YC, 2012, NEOPLASIA, V14, P360, DOI 10.1593/neo.12532; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Soucy TA, 2009, CLIN CANCER RES, V15, P3912, DOI 10.1158/1078-0432.CCR-09-0343; Newlands ES, 1996, BRIT J CANCER, V74, P648, DOI 10.1038/bjc.1996.415; Milhollen MA, 2011, CANCER RES, V71, P3042, DOI 10.1158/0008-5472.CAN-10-2122; Shen M, 2013, EXPERT OPIN THER TAR, V17, P1091, DOI 10.1517/14728222.2013.815728; Turner JG, 2013, J CANCER, V4, P614, DOI 10.7150/jca.7080; Buac D, 2013, CURR PHARM DESIGN, V19, P4025; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Mutka SC, 2009, CANCER RES, V69, P510, DOI 10.1158/0008-5472.CAN-08-0858; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Ranganathan P, 2012, BLOOD, V120, P1765, DOI 10.1182/blood-2012-04-423160; Schmidt MW, 2009, MOL CELL, V35, P586, DOI 10.1016/j.molcel.2009.07.024; Sun QX, 2013, P NATL ACAD SCI USA, V110, P1303, DOI 10.1073/pnas.1217203110; Turner JG, 2012, BIOCHEM PHARMACOL, V83, P1021, DOI 10.1016/j.bcp.2011.12.016; Stickle NH, 2004, MOL CELL BIOL, V24, P3251, DOI 10.1128/MCB.24.8.3251-3261.2004; Yang YL, 2009, CANCER SCI, V100, P24, DOI 10.1111/j.1349-7006.2008.01013.x; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Luo ZG, 2012, CANCER RES, V72, P3360, DOI 10.1158/0008-5472.CAN-12-0388; Jia L, 2011, CURR CANCER DRUG TAR, V11, P347, DOI 10.2174/156800911794519734; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Van der Watt PJ, 2009, INT J CANCER, V124, P1829, DOI 10.1002/ijc.24146; Tai YT, 2014, LEUKEMIA, V28, P155, DOI 10.1038/leu.2013.115; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Pierce NW, 2013, CELL, V153, P206, DOI 10.1016/j.cell.2013.02.024; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Sakakibara K, 2011, BLOOD, V118, P3922, DOI 10.1182/blood-2011-01-333138; Parlati F, 2009, BLOOD, V114, P3439, DOI 10.1182/blood-2009-05-223677; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; NISHI K, 1994, J BIOL CHEM, V269, P6320; Plafker K, 2000, MOL CELL BIOL, V20, P3510, DOI 10.1128/MCB.20.10.3510-3521.2000; Cope Gregory A, 2006, BMC Biochem, V7, P1, DOI 10.1186/1471-2091-7-1; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Lee Jennifer, 2010, Genes Cancer, V1, P690, DOI 10.1177/1947601910382899; McMillin DW, 2012, MOL CANCER THER, V11, P942, DOI 10.1158/1535-7163.MCT-11-0563; Mikus P, 2005, SEMIN CELL DEV BIOL, V16, P462, DOI 10.1016/j.semcdb.2005.03.002; Nguyen Kevin T, 2012, Int J Biochem Mol Biol, V3, P137; Pearce C, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-31; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Watanabe M, 1999, GENES CELLS, V4, P291, DOI 10.1046/j.1365-2443.1999.00259.x; Wu SD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2636; Zemla A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2628; Zhao Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.125; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0	49	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	DEC	2014	13	12					3013	3023		10.1158/1535-7163.MCT-14-0064		11	Oncology	Oncology	AW2QH	WOS:000346132900022		
J	Sogabe, S; Togashi, Y; Kato, H; Kogita, A; Mizukami, T; Sakamoto, Y; Banno, E; Terashima, M; Hayashi, H; de Velasco, MA; Sakai, K; Fujita, Y; Tomida, S; Yasuda, T; Takeyama, Y; Okuno, K; Nishio, K				Sogabe, Shunsuke; Togashi, Yosuke; Kato, Hiroaki; Kogita, Akihiro; Mizukami, Takuro; Sakamoto, Yoichi; Banno, Eri; Terashima, Masato; Hayashi, Hidetoshi; de Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Yasuda, Takushi; Takeyama, Yoshifumi; Okuno, Kiyotaka; Nishio, Kazuto			MEK Inhibitor for Gastric Cancer with MEK1 Gene Mutations	MOLECULAR CANCER THERAPEUTICS			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; COLORECTAL-CANCER; THERAPEUTIC TARGET; POOR-PROGNOSIS; OVARIAN-CANCER; PHASE-III; IN-VITRO; BRAF; AMPLIFICATION	The prognosis for patients with unresectable advanced or recurrent gastric cancer remains poor. The identification of additional oncogenes with influences similar to those of epidermal growth factor receptor gene mutations, upon which the growth of cancer cells is dependent, is needed. In this study, we evaluated sensitivity to MEK inhibitors (GSK1120212 and PD0325901) in several gastric cancer cell lines in vitro and found three poorly differentiated gastric cancer cell lines that were hypersensitive to the inhibitors. The sequence analyses in these three cell lines revealed that one cell line had a novel MEK1 mutation, while the other two had previously reported KRAS and MEK1 mutations, respectively; the gene statuses of the other resistant cell lines were all wild-type. Experiments using MEK1 expression vectors demonstrated that the MEK1 mutations induced the phosphorylation of ERK1/2 and had a transforming potential, enhancing the tumorigenicity. The MEK inhibitor dramatically reduced the phosphorylation of ERK1/2 and induced apoptosis in the cell lines with MEK1 mutations. In vivo, tumor growth was also dramatically decreased by an inhibitor. One of the 46 gastric cancer clinical samples that were examined had a MEK1 mutation; this tumor had a poorly differentiated histology. Considering the addiction of cancer cells to active MEK1 mutations for proliferation, gastric cancer with such oncogenic MEK1 mutations might be suitable for targeted therapy with MEK inhibitors. (C)2014 AACR.	[Sogabe, Shunsuke; Togashi, Yosuke; Kato, Hiroaki; Kogita, Akihiro; Mizukami, Takuro; Sakamoto, Yoichi; Banno, Eri; Terashima, Masato; Hayashi, Hidetoshi; de Velasco, Marco A.; Sakai, Kazuko; Fujita, Yoshihiko; Tomida, Shuta; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Sayama, Osaka 5898511, Japan; [Sogabe, Shunsuke; Kato, Hiroaki; Kogita, Akihiro; Yasuda, Takushi; Takeyama, Yoshifumi; Okuno, Kiyotaka] Kinki Univ, Fac Med, Dept Surg, Sayama, Osaka 5898511, Japan	Nishio, K (reprint author), Kinki Univ, Fac Med, Dept Genome Biol, 377-2 Ohno Higashi, Sayama, Osaka 5898511, Japan.	knishio@med.kindai.ac.jp			Third-Term Comprehensive 10-Year Strategy for Cancer Control [13801892]; Japan Society for Promotion of Science [26-12493]	This study was supported by the Third-Term Comprehensive 10-Year Strategy for Cancer Control (to K. Nishio; 13801892) and Grant-in Aid for Japan Society for Promotion of Science Fellows (to Y. Togashi; 26-12493).	Yamaguchi T, 2011, INT J ONCOL, V39, P23, DOI 10.3892/ijo.2011.1015; Yeh JJ, 2009, MOL CANCER THER, V8, P834, DOI 10.1158/1535-7163.MCT-08-0972; Gravalos C, 2008, ANN ONCOL, V19, P1523, DOI 10.1093/annonc/mdn169; Murugan AK, 2009, CELL CYCLE, V8, P2122, DOI 10.4161/cc.8.13.8710; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Nikolaev SI, 2012, NAT GENET, V44, P133, DOI 10.1038/ng.1026; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Henderson YC, 2010, MOL CANCER THER, V9, P1968, DOI 10.1158/1535-7163.MCT-10-0062; Arao T, 2013, HEPATOLOGY, V57, P1407, DOI 10.1002/hep.25956; Ruschoff J, 2012, MODERN PATHOL, V25, P637, DOI 10.1038/modpathol.2011.198; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Ohtsu A, 2008, J GASTROENTEROL, V43, P256, DOI 10.1007/s00535-008-2177-6; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Piessen G, 2009, ANN SURG, V250, P878, DOI 10.1097/SLA.0b013e3181b21c7b; Nakayama N, 2008, BRIT J CANCER, V99, P2020, DOI 10.1038/sj.bjc.6604783; Kawakami H, 2013, ONCOTARGET, V4, P9; Liu YJ, 2014, BRIT J CANCER, V110, P1169, DOI 10.1038/bjc.2014.61; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Hofmann M, 2008, HISTOPATHOLOGY, V52, P797, DOI 10.1111/j.1365-2559.2008.03028.x; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Marks JL, 2008, CANCER RES, V68, P5524, DOI 10.1158/0008-5472.CAN-08-0099; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Arao T, 2004, CANCER RES, V64, P9101, DOI 10.1158/0008-5472.CAN-04-2360; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Choi YL, 2012, CARCINOGENESIS, V33, P956, DOI 10.1093/carcin/bgs099; De Luca A, 2012, EXPERT OPIN THER S2, V2, pS17, DOI DOI 10.1517/147; Estep AL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001279; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Matsumoto K, 2012, BRIT J CANCER, V106, P727, DOI 10.1038/bjc.2011.603; Sasaki H, 2010, J THORAC ONCOL, V5, P597, DOI 10.1097/JTO.0b013e3181d35236	37	4	4	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	DEC	2014	13	12					3098	3106		10.1158/1535-7163.MCT-14-0429		9	Oncology	Oncology	AW2QH	WOS:000346132900029		
J	Rempel, RE; Jiang, XL; Fullerton, P; Tan, TZ; Ye, JR; Lau, JA; Mori, S; Chi, JT; Nevins, JR; Friedman, DR				Rempel, Rachel E.; Jiang, Xiaolei; Fullerton, Paul; Tan, Tuan Zea; Ye, Jieru; Lau, Jieying Amelia; Mori, Seiichi; Chi, Jen-Tsan; Nevins, Joseph R.; Friedman, Daphne R.			Utilization of the E mu-Myc Mouse to Model Heterogeneity of Therapeutic Response	MOLECULAR CANCER THERAPEUTICS			English	Article							B-CELL LYMPHOMA; GENE-EXPRESSION SIGNATURE; NON-HODGKINS-LYMPHOMA; IN-VIVO; PATHWAY SIGNATURES; BURKITTS-LYMPHOMA; TRANSGENIC MICE; DISTINCT TYPES; KAPPA-B; CHEMORESISTANCE	Human aggressive B-cell non-Hodgkin lymphomas (NHL) encompass the continuum between Burkitt lymphoma and diffuse large B-cell lymphoma (DLBCL), and display considerable clinical and biologic heterogeneity, most notably related to therapy response. We previously showed that lymphomas arising in the E mu-Myc transgenic mouse are heterogeneous, mirroring genomic differences between Burkitt lymphoma and DLBCL. Given clinical heterogeneity in NHL and the need to develop strategies to match therapeutics with discrete forms of disease, we investigated the extent to which genomic variation in the E mu-Myc model predicts response to therapy. We used genomic analyses to classify E mu-Myc lymphomas, link E mu-Myc lymphomas with NHL subtypes, and identify lymphomas with predicted resistance to conventional and NF-kappa B-targeted therapies. Experimental evaluation of these predictions links genomic profiles with distinct outcomes to conventional and targeted therapies in the E mu-Myc model, and establishes a framework to test novel targeted therapies or combination therapies in specific genomically defined lymphoma subgroups. In turn, this will rationally inform the design of new treatment options for aggressive human NHL. (C) 2014 AACR.	[Rempel, Rachel E.; Jiang, Xiaolei; Chi, Jen-Tsan; Nevins, Joseph R.; Friedman, Daphne R.] Duke Univ, Med Ctr, Duke Inst Genome Sci & Policy, Durham, NC 27705 USA; [Fullerton, Paul] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Tan, Tuan Zea; Ye, Jieru; Lau, Jieying Amelia] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117548, Singapore; [Mori, Seiichi] Japanese Fdn Canc Res, Inst Canc, Tokyo 170, Japan; [Chi, Jen-Tsan; Nevins, Joseph R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Friedman, Daphne R.] Durham Vet Affairs Med Ctr, Durham, NC USA	Friedman, DR (reprint author), Duke Univ, 508 Fulton St 111G, Durham, NC 27705 USA.	daphne.friedman@duke.edu		Tan, Tuan Zea/0000-0001-6624-1593	NIH [CA106520]	This work was supported by a grant from the NIH (CA106520; to J. R. Nevins).	Young KH, 2008, BLOOD, V112, P3088, DOI 10.1182/blood-2008-01-129783; Lindemann RK, 2007, P NATL ACAD SCI USA, V104, P8071, DOI 10.1073/pnas.0702294104; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Klapproth K, 2010, BRIT J HAEMATOL, V149, P484, DOI 10.1111/j.1365-2141.2010.08159.x; Hideshima T, 2001, CANCER RES, V61, P3071; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Jaffe ES, 2011, HEMATOL-AM SOC HEMAT, P506, DOI 10.1182/asheducation-2011.1.506; Ruan J, 2011, J CLIN ONCOL, V29, P690, DOI 10.1200/JCO.2010.31.1142; Gatza ML, 2010, P NATL ACAD SCI USA, V107, P6994, DOI 10.1073/pnas.0912708107; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Zhang J, 2013, P NATL ACAD SCI USA, V110, P1398, DOI 10.1073/pnas.1205299110; Klapproth K, 2009, BLOOD, V114, P2448, DOI 10.1182/blood-2008-09-181008; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004.07.2947; Thomas DA, 2006, CANCER, V106, P1569, DOI 10.1002/cncr.21776; Mori S, 2008, CANCER RES, V68, P8525, DOI 10.1158/0008-5472.CAN-08-1329; Green MR, 2011, P NATL ACAD SCI USA, V108, P2873, DOI 10.1073/pnas.1019537108; Dunleavy K, 2009, BLOOD, V113, P6069, DOI 10.1182/blood-2009-01-199679; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Burgess DJ, 2008, P NATL ACAD SCI USA, V105, P9053, DOI 10.1073/pnas.0803513105; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Andrechek ER, 2009, P NATL ACAD SCI USA, V106, P16387, DOI 10.1073/pnas.0901250106; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Ziepert M, 2010, J CLIN ONCOL, V28, P2373, DOI 10.1200/JCO.2009.26.2493; Klapper W, 2008, LEUKEMIA, V22, P2226, DOI 10.1038/leu.2008.230; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Wendel HG, 2006, CANCER RES, V66, P7639, DOI 10.1158/0008-5472.CAN-06-0419; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Xu-Monette ZY, 2012, BLOOD, V120, P3986, DOI 10.1182/blood-2012-05-433334; SHIPP MA, 1993, NEW ENGL J MED, V329, P987; Chang JT, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-443; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Loboda A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-26; Pittman J, 2004, P NATL ACAD SCI USA, V101, P8431, DOI 10.1073/pnas.0401736101; Rempel RE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000640; Schmitt CA, 2000, NAT MED, V6, P1029; Schmitt CA, 2001, BLOOD CELL MOL DIS, V27, P206, DOI 10.1006/bcmd.2000.0372; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106	47	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1535-7163	1538-8514		MOL CANCER THER	Mol. Cancer Ther.	DEC	2014	13	12					3219	3229		10.1158/1535-7163.MCT-13-0044		11	Oncology	Oncology	AW2QH	WOS:000346132900039		
J	Funatsu, K				Funatsu, Kimito			Chemoinformatics in Japan	MOLECULAR INFORMATICS			English	Editorial Material									Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Funatsu, K (reprint author), Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.							0	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1868-1743	1868-1751		MOL INFORM	Mol. Inf.	DEC	2014	33	11-12			SI		712	712		10.1002/minf.201480632		1	Chemistry, Medicinal; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology	Pharmacology & Pharmacy; Computer Science; Mathematical & Computational Biology	AW0IG	WOS:000345974300001		
J	Sawada, R; Kotera, M; Yamanishi, Y				Sawada, Ryusuke; Kotera, Masaaki; Yamanishi, Yoshihiro			Benchmarking a Wide Range of Chemical Descriptors for Drug-Target Interaction Prediction Using a Chemogenomic Approach	MOLECULAR INFORMATICS			English	Review						Chemogenomics; Descriptors; Fingerprint; Drug-target interactions; Machine learning	GRAPH KERNELS; INTERACTION NETWORKS; IN-VITRO; MOLECULES; INTEGRATION; DISCOVERY; QSAR; KEGG; PLS	The identification of drug-target interactions, or interactions between drug candidate compounds and target candidate proteins, is a crucial process in genomic drug discovery. In silico chemogenomic methods are recently recognized as a promising approach for genome-wide scale prediction of drug-target interactions, but the prediction performance depends heavily on the descriptors and similarity measures of drugs and proteins. In this paper, we investigated the performance of various descriptors and similarity measures of drugs and proteins for the drug-target interaction prediction using a chemogenomic approach. We compared the prediction accuracy of 18 chemical descriptors of drugs (e.g., ECFP, FCFP, E-state, CDK, Klekota-Roth, MACCS, PubChem, Dragon, KCF-S, and graph kernels) and 4 descriptors of proteins (e.g., amino acid composition, domain profile, local sequence similarity, and string kernel) on about one hundred thousand drug-target interactions. We examined the combinatorial effects of drug descriptors and protein descriptors using the same benchmark data under several experimental conditions. Large-scale experiments showed that our proposed KCF-S descriptor worked the best in terms of prediction accuracy. The comparative results are expected to be useful for selecting chemical descriptors in various pharmaceutical applications.	[Sawada, Ryusuke; Yamanishi, Yoshihiro] Kyushu Univ, Med Inst Bioregulat, Div Syst Cohort, Multiscale Res Ctr Med Sci,Higashi Ku, Fukuoka 8128582, Japan; [Kotera, Masaaki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo 1528550, Japan; [Yamanishi, Yoshihiro] Kyushu Univ, Inst Adv Study, Higashi Ku, Fukuoka 8128581, Japan	Yamanishi, Y (reprint author), Kyushu Univ, Med Inst Bioregulat, Div Syst Cohort, Multiscale Res Ctr Med Sci,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yamanishi@bioreg.kyushu-u.ac.jp			JSPS KAKENHI [25700029]; Program to Disseminate Tenure Tracking System, MEXT, Japan; Kyushu University Interdisciplinary Programs in Education and Projects in Research Development	This work is supported by JSPS KAKENHI Grant Number 25700029, and the Program to Disseminate Tenure Tracking System, MEXT, Japan, and Kyushu University Interdisciplinary Programs in Education and Projects in Research Development.	Ralaivola L, 2005, NEURAL NETWORKS, V18, P1093, DOI 10.1016/j.neunet.2005.07.009; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Mahe P, 2005, J CHEM INF MODEL, V45, P939, DOI 10.1021/ci050039t; Takarabe M, 2012, BIOINFORMATICS, V28, pI611, DOI 10.1093/bioinformatics/bts413; Chen B, 2009, J CHEM INF MODEL, V49, P2044, DOI 10.1021/ci9001876; Blagg J, 2006, ANNU REP MED CHEM, V41, P353, DOI 10.1016/S0065-7743(06)41024-1; Kolb P, 2009, CURR OPIN BIOTECH, V20, P429, DOI 10.1016/j.copbio.2009.08.003; Yamanishi Y, 2011, J CHEM INF MODEL, V51, P1183, DOI 10.1021/ci100476q; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Yamanishi Y, 2008, BIOINFORMATICS, V24, pI232, DOI 10.1093/bioinformatics/btn162; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Vuignier K, 2010, ANAL BIOANAL CHEM, V398, P53, DOI 10.1007/s00216-010-3737-1; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Steinbeck C, 2006, CURR PHARM DESIGN, V12, P2111, DOI 10.2174/138161206777585274; Saigo H, 2004, BIOINFORMATICS, V20, P1682, DOI 10.1093/bioinformatics/bth141; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Mahe P, 2009, MACH LEARN, V75, P3, DOI 10.1007/s10994-008-5086-2; Whitebread S, 2005, DRUG DISCOV TODAY, V10, P1421, DOI 10.1016/S1359-6446(05)03632-9; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Jacob L, 2008, BIOINFORMATICS, V24, P2149, DOI 10.1093/bioinformatics/btn409; HALL LH, 1995, J CHEM INF COMP SCI, V35, P1039, DOI 10.1021/ci00028a014; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Dobson CM, 2004, NATURE, V432, P824, DOI 10.1038/nature03192; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Liu PX, 2009, INT J MOL SCI, V10, P1978, DOI 10.3390/ijms10051978; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Faulon JL, 2008, BIOINFORMATICS, V24, P225, DOI 10.1093/bioinformatics/btm580; Roth BL, 2000, NEUROSCIENTIST, V6, P252; Klekota J, 2008, BIOINFORMATICS, V24, P2518, DOI 10.1093/bioinformatics/btn479; Bleakley K, 2009, BIOINFORMATICS, V25, P2397, DOI 10.1093/bioinformatics/btp433; Stanton DT, 2012, CURR COMPUT-AID DRUG, V8, P107; Nagamine N, 2007, BIOINFORMATICS, V23, P2004, DOI 10.1093/bioinformatics/btm266; [Anonymous], 2013, BMC SYST BIOL; [Anonymous], 2013, BMC SYST BIOL; Consortium U, 2010, NUCLEIC ACIDS RES, V38, P142; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Kashima H., 2004, KERNEL METHODS COMPU, P155; Li YY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002139; Saxena AK, 2003, SAR QSAR ENVIRON RES, V14, P433, DOI 10.1080/10629360310001624015; Tabei Y, 2012, BIOINFORMATICS, V28, pI487, DOI 10.1093/bioinformatics/bts412; Yabuuchi H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.5; Yang L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000441	44	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1868-1743	1868-1751		MOL INFORM	Mol. Inf.	DEC	2014	33	11-12			SI		719	731		10.1002/minf.201400066		13	Chemistry, Medicinal; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology	Pharmacology & Pharmacy; Computer Science; Mathematical & Computational Biology	AW0IG	WOS:000345974300002		
J	Brown, JB; Nakatsui, M; Okuno, Y				Brown, J. B.; Nakatsui, Masahiko; Okuno, Yasushi			Constructing a Foundational Platform Driven by Japan's K Supercomputer for Next-Generation Drug Design	MOLECULAR INFORMATICS			English	Review						Drug design; Virtual screening; Chemogenomics; Molecular dynamics; Free energy calculation		The cost of pharmaceutical R&D has risen enormously, both worldwide and in Japan. However, Japan faces a particularly difficult situation in that its population is aging rapidly, and the cost of pharmaceutical R&D affects not only the industry but the entire medical system as well. To attempt to reduce costs, the newly launched K supercomputer is available for big data drug discovery and structural simulation-based drug discovery. We have implemented both primary (direct) and secondary (infrastructure, data processing) methods for the two types of drug discovery, custom tailored to maximally use the 88128 compute nodes/CPUs of K, and evaluated the implementations. We present two types of results. In the first, we executed the virtual screening of nearly 19 billion compound-protein interactions, and calculated the accuracy of predictions against publicly available experimental data. In the second investigation, we implemented a very computationally intensive binding free energy algorithm, and found that comparison of our binding free energies was considerably accurate when validated against another type of publicly available experimental data. The common feature of both result types is the scale at which computations were executed. The frameworks presented in this article provide prospectives and applications that, while tuned to the computing resources available in Japan, are equally applicable to any equivalent large-scale infrastructure provided elsewhere.	[Brown, J. B.; Okuno, Yasushi] Kyoto Univ, Grad Sch Med, Dept Clin Syst Onco Informat, Yoshida Shimoadachi, Kyoto 6068501, Japan; [Nakatsui, Masahiko] Kobe Univ, Grad Sch Engn, Kobe, Hyogo 657, Japan; [Nakatsui, Masahiko; Okuno, Yasushi] RIKEN Adv Inst Computat Sci, Div Res, Wako, Saitama, Japan	Okuno, Y (reprint author), Kyoto Univ, Grad Sch Med, Dept Clin Syst Onco Informat, Yoshida Shimoadachi, Kyoto 6068501, Japan.	okuno@pharm.kyoto-u.ac.jp			Funding Program for Next-Generation World-Leading Researchers (NEXT); CREST program for Big Data of the Japan Science and Technology Agency (JST); Japanese Society for the Promotion of Science [25870336]; Chugai Pharmaceutical Co. Ltd.; Mitsui Knowledge Industry Co. Ltd.	In conjunction with the execution of the project reported here, deep gratitude is expressed to all participants of the KBDD consortium, the Riken Advanced Institute for Computational Science (AICS), the Research Organization for Information Science and Technology (RIST), and the Foundation for Biomedical Research and Innovation (FBRI). Funding support for parts of the work herein were provided by the Funding Program for Next-Generation World-Leading Researchers (NEXT), the CREST program for Big Data of the Japan Science and Technology Agency (JST), and a Grant-in-Aid for Young Scientists from the Japanese Society for the Promotion of Science (Kakenhi (B) 25870336) to J. B. Brown. Yasushi Okuno and J. B. Brown wish to thank Chugai Pharmaceutical Co. Ltd. and Mitsui Knowledge Industry Co. Ltd. for their support.	Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Dunbar JB, 2011, J CHEM INF MODEL, V51, P2036, DOI 10.1021/ci200082t; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Fujitani H, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.021914; Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6; Bolton E., 2008, ANN REP COMPUT CHEM, V4; Brown JB, 2013, MOL INFORM, V32, P906, DOI 10.1002/minf.201300101; Cortes, 1995, MACH LEARN, V20, P273; Yabuuchi H, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.5; Yonezawa A., 2011, P INT C HIGH PERF CO, P1	10	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1868-1743	1868-1751		MOL INFORM	Mol. Inf.	DEC	2014	33	11-12			SI		732	741		10.1002/minf.201400067		10	Chemistry, Medicinal; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology	Pharmacology & Pharmacy; Computer Science; Mathematical & Computational Biology	AW0IG	WOS:000345974300003		
J	Choi, SB; Choong, YS; Saito, A; Wahab, HA; Najimudin, N; Watanabe, N; Osada, H; Ong, EBB				Choi, Sy Bing; Choong, Yee Siew; Saito, Akiko; Wahab, Habibah A.; Najimudin, Nazalan; Watanabe, Nobumoto; Osada, Hiroyuki; Ong, Eugene Boon Beng			In Silico Investigation of a HIV-1 Vpr Inhibitor Binding Site: Potential for Virtual Screening and anti-HIV Drug Design	MOLECULAR INFORMATICS			English	Article						HIV; Vpr; SAR; Docking; Coumarin	IMMUNODEFICIENCY-VIRUS TYPE-1; ACCESSORY PROTEIN VPR; CELL-CYCLE ARREST; UBIQUITIN LIGASE; PATHOGENESIS; RECEPTOR; COMPLEX	Present HIV antiviral therapy only targets structural proteins of HIV, but evidence shows that the targeting of accessory proteins will expand our options in combating HIV. HIV-1 Vpr, a multifunctional accessory protein involved in viral infection, replication and pathogenesis, is a potential target. Previously, we have shown that phenyl coumarin compounds can inhibit the growth arrest activity of Vpr in host cells and predicted that the inhibitors' binding site is a hydrophobic pocket on Vpr. To investigate our prediction of the inhibitors' binding site, we docked the coumarin inhibitors into the predicted hydrophobic binding pocket on a built model of Vpr and observed a linear trend between their calculated binding energies and prior experimentally determined potencies. Subsequently, to analyze the inhibitor-protein binding interactions in detail, we built homology models of Vpr mutants and performed docking studies on these models too. The results revealed that structural changes on the binding pocket that were caused by the mutations affected inhibitor binding. Overall, this study showed that the binding energies of the docked molecules are good indicators of the activity of the inhibitors. Thus, the model can be used in virtual screening to identify other Vpr inhibitors and for designing more potent inhibitors.	[Choi, Sy Bing; Wahab, Habibah A.] Minist Sci Technol & Innovat, Natl Inst Biotechnol Malaysia, Malaysian Inst Pharmaceut & Nutraceut, Nat Prod & Drug Discovery Ctr, George Town 11700, Malaysia; [Choi, Sy Bing; Wahab, Habibah A.; Osada, Hiroyuki] Univ Sains Malaysia, Sch Pharmaceut Sci, Minden 11800, Penang, Malaysia; [Choi, Sy Bing] Univ Sains Malaysia, Sch Ind Technol, Minden 11800, Penang, Malaysia; [Choong, Yee Siew; Ong, Eugene Boon Beng] Univ Sains Malaysia, Inst Res Mol Med, Minden 11800, Penang, Malaysia; [Saito, Akiko] Osaka Electrocommun Univ, Fac Engn, Dept Appl Chem, Neyagawa, Osaka 5728530, Japan; [Najimudin, Nazalan; Watanabe, Nobumoto] Univ Sains Malaysia, Sch Biol Sci, Minden 11800, Penang, Malaysia; [Watanabe, Nobumoto; Osada, Hiroyuki] RIKEN Ctr Sustainable Resource Sci, Chem Biol Res Grp, Wako, Saitama 3510198, Japan	Ong, EBB (reprint author), Univ Sains Malaysia, Inst Res Mol Med, Minden 11800, Penang, Malaysia.	eugene@usm.my	Ong, Eugene/A-2774-2015; Najimudin, Nazalan/B-2952-2011; Osada, Hiroyuki/N-4305-2014; Choong, Yee Siew/A-6907-2011	Ong, Eugene/0000-0001-6259-9029; 	Universiti Sains Malaysia; RIKEN Japan; USM	This publication was made possible by collaboration grants from Universiti Sains Malaysia and RIKEN Japan for the USM-RIKEN Joint Laboratory for Bioprobe Discovery. SBC gratefully acknowledges the postdoctoral fellowship from USM during the course of this work.	Wen XY, 2007, J BIOL CHEM, V282, P27046, DOI 10.1074/jbc.M703955200; Ong EBB, 2011, J BIOL CHEM, V286, P14049, DOI 10.1074/jbc.M110.185397; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Wlodawer A, 2002, ANNU REV MED, V53, P595, DOI 10.1146/annurev.med.53.052901.131947; Desrosiers RC, 1998, J VIROL, V72, P1431; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Andersen JL, 2005, CURR HIV RES, V3, P43, DOI 10.2174/1570162052772988; Collins DR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003851; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DeLano W. L., 2002, 0 99RC6; Henklein P, 2000, J BIOL CHEM, V275, P32016, DOI 10.1074/jbc.M004044200; Kamata M, 2006, BIOCHEM BIOPH RES CO, V348, P1101, DOI 10.1016/j.bbrc.2006.07.158; Kino T, 2004, DNA CELL BIOL, V23, P193, DOI 10.1089/104454904773819789; Kogan M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-25; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leroux FR, 2008, BEILSTEIN J ORG CHEM, V4, DOI 10.3762/bjoc.4.13; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Mahalingam S, 1997, J VIROL, V71, P6339; Morellet N, 2009, CURR HIV RES, V7, P184; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Muthumani K, 2006, NAT CELL BIOL, V8, P170, DOI 10.1038/ncb1352; Richter SN, 2009, CURR MED CHEM, V16, P267; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Singh N, 2012, PROTEINS, V80, P1110, DOI 10.1002/prot.24012; Watanabe N, 2006, FEBS LETT, V580, P2598, DOI 10.1016/j.febslet.2006.04.007	25	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1868-1743	1868-1751		MOL INFORM	Mol. Inf.	DEC	2014	33	11-12			SI		742	748		10.1002/minf.201400080		7	Chemistry, Medicinal; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology	Pharmacology & Pharmacy; Computer Science; Mathematical & Computational Biology	AW0IG	WOS:000345974300004		
J	Hasegawa, K; Funatsu, K				Hasegawa, Kiyoshi; Funatsu, Kimito			Data Mining of Chemogenomics Data Using Bi-Modal PLS Methods and Chemical Interpretation for Molecular Design	MOLECULAR INFORMATICS			English	Article						Data mining; Chemogenomics; Bi-modal PLS; Chemical interpretation; Molecular design	L-SHAPED PLS; INTERACTION PREDICTION; LIGAND	Chemogenomics is a new strategy in drug discovery for interrogating all molecules capable of interacting with all biological targets. Because of the almost infinite number of drug-like organic molecules, bench-based experimental chemogenomics methods are not generally feasible. Several in silico chemogenomics models have therefore been developed for high-throughput screening of large numbers of drug candidate compounds and target proteins. In previous studies, we described two novel bi-modal PLS approaches. These methods provide a significant advantage in that they enable direct connections to be made between biological activities and ligand and protein descriptors. In this special issue, we review these two PLS-based approaches using two different chemogenomics datasets for illustration. We then compare the predictive and interpretive performance of the two methods using the same congeneric data set.	[Hasegawa, Kiyoshi] Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Kamakura, Kanagawa 2478530, Japan; [Funatsu, Kimito] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Funatsu, K (reprint author), Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	funatsu@chemsys.t.u-tokyo.ac.jp					Sun HM, 2008, CURR MED CHEM, V15, P1018, DOI 10.2174/092986708784049630; Caron PR, 2001, CURR OPIN CHEM BIOL, V5, P464, DOI 10.1016/S1367-5931(00)00229-5; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Kroemer RT, 2007, CURR PROTEIN PEPT SC, V8, P312; Jacob L, 2008, BIOINFORMATICS, V24, P2149, DOI 10.1093/bioinformatics/btn409; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; HELLBERG S, 1987, J MED CHEM, V30, P1126, DOI 10.1021/jm00390a003; Brown JB, 2013, MOL INFORM, V32, P906, DOI 10.1002/minf.201300101; Hasegawa K., 2010, J COMPUT AIDED CHEM, V11, P19; Hasegawa K, 2012, MOL INFORM, V31, P766, DOI 10.1002/minf.201200090; Hasegawa K, 2014, CHEMOMETR INTELL LAB, V130, P166, DOI 10.1016/j.chemolab.2013.11.003; Hasegawa K, 2014, CHEMOMETR INTELL LAB, V135, P166, DOI 10.1016/j.chemolab.2014.04.015; Hasegawa K., 2013, CHEMOINFORMATICS CAS, P85; Jacob L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-363; Kumar D, 2003, BIOORGAN MED CHEM, V11, P421, DOI 10.1016/S0968-0896(02)00438-8; Loftstedt T., 2012, J CHEMOMETR, V26, P236; Mahe P, 2009, COMB CHEM HIGH T SCR, V12, P409; Puwakktiya-Kankanamage E. H., 2014, J CHEMOM IN PRESS; Saebo S., 2010, HDB PARTIAL LEAST SQ, P359; Tanrikulu Y, 2010, MOL INFORM, V29, P678, DOI 10.1002/minf.201000073; Yamanishi Y, 2013, MOL INFORM, V32, P991, DOI 10.1002/minf.201300079	21	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1868-1743	1868-1751		MOL INFORM	Mol. Inf.	DEC	2014	33	11-12			SI		749	756		10.1002/minf.201400061		8	Chemistry, Medicinal; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology	Pharmacology & Pharmacy; Computer Science; Mathematical & Computational Biology	AW0IG	WOS:000345974300005		
J	Hasegawa, K; Funatsu, K				Hasegawa, Kiyoshi; Funatsu, Kimito			Multivariate Analysis of Side Effects of Drug Molecules Based on Knowledge of Protein Bindings and Protein-Protein Interactions	MOLECULAR INFORMATICS			English	Article						Side effect; Protein binding; Protein-protein interaction; LPLS; Bayesian classifier model	NETWORK	Here, we examined the relationships between 969 side effects associated with 658 drugs and their 1368 human protein targets using our hybrid approaches. Firstly, L-shaped PLS (LPLS) was used to construct a multivariate model of side effects and protein bindings of drug molecules. LPLS is an extension of standard PLS regression, where, in addition to the response matrix Y and the regressor matrix X, an extra data matrix Z is constructed that summarizes the background information of X. X and Y are matrices comprising drugs-target proteins, and drugs-side effects, respectively. The Z matrix is the protein-protein interaction data. From the loading plot of Y, we could identify two remarkable side effects (urinary incontinence and increased salivation) From the corresponding loading plot of X, the responsible protein targets causing each side effect could be estimated (sodium channels and gamma-aminobutyric acid (GABA) receptors). The loading plot of the Z matrix indicated that the GABA receptors interact with each other and they heavily influence the side effect of increased salivation. Secondly, Bayesian classifier methods were separately applied to the cases of the two side effects. That is, the Bayesian classifier method was used to classify drug molecules as binding or not binding to the responsible protein targets associated with each side effect. Using atom-coloring techniques, it was possible to estimate which fragments on the drug molecule might cause the specific side effects. This information is valuable for drug design to avoid specific side effects.	[Hasegawa, Kiyoshi] Chugai Pharmaceut Co Ltd, Kamakura Res Labs, Kamakura, Kanagawa 2478530, Japan; [Funatsu, Kimito] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Funatsu, K (reprint author), Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	funatsu@chemsys.t.u-tokyo.ac.jp					Yamanishi Y, 2012, J CHEM INF MODEL, V52, P3284, DOI 10.1021/ci2005548; Gunther S, 2008, NUCLEIC ACIDS RES, V36, pD919, DOI 10.1093/nar/gkm862; Patro R, 2013, BIOINFORMATICS, V29, P237, DOI 10.1093/bioinformatics/btt224; Mizutani S, 2012, BIOINFORMATICS, V28, pI522, DOI 10.1093/bioinformatics/bts383; Scheiber J, 2009, J MED CHEM, V52, P3103, DOI 10.1021/jm801546k; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Rogers D, 2010, J CHEM INF MODEL, V50, P742, DOI 10.1021/ci100050t; Allison M, 2012, NAT BIOTECHNOL, V30, P41, DOI 10.1038/nbt.2083; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Hasegawa K., 2010, J COMPUT AIDED CHEM, V11, P19; Hasegawa K, 2012, MOL INFORM, V31, P766, DOI 10.1002/minf.201200090; Hasegawa K, 2014, MOL INFORM, V33, P65, DOI 10.1002/minf.201300137; Javad Z., 2013, CURR GENOMICS, V14, P397; Kuhn M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.98; Kuhn M., 2013, MOL SYST BIO, V9; Pauwels E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-169; Sabo S., 2008, CHEMOM INTELL LAB SY, V91, P121, DOI 10.1016/j.chemolab.2007.10.006; Wallach I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012063; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387	20	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1868-1743	1868-1751		MOL INFORM	Mol. Inf.	DEC	2014	33	11-12			SI		757	763		10.1002/minf.201400064		7	Chemistry, Medicinal; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology	Pharmacology & Pharmacy; Computer Science; Mathematical & Computational Biology	AW0IG	WOS:000345974300006		
J	Miyao, T; Kaneko, H; Funatsu, K				Miyao, Tomoyuki; Kaneko, Hiromasa; Funatsu, Kimito			Ring-System-Based Exhaustive Structure Generation for Inverse-QSPR/QSAR	MOLECULAR INFORMATICS			English	Article						Inverse QSPR/QSAR; Structure generation; Drug design; Chemoinformatics	SIGNATURE MOLECULAR DESCRIPTOR; EXTENDED VALENCE SEQUENCES; DRUG DESIGN; TOPOLOGICAL INDEXES; CHEMICAL GRAPHS; QSAR MODELS; DISCOVERY; QSPR; VALIDATION	Inverse-QSPR/QSAR aims to solve the inverse problem of chemical structure generation based on QSPR/QSAR models, once the properties or activities are specified. To efficiently solve this problem, an exhaustive ring-system-based structure generation methodology was developed. The concept of the applicability domain (AD) is automatically acknowledged within the proposed strategy. The local AD is considered by introducing the probability distribution of a given data set, and the universal AD is considered using ring-system-based fragments in the training data set. Structures with desired properties or activities are enumerated by assembling fragments, including atomic elements, in a tree-like way. The usefulness of the proposed method is demonstrated through a case study of ligand design for the human alpha 2A adrenergic receptor (ADR2A_HUMAN). We succeeded in generating structures focusing only on a pre-defined region in chemical space, resulting in structures whose desired activity has a high likelihood being efficiently generated. In addition, the limitations of our proposed method and future challenges are discussed.	[Miyao, Tomoyuki; Kaneko, Hiromasa; Funatsu, Kimito] Univ Tokyo, Dept Chem Syst Engn, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan	Funatsu, K (reprint author), Univ Tokyo, Dept Chem Syst Engn, Grad Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	funatsu@chemsys.t.u-tokyo.ac.jp			Japan Science and Technology Agency (JST)	We thank GVK Bioscience for providing the data set used as the case study of ligand design for the adrenergic receptor. We acknowledge the support of the Core Research for Evolutionary Science and Technology (CREST) project 'Development of a knowledge-generating platform driven by big data in drug discovery through production processes' of the Japan Science and Technology Agency (JST).	Akutsu T., 2013, COMPUT STRUCT BIOTEC; McKay BD, 1998, J ALGORITHM, V26, P306, DOI 10.1006/jagm.1997.0898; RANDIC M, 1975, J AM CHEM SOC, V97, P6609, DOI 10.1021/ja00856a001; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Walters WP, 1998, DRUG DISCOV TODAY, V3, P160, DOI 10.1016/S1359-6446(97)01163-X; GUTMAN I, 1972, CHEM PHYS LETT, V17, P535, DOI 10.1016/0009-2614(72)85099-1; Schneider G, 1999, ANGEW CHEM INT EDIT, V38, P2894, DOI 10.1002/(SICI)1521-3773(19991004)38:19<2894::AID-ANIE2894>3.0.CO;2-F; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Faulon JL, 2003, J CHEM INF COMP SCI, V43, P707, DOI 10.1021/ci020345w; Gramatica P, 2007, QSAR COMB SCI, V26, P694, DOI 10.1002/qsar.200610151; BALABAN AT, 1979, THEOR CHIM ACTA, V53, P355, DOI 10.1007/BF00555695; Reutlinger M, 2014, ANGEW CHEM INT EDIT, V53, P4244, DOI 10.1002/anie.201310864; Polishchuk PG, 2013, J COMPUT AID MOL DES, V27, P675, DOI 10.1007/s10822-013-9672-4; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Faulon JL, 2003, J CHEM INF COMP SCI, V43, P721, DOI 10.1021/ci020346o; Ghasemi J, 2007, J MOL STRUC-THEOCHEM, V805, P27, DOI 10.1016/j.theochem.2006.09.026; REDNER RA, 1984, SIAM REV, V26, P195, DOI 10.1137/1026034; Clark DE, 1996, J COMPUT AID MOL DES, V10, P337, DOI 10.1007/BF00124503; Bemis GW, 1996, J MED CHEM, V39, P2887, DOI 10.1021/jm9602928; Bohacek RS, 1996, MED RES REV, V16, P3, DOI 10.1002/(SICI)1098-1128(199601)16:1<3::AID-MED1>3.0.CO;2-6; Bishop CM, 1998, NEURAL COMPUT, V10, P215, DOI 10.1162/089976698300017953; Bakir GH, 2004, LECT NOTES COMPUT SC, V3175, P253; Baskin II, 2010, MOL INFORM, V29, P581, DOI 10.1002/minf.201000063; Bishop C. M., 2006, PATTERN RECOGN, P423; Bishop C.M., 2006, PATTERN RECOGN, P370; Bishop C.M., 2004, NETLAB TOOLBOX; BROTO P, 1984, EUR J MED CHEM, V19, P66; ChemAxon, STAND US GUID; Churchwell CJ, 2004, J MOL GRAPH MODEL, V22, P263, DOI 10.1016/j.jmgm.2003.10.002; Ekins S., 2007, BRIT J PHARMACOL, V152, P20; Fujiwara H, 2008, J CHEM INF MODEL, V48, P1345, DOI 10.1021/ci700385a; Funatsu K, 2011, CURR COMPUT-AID DRUG, V7, P1, DOI 10.2174/157340911793743556; Ishida Y, 2010, J CHEM INF MODEL, V50, P934, DOI 10.1021/ci900447z; Mckay B. D., NAUTY USERS GUID VER; Miyao T, 2010, MOL INFORM, V29, P111, DOI 10.1002/minf.200900038; Molchanova MS, 1996, J CHEM INF COMP SCI, V36, P888, DOI 10.1021/ci950393z; Nakano S., 2003, NII2033005E; Patel S. J., 2009, IND ENG CHEM RES, P7378; Rasmussen C. E., 2006, GAUSSIAN PROCESS MAC; SKVORTSOVA MI, 1993, J CHEM INF COMP SCI, V33, P630, DOI 10.1021/ci00014a017; Skvortsova MI, 2001, DOKL CHEM, V379, P191, DOI 10.1023/A:1019217526008; Todeschini R., 2009, MOL DESCRIPTORS CHEM, P516; Tropsha A, 2010, MOL INFORM, V29, P476, DOI 10.1002/minf.201000061	44	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1868-1743	1868-1751		MOL INFORM	Mol. Inf.	DEC	2014	33	11-12			SI		764	778		10.1002/minf.201400072		15	Chemistry, Medicinal; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology	Pharmacology & Pharmacy; Computer Science; Mathematical & Computational Biology	AW0IG	WOS:000345974300007		
J	Mishima, K; Kaneko, H; Funatsu, K				Mishima, Kazuaki; Kaneko, Hiromasa; Funatsu, Kimito			Development of a New De Novo Design Algorithm for Exploring Chemical Space	MOLECULAR INFORMATICS			English	Article						Chemical space; De novo design; Drug disco/very; Molecular diversity; Visualization of chemical space	ACTIVITY LANDSCAPES; DESIRED PROPERTIES; GENETIC ALGORITHM; MOLECULAR DESIGN; DRUG DISCOVERY; OPTIMIZATION	In the first stage of development of new drugs, various lead compounds with high activity are required. To design such compounds, we focus on chemical space defined by structural descriptors. New compounds close to areas where highly active compounds exist will show the same degree of activity. We have developed a new de novo design system to search a target area in chemical space. First, highly active compounds are manually selected as initial seeds. Then, the seeds are entered into our system, and structures slightly different from the seeds are generated and pooled. Next, seeds are selected from the new structure pool based on the distance from target coordinates on the map. To test the algorithm, we used two datasets of ligand binding affinity and showed that the proposed generator could produce diverse virtual compounds that had high activity in docking simulations.	[Mishima, Kazuaki; Kaneko, Hiromasa; Funatsu, Kimito] Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Funatsu, K (reprint author), Univ Tokyo, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	funatsu@chemsys.t.u-tokyo.ac.jp			Japan Science and Technology Agency (JST)	We would like to thank CTC Laboratory Systems, Japan and GVK Biosciences, India for allowing us to use the data. The authors acknowledge the support of the Core Research for Evolutionary Science and Technology (CREST) Project 'Development of a knowledge-generating platform driven by big data in drug discovery through production processes' of the Japan Science and Technology Agency (JST).	Honma T, 2003, MED RES REV, V23, P606, DOI 10.1002/med.10046; Globus A, 1999, NANOTECHNOLOGY, V10, P290, DOI 10.1088/0957-4484/10/3/312; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; KUNTZ ID, 1994, ACCOUNTS CHEM RES, V27, P117, DOI 10.1021/ar00041a001; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Iyer P, 2013, MOL INFORM, V32, P421, DOI 10.1002/minf.201200120; Schneider G, 2003, J COMB CHEM, V5, P233, DOI 10.1021/cc020092j; Zettl H, 2010, TRENDS PHARMACOL SCI, V31, P402, DOI 10.1016/j.tips.2010.05.007; Dey F, 2008, J CHEM INF MODEL, V48, P679, DOI 10.1021/ci700424b; Jaworska J, 2005, ATLA-ALTERN LAB ANIM, V33, P445; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; Schneider G, 2005, NAT REV DRUG DISCOV, V4, P649, DOI 10.1038/nrd1799; Mauser H, 2008, CURR OPIN DRUG DISC, V11, P365; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Bishop CM, 1998, NEURAL COMPUT, V10, P215, DOI 10.1162/089976698300017953; Ekins S., 2002, J COMPUT AID MOL DES, V4, P649; Kamphausen S, 2002, J COMPUT AID MOL DES, V16, P551, DOI 10.1023/A:1021928016359; Kohonen T, 2000, SELF ORGANIZING MAPS; Nachbar R. B., 2000, Genetic Programming and Evolvable Machines, V1, DOI 10.1023/A:1010072431120; Nicolaou CA, 2012, MINI-REV MED CHEM, V12, P979; Nicolaou CA, 2009, J CHEM INF MODEL, V49, P295, DOI 10.1021/ci800308h; Pirard B, 2011, EXPERT OPIN DRUG DIS, V6, P225, DOI 10.1517/17460441.2011.554394; Renner S, 2007, ANGEW CHEM INT EDIT, V46, P5336, DOI 10.1002/anie.200604125; Reutlinger M, 2011, ANGEW CHEM INT EDIT, V50, P11633, DOI 10.1002/anie.201105156; Reymond JL, 2010, MEDCHEMCOMM, V1, P30, DOI 10.1039/c0md00020e; Schneider G, 2013, DE NOVO MOL DESIGN; TOVAR A, 2007, CHEMMEDCHEM, V2, P208; Turner DB, 1997, J CHEM INF COMP SCI, V37, P18, DOI 10.1021/ci960463h; VENKATASUBRAMANIAN V, 1995, J CHEM INF COMP SCI, V35, P188, DOI 10.1021/ci00024a003; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9	30	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1868-1743	1868-1751		MOL INFORM	Mol. Inf.	DEC	2014	33	11-12			SI		779	789		10.1002/minf.201400056		11	Chemistry, Medicinal; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology	Pharmacology & Pharmacy; Computer Science; Mathematical & Computational Biology	AW0IG	WOS:000345974300008		
J	Ohtana, Y; Abdullah, AA; Altaf-Ul-Amin, M; Huang, M; Ono, N; Sato, T; Sugiura, T; Horai, H; Nakamura, Y; Hirai, AM; Lange, KW; Kibinge, NK; Katsuragi, T; Shirai, T; Kanaya, S				Ohtana, Yuki; Abdullah, Azian Azamimi; Altaf-Ul-Amin, Md.; Huang, Ming; Ono, Naoaki; Sato, Tetsuo; Sugiura, Tadao; Horai, Hisayuki; Nakamura, Yukiko; Hirai, Aki Morita; Lange, Klaus W.; Kibinge, Nelson K.; Katsuragi, Tetsuo; Shirai, Tsuyoshi; Kanaya, Shigehiko			Clustering of 3D-Structure Similarity Based Network of Secondary Metabolites Reveals Their Relationships with Biological Activities	MOLECULAR INFORMATICS			English	Article						Clustering of 3D-structure similarity; Network of secondary metabolites; Metabolites; Biological activities; KNApSAcK family databases; Phytochemistry; Structure-property relationships; Visualization, Cheminformatics; 'Bioinformatics	BIG; METABOLOMICS; ALGORITHM	Developing database systems connecting diverse species based on omics is the most important theme in big data biology. To attain this purpose, we have developed KNApSAcK Family Databases, which are utilized in a number of researches in metabolomics. In the present study, we have developed a network-based approach to analyze relationships between 3D structure and biological activity of metabolites consisting of four steps as follows: construction of a network of metabolites based on structural similarity (Step 1), classification of metabolites into structure groups (Step 2), assessment of statistically significant relations between structure groups and biological activities (Step 3), and 2-dimensional clustering of the constructed data matrix based on statistically significant relations between structure groups and biological activities (Step 4). Applying this method to a data set consisting of 2072 secondary metabolites and 140 biological activities reported in KNApSAcK Metabolite Activity DB, we obtained 983 statistically significant structure group-biological activity pairs. As a whole, we systematically analyzed the relationship between 3D-chemical structures of metabolites and biological activities.	[Ohtana, Yuki; Abdullah, Azian Azamimi; Altaf-Ul-Amin, Md.; Huang, Ming; Ono, Naoaki; Sato, Tetsuo; Sugiura, Tadao; Nakamura, Yukiko; Hirai, Aki Morita; Kibinge, Nelson K.; Katsuragi, Tetsuo; Kanaya, Shigehiko] Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma, Nara 6300192, Japan; [Shirai, Tsuyoshi] Nagahama Inst Biosci & Technol, Nagahama, Shiga 5260829, Japan; [Horai, Hisayuki] Ibaraki Natl Coll Technol, Hitachinaka, Ibaraki 3128508, Japan; [Lange, Klaus W.] Univ Regensburg, Dept Expt Psychol, D-93040 Regensburg, Germany	Kanaya, S (reprint author), Nara Inst Sci & Technol, Grad Sch Informat Sci, 8916-5 Takayama, Ikoma, Nara 6300192, Japan.	t_shirai@nagahama-i-bio.ac.jp; skanaya@gtc.naist.jp	Abdullah, Azian Azamimi/F-5186-2010	Abdullah, Azian Azamimi/0000-0001-5851-7705	National Bioscience Database Center in Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	The National Bioscience Database Center in Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan [Grant-in-Aid for Scientific Research on Innovation Area 'Biosynthetic Machinery. Deciphering and Regulating the System for Creating Structural Diversity of Bioactivity Metabolites (2007)'] have partly supported this work.	Afendi FM, 2012, PLANT CELL PHYSIOL, V53, DOI 10.1093/pcp/pcr165; Afendi F. M., 2013, COMPUTATIONAL STRUCT, V4; Afendi Farit Mochamad, 2012, Current Pharmacogenomics & Personalized Medicine, V10, P111; Al-Tarifi M. A., 2012, ISRN BIOMATH, P1; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Kelling S, 2009, BIOSCIENCE, V59, P613, DOI 10.1525/bio.2009.59.7.12; Birney E, 2012, NATURE, V489, P49, DOI 10.1038/489049a; Dixon RA, 2001, NATURE, V411, P843, DOI 10.1038/35081178; Wijaya SH, 2014, BIOMED RES INT, DOI 10.1155/2014/831751; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; BENJAMINI Y, 1995, J ROY STAT SOC B MET, V57, P289; Patterson DJ, 2010, TRENDS ECOL EVOL, V25, P686, DOI 10.1016/j.tree.2010.09.004; Wink M, 1998, J CHEM ECOL, V24, P1881, DOI 10.1023/A:1022315802264; Thessen AE, 2011, ZOOKEYS, P15, DOI 10.3897/zookeys.150.1766; Callebaut Werner, 2012, Stud Hist Philos Biol Biomed Sci, V43, P69, DOI 10.1016/j.shpsc.2011.10.007; Connolly J, 1991, DICT TERPENOIDS; Ibrahim M, 2012, BIOCHEM BIOPH RES CO, V428, P278, DOI 10.1016/j.bbrc.2012.10.045; Ikeda S., 2013, PLANT CELL PHYSL, V54, P717; KANAYA S, 1994, INT J GENOME RES, V1, P261; Katsuragi T., 2013, FOODS FOOD INGREDIEN, V218, P43; Kelling S., 2009, 4 PARADIGM DATA INTE; Altaf-Ul-Amin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-207; Nakamura Y, 2014, PLANT CELL PHYSIOL, V55, DOI 10.1093/pcp/pct176; Pennisi E, 2005, SCIENCE, V309, P94, DOI 10.1126/science.309.5731.94; Saito M, 2012, J MOL BIOL, V424, P379, DOI 10.1016/j.jmb.2012.10.001; Takahashi H, 2008, ANAL BIOANAL CHEM, V391, P2769, DOI 10.1007/s00216-008-2195-5; Wang H, 2013, MATH PROBL ENG, DOI 10.1155/2013/541359	30	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1868-1743	1868-1751		MOL INFORM	Mol. Inf.	DEC	2014	33	11-12			SI		790	801		10.1002/minf.201400123		12	Chemistry, Medicinal; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology	Pharmacology & Pharmacy; Computer Science; Mathematical & Computational Biology	AW0IG	WOS:000345974300009		
J	Mashima, A; Kurahashi, M; Sasahara, K; Yoshida, T; Chuman, H				Mashima, Akira; Kurahashi, Masahiro; Sasahara, Katsunori; Yoshida, Tatsusada; Chuman, Hiroshi			Connecting Classical QSAR and LERE Analyses Using Modern Molecular Calculations, LERE-QSAR (VI): Hydrolysis of Substituted Hippuric Acid Phenyl Esters by Trypsin	MOLECULAR INFORMATICS			English	Article						Hammett sigma constant; Protein-ligand kinetics; Quantum chemistry; Structure-activity relationships	BARRIER HYDROGEN-BOND; INITIO MO CALCULATIONS; SERINE PROTEASES; BINDING-AFFINITY; TETRAHEDRAL INTERMEDIATE; COMPLEX STRUCTURES; ALPHA-CHYMOTRYPSIN; ACYLATION PROCESS; CATALYTIC TRIAD; CHEMICAL-SHIFTS	The reaction mechanism of trypsin was studied by applying DFT and ab initio molecular orbital (MO) calculations to complexes of trypsin with a congeneric series of eight para-substituted hippuric acid phenyl esters, for which a previous quantitative structure-activity relationship (QSAR) study revealed nice linearity of Hammett substitution constant sigma(-) with logarithmic values of the Michaelis-Menten and catalytic rate constants. Based on the LERE procedure, we performed QSAR analyses on each elementary reaction step during the acylation process. The present calculations showed that the rate-determining step during the acylation process is the transition state (TS) between the enzyme-substrate complex (ES) and tetrahedral inter-mediate (TET), and that the proton transfer occurs from Ser195 to His57, not between His57 and Asp102. The LERE-QSAR analysis statistically suggested that the variation of overall free-energy changes leading to formation of TS is governed mostly by that of activation energies required to form TS from ES. In spite of a very limited number of congeneric ligands in the current work, it is critically essential to clarify and verify physicochemical meanings of a typical QSAR/Chemoinformatics parameter, Hammett sigma(-) based on quantum chemical calculations on the protein-ligand kinetics; how Hammett sigma(-) behaves in terms of protein-ligand interaction energies.	[Mashima, Akira; Kurahashi, Masahiro; Sasahara, Katsunori; Yoshida, Tatsusada; Chuman, Hiroshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Tokushima 7708505, Japan	Chuman, H (reprint author), Univ Tokushima, Grad Sch, Inst Hlth Biosci, 1-78 Shomachi, Tokushima 7708505, Japan.	hchuman@tokushima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [24590051, 23710272]	This work was supported by Grants-in-Aid for Scientific Research (No. 24590051 and 23710272) from the Ministry of Education, Culture, Sports, Science and Technology.	Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Varekova RS, 2011, J CHEM INF MODEL, V51, P1795, DOI 10.1021/ci200133w; Xu Q, 2010, J PHYS CHEM B, V114, P10594, DOI 10.1021/jp102785s; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Talhout R, 2003, J AM CHEM SOC, V125, P10570, DOI 10.1021/ja034676g; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; Petrillo T, 2012, BIOCHEMISTRY-US, V51, P6164, DOI 10.1021/bi300688k; Bobofchak KM, 2005, J BIOL CHEM, V280, P25644, DOI 10.1074/jbc.M503499200; Cassidy CS, 1997, BIOCHEMISTRY-US, V36, P4576, DOI 10.1021/bi962013o; Hirota M, 2006, J GASTROENTEROL, V41, P832, DOI 10.1007/s00535-006-1874-2; Tyndall JDA, 2005, CHEM REV, V105, P973, DOI 10.1021/cr040669e; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Cleland WW, 1998, J BIOL CHEM, V273, P25529, DOI 10.1074/jbc.273.40.25529; Scott AD, 2009, CHEMMEDCHEM, V4, P1985, DOI 10.1002/cmdc.200900386; Zhou YZ, 2011, CHEM COMMUN, V47, P1577, DOI 10.1039/c0cc04112b; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; JAFFE HH, 1953, CHEM REV, V53, P191, DOI 10.1021/cr60165a003; Krishnamurthy VM, 2006, J AM CHEM SOC, V128, P5802, DOI 10.1021/ja060070r; Heutinck KM, 2010, MOL IMMUNOL, V47, P1943, DOI 10.1016/j.molimm.2010.04.020; Fedorov DG, 2004, J CHEM PHYS, V120, P6832, DOI 10.1063/1.1687334; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Chodera JD, 2013, ANNU REV BIOPHYS, V42, P121, DOI 10.1146/annurev-biophys-083012-130318; Tomasi J, 2004, THEOR CHEM ACC, V112, P184, DOI 10.1007/s00214-004-0582-3; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Poi MJ, 2003, J MOL BIOL, V329, P997, DOI 10.1016/S0022-2836(03)00512-6; Hitaoka S, 2011, J CHEM INF MODEL, V51, P2706, DOI 10.1021/ci2002395; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; HANSCH C, 1964, J AM CHEM SOC, V86, P1616, DOI 10.1021/ja01062a035; Topf M, 2002, J AM CHEM SOC, V124, P14780, DOI 10.1021/ja026219q; Kuhn P, 1998, BIOCHEMISTRY-US, V37, P13446, DOI 10.1021/bi9813983; Dullweber F, 2001, J MOL BIOL, V313, P593, DOI 10.1006/jmbi.2001.5062; Ekici OD, 2008, PROTEIN SCI, V17, P2023, DOI 10.1110/ps.035436.108; FUJITA T, 1964, J AM CHEM SOC, V86, P5175, DOI 10.1021/ja01077a028; Grimme S, 2011, J COMPUT CHEM, V32, P1456, DOI 10.1002/jcc.21759; Ishida T, 2003, J AM CHEM SOC, V125, P12035, DOI 10.1021/ja021369m; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Yousef GM, 2004, BBA-PROTEINS PROTEOM, V1698, P77, DOI 10.1016/j.bbapap.2003.10.008; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Bachovchin WW, 2001, MAGN RESON CHEM, V39, pS199, DOI 10.1002/mrc.951; BACHOVCHIN WW, 1985, P NATL ACAD SCI USA, V82, P7948, DOI 10.1073/pnas.82.23.7948; Brandt T, 2011, J MOL BIOL, V405, P1170, DOI 10.1016/j.jmb.2010.11.038; Davies TG, 1999, PROTEIN SCI, V8, P1432; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gleeson MP, 2004, ORG BIOMOL CHEM, V2, P2275, DOI 10.1039/b402399d; Goerigk L, 2013, J CHEM THEORY COMPUT, V9, P3240, DOI 10.1021/ct400321m; Hitaoka S, 2013, J PESTIC SCI, V38, P60, DOI 10.1584/jpestics.D12-082; Hitaoka S, 2010, J CHEM INF MODEL, V50, P1796, DOI 10.1021/ci100225b; Hosur MV, 2013, CRYSTALLOGR REV, V19, P3, DOI 10.1080/0889311X.2013.771633; Ishida T, 2006, BIOCHEMISTRY-US, V45, P5413, DOI 10.1021/bi051515b; Ishida T, 2004, J AM CHEM SOC, V126, P7111, DOI 10.1021/ja030405u; Johnson E. R., 2006, J CHEM PHYS, V124; Kawai Y, 2000, J CHEM SOC PERK T 2, V4, P887; KOSSIAKOFF AA, 1980, NATURE, V288, P414, DOI 10.1038/288414a0; KOSSIAKOFF AA, 1981, BIOCHEMISTRY-US, V20, P6462, DOI 10.1021/bi00525a027; Kruse H., 2012, J CHEM PHYS, V136; Lepp Z, 2005, BIOORGAN MED CHEM, V13, P3093, DOI 10.1016/j.bmc.2005.02.057; Lundberg M, 2010, J CHEM THEORY COMPUT, V6, P1413, DOI 10.1021/ct100029p; Masuda Y, 2013, PROTEINS, V81, P526, DOI 10.1002/prot.24206; Molina PA, 2003, THEOR CHEM ACC, V109, P100, DOI 10.1007/s00214-002-0415-1; Munei Y, 2011, BIOORG MED CHEM LETT, V21, P141, DOI 10.1016/j.bmcl.2010.11.050; Nemukhin AV, 2004, THEOR CHEM ACC, V111, P36, DOI 10.1007/s00214-003-0556-x; Page M.J., 2007, ELS, DOI [10.1002/9780470015902.a0005902.pub2., DOI 10.1002/9780470015902.A0005902.PUB2]; Recacha R, 1999, ACTA CRYSTALLOGR D, V55, P1785, DOI 10.1107/S0907444999008732; SELASSIE CD, 1988, CHEM-BIOL INTERACT, V68, P13; Tamada T, 2009, J AM CHEM SOC, V131, P11033, DOI 10.1021/ja9028846; Topf M, 2004, J AM CHEM SOC, V126, P14631, DOI 10.1021/ja047010a; UMEYAMA H, 1981, J MOL BIOL, V150, P409, DOI 10.1016/0022-2836(81)90556-8; UMEYAMA H, 1984, P NATL ACAD SCI-BIOL, V81, P6266, DOI 10.1073/pnas.81.20.6266; Yoshida T, 2009, CURR COMPUT-AID DRUG, V5, P38; Yoshida T, 2010, J CHEM INF MODEL, V50, P850, DOI 10.1021/ci100068w; Yoshida T, 2011, J ORG CHEM, V76, P4564, DOI 10.1021/jo200450p; Yoshida T, 2012, J PHYS CHEM B, V116, P10283, DOI 10.1021/jp305476x	74	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1868-1743	1868-1751		MOL INFORM	Mol. Inf.	DEC	2014	33	11-12			SI		802	814		10.1002/minf.201400099		13	Chemistry, Medicinal; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology	Pharmacology & Pharmacy; Computer Science; Mathematical & Computational Biology	AW0IG	WOS:000345974300010		
J	Ghani, S; Khan, N; Koriyama, C; Akiba, S; Yamamoto, M				Ghani, Sidra; Khan, Noureen; Koriyama, Chihaya; Akiba, Suminori; Yamamoto, Megumi			N-acetyl-L-cysteine reduces arsenite-induced cytotoxicity through chelation in U937 monocytes and macrophages	MOLECULAR MEDICINE REPORTS			English	Article						arsenite; U937; N-acetyl-L-cysteine	INDUCED OXIDATIVE STRESS; SIGNALING PATHWAYS; DRINKING-WATER; LEUKEMIA-CELLS; HL-60 CELLS; ENDOTHELIAL-CELLS; CYTOCHROME-C; APOPTOSIS; TRIOXIDE; DIFFERENTIATION	In the present study, in order to clarify the preventive mechanism of N-acetyl-L-cysteine (NAC) on arsdnite-induced apoptosis in U937 cells, which lack functional p53, the cytotoxicity among U937 cells [monocytes and 12- O-tetradecanoylphorbol-13-acetate (TPA)-treated macrophages] receiving NAC treatment at different times post arsenite treatment was examined. TPA-treated macrophages were more resistant to arsenite-induced apoptosis than monocytes, which may be associated with the induction of Bcl-2 expression. Pretreatment with 20 mM NAC prior to arsenite exposure suppressed apoptosis up to 75% in the monocytes and 100% in the macrophages. However, 6-h NAC pretreatment and subsequent washing out of NAC from the culture medium prior to arsenite treatment did not inhibit the arsenite-induced apoptosis. Post-treatment by NAC up to 1 h following arsenite exposure almost completely inhibited the cytotoxic effects of arsenite in U937 monocytes and macrophages. The results of the current study indicate that the preventive mechanism of NAC on arsenite-induced apoptosis in U937 monocytes and macrophages mainly involves chelation of arsenite in culture medium.	[Ghani, Sidra; Khan, Noureen; Koriyama, Chihaya; Akiba, Suminori] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Epidemiol & Prevent Med, Kagoshima 8908544, Japan; [Yamamoto, Megumi] Natl Inst Minamata Dis, Dept Basic Med Sci, Integrated Physiol Sect, Minamata, Kumamoto 8670008, Japan	Koriyama, C (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Epidemiol & Prevent Med, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	fiy@m.kufm.kagoshima-u.ac.jp					Ahmad S. A., 2013, World Applied Sciences Journal, V24, P634; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Smith AH, 1998, AM J EPIDEMIOL, V147, P660; Flora SJS, 2011, FREE RADICAL BIO MED, V51, P257, DOI 10.1016/j.freeradbiomed.2011.04.008; Vogel CFA, 2005, ENVIRON HEALTH PERSP, V113, P1536, DOI 10.1289/ehp.8094; States JC, 2011, ENVIRON HEALTH PERSP, V119, P1356, DOI 10.1289/ehp.1103441; ASHRAF M, 1991, FISH RES, V12, P355, DOI 10.1016/0165-7836(91)90018-B; Rosato RR, 2003, CANCER RES, V63, P3637; Ramos AM, 2005, BLOOD, V105, P4013, DOI 10.1182/blood-2004-07-2802; Biswas R, 2008, HUM EXP TOXICOL, V27, P381, DOI 10.1177/0960327108094607; Sordet O, 2001, BLOOD, V97, P3931, DOI 10.1182/blood.V97.12.3931; Marchiset-Ferlay N, 2012, ENVIRON INT, V39, P150, DOI 10.1016/j.envint.2011.07.015; Nickson RT, 2005, APPL GEOCHEM, V20, P55, DOI 10.1016/j.apgeochem.2004.06.004; Banerjee N, 2009, J CLIN IMMUNOL, V29, P582, DOI 10.1007/s10875-009-9304-x; Meinhardt G, 2000, CELL DEATH DIFFER, V7, P795, DOI 10.1038/sj.cdd.4400709; Takada Y, 1999, J BIOL CHEM, V274, P28286, DOI 10.1074/jbc.274.40.28286; BANNER W, 1986, TOXICOL APPL PHARM, V83, P142, DOI 10.1016/0041-008X(86)90331-5; Ho SY, 2011, CHEM-BIOL INTERACT, V193, P162, DOI 10.1016/j.cbi.2011.06.007; Banerjee N, 2008, TOXICOLOGY, V246, P101, DOI 10.1016/j.tox.2007.12.029; Hirano S, 2003, ARCH TOXICOL, V77, P305, DOI 10.1007/s00204-003-0447-x; Fernandez C, 2004, J BIOL CHEM, V279, P3877, DOI 10.1074/jbc.M310665200; FOTI A, 1990, BRIT J HAEMATOL, V76, P143, DOI 10.1111/j.1365-2141.1990.tb07849.x; HENDERSON P, 1985, VET HUM TOXICOL, V27, P522; Hirano S, 2004, TOXICOL APPL PHARM, V198, P458, DOI 10.1016/j.taap.2003.10.023; Iwama K, 2001, INT J CANCER, V92, P518, DOI 10.1002/ijc.1220; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Liu YQ, 2005, BIOL PHARM BULL, V28, P461, DOI 10.1248/bpb.28.461; Luna AL, 2010, TOXICOL APPL PHARM, V245, P244, DOI 10.1016/j.taap.2010.03.006; Martin D S, 1990, J Am Board Fam Pract, V3, P293; Meinhardt G, 2000, EUR J CELL BIOL, V79, P824, DOI 10.1078/0171-9335-00100; Reddy PS, 2011, J TRACE ELEM MED BIO, V25, P247, DOI 10.1016/j.jtemb.2011.08.145; Riganti C, 2003, TOXICOL APPL PHARM, V193, P106, DOI 10.1016/S0041-008X(03)00339-9; Shiiki K, 2000, CELL DEATH DIFFER, V7, P939, DOI 10.1038/sj.cdd.4400727; SOLARY E, 1993, BLOOD, V81, P1359; Sordet O, 1999, CELL DEATH DIFFER, V6, P351, DOI 10.1038/sj.cdd.4400499; United States Environmental Protection Agency, 2002, EPA542S02002; Uqaili AA, 2012, INT J ENG RES APPL, V3, P259; Yamamoto M, 2008, J BIOCHEM MOL TOXIC, V22, P136, DOI 10.1002/jbt.20222	38	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	DEC	2014	10	6					2961	2966		10.3892/mmr.2014.2612		6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	AU9YM	WOS:000345947900026		
J	Unser-Schutz, G				Unser-Schutz, Giancarla			The Use and Non-Use of Japanese Names by Non-Japanese	NAMES-A JOURNAL OF ONOMASTICS			English	Article						Japan; immigrants; personal names; identity; adaptation; foreigners; race	PARENTS	While Japan is often said to be homogenous in population, recent years have seen an increase in foreign residents, making it interesting to consider if the same patterns of adaptation of names found in other countries could be observed. A survey amongst foreign residents of Japan showed that while adaptation of names in their pronunciation was common, it was generally uncommon to use Japanese personal names. However, people of Asian heritage used them more commonly. It is suggested that the binary positioning of Japanese identities may make it difficult for some foreigners to take Japanese names, with additional factors such as racial expectations for foreigners possibly influencing some groups' ability to take Japanese names.	[Unser-Schutz, Giancarla] Rissho Univ, Fac Psychol, Tokyo 1418602, Japan	Unser-Schutz, G (reprint author), Rissho Univ, Fac Psychol, Shinagawa Ku, 4-2-16-1Gokan, Tokyo 1418602, Japan.	giancarlaunserschutz@ris.ac.jp					Alatis James E., 1955, NAMES, V3, P137; Gerhards J, 2009, AM J SOCIOL, V114, P1102; [Anonymous], 2005, AMAMI GAKU SONO CHIH; Becker B, 2009, ETHNICITIES, V9, P200, DOI 10.1177/1468796809103460; Debito Arudou, 2004, JAPANESE ONLY OTARU; e-Stat, 2012, ZAIR SHIK BETS NENR; e-Stat, 2012, DAIIH 2 KOK CHIIK BE; Hatano Lilian Terumi, 2008, MAINORITI NAMAE WA D; Huber Jonas, 2013, GENEVA ASS LIFE PENS, P1; Immigration Bureau of Japan, 2013, KOD JINZ POINT SEI N; Kim Taeyoung, 2002, INT ED J, V3, P56; Kim Tae-Young, 2007, J MULTILING MULTICUL, V28, P117; Klymasz Robert, 1963, NAMES, V11, P182; Klymasz Robert, 1963, NAMES, V11, P229; Klymasz Robert, 1963, NAMES, V11, P81; KOMAI H., 2000, ASIAN PAC MIGR J, V9, P311; Lie J, 2001, MULTIETHNIC JAPAN; Louie Emma Woo, 1991, NAMES, V39, P225; Maeda Margaret, 2002, KANAGAWA DAIGAKU GEN, V25, P139; Ministry of Education Culture Sports Science and Technology, 2013, RYUG 30MAN NIN KEIK; Ministry of Health Labour and Welfare, 2013, HEIS 25NEN WAG KUN J; Ministry of Internal Affairs and Communications, 2012, KOK CHIIK BETS ZAIR; Ministry of Justice, 2013, KOK KEKK KAIG SHUSS; Ministry of Justice, 2013, EIJ KYOK NI KANS GAI; Ministry of Justice, 2013, KIK KYOK SHINS TO SU; Mizuno Naoki, 2008, SOSHI KAIMEI NIHON C; Murphy-Shigematsu Stephen, 1993, MELUS, V18, P63, DOI 10.2307/468120; Niedzielski Nancy A, 2003, FOLK LINGUISTICS; Osaki T, 2013, JAPAN TIMES; Saito Yoshifumi, 2012, HOM NYUK KANR ZAIR K; Taira Koji, 1997, JAPANS MINORITIES IL, P140; Tsukada N, 2013, GENERATIONS, V37, P66; U.S. Census Bureau, 2012, AM COMM SURV REP; Watkins-Goffman, 2001, LIVES 2 LANGUAGES EX; Weiner M, 2009, SHEFF CENT JPN STUD, P1; Wu Ellen Dionne, 1999, NAMES, V47, P21; Zainihon Daikan-minzoku Seinen-kai, 1994, ZAIN KANK SEIN ISH C	37	1	1	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0027-7738	1756-2279		NAMES	Names	DEC	2014	62	4					202	213		10.1179/0027773814Z.00000000086		12	Linguistics; Language & Linguistics	Linguistics	AW2ZE	WOS:000346154300003		
J	Peng, X; Alfoldi, J; Gori, K; Eisfeld, AJ; Tyler, SR; Tisoncik-Go, J; Brawand, D; Law, GL; Skunca, N; Hatta, M; Gasper, DJ; Kelly, SM; Chang, J; Thomas, MJ; Johnson, J; Berlin, AM; Lara, M; Russell, P; Swofford, R; Turner-Maier, J; Young, S; Hourlier, T; Aken, B; Searle, S; Sun, XS; Yi, YL; Suresh, M; Tumpey, TM; Siepel, A; Wisely, SM; Dessimoz, C; Kawaoka, Y; Birren, BW; Lindblad-Toh, K; Di Palma, F; Engelhardt, JF; Palermo, RE; Katze, MG				Peng, Xinxia; Alfoeldi, Jessica; Gori, Kevin; Eisfeld, Amie J.; Tyler, Scott R.; Tisoncik-Go, Jennifer; Brawand, David; Law, G. Lynn; Skunca, Nives; Hatta, Masato; Gasper, David J.; Kelly, Sara M.; Chang, Jean; Thomas, Matthew J.; Johnson, Jeremy; Berlin, Aaron M.; Lara, Marcia; Russell, Pamela; Swofford, Ross; Turner-Maier, Jason; Young, Sarah; Hourlier, Thibaut; Aken, Bronwen; Searle, Steve; Sun, Xingshen; Yi, Yaling; Suresh, M.; Tumpey, Terrence M.; Siepel, Adam; Wisely, Samantha M.; Dessimoz, Christophe; Kawaoka, Yoshihiro; Birren, Bruce W.; Lindblad-Toh, Kerstin; Di Palma, Federica; Engelhardt, John F.; Palermo, Robert E.; Katze, Michael G.			The draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease	NATURE BIOTECHNOLOGY			English	Article							CYSTIC-FIBROSIS; INFLUENZA-VIRUS; RNA; EXPRESSION; TRACT; ANNOTATION; PHENOTYPE; INFECTION; IMMUNITY; MODELS	The domestic ferret (Mustela putorius furo) is an important animal model for multiple human respiratory diseases. It is considered the 'gold standard' for modeling human influenza virus infection and transmission(1-)4. Here we describe the 2.41 Gb draft genome assembly of the domestic ferret, constituting 2.28 Gb of sequence plus gaps. We annotated 19,910 protein-coding genes on this assembly using RNA-seq data from 21 ferret tissues. We characterized the ferret host response to two influenza virus infections by RNA-seq analysis of 42 ferret samples from influenza time-course data and showed distinct signatures in ferret trachea and lung tissues specific to 1918 or 2009 human pandemic influenza virus infections. Using microarray data from 16 ferret samples reflecting cystic fibrosis disease progression, we showed that transcriptional changes in the CFTR-knockout ferret lung reflect pathways of early disease that cannot be readily studied in human infants with cystic fibrosis disease.	[Peng, Xinxia; Tisoncik-Go, Jennifer; Law, G. Lynn; Kelly, Sara M.; Chang, Jean; Thomas, Matthew J.; Katze, Michael G.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Alfoeldi, Jessica; Brawand, David; Johnson, Jeremy; Berlin, Aaron M.; Lara, Marcia; Russell, Pamela; Swofford, Ross; Turner-Maier, Jason; Young, Sarah; Birren, Bruce W.; Lindblad-Toh, Kerstin; Di Palma, Federica] Broad Inst MIT & Harvard, Cambridge, MA USA; [Gori, Kevin; Dessimoz, Christophe] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England; [Eisfeld, Amie J.; Hatta, Masato; Gasper, David J.; Suresh, M.; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Tyler, Scott R.; Sun, Xingshen; Yi, Yaling; Engelhardt, John F.] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA USA; [Tyler, Scott R.] Univ Iowa, Carver Coll Med, Mol & Cellular Biol Program, Iowa City, IA USA; [Skunca, Nives] ETH, Swiss Fed Inst Technol, Dept Comp Sci, Zurich, Switzerland; [Skunca, Nives] Swiss Inst Bioinformat, Zurich, Switzerland; [Hourlier, Thibaut; Aken, Bronwen; Searle, Steve] Wellcome Trust Sanger Inst, Cambridge, England; [Tumpey, Terrence M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Siepel, Adam] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Wisely, Samantha M.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Dessimoz, Christophe] UCL, Dept Genet Evolut & Environm, London, England; [Dessimoz, Christophe] UCL, Dept Comp Sci, London, England; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, ERATO Infect Induced Host Responses Project, Saitama, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Special Pathogens,Minato Ku, Tokyo, Japan; [Kawaoka, Yoshihiro] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Bioresponses Regulat, Kyoto 606, Japan; [Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Engelhardt, John F.] Univ Iowa, Carver Coll Med, Ctr Gene Therapy, Iowa City, IA USA; [Katze, Michael G.] Washington Natl Primate Res Ctr, Seattle, WA USA	Katze, MG (reprint author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	palermor@uw.edu; honey@uw.edu	Dessimoz, Christophe/D-3678-2011	Gori, Kevin/0000-0001-7975-4275; Dessimoz, Christophe/0000-0002-2170-853X	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services [HHSN272200800060C, HHSN272201400005C, HHSN272200900018C]; Public Health Service Grant [P51OD010425]; NIH Office of the Director [9T32OD010423-06, 5T32RR023916-05]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R37 DK047967, R24 DK096518, P30 DK054759]; National Heart, Lung, and Blood Institute [R01 HL108902]; SNSF [136461]; NIH National Institute of General Medical Sciences [R01 GM102192]; EURYI ERC	This project was funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services, under Contract Nos. HHSN272200800060C and HHSN272201400005C and Public Health Service Grant P51OD010425 (M.G.K.). For the Broad Institute of MIT and Harvard, this project was funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900018C. D.J.G. also received training grants 9T32OD010423-06 and 5T32RR023916-05 from the NIH Office of the Director. J.F.E., S.R.T., X.S. and Y.Y. (University of Iowa) were supported under the NIH National Institute of Diabetes and Digestive and Kidney Diseases grants R37 DK047967, R24 DK096518 and P30 DK054759, and National Heart, Lung, and Blood Institute grant R01 HL108902. C.D. acknowledges support by SNSF advanced researcher fellowship (#136461). A.S. receives support under NIH National Institute of General Medical Sciences R01 GM102192. For S.S., B.A. and T.H., the Wellcome Trust Sanger Institute is operated by Genome Research Limited, a charity registered in England with number 1021457 and a company registered in England with number 2742969. K.L.-T. also receives support under EURYI ERC. We thank Marshall Farms, New York, for providing three adult sable female ferrets (M. putorius furo; 421 days old).	Altenhoff AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053786; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Ciofu O, 2013, CURR OPIN PULM MED, V19, P251, DOI 10.1097/MCP.0b013e32835f1afc; Ouborg NJ, 2010, TRENDS GENET, V26, P177, DOI 10.1016/j.tig.2010.01.001; Olivier AK, 2012, J CLIN INVEST, V122, P3755, DOI 10.1172/JCI60610; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319; Wolk K, 2008, J LEUKOCYTE BIOL, V83, P1181, DOI 10.1189/jlb.0807525; Altenhoff AM, 2011, NUCLEIC ACIDS RES, V39, pD289, DOI 10.1093/nar/gkq1238; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Ogilvie V, 2011, GENOMICS, V98, P327, DOI 10.1016/j.ygeno.2011.06.008; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231; Wisely SM, 2003, ZOO BIOL, V22, P287, DOI 10.1002/zoo.10089; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Sun XS, 2014, AM J RESP CELL MOL, V50, P502, DOI 10.1165/rcmb.2013-0261OC; Cavagna P, 2000, MAMM GENOME, V11, P866, DOI 10.1007/s003350010172; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/nmeth.1491, 10.1038/NMETH.1491]; Belser JA, 2011, DIS MODEL MECH, V4, P575, DOI 10.1242/dmm.007823; Tripp RA, 2009, CURR TOP MICROBIOL, V333, P397, DOI 10.1007/978-3-540-92165-3_19; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; BONFIELD TL, 1995, AM J RESP CRIT CARE, V152, P2111; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Schrauwen EJA, 2011, EMERG INFECT DIS, V17, P200, DOI 10.3201/eid1702.101268; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P588, DOI 10.1073/pnas.0806959106	42	4	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	DEC	2014	32	12					1250	U114		10.1038/nbt.3079		10	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AW3AD	WOS:000346156800027		
J	Veldhorst, M; Hwang, JCC; Yang, CH; Leenstra, AW; de Ronde, B; Dehollain, JP; Muhonen, JT; Hudson, FE; Itoh, KM; Morello, A; Dzurak, AS				Veldhorst, M.; Hwang, J. C. C.; Yang, C. H.; Leenstra, A. W.; de Ronde, B.; Dehollain, J. P.; Muhonen, J. T.; Hudson, F. E.; Itoh, K. M.; Morello, A.; Dzurak, A. S.			An addressable quantum dot qubit with fault-tolerant control-fidelity	NATURE NANOTECHNOLOGY			English	Article							ELECTRON-SPIN; SILICON; OSCILLATIONS; COMPUTATION; GATE	Exciting progress towards spin-based quantum computing(1,2) has recently been made with qubits realized using nitrogen-vacancy centres in diamond and phosphorus atoms in silicon(3). For example, long coherence times were made possible by the presence of spin-free isotopes of carbon(4) and silicon(5). However, despite promising single-atom nanotechnologies(6), there remain substantial challenges in coupling such qubits and addressing them individually. Conversely, lithographically defined quantum dots have an exchange coupling that can be precisely engineered(1), but strong coupling to noise has severely limited their dephasing times and control fidelities. Here, we combine the best aspects of both spin qubit schemes and demonstrate a gate-addressable quantum dot qubit in isotopically engineered silicon with a control fidelity of 99.6%, obtained via Clifford-based randomized benchmarking and consistent with that required for fault-tolerant quantum computing(7,8). This qubit has dephasing time T-2(*) = 120 mu s and coherence time T-2 = 28 ms, both orders of magnitude larger than in other types of semiconductor qubit. By gate-voltage-tuning the electron g*-factor we can Stark shift the electron spin resonance frequency by more than 3,000 times the 2.4 kHz electron spin resonance linewidth, providing a direct route to large-scale arrays of addressable high-fidelity qubits that are compatible with existing manufacturing technologies.	[Veldhorst, M.; Hwang, J. C. C.; Yang, C. H.; Dehollain, J. P.; Muhonen, J. T.; Hudson, F. E.; Morello, A.; Dzurak, A. S.] Univ New S Wales, Sch Elect Engn & Telecommun, Ctr Quantum Computat & Commun Technol, Sydney, NSW 2052, Australia; [Leenstra, A. W.; de Ronde, B.] Univ Twente, NL-7500 AE Enschede, Netherlands; [Itoh, K. M.] Keio Univ, Sch Fundamental Sci & Technol, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Veldhorst, M (reprint author), Univ New S Wales, Sch Elect Engn & Telecommun, Ctr Quantum Computat & Commun Technol, Sydney, NSW 2052, Australia.	m.veldhorst@unsw.edu.au; a.dzurak@unsw.edu.au	Muhonen, Juha/E-7152-2011; Itoh, Kohei/C-5738-2014; Dehollain, Juan Pablo/G-9915-2012; Morello, Andrea/B-6475-2008; McKenzie, Warren/J-2137-2014	Muhonen, Juha/0000-0001-6520-6999; Dehollain, Juan Pablo/0000-0002-0425-4345; Morello, Andrea/0000-0001-7445-699X; 	Australian Research Council [CE11E0096]; US Army Research Office [W911NF-13-1-0024]; NSW Node of the Australian National Fabrication Facility; Netherlands Organization for Scientific Research (NWO); FIRST; Core-to-Core Program by JSPS; MEXT	The authors thank D. J. Reilly and J. R. Petta for discussions. The authors acknowledge support from the Australian Research Council (CE11E0096), the US Army Research Office (W911NF-13-1-0024) and the NSW Node of the Australian National Fabrication Facility. M.V. acknowledges support from the Netherlands Organization for Scientific Research (NWO) through a Rubicon Grant. The work at Keio has been supported in part by FIRST, the Core-to-Core Program by JSPS, and the Grant-in-Aid for Scientific Research and Project for Developing Innovation Systems by MEXT.	Loss D, 1998, PHYS REV A, V57, P120, DOI 10.1103/PhysRevA.57.120; Elzerman JM, 2004, NATURE, V430, P431, DOI 10.1039/nature02693; Koppens FHL, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.236802; Shulman MD, 2012, SCIENCE, V336, P202, DOI 10.1126/science.1217692; Nadj-Perge S, 2010, NATURE, V468, P1084, DOI 10.1038/nature09682; Bluhm H, 2011, NAT PHYS, V7, P109, DOI [10.1038/nphys1856, 10.1038/NPHYS1856]; Nowack KC, 2011, SCIENCE, V333, P1269, DOI 10.1126/science.1209524; Tyryshkin AM, 2012, NAT MATER, V11, P143, DOI [10.1038/nmat3182, 10.1038/NMAT3182]; Knill E, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.012307; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Fuechsle M, 2012, NAT NANOTECHNOL, V7, P242, DOI [10.1038/nnano.2012.21, 10.1038/NNANO.2012.21]; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Pla JJ, 2012, NATURE, V489, P541, DOI 10.1038/nature11449; Bradbury FR, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.176404; Maune BM, 2012, NATURE, V481, P344, DOI 10.1038/nature10707; Angus SJ, 2007, NANO LETT, V7, P2051, DOI 10.1021/nl070949k; Rahman R, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155301; Awschalom D. D., 2012, SCIENCE, V339, P1174; Bar-Gill N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2771; Bluhm H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.216803; Buch H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3017; DiVincenzo DP, 2000, FORTSCHR PHYS, V48, P771, DOI 10.1002/1521-3978(200009)48:9/11<771::AID-PROP771>3.0.CO;2-E; Fowler A., 2012, PHYS REV A, V86, P1; Fukatsu S, 2003, APPL PHYS LETT, V83, P3897, DOI 10.1063/1.1625775; Hao XJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4860; Kalra R, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021044; Muhonen J. T., 2014, STORING QUANTUM INFO; Yang CH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3069; Yang CH, 2011, AIP ADV, V1, DOI 10.1063/1.3654496	30	35	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-3387	1748-3395		NAT NANOTECHNOL	Nat. Nanotechnol.	DEC	2014	9	12					981	985		10.1038/NNANO.2014.216		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	AW0EN	WOS:000345963500013		
J	Muhonen, JT; Dehollain, JP; Laucht, A; Hudson, FE; Kalra, R; Sekiguchi, T; Itoh, KM; Jamieson, DN; McCallum, JC; Dzurak, AS; Morello, A				Muhonen, Juha T.; Dehollain, Juan P.; Laucht, Arne; Hudson, Fay E.; Kalra, Rachpon; Sekiguchi, Takeharu; Itoh, Kohei M.; Jamieson, David N.; McCallum, Jeffrey C.; Dzurak, Andrew S.; Morello, Andrea			Storing quantum information for 30 seconds in a nanoelectronic device	NATURE NANOTECHNOLOGY			English	Article							ELECTRON-SPIN; SILICON; QUBIT; COHERENCE; READOUT; DIAMOND; STORAGE; SI-28	The spin of an electron or a nucleus in a semiconductor(1) naturally implements the unit of quantum information-the qubit. In addition, because semiconductors are currently used in the electronics industry, developing qubits in semiconductors would be a promising route to realize scalable quantum information devices(2). The solid-state environment, however, may provide deleterious interactions between the qubit and the nuclear spins of surrounding atoms(3), or charge and spin fluctuations arising from defects in oxides and interfaces(4). For materials such as silicon, enrichment of the spin-zero Si-28 isotope drastically reduces spin-bath decoherence(5). Experiments on bulk spin ensembles in Si-28 crystals have indeed demonstrated extraordinary coherence times(6-8). However, it remained unclear whether these would persist at the single-spin level, in gated nanostructures near amorphous interfaces. Here, we present the coherent operation of individual P-31 electron and nuclear spin qubits in a top-gated nanostructure, fabricated on an isotopically engineered Si-28 substrate. The P-31 nuclear spin sets the new benchmark coherence time (>30 s with Carr-Purcell-Meiboom-Gill (CPMG) sequence) of any single qubit in the solid state and reaches >99.99% control fidelity. The electron spin CPMG coherence time exceeds 0.5 s, and detailed noise spectroscopy(9) indicates that-contrary to widespread belief-it is not limited by the proximity to an interface. Instead, decoherence is probably dominated by thermal and magnetic noise external to the device, and is thus amenable to further improvement.	[Muhonen, Juha T.; Dehollain, Juan P.; Laucht, Arne; Hudson, Fay E.; Kalra, Rachpon; Dzurak, Andrew S.; Morello, Andrea] Univ New S Wales, Sch Elect Engn & Telecommun, Ctr Quantum Computat & Commun Technol, Sydney, NSW 2052, Australia; [Sekiguchi, Takeharu; Itoh, Kohei M.] Keio Univ, Sch Fundamental Sci & Technol, Yokohama, Kanagawa 2238522, Japan; [Jamieson, David N.; McCallum, Jeffrey C.] Univ Melbourne, Sch Phys, Ctr Quantum Computat & Commun Technol, Melbourne, Vic 3010, Australia	Muhonen, JT (reprint author), Univ New S Wales, Sch Elect Engn & Telecommun, Ctr Quantum Computat & Commun Technol, Sydney, NSW 2052, Australia.	juha.muhonen@unsw.edu.au; a.morello@unsw.edu.au	Muhonen, Juha/E-7152-2011; Itoh, Kohei/C-5738-2014; Dehollain, Juan Pablo/G-9915-2012; Jamieson, David/G-3753-2010; Morello, Andrea/B-6475-2008; McKenzie, Warren/J-2137-2014	Muhonen, Juha/0000-0001-6520-6999; Dehollain, Juan Pablo/0000-0002-0425-4345; Morello, Andrea/0000-0001-7445-699X; 	Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology [CE11E0001027]; US Army Research Office [W911NF-131-0024]; Australian National Fabrication Facility; laboratory of Robert Elliman at the Australian National University; FIRST; Core-to-Core Program by JSPS; MEXT	The authors thank M.J. Biercuk for discussions. This research was funded by the Australian Research Council Centre of Excellence for Quantum Computation and Communication Technology (project no. CE11E0001027) and the US Army Research Office (W911NF-131-0024). The authors acknowledge support from the Australian National Fabrication Facility and from the laboratory of Robert Elliman at the Australian National University for ion implantation facilities. The work at Keio has been supported in part by FIRST, the Core-to-Core Program by JSPS and the Grant-in-Aid for Scientific Research and Project for Developing Innovation Systems by MEXT.	Alvarez GA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.230501; Cywinski L, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.174509; Medford J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.086802; Steger M, 2012, SCIENCE, V336, P1280, DOI 10.1126/science.1217635; Saeedi K, 2013, SCIENCE, V342, P830, DOI 10.1126/science.1239584; Paik SY, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.075214; Bylander J, 2011, NAT PHYS, V7, P565, DOI [10.1038/nphys1994, 10.1038/NPHYS1994]; Morello A, 2010, NATURE, V467, P687, DOI 10.1038/nature09392; Pla JJ, 2013, NATURE, V496, P334, DOI 10.1038/nature12011; Laird EA, 2013, NAT NANOTECHNOL, V8, P565, DOI [10.1038/nnano.2013.140, 10.1038/NNANO.2013.140]; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; Greenland PT, 2010, NATURE, V465, P1057, DOI 10.1038/nature09112; Tyryshkin AM, 2012, NAT MATER, V11, P143, DOI [10.1038/nmat3182, 10.1038/NMAT3182]; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Dehollain JP, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/1/015202; Zwanenburg FA, 2013, REV MOD PHYS, V85, P961, DOI 10.1103/RevModPhys.85.961; Hu XD, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035314; Wolfowicz G, 2013, NAT NANOTECHNOL, V8, P561, DOI [10.1038/nnano.2013.117, 10.1038/NNANO.2013.117]; Mohiyaddin FA, 2013, NANO LETT, V13, P1903, DOI 10.1021/nl303863s; Yao W, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195301; Pla JJ, 2012, NATURE, V489, P541, DOI 10.1038/nature11449; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Awschalom DD, 2013, SCIENCE, V339, P1174, DOI 10.1126/science.1231364; Rahman R, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.155301; De Sousa R, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.245306; Jamieson DN, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1925320; Kalra R, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021044; Morton JJL, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.012332; Schenkel T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2182068; Witzel WM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.187602	30	47	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1748-3387	1748-3395		NAT NANOTECHNOL	Nat. Nanotechnol.	DEC	2014	9	12					986	991		10.1038/NNANO.2014.211		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	AW0EN	WOS:000345963500014		
J	Miyatake, S; Matsumoto, N				Miyatake, Satoko; Matsumoto, Naomichi			GENETICS Clinical exome sequencing in neurology practice	NATURE REVIEWS NEUROLOGY			English	Editorial Material							INTELLECTUAL DISABILITY; DIAGNOSIS		[Miyatake, Satoko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanagawa Ku, Yokohama, Kanagawa 2360004, Japan	Matsumoto, N (reprint author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanagawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	naomat@yokohama-cu.ac.jp					de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Koboldt DC, 2013, CELL, V155, P27, DOI 10.1016/j.cell.2013.09.006; Biesecker LG, 2014, NEW ENGL J MED, V370, P2418, DOI 10.1056/NEJMra1312543; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Srivastava S, 2014, ANN NEUROL, V76, P473, DOI 10.1002/ana.24251; Majewski J, 2011, J MED GENET, V48, P580, DOI 10.1136/jmedgenet-2011-100223; Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Fogel BL, 2014, JAMA NEUROL, V71, P1237, DOI 10.1001/jamaneurol.2014.1944	10	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4758	1759-4766		NAT REV NEUROL	Nat. Rev. Neurol.	DEC	2014	10	12					676	678		10.1038/nrneurol.2014.213		3	Clinical Neurology	Neurosciences & Neurology	AW2JP	WOS:000346114200002		
J	Fujihara, K; Palace, J				Fujihara, Kazuo; Palace, Jacqueline			NEUROIMMUNOLOGY: Towards more-accurate diagnosis in neuromyelitis optica	NATURE REVIEWS NEUROLOGY			English	Editorial Material							MULTIPLE-SCLEROSIS; MARKER; NMO		[Fujihara, Kazuo] Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Palace, Jacqueline] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England	Fujihara, K (reprint author), Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut, Aoba Ku, Sendai, Miyagi 9808574, Japan.	fujikazu@med.tohoku.ac.jp					Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Waters PJ, 2012, NEUROLOGY, V78, P665, DOI 10.1212/WNL.0b013e318248dec1; Sato DK, 2013, NEUROLOGY, V80, P2210, DOI 10.1212/WNL.0b013e318296ea08; Marignier R, 2013, NEUROLOGY, V80, P2194, DOI 10.1212/WNL.0b013e318296e917; Fujihara K, 2012, CLIN EXP NEUROIMMUNO, V3, P58; Kimbrough DJ, 2012, MULT SCLER RELAT DIS, V1, P180, DOI 10.1016/j.msard.2012.06.002; Pittock S. J., JAMA NEUROL; Siritho S, 2011, NEUROLOGY, V77, P827, DOI 10.1212/WNL.0b013e31822c61b1; Wingerchuk D., 2014, NEUROLOGY S10, V82	10	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1759-4758	1759-4766		NAT REV NEUROL	Nat. Rev. Neurol.	DEC	2014	10	12					679	681		10.1038/nrneurol.2014.216		3	Clinical Neurology	Neurosciences & Neurology	AW2JP	WOS:000346114200004		
J	Li, DW; Miwa, T; Morikawa, T				Li, Dawei; Miwa, Tomio; Morikawa, Takayuki			Considering En-Route Choices in Utility-Based Route Choice Modelling	NETWORKS & SPATIAL ECONOMICS			English	Article						Route choice; En-route choice; Taste heterogeneity; Mixed-logit	NESTED LOGIT MODEL; EM ALGORITHM; BEHAVIOR; HETEROGENEITY; DECISION; SET	This paper discusses how to take into account en-route choices in utility-based route choice modelling. A path observation through a network is divided into a sequence of route choices and decision making choices at decision nodes. A driver's dynamic taste for different routes at different decision nodes is described by a mixed-logit specification. Four estimation methods are proposed. Two numerical experiments are designed to illustrate estimation issues arising with the proposed model, as well as to illustrate the potential biases introduced by over-simplifying assumptions on en-route choices. The numerical results show that maximum likelihood estimation based on path observations is unable to recover the true parameters, while the other three methods give consistent estimates. The model fit is significant improved by considering dynamic taste for different routes. Path share predictions diverge greatly from those of the proposed model if the assumptions about en-route choices are simplified. The experiment on a real scale network shows that it is feasible to apply the proposed model in practice.	[Li, Dawei] Southeast Univ, Sch Transportat, Nanjing 210018, Jiangsu, Peoples R China; [Miwa, Tomio] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648601, Japan; [Miwa, Tomio; Morikawa, Takayuki] Nagoya Univ, Green Mobil Collaborat Res Ctr, Nagoya, Aichi 4648601, Japan; [Morikawa, Takayuki] Nagoya Univ, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan	Li, DW (reprint author), Southeast Univ, Sch Transportat, Jinxianghe 35, Nanjing 210018, Jiangsu, Peoples R China.	godavid87@gmail.com; miwa@civil.nagoya-u.ac.jp; morikawa@nagoya-u.jp	Miwa, Tomio/I-6084-2014				DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1; Bekhor S, 2001, TRANSPORT RES REC, P84; Prato CG, 2006, TRANSPORT RES REC, P19; Mahmassani HS, 1999, TRANSPORT RES C-EMER, V7, P91, DOI 10.1016/S0968-090X(99)00014-5; WEI GCG, 1990, J AM STAT ASSOC, V85, P699, DOI 10.2307/2290005; Gao S, 2012, IEEE T INTELL TRANSP, V13, P1298, DOI 10.1109/TITS.2012.2187197; Cascetta E, 1996, TRANSPORTATION AND TRAFFIC THEORY, P697; Hess S, 2011, TRANSPORT RES B-METH, V45, P973, DOI 10.1016/j.trb.2011.05.002; Bhat CR, 2000, TRANSPORT SCI, V34, P228, DOI 10.1287/trsc.34.2.228.12306; de Palma A, 2005, TRANSPORT RES A-POL, V39, P295, DOI 10.1016/j.tra.2004.10.001; Yai T, 1997, TRANSPORT RES B-METH, V31, P195, DOI 10.1016/S0191-2615(96)00025-2; Bekhor S, 2002, TRANSPORT RES REC, P78; Peeta S, 2005, NETW SPAT ECON, V5, P21, DOI 10.1007/s11067-005-6660-9; [Anonymous], 2002, APPL OPTIMIZAT; Gao S, 2008, TRANSP RES RECORD, P136, DOI 10.3141/2085-15; Vovsha P, 1998, TRANSPORT RES REC, P133; Peeta S, 2000, TRANSPORT RES REC, P102; Prato CG, 2007, TRANSP RES RECORD, P64, DOI 10.3141/2003-09; Prashker JN, 1998, TRANSPORT RES REC, P94; Gao S, 2010, TRANSPORT RES C-EMER, V18, P727, DOI 10.1016/j.trc.2009.08.001; AZEVEDO JA, 1993, EUR J OPER RES, V69, P97, DOI 10.1016/0377-2217(93)90095-5; Ben-Akiva M, 2014, NETW SPAT ECON, P1; Ben-Akiva M, 1999, INT SERIES OPERATION, P5; Ben-Akiva Moshe, 2001, NETW SPAT ECON, V1, P293, DOI DOI 10.1023/A:1012883811652; Bogers EAI, 2009, PROEFSCHRIFT TU DELF; Boyce DE, 1985, IMPLEMENTATION EVALU; Chen A, 2012, TRANSP RES A; DIAL RB, 1971, TRANSPORT RES, V5, P83, DOI 10.1016/0041-1647(71)90012-8; Hartman JL, 2012, NETW SPAT ECON, V12, P205, DOI 10.1007/s11067-009-9111-1; Hess S, 2009, TRANSPORT RES B-METH, V43, P708, DOI 10.1016/j.trb.2009.01.007; Li D, 2013, J NANOPART RES, V15, P1, DOI DOI 10.1145/2503210.2503226; Li DW, 2013, TRANSPORT RES REC, P20, DOI 10.3141/2338-03; Miwa T, 2010, TRANSP RES RECORD, P142, DOI 10.3141/2196-15; Morikawa T, 2006, JOURNAL OF ADVANCED, V40, P140; Parkany E, 2006, TRANSPORT RES REC, P29; Prato C.G., 2009, J CHOICE MODEL, V2, P65, DOI DOI 10.1016/S1755-5345(13)70005-8; Xiao L, 2014, NETW SPAT ECON, P1; Yamamoto T, 2012, P 91 ANN M TRANSP RE	38	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1566-113X	1572-9427		NETW SPAT ECON	Netw Spat. Econ.	DEC	2014	14	3-4					581	604		10.1007/s11067-014-9255-5		24	Operations Research & Management Science; Transportation Science & Technology	Operations Research & Management Science; Transportation	AW0HM	WOS:000345972100013		
J	Tando, S; Itoh, K; Yaoi, T; Ogi, H; Goto, S; Mori, M; Fushiki, S				Tando, So; Itoh, Kyoko; Yaoi, Takeshi; Ogi, Hiroshi; Goto, Shoko; Mori, Miyuki; Fushiki, Shinji			Bisphenol A exposure disrupts the development of the locus coeruleus-noradrenergic system in mice	NEUROPATHOLOGY			English	Article						bisphenol A (BPA); development; locus coeruleus (LC); norepinephrine transporter (NET); tyrosine hydroxylase (TH)	SEXUAL-DIFFERENTIATION; ANDROGEN RECEPTOR; PREOPTIC AREA; RATS; HYDROXYLASE; BEHAVIOR; BRAIN; PROJECTIONS; ESTROGEN; AROUSAL	It has been reported that bisphenol A (BPA), a widespread xenoestrogen employed in the production of polycarbonate plastics, affects brain development in both humans and rodents. In the present study employing mice, we examined the effects of exposure to BPA (500g/kg/day) during fetal and lactational periods on the development of the locus coeruleus (LC) at the age of embryonic day 18 (E18), postnatal 3 weeks (P3W), P8W and P16W. The number of tyrosine hydroxylase-immunoreactive cells (TH-IR cells) in females exposed to BPA was decreased, compared with the control females at P3W. At P8W, the number of TH-IR cells in females exposed to BPA was significantly decreased, compared with the control females, whereas the number of TH-IR cells in males exposed to BPA was significantly increased, compared with the control males, which resulted in reversed transient sexual differences in the numbers of TH-IR cells observed in the controls at P8W. However, no significant changes were demonstrated at E18 or P16W. Next, we examined the density of the fibers containing norepinephrine transporter (NET) in the anterior cingulate cortex (ACC) and prefrontal cortex, at P3W, P8W and P16W, because NET would be beneficial in identifying the targets of the LC noradrenergic neurons. There were no significant differences shown in the density of the NET-positive fibers, between the control and the groups exposed to BPA. These results suggested that BPA might disrupt the development of physiological sexual differences in the LC-noradrenergic system in mice, although further studies are necessary to clarify the underlying mechanisms.	[Tando, So; Itoh, Kyoko; Yaoi, Takeshi; Ogi, Hiroshi; Goto, Shoko; Mori, Miyuki; Fushiki, Shinji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kyoto 6028566, Japan	Itoh, K (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	kxi14@koto.kpu-m.ac.jp			Ministry of the Environment, Japanese National Government [5S2-12]	This study was supported by the Environment Research and Technology Development Fund of the Ministry of the Environment (5S2-12 to S.F.), Japanese National Government.	Kubo K, 2001, NEUROSCI LETT, V304, P73, DOI 10.1016/S0304-3940(01)01760-8; Robertson SD, 2013, NAT NEUROSCI, V16, P1016, DOI 10.1038/nn.3458; SWANSON LW, 1975, J COMP NEUROL, V163, P467, DOI 10.1002/cne.901630406; Howells FM, 2012, METAB BRAIN DIS, V27, P267, DOI 10.1007/s11011-012-9287-9; Kubo K, 2003, NEUROSCI RES, V45, P345, DOI 10.1016/S0168-0102(02)00251-1; Pendergast JS, 2008, J NEUROENDOCRINOL, V20, P1155, DOI 10.1111/j.1365-2826.2008.01776.x; Adriani W, 2003, ENVIRON HEALTH PERSP, V111, P395, DOI 10.1289/ehp.5856; Patisaul HB, 2007, NEUROTOXICOLOGY, V28, P1, DOI 10.1016/j.neuro.2006.10.001; Teng C, 2013, CHEM-BIOL INTERACT, V203, P556, DOI 10.1016/j.cbi.2013.03.013; Matsuda S, 2010, CHEMOSPHERE, V78, P894, DOI 10.1016/j.chemosphere.2009.11.010; Eschenko O, 2012, NEUROIMAGE, V59, P3252, DOI 10.1016/j.neuroimage.2011.11.031; Kwon S, 2000, TOXICOL SCI, V55, P399, DOI 10.1093/toxsci/55.2.399; Garcia-Falgueras A, 2005, BRAIN RES, V1035, P13, DOI 10.1016/j.brainres.2004.11.060; Aston-Jones G, 1999, BIOL PSYCHIAT, V46, P1309, DOI 10.1016/S0006-3223(99)00140-7; Chandler DJ, 2013, BRAIN RES, V1522, P38, DOI 10.1016/j.brainres.2013.04.057; Toyohira Y, 2003, BIOCHEM PHARMACOL, V65, P2049, DOI 10.1016/S0006-2952(03)00159-X; Ahmed EI, 2008, NAT NEUROSCI, V11, P995, DOI 10.1038/nn.2178; Pinos H, 2001, BRAIN RES BULL, V56, P73, DOI 10.1016/S0361-9230(01)00540-8; McCaffrey KA, 2013, NEUROTOXICOLOGY, V36, P55, DOI 10.1016/j.neuro.2013.03.001; Sara SJ, 2012, NEURON, V76, P130, DOI 10.1016/j.neuron.2012.09.011; Castro B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073584; desCock M, 2012, REV ACTA PAEDIAT, V101, P811; Guillamón A, 1988, Brain Res, V468, P306; He Z, 2012, NEUROTOXICOL TERATOL, V34, P329, DOI 10.1016/j.ntt.2012.03.004; Liu Jing, 2012, Psychiatry Res, V201, P54, DOI 10.1016/j.pscychresns.2011.05.008; Nagao T, 1999, REPROD TOXICOL, V13, P303, DOI 10.1016/S0890-6238(99)00017-9; Ogi H, 2013, BRAIN BEHAV, V3, P223, DOI 10.1002/brb3.130; RODRIGUEZZAFRA M, 1993, NEUROTOXICOL TERATOL, V15, P139, DOI 10.1016/0892-0362(93)90072-V; Thanky NR, 2002, MOL BRAIN RES, V104, P220, DOI 10.1016/S0169-328X(02)00383-2; Zikopoulos B, 2013, FRONT HUM NEUROSCI, V7, P1, DOI 10.3389/fnhum.2013.00609	30	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2014	34	6					527	534		10.1111/neup.12137		8	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AW1EO	WOS:000346033500002		
J	Okamoto, K; Amari, M; Fujita, Y; Makioka, K; Fukuda, T; Suzuki, K; Takatama, M				Okamoto, Koichi; Amari, Masakuni; Fujita, Yukio; Makioka, Kouki; Fukuda, Toshio; Suzuki, Keiji; Takatama, Masamitsu			Cytoplasmic TDP-43 accumulation in cells of the adrenal medulla in individuals with or without amyotrophic lateral sclerosis	NEUROPATHOLOGY			English	Article						adrenal medulla; ALS; human pathology; phosphorylated TDP-43; TDP-43	FRONTOTEMPORAL LOBAR DEGENERATION; BINDING PROTEIN 43; TAR-DNA-BINDING; MOTOR-NEURON DISEASE; PHOSPHORYLATED TDP-43; INCLUSIONS; ALS; DEMENTIA; MUTATION	The transactive response DNA-binding protein of 43kDa (TDP-43) is normally located predominantly in the nucleus, whereas pathological TDP-43 is mostly found in the cytoplasm. Cytoplasmic TDP-43 accumulation has not yet been reported in normal general organs. In our preliminary study, paraffin sections of the general organs of individuals with or without amyotrophic lateral sclerosis (ALS) were immunostained with antibodies against TDP-43 and phosphorylated TDP-43 (pTDP-43). Diffuse and granular immunostaining pattern of TDP-43 and pTDP-43 were observed frequently in the cytoplasm of renal tubular cells, and less frequently in the cells of several organs; however, the majority of these immunoreactivities were nonspecific biotin reactions. Conversely, many TDP-43-positive and pTDP-43-negative cytoplasmic accumulations were observed in the adrenal medulla in every individual (with or without ALS). Skein-like or round inclusions were not observed. The cells in the adrenal medulla were well preserved, and the cytoplasmic TDP-43 accumulations were frequent in the cells of all routine autopsy cases without loss of nuclear TDP-43 immunostaining; therefore, we considered that this was a physiological phenomenon. This is the first study that demonstrated the cytoplasmic accumulation of TDP-43 in routinely autopsied cases.	[Okamoto, Koichi; Amari, Masakuni] Geriatr Res Inst & Hosp, Dept Neurol, Maebashi, Gunma 3710847, Japan; [Fujita, Yukio; Makioka, Kouki] Gunma Univ Grad Sch Med, Dept Neurol, Maebashi, Gunma, Japan; [Fukuda, Toshio] Gunma Univ Grad Sch Hlth Sci, Dept Histopathol & Cytopathol, Maebashi, Gunma, Japan; [Suzuki, Keiji; Takatama, Masamitsu] Geriatr Res Inst & Hosp, Dept Internal Med, Maebashi, Gunma, Japan	Okamoto, K (reprint author), Geriatr Res Inst & Hosp, Dept Neurol, 3-26-8 Otomo Machi, Maebashi, Gunma 3710847, Japan.	okamotok@ronenbyo.or.jp			Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by grants from the Ministry of Health, Labour and Welfare of Japan to K.O. and Y.F., and from the Ministry of Education, Culture, Sports, Science and Technology of Japan to Y.F. The authors express our appreciation to Ms. Kunie Watanabe for her excellent technical assistance.	Kadokura A, 2009, NEUROSCI LETT, V463, P87, DOI 10.1016/j.neulet.2009.06.024; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; WOOD GS, 1981, J HISTOCHEM CYTOCHEM, V29, P1196; Olive M, 2009, J NEUROPATH EXP NEUR, V68, P262, DOI 10.1097/NEN.0b013e3181996d8f; Steinacker P, 2008, ARCH NEUROL-CHICAGO, V65, P1481, DOI 10.1001/archneur.65.11.1481; Fung MM, 2008, ACTA PHYSIOL, V192, P325, DOI 10.1111/j.1748-1716.2007.01809.x; Foulds PG, 2009, ACTA NEUROPATHOL, V118, P647, DOI 10.1007/s00401-009-0594-0; Hu WT, 2010, NEUROLOGY, V75, P2079, DOI 10.1212/WNL.0b013e318200d78d; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; De Marco G, 2011, ACTA NEUROPATHOL, V121, P611, DOI 10.1007/s00401-010-0786-7; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Chen-Plotkin AS, 2010, NAT REV NEUROL, V6, P211, DOI 10.1038/nrneurol.2010.18; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Fujita Y, 2011, NEUROLOGY, V77, P1427, DOI 10.1212/WNL.0b013e318232ab87; Okamoto K, 2010, NEUROPATHOLOGY, V30, P486, DOI 10.1111/j.1440-1789.2010.01121.x; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Geser F, 2011, PROG NEUROBIOL, V95, P649, DOI 10.1016/j.pneurobio.2011.08.011; Wilson AC, 2011, INT J CLIN EXP PATHO, V4, P147; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Dewey CM, 2012, BRAIN RES, V1462, P16, DOI 10.1016/j.brainres.2012.02.032; Lin WL, 2008, ACTA NEUROPATHOL, V116, P205, DOI 10.1007/s00401-008-0408-9; Kadokura A, 2009, NEUROPATHOLOGY, V29, P566, DOI 10.1111/j.1440-1789.2009.01017.x; Kim SH, 2002, HISTOCHEM J, V34, P97; Meyerowitz J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-57; Mizuno Y, 2012, J NEUROL SCI, V315, P20, DOI 10.1016/j.jns.2011.12.012; Ou S.-H. Ignatius, 1995, Journal of Virology, V69, P3584; Sakurai A, 2013, NEUROPATHOLOGY, V33, P673, DOI 10.1111/neup.12038	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2014	34	6					535	540		10.1111/neup.12139		6	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AW1EO	WOS:000346033500003		
J	Araki, K; Nakano, Y; Kobayashi, A; Matsudaira, T; Sugiura, A; Takao, M; Kitamoto, T; Murayama, S; Obi, T				Araki, Kunihiko; Nakano, Yuta; Kobayashi, Atsushi; Matsudaira, Takashi; Sugiura, Akira; Takao, Masaki; Kitamoto, Tetsuyuki; Murayama, Shigeo; Obi, Tomokazu			Extensive cortical spongiform changes with cerebellar small amyloid plaques: The clinicopathological case of MV2K+C subtype in Creutzfeldt-Jakob disease	NEUROPATHOLOGY			English	Article						cerebellum; Creutzfeldt-Jakob disease; MV2K+C; single unglycosylated band; small amyloid plaques	CLASSIFICATION	We report a clinical case report of the MV2K+C subtype of sporadic Creutzfeldt-Jakob disease (sCJD). The patient was a 72-year-old woman who exhibited progressive dementia over the course of 22 months. Diffusion-weighted MRI during this period showed abnormal hyperintensity in the cerebral cortex in the early stage. The clinical course was similar to that of previously reported patients with the MV2K or MV2K+C subtype of sCJD. However, histopathological examination revealed unique features: severe extensive spongiform changes with perivacuolar deposits in the cerebrum and basal ganglia, plaque-like PrP deposits in the cerebrum, and only mild changes in the cerebellum with small amyloid plaques (approximate to 20m in diameter), smaller than those in the MV2K subtype or variant CJD (40-50m in diameter). Molecular analysis showed a methionine/valine heterozygosity at codon 129 and no pathogenic mutation in the PrP gene (PRNP). Western blot analysis of the protease-resistant PrP (PrPSc) in the right temporal pole revealed the type 2 pattern, which is characterized by a single unglycosylated band, in contrast to the doublet described for the typical MV2 subtype of sCJD. The other intermediate band might exist in the cerebellum with kuru plaques. Therefore, small amyloid plaques in the cerebellum can be crucial for MV2K+C subtype.	[Araki, Kunihiko; Matsudaira, Takashi; Sugiura, Akira; Obi, Tomokazu] Shizuoka Inst Epilepsy & Neurol Disorders, Dept Neurol, Natl Epilepsy Ctr, Shizuoka, Japan; [Nakano, Yuta; Takao, Masaki; Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Dept Neuropathol, Tokyo 173, Japan; [Kobayashi, Atsushi; Kitamoto, Tetsuyuki] Tohoku Univ Grad Sch Med, Dept Neurol Sci, Sendai, Miyagi, Japan	Araki, K (reprint author), Shizuoka Inst Epilepsy & Neurol Disorders, Dept Neurol, Natl Epilepsy Ctr, Aoi Ku, 886 Urushiyama, Shizuoka 4208688, Japan.	kunihiko_araki@hotmail.com			Research Committee of Prion Disease and Slow Virus Infection, Research on Rare and Intractable Diseases, Health and Labour Sciences Research Grants, the Ministry of Health, Labour and Welfare of Japan; JSPS [26430060]	This study was supported in part by the Research Committee of Prion Disease and Slow Virus Infection, Research on Rare and Intractable Diseases, Health and Labour Sciences Research Grants, the Ministry of Health, Labour and Welfare of Japan (M Takao) and JSPS KAKENHI, Grant-in-Aid for Scientific Research (C; 26430060) (M Takao). We gratefully acknowledge Naoo Aikyo, Mieko Harada and Yuki Kimura, for technical help.	Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 2011, ACTA NEUROPATHOL, V121, P91, DOI 10.1007/s00401-010-0779-6; Parchi P, 2000, P NATL ACAD SCI USA, V97, P10168, DOI 10.1073/pnas.97.18.10168; Parchi P, 2009, ACTA NEUROPATHOL, V118, P659, DOI 10.1007/s00401-009-0585-1; Parchi P, 2012, ACTA NEUROPATHOL, V124, P517, DOI 10.1007/s00401-012-1002-8; Krasnianski A, 2006, BRAIN, V129, P2288, DOI 10.1093/brain/awl123; Guerrero D, 2008, CLIN NEUROPATHOL, V27, P408; Hizume M, 2009, J BIOL CHEM, V284, P3603, DOI 10.1074/jbc.M809254200; Ishihara K, 2006, NEUROPATHOLOGY, V26, P433, DOI 10.1111/j.1440-1789.2006.00705.x; Kobayashi A, 2010, J VIROL, V84, P3230, DOI 10.1128/JVI.02387-09; Kobayashi Atsushi, 2013, Acta Neuropathol Commun, V1, P74, DOI 10.1186/2051-5960-1-74; Meissner B, 2009, NEUROLOGY, V72, P1994, DOI 10.1212/WNL.0b013e3181a96e5d; Zeidler M, 1998, WHO MANUAL STRENGTHE	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2014	34	6					541	546		10.1111/neup.12133		6	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AW1EO	WOS:000346033500004		
J	Shintaku, M; Toyooka, N; Koyama, T; Teraoka, S; Tsudo, M				Shintaku, Masayuki; Toyooka, Nao; Koyama, Takashi; Teraoka, Shunsuke; Tsudo, Mitsuru			Methotrexate myelopathy with extensive transverse necrosis: Report of an autopsy case	NEUROPATHOLOGY			English	Article						cytosine arabinoside; methotrexate; myelopathy; pathogenesis; transverse necrosis	CENTRAL-NERVOUS-SYSTEM; DISSEMINATED NECROTIZING LEUKOENCEPHALOPATHY; ACUTE LYMPHOBLASTIC-LEUKEMIA; WHITE-MATTER CHANGES; INTRATHECAL CHEMOTHERAPY; NEUROPATHOLOGIC FINDINGS; METHIONINE METABOLISM; RADIATION MYELOPATHY; CHILDHOOD LEUKEMIA; NEUROTOXICITY	The patient was a 70-year-old woman with lymphoplasmacytic lymphoma which showed a predominantly diffuse involvement of the bone marrow and kidney. Because atypical lymphocytes appeared in the cerebrospinal fluid, the intrathecal administration of methotrexate (MTX) and cytosine arabinoside (Ara-C) was repeated several times. The patient developed flaccid paraplegia 8 months after the beginning of intrathecal administration, and died 4 months later. Autopsy demonstrated extensive transverse necrosis involving the lower thoracic cord and marked vacuolar degeneration of the white matter of the cervical, upper thoracic and lumbo-sacral cord. Focal vacuolar degeneration of the white matter was also noted in the left parietal lobe. Although vacuolar degeneration of the white matter is a common feature in MTX myelopathy, extensive transverse necrosis is rare. In the present case, an overlapping of two mechanisms, that is, injury of vascular endothelial cells and the direct toxic effect of MTX and Ara-C on the white matter, probably played a crucial role in the pathogenesis of severe myelopathy. Because severe myelopathy occurs infrequently, considering the large number of patients receiving the intrathecal administration of MTX, it is possible that a constitutional predisposition or abnormal sensitivity to MTX was involved in the pathogenesis in the present patient.	[Shintaku, Masayuki] Osaka Red Cross Hosp, Dept Pathol, Osaka 5438555, Japan; [Toyooka, Nao; Teraoka, Shunsuke; Tsudo, Mitsuru] Osaka Red Cross Hosp, Dept Hematol, Osaka 5438555, Japan; [Koyama, Takashi] Osaka Red Cross Hosp, Dept Diagnost Radiol, Osaka 5438555, Japan	Shintaku, M (reprint author), Osaka Red Cross Hosp, Dept Pathol, Tennoji Ku, Osaka 5438555, Japan.	masa-s@sings.jp					Ackermann R, 2010, J NEURO-ONCOL, V97, P425, DOI 10.1007/s11060-009-0028-9; Perry A, 2006, ACTA NEUROPATHOL, V111, P197, DOI 10.1007/s00401-005-0023-y; RUBINSTEIN LJ, 1975, CANCER, V35, P291, DOI 10.1002/1097-0142(197502)35:2<291::AID-CNCR2820350202>3.0.CO;2-V; BLEYER WA, 1973, NEW ENGL J MED, V289, P770, DOI 10.1056/NEJM197310112891503; BREUER AC, 1977, CANCER, V40, P2817, DOI 10.1002/1097-0142(197712)40:6<2817::AID-CNCR2820400611>3.0.CO;2-V; BURNS RJ, 1972, J NEUROL NEUROSUR PS, V35, P888, DOI 10.1136/jnnp.35.6.888; CLARK AW, 1982, CANCER, V50, P42, DOI 10.1002/1097-0142(19820701)50:1<42::AID-CNCR2820500109>3.0.CO;2-M; GRISOLD W, 1980, ACTA NEUROPATHOL, V49, P231; HENDIN B, 1974, CANCER, V33, P468, DOI 10.1002/1097-0142(197402)33:2<468::AID-CNCR2820330223>3.0.CO;2-F; Honda D, 2012, NEUROL MED TOKYO, V77, P35; JELLINGE.K, 1971, J NEUROL SCI, V14, P389, DOI 10.1016/0022-510X(71)90174-2; Linnebank M, 2009, NEURO-ONCOLOGY, V11, P2, DOI 10.1215/15228517-2008-082; Linnebank M, 2005, NEUROLOGY, V64, P912; LIU HM, 1978, HUM PATHOL, V9, P635; Matsubayashi J, 2009, NEUROPATHOLOGY, V29, P105, DOI 10.1111/j.1440-1789.2008.00945.x; Okeda R, 1971, ADV NEUROL SCI, V15, P619; Pant SS, 1968, ACTA NEUROL SCAN S35, V44, P1; PRICE RA, 1975, CANCER, V35, P306, DOI 10.1002/1097-0142(197502)35:2<306::AID-CNCR2820350203>3.0.CO;2-J; REZNIK M, 1979, ACTA NEUROPATHOL, V45, P153; SAIKI JH, 1972, CANCER, V29, P370, DOI 10.1002/1097-0142(197202)29:2<370::AID-CNCR2820290217>3.0.CO;2-Z; SCHEITHAUER BW, 1984, J NEUROPATH EXP NEUR, V43, P408, DOI 10.1097/00005072-198407000-00006; SHIBUTANI M, 1989, ACTA NEUROPATHOL, V79, P333; SHIBUTANI M, 1989, ACTA NEUROPATHOL, V78, P291; SKULLERUD K, 1978, CANCER, V42, P1211, DOI 10.1002/1097-0142(197809)42:3<1211::AID-CNCR2820420326>3.0.CO;2-X; SUZUKI K, 1984, ACTA NEUROPATHOL, V65, P145; Tomonaga M, 1978, ADV NEUROL SCI TOKYO, V22, P1204; VONDERWEID NX, 1991, MED PEDIATR ONCOL, V19, P192, DOI 10.1002/mpo.2950190309; WOLF HK, 1990, CLIN NEUROPATHOL, V9, P60; Yokoo H, 2007, ACTA NEUROPATHOL, V114, P425, DOI 10.1007/s00401-007-0214-9	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2014	34	6					547	553		10.1111/neup.12135		7	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AW1EO	WOS:000346033500005		
J	Uchihara, T; Yoshida, M				Uchihara, Toshiki; Yoshida, Mari			Definition and differentials: How to distinguish disease-specific changes on microscopy Preface	NEUROPATHOLOGY			English	Editorial Material									[Uchihara, Toshiki] Tokyo Metropolitan Inst Med Sci, Lab Struct Neuropathol, Tokyo 113, Japan; [Yoshida, Mari] Aichi Med Univ, Dept Neuropathol, Nagakute, Aichi, Japan	Uchihara, T (reprint author), Tokyo Metropolitan Inst Med Sci, Lab Struct Neuropathol, Tokyo 113, Japan.							0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2014	34	6					554	554		10.1111/neup.12110		1	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AW1EO	WOS:000346033500006		
J	Yoshida, M				Yoshida, Mari			Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration	NEUROPATHOLOGY			English	Review						astrocytic plaque; corticobasal degeneration; fibril formation; progressive supranuclear palsy; tufted astrocyte	TUFT-SHAPED ASTROCYTES; NINDS NEUROPATHOLOGIC CRITERIA; TAU-POSITIVE GLIA; SPINAL-CORD; RICHARDSONS-SYNDROME; ALZHEIMERS-DISEASE; CEREBRAL-CORTEX; PATHOLOGY; PLAQUES; TAUOPATHIES	Tufted astrocytes (TAs) in progressive supranuclear palsy (PSP) and astrocytic plaques (APs) in corticobasal degeneration (CBD) have been regarded as the pathological hallmarks of major sporadic 4-repeat tauopathies. To better define the astrocytic inclusions in PSP and CBD and to outline the pathological features of each disease, we reviewed 95 PSP cases and 30 CBD cases that were confirmed at autopsy. TAs exhibit a radial arrangement of thin, long, branching accumulated tau protein from the cytoplasm to the proximal processes of astrocytes. APs show a corona-like arrangement of tau aggregates in the distal portions of astrocytic processes and are composed of fuzzy, short processes. Immunoelectron microscopic examination using quantum dot nanocrystals revealed filamentous tau accumulation of APs located in the immediate vicinity of the synaptic structures, which suggested synaptic dysfunction by APs. The pathological subtypes of PSP and CBD have been proposed to ensure that the clinical phenotypes are in accordance with the pathological distribution and degenerative changes. The pathological features of PSP are divided into 3 representative subtypes: typical PSP type, pallido-nigro-luysian type (PNL type), and CBD-like type. CBD is divided into three pathological subtypes: typical CBD type, basal ganglia- predominant type, and PSP-like type. TAs are found exclusively in PSP, while APs are exclusive to CBD, regardless of the pathological subtypes, although some morphological variations exist, especially with regard to TAs. The overlap of the pathological distribution of PSP and CBD makes their clinical diagnosis complicated, although the presence of TAs and APs differentiate these two diseases. The characteristics of tau accumulation in both neurons and glia suggest a different underlying mechanism with regard to the sites of tau aggregation and fibril formation between PSP and CBD: proximal-dominant aggregation of TAs and formation of filamentous NFTs in PSP in contrast to the distal-dominant aggregation of APs and formation of less filamentous pretangles in CBD.	Aichi Med Univ, Inst Med Sci Aging, Nagakute, Aichi 4801195, Japan	Yoshida, M (reprint author), Aichi Med Univ, Inst Med Sci Aging, 1-1 Yazakokarimata, Nagakute, Aichi 4801195, Japan.	myoshida@aichi-med-u.ac.jp			Brain Research Institute, Niigata University; Ministry of Health, Labour and Welfare of Japan	This work was presented in part at the 54th Annual Meeting of the Japanese Society of Neuropathology (Tokyo, Japan, 2013) and was supported by grants from the Collaborative Research Project [2012-2308 to MY] of the Brain Research Institute, Niigata University and grants-in-aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan. The author acknowledges Dr. S. Tatsumi, Dr. M. Mimuro, and Dr. Y. Iwasaki, and also thanks K. Koutani, T. Mizuno, C. Sano and C. Uno for excellent technical assistance.	Togo T, 2002, ACTA NEUROPATHOL, V104, P398, DOI 10.1007/s00401-002-0569-x; Tuite PJ, 2005, ARCH NEUROL-CHICAGO, V62, P1453, DOI 10.1001/archneur.62.9.1453; Murray R, 2007, NEUROLOGY, V68, P1274, DOI 10.1212/01.wnl.0000259519.78480.c3; Arima K, 2006, NEUROPATHOLOGY, V26, P475, DOI 10.1111/j.1440-1789.2006.00669.x; Hattori M, 2003, ACTA NEUROPATHOL, V106, P143, DOI 10.1007/s00401-003-0711-4; NISHIMURA M, 1992, NEUROSCI LETT, V143, P35, DOI 10.1016/0304-3940(92)90227-X; Armstrong MJ, 2013, NEUROLOGY, V80, P496, DOI 10.1212/WNL.0b013e31827f0fd1; Komori T, 1998, ACTA NEUROPATHOL, V96, P401; Arai T, 2004, ANN NEUROL, V55, P72, DOI 10.1002/ana.10793; Iwasaki Y, 2013, NEUROPATHOLOGY, V33, P561, DOI 10.1111/neup.12012; Dickson DW, 2002, J NEUROPATH EXP NEUR, V61, P935; Boeve BF, 1999, NEUROLOGY, V53, P795; HAUW JJ, 1994, NEUROLOGY, V44, P2015; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Ling HL, 2010, BRAIN, V133, P2045, DOI 10.1093/brain/awq123; Josephs KA, 2005, NEUROCASE, V11, P283, DOI 10.1080/13554790590963004; FEANY MB, 1995, AM J PATHOL, V146, P1388; Ahmed Z, 2013, ACTA NEUROPATHOL, V126, P537, DOI 10.1007/s00401-013-1171-0; Williams DR, 2005, BRAIN, V128, P1247, DOI 10.1093/brain/awh488; Williams DR, 2007, BRAIN, V130, P1566, DOI 10.1093/brain/awm104; Tan CF, 2005, ACTA NEUROPATHOL, V109, P329, DOI 10.1007/s00401-004-0933-0; GIBB WRG, 1989, BRAIN, V112, P1171, DOI 10.1093/brain/112.5.1171; Williams DR, 2007, MOVEMENT DISORD, V22, P2235, DOI 10.1002/mds.21698; Yoshida M, 2006, NEUROPATHOLOGY, V26, P457, DOI 10.1111/j.1440-1789.2006.00743.x; Giepmans BNG, 2005, NAT METHODS, V2, P743, DOI 10.1038/NMETH791; HAUW JJ, 1990, NEUROSCI LETT, V119, P182, DOI 10.1016/0304-3940(90)90829-X; RILEY DE, 1990, NEUROLOGY, V40, P1203; Arai N, 1996, NEUROPATHOLOGY, V16, P133, DOI 10.1111/j.1440-1789.1996.tb00168.x; Hattori M, 2000, Rinsho Shinkeigaku, V40, P372; Heines MA, 1996, J PHYS CHEM-US, V100, P468; Hirano A, 1981, GUIDE NEUROPATHOLOGY; Ikeda K, 1997, NEUROPATHOLOGY, V17, P127, DOI 10.1111/j.1440-1789.1997.tb00026.x; Iwasaki Y, 2007, NEUROPATHOLOGY, V27, P331, DOI 10.1111/j.1440-1789.2007.00787.x; Iwasaki Y, 2004, ACTA NEUROPATHOL, V108, P399, DOI 10.1007/s00401-004-0904-5; Josephs KA, 2004, ARCH NEUROL-CHICAGO, V61, P1881, DOI 10.1001/archneur.61.12.1881; Kanazawa M, 2009, MOVEMENT DISORD, V24, P1312, DOI 10.1002/mds.22583; KATO T, 1986, ACTA NEUROPATHOL, V71, P11; Katsuse O, 2003, ACTA NEUROPATHOL, V106, P251, DOI 10.1007/s00401-003-0728-8; Kikuchi H, 1999, ACTA NEUROPATHOL, V97, P577; Mizuno T, 2005, J NEUROL, V252, P687, DOI 10.1007/s00415-005-0718-y; Mochizuki A, 2003, ACTA NEUROPATHOL, V105, P610, DOI 10.1007/s00401-003-0682-5; Nishimura T, 1995, NEUROSCI LETT, V201, P123, DOI 10.1016/0304-3940(95)12151-X; Nukina N, 1992, Rinsho Shinkeigaku, V32, P1093; REBEIZ JEAN J., 1967, TRANS AMER NEUROL ASS, V92, P23; Shibuya K, 2011, BRAIN RES, V1404, P50, DOI 10.1016/j.brainres.2011.06.014; STEELE JC, 1964, ARCH NEUROL-CHICAGO, V10, P333; UCHIHARA T, 1994, ACTA NEUROPATHOL, V88, P379; Uematsu M, 2012, AM J PATHOL, V180, P1394, DOI 10.1016/j.ajpath.2011.12.029; YAMADA T, 1992, NEUROSCI LETT, V135, P99, DOI 10.1016/0304-3940(92)90145-W; YAMADA T, 1993, ACTA NEUROPATHOL, V85, P308	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2014	34	6					555	570		10.1111/neup.12143		16	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AW1EO	WOS:000346033500007		
J	Uchihara, T				Uchihara, Toshiki			Pretangles and neurofibrillary changes: Similarities and differences between AD and CBD based on molecular and morphological evolution	NEUROPATHOLOGY			English	Article						corticobasal degeneration; electron microscopy; four repeat tau; ghost tangles; tau	PROGRESSIVE SUPRANUCLEAR PALSY; PAIRED HELICAL FILAMENTS; TAU-POSITIVE NEURONS; ALZHEIMERS-DISEASE; CORTICOBASAL DEGENERATION; THIAZIN RED; DOUBLE IMMUNOFLUORESCENCE; ABNORMAL PHOSPHORYLATION; CYTOSKELETAL PATHOLOGY; GALLYAS METHOD	Pretangles are cytoplasmic tau immunoreactivity in neurons without apparent formation of fibrillary structures. In Alzheimer disease, such tau deposition is considered to represent a premature state prior to fibril formation (AD-pretangles), later to form neurofibrillary tangles and finally ghost tangles. This morphological evolution from pretangles to ghost tangles is in parallel with their profile shift from four repeat (4R) tau-positive pretangles to three repeat (3R) tau-positive ghost tangles with both positive neurofibrillary tangles in between. This complementary shift of tau profile from 4R to 3R suggests that these tau epitopes are represented interchangeably along tangle evolution. Similar tau immunoreactivity without fibril formation is also observed in corticobasal degeneration (CBD-pretangles). CBD-pretangles and AD-pretangles share: (i) selective 4R tau immunoreactivity without involvement of 3R tau; and (ii) argyrophilia with Gallyas silver impregnation. However, CBD-pretangles neither evolve into ghost tangles nor exhibit 3R tau immunoreactivity even at the advanced stage. Because electron microscopic studies on these pretangles are quite limited, it remains to be clarified whether such differences in later evolution are related to their primary ultrastructures, potentially distinct between AD and CBD. As double staining for 3R and 4R tau clarified complementary shift from 4R to 3R tau along evolution from pretangles to ghost tangles, double immunoelectron microscopy, if possible, may clarify similar profile shifts in relation to each tau fibril at the ultrastructural dimension. This will provide a unique viewpoint on how molecular (epitope) representations are related to pathogenesis of fibrillary components.	[Uchihara, Toshiki] Tokyo Metropolitan Inst Med Sci, Lab Struct Neuropathol, Tokyo 1568506, Japan	Uchihara, T (reprint author), Tokyo Metropolitan Inst Med Sci, Lab Struct Neuropathol, Setagaya Ku, 2-1-6 Kamikitazawa, Tokyo 1568506, Japan.	uchihara-ts@igakuken.or.jp			Ministry of Education, Culture, Sports, Science and Technology [25430057]; Japan Foundation for Neuroscience and Mental Health; Mitsui Life Social Welfare Foundation; Tokyo Metropolitan Institute of Medical Science	This work is supported Grants-in-Aid for Scientific Research (JSPS KAKENHI 25430057) from the Ministry of Education, Culture, Sports, Science and Technology, Grant from Japan Foundation for Neuroscience and Mental Health, the Mitsui Life Social Welfare Foundation, and the Tokyo Metropolitan Institute of Medical Science project 'Mechanism for Early Diagnosis and Prevention of Parkinson's disease.	Alzheimer A, 1911, Z GESAMTE NEUROL PSY, V4, P365; Uchihara T, 2001, ACTA NEUROPATHOL, V101, P535; Uchihara T, 2012, HISTOCHEM CELL BIOL, V137, P261, DOI 10.1007/s00418-011-0891-2; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Uchihara T, 2011, BRAIN PATHOL, V21, P180, DOI 10.1111/j.1750-3639.2010.00433.x; NUKINA N, 1987, P NATL ACAD SCI USA, V84, P3415, DOI 10.1073/pnas.84.10.3415; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; BANCHER C, 1991, BRAIN RES, V539, P11, DOI 10.1016/0006-8993(91)90681-K; Mena R, 1996, ACTA NEUROPATHOL, V91, P633; Uchihara T, 2001, ACTA NEUROPATHOL, V102, P462; Hara M, 2013, ACTA NEUROPATHOL, V125, P565, DOI 10.1007/s00401-013-1097-6; Braak H, 2012, CURR OPIN NEUROL, V25, P708, DOI 10.1097/WCO.0b013e32835a3432; Lace G, 2009, BRAIN, V132, P1324, DOI 10.1093/brain/awp059; Uchihara T, 2007, ACTA NEUROPATHOL, V113, P483, DOI 10.1007/s00401-007-0200-2; Kanazawa T, 2012, BRAIN PATHOL, V22, P67, DOI 10.1111/j.1750-3639.2011.00509.x; WAKABAYASHI K, 1994, ACTA NEUROPATHOL, V87, P545; ARIMA K, 1994, J NEUROL SCI, V127, P186, DOI 10.1016/0022-510X(94)90072-8; desSilva R, 2003, NEUROPATHOL APPL NEU, V29, P288; Ichihara K, 2009, J NEUROPATH EXP NEUR, V68, P1029, DOI 10.1097/NEN.0b013e3181b56bf4; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807; Iseki E, 2006, NEUROSCI LETT, V405, P29, DOI 10.1016/j.neulet.2006.06.036; Kitamura T, 2005, ACTA NEUROL SCAND, V112, P327, DOI 10.1111/j.1600-0404.2005.00488.x; LEE VMY, 1988, P NATL ACAD SCI USA, V85, P7384, DOI 10.1073/pnas.85.19.7384; Li F, 1998, J NEUROL SCI, V159, P73, DOI 10.1016/S0022-510X(98)00136-1; Lowe J, 2008, GREENFIELDS NEUROPAT, P1030; Mannen H, 2011, HIST REV; MENA R, 1995, ACTA NEUROPATHOL, V89, P50; MORI H, 1994, ACTA NEUROPATHOL, V88, P113; Sano Y, 1995, NEUROSCIENCE MORPHOL; Takahashi T, 1996, J NEUROL SCI, V138, P66, DOI 10.1016/0022-510X(95)00347-5; Uchihara T, 1998, ACTA NEUROPATHOL, V96, P553; Uchihara T, 2000, ACTA NEUROPATHOL, V100, P385; UCHIHARA T, 1994, ACTA NEUROPATHOL, V88, P379; Uematsu M, 2012, AM J PATHOL, V180, P1394, DOI 10.1016/j.ajpath.2011.12.029	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2014	34	6					571	577		10.1111/neup.12108		7	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AW1EO	WOS:000346033500008		
J	Arai, T				Arai, Tetsuaki			Significance and limitation of the pathological classification of TDP-43 proteinopathy	NEUROPATHOLOGY			English	Article						fragment; phosphorylation; propagation; truncation; ubiquitin	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; TAR-DNA-BINDING; POSITIVE INTRANEURONAL INCLUSIONS; PARKINSONISM-DEMENTIA COMPLEX; NUCLEAR FACTOR TDP-43; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; PHOSPHORYLATED TDP-43	Based on the cerebral tans-activation response DNA protein 43 (TDP-43) immunohistochemistry, frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP) is classified into four subtypes: type A has numerous neuronal cytoplasmic inclusions (NCIs) and dystrophic neurites (DNs); type B has numerous NCIs with few DNs; type C is characterized by DNs which are often longer and thicker than DNs in type A, with few NCIs; and type D has numerous neuronal intranuclear inclusions and DNs with few NCIs. The relevance of this classification system is supported by clinical, biochemical and genetic correlations, although there is still significant heterogeneity, especially in cases with type A pathology. The subtypes of TDP-43 pathology should be determined in cases with other neurodegenerative disorders, including Alzheimer's disease and dementia with Lewy bodies, to evaluate the pathological significance of TDP-43 abnormality in them. The results of the biochemical analyses of the diseased brains and the cellular models suggest that different strains of TDP-43 with different conformations may determine the clinicopathological phenotypes of TDP-43 proteinopathy, like prion disease. Clarifying the mechanism of the conformational changes of TDP-43 leading to the formation of multiple abnormal strains may be important for differential diagnosis and developing disease-modifying therapy for TDP-43 proteinopathy.	[Arai, Tetsuaki] Univ Tsukuba, Div Clin Med, Dept Neuropsychiat, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Arai, Tetsuaki] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Tokyo 113, Japan	Arai, T (reprint author), Univ Tsukuba, Div Clin Med, Dept Neuropsychiat, Fac Med, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	4632tetsu@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	I thank Drs M. Hasegawa, H. Akiyama, T. Nonaka, M. Hosokawa and T. Asada for advice and support. I also thank Ms H. Kondo, C. Haga and Y. Shimomura for their technical assistance. This work was supported by a Grant-in-Aid for Scientific Research (C) from Ministry of Education, Culture, Sports, Science and Technology of Japan, and grants from Ministry of Health, Labor and Welfare of Japan.	Abhyankar MM, 2007, J BIOL CHEM, V282, P36143, DOI 10.1074/jbc.M705811200; Higashi S, 2007, BRAIN RES, V1184, P284, DOI 10.1016/j.brainres.2007.09.048; Josephs KA, 2013, BRAIN, V136, P455, DOI 10.1093/brain/aws324; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Kadokura A, 2009, NEUROSCI LETT, V463, P87, DOI 10.1016/j.neulet.2009.06.024; Miklossy J, 2008, ACTA NEUROPATHOL, V116, P625, DOI 10.1007/s00401-008-0439-2; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Kelley BJ, 2009, NEUROBIOL AGING, V30, P739, DOI 10.1016/j.neurobiolaging.2007.08.022; Perry DC, 2013, JAMA NEUROL, V70, P774, DOI 10.1001/2013.jamaneurol.393; Josephs KA, 2009, ACTA NEUROPATHOL, V118, P349, DOI 10.1007/s00401-009-0547-7; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Bose JK, 2008, J BIOL CHEM, V283, P28852, DOI 10.1074/jbc.M805376200; Ikeda M, 2004, DEMENT GERIATR COGN, V17, P265, DOI 10.1159/000077151; Schwab C, 2009, ACTA NEUROPATHOL, V118, P303, DOI 10.1007/s00401-009-0514-3; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Josephs KA, 2011, ACTA NEUROPATHOL, V122, P137, DOI 10.1007/s00401-011-0839-6; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Geser F, 2008, ACTA NEUROPATHOL, V115, P133, DOI 10.1007/s00401-007-0257-y; Davidson Y, 2007, ACTA NEUROPATHOL, V113, P521, DOI 10.1007/s00401-006-0189-y; Jackson M, 1996, NEURODEGENERATION, V5, P339, DOI 10.1006/neur.1996.0046; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Rademakers R, 2007, LANCET NEUROL, V6, P857, DOI 10.1016/S14744422(07)70221-1; Sieben A, 2012, ACTA NEUROPATHOL, V124, P353, DOI 10.1007/s00401-012-1029-x; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Tan CF, 2007, ACTA NEUROPATHOL, V113, P535, DOI 10.1007/s00401-007-0206-9; Hasegawa M, 2007, BRAIN, V130, P1386, DOI 10.1093/brain/awm065; Buratti E, 2008, FRONT BIOSCI-LANDMRK, V13, P867, DOI 10.2741/2727; Arai T, 2004, ANN NEUROL, V55, P72, DOI 10.1002/ana.10793; Piao YS, 2003, BRAIN PATHOL, V13, P10; Nishihira Y, 2009, ACTA NEUROPATHOL, V117, P45, DOI 10.1007/s00401-008-0443-6; Kobayashi Z, 2010, J NEUROL SCI, V298, P70, DOI 10.1016/j.jns.2010.08.013; WIGHTMAN G, 1992, NEUROSCI LETT, V139, P269, DOI 10.1016/0304-3940(92)90569-S; Hu WT, 2008, ACTA NEUROPATHOL, V116, P215, DOI 10.1007/s00401-008-0400-4; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Tsuji H, 2012, BRAIN, V135, P3380, DOI 10.1093/brain/aws230; Lee MJ, 2011, NEURODEGENER DIS, V8, P216, DOI 10.1159/000322538; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Brouwers N, 2008, NEUROLOGY, V71, P656, DOI 10.1212/01.wnl.0000319688.89790.7a; Zhang H, 2008, ACTA NEUROPATHOL, V115, P115, DOI 10.1007/s00401-007-0285-7; OKAMOTO K, 1992, J NEUROL, V239, P426, DOI 10.1007/BF00856806; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Le Ber I, 2008, BRAIN, V131, P732, DOI 10.1093/brain/awn012; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P111, DOI 10.1007/s00401-011-0845-8; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Kosaka T, 2012, NEUROPATHOLOGY, V32, P373, DOI 10.1111/j.1440-1789.2011.01271.x; Arai T, 2009, ACTA NEUROPATHOL, V117, P125, DOI 10.1007/s00401-008-0480-1; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392; Fujishiro H, 2009, ACTA NEUROPATHOL, V117, P151, DOI 10.1007/s00401-008-0463-2; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bergmann M, 1996, ACTA NEUROPATHOL, V92, P170; OKAMOTO K, 1991, NEUROSCI LETT, V129, P233, DOI 10.1016/0304-3940(91)90469-A; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Woulfe J, 2001, ACTA NEUROPATHOL, V102, P94; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Snowden J, 2007, ACTA NEUROPATHOL, V114, P31, DOI 10.1007/s00401-007-0236-3; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Josephs KA, 2013, BRAIN LANG, V127, P127, DOI 10.1016/j.bandl.2013.02.003; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Arai T, 2010, NEUROPATHOLOGY, V30, P170, DOI 10.1111/j.1440-1789.2009.01089.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Uryu K, 2008, J NEUROPATH EXP NEUR, V67, P555, DOI 10.1097/NEN.0b013e31817713b5; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Mackenzie IRA, 2006, ACTA NEUROPATHOL, V112, P539, DOI 10.1007/s00401-006-0138-9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Hasegawa M, 1996, FEBS LETT, V384, P25, DOI 10.1016/0014-5793(96)00271-2; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Mori F, 2008, ACTA NEUROPATHOL, V116, P193, DOI 10.1007/s00401-008-0396-9; Arai T, 2003, NEUROSCI LETT, V342, P41, DOI 10.1016/S0304-3940(03)00216-7; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Sampathu DM, 2006, AM J PATHOL, V169, P1343, DOI 10.2353/ajpath.2006.060438; Lin WL, 2008, ACTA NEUROPATHOL, V116, P205, DOI 10.1007/s00401-008-0408-9; LEIGH PN, 1988, NEUROSCI LETT, V93, P197, DOI 10.1016/0304-3940(88)90081-X; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Nakashima-Yasuda H, 2007, ACTA NEUROPATHOL, V114, P221, DOI 10.1007/s00401-007-0261-2; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Josephs KA, 2008, NEUROLOGY, V70, P1850, DOI 10.1212/01.wnl.0000304041.09418.b1; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P62, DOI 10.1097/nen.0b013e3181609361; Hasegawa M, 2011, J MOL NEUROSCI, V45, P480, DOI 10.1007/s12031-011-9571-x; Hatanpaa KJ, 2008, J NEUROPATH EXP NEUR, V67, P271, DOI 10.1097/NEN.0b013e31816a12a6; Ikeda K, 2000, NEUROPATHOLOGY, V20, P76, DOI 10.1046/j.1440-1789.2000.00270.x; Iseki E, 1998, J NEUROL SCI, V159, P194, DOI 10.1016/S0022-510X(98)00168-3; Josephs KA, 2007, NEUROLOGY, V69, P1800, DOI 10.1212/01.wnl.0000277270.99272.7e; Kwong LK, 2008, NEUROSIGNALS, V16, P41, DOI 10.1159/000109758; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Mackenzie IRA, 2003, ACTA NEUROPATHOL, V105, P543, DOI 10.1007/s00401-003-0678-1; Mizusawa H., 1993, NEUROPATHOLOGY, V13, P201, DOI 10.1111/j.1440-1789.1993.tb00198.x; Brouwers N, 2007, ARCH NEUROL-CHICAGO, V64, P1436, DOI 10.1001/archneur.64.10.1436; Ou S.-H. Ignatius, 1995, Journal of Virology, V69, P3584; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Yokota O, 2010, ACTA NEUROPATHOL, V120, P55, DOI 10.1007/s00401-010-0702-1; Yokota O, 2009, ACTA NEUROPATHOL, V117, P429, DOI 10.1007/s00401-009-0493-4	108	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2014	34	6					578	588		10.1111/neup.12138		11	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AW1EO	WOS:000346033500009		
J	Ito, H				Ito, Hidefumi			Basophilic inclusions and neuronal intermediate filament inclusions in amyotrophic lateral sclerosis and frontotemporal lobar degeneration	NEUROPATHOLOGY			English	Article						amyotrophic lateral sclerosis; basophilic inclusion; frontotemporal lobar degeneration; neuronal intermediate filament inclusion; review	FUS MUTATIONS; PICKS-DISEASE; CYTOPLASMIC INCLUSIONS; BODY DISEASE; ALPHA-INTERNEXIN; FUS/TLS GENE; ALS; ONSET; RNA; DEMENTIA	Basophilic inclusions (BIs) and neuronal intermediate filament inclusions (NIFIs) are key structures of basophilic inclusion body disease and neuronal intermediate filament inclusion disease (NIFID), respectively. BIs are sharply-defined, oval or crescent neuronal intracytoplasmic inclusions that appear pale blue-gray in color with HE staining and purple in color with Nissl but are stained poorly with silver impregnation techniques. Immunohistochemically BIs are negative for tau, trans-activation response DNA 43 (TDP-43), -synuclein, neurofilament (NF) and -internexin, positive for p62, and variably ubiquitinated. Noticeably, BIs are consistently fused in sarcoma (FUS) positive. NIFIs are by definition immuno-positive for class IV IFs including three NF triplet subunit proteins and -internexin but negative for tau, TDP-43, and -synuclein. In NIFID cases several types of inclusions have been identified. Among them, hyaline conglomerate-like inclusions are the only type that meets the above immunohistochemical features of NIFIs. This type of inclusion appears upon HE staining as multilobulated, faintly eosinophilic or pale amphophilic spherical masses with a glassy appearance. These hyaline conglomerates appear strongly argyrophilic, and robustly and consistently immuno-positive for IFs. In contrast, this type of inclusion shows no or only occasional dot-like FUS immunoreactivity. Therefore, BIs and NIFIs are distinct from each other in terms of morphological, tinctorial and immunohistochemical features. However, basophilic inclusion body disease (BIBD) and NIFID are difficult to differentiate clinically. Moreover, Pick body-like inclusions, the predominant type of inclusions seen in NIFID, are considerably similar to the BIs of BIBD in that this type of inclusion is basophilic, poorly argyrophilic, negative for IFs and intensely immuno-positive for FUS. As BIBD and NIFID share FUS accumulation as the most prominent molecular pathology, whether these two diseases are discrete entities or represent a pathological continuum remains a question to be answered.	Wakayama Med Univ, Dept Neurol, Wakayama 6418509, Japan	Ito, H (reprint author), Wakayama Med Univ, Dept Neurol, 811-1 Kimiidera, Wakayama 6418509, Japan.	ito@wakayama-med.ac.jp			Japan Society for the Promotion of Science [24300132]	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (No. 24300132).	Aizawa H, 2000, J NEUROL SCI, V176, P109, DOI 10.1016/S0022-510X(00)00321-X; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; YOKOO H, 1994, ACTA NEUROPATHOL, V88, P267; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P87, DOI 10.1007/s00401-011-0838-7; Gelpi E, 2012, J NEUROPATH EXP NEUR, V71, P795, DOI 10.1097/NEN.0b013e318266efb1; Baumer D, 2010, NEUROLOGY, V75, P611, DOI 10.1212/WNL.0b013e3181ed9cde; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Cairns NJ, 2003, NEUROSCI LETT, V341, P177, DOI 10.1016/S0304-3940(03)00100-9; Mochizuki Y, 2012, J NEUROL SCI, V323, P85, DOI 10.1016/j.jns.2012.08.016; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Suzuki N, 2012, J NEUROPATH EXP NEUR, V71, P779, DOI 10.1097/NEN.0b013e318264f164; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Suzuki N, 2010, J HUM GENET, V55, P252, DOI 10.1038/jhg.2010.16; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V121, P207, DOI 10.1007/s00401-010-0764-0; Cairns NJ, 2004, AM J PATHOL, V164, P2153, DOI 10.1016/S0002-9440(10)63773-X; Yokota O, 2008, ACTA NEUROPATHOL, V115, P561, DOI 10.1007/s00401-007-0329-z; Tateishi T, 2010, ACTA NEUROPATHOL, V119, P355, DOI 10.1007/s00401-009-0621-1; Neumann M, 2009, ACTA NEUROPATHOL, V118, P605, DOI 10.1007/s00401-009-0581-5; Thomas M, 2013, BRAIN, V136, P1345, DOI 10.1093/brain/awt030; Bigio EH, 2003, NEUROPATH APPL NEURO, V29, P239, DOI 10.1046/j.1365-2990.2003.00466.x; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Munoz DG, 2009, ACTA NEUROPATHOL, V118, P617, DOI 10.1007/s00401-009-0598-9; Mackenzie IRA, 2009, ACTA NEUROPATHOL, V117, P15, DOI 10.1007/s00401-008-0460-5; Page T, 2011, J MOL NEUROSCI, V45, P409, DOI 10.1007/s12031-011-9549-8; Uchikado H, 2006, NEUROPATHOLOGY, V26, P417, DOI 10.1111/j.1440-1789.2006.00709.x; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Cairns NJ, 2004, NEUROLOGY, V63, P1376; Fujita K, 2008, ACTA NEUROPATHOL, V116, P439, DOI 10.1007/s00401-008-0415-x; HAMADA K, 1995, CLIN NEUROPATHOL, V14, P1; Hilton DA, 2002, BRAIN PATHOL, V12, P267; Ishihara K, 2006, NEUROPATHOLOGY, V26, P447, DOI 10.1111/j.1440-1789.2006.00717.x; Ito H, 2011, ACTA NEUROPATHOL, V121, P555, DOI 10.1007/s00401-011-0809-z; Josephs KA, 2003, BRAIN, V126, P2291, DOI 10.1093/brain/awg231; Kobayashi Z, 2010, J NEUROL SCI, V293, P6, DOI 10.1016/j.jns.2010.03.029; KUSAKA H, 1990, ACTA NEUROPATHOL, V80, P660; KUSAKA H, 1993, CLIN NEUROPATHOL, V12, P215; MATSUMOTO S, 1992, ACTA NEUROPATHOL, V83, P579; MIZUTANI T, 1992, ACTA NEUROPATHOL, V84, P372; Munoz DG, 1998, PICK'S DISEASE AND PICK COMPLEX, P211; MUNOZGARCIA D, 1984, ANN NEUROL, V16, P467, DOI 10.1002/ana.410160408; NELSON JS, 1972, ARCH NEUROL-CHICAGO, V27, P300; ODA M, 1978, ACTA NEUROPATHOL, V44, P211; SAM M, 1991, NEUROLOGY, V41, P1831; Sasaki S, 2001, ACTA NEUROPATHOL, V102, P200; Tsuchiya K, 2001, CLIN NEUROPATHOL, V20, P53; Uchikado H, 2005, NEUROLOGY, V64, P1658, DOI 10.1212/01.WNL.0000160328.17975.9C; Wohlfart G, 1941, ARCH NEURO PSYCHIATR, V46, P0783; Yamamoto-Watanabe Y, 2010, J NEUROL SCI, V296, P59, DOI 10.1016/j.jns.2010.06.008	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2014	34	6					589	595		10.1111/neup.12119		7	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AW1EO	WOS:000346033500010		
J	Miyaji, Y; Yagishita, S; Zhang, N; Watanabe, D; Miyasaki, H; Mabuchi, I; Taira, S; Tanaka, F				Miyaji, Yosuke; Yagishita, Saburo; Zhang, Ning; Watanabe, Daisuke; Miyasaki, Hidetake; Mabuchi, Ikki; Taira, Sayoko; Tanaka, Fumiaki			Obstructive hydrocephalus and leptomeningeal dissemination with an unknown primary lesion in a 67-year-old man	NEUROPATHOLOGY			English	Article							PINEAL REGION TUMORS; GLIOBLASTOMA-MULTIFORME; PLEOMORPHIC XANTHOASTROCYTOMA; PROGNOSIS; CHILDREN; GLIOMA; GLAND		[Miyaji, Yosuke; Zhang, Ning; Watanabe, Daisuke; Miyasaki, Hidetake] Chigasaki Municipal Hosp, Dept Neurol, Chigasaki, Kanagawa 2530042, Japan; [Mabuchi, Ikki] Chigasaki Municipal Hosp, Dept Neurosurg, Chigasaki, Kanagawa 2530042, Japan; [Taira, Sayoko] Chigasaki Municipal Hosp, Dept Pathol, Chigasaki, Kanagawa 2530042, Japan; [Yagishita, Saburo] Kanagawa Rehabil Ctr, Dept Pathol, Atsugi, Kanagawa, Japan; [Tanaka, Fumiaki] Yokohama City Univ Grad Sch Med, Dept Neurol & Stroke Med, Yokohama, Kanagawa, Japan	Miyaji, Y (reprint author), Chigasaki Municipal Hosp, Dept Neurol, 5-15-1 Honson, Chigasaki, Kanagawa 2530042, Japan.	mmmyosuke@yahoo.co.jp					Amini A, 2006, J NEURO-ONCOL, V79, P307, DOI 10.1007/s11060-006-9145-x; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; [Anonymous], 2009, NEUROL MED CHIR TOKY, V49, pS26; Jia WQ, 2011, J NEUROSURG-PEDIATR, V7, P98, DOI 10.3171/2010.10.PEDS0976; Li G, 2010, NEUROSURGERY, V66, P963, DOI 10.1227/01.NEU.0000367726.49003.F1; Shah B, 2005, AM J NEURORADIOL, V26, P1858; Birbilis TA, 2010, SPINE, V35, pE264, DOI 10.1097/BRS.0b013e3181c11748; BRADFIEL.JS, 1972, RADIOLOGY, V103, P399; Cho BK, 1998, CHILD NERV SYST, V14, P53, DOI 10.1007/s003810050175; Debono B, 2006, SURG NEUROL, V65, P273, DOI 10.1016/j.surneu.2005.06.038; EDWARDS MSB, 1988, J NEUROSURG, V68, P689, DOI 10.3171/jns.1988.68.5.0689; FRANK F, 1985, SURG NEUROL, V23, P275, DOI 10.1016/0090-3019(85)90095-3; Gasparetto EL, 2003, ARQ NEURO-PSIQUIAT, V61, P468, DOI 10.1590/S0004-282X2003000300027; KALYANARAMAN UP, 1979, ARCH NEUROL-CHICAGO, V36, P717; KEPES JJ, 1979, CANCER, V44, P1839, DOI 10.1002/1097-0142(197911)44:5<1839::AID-CNCR2820440543>3.0.CO;2-0; Moon Kyung-Sub, 2008, J Med Case Rep, V2, P288, DOI 10.1186/1752-1947-2-288; Nakajima T, 2006, ACTA NEUROCHIR, V148, P67, DOI 10.1007/s00701-005-0549-8; NORBUT AM, 1981, CANCER, V47, P592, DOI 10.1002/1097-0142(19810201)47:3<592::AID-CNCR2820470328>3.0.CO;2-G; Ozgural O, 2013, TURK NEUROSURG, V23, P572, DOI 10.5137/1019-5149.JTN.5994-12.1; POPLE IK, 1993, CHILD NERV SYST, V9, P422, DOI 10.1007/BF00306198; DEGIROLA.U, 1973, J NEUROSURG, V39, P455, DOI 10.3171/jns.1973.39.4.0455; Toyooka T, 2005, J CLIN NEUROSCI, V12, P834, DOI 10.1016/j.jocn.2004.09.027; Vaquero J, 1990, J Neurosurg Sci, V34, P149	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2014	34	6					596	601		10.1111/neup.12136		6	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AW1EO	WOS:000346033500011		
J	Oyanagi, K				Oyanagi, Kiyomitsu			In Memoriam: Dr. Imaharu Nakano (1948-2014)	NEUROPATHOLOGY			English	Biographical-Item									Shinshu Univ, Nagano, Japan	Oyanagi, K (reprint author), Shinshu Univ, Nagano, Japan.						NAKANO I, PUBLICATION LIST	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	DEC	2014	34	6					604	606		10.1111/neup.12190		3	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	AW1EO	WOS:000346033500012		
J	Chaki, S; Fukumoto, K; Iijima, M				Chaki, Shigeyuki; Fukumoto, Kenichi; Iijima, Michihiko			Role of Serotonergic Transmission in Antidepressant Effects of an mGlu2/3 Receptor Antagonist and Ketamine	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	53rd Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 07-11, 2014	Phoenix, AZ	Amer Coll Neuropsychopharmacol		ketamine; mGlu2/3 receptor; antidepressant; serotonin			[Chaki, Shigeyuki; Fukumoto, Kenichi; Iijima, Michihiko] Taisho Pharmaceut Co, Saitama, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2014	39			1		W185	S591	S592				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AU9IJ	WOS:000345905002184		
J	Hashimoto, R; Ohi, K; Ikeda, M; Yamamori, H; Yasuda, Y; Fujimoto, M; Umeda-Yano, S; Fukunaga, M; Fujino, H; Watanabe, Y; Iwase, M; Kazui, H; Iwata, N; Weinberger, D; Takeda, M				Hashimoto, Ryota; Ohi, Kazutaka; Ikeda, Masashi; Yamamori, Hidenaga; Yasuda, Yuka; Fujimoto, Michiko; Umeda-Yano, Satomi; Fukunaga, Masaki; Fujino, Haruo; Watanabe, Yoshiyuki; Iwase, Masao; Kazui, Hiroaki; Iwata, Nakao; Weinberger, Daniel; Takeda, Masatoshi			Glutamate Networks Implicate Cognitive Impairments in Schizophrenia; Genome-wide Association Studies of 52 Cognitive Phenotypes	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	53rd Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 07-11, 2014	Phoenix, AZ	Amer Coll Neuropsychopharmacol		schizophrenia; genome-wide association study; cognitive phenotypes; glutamate receptor activity			[Hashimoto, Ryota; Ohi, Kazutaka; Ikeda, Masashi; Yamamori, Hidenaga; Yasuda, Yuka; Fujimoto, Michiko; Umeda-Yano, Satomi; Fukunaga, Masaki; Fujino, Haruo; Watanabe, Yoshiyuki; Iwase, Masao; Kazui, Hiroaki; Iwata, Nakao; Weinberger, Daniel; Takeda, Masatoshi] Osaka Univ, Suita, Osaka, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2014	39			1		T169	S406	S407				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AU9IJ	WOS:000345905001168		
J	Miyakawa, T; Koshimizu, H; Ohira, K; Hagihara, H; Takeuchi, R; Takao, K				Miyakawa, Tsuyoshi; Koshimizu, Hisatsugu; Ohira, Koji; Hagihara, Hideo; Takeuchi, Rika; Takao, Keizo			Transcriptomic Effects of Antidepressant Treatment and Glucocorticoid Receptor-overexpression on the Maturational Status of Brain Cells in Mice	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	53rd Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 07-11, 2014	Phoenix, AZ	Amer Coll Neuropsychopharmacol		antidepressant; mood disorder; glucocorticoid receptor; gene expression			[Miyakawa, Tsuyoshi; Koshimizu, Hisatsugu; Ohira, Koji; Hagihara, Hideo; Takeuchi, Rika; Takao, Keizo] Fujita Hlth Univ, Inst Comprehens Med Sci, Toyoake, Aichi, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2014	39			1		T66	S333	S334				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AU9IJ	WOS:000345905001066		
J	Nakazawa, T; Hashimoto, R; Tanimura, A; Ohi, K; Yamamori, H; Yasuda, Y; Umeda-Yano, S; Kiyama, Y; Konno, K; Inoue, T; Numata, S; Ohnuma, T; Iwata, N; Ozaki, N; Hashimoto, H; Watanabe, M; Manabe, T; Yamamoto, T; Takeda, M; Kano, M				Nakazawa, Takanobu; Hashimoto, Ryota; Tanimura, Asami; Ohi, Kazutaka; Yamamori, Hidenaga; Yasuda, Yuka; Umeda-Yano, Satomi; Kiyama, Yuji; Konno, Kohtarou; Inoue, Takafumi; Numata, Shusuke; Ohnuma, Tohru; Iwata, Nakao; Ozaki, Norio; Hashimoto, Hitoshi; Watanabe, Masahiko; Manabe, Toshiya; Yamamoto, Tadashi; Takeda, Masatoshi; Kano, Masanobu			Brain-enriched Sorting Nexin Family Proteins Regulate Spine Morphogenesis and Are Associated with Risk for Schizophrenia	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	53rd Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 07-11, 2014	Phoenix, AZ	Amer Coll Neuropsychopharmacol		schizophrenia; sorting nexin; spine morphogenesis; Rho family GTPase			[Nakazawa, Takanobu; Hashimoto, Ryota; Tanimura, Asami; Ohi, Kazutaka; Yamamori, Hidenaga; Yasuda, Yuka; Umeda-Yano, Satomi; Kiyama, Yuji; Konno, Kohtarou; Inoue, Takafumi; Numata, Shusuke; Ohnuma, Tohru; Iwata, Nakao; Ozaki, Norio; Hashimoto, Hitoshi; Watanabe, Masahiko; Manabe, Toshiya; Yamamoto, Tadashi; Takeda, Masatoshi; Kano, Masanobu] Osaka Univ, Osaka, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2014	39			1		T25	S306	S307				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AU9IJ	WOS:000345905001025		
J	Nitta, A; Iegaki, N; Ishikawa, Y; Sumi, K; Furukawa-Hibi, Y; Muramatsu, S; Nabeshima, T; Uno, K; Miyamoto, Y				Nitta, Atsumi; Iegaki, Noriyuki; Ishikawa, Yudai; Sumi, Kazuyuki; Furukawa-Hibi, Yoko; Muramatsu, Shin-ichi; Nabeshima, Toshitaka; Uno, Kyosuke; Miyamoto, Yoshiaki			N-Acetyltransferase Shati/Nat8l in the Dorsal Striatum Regulates Sociability and Motivation via Control of the Serotonergic Neuronal System in Mice	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	53rd Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 07-11, 2014	Phoenix, AZ	Amer Coll Neuropsychopharmacol		Shati/Nat8l; social withdrawal; behavioral despair; serotonergic system			[Nitta, Atsumi; Iegaki, Noriyuki; Ishikawa, Yudai; Sumi, Kazuyuki; Furukawa-Hibi, Yoko; Muramatsu, Shin-ichi; Nabeshima, Toshitaka; Uno, Kyosuke; Miyamoto, Yoshiaki] Toyama Univ, Toyama 930, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2014	39			1		W97	S534	S535				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AU9IJ	WOS:000345905002096		
J	Okada, G; Okamoto, Y; Takamura, M; Toki, S; Yamamoto, T; Yamawaki, S				Okada, Go; Okamoto, Yasumasa; Takamura, Masahiro; Toki, Shigeru; Yamamoto, Tetsuya; Yamawaki, Shigeto			Resting State Amygdala Functional Connectivity and Antidepressant Treatment Response in Major Depressive Disorder	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	53rd Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 07-11, 2014	Phoenix, AZ	Amer Coll Neuropsychopharmacol		major depressive disorder; fMRI; functional connectivity; antidepressant			[Okada, Go; Okamoto, Yasumasa; Takamura, Masahiro; Toki, Shigeru; Yamamoto, Tetsuya; Yamawaki, Shigeto] Hiroshima Univ, Hiroshima, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2014	39			1		M195	S241	S241				1	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AU9IJ	WOS:000345905000403		
J	Saito, T; Ukai, W; Kigawa, Y; Ishi, T; Furuse, K; Tsujino, H; Tayama, M; Hashimoto, E				Saito, Toshikazu; Ukai, Wataru; Kigawa, Yoshiyasu; Ishi, Takao; Furuse, Kengo; Tsujino, Hanako; Tayama, Masaya; Hashimoto, Eri			Stem Cell Therapy as a Candidate Treatment Approach for Neural Plasticity Change in Refractory Depression	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	53rd Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 07-11, 2014	Phoenix, AZ	Amer Coll Neuropsychopharmacol		depression; neural stem cell; regenerative therapy; fetal alcohol syndrome			[Saito, Toshikazu; Ukai, Wataru; Kigawa, Yoshiyasu; Ishi, Takao; Furuse, Kengo; Tsujino, Hanako; Tayama, Masaya; Hashimoto, Eri] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2014	39			1		T4	S292	S293				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AU9IJ	WOS:000345905001004		
J	Sato, A; Takamatsu, Y; Tanaka, M; Kasai, S; Kobayashi, T; Hino, O; Ikeda, K; Mizuguchi, M				Sato, Atsushi; Takamatsu, Yukio; Tanaka, Miho; Kasai, Shinya; Kobayashi, Toshiyuki; Hino, Okio; Ikeda, Kazutaka; Mizuguchi, Masashi			Autistic-like Behavioral Deficits in Mouse Models of Tuberous Sclerosis Complex Are Severer in TSC2 Mutation than in TSC1 Mutation	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	53rd Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 07-11, 2014	Phoenix, AZ	Amer Coll Neuropsychopharmacol		autism spectrum disorder; tuberous sclerosis complex; rapamycin; mouse			[Sato, Atsushi; Takamatsu, Yukio; Tanaka, Miho; Kasai, Shinya; Kobayashi, Toshiyuki; Hino, Okio; Ikeda, Kazutaka; Mizuguchi, Masashi] Tokyo Metropolitan Inst Med Sci, Katsushika, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2014	39			1		M15	S120	S121				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AU9IJ	WOS:000345905000223		
J	Sora, I; Sasaki, K; Sumiyoshi, A; Nonaka, H; Kasahara, Y; Ikeda, K; Hall, FS; Uhl, GR; Watanabe, M; Kawashima, R				Sora, Ichiro; Sasaki, Kazumasu; Sumiyoshi, Akira; Nonaka, Hiroi; Kasahara, Yoshiyuki; Ikeda, Kazutaka; Hall, F. Scott; Uhl, George R.; Watanabe, Masahiko; Kawashima, Ryuta			Specific Regions Display Altered Grey Matter Volume in m-Opioid Receptor Knockout Mice: MRI Voxel-based Morphometry	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	53rd Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 07-11, 2014	Phoenix, AZ	Amer Coll Neuropsychopharmacol		voxel-based morphometry (VBM); periaqueductal grey (PAG); hypothalamus; hyperalgesia			[Sora, Ichiro; Sasaki, Kazumasu; Sumiyoshi, Akira; Nonaka, Hiroi; Kasahara, Yoshiyuki; Ikeda, Kazutaka; Hall, F. Scott; Uhl, George R.; Watanabe, Masahiko; Kawashima, Ryuta] Kobe Univ, Grad Sch Med, Kobe, Hyogo 657, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2014	39			1		M37	S134	S135				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AU9IJ	WOS:000345905000245		
J	Uchida, H; Mizuno, Y; Hofer, A; Fleischhacker, W				Uchida, Hiroyuki; Mizuno, Yuya; Hofer, Alex; Fleischhacker, Wolfgang			Biological and Clinical Correlates of Resilience in Patients with Schizophrenia: A Cross-sectional Study	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	53rd Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 07-11, 2014	Phoenix, AZ	Amer Coll Neuropsychopharmacol		resilience; stress; BDNF; schizophrenia			[Uchida, Hiroyuki; Mizuno, Yuya; Hofer, Alex; Fleischhacker, Wolfgang] Keio Univ, Sch Med, Tokyo, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2014	39			1		W13	S480	S481				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AU9IJ	WOS:000345905002013		
J	Yamada, H; Akuzawa, S; Honda, S; Nagakura, A				Yamada, Hiroshi; Akuzawa, Shinobu; Honda, Sokichi; Nagakura, Akira			ASP0777: NMDA Channel Blocker with the Equal Subtype Selectivity and the Fast-Off Rate Has Potential as a Rapid Onset Antidepressant without Psychotomimetic Adverse Effects	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	53rd Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 07-11, 2014	Phoenix, AZ	Amer Coll Neuropsychopharmacol		ASP0777; Antidepressant; NMDA channel blocker; Ketamine			[Yamada, Hiroshi; Akuzawa, Shinobu; Honda, Sokichi; Nagakura, Akira] Astellas, Tsukuba, Ibaraki, Japan								0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2014	39			1		W213	S610	S611				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AU9IJ	WOS:000345905002212		
J	Yamazaki, M; Yarimizu, J; Harada, K; Yamamoto, N; Okabe, M; Ni, KN; Marcus, M; Svensson, T; Matsumoto, M				Yamazaki, Mayako; Yarimizu, Junko; Harada, Katsuya; Yamamoto, Noriyuki; Okabe, Mayuko; Ni, Keni Ni; Marcus, Monica; Svensson, Torgny; Matsumoto, Mitsuyuki			Preclinical Characterization and Functional Mechanism of ASP5736, a Selective Serotonin 5-HT5A Receptor Antagonist with Potential Utility for the Treatment of Schizophrenia and Affective Disorders	NEUROPSYCHOPHARMACOLOGY			English	Meeting Abstract	53rd Annual Meeting of the American-College-of-Neuropsychopharmacology (ACNP)	DEC 07-11, 2014	Phoenix, AZ	Amer Coll Neuropsychopharmacol		5HT5A receptor antagonist; schizophrenia; dopamine; GABA			[Yamazaki, Mayako; Yarimizu, Junko; Harada, Katsuya; Yamamoto, Noriyuki; Okabe, Mayuko; Ni, Keni Ni; Marcus, Monica; Svensson, Torgny; Matsumoto, Mitsuyuki] Astellas Phama Inc, Tsukuba, Ibaraki, Japan			Matsumoto, Mitsuyuki/G-3207-2012	Matsumoto, Mitsuyuki/0000-0002-1172-2354				0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0893-133X	1740-634X		NEUROPSYCHOPHARMACOL	Neuropsychopharmacology	DEC	2014	39			1		W191	S595	S596				2	Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AU9IJ	WOS:000345905002190		
J	Stone, TE; Francis, L; van der Riet, P; Dedkhard, S; Junlapeeya, P; Orwat, E				Stone, Teresa E.; Francis, Lyn; van der Riet, Pamela; Dedkhard, Saowapa; Junlapeeya, Piyatida; Orwat, Edith			Awakening to the other: Reflections on developing intercultural competence through an undergraduate study tour	NURSING & HEALTH SCIENCES			English	Article						complementary therapies; cross-cultural awareness; cultural competence; empathy; holistic care; Thailand	NURSING-STUDENTS; EXPERIENCE; CARE	For the past 4 years, undergraduate students from the Faculty of Health, University of Newcastle, Newcastle, Australia, have undertaken a two week cultural study tour in Thailand, being exposed to a broad range of cultural interactions, health settings in rural and remote areas, and health-treatment approaches, including traditional and complementary therapies. Student evaluations and reflections were collected after the 2010 and 2011 study tours. This paper reports on findings following thematic analysis of the data, which identified central themes, including connectivity to others, awakenings, embodiment, and looking to the future. Findings included a recognition by students of a growth in awareness and change in perspective, which they felt would impact on their future approach in caring for patients from culturally- and linguistically-diverse backgrounds. We conclude that the study tour provided an effective way of sensitizing students to cultural differences and promoting cross-cultural awareness.	[Stone, Teresa E.] Yamaguchi Univ, Dept Nursing, Ube, Yamaguchi 7558505, Japan; [Francis, Lyn; van der Riet, Pamela; Orwat, Edith] Univ Newcastle, Sch Nursing & Midwifery, Newcastle, NSW 2300, Australia; [Dedkhard, Saowapa] Boromarajonani Coll Nursing, Dept Community Hlth Nursing, Lampang, Thailand; [Junlapeeya, Piyatida] Boromarajonani Coll Nursing, Dept Nursing, Lampang, Thailand	Stone, TE (reprint author), Yamaguchi Univ, Fac Hlth Sci, Grad Sch Med, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	teriston@yamaguchi-u.ac.jp					Abbs P, 1995, SALISBURY RE     JUN, P27; ADLER PS, 1975, J HUMANIST PSYCHOL, V15, P13; Pagis M, 2009, SOC PSYCHOL QUART, V72, P265; Ngo-Metzger Q, 2003, J GEN INTERN MED, V18, P44, DOI 10.1046/j.1525-1497.2003.20205.x; Cunico L, 2012, J CLIN NURS, V21, P2016, DOI 10.1111/j.1365-2702.2012.04105.x; Koskinen L, 2009, INT J NURS PRACT, V15, P502, DOI 10.1111/j.1440-172X.2009.01776.x; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; BCFN (Barilla Center for Food and Nutrition), CULT DIM FOOD POS PA; Blue A. V., 2012, PROVISION CULTURALLY; Borbasi S, 2008, NAVIGATING MAZE NURS, P2; Buddharakkhita A., 2013, METTA PHILOS PRACTIC; Commonwealth of Australia, 2008, CULT COMP HLTH GUID; Denzin N., 2008, INTERPRETIVE BIOGRAP; Dorn G, 2005, INTERCULTURAL SKILLS; Findlay L, 2005, HUMANIST PSYCHOL, V33, P271; Hall E. T, 1990, SILENT LANGUAGE; Huch MH, 2003, NURS SCI QUART, V16, P168, DOI 10.1177/0894318403251795; Jones EE., 2013, U WORLD NEWS, P35; Kelly K, 2011, INT J HUMAN CARING, V15, P22; Kleiman S, 2009, HUMAN CTR NURSING FD; Lambert C, 2010, BRIT J MIDWIFERY, V18, P321; Lather P., 1991, GETTING SMART FEMINI; Leininger M, 1996, NURS SCI QUART, V9, P71, DOI 10.1177/089431849600900208; Montuori A, 2004, J HUMANIST PSYCHOL, V44, P243, DOI 10.1177/0022167804263414; Neuliep J. W., 2012, INTERCULTURAL COMMUN; Owens KM, 1991, HOLIST NURS PRACT, V6, P32; Pesquera Marcos, 2008, Medsurg Nurs, V17, P114; Pinikahana Jaya, 2003, Nurs Health Sci, V5, P149, DOI 10.1046/j.1442-2018.2003.00146.x; REED PG, 1992, RES NURS HEALTH, V15, P349, DOI 10.1002/nur.4770150505; Schultz E. A., 2009, CULTURAL ANTHR PERSP; Shinebourne P, 2010, PSYCHOL PSYCHOTHER-T, V83, P59, DOI 10.1348/147608309X468077; Skott C, 2001, NURS SCI QUART, V14, P249, DOI 10.1177/08943180122108364; TAYLOR EW, 1994, ADULT EDUC QUART, V44, P154, DOI 10.1177/074171369404400303; Trochim W, 2000, INTRO EVALUATION RES; van der Riet P, 1999, Aust J Holist Nurs, V6, P20; van dersRiet P, 2012, PHILIPP J NURS, V82, P28; van der Riet P, 2011, COLLEGIAN, V18, P36, DOI 10.1016/j.colegn.2010.10.002; van der Riet P, 2012, J CLIN NURS, V21, P657, DOI 10.1111/j.1365-2702.2011.03852.x	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1441-0745	1442-2018		NURS HEALTH SCI	Nurs. Health Sci.	DEC	2014	16	4			SI		521	527		10.1111/nhs.12139		7	Nursing	Nursing	AW1RO	WOS:000346067500016		
J	Okazaki, Y; Katayama, T				Okazaki, Yukako; Katayama, Tetsuyuki			Dietary phytic acid modulates characteristics of the colonic luminal environment and reduces serum levels of proinflammatory cytokines in rats fed a high-fat diet	NUTRITION RESEARCH			English	Article						Phytic acid; Cecal organic acids; Microflora; Mucins; beta-Glucosidase; Proinflammatory cytokines; Rats	GOBLET CELL-PROLIFERATION; PROTEIN-COUPLED RECEPTOR; P-CHLOROPHENYL ETHANE; INOSITOL HEXAPHOSPHATE; COLORECTAL-CANCER; MUCIN SECRETION; HUMAN FECES; CALCIUM; PHYTATE; INULIN	Dietary phytic acid (PA; myo-inositol [MI] hexaphosphate) is known to inhibit colon carcinogenesis in rodents. Dietary fiber, which is a negative risk factor of colon cancer, improves characteristics of the colonic environment, such as the content of organic acids and microflora. We hypothesized that dietary PA would improve the colonic luminal environment in rats fed a high-fat diet. To test this hypothesis, rats were fed diets containing 30% beef tallow with 2.04% sodium PA, 0.4% MI, or 1.02% sodium PA + 0.2% MI for 3 weeks. Compared with the control diet, the sodium PA diet up-regulated cecal organic acids, including acetate, propionate, and n-butyrate; this effect was especially prominent for cecal butyrate. The sodium PA + MI diet also significantly increased cecal butyrate, although this effect was less pronounced when compared with the sodium PA diet. The cecal ratio of Lactobacillales, cecal and fecal mucins (an index of intestinal barrier function), and fecal p-glucosidase activity were higher in rats fed the sodium PA diet than in those fed the control diet. The sodium PA, MI, and sodium PA + MI diets decreased levels of serum tumor necrosis factor a, which is a proinflammatory cytokine. Another proinflammatory cytokine, serum interleukin-6, was also down-regulated by the sodium PA and sodium PA + MI diets. These data showed that PA may improve the composition of cecal organic acids, microflora, and mucins, and it may decrease the levels of serum proinflammatory cytokines in rats fed a high-fat, mineral-sufficient diet. (C) 2014 Elsevier Inc. All rights reserved.	[Okazaki, Yukako] Fuji Womens Univ, Fac Human Life Sci, Ishikari, Hokkaido 0613204, Japan; [Katayama, Tetsuyuki] Inst Life Sci & Nutr, Kita Ku, Sapporo, Hokkaido 0010037, Japan	Okazaki, Y (reprint author), Fuji Womens Univ, Fac Human Life Sci, Ishikari, Hokkaido 0613204, Japan.	yokazaki@fujijoshi.ac.jp			Tojuro Iijima Foundation for Food Science and Technology in Japan [G-9]	This research was supported, in part, by a Grant-in-Aid (No. 5, G-9, 2012) from The Tojuro Iijima Foundation for Food Science and Technology in Japan.	Tang Y, 2011, INT J CANCER, V128, P847, DOI 10.1002/ijc.25638; REEVES PG, 1993, J NUTR, V123, P1939; Onomi S, 2004, BIOSCI BIOTECH BIOCH, V68, P1379, DOI 10.1271/bbb.68.1379; Barcelo A, 2000, GUT, V46, P218, DOI 10.1136/gut.46.2.218; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; REDDY BS, 1981, CANCER RES, V41, P3700; Hino S, 2013, J NUTR, V143, P34, DOI 10.3945/jn.112.167064; Wu WT, 2011, J AGR FOOD CHEM, V59, P989, DOI 10.1021/jf103532x; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Nakashima A, 1997, J NUTR SCI VITAMINOL, V43, P419; Nyman M, 2002, BRIT J NUTR, V87, pS163, DOI [10.1079/BJN2001504, 10.1079/BJN/2002533]; Okazaki Y, 2011, J NUTR, V141, P1975, DOI 10.3945/jn.111.144246; Manco M, 2007, AM J CLIN PATHOL, V127, P954, DOI 10.1309/6VJ4DWGYDI0XYJ8Q; Ito H, 2009, DIGEST DIS SCI, V54, P2100, DOI 10.1007/s10620-008-0599-x; Nagashima K, 2003, APPL ENVIRON MICROB, V69, P1251, DOI 10.1128/AEM.69.2.1251-1262.2003; FREEMAN HJ, 1986, CANCER RES, V46, P5529; BoveeOudenhoven IMJ, 1997, GUT, V40, P497; SAKAMOTO K, 1993, J NUTR, V123, P713; Miyazawa E, 1996, NUTR RES, V16, P603, DOI 10.1016/0271-5317(96)00038-3; CHEN HM, 1989, CLIN CHEM, V35, P74; Coxam V, 2007, J NUTR, V137, p2527S; Fernandes J, 2000, J NUTR, V130, P1932; Growther RS, 1987, ANAL BIOCHEM, V163, P170; Hashimoto N, 2011, PLANT FOOD HUM NUTR, V66, P401, DOI 10.1007/s11130-011-0255-z; Hayashi K, 2001, BRIT J NUTR, V86, P443, DOI 10.1079/BJN2001417; Hino S, 2012, J NUTR, V142, P1429, DOI 10.3945/jn.112.159731; Ishizuka S, 2004, EXP BIOL MED, V229, P876; Katayama T, 1997, NUTR RES, V17, P721, DOI 10.1016/S0271-5317(97)00042-0; Kolida S, 2002, BRIT J NUTR, V87, pS193, DOI [10.1079/BJN/2002537, 10.1079/BJNBJN/2002537]; Kumar V, 2010, FOOD CHEM, V120, P949; Lopez HW, 1998, J NUTR, V128, P1192; Lopez-Gonzalez AA, 2013, EUR J NUTR, V52, P3717; McIntosh GH, 1999, NUTR CANCER, V35, P153, DOI 10.1207/S15327914NC352_9; Nagashima K., 2006, Bioscience and Microflora, V25, P99; Nakahara N, 2000, TRACE NUTR RES, V17, P47; Okazaki Y, 2008, NUTR RES, V28, P714, DOI 10.1016/j.nutres.2008.07.003; Okazaki Y, 2003, J NUTR BIOCHEM, V14, P81, DOI 10.1016/S0955-2863(02)00279-6; Omoruyi FO, 2013, ADV PHARM SCI, DOI 10.1155/2013/172494; REDDY BS, 1993, CANCER RES, V53, P3914; REDDY NR, 1982, ADV FOOD RES, V28, P1; SANDBERG AS, 1988, J NUTR, V118, P469; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; SHAMSUDDIN AM, 1989, CARCINOGENESIS, V10, P1461, DOI 10.1093/carcin/10.8.1461; SHAMSUDDIN AM, 1988, CARCINOGENESIS, V9, P577, DOI 10.1093/carcin/9.4.577; Shibata M., 1966, J JPN SOC NUTR FOOD, V11, P134; Shimotoyodome A, 2000, COMP BIOCHEM PHYS A, V125, P525, DOI 10.1016/S1095-6433(00)00183-5; Shinoda S, 1995, J JPN SOC NUTR FOOD, V48, P371; Suzuki T, 2010, MOL NUTR FOOD RES, V54, P947, DOI 10.1002/mnfr.200900279; Uehara M, 2001, J NUTR, V131, P787; Yadav S, 2011, BIOFACTORS, V37, P58, DOI 10.1002/biof.137	50	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0271-5317			NUTR RES	Nutr. Res.	DEC	2014	34	12					1085	1091		10.1016/j.nutres.2014.09.012		7	Nutrition & Dietetics	Nutrition & Dietetics	AW2JI	WOS:000346113500008		
J	Fuda, T				Fuda, Toru			Convergence Conditions of Mixed States and their von Neumann Entropy in Continuous Quantum Measurements	OPEN SYSTEMS & INFORMATION DYNAMICS			English	Article								By carrying out appropriate continuous quantum measurements with a family of projection operators, a unitary channel can be approximated in an arbitrary precision in the trace norm sense. In particular, the quantum Zeno effect is described as an application. In the case of an infinite dimension, although the von Neumann entropy is not necessarily continuous, the difference of the entropies between the states, as mentioned above, can be made arbitrarily small under some conditions.	Hokkaido Univ, Dept Math, Sapporo, Hokkaido 0600810, Japan	Fuda, T (reprint author), Hokkaido Univ, Dept Math, Sapporo, Hokkaido 0600810, Japan.	t-fuda@math.sci.hokudai.ac.jp					LIEB EH, 1973, J MATH PHYS, V14, P1938, DOI 10.1063/1.1666274; FANNES M, 1973, COMMUN MATH PHYS, V31, P291, DOI 10.1007/BF01646490; MISRA B, 1977, J MATH PHYS, V18, P756, DOI 10.1063/1.523304; Facchi P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.080401; Facchi P, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/49/493001; Arai A, 2012, LETT MATH PHYS, V100, P245, DOI 10.1007/s11005-011-0539-0; Arai A., 2008, MATH PRINCIPLES QUAN; Doob J.L., 1994, MEASURE THEORY; Exner P, 1985, OPEN QUANTUM SYSTEMS; Facchi P, 1999, PHYS LETT A, V257, P232, DOI 10.1016/S0375-9601(99)00323-0; Ingarden R. S., 1997, INFORM DYNAMICS OPEN; Nielsen M, 2000, QUANTUM COMPUTATION; Umegaki H., 1984, QUANTUM MECH ENTROPY; von Neumann J., 1932, MATH GRUNDLAGEN QUAN; Wehrl A., 1976, Reports on Mathematical Physics, V10, DOI 10.1016/0034-4877(76)90037-9	15	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1230-1612	1793-7191		OPEN SYST INF DYN	Open Syst. Inf. Dyn.	DEC	2014	21	4							1450010	10.1142/S1230161214500103		14	Physics, Mathematical; Statistics & Probability	Physics; Mathematics	AW1UH	WOS:000346075500004		
J	Ito, H; Iida, S				Ito, Hideaki; Iida, Saburou			Method for Organizing Grover's Quantum Oracle	OPEN SYSTEMS & INFORMATION DYNAMICS			English	Article								In a quantum computation, some algorithms use oracles (black boxes) for abstract computational objects. This paper presents an example for organizing Grover's quantum oracle by synthesizing several unitary gates such as CNOT gates, Toffoli gates, and Hadamard gates. As an example, we show a concrete quantum circuit for the knapsack problem, which belongs to the class of NP-complete problems. The time complexity of an oracle for the knapsack problem is estimated to be O(n(2)), where n is the number of variables. And the same order is obtained for space complexity.	[Ito, Hideaki; Iida, Saburou] Chukyo Univ, Dept Informat Engn, Toyota, Aichi 4700393, Japan	Ito, H (reprint author), Chukyo Univ, Dept Informat Engn, Toyota, Aichi 4700393, Japan.						Vedral V, 1996, PHYS REV A, V54, P147, DOI 10.1103/PhysRevA.54.147; Brassard G, 1998, LECT NOTES COMPUT SC, V1443, P820; De Vos A., 2010, REVERSIBLE COMPUTING; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Rich E., 2009, AUTOMATA COMPUTABILI; Rieffel E., 2011, QUANTUM COMPUTING; Sasao T., 1999, SWITCHING THEORY LOG	7	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	1230-1612	1793-7191		OPEN SYST INF DYN	Open Syst. Inf. Dyn.	DEC	2014	21	4							1450011	10.1142/S1230161214500115		12	Physics, Mathematical; Statistics & Probability	Physics; Mathematics	AW1UH	WOS:000346075500005		
J	Abe, T; Kim, SW; Ishigaki, T; Uematsu, K; Toda, K; Sato, M				Abe, Takeshi; Kim, Sun Woog; Ishigaki, Tadashi; Uematsu, Kazuyoshi; Toda, Kenji; Sato, Mineo			Synthesis of new green-emitting KBa1-xScSi3O9:Eu-x(2+) phosphors for white LEDs	OPTICAL MATERIALS			English	Article						White LEDs; Green emission phosphor; Crystal field modification	TEMPERATURE-DEPENDENT EMISSION; LUMINESCENCE PROPERTIES; NITRIDE PHOSPHORS; RED EMISSION; DIODES; EU2+; PHASE; SR	New green-emitting KBa1-xScSi3O9:Eu-x(2+) phosphors for white LEDs were synthesized by a conventional solid-state reaction method. The obtained KBa1_xScSi3O9:Eu-x(2+) phosphors show the strong broad optical absorption band from UV to blue light region and exhibit broad green emission with a peak at 521 nm under excitation at 405 nm due to the allowed 4f(6)5d(1)-4f(7) transition of Eu2+. Optimization of Eu2+ concentration resulted in the highest green emission peak intensity was obtained at the composition of KBa0.94ScSi3O9:Eu-0.06(2+), and the relative emission intensity of this phosphor was 32% of that of a commercial YAG:Ce3+ phosphor. (C) 2014 Elsevier B.V. All rights reserved.	[Abe, Takeshi; Kim, Sun Woog; Ishigaki, Tadashi; Toda, Kenji] Niigata Univ, Grad Sch Sci & Technol, Niigata 9502181, Japan; [Uematsu, Kazuyoshi; Sato, Mineo] Niigata Univ, Dept Chem & Chem Engn, Niigata 9502181, Japan	Toda, K (reprint author), Niigata Univ, Grad Sch Sci & Technol, 8050 Ikarashi 2 Nocho, Niigata 9502181, Japan.	ktoda@eng.niigata-u.ac.jp	TODA, KENJI/D-7286-2015; KIM, Sun Woog/O-5366-2015	TODA, KENJI/0000-0001-8359-477X; 			Abe T., 2013, PHOSPHOR SAFARI 2013, P49; Yang ZP, 2008, MATER LETT, V62, P1884, DOI 10.1016/j.matlet.2007.10.030; Kim JS, 2005, SOLID STATE COMMUN, V133, P445, DOI 10.1016/j.ssc.2004.12.002; Shao QY, 2014, J LUMIN, V151, P165, DOI 10.1016/j.jlumin.2014.02.027; Chen L, 2010, MATERIALS, V3, P2172, DOI 10.3390/ma3032172; Narendran N, 2000, P SOC PHOTO-OPT INS, V3938, P240, DOI 10.1117/12.382836; Park JK, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2166471; Li YQ, 2006, J ALLOY COMPD, V417, P273, DOI 10.1016/j.jallcom.2005.09.041; Xia ZG, 2013, J PHYS CHEM C, V117, P20847, DOI 10.1021/jp4062225; Narukawa Y, 2007, PHYS STATUS SOLIDI A, V204, P2087, DOI 10.1002/pssa.200674782; Dorenbos P, 2003, J LUMIN, V104, P239, DOI 10.1016/S0022-2313(03)00078-4; Han JK, 2012, ECS J SOLID STATE SC, V1, pR37, DOI 10.1149/2.026201jss; Xia ZG, 2013, J MATER CHEM C, V1, P5917, DOI 10.1039/c3tc30897a; Wu ZC, 2006, J SOLID STATE CHEM, V179, P2356, DOI 10.1016/j.jssc.2006.04.030; Tezuka S, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.072101; Baginskiy I, 2011, J ELECTROCHEM SOC, V158, pP118, DOI 10.1149/1.3625282; Nakano T, 2009, J LUMIN, V129, P1654, DOI 10.1016/j.jlumin.2009.04.028; Schubert EF, 2005, SCIENCE, V308, P1274, DOI 10.1126/science.1108712; Momma K, 2008, J APPL CRYSTALLOGR, V41, P653, DOI 10.1107/S0021889808012016; Uheda K, 2006, ELECTROCHEM SOLID ST, V9, pH22, DOI 10.1149/1.2173192; Sato Y, 2014, ANGEW CHEM INT EDIT, V53, P7756, DOI 10.1002/anie.201402520; Xie RJ, 2004, J PHYS CHEM B, V108, P12027, DOI 10.1021/jp048295g; Xie RJ, 2010, MATERIALS, V3, P3777, DOI 10.3390/ma3063777; Jo DS, 2011, J CERAM PROCESS RES, V12, pS47; Kaufmann U, 2002, PHYS STATUS SOLIDI A, V192, P246, DOI 10.1002/1521-396X(200208)192:2<246::AID-PSSA246>3.0.CO;2-I; Kim SW, 2013, ECS SOLID STATE LETT, V2, pR49, DOI 10.1149/2.004312ssl; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Tamaki H., 2007, PHOSPHOR HDB, P413; Toda K, 2006, IEICE T ELECTRON, VE89C, P1406, DOI 10.1093/ietele/e89-c.10.1406; Watanabe H, 2009, J ALLOY COMPD, V475, P434, DOI 10.1016/j.jallcom.2008.07.054; Wierzbicka-Wieczorek M, 2010, CAN MINERAL, V48, P51, DOI 10.3749/canmin.48.1.51	31	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	DEC	2014	38						57	60		10.1016/j.optmat.2014.10.003		4	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	AW4CK	WOS:000346228800012		
J	Gui, SCR; Imakita, K; Lin, H; Fujii, M				Gui, Sa Chu Rong; Imakita, Kenji; Lin, Hui; Fujii, Minoru			Ag and Dy doped zeolite as a broadband phosphor	OPTICAL MATERIALS			English	Article						Dysprosium; Silver ion; Energy transfer; White light	SILVER-CLUSTERS; EXCHANGED ZEOLITE; LUMINESCENCE; IONS; GLASS; SEMICONDUCTORS	Photoluminescence (PL) properties of silver (Ag) and dysprosium (Dy) codoped zeolites were investigated. It was found that PL from the F-4(9/2)-H-6(13/2) transition of Dy3+ ions at 575 nm is more than 50 times enhanced by the presence of Ag+ ions under ultraviolet excitation. The excitation wavelength dependence of the PL intensity coincided well with the absorption spectra of Ag+ ions, indicating that Dy3+ ions are excited by the energy transfer from Ag+ ions. In addition, by carefully optirnizing annealing condition and Dy and Ag concentration, white light was realized due to the conibination of blue emission of Ag+ ions, yellow emission of Dy3+ ions and red emission of Ag clusters. (C) 2014 Elsevier B.V. All rights reserved.	[Gui, Sa Chu Rong; Imakita, Kenji; Lin, Hui; Fujii, Minoru] Kobe Univ, Grad Sch Engn, Dept Elect & Elect Engn, Kobe, Hyogo 6578501, Japan	Imakita, K (reprint author), Kobe Univ, Grad Sch Engn, Dept Elect & Elect Engn, Kobe, Hyogo 6578501, Japan.	Imakita@eedept.kobe-u.ac.jp	Fujii, Minoru/G-3777-2011	Fujii, Minoru/0000-0003-4869-7399			Seifert R, 2000, J PHYS CHEM A, V104, P7473, DOI 10.1021/jp000905z; Izeddin I, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035327; Calzaferri G, 2003, CHEM SOC REV, V32, P29, DOI 10.1039/b108571a; CARLEY AF, 1978, P ROY SOC LOND A MAT, V363, P403, DOI 10.1098/rspa.1978.0175; Waltereit P, 2000, NATURE, V406, P865, DOI 10.1038/35022529; Coutino-Gonzalez E, 2013, J PHYS CHEM C, V117, P6998, DOI 10.1021/jp400511z; Fan SJ, 2012, OPT MATER EXPRESS, V2, P765; Liu SM, 2008, OPT MATER, V31, P47, DOI 10.1016/j.optmat.2008.01.007; Viornery C, 2002, LANGMUIR, V18, P2582, DOI 10.1021/la010908i; Sharma J, 2010, CHEM COMMUN, V46, P3280, DOI 10.1039/b927268b; KYNAST U, 1994, ADV MATER, V6, P937, DOI 10.1002/adma.19940061207; KIDO J, 1995, APPL PHYS LETT, V67, P2281, DOI 10.1063/1.115126; Li JJ, 2012, OPT EXPRESS, V20, P10122, DOI 10.1364/OE.20.010122; Eichelbaum M., 2009, ADV FUNCT MATER, V19, P1; FRANCIOSI A, 1984, PHYS REV B, V29, P5611, DOI 10.1103/PhysRevB.29.5611; Gremer G.D., 2009, J AM CHEM SOC, V131, P3049; Gui Sa Chu Rong, 2014, JPN J APPL PHYS, V53; Gui SCR, 2014, OPT MATER, V36, P916, DOI 10.1016/j.optmat.2013.12.029; Jayasankar C.K., 2004, J ALLOY COMPD, V374, P220; Justel T, 1998, ANGEW CHEM INT EDIT, V37, P3084, DOI DOI 10.1002/(SICI)1521-3773(19981204)37:22<3084::AID-ANIE3084>3.0.CO;2-W; Justel T, 2001, ADV FUNCT MATER, V11, P105; Kanan MC, 2003, ENVIRON SCI TECHNOL, V37, P2280, DOI 10.1021/es026136+; KELLERMAN R, 1979, J CHEM PHYS, V70, P1562, DOI 10.1063/1.437550; Li P., 2002, CHEM PHYS LETT, V365, P22; Lv W., 2011, INORG CHEM, V50, P7846; Nagli L, 1997, J NON-CRYST SOLIDS, V217, P208, DOI 10.1016/S0022-3093(97)00139-7; Nakazawa E, 2002, J LUMIN, V100, P89, DOI 10.1016/S0022-2313(02)00429-5; Paje SE, 2003, J NON-CRYST SOLIDS, V318, P239, DOI 10.1016/S0022-3093(02)01904-X; Pillonnet A, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3703120; Pimputkar P., 2009, NAT PHOTONICS, V3, P180; Ryo M, 2002, J MATER CHEM, V12, P1748, DOI 10.1039/b111032m; TEXTER J, 1981, PHYS REV B, V23, P4407, DOI 10.1103/PhysRevB.23.4407	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	DEC	2014	38						75	79		10.1016/j.optmat.2014.09.031		5	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	AW4CK	WOS:000346228800014		
J	Yanagida, T; Sato, H				Yanagida, Takayuki; Sato, Hiroki			Optical and scintillation properties of Nd-doped complex garnet	OPTICAL MATERIALS			English	Article						Crystal; Scintillation detector; Nd+; Scintillator	CRYSTAL-GROWTH; LASER	Nd 1% doped complex garnet scintiliators were prepared by Furukawa and their optical and scintillation properties were investigated on a comparison with previously reported Nd-doped YAG. Chemical compositions of newly developed complex garnets were Lu2Y1Al5O12, Lu2Y1Ga3Al2O12, Lu2Gd1Al5O12, Lu2Gd1Ga3 Al2O12, Gd1Y2Al5O12, Gd1Y2Ga3Al2O12, and Gd3Ga3Al2O12. They all showed 50-80% transmittance from ultraviolet to near infrared wavelengths with several absorption bands due to Gd3+ or Nd3+ 4f-4f transition. In X-ray induced radioluminescence spectra, all samples exhibited intense lines at 310 nm due to Gd3+ or 400 nm due to Nd3+ depending on their chemical composition. Among them, the highest scintillation light yield was achieved by Lu2Y1Al5O12. Typical scintillation decay times of them resulted 1.5-3 mu s. Thermally stimulated glow curve after 1 Gy exposure and X-ray induced afterglow were also investigated. (C) 2014 Elsevier B.V. All rights reserved.	[Yanagida, Takayuki] Kyushu Inst Technol, Wakamatsu Ku, Kitakyushu, Fukuoka 8080196, Japan; [Sato, Hiroki] Furukawa Co Ltd, Tsukuba, Ibaraki 3050856, Japan	Yanagida, T (reprint author), Kyushu Inst Technol, Wakamatsu Ku, 2-4 Hibikino, Kitakyushu, Fukuoka 8080196, Japan.	yanagida@lsse.kyutech.ac.jp	Yanagida, Takayuki/F-1814-2014	Yanagida, Takayuki/0000-0002-4298-5886	Ministry of Education, Culture, Sports, Science and Technology of the Japanese government (MEXT) [26249147]; JST A-step	This work was mainly supported by a Grant in Aid for Scientific Research (A)-26249147 from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government (MEXT) and partially by JST A-step. Partial assistance from the Yazaki Memorial Foundation for Science and Technology, Nippon Sheet Glass Foundation for Materials Science and Engineering, Tokuyama Science foundation, Iketani Science and Technology Foundation, Hitachi Metals Materials Science Foundation, Mazda Foundation, JFE 21st century Foundation, and The Asahi Glass Foundation, are also gratefully acknowledged.	Yanagida T, 2011, NUCL INSTRUM METH A, V631, P54, DOI 10.1016/j.nima.2010.12.038; Yanagida T, 2014, OPT MATER, V36, P1044, DOI 10.1016/j.optmat.2014.01.022; Yanagida T, 2013, OPT MATER, V35, P1987, DOI 10.1016/j.optmat.2012.11.002; Yanagida T, 2013, OPT MATER, V35, P2480, DOI 10.1016/j.optmat.2013.07.002; Kamada K, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/50/505104; Danevich FA, 2005, NUCL INSTRUM METH A, V541, P583, DOI 10.1016/j.nima.2004.12.014; ROBBINS DJ, 1980, J ELECTROCHEM SOC, V127, P2694, DOI 10.1149/1.2129574; Kamada K, 2012, IEEE T NUCL SCI, V59, P2112, DOI 10.1109/TNS.2012.2197024; KUWANO Y, 1988, J CRYST GROWTH, V92, P17, DOI 10.1016/0022-0248(88)90427-7; McKeever S.W.S., 1985, THERMOLUMINESCENCE S; Nikl M., 2006, APPL PHYS LETT, V88; Rodnyi P. A., 1997, PHYS PROCESSES INORG; Yamaji A, 2012, IEEE T NUCL SCI, V59, P2135, DOI 10.1109/TNS.2012.2189895; Yanagida T., 2013, J CERAM SOC JPN, V121, P989; Yanagida T., 2014, APPL PHYS E IN PRESS; Yanagida T., 2010, APPL PHYS EXP, V3; Yanagida T, 2013, OPT MATER, V35, P788, DOI 10.1016/j.optmat.2012.05.034; Yanagida T., 2014, RAD MEAS IN PRESS; Zhang BT, 2010, OPT EXPRESS, V18, P12052, DOI 10.1364/OE.18.012052; Zhi YC, 2010, OPT EXPRESS, V18, P7584, DOI 10.1364/OE.18.007584	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	DEC	2014	38						174	178		10.1016/j.optmat.2014.10.020		5	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	AW4CK	WOS:000346228800030		
J	Empizo, MJF; Fukuda, K; Arita, R; Minami, Y; Yamanoi, K; Shimizu, T; Sarukura, N; Vargas, RM; Salvador, AA; Sarmago, RV				Empizo, Melvin John F.; Fukuda, Kazuhito; Arita, Ren; Minami, Yuki; Yamanoi, Kohei; Shimizu, Toshihiko; Sarukura, Nobuhiko; Vargas, Ray M.; Salvador, Arnel A.; Sarmago, Roland V.			Photoluminescence properties of a single ZnO microstructure for potential scintillator applications	OPTICAL MATERIALS			English	Article						ZnO; Oxides; Microstructure; Photoluminescence	TIME-RESOLVED PHOTOLUMINESCENCE; OPTICAL-PROPERTIES; LASER-PULSES; WAVE-GUIDES; CRYSTAL; EMISSION; GAP	Photoluminescence properties of ZnO microstructures are investigated for potential scintillator applications. Samples are successfully prepared by the carbothermal reduction method. A single free-standing ZnO microribbon exhibits UV and visible emissions which behave differently along the microstructure. Fast UV emission lifetimes of 40 and 150 ps have been observed for the microstructures compared to 440 ps and 2 ns for a bulk crystal. With waveguided emissions and fast lifetimes, the ZnO microstructures have promising applications as future XFEL scintillators. (C) 2014 Elsevier B.V. All rights reserved.	[Empizo, Melvin John F.; Fukuda, Kazuhito; Arita, Ren; Minami, Yuki; Yamanoi, Kohei; Shimizu, Toshihiko; Sarukura, Nobuhiko] Osaka Univ, Inst Laser Engn, Suita, Osaka 5650871, Japan; [Vargas, Ray M.; Salvador, Arnel A.; Sarmago, Roland V.] Univ Philippines Diliman, Natl Inst Phys, Quezon City 1101, Philippines	Empizo, MJF (reprint author), Osaka Univ, Inst Laser Engn, 2-6 Yamadaoka, Suita, Osaka 5650871, Japan.	mjfempizo@ile.osaka-u.ac.jp	Sarukura, Nobuhiko/F-3276-2015; Shimizu, Toshihiko/F-5079-2015; Yamanoi, Kohei/B-2150-2013	Sarukura, Nobuhiko/0000-0003-2353-645X; Shimizu, Toshihiko/0000-0001-6712-3804; Yamanoi, Kohei/0000-0003-4492-4099	Japan Science and Technology Agency (JST) through the Adaptable & Seamless Technology Transfer Program through Target-driven RD (A-STEP) [AS241047M]	This work was supported by the Japan Science and Technology Agency (JST) through the Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) Grant Number AS241047M.	Koida T, 2003, APPL PHYS LETT, V82, P532, DOI 10.1063/1.1540220; Ozgur U, 2004, APPL PHYS LETT, V84, P3223, DOI 10.1063/1.1713034; Law M, 2004, SCIENCE, V305, P1269, DOI 10.1126/science.1100999; Johnson JC, 2003, J PHYS CHEM B, V107, P8816, DOI 10.1021/jp034482n; Yang XB, 2009, J CRYST GROWTH, V311, P3692, DOI 10.1016/j.jcrysgro.2009.06.010; Nakazato T, 2009, J CRYST GROWTH, V311, P875, DOI 10.1016/j.jcrysgro.2008.09.106; LYU LJ, 1991, J LUMIN, V48-9, P251, DOI 10.1016/0022-2313(91)90116-D; Kwok WM, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2137456; Xiong G, 2007, J APPL PHYS, V101, DOI 10.1063/1.2424538; Chen SJ, 2005, ADV MATER, V17, P586, DOI 10.1002/adma.200401263; Shimizu T, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3310276; Tanaka M, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2815920; Kano M, 2011, J CRYST GROWTH, V318, P788, DOI 10.1016/j.jcrysgro.2010.10.192; Hauschild R, 2006, PHYS STATUS SOLIDI C, V3, P976, DOI 10.1002/pssc.200564643; Yamanoi K, 2013, J CRYST GROWTH, V362, P264, DOI 10.1016/j.jcrysgro.2012.01.008; Wilkinson J, 2004, RADIAT MEAS, V38, P501, DOI 10.1016/j.radmeas.2004.01.022; Arita R, 2014, OPT MATER, V36, P2012, DOI 10.1016/j.optmat.2014.01.031; Furukawa Y, 2008, J OPT SOC AM B, V25, pB118, DOI 10.1364/JOSAB.25.00B118; International Centre for Diffraction Data (ICDD), 000361451 ICDD; Magdaluyo Jr Eduardo R., 2008, ADV MAT RES, V31, P92; Ozgiir U., 2009, ZINC OXIDE FUNDAMENT; Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666; Saint-Gobain Ceramics & Plastics Inc., YAGCE YTT AL GARN SC; Yamanoi K, 2012, IEEE T NUCL SCI, V59, P2298, DOI 10.1109/TNS.2012.2184140	24	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-3467	1873-1252		OPT MATER	Opt. Mater.	DEC	2014	38						256	260		10.1016/j.optmat.2014.10.044		5	Materials Science, Multidisciplinary; Optics	Materials Science; Optics	AW4CK	WOS:000346228800045		
J	Guo, JX; Fujii, R; Ono, T; Klepp, J; Pruner, C; Fally, M; Tomita, Y				Guo, Jinxin; Fujii, Ryuta; Ono, Takanori; Klepp, Juergen; Pruner, Christian; Fally, Martin; Tomita, Yasuo			Effects of chain-transferring thiol functionalities on the performance of nanoparticle-polymer composite volume gratings	OPTICS LETTERS			English	Article							PHOTOPOLYMER; SHRINKAGE; MECHANISM; HOLOGRAMS; NETWORKS; SYSTEMS; STRESS; LENGTH; FILMS	We report influences of varying functionalities of thiols as chain transfer agents on the spatial frequency response, polymerization shrinkage, and thermal stability of a volume grating recorded in a photopolymerizable ZrO2 nanoparticle-polymer composite film. It is shown that a substantial increase in the saturated refractive index modulation is realized at high spatial frequencies by doping with multifunctional thiols. Moreover, the incorporation of multifunctional thiols considerably suppresses polymerization shrinkage of recorded volume gratings and thermal changes in refractive index and film thickness as compared with the case of mono-thiol. These results indicate that multifunctional thiols provide effective control of the properties of nanoparticle-polymer composite volume gratings for various applications in light and neutron optics. (C) 2014 Optical Society of America	[Guo, Jinxin; Fujii, Ryuta; Ono, Takanori; Tomita, Yasuo] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan; [Klepp, Juergen; Fally, Martin] Univ Vienna, Fac Phys, A-1090 Vienna, Austria; [Pruner, Christian] Salzburg Univ, Dept Mat Sci & Phys, A-5020 Salzburg, Austria	Guo, JX (reprint author), Univ Electrocommun, Dept Engn Sci, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	jinxin@bellevue.ee.uec.ac.jp	Fally, Martin/C-2226-2009; 	Fally, Martin/0000-0001-7440-9923; Klepp, Juergen/0000-0002-9490-5075	JSPS KAKENHI [25-03052]	One of the authors, J. Guo, would like to acknowledge the financial support by JSPS KAKENHI (Grant No. 25-03052).	Guo JX, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/9/095602; Beecroft LL, 1997, CHEM MATER, V9, P1302, DOI 10.1021/cm960441a; Suzuki N, 2002, APPL PHYS LETT, V81, P4121, DOI 10.1063/1.1525391; Tomita Y, 2008, OPT LETT, V33, P1750, DOI 10.1364/OL.33.001750; Suzuki N, 2006, OPT EXPRESS, V14, P12712, DOI 10.1364/OE.14.012712; Moothanchery M, 2011, OPT EXPRESS, V19, P25786, DOI 10.1364/OE.19.025786; Sheridan JT, 2000, J OPT SOC AM A, V17, P1108, DOI 10.1364/JOSAA.17.001108; Suzuki N, 2004, APPL OPTICS, V43, P2125, DOI 10.1364/AO.43.002125; Gleeson MR, 2008, J OPT SOC AM B, V25, P396, DOI 10.1364/JOSAB.25.000396; Fujii R, 2014, OPT LETT, V39, P3453, DOI 10.1364/OL.39.003453; Dhar L, 1998, APPL PHYS LETT, V73, P1337, DOI 10.1063/1.122375; Hata E, 2011, OPT MATER EXPRESS, V1, P207; Pfeifer CS, 2011, POLYMER, V52, P3295, DOI 10.1016/j.polymer.2011.05.034; Sakhno OV, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/10/105704; Campbell S, 1996, J OPT SOC AM B, V13, P2218, DOI 10.1364/JOSAB.13.002218; Chu TMG, 2000, J AM CERAM SOC, V83, P2375; Fally M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.123904; Fally M, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/2/024019; Hata E, 2011, OPT MATER EXPRESS, V1, P1113; Kaczmarek M, 2009, J OPT A-PURE APPL OP, V11, DOI 10.1088/1464-4258/11/2/020201; Klepp J, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.013621; Lee TY, 2007, MACROMOLECULES, V40, P1473, DOI 10.1021/ma0624954; Odian G., 1994, PRINCIPLES POLYM, P238; Rydholm AE, 2006, MACROMOLECULES, V39, P7882, DOI 10.1021/ma060858u	24	2	2	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	DEC 1	2014	39	23					6743	6746		10.1364/OL.39.006743		4	Optics	Optics	AW0EQ	WOS:000345963800049		
J	Fedotov, IV; Doronina-Amitonova, LV; Sidorov-Biryukov, DA; Safronov, NA; Levchenko, AO; Zibrov, SA; Blakley, S; Perez, H; Akimov, AV; Fedotov, AB; Hemmer, P; Sakoda, K; Velichansky, VL; Scully, MO; Zheltikov, AM				Fedotov, I. V.; Doronina-Amitonova, L. V.; Sidorov-Biryukov, D. A.; Safronov, N. A.; Levchenko, A. O.; Zibrov, S. A.; Blakley, S.; Perez, H.; Akimov, A. V.; Fedotov, A. B.; Hemmer, P.; Sakoda, K.; Velichansky, V. L.; Scully, M. O.; Zheltikov, A. M.			Fiber-optic magnetometry with randomly oriented spins	OPTICS LETTERS			English	Article							SINGLE-PHOTON SOURCE; DIAMOND; ELECTRON; CENTERS; QUBITS	We demonstrate fiber-optic magnetometry using a random ensemble of nitrogen-vacancy (NV) centers in nanodiamond coupled to a tapered optical fiber, which provides a waveguide delivery of optical fields for the initialization, polarization, and readout of the electron spin in NV centers. (C) 2014 Optical Society of America	[Fedotov, I. V.; Doronina-Amitonova, L. V.; Sidorov-Biryukov, D. A.; Safronov, N. A.; Fedotov, A. B.; Zheltikov, A. M.] Moscow MV Lomonosov State Univ, Ctr Int Laser, Dept Phys, Moscow 119992, Russia; [Fedotov, I. V.; Zibrov, S. A.; Blakley, S.; Perez, H.; Hemmer, P.; Scully, M. O.; Zheltikov, A. M.] Texas A&M Univ, College Stn, TX 77843 USA; [Fedotov, I. V.; Doronina-Amitonova, L. V.; Sidorov-Biryukov, D. A.; Safronov, N. A.; Akimov, A. V.; Fedotov, A. B.; Zheltikov, A. M.] Russian Quantum Ctr, Skolkovo 1430125, Moscow Region, Russia; [Levchenko, A. O.; Zibrov, S. A.; Velichansky, V. L.] Russian Acad Sci, PN Lebedev Phys Inst, Moscow 119991, Russia; [Sakoda, K.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Scully, M. O.] Princeton Univ, Princeton, NJ 08544 USA	Zheltikov, AM (reprint author), Moscow MV Lomonosov State Univ, Ctr Int Laser, Dept Phys, Moscow 119992, Russia.	zheltikov@physics.msu.ru	SAKODA, Kazuaki/H-3006-2011; Velichansky, Vladimir/M-4861-2015; Zibrov, Sergei/M-6400-2015		Russian Foundation for Basic Research [13-02-92115, 13-04-40335, 14-02-90030, 14-22-02100]; Welch Foundation [A-1801]; National Science Foundation [1202258]; Russian Science Foundation [14-12-00772]	This research was supported in part by the Russian Foundation for Basic Research (project nos. 13-02-92115, 13-04-40335, 14-02-90030, and 14-22-02100), the Welch Foundation (grant no. A-1801), and the National Science Foundation (grant no. 1202258). Research into the optics of tapered fibers has been supported by the Russian Science Foundation (project no. 14-12-00772).	Acosta VM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070801; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Kucsko G, 2013, NATURE, V500, P54, DOI 10.1038/nature12373; Bending SJ, 1999, ADV PHYS, V48, P449, DOI 10.1080/000187399243437; Gaebel T, 2006, NAT PHYS, V2, P408, DOI 10.1038/nphys318; Epstein RJ, 2005, NAT PHYS, V1, P94, DOI 10.1038/nphys141; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Babinec TM, 2010, NAT NANOTECHNOL, V5, P195, DOI [10.1038/nnano.2010.6, 10.1038/NNANO.2010.6]; Le Sage D, 2013, NATURE, V496, P486, DOI 10.1038/nature12072; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Aharonovich I, 2011, NAT PHOTONICS, V5, P397, DOI [10.1038/nphoton.2011.54, 10.1038/NPHOTON.2011.54]; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Liu XD, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4823548; McGuinness LP, 2011, NAT NANOTECHNOL, V6, P358, DOI [10.1038/nnano.2011.64, 10.1038/NNANO.2011.64]; Fedotov IV, 2014, SCI REP-UK, V4, DOI 10.1038/srep05362; Fedotov IV, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4731762; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; Nizovtsev AP, 2005, OPT SPECTROSC+, V99, P233, DOI 10.1134/1.2034610; Schroder T, 2011, NANO LETT, V11, P198, DOI 10.1021/nl103434r	20	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0146-9592	1539-4794		OPT LETT	Opt. Lett.	DEC 1	2014	39	23					6755	6758		10.1364/OL.39.006755		4	Optics	Optics	AW0EQ	WOS:000345963800052		
J	Shinohara, T; Ebata, Y; Ayabe, R; Fukui, A; Okada, N; Yufu, K; Nakagawa, M; Takahashi, N				Shinohara, Tetsuji; Ebata, Yuki; Ayabe, Reika; Fukui, Akira; Okada, Norihiro; Yufu, Kunio; Nakagawa, Mikiko; Takahashi, Naohiko			Cardiac Autonomic Dysfunction in Patients with Head-up Tilt Test-Induced Vasovagal Syncope	PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY			English	Article						baroreflex sensitivity; cardiac autonomic modulation; cardiac I-123-MIBG scintigraphy; head-up tilt test; vasovagal syncope	BAROREFLEX SENSITIVITY; RATE-VARIABILITY; ESSENTIAL-HYPERTENSION; MYOCARDIAL-INFARCTION; CARDIOMYOPATHY; SCINTIGRAPHY	Background: Vasovagal syncope (VVS) is the result of an autonomic reflex that has a final effect of reducing sympathetic drive and increasing vagal activity. However, whether syncopal symptoms are associated with pathological cardiac autonomic modulation is not fully known. We tested the hypothesis that cardiac autonomic function is impaired in patients with VVS. Methods: Eighty-four consecutive patients (59 males; 48.8 +/- 20.9 years) with recurrent unexplained syncope were enrolled. The head-up tilt test (HUTT) was positive in 38 patients and negative in 46 patients. Cardiac autonomic function was assessed by baroreflex sensitivity (BRS), heart rate variability, plasma concentrations of norepinephrine, and I-123-metaiodobenzylguanidine (MIBG) scintigraphy. Results: BRS indices were significantly lower in the HUTT-positive group than in the HUTT-negative group (6.1 +/- 5.5 mm Hg/s vs 9.8 +/- 7.6 mm Hg/s, P = 0.02). With regard to cardiac I-123-MIBG scintigraphy, the mean heart-to-mediastinum ratio at the delayed phase tended to be lower in HUTT-positive than in HUTT-negative individuals, but this difference was not significant (2.75 +/- 0.55 vs 3.02 +/- 0.49, P = 0.08). The percent washout rate of I-123-MIBG was significantly higher in the positive group compared with the negative group (40.7 +/- 13.1% vs 31.5 +/- 13.3%, P = 0.02). Multivariate logistic analysis revealed that the appearance of HUTT-induced VVS was predicted independently by a high percent washout rate of I-123-MIBG (odds ratio, 0.954; 95% confidence interval, 0.903-0.998; P = 0.048). Conclusions: Our results suggest that pathological autonomic cardiac modulation may play a role in the appearance of syncope in VVS patients.	[Shinohara, Tetsuji; Ebata, Yuki; Ayabe, Reika; Fukui, Akira; Okada, Norihiro; Yufu, Kunio; Nakagawa, Mikiko; Takahashi, Naohiko] Oita Univ, Fac Med, Dept Cardiol & Clin Examinat, Oita 8795593, Japan	Shinohara, T (reprint author), Oita Univ, Fac Med, Dept Cardiol & Clin Examinat, 1-1 Idaigaoka,Hasama Machi, Oita 8795593, Japan.	shinohar@oita-u.ac.jp			Japanese Ministry of Education, Science and Culture [23790249]	This study was supported in part by a Grant-in-Aid (grant number 23790249) from the Japanese Ministry of Education, Science and Culture (T. Shinohara).	Iacoviello M, 2010, EUROPACE, V12, P1149, DOI 10.1093/europace/euq149; Watanabe K, 1999, J HYPERTENS, V17, P1161, DOI 10.1097/00004872-199917080-00016; Takahashi N, 2001, J AM COLL CARDIOL, V38, P232, DOI 10.1016/S0735-1097(01)01363-8; Benditt DG, 1996, J AM COLL CARDIOL, V28, P263; Sagrista-Sauleda J, 2002, EUR HEART J, V23, P1706, DOI 10.1053/euhj.2002.3166; La Rovere MT, 1998, LANCET, V351, P478; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; Kochiadakis GE, 1997, PACE, V20, P1332, DOI 10.1111/j.1540-8159.1997.tb06788.x; ABISAMRA F, 1988, PACE, V11, P1202, DOI 10.1111/j.1540-8159.1988.tb03973.x; Kochiadakis G, 2012, EUROPACE, V14, P1352, DOI 10.1093/europace/eus063; Boh-Oka S, 2001, J CARDIOVASC PHARM, V38, P75; DEFERRARI GM, 1995, AM HEART J, V130, P473, DOI 10.1016/0002-8703(95)90354-2; Ganzeboom KS, 2006, J CARDIOVASC ELECTR, V17, P1172, DOI 10.1111/j.1540-8167.2006.00595.x; HENDERSON EB, 1988, CIRCULATION, V78, P1192; IMAMURA Y, 1995, J AM COLL CARDIOL, V26, P1594, DOI 10.1016/0735-1097(95)00374-6; Jardine DL, 2009, CLIN SCI, V117, P345, DOI 10.1042/CS20080497; Jardine DL, 1998, AM J PHYSIOL-HEART C, V274, pH2110; Nagamachi S, 1998, Ann Nucl Med, V12, P323; SCHOFER J, 1988, J AM COLL CARDIOL, V12, P1252; Shinohara T, 2011, PACE, V34, P1225, DOI 10.1111/j.1540-8159.2011.03156.x; SNEDDON JF, 1993, AM J CARDIOL, V72, P1314, DOI 10.1016/0002-9149(93)90304-U; Spallone V, 1997, DIABETES S2, V46, P67; Sutton R, 1992, EUR J CARDIAC PACING, V2, P180; Takahashi N, 1999, J AM COLL CARDIOL, V34, P211, DOI 10.1016/S0735-1097(99)00158-8	24	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0147-8389	1540-8159		PACE	PACE-Pacing Clin. Electrophysiol.	DEC	2014	37	12					1694	1701		10.1111/pace.12484		8	Cardiac & Cardiovascular Systems; Engineering, Biomedical	Cardiovascular System & Cardiology; Engineering	AW0PS	WOS:000345996100015		
J	Matsui, K; Kataoka, A; Yamamoto, A; Tanoue, K; Kurosawa, K; Shibasaki, J; Ohyama, M; Aida, N				Matsui, Kiyoshi; Kataoka, Ai; Yamamoto, Atsuko; Tanoue, Koji; Kurosawa, Kenji; Shibasaki, Jun; Ohyama, Makiko; Aida, Noriko			Clinical Characteristics and Outcomes of Mobius Syndrome in a Children's Hospital	PEDIATRIC NEUROLOGY			English	Article						Mobius syndrome; Poland anomaly; brainstem hypoplasia; home medical care; aqueductal stenosis; global developmental delay	BRAIN-STEM CALCIFICATION; CEREBRAL-PALSY; VASCULAR ETIOLOGY; MOEBIUS SYNDROME; SEQUENCE; MISOPROSTOL; NERVE; PREGNANCY; SPECTRUM; UTERO	BACKGROUND: Mobius syndrome is a congenital disorder with facial and abducens palsy. Although a few case series studies have examined comorbid conditions in Mobius syndrome, follow-up and outcome data are sparse. OBJECTIVES: To examine the clinical characteristics and outcomes of Mobius syndrome. METHODS: Clinical data were reviewed for 10 patients. Neonatal history, neurological examination, comorbid anomalies, medical home care, outcomes, and neuroimaging were summarized. RESULTS: The patients' mean age was 7.3 +/- 6.2 years. On neurological examination, absent blink reflex, jaw ankylosis, absent gag reflex, and tongue atrophy were frequently observed. Poland anomaly and clubfoot were present in three and six patients, respectively. Specific therapies required for patients included medical home care (six patients), suction apparatus (six), tube feeding (five), gastrostomy (two), tracheostomy (three), oxygen therapy (three), and home ventilator (two). Punctate calcification in the brainstem was observed in four patients. Pontine and medulla hypoplasia were detected on the basis of anteroposterior diameter in four and seven patients, respectively. Two patients had congenital hydrocephalus with aqueductal stenosis. Global developmental delay occurred in five patients. Three patients died. CONCLUSION: The rate of both the use of home medical devices and death was high in our patients. Mobius syndrome is extremely diverse, not only in clinical manifestation, but also outcome. Early multidisciplinary intervention is important to ensure an optimal outcome. Aqueductal stenosis is an occasional comorbid anomaly resulting from midbrain abnormality.	[Matsui, Kiyoshi; Kataoka, Ai; Yamamoto, Atsuko; Tanoue, Koji] Kanagawa Childrens Med Ctr, Div Gen Med, Yokohama, Kanagawa 2328555, Japan; [Matsui, Kiyoshi; Shibasaki, Jun; Ohyama, Makiko] Kanagawa Childrens Med Ctr, Div Neonatol, Yokohama, Kanagawa 2328555, Japan; [Kurosawa, Kenji] Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa 2328555, Japan; [Aida, Noriko] Kanagawa Childrens Med Ctr, Div Radiol, Yokohama, Kanagawa 2328555, Japan	Matsui, K (reprint author), Kanagawa Childrens Med Ctr, Div Gen Med, Minami Ku, 2-138-4 Mutsukawa, Yokohama, Kanagawa 2328555, Japan.	kmatsui3310@gmail.com			Ministry of Health, Labour and Welfare of Japan [23163801]	The authors are grateful to Professor Mitsuo Masuno (Kawasaki University of Medical Welfare) for his valuable comments. This research was supported in part by a Grant-in-Aid for Research on Intractable Diseases (23163801) from the Ministry of Health, Labour and Welfare of Japan. The authors declare no competing financial interests.	Roig M, 2003, DEV MED CHILD NEUROL, V45, P489, DOI 10.1017/S0012162203000902; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214; BAVINCK JNB, 1986, AM J MED GENET, V23, P903, DOI 10.1002/ajmg.1320230405; Sarnat HB, 2004, EUR J PAEDIATR NEURO, V8, P71, DOI 10.1016/j.ejpn.2003.12.005; Verzijl HTFM, 2005, NEUROLOGY, V64, P849; Barth PG, 2007, BRAIN, V130, P2258, DOI 10.1093/brain/awm188; Verzijl HTFM, 2003, NEUROLOGY, V61, P327; Hiyane M, 2012, BRAIN DEV-JPN, V34, P787, DOI 10.1016/j.braindev.2012.01.003; Sjogreen L, 2001, INT J PEDIATR OTORHI, V60, P197, DOI 10.1016/S0165-5876(01)00532-8; Cattaneo L, 2006, NEUROLOGY, V66, P1907, DOI 10.1212/01.wnl.0000219766.96499.6c; Deda Gulhis, 2001, Indian Journal of Pediatrics, V68, P455, DOI 10.1007/BF02723027; Dooley JM, 2004, PEDIATR NEUROL, V30, P39, DOI 10.1016/S0887-8994(03)00408-9; Enjoji M, 2009, ENJOJI SCALES INFANT; Gonzalez CH, 1998, LANCET, V351, P1624, DOI 10.1016/S0140-6736(97)12363-7; Igarashi M, 1997, PEDIATR NEUROL, V16, P237, DOI 10.1016/S0887-8994(97)00012-X; Johansson M, 2001, DEV MED CHILD NEUROL, V43, P338, DOI 10.1017/S0012162201000627; Lipson AH, 1996, EUR J PEDIATR, V155, P800, DOI 10.1007/BF02002911; Marques-Dias MJ, 2003, BIRTH DEFECTS RES A, V67, P1002, DOI 10.1002/bdra.10144; Pastuszak AL, 1998, NEW ENGL J MED, V338, P1881, DOI 10.1056/NEJM199806253382604; Peleg D, 2001, PEDIATR NEUROL, V24, P306, DOI 10.1016/S0887-8994(01)00239-9; Saint-Martin C, 1998, PEDIATR RADIOL, V28, P932, DOI 10.1007/s002470050503; Sudarshan A, 1985, Pediatr Neurol, V1, P180, DOI 10.1016/0887-8994(85)90061-X; Sugama S, 2003, PEDIATR NEUROL, V29, P256, DOI 10.1016/S0887-8994(03)00232-7; Verzijl HTFM, 2005, BRAIN, V128, P1728, DOI 10.1093/brain/awh502; Verzijl HTFM, 1999, AM J HUM GENET, V65, P752, DOI 10.1086/302539; Yoon KH, 1997, PEDIATR RADIOL, V27, P150, DOI 10.1007/s002470050088	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	DEC	2014	51	6					781	789		10.1016/j.pediatrneurol.2014.08.011		9	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	AW2JM	WOS:000346113900006		
J	Okubo, Y; Goto, M; Sakakibara, H; Terakawa, T; Kaneko, T; Miyama, S				Okubo, Yusuke; Goto, Masahiro; Sakakibara, Hiroshi; Terakawa, Toshiro; Kaneko, Takashi; Miyama, Sahoko			The Absence of Later Wave Components in Auditory Brainstem Responses as an Initial Manifestation of Type 2 Gaucher Disease	PEDIATRIC NEUROLOGY			English	Article						splenomegaly; failure to thrive; deafness	ABR	BACKGROUND: Type 2 Gaucher disease is the most severe neuronopathic form of Gaucher disease and is characterized by severe neurodegeneration with brainstem involvement and organ failure. Prediction or diagnosis of type 2 Gaucher disease before the development of neurological complications is difficult. PATIENT: A 5-month-old female infant presented with deafness without other neurological abnormalities. Auditory brainstem response analysis revealed the absence of later wave components. Two months later, muscular rigidity became evident, followed by the development of opisthotonus and strabismus. Rapid progression of splenomegaly led to the diagnosis of type 2 Gaucher disease. CONCLUSIONS: Abnormal auditory brainstem response findings may already exist before the development of severe brainstem abnormalities such as muscular rigidity and opisthotonus in type 2 Gaucher disease. When patients present with deafness and absent later wave components on auditory brainstem response, type 2 Gaucher disease should be included in the differential diagnosis even in the absence of other neurological abnormalities.	[Okubo, Yusuke; Sakakibara, Hiroshi; Terakawa, Toshiro] Tokyo Metropolitan Childrens Med Ctr, Dept Gen Pediat, Fuchu, Tokyo 1838561, Japan; [Goto, Masahiro] Tokyo Metropolitan Childrens Med Ctr, Dept Endocrinol & Metab, Fuchu, Tokyo 1838561, Japan; [Kaneko, Takashi] Tokyo Metropolitan Childrens Med Ctr, Dept Hematooncol, Fuchu, Tokyo 1838561, Japan; [Miyama, Sahoko] Tokyo Metropolitan Childrens Med Ctr, Dept Neurol, Fuchu, Tokyo 1838561, Japan	Okubo, Y (reprint author), Tokyo Metropolitan Childrens Med Ctr, Dept Gen Pediat, 2-8-29 Musashidai, Fuchu, Tokyo 1838561, Japan.	sunning_dale@yahoo.co.jp					KAGA M, 1982, NEUROPEDIATRICS, V13, P207, DOI 10.1055/s-2008-1059624; Chou ST, 2004, PEDIATR EMERG CARE, V20, P181, DOI 10.1097/01.pec.0000117929.65522.d7; Eapen M, 1999, J PEDIAT HEMATOL ONC, V21, P47, DOI 10.1097/00043426-199901000-00013; KAGA M, 1990, BRAIN DEV-JPN, V12, P380; Mignot C, 2006, BRAIN DEV-JPN, V28, P39, DOI 10.1016/j.braindev.2005.04.005; Miyata Rie, 2006, No To Hattatsu, V38, P289	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	DEC	2014	51	6					837	839		10.1016/j.pediatrneurol.2014.08.029		3	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	AW2JM	WOS:000346113900016		
J	Nozaki, F; Kumada, T; Kusunoki, T; Fujii, T; Murayama, K; Ohtake, A				Nozaki, Fumihito; Kumada, Tomohiro; Kusunoki, Takashi; Fujii, Tatsuya; Murayama, Kei; Ohtake, Akira			Fever of Unknown Origin as the Initial Manifestation of Valproate-Induced Fanconi Syndrome	PEDIATRIC NEUROLOGY			English	Article						Fanconi syndrome; valproate; fever of unknown origin; side effects; valproate-induced Fanconi syndrome	SODIUM VALPROATE; THERAPY; ACID; CHILDREN	BACKGROUND: Valproate-induced Fanconi syndrome is a rare adverse effect of valproate. Severely disabled patients who require tube feeding are reported to be susceptible to valproate-induced Fanconi syndrome. Although most patients with valproate-induced Fanconi syndrome are asymptomatic and detected incidentally with findings such as hypophosphatemia, hypouricemia, increased urinary beta 2-microglobulin, and generalized hyperaminoaciduria, clinical symptoms such as bone fracture, fever, tachypnea, and edema have been reported. PATIENT DESCRIPTION: This 15-year-old, severely disabled, tube-fed, male patient with cytochrome oxidase deficiency had taken valproate for 3 years when he developed fever for 3 weeks. Hypophosphatemia, hypouricemia, hypokalemia, increased urinary beta 2-microglobulin, and generalized hyperaminoaciduria, as well as hypocarnitinemia, were found, indicating that he had Fanconi syndrome. Valproate was the most likely cause of Fanconi syndrome in this patient. After discontinuation of valproate, the fever resolved immediately, and the laboratory findings normalized. CONCLUSION: Valproate-induced Fanconi syndrome should be considered when individuals taking valproate develop fever of unknown origin.	[Nozaki, Fumihito; Kumada, Tomohiro; Kusunoki, Takashi; Fujii, Tatsuya] Shiga Med Ctr Children, Dept Pediat, Moriyama, Shiga 5240022, Japan; [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Midori, Chiba, Japan; [Ohtake, Akira] Saitama Med Univ, Fac Med, Dept Pediat, Saitama, Japan	Nozaki, F (reprint author), Shiga Med Ctr Children, Dept Pediat, 5-7-30 Moriyama, Moriyama, Shiga 5240022, Japan.	nozaki-kgw@umin.ac.jp			Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation); MEXT; Ministry of Health, Labour and Welfare (MHLW) of Japan; Kawano Masanori Memorial Public Interest Incorporated Foundation	This study was supported in part by a grant from the Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation), a Grant-in-Aid for the Development of New Technology from The Promotion and Mutual Aid Corporation for Private Schools of Japan from MEXT, and Grants-in-Aid for the Research on Intractable Diseases (Mitochondrial Disease) from the Ministry of Health, Labour and Welfare (MHLW) of Japan to A. O. and K. M. Dr Murayama was supported by the Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics.	Anand G, 2009, BMJ CASE REP, V2009; LUFT R, 1962, J CLIN INVEST, V41, P1776, DOI 10.1172/JCI104637; Dhillon N, 2011, NEUROPEDIATRICS, V42, P119, DOI [http://dx.doi.org/10.1055/s-0031-1279783, 10.1055/s-0031-1279783]; Endo A, 2010, PEDIATR NEUROL, V42, P287, DOI 10.1016/j.pediatrneurol.2009.12.003; Fukuda Y, 1996, NEPHRON, V72, P328; HAWKINS E, 1993, PEDIATR PATHOL, V13, P863; Hayashi A, 2014, BRAIN DEV-JPN, V36, P830, DOI 10.1016/j.braindev.2013.12.003; Hoshino H, 2009, PEDIAT JPN, V50, P1575; Inoue Takeshi, 2011, No To Hattatsu, V43, P233; Knights MJ, 2014, PEDIATR NEPHROL, V29, P1131, DOI 10.1007/s00467-013-2512-x; Knorr M, 2004, EPILEPSIA, V45, P868, DOI 10.1111/j.0013-9580.2004.05504.x; Lau KK, 2012, BMJ CASE REP; Ono H., 2007, No To Hattatsu, V39, P226; Oshima K, 2005, JSCMC, V24, P98; Patel SM, 2011, J GEN INTERN MED, V26, P1072, DOI 10.1007/s11606-011-1708-7; Ryan SJ, 1996, J EPILEPSY, V9, P35, DOI 10.1016/0896-6974(95)00056-9; Saito Y, 2013, BRAIN DEV; Shiari R, 2011, IRAN RED CRESCENT ME, V13, P844; Tanaka S, 2008, JPN J PEDIAT NEPHROL, V21, P92; Watanabe T, 2005, PEDIATR NEPHROL, V20, P814, DOI 10.1007/s00467-005-1827-7; Yagyu K, 2007, J CLIN PEDIAT SAPPOR, V55, P112	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0887-8994	1873-5150		PEDIATR NEUROL	Pediatr. Neurol.	DEC	2014	51	6					846	849		10.1016/j.pediatrneurol.2014.09.007		4	Clinical Neurology; Pediatrics	Neurosciences & Neurology; Pediatrics	AW2JM	WOS:000346113900019		
J	Aoe, S; Ikenaga, T; Noguchi, H; Kohashi, C; Kakumoto, K; Kohda, N				Aoe, Seiichiro; Ikenaga, Takeshi; Noguchi, Hiroki; Kohashi, Chieko; Kakumoto, Keiji; Kohda, Noriyuki			Effect of Cooked White Rice with High beta-glucan Barley on Appetite and Energy Intake in Healthy Japanese Subjects: A Randomized Controlled Trial	PLANT FOODS FOR HUMAN NUTRITION			English	Article						Barley; beta-glucan; Fibre; Appetite; Energy intake; Obesity	EATING ATTITUDES; DIETARY PATTERNS; OBESITY; GLUCOSE; WEIGHT; MEAL; BREAKFAST; CAPACITY; SATIETY	White rice is a dominant grain-based food in Japan, but excess intake of polished rice may cause obesity. Barley is a grain-based food, similar to white rice, but it has the potential to control appetite and reduce energy intake. We investigated the effect of cooked white rice with high beta-glucan barley on appetite and energy intake. The study was conducted as a randomized crossover design with twenty-one healthy Japanese women [mean +/- standard deviation body mass index (BMI) 23.3 +/- 0.7 kg/m(2)]. Subjects consumed a breakfast of cooked white rice with high beta-glucan barley (BAR) or white rice (WR), followed by an ad libitum lunch and dinner. Energy intake was measured at the lunch and the dinner using plate waste. Subjects' perception scores on hunger, fullness, satiety, and prospective food consumption were assessed using a visual analogue scale (VAS) before and after the breakfast, lunch and dinner. BAR significantly reduced the VAS scores of hunger and prospective food consumption, and increased fullness before lunch compared to WR (P = 0.032, 0.019 and 0.038, respectively). Energy intake at lunch and the cumulative energy intake (lunch + dinner) subsequent to BAR consumption were significantly lower than WR (P = 0.035 and 0.021, respectively). BAR was able to modulate appetite and reduce energy intake. The combination of white rice with high beta-glucan barley could play a beneficial role in preventing and treating obesity and other obesity-related metabolic diseases.	[Aoe, Seiichiro] Otsuma Womens Univ, Fac Home Econ, Dept Food Sci, Chiyoda Ku, Tokyo 1028357, Japan; [Ikenaga, Takeshi; Noguchi, Hiroki; Kohashi, Chieko; Kohda, Noriyuki] Otsuka Pharmaceut Co Ltd, Otsu Nutraceut Res Inst, Nutraceut Div, Otsu, Shiga 5200002, Japan; [Kakumoto, Keiji] Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Div Pharmaceut, Tokushima 7710192, Japan	Kohda, N (reprint author), Otsuka Pharmaceut Co Ltd, Otsu Nutraceut Res Inst, Nutraceut Div, 3-31-13 Saigawa, Otsu, Shiga 5200002, Japan.	Kohda.Noriyuki@otsuka.jp			Otsuka Pharmaceutical Co., Ltd., Japan	We thank Prof. Narumi Nagai (Department of Food Science and Nutrition, University of Hyogo) for her advice regarding the setting of study conditions. The present study was financially supported by Otsuka Pharmaceutical Co., Ltd., Japan.	MUKAI T, 1994, J CHILD PSYCHOL PSYC, V35, P677, DOI 10.1111/j.1469-7610.1994.tb01213.x; Flint A, 2000, INT J OBESITY, V24, P38, DOI 10.1038/sj.ijo.0801083; Abelson P, 2004, SCIENCE, V304, P1413, DOI 10.1126/science.304.5676.1413; Thondre PS, 2013, BRIT J NUTR, V110, P2173, DOI 10.1017/S0007114513001682; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Vitaglione P, 2010, J AM COLL NUTR, V29, P113; Powley TL, 2004, PHYSIOL BEHAV, V82, P69, DOI 10.1016/j.physbeh.2004.04.037; Peters HPF, 2009, AM J CLIN NUTR, V89, P58, DOI 10.3945/ajcn.2008.26701; Nilsson AC, 2008, J NUTR, V138, P732; Okubo H, 2008, INT J OBESITY, V32, P541, DOI 10.1038/sj.ijo.0803737; Kim J, 2012, J ACAD NUTR DIET, V112, P246, DOI 10.1016/j.jada.2011.10.005; Rendell M, 2005, PLANT FOOD HUM NUTR, V60, P63, DOI 10.1007/s11130-005-5101-8; Vitaglione P, 2009, APPETITE, V53, P338, DOI 10.1016/j.appet.2009.07.013; Lin H, 2003, J NUTR, V133, P3651; Massimino SP, 1998, J NUTR, V128, P1786; Bloomgarden ZT, 2004, DIABETES CARE, V27, P602, DOI 10.2337/diacare.27.2.602; Chaudhri OB, 2008, ANNU REV PHYSIOL, V70, P239, DOI 10.1146/annurev.physiol.70.113006.100506; Darwiche G, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-12; Fukuhara I, 2013, JPN PHARMACOL THER, V41, P789; Ikegami S, 1996, PLANT FOOD HUM NUTR, V49, P317, DOI 10.1007/BF01091981; Lumaga RB, 2012, FOOD FUNCT, V3, P67, DOI 10.1039/c1fo10065c; Nagai N, 2012, JPN SOC STUDY OBES, V18, P39; Shimizu C, 2008, PLANT FOOD HUM NUTR, V63, P21, DOI 10.1007/s11130-007-0064-6; WELLS JE, 1985, PSYCHOL MED, V15, P141	24	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0921-9668	1573-9104		PLANT FOOD HUM NUTR	Plant Food Hum. Nutr.	DEC	2014	69	4					325	330		10.1007/s11130-014-0437-6		6	Plant Sciences; Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics	Plant Sciences; Chemistry; Food Science & Technology; Nutrition & Dietetics	AW1OH	WOS:000346058300006		
J	Peret, B; Desnos, T; Jost, R; Kanno, S; Berkowitz, O; Nussaume, L				Peret, Benjamin; Desnos, Thierry; Jost, Ricarda; Kanno, Satomi; Berkowitz, Oliver; Nussaume, Laurent			Root Architecture Responses: In Search of Phosphate	PLANT PHYSIOLOGY			English	Article							LOW PHOSPHORUS AVAILABILITY; ARABIDOPSIS-THALIANA; CLUSTER ROOTS; SYSTEM ARCHITECTURE; WHITE LUPIN; STARVATION RESPONSES; TRANSCRIPTION FACTOR; GENE-EXPRESSION; IRON-DEFICIENCY; PROTEOID ROOTS	Soil phosphate represents the only source of phosphorus for plants and, consequently, is its entry into the trophic chain. This major component of nucleic acids, phospholipids, and energy currency of the cell (ATP) can limit plant growth because of its low mobility in soil. As a result, root responses to low phosphate favor the exploration of the shallower part of the soil, where phosphate tends to be more abundant, a strategy described as topsoil foraging. We will review the diverse developmental strategies that can be observed among plants by detailing the effect of phosphate deficiency on primary and lateral roots. We also discuss the formation of cluster roots: an advanced adaptive strategy to cope with low phosphate availability observed in a limited number of species. Finally, we will put this work into perspective for future research directions.	[Peret, Benjamin; Desnos, Thierry; Nussaume, Laurent] Ctr Natl Rech Sci, Unite Mixte Rech Biol Vegetale & Microbiol Enviro, F-13108 St Paul Les Durance, France; [Peret, Benjamin; Desnos, Thierry; Nussaume, Laurent] Commissariat Energie Atom & Energies Alternat, Inst Biol Environm & Biotechnol, Lab Biol Dev Plantes, F-13108 St Paul Les Durance, France; [Peret, Benjamin; Desnos, Thierry; Nussaume, Laurent] Aix Marseille Univ, Fac Sci Luminy, F-13108 St Paul Les Durance, France; [Jost, Ricarda; Berkowitz, Oliver] Univ Western Australia, Sch Plant Biol M084, Crawley, WA 6009, Australia; [Berkowitz, Oliver] Univ Western Australia, Australian Res Council Ctr Excellence Plant Energ, Crawley, WA 6009, Australia; [Kanno, Satomi] Kobe Univ, Grad Sch Sci, Kobe, Hyogo 6578501, Japan	Peret, B (reprint author), Ctr Natl Rech Sci, Unite Mixte Rech Biol Vegetale & Microbiol Enviro, F-13108 St Paul Les Durance, France.	benjamin.peret@cea.fr	Jost, Ricarda/B-1254-2011	Jost, Ricarda/0000-0002-3819-6358	Agence Nationale de la Recherche (Retour Post-Doc) [ANR-11-PDOC-003-01, ANR-09-BLAN-0118]; Commissariat a l'Energie Atomique et aux Energies Alternatives [APTTOX021401]; Australian Research Council [DP110101120, DP140100148];  [25-3284]	This work was supported by the Agence Nationale de la Recherche (Retour Post-Doc grant nos. ANR-11-PDOC-003-01 to B.P. and ANR-09-BLAN-0118 to T.D.), the Commissariat a l'Energie Atomique et aux Energies Alternatives (grant no. APTTOX021401 to T.D.), the Japanese Society for the Promotion of Science Fellows (grant-in-aid no. 25-3284 to S.K.), and the Australian Research Council (grant nos. DP110101120 and DP140100148 for work on Australian Proteaceae).	Al-Ghazi Y, 2003, PLANT CELL ENVIRON, V26, P1053, DOI 10.1046/j.1365-3040.2003.01030.x; Watt M, 1999, PLANT PHYSIOL, V120, P705, DOI 10.1104/pp.120.3.705; Berkowitz O, 2013, J EXP BOT, V64, P1731, DOI 10.1093/jxb/ert037; Bonser AM, 1996, NEW PHYTOL, V132, P281, DOI 10.1111/j.1469-8137.1996.tb01847.x; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Rath M, 2010, PLANT SOIL, V334, P137, DOI 10.1007/s11104-010-0373-7; Komori R, 2009, P NATL ACAD SCI USA, V106, P15067, DOI 10.1073/pnas.0902801106; Lavenus J, 2013, TRENDS PLANT SCI, V18, P455, DOI 10.1016/j.tplants.2013.04.006; Zhou J, 2008, PLANT PHYSIOL, V146, P1673, DOI 10.1104/pp.107.111443; Nagarajan VK, 2012, PLANT CELL PHYSIOL, V53, P277, DOI 10.1093/pcp/pcr186; Hammond JP, 2011, PLANT PHYSIOL, V156, P1033, DOI 10.1104/pp.111.175380; O'Rourke JA, 2013, PLANT PHYSIOL, V161, P705, DOI 10.1104/pp.112.209254; Vandenbussche F, 2012, NEW PHYTOL, V194, P895, DOI 10.1111/j.1469-8137.2012.04100.x; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Shi L, 2013, ANN BOT-LONDON, V112, P381, DOI 10.1093/aob/mcs245; Shane MW, 2004, PLANT CELL ENVIRON, V27, P991, DOI 10.1111/j.1365-3040.2004.01204.x; Giehl RFH, 2014, J EXP BOT, V65, P769, DOI 10.1093/jxb/ert421; Gonzalez-Mendoza V, 2013, PLANT SCI, V205, P2, DOI 10.1016/j.plantsci.2012.12.015; Ticconi CA, 2001, PLANT PHYSIOL, V127, P963, DOI 10.1104/pp.127.3.963; Shane MW, 2005, PLANT SOIL, V274, P101, DOI 10.1007/s11104-004-2725-7; Ticconi CA, 2004, PLANT J, V37, P801, DOI 10.1111/j.1365-313X.2003.02005.x; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P207; Ticconi CA, 2009, P NATL ACAD SCI USA, V106, P14174, DOI 10.1073/pnas.0901778106; Lopez-Bucio J, 2002, PLANT PHYSIOL, V129, P244, DOI 10.1104/pp010934; Ramaekers L, 2010, FIELD CROP RES, V117, P169, DOI 10.1016/j.fcr.2010.03.001; Veneklaas EJ, 2012, NEW PHYTOL, V195, P306, DOI 10.1111/j.1469-8137.2012.04190.x; Wang H, 2014, PLANT PHYSIOL, V164, P2020, DOI 10.1104/pp.113.235077; Lopez-Bucio J, 2005, PLANT PHYSIOL, V137, P681, DOI 10.1104/pp.104.049577; Calderon-Vazquez C, 2011, PLANT PHYSIOL, V156, P1067, DOI 10.1104/pp.111.174987; Thibaud MC, 2010, PLANT J, V64, P775, DOI 10.1111/j.1365-313X.2010.04375.x; Waldie T, 2014, PLANT J, V79, P607, DOI 10.1111/tpj.12488; Nacry P, 2005, PLANT PHYSIOL, V138, P2061, DOI 10.1104/pp.105.060061; Hu B, 2011, PLANT PHYSIOL, V156, P1101, DOI 10.1104/pp.110.170209; Svistoonoff S, 2007, NAT GENET, V39, P792, DOI 10.1038/ng2041; Hochholdinger F, 2008, CURR OPIN PLANT BIOL, V11, P70, DOI 10.1016/j.pbi.2007.10.002; Wang LS, 2011, PLANT PHYSIOL, V157, P1283, DOI 10.1104/pp.111.183723; Zaid H, 2003, ANN BOT-LONDON, V92, P673, DOI 10.1093/aob/mcg186; Dai XY, 2012, PLANT PHYSIOL, V159, P169, DOI 10.1104/pp.112.194217; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Shane MW, 2003, PLANT CELL ENVIRON, V26, P265, DOI 10.1046/j.1365-3040.2003.00957.x; Ward JT, 2008, PLANT PHYSIOL, V147, P1181, DOI 10.1104/pp.108.118562; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Abel S, 2011, CURR OPIN PLANT BIOL, V14, P303, DOI 10.1016/j.pbi.2011.04.007; Lei MG, 2011, PLANT PHYSIOL, V156, P1116, DOI 10.1104/pp.110.171736; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; LAMONT B, 1972, AUST J BOT, V20, P155, DOI 10.1071/BT9720155; Sanchez-Calderon L, 2005, PLANT CELL PHYSIOL, V46, P174, DOI 10.1093/pcp/pci011; Niu YF, 2013, ANN BOT-LONDON, V112, P391, DOI 10.1093/aob/mcs285; Sulpice R, 2014, PLANT CELL ENVIRON, V37, P1276, DOI 10.1111/pce.12240; Kang J, 2014, PLANT PHYSIOL, V165, P1156, DOI 10.1104/pp.114.238725; Remy E, 2012, NEW PHYTOL, V195, P356, DOI 10.1111/j.1469-8137.2012.04167.x; Wang SK, 2014, NEW PHYTOL, V201, P91, DOI 10.1111/nph.12499; Lambers H, 2012, NEW PHYTOL, V196, P1098, DOI 10.1111/j.1469-8137.2012.04285.x; Yu HL, 2012, J EXP BOT, V63, P4527, DOI 10.1093/jxb/ers131; Gamuyao R, 2012, NATURE, V488, P535, DOI 10.1038/nature11346; Lobet G, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-38; Hopper SD, 2009, PLANT SOIL, V322, P49, DOI 10.1007/s11104-009-0068-0; Skene KR, 1998, J ECOL, V86, P1060, DOI 10.1046/j.1365-2745.1998.00326.x; Shane MW, 2013, PLANT PHYSIOL, V161, P1634, DOI 10.1104/pp.112.213496; Lamont BB, 2003, PLANT SOIL, V248, P1, DOI 10.1023/A:1022314613217; Panigrahy M, 2009, BIOTECHNOL ADV, V27, P389, DOI 10.1016/j.biotechadv.2009.02.006; Zhou WK, 2010, PLANT CELL, V22, P3692, DOI 10.1105/tpc.110.075721; Varadarajan DK, 2002, PLANT PHYSIOL, V129, P1232, DOI 10.1104/pp.010835; Shane MW, 2004, PLANT PHYSIOL, V135, P549, DOI 10.1104/pp.103.035659; Wang LS, 2012, PLANT CELL PHYSIOL, V53, P1093, DOI 10.1093/pcp/pcs072; Lei MG, 2011, NEW PHYTOL, V189, P1084, DOI 10.1111/j.1469-8137.2010.03555.x; Lynch JP, 2011, PLANT PHYSIOL, V156, P1041, DOI 10.1104/pp.111.175414; Peret B, 2011, TRENDS PLANT SCI, V16, P442, DOI 10.1016/j.tplants.2011.05.006; Gruber BD, 2013, PLANT PHYSIOL, V163, P161, DOI 10.1104/pp.113.218453; Lambers H, 2006, ANN BOT-LONDON, V98, P693, DOI 10.1093/aob/mcl114; Lambers H, 2011, PLANT PHYSIOL, V156, P1058, DOI 10.1104/pp.111.174318; Williamson LC, 2001, PLANT PHYSIOL, V126, P875, DOI 10.1104/pp.126.2.875; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; Lynch JP, 2001, PLANT SOIL, V237, P225, DOI 10.1023/A:1013324727040; AESCHBACHER RA, 1995, GENE DEV, V9, P330, DOI 10.1101/gad.9.3.330; Arahou M, 1997, PLANT SOIL, V196, P71, DOI 10.1023/A:1004268825395; Bournier M, 2013, J BIOL CHEM, V288, P22670, DOI 10.1074/jbc.M113.482281; CELENZA JL, 1995, GENE DEV, V9, P2131, DOI 10.1101/gad.9.17.2131; Cheng LY, 2011, PLANT PHYSIOL, V156, P1025, DOI 10.1104/pp.111.175174; Dasgupta K, 2014, PLANT PHYSIOL, V165, P715, DOI 10.1104/pp.114.238410; Igarashi D, 2012, PLANT J, V71, P194, DOI 10.1111/j.1365-313X.2012.04950.x; Karthikeyan AS, 2014, PLANT PHYSIOL BIOCH, V77, P60, DOI 10.1016/j.plaphy.2013.12.009; Kellermeier F, 2014, PLANT CELL, V26, P1480, DOI 10.1105/tpc.113.122101; Li H, 2000, ACTA BOT SIN, V43, P1154; Li ZX, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-89; McCluskey J, 2004, PHYSIOL PLANTARUM, V121, P586, DOI 10.1111/j.1399-3054.2004.00372.x; Neumann G, 2002, TRENDS PLANT SCI, V7, P162, DOI 10.1016/S1360-1385(02)02241-0; Nussaume L, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00083; Robinson WD, 2012, J EXP BOT, V63, P6531, DOI 10.1093/jxb/ers309; Secco D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-230; Shane MW, 2003, PLANT SOIL, V248, P209, DOI 10.1023/A:1022320416038; Shu LZ, 2007, J PLANT NUTR, V30, P271, DOI 10.1080/01904160601118075; Skene KR, 2000, ANN BOT-LONDON, V85, P901, DOI 10.1006/anbo.2000.1140; Sun H, 2014, J EXP BOT IN PRESS; Tran HT, 2010, PLANT CELL ENVIRON, V33, P1789, DOI 10.1111/j.1365-3040.2010.02184.x; Yang WT, 2014, PLANT PHYSIOL BIOCH, V80, P259, DOI 10.1016/j.plaphy.2014.02.024; Zhang YM, 2012, MOL PLANT, V5, P63, DOI 10.1093/mp/ssr066	98	5	5	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	DEC	2014	166	4					1713	1723		10.1104/pp.114.244541		11	Plant Sciences	Plant Sciences	AW0YF	WOS:000346016400008		
J	Hamada, T; Ueda, H; Kawase, T; Hara-Nishimura, I				Hamada, Takahiro; Ueda, Haruko; Kawase, Takashi; Hara-Nishimura, Ikuko			Microtubules Contribute to Tubule Elongation and Anchoring of Endoplasmic Reticulum, Resulting in High Network Complexity in Arabidopsis	PLANT PHYSIOLOGY			English	Article							F-ACTIN ORGANIZATION; END-DIRECTED KINESIN; CLASS XI MYOSINS; SPINDLE MORPHOGENESIS; GOLGI BODIES; CELLS; PROTEIN; THALIANA; TOBACCO; ER	The endoplasmic reticulum (ER) is a network of tubules and sheet-like structures in eukaryotic cells. Some ER tubules dynamically change their morphology, and others form stable structures. In plants, it has been thought that the ER tubule extension is driven by the actin-myosin machinery. Here, we show that microtubules also contribute to the ER tubule extension with an almost 20-fold slower rate than the actin filament-based ER extension. Treatment with the actin-depolymerizing drug Latrunculin B made it possible to visualize the slow extension of the ER tubules in transgenic Arabidopsis (Arabidopsis thaliana) plants expressing ER-targeted green fluorescent protein. The ER tubules elongated along microtubules in both directions of microtubules, which have a distinct polarity. This feature is similar to the kinesin- or dynein-driven ER tubule extension in animal cells. In contrast to the animal case, ER tubules elongating with the growing microtubule ends were not observed in Arabidopsis. We also found the spots where microtubules are stably colocalized with the ER subdomains during long observations of 1,040 s, suggesting that cortical microtubules contribute to provide ER anchoring points. The anchoring points acted as the branching points of the ER tubules, resulting in the formation of multiway junctions. The density of the ER tubule junction positively correlated with the microtubule density in both elongating cells and mature cells of leaf epidermis, showing the requirement of microtubules for formation of the complex ER network. Taken together, our findings show that plants use microtubules for ER anchoring and ER tubule extension, which establish fine network structures of the ER within the cell.	[Hamada, Takahiro; Ueda, Haruko; Kawase, Takashi; Hara-Nishimura, Ikuko] Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan	Hara-Nishimura, I (reprint author), Kyoto Univ, Grad Sch Sci, Kyoto 6068502, Japan.	ihnishi@gr.bot.kyoto-u.ac.jp			Japan Society for the Promotion of Science [11J01084, 21200065, 25440132, 22000014]	This work was supported by the Japan Society for the Promotion of Science (research fellowship no. 11J01084 to T.H., Grants-in-Aid for Scientific Research nos. 21200065 and 25440132 to H.U., and Grant-in-Aid for Specially Promoted Research no. 22000014 to I.H-.N.).	Era A, 2009, PLANT CELL PHYSIOL, V50, P1041, DOI 10.1093/pcp/pcp055; van der Honing HS, 2011, CYTOSKELETON, V68, P578, DOI 10.1002/cm.20534; Takeuchi M, 2000, PLANT J, V23, P517, DOI 10.1046/j.1365-313x.2000.00823.x; Ambrose JC, 2005, MOL BIOL CELL, V16, P1584, DOI 10.1091/mbc.E04-10-0935; TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121; Richardson DN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-18; Wang PW, 2014, CURR BIOL, V24, P1397, DOI 10.1016/j.cub.2014.05.003; Deeks MJ, 2010, J CELL SCI, V123, P1209, DOI 10.1242/jcs.065557; Sparkes IA, 2009, TRAFFIC, V10, P567, DOI 10.1111/j.1600-0854.2009.00891.x; Wozniak MJ, 2009, J CELL SCI, V122, P1979, DOI 10.1242/jcs.041962; Peremyslov VV, 2010, PLANT CELL, V22, P1883, DOI 10.1105/tpc.110.076315; Foissner I, 2009, CELL MOTIL CYTOSKEL, V66, P142, DOI 10.1002/cm.20337; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; QUADER H, 1989, PLANTA, V177, P273, DOI 10.1007/BF00392816; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Sparkes I, 2009, PLANT CELL, V21, P3937, DOI 10.1105/tpc.109.072249; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; Yokota E, 2011, PLANT PHYSIOL, V156, P129, DOI 10.1104/pp.111.175018; Langhans M, 2009, PROTOPLASMA, V236, P73, DOI 10.1007/s00709-009-0059-2; Mathur J, 2003, CURR BIOL, V13, P1991, DOI 10.1016/j.cub.2003.10.033; Chen CB, 2002, DEVELOPMENT, V129, P2401; Prokhnevsky AI, 2008, P NATL ACAD SCI USA, V105, P19744, DOI 10.1073/pnas.0810730105; Gupton SL, 2006, PLANT PHYSIOL BIOCH, V44, P95, DOI 10.1016/j.plaphy.2006.03.003; Hamada T, 2012, PLANT CELL PHYSIOL, V53, P699, DOI 10.1093/pcp/pcs025; HAUGHN GW, 1986, MOL GEN GENET, V204, P430, DOI 10.1007/BF00331020; HEPLER PK, 1990, J CELL SCI, V96, P355; HEPLER PK, 1984, INT REV CYTOL, V90, P169, DOI 10.1016/S0074-7696(08)61490-4; KNEBEL W, 1990, EUR J CELL BIOL, V52, P328; LANCELLE SA, 1987, PROTOPLASMA, V140, P141, DOI 10.1007/BF01273723; Lichtscheidl IK, 1996, MEMBRANES SPECIALISE, P383; Marcus AI, 2002, CELL MOTIL CYTOSKEL, V52, P144, DOI 10.1002/cm.10045; Marcus AI, 2003, MOL BIOL CELL, V14, P1717, DOI 10.1091/mbc.E02-09-0586; MCCAULEY MM, 1992, PROTOPLASMA, V169, P168, DOI 10.1007/BF01323616; Okamoto M, 2012, J CELL SCI, V125, P3412, DOI 10.1242/jcs.100065	34	6	6	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	DEC	2014	166	4					1869	U1042		10.1104/pp.114.252320		13	Plant Sciences	Plant Sciences	AW0YF	WOS:000346016400019		
J	Chen, Y; Hou, MM; Liu, LJ; Wu, S; Shen, Y; Ishiyama, K; Kobayashi, M; McCarty, DR; Tan, BC				Chen, Yi; Hou, Mingming; Liu, Lijuan; Wu, Shan; Shen, Yun; Ishiyama, Kanako; Kobayashi, Masatomo; McCarty, Donald R.; Tan, Bao-Cai			The Maize DWARF1 Encodes a Gibberellin 3-Oxidase and Is Dual Localized to the Nucleus and Cytosol([W])	PLANT PHYSIOLOGY			English	Article							ARABIDOPSIS-THALIANA; SEX DETERMINATION; GREEN-REVOLUTION; RICE; GENE; BIOSYNTHESIS; PATHWAY; MUTANT; PROTEINS; RECEPTOR	The maize (Zea mays) gibberellin (GA)-deficient mutant dwarf1 (d1) displays dwarfism and andromonoecy (i.e. forming anthers in the female flower). Previous characterization indicated that the d1 mutation blocked three steps in GA biosynthesis; however, the locus has not been isolated and characterized. Here, we report that D1 encodes a GA 3-oxidase catalyzing the final step of bioactive GA synthesis. Recombinant D1 is capable of converting GA(20) to GA(1), GA(20) to GA(3), GA(5) to GA(3), and GA(9) to GA(4) in vitro. These reactions are widely believed to take place in the cytosol. However, both in vivo GFP fusion analysis and westernblot analysis of organelle fractions using a D1-specific antibody revealed that the D1 protein is dual localized in the nucleus and cytosol. Furthermore, the upstream gibberellin 20-oxidase1 (ZmGA20ox1) protein was found dual localized in the nucleus and cytosol as well. These results indicate that bioactive GA can be synthesized in the cytosol and the nucleus, two compartments where GA receptor Gibberellin-insensitive dwarf protein1 exists. Furthermore, the D1 protein was found to be specifically expressed in the stamen primordia in the female floret, suggesting that the suppression of stamen development is mediated by locally synthesized GAs.	[Chen, Yi; Hou, Mingming; Shen, Yun; Tan, Bao-Cai] Chinese Univ Hong Kong, Inst Plant Mol Biol & Agr Biotechnol, State Key Lab Agrobiotechnol, Shatin 852, Hong Kong, Peoples R China; [Hou, Mingming; Tan, Bao-Cai] Shandong Univ, Sch Life Sci, Key Lab Plant Cell Engn & Germplasm Innovat, Minist Educ, Jinan 250100, Peoples R China; [Liu, Lijuan; Wu, Shan; McCarty, Donald R.] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Ishiyama, Kanako; Kobayashi, Masatomo] RIKEN, BioResource Ctr, Expt Plant Div, Tsukuba, Ibaraki 3050074, Japan	Tan, BC (reprint author), Chinese Univ Hong Kong, Inst Plant Mol Biol & Agr Biotechnol, State Key Lab Agrobiotechnol, Shatin 852, Hong Kong, Peoples R China.	bctan@sdu.edu.cn			National Natural Science Foundation of China [31170298]; Research Grants Council of the Hong Kong Special Administrative Region [473512, 473611]	This work was supported by the National Natural Science Foundation of China (grant for project no. 31170298 to B.-C.T.) and the Research Grants Council of the Hong Kong Special Administrative Region (grants for project nos. 473512 and 473611 to B.-C.T.).	de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; CHIANG HH, 1995, PLANT CELL, V7, P195, DOI 10.1105/tpc.7.2.195; Mitchum MG, 2006, PLANT J, V45, P804, DOI 10.1111/j.1365-313X.2005.02642.x; Teng F, 2013, PLANT J, V73, P405, DOI 10.1111/tpj.12038; SUN TP, 1994, PLANT CELL, V6, P1509, DOI 10.1105/tpc.6.10.1509; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; ROOD SB, 1980, PLANT PHYSIOL, V66, P793, DOI 10.1104/pp.66.5.793; HARBERD NP, 1989, GENETICS, V121, P827; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Spielmeyer W, 2004, THEOR APPL GENET, V109, P847, DOI 10.1007/s00122-004-1689-6; Martin DN, 1997, P NATL ACAD SCI USA, V94, P8907, DOI 10.1073/pnas.94.16.8907; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Magome H, 2013, P NATL ACAD SCI USA, V110, P1947, DOI 10.1073/pnas.1215788110; Sasaki A, 2002, NATURE, V416, P701, DOI 10.1038/416701a; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Hong GJ, 2012, PLANT CELL, V24, P2635, DOI 10.1105/tpc.112.098749; Lester DR, 1997, PLANT CELL, V9, P1435; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Itoh H, 2001, P NATL ACAD SCI USA, V98, P8909, DOI 10.1073/pnas.141239398; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; FUJIOKA S, 1988, PLANT PHYSIOL, V88, P1367, DOI 10.1104/pp.88.4.1367; Spray CR, 1996, P NATL ACAD SCI USA, V93, P10515, DOI 10.1073/pnas.93.19.10515; Hu JH, 2008, PLANT CELL, V20, P320, DOI 10.1105/tpc.107.057752; Aya K, 2009, PLANT CELL, V21, P1453, DOI 10.1105/tpc.108.062935; Arnaud N, 2010, GENE DEV, V24, P2127, DOI 10.1101/gad.593410; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Tan BC, 2011, G3-GENES GENOM GENET, V1, P293, DOI 10.1534/g3.111.000398; Hedden P, 2012, BIOCHEM J, V444, P11, DOI 10.1042/BJ20120245; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Helliwell CA, 2001, PLANT J, V28, P201, DOI 10.1046/j.1365-313X.2001.01150.x; DELLAPORTA SL, 1994, SCIENCE, V266, P1501, DOI 10.1126/science.7985019; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Pandey A, 2006, J PROTEOME RES, V5, P3301, DOI 10.1021/pr060147a; Picault N, 2009, PLANT J, V58, P754, DOI 10.1111/j.1365-313X.2009.03813.x; Kaneko M, 2003, PLANT J, V35, P104, DOI 10.1046/j.1365-313X.2003.01780.x; Appleford NEJ, 2006, PLANTA, V223, P568, DOI 10.1007/s00425-005-0104-0; Baucom RS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000732; Calderon-Urrea A, 1999, DEVELOPMENT, V126, P435; Kim JC, 2007, GENETICS, V177, P2547, DOI 10.1534/genetics.107.082446; Neuffer MG, 1995, MAIZE GENET COOP NEW, V69, P43; NICKERSON NORTON H., 1959, ANN MISSOURI BOT GARD, V46, P19, DOI 10.2307/2394566; PHINNEY BO, 1956, P NATL ACAD SCI USA, V42, P185, DOI 10.1073/pnas.42.4.185; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sponsel V.M., 2010, PLANT HORMONES BIOSY, Vthird, P63, DOI 10.1007/978-1-4020-2686-7_4; Stinard PS, 2009, MAIZE GENET COOP NEW, V83, P51; Sun TP, 2011, CURR BIOL, V21, pR338, DOI 10.1016/j.cub.2011.02.036; TAKAHASHI M, 1986, PLANTA, V168, P190, DOI 10.1007/BF00402963; Tan BC, 1997, P NATL ACAD SCI USA, V94, P12235, DOI 10.1073/pnas.94.22.12235; Xu WH, 2006, PLANT J, V45, P740, DOI 10.1111/j.1365-313X.2005.02638.x; Yamaguchi Shinjiro, 2006, Phytochemistry Reviews, V5, P39, DOI 10.1007/s11101-005-4248-0	57	1	2	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	DEC	2014	166	4					2028	U1267		10.1104/pp.114.247486		15	Plant Sciences	Plant Sciences	AW0YF	WOS:000346016400030		
J	Kato, K; Shoji, T; Hashimoto, T				Kato, Keita; Shoji, Tsubasa; Hashimoto, Takashi			Tobacco Nicotine Uptake Permease Regulates the Expression of a Key Transcription Factor Gene in the Nicotine Biosynthesis Pathway	PLANT PHYSIOLOGY			English	Article							ALKALOID BIOSYNTHESIS; RESPONSE FACTOR; DNA-BINDING; JASMONATE; METABOLISM; TABACUM; ARABIDOPSIS; INDUCTION; MULTIDRUG; DEFENSE	The down-regulation of a tobacco (Nicotiana tabacum) plasma membrane-localized nicotine uptake permease, NUP1, was previously reported to reduce total alkaloid levels in tobacco plants. However, it was unclear how this nicotine transporter affected the biosynthesis of the alkaloid nicotine. When NUP1 expression was suppressed in cultured tobacco cells treated with jasmonate, which induces nicotine biosynthesis, the NICOTINE2-locus transcription factor gene ETHYLENE RESPONSE FACTOR189 (ERF189) and its target structural genes, which function in nicotine biosynthesis and transport, were strongly suppressed, resulting in decreased total alkaloid levels. Conversely, NUP1 overexpression had the opposite effect. In these experiments, the expression levels of the MYC2 transcription factor gene and its jasmonate-inducible target gene were not altered. Inhibiting tobacco alkaloid biosynthesis by suppressing the expression of genes encoding enzymes in the nicotine pathway did not affect the expression of ERF189 and other nicotine pathway genes, indicating that ERF189 is not regulated by cellular alkaloid levels. Suppressing the expression of jasmonate signaling components in cultured tobacco cells showed that NUP1 acts downstream of the CORONATINE INSENSITIVE1 receptor and MYC2, but upstream of ERF189. These results suggest that although jasmonate-activated expression of MYC2 induces the expression of both NUP1 and ERF189, expression of ERF189 may actually be mediated by NUP1. Furthermore, NUP1 overexpression in tobacco plants inhibited the long-range transport of nicotine from the roots to the aerial parts. Thus, NUP1 not only mediates the uptake of tobacco alkaloids into root cells, but also positively controls the expression of ERF189, a key gene in the biosynthesis of these alkaloids.	[Kato, Keita; Shoji, Tsubasa; Hashimoto, Takashi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan	Hashimoto, T (reprint author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan.	hasimoto@bs.naist.jp	Shoji, Tsubasa/C-6449-2014; 	Shoji, Tsubasa/0000-0002-6917-3773; Kato, Keita/0000-0002-2901-2502	Japan Society for the Promotion of Science [26440144]	This work was supported in part by the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research no. 26440144 to T.S.).	HIBI N, 1994, PLANT CELL, V6, P723, DOI 10.1105/tpc.6.5.723; Shoji T, 2002, PLANT MOL BIOL, V50, P427, DOI 10.1023/A:1019867732278; Shoji T, 2011, PLANT CELL PHYSIOL, V52, P1117, DOI 10.1093/pcp/pcr063; Shoji T, 2008, PLANT CELL PHYSIOL, V49, P1209, DOI 10.1093/pcp/pcn096; Todd AT, 2010, PLANT J, V62, P589, DOI 10.1111/j.1365-313X.2010.04186.x; NAGATA T, 1992, INT REV CYTOL, V132, P1; AN GH, 1985, PLANT PHYSIOL, V79, P568, DOI 10.1104/pp.79.2.568; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; De Boer K, 2011, PLANT J, V66, P1053, DOI 10.1111/j.1365-313X.2011.04566.x; Shoji T, 2000, PLANT CELL PHYSIOL, V41, P831, DOI 10.1093/pcp/pcd001; Paschold A, 2007, PLANT J, V51, P79, DOI 10.1111/j.1365-313X.2007.03119.x; Morita M, 2009, P NATL ACAD SCI USA, V106, P2447, DOI 10.1073/pnas.0812512106; Hildreth SB, 2011, P NATL ACAD SCI USA, V108, P18179, DOI 10.1073/pnas.1108620108; Dewey RE, 2013, PHYTOCHEMISTRY, V94, P10, DOI 10.1016/j.phytochem.2013.06.002; Shoji T, 2010, PLANT CELL, V22, P3390, DOI 10.1105/tpc.110.078543; Shoji T, 2013, PLANT PHYSIOL, V162, P977, DOI 10.1104/pp.113.217455; Kajikawa M, 2011, PLANT PHYSIOL, V155, P2010, DOI 10.1104/pp.110.170878; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Katoh A, 2006, PLANT PHYSIOL, V141, P851, DOI 10.1104/pp.106.081091; Zhang HB, 2012, MOL PLANT, V5, P73, DOI 10.1093/mp/ssr056; Shoji T, 2009, PLANT PHYSIOL, V149, P708, DOI 10.1104/pp.108.132811; HORSCH RB, 1985, SCIENCE, V227, P1229; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Shoji T, 2008, PLANT CELL PHYSIOL, V49, P1003, DOI 10.1093/pcp/pcn077; BALANDIN T, 1995, PLANT MOL BIOL, V27, P1197, DOI 10.1007/BF00020893; Kato K, 2014, PHYTOCHEMISTRY; LEGG PD, 1971, CAN J GENET CYTOL, V13, P287; Pakdeechanuan P, 2012, PLANT CELL PHYSIOL, V53, P1247, DOI 10.1093/pcp/pcs065; Shoji T, 2011, PLANT METABOLISM BIO, P191, DOI DOI 10.1002/9781119991311.CH7; Shoji T, 2012, PLANT BIOTECHNOL-NAR, V29, P35, DOI 10.5511/plantbiotechnology.11.1216a; Shoji T, 2013, HERBACEOUS PLANTS CU, P37; Shoji T, 2011, PLANT J, V67, P949, DOI 10.1111/j.1365-313X.2011.04647.x; Shoji T, 2014, PHYTOCHEMISTRY; Xie JH, 2004, RECENT ADV TOBACCO S, V30, P17	35	1	1	AMER SOC PLANT BIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889	1532-2548		PLANT PHYSIOL	Plant Physiol.	DEC	2014	166	4					2195	U1500		10.1104/pp.114.251645		13	Plant Sciences	Plant Sciences	AW0YF	WOS:000346016400042		
J	Okano, K; Nogami, A; Asakura, K				Okano, Kunihiko; Nogami, Aya; Asakura, Kouichi			High-strength gel actuator driven by a photothermal effect	POLYMER JOURNAL			English	Article							ELASTOMERS; HYDROGELS; POLYMERS		[Okano, Kunihiko; Nogami, Aya; Asakura, Kouichi] Keio Univ, Dept Appl Chem, Yokohama, Kanagawa 223, Japan	Okano, K (reprint author), Keio Univ, Dept Appl Chem, 3-14-1 Hiyoshi, Yokohama, Kanagawa 223, Japan.	okano@applc.keio.ac.jp	Asakura, Kouichi/E-8045-2014		CLUSTER (the second stage) of the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by CLUSTER (the second stage) of the Ministry of Education, Culture, Sports, Science and Technology, Japan.	OSADA Y, 1992, NATURE, V355, P242, DOI 10.1038/355242a0; Ahir SV, 2005, NAT MATER, V4, P491, DOI 10.1038/nmat1391; Ikeda T, 2003, J MATER CHEM, V13, P2037, DOI 10.1039/b306216n; Gong JP, 2010, SOFT MATTER, V6, P2583, DOI 10.1039/b924290b; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059; Hogan PM, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041720; Na YH, 2006, MACROMOLECULES, V39, P4641, DOI 10.1021/ma060568d; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Ji Y, 2010, ADV MATER, V22, P3436, DOI 10.1002/adma.200904103; Ikeda T, 2007, ANGEW CHEM INT EDIT, V46, P506, DOI 10.1002/anie.200602372; Baughman RH, 1996, SYNTHETIC MET, V78, P339, DOI 10.1016/0379-6779(96)80158-5; Finkelmann H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.015501; Jeu De, 2012, LIQUID CRYSTAL ELAST; Natansohn A, 2002, CHEM REV, V102, P4109; Zentel R., 1989, ADV MATER, V1, P321, DOI 10.1002/adma.19890011003	16	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	DEC	2014	46	12					827	830		10.1038/pj.2014.78		4	Polymer Science	Polymer Science	AW1YX	WOS:000346086000001		
J	Shimizu, T; Minamikawa, H; Kogiso, M; Aoyagi, M; Kameta, N; Ding, WX; Masuda, M				Shimizu, Toshimi; Minamikawa, Hiroyuki; Kogiso, Masaki; Aoyagi, Masaru; Kameta, Naohiro; Ding, Wuxiao; Masuda, Mitsutoshi			Self-organized nanotube materials and their application in bioengineering	POLYMER JOURNAL			English	Review							ASSEMBLING PEPTIDE NANOTUBES; AXIAL-RATIO NANOSTRUCTURES; METAL-OXIDE NANOTUBES; SOL-GEL TRANSCRIPTION; II-TYPE STRUCTURE; LIPID NANOTUBE; SUPRAMOLECULAR NANOTUBE; GLYCOLIPID NANOTUBE; UNSYMMETRICAL BOLAAMPHIPHILES; PROTEIN ENCAPSULATION	Although a large number of studies on organic nanotubes have focused on the molecular design of building blocks and their material function, there has been little research that has addressed the function of the nanochannels themselves, such as their encapsulation ability. The dimensions of self-assembled organic nanotubes (S-ONTs) are well compatible with those of diverse nanostructures, including proteins, organic, inorganic or metal nanoparticles, dendrimers, viruses and DNAs. S-ONTs can give rise to a novel research field of mesoscale host-guest science and engineering. More interestingly, S-ONTs can accommodate extremely small liquid volumes on the order of attoliters in their nanochannels. Focusing on the distinctive function and structural characteristics of these nanochannels, herein we describe the recent progress in research on the unique properties of nanochannels that can encapsulate, transport and release biomacromolecules as well as exert a confinement effect on water.	[Shimizu, Toshimi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Minamikawa, Hiroyuki; Kogiso, Masaki; Aoyagi, Masaru; Kameta, Naohiro; Ding, Wuxiao; Masuda, Mitsutoshi] AIST, Nanosyst Res Inst, Tsukuba, Ibaraki, Japan	Shimizu, T (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	tshmz-shimizu@aist.go.jp	Shimizu, Toshimi/H-8733-2015	Shimizu, Toshimi/0000-0002-4342-0713	Japan Science and Technology Agency (JST)	We thank our many colleagues, including Drs M Asakawa, JH Jung, G John, M Kamiya, H Yui, Y Guo, R Iwaura, K Yoshida, Q Ji, Y Zhou, Y Bo, Y Mishima, SJ Lee, K Ishikawa, YG Han, H Furusho, M Mukai, T Chattopadhyay and K Hirano for their enthusiastic collaboration. Professors T Sawada, K Ito, H Frusawa, I Yamashita, T Fukuda, M Arai, S Isoda and Y Maitani are also acknowledged for their fruitful collaboration. The Japan Science and Technology Agency (JST) is acknowledged for providing financial support to the CREST and SORST projects.	Ahn R. W., 2013, PLOS ONE, V8, P1; Bocquet L, 2010, CHEM SOC REV, V39, P1073, DOI 10.1039/b909366b; Immordino ML, 2006, INT J NANOMED, V1, P297; Shchukin DG, 2004, ADV MATER, V16, P671, DOI 10.1002/adma.200306466; Banerjee IA, 2005, ADV MATER, V17, P1128, DOI 10.1002/adma.200400724; Dong QY, 2013, INT J FOOD SCI TECH, V48, P1339, DOI 10.1111/ijfs.12078; Komatsu T, 2011, J AM CHEM SOC, V133, P3246, DOI 10.1021/ja1096122; Sun Y, 2011, LANGMUIR, V27, P11364, DOI 10.1021/la202107r; Hirano K, 2009, ANAL CHEM, V81, P1459, DOI 10.1021/ac8022795; Khandare J, 2006, PROG POLYM SCI, V31, P359, DOI 10.1016/j.progpolymsci.2005.09.004; Sendai T, 2013, J AM CHEM SOC, V135, P11509, DOI 10.1021/ja4060146; Latibari ST, 2013, ENERGY, V61, P664, DOI 10.1016/j.energy.2013.09.012; Versluis F, 2009, J AM CHEM SOC, V131, P13186, DOI 10.1021/ja9026264; Tsukahara T, 2007, ANGEW CHEM INT EDIT, V46, P1180, DOI 10.1002/anie.200604502; Chattopadhyay T, 2011, GREEN CHEM, V13, P1138, DOI 10.1039/c1gc00005e; Brizard A, 2007, J AM CHEM SOC, V129, P3754, DOI 10.1021/ja0682172; Henricus MM, 2008, BIOCONJUGATE CHEM, V19, P2394, DOI 10.1021/bc800254n; Adler-Abramovich L, 2009, NAT NANOTECHNOL, V4, P849, DOI [10.1038/nnano.2009.298, 10.1038/NNANO.2009.298]; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; An S, 2012, NANOSCALE, V4, P6493, DOI 10.1039/c2nr30972f; Yui H, 2005, CHEM LETT, V34, P232, DOI 10.1246/cl.2005.232; Okamoto K, 2004, NANO LETT, V4, P233, DOI 10.1021/nl034954+; Ziserman L, 2011, J AM CHEM SOC, V133, P2511, DOI 10.1021/ja107069f; Panda JJ, 2013, J CONTROL RELEASE, V172, P1151, DOI 10.1016/j.jconrel.2013.09.016; Qu X, 2010, ACS NANO, V4, P563, DOI 10.1021/nn901474y; Yang B, 2004, CHEM MATER, V16, P2826, DOI 10.1021/cm049695j; Mahajan N, 2005, LANGMUIR, V21, P3153, DOI 10.1021/la0046928c; Zhang W, 2009, ANGEW CHEM INT EDIT, V48, P4747, DOI 10.1002/anie.200900756; Valery C, 2011, SOFT MATTER, V7, P9583, DOI 10.1039/c1sm05698k; Wang ZC, 2004, J AM CHEM SOC, V126, P15954, DOI 10.1021/ja045068j; Shao H, 2010, ANGEW CHEM INT EDIT, V49, P7688, DOI 10.1002/anie.201003415; Walker EK, 2011, J PHYS CHEM C, V115, P2470, DOI 10.1021/jp1108015; Song S, 2011, INT J NANOMED, V6, P101, DOI 10.2147/IJN.S11957; Kogiso M, 1998, LANGMUIR, V14, P4978, DOI 10.1021/la9802419; Kameta N, 2008, SOFT MATTER, V4, P1681, DOI 10.1039/b803742f; Carny O, 2006, NANO LETT, V6, P1594, DOI 10.1021/nl060468l; Ponnuswamy N, 2012, J AM CHEM SOC, V134, P566, DOI 10.1021/ja2088647; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Andresen TL, 2005, PROG LIPID RES, V44, P68, DOI 10.1016/j.plipres.2004.12.001; Aida T, 2012, SCIENCE, V335, P813, DOI 10.1126/science.1205962; Yamamoto Y, 2006, SCIENCE, V314, P1761, DOI 10.1126/science.1134441; Guler MO, 2007, J AM CHEM SOC, V129, P12082, DOI 10.1021/ja075044n; Djalali R, 2003, J AM CHEM SOC, V125, P5873, DOI 10.1021/ja0299598; Wan RZ, 2010, SOLID STATE COMMUN, V150, P968, DOI 10.1016/j.ssc.2010.01.016; Deng HX, 2012, SCIENCE, V336, P1018, DOI 10.1126/science.1220131; Ishibashi R, 2012, SMALL, V8, P1237, DOI 10.1002/smll.201102420; Masuda M, 2004, LANGMUIR, V20, P5969, DOI 10.1021/la049085y; Hudson S, 2008, ANGEW CHEM INT EDIT, V47, P8582, DOI 10.1002/anie.200705238; Ferey G, 2008, CHEM SOC REV, V37, P191, DOI 10.1039/b618320b; Kameta N, 2010, CHEM-EUR J, V16, P4217, DOI 10.1002/chem.200903413; Rescignano N, 2013, MACROMOL BIOSCI, V13, P1204, DOI 10.1002/mabi.201300140; Blanazs A, 2011, J AM CHEM SOC, V133, P16581, DOI 10.1021/ja206301a; Kameta N, 2007, LANGMUIR, V23, P4634, DOI 10.1021/la063542o; Roco MC, 2011, J NANOPART RES, V13, P897, DOI 10.1007/s11051-011-0275-5; Zhang L, 2013, SOFT MATTER, V9, P7966, DOI 10.1039/c3sm51204e; Kameta N, 2012, CHEM MATER, V24, P209, DOI 10.1021/cm2030526; Masuda M, 2005, CARBOHYD RES, V340, P2502, DOI 10.1016/j.carres.2005.08.005; Yang HF, 2005, J MATER CHEM, V15, P1217, DOI 10.1039/b414402c; Scanlon S, 2008, NANO TODAY, V3, P22, DOI 10.1016/S1748-0132(08)70041-0; Tominaga M, 2004, ANGEW CHEM INT EDIT, V43, P5621, DOI 10.1002/anie.200461422; Pasut G, 2007, PROG POLYM SCI, V32, P933, DOI 10.1016/j.progpolymsci.2007.05.008; Torchilin VP, 2007, PHARM RES, V24, P1, DOI 10.1007/s11095-006-9132-0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Kameta N, 2009, CHEM MATER, V21, P5892, DOI 10.1021/cm903108h; Kim JH, 2012, ANGEW CHEM INT EDIT, V51, P517, DOI 10.1002/anie.201103244; Worsdorfer B, 2012, J AM CHEM SOC, V134, P909, DOI 10.1021/ja211011k; Shimizu T, 2002, MACROMOL RAPID COMM, V23, P311, DOI 10.1002/1521-3927(20020401)23:5/6<311::AID-MARC311>3.0.CO;2-U; Hsieh WH, 2012, MOL PHARMACEUT, V9, P1231, DOI 10.1021/mp200523n; Schoch RB, 2008, REV MOD PHYS, V80, P839, DOI 10.1103/RevModPhys.80.839; Cheetham AG, 2013, J AM CHEM SOC, V135, P2907, DOI 10.1021/ja3115983; Huang Z, 2012, SCIENCE, V337, P1521, DOI 10.1126/science.1224741; Yamashita I, 2010, BBA-GEN SUBJECTS, V1800, P846, DOI 10.1016/j.bbagen.2010.03.005; Kaji N, 2006, ANAL BIOANAL CHEM, V386, P759, DOI 10.1007/s00216-006-0469-3; Park C, 2006, P NATL ACAD SCI USA, V103, P1199, DOI 10.1073/pnas.0505364103; Ji QM, 2004, CHEM LETT, V33, P504, DOI 10.1246/cl.2004.504; Yagai S, 2012, J AM CHEM SOC, V134, P18205, DOI 10.1021/ja308519b; Numata M, 2008, CHEM-EUR J, V14, P2398, DOI 10.1002/chem.200701205; Shao H, 2009, ANGEW CHEM INT EDIT, V48, P2525, DOI 10.1002/anie.200805010; Harris K, 2013, CHEM COMMUN, V49, P6703, DOI 10.1039/c3cc43191f; Beckstein O, 2003, P NATL ACAD SCI USA, V100, P7063, DOI 10.1073/pnas.1136844100; Huang ZP, 2013, J MATER CHEM B, V1, P2297, DOI 10.1039/c3tb20156b; PROULXCURRY PM, 1995, COORDIN CHEM REV, V144, P347, DOI 10.1016/0010-8545(95)01148-I; Jaworek A, 2008, J MICROENCAPSUL, V25, P443, DOI 10.1080/02652040802049109; Nara TY, 2009, COLLOID SURFACE B, V68, P68, DOI 10.1016/j.colsurfb.2008.09.012; Maniwa Y, 2005, CHEM PHYS LETT, V401, P534, DOI 10.1016/j.cplett.2004.11.112; CRICK FHC, 1955, NATURE, V176, P780, DOI 10.1038/176780a0; Sozer N, 2009, TRENDS BIOTECHNOL, V27, P82, DOI 10.1016/j.tibtech.2008.10.010; Walther A, 2010, NANO LETT, V10, P2742, DOI 10.1021/nl1003224; Eisele DM, 2012, NAT CHEM, V4, P655, DOI [10.1038/nchem.1380, 10.1038/NCHEM.1380]; Yamamoto Y, 2009, P NATL ACAD SCI USA, V106, P21051, DOI 10.1073/pnas.0905655106; Saeki A, 2012, ACCOUNTS CHEM RES, V45, P1193, DOI 10.1021/ar200283b; Abbo HS, 2012, APPL CATAL A-GEN, V435, P148, DOI 10.1016/j.apcata.2012.05.048; Wang Y, 2008, CHEM MATER, V20, P848, DOI 10.1021/cm7024813; Zhang W, 2013, J AM CHEM SOC, V135, P114, DOI 10.1021/ja311738m; Kataoka K, 2012, ADV DRUG DELIVER REV, V64, P37, DOI 10.1016/j.addr.2012.09.013; Szejtli J, 1998, CHEM REV, V98, P1743, DOI 10.1021/cr970022c; Chapman R, 2012, CHEM SOC REV, V41, P6023, DOI 10.1039/c2cs35172b; Yamamoto Y, 2007, J AM CHEM SOC, V129, P9276, DOI 10.1021/ja073577q; Miyata K, 2011, REACT FUNCT POLYM, V71, P227, DOI 10.1016/j.reactfunctpolym.2010.10.009; Eisele DM, 2010, J AM CHEM SOC, V132, P2104, DOI 10.1021/ja907373h; Roger C, 2008, J AM CHEM SOC, V130, P5929, DOI 10.1021/ja710253q; Hibara A, 2002, ANAL CHEM, V74, P6170, DOI 10.1021/ac025808b; Meilander NJ, 2001, J CONTROL RELEASE, V71, P141, DOI 10.1016/S0168-3659(01)00214-0; Ishikawa K, 2013, ADV FUNCT MATER, V23, P1677, DOI 10.1002/adfm.201202160; Giaya A, 2002, J CHEM PHYS, V117, P3464, DOI 10.1063/1.1494419; Reches M, 2006, NAT NANOTECHNOL, V1, P195, DOI 10.1038/nnano.2006.139; Hartgerink JD, 1996, J AM CHEM SOC, V118, P43, DOI 10.1021/ja953070s; Gu JL, 2013, J COLLOID INTERF SCI, V407, P236, DOI 10.1016/j.jcis.2013.06.028; Conn CE, 2013, SOFT MATTER, V9, P3449, DOI 10.1039/c3sm27743g; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; SCHNUR JM, 1994, SCIENCE, V264, P945, DOI 10.1126/science.264.5161.945; SCHNUR JM, 1993, SCIENCE, V262, P1669, DOI 10.1126/science.262.5140.1669; Dujardin E, 2003, NANO LETT, V3, P413, DOI 10.1021/nl034004o; Zhang W, 2011, SCIENCE, V334, P340, DOI 10.1126/science.1210369; Vemmer M, 2013, BIOL CONTROL, V67, P380, DOI 10.1016/j.biocontrol.2013.09.003; Sawada S, 2010, MACROMOL BIOSCI, V10, P353, DOI 10.1002/mabi.200900304; Cao H, 2012, CHEM-EUR J, V18, P5546, DOI 10.1002/chem.201103654; de La Rica R, 2011, ADV FUNCT MATER, V21, P1018, DOI 10.1002/adfm.201001419; Geng Y, 2007, NAT NANOTECHNOL, V2, P249, DOI 10.1038/nnano.2007.70; Yu LT, 2005, BIOCONJUGATE CHEM, V16, P1484, DOI 10.1021/bc050199a; Hill JP, 2004, SCIENCE, V304, P1481, DOI 10.1126/science.1097789; Yang ZM, 2006, J AM CHEM SOC, V128, P3038, DOI 10.1021/ja057412y; Jung JH, 2002, J AM CHEM SOC, V124, P10674, DOI 10.1021/ja020752o; Berger C, 2003, LANGMUIR, V19, P1, DOI 10.1021/la020667u; Jung JH, 2005, J MATER CHEM, V15, P3979, DOI 10.1039/b503441h; Nijem N, 2013, J AM CHEM SOC, V135, P12615, DOI 10.1021/ja400754p; Kamiya S, 2005, LANGMUIR, V21, P743, DOI 10.1021/la047765v; Kameta N, 2005, ADV MATER, V17, P2732, DOI 10.1002/adma.200501092; Muller A, 2002, ANGEW CHEM INT EDIT, V41, P1162, DOI 10.1002/1521-3773(20020402)41:7<1162::AID-ANIE1162>3.0.CO;2-8; John G, 2001, ADV MATER, V13, P715, DOI 10.1002/1521-4095(200105)13:10<715::AID-ADMA715>3.0.CO;2-Z; Shimizu T, 2005, CHEM REV, V105, P1401, DOI 10.1021/cr030072j; Meek ST, 2011, ADV MATER, V23, P249, DOI 10.1002/adma.201002854; Huang QR, 2010, J FOOD SCI, V75, pR50, DOI 10.1111/j.1750-3841.2009.01457.x; Sasaki Y, 2010, CHEM REC, V10, P366, DOI 10.1002/tcr.201000008; Zhou Y, 2008, CHEM MATER, V20, P625, DOI 10.1021/cm701999m; Kameta N, 2013, LANGMUIR, V29, P13291, DOI 10.1021/la4028018; Shimizu T, 2006, J POLYM SCI POL CHEM, V44, P5137, DOI 10.1002/pola.21619; YAMADA K, 1984, CHEM LETT, P1713, DOI 10.1246/cl.1984.1713; Shimizu T, 1997, J AM CHEM SOC, V119, P6209, DOI 10.1021/ja970844r; Gao XY, 2005, ADV MATER, V17, P2037, DOI 10.1002/adma.200401849; Yan XH, 2007, ANGEW CHEM INT EDIT, V46, P2431, DOI 10.1002/anie.200603387; Zhang XJ, 2011, J PHYS CHEM B, V115, P14445, DOI 10.1021/jp2064276; Komatsu T, 2012, NANOSCALE, V4, P1910, DOI 10.1039/c1nr11224d; Liu YQ, 2013, ADV MATER, V25, P5875, DOI 10.1002/adma.201302345; Uekama K, 1998, CHEM REV, V98, P2045, DOI 10.1021/cr970025p; Kameta N, 2011, SOFT MATTER, V7, P4539, DOI 10.1039/c0sm01559h; Matsui H, 2001, NANO LETT, V1, P671, DOI 10.1021/nl0156080; Asakawa Masumi, 2009, Synthesiology (English Edition), V1; Benaglia M., 2009, RECOVERABLE RECYCLAB; Bera T, 2013, RSC ADV, V3, P21576, DOI 10.1039/c3ra41894d; Bernet A, 2011, SOFT MATTER, V7, P1058, DOI 10.1039/c0sm00456a; Bhattacharyya K, 2003, ACCOUNTS CHEM RES, V36, P95, DOI 10.1021/ar020067m; Bilensoy E., 2011, CYCLODEXTRINS PHARM; Bushetti SS, 2009, INDIAN J PHARM EDUC, V43, P241; Chattopadhyay T, 2010, CATAL COMMUN, V12, P9, DOI 10.1016/j.catcom.2010.07.013; Cho EJ, 2009, CHEM MATER, V21, P3, DOI 10.1021/cm803026c; Clarke RW, 2005, ANGEW CHEM INT EDIT, V44, P3747, DOI 10.1002/anie.200500196; Dalla-Bona A, 2010, MACROMOL SYMP, V287, P32, DOI 10.1002/masy.201050105; Das SK, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq673; Ding WX, 2012, ADV HEALTHC MATER, V1, P699, DOI 10.1002/adhm.201200133; Ding WX, 2011, J CONTROL RELEASE, V156, P70, DOI 10.1016/j.jconrel.2011.07.007; Ding WX, 2012, CHEM COMMUN, V48, P8625, DOI 10.1039/c2cc33970f; Douliez JP, 2006, CHEMPHYSCHEM, V7, P2071, DOI 10.1002/cphc.200600264; Frusawa H, 2003, ANGEW CHEM INT EDIT, V42, P72, DOI 10.1002/anie.200390056; Frusawa H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02165; Fuhrhop Jürgen-Hinrich, 2004, Chem Rev, V104, P2901, DOI 10.1021/cr030602b; Fujima T, 2006, J PHYS-CONDENS MAT, V18, P3089, DOI 10.1088/0953-8984/18/11/014; Fujita D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2093; Furusho H, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.097001; Furusho H, 2008, JPN J APPL PHYS, V47, P394, DOI 10.1143/JJAP.47.394; Gao XY, 2005, ADV MATER, V17, P1753, DOI 10.1002/adma.200500357; Gemeay AH, 2004, J CHEM TECHNOL BIOT, V79, P85, DOI 10.1002/jctb.917; Goren M, 2000, CHEM MATER, V12, P1222, DOI 10.1021/cm990736z; Guo Y, 2006, J NANOSCI NANOTECHNO, V6, P1464, DOI 10.1166/jnn.2006.325; Guo YL, 2005, LANGMUIR, V21, P4610, DOI 10.1021/la046906q; Han YG, 2012, COLLOID SURFACE A, V395, P63, DOI 10.1016/j.colsurfa.2011.12.004; Han YG, 2012, ACS APPL MATER INTER, V4, P2439, DOI 10.1021/am300122f; Imaoka T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3581; Islam SM, 2012, J INORG ORGANOMET P, V22, P717, DOI 10.1007/s10904-012-9666-z; Iwamoto M, 2001, CATAL SURV JPN, V5, P25, DOI 10.1023/A:1012257731538; Ji QM, 2007, CHEM MATER, V19, P1329, DOI 10.1021/cm0625124; Jintoku H, 2011, CHEM LETT, V40, P561, DOI 10.1246/cl.2011.561; John G, 2002, CHEM-EUR J, V8, P5494, DOI 10.1002/1521-3765(20021202)8:23<5494::AID-CHEM5494>3.0.CO;2-P; Jung JH, 2003, CHEM-EUR J, V9, P5307, DOI 10.1002/chem.200305008; Kameta N, 2012, ACS NANO, V6, P5249, DOI 10.1021/nn301041y; Kameta N, 2007, CHEM LETT, V36, P896, DOI 10.1246/cl.2007.896; Kameta N, 2008, SMALL, V4, P561, DOI 10.1002/smll.200700710; Kameta N, 2011, SOFT MATTER, V7, P85, DOI 10.1039/c0sm00375a; Kameta N, 2011, CHEM-EUR J, V17, P5251, DOI 10.1002/chem.201100179; Kameta N, 2013, J MATER CHEM B, V1, P276, DOI 10.1039/c2tb00101b; Karlsson R, 2002, LANGMUIR, V18, P4186, DOI 10.1021/la025533v; Karlsson R, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-421; Kogiso M, 1998, SUPRAMOL CHEM, V9, P183, DOI 10.1080/10610279808034985; Kogiso M, 2007, ADV MATER, V19, P242, DOI 10.1002/adma.200601117; Kogiso M, 2010, CHEM LETT, V39, P822, DOI 10.1246/cl.2010.822; Kogiso M, 2010, SOFT MATTER, V6, P4528, DOI 10.1039/c0sm00077a; Kometani R, 2003, JPN J APPL PHYS 1, V42, P4107, DOI 10.1143/JJAP.42.4107; Li JY, 1996, J CHROMATOGR A, V726, P25, DOI 10.1016/0021-9673(95)01017-3; Lilavivat S, 2012, J AM CHEM SOC, V134, P13152, DOI 10.1021/ja302743g; Lobovkina T, 2008, EUR PHYS J E, V26, P295, DOI 10.1140/epje/i2007-10325-x; Lvov YM, 2000, LANGMUIR, V16, P5932, DOI 10.1021/la000069k; Maitani Y, 2013, INT J NANOMED, V8, P315, DOI 10.2147/IJN.S38462; Mani RC, 2003, NANO LETT, V3, P671, DOI 10.1021/nl034125o; Matsui H, 2000, J PHYS CHEM B, V104, P3383, DOI 10.1021/jp994117p; Meilander NJ, 2003, J CONTROL RELEASE, V88, P321, DOI 10.1016/S0168-3659(03)00007-5; Mishchenko L, 2011, PROC SPIE, V7946, DOI 10.1117/12.881270; Miyabe K, 2000, ANAL SCI, V16, P719, DOI 10.2116/analsci.16.719; Mukai M, 2011, CHEM LETT, V40, P218, DOI 10.1246/cl.2011.218; Mynar JL, 2008, J AM CHEM SOC, V130, P1530, DOI 10.1021/ja075822b; NAKASHIMA N, 1984, CHEM LETT, P1709, DOI 10.1246/cl.1984.1709; Nishimura T, 2011, PHYS CHEM CHEM PHYS, V13, P15899, DOI 10.1039/c1cp21065c; Nogawa K., 2007, J ROBOT MECHATRONICS, V19, P528; Nomura SM, 2005, BBA-BIOMEMBRANES, V1669, P164, DOI 10.1016/.j.bbamem.2005.02.005; Numata M, 2007, SUPRAMOL CHEM, V19, P107, DOI 10.1080/10610270600982508; Piper JD, 2006, J AM CHEM SOC, V128, P16462, DOI 10.1021/ja0650899; Renberg B, 2009, LAB CHIP, V9, P1517, DOI 10.1039/b823436a; Ricci MA, 2000, J PHYS-CONDENS MAT, V12, pA345, DOI 10.1088/0953-8984/12/8A/346; Rodolfa KT, 2005, ANGEW CHEM INT EDIT, V44, P6854, DOI 10.1002/anie.200502338; Sekine T, 2004, CHEM LETT, V33, P600, DOI 10.1246/cl.2004.600; Shimizu T, 1996, NATURE, V383, P487, DOI 10.1038/383487b0; Kameta N, 2007, CHEM MATER, V19, P3553, DOI 10.1021/cm070626p; Shimizu T, 2008, J POLYM SCI POL CHEM, V46, P2601, DOI 10.1002/pola.22652; Soper AK, 2013, CHEM PHYS LETT, V590, P1, DOI 10.1016/j.cplett.2013.10.075; Takezawa T, 2010, YAKUGAKU ZASSHI, V130, P565; Ueda M, 2013, POLYM J, V45, P509, DOI 10.1038/pj.2013.4; Vilozny B, 2011, ACS NANO, V5, P3191, DOI 10.1021/nn200320b; Wakasugi A, 2011, INT J PHARMACEUT, V413, P271, DOI 10.1016/j.ijpharm.2011.04.038; Warner J.C., 2000, GREEN CHEM THEORY PR; Yang B, 2004, CHEM COMMUN, P500, DOI 10.1039/b313100a; Yoshida D, 2013, MED MOL MORPHOL, V46, P86, DOI 10.1007/s00795-013-0011-6; YOSHIDA H, 1994, AICHE J, V40, P2034, DOI 10.1002/aic.690401213; Yu LT, 2003, J AM CHEM SOC, V125, P14837, DOI 10.1021/ja037117i; Yu LT, 2004, ADV MATER, V16, P709, DOI 10.1002/adma.200306373; Yui H, 2005, LANGMUIR, V21, P721, DOI 10.1021/la040109a; Zabetakis D, 2000, J MATER RES, V15, P2368, DOI 10.1557/JMR.2000.0341; Zhang XJ, 2010, J MATER CHEM, V20, P3716, DOI 10.1039/b927038h; Zhao Y, 2007, NANO LETT, V7, P1360, DOI 10.1021/nl070408v; Zhao Y, 2008, J PHYS CHEM B, V112, P10964, DOI 10.1021/jp804793c; Zhou Y, 2009, ADV MATER, V21, P1742, DOI 10.1002/adma.200803072; Zhou Y, 2007, ADV MATER, V19, P1055, DOI 10.1002/adma.200602001; Zhou Y, 2006, CHEM MATER, V18, P403, DOI 10.1021/cm051928z; Jin QX, 2011, LANGMUIR, V27, P13847, DOI 10.1021/la203110z	242	6	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	DEC	2014	46	12					831	858		10.1038/pj.2014.72		28	Polymer Science	Polymer Science	AW1YX	WOS:000346086000002		
J	Shirai, M				Shirai, Masamitsu			Photocrosslinkable polymers with degradable properties	POLYMER JOURNAL			English	Review							CROSS-LINKABLE POLYMERS; REDISSOLUTION PROPERTY; CHAIN PROPAGATION; NETWORK POLYMERS; PYROLYSIS-GC/MS; LINKING; SYSTEM; RESIN; CHEMISTRY; DI(METH)ACRYLATES	Photocrosslinkable polymers and ultraviolet (UV)-curable resins are significant applications such as coatings, adhesives, photoresists and printing plates. Crosslinked polymers are insoluble and infusible; therefore, it is very difficult to remove crosslinked materials from substrates. Recently, much attention has been paid to the recovery or recycling of crosslinked polymers due to environmental regulations. To this end, photocrosslinkable polymers with degradable properties have been studied. Photocrosslinkable polymers and UV-curable resins with degradable properties are also realized as highly functionalized photopolymers. This article reviews our recent research on photocrosslinkable polymers with degradable properties. Multifunctional methacrylates and epoxides with degradable properties were prepared, and their UV-curing and degradation profiles were studied. Furthermore, polymers with crosslinkable units and degradable side chains were prepared and characterized in a similar manner. Some potential applications of these monomers and polymers were also described.	[Shirai, Masamitsu] Osaka Prefecture Univ, Dept Appl Chem, Osaka, Japan	Shirai, M (reprint author), Osaka Prefecture Univ, Dept Appl Chem, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	mshirai@chem.osakafu-u.ac.jp					Amamoto Y, 2009, MACROMOLECULES, V42, P8733, DOI 10.1021/ma901746n; Shirai M, 2004, POLYMER, V45, P7519, DOI 10.1016/j.polymer.2004.09.003; Wang LJ, 2000, J POLYM SCI POL CHEM, V38, P3771, DOI 10.1002/1099-0518(20001015)38:20<3771::AID-POLA80>3.0.CO;2-4; Ito H, 2005, ADV POLYM SCI, V172, P37, DOI 10.1007/b97574; Chen JS, 2002, POLYMER, V43, P131, DOI 10.1016/S0032-3861(01)00605-X; Shirai M, 2002, CHEM MATER, V14, P334, DOI 10.1021/cm0103646; Bitoh Y, 2011, MACROMOLECULES, V44, P8661, DOI 10.1021/ma201530z; CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851; Andrzejewska E, 2001, PROG POLYM SCI, V26, P605, DOI 10.1016/S0079-6700(01)00004-1; Ito K, 2012, POLYM J, V44, P38, DOI 10.1038/pj.2011.85; Malik J, 2002, POLYMER, V43, P2561, DOI 10.1016/S0032-3861(02)00032-0; Tsuge S, 1997, POLYM DEGRAD STABIL, V58, P109, DOI 10.1016/S0141-3910(97)00031-1; Yang S, 1998, CHEM MATER, V10, P1475, DOI 10.1021/cm970667t; Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o; Zhang XQ, 2002, POLYMER, V43, P5791, DOI 10.1016/S0032-3861(02)00546-3; Shirai M, 2003, CHEM MATER, V15, P4075, DOI 10.1021/cm0302734; Buchwalter SL, 1996, J POLYM SCI POL CHEM, V34, P249, DOI 10.1002/(SICI)1099-0518(19960130)34:2<249::AID-POLA11>3.0.CO;2-Q; Fouassier J.-P., 2012, PHOTOINITIATORS POLY; Hitomi M, 1998, J POLYM SCI POL CHEM, V36, P2823, DOI 10.1002/(SICI)1099-0518(19981115)36:15<2823::AID-POLA19>3.0.CO;2-H; Hosaka A, 2014, J ANAL APPL PYROL, V106, P160, DOI 10.1016/j.jaap.2014.01.014; Hoyle CE, 2004, J POLYM SCI POL CHEM, V42, P5301, DOI 10.1002/pola.20366; Khosravi E, 2011, EUR POLYM J, V47, P465, DOI 10.1016/j.eurpolymj.2010.09.023; Matsukawa D, 2010, J PHOTOPOLYM SCI TEC, V23, P125, DOI 10.2494/photopolymer.23.125; Matsukawa D, 2011, J MATER CHEM, V21, P10407, DOI 10.1039/c0jm04386a; Matsukawa D, 2009, EUR POLYM J, V45, P2087, DOI 10.1016/j.eurpolymj.2009.03.015; Matsukawa D, 2010, J PHOTOPOLYM SCI TEC, V23, P781, DOI 10.2494/photopolymer.23.781; Matsukawa D, 2009, J MATER CHEM, V19, P4085, DOI 10.1039/b905188k; Matsukawa D, 2010, POLYM INT, V59, P263, DOI 10.1002/pi.2719; Mihashi A, 2010, PROG ORG COAT, V68, P42, DOI 10.1016/j.porgcoat.2009.07.014; Ogino K, 1998, CHEM MATER, V10, P3833, DOI 10.1021/cm9801183; Okamura H, 2002, J POLYM SCI POL CHEM, V40, P3055, DOI 10.1002/pola.10394; Okamura H, 2009, RES CHEM INTERMEDIAT, V35, P865, DOI 10.1007/s11164-009-0070-4; Okamura H, 2011, J PHOTOPOLYM SCI TEC, V24, P561, DOI 10.2494/photopolymer.24.561; Okamura H, 2010, POLYMER, V51, P5087, DOI 10.1016/j.polymer.2010.09.010; Okamura H, 2004, J POLYM SCI POL CHEM, V42, P3685, DOI 10.1002/pola.20232; Okamura H., 2005, Journal of Photopolymer Science and Technology, V18, DOI 10.2494/photopolymer.18.715; Okamura H, 2011, REACT FUNCT POLYM, V71, P480, DOI 10.1016/j.reactfunctpolym.2011.01.008; Okamura H, 2006, POLYM J, V38, P1237, DOI 10.1295/polymj.PJ2006007; Oya N, 2012, J POLYM SCI POL CHEM, V50, P1926, DOI 10.1002/pola.25966; Shirai M, 2008, CHEM MATER, V20, P1971, DOI 10.1021/cm702965e; Shirai M, 2002, CHEM LETT, P940, DOI 10.1246/cl.2002.940; Shirai M, 2005, J PHOTOPOLYM SCI TEC, V18, P199, DOI 10.2494/photopolymer.18.199; Tcherbi-Narteh A, 2014, POLYM DEGRAD STABIL, V101, P81, DOI 10.1016/j.polymdegradstab.2013.12.033; Tesero G. C., 1990, J APPL POLYM SCI, V39, P1425; Yamaguchi H, 2011, MACROMOLECULES, V44, P2395, DOI 10.1021/ma200398y; Zhang XQ, 1998, CHEM MATER, V10, P1833, DOI 10.1021/cm9800175; Zhou ZW, 2014, POLYM POLYM COMPOS, V22, P45	47	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	DEC	2014	46	12					859	865		10.1038/pj.2014.79		7	Polymer Science	Polymer Science	AW1YX	WOS:000346086000003		
J	Oshimura, M; Okazaki, R; Hirano, T; Ute, K				Oshimura, Miyuki; Okazaki, Ryo; Hirano, Tomohiro; Ute, Koichi			Ring-opening polymerization of epsilon-caprolactone with dilithium tetra-tert-butylzincate under mild conditions	POLYMER JOURNAL			English	Article							ANIONIC-POLYMERIZATION; ALKOXIDES; KINETICS; DESIGN	We performed ring-opening polymerization (ROP) of epsilon-caprolactone with dilithium tetra-tert-butylzincate (TBZL) in toluene. TBZL is a bulky zincate complex with a range of unique reactivities such as unusually low basicity and high chemoselectivity; it is a metal catalyst of low toxicity. The initiating species for ROP of epsilon-caprolactone is, however, not the tert-butyl anion of TBZL but the hydroxyl anion derived from a trace amount of H2O in the system. Instead of a trace amount of H2O in the system, a known amount of benzyl alcohol (BnOH) was added as an ROP initiator. Poly(epsilon-caprolactone) with a BnO group at the initiating chain-end was obtained, as expected. H-1 and C-13 NMR spectra of a TBZL-BnOH mixture suggested the formation of a complex; the complex was the initiating species. The M-n increased linearly with increasing conversion. This means that the number of polymer chains is constant throughout the polymerization. The molecular weight distributions were relatively narrow, except with increased temperatures and/or prolonged polymerization times. This system does not need a high polymerization temperature or long polymerization time and uses a metal compound that has little effect on the environment. Poly(epsilon-caprolactone) with a narrow molecular weight distribution can therefore be obtained under mild conditions.	[Oshimura, Miyuki; Okazaki, Ryo; Hirano, Tomohiro; Ute, Koichi] Univ Tokushima, Inst Sci & Technol, Dept Chem Sci & Technol, Tokushima 7708506, Japan	Oshimura, M (reprint author), Univ Tokushima, Inst Sci & Technol, Dept Chem Sci & Technol, 2-1 Minamijosanjima, Tokushima 7708506, Japan.	oshimura@chem.tokushima-u.ac.jp					DUDA A, 1995, MACROMOLECULES, V28, P5981, DOI 10.1021/ma00122a001; Kakuchi R, 2010, MACROMOLECULES, V43, P7090, DOI 10.1021/ma100798u; Kobayashi M, 2004, MACROMOLECULES, V37, P4339, DOI 10.1021/ma0400261; Chen HL, 2013, INORG CHEM COMMUN, V35, P247, DOI 10.1016/j.inoche.2013.06.048; Stevels WM, 1996, MACROMOLECULES, V29, P8296, DOI 10.1021/ma960701+; Dubois P, 1996, MACROMOLECULES, V29, P1965, DOI 10.1021/ma951738h; Furuyama T, 2008, CHEM-EUR J, V14, P10348, DOI 10.1002/chem.200800536; Labet M, 2009, CHEM SOC REV, V38, P3484, DOI 10.1039/b820162p; Petrus R, 2012, ORGANOMETALLICS, V31, P4755, DOI 10.1021/om300321h; Hirano T, 2012, POLYMER, V53, P4961, DOI 10.1016/j.polymer.2012.09.004; Kitayama T, 2000, POLYM BULL, V45, P97, DOI 10.1007/PL00006834; Uchiyama M, 2008, J AM CHEM SOC, V130, P472, DOI 10.1021/ja071268u	12	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	DEC	2014	46	12					866	872		10.1038/pj.2014.76		7	Polymer Science	Polymer Science	AW1YX	WOS:000346086000004		
J	Yang, CM; Ishimoto, K; Matsuura, S; Koyasu, N; Takahashi, I				Yang, Chunming; Ishimoto, Kohei; Matsuura, Syunsui; Koyasu, Naoki; Takahashi, Isao			Depth-dependent inhomogeneous characteristics in supported glassy polystyrene films revealed by ultra-low X-ray reflectivity measurements	POLYMER JOURNAL			English	Article							THIN POLYMER LAYERS; TRANSITION TEMPERATURES; MOLECULAR-WEIGHT; DYNAMICS; INTERFACE; SURFACE; MOTION; CONFINEMENT; THICKNESS; MOBILITY	This study reports X-ray reflectivity measurements of the glass transition of polystyrene thin films supported on Si substrates and heated at low heating rates that ranged from 0.14 to 0.01 degrees C min(-1). At a heating rate of 0.14 degrees C min(-1), the glass transition temperature T-g was independent of the film thickness down to a thickness of 6 nm. However, at a heating rate of 0.04 degrees C min(-1), the value of T-g decreased with decreased thickness. The reduction in T-g was most significant at the ultra-low heating rate of 0.01 degrees C min(-1). Furthermore, with decreased film thickness, the linear thermal expansivity in the glassy state alpha(glass) slightly decreased at a heating rate of 0.14 degrees C min(-1), whereas alpha(glass) exhibited a significant increase at the ultra-low heating rate of 0.01 degrees C min(-1). Reconstructed depth profiles of thermal expansivity, which were obtained by fitting the alpha(glass) values using an integral model, indicated a decrease in the thickness of the interfacial dead layer with a decrease in the heating rate, whereas the volume fraction of the free surface region increased under this condition. The observed reduction in T-g can be attributed to surface and interface effects perturbing the glass transition dynamics of the thin films under slower probing conditions.	[Yang, Chunming] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai, Peoples R China; [Ishimoto, Kohei; Matsuura, Syunsui; Koyasu, Naoki; Takahashi, Isao] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Phys, Sanda, Hyogo 6691337, Japan	Yang, CM (reprint author), Kwansei Gakuin Univ, Sch Sci & Technol, Dept Phys, 2-1 Gakuen, Sanda, Hyogo 6691337, Japan.	yangchunming@sinap.ac.cn; z96019@kwansei.ac.jp			Japan Society for the Promotion of Science [24560033]	This study was financially supported by the Japan Society for the Promotion of Science (Grant-in-Aid for Scientific Research(C) 24560033).	Tanaka K, 2009, J PHYS CHEM B, V113, P4571, DOI 10.1021/jp810370f; Bhattacharya M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.041801; Soles CL, 2004, MACROMOLECULES, V37, P2890, DOI 10.1021/ma035579a; Tress M, 2010, MACROMOLECULES, V43, P9937, DOI 10.1021/ma102031k; Reiter G, 2005, NAT MATER, V4, P754, DOI 10.1038/nmat1484; Ge S, 2000, PHYS REV LETT, V85, P2340, DOI 10.1103/PhysRevLett.85.2340; Forrest JA, 2001, ADV COLLOID INTERFAC, V94, P167, DOI 10.1016/S0001-8686(01)00060-4; Zheng X, 1997, PHYS REV LETT, V79, P241, DOI 10.1103/PhysRevLett.79.241; Paeng K, 2011, J AM CHEM SOC, V133, P8444, DOI 10.1021/ja2022834; DeMaggio GB, 1997, PHYS REV LETT, V78, P1524, DOI 10.1103/PhysRevLett.78.1524; Kawana S, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021501; Gao SY, 2013, MACROMOLECULES, V46, P562, DOI 10.1021/ma3020036; Napolitano S, 2010, ACS NANO, V4, P841, DOI 10.1021/nn9014517; Roland CM, 2003, J CHEM PHYS, V119, P1838, DOI 10.1063/1.1581850; Dalnoki-Veress K, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.031801; Serghei A, 2008, MACROMOLECULES, V41, P3636, DOI 10.1021/ma702381t; Alcoutlabi M, 2005, J PHYS-CONDENS MAT, V17, pR461, DOI 10.1088/0953-8984/17/15/R01; Kim S, 2011, MACROMOLECULES, V44, P4546, DOI 10.1021/ma200617j; Ellison CJ, 2003, NAT MATER, V2, P695, DOI 10.1038/nmat980; Miyazaki T, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.061803; Zhang C, 2012, ACS MACRO LETT, V1, P1317, DOI 10.1021/mz300391g; Paeng K, 2012, SOFT MATTER, V8, P819, DOI 10.1039/c1sm06501g; Efremov MY, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.085703; Fakhraai Z, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.025701; Kim S, 2009, EUR PHYS J E, V30, P83, DOI 10.1140/epje/i2009-10510-y; Bahar I., 1992, MACROMOLECULES, V25, P826; Erber M, 2010, MACROMOLECULES, V43, P7729, DOI 10.1021/ma100912r; Inoue R, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032601; Inoue R, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031802; Keddie J. L., 1994, EPL, V27, P1994; Miyazaki T, 2007, EUR PHYS J-SPEC TOP, V141, P203, DOI 10.1141/epjst/e2007-00035-6; Qi D, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11056-1; Sharp JS, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031805; Singh L, 2004, THIN SOLID FILMS, V449, P231, DOI 10.1016/S0040-6090(03)01353-1; Yang CM, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13066-3; Yang CM, 2011, POLYM J, V43, P390, DOI 10.1038/pj.2010.145; Yang CM, 2009, POLYM J, V41, P1036, DOI 10.1295/polymj.PJ2009077	37	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	DEC	2014	46	12					873	879		10.1038/pj.2014.80		7	Polymer Science	Polymer Science	AW1YX	WOS:000346086000005		
J	Yamaguchi, S; Kawabata, R; Yamamoto, E; Nagamune, T				Yamaguchi, Satoshi; Kawabata, Ryoichiro; Yamamoto, Etsushi; Nagamune, Teruyuki			Imidazolium-based polymer hydrogels with microdomains as carriers of hydrophobic molecules	POLYMER JOURNAL			English	Article							CHROMATOGRAPHY	Alkyl imidazolium-based polymer hydrogels were prepared by copolymerizing N-allylimidazolium chloride monomers (AlImCls) bearing four types of alkyl groups with N-isopropylacrylamide and N, N'-methylenebisacrylamide. The conditions for preparing the anion-responsive hydrogels were screened by gelation test before and after the addition of tetrafluoroborate anions. The sol-gel phase transition was observed in N-dodecyl and N-octadecyl AlImCls-based copolymer solutions. Considering the anion selectivity in the gelation test, this phase transition was assumed to be derived from the formation of water-immiscible ion pairs of N-allylimidazolium cations and large anions on the polymers. Microscopic observations revealed that spherical domains with micro-sized diameters were formed in the hydrogels. A hydrophobized fluorescent dye was localized to the microdomains. Observations using time-lapse confocal microscopy and electron microscopy indicated that large microdomains were captured by the gel meshes consisting of thin sub-micron fibers. Based on the data collected during the analysis of the copolymer solutions, the spherical microdomains and the thin gel meshes were presumably formed through the anion-induced aggregation of small copolymer assemblies. Furthermore, the high fluidity of the microdomains was confirmed by measuring fluorescence recovery after photobleaching. In summary, anion-responsive hydrogels with hydrophobic microdomains were developed using ionic salt-based copolymers. These hydrogels are promising as a unique carriers for the use in biotechnology.	[Yamaguchi, Satoshi; Kawabata, Ryoichiro; Yamamoto, Etsushi; Nagamune, Teruyuki] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan; [Nagamune, Teruyuki] Univ Tokyo, Grad Sch Engn, Dept Bioengn, Tokyo 1138656, Japan	Yamaguchi, S (reprint author), Univ Tokyo, Grad Sch Engn, Dept Bioengn,Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	yamaguchi@bioorg.rcast.u-tokyo.ac.jp; nagamune@bio.t.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Center for NanoBio Integration	This work was supported by a Grant-in-Aid for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science and Technology and the Center for NanoBio Integration. We thank Prof. Kazunari Akiyoshi at Kyoto University for assisting with the TEM observation of the hydrogels and for helpful advice on this study. We thank Prof. Ryosuke Matsuno at Kyushu University for kindly helping us with the analysis of the copolymer solutions.	Penaloza DP, 2013, SOFT MATTER, V9, P5166, DOI 10.1039/c3sm50225b; Qiu HD, 2012, ANAL CHIM ACTA, V738, P95, DOI 10.1016/j.aca.2012.06.018; Tamaru S, 2005, CHEM LETT, V34, P294, DOI 10.1246/cl.2005.294; Texter J, 2012, MACROMOL RAPID COMM, V33, P1996, DOI 10.1002/marc.201200525; Yamaguchi S, 2005, J AM CHEM SOC, V127, P11835, DOI 10.1021/ja052838y; Yan F, 2007, ANGEW CHEM INT EDIT, V46, P2440, DOI 10.1002/anie.200604127; Wada A, 2009, J AM CHEM SOC, V131, P5321, DOI 10.1021/ja900500j; Huddleston JG, 2001, GREEN CHEM, V3, P156, DOI 10.1039/b103275p; Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619; Gombotz WR, 2012, ADV DRUG DELIVER REV, V64, P194, DOI 10.1016/j.addr.2012.09.007; Liu Y, 2012, SOFT MATTER, V8, P4517, DOI 10.1039/c2sm25092f; PARK TG, 1993, ENZYME MICROB TECH, V15, P476, DOI 10.1016/0141-0229(93)90079-H; Read TA, 2001, NAT BIOTECHNOL, V19, P29, DOI 10.1038/83471; Tamaru S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1018; Yoshimoto M, 1998, J CHROMATOGR B, V712, P59, DOI 10.1016/S0378-4347(98)00157-1; Zalipsky S., 2007, J DRUG TARGET, V15, P18	16	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0032-3896	1349-0540		POLYM J	Polym. J.	DEC	2014	46	12					880	886		10.1038/pj.2014.77		7	Polymer Science	Polymer Science	AW1YX	WOS:000346086000006		
J	Honda, T; Fujimoto, K; Miyao, Y				Honda, Tsuyoshi; Fujimoto, Kazuteru; Miyao, Yuji			Feasibility of virtual 3-Fr percutaneous coronary intervention using standard guiding catheters	POSTEPY W KARDIOLOGII INTERWENCYJNEJ			English	Article						virtual 3-Fr percutaneous coronary intervention	SHEATH	Introduction: Recent studies have reported the efficacy of sheathless percutaneous coronary intervention (PCI) using hydrophilic-coated 5-Fr guiding catheters that are one to two Fr sizes smaller in diameter than the corresponding introducer sheath (virtual 3-Fr PCI). However, the limited number of shapes of hydrophilic-coated guiding catheters occasionally makes them difficult to engage and control. Aim: To evaluate the efficacy and feasibility of virtual 3-Fr PCI using standard guiding catheters of various shapes. Material and methods: We identified 35 consecutive patients with stable angina, who underwent virtual 3-Fr PCI using either hydrophilic-coated guiding catheters (Works (TM), Medikit, Japan) or standard guiding catheters (Heartrail (TM), Terumo, Japan). Results: Thirty-five patients were identified (63% men; mean age 70 +/- 13 years). In 2 cases, hydrophilic-coated guiding catheters were exchanged to standard guiding catheters because of difficulty in engaging the target coronary arteries. Ultimately, standard guiding catheters were used in 20 patients (57%) and hydrophilic-coated catheters were used in 15 (43%). One Of 20 patients treated with standard guiding catheters and 1 of 15 treated with hydrophilic-coated guiding catheters underwent the 4-in-3 "slender mother and child" PCI technique due to difficulty of stent deployment. There were no differences between the two groups in PCI procedural variables such as procedural time, fluoroscopy time, radiation dose, or contrast dye volume. There were no access site-related complications in this study. Conclusions: These findings indicate that virtual 3-Fr PCI using standard guiding catheters is as efficient and safe as virtual 3-Fr PCI using hydrophilic-coated guiding catheters.	[Honda, Tsuyoshi] Natl Hosp Org, Kumamoto Saisyunsou Hosp, Dept Cardiol, Kumamoto 8611196, Japan; [Fujimoto, Kazuteru; Miyao, Yuji] Natl Hosp Org, Kumamoto Med Ctr, Ctr Cardiovasc, Dept Cardiol, Kumamoto, Japan	Honda, T (reprint author), Natl Hosp Org, Kumamoto Saisyunsou Hosp, Dept Cardiol, 2659 Suya, Kumamoto 8611196, Japan.	tsuyohonda-circ@umin.ac.jp					Honda T, 2010, J CARDIOL, V56, P197, DOI 10.1016/j.jjcc.2010.05.006; Saito S, 1999, CATHETER CARDIO INTE, V46, P173, DOI 10.1002/(SICI)1522-726X(199902)46:2<173::AID-CCD12>3.0.CO;2-4; Bayard YL, 2011, CATHETER CARDIO INTE, V78, P47, DOI 10.1002/ccd.22853; GRUNTZIG A, 1977, SCHWEIZ MED WSCHR, V107, P1588; Honda T, 2013, POSTEP KARDIOL INTER, V9, P286, DOI 10.5114/pwki.2013.37511; Honda T, 2014, J CARDIOL, V63, P358, DOI 10.1016/j.jjcc.2013.10.007; Honda Tsuyoshi, 2012, Cardiovasc Interv Ther, V27, P174; Ikari Y, 2012, CARDIOVASC INTERV TH, V27, P84; Kiemeneij F, 1997, J AM COLL CARDIOL, V29, P1269; Mizuno S, 2010, CATHETER CARDIO INTE, V75, P983, DOI 10.1002/ccd.22379; Sakatani T, 2003, CIRC J, V67, P895, DOI 10.1253/circj.67.895; Takeshita S, 2009, CATHETER CARDIO INTE, V74, P862, DOI 10.1002/ccd.22098; Thygesen K, 2007, CIRCULATION, V116, P2643; Yoshimachi F, 2008, J INVASIVE CARDIOL, V20, P168; Yoshimachi Fuminobu, 2007, J Invasive Cardiol, V19, P519	15	0	0	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	WENEDOW ST 9-1, POZNAN, 61-614, POLAND	1734-9338	1897-4295		POSTEP KARDIOL INTER	Postep. Kardiol. Interwencyjnej	DEC	2014	10	4					231	237		10.5114/pwki.2014.46763		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AW1IH	WOS:000346042800003		
J	Ninomiya, Y; Miyamoto, S; Tenjin, T; Ogino, S; Miyake, N; Kaneda, Y; Sumiyoshi, T; Yamaguchi, N				Ninomiya, Yuriko; Miyamoto, Seiya; Tenjin, Tomomi; Ogino, Shin; Miyake, Nobumi; Kaneda, Yasuhiro; Sumiyoshi, Tomiki; Yamaguchi, Noboru			Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: A 1-year open-label trial	PSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article						blonanserin; cognition; first-episode schizophrenia; second-generation antipsychotics; subjective well-being	QUALITY-OF-LIFE; ANTIPSYCHOTIC-DRUGS; DOUBLE-BLIND; JAPANESE VERSION; VALIDATION; REMISSION; SYMPTOMS; SCALE; INDIVIDUALS; PREDICTION	AimsThe purpose of this study was to evaluate the long-term effectiveness and safety of blonanserin, a second-generation antipsychotic drug developed in Japan, in patients with first-episode schizophrenia. MethodsTwenty-three antipsychotic-naive patients with first-episode schizophrenia were treated within an open-label, 1-year, prospective trial of blonanserin (2-24mg/day). Clinical evaluations were conducted at baseline and 2, 6, and 12 months after the start of treatment. The main outcome measures were changes in subjective well-being and subjective quality of life, as assessed by the Subjective Well-being under Neuroleptic treatment scale Short form-Japanese version and the Schizophrenia Quality of Life Scale-Japanese version, respectively. Secondary outcome measures included the Positive and Negative Syndrome Scale, the Brief Assessment of Cognition in Schizophrenia-Japanese version, laboratory tests, bodyweight, and extrapyramidal symptoms. ResultsFourteen patients (60.9%) remained on the study at 1 year. In the intention-to-treat analysis, significant improvements were observed in several subscales on the Subjective Well-being under Neuroleptic treatment scale Short form-Japanese version, the Schizophrenia Quality of Life Scale-Japanese version, and the Brief Assessment of Cognition in Schizophrenia-Japanese version, and in all factor scores on the Positive and Negative Syndrome Scale. Improvement in depressive symptoms with blonanserin treatment was positively correlated with improvements in subjective well-being and subjective quality of life, as well as verbal memory. No significant changes were noted for any safety measure during the 1-year study period. ConclusionsBlonanserin was well tolerated and effective for the treatment of first-episode schizophrenia in terms of subjective wellness, cognition, and a wide range of pathological symptoms. Further large-scale studies are warranted to confirm our findings.	[Ninomiya, Yuriko; Miyamoto, Seiya; Tenjin, Tomomi; Ogino, Shin; Miyake, Nobumi; Yamaguchi, Noboru] St Marianna Univ, Sch Med, Dept Neuropsychiat, Kawasaki, Kanagawa 2168511, Japan; [Kaneda, Yasuhiro] Iwaki Clin, Dept Psychiat, Tokushima, Japan; [Sumiyoshi, Tomiki] Natl Ctr Neurol & Psychiat, Tokyo, Japan	Ninomiya, Y (reprint author), St Marianna Univ, Sch Med, Dept Neuropsychiat, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	y2ninomiya@marianna-u.ac.jp			Health and Labour Sciences Research Grants, Comprehensive Research on Disability, Health and Welfare; Japan Society for Promotion of Sciences	This work was supported in part by Health and Labour Sciences Research Grants, Comprehensive Research on Disability, Health and Welfare, and grants from the Japan Society for Promotion of Sciences. The authors thank Jun Arai, Haruki Teramoto, Sachiko Tsukahara, Yukie Ito, Masanori Tadokoro, Kiriko Anai, and Yasuyuki Funamoto for cognitive assessment. Dr Miyamoto is a consultant for Dainippon Sumitomo and has received advisory board honoraria from Chugai Pharmaceutical and speaker's honoraria from Dainippon Sumitomo and Otsuka. Dr Tenjin has received speaker's honoraria from Dainippon Sumitomo. Dr Miyake has received speaker's honoraria from Dainippon Sumitomo, Eli Lilly, Mitsubishi Tanabe, Otsuka, and Yoshitomi. Dr Sumiyoshi has received advisory board and/or speaker's honoraria from Dainippon Sumitomo, Eli Lilly, Mitsubishi Tanabe, Yoshitomi, and Takeda. Dr Yamaguchi has received advisory board and/or speaker's honoraria from Daiichi Sankyo, Eizai, Eli Lilly, Janssen, Otsuka, and Takeda. No other authors have any conflicts of interest.	American Psychiatric Association, 2000, DIAGN CRIT DSM 4 TR; Lambert M, 2008, ACTA PSYCHIAT SCAND, V118, P220, DOI 10.1111/j.1600-0447.2008.01213.x; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261; Naber D, 2001, SCHIZOPHR RES, V50, P79, DOI 10.1016/S0920-9964(00)00166-3; Gorna K, 2008, QUAL LIFE RES, V17, P237, DOI 10.1007/s11136-007-9296-z; Kahn RS, 2008, LANCET, V371, P1085, DOI 10.1016/S0140-6736(08)60486-9; Kaneda Y, 2002, PSYCHIAT RES, V113, P107, DOI 10.1016/S0165-1781(02)00240-8; Garcia E, 2009, CNS DRUGS, V23, P615, DOI 10.2165/00023210-200923070-00006; Bowie CR, 2010, AM J PSYCHIAT, V167, P1116, DOI 10.1176/appi.ajp.2010.09101406; LINDENMAYER JP, 1994, J NERV MENT DIS, V182, P631, DOI 10.1097/00005053-199411000-00006; Karow A, 2002, PSYCHOPHARMACOLOGY, V162, P3, DOI 10.1007/s00213-002-1052-z; Kim JH, 2012, PSYCHIAT RES, V197, P285, DOI 10.1016/j.psychres.2011.10.006; Tenjin T, 2013, NEUROPSYCH DIS TREAT, V9, P587, DOI 10.2147/NDT.S34433; Lambert M, 2006, J CLIN PSYCHIAT, V67, P1690; Strauss GP, 2012, COMPR PSYCHIAT, V53, P1137, DOI 10.1016/j.comppsych.2012.05.009; Leucht S, 2006, NEUROPSYCHOPHARMACOL, V31, P2318, DOI 10.1038/sj.npp.1301147; Kishi T, 2013, J PSYCHIATR RES, V47, P149, DOI 10.1016/j.jpsychires.2012.10.011; Baker SC, 1996, NEUROPSYCHOLOGIA, V34, P515, DOI 10.1016/0028-3932(95)00133-6; Ohoyama K, 2011, EUR J PHARMACOL, V653, P47, DOI 10.1016/j.ejphar.2010.11.023; Gourovitch ML, 2000, NEUROPSYCHOLOGY, V14, P353, DOI 10.1037//0894-4105.14.3.353; Yang J, 2010, CLIN NEUROPHARMACOL, V33, P169, DOI 10.1097/WNF.0b013e3181dcda50; Deeks ED, 2010, CNS DRUGS, V24, P65, DOI 10.2165/11202620-000000000-00000; Kaneda Y, 2007, PSYCHIAT CLIN NEUROS, V61, P602, DOI 10.1111/j.1440-1819.2007.01725.x; Hasan A, 2012, WORLD J BIOL PSYCHIA, V13, P318, DOI 10.3109/15622975.2012.696143; Harvey Philip D, 2011, Innov Clin Neurosci, V8, P14; Inada T, 1996, EVALUATION DIAGNOSIS; Kaneda Y, 2013, SEISHIN IGAKU CLIN P, V55, P167; Kim JH, 2014, COMPR PSYCHIAT, V55, P708, DOI 10.1016/j.comppsych.2013.11.002; Kinoshita T., 2008, JPN J CLIN PSYCHOPHA, V11, P135; Lambert M, 2007, ACTA PSYCHIAT SCAND, V115, P106, DOI 10.1111/j.1600-0447.2006.00862.x; Miura S., 2008, JPN J CLIN PSYCHOPHA, V11, P297; Miyake N, 2008, JPN J CLIN PSYCHOPHA, V11, P315; Miyamoto S, 2008, PSYCHIATRY, P2161; Murasaki M., 2007, JPN J CLIN PSYCHOPHA, V10, P2059; Tenjin T, 2012, HUM PSYCHOPHARM CLIN, V27, P90, DOI 10.1002/hup.1276; Uzenoff SR, 2010, EARLY INTERV PSYCHIA, V4, P174, DOI 10.1111/j.1751-7893.2010.00178.x; VANPUTTEN T, 1981, ARCH GEN PSYCHIAT, V38, P187; Vothknecht S, 2011, AUST NZ J PSYCHIAT, V45, P182, DOI 10.3109/00048674.2010.545984; Watanabe M, 2003, JPN J CLIN PSYCHOPHA, V6, P905	39	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1323-1316	1440-1819		PSYCHIAT CLIN NEUROS	Psychiatry Clin. Neurosci.	DEC	2014	68	12					841	849		10.1111/pcn.12202		9	Clinical Neurology; Neurosciences; Psychiatry	Neurosciences & Neurology; Psychiatry	AW0LJ	WOS:000345983400004		
J	Shinomura, M; Kishi, K; Tomita, A; Kawasumi, M; Kanezashi, H; Kuroda, Y; Tsunekawa, N; Ozawa, A; Aiyama, Y; Yoneda, A; Suzuki, H; Saito, M; Picard, JY; Kohno, K; Kurohmaru, M; Kanai-Azuma, M; Kanai, Y				Shinomura, Mai; Kishi, Kasane; Tomita, Ayako; Kawasumi, Miyuri; Kanezashi, Hiromi; Kuroda, Yoshiko; Tsunekawa, Naoki; Ozawa, Aisa; Aiyama, Yoshimi; Yoneda, Asuka; Suzuki, Hitomi; Saito, Michiko; Picard, Jean-Yves; Kohno, Kenji; Kurohmaru, Masamichi; Kanai-Azuma, Masami; Kanai, Yoshiakira			A novel Amh-Treck transgenic mouse line allows toxin-dependent loss of supporting cells in gonads	REPRODUCTION			English	Article							ANTI-MULLERIAN HORMONE; GERM-CELL; TESTIS DIFFERENTIATION; FOLLICLE DEVELOPMENT; MICE; EXPRESSION; SERTOLI; SOX9; GENE	Cell ablation technology is useful for studying specific cell lineages in a developing organ in vivo. Herein, we established a novel anti-Mullerian hormone (AMH)-toxin receptor-mediated cell knockout (Treck) mouse line, in which the diphtheria toxin (DT) receptor was specifically activated in Sertoli and granulosa cells in postnatal testes and ovaries respectively. In the postnatal testes of Amh-Treck transgenic (Tg) male mice, DT injection induced a specific loss of the Sertoli cells in a dose-dependent manner, as well as the specific degeneration of granulosa cells in the primary and secondary follicles caused by DT injection in Tg females. In the testes with depletion of Sertoli cell, germ cells appeared to survive for only several days after DT treatment and rapidly underwent cell degeneration, which led to the accumulation of a large amount of cell debris within the seminiferous tubules by day 10 after DT treatment. Transplantation of exogenous healthy Sertoli cells following DT treatment rescued the germ cell loss in the transplantation sites of the seminiferous epithelia, leading to a partial recovery of the spermatogenesis. These results provide not only in vivo evidence of the crucial role of Sertoli cells in the maintenance of germ cells, but also show that the Amh-Treck Tg line is a useful in vivo model of the function of the supporting cell lineage in developing mammalian gonads.	[Shinomura, Mai; Kishi, Kasane; Tomita, Ayako; Kanezashi, Hiromi; Kuroda, Yoshiko; Tsunekawa, Naoki; Ozawa, Aisa; Aiyama, Yoshimi; Yoneda, Asuka; Kurohmaru, Masamichi; Kanai, Yoshiakira] Univ Tokyo, Dept Vet Anat, Bunkyo Ku, Tokyo 1138657, Japan; [Kawasumi, Miyuri; Suzuki, Hitomi; Kanai-Azuma, Masami] Tokyo Med & Dent Univ, Ctr Expt Anim, Dept Expt Animal Model Human Dis, Bunkyo Ku, Tokyo 1138510, Japan; [Saito, Michiko; Kohno, Kenji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara 6300192, Japan; [Picard, Jean-Yves] Univ Paris 07, BFA, INSERM U1133, F-75205 Paris 13, France	Kanai, Y (reprint author), Univ Tokyo, Dept Vet Anat, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	aykanai@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [S-24228005, PA-23132504, PA-25132703, C-24500485]	This work was supported by a grant from the Ministry of Education, Science, Sports and Culture of Japan to (S-24228005, PA-23132504, PA-25132703, and C-24500485). M Shinomura and Y Aiyama are DC1 JSPS Research Fellows.	AlAttar L, 1997, J CLIN INVEST, V100, P1335, DOI 10.1172/JCI119653; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Harikae K, 2013, DEV DYNAM, V242, P330, DOI 10.1002/dvdy.23872; Harikae K, 2013, J CELL SCI, V126, P2834, DOI 10.1242/jcs.122663; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Choi Y, 2006, CELL MOL LIFE SCI, V63, P579, DOI 10.1007/s00018-005-5394-7; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Kidokoro T, 2005, DEV BIOL, V278, P511, DOI 10.1016/j.ydbio.2004.11.006; Shinohara T, 2003, BIOL REPROD, V68, P1064, DOI 10.1095/biolreprod.102.009977; Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Hiramatsu R, 2010, DEVELOPMENT, V137, P303, DOI 10.1242/dev.040519; Gao F, 2006, P NATL ACAD SCI USA, V103, P11987, DOI 10.1073/pnas.0600994103; Feng CW, 2014, MOL CELL ENDOCRINOL, V382, P488, DOI 10.1016/j.mce.2013.09.026; Barrionuevo F, 2009, DEV BIOL, V327, P301, DOI 10.1016/j.ydbio.2008.12.011; Buratini J, 2011, REPROD FERT DEVELOP, V23, P32, DOI 10.1071/RD10224; Furukawa N, 2006, J BIOCHEM, V140, P831, DOI 10.1093/jb/mvj216; GUERRIER D, 1990, J REPROD FERTIL, V88, P695; Hummitzsch K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055578; Matsui Y, 1998, APMIS, V106, P142; Matsuoka K, 2013, BIOCHEM BIOPH RES CO, V436, P400, DOI 10.1016/j.bbrc.2013.05.114; Mork L, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095208; Nagai R, 2012, DEV DYNAM, V241, P1374, DOI 10.1002/dvdy.23824; Sato T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028367; Takada T, 2008, TRANSGENIC RES, V17, P1155, DOI 10.1007/s11248-008-9203-6; Zhang L, 2011, SPERMATOGENESIS, V1, P186, DOI DOI 10.4161/SPMG.1.3.17760	28	2	2	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	1470-1626			REPRODUCTION	Reproduction	DEC	2014	148	6					H1	H9		10.1530/REP-14-0171		9	Developmental Biology; Reproductive Biology	Developmental Biology; Reproductive Biology	AU9LN	WOS:000345914400001		
J	Murata, Y; Nakajima, R; Okamoto, R; Tamura, R				Murata, Yasusada; Nakajima, Ryo; Okamoto, Ryosuke; Tamura, Ryuichi			LOCALIZED KNOWLEDGE SPILLOVERS AND PATENT CITATIONS: A DISTANCE-BASED APPROACH	REVIEW OF ECONOMICS AND STATISTICS			English	Article							MANUFACTURING-INDUSTRIES; GEOGRAPHY; REASSESSMENT; SENSITIVITY; EXOGENEITY; PATTERNS	We develop a new distance-based test of localized knowledge spillovers that embeds the concept of control patents. Using microgeographic data, we identify localization distance for each technology class while allowing for spillovers across geographic units. We revisit the debate between Thompson and Fox-Kean (2005a, 2005b) and Henderson, Jaffe, and Trajtenberg (2005) on the existence of localized knowledge spillovers and find solid evidence supporting localization even when using finely grained controls. Unless biases induced by imperfect matching between citing and control patents due to unobserved heterogeneity are extremely large, our distance-based test detects localization for the majority of technology classes.	[Murata, Yasusada] Nihon Univ, Adv Res Inst Sci & Humanities, Tokyo 102, Japan; [Nakajima, Ryo] Keio Univ, Tokyo 108, Japan; [Tamura, Ryuichi] Hitotsubashi Univ, Inst Innovat Res, Tokyo, Japan	Murata, Y (reprint author), Nihon Univ, Adv Res Inst Sci & Humanities, Tokyo 102, Japan.						Agrawal A, 2010, J URBAN ECON, V67, P78, DOI 10.1016/j.jue.2009.10.004; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Nakajima R, 2010, LABOUR ECON, V17, P723, DOI 10.1016/j.labeco.2009.11.006; Ellison G, 2010, AM ECON REV, V100, P1195, DOI 10.1257/aer.100.3.1195; Imbens GW, 2004, REV ECON STAT, V86, P4, DOI 10.1162/003465304323023651; Duranton G, 2008, J REGIONAL SCI, V48, P213; Agrawal A, 2008, J URBAN ECON, V64, P258, DOI 10.1016/j.jue.2008.01.003; Altonji JG, 2005, J POLIT ECON, V113, P151, DOI 10.1086/426036; Imbens GW, 2003, AM ECON REV, V93, P126, DOI 10.1257/000282803321946921; Ichino A, 2008, J APPL ECONOM, V23, P305, DOI 10.1002/jae.998; Henderson R, 2005, AM ECON REV, V95, P461, DOI 10.1257/0002828053828644; Duranton G, 2005, REV ECON STUD, V72, P1077, DOI 10.1111/0034-6527.00362; Almeida P, 1996, STRATEGIC MANAGE J, V17, P155; Combes PP, 2006, REG SCI URBAN ECON, V36, P1, DOI 10.1016/j.regsciurbeco.2005.06.003; Thompson P, 2005, AM ECON REV, V95, P450, DOI 10.1257/0002828053828509; Desmet Klaus, 2009, 200918 I MADR EST AV; Ellison G, 1997, J POLIT ECON, V105, P889, DOI 10.1086/262098; Hall B. H., 2001, 8498 NBER; JAFFE AB, 1993, Q J ECON, V108, P577, DOI 10.2307/2118401; Kendall MG, 1963, GEOMETRICAL PROBABIL; Kerr William R., 2012, US CENSUS BUREAU WOR; Manski C. F., 2007, IDENTIFICATION PREDI; Murata Yasusada, 2011, GRIPS DISCUSSION PAP; Rosenbaum PR, 2002, OBSERVATIONAL STUDIE; Silverman BW, 1986, DENSITY ESTIMATION S; Singh Jasjit, 2012, GEOGRAPHIC CONSTRAIN; Thompson P, 2005, AM ECON REV, V95, P465, DOI 10.1257/0002828053828617; Thompsori P, 2006, REV ECON STAT, V88, P383, DOI 10.1162/rest.88.2.383; Trajtenberg M, 2006, 12479 NBER; Wooldridge JM, 2010, ECONOMETRIC ANALYSIS OF CROSS SECTION AND PANEL DATA, 2ND EDITION, P1	30	2	2	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA	0034-6535	1530-9142		REV ECON STAT	Rev. Econ. Stat.	DEC	2014	96	5					967	985		10.1162/REST_a_00422		19	Economics; Social Sciences, Mathematical Methods	Business & Economics; Mathematical Methods In Social Sciences	AW1MK	WOS:000346053300014		
J	Imai, A; Hayashi, N; Shiina, A; Sakikawa, N; Igarashi, Y				Imai, Atsushi; Hayashi, Naoki; Shiina, Akihiro; Sakikawa, Noriko; Igarashi, Yoshito			Factors associated with violence among Japanese patients with schizophrenia prior to psychiatric emergency hospitalization: A case-controlled study	SCHIZOPHRENIA RESEARCH			English	Article						Violence; Schizophrenia; Japanese; Case-control study	BEHAVIOR; HALLUCINATIONS; DELUSIONS; HOMICIDE; SUICIDE	Background: Numerous studies have examined a wide range of risk factors associated with violence among patients with schizophrenia. However, risk factors linked to different socio-cultural backgrounds remain unclear. Objective: The objectives were to investigate factors associated with violence among Japanese patients with schizophrenia prior to emergency hospitalizations and to compare them with factors found in studies on other populations. Methods: We recruited 420 Japanese patients with schizophrenia who had committed violent acts immediately prior to emergency admission to a psychiatric hospital in Tokyo, during the period 1986 to 2005. Cases were compared with controls (non violent hospitalized patients with schizophrenia) matched for gender, age and admission year. All medical records were reviewed retrospectively. Inter-rater reliability tests of assessment were performed. Conditional logistic regression analysis was used to identify factors associated with violence. Results: The symptoms of gross excitement, prior violence, auditory hallucinations, systematization of delusions, incoherence of speech, delusions of reference, TCO symptoms, living with others and long duration of illness were found to be associated with violence. In contrast, antisocial traits such as substance abuse and antisocial episodes were not recognized as significant violence-associated factors. Conclusion: Violence among Japanese patients with schizophrenia was strongly associated with elements of schizophrenia itself, rather than antisocial traits. This study highlighted associated factors for violence among Japanese patients with schizophrenia which differ distinctly from associated factors in other countries. This result demonstrates that future studies assessing the risk of violence among patients with schizophrenia need to consider cultural and racial differences in cohorts. (C) 2014 Elsevier B.V. All rights reserved.	[Imai, Atsushi; Sakikawa, Noriko] Tokyo Metropolitan Matsuzawa Hosp, Dept Psychiat, Tokyo 1560057, Japan; [Imai, Atsushi; Igarashi, Yoshito] Chiba Univ, Div Law & Psychiat, Ctr Forens Mental Hlth, Chiba, Japan; [Hayashi, Naoki] Teikyo Univ, Sch Med, Dept Psychiat, Tokyo 173, Japan; [Shiina, Akihiro] Chiba Univ Hosp, Dept Psychiat, Chiba, Japan	Imai, A (reprint author), Tokyo Metropolitan Matsuzawa Hosp, Dept Psychiat, Setagaya Ku, 2-1-1 Kamikitazawa, Tokyo 1560057, Japan.	atsushi.imai0518@gmail.com					Swanson JW, 2008, BRIT J PSYCHIAT, V193, P37, DOI 10.1192/bjp.bp.107.042630; Nakatani Y, 2010, INT J LAW PSYCHIAT, V33, P7, DOI 10.1016/j.ijlp.2009.10.005; Nolan KA, 2003, PSYCHIAT SERV, V54, P1012, DOI 10.1176/appi.ps.54.7.1012; Cheung P, 1997, SCHIZOPHR RES, V26, P181, DOI 10.1016/S0920-9964(97)00049-2; Fullam RS, 2008, BRIT J PSYCHIAT, V193, P247, DOI 10.1192/bjp.bp.107.040345; Walsh E, 2004, SCHIZOPHR RES, V67, P247, DOI 10.1016/S0920-9964(03)00091-4; Rasanen P, 1998, SCHIZOPHRENIA BULL, V24, P437; Swanson JW, 2006, ARCH GEN PSYCHIAT, V63, P490, DOI 10.1001/archpsyc.63.5.490; Bo S, 2011, CLIN PSYCHOL REV, V31, P711, DOI 10.1016/j.cpr.2011.03.002; Appelbaum PS, 2000, AM J PSYCHIAT, V157, P566, DOI 10.1176/appi.ajp.157.4.566; Witt K, 2014, SCHIZOPHR RES, V154, P61, DOI 10.1016/j.schres.2014.02.001; Large MM, 2011, SCHIZOPHR RES, V125, P209, DOI 10.1016/j.schres.2010.11.026; McNiel DE, 2000, PSYCHIATR SERV, V51, P1288, DOI 10.1176/appi.ps.51.10.1288; COID J, 1983, PSYCHOL MED, V13, P855; Fazel S, 2010, SCHIZOPHR RES, V123, P263, DOI 10.1016/j.schres.2010.08.019; Heilbrun K., 2009, FDN FORENSIC MENTAL; Kay R. S., 1988, J NERV MENT DIS, V176, P539; Krakowski M. I., 2013, SCHIZOPHR B, V13; Large M, 2008, BRIT J PSYCHIAT, V193, P130, DOI 10.1192/bjp.bp.107.046581; Link B. G., 1994, VIOLENCE MENTAL DISO, P137; Lynn R, 2002, PERS INDIV DIFFER, V32, P273, DOI 10.1016/S0191-8869(01)00029-0; McNiel D. E., 1994, DEV RISK ASSESSMENT, P183; Monahan J., 2001, RETHINKING RISK ASSE; Sato M., 1999, RINSYOU SEISIN IGAKU, P222; Soyka M, 2007, SCHIZOPHR RES, V94, P89, DOI 10.1016/j.schres.2007.03.027; Steadman H. J., 1994, VIOLENCE MENTAL DISO; Tsushima M., 1996, J SOCIOECONOMICS, V25, P497, DOI 10.1016/S1053-5357(96)90041-4; United Nations Office on Drugs and Crime, 2012, WORLD DRUG REP 2012; United Nations Office on Drugs and Crime, 2013, UNODC HOM STAT 2013; Wing JK, 1974, MEASUREMENT CLASSIFI; World Health Organization, 1992, ICD 10 CLASS MENT BE; Yokota K, 2012, PERS INDIV DIFFER, V53, P907, DOI 10.1016/j.paid.2012.07.006; Yoshikawa K., 1995, ACT CRIM JPN, V61, P216	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	DEC	2014	160	1-3					27	32		10.1016/j.schres.2014.10.016		6	Psychiatry	Psychiatry	AW0DU	WOS:000345961300022		
J	Miura, K; Hashimoto, R; Fujimoto, M; Yamamori, H; Yasuda, Y; Ohi, K; Umeda-Yano, S; Fukunaga, M; Iwase, M; Umeda-Yano, S				Miura, Kenichiro; Hashimoto, Ryota; Fujimoto, Michiko; Yamamori, Hidenaga; Yasuda, Yuka; Ohi, Kazutaka; Umeda-Yano, Satomi; Fukunaga, Masaki; Iwase, Masao; Umeda-Yano, Satomi			An integrated eye movement score as a neurophysiological marker of schizophrenia	SCHIZOPHRENIA RESEARCH			English	Letter							PERFORMANCE; VARIANT; IMPACT; GENE		[Miura, Kenichiro] Kyoto Univ, Grad Sch Med, Dept Integrat Brain Sci, Kyoto 6068501, Japan; [Hashimoto, Ryota; Fujimoto, Michiko; Yamamori, Hidenaga; Yasuda, Yuka; Ohi, Kazutaka; Umeda-Yano, Satomi; Iwase, Masao; Umeda-Yano, Satomi] Osaka Univ, Dept Psychiat, Grad Sch Med, Suita, Osaka 5650871, Japan; [Hashimoto, Ryota; Umeda-Yano, Satomi] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Suita, Osaka 5650871, Japan; [Yamamori, Hidenaga] Osaka Univ, Grad Sch Med, Dept Mol Neuropsychiat, Osaka, Japan; [Fukunaga, Masaki] Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi 444, Japan	Miura, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Integrat Brain Sci, Konoe Cho, Kyoto 6068501, Japan.	kmiura@brain.med.kyoto-u.ac.jp; hashimor@psy.med.osaka-u.ac.jp					Hashimoto R, 2010, AM J MED GENET B, V153B, P1459, DOI 10.1002/ajmg.b.31123; Arango C, 1999, AM J PSYCHIAT, V156, P1349; Arolt V, 1998, BIOL PSYCHIAT, V44, P448, DOI 10.1016/S0006-3223(97)00479-4; Benson PJ, 2012, BIOL PSYCHIAT, V72, P716, DOI 10.1016/j.biopsych.2012.04.019; Campana A, 1999, SCHIZOPHRENIA BULL, V25, P789; John JP, 2008, COMPR PSYCHIAT, V49, P78, DOI 10.1016/j.comppsych.2007.07.005; Ohi K, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-40; Perry W, 1998, SCHIZOPHR RES, V33, P69, DOI 10.1016/S0920-9964(98)00061-9; Price GW, 2006, BIOL PSYCHIAT, V60, P1, DOI 10.1016/j.biopsych.2005.09.010	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	DEC	2014	160	1-3					228	229		10.1016/j.schres.2014.10.023		2	Psychiatry	Psychiatry	AW0DU	WOS:000345961300055		
J	Takayanagi, Y; Petersen, L; Laursen, TM; Cascella, NG; Sawa, A; Mortensen, PB; Eaton, W				Takayanagi, Yoichiro; Petersen, Liselotte; Laursen, Thomas M.; Cascella, Nicola G.; Sawa, Akira; Mortensen, Preben B.; Eaton, WilliamW.			Risk of schizophrenia spectrum and affective disorders associated with small for gestational age birth and height in adulthood	SCHIZOPHRENIA RESEARCH			English	Letter							CENTRAL RESEARCH REGISTER; SWEDISH MEN; DANISH		[Takayanagi, Yoichiro; Sawa, Akira; Eaton, WilliamW.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, Baltimore, MD 21205 USA; [Takayanagi, Yoichiro] Toyama Univ, Dept Neuropsychiat, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Petersen, Liselotte; Laursen, Thomas M.; Mortensen, Preben B.] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Cascella, Nicola G.] Sheppard Enoch Pratt Hosp, Neuropsychiat Program, Baltimore, MD USA; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Takayanagi, Y (reprint author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, 624 North Broadway, Baltimore, MD 21205 USA.	ytakaya1@jhu.edu	Mortensen, Preben/D-2358-2015				Knudsen LB, 1998, DAN MED BULL, V45, P320; Gunnell D, 2005, SCHIZOPHR RES, V79, P315, DOI 10.1016/j.schres.2005.07.022; Abel KM, 2010, ARCH GEN PSYCHIAT, V67, P923, DOI 10.1001/archgenpsychiatry.2010.100; Zammit S, 2007, ACTA PSYCHIAT SCAND, V116, P378, DOI 10.1111/j.1600-0447.2007.01063.x; Byrne M, 2004, SOC PSYCH PSYCH EPID, V39, P87, DOI 10.1007/s00127-004-0715-7; Mors O, 2011, SCAND J PUBLIC HEALT, V39, P54, DOI 10.1177/1403494810395825; Nielsen P. R., 2012, SCHIZOPHR B, V39, P1337; Teasdale TW, 2009, SCAND J PSYCHOL, V50, P633, DOI 10.1111/j.1467-9450.2009.00789.x; Uggerby P, 2013, DAN MED J, V60	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-9964	1573-2509		SCHIZOPHR RES	Schizophr. Res.	DEC	2014	160	1-3					230	232		10.1016/j.schres.2014.10.018		3	Psychiatry	Psychiatry	AW0DU	WOS:000345961300056		
J	Zhai, SM; Xue, WH; Yamazaki, D; Ma, F				Zhai ShuangMeng; Xue WeiHong; Yamazaki, Daisuke; Ma Fang			Trace element composition in tuite decomposed from natural apatite in high-pressure and high-temperature experiments	SCIENCE CHINA-EARTH SCIENCES			English	Article						tuite; trace elements; high-pressure and high-temperature	SULU UHP TERRANE; TRICALCIUM PHOSPHATE; MARTIAN METEORITE; DENSE POLYMORPH; ICP-MS; MANTLE; MINERALS; CA3(PO4)2; EARTH; REE	Tuite has been suggested as a potential reservoir for trace elements in the deep mantle, but no evidence confirms this supposition. By using a natural apatite as starting material, the trace-element-bearing tuite large crystals were obtained under high-pressure and high-temperature conditions (15 GPa and 1800 K). X-ray diffraction pattern and Micro-Raman spectrum of the run product confirm that tuite was synthesized. The concentrations of trace elements in tuite crystals were analyzed by laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS). The rare earth element patterns of tuite show enrichment of light rare earth elements relative to heavy rare earth elements. Tuite shows high concentrations of Th and Sr, and negative anomalies of Rb, Nb, and Hf. The results show that tuite can accommodate a large amount of trace elements. Tuite might be an important host to accommodate trace elements if there is much apatite subducted into the deep mantle.	[Zhai ShuangMeng; Xue WeiHong] Chinese Acad Sci, Inst Geochem, Key Lab High Temp & High Pressure Study Earths In, Guiyang 550002, Peoples R China; [Zhai ShuangMeng; Ma Fang] Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China; [Yamazaki, Daisuke] Okayama Univ, Inst Study Earths Interior, Misasa, Tottori 6820193, Japan	Zhai, SM (reprint author), Chinese Acad Sci, Inst Geochem, Key Lab High Temp & High Pressure Study Earths In, Guiyang 550002, Peoples R China.	zhaishuangmeng@vip.gyig.ac.cn			National Natural Science Foundation of China [40973045]	The natural trace-element-bearing apatite sample used in this study was kindly provided by Dr. Geeth Manthilake. We thank Shan Shuangming and Guo Xinzhuan for their helps with the high-pressure and high-temperature experiment and SEM observation. The LA-ICP-MS analysis was performed at Peking University with helps from Sun Yi. Cheng Hao, Liu Shuwen and Ito Eiji are thanked for helpful discussion. This work was financially supported by National Natural Science Foundation of China (Grant No. 40973045).	JOLLIFF BL, 1993, GEOCHIM COSMOCHIM AC, V57, P4069, DOI 10.1016/0016-7037(93)90354-Y; MURAYAMA JK, 1986, PHYS EARTH PLANET IN, V44, P293, DOI 10.1016/0031-9201(86)90057-9; Santosh M, 2010, GEOL MAG, V147, P777, DOI 10.1017/S0016756810000154; Xie XD, 2002, GEOCHIM COSMOCHIM AC, V66, P2439, DOI 10.1016/S0016-7037(02)00833-5; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; BAU M, 1995, CONTRIB MINERAL PETR, V119, P213, DOI 10.1007/s004100050037; Zheng JP, 2005, CHEM GEOL, V221, P243, DOI 10.1016/j.chemgeo.2005.05.002; BESWICK AE, 1978, CONTRIB MINERAL PETR, V67, P317, DOI 10.1007/BF00381459; Konzett J, 2009, J PETROL, V50, P2043, DOI 10.1093/petrology/egp068; Gaspar M, 2008, GEOCHIM COSMOCHIM AC, V72, P185, DOI 10.1016/j.gca.2007.09.033; Schwinn G, 2005, CHEM GEOL, V216, P225, DOI 10.1016/j.chemgeo.2004.11.012; SUGIYAMA K, 1987, PHYS CHEM MINER, V15, P125, DOI 10.1007/BF00308774; Degi J, 2010, CONTRIB MINERAL PETR, V159, P293, DOI 10.1007/s00410-009-0428-z; JACKSON SE, 1992, CAN MINERAL, V30, P1049; Baziotis IP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2414; DOWTY E, 1977, EARTH PLANET SC LETT, V35, P347, DOI 10.1016/0012-821X(77)90136-4; GOPAL R, 1972, NATURE-PHYS SCI, V237, P30; Gramaccioli CM, 1999, EUR J MINERAL, V11, P983; Greshake A, 2009, LUN PLAN 2 I SCI C, V40, P1586; GRIFFIN WL, 1972, EARTH PLANET SC LETT, V15, P53, DOI 10.1016/0012-821X(72)90028-3; Konzett J, 2012, CONTRIB MINERAL PETR, V163, P277, DOI 10.1007/s00410-011-0672-x; Manthilake MAGM, 2008, J ASIAN EARTH SCI, V32, P66, DOI 10.1016/j.jseaes.2007.10.015; Miyahara M, 2011, P NATL ACAD SCI USA, V108, P5999, DOI 10.1073/pnas.1016921108; Nash W. P., 1984, Phosphate Minerals, P215; Ozawa S, 2007, AGU FALL M, V1, P1234; Pearce NJG, 1997, GEOSTANDARD NEWSLETT, V21, P115, DOI 10.1111/j.1751-908X.1997.tb00538.x; Prewitt CT, 1975, LUNAR PLANET SCI, V6, P646; PUCHELT H, 1976, EARTH PLANET SC LETT, V31, P279, DOI 10.1016/0012-821X(76)90220-X; Python M, 2007, J MINER PETROL SCI, V102, P143, DOI 10.2465/jmps.060830; Van Achterbergh E, 2001, LASER ABLATION ICPMS, P239; [谢先德 XIE Xiande], 2008, [地球化学, Geochimica], V37, P297; Xie XD, 2003, EUR J MINERAL, V15, P1001, DOI 10.1127/0935-1221/2003/0015-1001; Zhai SM, 2010, J RAMAN SPECTROSC, V41, P1011, DOI 10.1002/jrs.2522; Zhai SM, 2011, PHYS CHEM MINER, V38, P639, DOI 10.1007/s00269-011-0436-1; Zhai SM, 2009, AM MINERAL, V94, P1388, DOI 10.2138/am.2009.3160; Zhang RY, 2009, LITHOS, V109, P176, DOI 10.1016/j.lithos.2008.08.002	36	0	0	SCIENCE PRESS	BEIJING	16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA	1674-7313	1869-1897		SCI CHINA EARTH SCI	Sci. China-Earth Sci.	DEC	2014	57	12					2922	2927		10.1007/s11430-014-4980-7		6	Geosciences, Multidisciplinary	Geology	AW3FE	WOS:000346170700006		
J	Ata, S; Mizuno, T; Nishizawa, A; Subramaniam, C; Futaba, DN; Hata, K				Ata, Seisuke; Mizuno, Takaaki; Nishizawa, Ayumi; Subramaniam, Chandramouli; Futaba, Don N.; Hata, Kenji			Influence of matching solubility parameter of polymer matrix and CNT on electrical conductivity of CNT/rubber composite	SCIENTIFIC REPORTS			English	Article							ELECTRONIC-CIRCUITS; ELASTIC CONDUCTORS; CARBON NANOTUBES; TEMPERATURE; PERFORMANCE; DISPERSION; SILICON; DESIGN	We report a general approach to fabricate elastomeric composites possessing high electrical conductivity for applications ranging from wireless charging interfaces to stretchable electronics. By using arbitrary nine kinds of rubbers as matrices, we experimentally demonstrate that the matching the solubility parameter of CNTs and the rubber matrix is important to achieve higher electrical conductivity in CNT/rubber composite, resulting in continuous conductive pathways leading to electrical conductivities as high as 15 S/cm with 10 vol% CNT in fluorinated rubber. Further, using thermodynamic considerations, we demonstrate an approach to mix CNTs to arbitrary rubber matrices regardless of solubility parameter of matrices by adding small amounts of fluorinated rubber as a polymeric-compatibilizer of CNTs. We thereby achieved electrical conductivities ranging from 1.2 to 13.8 S/cm ( 10 vol% CNTs) using nine varieties of rubber matrices differing in chemical structures and physical properties. Finally, we investigated the components of solubility parameter of CNT by using Hansen solubility parameters, these findings may useful for controlling solubility parameter of CNTs.	[Ata, Seisuke; Futaba, Don N.; Hata, Kenji] Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, Tsukuba, Ibaraki 3058565, Japan; [Ata, Seisuke; Mizuno, Takaaki; Nishizawa, Ayumi; Subramaniam, Chandramouli; Futaba, Don N.; Hata, Kenji] Technol Res Assoc Single Wall Carbon Nanotubes TA, Tsukuba, Ibaraki 3058565, Japan	Hata, K (reprint author), Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, Cent 5,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.	kenji-hata@aist.go.jp	Futaba, Don /C-8294-2009		Technology Research Association for Single Wall Carbon Nanotubes; New Energy and Industrial Technology Development Organization (NEDO)	We gratefully acknowledge Dr. Kazufumi Kobashi and Dr. Shunsuke Sakurai for useful discussions. Supported by Technology Research Association for Single Wall Carbon Nanotubes are acknowledged. This paper is based on results obtained from a project commissioned by the New Energy and Industrial Technology Development Organization (NEDO).	Khang DY, 2006, SCIENCE, V311, P208, DOI 10.1126/science.1121401; Kobashi K, 2013, CHEM SCI, V4, P727, DOI 10.1039/c2sc21266h; Bergin SD, 2009, ACS NANO, V3, P2340, DOI 10.1021/nn900493u; Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962; Karasek L, 1996, J MATER SCI, V31, P281, DOI 10.1007/BF01139141; Bauhofer W, 2009, COMPOS SCI TECHNOL, V69, P1486, DOI 10.1016/j.compscitech.2008.06.018; Tchoudakov R, 1996, POLYM ENG SCI, V36, P1336, DOI 10.1002/pen.10528; Das NC, 2002, CARBON, V40, P807, DOI 10.1016/S0008-6223(01)00229-9; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Sekitani T, 2008, SCIENCE, V321, P1468, DOI 10.1126/science.1160309; Sekitani T, 2010, ADV MATER, V22, P2228, DOI 10.1002/adma.200904054; Li Y, 2008, MACROMOLECULES, V41, P5339, DOI 10.1021/ma8006834; Das A, 2009, CARBON, V47, P3313, DOI 10.1016/j.carbon.2009.07.052; ELBRO HS, 1991, IND ENG CHEM RES, V30, P2576, DOI 10.1021/ie00060a011; Sekitani T, 2009, NAT MATER, V8, P494, DOI [10.1038/nmat2459, 10.1038/NMAT2459]; Lacour SP, 2004, IEEE ELECTR DEVICE L, V25, P179, DOI 10.1109/LED.2004.825190; Futaba DN, 2006, J PHYS CHEM B, V110, P8035, DOI 10.1021/jp060080e; Brosteaux D, 2007, IEEE ELECTR DEVICE L, V28, P552, DOI 10.1109/LED.2007.897887; Li YJ, 2009, MACROMOLECULES, V42, P2587, DOI 10.1021/ma802662c; Jeong SH, 2007, SYNTHETIC MET, V157, P570, DOI 10.1016/j.synthmet.2007.06.012; Ata S., NANO LETT, V12, P2710; Brandrup J., 1999, POLYM HDB, P675; Dooher T, 2011, POLYM COMPOSITE, V32, P1895, DOI 10.1002/pc.21222; Hansen C M, 2007, HANSEN SOLUBILITY PA; Hansen C. M., 1967, J PAINT TECHNOL, V39, P511; Hildebrand J., 1936, SOLUBILITY NON ELECT; Launay H, 2007, CARBON, V45, P2859, DOI 10.1016/j.carbon.2007.10.011; Ma J, 2012, POLYM BULL, V68, P1053, DOI 10.1007/s00289-011-0607-8; Mizuno K, 2005, J PHYS CHEM B, V109, P2632, DOI 10.1021/jp0454117; Verge P., COMPOSITES SCI TECHN, V70, P1453	30	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 1	2014	4								7232	10.1038/srep07232		8	Multidisciplinary Sciences	Science & Technology - Other Topics	AW4NG	WOS:000346257300001		
J	Daghero, D; Pecchio, P; Ummarino, GA; Nabeshima, F; Imai, Y; Maeda, A; Tsukada, I; Komiya, S; Gonnelli, RS				Daghero, D.; Pecchio, P.; Ummarino, G. A.; Nabeshima, F.; Imai, Y.; Maeda, A.; Tsukada, I.; Komiya, S.; Gonnelli, R. S.			Point-contact Andreev-reflection spectroscopy in Fe(Te, Se) films: multiband superconductivity and electron-boson coupling	SUPERCONDUCTOR SCIENCE & TECHNOLOGY			English	Article						chalcogenide superconductors; superconducting films; Andreev reflection spectroscopy		We report on a study of the superconducting order parameter in Fe(Te1-xSex) thin films (with different Se contents: x = 0.3, 0.4, 0.5) by means of point-contact Andreev-reflection spectroscopy (PCARS). The PCARS spectra show reproducible evidence of multiple structures, namely two clear conductance maxima associated to a superconducting gap of amplitude Delta(E) similar or equal to 2.75k(B)T(c) and additional shoulders at higher energy that, as we show, are the signature of the strong interaction of charge carriers with a bosonic mode whose characteristic energy coincides with the spin-resonance energy. The details of some PCARS spectra at low energy suggest the presence of a smaller and not easily discernible gap of amplitude Delta(H) similar or equal to 1.75k(B)T(c). The existence of this gap and its amplitude are confirmed by PCARS measurements in Fe(Te1-xSex) single crystals. The values of the two gaps Delta(E) and Delta(H), once plotted as a function of the local critical temperature T-c(A), turn out to be in perfect agreement with the results obtained by various experimental techniques reported in literature.	[Daghero, D.; Pecchio, P.; Ummarino, G. A.; Gonnelli, R. S.] Politecn Torino, Dipartimento Sci Appl & Tecnol, I-10129 Turin, Italy; [Nabeshima, F.; Imai, Y.; Maeda, A.] Univ Tokyo, Dept Basic Sci, Tokyo 1538902, Japan; [Tsukada, I.; Komiya, S.] Cent Res Inst Elect Power Ind, Yokosuka, Kanagawa 2400196, Japan	Daghero, D (reprint author), Politecn Torino, Dipartimento Sci Appl & Tecnol, I-10129 Turin, Italy.	dario.daghero@polito.it	Imai, Yoshinori/F-4483-2015; Daghero, Dario/M-6387-2015; 	Daghero, Dario/0000-0003-2180-7682; ummarino, giovanni/0000-0002-6226-8518	Collaborative EU-Japan Project 'IRON SEA' [NMP3-SL-2011-283141]	This work was done under the Collaborative EU-Japan Project 'IRON SEA' (NMP3-SL-2011-283141). We wish to thank Lesley F Cohen and Karen Yates for early discussions about the interpretation of the larger energy scale as an EBI structure.	Wu CT, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3370355; Kim H, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.180503; Ichinose A, 2013, SUPERCOND SCI TECH, V26, DOI 10.1088/0953-2048/26/7/075002; Komiya S, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.064710; Ummarino GA, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.172503; Imai Y, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.043102; Kashiwaya S, 2000, REP PROG PHYS, V63, P1641, DOI 10.1088/0034-4885/63/10/202; Nabeshima F, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826945; Tsukada I, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.053101; Golubov AA, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4788720; Miao H, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.094506; Kato T, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.180507; Paglione J, 2010, NAT PHYS, V6, P645, DOI 10.1038/NPHYS1759; Nakayama K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.197001; Chen TY, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.214444; Daghero D, 2010, SUPERCOND SCI TECH, V23, DOI 10.1088/0953-2048/23/4/043001; Hu J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.134521; Daghero D, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124509; Bendele M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.224520; Ummarino GA, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.092508; Daghero D, 2013, LOW TEMP PHYS, V39, P261; Doring S, 2014, J PHYS C SER, V507; Gonnelli RS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.247004; Hanaguri T, 2010, SCIENCE, V328, P474, DOI 10.1126/science.1187399; Homes CC, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.180508; Maeda A, 2014, APPL SURF SCI, V312, P43, DOI 10.1016/j.apsusc.2014.02.124; Naidyuk Y. G., 2004, SPRINGER SERIES SOLI, V145; Park W K, 2010, STRONG COUPLING SUPE; Pecchio P, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.174506; Qiu YM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.067008; Sales BC, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.094521; Tortello M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.237002; Tsukada I, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054515; Yin J X, 2014, OBSERVATION ROBUST Z; Zeng B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1115	35	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0953-2048	1361-6668		SUPERCOND SCI TECH	Supercond. Sci. Technol.	DEC	2014	27	12							124014	10.1088/0953-2048/27/12/124014		8	Physics, Applied; Physics, Condensed Matter	Physics	AW3OS	WOS:000346196900018		
J	Tanosaki, M; Shimizu, N; Lian, CG; Jurchak, M; Patel, V				Tanosaki, Megumi; Shimizu, Naomi; Lian, Christine G.; Jurchak, Martha; Patel, Vihas			Purpura Fulminans Managed with Multi-Limb Amputation: Substituted Judgment and Surrogate Decision-Making in the Surgical Management of Necrotizing Soft Tissue Infections	SURGICAL INFECTIONS			English	Article							PALLIATIVE CARE; CRITICALLY-ILL	Background: Purpura fulminans (PF) is a rare but lethal complication of severe infection. Aggressive surgical debridement of irreversibly devitalized tissue improves survival frequently at the cost of disfigurement. The ethical dilemma of surrogate decision-making for these often incapacitated patients presents a unique challenge for acute care surgeons managing necrotizing soft tissue infections (NSTI). Methods: Case presentation and scholarly discussion of substituted judgment. Results: A previously healthy 72-y-old fisherman developed PF as a consequence of Neisseria meningiditis severe sepsis requiring bilateral partial finger amputations and bilateral below-knee amputations of the affected gangrenous extremities. Skin biopsy confirmed the clinical impression of disseminated intra-vascular coagulation (DIC). During his 55-d hospitalization, medical decisions were made by a surrogate because the patient's mental status failed to recover to his pre-morbid baseline. A literature review revealed a paucity of data on the accuracy of a health care agent's ability to represent a patient's preferences accurately in elective as well as emergency surgery. Conclusions: Patients with NSTI and the surgeons who care for them are often confronted with the need to make prompt decisions of radical debridement or amputation. These patients are frequently incapable of making these decisions because of the severity of systemic illness. In such cases, physicians must help patient surrogates or health care agents (when identified) navigate a complex process of acute interventions balancing known or inferred patient's wishes. We urge surgeons to become familiar with the concept of substituted judgment and the challenges of surrogate decision-making.	[Tanosaki, Megumi] Tokyo Med & Dent Univ, Tokyo, Japan; [Shimizu, Naomi; Patel, Vihas] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Lian, Christine G.] Brigham & Womens Hosp, Program Dermatopathol, Boston, MA 02115 USA; [Jurchak, Martha] Brigham & Womens Hosp, Dept Pathol, Brigham & Womens Hosp Eth Serv, Boston, MA 02115 USA; [Shimizu, Naomi; Patel, Vihas] Harvard Univ, Sch Med, Boston, MA USA	Patel, V (reprint author), Brigham & Womens Hosp, Div Trauma Burn & Surg Crit Care, Dept Surg, 75 Francis St, Boston, MA 02115 USA.	vpatel3@partners.org		Lian, Christine/0000-0003-4626-1612			Fox E, 2007, AM J BIOETHICS, V7, P13, DOI 10.1080/1526516060109085; Mantravadi AV, 2007, J CATARACT REFR SURG, V33, P2091, DOI 10.1016/j.jcrs.2007.07.036; Keung EZ, 2013, JAMA SURG, V148, P419, DOI 10.1001/jamasurg.2013.173; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI [10.7326/0003-4819-154-5-201103010-00008, 10.1059/0003-4819-154-5-201103010-00008]; Berger J, 2008, THEATER HEUTE, P48; King DA, 2006, J PALLIAT MED, V9, P704, DOI 10.1089/jpm.2006.9.704; Fine RL, 2010, J PAIN SYMPTOM MANAG, V40, P621, DOI 10.1016/j.jpainsymman.2010.06.008; Beauchamp T. L., 2012, PRINCIPLES BIOMEDICA; Davis MDP, 2007, J AM ACAD DERMATOL, V57, P944, DOI 10.1016/j.jaad.2007.07.039; DeLoughery TG, 2005, CRIT CARE CLIN, V21, P531, DOI 10.1016/j.ccc.2005.05.003; Fleury AM, 2013, GERIATR GERONTOL INT, V13, P264, DOI 10.1111/ggi.12016; Holloway RG, 2010, NEW ENGL J MED, V362, P1757, DOI 10.1056/NEJMp0907808; JOHANSEN K, 1991, CRIT CARE MED, V19, P114, DOI 10.1097/00003246-199101000-00025; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Lissauer ME, 2011, J AM COLL SURGEONS, V213, P766, DOI 10.1016/j.jamcollsurg.2011.09.003; Mosenthal AC, 2002, J AM COLL SURGEONS, V194, P75, DOI 10.1016/S1072-7515(01)01133-4; Nelson JE, 2009, J CRIT CARE, V24, P626; Rier DA, 2000, SOCIOL HEALTH ILL, V22, P68, DOI 10.1111/1467-9566.00192; Talwar Ankur, 2012, Indian J Dermatol Venereol Leprol, V78, P228, DOI 10.4103/0378-6323.93655	19	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1096-2964	1557-8674		SURG INFECT	Surg. Infect.	DEC 1	2014	15	6					853	856		10.1089/sur.2013.223		4	Infectious Diseases; Surgery	Infectious Diseases; Surgery	AW5TA	WOS:000346335500033		
J	Arai, T; Sakon, M; Fujii, T; Sawano, S; Nagano, S; Umegaki, M; Kawashima, A; Miwa, S				Arai, Takuma; Sakon, Masahiro; Fujii, Taishi; Sawano, Shinji; Nagano, Satoshi; Umegaki, Mitsuyo; Kawashima, Akira; Miwa, Shiro			Efficacy of Self-expanding Metallic Stent for Right-sided Colonic Obstruction Due to Carcinoma Before 1-Stage Laparoscopic Surgery	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						laparoscopic surgery; Self-expanding metallic stent; right-sided colonic obstruction; minimally invasive surgery	LARGE-BOWEL OBSTRUCTION; MALIGNANT COLORECTAL OBSTRUCTION; PROXIMAL COLON; OPEN COLECTOMY; EMERGENCY-SURGERY; RANDOMIZED-TRIAL; CANCER; MANAGEMENT; RESECTION; OUTCOMES	Purpose: The aim of this small study was to assess the clinical outcomes of self-expanding metallic stent (SEMS) placement followed by 1-stage laparoscopic resection for treatment of acute right-sided colonic obstruction due to carcinoma. Method: From January 2012 to December 2012, we performed 1-stage laparoscopic colectomy after placement of SEMS for right-sided obstructive colon carcinoma in 4 patients. Results: SEMS placement was technically successful in all cases and symptoms were immediately relieved. The presence of the endoluminal stent did not prevent a laparoscopic approach; moreover, decompression of the bowel obstruction provided a wide field of view and working space for the laparoscopic procedure. There were no cases of conversion to laparotomy and no intraoperative complications. Conclusion: One-stage laparoscopic surgery, as a minimally invasive therapy, can be safely performed by SEMS placement in patients with acute right-sided colonic obstruction due to carcinoma. A large sample study is required to confirm the efficacy of this procedure.	[Arai, Takuma; Sakon, Masahiro; Fujii, Taishi; Sawano, Shinji; Miwa, Shiro] Okaya Municipal Hosp, Dept Surg, Okaya 3948512, Japan; [Nagano, Satoshi; Umegaki, Mitsuyo; Kawashima, Akira] Okaya Municipal Hosp, Dept Gastroenterol, Okaya 3948512, Japan	Arai, T (reprint author), Okaya Municipal Hosp, Dept Surg, Honmachi 4-11-33, Okaya 3948512, Japan.	t-arai@gd5.so-net.ne.jp					OHMAN U, 1982, AM J SURG, V143, P742, DOI 10.1016/0002-9610(82)90050-2; Stipa F, 2008, SURG ENDOSC, V22, P1477, DOI 10.1007/s00464-007-9654-5; Hsu TC, 2005, AM J SURG, V189, P384, DOI 10.1016/j.amjsurg.2004.06.046; Alcantara M, 2011, WORLD J SURG, V35, P1904, DOI 10.1007/s00268-011-1139-y; PHILLIPS RKS, 1985, BRIT J SURG, V72, P296, DOI 10.1002/bjs.1800720417; Small AJ, 2010, GASTROINTEST ENDOSC, V71, P560, DOI 10.1016/j.gie.2009.10.012; IRVIN GL, 1984, ANN SURG, V199, P598, DOI 10.1097/00000658-198405000-00015; Pirlet IA, 2011, SURG ENDOSC, V25, P1814, DOI 10.1007/s00464-010-1471-6; Camunez F, 2000, RADIOLOGY, V216, P492; van Hooft JE, 2011, LANCET ONCOL, V12, P344, DOI 10.1016/S1470-2045(11)70035-3; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Meisner S, 2011, GASTROINTEST ENDOSC, V74, P876, DOI 10.1016/j.gie.2011.06.019; Tan CJ, 2012, BRIT J SURG, V99, P469, DOI 10.1002/bjs.8689; Chung TS, 2008, WORLD J SURG, V32, P2275, DOI 10.1007/s00268-008-9695-5; Dronamraju SS, 2009, DIS COLON RECTUM, V52, P1657, DOI 10.1007/DCR.0b013e3181a8f4af; Repici A, 2007, GASTROINTEST ENDOSC, V66, P940, DOI 10.1016/j.gie.2007.04.032; Park IJ, 2009, J GASTROINTEST SURG, V13, P960, DOI 10.1007/s11605-008-0798-y; Bhardwaj R, 2003, Colorectal Dis, V5, P518, DOI 10.1046/j.1463-1318.2003.00519.x; Bonjer HJ, 2009, LANCET ONCOL, V10, P44; DEANS GT, 1994, BRIT J SURG, V81, P1270, DOI 10.1002/bjs.1800810905; LACY AM, 1995, SURG ENDOSC-ULTRAS, V9, P1101; LEITMAN IM, 1992, SURG GYNECOL OBSTET, V174, P513; Manes G, 2011, ARCH SURG-CHICAGO, V146, P1157, DOI 10.1001/archsurg.2011.233; Meisner S, 2012, GASTROENT RES PRACT, V2012, P296; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Yao LQ, 2011, WORLD J GASTROENTERO, V17, P3342, DOI 10.3748/wjg.v17.i28.3342; Zorcolo L, 2003, Colorectal Dis, V5, P262, DOI 10.1046/j.1463-1318.2003.00432.x	27	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	DEC	2014	24	6					537	541				5	Surgery	Surgery	AW1WE	WOS:000346078200022		
J	Inokuchi, M; Kojima, K; Kato, K; Sugita, H; Sugihara, K				Inokuchi, Mikito; Kojima, Kazuyuki; Kato, Keiji; Sugita, Hirofumi; Sugihara, Kenichi			Laparoscopy Versus Open Distal Gastrectomy for Advanced Gastric Cancer: A Systematic Review and Meta-analysis (Qiu J et al. Surg Laparosc Endosc Percutan Tech 2013;23:1-7)	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Letter							D2 LYMPHADENECTOMY; PHASE-III; EXPERIENCE; TRIAL; D1		[Inokuchi, Mikito; Kato, Keiji; Sugita, Hirofumi; Sugihara, Kenichi] Tokyo Med & Dent Univ, Dept Surg Oncol, Tokyo, Japan; [Kojima, Kazuyuki] Tokyo Med & Dent Univ, Dept Minimally Invas Surg, Tokyo, Japan	Inokuchi, M (reprint author), Tokyo Med & Dent Univ, Dept Surg Oncol, Tokyo, Japan.						Degiuli M, 2010, BRIT J SURG, V97, P643, DOI 10.1002/bjs.6936; Nakamura K, 2013, JPN J CLIN ONCOL, V43, P324, DOI 10.1093/jjco/hys220; Kim HH, 2013, J KOREAN SURG SOC, V84, P123, DOI 10.4174/jkss.2013.84.2.123; Zhao YL, 2011, SURG ENDOSC, V25, P2960, DOI 10.1007/s00464-011-1652-y; Schmidt B, 2013, J SURG ONCOL, V107, P259, DOI 10.1002/jso.23127; Qiu JG, 2013, SURG LAPARO ENDO PER, V23, P1, DOI 10.1097/SLE.0b013e3182747af7; Hur H, 2008, J SURG ONCOL, V98, P515, DOI 10.1002/jso.21155; Du XH, 2009, CHINESE MED J-PEKING, V122, P1404, DOI 10.3760/cma.j.issn.0366-6999.2009.12.009	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	DEC	2014	24	6					542	542				1	Surgery	Surgery	AW1WE	WOS:000346078200023		
J	Otsuka, K; Itabashi, T; Sasaki, A; Kimura, T; Kato, K; Wakabayashi, G				Otsuka, Koki; Itabashi, Tetsuya; Sasaki, Akira; Kimura, Toshimoto; Kato, Kuniyuki; Wakabayashi, Go			Laparoscopic-assisted Proctocolectomy With Prolapsing Technique for Familial Adenomatous Polyposis	SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES			English	Article						laparoscopic colectomy; total colectomy; total proctocolectomy; IPAA; prolapsing technique; familial adenomatous polyposis	POUCH-ANAL ANASTOMOSIS; RESTORATIVE PROCTOCOLECTOMY; ADENOCARCINOMA; COLECTOMY	Purpose: The role of laparoscopic total proctocolectomy (TPC) and ileal pouch-anal anastomosis (IPAA) for familial adenomatous polyposis (FAP) has been controversial, given its technical difficulty of selecting the appropriate distal transection line and achieving safe anastomosis. We herein describe our initial experience with the prolapsing technique for laparoscopic-assisted TPC and IPAA (J-pouch) in the treatment of FAP. Methods: A consecutive series of patients with FAP undergoing laparoscopic-assisted TPC with IPAA were identified from a prospectively collected database between June 2004 and February 2012. Medical records were reviewed for patient demographics, operative outcomes, and follow-up. Results: The surgery was successfully completed in all 6 patients without any conversion to open surgery. The median operating time was 279 minutes (range, 240 to 386 min) and the median blood loss was 17.5mL (range, 5 to 161 mL). No patient required blood transfusion. The median length of diet resumption and postoperative hospital stay were 7 days (range, 6 to 10 d) and 15 days (range, 13 to 21 d), respectively. A postoperative complication, wound infection, occurred in 1 patient. No anastomotic leakages or small bowel obstructions occurred. At a median follow-up of 59 months (range, 14.2 to 107.5 mo), no carcinoma had developed at the pouch or at the anastomotic site. Sexual function and fertility were unchanged as compared with preoperatively in 2 male patients. None of the patients experienced night-time incontinence or had to use a pad. Conclusions: Our limited experience suggests that this prolapsing technique helps prevent problems with laparoscopic-assisted TPC and IPAA for FAP patients.	[Otsuka, Koki; Itabashi, Tetsuya; Sasaki, Akira; Kimura, Toshimoto; Kato, Kuniyuki; Wakabayashi, Go] Iwate Med Univ, Sch Med, Dept Surg, Morioka, Iwate 0208505, Japan	Otsuka, K (reprint author), Iwate Med Univ, Sch Med, Dept Surg, 19-1 Uchimaru, Morioka, Iwate 0208505, Japan.	kokiotsu@iwate-med.ac.jp					Ahmed Ali U, 2009, COCHRANE DB SYST REV, V1; Michelassi F, 2003, ANN SURG, V238, P433, DOI 10.1097/01.sla.0000086658.60555.ea; Dunker MS, 2001, DIS COLON RECTUM, V44, P1800, DOI 10.1007/BF02234458; Dowson HM, 2008, BRIT J SURG, V95, P909, DOI 10.1002/bjs.6211; Vitellaro M, 2011, SURG ENDOSC, V25, P1866, DOI 10.1007/s00464-010-1478-z; Brown SR, 2001, DIS COLON RECTUM, V44, P397, DOI 10.1007/BF02234739; Busey HJR, 1975, FAMILIAL POLYPOSIS C; DEEN KI, 1995, DIS COLON RECTUM, V38, P133, DOI 10.1007/BF02052440; Duff S E, 2002, Colorectal Dis, V4, P420, DOI 10.1046/j.1463-1318.2002.00422.x; HOEHNER JC, 1994, DIS COLON RECTUM, V37, P824, DOI 10.1007/BF02050149; Kartheuser A, 2006, FAM CANCER, V5, P241, DOI 10.1007/s10689-005-5672-4; Maggiori L, 2013, J GASTROINTEST SURG, V17, P408, DOI 10.1007/s11605-012-2004-5; Mandl F., 1992, DT Z CHIR, V168, P145; McNicol FJ, 2011, COLORECTAL DIS, V14, P458; Milsom JW, 1997, DIS COLON RECTUM, V40, P675, DOI 10.1007/BF02140896; Palanivelu C, 2008, JSLS-J SOC LAPAROEND, V12, P256; Polese L, 2003, AM J SURG, V186, P32, DOI 10.1016/S0002-9610(03)00121-1; Rotholtz NA, 2008, SURG ENDOSC, V22, P1303, DOI 10.1007/s00464-007-9616-y; SLORS JFM, 1995, DIS COLON RECTUM, V38, P207, DOI 10.1007/BF02052453; Vrouenraets BC, 2004, DIS COLON RECTUM, V47, P530, DOI 10.1007/s10350-003-0073-y	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1530-4515	1534-4908		SURG LAPARO ENDO PER	Surg. Laparosc. Endosc. Pct. Tech.	DEC	2014	24	6					E228	E232				5	Surgery	Surgery	AW1WE	WOS:000346078200008		
J	Sada, M; Uchiyama, M; Matsubara, S				Sada, Mutsumi; Uchiyama, Masanobu; Matsubara, Seijiro			Design of Molecular Transformations Based on the Concerted Function of Two Zinc Atoms in Bis(iodozincio)methane	SYNLETT			English	Article						zinc; dizinc; cyclopropanation; oxy-Cope rearrangement; 1,4-addition; organometallic reagents; ring contractions; pi-allylpalladium	CARBONYL-COMPOUNDS; ALPHA,BETA-UNSATURATED KETONES; NUCLEOPHILIC CYCLOPROPANATION; PI-ALLYLPALLADIUM; ENANTIOSELECTIVE SYNTHESIS; 1,4-ADDITION REACTIONS; ENANTIOMERIC PURITY; ENOLATE EQUIVALENT; CYCLOHEPTANE RING; ALLYLIC ALCOHOLS	Bis(iodozincio)methane, prepared from diiodomethane and zinc metal in the presence of a lead catalyst, is capable of performing several unique molecular transformations. It can operate not only as a dianion, but also as a bidentate Lewis acid. In this account, the methylenation of carbonyl compounds, nucleophilic cyclopropanation reactions, 1,4-addition reactions of bis(iodozincio)methane, and reduction reactions of -allylpalladium are discussed, along with the associated density functional theory calculations. 1Introduction 2Methylenation of Carbonyl Compounds 3Nucleophilic Cyclopropanation 3.1Cyclopropanation of 1,2-Diketones 3.2Asymmetric Construction of Quaternary Carbon Atoms by Stereospecific Cyclopropanation 41,4-Addition Reactions of Bis(iodozincio)methane 4.1Three-Atom Ring-Contraction Reaction 4.2Enolate-Homoenolate Intermediates and Their Reactions 5Reduction of -Allylpalladium Derivatives 6Conclusions and Outlook	[Sada, Mutsumi; Matsubara, Seijiro] Kyoto Univ, Dept Chem Mat, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Uchiyama, Masanobu] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Matsubara, S (reprint author), Kyoto Univ, Dept Chem Mat, Grad Sch Engn, Nishikyo Ku, Kyoto 6158510, Japan.	matsubara.seijiro.2e@kyoto-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology	This work was supported financially by the Japanese Ministry of Education, Culture, Sports, Science, and Technology.	Tamaru Y, 1999, J ORGANOMET CHEM, V576, P215, DOI 10.1016/S0022-328X(98)01060-2; HARRISON IT, 1971, J ORG CHEM, V36, P3515, DOI 10.1021/jo00822a010; Christoffers J, 2007, SYNTHESIS-STUTTGART, P1279, DOI 10.1055/s-2007-966005; Marek I, 1996, CHEM REV, V96, P3241, DOI 10.1021/cr9600161; Zanoni G, 2004, ANGEW CHEM INT EDIT, V43, P846, DOI 10.1002/anie.200352743; TAKAI K, 1986, J AM CHEM SOC, V108, P7408, DOI 10.1021/ja00283a046; MARTIN VS, 1981, J AM CHEM SOC, V103, P6237, DOI 10.1021/ja00410a053; HASHIYAMA T, 1992, J ORG CHEM, V57, P5067, DOI 10.1021/jo00045a011; Nomura K, 2007, CHEM LETT, V36, P164, DOI 10.1246/cl.2007.164; Das PP, 2012, ANGEW CHEM INT EDIT, V51, P9517, DOI 10.1002/anie.201205190; Barczak NT, 2007, ORGANOMETALLICS, V26, P4863, DOI 10.1021/om700605y; TAKAI K, 1994, J ORG CHEM, V59, P2668, DOI 10.1021/jo00089a002; Cheng K, 2011, ORG LETT, V13, P2346, DOI 10.1021/ol200597h; Howell GP, 2006, ORG BIOMOL CHEM, V4, P1278, DOI 10.1039/b518165h; Marek I, 2000, CHEM REV, V100, P2887, DOI 10.1021/cr990288e; TAKAHARA JP, 1992, J AM CHEM SOC, V114, P2577, DOI 10.1021/ja00033a034; SCHAUB B, 1984, TETRAHEDRON LETT, V25, P4097, DOI 10.1016/S0040-4039(01)90191-1; Sada M, 2010, J AM CHEM SOC, V132, P17452, DOI 10.1021/ja104439w; Nomura K, 2005, ANGEW CHEM INT EDIT, V44, P5860, DOI 10.1002/anie.200501644; Hashimoto Y, 2001, J AM CHEM SOC, V123, P1503, DOI 10.1021/ja001843t; Sada M, 2010, J AM CHEM SOC, V132, P432, DOI 10.1021/ja910428y; Davies HML, 1999, J ORG CHEM, V64, P8501, DOI 10.1021/jo990888d; MARYANOFF BE, 1989, CHEM REV, V89, P863, DOI 10.1021/cr00094a007; Haraguchi R, 2014, SYNTHESIS-STUTTGART, V46, P2272, DOI 10.1055/s-0034-1378514; Sada M, 2010, CHEM-EUR J, V16, P10474, DOI 10.1002/chem.201000738; Matsubara S, 2001, J ORGANOMET CHEM, V617, P39, DOI 10.1016/S0022-328X(00)00546-5; TABUCHI T, 1986, TETRAHEDRON LETT, V27, P1195, DOI 10.1016/S0040-4039(00)84214-8; WITTIG G, 1953, LIEBIGS ANN CHEM, V580, P44; TAMARU Y, 1995, ANGEW CHEM INT EDIT, V34, P787, DOI 10.1002/anie.199507871; Chapman CJ, 2007, SYNTHESIS-STUTTGART, P1, DOI 10.1055/s-2006-950379; Haraguchi R, 2012, CHEM LETT, V41, P628, DOI 10.1246/cl.2012.628; Haraguchi R, 2013, ORG LETT, V15, P3378, DOI 10.1021/ol401425s; HASHIMOT.H, 1967, J ORGANOMET CHEM, V10, P518, DOI 10.1016/S0022-328X(00)83178-2; Hashimoto H., 1966, KOGYO KAGAKU ZASSHI, V69, P174; Hashimoto Y, 2001, J AM CHEM SOC, V123, P4869, DOI 10.1021/ja015152o; Hermes AR, 1998, INORG SYN, V32, P309, DOI 10.1002/9780470132630.ch50; HIBINO J, 1985, TETRAHEDRON LETT, V26, P5579, DOI 10.1016/S0040-4039(01)80892-3; Hirayama T, 2005, ANGEW CHEM INT EDIT, V44, P3293, DOI 10.1002/anie.200500133; Knochel P., 1996, HDB GRIGNARD REAGENT, P633; LOMBARDO L, 1982, TETRAHEDRON LETT, V23, P4293, DOI 10.1016/S0040-4039(00)88728-6; Lombardo L., 1987, ORG SYNTH, V65, P81; Maercker A., 1965, ORG REACTIONS, V14, P270; Marek I., 1999, ORGANOZINC REAGENTS, P119; Matsubara S., 2006, CHEM ORGANOZINC CO 2, P641, DOI 10.1002/9780470093399.ch14; Matsubara S, 2003, P JPN ACAD B-PHYS, V79, P71, DOI 10.2183/pjab.79B.71; Matsubara S, 2005, CHEM LETT, V34, P952, DOI 10.1246/cl.2005.952; Matsubara S, 2005, J ORGANOMET CHEM, V690, P5546, DOI 10.1016/j.jorganchem.2005.06.046; Matsubara S, 1999, SYNLETT, P1253; Matsubara S, 1998, SYNLETT, P1369; Matsubara S, 2002, TETRAHEDRON, V58, P8255, DOI 10.1016/S0040-4020(02)00975-4; Matsubara S, 2000, SYNLETT, P1202; Matsubara S, 1999, CHEM LETT, P825, DOI 10.1246/cl.1999.825; Matsubara S, 1999, SYNLETT, P1471; Matsubara S., 2004, MODERN CARBONYL OLEF, P200; Muller JFK, 2000, EUR J INORG CHEM, P789; Naula S. P., 1985, INORG SYNTH, V24, P181; Nomura K, 2009, CHEM-ASIAN J, V4, P1298, DOI 10.1002/asia.200900123; Nomura K, 2010, CHEM-ASIAN J, V5, P147, DOI 10.1002/asia.200900289; Nomura K, 2008, HETEROCYCLES, V76, P1381; Normant JF, 2001, ACCOUNTS CHEM RES, V34, P640, DOI 10.1021/ar000043k; Nysted L. N., 1975, U.S. Patent, Patent No. [3,865,848, 3865848]; OKAZOE T, 1985, TETRAHEDRON LETT, V26, P5581, DOI 10.1016/S0040-4039(01)80893-5; Sada M, 2011, ORG BIOMOL CHEM, V9, P1389, DOI 10.1039/c0ob00806k; Schlosser M., 1970, TOP STEREOCHEM, V5, P1, DOI 10.1002/9780470147146.ch1; Takada Y, 2010, ORG LETT, V12, P5204, DOI 10.1021/ol102237b; TAKAI K, 1978, TETRAHEDRON LETT, P2417; Thomas E, 2006, TETRAHEDRON LETT, V47, P9181, DOI 10.1016/j.tetlet.2006.10.132; TURNBULL P, 1966, J AM CHEM SOC, V88, P4764, DOI 10.1021/ja00972a067; Ueno S, 2010, CHEM LETT, V39, P96, DOI 10.1246/cl.2010.96; Ukai K, 2000, J AM CHEM SOC, V122, P12047, DOI 10.1021/ja003360v; Wallock NJ, 2005, ORG LETT, V7, P2047, DOI 10.1021/ol050637t; WENDER PA, 1976, J ORG CHEM, V41, P3490, DOI 10.1021/jo00883a043; Yoshino H., 2004, CHEM LETT, P1224	73	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	DEC	2014	25	20					2831	2841		10.1055/s-0034-1379250		11	Chemistry, Organic	Chemistry	AU9HL	WOS:000345902500003		
J	Kamihigashi, S; Shibata, N; Sakaguchi, S				Kamihigashi, Shun; Shibata, Naoatsu; Sakaguchi, Satoshi			Cu-Catalyzed Asymmetric Conjugate Addition of Dialkylzincs to Enones Using a (+/-)-trans-1,2-Cyclohexanediamine-Based Bis(NHC) Derived from L-Leucinol	SYNLETT			English	Article						asymmetric catalysis; carbene complexes; copper; Michael addition; ligands	N-HETEROCYCLIC CARBENES; QUATERNARY STEREOGENIC CENTERS; SUBSTITUTED CYCLIC ENONES; ALKOXY-NHC LIGANDS; GRIGNARD-REAGENTS; ENANTIOSELECTIVE SYNTHESIS; PALLADIUM COMPLEXES; CHIRAL CENTERS; DESIGN; SILVER(I)	A hydroxyamide-functionalized azolium salt as the precursor of a (+/-)-trans-1,2-cyclohexanediamine-based bis(NHC) ligand was designed and synthesized from readily accessible l-leucinol. The combination of a Cu salt with this chiral ligand precursor promoted the asymmetric conjugate addition of Et2Zn to 2-cyclohexen-1-one at room temperature without the need for temperature control to afford the corresponding 1,4-adduct with up to 95% ee.	Kansai Univ, Dept Chem & Mat Engn, Fac Chem, Mat & Bioengineering, Suita, Osaka 56486808163, Japan; [Kamihigashi, Shun; Shibata, Naoatsu; Sakaguchi, Satoshi] Kansai Univ, Dept Chem & Mat Engn, Fac Chem Mat & Bioengn, Suita, Osaka 5648680, Japan	Sakaguchi, S (reprint author), Kansai Univ, Dept Chem & Mat Engn, Fac Chem Mat & Bioengn, Suita, Osaka 5648680, Japan.	satoshi@kansai-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [23550128]	This work was financially supported by a Grant-in-Aid for Scientific Research (C) (23550128) from Japan Society for the Promotion of Science (JSPS). We thank Prof. Ryuichi Arakawa for the HRMS analysis of compound L1.	Alexakis A, 2002, EUR J ORG CHEM, P3221; Alexakis A, 2003, ADV SYNTH CATAL, V345, P345, DOI 10.1002/adsc.200390037; Kantchev EAB, 2007, ANGEW CHEM INT EDIT, V46, P2768, DOI 10.1002/anie.200601663; Henon H, 2008, ANGEW CHEM INT EDIT, V47, P9122, DOI 10.1002/anie.200803735; Clavier H, 2005, TETRAHEDRON-ASYMMETR, V16, P921, DOI 10.1016/j.tetasy.2005.01.015; Tissot M, 2011, ORG LETT, V13, P1524, DOI 10.1021/ol200219m; Riederer SKU, 2011, DALTON T, V40, P41, DOI 10.1039/c0dt00724b; Martin D, 2006, J AM CHEM SOC, V128, P8416, DOI 10.1021/ja0629920; Wencel J, 2009, ALDRICHIM ACTA, V42, P43; Brown MK, 2007, ANGEW CHEM INT EDIT, V46, P1097, DOI 10.1002/anie.200604511; Hodgson R, 2005, J ORGANOMET CHEM, V690, P5822, DOI 10.1016/j.jorganchem.2005.07.110; Pytkowicz J, 2001, TETRAHEDRON-ASYMMETR, V12, P2087, DOI 10.1016/S0957-4166(01)00325-1; Matsumoto Y, 2008, J ORG CHEM, V73, P4578, DOI 10.1021/jo800613h; Uchida T, 2009, TETRAHEDRON LETT, V50, P4741, DOI 10.1016/j.tetlet.2009.06.026; Clavier H, 2005, J ORGANOMET CHEM, V690, P5237, DOI 10.1016/j.jorganchem.2005.04.027; Lee KS, 2009, J ORG CHEM, V74, P4455, DOI 10.1021/jo900589x; Diez-Gonzalez S, 2009, CHEM REV, V109, P3612, DOI 10.1021/cr900074m; Jerphagnon T, 2009, CHEM SOC REV, V38, P1039, DOI 10.1039/b816853a; Cesar V, 2004, CHEM SOC REV, V33, P619, DOI 10.1039/b406802p; Guillen F, 2001, TETRAHEDRON-ASYMMETR, V12, P2083, DOI 10.1016/S0957-4166(01)00387-1; Lee KS, 2006, J AM CHEM SOC, V128, P7182, DOI 10.1021/ja062061o; May TL, 2011, J AM CHEM SOC, V133, P736, DOI 10.1021/ja110054q; Gigler P, 2011, J AM CHEM SOC, V133, P1589, DOI 10.1021/ja110017c; Kehrli S, 2010, CHEM-EUR J, V16, P9890, DOI 10.1002/chem.201000471; Alexakis A, 2008, CHEM REV, V108, P2796, DOI 10.1021/cr0683515; May TL, 2008, ANGEW CHEM INT EDIT, V47, P7358, DOI 10.1002/anie.200802910; Peris E, 2004, COORDIN CHEM REV, V248, P2239, DOI 10.1016/j.ccr.2004.04.014; Brown MK, 2008, J AM CHEM SOC, V130, P12904, DOI 10.1021/ja8058414; Fraser PK, 2001, TETRAHEDRON LETT, V42, P2747, DOI 10.1016/S0040-4039(01)00280-5; Winn CL, 2005, J ORGANOMET CHEM, V690, P5672, DOI 10.1016/j.jorganchem.2005.07.024; Benhamou L, 2011, CHEM REV, V111, P2705, DOI 10.1021/cr100328e; Muller D, 2011, ORG LETT, V13, P3040, DOI 10.1021/ol200898c; Arnold PL, 2004, CHEM COMMUN, P1612, DOI 10.1039/b404614e; Bonnet LG, 2003, ORGANOMETALLICS, V22, P4384, DOI 10.1021/om030527v; Clavier H, 2007, CHIRALITY, V19, P471, DOI 10.1002/chir.20403; DiezGonzalez S, 2011, RSC CATAL SER, P1; Dohi K, 2012, EUR J ORG CHEM, P7143, DOI 10.1002/ejoc.201201082; Douthwaite RE, 2007, COORDIN CHEM REV, V251, P702, DOI 10.1016/j.ccr.2006.08.003; Dyson G, 2009, DALTON T, P7141, DOI 10.1039/b909290k; Glorius F, 2007, TOP ORGANOMETAL CHEM, V21, P1, DOI 10.1007/3418_2006_059; Herrmann WA, 2002, ANGEW CHEM INT EDIT, V41, P1290, DOI 10.1002/1521-3773(20020415)41:8<1290::AID-ANIE1290>3.0.CO;2-Y; Hoveyda AH, 2004, CHEM COMMUN, P1779, DOI 10.1039/b401123f; Kuhl O., 2010, FUNCTIONALISED N HET; Nolan S. P., 2006, N HETEROCYCLIC CARBE; Okamoto M, 2009, CHEM COMMUN, P7363, DOI 10.1039/b916103a; Rix D, 2009, EUR J INORG CHEM, P1989, DOI 10.1002/ejic.200801243; Shibata N, 2012, J ORG CHEM, V77, P4079, DOI 10.1021/jo300472r; Shibata N., 2010, J ORG CHEM, V16, P5707; Snead DR, 2008, CURR ORG CHEM, V12, P1370, DOI 10.2174/138527208786241510; Shigeng GW, 2012, J ORGANOMET CHEM, V700, P223, DOI 10.1016/j.jorganchem.2011.12.008	50	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	DEC	2014	25	20					2933	2937		10.1055/s-0034-1378916		5	Chemistry, Organic	Chemistry	AU9HL	WOS:000345902500019		
J	Tanda, K; Toyao, A; Watanabe, A; Sakamoto, M; Yamasaki, T				Tanda, Kazuhiro; Toyao, Atsushi; Watanabe, Akiko; Sakamoto, Masanori; Yamasaki, Tetsuo			Magnesium-Coordinated Chelation Control in 1,3-Dipolar Cycloaddition of Chiral alpha-Alkoxymethyl Ether Nitrile Oxide: Application to the Synthesis of (-)/(-)-cis-Clausenamide	SYNLETT			English	Article						cycloaddition; magnesium; nitrile oxide; diastereoselectivity; natural products	ASYMMETRIC-SYNTHESIS; LEWIS-ACID; STEREOSELECTIVE SYNTHESES; SODIUM-BOROHYDRIDE; HIGHLY EFFICIENT; ALLYLIC ALCOHOLS; EPOTHILONE-A; AMINO-ACIDS; CLAUSENAMIDE; REDUCTION	A facile regio- and diastereoselective nitrile oxide cycloaddition method using magnesium-coordinated chelation control of chiral -alkoxymethyl ether nitrile oxide is reported. This reaction could be successfully applied as a key step in both the formal total synthesis of (-)-clausenamide and the total synthesis of (-)-cis-clausenamide.	[Tanda, Kazuhiro; Toyao, Atsushi; Watanabe, Akiko; Sakamoto, Masanori; Yamasaki, Tetsuo] Kyushu Univ Hlth & Welf, Dept Pharmaceut Chem, Nobeoka, Miyazaki 8828508, Japan	Tanda, K (reprint author), Kyushu Univ Hlth & Welf, Dept Pharmaceut Chem, 1714-1 Yoshino, Nobeoka, Miyazaki 8828508, Japan.	tanda@phoenix.ac.jp; tetsuyam@phoenix.ac.jp			Science Research Promotion Fund	This work was financially supported by The Science Research Promotion Fund. We also thank Dr. Osamu Tamura and Dr. Tamiko Kiyotani at Showa Pharmaceutical University for X-ray analysis of 7.	HARTWIG W, 1983, TETRAHEDRON, V39, P2609, DOI 10.1016/S0040-4020(01)91972-6; Bode JW, 2001, J ORG CHEM, V66, P6410, DOI 10.1021/jo015791h; Gothelf KV, 1998, CHEM REV, V98, P863, DOI 10.1021/cr970324e; Bode JW, 2001, J AM CHEM SOC, V123, P3611, DOI 10.1021/ja0155635; Feng ZQ, 2009, BIOORG MED CHEM LETT, V19, P2112, DOI 10.1016/j.bmcl.2009.03.018; Suga H, 2009, J ORG CHEM, V74, P1099, DOI 10.1021/jo802392c; Sibi MP, 2005, ORG LETT, V7, P2349, DOI 10.1021/ol050599d; Li XZ, 2010, EUR J MED CHEM, V45, P5531, DOI 10.1016/j.ejmech.2010.08.041; GEMAL AL, 1981, J AM CHEM SOC, V103, P5454, DOI 10.1021/ja00408a029; KANEMASA S, 1994, J AM CHEM SOC, V116, P2324, DOI 10.1021/ja00085a012; Yang L, 2009, ORG BIOMOL CHEM, V7, P2628, DOI 10.1039/b901965k; HARTWIG W, 1987, J ORG CHEM, V52, P4352, DOI 10.1021/jo00228a037; Sibi MP, 2004, J AM CHEM SOC, V126, P5366, DOI 10.1021/ja0318636; Bode JW, 2001, ANGEW CHEM INT EDIT, V40, P2082; CRICH D, 1989, CHEM REV, V89, P1413, DOI 10.1021/cr00097a001; Pellissier H, 2007, TETRAHEDRON, V63, P3235, DOI 10.1016/j.tet.2007.01.009; BARTON DHR, 1975, J CHEM SOC PERK T 1, P1574, DOI 10.1039/p19750001574; Becker N, 2007, ORG LETT, V9, P3857, DOI 10.1021/ol7017032; Brinkmann Y, 2007, TETRAHEDRON, V63, P8413, DOI 10.1016/j.tet.2007.06.033; Cappi MW, 1998, CHEM COMMUN, P1159, DOI 10.1039/a801450g; CERRI A, 1974, SYNTHESIS-STUTTGART, P710; Fader LD, 2004, ORG LETT, V6, P2485, DOI 10.1021/ol0490633; Hennebohle M, 2004, Z NATURFORSCH B, V59, P451; HUANG DF, 1990, TETRAHEDRON, V46, P3135; Jager V, 2010, Z NATURFORSCH B, V65, P821; Kanemasa S, 1997, TETRAHEDRON LETT, V38, P4095, DOI 10.1016/S0040-4039(97)00834-4; Kanemasa S., 2003, SYNLETT, P1371; KANEMASA S, 1990, HETEROCYCLES, V30, P719; KOZIKOWSKI AP, 1984, ACCOUNTS CHEM RES, V17, P410, DOI 10.1021/ar00108a001; Muri D, 2005, ANGEW CHEM INT EDIT, V44, P4036, DOI 10.1002/anie.200500172; Padwa A., 2002, SYNTHETIC APPL 1 3 D; Ukaji Y, 2003, SYNLETT, P1075; Xuan YN, 2013, ORG BIOMOL CHEM, V11, P1815, DOI 10.1039/c3ob00056g; YAKURA T, 1991, SYNLETT, P343; Yamamoto H, 2007, EUR J ORG CHEM, P2859, DOI 10.1002/ejoc.200601014; Yang M. H., 1984, Ger. Offen, Patent No. [DE3431257, 3431257]; Zhang L, 2012, SYNLETT, P1217, DOI 10.1055/s-0031-1290804	37	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214	1437-2096		SYNLETT	Synlett	DEC	2014	25	20					2953	2956		10.1055/s-0034-1379485		4	Chemistry, Organic	Chemistry	AU9HL	WOS:000345902500023		
J	Terasako, T; Ohmae, K; Yamane, M; Shirakata, S				Terasako, Tomoaki; Ohmae, Ken; Yamane, Motohiro; Shirakata, Sho			Carrier transport in undoped CdO films grown by atmospheric-pressure chemical vapor deposition	THIN SOLID FILMS			English	Article						CdO; Chemical vapor deposition; Hall mobility; Carrier transport; Grain boundary scattering; Ionized impurity scattering; Phonon scattering	DOPED ZNO FILMS; OXIDE THIN-FILMS; CADMIUM-OXIDE; OPTICAL-PROPERTIES; ELECTRICAL-PROPERTIES; TEMPERATURE-DEPENDENCE; CHARGE-CARRIERS; TRANSPARENT; SEMICONDUCTORS; SCATTERING	Temperature dependent Hall effect measurements were performed for the undoped CdO films with carrier concentrations (n) ranging from 2.4 x 10(19) to 2.0 x 10(20) cm(-3) grown on c- and r-plane sapphire substrates by the atmospheric-pressure chemical vapor deposition using Cd powder and H2O as source materials. The n dependence of the optical gap energy (E-opt) could be explained by the combination of the band gap widening due to Burstein-Moss shift and the band gap shrinkages due to the electron-electron and electron-impurity interactions. For all the films, the carrier concentrations (n) were independent of measurement temperature (T), indicating that these films were n-type degenerate semiconductors. The barrier heights at grain boundaries determined from the 1000/T-ln(mu T) curves were smaller than the thermal energy at 300 K, suggesting that the grain boundary scattering plays a minor role on the carrier transport in comparison with the intra-grain scattering. The n dependence of the gradient of the mu-T curve revealed the continuous transformation of the dominant intra-grain scattering mechanism from the phonon scattering to the ionized impurity scattering with increasing n. (C) 2014 Elsevier B.V. All rights reserved.	[Terasako, Tomoaki; Ohmae, Ken; Shirakata, Sho] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Yamane, Motohiro] Ehime Univ, Fac Engn, Matsuyama, Ehime 7908577, Japan	Terasako, T (reprint author), Ehime Univ, Grad Sch Sci & Engn, 3 Bunkyo Cho, Matsuyama, Ehime 7908577, Japan.	terasako.tomoaki.mz@ehime-u.ac.jp					Vigil O, 2001, MATER CHEM PHYS, V68, P249, DOI 10.1016/S0254-0584(00)00358-8; Saha B, 2007, SOL ENERG MAT SOL C, V91, P1692, DOI 10.1016/j.solmat.2007.05.025; CHATTOPADHYAY D, 1981, REV MOD PHYS, V53, P745, DOI 10.1103/RevModPhys.53.745; Dantus C, 2008, APPL SURF SCI, V255, P2665, DOI 10.1016/j.apsusc.2008.07.176; Santos-Cruz J, 2005, THIN SOLID FILMS, V493, P83, DOI 10.1016/j.tsf.2005.07.237; Myong SY, 2007, SOL ENERG MAT SOL C, V91, P1269, DOI 10.1016/j.solmat.2007.04.022; HAMBERG I, 1984, PHYS REV B, V30, P3240, DOI 10.1103/PhysRevB.30.3240; PISARKIEWICZ T, 1989, THIN SOLID FILMS, V174, P217, DOI 10.1016/0040-6090(89)90892-4; Rodl C, 2014, PHYS STATUS SOLIDI A, V211, P74, DOI 10.1002/pssa.201330181; CIMINO A, 1960, J PHYS CHEM SOLIDS, V17, P57, DOI 10.1016/0022-3697(60)90175-X; Terasako T, 2013, THIN SOLID FILMS, V549, P12, DOI 10.1016/j.tsf.2013.06.039; Zhao ZY, 2002, THIN SOLID FILMS, V413, P203, DOI 10.1016/S0040-6090(02)00344-9; Yan M, 2001, APPL PHYS LETT, V78, P2342, DOI 10.1063/1.1365410; Gessert TA, 2011, THIN SOLID FILMS, V519, P7146, DOI 10.1016/j.tsf.2011.01.143; Gupta RK, 2008, APPL SURF SCI, V255, P2414, DOI 10.1016/j.apsusc.2008.07.102; Dakhel AA, 2003, CRYST RES TECHNOL, V38, P979, DOI 10.1002/crat.200310124; Terasako T, 2013, THIN SOLID FILMS, V528, P19, DOI 10.1016/j.tsf.2012.07.140; Yamada T, 2007, SUPERLATTICE MICROST, V42, P68, DOI 10.1016/j.spmi.2007.04.080; Zhu YK, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/19/195102; Zhu YZ, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.245209; Wang A, 2001, P NATL ACAD SCI USA, V98, P7113, DOI 10.1073/pnas.121188298; BURSTEIN E, 1954, PHYS REV, V93, P632, DOI 10.1103/PhysRev.93.632; Terasako T, 2007, THIN SOLID FILMS, V516, P159, DOI 10.1016/j.tsf.2007.06.130; Zhou QA, 2007, MATER LETT, V61, P531, DOI 10.1016/j.matlet.2006.05.004; AUVERGNE D, 1975, PHYS REV B, V11, P2251, DOI 10.1103/PhysRevB.11.2251; BRUNEAUX J, 1991, THIN SOLID FILMS, V197, P129, DOI 10.1016/0040-6090(91)90226-N; Carballeda-Galicia DM, 2000, THIN SOLID FILMS, V371, P105, DOI 10.1016/S0040-6090(00)00987-1; Feng Peng, 2008, Solid State Communications, V148, DOI 10.1016/j.ssc.2008.07.024; Feng WX, 2010, PHYS STATUS SOLIDI B, V247, P2202, DOI 10.1002/pssb.201046098; Giaever L., 1968, PHYS REV LETT, V21, P1385; Grumurugan K.C., 1996, MATER LETT, V28, P307; Grundmann M., 2006, PHYS SEMICONDUCTORS, P193; Grundmann M., 2006, PHYS SEMICONDUCTORS, P194; HAUL R, 1962, J APPL PHYS, V33, P487, DOI 10.1063/1.1777147; HUANG KF, 1987, THIN SOLID FILMS, V148, P7, DOI 10.1016/0040-6090(87)90116-7; Kawamura K, 2003, THIN SOLID FILMS, V445, P182, DOI 10.1016/S0040-6090(03)01172-6; King PDC, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.035203; Lokhande BJ, 2004, MATER CHEM PHYS, V84, P238, DOI 10.1016/S0254-0584(03)00231-1; Mendelsberg R.J., 1992, J PHYS D, V45; MOSS TS, 1954, P PHYS SOC LOND B, V67, P775, DOI 10.1088/0370-1301/67/10/306; Nakamura A, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2709913; Seeger K., 1985, SEMICONDUCTOR PHYS, P160; Seeger K., 1985, SEMICONDUCTOR PHYS, P309; Segura A, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3651338; Skierbiszewski C, 2000, APPL PHYS LETT, V76, P2409, DOI 10.1063/1.126360; Speaks DT, 2010, J APPL PHYS, V107, DOI 10.1063/1.3428444; Terasako T, 2013, SURF COAT TECH, V230, P245, DOI 10.1016/j.surfcoat.2013.06.015; Yu KM, 2012, J APPL PHYS, V111, DOI 10.1063/1.4729563; Zhang DH, 1996, APPL PHYS A-MATER, V62, P487, DOI 10.1007/BF01567122	49	2	2	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	DEC 1	2014	572						20	27		10.1016/j.tsf.2014.07.061		8	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	AW1NM	WOS:000346056100005		
J	Moritani, S				Moritani, Sueyoshi			Impact of Invasive Extranodal Extension on the Prognosis of Patients with Papillary Thyroid Carcinoma	THYROID			English	Article							LYMPH-NODE METASTASIS; SURGICAL-MANAGEMENT; SCORING SYSTEM; CANCER; SURVIVAL; RATIO; COMPARTMENT; RECURRENCE; NUMBER; WELL	Background: Although 20-50% of papillary thyroid carcinoma (PTC) patients initially present with lymph node metastases, prognosis is excellent. Thus, the significance of lymph node metastasis in PTC remains controversial. In this study, we examined the impact of extranodal extension to surrounding organs (invasive extranodal extension) on the prognosis for PTC patients. Methods: Medical records of PTC patients who underwent surgery as their initial treatment at our institution between 1981 and 2008 were retrospectively reviewed. Patients with or without invasive extranodal extension were selected. Our therapeutic strategy for PTC with invasive extranodal extension included complete resection and functional reconstruction. Intergroup comparison was performed using Student's t-test or the chi-square test as appropriate. Survival curves determined by the Kaplan-Meier method were compared for statistical significance using the log-rank test. A Cox-hazard regression model with the forward stepwise method was used for multivariate analysis. Results: The study cohort included 60 (12.3%) patients with and 428 (87.7%) without invasive extranodal extension. The most common site of invasive extranodal extension in the central neck compartment was the recurrent laryngeal nerve, whereas the internal jugular vein was the most frequently invaded site in the lateral neck compartment. The locoregional recurrence rate did not differ significantly between patients with and without invasive extranodal extension, but the distant recurrence rate was higher for those with invasive extranodal extension. The 10-year disease-specific survival rate was significantly lower for patients with invasive extranodal extension than for those without invasive extranodal extension. Furthermore, multivariate analysis revealed that being aged >= 45 years, poor differentiation, and extrathyroidal extension were independent predictive factors for disease-specific death in PTC. Invasive extranodal extension had no effect on the survival of PTC patients. Conclusions: Invasive extranodal extension did not affect the survival of patients with PTC. Despite a negative impact on distant recurrence, invasive extranodal extension did not affect locoregional recurrence in PTC patients.	Kusatsu Gen Hosp, Ctr Head & Neck Surg, Kusatsu, Shiga 5258585, Japan	Moritani, S (reprint author), Kusatsu Gen Hosp, Ctr Head & Neck Surg, 1660 Yabase Cho, Kusatsu, Shiga 5258585, Japan.	suemoritani@gmail.com					Mulla M, 2012, CLIN ENDOCRINOL, V76, P131, DOI 10.1111/j.1365-2265.2011.04162.x; Choi YJ, 2010, WORLD J SURG, V34, P1494, DOI 10.1007/s00268-010-0541-1; Spriano G, 2009, ACTA OTORHINOLARYNGO, V29, P312; Randolph GW, 2012, THYROID, V22, P1144, DOI 10.1089/thy.2012.0043; Schneider DF, 2013, ONCOLOGIST, V18, P157, DOI 10.1634/theoncologist.2012-0240; Schneider DF, 2013, ANN SURG ONCOL, V20, P1906, DOI 10.1245/s10434-012-2802-8; Hwang HS, 2011, LARYNGOSCOPE, V121, P487, DOI 10.1002/lary.21227; HAY ID, 1987, SURGERY, V102, P1088; CADY B, 1988, SURGERY, V104, P947; Jeon MJ, 2013, EUR J ENDOCRINOL, V168, P219, DOI 10.1530/EJE-12-0744; Sugitani I, 2004, SURGERY, V135, P139, DOI 10.1016/S0039-6060(03)00384-2; SCHEUMANN GFW, 1994, WORLD J SURG, V18, P559; Podnos YD, 2005, AM SURGEON, V71, P731; Yamashita H, 1997, CANCER, V80, P2268; Moreno MA, 2012, THYROID, V22, P347, DOI 10.1089/thy.2011.0121; Fukushima M, 2010, WORLD J SURG, V34, P3007, DOI 10.1007/s00268-010-0776-x; Hay ID, 1993, SURGERY, V114, P1057; HAY ID, 1993, SURGERY, V114, P1050; Hughes CJ, 1996, HEAD NECK-J SCI SPEC, V18, P127, DOI 10.1002/(SICI)1097-0347(199603/04)18:2<127::AID-HED3>3.0.CO;2-3; Ito Y, 2012, WORLD J SURG, V36, P593, DOI 10.1007/s00268-011-1391-1; Kamani D, 2013, OTOLARYNG HEAD NECK, V149, P682, DOI 10.1177/0194599813504735; Kim JM, 2006, LARYNGOSCOPE, V116, P2081, DOI 10.1097/01.mlg.0000242118.79647.a9; Lee DW, 2013, EJSO-EUR J SURG ONC, V39, P191, DOI 10.1016/j.ejso.2012.07.119; Ricarte J, 2012, THYROID, V22, P575, DOI 10.1089/thy.2011.0431; Smith VA, 2012, J SURG ONCOL, V106, P357, DOI 10.1002/jso.23090; Zaydfudim V, 2008, SURGERY, V144, P1070, DOI 10.1016/j.surg.2008.08.034	26	1	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1050-7256	1557-9077		THYROID	Thyroid	DEC 1	2014	24	12					1779	1783		10.1089/thy.2014.0167		5	Endocrinology & Metabolism	Endocrinology & Metabolism	AW4KL	WOS:000346249900007		
J	Hirano, T				Hirano, Tatsuya			Condensins and the evolution of torsion-mediated genome organization	TRENDS IN CELL BIOLOGY			English	Review						DNA supercoiling; nucleosomes; condensins; chromosomes; genomes; evolution	MITOTIC CHROMOSOME; DNA; CONDENSATION; SEGREGATION; CHROMATIN; BACTERIAL; PROTEIN; MUKB	At first glance, bacteria and eukaryotes appear to use different strategies to pack and organize their genomes. At the basal level, bacterial genome compaction relies on unconstrained, negative supercoils, whereas eukaryotic genomes are packaged into nucleosomes via constrained, negative supercoils. Here, I integrate the action of condensins, chromosome-packaging complexes conserved from bacteria to humans, into this picture, and discuss how torsional stress on DNA might have dual impacts on genome organization and function. A common theme is that organisms have evolved flexible and reversible strategies to pack their genomes while keeping them readily accessible to many activities such as gene expression.	RIKEN, Chromosome Dynam Lab, Wako, Saitama 3510198, Japan	Hirano, T (reprint author), RIKEN, Chromosome Dynam Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	hiranot@riken.jp	Hirano, Tatsuya/F-6008-2011				Gilbert N, 2014, CURR OPIN GENET DEV, V25, P15, DOI 10.1016/j.gde.2013.10.013; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Reyes-Lamothe R, 2012, ANNU REV GENET, V46, P121, DOI 10.1146/annurev-genet-110711-155421; Woo JS, 2009, CELL, V136, P85, DOI 10.1016/j.cell.2008.10.050; Sawitzke JA, 2000, P NATL ACAD SCI USA, V97, P1671, DOI 10.1073/pnas.030528397; St-Pierre J, 2009, MOL CELL, V34, P416, DOI 10.1016/j.molcel.2009.04.013; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Swedlow JR, 2003, MOL CELL, V11, P557, DOI 10.1016/S1097-2765(03)00103-5; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI 10.1080/10409230802528488 ; Holmes VF, 2000, P NATL ACAD SCI USA, V97, P1322, DOI 10.1073/pnas.040576797; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Marko JF, 2008, CHROMOSOME RES, V16, P469, DOI 10.1007/s10577-008-1233-7; SAITOH N, 1994, J CELL BIOL, V127, P303, DOI 10.1083/jcb.127.2.303; Wang XD, 2013, NAT REV GENET, V14, P191, DOI 10.1038/nrg3375; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Becker PB, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017905; Belmont A. S., 2006, CURR OPIN CELL BIOL, V18, P1; Cui YB, 2008, NAT STRUCT MOL BIOL, V15, P411, DOI 10.1038/nsmb.1410; DOBZHANS.T, 1973, AM BIOL TEACH, V35, P125, DOI 10.2307/4444260; Petrushenko ZM, 2006, J BIOL CHEM, V281, P4606, DOI 10.1074/jbc.M504754200; Strick TR, 2004, CURR BIOL, V14, P874, DOI 10.1016/j.cub.2004.04.038; Travers A, 2007, EMBO REP, V8, P147, DOI 10.1038/sj.embor.7400898; Valenti A, 2011, BIOCHEM SOC T, V39, P58, DOI 10.1042/BST0390058	27	2	2	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0962-8924			TRENDS CELL BIOL	Trends Cell Biol.	DEC	2014	24	12					727	733		10.1016/j.tcb.2014.06.007		7	Cell Biology	Cell Biology	AW4EH	WOS:000346233500002		
J	Maeda, S; Hang, NTL; Lien, LT; Thuong, PH; Hung, NV; Hoang, NP; Cuong, VC; Hijikata, M; Sakurada, S; Keicho, N				Maeda, Shinji; Hang, Nguyen T. L.; Lien, Luu T.; Thuong, Pham H.; Hung, Nguyen V.; Hoang, Nguyen P.; Cuong, Vu C.; Hijikata, Minako; Sakurada, Shinsaku; Keicho, Naoto			Mycobacterium tuberculosis strains spreading in Hanoi, Vietnam: Beijing sublineages, genotypes, drug susceptibility patterns, and host factors	TUBERCULOSIS			English	Article						Beijing genotype; Sublineage; Drug resistance; Genetic clustering; Vietnam; Variable number of tandem repeat	POPULATION-STRUCTURE ANALYSIS; DISCRIMINATORY ABILITY; GENETIC DIVERSITY; TANDEM REPEATS; FAMILY; RESISTANCE; TRANSMISSION; LOCI; EPIDEMIOLOGY; ASSOCIATION	Beijing genotype strains are divided into two major sublineages, ancient (atypical) and modern (typical) types, but their phenotypic variations remain largely unknown. Mycobacterium tuberculosis (MTB) isolates from Hanoi, Vietnam, were analyzed by single-nucleotide polymorphisms and spoligotyping. Patient information and drug susceptibility patterns were obtained. Genetic clustering was assessed by variable number of tandem repeat (VNTR) locus sets. Multivariate analysis was also performed to investigate factors possibly associated with these sublineages. Of the 465 strains tested, 175 (37.6%) belonged to the ancient Beijing sublineage and 97 (20.9%) were of the modern Beijing sublineage. Patients with the Beijing genotype were significantly younger and more undernourished than those with non-Beijing genotype. The proportion of clustered strains calculated from 15 locus-optimized mycobacterial interspersed repetitive units [optimized-(MIRU)15]-, optimized-MIRU24-, optimized-MIRU28-, Japan Anti-Tuberculosis Association (JATA)15-, and JATA18-VNTRs were 55.7%, 49.2%, 33.8%, 44.5%, and 32.0%, respectively. Ancient and modern Beijing genotype strains were more frequently clustered than non-Beijing genotype strains, even when using VNTR sets with high discriminatory power. Isoniazid and streptomycin resistance tended to be more frequently observed in ancient Beijing strains than in modern Beijing strains and others. Our findings may provide insight into area-dependent differences in Beijing family strain characteristics. (C) 2014 The Authors. Published by Elsevier Ltd.	[Maeda, Shinji] JATA, Res Inst TB, Dept Mycobacterium Reference & Res, Tokyo, Japan; [Hang, Nguyen T. L.] NCGM BMH Med Collaborat Ctr, Hanoi, Vietnam; [Lien, Luu T.] Hanoi Dept Hlth, Hanoi, Vietnam; [Thuong, Pham H.; Cuong, Vu C.] Hanoi Lung Hosp, Hanoi, Vietnam; [Hung, Nguyen V.] Natl Lung Hosp, Dept Microbiol, Hanoi, Vietnam; [Hoang, Nguyen P.] Hanoi Lung Hosp, Dept Microbiol, Hanoi, Vietnam; [Hijikata, Minako; Keicho, Naoto] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Hijikata, Minako; Keicho, Naoto] Res Inst TB JATA, Dept Pathophysiol & Host Def, Tokyo, Japan; [Sakurada, Shinsaku] Natl Ctr Global Hlth & Med, Bur Int Med Cooperat, Tokyo, Japan	Keicho, N (reprint author), Japan AntiTB Assoc, Res Inst TB, Dept Pathophysiol & Host Def, 3-1-24 Matsuyama, Tokyo 2048533, Japan.	maeda@jata.or.jp; lehang0310@gmail.com; luuthilien.hth@gmail.com; phamhuuthuong.hth@gmail.com; ngvanhung.nth@gmail.com; nphoang.hth28@yahoo.com; vucaocuong.hth@gmail.com; mhijikata@jata.or.jp; ssakura@mti.biglobe.ne.jp; nkeicho-tky@umin.ac.jp			Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), MEXT, Japan	This work was supported by a grant from the Program of Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Strauss OJ, 2008, J CLIN MICROBIOL, V46, P1514, DOI 10.1128/JCM.01938-07; Kang HY, 2010, J MED MICROBIOL, V59, P1191, DOI 10.1099/jmm.0.022103-0; Gagneux Sebastien, 2006, PLoS Pathogens, V2, P603, DOI 10.1371/journal.ppat.0020061; Kremer K, 2009, EMERG INFECT DIS, V15, P335, DOI 10.3201/eid1502.080795; Hoa BK, 2008, TISSUE ANTIGENS, V71, P127, DOI 10.1111/j.1399-0039.2007.00982.x; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Glynn JR, 1999, AM J EPIDEMIOL, V149, P366; Yang CG, 2012, CLIN INFECT DIS, V55, P1179, DOI 10.1093/cid/cis670; Nakajima C, 2013, J CLIN MICROBIOL, V51, P2025, DOI 10.1128/JCM.03404-12; Hanekom M, 2011, TUBERCULOSIS, V91, P510, DOI 10.1016/j.tube.2011.07.005; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Maeda S, 2010, INT J TUBERC LUNG D, V14, P1201; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907; Glynn JR, 1999, INT J TUBERC LUNG D, V3, P1055; Iwamoto T, 2007, FEMS MICROBIOL LETT, V270, P67, DOI 10.1111/j.1574-6968.2007.00658.x; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Iwamoto T, 2009, J CLIN MICROBIOL, V47, P3340, DOI 10.1128/JCM.01061-09; Allix-Beguec C, 2014, J CLIN MICROBIOL, V52, P164, DOI 10.1128/JCM.02519-13; Anh DD, 2000, EMERG INFECT DIS, V6, P302; Wada T, 2009, FEMS MICROBIOL LETT, V291, P35, DOI 10.1111/j.1574-6968.2008.01431.x; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Iwamoto T, 2008, ANTIMICROB AGENTS CH, V52, P3805, DOI 10.1128/AAC.00579-08; Aguilar D, 2010, TUBERCULOSIS, V90, P319, DOI 10.1016/j.tube.2010.08.004; Wada T, 2009, TUBERCULOSIS, V89, P252, DOI 10.1016/j.tube.2009.05.007; Murase Y, 2008, J MED MICROBIOL, V57, P873, DOI 10.1099/jmm.0.47564-0; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Buu TN, 2009, EMERG INFECT DIS, V15, P1570, DOI 10.3201/eid1510.090170; Buu TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042323; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Chang JR, 2011, CLIN MICROBIOL INFEC, V17, P1391, DOI 10.1111/j.1469-0691.2010.03436.x; European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis, 2006, EMERG INFECT DIS, V12, P736; HANG NTL, 2011, PLOS ONE, V0006; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465; Luo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089726; Mokrousov I, 2006, ANTIMICROB AGENTS CH, V50, P2820, DOI 10.1128/AAC.00324-06; Mokrousov I, 2006, J CLIN MICROBIOL, V44, P2851, DOI 10.1128/JCM.00705-06; Nhu NTQ, 2012, INT J TUBERC LUNG D, V16, P527, DOI 10.5588/ijtld.11.0202; Semba RD, 2010, FOOD NUTR BULL, V31, pS345; Smittipat N, 2005, J CLIN MICROBIOL, V43, P5034, DOI 10.1128/JCM.43.10.5034-5043.2005; Theus S, 2007, Int J Tuberc Lung Dis, V11, P1087; Wan KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029190; WHO, 2013, WHO LIB CAT IN PUBL	42	4	4	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1472-9792			TUBERCULOSIS	Tuberculosis	DEC	2014	94	6					649	656		10.1016/j.tube.2014.09.005		8	Immunology; Microbiology; Respiratory System	Immunology; Microbiology; Respiratory System	AW0KB	WOS:000345979900015		
J	Kato, Y; Funato, R; Hirata, A; Murakami, M; Mori, T; Maruo, K; Yanai, T; Sakai, H				Kato, Yuki; Funato, Risa; Hirata, Akihiro; Murakami, Mami; Mori, Takashi; Maruo, Koji; Yanai, Tokuma; Sakai, Hiroki			Immunocytochemical detection of the class A macrophage scavenger receptor CD204 using air-dried cytologic smears of canine histiocytic sarcoma	VETERINARY CLINICAL PATHOLOGY			English	Article						Dog; fine-needle aspiration; immunocytochemistry; neoplasia; round cell tumor; SR-A	MALIGNANT HISTIOCYTOSIS; DOG; TUMORS	Background: Cytologic diagnosis of canine histiocytic sarcoma (CHS) can be challenging because neoplastic histiocytes commonly show marked nuclear and cellular atypia and may resemble other pleomorphic malignant round cell tumors. Therefore, even on histopathologic examination, immunostaining is often necessary for a definitive diagnosis. Objectives: The objective of this study was to validate an anti-human CD204 antibody for immunocytochemical staining of air-dried smears for a rapid definitive diagnosis of CHS. Methods: Cytologic specimens were obtained from 10 dogs with CHS and 45 dogs with other tumors. After the cytologic evaluation of modified Giemsa-stained smears, acetone-fixed specimens were immunostained using mouse anti-human CD204 antibodies. All immunocytochemical specimens were assessed blinded and at high-power magnification (9 40 objective) in 10 randomly selected fields per sample. Parameters evaluated were the subjective staining intensity and location, and the proportion of positive cells. Results: All 10 CHS samples showed intense positive staining for CD204 in >= 50% of the cells, whereas the 45 other tumors were negative for CD204 staining. Conclusions: Immunocytochemistry of air-dried cytologic smears of CHS for CD204 is useful for a rapid confirmation of a cytologic diagnosis of CHS.	[Kato, Yuki; Funato, Risa; Yanai, Tokuma; Sakai, Hiroki] Gifu Univ, Fac Appl Biol Sci, Lab Vet Pathol, Gifu 5011193, Japan; [Hirata, Akihiro] Gifu Univ, Life Sci Res Ctr, Div Anim Expt, Gifu 5011193, Japan; [Hirata, Akihiro; Murakami, Mami; Mori, Takashi; Maruo, Koji; Sakai, Hiroki] Gifu Univ, Comparat Canc Ctr, Gifu 5011193, Japan; [Murakami, Mami; Mori, Takashi; Maruo, Koji] Gifu Univ, Dept Vet Med, Lab Clin Oncol, Gifu 5011193, Japan	Sakai, H (reprint author), Gifu Univ, Fac Appl Biol Sci, Dept Vet Med, Lab Vet Pathol, 1-1 Yanagido, Gifu 5011193, Japan.	shiroki@gifu-u.ac.jp					Tomokiyo R, 2002, ATHEROSCLEROSIS, V161, P123, DOI 10.1016/S0021-9150(01)00624-4; Affolter VK, 2002, VET PATHOL, V39, P74, DOI 10.1354/vp.39-1-74; Soare T, 2012, J COMP PATHOL, V146, P168, DOI 10.1016/j.jcpa.2011.05.006; Moore PF, 2006, VET PATHOL, V43, P632, DOI 10.1354/vp.43-5-632; Kato Y, 2013, J COMP PATHOL, V148, P188, DOI 10.1016/j.jcpa.2012.06.009; Fulmer AK, 2007, CAN VET J, V48, P1041; DUNCAN JR, 1979, VET PATHOL, V16, P673; Giancarlo A, 2010, VET CLIN PATH, V39, P499; HAYDEN DW, 1993, VET PATHOL, V30, P256; Hoinghaus R, 2008, VET CLIN PATH, V37, P104, DOI [10.1111/j.1939-165X.2008.00017.x, 10.1111/j.1939-165x.2008.00017.x]; Rossi S, 2009, VET CLIN PATH, V38, P126, DOI 10.1111/j.1939-165X.2008.00104.x; Valli VE, 2002, HISTOLOGICAL CLASSIF, P60; Valli VE., 2007, VET COMP HEMATOPATHO, P505; WELLMAN ML, 1988, IN VITRO CELL DEV B, V24, P223	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0275-6382	1939-165X		VET CLIN PATH	Vet. Clin. Pathol.	DEC	2014	43	4					589	593		10.1111/vcp.12190		5	Veterinary Sciences	Veterinary Sciences	AW1OZ	WOS:000346060100017		
J	Tsubaki, R; Hosoda, N; Kitajima, H; Takanashi, T				Tsubaki, Remi; Hosoda, Naoe; Kitajima, Hiroshi; Takanashi, Takuma			Substrate-Borne Vibrations Induce Behavioral Responses in the Leaf-Dwelling Cerambycid, Paraglenea fortunei	ZOOLOGICAL SCIENCE			English	Article						vibration; behavior; longicorn beetle; insect; freeze response	MATE LOCATION; COMMUNICATION; COLEOPTERA; ORIENTATION; BEETLE	Many insects utilize substrate-borne vibrations as a source of information for recognizing mates or predators. Among various substrates, plant leaves are commonly used for transmitting and receiving vibrational information. However, little is known about the utilization of vibrations by leaf-dwelling insects, especially coleopteran beetles. We conducted two experiments to examine the response of the leaf-dwelling cerambycid beetle, Paraglenea fortunei, to substrate-borne vibrations. We recorded and analyzed vibrations of host plant leaves from four different sources: wind (0.5 m/s), a beetle during landing, a walking beetle, and a beetle walking in the wind (0.5 m/s). We then measured the behavioral thresholds, the lowest amplitudes that induce behavioral responses, from beetles walking and resting on horizontal and vertical substrates with pulsed vibrations ranging from 20 Hz to 1 kHz. The vibrational characteristics of biotic and abiotic stimuli clearly differed. Beetle-generated vibrations (landing, walking, and walking in the wind) were broadly high in the low-frequency components above similar to 30 Hz, while wind-generated vibrations showed a dominant peak at similar to 30 Hz and a steep decrease thereafter. Among four situations, beetles walking on horizontal substrates showed lowest thresholds to vibrations of 75-500 Hz, which are characteristic of beetle-generated vibrations. Given that P. fortunei beetles are found on horizontal leaf surfaces of the host plant, vibrations transmitted though horizontal substrates may induce a strong freeze response in walking beetles to detect conspecifics or heterospecifics. Our findings provide evidence that leaf-dwelling beetles can discriminate among biotic and abiotic factors via differences in vibrational characteristics.	[Tsubaki, Remi; Kitajima, Hiroshi; Takanashi, Takuma] Forestry & Forestry Prod Res Inst, Dept Forest Entomol, Tsukuba, Ibaraki 3058687, Japan; [Hosoda, Naoe] Natl Inst Mat Sci, Interconnect Design Grp, Hybrid Mat Unit, Tsukuba, Ibaraki 3050044, Japan	Takanashi, T (reprint author), Forestry & Forestry Prod Res Inst, Dept Forest Entomol, Tsukuba, Ibaraki 3058687, Japan.	takanasi@affrc.go.jp			Ministry of Education, Culture, Sports, Science and Technology [24120006, 24120005, 24120001]	We thank M. Shimomura, N. Mori, M. Fukaya, S. Nomura, T. Koike, and D. Voigt for providing valuable comments and kind assistance throughout this study. This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (Nos. 24120006, 24120005 and 24120001).	Guedes RNC, 2012, J COMP PHYSIOL A, V198, P325, DOI 10.1007/s00359-012-0711-8; Friedel T, 1999, J EXP BIOL, V202, P2151; Cocroft RB, 2006, ETHOLOGY, V112, P779, DOI 10.1111/j.1439-0310.2006.01226.x; Castellanos I, 2006, ANIM BEHAV, V72, P461, DOI 10.1016/j.anbehav.2006.02.005; Field LH, 1998, ADV INSECT PHYSIOL, V27, P1, DOI 10.1016/S0065-2806(08)60013-2; McNett GD, 2010, BEHAV ECOL SOCIOBIOL, V64, P2043, DOI 10.1007/s00265-010-1018-9; Hill PSM, 2009, NATURWISSENSCHAFTEN, V96, P1355, DOI 10.1007/s00114-009-0588-8; Kojima W, 2012, BEHAV ECOL SOCIOBIOL, V66, P171, DOI 10.1007/s00265-011-1264-5; Yack JE, 2001, P NATL ACAD SCI USA, V98, P11371, DOI 10.1073/pnas.191378898; OTA D, 1991, J INSECT BEHAV, V4, P441, DOI 10.1007/BF01049329; Bacher S, 1997, J INSECT PHYSIOL, V43, P945, DOI 10.1016/S0022-1910(97)00058-9; Barth FG, 1997, EXS, V84, P247; BREIDBACH O, 1986, BEHAV PROCESS, V12, P169, DOI 10.1016/0376-6357(86)90055-0; Djemai I, 2001, P ROY SOC B-BIOL SCI, V268, P2403, DOI 10.1098/rspb.2001.1811; Djemai I, 2004, ANIM BEHAV, V67, P567, DOI 10.1016/j.anbehav.2003.07.006; Eriksson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019692; Fleming AJ, 2013, CAN J ZOOL, V91, P235, DOI 10.1139/cjz-2012-0239; GOULSON D, 1994, ANIM BEHAV, V47, P899, DOI 10.1006/anbe.1994.1122; HANRAHAN SA, 1994, ETHOLOGY, V97, P26; Kitajima H, 2011, JPN J APPL ENTOMOL Z, V55, P67, DOI 10.1303/jjaez.2011.67; LINSLEY EG, 1959, ANNU REV ENTOMOL, V4, P99, DOI 10.1146/annurev.en.04.010159.000531; Magal C, 2000, J ACOUST SOC AM, V108, P2412, DOI 10.1121/1.1286098; MICHELSEN A, 1982, BEHAV ECOL SOCIOBIOL, V11, P269, DOI 10.1007/BF00299304; Ohbayashi N., 2007, LONGICORN BEETLES JA; Ruxton G. D., 2004, AVOIDING ATTACK; WANG Q, 1990, ANN ENTOMOL SOC AM, V83, P860	26	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	DEC	2014	31	12					789	794		10.2108/zs140029		6	Zoology	Zoology	AW3CW	WOS:000346164100002		
J	Mizuno, T; Yamaguchi, S; Yamamoto, I; Yamaoka, R; Akino, T				Mizuno, Takafumi; Yamaguchi, Susumu; Yamamoto, Ichiro; Yamaoka, Ryohei; Akino, Toshiharu			"Double-trick" Visual and Chemical Mimicry by the Juvenile Orchid Mantis Hymenopus coronatus Used in Predation of the Oriental Honeybee Apis cerana	ZOOLOGICAL SCIENCE			English	Article						orchid mantis; Hymenopus coronatus; oriental honeybee; Apis cerana; aggressive mimicry; chemical mimicry	SEXUALLY DECEPTIVE ORCHID; BOLAS SPIDER; POLLINATOR ATTRACTION; ULTRAVIOLET VISION; MANTODEA MANTIDAE; FLOWER VISITORS; PRAYING MANTIDS; SEX-PHEROMONE; CRAB-SPIDERS; BEHAVIOR	It has long been hypothesized that the flower-like appearance of the juvenile orchid mantis is used as visual camouflage to capture flower-visiting insects, although it is doubtful whether such morphological resemblance alone could increase their success in hunting. We confirmed that juvenile female orchid mantes often succeed in capturing oriental honeybees, while adult females often fail. Since most of the honeybees approached the juveniles from the front, we hypothesized that juvenile orchid mantes might attract honeybees by emitting some volatile chemical cues. Gas chromatography-mass spectrometry analyses revealed that the mantes' mandibular adducts contained 3-hydroxyoctanoic acid (3HOA) and 10-hydroxy-(E)-2-decenoic acid (10HDA), both of which are also features of the pheromone communication of the oriental honeybee. We also successfully detected 3HOA emitted in the head space air only at the time when the juvenile mantes were attempting to capture their prey. Field bioassay showed that the Oriental Honeybee predominantly preferred to visit dummies impregnated with a mixture of the appropriate amounts and ratios of 3HOA and 10HDA. We therefore conclude that the juvenile mantes utilize these as allelochemicals to trick and attract oriental honeybees.	[Mizuno, Takafumi; Akino, Toshiharu] Kyoto Inst Technol, Ctr Bioresources Field Sci, Appl Entomol Lab, Kyoto 6168354, Japan; [Yamamoto, Ichiro] Win K Corp, Shibuya Ku, Tokyo 1500001, Japan	Mizuno, T (reprint author), Kyoto Inst Technol, Ctr Bioresources Field Sci, Appl Entomol Lab, Saga Ippongi Cho 1, Kyoto 6168354, Japan.	takafumi.takafumizuno@gmail.com			Kyoto Institute of Technology-Venture Laboratory (KIT-VL)	We thank Dr. T. Ichioka of Kyoto University for identification of the oriental honeybee, H. Egawa of NHK Enterprises Inc. for providing photos and videotapes of the orchid mantis, S. Tanaka of the National Institute of Agrobiological Sciences for editing our revised English and J. Ryder for proofreading the English of the manuscript. This study is partially supported by Kyoto Institute of Technology-Venture Laboratory (KIT-VL) training grants 2013.	Akino T, 2004, CHEMOECOLOGY, V14, P165, DOI 10.1007/s00049-004-0274-4; Gemeno C, 2000, J CHEM ECOL, V26, P1235, DOI 10.1023/A:1005488128468; Heiling AM, 2005, J EXP BIOL, V208, P1785, DOI 10.1242/jeb.01585; O''Hanlon JC, 2014, AM NAT, V183, P126, DOI 10.1086/673858; Streinzer M, 2009, J EXP BIOL, V212, P1365, DOI 10.1242/jeb.027482; Dotterl S, 2010, CAN J ZOOL, V88, P668, DOI 10.1139/Z10-031; Sugahara M, 2013, ZOOL SCI, V30, P99, DOI 10.2108/zsj.30.99; Heiling AM, 2003, NATURE, V421, P334, DOI 10.1038/421333a; Yamamura K, 1999, RES POPUL ECOL, V41, P229; CHITTKA L, 1992, J COMP PHYSIOL A, V171, P171; Foster JJ, 2014, CURR BIOL, V24, P1415, DOI 10.1016/j.cub.2014.05.007; KEVAN PG, 1983, ANNU REV ENTOMOL, V28, P407, DOI 10.1146/annurev.en.28.010183.002203; Dotterl S, 2005, PLANT SYST EVOL, V255, P99, DOI 10.1007/s00606-005-0344-2; Spaethe J, 2007, PLANT SYST EVOL, V264, P31, DOI 10.1007/s00606-006-0503-0; CHEN DM, 1986, J COMP PHYSIOL A, V159, P473, DOI 10.1007/BF00604167; CHEN DM, 1984, SCIENCE, V225, P337, DOI 10.1126/science.6740315; Rakosy D, 2012, ARTHROPOD-PLANT INTE, V6, P671, DOI 10.1007/s11829-012-9217-0; SASAKI M, 1991, EXPERIENTIA, V47, P1229, DOI 10.1007/BF01918392; Keeling CI, 2001, APIDOLOGIE, V32, P243, DOI 10.1051/apido:2001126; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Barth FG, 1991, INSECTS FLOWERS BIOL; EBERHARD WG, 1977, SCIENCE, V198, P1173, DOI 10.1126/science.198.4322.1173; EDMUNDS M, 1972, ZOOL J LINN SOC-LOND, V51, P1, DOI 10.1111/j.1096-3642.1972.tb00771.x; Evans DL, 1990, EVOLUTION CRYPTIC CO; FLEISHMAN LJ, 1993, NATURE, V365, P397, DOI 10.1038/365397a0; Gullan P.J., 2010, INSECTS OUTLINE ENTO; Haynes KF, 2002, CHEMOECOLOGY, V12, P99, DOI 10.1007/s00049-002-8332-2; Honkavaara J, 2002, OIKOS, V98, P505, DOI 10.1034/j.1600-0706.2002.980315.x; Hurd LE, 2004, J CHEM ECOL, V30, P155, DOI 10.1023/B:JOEC.0000013188.79411.18; Kinoshita M, 2011, P ROY SOC B, V279, P1911; O'Hanlon J.C., 2013, Journal of Orthoptera Research, V22, P35; Lunau K, 1996, ZOOL ANZ, V235, P11; Maxwell MR, 2010, ANN ENTOMOL SOC AM, V103, P120, DOI 10.1603/008.103.0115; Milet-Pinheiro P, 2012, BEHAV ECOL, V23, P531, DOI 10.1093/beheco/arr219; O'Hanlon JC, 2014, CURR ZOOL, V60, P90; Owen D., 1980, CAMOUFLAGE MIMICRY; Perez B, 2005, PHYSIOL ENTOMOL, V30, P42, DOI 10.1111/j.0307-6962.2005.00426.x; Rae JM, 2013, PLANT SPEC BIOL, V28, P177, DOI 10.1111/j.1442-1984.2012.00375.x; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; Spaethe Johannes, 2010, Communicative & Integrative Biology, V3, P139; Stoddard MC, 2012, CURR ZOOL, V58, P630; STOWE MK, 1987, SCIENCE, V236, P964, DOI 10.1126/science.236.4804.964; Sugahara M, 2006, HONEYBEE SCI, V26, P159; Watanabe H, 2013, ENTOMOL SCI, V16, P40, DOI 10.1111/j.1479-8298.2012.00536.x; Wickler W, 1968, MIMICRY PLANTS ANIMA	45	1	1	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	DEC	2014	31	12					795	801		10.2108/zs140126		7	Zoology	Zoology	AW3CW	WOS:000346164100003		
J	Katagiri, N; Katagiri, Y; Wada, M; Okano, D; Shigematsu, Y; Yoshioka, T				Katagiri, Nobuko; Katagiri, Yasuo; Wada, Masaaki; Okano, Daisuke; Shigematsu, Yasuhide; Yoshioka, Toshitada			Three-Dimensional Reconstruction of the Axon Extending from the Dermal Photoreceptor Cell in the Extraocular Photoreception System of a Marine Gastropod, Onchidium	ZOOLOGICAL SCIENCE			English	Article						dermal photoreceptor cell; extraocular photoreceptor; axon; sheath; Onchidium; three-dimensional reconstruction; high-voltage transmission electron microscope (HVTEM); DeltaViewer	RHODOPSIN-RETINOCHROME SYSTEM; FINE-STRUCTURE; LIGHT SENSE; STALK-EYE; DROSOPHILA; VERRUCULATUM; MIGRATION; NERVE; ULTRASTRUCTURE; INVERTEBRATES	The marine gastropod Onchidium has a multiple photoreceptive system consisting of stalk eyes, dorsal eyes, photosensitive neurons, and extraocular dermal photoreceptor cells (DPCs). The DPCs were widespread all over the dorsal mantle and distributed singly or in groups in the dermis, but were not discernible by the naked eye. The DPC was oval in shape and large in size, and characterized by features specific to gastropod photoreceptor cells such as massive microvilli, photic vesicles, and a depolarized response. DPC-17, one of a group of 19 DPCs, was examined on serial semi-thin sections of 0.4 mu m in thickness with a high-voltage transmission electron microscope (HVTEM). The axon emerged specifically from the lateral side between the distal microvillous portion and proximal cytoplasm, travelled through the connective tissue, and joined a small nerve bundle (NB). Two types of supportive cells were found along the length of the axon. The first type was a covering cell (CC) surrounding the surface of the DPC body and continuing onward to the axon sheath. DPC-17 was covered by 11 CCs, while the larger DPC-6 was only covered by four CCs. The second type was a sheath cell (ShC) wrapping the surface of the small NB where the axon of the DPC merged with undefined nerve fibers. The axon extending directly from DPC-17 was reconstructed three-dimensionally (3D) using DeltaViewer software. The 3D-reconstructed image of the sheath of the axon and the CC demonstrated the continuity between the two structures, especially when the image was rotated using DeltaViewer.	[Katagiri, Nobuko; Katagiri, Yasuo; Yoshioka, Toshitada] Hirosaki Gakuin Univ, Fac Nursing, Hirosaki, Aomori 0368231, Japan; [Wada, Masaaki] Osaka Univ, Dept Pure & Appl Math, Grad Sch Informat Sci & Technol, Toyonaka, Osaka 5600043, Japan; [Okano, Daisuke] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Okano, Daisuke] Hirosaki Univ, Dept Biofunct Sci, Fac Agr & Life Sci, Hirosaki, Aomori 0368561, Japan; [Shigematsu, Yasuhide] Tokyo Womens Med Univ, Med Res Inst, Shinjuku Ku, Tokyo 1628666, Japan	Yoshioka, T (reprint author), Hirosaki Gakuin Univ, Fac Nursing, 20-7 Minori Cho, Hirosaki, Aomori 0368231, Japan.	yoshioka_toshitada@hirogaku-u.ac.jp			National Institute for Physiological Sciences (NIPS), Japan; Ministry of Education, Culture, Sports, Science, and Technology, Japan [182000425001]	The work was performed at Tokyo Women's Medical University, Medical Research Institute. We are grateful to Emeritus Prof. K. Hama for his significant advice, and to Dr. T. Arii for allowing us to use the H-1200 M HVTEM at the National Institute for Physiological Sciences. The study was supported in part by joint research programs of the National Institute for Physiological Sciences (NIPS), Japan and a Grant-in-Aid for Science Research (A) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (grant Number 182000425001 to T. Yoshioka).	Wilson CH, 2011, J COMP NEUROL, V519, P3259, DOI 10.1002/cne.22695; Ramirez MD, 2011, VISUAL NEUROSCI, V28, P265, DOI 10.1017/S0952523811000150; HAMA K, 1966, J CELL BIOL, V31, P624, DOI 10.1083/jcb.31.3.624; Oland LA, 1999, CELL TISSUE RES, V297, P527, DOI 10.1007/s004410051379; STEVEN DM, 1963, BIOL REV, V38, P204, DOI 10.1111/j.1469-185X.1963.tb00783.x; Dayrat B, 2009, ZOOTAXA, P1; Pereanu W, 2005, DEV BIOL, V283, P191, DOI 10.1016/j.ydbio.2005.04.024; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; TERAKITA A, 1989, VISION RES, V29, P639, DOI 10.1016/0042-6989(89)90026-6; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Silies M, 2007, J NEUROSCI, V27, P13130, DOI 10.1523/JNEUROSCI.3583-07.2007; Arikawa K, 1997, J COMP PHYSIOL A, V180, P295, DOI 10.1007/s003590050049; Xie XJ, 2011, DEVELOPMENT, V138, P3813, DOI 10.1242/dev.064816; Klambt C, 2009, NAT REV NEUROSCI, V10, P769, DOI 10.1038/nrn2720; Arey LB, 1921, J EXP ZOOL, V32, P443, DOI 10.1002/jez.1400320305; Aschenbrenner S, 1998, CELL TISSUE RES, V293, P253, DOI 10.1007/s004410051117; BARBER VC, 1967, Z ZELLFORSCH MIK ANA, V76, P295, DOI 10.1007/BF00339290; Chono K, 2002, BRAIN RES, V951, P107, DOI 10.1016/S0006-8993(02)03143-8; Eakin RM., 1972, HDB SENSORY PHYSL, P625; FLEISSNER G, 1993, CELL TISSUE RES, V273, P435, DOI 10.1007/BF00333698; Garm A, 2010, INT REV CEL MOL BIO, V280, P41, DOI 10.1016/S1937-6448(10)80002-4; Gotow T, 2008, BRAIN RES, V1225, P3, DOI 10.1016/j.brainres.2008.04.059; GRAY EG, 1970, COMP BIOCHEM PHYSIOL, V36, P419, DOI 10.1016/0010-406X(70)91021-2; Gutierrez LM, 2001, VELIGER, V44, P1; HERMAN KG, 1984, J COMP NEUROL, V230, P593, DOI 10.1002/cne.902300408; HISANO N, 1972, J EXP BIOL, V57, P651; JACKLET JW, 1983, J NEUROCYTOL, V12, P673, DOI 10.1007/BF01181530; Katagiri N, 2004, P 16 INT C IFAA, P372; KATAGIRI N, 1995, J ELECTRON MICROSC, V44, P219; Katagiri N, 2009, COMP PHYSL BIOCH, V26, P58; Katagiri N, 2001, J COMP NEUROL, V433, P380, DOI 10.1002/cne.1146; Katagiri N, 2008, COMP PHYSL BIOCH, V25, P4; KATAGIRI N, 1984, J ELECTRON MICROSC, V33, P142; KATAGIRI N, 1990, J ELECTRON MICROSC, V39, P363; Katagiri N, 1997, J TOKYO WOMENS MED C, V67, P322; Katagiri N, 2003, KEIO U INT SYMP LIFE, V11, P86; Katagiri N, 2006, 16 INT MICR C P, P293; Katagiri Y, 1985, Neurosci Res Suppl, V2, pS1, DOI 10.1016/0921-8696(85)90004-0; MCFARLANE ID, 1980, MAR BEHAV PHYSIOL, V7, P95; Messenger JB, 1991, EVOLUTION EYE VISUAL, P364; Miyako Y, 1993, J COMP NEUROL, V327, P456; OZAKI K, 1986, VISION RES, V26, P691, DOI 10.1016/0042-6989(86)90083-0; PENTREAT.VW, 1974, CELL TISSUE RES, V151, P369; ROHLICH P, 1970, Z ZELLFORSCH MIK ANA, V104, P345, DOI 10.1007/BF00335687; Roots BI, 2009, NEURON GLIA BIOL, V4, P101; Stantschinsky W, 1908, Z WISS ZOOL ABT A, V90, P137; Uehara R, 2007, CHIRIBOTAN, V38, P43; Wada M, 2007, COMP PHYS BIOCH, V24, P160; Yamamoto M, 2004, J VET MED SCI, V66, P635, DOI 10.1292/jvms.66.635; Yasuyama K, 1999, J COMP NEUROL, V412, P193, DOI 10.1002/(SICI)1096-9861(19990920)412:2<193::AID-CNE1>3.0.CO;2-0; Yoshida M, 1979, HDB SENSORY PHYSL, V7/6A, P581	51	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	DEC	2014	31	12					810	819		10.2108/zs140085		10	Zoology	Zoology	AW3CW	WOS:000346164100005		
J	Katoh, T; Koji, S; Ishida, TA; Matsubayashi, KW; Kahono, S; Kobayashi, N; Furukawa, K; Viet, BT; Vasconcellos-Neto, J; Lange, CN; Goergen, G; Nakano, S; Li, NN; Yu, GY; Katakura, H				Katoh, Toru; Koji, Shinsaku; Ishida, Takahide A.; Matsubayashi, Kei W.; Kahono, Sih; Kobayashi, Norio; Furukawa, Kota; Bui Tuan Viet; Vasconcellos-Neto, Joao; Lange, Charles N.; Goergen, Georg; Nakano, Susumu; Li, Nan-Nan; Yu, Guo-Yue; Katakura, Haruo			Phylogeny of Epilachna, Henosepilachna, and Some Minor Genera of Phytophagous Ladybird Beetles (Coleoptera: Coccinellidae: Coccinellinae: Epilachnini), with an Analysis of Ancestral Biogeography and Host-Plant Utilization	ZOOLOGICAL SCIENCE			English	Article						Epilachnini; Epilachna; Henosepilachna; Epiverta; historical biogeography; host shift	INTERNAL REPRODUCTIVE-ORGANS; MAXIMUM-LIKELIHOOD; SPERM TRANSFER; NEW-GUINEA; EVOLUTION; COMPLEX; PAIR; CHRYSOMELIDAE; ASSOCIATIONS; SPECIATION	Ladybird beetles in the tribe Epilachnini include notorious crop pests and model species studied intensively in various fields of evolutionary biology. From a combined dataset of mitochondrial (ND2) and nuclear (28S) DNA sequences, we reconstructed the phylogeny of 46 species of Epilachnini from Asia, Africa, America, and the Australian region: 16 species in Epilachna, 24 species in Henosepilachna, and one species each in Adira, Afidenta, Afidentula, Afissula, Chnootriba, and Epiverta. In our phylogenetic trees, both Epilachna and Henosepilachna were reciprocally polyphyletic. Asian Epilachna species were monophyletic, except for the inclusion of Afissula sp. Asian and Australian Henosepilachna species likewise formed a monophyletic group, excluding H. boisduvali. African Epilachna and Henosepilachna species did not group with their respective Asian and American congeners, but were paraphyletic to other clades (Epilachna species) or formed a separate monophyletic group (Henosepilachna species) together with Chnootriba similis. The American Epilachna species were monophyletic and formed a clade with American Adira clarkii and Asian Afidentula manderstjernae bielawskii; this clade was the sister group to Asian and Australian Henosepilachna, but was distant from Asian Epilachna. Chnootriba was embedded in the African Henosepilachna clade, and Afissula in the Asian Epilachna clade. Epiverta, which is morphologically unique, was the sister group to Asian Epilachna, although with weak support. From reconstructions of biogeographical distribution and host-plant utilization at ancestral nodes, we inferred an African origin for the common ancestor of the species studied, and found the frequency of host shifts to differ greatly between the two major lineages of Epilachnini examined.	[Katoh, Toru; Katakura, Haruo] Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Koji, Shinsaku] Kanazawa Univ, Ctr Reg Collaborat, Suzu 9271462, Japan; [Matsubayashi, Kei W.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Kahono, Sih] Res Ctr Biol LIPI, Div Zool, Museum Zoologicum Bogoriense, Cibinong 16911, Indonesia; [Kobayashi, Norio] Saitama Prefectural Univ, Ctr Univ Wide Educ, Koshigaya 3438540, Japan; [Furukawa, Kota] Hokkaido Univ, Grad Sch Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Bui Tuan Viet] Vietnamese Acad Sci & Technol, Vietnam Natl Museum Nat, Hanoi, Vietnam; [Vasconcellos-Neto, Joao] Univ Estadual Campinas Unicamp, Inst Biol, Dept Biol Anim, BR-13083970 Campinas, SP, Brazil; [Lange, Charles N.] Natl Museums Kenya, Dept Invertebrate Zool, Nairobi, Kenya; [Goergen, Georg] Int Inst Trop Agr, Cotonou, Benin; [Nakano, Susumu] Hiroshima Shudo Univ, Fac Human Environm Studies, Hiroshima 7313195, Japan; [Li, Nan-Nan] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Yunnan, Peoples R China; [Yu, Guo-Yue] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing 100097, Peoples R China; [Katakura, Haruo] Hokkaido Univ, Hokkaido Univ Museum, Sapporo, Hokkaido 0600810, Japan	Katakura, H (reprint author), Hokkaido Univ, Fac Sci, Dept Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan.	katakura@sci.hokudai.ac.jp			Ministry of Education, Japan [14204081, 18207005, 23405012]; MEXT Grant-in Aid for the 21st Century COE Program at Hokkaido University [J01]; CNPq (National Council for Scientific and Technological Development, Brazil)	We thank I. Abbas, S. Hartini, N. Fujiyama, J.-J. Gao, D. M. Windsor, and S. Higashi for help in various ways; H. Fursch for identifying some of the African epilachnines; and M. H. Dick for editing the manuscript. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Japan (Nos. 14204081, 18207005, and 23405012 to HK); by a MEXT Grant-in Aid for the 21st Century COE Program at Hokkaido University (J01); and by a research fellowship to JVN from CNPq (National Council for Scientific and Technological Development, Brazil). The Indonesian Ministry for Research and Technology (Ristek) and the Research Center for Biology, Indonesian Institute of Science (LIPI), permitted us to conduct part of this study in Indonesia.	Adler PH, 2009, INSECT BIODIVERSITY, P1, DOI 10.1002/9781444308211.ch1; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Soltis DE, 2000, BOT J LINN SOC, V133, P381, DOI 10.1006/bojl.2000.0380; Kobayashi N, 2009, J NAT HIST, V43, P1637, DOI 10.1080/00222930902968817; Becerra JX, 1999, P NATL ACAD SCI USA, V96, P12626, DOI 10.1073/pnas.96.22.12626; BOOM R, 1990, J CLIN MICROBIOL, V28, P495; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Magro A, 2010, MOL PHYLOGENET EVOL, V54, P833, DOI 10.1016/j.ympev.2009.10.022; Futuyma DJ, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P136; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; FARRELL B, 1990, EVOLUTION, V44, P1389, DOI 10.2307/2409325; Soltis PS, 1999, NATURE, V402, P402, DOI 10.1038/46528; Matsubayashi KW, 2009, EVOLUTION, V63, P2563, DOI 10.1111/j.1558-5646.2009.00738.x; Giorgi JA, 2009, BIOL CONTROL, V51, P215, DOI 10.1016/j.biocontrol.2009.05.019; Winkler IS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P240; FUTUYMA DJ, 1990, EVOLUTION, V44, P1885, DOI 10.2307/2409602; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; Seago AE, 2011, MOL PHYLOGENET EVOL, V60, P137, DOI 10.1016/j.ympev.2011.03.015; RICHARDS AM, 1983, INT J ENTOMOL, V25, P11; Dobler S, 1996, EVOLUTION, V50, P2373, DOI 10.2307/2410706; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Aruggoda A. G. B., 2010, Tropical Agricultural Research, V21, P209; Bernays EA, 1994, HOST PLANT SELECTION; BIELAWSKI RYSZARD, 1965, POL PISMO ENTOMOL [BULL ENTOMOL POLOGNE], V35, P535; Bielawski R., 1963, Annales Zoologici Warszawa, V21, P295; Dieke G. H., 1947, Smithsonian Miscellaneous Collections, V106, P1; FARRIS JS, 1994, CLADISTICS, V10, P315; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Fujiyama N, 1998, APPL ENTOMOL ZOOL, V33, P327; Fursch H., 1990, Coccinella, V2, P45; Fursch H, 1964, REICHENBACHIA, V16, P181; Fursch H., 1991, Entomofauna, V12, P217; Fursch H., 1991, Coccinella, V3, P23; Gordon RD, 1975, TECHNICAL B USDA, V1493; Grimaldi David, 2005, pi; Hilu KW, 2003, AM J BOT, V90, P1758, DOI 10.3732/ajb.90.12.1758; Hirai Y, 2006, ENTOMOL EXP APPL, V118, P129, DOI 10.1111/j.1570-7458.2006.00365.x; Iablokoff-Khnzorian S.M., 1980, Entomologicheskoe Obozrenie, V59, P297; International Commission on Zoological Nomenclature (ICZN), 1999, INT CODE ZOOLOGICAL; Jadwiszczak A. S., 2003, WORLD CATALOGUE CO 1; KAPUR A. P., 1967, Proceedings of the National Institute of Sciences of India, V32B, P148; Katakura Haruo, 1997, Japanese Journal of Entomology, V65, P75; KATAKURA H, 1994, ENTOMOL EXP APPL, V71, P81; KATAKURA H, 1994, J NAT HIST, V28, P577, DOI 10.1080/00222939400770261; Katakura H, 1997, ZOOL SCI, V14, P869, DOI 10.2108/zsj.14.869; KATAKURA H, 1989, EVOLUTION, V43, P1045, DOI 10.2307/2409584; Katakura H, 2001, TROPICS, V10, P325; Kobayashi N, 2011, J ZOOL SYST EVOL RES, V49, P16, DOI 10.1111/j.1439-0469.2010.00581.x; Kobayashi N, 1998, ZOOL SCI, V15, P147, DOI 10.2108/zsj.15.147; Kobayashi N, 2000, ZOOL SCI, V17, P1159, DOI 10.2108/zsj.17.1159; Kova I., 1996, ECOLOGY COCCINELLIDA, P19; Kuwajima M, 2010, ENTOMOL EXP APPL, V134, P280, DOI 10.1111/j.1570-7458.2009.00955.x; LI CS, 1993, J AUST ENTOMOL SOC, V32, P209; LI C. S., 1961, PACIFIC INSECTS, V3, P31; Matsubayashi KW, 2007, ETHOLOGY, V113, P686, DOI 10.1111/j.1439-0310.2007.01368.x; Matsubayashi KW, 2011, J EVOLUTION BIOL, V24, P1421, DOI 10.1111/j.1420-9101.2011.02274.x; Mulsant E, 1850, ANN SCI PHYSIQUES NA, V2, P1, DOI [10.5962/bhl.title.8953, DOI 10.5962/BHL.TITLE.8953]; Nakano S, 2001, TROPICS, V10, P353; Nedved Oldrich, 2012, P1; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nyman T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-266; Ohshima I, 2006, MOL PHYLOGENET EVOL, V38, P231, DOI 10.1016/j.ympev.2005.06.010; Pang H, 2012, ZOOTAXA, P1; Pang X. F., 1979, EC INSECT FAUNA CHIN; Poorani J, 2004, ANNOTATED CHECKLIST; Posada D., 2003, CURRENT PROTOCOLS BI, DOI DOI 10.1002/0471250953.BIO605S00; Rambaut A., 2009, TRACER V 1 5; Resh VH, 2009, ENCY INSECTS; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sasaji H., 1971, FAUNA JAPONICA COCCI; Sasaji H., 1968, Etizenia, VNo. 35, P1; Schaefer PW, 1983, B AGR EXP STN U DELA, V445, P1; Schoonhoven LM, 2005, INSECT PLANT BIOL; Slipinski A, 2007, AUSTR LADYBIRD COLEO; Strong DR, 1984, INSECTS PLANTS COMMU, P313; Swofford D. L., 2002, PAUP PHYLOGENETIC AN; Szawaryn K, 2013, J NAT HIST, V47, P2427, DOI 10.1080/00222933.2012.763067; Szawaryn K, 2011, ANN ZOOL, V61, P685, DOI 10.3161/000345411X622525; Tavare S., 1986, SOME MATH QUESTIONS, P57; Yu Guoyue, 1994, Entomologia Sinica, V1, P17; Yu Y., 2013, RASP RECONSTRUCT ANC	87	1	1	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	DEC	2014	31	12					820	830		10.2108/zs140088		11	Zoology	Zoology	AW3CW	WOS:000346164100006		
J	Kawazu, I; Kino, M; Maeda, K; Yamaguchi, Y; Sawamukai, Y				Kawazu, Isao; Kino, Masakatsu; Maeda, Konomi; Yamaguchi, Yasuhiro; Sawamukai, Yutaka			Induction of Oviposition by the Administration of Oxytocin in Hawksbill Turtles	ZOOLOGICAL SCIENCE			English	Article						oxytocin dosage; induced oviposition; oviposited eggs; clutch size; egg diameter	ERETMOCHELYS-IMBRICATA; SEA-TURTLES; ARTIFICIAL-INSEMINATION; REPRODUCTIVE-BIOLOGY; ARGININE VASOTOCIN; OVULATION; ISLAND	We set out to develop an oviposition induction technique for captive female hawksbill turtles Eretmochelys imbricata. The infertile eggs of nine females were induced to develop by the administration of follicle-stimulating hormone, after which we investigated the effects of administering oxytocin on oviposition. Seven of the turtles were held in a stationary horizontal position on a retention stand, and then oxytocin was administrated (0.6-0.8 units/kg of body weight; 5 mL). The seven turtles were retained for a mandatory 2 h period after oxytocin administration, and were then returned to the holding tanks. As the control, normal saline (5 mL) was administered to the other two turtles, followed by the administration of oxytocin after 24 h. The eggs in oviducts of all nine turtles were observed by ultrasonography at 24 h after oxytocin administration. The control experiment validated that stationary retention and normal saline administration had no effect on egg oviposition. Eight of the turtles began ovipositing eggs at 17-43 min after oxytocin administration, while one began ovipositing in the holding tank immediately after retention. All turtles finished ovipositing eggs within 24 h of oxytocin administration. This report is the first to demonstrate successful induced oviposition in sea turtles. We suggest that the muscles in the oviducts of hawksbill turtles may respond to relatively lower doses of oxytocin (inducing contractions) compared to land and freshwater turtles (4-40 units/kg) based on existing studies.	[Kawazu, Isao; Kino, Masakatsu; Maeda, Konomi] Okinawa Churashima Fdn, Motobu, Okinawa 9050206, Japan; [Yamaguchi, Yasuhiro] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 8528521, Japan; [Sawamukai, Yutaka] Yokoo Vet Clin, Nasushiobara, Tochigi 3292801, Japan	Kawazu, I (reprint author), Okinawa Churashima Fdn, 888 Ishikawa, Motobu, Okinawa 9050206, Japan.	i-kawazu@okichura.jp					Bazer FW, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 5: MAMMALS, P73; WITZELL WN, 1980, B MAR SCI, V30, P571; LIMPUS CJ, 1983, AUST WILDLIFE RES, V10, P185; BJORNDAL KA, 1985, BIOL CONSERV, V34, P353, DOI 10.1016/0006-3207(85)90040-0; Blanvillain G, 2011, HORMONES REPROD VERT, V3, P277; EWERT MA, 1978, HERPETOLOGICA, V34, P314; Feldman ML, 2007, CHELONIAN CONSERV BI, V6, P313, DOI 10.2744/1071-8443(2007)6[313:SOTIOI]2.0.CO;2; FIGLER RA, 1989, GEN COMP ENDOCR, V73, P223, DOI 10.1016/0016-6480(89)90095-6; Foote R. H., 2002, J ANIM SCI, V80, P1; HIRTH HF, 1980, AM ZOOL, V20, P507; Hoggard Cheryl, 2000, Wildlife Rehabilitation, V18, P15; Jones R, 1978, HERPETOLOGICA, V38, P80; Kawazu Isao, 2014, Current Herpetology, V33, P88, DOI 10.5358/hsj.33.88; MAHMOUD IY, 1988, GEN COMP ENDOCR, V69, P56, DOI 10.1016/0016-6480(88)90052-4; Manire CA, 2008, ZOO BIOL, V27, P213, DOI 10.1002/zoo.20171; Miller Jeffrey D., 1999, P124; Moncada Felix, 1999, Chelonian Conservation and Biology, V3, P257; MOORE HDM, 1984, J ZOOL, V203, P269; Mortimer JA, 2008, MARINE TURTLE SPECIA; OWENS DW, 1980, AM ZOOL, V20, P549; Owens David W., 1997, P315; Pilcher Nicolas J., 1999, Chelonian Conservation and Biology, V3, P330; Rodger JC, 2009, THERIOGENOLOGY, V71, P176, DOI 10.1016/j.theriogenology.2008.09.006; Tucker JK, 2007, CHELONIAN CONSERV BI, V6, P321, DOI 10.2744/1071-8443(2007)6[321:ODIT]2.0.CO;2; Wilgenbusch JC, 2000, HERPETOLOGICA, V38, P80; WITZELL W N, 1985, Japanese Journal of Herpetology, V11, P46; WOOD VE, 1986, BIOL CONSERV, V37, P321, DOI 10.1016/0006-3207(86)90076-5; Xavier R, 2006, AMPHIBIA-REPTILIA, V27, P539, DOI 10.1163/156853806778877077	28	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	DEC	2014	31	12					831	835		10.2108/zs140032		5	Zoology	Zoology	AW3CW	WOS:000346164100007		
J	Rajapakse, S; Ogiwara, K; Takahashi, T				Rajapakse, Sanath; Ogiwara, Katsueki; Takahashi, Takayki			Characterization and Expression of Trypsinogen and Trypsin in Medaka Testis	ZOOLOGICAL SCIENCE			English	Article						teleost; medaka; testis; spermiation; protease; trypsin	ORYZIAS-LATIPES; PYLORIC CECA; DEVELOPMENTAL GENETICS; PROTEASE INHIBITORS; SERTOLI-CELL; CATHEPSIN-B; MALE GENOME; IN-VITRO; SPERMATOGENESIS; FISH	Previously, we reported that the medaka testis abundantly expresses the mRNA for trypsinogen, which is a well-known pancreatic proenzyme that is secreted into and activated in the intestine. Currently, we report our characterization of the medaka trypsin using a recombinant enzyme and show that this protein is a serine protease that shares properties with trypsins from other species. Two polypeptides (28- and 26-kDa) were detected in the testis extracts by Western blot analysis using antibodies that are specific for medaka trypsinogen. The 28-kDa polypeptide was shown to be trypsinogen (inactive precursor), and the 26-kDa polypeptide was shown to be trypsin (active protease). We did not detect enteropeptidase, which is the specific activator of trypsinogen, in the testis extract. Immunohistochemical analyses using the same trypsinogen-specific antibody produced a strong signal in the spermatogonia and spermatozoa of the mature medaka testis. Substantial staining was found with spermatocytes, whereas extremely weak signals were observed with spermatids. In vitro incubation of testis fragments with the trypsinogen antibody strongly inhibited the release of sperm from the testis into the medium. Trypsin activity was detected in sperm extracts using gelatin zymographic analysis. Immunocytochemistry showed that trypsinogen and trypsin were localized to the cell membranes surrounding the sperm head. Collectively, these results suggest that trypsin plays an important role in the testis function of the medaka.	[Rajapakse, Sanath] Univ Peradeniya, Fac Sci, Dept Mol Biol & Biotechnol, Peradeniya 20400, Sri Lanka; [Ogiwara, Katsueki; Takahashi, Takayki] Hokkaido Univ, Fac Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 0600810, Japan	Takahashi, T (reprint author), Hokkaido Univ, Fac Sci, Lab Reprod & Dev Biol, Sapporo, Hokkaido 0600810, Japan.	ttakaha@sci.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24247010]	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24247010 to T. T.).	Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Szenthe B, 2005, BBA-PROTEINS PROTEOM, V1748, P35, DOI 10.1016/j.bbapap.2004.12.006; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; Bezerra RS, 2001, J FOOD BIOCHEM, V25, P199, DOI 10.1111/j.1745-4514.2001.tb00734.x; Ishikawa Y, 2000, BIOESSAYS, V22, P487, DOI 10.1002/(SICI)1521-1878(200005)22:5<487::AID-BIES11>3.3.CO;2-#; WANG K, 1995, BIOCHEM J, V307, P471; Gaucher J, 2012, EMBO J, V31, P3809, DOI 10.1038/emboj.2012.233; Ogiwara K, 2005, P NATL ACAD SCI USA, V102, P8442, DOI 10.1073/pnas.0502423102; Alves MG, 2013, BBA-MOL BASIS DIS, V1832, P626, DOI 10.1016/j.bbadis.2013.01.011; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; Gaucher J, 2010, FEBS J, V277, P599, DOI 10.1111/j.1742-4658.2009.07504.x; GRIER HJ, 1980, AM J ANAT, V159, P331, DOI 10.1002/aja.1001590307; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; Castillo-Yanez FJ, 2005, COMP BIOCHEM PHYS B, V140, P91, DOI 10.1016/j.cbpc.2004.09.031; Macouzet M, 2005, FEMS YEAST RES, V5, P851, DOI 10.1016/j.femsyr.2005.02.007; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Boussouar F, 2004, TRENDS ENDOCRIN MET, V15, P345, DOI 10.1016/j.tem.2004.07.003; Montellier E, 2013, GENE DEV, V27, P1680, DOI 10.1101/gad.220095.113; Szilagyi L, 2001, J BIOL CHEM, V276, P24574, DOI 10.1074/jbc.M011374200; BARRETT AJ, 1980, BIOCHEM J, V187, P909; Boussouar F, 2014, ANDROLOGY-US, V2, P351, DOI 10.1111/j.2047-2927.2014.00184.x; Cao MJ, 2000, FISHERIES SCI, V66, P1172, DOI 10.1046/j.1444-2906.2000.00185.x; Chen JM, 2004, HDB PROTEOLYTIC ENZY, P1489; Genicot S, 1996, BBA-PROTEIN STRUCT M, V1298, P45, DOI 10.1016/S0167-4838(96)00095-7; GRESIK EW, 1973, GEN COMP ENDOCR, V21, P341, DOI 10.1016/0016-6480(73)90066-X; GRIER HJ, 1981, AM ZOOL, V21, P345; Halfon S, 2004, HDB PROTEOLYTIC ENZY, P1483; HEDSTROM L, 1992, SCIENCE, V255, P1249, DOI 10.1126/science.1546324; Horiguchi M, 2008, ZOOL SCI, V25, P937, DOI 10.2108/zsj.25.937; Iwai T, 2006, EXP CELL RES, V312, P2528, DOI 10.1016/j.jexcr.2006.04.015; Jelinek B, 2004, PROTEIN ENG DES SEL, V17, P127, DOI 10.1093/protein/gzh014; Kato Y, 2010, CELL TISSUE RES, V340, P595, DOI 10.1007/s00441-010-0969-5; Klomklao S, 2006, COMP BIOCHEM PHYS B, V144, P47, DOI 10.1016/j.cbpb.2006.01.006; Kurtovic I, 2006, COMP BIOCHEM PHYS B, V143, P432, DOI 10.1016/j.cbpb.2005.12.020; Longin J, 2001, J CELL SCI, V114, P2125; Matsui H, 2001, ENDOCRINOLOGY, V142, P4918, DOI 10.1210/en.142.11.4918; Miura C, 2009, P NATL ACAD SCI USA, V106, P20972, DOI 10.1073/pnas.0907631106; Mruk D, 1997, J ANDROL, V18, P612; Nagahama Yoshitaka, 1994, P393; Ogiwara K, 2007, P NATL ACAD SCI USA, V104, P7021, DOI 10.1073/pnas.0610447104; OZATO K, 1994, DEV GROWTH DIFFER, V36, P437; PUDNEY J, 1995, MICROSC RES TECHNIQ, V32, P459, DOI 10.1002/jemt.1070320602; Rousseaux S, 2008, REPROD BIOMED ONLINE, V16, P492; SHIBATA N, 1986, ZOOL SCI, V3, P331; Simpson B. K., 2000, SEAFOOD ENZYMES UTIL, P531; SIMPSON BK, 1984, COMP BIOCHEM PHYS B, V79, P613, DOI 10.1016/0305-0491(84)90375-4; Varallyay E, 1998, BIOCHEM BIOPH RES CO, V243, P56; Walsh K. F., 1970, METHOD ENZYMOL, V19, P31	49	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	DEC	2014	31	12					840	848		10.2108/zs140111		9	Zoology	Zoology	AW3CW	WOS:000346164100009		
J	Tanaka, M; Kon, T; Nishikawa, T				Tanaka, Masaatsu; Kon, Takeshi; Nishikawa, Teruaki			Unraveling a 70-year-old Taxonomic Puzzle: Redefining the Genus Ikedosoma (Annelida: Echiura) on the Basis of Morphological and Molecular Analyses	ZOOLOGICAL SCIENCE			English	Article						Annelida; Echiura; Echiuridae; Thalassematinae; Ikedosoma; revision; taxonomy; molecular phylogeny	BAYESIAN PHYLOGENETIC INFERENCE; MULTIPLE SEQUENCE ALIGNMENT; MAXIMUM-LIKELIHOOD; PHYLUM ECHIURA; DNA-SEQUENCES; NUCLEOTIDE-SEQUENCES; SOUTHERN-AFRICA; WORMS; CLASSIFICATION; EVOLUTION	After a long-standing taxonomic confusion, the echiurid genus Ikedosoma Bock, 1942, endemic to Japan and surroundings, is redefined on the basis of morphological and molecular analyses of many new Japanese materials and some museum specimens. The re-examination of a syntype of I. elegans (Ikeda, 1904), the type species of the genus, first revealed that its oblique muscle layer is continuous throughout and never fasciculate between longitudinal muscle bands, unlike those described in the definitions that have prevailed for ca. 70 years, making this genus indistinguishable from Listriolobus Spengel, 1912. Two Japanese species of Ikedosoma, I. elegans and I. gogoshimense (Ikeda, 1904), which were thus redefined, had also been poorly defined in the past to the point of being nearly indistinguishable from each other, largely due to incomplete descriptions and poor collections. Molecular phylogenetic analyses using 18S and 28S ribosomal RNA, histone H3, and cytochrome c oxidase subunit I (COI) genes clearly confirmed the distinction between these two species, their monophyletic origin, and their distinction from L. sorbillans (Lampert, 1883). The genus Ikedosoma thus validated is morphologically distinguishable from Listriolobus by the absence of a rectal caecum. Ikedosoma elegans and I. gogoshimense also differ in the disposition of gonoduct pairs. The third known species, I. qingdaoense Li, Wang and Zhou, 1994, from Qingdao, North China, lacks information on oblique muscle layers, which makes even its generic affiliation uncertain.	[Tanaka, Masaatsu; Kon, Takeshi; Nishikawa, Teruaki] Toho Univ, Fac Sci, Chiba 2748510, Japan	Tanaka, M (reprint author), Toho Univ, Fac Sci, 2-2-1 Miyama, Chiba 2748510, Japan.	echiura.sipuncula@gmail.com			Faculty of Science, Toho University	Our cordial thanks to Hiroshi Namikawa (NSMT), Noboru Nunomura (TOYA), Shin'ichi Sato (TUM), and Rei Ueshima (UMUTZ) for loan of specimens and permission to dissect; Shoichi Kimura (Aichi Pref.), Taeko Kimura (Mie University), Kazuki Okada (Hiroshima Pref.), Yoshitaka Saito (Hamamatsu City Office), Kaoru Saotome (Toho University), Kensuke Shibata (Ehime Pref.), and Tomo'o Unagami (Center for Environmental Studies) for field work; Gyo Itani (Kochi University), Katsutoshi Ito (Shizuoka Pref.), and Hisanori Kohtsuka and Mamoru Sekifuji (MMBS) for specimens; MMBS (The University of Tokyo), Tropical Biosphere Research Center, Sesoko Station (University of the Ryukyus), Takehara Marine Science Station (Hiroshima University), and Ushimado Marine Laboratory (Okayama University) for facilities; Hong Zhou (Ocean University of China) for information on Ikedosoma qingdaoense; Junji Okuno (Coastal Branch of Natural History Museum and Institute, Chiba) for advice on the authorship of Ochetostoma; and Shinsuke Fukino (Chiba Pref.), Kaoru Kuriiwa (University of the Ryukyus), and Kaoru Saotome and Yusuke Yamanoue (Toho University) for technical assistance and/or helpful discussion. This study was partly supported by a Grant-in-Aid for Field Research from Faculty of Science, Toho University to TN.	Annandale N., 1922, Bijdragen tot de Dierkunde, V1922, P143; Weigert A, 2014, MOL BIOL EVOL, V31, P1391, DOI 10.1093/molbev/msu080; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Castresana J, 2000, MOL BIOL EVOL, V17, P540; Bely AE, 2004, MOL PHYLOGENET EVOL, V30, P50, DOI 10.1016/S1055-7903(03)00180-5; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Vonnemann V, 2005, J MOLLUS STUD, V71, P113, DOI 10.1093/mollus/eyi014; Andrade SCS, 2012, CLADISTICS, V28, P141, DOI 10.1111/j.1096-0031.2011.00376.x; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kvist S, 2013, CLADISTICS, V29, P435, DOI 10.1111/cla.12015; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; ARAKAWA K Y, 1971, Publications of the Seto Marine Biological Laboratory, V19, P231; BISESWAR R, 1984, S AFR J ZOOL, V19, P16; Biseswar R, 2012, ZOOTAXA, P69; BISESWAR R, 1988, S AFR J ZOOL, V23, P81; BISESWAR R, 1988, Annals of the South African Museum, V98, P29; Bock S., 1942, Goteborgs Vetenskaps Samhalles Handlingar (6), V2B, P1; Carr CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022232; Colgan D. J., 2003, Molluscan Research, V23, P123, DOI 10.1071/MR03002; DattaGupta AK, 1974, P ZOOL SOC CALCUTTA, V27, P29; DattaGupta AK, 1976, P INT S BIOL SIP ECH, V2, P135; Edmonds S.J., 2000, POLYCHAETES ALLIES A, P353; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Fisher Walter Kenrick, 1946, PROC U S NATION MUS, V96, P215; FISHER WALTER KENRICK, 1949, PROC U S NATION MUS, V99, P479; Forbes E, 1841, EDINBURGH NEW PHILOS, V30, P369; Goto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056809; Goto R, 2011, ZOOL SCI, V28, P225, DOI 10.2108/zsj.28.225; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Ikeda I, 1907, J COLL SCI IMP U TOK, V21, P1; Ikeda I., 1904, J COLL SCI IMP U TOK, V20, P1; Ishikawa H, 1938, STUDIES WORMS USED F; JUKES T H, 1969, P21; Kawaguti S, 1971, BIOL J OKAYAMA U, V14, P67; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lacaze-Duthiers H, 1858, ANN SCI NAT ZOOL   4, V10, P49; Lampert K, 1883, Z WISS ZOOL, V39, P334; Lehrke J, 2012, THESIS FRIEDRICH WIL; Li Fenglu, 1994, Journal of Ocean University of Qingdao, V24, P203; Maddison W. P., 2011, MESQUITE MODULAR SYS; MENON P. K. B., 1962, ANN AND MAG NAT HIST, V5, P305; MONRO C. C. A., 1927, ANN & MAG NAT HIST, V20, P615; Mori T, 1932, B HIROSHIMA FISHERIE, V1932, P1; Nishikawa T, 2002, ZOOL SCI, V19, P1175, DOI 10.2108/zsj.19.1175; Nishikawa T, 2012, THREATENED ANIMALS J, P237; Nishikawa Teruaki, 2004, Species Diversity, V9, P109; Nishikawa T, 2007, 7 NAT SURV NAT ENV, P177; Nishikawa T, 1998, P BIOL SOC WASH, V111, P249; Nishikawa T, 1992, GUIDE SEASHORE ANIMA, V1, P306; Ochi O., 1963, Memoirs of Ehime University, V4B, P515; Ochi O, 1976, P INT S BIOL SIP ECH, V2, P197; Pallas PS, 1774, FASCICULUS 10; Passamaneck Y, 2006, MOL PHYLOGENET EVOL, V40, P20, DOI 10.1016/j.ympev.2006.02.001; Quatrefages A de, 1847, CR HEBD ACAD SCI, V24, P776; Rambaut A., 2009, TRACER VER 1 5; Ruppell E, 1828, ATLAS REISE NORDLICH; Sato H., 1934, Dobutsugaku Zasshi Tokyo, V46, P245; Sato H., 1939, Science Reports of the Tohoku University, V14, P339; Sato H, 1935, FAUNA NIPPONICA; SAUNDERS GW, 1994, CAN J BOT, V72, P1250; Sawada N, 1962, MEM EHIME U, V4, P437; Sawada N., 1963, Memoirs of Ehime University, V4B, P551; SAWADA N, 1975, DEV GROWTH DIFFER, V17, P77; Spengel J. W., 1912, Verhandlungen der Deutschen Zoologischen Gesellschaft Leipzig, V22; Stephen A.C., 1972, PHYLA SIPUNCULA ECHI; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Tanaka M, 2013, ZOOKEYS, P13, DOI 10.3897/zookeys.312.5456; Tavare S., 1986, SOME MATH QUESTIONS, P57; Wang Wei, 1995, Journal of Oceanography of Huanghai & Bohai Seas, V13, P30; Wharton Lawrence D., 1913, Philippine Journal of Science, V8; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Zhou H, 2007, FAUNA SINICA INVERTE, V46	81	1	1	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	DEC	2014	31	12					849	861		10.2108/zs140155		13	Zoology	Zoology	AW3CW	WOS:000346164100010		
J	Song, Y; Chung, D; Choi, SJ; Kang, IM; Park, C; Itaya, T; Yi, K				Song, Yungoo; Chung, Donghoon; Choi, Sung-Ja; Kang, Ii-Mo; Park, Changyun; Itaya, Tetsumaru; Yi, Keewook			K-Ar illite dating to constrain multiple events in shallow crustal rocks: Implications for the Late Phanerozoic evolution of NE Asia	JOURNAL OF ASIAN EARTH SCIENCES			English	Article						Fault clay; Illite polytype; K-Ar age-dating; Multiple events; Chugaryeong fault	HYDROTHERMAL ILLITE; TECTONIC IMPLICATIONS; KOREAN PENINSULA; CLAY-MINERALS; SOUTH-KOREA; FAULT; ZIRCON; COLLISION; AGE; QUANTIFICATION	A recently developed illite-age-analysis (IAA) approach was applied to determine the multiple events for the Chugaryeong fault belt, Korea. Each event was determined by a combined approach of the optimized illite-polytype quantification and the K-Ar age-dating of clay fractions separated from the fault clays. The Late Cretaceous to Paleogene events (76.5 +/- 0.8, 69.1 +/- 0.6, 59.3 +/- 0.7, and 48.2 +/- 0.7 Ma) were recognized by calculating the authigenic 1M/1M(d) illite ages on the IAA plots of the fault clays. The Early Cretaceous ages (121.7-124.7 and 112.4 +/- 1.5 Ma) were also obtained from the convergent intercepts of 100% 2M(1) illite on the IAA plots. The absence of the 2M(1) illites in the host-rock indicates that the Early Cretaceous ages represent the timings of high-T hydrothermal events of >280 degrees C. The 2M(1) illites in the fault clays should be pre-formed by a fluid-rock interaction under a relatively high-T subsurface condition, and be mechanically reworked into the near surface along the fault by post-tectonic events. This is the first report determining the absolute age constraints of multi-activated tectonic events from a fault. These geochronological determinations of the multiple events recorded in the Chugaryeong fault belt are crucial to establish the tectonic evolution of the Korean Peninsula since the Late Cretaceous. (C) 2014 Elsevier Ltd. All rights reserved.	[Song, Yungoo; Chung, Donghoon; Park, Changyun] Yonsei Univ, Dept Earth Syst Sci, Seoul 120749, South Korea; [Choi, Sung-Ja; Kang, Ii-Mo] Korea Inst Geosci & Mineral Resources, Taejon 305350, South Korea; [Itaya, Tetsumaru] Okayama Univ Sci, Res Inst Nat Sci, Okayama 7000005, Japan; [Yi, Keewook] Korea Basic Sci Inst, Taejon 305806, South Korea	Song, Y (reprint author), Yonsei Univ, Dept Earth Syst Sci, 50 Yonsei Ro, Seoul 120749, South Korea.	yungoo@yonsei.ac.kr			Korea Meteorological Administration Research and Development Program [CATER 2012-8120]	The authors are grateful to two anonymous reviewers for their creative comments and Prof. S. Kwon for discussions and corrections. This work was supported by the Korea Meteorological Administration Research and Development Program under Grant No. CATER 2012-8120 to Y. Song.	ALT JC, 1991, GEOLOGY, V19, P570, DOI 10.1130/0091-7613(1991)019<0570:HPMLIS>2.3.CO;2; Williams IS, 2009, LITHOS, V107, P239, DOI 10.1016/j.lithos.2008.10.017; Duvall AR, 2011, EARTH PLANET SC LETT, V304, P520, DOI 10.1016/j.epsl.2011.02.028; Clauer N, 2012, EARTH-SCI REV, V115, P76, DOI 10.1016/j.earscirev.2012.07.003; Solum JG, 2005, J STRUCT GEOL, V27, P1563, DOI 10.1016/j.jsg.2005.05.002; Ree JH, 1996, GEOLOGY, V24, P1071, DOI 10.1130/0091-7613(1996)024<1071:PEEOCC>2.3.CO;2; van der Pluijm BA, 2006, GEOLOGY, V34, P837, DOI 10.1130/G22610.1; Sajeev K, 2010, GONDWANA RES, V17, P75, DOI 10.1016/j.gr.2009.07.001; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Schleicher AM, 2006, CONTRIB MINERAL PETR, V152, P349, DOI 10.1007/s00410-006-0110-7; Pevear DR, 1999, P NATL ACAD SCI USA, V96, P3440, DOI 10.1073/pnas.96.7.3440; Schleicher AM, 2010, GEOLOGY, V38, P667, DOI 10.1130/G31091.1; Kwon S, 2009, EARTH PLANET SC LETT, V279, P340, DOI 10.1016/j.epsl.2009.01.016; Grathoff GH, 1996, CLAY CLAY MINER, V44, P835, DOI 10.1346/CCMN.1996.0440615; YIN A, 1993, TECTONICS, V12, P801, DOI 10.1029/93TC00313; van der Pluijm BA, 2001, NATURE, V412, P172, DOI 10.1038/35084053; Chough SK, 2010, EARTH-SCI REV, V101, P225, DOI 10.1016/j.earscirev.2010.05.004; Kim SW, 2011, GONDWANA RES, V20, P852, DOI 10.1016/j.gr.2011.01.012; Haines SH, 2008, J STRUCT GEOL, V30, P525, DOI 10.1016/j.jsg.2007.11.012; Kim SW, 2011, GONDWANA RES, V20, P890, DOI 10.1016/j.gr.2011.05.004; Rahl JM, 2011, EARTH PLANET SC LETT, V307, P180, DOI 10.1016/j.epsl.2011.04.036; WILLIAMS IS, 1987, CONTRIB MINERAL PETR, V97, P205, DOI 10.1007/BF00371240; Chough SK, 2000, EARTH-SCI REV, V52, P175, DOI 10.1016/S0012-8252(00)00029-5; Bojanowski MJ, 2012, CONTRIB MINERAL PETR, V164, P245, DOI 10.1007/s00410-012-0736-6; Choi S.J., 2012, EC ENV GEOL, V45, P441; Chung Donghoon, 2013, [Economic and Environmental Geology, 자원환경지질], V46, P1; Chwae U., 1998, J EARTH PLANET SCI N, V45, P41; ERNST WG, 1995, GEOLOGY, V23, P353, DOI 10.1130/0091-7613(1995)023<0353:CPTSOT>2.3.CO;2; Geisler T, 2001, CONTRIB MINERAL PETR, V141, P53; Grathoff GH, 2001, GEOL SOC AM BULL, V113, P1092, DOI 10.1130/0016-7606(2001)113<1092:OOIITL>2.0.CO;2; Hay DC, 2010, CONTRIB MINERAL PETR, V159, P81, DOI 10.1007/s00410-009-0417-2; Hwang S.K., 2011, J PETROL SOC KOREA, V20, P231; Inoue A., 1992, APPL CLAY SCI, V7, P131, DOI 10.1016/0169-1317(92)90035-L; Itaya T., 1991, MINERALOGICAL J, V15, P203, DOI 10.2465/minerj.15.203; Kim S.W., 2013, GONDWANA RES; Kim SW, 2012, J GEOL, V120, P625, DOI 10.1086/667811; Kubler B, 1984, THERMOMETRIE BAROMET, P489; Kuwahara Y, 1998, CLAY CLAY MINER, V46, P574, DOI 10.1346/CCMN.1998.0460511; Kuwahara Y, 2001, CLAY CLAY MINER, V49, P300, DOI 10.1346/CCMN.2001.0490404; Lee D.-S., 1987, GEOLOGY KOREA; Ludwig K.R., 2003, USERS MANUAL ISOPLOT; MEUNIER A, 1989, AM MINERAL, V74, P1106; Meunier A., 2005, CLAYS; Park S.I., 2013, GONDWANA RES; PEVEAR DR, 1992, WATER-ROCK INTERACTION, VOLS 1 AND 2, P1251; Reynolds Jr R.C., 1994, WILDFIRE COMPUTER PR; SRODON J, 1984, REV MINERAL, V13, P495; TANAKA H, 1995, CONTRIB MINERAL PETR, V120, P150; Vrolijk P, 1999, J STRUCT GEOL, V21, P1039, DOI 10.1016/S0191-8141(99)00103-0; Williams I. S., 1998, REV EC GEOLOGY, V7, P1	50	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1367-9120	1878-5786		J ASIAN EARTH SCI	J. Asian Earth Sci.	DEC 1	2014	95				SI		313	322		10.1016/j.jseaes.2014.05.018		10	Geosciences, Multidisciplinary	Geology	AW6SJ	WOS:000346398400023		
J	Tsukada, H; Li, W; Duo, H; Guo, ZH; Fu, Y; Peng, M; Shen, XY; Jing, JW; Yuan, AS; Ni, M; He, S; Huang, FQ; Feng, K; Ishikawa, K; Kobayashi, I; Shinohara, A; Nonaka, N				Tsukada, Hideharu; Li, Wei; Duo, Hong; Guo, Zhihong; Fu, Yong; Peng, Mao; Shen, Xiuying; Jing, Jianwu; Yuan, Aishan; Ni, Ma; He, Shengde; Huang, Fuqiang; Feng, Kai; Ishikawa, Keisuke; Kobayashi, Ikuo; Shinohara, Akio; Nonaka, Nariaki			A comparison of the diet and fine-scale distribution of sympatric Tibetan and red foxes in Qinghai, PR China	WILDLIFE BIOLOGY			English	Article							POINT-FRAME METHOD; ECHINOCOCCUS-MULTILOCULARIS; VULPES-FERRILATA; BEHAVIOR; HABITATS; PROVINCE; PLATEAU; OVERLAP; MARKING; PIKA	We compared the diet and the spatial distribution of the Tibetan fox Vulpes ferrilata and the red fox Vulpes vulpes in the Tibetan plateau, to elucidate mechanisms of coexistence for these two sympatric canids and to clarify their roles as definitive hosts for zoonotic Echinococcus parasites. Diet and fine-scale distribution patterns were assessed by fecal DNA analysis. A total of 45 fecal samples (15 belonging to Tibetan fox, 30 belonging to red fox were collected from 15 sites into three of which contained only Tibetan fox feces, six only red fox feces, and six contained feces of both species. The abundance of pika burrows, a key prey item for both species, did not differ among the sites. Food composition analysis, estimated using a point-frame method, revealed slight but insignificant differences between the two species. Tibetan foxes consumed primarily mammals, whereas red foxes consumed primarily insects. The dietary range of the Tibetan fox was narrower than that of the red fox but there was little dietary overlap between the two species. These findings suggest that the weak partitioning of food resources between Tibetan and red foxes can facilitate their coexistence even within the same habitat where they share the same key prey items, i.e. small mammals such as pikas. These dietary differences between the two fox species also suggest that the Tibetan fox is a more important definitive host for Echinococcus on the Tibetan plateau than is the red fox.	[Tsukada, Hideharu; Ishikawa, Keisuke] NARO Inst Livestock & Grassland Sci, JP-3890201 Nagano, Japan; [Li, Wei; Duo, Hong; Guo, Zhihong; Fu, Yong; Peng, Mao; Huang, Fuqiang; Feng, Kai] Univ Qinghai, Acad Anim & Vet Med, Sci Biol Ind Areas, Xining, Qinghai, Peoples R China; [Jing, Jianwu; Yuan, Aishan] Heka Sheep Farm Qinghai Prov, Xinghai, Hainan, Peoples R China; [Ni, Ma; He, Shengde] Anim Husb & Vet Stn Qinghai Prov, Xining 810001, Qinghai, Peoples R China; [Kobayashi, Ikuo] Miyazaki Univ, Field Sci Ctr, Sumiyoshi Livestock Sci Stn, JP-8800121 Shimanouchi, Miyazaki, Japan; [Shinohara, Akio] Miyazaki Univ, Frontier Sci Res Ctr, Div Bioresources, JP-8891692 Miyazaki, Japan; [Nonaka, Nariaki] Miyazaki Univ, Interdisciplinary Grad Sch Med & Vet Med, Lab Vet Parasit Dis, Nishi Ku, JP-8892192 Miyazaki, Japan	Tsukada, H (reprint author), NARO Inst Livestock & Grassland Sci, 375-716 Shiono, JP-3890201 Nagano, Japan.	htsuka@affrc.go.jp			Strategic Japanese-Chinese Cooperative Program of Japan Science and Technology Agency (JST); Integrated Research Project for Human and Veterinary Medicine at Univ. of Miyazaki - Ministry of Education, Culture, Sports, Science and Technology in Japan	This study was supported by the Strategic Japanese-Chinese Cooperative Program of Japan Science and Technology Agency (JST), and by the Integrated Research Project for Human and Veterinary Medicine at Univ. of Miyazaki funded by the Ministry of Education, Culture, Sports, Science and Technology in Japan.	ABLES ED, 1969, J WILDLIFE MANAGE, V33, P145, DOI 10.2307/3799662; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Cypher BL, 1998, J MAMMAL, V79, P204, DOI 10.2307/1382855; Nonaka N, 2009, PARASITOL RES, V106, P75, DOI 10.1007/s00436-009-1629-0; Jiang WB, 2012, PARASITOL RES, V111, P1531, DOI 10.1007/s00436-012-2993-8; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1111/j.1442-9993.2001.01070.pp.x; Murdoch JD, 2010, MAMM BIOL, V75, P36, DOI 10.1016/j.mambio.2008.12.003; Li W, 2013, J VET MED SCI, V75, P1329, DOI 10.1292/jvms.13-0187; Xiao N, 2005, INT J PARASITOL, V35, P693, DOI 10.1016/j.ijpara.2005.01.003; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; HENRY JD, 1977, BEHAVIOUR, V61, P82, DOI 10.1163/156853977X00496; Wang ZH, 2008, ECOHEALTH, V5, P115, DOI 10.1007/s10393-008-0174-0; Raoul F, 2010, OECOLOGIA, V164, P129, DOI 10.1007/s00442-010-1647-8; Smith AT, 1999, ANIM CONSERV, V2, P235, DOI 10.1111/j.1469-1795.1999.tb00069.x; Jenkins DJ, 2005, INT J PARASITOL, V35, P1205, DOI 10.1016/j.ijpara.2005.07.014; Hegglin D, 2007, FUNCT ECOL, V21, P552, DOI 10.1111/j.1365-2435.2007.01257.x; Monclus R, 2009, J ETHOL, V27, P153, DOI 10.1007/s10164-008-0098-8; VEIT P, 1995, PARASITOLOGY, V110, P79; Saitoh T, 1998, RES POPUL ECOL, V40, P97, DOI 10.1007/BF02765225; Ruiz-Gonzalez A, 2008, EUR J WILDLIFE RES, V54, P253, DOI 10.1007/s10344-007-0138-7; Bates D. M., 2014, LME4 LINEAR MIXED EF; Clark Howard O. Jr., 2008, Mammalian Species, P1, DOI 10.1644/821.1; Doncaster CP, 1997, J ZOOL, V241, P73; EGUCHI K, 1980, Japanese Journal of Ecology, V30, P9; Fox J, 2011, R COMPANION APPL REG; Giraudoux P, 2006, PARASITOL INT, V55, pS237, DOI 10.1016/j.parint.2005.11.036; Heinemeyer Kimberly S., 2008, P45; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Lin Xuanlong, 2010, Acta Theriologica Sinica, V30, P346; Liu QX, 2010, MAMM BIOL, V75, P283, DOI 10.1016/j.mambio.2009.02.002; Liu Qunxiu, 2007, Acta Theriologica Sinica, V27, P370; Liu Wei, 2003, Acta Theriologica Sinica, V23, P214; Macdonald D. W., 1985, SOCIAL ODOURS MAMMAL, V2, P619; Oksanen J., 2013, VEGAN COMMUNITY ECOL; SCHALLER G. B., 2004, CANIDS FOXES WOLVES, P148; Schaller G.B., 1998, WILDLIFE TIBETAN STE; SMITH A E, 1990, P14; Takatsuki Seiki, 2007, Mammal Study, V32, P1, DOI 10.3106/1348-6160(2007)32[1:ACOTPM]2.0.CO;2; Takatsuki Seiki, 2012, Honyurui Kagaku, V52, P167; Tanner F, 2006, SCHWEIZ ARCH TIERH, V148, P501, DOI 10.1024/0036-7281.148.9.501; Tsukada Hideharu, 2005, Honyurui Kagaku, V45, P91; Wang Zhenghuan, 2004, Acta Theriologica Sinica, V24, P357; WEBER JM, 1994, MAMM BIOL, V59, P9; WOZENCRAFT W. C., 2008, GUIDE MAMMALS CHINA, P416; XUANLONG L, 2010, ACTA THERIOL SIN, V30, P346; Yokohata Yasushi, 2004, Japanese Journal of Zoo and Wildlife Medicine, V9, P91; ZHENG S, 1985, Acta Theriologica Sinica, V5, P240; Zhou Wenyang, 1995, Acta Theriologica Sinica, V15, P267	48	0	0	WILDLIFE BIOLOGY	RONDE	C/O JAN BERTELSEN, GRENAAVEJ 14, KALO, DK-8410 RONDE, DENMARK	0909-6396	1903-220X		WILDLIFE BIOL	Wildlife Biol.	DEC	2014	20	6					356	361		10.2981/wlb.00066		6	Ecology; Zoology	Environmental Sciences & Ecology; Zoology	AW2OM	WOS:000346127900005		
J	Jin-Long; Uemura, K; Ebihara, M				Jin-Long; Uemura, Kazuhiro; Ebihara, Masahiro			Assembled structures of tetrakis(biimidazole)dirhodium complexes hydrogen-bonded with common inorganic anions	ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE CRYSTAL ENGINEERING AND MATERIALS			English	Article							PADDLEWHEEL DIRHODIUM COMPLEXES; MIXED OXIDATION-STATES; ONE-DIMENSIONAL CHAINS; METAL-METAL BONDS; CRYSTAL-STRUCTURES; ZIGZAG CHAIN; COPPER(II) COMPLEXES; DIPLATINUM COMPLEXES; MOLECULAR STRUCTURE; SINGLE BOND	Eight new structures of dirhodium complexes, each with four biimidazole (H(2)bim) ligands, were obtained: [Rh-2(H(2)bim)(4)(H2O)(2)](NO3)(4)center dot 4H(2)O (I), [Rh-2(H(2)bim)(4)(H2O)(2)](ClO4)(4)center dot 5H(2)O (II), [Rh-2(H(2)bim)(4)(MeOH)(2)](ClO4)(4) (III), [Rh-2(H(2)bim)(4)(DMF)(2)](BF4)(4) (IV), [Rh-2(H(2)bim)(4)(Mepy)(2)](SiF6)(2)center dot 8H(2)O (V), [{Rh-2(H(2)bim)(4)(pz)}(2)(mu-pz)](SiF6)(ClO4)(6)center dot 12.7H(2)O (VI), [{Rh-2(H(2)bim)(4)(pz)}(2)(mu-pz)](ClO4)(8)center dot 11.4H(2)O (VII) and [Rh-2(H(2)bim)(4)(mu-pz)](SiF6)(2)center dot 6H(2)O (VIII). The unbridged Rh-Rh bond distances range between 2.6313 (8) and 2.7052 (5) angstrom. The dirhodium units adopt a staggered conformation with torsion angles N-Rh-Rh-N of 37.6 (4)-48.98 (8)degrees. Various assembled structures were constructed by hydrogen bonding between the complexes and the anions: a discrete structure in (IV), one-dimensional structure in (II), two-dimensional structures in (I), (III), (VI), (VII) and (VIII) and a three-dimensional structure in (V).	[Jin-Long; Uemura, Kazuhiro; Ebihara, Masahiro] Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu 5011193, Japan	Ebihara, M (reprint author), Gifu Univ, Fac Engn, Dept Chem & Biomol Sci, Gifu 5011193, Japan.	ebihara@gifu-u.ac.jp	Uemura, Kazuhiro/B-6556-2008		JSPS KAKENHI [22550058, 26410068]	We thank Professor Tadokoro (Tokyo University of Science) for provision of biimidazole. This work was supported by JSPS KAKENHI Grant Nos. 22550058 and 26410068.	Uemura K, 2011, INORG CHEM, V50, P7919, DOI 10.1021/ic200786k; Uemura K, 2014, INORG CHEM, V53, P4621, DOI 10.1021/ic500305n; Zhong YR, 2008, CRYST GROWTH DES, V8, P2282, DOI 10.1021/cg700980v; FLACK HD, 1983, ACTA CRYSTALLOGR A, V39, P876, DOI 10.1107/S0108767383001762; Fuma Y, 2006, CHEM LETT, V35, P1298, DOI 10.1246/cl.2006.1298; Qiu QM, 2012, POLYHEDRON, V44, P215, DOI 10.1016/j.poly.2012.07.003; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; Tang J, 2008, CRYST GROWTH DES, V8, P1005, DOI 10.1021/cg700993s; Galstyan A, 2013, DALTON T, V42, P16151, DOI 10.1039/c3dt51589c; Altomare A, 1999, J APPL CRYSTALLOGR, V32, P115, DOI 10.1107/S0021889898007717; Uemura K, 2013, INORG CHEM, V52, P5535, DOI 10.1021/ic400470g; Fuma Y, 2004, J AM CHEM SOC, V126, P12238, DOI 10.1021/ja047421r; Anwar MU, 2011, DALTON T, V40, P4623, DOI 10.1039/c1dt10047e; Atencio R, 2005, INORG CHIM ACTA, V358, P520, DOI 10.1016/j.ica.2004.09.059; CAULTON KG, 1971, J AM CHEM SOC, V93, P1914; Dai YC, 2010, ACTA CRYSTALLOGR E, V66, pM1124, DOI 10.1107/S1600536810031922; Dikareva L. M., 1989, RUSS J INORG CHEM, V34, P240; DUNBAR KR, 1988, J AM CHEM SOC, V110, P8247, DOI 10.1021/ja00232a054; Ebihara M, 2006, ACTA CRYSTALLOGR C, V62, pM556, DOI 10.1107/S0108270106040121; Ebihara M, 2006, ACTA CRYSTALLOGR C, V62, pM284, DOI 10.1107/S0108270106018531; Ebihara M, 2013, ACTA CRYSTALLOGR B, V69, P480, DOI 10.1107/S2052519213024068; Fuma Y, 2012, DALTON T, V41, P8242, DOI 10.1039/c2dt11609j; Galstyan A, 2011, CHEM-EUR J, V17, P10771, DOI 10.1002/chem.201101381; Gamez P, 2002, INORG CHIM ACTA, V333, P51, DOI 10.1016/S0020-1693(02)00754-5; Gruia LM, 2007, INORG CHIM ACTA, V360, P1825, DOI 10.1016/j.ica.2006.09.029; Higashi T., 1999, NUMABS; Huang YQ, 2006, CHEM COMMUN, P4906, DOI 10.1039/b610185b; Huckstadt H, 1997, J PORPHYR PHTHALOCYA, V1, P367, DOI 10.1002/(SICI)1099-1409(199710)1:4<367::AID-JPP31>3.0.CO;2-Q; Inoki D, 2012, ORGANOMETALLICS, V31, P2996, DOI 10.1021/om2009759; Jin QH, 2010, POLYHEDRON, V29, P317, DOI 10.1016/j.poly.2009.05.052; Kabuto C., 2009, J CRYST SOC JPN, V51, P218; KAWAMURA T, 1993, CHEM LETT, P1509, DOI 10.1246/cl.1993.1509; Kawamura T, 2000, B CHEM SOC JPN, V73, P657, DOI 10.1246/bcsj.73.657; Klingele J, 2005, EUR J INORG CHEM, P1530, DOI 10.1002/ejic.200400908; Koningsbruggen P. J. van, 1993, J CHEM SOC DA, P483; Kuz'menko I. V., 1991, RUSS J INORG CHEM, V36, P89; Li YP, 2008, J CHEM CRYSTALLOGR, V38, P529, DOI 10.1007/s10870-008-9368-0; Li ZY, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0128; Ma Q, 2009, ACTA CRYSTALLOGR E, V65, pM1488, DOI 10.1107/S1600536809044717; Maiboroda A, 2001, EUR J INORG CHEM, P2263; Mastropietro TF, 2008, DALTON T, P514, DOI 10.1039/b713960h; MIGHELL AD, 1969, ACTA CRYSTALL B-STRU, VB 25, P60, DOI 10.1107/S0567740869001762; Nakamoto K., 1997, INFRARED RAMAN SPECT; OLMSTEAD MM, 1978, J ORGANOMET CHEM, V148, pC15, DOI 10.1016/S0022-328X(00)90991-4; Prater ME, 1999, J AM CHEM SOC, V121, P8005, DOI 10.1021/ja991130e; Reger DL, 2012, EUR J INORG CHEM, P4593, DOI 10.1002/ejic.201200118; Rempel G. A., 1971, INORG SYNTH, V13, P90; Rigaku, 2011, CRYSTAL CLEAR VERSIO; Sakai K, 1998, J AM CHEM SOC, V120, P11353, DOI 10.1021/ja980055p; Sang RL, 2005, ACTA CRYSTALLOGR E, V61, pM793, DOI 10.1107/S1600536805008378; Sang RL, 2006, POLYHEDRON, V25, P2167, DOI 10.1016/j.poly.2005.12.031; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stephenson A, 2011, J AM CHEM SOC, V133, P858, DOI 10.1021/ja107403p; Takazaki Y, 2003, CHEM LETT, V32, P120, DOI 10.1246/cl.2003.120; WAMSER CA, 1948, J AM CHEM SOC, V70, P1209, DOI 10.1021/ja01183a101; Yang ZY, 2000, CHEM LETT, P1006, DOI 10.1246/cl.2000.1006; Yang ZY, 2001, INORG CHIM ACTA, V321, P97, DOI 10.1016/S0020-1693(01)00519-9; Yang ZY, 2006, INORG CHIM ACTA, V359, P2465, DOI 10.1016/j.ica.2006.02.034; Zhang LC, 2008, ACTA CRYSTALLOGR E, V64, pM308, DOI 10.1107/S160053680706833X	59	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0108-7681	1600-5740		ACTA CRYSTALLOGR B	Acta Crystallogr. Sect. B-Struct. Sci.Cryst. Eng. Mat.	DEC	2014	70		6				1006	1019		10.1107/S2052520614021428		14	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	AU9HI	WOS:000345902200011		
J	Zheng, AP; Yu, J; Yamamoto, R; Ose, T; Tanaka, I; Yao, M				Zheng, Aiping; Yu, Jian; Yamamoto, Reo; Ose, Toyoyuki; Tanaka, Isao; Yao, Min			X-ray structures of eIF5B and the eIF5B-eIF1A complex: the conformational flexibility of eIF5B is restricted on the ribosome by interaction with eIF1A	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article							INITIATION-FACTOR IF2; EUKARYOTIC TRANSLATION INITIATION; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STRUCTURE REVEALS; RNA-BINDING; FACTORS 1A; FACTOR-II; SUBUNIT; REFINEMENT	eIF5B and eIF1A are two translation-initiation factors that are universally conserved among all kingdoms. They show a unique interaction in eukaryotes which is important for ribosomal subunit joining. Here, the structures of two isolated forms of yeast eIF5B and of the eIF5B-eIF1A complex (eIF1A and eIF5B do not contain the respective N-terminal domains) are reported. The eIF5B-eIF1A structure shows that the C-terminal tail of eIF1A binds to eIF5B domain IV, while the core domain of eIF1A is invisible in the electron-density map. Although the individual domains in all structures of eIF5B or archaeal IF5B (aIF5B) are similar, their domain arrangements are significantly different, indicating high structural flexibility, which is advantageous for conformational change during ribosomal subunit joining. Based on these structures, models of eIF5B, eIF1A and tRNA(i)(Met) on the 80S ribosome were built. The models suggest that the interaction between the eIF1A C-terminal tail and eIF5B helps tRNA(i)(Met) to bind to eIF5B domain IV, thus preventing tRNA(i)(Met) dissociation, stabilizing the interface for subunit joining and providing a checkpoint for correct ribosome assembly.	[Zheng, Aiping; Yu, Jian; Yamamoto, Reo; Ose, Toyoyuki; Tanaka, Isao; Yao, Min] Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Yu, Jian; Ose, Toyoyuki; Tanaka, Isao; Yao, Min] Hokkaido Univ, Fac Adv Life Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan	Yao, M (reprint author), Hokkaido Univ, Grad Sch Life Sci, Kita Ku, Kita 10 Nishi 8, Sapporo, Hokkaido 0600810, Japan.	yao@castor.sci.hokudai.ac.jp	yao, min/F-5287-2011; 	yao, min/0000-0003-1687-5904; Zheng, Aiping/0000-0003-4982-0109	International Graduate Program for Research Pioneers in Life Sciences (IGP-RPLS); Ministry of Education, Culture, Sports, Science and Technology of Japan [25291008]	We thank Dr Massaki Sokabe for preparing the vectors of eIF5B and eIF1A. AZ was supported by the International Graduate Program for Research Pioneers in Life Sciences (IGP-RPLS) and this project was supported by a Grant-in-Aid for Scientific Research (B) (25291008 to MY) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Acker MG, 2006, J BIOL CHEM, V281, P8469, DOI 10.1074/jbc.M600210200; Weisser M, 2013, NAT STRUCT MOL BIOL, V20, P1015, DOI 10.1038/nsmb.2622; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Allen GS, 2005, CELL, V121, P703, DOI 10.1016/j.cell.2005.03.023; Nomura N, 2012, P NATL ACAD SCI USA, V109, P3748, DOI 10.1073/pnas.1112934109; Leibundgut M, 2005, EMBO J, V24, P11, DOI 10.1038/sj.emboj.7600505; Sette M, 1997, EMBO J, V16, P1436, DOI 10.1093/emboj/16.6.1436; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Guillon L, 2005, BIOCHEMISTRY-US, V44, P15594, DOI 10.1021/bi051514j; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; Caserta E, 2006, J MOL BIOL, V362, P787, DOI 10.1016/j.jmb.2006.07.043; Simonetti A, 2013, P NATL ACAD SCI USA, V110, P15656, DOI 10.1073/pnas.1309578110; Simonetti A, 2013, ACTA CRYSTALLOGR D, V69, P925, DOI 10.1107/S0907444913006422; Marshall RA, 2009, MOL CELL, V35, P37, DOI 10.1016/j.molcel.2009.06.008; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Fringer JM, 2007, MOL CELL BIOL, V27, P2384, DOI 10.1128/MCB.02254-06; Myasnikov AG, 2005, NAT STRUCT MOL BIOL, V12, P1145, DOI 10.1038/nsmb1012; Choi SK, 1998, SCIENCE, V280, P1757, DOI 10.1126/science.280.5370.1757; Lee JH, 1999, P NATL ACAD SCI USA, V96, P4342, DOI 10.1073/pnas.96.8.4342; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Moreno JMP, 1999, FEBS LETT, V455, P130, DOI 10.1016/S0014-5793(99)00858-3; Acker MG, 2009, J MOL BIOL, V385, P491, DOI 10.1016/j.jmb.2008.10.029; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Eiler D, 2013, P NATL ACAD SCI USA, V110, P15662, DOI 10.1073/pnas.1309360110; Battiste JL, 2000, MOL CELL, V5, P109, DOI 10.1016/S1097-2765(00)80407-4; BOILEAU G, 1983, BIOCHEMISTRY-US, V22, P3162, DOI 10.1021/bi00282a020; Bricogne G., 2011, AUTOBUSTER; Choi SK, 2000, MOL CELL BIOL, V20, P7183, DOI 10.1128/MCB.20.19.7183-7191.2000; CUMMINGS HS, 1994, J BACTERIOL, V176, P198; Fernandez IS, 2013, SCIENCE, V342, P824, DOI 10.1126/science.1240585; KOLAKOFS.D, 1968, NATURE, V220, P244, DOI 10.1038/220244a0; Krafft C, 2000, FEBS LETT, V471, P128, DOI 10.1016/S0014-5793(00)01377-6; LAALAMI S, 1991, BIOCHIMIE, V73, P1557, DOI 10.1016/0300-9084(91)90191-3; Li W, 2001, PROTEIN SCI, V10, P2426, DOI 10.1110/ps.ps.18201; LUCASLEN.J, 1971, ANNU REV BIOCHEM, V40, P409, DOI 10.1146/annurev.bi.40.070171.002205; Marintchev A, 2003, P NATL ACAD SCI USA, V100, P1535, DOI 10.1073/pnas.0437845100; Olsen DS, 2003, EMBO J, V22, P193, DOI 10.1093/emboj/cdg030; SHIBA K, 1986, EMBO J, V5, P3001; Shin BS, 2002, CELL, V111, P1015, DOI 10.1016/S0092-8674(02)01171-6; WEI CL, 1995, J BIOL CHEM, V270, P22788; WEISSBACH H, 1976, ANNU REV BIOCHEM, V45, P191, DOI 10.1146/annurev.bi.45.070176.001203; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965; Zheng A, 2011, ACTA CRYSTALLOGR F, V67, P730, DOI 10.1107/S1744309111015910	51	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0907-4449	1399-0047		ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	DEC	2014	70		12				3090	3098		10.1107/S1399004714021476		9	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	AU8LT	WOS:000345848700002		
J	Kiema, TR; Harijan, RK; Strozyk, M; Fukao, T; Alexson, SEH; Wierenga, RK				Kiema, Tiila-Riikka; Harijan, Rajesh K.; Strozyk, Malgorzata; Fukao, Toshiyuki; Alexson, Stefan E. H.; Wierenga, Rik K.			The crystal structure of human mitochondrial 3-ketoacyl-CoA thiolase (T1): insight into the reaction mechanism of its thiolase and thioesterase activities	ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY			English	Article							ACETOACETYL-COA THIOLASE; BETA-KETOACYL THIOLASE; ACTIVE-SITE BASE; RAT-LIVER; BIOSYNTHETIC THIOLASE; COENZYME-A; ZOOGLOEA-RAMIGERA; 3-OXOACYL-COA THIOLASE; FATTY-ACIDS; SACCHAROMYCES-CEREVISIAE	Crystal structures of human mitochondrial 3-ketoacyl-CoA thiolase (hT1) in the apo form and in complex with CoA have been determined at 2.0 angstrom resolution. The structures confirm the tetrameric quaternary structure of this degradative thiolase. The active site is surprisingly similar to the active site of the Zoogloea ramigera biosynthetic tetrameric thiolase (PDB entries 1dm3 and 1m1o) and different from the active site of the peroxisomal dimeric degradative thiolase (PDB entries 1afw and 2iik). A cavity analysis suggests a mode of binding for the fatty-acyl tail in a tunnel lined by the N beta 2-N alpha 2 loop of the adjacent subunit and the L alpha 1 helix of the loop domain. Soaking of the apo hT1 crystals with octanoyl-CoA resulted in a crystal structure in complex with CoA owing to the intrinsic acyl-CoA thioesterase activity of hT1. Solution studies confirm that hT1 has low acyl-CoA thioesterase activity for fatty acyl-CoA substrates. The fastest rate is observed for the hydrolysis of butyryl-CoA. It is also shown that T1 has significant biosynthetic thiolase activity, which is predicted to be of physiological importance.	[Kiema, Tiila-Riikka; Harijan, Rajesh K.; Wierenga, Rik K.] Univ Oulu, Fac Biochem & Mol Med, Bioctr Oulu, FIN-90014 Oulu, Finland; [Strozyk, Malgorzata; Alexson, Stefan E. H.] Karolinska Inst, Dept Lab Med, Div Clin Chem, Karolinska Univ Hosp, SE-14186 Stockholm, Sweden; [Fukao, Toshiyuki] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu 5011194, Japan	Wierenga, RK (reprint author), Univ Oulu, Fac Biochem & Mol Med, Bioctr Oulu, POB 3000, FIN-90014 Oulu, Finland.	rik.wierenga@oulu.fi			European Community's Seventh Framework Programme (FP7) under BioStruct-X [283570]; Academy of Finland [131795]	Human mitochondrial 3-ketoacyl-CoA thiolase cDNA in pGEM vector was a kind gift from Dr Ohtake, Japan. Erasmus exchange student Maike Eberhart is acknowledged for the initial purification and crystallization of human mitochondrial 3-ketoacyl-CoA thiolase. The research leading to these results received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant agreement No. 283570). This research was supported through the Academy of Finland (grant No. 131795 to RKW).	ABE H, 1993, BIOCHIM BIOPHYS ACTA, V1216, P304, DOI 10.1016/0167-4781(93)90160-F; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Svedendahl M, 2005, J AM CHEM SOC, V127, P17988, DOI 10.1021/ja056660r; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; MIYAZAWA S, 1981, J BIOCHEM-TOKYO, V90, P511; MIDDLETON B, 1983, CLIN CHIM ACTA, V128, P291, DOI 10.1016/0009-8981(83)90329-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Modis Y, 2000, J MOL BIOL, V297, P1171, DOI 10.1006/jmbi.2000.3638; Anbazhagan P, 2014, TUBERCULOSIS, V94, P405, DOI 10.1016/j.tube.2014.03.003; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HORECKER BL, 1948, J BIOL CHEM, V175, P385; Haapalainen AM, 2006, TRENDS BIOCHEM SCI, V31, P64, DOI 10.1016/j.tibs.2005.11.011; Haapalainen AM, 2007, BIOCHEMISTRY-US, V46, P4305, DOI 10.1021/bi6026192; Kursula P, 2002, BIOCHEMISTRY-US, V41, P15543, DOI 10.1021/bi0266232; Modis Y, 1999, STRUCT FOLD DES, V7, P1279, DOI 10.1016/S0969-2126(00)80061-1; Kamerlin SCL, 2010, J ORG CHEM, V75, P6391, DOI 10.1021/jo100651s; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; MAO LF, 1995, ARCH BIOCHEM BIOPHYS, V321, P221, DOI 10.1006/abbi.1995.1389; WILLIAMS SF, 1992, J BIOL CHEM, V267, P16041; Carlqvist P, 2005, CHEMBIOCHEM, V6, P331, DOI 10.1002/cbic.200400213; Mathieu M, 1997, J MOL BIOL, V273, P714, DOI 10.1006/jmbi.1997.1331; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; THOMPSON S, 1989, BIOCHEMISTRY-US, V28, P5735, DOI 10.1021/bi00440a006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; BOUT A, 1991, BIOCHIM BIOPHYS ACTA, V1090, P43, DOI 10.1016/0167-4781(91)90035-K; RIDDLES PW, 1983, METHOD ENZYMOL, V91, P49; Simon L, 2010, J ORG CHEM, V75, P1831, DOI 10.1021/jo901503d; STAACK H, 1978, J BIOL CHEM, V253, P1827; Kursula P, 2005, J MOL BIOL, V347, P189, DOI 10.1016/j.jmb.2005.01.018; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; MATHIEU M, 1994, STRUCTURE, V2, P797, DOI 10.1016/S0969-2126(94)00081-6; Fukao T, 1997, PEDIATR RES, V42, P498, DOI 10.1203/00006450-199710000-00013; Antonenkov VD, 1999, BBA-MOL CELL BIOL L, V1437, P136, DOI 10.1016/S1388-1981(99)00003-7; Antonenkov VD, 1997, J BIOL CHEM, V272, P26023, DOI 10.1074/jbc.272.41.26023; Barycki JJ, 1999, BIOCHEMISTRY-US, V38, P5786, DOI 10.1021/bi9829027; BUDDE RJA, 1991, PLANT PHYSIOL, V95, P131, DOI 10.1104/pp.95.1.131; Fukao T., 2002, ENCY MOL MED, P3125, DOI [10.1002/0471203076.emm0319, DOI 10.1002/0471203076.EMM0319]; Fukao T, 2001, MOL GENET METAB, V72, P109, DOI 10.1006/mgme.2000.3113; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI DOI 10.1385/1-59259-890-0:571; Gehring U., 1972, ENZYMES, P391; GEHRING U, 1968, EUR J BIOCHEM, V6, P264, DOI 10.1111/j.1432-1033.1968.tb00446.x; GILBERT HF, 1981, BIOCHEMISTRY-US, V20, P5643, DOI 10.1021/bi00523a001; GILBERT HF, 1981, J BIOL CHEM, V256, P7371; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MASAMUNE S, 1989, PURE APPL CHEM, V61, P303, DOI 10.1351/pac198961030303; Merilainen G, 2009, BIOCHEMISTRY-US, V48, P11011, DOI 10.1021/bi901069h; MIDDLETO.B, 1973, BIOCHEM J, V132, P731; MIDDLETO.B, 1974, BIOCHEM J, V139, P109; NADA MA, 1995, J BIOL CHEM, V270, P530; PALMER MAJ, 1991, J BIOL CHEM, V266, P8369; Schulz H, 1981, Methods Enzymol, V71 Pt C, P398; SEUBERT W, 1968, BIOCHIM BIOPHYS ACTA, V164, P498, DOI 10.1016/0005-2760(68)90180-X; SIESS EA, 1976, FEBS LETT, V69, P265, DOI 10.1016/0014-5793(76)80701-6; SIESS EA, 1978, H-S Z PHYSIOL CHEM, V359, P785, DOI 10.1515/bchm2.1978.359.2.785; Sikkila H., 2004, THESIS U OULU FINLAN; ZEELEN JP, 1994, ACTA CRYSTALLOGR D, V50, P443, DOI 10.1107/S0907444994001277	59	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0907-4449	1399-0047		ACTA CRYSTALLOGR D	Acta Crystallogr. Sect. D-Biol. Crystallogr.	DEC	2014	70		12				3212	3225		10.1107/S1399004714023827		14	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	AU8LT	WOS:000345848700013		
J	Venditto, I; Santos, H; Sandy, J; Sanchez-Weatherby, J; Ferreira, LMA; Sakka, K; Fontes, CMGA; Najmudin, S				Venditto, Immacolata; Santos, Helena; Sandy, James; Sanchez-Weatherby, Juan; Ferreira, Luis M. A.; Sakka, Kazuo; Fontes, Carlos M. G. A.; Najmudin, Shabir			Crystallization and preliminary X-ray diffraction analysis of a trimodular endo-beta-1,4-glucanase (Cel5B) from Bacillus halodurans	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article							CARBOHYDRATE-BINDING MODULE; MACROMOLECULAR CRYSTALLOGRAPHY; GLYCOSIDE HYDROLASES; CELLULOSOMES; DEGRADATION; SEQUENCE; XIA2	Cellulases catalyze the hydrolysis of cellulose, the major constituent of plant biomass and the most abundant organic polymer on earth. Cellulases are modular enzymes containing catalytic domains connected, via linker sequences, to noncatalytic carbohydrate-binding modules (CBMs). A putative modular endo-beta-1,4-glucanase (BhCel5B) is encoded at locus BH0603 in the genome of Bacillus halodurans. It is composed of an N-terminal glycoside hydrolase family 5 catalytic module (GH5) followed by an immunoglobulin-like module and a C-terminal family 46 CBM (BhCBM46). Here, the crystallization and preliminary X-ray diffraction analysis of the trimodular BhCel5B are reported. The crystals of BhCel5B belonged to the orthorhombic space group P2(1)2(1) 2 and data were processed to a resolution of 1.64 angstrom. A molecular-replacement solution has been found.	[Venditto, Immacolata; Santos, Helena; Ferreira, Luis M. A.; Fontes, Carlos M. G. A.; Najmudin, Shabir] Univ Lisbon, CIISA, Fac Med Vet, P-1300477 Lisbon, Portugal; [Sandy, James; Sanchez-Weatherby, Juan] Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Sakka, Kazuo] Mie Univ, Grad Sch Bioresources, Tsu, Mie 5148507, Japan	Fontes, CMGA (reprint author), Univ Lisbon, CIISA, Fac Med Vet, Ave Univ Tecn, P-1300477 Lisbon, Portugal.	cafontes@fmv.ulisboa.pt; shabir@fmv.ulisboa.pt		Fontes, Carlos/0000-0002-1219-9753; Najmudin, Shabir/0000-0002-0429-5454	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/BIA-PRO/103980/2008, PTDC/BIAPRO/100359/2008]; European Union [263916, 283570]	The authors acknowledge financial support from Fundacao para a Ciencia e a Tecnologia, Portugal through projects PTDC/BIA-PRO/103980/2008 and PTDC/BIAPRO/100359/2008. This work was supported by the European Union Seventh Framework Programme (FP7 2007-2013) under the WallTraC project (grant agreement No. 263916) and BioStruct-X (grant agreement No. 283570, Biostruct-X_4399). This paper reflects the authors' views only. The European Community is not liable for any use that may be made of the information contained herein. We acknowledge Diamond Light Source, Oxfordshire for provision of synchrotron-radiation facilities (beamlines I04 and I02). We would also like to thank Cecilia Bonifacio and Pedro Bule for help with crystallization.	Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Najmudin S, 2006, J BIOL CHEM, V281, P8815, DOI 10.1074/jbc.M510559200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Winter G, 2011, METHODS, V55, P81, DOI 10.1016/j.ymeth.2011.06.010; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Takami H, 2000, NUCLEIC ACIDS RES, V28, P4317, DOI 10.1093/nar/28.21.4317; Minic Z, 2006, PLANT PHYSIOL BIOCH, V44, P435, DOI 10.1016/j.plaphy.2006.08.001; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Gowen CM, 2010, CHEM BIODIVERS, V7, P1086, DOI 10.1002/cbdv.200900314; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Fontes CMGA, 2010, ANNU REV BIOCHEM, V79, P655, DOI 10.1146/annurev-biochem-091208-085603; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Venditto I, 2014, ACTA CRYSTALLOGR F, V70, P754, DOI 10.1107/S2053230X14008395; Wamalwa BM, 2006, APPL ENVIRON MICROB, V72, P6851, DOI 10.1128/AEM.01209-06	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-3091			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	DEC	2014	70		12				1628	1630		10.1107/S2053230X1402319X		3	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	AU8JS	WOS:000345843300012		
J	Asano, N; Nakamura, A; Komoda, K; Kato, K; Tanaka, I; Yao, M				Asano, Nozomi; Nakamura, Akiyoshi; Komoda, Keisuke; Kato, Koji; Tanaka, Isao; Yao, Min			Crystallization and preliminary X-ray crystallographic analysis of ribosome assembly factors: the Rpf2-Rrs1 complex	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article							PROTEIN L11-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; SUBUNIT; RNA; PREDICTION; SERVER; DEFECT; RRS1P	Rpf2 and Rrs1 are essential proteins for ribosome biogenesis. These proteins form a complex (the Rpf2-subcomplex) with 5S rRNA and two ribosomal proteins (L5 and L11). This complex is recruited to the ribosome precursor (the 90S pre-ribosome). This recruitment is necessary for the maturation of 25S rRNA. Genetic depletion of Rpf2 and Rrs1 results in accumulation of the 25S rRNA precursor. In this study, Rpf2 and Rrs1 from Aspergillus nidulans were co-overexpressed in Escherichia coli, purified and crystallized. Subsequent analysis revealed that these crystals contained the central core region of the complex consisting of both N-terminal domains. X-ray diffraction data were collected to 2.35 angstrom resolution. Preliminary analysis revealed that the crystals belonged to space group P2(1)2(1)2(1), with unit-cell parameters a = 54.1, b = 123.3, c = 133.8 angstrom. There are two complexes in the asymmetric unit. Structure determination using selenomethionine-labelled protein is in progress.	[Asano, Nozomi; Kato, Koji; Yao, Min] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan; [Nakamura, Akiyoshi; Komoda, Keisuke; Kato, Koji; Tanaka, Isao; Yao, Min] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0600810, Japan	Yao, M (reprint author), Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0600810, Japan.	yao@castor.sci.hokudai.ac.jp	yao, min/F-5287-2011; Komoda, Keisuke/O-9651-2015	yao, min/0000-0003-1687-5904; Komoda, Keisuke/0000-0002-9563-1061	Ministry of Education, Culture, Sports, Science and Technology of Japan [25291008, 24657068]	We are grateful to the beamline staff of SPring-8 and PF for their help in data collection. This work was supported by a Grant-in-Aid for Scientific Research (B) (No. 25291008 to MY) and Challenging Exploratory Research (No. 24657068 to MY) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Miyoshi K, 2002, J BIOL CHEM, V277, P18334, DOI 10.1074/jbc.M201667200; Miyoshi K, 2004, FEBS LETT, V565, P106, DOI 10.1016/j.febslet.2004.03.087; Morita D, 2002, J BIOL CHEM, V277, P28780, DOI 10.1074/jbc.M203399200; Nariai M, 2005, NUCLEIC ACIDS RES, V33, P4553, DOI 10.1093/nar/gki772; Sprengart ML, 1996, EMBO J, V15, P665; Yao K, 2008, LANGMUIR, V24, P302, DOI 10.1021/la702700s	14	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-3091			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	DEC	2014	70		12				1649	1652		10.1107/S2053230X14024182		4	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	AU8JS	WOS:000345843300018		
J	Watanabe, M; Ishikawa, K				Watanabe, Masahiro; Ishikawa, Kazuhiko			Crystallization and preliminary X-ray crystallographic analysis of a putative feruloyl esterase from Talaromyces cellulolyticus	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article							ACREMONIUM-CELLULOLYTICUS; ENZYME; DEGRADATION; SYSTEM; GENE	Feruloyl esterase (FAE; EC 3.1.1.73) catalyzes the cleavage of the ester bond between ferulic acid and polysaccharides in plant cell walls, and thus holds significant potential for the industrial utilization of biomass saccharification. A feruloyl esterase was identified from the genome database of Talaromyces cellulolyticus (formerly known as Acremonium cellulolyticus). The gene consists of the catalytic domain and a carbohydrate-binding module connected through a serine/threonine-rich linker region. The recombinant enzyme was prepared, purified and crystallized at 293 K using 0.1 M imidazole pH 8.0, 0.2 M calcium acetate, 14% PEG 8000 as the precipitant. The crystal diffracted to 2.6 angstrom resolution and the crystal system is primitive orthorhombic, with unit-cell parameters a = 90.9, b = 123.4, c = 135.4 angstrom. Four molecules are assumed to be present per asymmetric unit, corresponding to a Matthews coefficient of 2.50 angstrom 3 Da(-1) and a solvent content of 50.88%(v/v).	[Watanabe, Masahiro; Ishikawa, Kazuhiko] AIST, Biomass Refinery Res Ctr, Higashihiroshima 7390046, Japan	Ishikawa, K (reprint author), AIST, Biomass Refinery Res Ctr, 3-11-32 Kagamiyama, Higashihiroshima 7390046, Japan.	kazu-ishikawa@aist.go.jp					Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; De Vries RP, 1999, APPL ENVIRON MICROB, V65, P5500; Abokitse K, 2010, APPL MICROBIOL BIOT, V87, P195, DOI 10.1007/s00253-010-2441-6; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Fujii T, 2012, BIOSCI BIOTECH BIOCH, V76, P245, DOI 10.1271/bbb.110498; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Wong DWS, 2006, APPL BIOCHEM BIOTECH, V133, P87, DOI 10.1385/ABAB:133:2:87; Damasio ARL, 2013, APPL MICROBIOL BIOT, V97, P6759, DOI 10.1007/s00253-012-4548-4; Donaghy J, 1997, J APPL MICROBIOL, V83, P718, DOI 10.1046/j.1365-2672.1997.00307.x; Drenth J, 1999, PRINCIPLES PROTEIN X, P41; Esteban-Torres M, 2013, APPL ENVIRON MICROB, V79, P5130, DOI 10.1128/AEM.01523-13; Inoue H, 2013, J IND MICROBIOL BIOT, V40, P823, DOI 10.1007/s10295-013-1286-2; Kroon PA, 2000, EUR J BIOCHEM, V267, P6740, DOI 10.1046/j.1432-1033.2000.01742.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; YAMANOBE T, 1987, AGR BIOL CHEM TOKYO, V51, P65	16	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-3091			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	DEC	2014	70		12				1664	1667		10.1107/S2053230X14024650		4	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	AU8JS	WOS:000345843300021		
J	Watanabe, M; Ishikawa, K				Watanabe, Masahiro; Ishikawa, Kazuhiko			Crystallization and preliminary X-ray crystallographic analysis of a putative acetylxylan esterase from Talaromyces cellulolyticus	ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS			English	Article								Acetylxylan esterase (AXE) catalyzes the hydrolytic cleavage of the ester bond between acetic acid and hemicellulose in plant cell walls. A putative AXE gene exhibiting high homology to carbohydrate esterase family 3 was found in the genome database of the fungus Talaromyces cellulolyticus (formerly known as Acremonium cellulolyticus). A truncated form of the protein, the catalytic domain of the enzyme, was prepared and crystallized. The best crystal was obtained at 293 K using 0.17 M ammonium sulfate, 28% PEG 4000, 5%(v/v) glycerol, 0.5%(w/v) n-octyl-beta-D-glucoside. X-ray diffraction data were collected to 1.50 angstrom resolution. The crystal belonged to space group P4(1)2(1)2 or P4(3)2(1)2, with unit-cell parameters a = 70.90, b = 70.90, c = 87.09 angstrom. One enzyme molecule per asymmetric unit gave a crystal volume per protein mass (VM) of 2.62 angstrom(3) Da(-1) and a solvent content of 53.0%(v/v).	[Watanabe, Masahiro; Ishikawa, Kazuhiko] AIST, Biomass Refinery Res Ctr, Higashihiroshima 7390046, Japan	Ishikawa, K (reprint author), AIST, Biomass Refinery Res Ctr, 3-11-32 Kagamiyama, Higashihiroshima 7390046, Japan.	kazu-ishikawa@aist.go.jp					Sunna A, 1997, CRIT REV BIOTECHNOL, V17, P39, DOI 10.3109/07388559709146606; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Chavez R, 2006, J BIOTECHNOL, V123, P413, DOI 10.1016/j.jbiotec.2005.12.036; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; CHRISTOV LP, 1993, ENZYME MICROB TECH, V15, P460, DOI 10.1016/0141-0229(93)90078-G; Brink J., 2011, APPL MICROBIOL BIOT, V91, P1477; Correia MAS, 2008, J MOL BIOL, V379, P64, DOI 10.1016/j.jmb.2008.03.037; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X	8	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-3091			ACTA CRYSTALLOGR F	Acta Crystallogr. F-Struct. Biol. Commun.	DEC	2014	70		12				1668	1670		10.1107/S2053230X14024595		3	Biochemical Research Methods; Biochemistry & Molecular Biology; Biophysics; Crystallography	Biochemistry & Molecular Biology; Biophysics; Crystallography	AU8JS	WOS:000345843300022		
J	Kalaee, MJ; Katoh, Y				Kalaee, Mohammad Javad; Katoh, Yuto			A simulation study on the mode conversion process from slow Z-mode to LO mode by the tunneling effect and variations of beaming angle	ADVANCES IN SPACE RESEARCH			English	Article						Density gradient; LO mode; Mode conversion; Tunneling effect	PLASMA; RADIATION; EMISSIONS; CONTINUUM; WAVES	For a particular angle of incidence wave, it is possible for a slow Z-mode wave incident on an inhomogeneous plasma slab to be converted into an LO mode wave. But for another wave normal angle of the incident wave, it has been considered impossible, since an evanescence region exists between two mode branches. In this case we expect that the mode conversion takes place through the tunneling effect. We investigate the effect of the spatial scale of the density gradient on the mode conversion efficiency in an inhomogeneous plasma where the mode conversion can occur only by the tunneling effect. We use the computer simulation solving Maxwell's equations and the motion of a cold electron fluid. By considering the steepness of the density gradient, the simulation results show the efficient mode conversion could be expected even in the case that the mismatch of the refractive indexes prevents the close coupling of plasma waves. Also, we show for these cases the beaming angle does not correspond to Jones' formula. This effect leads to the angles larger and smaller than the angle estimated by the formula. This type of mode conversion process becomes important in a case where the different plasmas form a discontinuity at their contact boundary. (C) 2014 COSPAR. Published by Elsevier Ltd. All rights reserved.	[Kalaee, Mohammad Javad] Univ Tehran, Inst Geophys, Space Phys Grp, Tehran 14174, Iran; [Katoh, Yuto] Tohoku Univ, Grad Sch Sci, Dept Geophys, Sendai, Miyagi 980, Japan	Kalaee, MJ (reprint author), Univ Tehran, Inst Geophys, Space Phys Grp, Tehran 14174, Iran.	mjkalaee@ut.ac.ir; yuto@stpp.gp.tohoku.ac.jp	Katoh, Yuto/B-8007-2015	Katoh, Yuto/0000-0002-4318-0633	University of Tehran [28905/1/02]	The authors would like to acknowledge the financial support of University of Tehran for research under grant number 28905/1/02.	MORGAN DD, 1991, J GEOPHYS RES, V96, P9595, DOI 10.1029/91JA00314; Boardsen SA, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012319; Hashimoto K, 2006, LECT NOTES PHYS, V687, P37; JONES D, 1980, NATURE, V288, P225, DOI 10.1038/288225a0; JONES D, 1987, NATURE, V328, P391, DOI 10.1038/328391a0; Jones D., 1981, ADV SPACE RES, V1, P373, DOI 10.1016/0273-1177(81)90137-X; Kalaee MJ, 2010, ANN GEOPHYS-GERMANY, V28, P1289, DOI 10.5194/angeo-28-1289-2010; Kalaee MJ, 2009, EARTH PLANETS SPACE, V61, P1243; OYA H, 1971, RADIO SCI, V6, P1131, DOI 10.1029/RS006i012p01131; OYA H, 1974, PLANET SPACE SCI, V22, P687, DOI 10.1016/0032-0633(74)90140-8; Stix T.H., 1992, WAVES PLASMAS; WARREN ES, 1968, NATURE, V220, P466, DOI 10.1038/220466a0	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0273-1177	1879-1948		ADV SPACE RES	Adv. Space Res.	DEC 1	2014	54	11					2218	2223		10.1016/j.asr.2014.08.025		6	Astronomy & Astrophysics; Geosciences, Multidisciplinary; Meteorology & Atmospheric Sciences	Astronomy & Astrophysics; Geology; Meteorology & Atmospheric Sciences	AU6OO	WOS:000345722300008		
J	Wang, L; Harada, J; Endo, Y; Hisamoto, M; Saito, F; Okuda, T				Wang, Lin; Harada, Jun; Endo, Yuka; Hisamoto, Masashi; Saito, Fumie; Okuda, Tohru			Diurnal Changes in Amino Acid Concentrations in Riesling and Chardonnay Grape Juices and a Possible Role of Sunlight	AMERICAN JOURNAL OF ENOLOGY AND VITICULTURE			English	Article						amino acid; grape juice; photosynthesis; diurnal	VITIS-VINIFERA; NITROGEN-METABOLISM; MODEL SOLUTIONS; WINE AROMA; LEAVES; BERRIES; PROFILES; PATTERNS	Diurnal changes in the concentrations of amino acids in grape juice (Vitis vinifera L.) were investigated during mid to late ripening over three consecutive years. To avoid the effect of harvest shock, samples were prepared within 15 min after grape berry picking. Changes in the amino acid concentrations of juices were classified into three patterns. The concentrations of aspartic acid (Asp) and glutamic acid (Glu) decreased during the morning and gradually increased at night. The alanine (Ala) concentration increased during the morning and decreased at night. The amino acid peak times were 0600 to 0900 hr for Asp, 0600 to 0700 hr for Glu, and 1300 to 1900 hr for Ala for Riesling harvested from 31 Aug to 1 Sep 2010. Some of the other amino acids, such as phenylalanine, serine, proline, and threonine showed minimal or no diurnal changes in concentration. Yeast assimilable nitrogen (YAN) showed minimal daily changes. During cloudy days, these diurnal changes diminished. When grape clusters were shaded with aluminum foil, the patterns of amino acid concentrations did not change, with some exceptions. Photosynthesis is proposed as the main contributor to these changes, since minimal changes were observed under cloud cover. Moreover, leaf rather than berry photosynthesis is likely an important factor in the composition of berry amino acids.	[Wang, Lin; Harada, Jun; Endo, Yuka; Hisamoto, Masashi; Saito, Fumie; Okuda, Tohru] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Inst Enol & Viticulture, Kofu, Yamanashi 4000005, Japan	Okuda, T (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Inst Enol & Viticulture, 13-1 Kitashin 1 Chome, Kofu, Yamanashi 4000005, Japan.	okuda@yamanashi.ac.jp					Lee SJ, 2003, J AGR FOOD CHEM, V51, P8036, DOI 10.1021/jf034747v; Swiegers JH, 2005, AUST J GRAPE WINE R, V11, P139, DOI 10.1111/j.1755-0238.2005.tb00285.x; Bell SJ, 2005, AUST J GRAPE WINE R, V11, P242, DOI 10.1111/j.1755-0238.2005.tb00028.x; LAKSO AN, 1975, PLANT PHYSIOL, V56, P370, DOI 10.1104/pp.56.3.370; Conconi A, 1996, PLANT PHYSIOL, V111, P797; Francis IL, 2005, AUST J GRAPE WINE R, V11, P114, DOI 10.1111/j.1755-0238.2005.tb00283.x; KING GA, 1994, J AM SOC HORTIC SCI, V119, P1000; Famiani F, 2000, J EXP BOT, V51, P675, DOI 10.1093/jexbot/51.345.675; Dokoozlian NK, 1996, J AM SOC HORTIC SCI, V121, P869; Pereira GE, 2006, J AGR FOOD CHEM, V54, P6765, DOI 10.1021/jf061013k; Hernandez-Orte P, 2002, J AGR FOOD CHEM, V50, P2891, DOI 10.1021/jf011395o; BAUER A, 1977, PLANT PHYSIOL, V59, P915, DOI 10.1104/pp.59.5.915; BISSON LF, 1991, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON NITROGEN IN GRAPES AND WINE, P78; Dartiguenave C, 2000, AM J ENOL VITICULT, V51, P347; DURZAN DJ, 1968, CAN J BOTANY, V46, P929; Henschke P.A., 1993, WINE MICROBIOLOGY BI, P77; HUANG Z, 1991, AM J ENOL VITICULT, V42, P261; Inada K., 1984, LIGHT PLANT GROWTH; KLIEWER WM, 1968, AM J ENOL VITICULT, V19, P166; Kobayashi H, 2012, AM J ENOL VITICULT, V63, P544, DOI 10.5344/ajev.2012.12051; KRUEGER R, 1995, AM J ENOL VITICULT, V46, P37; KUNKEE RE, 1991, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON NITROGEN IN GRAPES AND WINE, P148; LAFON-LAFOURCADE S., 1962, Vitis, V3, P130; Lamikanra O, 1999, J AGR FOOD CHEM, V47, P4837, DOI 10.1021/jf981085e; Matsui M., 1985, J JAPAN SOC HORT SCI, V54, P184; Matsui M., 1980, J JAPAN SOC HORT SCI, V48, P405; MITCHELL DE, 1992, PLANT PHYSIOL, V99, P959, DOI 10.1104/pp.99.3.959; MULLINS M. G., 1992, BIOL GRAPEVINE; NASSAR AR, 1966, P AM SOC HORTIC SCI, V89, P281; NOGUCHI M, 1962, ARCH BIOCHEM BIOPHYS, V98, P197, DOI 10.1016/0003-9861(62)90173-X; PANDEY RM, 1977, VITIS, V16, P106; PONI S, 1994, AM J ENOL VITICULT, V45, P71; Rapp A., 1996, WEIN WISSENSCHAFT, V51, P193; SOLMS J, 1969, J AGR FOOD CHEM, V17, P686, DOI 10.1021/jf60164a016; STEER BT, 1973, PLANT PHYSIOL, V51, P744, DOI 10.1104/pp.51.4.744; WINTER H, 1992, PLANT PHYSIOL, V99, P996, DOI 10.1104/pp.99.3.996	36	0	0	AMER SOC ENOLOGY VITICULTURE	DAVIS	PO BOX 1855, DAVIS, CA 95617-1855 USA	0002-9254	1943-7749		AM J ENOL VITICULT	Am. J. Enol. Vitic.	DEC	2014	65	4					435	442		10.5344/ajev.2014.13144		8	Biotechnology & Applied Microbiology; Food Science & Technology; Horticulture	Biotechnology & Applied Microbiology; Food Science & Technology; Agriculture	AU7KC	WOS:000345778400004		
J	Imaizumi, Y; Eguchi, K; Taketomi, A; Tsuchihashi, T; Kario, K				Imaizumi, Yuki; Eguchi, Kazuo; Taketomi, Akira; Tsuchihashi, Takuya; Kario, Kazuomi			Exaggerated Blood Pressure Variability in Patients With Pneumoconiosis: A Pilot Study	AMERICAN JOURNAL OF HYPERTENSION			English	Article						ambulatory blood pressure monitoring; blood pressure; blood pressure variability; hypertension; hypoxia; pneumoconiosis; pulse oximetry	OBSTRUCTIVE PULMONARY-DISEASE; AMBULATORY HEART-RATE; ARTERIAL-PRESSURE; PREDICTIVE-VALUE; HYPERTENSION; COPD; POPULATION; MORTALITY; ACCURACY; OXIMETRY	BACKGROUND Chronic hypoxia is a risk factor for cardiovascular disease, but its association with blood pressure (BP) remains unclear. We performed this study to clarify the hypothesis that chronic hypoxia is associated with abnormal BP variability in patients with pneumoconiosis. METHODS We recruited 19 patients with pneumoconiosis and 30 age- and BP level-matched control subjects. We used simultaneous pulse oximetry and ambulatory BP monitoring for all subjects. We evaluated their BP levels and variability by determining the SD and coefficient of variation (CV) of the BP data. The dipper pattern was defined as nocturnal BP fall >= 10%; the nondipper pattern was defined as nocturnal BP fall >= 0% but <10%; the riser pattern was defined as nocturnal BP fall <0%. Pearson and Spearman correlation coefficients were used to calculate the correlations between parameters. RESULTS In patients with pneumoconiosis, the daytime systolic BP (SBP) level was lower, the CV in 24-hour SBP (P < 0.05) and diastolic BP (P < 0.001) were higher than that in control subjects. And although not statistically significant (P = 0.13), the odds ratio of riser pattern was 3.73 in patients with pneumoconiosis, and their nighttime pulse rate was significantly higher (P < 0.05) than that in control subjects. The median daytime pulse oximetry oxygen saturation was inversely associated with mean (r = -0.30; P < 0.01) and SD (r = -0.38; P < 0.001) in daytime SBP. The median nighttime pulse oximetry oxygen saturation was inversely associated (r = -0.55; P < 0.001) and the mean nighttime pulse rate was associated (r = 0.51; P < 0.001) with CV in nighttime SBP. Partial pressure of oxygen was inversely associated with CV in daytime SBP (r = -0.24; P < 0.05). CONCLUSIONS Exaggerated BP variability was seen in patients with pneumoconiosis, and the measures of hypoxia were associated with large fluctuations in ambulatory BP. Chronic and intermittent hypoxia could be the contributing factors of these findings.	[Imaizumi, Yuki] Munakata Oshima Clin, Fukuoka, Japan; [Imaizumi, Yuki; Eguchi, Kazuo; Kario, Kazuomi] Jichi Med Univ, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan; [Taketomi, Akira] Iizuka Municipal Hosp, Fukuoka, Japan; [Tsuchihashi, Takuya] Steel Mem Yawata Hosp, Hypertens Ctr, Fukuoka, Japan	Kario, K (reprint author), Jichi Med Univ, Dept Med, Div Cardiovasc Med, Shimotsuke, Tochigi, Japan.	kkario@jichi.ac.jp					Aidar NA, 2009, ARQ BRAS CARDIOL, V93, P275, DOI 10.1590/S0066-782X2009000900012; Palatini P, 2002, ARCH INTERN MED, V162, P2313, DOI 10.1001/archinte.162.20.2313; de Lucas-Ramos P, 2012, INT J CHRONIC OBSTR, V7, P679, DOI 10.2147/COPD.S36222; Verdecchia P, 2007, AM J HYPERTENS, V20, P154, DOI 10.1016/j.amjhyper.2006.07.017; Mattace-Raso FUS, 2007, J HYPERTENS, V25, P1421, DOI 10.1097/HJH.0b013e32811d6a07; Fagard RH, 1997, HYPERTENSION, V29, P22; Hozawa A, 2008, J HYPERTENS, V26, P1571, DOI 10.1097/HJH.0b013e3283041172; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Kikuya M, 2000, HYPERTENSION, V36, P901; Maclay JD, 2013, CHEST, V143, P798, DOI 10.1378/chest.12-0938; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; STAESSEN J, 1988, J HUM HYPERTENS, V2, P207; Pringle E, 2003, J HYPERTENS, V21, P2251, DOI 10.1097/01.hjh.0000098144.70956.0f; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Heindl S, 2001, AM J RESP CRIT CARE, V164, P597; Clarenbach CF, 2013, EUR RESPIR J, V42, P1194, DOI 10.1183/09031936.00144612; Eguchi K, 2009, J HYPERTENS, V27, P2265, DOI 10.1097/HJH.0b013e328330a938; Engstrom G, 2001, J HYPERTENS, V19, P1203, DOI 10.1097/00004872-200107000-00004; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011, GLOB STRAT DIAGN MAN; Hoshide S, 2014, AM J HYPERTENS; IMAI Y, 1992, AM J HYPERTENS, V5, P719; Japan Industry Safety & Health Association, 1987, HDB DIAGN PNEUM; Levy P, 1996, CHEST, V109, P395, DOI 10.1378/chest.109.2.395; Macefield VG, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00153; Magalang UJ, 2003, CHEST, V124, P1694, DOI 10.1378/chest.124.5.1694; Mapel Douglas W, 2005, COPD, V2, P35; Nakano H, 2005, THERAPEUTIC RES, V26, P931; Olbinskaya LI, 2002, TERAPEVT ARKH, V74, P59; Palatini P, 2013, INT J CARDIOL, V168, P1490, DOI 10.1016/j.ijcard.2012.12.103; PICKERING TG, 1994, J HYPERTENS, V12, pS29; Pronzato C, 2010, Monaldi Arch Chest Dis, V73, P155; Ross B, 2010, AM J HYPERTENS, V23, P1228, DOI 10.1038/ajh.2010.160; Sin Don D, 2005, Proc Am Thorac Soc, V2, P8, DOI 10.1513/pats.200404-032MS; van Gestel AJ, 2012, DISCOV MED, V14, P350; Verdecchia P, 1998, J HYPERTENS, V16, P1335, DOI 10.1097/00004872-199816090-00015	36	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	DEC	2014	27	12					1456	1463		10.1093/ajh/hpu073		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AU7LM	WOS:000345782100004		
J	Sueta, D; Koibuchi, N; Hasegawa, Y; Toyama, K; Uekawa, K; Katayama, T; Ma, M; Nakagawa, T; Ogawa, H; Kim-Mitsuyama, S				Sueta, Daisuke; Koibuchi, Nobutaka; Hasegawa, Yu; Toyama, Kensuke; Uekawa, Ken; Katayama, Tetsuji; Ma, MingJie; Nakagawa, Takashi; Ogawa, Hisao; Kim-Mitsuyama, Shokei			Telmisartan Exerts Sustained Blood Pressure Control and Reduces Blood Pressure Variability in Metabolic Syndrome by Inhibiting Sympathetic Activity	AMERICAN JOURNAL OF HYPERTENSION			English	Article						angiotensin receptor blocker; blood pressure; blood pressure variability; hypertension; oxidative stress; sympathetic activity; telemetry	ROSTRAL VENTROLATERAL MEDULLA; SPONTANEOUSLY HYPERTENSIVE-RATS; TO-VISIT VARIABILITY; OXIDATIVE STRESS; EPISODIC HYPERTENSION; HEART-FAILURE; RECEPTOR; DISEASE; OBESITY; SYMPATHOINHIBITION	BACKGROUND Accumulating evidence on blood pressure (BP) reduction with various angiotensin II receptor blockers (ARBs) show that the magnitudes and durations of BP control differ across ARBs. However, the mechanism of ARBs is unknown. This work was undertaken to compare telmisartan and valsartan in duration of BP control, BP variability, and effects on the autonomic nervous system. METHODS Using radiotelemetry combined with spectral analysis with a fast Fourier transformation algorithm, we compared the effects of various doses of telmisartan and valsartan on BP and its variability during dark (active phase) and light (inactive phase) periods over 5 weeks in SHR/NDmcr-cp(+/+)(SHRcp) rats, a model of metabolic syndrome. We also compared the effects of these ARBs on autonomic nervous system, central oxidative stress, and inflammation in SHRcp rats. RESULTS Telmisartan exerted a longer-lasting BP-lowering effect and greater attenuation of BP variability in SHRcp than valsartan. Telmisartan decreased low frequency power of systolic BP and increased spontaneous baroreflex gain in SHRcp during both the dark and light periods more than valsartan. Telmisartan reduced 24-hour urinary norepinephrine excretion more than valsartan. Furthermore, telmisartan attenuated oxidative stress and the numbers of gp91(phox)-positive cells and activated microglia and astrocytes in the rostral ventrolateral medulla of SHRcp rats more than valsartan. CONCLUSIONS The superiority of telmisartan over valsartan in sustained BP control and reduction of BP variability was attributed to more suppression of sympathetic activity and more improvement of baroreceptor reflex. The greater suppression of sympathetic activity by telmisartan appeared to be partially mediated by a stronger amelioration of central oxidative stress.	[Sueta, Daisuke; Koibuchi, Nobutaka; Hasegawa, Yu; Toyama, Kensuke; Uekawa, Ken; Katayama, Tetsuji; Ma, MingJie; Nakagawa, Takashi; Kim-Mitsuyama, Shokei] Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto, Japan; [Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan	Kim-Mitsuyama, S (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Pharmacol & Mol Therapeut, Kumamoto, Japan.	mitsuyam@gpo.kumamoto-u.ac.jp			Astellas; AstraZeneca; Bayer; Boehringer Ingelheim; Chugai; Daiichi Sankyo; Dainippon Sumitomo Pharma; Eisai; Kowa; Kyowa Hakko Kirin; Mitsubishi Tanabe; MSD; Novartis; Otsuka; Pfizer; Sanofi; Sionogi; Takeda	H.O. received lecture fees and research grant from Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Chugai, Daiichi Sankyo, Dainippon Sumitomo Pharma, Eisai, Kowa, Kyowa Hakko Kirin, Mitsubishi Tanabe, MSD, Novartis, Otsuka, Pfizer, Sanofi, Sionogi, and Takeda. S.K.-M. received lecture fees and research grant from Astellas, AstraZeneca, Boehringer Ingelheim, Daiichi Sankyo, Novartis, Sionogi, Takeda, and Kyowa Hakko Kirin.	Michel MC, 2013, PHARMACOL REV, V65, P809, DOI 10.1124/pr.112.007278; Griendling KK, 2000, CIRC RES, V86, P494; Hata J, 2013, CIRCULATION, V128, P1325, DOI 10.1161/CIRCULATIONAHA.113.002717; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Kishi T, 2012, HYPERTENS RES, V35, P940, DOI 10.1038/hr.2012.63; Takaya K, 1996, NAT GENET, V14, P130, DOI 10.1038/ng1096-130; Kishi T, 2004, CIRCULATION, V109, P2357, DOI 10.1161/01.CIR.0000128695.49900.12; Nagase M, 2007, HYPERTENSION, V50, P877, DOI 10.1161/HYPERTENSIONAHA.107.091058; Verdecchia P, 2012, HYPERTENSION, V60, P34, DOI 10.1161/HYPERTENSIONAHA.112.191858; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Nagae A, 2009, CIRCULATION, V119, P978, DOI 10.1161/CIRCULATIONAHA.108.824730; de la Sierra A, 2009, HYPERTENSION, V53, P466, DOI 10.1161/HYPERTENSIONAHA.108.124008; Guo F, 2010, CARDIOVASC RES, V87, P578, DOI 10.1093/cvr/cvq059; Sueta D, 2012, AM J HYPERTENS, V25, P704, DOI 10.1038/ajh.2012.26; Palatini P, 2009, CURR HYPERTENS REP, V11, P199, DOI 10.1007/s11906-009-0035-4; Oliveira-Sales EB, 2010, HYPERTENSION, V56, P290, DOI 10.1161/HYPERTENSIONAHA.110.150425; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; VERDECCHIA P, 1994, HYPERTENSION, V24, P793; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Boer-Martins L, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-24; Chrysant SG, 2005, J HUM HYPERTENS, V19, P173, DOI 10.1038/sj.jhh.1001808; Dong YF, 2011, HYPERTENSION, V58, P635, DOI 10.1161/HYPERTENSIONAHA.111.173534; Katayama T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000197; Kishi T, 2014, AM J HYPERTENS, V27, P260, DOI 10.1093/ajh/hpt188; Konno S, 2012, J HYPERTENS, V30, P1992, DOI 10.1097/HJH.0b013e328357fa98; Lacourciere Y, 2004, BLOOD PRESS MONIT, V9, P203, DOI 10.1097/00126097-200408000-00005; Marina N, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0317-x; Neutel Joel, 2003, J Clin Hypertens (Greenwich), V5, P58, DOI 10.1111/j.1524-6175.2003.01612.x; Parati G, 2010, J HYPERTENS, V28, P2177, DOI 10.1097/HJH.0b013e32833e1150; Sueta D, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000035; Toyama K, 2013, ARTERIOSCLER THROMB, V34, P616; White WB, 2008, AM J MED, V121, pS2, DOI 10.1016/j.amjmed.2008.05.016	34	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	DEC	2014	27	12					1464	1471		10.1093/ajh/hpu076		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AU7LM	WOS:000345782100005		
J	Tomiyama, H; Odaira, M; Kimura, K; Matsumoto, C; Shiina, K; Eguchi, K; Miyashita, H; Shimada, K; Yamashina, A				Tomiyama, Hirofumi; Odaira, Mari; Kimura, Kazutaka; Matsumoto, Chisa; Shiina, Kazuki; Eguchi, Kazuo; Miyashita, Hiroshi; Shimada, Kazuyuki; Yamashina, Akira			Differences in Effects of Age and Blood Pressure on Augmentation Index	AMERICAN JOURNAL OF HYPERTENSION			English	Article						age; augmentation index; blood pressure; hypertension	COLLABORATIVE TRIAL ACCT; ARTERIAL STIFFNESS; WAVE REFLECTIONS; CARDIOVASCULAR EVENTS; AORTIC STIFFNESS; PROGRESSION; ATENOLOL; IMPACT	BACKGROUND The effect of age on the augmentation index (AI) differs between young adults and the elderly, and the AI reaches a plateau after the age of 60 years. We examined whether the effects of age and an elevation in blood pressure on the AI differ between young adults and the elderly, between subjects with and without high blood pressure, or between subjects with and without a high AI. METHODS The radial AI was measured in 10,190 subjects who were either healthy or had hypertension (n = 5,477 men and 4,743 women). RESULTS In both sexes, a phased increase in the radial AI with age could only be confirmed up to an age of 60 years. A phased increase in the radial AI with the systolic blood pressure (SBP) could be confirmed up to an SBP of > 170 mm Hg. Among subjects categorized within the highest age tertile, the highest SBP tertile, or the highest radial AI tertile, stepwise multivariable analyses demonstrated that SBP, but not age, was a significant independent factor influencing the radial AI. CONCLUSIONS The effect of age and blood pressure on AI differ not only between young adults and the elderly but also between those with and those without high blood pressure or between those with and those without a high AI. The effect of an elevation in blood pressure, but not aging, on the AI is significant in the elderly, in subjects with high blood pressure, or in those with a high AI.	[Tomiyama, Hirofumi; Odaira, Mari; Kimura, Kazutaka; Matsumoto, Chisa; Shiina, Kazuki; Yamashina, Akira] Tokyo Med Univ, Dept Internal Med 2, Tokyo 1608402, Japan; [Eguchi, Kazuo; Miyashita, Hiroshi; Shimada, Kazuyuki] Jichi Med Univ, Shimotsuke, Tochigi, Japan	Tomiyama, H (reprint author), Tokyo Med Univ, Dept Internal Med 2, Tokyo 1608402, Japan.	tomiyama@tokyo-med.ac.jp			OMRON Health Care (Kyoto, Japan)	This work was partially supported by a grant from OMRON Health Care (Kyoto, Japan).	O'Rourke MF, 2007, J AM COLL CARDIOL, V50, P1, DOI 10.1016/j.jacc.2006.12.050; Tomiyama H, 2009, HYPERTENS RES, V32, P122, DOI 10.1038/hr.2008.20; McEniery CM, 2010, HYPERTENSION, V56, P591, DOI 10.1161/HYPERTENSIONAHA.110.156950; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; Miyashita H, 2010, AM J HYPERTENS, V23, P260, DOI 10.1038/ajh.2009.255; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Chirinos JA, 2011, HYPERTENSION, V57, P1108, DOI 10.1161/HYPERTENSIONAHA.110.166348; Dhakam Z, 2008, J HYPERTENS, V26, P351, DOI 10.1097/HJH.0b013e3282f283c9; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Tomiyama H, 2010, CIRC J, V74, P24, DOI 10.1253/circj.CJ-09-0534; O'Rourke MF, 2009, MED BIOL ENG COMPUT, V47, P119, DOI 10.1007/s11517-008-0370-7; Asmar RG, 2001, HYPERTENSION, V38, P922, DOI 10.1161/hy1001.095774; Melenovsky V, 2007, J HYPERTENS, V25, P1403, DOI 10.1097/HJH.0b013e32811d69df; Sugawara J, 2007, J HYPERTENS, V25, P375, DOI 10.1097/HJH.0b013e32801092ae; Takenaka T, 2005, AM J NEPHROL, V25, P417, DOI 10.1159/000087605; Thomas F, 2013, J AM SOC HYPERTENS, V7, P440, DOI 10.1016/j.jash.2013.07.005; Vyas M, 2007, AM J HYPERTENS, V20, P642, DOI 10.1016/j.amjhyper.2007.01.008	17	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0895-7061	1941-7225		AM J HYPERTENS	Am. J. Hypertens.	DEC	2014	27	12					1479	1485		10.1093/ajh/hpu082		7	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AU7LM	WOS:000345782100007		
J	Yamada, H; Hangai, M; Nakano, N; Takayama, K; Kimura, Y; Miyake, M; Akagi, T; Ikeda, HO; Noma, H; Yoshimura, N				Yamada, Hiroshi; Hangai, Masanori; Nakano, Noriko; Takayama, Kohei; Kimura, Yugo; Miyake, Masahiro; Akagi, Tadamichi; Ikeda, Hanako Ohashi; Noma, Hisashi; Yoshimura, Nagahisa			Asymmetry Analysis of Macular Inner Retinal Layers for Glaucoma Diagnosis	AMERICAN JOURNAL OF OPHTHALMOLOGY			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; PREPERIMETRIC GLAUCOMA; DOMAIN OCT; THICKNESS; DEFECTS; PERIMETRY; ONSET; EYES	PURPOSE: To determine if asymmetry in thickness of the retinal nerve fiber layer (RNFL), ganglion cell layer, ganglion cell complex, and total retina between upper and lower macula halves can predict glaucoma. DESIGN: Retrospective case-control series. METHODS: One hundred twenty-two eyes of 122 patients (30 normal eyes and 30 preperimetric, 31 early, and 31 advanced glaucoma eyes) were studied. The RNFL, ganglion cell layer, ganglion cell complex, and total retina were segmented and measured on 10 vertical B-scans over a 30 x 15 degree macular area. The equation asymmetry index = vertical bar log(10) (lower hemiretinal thickness/upper hemiretinal thickness)vertical bar was used to calculate asymmetry indices for 8 pairs of upper and lower 0.5-mm segments equidistant from the fovea on each scan. Areas under the receiver operating characteristic curve (AROCs) for mean thickness and mean asymmetry index of 10 B-scans were compared. RESULTS: The overlap in values for normal and glaucomatous eyes was minimal for the ganglion cell layer asymmetry index. Thickness parameters decreased with the severity of glaucoma, whereas asymmetry indices did not. AROCs for thickness measurements tended to increase with increasing glaucoma severity (preperimetric, 0.746-0.808; early, 0.842-0.940; advanced, 0.943-0.995), whereas AROCs for asymmetry indices did not have distinct ranges according to glaucoma severity (advanced, 0.819-0.996; early, 0.861-0.998; preperimetric, 0.773-0.994). The AROC for the ganglion cell layer asymmetry index remained almost perfect regardless of glaucoma severity (0.994-0.998). CONCLUSIONS: Macular retinal layer thickness asymmetry indices, particularly for the ganglion cell layer, show promise as early indicators of glaucomatous retinal damage. (C) 2014 by Elsevier Inc. All rights reserved.	[Yamada, Hiroshi; Hangai, Masanori; Nakano, Noriko; Takayama, Kohei; Kimura, Yugo; Miyake, Masahiro; Akagi, Tadamichi; Ikeda, Hanako Ohashi; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Hangai, Masanori] Saitama Med Univ, Dept Ophthalmol, Moroyama, Saitama 3500451, Japan; [Noma, Hisashi] Inst Stat Math, Tokyo, Japan	Hangai, M (reprint author), Saitama Med Univ, Dept Ophthalmol, 38 Morohongo, Moroyama, Saitama 3500451, Japan.	hangai@saitama-med.ac.jp			Canon; Astellas Foundation for Research on Metabolic Disorders; Japan Foundation for Applied Enzymology; Uehara Memorial Foundation; SAS Institute Japan, Ltd; Nidek; Topcon; Japan Society for the Promotion of Science (JSPS), Tokyo, Japan [20592038]	Masanori Hangai is a paid advisory board member for NIDEK, received consulting fees from Canon, and received research funding from Canon. Hanako Ikeda received research grants from the Astellas Foundation for Research on Metabolic Disorders, the Japan Foundation for Applied Enzymology, and the Uehara Memorial Foundation. Hisashi Noma received lecture fees from the SAS Institute Japan, Ltd. Nagahisa Yoshimura is a paid advisory board member for NIDEK and received lecture fees and research funding from Nidek, Topcon, and Canon. None of the other authors has financial interests to disclose. This research was supported in part by a Grant-in-Aid for Scientific Research (20592038) from the Japan Society for the Promotion of Science (JSPS), Tokyo, Japan.	Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kim NR, 2010, INVEST OPHTH VIS SCI, V51, P4646, DOI 10.1167/iovs.09-5053; Arintawati P, 2013, J GLAUCOMA, V22, P713, DOI 10.1097/IJG.0b013e318259b2e1; Morooka S, 2012, INVEST OPHTH VIS SCI, V53, P4805, DOI 10.1167/iovs.12-9870; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Kotera Y, 2011, INVEST OPHTH VIS SCI, V52, P1412, DOI 10.1167/iovs.10-5572; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P77; Harwerth RS, 1999, INVEST OPHTH VIS SCI, V40, P2242; Tan Ou, 2009, Ophthalmology, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; ASMAN P, 1992, ARCH OPHTHALMOL-CHIC, V110, P820; Ooto S, 2011, INVEST OPHTH VIS SCI, V52, P8769, DOI 10.1167/iovs.11-8388; Seo JH, 2012, INVEST OPHTH VIS SCI, V53, P4347, DOI 10.1167/iovs.12-9673; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453; SOMMER A, 1977, ARCH OPHTHALMOL-CHIC, V95, P2149; Lisboa R, 2013, INVEST OPHTH VIS SCI, V54, P3417, DOI 10.1167/iovs.13-11676; ASMAN P, 1992, ARCH OPHTHALMOL-CHIC, V110, P812; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258; Mori S, 2010, J GLAUCOMA, V19, P528, DOI 10.1097/IJG.0b013e3181ca7acf; Asrani S, 2011, ARCH OPHTHALMOL-CHIC, V129, P1205, DOI 10.1001/archophthalmol.2011.242; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Um TW, 2012, INVEST OPHTH VIS SCI, V53, P1139, DOI 10.1167/iovs.11-8373; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Nakano N, 2011, OPHTHALMOLOGY, V118, P2414, DOI 10.1016/j.ophtha.2011.06.015; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Fleiss JL, 1986, WILEY SERIES PROBABI, P1; Hangai M, 2009, OPT EXPRESS, V17, P4221, DOI 10.1364/OE.17.004221; Hirashima T, 2013, GRAEF ARCH CLIN EXP, V251, P129, DOI 10.1007/s00417-012-2076-7; Hodapp E., 1993, CLIN DECISIONS GLAUC, P52; MOTOLKO M, 1981, ARCH OPHTHALMOL-CHIC, V99, P1992; Rolle Teresa, 2011, Clin Ophthalmol, V5, P961, DOI 10.2147/OPTH.S20249; TUULONEN A, 1993, OPHTHALMOLOGY, V100, P587	31	5	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9394	1879-1891		AM J OPHTHALMOL	Am. J. Ophthalmol.	DEC	2014	158	6					1318	1329		10.1016/j.ajo.2014.08.040		12	Ophthalmology	Ophthalmology	AU8AZ	WOS:000345820400029		
J	Iwasaki, T; Takemoto, Y; Inada, E; Sato, H; Saitoh, I; Kakuno, E; Kanomi, R; Yamasaki, Y				Iwasaki, Tomonori; Takemoto, Yoshihiko; Inada, Emi; Sato, Hideo; Saitoh, Issei; Kakuno, Eriko; Kanomi, Ryuzo; Yamasaki, Youichi			Three-dimensional cone-beam computed tomography analysis of enlargement of the pharyngeal airway by the Herbst appliance	AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS			English	Article							OBSTRUCTIVE SLEEP-APNEA; RAPID MAXILLARY EXPANSION; MANDIBULAR SETBACK SURGERY; CLASS-II MALOCCLUSIONS; MAXILLOMANDIBULAR ADVANCEMENT; CHILDREN; ADOLESCENTS; POSTURE; GROWTH; SPACE	Introduction: Pharyngeal airway size is increasingly recognized as an important factor in obstructive sleep apnea. However, few studies have examined the changes of pharyngeal airway form after dental procedures for treating obstructive sleep apnea during growth. The purpose of this study was to evaluate the effect of the Herbst appliance on the 3-dimensional form of the pharyngeal airway using cone-beam computed tomography. Methods: Twenty-four Class II subjects (ANB, >= 5 degrees; 11 boys; mean age, 11.6 years) who required Herbst therapy with edgewise treatment had cone-beam computed tomography images taken before and after Herbst treatment. Twenty Class I control subjects (9 boys; mean age, 11.5 years) received edgewise treatment only. The volume, depth, and width of the pharyngeal airway were compared between the groups using measurements from 3-dimensional cone-beam computed tomography images of the entire pharyngeal airway. Results: The increase of the oropharyngeal airway volume in the Herbst group (5000.2 mm(3)) was significantly greater than that of the control group (2451.6 mm(3)). Similarly, the increase of the laryngopharyngeal airway volume in the Herbst group (1941.8 mm(3)) was significantly greater than that of the control group (1060.1 mm(3)). Conclusions: The Herbst appliance enlarges the oropharyngeal and laryngopharyngeal airways. These results may provide a useful assessment of obstructive sleep apnea treatment during growth.	[Iwasaki, Tomonori; Takemoto, Yoshihiko; Inada, Emi; Sato, Hideo; Yamasaki, Youichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Hlth Res Course, Kagoshima 8908544, Japan; [Saitoh, Issei] Niigata Univ, Div Pediat Dent, Dept Oral Hlth Sci, Course Oral Life Sci,Grad Sch Med & Dent Sci, Niigata, Japan	Iwasaki, T (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	yamame@dent.kagoshima-u.ac.jp			KAKENHI from the Japan Society for the Promotion of Science [19592360, 22592292, 22390392, 24659914, 24792298, 25293420, 25670878]	Supported by KAKENHI (Grants-in-Aid for Scientific Research) from the Japan Society for the Promotion of Science (numbers 19592360, 22592292, 22390392, 24659914, 24792298, 25293420, and 25670878).	Buchenau W, 2007, J PEDIATR-US, V151, P145, DOI 10.1016/j.jpeds.2007.02.063; Park JW, 2010, AM J ORTHOD DENTOFAC, V138, P292, DOI 10.1016/j.ajodo.2009.10.036; Abramson Z, 2011, J ORAL MAXIL SURG, V69, P677, DOI 10.1016/j.joms.2010.11.037; Degerliyurt K, 2008, ORAL SURG ORAL MED O, V105, P495, DOI 10.1016/j.tripleo.2007.11.012; Miloro M, 2010, J ORAL MAXIL SURG, V68, P1512, DOI 10.1016/j.joms.2009.09.099; Baccetti T, 2002, ANGLE ORTHOD, V72, P316; Chang Y, 2013, AM J ORTHOD DENTOFAC, V143, P462, DOI 10.1016/j.ajodo.2012.11.019; Li HY, 2003, OTOLARYNG HEAD NECK, V129, P336, DOI 10.1016/S0194-5998(03)00629-6; Aboudara C, 2009, AM J ORTHOD DENTOFAC, V135, P468, DOI 10.1016/j.ajodo.2007.04.043; Villa MP, 2002, AM J RESP CRIT CARE, V165, P123; Kyung SH, 2005, ANGLE ORTHOD, V75, P15; Muto T, 2002, INT J ORAL MAX SURG, V31, P579, DOI 10.1054/ijom.2002.0279; Guilleminault C, 2005, ARCH PEDIAT ADOL MED, V159, P775, DOI 10.1001/archpedi.159.8.775; FIELDS HW, 1991, AM J ORTHOD DENTOFAC, V99, P147, DOI 10.1016/0889-5406(91)70117-F; Fairburn SC, 2007, J ORAL MAXIL SURG, V65, P6, DOI 10.1016/j.joms.2005.11.119; Schwab RJ, 1998, CLIN CHEST MED, V19, P33, DOI 10.1016/S0272-5231(05)70430-5; Walsh JH, 2008, J SLEEP RES, V17, P230, DOI 10.1111/j.1365-2869.2008.00647.x; Sutherland K, 2011, SLEEP, V34, P469; Okushi T, 2011, J ORAL MAXIL SURG, V69, P877, DOI 10.1016/j.joms.2010.10.012; Bock N, 2006, ANGLE ORTHOD, V76, P930, DOI 10.2319/100605-352; Dahlberg G, 1940, STASTISTICAL METHODS; Hagglund P, 2008, EUR J ORTHODONT, V30, P120, DOI 10.1093/ejo/cjm102; Itzhaki S, 2007, CHEST, V131, P740, DOI 10.1378/chest.06-0965; Iwasaki T, 2011, AM J ORTHOD DENTOFAC, V139, DOI 10.1016/j.ajodo.2010.08.014; Iwasaki T, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2009.04.010; Iwasaki T, 2014, INT J PEDIATR OTORHI, V78, P1258, DOI 10.1016/j.ijporl.2014.05.004; Iwasaki T, 2009, AM J ORTHOD DENTOFAC, V136; Kim YJ, 2010, AM J ORTHOD DENTOFAC, V137; Kim YJ, 2010, AM J ORTHOD DENTOFAC, V137, P306; LaHaye MB, 2006, AM J ORTHOD DENTOFAC, V130, P732, DOI 10.1016/j.ajodo.2005.02.028; PANCHERZ H, 1979, AM J ORTHOD DENTOFAC, V76, P423, DOI 10.1016/0002-9416(79)90227-6; Ronen O, 2007, PEDIATRICS, V120, pE1028, DOI 10.1542/peds.2006-3433; Ryan CF, 1999, THORAX, V54, P972; Schutza TCB, 2011, ANGLE ORTHOD, V81, P222, DOI 10.2319/052710-233.1; VanLaecken Ryan, 2006, Am J Orthod Dentofacial Orthop, V130, P582, DOI 10.1016/j.ajodo.2005.01.030; Warren DW, 1991, CURRENT CONTROVERSIE, P45; Iwasaki T, 2013, AM J ORTHOD DENTOFAC, V143, P235, DOI 10.1016/j.ajodo.2012.09.014; Zhao XG, 2008, AM J ORTHOD DENTOFAC, V133, P661, DOI 10.1016/j.ajodo.2006.06.024	38	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0889-5406	1097-6752		AM J ORTHOD DENTOFAC	Am. J. Orthod. Dentofac. Orthop.	DEC	2014	146	6					776	785		10.1016/j.ajodo.2014.08.017		10	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU5PQ	WOS:000345659600015		
J	Minobe, E; Maeda, S; Xu, JJ; Hao, LY; Kameyama, A; Kameyama, M				Minobe, Etsuko; Maeda, Sachiko; Xu, Jianjun; Hao, Liying; Kameyama, Asako; Kameyama, Masaki			A new phosphorylation site in cardiac L-type Ca2+ channels (Cav1.2) responsible for its cAMP-mediated modulation	AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY			English	Article						calcium channels; protein kinase A; adenosine 3 ',5 '-cyclic monophosphate	L-TYPE CALCIUM; DEPENDENT PROTEIN-KINASE; BETA-ADRENERGIC STIMULATION; OR-FLIGHT RESPONSE; ALPHA(1C) SUBUNIT; CA(V)1.2 CHANNELS; PHOSPHATASE INHIBITORS; CARBOXYL-TERMINUS; CURRENTS; INACTIVATION	Cardiac L-type Ca2+ channels are modulated by phosphorylation by protein kinase A (PKA). To explore the PKA-targeted phosphorylation site(s), five potential phosphorylation sites in the carboxyl (COOH) terminal region of the alpha(1C)-subunit of the guinea pig Cav1.2 Ca2+ channel were mutated by replacing serine (S) or threonine (T) residues with alanine (A): S1574A (C1 site), S1626A (C2), S1699A (C3), T1908A, (C4), S1927A (C5), and their various combinations. The wild-type Ca2+ channel activity was enhanced three- to fourfold by the adenylyl cyclase activator forskolin (Fsk, 5 mu M), and that of mutants at C3, C4, C5, and combination of these sites was also significantly increased by Fsk. However, Fsk did not modulate the activity of the C1 and C2 mutants and mutants of combined sites involving the C1 site. Three peptides of the COOH-terminal tail of alpha(1C), termed CT1 [corresponding to amino acids (aa) 1509-1789, containing sites C1-3], CT2 (aa 1778-2003, containing sites C4 and C5), and CT3 (aa 1942-2169), were constructed, and their phosphorylation by PKA was examined. CT1 and CT2, but not CT3, were phosphorylated in vitro by PKA. Three CT1 mutants at two sites of C1-C3 were also phosphorylated by PKA, but the mutant at all three sites was not. The CT2 mutant at the C4 site was phosphorylated by PKA, but the mutant at C5 sites was not. These results suggest that Ser(1574) (C1 site) may be a potential site for the channel modulation mediated by PKA.	[Minobe, Etsuko; Maeda, Sachiko; Xu, Jianjun; Hao, Liying; Kameyama, Asako; Kameyama, Masaki] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Physiol, Kagoshima 8908544, Japan; [Maeda, Sachiko] Sapporo Med Univ, Sch Med, Dept Cellular Physiol & Signal Transduct, Sapporo, Hokkaido, Japan; [Hao, Liying] China Med Univ, Sch Pharmaceut Sci, Dept Pharmaceut Toxicol, Shenyang, Peoples R China	Kameyama, M (reprint author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Physiol, Kagoshima 8908544, Japan.	kame@m.kufm.kagoshima-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [21790206, 23790251, 25460294, 19590210, 21390059]; Inamori Foundation; Kodama Memorial Foundation for Medical Research	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant Nos. 21790206, 23790251, 25460294, 19590210, and 21390059 (to E. Minobe and M. Kameyama) and a grant from the Inamori Foundation (to L. Hao) and the Kodama Memorial Foundation for Medical Research (to E. Minobe and J. Xu).	Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Nichols CB, 2010, CIRC RES, V107, P747, DOI 10.1161/CIRCRESAHA.109.216127; Fuller MD, 2014, J GEN PHYSIOL, V143, P315, DOI 10.1085/jgp.201311075; BEAN BP, 1984, NATURE, V307, P371, DOI 10.1038/307371a0; MCDONALD TF, 1994, PHYSIOL REV, V74, P365; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Fu Y, 2013, P NATL ACAD SCI USA, V110, P19621, DOI 10.1073/pnas.1319421110; Gerhardstein BL, 1999, BIOCHEMISTRY-US, V38, P10361, DOI 10.1021/bi990896o; Hofmann F, 2014, PHYSIOL REV, V94, P303, DOI 10.1152/physrev.00016.2013; Weiss S, 2013, CIRC RES, V113, P617, DOI 10.1161/CIRCRESAHA.113.301781; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Brandmayr J, 2012, J BIOL CHEM, V287, P22584, DOI 10.1074/jbc.M112.366484; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; Charnet P, 1995, BIOCHIMIE, V77, P957, DOI 10.1016/0300-9084(95)80008-5; Ding S, 1999, J BIOCHEM-TOKYO, V125, P750; Findlay I, 2002, J PHYSIOL-LONDON, V541, P741, DOI 10.1113/jphysiol.2002.019737; FRACE AM, 1993, J PHYSIOL-LONDON, V472, P305; Fu Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.175307; Fuller MD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001152; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202695.23001.e2; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; HAASE H, 1993, FEBS LETT, V335, P217, DOI 10.1016/0014-5793(93)80733-B; HARTZELL HC, 1995, J GEN PHYSIOL, V106, P393, DOI 10.1085/jgp.106.3.393; Harvey RD, 2013, J MOL CELL CARDIOL, V58, P143, DOI 10.1016/j.yjmcc.2012.12.006; Hirano Y, 1996, RECEPTOR CHANNEL, V4, P93; Jones BW, 2012, P NATL ACAD SCI USA, V109, P17099, DOI 10.1073/pnas.1215219109; Kemp TJ, 2000, CIRC RES, V87, P1095; KLOCKNER U, 1992, PFLUG ARCH EUR J PHY, V420, P413, DOI 10.1007/BF00374479; Leach RN, 1996, BBA-BIOMEMBRANES, V1281, P205, DOI 10.1016/0005-2736(96)00013-2; Lemke T, 2008, J BIOL CHEM, V283, P34738, DOI 10.1074/jbc.M804981200; Lundby A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003506; Mikala G, 1998, MOL CELL BIOCHEM, V185, P95, DOI 10.1023/A:1006878106672; Miriyala J, 2008, CIRC RES, V102, pE54, DOI 10.1161/CIRCRESAHA.108.171736; Mitarai S, 2000, AM J PHYSIOL-CELL PH, V279, pC603; Mitterdorfer J, 1996, BIOCHEMISTRY-US, V35, P9400, DOI 10.1021/bi960683o; Naguro I, 2001, FEBS LETT, V489, P87, DOI 10.1016/S0014-5793(01)02079-8; Perets T, 1996, FEBS LETT, V384, P189, DOI 10.1016/0014-5793(96)00303-1; PEREZREYES E, 1994, FEBS LETT, V342, P119, DOI 10.1016/0014-5793(94)80484-2; SCULPTOREANU A, 1993, P NATL ACAD SCI USA, V90, P10135, DOI 10.1073/pnas.90.21.10135; SINGERLAHAT D, 1994, RECEPTOR CHANNEL, V2, P215; Soldatov NM, 1997, J BIOL CHEM, V272, P3560; van der Heyden MAG, 2005, CARDIOVASC RES, V65, P28, DOI 10.1016/j.cardiores.2004.09.028; WIECHEN K, 1995, J PHYSIOL-LONDON, V484, P583; Yang L, 2013, CIRC RES, V113, P871, DOI 10.1161/CIRCRESAHA.113.301926; YOSHIDA A, 1992, FEBS LETT, V309, P343, DOI 10.1016/0014-5793(92)80804-P; ZONG XG, 1995, PFLUG ARCH EUR J PHY, V430, P340, DOI 10.1007/BF00373908	49	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6143	1522-1563		AM J PHYSIOL-CELL PH	Am. J. Physiol.-Cell Physiol.	DEC 1	2014	307	11					C999	C1009		10.1152/ajpcell.00267.2014		11	Cell Biology; Physiology	Cell Biology; Physiology	AW1BX	WOS:000346026800004		
J	Moustafa, A; Habara, Y				Moustafa, Amira; Habara, Yoshiaki			A novel role for carbon monoxide as a potent regulator of intracellular Ca2+ and nitric oxide in rat pancreatic acinar cells	AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY			English	Article						carbon monoxide; Ca2+; nitric oxide; pancreatic acinar cells	SMOOTH-MUSCLE-CELLS; SOLUBLE GUANYLATE-CYCLASE; HEME OXYGENASE; BETA-CELLS; SIGNALING MOLECULE; HYDROGEN-SULFIDE; HUMAN PLATELETS; CALCIUM-ENTRY; LUNG INJURY; EXPRESSION	Carbon monoxide (CO)is known as an essential gaseous messenger that regulates a wide array of physiological and pathological processes, similar to nitric oxide (NO) and hydrogen sulfide. The aim of the present study was to elucidate the potential role of CO in Ca2+ homeostasis and to explore the underlying mechanisms in pancreatic acinar cells. The exogenous application of a CO-releasing molecule dose-dependently increased intracellular Ca2+ concentration ([Ca2+](i)). A heme oxygenase (HO)inducer increased [Ca2+](i) in a concentration-dependent manner, and the increase was diminished by an HO inhibitor. The CO-induced [Ca2+](i) increase persisted in the absence of extracellular Ca2+, indicating that Ca2+ release is the initial source for the increase. The inhibition of G protein, phospholipase C (PLC), and inositol 1,4,5-trisphosphate (IP3) receptor diminished the COinduced [Ca2+](i) increase. CO upregulated endothelial nitric oxide synthase (eNOS) expression and stimulated NO production, and NOS inhibitor, calmodulin inhibitor, or the absence of extracellular Ca2+ eliminated the latter response. Blocking the phosphatidylinositol 3-kinase (PI3K)-Akt/protein kinase B (PKB) pathway abolished CO-induced NO production. Pretreatment with an NOS inhibitor, NO scavenger, or soluble guanylate cyclase inhibitor, did not affect the CO-induced [Ca2+](i) increase, indicating that NO, soluble guanylate cyclase, and cyclic guanosine 5'-monophosphate are not involved in the CO-induced [Ca2+](i) increase. CO inhibited the secretory responses to CCK-octapeptide or carbachol. We conclude that CO acts as a regulator not only for [Ca2+](i) homeostasis via a PLC-IP3-IP3 receptor cascade but also for NO production via the calmodulin and PI3K-Akt/PKB pathway, and both CO and NO interact. Moreover, CO may provide potential therapy to ameliorate acute pancreatitis by inhibiting amylase secretion.	[Moustafa, Amira; Habara, Yoshiaki] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Physiol Lab, Sapporo, Hokkaido 0600818, Japan; [Moustafa, Amira] Zagazig Univ, Fac Vet Med, Dept Physiol, Zagazig, Egypt	Habara, Y (reprint author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Physiol Lab, Sapporo, Hokkaido 0600818, Japan.	habara@vetmed.hokudai.ac.jp			Goho Life Science International Foundation; F3 project at Hokkaido University	This study was supported in part by Goho Life Science International Foundation and the F3 project at Hokkaido University.	ALVAREZ J, 1992, FASEB J, V6, P786; Ang AD, 2009, PANCREATOLOGY, V9, P150, DOI 10.1159/000178886; Suliman HB, 2007, J CELL SCI, V120, P299, DOI 10.1242/jcs.03318; Deshane J, 2005, ACTA BIOCHIM POL, V52, P273; UTZ J, 1991, BIOCHEM PHARMACOL, V41, P1195, DOI 10.1016/0006-2952(91)90658-R; Wang JY, 2009, J CELL PHYSIOL, V219, P617, DOI 10.1002/jcp.21711; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Fujita T, 2001, NAT MED, V7, P598, DOI 10.1038/87929; Leffler CW, 2011, AM J PHYSIOL-HEART C, V301, pH1, DOI 10.1152/ajpheart.00230.2011; DiMagno MJ, 2004, AM J PHYSIOL-GASTR L, V287, pG80, DOI 10.1152/ajpgi.00525.2003; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; KHARITONOV VG, 1995, P NATL ACAD SCI USA, V92, P2568, DOI 10.1073/pnas.92.7.2568; Xue J, 2014, J CLIN INVEST, V124, P437, DOI 10.1172/JCI71362; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x; Zhang XC, 2005, J BIOL CHEM, V280, P8714, DOI 10.1074/jbc.M408092200; Montezano AC, 2012, BASIC CLIN PHARMACOL, V110, P87, DOI 10.1111/j.1742-7843.2011.00785.x; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Stasch Johannes-Peter, 2009, V191, P277; Marazioti A, 2011, ARTERIOSCL THROM VAS, V31, P2570, DOI 10.1161/ATVBAHA.111.229039; Foresti R, 1999, FREE RADICAL RES, V31, P459, DOI 10.1080/10715769900301031; Gunther L, 2002, DIABETES, V51, P994, DOI 10.2337/diabetes.51.4.994; Nakamichi I, 2005, J CLIN INVEST, V115, P3007, DOI 10.1172/JCI24912; WEBER CM, 1994, J NEUROCHEM, V63, P953; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Thorup C, 1999, AM J PHYSIOL-RENAL, V277, pF882; Moustafa A, 2011, NITRIC OXIDE-BIOL CH, V24, P139, DOI 10.1016/j.niox.2011.02.001; Ndisang JF, 2009, J CARD FAIL, V15, P616, DOI 10.1016/j.cardfail.2009.02.003; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Moustafa A, 2014, ANTIOXID REDOX SIGN, V20, P747, DOI 10.1089/ars.2012.5108; BRUNE B, 1987, MOL PHARMACOL, V32, P497; Kim HS, 2008, AM J PHYSIOL-GASTR L, V295, pG146, DOI 10.1152/ajpgi.00105.2007; Wang R, 1997, J BIOL CHEM, V272, P8222; Leiria LO, 2013, J PHYSIOL-LONDON, V591, P2259, DOI 10.1113/jphysiol.2013.251843; Boehning D, 2004, J BIOL CHEM, V279, P30927, DOI 10.1074/jbc.C400222200; Bruce JIE, 2000, BRIT J PHARMACOL, V131, P761, DOI 10.1038/sj.bjp.0703631; CHRIST M, 1995, BIOCHEM BIOPH RES CO, V213, P123, DOI 10.1006/bbrc.1995.2106; Christova T, 2000, Acta Physiol Pharmacol Bulg, V25, P9; Dulak J, 2003, ACTA BIOCHIM POL, V50, P31; Fu K, 1997, AM J PHYSIOL-GASTR L, V273, pG696; Fujimoto H, 2004, ARTERIOSCL THROM VAS, V24, P1848, DOI 10.1161/01.ATV.0000142365.85911.0e; Gende OA, 2004, THROMB RES, V114, P113, DOI 10.1016/j.thromres.2004.04.015; Gilchrist M, 2004, BLOOD, V104, P462, DOI 10.1182/blood-2003-08-2990; Gobeil F, 2006, J BIOL CHEM, V281, P16058, DOI 10.1074/jbc.M602219200; HABARA Y, 1994, GEN PHARMACOL, V25, P843, DOI 10.1016/0306-3623(94)90085-X; HABARA Y, 1989, J PHYSIOL-LONDON, V414, P73; HABARA Y, 1991, CELL CALCIUM, V12, P533, DOI 10.1016/0143-4160(91)90073-N; Henningsson R, 1999, DIABETES, V48, P66, DOI 10.2337/diabetes.48.1.66; Henningsson R, 2001, AM J PHYSIOL-CELL PH, V280, pC1242; Ingi T, 1996, NEURON, V16, P835, DOI 10.1016/S0896-6273(00)80103-8; Kajimura M, 2003, FASEB J, V17, P506, DOI 10.1096/fj.02-0359fje; Kim HJ, 2013, OXID MED CELL LONGEV, DOI 10.1155/2013/306421; Koneru P, 2004, AM J PHYSIOL-HEART C, V286, pH304, DOI 10.1152/ajpheart.00810.2003; Konig P, 2002, GASTROENTEROLOGY, V123, P314, DOI 10.1053/gast.2002.34212; Li XQ, 2000, MOL BRAIN RES, V75, P179, DOI 10.1016/S0169-328X(99)00254-5; Lim I, 2005, AM J PHYSIOL-GASTR L, V288, pG7, DOI 10.1152/ajpgi.00205.2004; Lundquist I, 2003, AM J PHYSIOL-ENDOC M, V285, pE1055, DOI 10.1152/ajpendo.00498.2002; Ndisang Joseph Fomusi, 2007, Int J Angiol, V16, P92; Peers C, 2012, J MOL CELL CARDIOL, V52, P359, DOI 10.1016/j.yjmcc.2011.05.013; Roy S, 2011, BIOL TRACE ELEM RES, V144, P1095, DOI 10.1007/s12011-011-9139-1; SARGEANT P, 1992, CELL CALCIUM, V13, P553, DOI 10.1016/0143-4160(92)90035-Q; Sato H, 1997, FEBS LETT, V405, P219, DOI 10.1016/S0014-5793(97)00191-9; Strandell E, 1995, IMMUNOL LETT, V48, P145, DOI 10.1016/0165-2478(95)02459-X; Tronel C, 2013, OXIDATIVE MED CELLUL, V2013, P1, DOI DOI 10.1155/2013/264935; Tschugguel W, 2001, J CLIN ENDOCR METAB, V86, P3833, DOI 10.1210/jc.86.8.3833; Xi Q, 2004, AM J PHYSIOL-HEART C, V286, pH610, DOI 10.1152/ajpheart.00782.2003; Xi Q, 2010, AM J PHYSIOL-HEART C, V298, pH562, DOI 10.1152/ajpheart.00823.2009; Ye J, 1998, ENDOCRINOLOGY, V139, P4155, DOI 10.1210/en.139.10.4155	68	2	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6143	1522-1563		AM J PHYSIOL-CELL PH	Am. J. Physiol.-Cell Physiol.	DEC 1	2014	307	11					C1039	C1049		10.1152/ajpcell.00252.2014		11	Cell Biology; Physiology	Cell Biology; Physiology	AW1BX	WOS:000346026800008		
J	Nakayama, K; Watanabe, K; Boonvisut, S; Makishima, S; Miyashita, H; Iwamoto, S				Nakayama, Kazuhiro; Watanabe, Kazuhisa; Boonvisut, Supichaya; Makishima, Saho; Miyashita, Hiroshi; Iwamoto, Sadahiko			Common variants of GIP are associated with visceral fat accumulation in Japanese adults	AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY			English	Article						glucose-dependent insulinotropic polypeptide; glucose-dependent insulinotropic polypeptide receptor; single nucleotide polymorphism	BODY-MASS INDEX; INSULIN-RESISTANCE; GENETIC-VARIATION; GLUCOSE-INTOLERANCE; ENTEROINSULAR AXIS; POSTPRANDIAL GIP; OBESITY; MICE; ACID; DISTURBANCES	Animal studies have demonstrated that glucose-dependent insulinotropic polypeptide (GIP) and GIP receptor (GIPR) contribute to the etiology of obesity. In humans, genomewide association studies have identified single nucleotide polymorphisms (SNPs) in the GIPR gene that are strongly associated with body mass index (BMI); however, it is not clear whether genetic variations in the GIP gene are involved in the development of obesity. In the current study, we assessed the impact of GIP SNPs on obesity-related traits in Japanese adults. Six tag SNPs were tested for associations with obesity-related traits in 3,013 individuals. Multiple linear regression analyses showed that rs9904288, located at the 3'-end of GIP, was significantly associated with visceral fat area (VFA). Moreover, rs1390154 and rs4794008 showed significant associations with plasma triglyceride levels and hemoglobin A(lc) levels, respectively. Among the significant SNPs, rs9904288 and rs1390154 were independently linked with SNPs in active enhancers of the duodenum mucosa, the main GIP-secreting tissue. The haplotypes of these two SNPs exhibited stronger associations with VFA. Numbers of VFA-increasing alleles of rs9904288 and BMI-increasing alleles of previously identified GIPR SNPs showed a strong additive effect on VFA, waist circumference, and BMI in the subject population. These novel results support the notion that the GIP-GIPR axis plays a role in the etiology of central obesity in humans, which is characterized by the accumulation of visceral fat.	[Nakayama, Kazuhiro; Watanabe, Kazuhisa; Boonvisut, Supichaya; Makishima, Saho; Iwamoto, Sadahiko] Jichi Med Univ, Ctr Mol Med, Div Human Genet, Shimotsuke, Tochigi 3290498, Japan; [Miyashita, Hiroshi] Jichi Med Univ, Hlth Care Ctr, Shimotsuke, Tochigi 3290498, Japan	Nakayama, K (reprint author), Jichi Med Univ, Ctr Mol Med, Div Human Genet, Shimotsuke, Tochigi 3290498, Japan.	nakayama@jichi.ac.jp			MEXT KAKENHI [25291103, 26291096]	This study was supported in part by MEXT KAKENHI, Grant Nos. 25291103 and 26291096 (K. Nakayama).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Hansotia T, 2004, DIABETES, V53, P1326, DOI 10.2337/diabetes.53.5.1326; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Matsuzawa Y, 2011, J ATHEROSCLER THROMB, V18, P629; Shimotoyodome A, 2010, AM J PHYSIOL-ENDOC M, V298, pE652, DOI 10.1152/ajpendo.00468.2009; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chang CL, 2011, GENOME RES, V21, P21, DOI 10.1101/gr.110593.110; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Gault VA, 2007, DIABETOLOGIA, V50, P1752, DOI 10.1007/s00125-007-0710-4; Fujita Y, 2010, GASTROENTEROLOGY, V138, P1966, DOI 10.1053/j.gastro.2010.01.049; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Ryo M, 2005, DIABETES CARE, V28, P451, DOI 10.2337/diacare.28.2.451; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Miyawaki K, 1999, P NATL ACAD SCI USA, V96, P14843, DOI 10.1073/pnas.96.26.14843; Narita T, 2012, DIABETES OBES METAB, V14, P283, DOI 10.1111/j.1463-1326.2011.01526.x; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Musso G, 2009, AM J CLIN NUTR, V89, P558, DOI 10.3945/ajcn.2008.26720; McClean PL, 2007, AM J PHYSIOL-ENDOC M, V293, pE1746, DOI 10.1152/ajpendo.00460.2007; Fall T, 2014, MOL CELL ENDOCRINOL, V382, P740, DOI 10.1016/j.mce.2012.08.018; Alssema M, 2013, EUR J ENDOCRINOL, V169, P421, DOI 10.1530/EJE-13-0487; Ceperuelo-Mallafre V, 2014, J CLIN ENDOCR METAB, V99, pE908, DOI 10.1210/jc.2013-3350; Chang CL, 2011, DIABETES, V60, P726, DOI 10.2337/db10-1331; Cheung AT, 2000, SCIENCE, V290, P1959, DOI 10.1126/science.290.5498.1959; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002695; Nakayama K, 2013, HUM GENET, V132, P201, DOI 10.1007/s00439-012-1240-9; Qi QB, 2012, AM J CLIN NUTR, V95, P506, DOI 10.3945/ajcn.111.025270; Rudovich Natalia, 2007, Regul Pept, V142, P138, DOI 10.1016/j.regpep.2007.02.006; Shimotoyodome A, 2012, AM J PHYSIOL-GASTR L, V303, pG298, DOI 10.1152/ajpgi.00457.2011; Sugunan D, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-118; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Torekov SS, 2014, J CLIN ENDOCR METAB, V99, pE729, DOI 10.1210/jc.2013-3766; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Yamada C, 2007, BIOCHEM BIOPH RES CO, V364, P175, DOI 10.1016/j.bbrc.2007.09.128; Yeung CM, 1999, MOL CELL ENDOCRINOL, V154, P161, DOI 10.1016/S0303-7207(99)00106-9	34	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1857	1522-1547		AM J PHYSIOL-GASTR L	Am. J. Physiol.-Gastroint. Liver Physiol.	DEC 1	2014	307	11					G1108	G1114		10.1152/ajpgi.00282.2014		7	Gastroenterology & Hepatology; Physiology	Gastroenterology & Hepatology; Physiology	AW1DG	WOS:000346030200007		
J	Hodatsu, A; Konno, T; Hayashi, K; Funada, A; Fujita, T; Nagata, Y; Fujino, N; Kawashiri, M; Yamagishi, M				Hodatsu, Akihiko; Konno, Tetsuo; Hayashi, Kenshi; Funada, Akira; Fujita, Takashi; Nagata, Yoji; Fujino, Noboru; Kawashiri, Masa-aki; Yamagishi, Masakazu			Compound heterozygosity deteriorates phenotypes of hypertrophic cardiomyopathy with founder MYBPC3 mutation: evidence from patients and zebrafish models	AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY			English	Article						compound heterozygotes; hypertrophic cardiomyopathy; myosin-binding protein C; cardiac remodeling	BINDING-PROTEIN-C; MYOSIN HEAVY-CHAIN; CARDIAC TROPONIN-T; JAPANESE PATIENTS; GENE-MUTATIONS; MISSENSE MUTATION; DELETION MUTATION; DIAGNOSIS; DYSFUNCTION; HAPLOINSUFFICIENCY	Although most founder mutation carriers of hypertrophic cardiomyopathy (HCM), such as the cardiac myosin-binding protein C gene (MYBPC3), arose from a common ancestor exhibit favorable clinical phenotypes, there still remain small fractions of these carriers associated with increased cardiovascular events. However, few data exist regarding the defining factors that modify phenotypes of these patients, particularly in terms of multiple gene mutations. Therefore, we assessed genotype-phenotype correlations and investigated factors that contribute to phenotypic diversities of mutation carriers from 488 unrelated HCM probands. A prevalent founder mutation (Val762Asp) in MYBPC3 was identified in 33 subjects from 19 families. Among them, 28 carriers harbored an isolated Val762Asp mutation and exhibited a late onset of overt HCM compared with other MYBPC3 mutation carriers (62.8 +/- 3.0 vs 50.1 +/- 2.6 yr, P < 0.05). In contrast, the remaining five carriers had additional sarcomere gene mutations (3 carriers in MYBPC3 and 2 carriers in the cardiac troponin T gene). Of these five carriers, two carriers showed early disease onset and one carrier exhibited end-stage HCM. These phenotypes were recapitulated in zebrafish models; injection of MYBPC3 Val762Asp alone did not alter ventricular size or function, but ventricular dimension was significantly increased when MYBPC3 Val762Asp mRNA was coinjected with MYBPC3 Arg820Gln mRNA. These results demonstrate that MYBPC3 Val762Asp may be associated with unfavorable HCM phenotypes in some cases when combined with another MYBPC3 mutation.	[Hodatsu, Akihiko; Konno, Tetsuo; Hayashi, Kenshi; Funada, Akira; Fujita, Takashi; Nagata, Yoji; Fujino, Noboru; Kawashiri, Masa-aki; Yamagishi, Masakazu] Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, Kanazawa, Ishikawa 9208641, Japan; [Konno, Tetsuo] Kanazawa Univ, Res & Educ Ctr Innovat & Prevent Med, Kanazawa, Ishikawa 9208641, Japan	Yamagishi, M (reprint author), Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	myamagi@med.m.kanazawa-u.ac.jp			Japan Society for the Promotion of Science KAKENHI [25860589, 24790748]	This work was supported by Japan Society for the Promotion of Science KAKENHI Grants 25860589 and 24790748.	Alpert NR, 2005, AM J PHYSIOL-HEART C, V288, pH1097, DOI 10.1152/ajpheart.00650.2004; ANAN R, 1994, J CLIN INVEST, V93, P280, DOI 10.1172/JCI116957; Fujino N, 2013, CLIN CARDIOL, V36, P160, DOI 10.1002/clc.22082; Saltzman AJ, 2010, CIRC RES, V106, P1549, DOI 10.1161/CIRCRESAHA.109.216291; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Marston S, 2009, CIRC RES, V105, P219, DOI 10.1161/CIRCRESAHA.109.202440; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Otsuka H, 2012, CIRC J, V76, P453, DOI 10.1253/circj.CJ-11-0876; Kubo T, 2011, CIRC J, V75, P2654, DOI 10.1253/circj.CJ-10-1314; Girolami F, 2006, J CARDIOVASC MED, V7, P601; Seguchi O, 2007, J CLIN INVEST, V117, P2812, DOI 10.1172/JCI30804; Jaaskelainen P, 2004, ANN MED, V36, P23, DOI 10.1080/07853890310017161; Reed GH, 2004, CLIN CHEM, V50, P1748, DOI 10.1373/clinchem.2003.029751; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; Girolami F, 2010, J AM COLL CARDIOL, V55, P1444, DOI 10.1016/j.jacc.2009.11.062; Alders M, 2003, EUR HEART J, V24, P1848, DOI 10.1016/S0195-668X(03)00466-4; Richard P, 1999, J MED GENET, V36, P542; Kubo T, 2005, J AM COLL CARDIOL, V46, P1737, DOI 10.1016/j.jacc.2005.05.087; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; Carrier L, 1997, CIRC RES, V80, P427; Ingles J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033886; Simonetti OP, 2001, RADIOLOGY, V218, P215; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; Jou CJ, 2013, CIRC RES, V112, P826, DOI 10.1161/CIRCRESAHA.112.300664; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Lopes LR, 2013, HEART, V99, P1800, DOI 10.1136/heartjnl-2013-303939; Michels M, 2009, JACC-CARDIOVASC IMAG, V2, P58, DOI 10.1016/j.jcmg.2008.08.003; Anan R, 1998, CIRCULATION, V98, P391; Argulian E, 2013, AM J CARDIOL, V111, P1040, DOI 10.1016/j.amjcard.2012.12.026; Chen YH, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000231; GROMPE M, 1993, NAT GENET, V5, P111, DOI 10.1038/ng1093-111; Ho CY, 2000, CIRCULATION, V102, P1950; Kawashiri M, 2014, HEART VESSELS, V29, P129, DOI 10.1007/s00380-013-0391-5; Konno T, 2003, J AM COLL CARDIOL, V41, P781, DOI 10.1016/S0735-1097(02)02957-1; Konno T, 2006, CLIN SCI, V110, P125, DOI 10.1042/CS20050189; Konno T, 2007, CLIN SCI, V112, P577, DOI 10.1042/CS20060293; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; MARON BJ, 1995, CIRCULATION, V92, P785; Moolman-Smook JC, 1999, AM J HUM GENET, V65, P1308, DOI 10.1086/302623; NAKAJIMATANIGUCHI C, 1995, J MOL CELL CARDIOL, V27, P2607, DOI 10.1006/jmcc.1995.0047; Richard P, 2000, J MOL CELL CARDIOL, V32, P1575, DOI 10.1006/jmcc.2000.1193; Wang LB, 2010, ANN INTERN MED, V152, P513, DOI 10.7326/0003-4819-152-8-201004200-00008; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603	45	1	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6135	1522-1539		AM J PHYSIOL-HEART C	Am. J. Physiol.-Heart Circul. Physiol.	DEC 1	2014	307	11					H1594	H1604		10.1152/ajpheart.00637.2013		11	Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Physiology	AW0ZM	WOS:000346019900007		
J	Kato, R; Nomura, A; Sakamoto, A; Yasuda, Y; Amatani, K; Nagai, S; Sen, Y; Ijiri, Y; Okada, Y; Yamaguchi, T; Izumi, Y; Yoshiyama, M; Tanaka, K; Hayashi, T				Kato, Ryuji; Nomura, Atsuo; Sakamoto, Aiji; Yasuda, Yuki; Amatani, Koyuha; Nagai, Sayuri; Sen, Yoko; Ijiri, Yoshio; Okada, Yoshikatsu; Yamaguchi, Takehiro; Izumi, Yasukatsu; Yoshiyama, Minoru; Tanaka, Kazuhiko; Hayashi, Tetsuya			Hydrogen gas attenuates embryonic gene expression and prevents left ventricular remodeling induced by intermittent hypoxia in cardiomyopathic hamsters	AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY			English	Article						heart failure; intermittent hypoxia; oxidative stress; cardiomyopathic hamster; hydrogen gas	OBSTRUCTIVE SLEEP-APNEA; NF-KAPPA-B; REDUCES OXIDATIVE STRESS; HEART-FAILURE; THERAPEUTIC ANTIOXIDANT; OXYGEN RADICALS; RAT-HEART; MICE; AP-1; DYSFUNCTION	The prevalence of sleep apnea is very high in patients with heart failure (HF). The aims of this study were to investigate the influence of intermittent hypoxia (IH) on the failing heart and to evaluate the antioxidant effect of hydrogen gas. Normal male Syrian hamsters (n = 22) and cardiomyopathic (CM) hamsters (n = 33) were exposed to IH (repeated cycles of 1.5 min of 5% oxygen and 5 min of 21% oxygen for 8 h during the daytime) or normoxia for 14 days. Hydrogen gas (3.05 vol/100 vol) was inhaled by some CM hamsters during hypoxia. IH increased the ratio of early diastolic mitral inflow velocity to mitral annulus velocity (E/e', 21.8 vs. 16.9) but did not affect the LV ejection fraction (EF) in normal Syrian hamsters. However, IH increased E/e' (29.4 vs. 21.5) and significantly decreased the EF (37.2 vs. 47.2%) in CM hamsters. IH also increased the cardiomyocyte cross-sectional area (672 vs. 443 mu m(2)) and interstitial fibrosis (29.9 vs. 9.6%), along with elevation of oxidative stress and superoxide production in the left ventricular (LV) myocardium. Furthermore, IH significantly increased the expression of brain natriuretic peptide, beta-myosin heavy chain, c-fos, and c-jun mRNA in CM hamsters. Hydrogen gas inhalation significantly decreased both oxidative stress and embryonic gene expression, thus preserving cardiac function in CM hamsters. In conclusion, IH accelerated LV remodeling in CM hamsters, at least partly by increasing oxidative stress in the failing heart. These findings might explain the poor prognosis of patients with HF and sleep apnea.	[Kato, Ryuji; Nomura, Atsuo; Yasuda, Yuki; Amatani, Koyuha; Nagai, Sayuri; Sen, Yoko; Ijiri, Yoshio; Tanaka, Kazuhiko; Hayashi, Tetsuya] Osaka Univ Pharmaceut Sci, Lab Cardiovasc Pharmacotherapy & Toxicol, Takatsuki, Osaka 5691094, Japan; [Sakamoto, Aiji] Natl Cerebral & Cardiovasc Ctr, Lab Vasc Biol, Suita, Osaka, Japan; [Okada, Yoshikatsu] Osaka Med Coll, Dept Pathol, Takatsuki, Osaka 569, Japan; [Yamaguchi, Takehiro; Yoshiyama, Minoru] Osaka City Univ, Grad Sch Med, Dept Cardiovasc Med, Osaka 558, Japan; [Izumi, Yasukatsu] Osaka City Univ, Grad Sch Med, Dept Pharmacol, Osaka 558, Japan	Hayashi, T (reprint author), Osaka Univ Pharmaceut Sci, Lab Cardiovasc Pharmacotherapy & Toxicol, 4-20-1 Nasahara, Takatsuki, Osaka 5691094, Japan.	hayashi@gly.oups.ac.jp			Vehicle Racing Commemorative Foundation; Japanese Ministry of Education, Culture, Sports, Science and Technology (Kakenhi) [23590267]	This work was supported in part by the Vehicle Racing Commemorative Foundation and by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology Grant-in-Aid 23590267 (Kakenhi).	Ip MSM, 2004, AM J RESP CRIT CARE, V169, P348, DOI 10.1164/rccm.200306.767OC; Hastings PC, 2010, INT J CARDIOL, V139, P17, DOI 10.1016/j.ijcard.2008.08.022; Williams AL, 2010, SLEEP BREATH, V14, P51, DOI 10.1007/s11325-009-0279-x; Hayashi T, 2011, AM J PHYSIOL-HEART C, V301, pH1062, DOI 10.1152/ajpheart.00150.2011; HAYASHI T, 1995, AM HEART J, V129, P946, DOI 10.1016/0002-8703(95)90116-7; Lattimore JDL, 2003, J AM COLL CARDIOL, V41, P1429, DOI 10.1016/S0735-1097/(03)00184-0; Inamoto S, 2010, HYPERTENS RES, V33, P579, DOI 10.1038/hr.2010.36; Arias MA, 2005, CIRCULATION, V112, P375, DOI 10.1161/CIRCULATIONAHA.104.501841; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Duran JM, 2014, CIRC RES, V114, P1700, DOI 10.1161/CIRCRESAHA.114.303200; Roberts CK, 2009, LIFE SCI, V84, P705, DOI 10.1016/j.lfs.2009.02.026; Shen GX, 2005, ANTIOXID REDOX SIGN, V7, P1648, DOI 10.1089/ars.2005.7.1648; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Yoshiyama M, 1998, CARDIOVASC DRUG THER, V12, P57, DOI 10.1023/A:1007789519005; Kasai T, 2012, J CARDIOL, V60, P78, DOI 10.1016/j.jjcc.2012.05.013; Maeda H, 2013, BBA-MOL BASIS DIS, V1832, P1159, DOI 10.1016/j.bbadis.2013.02.014; Chen L, 2005, AM J RESP CRIT CARE, V172, P915, DOI 10.1164/rccm.200504-5600C; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Hsu TC, 2000, FREE RADICAL BIO MED, V28, P1338, DOI 10.1016/S0891-5849(00)00220-3; Yamashita C, 2007, HYPERTENS RES, V30, P1219, DOI 10.1291/hypres.30.1219; Baguet JP, 2006, J HYPERTENS, V24, P205, DOI 10.1097/01.hjh.0000198039.39504.63; Blanchette J, 2009, IMMUNOLOGY, V127, P123, DOI 10.1111/j.1365-2567.2008.02929.x; Chen L, 2008, J APPL PHYSIOL, V104, P218, DOI 10.1152/japplphysiol.00301.2007; CHRISTL SU, 1992, GASTROENTEROLOGY, V102, P1269; Fan HY, 2002, AM J PHYSIOL-HEART C, V282, pH1778, DOI 10.1152/ajpheart.00796.2000; Javaheri S, 2011, PRINCIPLES PRACTICES, P1400; Nadruz W, 2004, AM J PHYSIOL-HEART C, V286, pH760, DOI 10.1152/ajpheart.00430.2003; Nakao A, 2009, J CLIN BIOCHEM NUTR, V44, P1, DOI 10.3164/jcbn.08-193R; Ohta S, 2014, PHARMACOL THERAPEUT, V144, P1, DOI 10.1016/j.pharmthera.2014.04.006; Okuda N, 2007, CHEST, V131, P1082, DOI 10.1378/chest.06-2444; PARTINEN M, 1990, CHEST, V97, P27, DOI 10.1378/chest.97.1.27; Sakamoto A, 1999, FEBS LETT, V447, P124, DOI 10.1016/S0014-5793(99)00267-7; Sakamoto A, 2011, MOL CELL BIOCHEM, V353, P275, DOI 10.1007/s11010-011-0796-3; Vatta M, 2009, J CARDIOVASC MED, V10, P149, DOI 10.2459/JCM.0b013e328318954c	34	2	2	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0363-6135	1522-1539		AM J PHYSIOL-HEART C	Am. J. Physiol.-Heart Circul. Physiol.	DEC 1	2014	307	11					H1626	H1633		10.1152/ajpheart.00228.2014		8	Cardiac & Cardiovascular Systems; Physiology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Physiology	AW0ZM	WOS:000346019900010		
J	Khazaka, R; Inoue, Y				Khazaka, Roni; Inoue, Yasuaki			Introduction to the special issue on "High performance analog circuits and design methodologies"	ANALOG INTEGRATED CIRCUITS AND SIGNAL PROCESSING			English	Editorial Material									[Khazaka, Roni] McGill Univ, AVIC 2013, Montreal, PQ, Canada; [Inoue, Yasuaki] Waseda Univ, AVIC 2013, Kitakyushu, Fukuoka, Japan	Inoue, Y (reprint author), Waseda Univ, AVIC 2013, Kitakyushu, Fukuoka, Japan.	roni.khazaka@mcgill.ca; inoue_yasuaki@waseda.jp						0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-1030	1573-1979		ANALOG INTEGR CIRC S	Analog Integr. Circuits Process.	DEC	2014	81	3			SI		549	550		10.1007/s10470-014-0425-7		2	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	AU8JJ	WOS:000345842200001		
J	Saeki, K; Nihei, D; Tatebe, T; Sekine, Y				Saeki, Katsutoshi; Nihei, Daisuke; Tatebe, Tatsuya; Sekine, Yoshifumi			IC implementation of an interstitial cell-based CPG model	ANALOG INTEGRATED CIRCUITS AND SIGNAL PROCESSING			English	Article						Central pattern generator; Pulse-type hardware neuron model; Interstitial cells model; Integrated circuit; CMOS	CMOS IMPLEMENTATION; LOCOMOTION; GAIT	It is well known that quadruped locomotion patterns are generated by central pattern generators (CPGs) residing within central nervous system interstitial cells. Based on this fact, many investigators have used CPG models to develop control adaptations in robots. Previously, the authors proposed a CPG model that generates and controls quadruped locomotion through single-pulse external inputs. However, in this model, a large capacitance was necessary for generating 1-10 Hz robot control patterns. In this paper, we suggest a CPG model in which swing and stance patterns produced by interstitial cells generate low-frequency patterns through a low-capacitance 0.18 mu m CMOS process. It is demonstrated that this model method can generate five basic quadruped locomotion patterns (walk, pace, trot, bound, and gallop) at a frequency suitable for controlling a quadruped locomotion robot.	[Saeki, Katsutoshi; Nihei, Daisuke; Tatebe, Tatsuya; Sekine, Yoshifumi] Nihon Univ, Coll Sci & Technol, Funabashi, Chiba 2748501, Japan	Saeki, K (reprint author), Nihon Univ, Coll Sci & Technol, 7-24-1 Narashinodai, Funabashi, Chiba 2748501, Japan.	ksaeki@ecs.cst.nihon-u.ac.jp			MEXT [25420344]; STARC; VLSI Design and Education Center (VDEC), the University of Tokyo; Cadence Design Systems, Inc.	This work has been supported in part by the MEXT Grant-in-Aid #25420344 and STARC. Furthermore, this work has been supported in part by the VLSI Design and Education Center (VDEC), the University of Tokyo in collaboration with Cadence Design Systems, Inc.	HOYT DF, 1981, NATURE, V292, P239, DOI 10.1038/292239a0; Kier RJ, 2006, IEEE T NEURAL NETWOR, V17, P1025, DOI 10.1109/TNN.2006.875983; Takakusaki K, 2008, ADV ROBOTICS, V22, P1629, DOI 10.1163/156855308X368958; PRIDMORE PA, 1992, J MORPHOL, V211, P137, DOI 10.1002/jmor.1052110203; MATSUOKA K, 1985, BIOL CYBERN, V52, P367, DOI 10.1007/BF00449593; TAGA G, 1995, BIOL CYBERN, V73, P97, DOI 10.1007/BF00204048; Arena P., 2006, CELL NEUR NETW THEIR, P1; Fukuoka Y., 2007, J ROBOTICS SOC JAPAN, V25, P138; Hasan SMR., 2007, INT C MICR, P155; Kharb A, 2011, IJCEM INT J COMPUTAT, V13, P78; Nakada K, 2005, IEEE IJCNN, P639; Nakada K, 2005, IEEE T CIRCUITS-I, V52, P1095, DOI 10.1109/TCSI.2005.849120; Nakada K., 2004, IEICE T NLP, V104, P1; Saeki K., 2005, IEEJ TECHN M EL CIRC, P41; Saeki K., 2008, IEICE T FUND ELECTR, V15, P27; Ito S., 1996, Transactions of the Society of Instrument and Control Engineers, V32; Takemura H., 2004, JRSJ, V22, P528; Yang ZJ, 2012, IEEE T NEUR NET LEAR, V23, P373, DOI 10.1109/TNNLS.2011.2177859	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-1030	1573-1979		ANALOG INTEGR CIRC S	Analog Integr. Circuits Process.	DEC	2014	81	3			SI		551	559		10.1007/s10470-014-0349-2		9	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	AU8JJ	WOS:000345842200002		
J	Okazawa, T; Akita, I; Ishida, M				Okazawa, Takayuki; Akita, Ippei; Ishida, Makoto			A digitally calibrated dynamic comparator using time-domain offset detection	ANALOG INTEGRATED CIRCUITS AND SIGNAL PROCESSING			English	Article						Comparator; Offset voltage; Calibration; Metastable; Time-to-digital converter	NOISE	This paper presents a self-calibrating dynamic latched comparator that does not require additional static current or load capacitors to reduce its offset voltage. The proposed comparator uses a reconfigurable differential pair at the input stage; the configuration is determined by a digital calibration scheme that automatically matches the differential pair, resulting in a low offset voltage. We present a novel time-domain offset detection technique in the calibration loop, which is based on measuring the metastable time of the comparator. The offset detector uses a ring time-to-digital converter with a simple time amplifier. The proposed comparator was fabricated with standard 180 nm CMOS technology; it achieves a standard deviation of 1.3 mV offset voltage and power consumption with a power supply of 1.5 V.	[Okazawa, Takayuki; Akita, Ippei; Ishida, Makoto] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan; [Ishida, Makoto] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst EIIRIS, Toyohashi, Aichi 4418580, Japan	Akita, I (reprint author), Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan.	ippei.akita@ieee.org			MEXT [25820141, 25249047]; CA-SIO Science Promotion Foundation	This work was supported in part by MEXT Grant-in-Aid for Scientific Research 25820141, 25249047 and by CA-SIO Science Promotion Foundation. We also thank Rohm Corp. and Toppan Printing Corp. with the VLSI Design and Education Center (VDEC), the University of Tokyo, for chip fabrication.	Akita I., 2013, IEEE INT SOL STAT CI, P178, DOI 10.1109/ISSCC.2013.6487689; Staszewski RB, 2005, IEEE J SOLID-ST CIRC, V40, P2469, DOI 10.1109/JSSC.2005.857417; Miyahara M, 2008, IEEE ASIAN SOLID STA, P269, DOI 10.1109/ASSCC.2008.4708780; Yip M, 2013, IEEE J SOLID-ST CIRC, V48, P1453, DOI 10.1109/JSSC.2013.2254551; Hajimiri A, 1999, IEEE J SOLID-ST CIRC, V34, P790, DOI 10.1109/4.766813; Straayer MZ, 2009, IEEE J SOLID-ST CIRC, V44, P1089, DOI 10.1109/JSSC.2009.2014709; Johns D.A., 2008, ANALOG INTEGRATED CI; Kinget PR, 2005, IEEE J SOLID-ST CIRC, V40, P1212, DOI 10.1109/JSSC.2005.848021; Matsuzawa A, 2009, 2009 IEEE 8TH INTERNATIONAL CONFERENCE ON ASIC, VOLS 1 AND 2, PROCEEDINGS, P218, DOI 10.1109/ASICON.2009.5351489; Paik D., 2011, IEEE 9 INT C ASIC AS, P461; Weigandt T. C., 1994, IEEE INT S CIRC SYST, V4, P27	11	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-1030	1573-1979		ANALOG INTEGR CIRC S	Analog Integr. Circuits Process.	DEC	2014	81	3			SI		561	570		10.1007/s10470-014-0410-1		10	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	AU8JJ	WOS:000345842200003		
J	Akita, I; Ishida, M				Akita, Ippei; Ishida, Makoto			A chopper-stabilized instrumentation amplifier using area-efficient self-trimming technique	ANALOG INTEGRATED CIRCUITS AND SIGNAL PROCESSING			English	Article						Instrumentation amplifier; Chopper stabilization; Digital assist; Self-trimming; Reconfigurable differential pair	OPERATIONAL-AMPLIFIER; MU-W; CMOS; FEEDBACK; DESIGN; FILTER; MM(2)	An area-efficient self-trimming technique for precision chopper-stabilized instrumentation amplifier (IA) is presented. The amplifier uses a reconfigurable differential pair for the input stage and it is automatically configured to reduce the mismatch of the differential pair, suppressing the chopper ripple. To confirm the effectiveness of the proposed scheme, an IA with the complete calibration logic is fabricated in a standard 180-nm CMOS and achieves active area, less than offset voltage, input-referred noise, and current consumption. The noise efficiency factor of the amplifier is 7.2.	[Akita, Ippei; Ishida, Makoto] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan; [Ishida, Makoto] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst EIIRIS, Toyohashi, Aichi 4418580, Japan	Akita, I (reprint author), Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan.	ippei.akita@ieee.org			MEXT [25820141, 25249047]; CASIO Science Promotion Foundation	This work was supported in part by MEXT Grant-in-Aid for Scientific Research 25820141, 25249047, and by CASIO Science Promotion Foundation. We thank also Rohm Corp. and Toppan Printing Corp. through the VLSI Design and Education Center (VDEC), the University of Tokyo, for chip fabrication.	Akita I., 2013, IEEE INT SOL STAT CI, P178, DOI 10.1109/ISSCC.2013.6487689; Akita I, 2009, IEEE J SOLID-ST CIRC, V44, P2790, DOI 10.1109/JSSC.2009.2028049; Akita I, 2011, IEEE T CIRCUITS-II, V58, P724, DOI 10.1109/TCSII.2011.2168013; Enz CC, 1996, P IEEE, V84, P1584, DOI 10.1109/5.542410; STEYAERT MSJ, 1987, IEEE J SOLID-ST CIRC, V22, P1163, DOI 10.1109/JSSC.1987.1052869; Guo S, 2009, IEEE T CIRCUITS-II, V56, P758, DOI 10.1109/TCSII.2009.2027954; Lin CH, 1998, IEEE J SOLID-ST CIRC, V33, P1948; Wu R, 2011, IEEE J SOLID-ST CIRC, V46, P2794, DOI 10.1109/JSSC.2011.2162923; Wu R, 2009, IEEE J SOLID-ST CIRC, V44, P3232, DOI 10.1109/JSSC.2009.2032710; Burt R, 2006, IEEE J SOLID-ST CIRC, V41, P2729, DOI 10.1109/JSSC.2006.884195; Xu JW, 2011, IEEE T BIOMED CIRC S, V5, P555, DOI 10.1109/TBCAS.2011.2170985; Fan QW, 2011, IEEE J SOLID-ST CIRC, V46, P1534, DOI 10.1109/JSSC.2011.2143610; Kusuda Y, 2010, IEEE J SOLID-ST CIRC, V45, P1436, DOI 10.1109/JSSC.2010.2048142; Belloni M, 2010, IEEE J SOLID-ST CIRC, V45, P2521, DOI 10.1109/JSSC.2010.2076430; Muller R, 2012, IEEE J SOLID-ST CIRC, V47, P232, DOI 10.1109/JSSC.2011.2163552; Bolatkale M, 2011, IEEE J SOLID-ST CIRC, V46, P2099, DOI 10.1109/JSSC.2011.2139530; Fan Q., 2013, ISSCC, P176, DOI DOI 10.1109/ISSCC.2013.6487688; Fan Q., 2012, IEEE INT SOL STAT CI, P374; Kinget PR, 2005, IEEE J SOLID-ST CIRC, V40, P1212, DOI 10.1109/JSSC.2005.848021; Kusuda Y., 2011, IEEE ISSCC, P242; Lewyn LL, 2009, P IEEE, V97, P1687, DOI 10.1109/JPROC.2009.2024663; Michel F., 2012, ISSCC, P372; Nielsen J. H., 2004, ANALOG INTEGR CIRC S, V42, P65, DOI 10.1007/s10470-004-6849-8; Razavi B., 2002, DESIGN ANALOG CMOS I; Tang A. T, 2002, IEEE INT SOL STAT CI, P386; Yeh T.-H., 2001, P IEEE INT C MICR TE, P77	26	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-1030	1573-1979		ANALOG INTEGR CIRC S	Analog Integr. Circuits Process.	DEC	2014	81	3			SI		571	582		10.1007/s10470-014-0371-4		12	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	AU8JJ	WOS:000345842200004		
J	Yang, X; Uchida, Y; Xu, KY; Wang, W; Yoshimasu, T				Yang, Xin; Uchida, Yorikatsu; Xu, Kangyang; Wang, Wei; Yoshimasu, Toshihiko			A 0.3-V power supply 2.4-GHz-band Class-C VCO IC with amplitude feedback loop in 65-nm CMOS	ANALOG INTEGRATED CIRCUITS AND SIGNAL PROCESSING			English	Article						Class-C; LC-VCO; Low voltage; 65-nm CMOS	PHASE-NOISE	A Class-C voltage-control-oscillator (VCO) IC with an amplitude feedback loop for ultra-low-voltage application is proposed. The Class-C VCO consists of an LC-VCO circuit and an amplitude feedback loop to shift LC-VCO bias condition from initial Class-AB start-up to steady Class-C low current oscillation. The amplitude feedback loop is formed by a detector and a comparator with low voltage supply. The LC-VCO IC has been designed, fabricated and fully evaluated using 65-nm CMOS technology. The fabricated Class-C VCO IC exhibits a measured phase noise of 111 dBc/Hz at 1 MHz offset from the 2.43 GHz carrier frequency at a supply voltage of only 0.3 V.	[Yang, Xin; Uchida, Yorikatsu; Xu, Kangyang; Wang, Wei; Yoshimasu, Toshihiko] Waseda Univ, Grad Sch Informat Prod & Syst, Kitakyushu, Fukuoka 8080135, Japan	Yoshimasu, T (reprint author), Waseda Univ, Grad Sch Informat Prod & Syst, Kitakyushu, Fukuoka 8080135, Japan.	yoshimasu@waseda.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23360162]; VDEC, University of Tokyo; Cadence Design Systems Inc; Mentor Graphics Inc; Agilent Technologies Japan Ltd.	This work is supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research Number 23360162. This work is supported by VDEC, University of Tokyo in collaboration with Cadence Design Systems Inc, Mentor Graphics Inc, and Agilent Technologies Japan Ltd.	Liu P, 2013, IEEE T MICROW THEORY, V61, P3658, DOI 10.1109/TMTT.2013.2279778; Kwok KC, 2005, IEEE J SOLID-ST CIRC, V40, P652, DOI 10.1109/JSSC.2005.843614; Chen J, 2011, IEEE MICROW WIREL CO, V21, P427, DOI 10.1109/LMWC.2011.2160620; Mazzanti A, 2008, IEEE J SOLID-ST CIRC, V43, P2716, DOI 10.1109/JSSC.2008.2004867; Li GS, 2012, IEEE J SOLID-ST CIRC, V47, P1295, DOI 10.1109/JSSC.2012.2190185; Mazzanti A, 2013, IEEE J SOLID-ST CIRC, V48, P724, DOI 10.1109/JSSC.2012.2230542; Arora N., 2007, MOSFET MODELING VLSI; Deng W, 2013, IEEE J SOLID-ST CIRC, V48, P429, DOI 10.1109/JSSC.2012.2227603; Fanori L., 2012, P EUR SOL STAT CIRC, P406; Ikeda S., 2012, IEEE AS SOL STAT CIR, P357; Kurachi S, 2007, IEICE T ELECTRON, VE90C, P1228, DOI 10.1093/ietele/e90-c.6.1228; Leeson D., 1966, IEEE P, V54, P329; Liu Q, 2011, IEICE T FUND ELECTR, VE94A, P568, DOI 10.1587/transfun.E94.A.568; OKADA K, 2009, S VLSI CIRC JUN, P228; Siriburanon T, 2013, 2013 8TH EUROPEAN MICROWAVE INTEGRATED CIRCUITS CONFERENCE (EUMIC), P109; Tohidian M., 2011, P EUR SOL STAT CIRC, P495; Yang X, 2013, ASIA PACIF MICROWAVE, P325; Yang X., 2012, IEEE MTT S INT MICR, P4	18	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0925-1030	1573-1979		ANALOG INTEGR CIRC S	Analog Integr. Circuits Process.	DEC	2014	81	3			SI		583	591		10.1007/s10470-014-0351-8		9	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	AU8JJ	WOS:000345842200005		
J	Kimura, MK; Uchiyama, K; Nakao, K; Moriguchi, Y; San Jose-Maldia, L; Tsumura, Y				Kimura, Megumi K.; Uchiyama, Kentaro; Nakao, Katsuhiro; Moriguchi, Yoshinari; San Jose-Maldia, Lerma; Tsumura, Yoshihiko			Evidence for cryptic northern refugia in the last glacial period in Cryptomeria japonica	ANNALS OF BOTANY			English	Article						Approximate Bayesian computation; cryptic refugia; Cryptomeria japonica; genetic divergence time estimation; last glacial maximum; microrefugia; species distribution modelling; sugi; Taxodiaceae	APPROXIMATE BAYESIAN COMPUTATION; MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; GENETIC-STRUCTURE; MICROSATELLITE MARKERS; NATURAL-POPULATIONS; OLD-GROWTH; ALLELIC RICHNESS; CLONAL STRUCTURE; CLIMATE-CHANGE	Background and Aims Distribution shifts and natural selection during past climatic changes are important factors in determining the genetic structure of forest species. In particular, climatic fluctuations during the Quaternary appear to have caused changes in the distribution ranges of plants, and thus strongly affected their genetic structure. This study was undertaken to identify the responses of the conifer Cryptomeria japonica, endemic to the Japanese Archipelago, to past climatic changes using a combination of phylogeography and species distribution modelling (SDM) methods. Specifically, this study focused on the locations of refugia during the last glacial maximum (LGM). Methods Genetic diversity and structure were examined using 20 microsatellite markers in 37 populations of C. japonica. The locations of glacial refugia were assessed using STRUCTURE analysis, and potential habitats under current and past climate conditions were predicted using SDM. The process of genetic divergence was also examined using the approximate Bayesian computation procedure (ABC) in DIY ABC to test the divergence time between the gene pools detected by the STRUCTURE analysis. Key Results STRUCTURE analysis identified four gene pools: northern Tohoku district; from Chubu to Chugoku district; from Tohoku to Shikoku district on the Pacific Ocean side of the Archipelago; and Yakushima Island. DIY ABC analysis indicated that the four gene pools diverged at the same time before the LGM. SDM also indicated potential northern cryptic refugia. Conclusions The combined evidence from microsatellites and SDM clearly indicates that climatic changes have shaped the genetic structure of C. japonica. The gene pool detected in northern Tohoku district is likely to have been established by cryptic northern refugia on the coast of the Japan Sea to the west of the Archipelago. The gene pool in Yakushima Island can probably be explained simply by long-term isolation from the other gene pools since the LGM. These results are supported by those of SDM and the predicted divergence time determined using ABC analysis.	[Kimura, Megumi K.; Uchiyama, Kentaro; San Jose-Maldia, Lerma; Tsumura, Yoshihiko] Forestry & Forest Prod Res Inst, Dept Forest Genet, Tsukuba, Ibaraki 3058687, Japan; [Nakao, Katsuhiro] Forestry & Forest Prod Res Inst, Dept Forest Vegetat, Tsukuba, Ibaraki 3058687, Japan; [Moriguchi, Yoshinari] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan	Tsumura, Y (reprint author), Forestry & Forest Prod Res Inst, Dept Forest Genet, Tsukuba, Ibaraki 3058687, Japan.	ytsumu@ffpri.affrc.go.jp			Forest Agency of Ministry of Agriculture, Forestry and Fishery; Programme for the Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry	The authors are grateful to Dr T. Nagamitsu for valuable discussions. We also thank Y. Taguchi, M. Koshiba and Y. Komatsu for their help in DNA analyses. This study was partly supported by a grant from the Forest Agency of Ministry of Agriculture, Forestry and Fishery, and by the Programme for the Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry. M.K.K., K.U., Y. M. and Y.T. conceived and designed the experiments. M.K.K. and L.S. J.M. performed molecular analyses and statistical analyses. K.N. estimated current and past distributions by species distribution modelling. M.K.K. and Y. T. wrote the manuscript; the other authors provided editorial advice.	Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Stuessy TF, 2006, J BIOGEOGR, V33, P1259, DOI 10.1111/j.1365-2699.2006.01504.x; [Anonymous], 2006, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2005.01155.X; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; STUESSY TF, 1990, SYST BOT, V15, P338, DOI 10.2307/2419187; Opgenoorth L, 2010, NEW PHYTOL, V185, P332, DOI 10.1111/j.1469-8137.2009.03007.x; Tsumura Y, 2012, HEREDITY, V109, P349, DOI 10.1038/hdy.2012.50; Takayama K, 2012, ANN BOT-LONDON, V109, P321, DOI 10.1093/aob/mcr280; Ohnishi N, 2009, HEREDITY, V102, P579, DOI 10.1038/hdy.2009.28; Pritchard JK, 2000, GENETICS, V155, P945; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Sakaguchi S, 2011, HEREDITY, V107, P338, DOI 10.1038/hdy.2011.20; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Walter R, 2001, MOL ECOL, V10, P103, DOI 10.1046/j.1365-294x.2001.01177.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Eriksson O, 1996, OIKOS, V77, P248, DOI 10.2307/3546063; Zou JB, 2013, ANN BOT-LONDON, V112, P1829, DOI 10.1093/aob/mct241; Savolainen O, 2004, FOREST ECOL MANAG, V197, P79, DOI 10.1016/j.foreco.2004.05.006; Qi XS, 2012, NEW PHYTOL, V196, P617, DOI 10.1111/j.1469-8137.2012.04242.x; Worth JRP, 2013, BIOL J LINN SOC, V108, P263, DOI 10.1111/j.1095-8312.2012.02017.x; Takahashi T, 2005, J PLANT RES, V118, P83, DOI 10.1007/s10265-005-0198-2; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Heuertz M, 2004, EVOLUTION, V58, P976; McLachlan JS, 2004, FOREST ECOL MANAG, V197, P139, DOI 10.1016/j.foreco.2004.05.026; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Hiraoka K, 2009, J PLANT RES, V122, P269, DOI 10.1007/s10265-009-0217-9; Parducci L, 2012, SCIENCE, V335, P1083, DOI 10.1126/science.1216043; Comps B, 2001, GENETICS, V157, P389; Beaumont MA, 2002, GENETICS, V162, P2025; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Tani N, 2004, ANN FOREST SCI, V61, P569, DOI 10.1051/forest:2004052; Falush D, 2003, GENETICS, V164, P1567; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ERIKSSON O, 1989, OIKOS, V55, P231, DOI 10.2307/3565427; Moriguchi Y, 2003, THEOR APPL GENET, V106, P751, DOI [10.1007/s00122-002-1149-0, 10.1007/s00122-003-1310-4]; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Burnham K. P., 2002, MODEL SELECTION MULT; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Eckert CG, 2002, EVOLUTIONARY ECOLOGY, V15, P501, DOI DOI 10.1023/A:1016005519651; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Endo R., 2012, Journal of the Japanese Forest Society, V94, P252, DOI 10.4005/jjfs.94.252; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hayashi Y., 1960, TAXONOMICAL PHYTOGEO; Hijmans R.J., 2005, WORLDCLIM VERSION 1; Hirayama K, 2008, CAN J FOREST RES, V38, P2804, DOI 10.1139/X08-127; Huntley B, 1983, ATLAS PRESENT POLLEN; K-1 Model Developers, 2004, K 1, V1, P1; Kawamura T, 1979, QUATERNARY RES, V18, P79; Kimura K, 1996, JAPANESE J HIST BOT, V4, P13; Kimura MK, 2013, FOREST ECOL MANAG, V304, P10, DOI 10.1016/j.foreco.2013.04.030; Kondo T, 1998, BREEDING SCI, V48, P177; Langella O, 1999, POPULATIONS POPULATI; Machida H, 1992, ATLAS TEPHRA JAPAN; Maiorano L, 2012, GLOBAL ECOL BIOGEOGR, V22, P302, DOI DOI 10.1111/J.1466-8238.2012.00767.X; MCCAULEY DE, 1995, TRENDS ECOL EVOL, V10, P198, DOI 10.1016/S0169-5347(00)89052-7; McDonald GM, 1993, ADV ECOL RES, V24, P67; Miyake N, 2011, JAPANESE J HIST BOT, V19, P61; Moriguchi Y, 2001, CAN J FOREST RES, V31, P377, DOI 10.1139/cjfr-31-3-377; Murai S., 1947, KOKUDO SAIKEN ZOURIN, P131; Nei M., 1987, MOL EVOLUTIONARY GEN; OHBA K, 1971, Silvae Genetica, V20, P101; Pornon A, 1997, PLANT ECOL, V130, P1, DOI 10.1023/A:1009724216796; Pornon A, 2000, MOL ECOL, V9, P1099, DOI 10.1046/j.1365-294x.2000.00976.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Sakaguchi S, 2010, ECOL RES, V25, P1183, DOI 10.1007/s11284-010-0743-x; Shimizu Y, 2002, BIOCHEM SYST ECOL, V30, P733, DOI 10.1016/S0305-1978(01)00109-0; Taira H, 1997, CAN J FOREST RES, V27, P447, DOI 10.1139/cjfr-27-4-447; Takahara H, 1998, NIPPON RETTOU SYOKUS, P207; Takahashi T, 2008, FOREST ECOL MANAG, V255, P2820, DOI 10.1016/j.foreco.2008.01.055; Tanaka N, 2012, PROCEDIA ENVIRON SCI, V13, P455, DOI 10.1016/j.proenv.2012.01.039; Thuiller W, 2003, J VEG SCI, V14, P669, DOI 10.1658/1100-9233(2003)014[0669:GMVCTA]2.0.CO;2; Toda R, 1969, SUGI NO SUBETE, P64; Tsuda Y, 2005, MOL ECOL, V14, P3929, DOI 10.1111/j.1365-294X.2005.02715.x; TSUKADA M, 1982, ECOLOGY, V63, P1091, DOI 10.2307/1937247; TSUKADA M, 1982, Japanese Journal of Ecology, V32, P113; Tsukada M, 1980, KAGAKU SCIENCE, V50, P538; Tsumura Y, 1995, THEOR APPL GENET, V91, P1222, DOI 10.1007/BF00220933; Tsumura Y, 2007, GENETICS, V176, P2393, DOI 10.1534/genetics.107.072652; Tsuyama I, 2014, J FOREST RES-JPN, V19, P154, DOI 10.1007/s10310-013-0399-9; Ueno S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-136; Wakeley J., 2008, COALESCENT THEORY IN; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.2307/2408641; Widmer A, 2001, TRENDS ECOL EVOL, V16, P267, DOI 10.1016/S0169-5347(01)02163-2; Worth J, 2014, CONSERVATIO IN PRESS; YAHARA T, 1987, Journal of the Faculty of Science University of Tokyo Section III Botany, V14, P69; Yamanaka M., 1990, Ecological Review, V22, P33; Yasue M., 1987, Journal of the Japanese Forestry Society, V69, P152; Yoshida A, 2009, J QUATERNARY SCI, V24, P1006, DOI 10.1002/jqs.1284; Yun JH, 2014, J FOREST RES-JPN, V19, P174, DOI 10.1007/s10310-013-0401-6	99	3	3	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0305-7364	1095-8290		ANN BOT-LONDON	Ann. Bot.	DEC	2014	114	8					1687	1700		10.1093/aob/mcu197		14	Plant Sciences	Plant Sciences	AU8CY	WOS:000345825300010		
J	Piccart, M; Hortobagyi, GN; Campone, M; Pritchard, KI; Lebrun, F; Ito, Y; Noguchi, S; Perez, A; Rugo, HS; Deleu, I; Burris, HA; Provencher, L; Neven, P; Gnant, M; Shtivelband, M; Wu, C; Fan, J; Feng, W; Taran, T; Baselga, J				Piccart, M.; Hortobagyi, G. N.; Campone, M.; Pritchard, K. I.; Lebrun, F.; Ito, Y.; Noguchi, S.; Perez, A.; Rugo, H. S.; Deleu, I.; Burris, H. A., III; Provencher, L.; Neven, P.; Gnant, M.; Shtivelband, M.; Wu, C.; Fan, J.; Feng, W.; Taran, T.; Baselga, J.			Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2	ANNALS OF ONCOLOGY			English	Article						everolimus; hormone-receptor-positive breast cancer; exemestane; overall survival	NONSTEROIDAL AROMATASE INHIBITOR; PLACEBO-CONTROLLED TRIAL; RANDOMIZED PHASE-II; POSTMENOPAUSAL WOMEN; ESTROGEN-RECEPTOR; DOUBLE-BLIND; ENDOCRINE THERAPY; FULVESTRANT; RESISTANCE; TAMOXIFEN	Background: The BOLERO-2 study previously demonstrated that adding everolimus (EVE) to exemestane (EXE) significantly improved progression-free survival (PFS) by more than twofold in patients with hormone-receptor-positive (HR+), HER2-negative advanced breast cancer that recurred or progressed during/after treatment with nonsteroidal aromatase inhibitors (NSAIs). The overall survival (OS) analysis is presented here. Patients and methods: BOLERO-2 is a phase III, double-blind, randomized international trial comparing EVE 10 mg/day plus EXE 25 mg/day versus placebo (PBO) + EXE 25 mg/day in postmenopausal women with HR+ advanced breast cancer with prior exposure to NSAIs. The primary end point was PFS by local investigator assessment; OS was a key secondary end point. Results: At the time of data cutoff (3 October 2013), 410 deaths had occurred and 13 patients remained on treatment. Median OS in patients receiving EVE + EXE was 31.0 months [95% confidence interval (CI) 28.0-34.6 months] compared with 26.6 months (95% CI 22.6-33.1 months) in patients receiving PBO + EXE (hazard ratio = 0.89; 95% CI 0.73-1.10; log-rank P = 0.14). Poststudy treatments were received by 84% of patients in the EVE + EXE arm versus 90% of patients in the PBO + EXE arm. Types of poststudy therapies were balanced across arms, except for chemotherapy (53% EVE + EXE versus 63% PBO + EXE). No new safety concerns were identified. Conclusions: In BOLERO-2, adding EVE to EXE did not confer a statistically significant improvement in the secondary end point OS despite producing a clinically meaningful and statistically significant improvement in the primary end point, PFS (4.6-months prolongation in median PFS; P < 0.0001). Ongoing translational research should further refine the benefit of mTOR inhibition and related pathways in this treatment setting.	[Piccart, M.; Lebrun, F.] Univ Libre Bruxelles, Inst Jules Bordet, Dept Med, B-1000 Brussels, Belgium; [Hortobagyi, G. N.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Multidisciplinary Breast Canc Res Program, Houston, TX 77030 USA; [Campone, M.] Ctr Rech Cancerol, Inst Cancerol Ouest, St Herblain, France; [Pritchard, K. I.] Sunnybrook Odette Canc Ctr, Dept Med, Toronto, ON, Canada; [Pritchard, K. I.] Univ Toronto, Toronto, ON, Canada; [Ito, Y.] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Breast Med Oncol, Tokyo, Japan; [Noguchi, S.] Osaka Univ, Grad Sch Med, Dept Breast & Endocrine Surg, Osaka, Japan; [Perez, A.] Mem Canc Inst, Breast Canc Ctr, Hollywood, FL USA; [Rugo, H. S.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Deleu, I.] AZ Nikolaas, Oncol Ctr, St Niklaas, Belgium; [Burris, H. A., III] Sarah Cannon Res Inst, Nashville, TN USA; [Provencher, L.] CHU Hop St Sacrement, Ctr Malad Sein Deschenes Fabia, Quebec City, PQ, Canada; [Neven, P.] Univ Hosp Leuven, Multidisciplinary Breast Ctr, Leuven, Belgium; [Neven, P.] Univ Hosp Leuven, Dept Gynecol Oncol, Leuven, Belgium; [Gnant, M.] Med Univ Vienna, Comprehens Canc Ctr Vienna, Dept Surg, Vienna, Austria; [Shtivelband, M.] Ironwood Canc & Res Ctr, Chandler, AZ USA; [Wu, C.; Fan, J.; Feng, W.; Taran, T.] Novartis Pharmaceut, E Hanover, NJ USA; [Baselga, J.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Piccart, M (reprint author), Univ Libre Bruxelles, Inst Jules Bordet, Dept Med, Clin Med Oncol, 125 Blvd Waterloo, B-1000 Brussels, Belgium.	martine.piccart@bordet.be		Gnant, Michael/0000-0003-1002-2118	Novartis Pharmaceuticals Corporation	This study was sponsored by Novartis Pharmaceuticals Corporation (no grant number). Financial support for medical editorial assistance was provided by Novartis Pharmaceuticals Corporation.	Rugo HS, 2014, ANN ONCOL, V25, P808, DOI 10.1093/annonc/mdu009; Robinson DR, 2013, NAT GENET, V45, P1446, DOI 10.1038/ng.2823; Cardoso F, 2012, BREAST, V21, P242, DOI 10.1016/j.breast.2012.03.003; Kaufmann M, 2000, J CLIN ONCOL, V18, P1399; Mehta RS, 2012, NEW ENGL J MED, V367, P435, DOI 10.1056/NEJMoa1201622; McArthur GA, 2014, LANCET ONCOL, V15, P323, DOI 10.1016/S1470-2045(14)70012-9; Di Leo A, 2010, J CLIN ONCOL, V28, P4594, DOI 10.1200/JCO.2010.28.8415; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Bachelot T, 2012, J CLIN ONCOL, V30, P2718, DOI 10.1200/JCO.2011.39.0708; Johnston S, 2009, J CLIN ONCOL, V27, P5538, DOI 10.1200/JCO.2009.23.3734; Yardley DA, 2013, J CLIN ONCOL, V31, P2128, DOI 10.1200/JCO.2012.43.7251; Toy W, 2013, NAT GENET, V45, P1439, DOI 10.1038/ng.2822; Andre F, 2013, CLIN CANCER RES, V19, P3693, DOI 10.1158/1078-0432.CCR-13-0190; Wolff AC, 2013, J CLIN ONCOL, V31, P195, DOI 10.1200/JCO.2011.38.3331; Robertson JFR, 2013, LANCET ONCOL, V14, P228, DOI 10.1016/S1470-2045(13)70026-3; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Simoncini T, 2000, NATURE, V407, P538; Osborne CK, 2011, CLIN CANCER RES, V17, P1147, DOI 10.1158/1078-0432.CCR-10-1869; Jeselsohn R, 2014, CLIN CANCER RES, V20, P1757, DOI 10.1158/1078-0432.CCR-13-2332; Martinez-Galan J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-59; Burris HA, 2013, CANCER-AM CANCER SOC, V119, P1908, DOI 10.1002/cncr.28010; Giuliano M, 2011, BREAST, V20, pS42, DOI 10.1016/S0960-9776(11)70293-4; Yardley DA, 2013, ADV THER, V30, P870, DOI 10.1007/s12325-013-0060-1; LoRusso PM, 2013, ONCOLOGY-BASEL, V84, P43, DOI 10.1159/000343063; Clark AS, 2002, MOL CANCER THER, V1, P707; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Baselga J, 2009, J CLIN ONCOL, V27, P2630, DOI 10.1200/JCO.2008.18.8391; Baselga J, 2012, NEW ENGL J MED, V366, P109, DOI 10.1056/NEJMoa1113216; Kaufman B, 2009, J CLIN ONCOL, V27, P5529, DOI 10.1200/JCO.2008.20.6847; Chia S, 2008, J CLIN ONCOL, V26, P1664, DOI 10.1200/JCO.2007.13.5822; Howell A, 2004, J CLIN ONCOL, V22, P1605, DOI 10.1200/JCO.2004.02.112; Chia S, 2007, SAN ANT BREAST CANC; Finn RS, 2013, ANN ONCOL S9, V24, pix32; Garcia-Becerra R, 2013, INT J MOL SCI, V14, P108, DOI 10.3390/ijms14010108; Di Leo A, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt337; Johnston SRD, 2013, LANCET ONCOL, V14, P989, DOI 10.1016/S1470-2045(13)70322-X; Mauriac L, 2009, CANC RES S1, V69; National Comprehensive Cancer Network Inc, NCCN CLIN PRACT GUID	40	35	35	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0923-7534	1569-8041		ANN ONCOL	Ann. Oncol.	DEC	2014	25	12					2357	2362		10.1093/annonc/mdu456		6	Oncology	Oncology	AU8DD	WOS:000345825800008		
J	Ishikawa, Y; Nakayama, H; Ito, H; Yokose, T; Tsuboi, M; Nishii, T; Masuda, M				Ishikawa, Yoshihiro; Nakayama, Haruhiko; Ito, Hiroyuki; Yokose, Tomoyuki; Tsuboi, Masahiro; Nishii, Teppei; Masuda, Munetaka			Surgical Treatment for Synchronous Primary Lung Adenocarcinomas	ANNALS OF THORACIC SURGERY			English	Article							FORTHCOMING 7TH EDITION; TNM CLASSIFICATION; STAGING PROJECT; CANCER; PROPOSALS; SURVIVAL; REVISION; DESCRIPTORS; EXPERIENCE; MANAGEMENT	Background. Surgical treatment has become the mainstay of treatment for multiple primary lung cancers. In particular, the prevalence of synchronous primary lung adenocarcinomas (SPLA) has recently increased, but few studies have evaluated surgical outcomes of patients with SPLA. We reviewed the clinicopathologic features and surgical outcomes of SPLA to identify factors related to survival. Methods. Data on 2,041 consecutive patients with primary non-small cell carcinoma who underwent surgical resection in our hospital from 1995 through 2009 were retrospectively analyzed. Results. The SPLA was pathologically diagnosed in 93 patients, including 26 with bilateral tumors. The rates of overall survival and recurrence-free survival at 5 years were 87.0% and 81.8%, respectively. There was no surgical mortality at 30 days. On univariate analysis, lymph node metastasis (p = 0.0000), nonlepidic predominant histologic subtype (p = 0.0018), and a solid appearance of the largest tumor on computed tomography (p = 0.0088) were significantly related to poor overall survival. On multivariate analysis, bilateral distribution of tumors (p = 0.031), lymph node metastasis (p = 0.004), and sublobar resection (p = 0.042) were independent predictors of poor survival. Conclusions. Surgery has good outcomes and should be aggressively performed for patients with SPLA. The evaluation of lymph node status has an important role in deciding whether surgery is indicated. Bilateral tumors are a predictor of poor outcomes, requiring that caution be exercised. Lobectomy has a high cure rate and should be performed whenever possible. However, sublobar resection should be considered for patients likely to have poor residual lung function postoperatively. (C) 2014 by The Society of Thoracic Surgeons.	Yokohama City Univ, Dept Thorac Surg, Kanagawa Canc Ctr Hosp, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Dept Pathol, Kanagawa Canc Ctr Hosp, Yokohama, Kanagawa 2360004, Japan; Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 2360004, Japan	Ishikawa, Y (reprint author), Yokohama City Univ, Dept Surg, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	y_ishikw@yokohama-cu.ac.jp					Kozower BD, 2013, CHEST, V143, pE369, DOI 10.1378/chest.12-2362; Chang YL, 2007, J THORAC CARDIOV SUR, V134, P630, DOI 10.1016/j.jtcvs.2007.06.001; Goldstraw P, 2007, J THORAC ONCOL, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; De Leyn P, 2008, EUR J CARDIO-THORAC, V34, P1215, DOI 10.1016/j.ejcts.2008.07.069; Tsunezuka Y, 2004, EJSO, V30, P781, DOI 10.1016/j.ejso.2004.05.008; Rusch VW, 2007, J THORAC ONCOL, V2, P603, DOI 10.1097/JTO.0b013e31807ec803; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Rostad H, 2008, ANN THORAC SURG, V85, P204, DOI 10.1016/j.athoracsur.2007.07.091; Girard N, 2009, AM J SURG PATHOL, V33, P1752, DOI 10.1097/PAS.0b013e3181b8cf03; Voltolini L, 2010, EUR J CARDIO-THORAC, V37, P1198, DOI 10.1016/j.ejcts.2009.11.025; Postmus PE, 2007, J THORAC ONCOL, V2, P686, DOI 10.1097/JTO.0b013e31811f4703; Yu YC, 2013, ANN THORAC SURG, V96, P1966, DOI 10.1016/j.athoracsur.2013.04.142; Nakata M, 2004, ANN THORAC SURG, V78, P1194, DOI 10.1016/j.athoracsur.2004.03.102; Finley DJ, 2010, J THORAC ONCOL, V5, P197, DOI 10.1097/JTO.0b013e3181c814c5; Okada M, 2004, J THORAC CARDIOV SUR, V127, P857, DOI 10.1016/j.jtcvs.2003.08.048; Jung EJ, 2011, LUNG CANCER, V73, P237, DOI 10.1016/j.lungcan.2010.11.008; MARTINI N, 1975, J THORAC CARDIOV SUR, V70, P606; Hashizume T, 2008, CHEST, V133, P441, DOI 10.1378/chest.07-1533; Trousse D, 2007, J THORAC CARDIOV SUR, V133, P1193, DOI 10.1016/j.jtcvs.2007.01.012; Fabian T, 2011, J THORAC CARDIOV SUR, V142, P547, DOI 10.1016/j.jtcvs.2011.03.035; Haraguchi N, 2007, CLIN LUNG CANCER, V8, P327, DOI 10.3816/CLC.2007.n.012; Kocaturk CI, 2011, EUR J CARDIO-THORAC, V39, P160, DOI 10.1016/j.ejcts.2010.05.037; Takuwa T, 2010, LUNG CANCER, V68, P498, DOI 10.1016/j.lungcan.2010.02.008; Tanvetyanon T, 2013, ANN ONCOL, V24, P889, DOI 10.1093/annonc/mds495	24	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2014	98	6					1983	1988		10.1016/j.athoracsur.2014.07.006		6	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6WX	WOS:000345743200022		
J	Ando, Y; Fukae, K; Hirayama, K; Oe, M; Iwai, T				Ando, Yusuke; Fukae, Koji; Hirayama, Kazuto; Oe, Masahiro; Iwai, Toshiro			Impact of Bilateral Superior Venae Cavae on Outcome of Staged Fontan Procedure	ANNALS OF THORACIC SURGERY			English	Article							CAVOPULMONARY SHUNT	Background. The presence of bilateral superior venae cavae may add complexity to the performance of a bidirectional Glenn procedure (BDG). Stagnation of blood flow between the two cavopulmonary anastomoses may increase the risk of thrombosis and impair central pulmonary artery growth. Methods. Forty patients underwent BDG from January 2004 to April 2011. The cohort was divided into two groups: those receiving bilateral BDG (b-BDG, n = 13) and those receiving unilateral BDG (u-BDG, n = 27). Operative, angiographic, and follow-up data were analyzed retrospectively. Results. None of the patients experienced thrombosis. There was no difference in actuarial survival rate (u-BDG vs b-BDG, 100% vs 92% at 5 years, p = 0.15). On follow-up angiography, no difference in central pulmonary artery index was noted (78.4 +/- 45.5 vs 60.4 +/- 32.1, p = 0.24). Central pulmonary artery stenosis was detected in 6 patients (4 with u-BDG and 2 with b-BDG), 4 of whom (2 from each group) underwent balloon pulmonary artery plasty before the Fontan procedure. There was no difference in freedom from reintervention for central pulmonary artery stenosis (93% vs 85% at 1 year, p = 0.59). The rate of Fontan completion was comparable between groups, with similar operative variables and satisfactory outcomes. Conclusions. Bilateral BDG did not increase the risks of thrombosis and central pulmonary artery hypoplasia and can be performed safely without altering the outcome of the Fontan procedure. (C) 2014 by The Society of Thoracic Surgeons.	Kumamoto City Hosp, Dept Pediat Cardiac Surg, Kumamoto 8628505, Japan; Kumamoto City Hosp, Dept Cardiovasc Surg, Kumamoto 8628505, Japan	Ando, Y (reprint author), Kumamoto City Hosp, Dept Pediat Cardiac Surg, Higashi Ku, 1-1-60 Koto, Kumamoto 8628505, Japan.	yuandou-circ@umin.ac.jp					Amodeo A, 2009, J THORAC CARDIOV SUR, V138, P1154, DOI 10.1016/j.jtcvs.2009.04.039; Amodeo A, 2007, ANN THORAC SURG, V84, P2134, DOI 10.1016/j.athoracsur.2007.04.071; Forbes TJ, 1997, AM HEART J, V134, P865, DOI 10.1016/S0002-8703(97)80009-9; Honjo O, 2010, J THORAC CARDIOV SUR, V140, P522, DOI 10.1016/j.jtcvs.2010.04.036; Iyer GKT, 2000, ANN THORAC SURG, V70, P711, DOI 10.1016/S0003-4975(00)01627-1; McElhinney DB, 1997, ANN THORAC SURG, V63, P1676, DOI 10.1016/S0003-4975(97)00364-0; Monagle P, 2011, J AM COLL CARDIOL, V58, P645, DOI 10.1016/j.jacc.2011.01.061; Muster AJ, 1998, PEDIATR CARDIOL, V19, P352; Tanoue Yoshihisa, 2007, Interact Cardiovasc Thorac Surg, V6, P97; Vida VL, 2006, EUR J CARDIO-THORAC, V29, P112, DOI 10.1016/j.ejcts.2005.10.019	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2014	98	6					2187	2193		10.1016/j.athoracsur.2014.07.063		7	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6WX	WOS:000345743200054		
J	Watanabe, Y; Sasada, S; Izumo, T; Nakamura, Y; Chavez, C; Watanabe, S; Tsuchida, T				Watanabe, Yukio; Sasada, Shinji; Izumo, Takehiro; Nakamura, Yukiko; Chavez, Christine; Watanabe, Shun-ichi; Tsuchida, Takaaki			Intractable Obstructive Endobronchial Granulation Caused by Surgical Materials After Sleeve Resection for Tracheal Carcinoma	ANNALS OF THORACIC SURGERY			English	Editorial Material							SUTURE	A 64-year-old woman underwent tracheal sleeve resection for adenocarcinoma. Thirteen months later minimal granuloma occurred at the anastomosis. Subsequently she had dyspnea from obstruction caused by the increasing size of the granuloma, which necessitated 4 repeated endobronchial debulking procedures and topical mitomycin C (MMC) application. However, the symptoms and granulation failed to resolve. Eventually, the granulation tissue and pledgeted sutures were removed from the anastomotic site using rigid bronchoscopy. Follow-up after 8 months showed no recurrence of symptoms, and the granuloma had resolved. Despite improvements in surgical suture material, removal of stitches should still be considered in the management of anastomotic obstruction caused by indolent and intractable granulation after tracheal resection or bronchoplasty. (C) 2014 by The Society of Thoracic Surgeons.	Natl Canc Ctr, Dept Endoscopy, Resp Endoscopy Div, Tokyo 1040045, Japan; Natl Canc Ctr, Div Thorac Surg, Tokyo 1040045, Japan	Sasada, S (reprint author), Natl Canc Ctr, Dept Endoscopy, Resp Endoscopy Div, Chuo Ku, 1-1 Tsukiji 5 Chome, Tokyo 1040045, Japan.	ssasada@ncc.go.jp					Aboudara M, 2012, BMJ CASE REP; TEDDER M, 1992, ANN THORAC SURG, V54, P387; BAUMGARTNER WA, 1981, J THORAC CARDIOV SUR, V81, P553; Kutlu CA, 1999, J THORAC CARDIOV SUR, V117, P1112, DOI 10.1016/S0022-5223(99)70247-3; MAEDA M, 1989, J THORAC CARDIOV SUR, V97, P402; Penafiel A, 2006, ANN THORAC SURG, V82, pE22, DOI 10.1016/j.athoracsur.2006.05.067; Precht LM, 2008, ANN THORAC SURG, V85, P2116, DOI 10.1016/j.athoracsur.2007.12.026; SHURE D, 1991, CHEST, V100, P1193, DOI 10.1378/chest.100.5.1193	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2014	98	6					2200	2202		10.1016/j.athoracsur.2014.02.062		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6WX	WOS:000345743200056		
J	Sano, A; Kawashima, M				Sano, Atsushi; Kawashima, Mitsuaki			Thymoma With Ring Calcification	ANNALS OF THORACIC SURGERY			English	Editorial Material								A 59-year-old man was referred to our department for evaluation of an asymptomatic abnormal mediastinal shadow detected on chest roentgenogram. Computed tomography (CT) of the chest showed an anterior mediastinal tumor with ring calcification. Thymectomy through a median sternotomy was performed. Pathologic examination showed an encapsulated type B2 thymoma with ring calcification. Microscopically, the calcified layer was within the fibrous capsule layer. A part of the fibrous capsule was thought to become calcified like a ring. Although focal calcification is sometimes found in thymomas, ring calcification is rare. (C) 2014 by The Society of Thoracic Surgeons	[Sano, Atsushi; Kawashima, Mitsuaki] Chigasaki Municipal Hosp, Dept Thorac Surg, Chigasaki, Kanagawa 2530042, Japan	Sano, A (reprint author), Chigasaki Municipal Hosp, Dept Thorac Surg, Honson 5-15-1, Chigasaki, Kanagawa 2530042, Japan.	sanoa-tky@umin.ac.jp					Tomiyama N, 2002, AM J ROENTGENOL, V179; Jung KJ, 2001, AM J ROENTGENOL, V176, P433; Harris K, 2011, WORLD J SURG ONCOL, V9, DOI 10.1186/1477-7819-9-95; Low A, 2013, QJM-INT J MED, V106, P371, DOI 10.1093/qjmed/hcs030; Siraj Fouzia, 2011, Gen Thorac Cardiovasc Surg, V59, P583, DOI 10.1007/s11748-010-0726-4	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2014	98	6					2202	2204		10.1016/j.athoracsur.2014.01.084		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6WX	WOS:000345743200057		
J	Kashimura, T; Nakazawa, H; Shimoda, K; Soejima, K; Kochi, M; Takayama, T				Kashimura, Tsutomu; Nakazawa, Hiroaki; Shimoda, Katsumi; Soejima, Kazutaka; Kochi, Mitsugu; Takayama, Tadatoshi			Successful Management of the Cervicothoracic Esophagus Reconstruction by Expanded Skin Flap	ANNALS OF THORACIC SURGERY			English	Editorial Material								The limited availability of reconstruction materials can often make it difficult to treat defects in the esophagus caused by necrosis of the transplanted intestinal tissue after cervicothoracic esophagus reconstruction. We were forced to perform flap reconstruction on a patient who suffered necrosis due to impeded blood flow of the transplanted intestinal tract after twice conducting cervicothoracic esophagus reconstruction with an intestinal tract flap. The procedure we performed was esophagus reconstruction using a pectoralis major myocutaneous flap that had been expanded with a tissue expander due to the small volume of tissue available to perform the reconstruction. This case suggested that esophagus reconstruction with a skin flap using a tissue expander should be considered as a possible treatment choice when performing reconstruction of the cervicothoracic esophagus, which requires stable blood flow and a large amount of tissue. (C) 2014 by The Society of Thoracic Surgeons.	[Kashimura, Tsutomu] Nihon Univ, Dept Plast & Reconstruct Surg, Sch Med, Itabashi Ku, Tokyo 1738610, Japan; Nihon Univ, Dept Digest Surg, Sch Med, Itabashi Ku, Tokyo 1738610, Japan	Kashimura, T (reprint author), Nihon Univ, Dept Plast & Reconstruct Surg, Sch Med, Itabashi Ku, 30-1 Ooyaguchikami Cho, Tokyo 1738610, Japan.	kasi2106@live.jp					Murray DJ, 2008, J PLAST RECONSTR AES, V61, P1148, DOI 10.1016/j.bjps.2007.09.030; ARIYAN S, 1979, PLAST RECONSTR SURG, V63, P73, DOI 10.1097/00006534-197901000-00012; Pesko P, 2006, DIS ESOPHAGUS, V19, P248, DOI 10.1111/j.1442-2050.2006.00585.x; Davis PA, 2003, ARCH SURG-CHICAGO, V138, P303, DOI 10.1001/archsurg.138.3.303; MANDERS EK, 1984, PLAST RECONSTR SURG, V74, P493, DOI 10.1097/00006534-198410000-00007; Hamai Y, 2009, ANN THORAC SURG, V87, P1605, DOI 10.1016/j.athoracsur.2008.09.069; Oki M, 2010, J PLAST RECONSTR AES, V63, P589, DOI 10.1016/j.bjps.2009.01.038; Sekido M, 2003, SURGERY, V134, P420, DOI 10.1067/S0039-6060(03)00219-8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2014	98	6					2211	2213		10.1016/j.athoracsur.2014.01.073		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6WX	WOS:000345743200061		
J	Kondo, T; Hirota, M; Hoshino, J; Takahashi, Y; Notomi, Y; Isomura, T				Kondo, Taichi; Hirota, Masanori; Hoshino, Joji; Takahashi, Yu; Notomi, Yuichi; Isomura, Tadashi			Temporary Epicardial Pacing Wire Migrating to and Exiting From the Jaw	ANNALS OF THORACIC SURGERY			English	Editorial Material							COMPLICATION	A 63-year-old woman underwent cardiac surgery, with atrial and ventricular temporary epicardial pacing wires being placed at the end of the procedure. Four months after the operation, the patient experienced tooth decay and underwent a tooth extraction. Thereafter, the patient developed an infected, swollen neck; computed tomography revealed that one of the temporary pacing wires had migrated into her neck. The patient was readmitted for removal of the wire, but it spontaneously exited through the skin of the lower jaw; the infection was resolved with intravenous antibiotic therapy. (C) 2014 by The Society of Thoracic Surgeons	[Kondo, Taichi; Hirota, Masanori; Hoshino, Joji; Takahashi, Yu; Notomi, Yuichi; Isomura, Tadashi] Hayama Heart Ctr, Dept Cardiovasc Surg, Hayama, Kanagawa 2400166, Japan	Kondo, T (reprint author), Hayama Heart Ctr, Dept Cardiovasc Surg, 1898-1 Shimoyamaguchi, Hayama, Kanagawa 2400166, Japan.	world1@bc4.so-net.ne.jp					Wolf LG, 2013, ANN THORAC SURG, V96, pE7, DOI 10.1016/j.athoracsur.2012.12.056; MANSUR AJ, 1984, AM HEART J, V108, P1049, DOI 10.1016/0002-8703(84)90482-4; Ono K, 1997, Nihon Kyobu Geka Gakkai Zasshi, V45, P1903; Smith DE, 2013, INTERACT CARDIOV TH, V16, P221, DOI 10.1093/icvts/ivs456; Worth PJ, 2011, J THORAC CARDIOV SUR, V142, pE136, DOI 10.1016/j.jtcvs.2010.05.058	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2014	98	6					2221	2223		10.1016/j.athoracsur.2014.02.055		4	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6WX	WOS:000345743200066		
J	Fukui, S; Mitsuno, M; Yamamura, M; Ryomoto, M; Hao, H; Miyamoto, Y				Fukui, Shinya; Mitsuno, Masataka; Yamamura, Mitsuhiro; Ryomoto, Masaaki; Hao, Hiroyuki; Miyamoto, Yuji			Partial Resection of Cystic Tumor of Atrioventricular Node	ANNALS OF THORACIC SURGERY			English	Editorial Material							EXCISION	We treated a 57-year-old female patient with an atrial tumor that was widely attached to the atrial septum. The tumor was diagnosed as a cystic tumor of the atrioventricular node (CTAVN). This type of tumor is rare, and its antemortem diagnosis is difficult because it is usually asymptomatic. This tumor may cause sudden death; thus surgical resection is recommended. We performed partial resection instead of total resection to avoid pacemaker implantation. (C) 2014 by The Society of Thoracic Surgeons	[Miyamoto, Yuji] Hyogo Coll Med, Dept Cardiovasc Surg, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo 6638501, Japan	Miyamoto, Y (reprint author), Hyogo Coll Med, Dept Cardiovasc Surg, 1-1 Mukogawa Chou, Nishinomiya, Hyogo 6638501, Japan.	y-miyamo@hyo-med.ac.jp					BALASUNDARAM S, 1992, EUR HEART J, V13, P718; Careddu L, 2013, ANN THORAC SURG, V96, P1873, DOI 10.1016/j.athoracsur.2013.03.036; Guo Jialong, 2009, Interact Cardiovasc Thorac Surg, V8, P592, DOI 10.1510/icvts.2008.191866; Kaminishi Yuichiro, 2002, Jpn J Thorac Cardiovasc Surg, V50, P37; Law KB, 2012, CARDIOVASC PATHOL, V21, P120, DOI 10.1016/j.carpath.2011.05.004; Nojima Y, 2003, HEART, V89, P122, DOI 10.1136/heart.89.2.122; Paniagua J R, 2000, Heart, V83, pE6, DOI 10.1136/heart.83.4.e6; Saito S, 2005, CIRC J, V69, P1293, DOI 10.1253/circj.69.1293	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2014	98	6					2223	2226		10.1016/j.athoracsur.2014.02.061		5	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6WX	WOS:000345743200067		
J	Ishikawa, N; Hatta, E; Hagiwara, T				Ishikawa, Natsuya; Hatta, Eiichiro; Hagiwara, Takayuki			A Rare Anatomic Variant: Interrupted and Right-Sided Aortic Arch With Bilateral Ductus Arteriosi	ANNALS OF THORACIC SURGERY			English	Editorial Material									Hokkaido Med Ctr Child Hlth & Rehabil, Dept Cardiovasc Surg, Sapporo, Hokkaido 0060041, Japan; Teine Keijinkai Hosp, Dept Cardiovasc Surg, Sapporo, Hokkaido, Japan	Ishikawa, N (reprint author), Hokkaido Med Ctr Child Hlth & Rehabil, Dept Cardiovasc Surg, Teine Ku, 1-240-6 Kanayama 1 Jo, Sapporo, Hokkaido 0060041, Japan.	natsuyai@yahoo.co.jp						0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2014	98	6					2235	2235		10.1016/j.athoracsur.2014.07.056		1	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6WX	WOS:000345743200074		
J	Yotsukura, M; Kinoshita, T; Kamiyama, I; Hato, T; Goto, T; Ohtsuka, T; Yoshitake, A; Kudo, M; Kohno, M				Yotsukura, Masaya; Kinoshita, Tomonari; Kamiyama, Ikuo; Hato, Tai; Goto, Taichiro; Ohtsuka, Takashi; Yoshitake, Akihiro; Kudo, Mikihiko; Kohno, Mitsutomo			Temporary Extravascular Shunt for Reconstruction of a Superior Vena Cava Invaded by a Lung Tumor	ANNALS OF THORACIC SURGERY			English	Editorial Material							PROSTHETIC REPLACEMENT; AUTOLOGOUS PERICARDIUM; RESECTION; CANCER	Advanced central lung cancers can invade the superior vena cava (SVC). Although the indications for resection of the vessel remain controversial, it has been suggested that it increases the long-term survival of selected patients; however, little consensus has been reached regarding the optimal method of vascular reconstruction. While the SVC is often replaced during unprotected cross-clamp, the placement of a temporary venous shunt with a view to preserve the periprocedural safety and facilitate the postoperative management seems preferable. We describe an SVC reconstruction procedure using an autologous pericardial patch and placement of a temporary extravascular shunt via a lateral thoracotomy. (C) 2014 by The Society of Thoracic Surgeons	Keio Univ, Sch Med, Dept Surg, Div Gen Thorac Surg, Tokyo 1608582, Japan; Keio Univ, Sch Med, Dept Surg, Div Cardiovasc Surg, Tokyo 1608582, Japan	Kamiyama, I (reprint author), Keio Univ, Sch Med, Dept Surg, Div Gen Thorac Surg,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	i_kami@rc4.so-net.ne.jp					Spaggiari L, 2004, LUNG CANCER-J IASLC, V44, P339, DOI 10.1016/j.lungcan.2003.11.010; D'Andrilli A, 2005, ANN THORAC SURG, V80, P357, DOI 10.1016/j.athoracsur.2004.02.012; Piccione W, 1998, ANN THORAC SURG, V66, P291; Politi L, 2007, J CARDIOVASC SURG, V48, P363; Sekine Y, 2010, ANN THORAC SURG, V90, P223, DOI 10.1016/j.athoracsur.2010.03.050; Shinohara H, 2009, SURG TODAY, V39, P787, DOI 10.1007/s00595-008-3927-z; Spaggiari L, 2002, EUR J CARDIO-THORAC, V21, P1080, DOI 10.1016/S1010-7940(02)00175-6	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2014	98	6					2242	2243		10.1016/j.athoracsur.2014.06.078		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6WX	WOS:000345743200077		
J	Ohira, S; Doi, K; Numata, S; Yamazaki, S; Yamamoto, T; Yaku, H				Ohira, Suguru; Doi, Kiyoshi; Numata, Satoshi; Yamazaki, Sachiko; Yamamoto, Tsunehisa; Yaku, Hitoshi			Reskeletonization of Patent Graft Using Ultrasonic Scalpel in Redo Surgery	ANNALS OF THORACIC SURGERY			English	Editorial Material							INTERNAL THORACIC ARTERY	A patent graft is one of the major concerns in redo cardiac surgery. A full skeletonization technique using an ultrasonic scalpel is a breakthrough method to harvest the internal thoracic artery, being first reported in 2000. Here, we describe a reskeletonization technique to safely dissect a patent internal thoracic artery graft using an ultrasonic scalpel in redo cardiac surgery after coronary artery bypass graft surgery. This technique can be used not only to expose the patent graft to simply mobilize or clamp it, but also to recycle a patent graft to revascularize other coronary arteries. (C) 2014 by The Society of Thoracic Surgeons	[Ohira, Suguru; Doi, Kiyoshi; Numata, Satoshi; Yamazaki, Sachiko; Yamamoto, Tsunehisa; Yaku, Hitoshi] Kyoto Prefectural Univ Med, Div Cardiovasc Surg, Kyoto 6028566, Japan	Ohira, S (reprint author), Kyoto Prefectural Univ Med, Div Cardiovasc Surg, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	s-ohira@koto.kpu-m.ac.jp					Higami T, 2000, ANN THORAC SURG, V70, P307, DOI 10.1016/S0003-4975(00)01436-3; Gillinov AM, 1999, ANN THORAC SURG, V67, P382, DOI 10.1016/S0003-4975(99)00009-0; Dohi M, 2014, ANN THORAC SURG, V98, P311, DOI 10.1016/j.athoracsur.2013.09.066; Higami T, 2000, J THORAC CARDIOV SUR, V120, P1142, DOI 10.1067/mtc.2000.110189; Kaneko T, 2012, J THORAC CARDIOV SUR, V144, P1036, DOI 10.1016/j.jtcvs.2012.07.057	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2014	98	6					E153	E155		10.1016/j.athoracsur.2014.09.060		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6WX	WOS:000345743200008		
J	Tauchi, Y; Tanioka, H; Kondoh, H; Satoh, H; Matsuda, H				Tauchi, Yuuya; Tanioka, Hideki; Kondoh, Haruhiko; Satoh, Hisashi; Matsuda, Hikaru			Emergency Rescue Endovascular Stent Grafting of Ascending Aorta to Relieve Life-Threatening Coronary Obstruction in a Case of Acute Aortic Dissection	ANNALS OF THORACIC SURGERY			English	Editorial Material							SURGICAL-MANAGEMENT; MALPERFUSION	Myocardial ischemia associated with acute aortic dissection is frequently a fatal complication, and the emergent management still remains a challenge. We report a patient with life-threatening myocardial ischemia due to acute aortic dissection managed by rescue stent grafting of the ascending aorta. Coronary blood flow improved immediately with this endovascular procedure, hemodynamic status was ameliorated dramatically, followed by uneventful open repair. (C) 2014 by The Society of Thoracic Surgeons	[Tauchi, Yuuya; Tanioka, Hideki; Kondoh, Haruhiko; Satoh, Hisashi; Matsuda, Hikaru] Higashi Takarazuka Satoh Hosp, Dept Cardiovasc Surg, Takarazuka, Hyogo 6650873, Japan	Tauchi, Y (reprint author), Higashi Takarazuka Satoh Hosp, Dept Cardiovasc Surg, 67-1 Nagao Cho, Takarazuka, Hyogo 6650873, Japan.	y-tauchi@mail.hts-hsp.com					Asakura Toshihisa, 2007, Kyobu Geka, V60, P297; Eren E, 2007, J CARDIAC SURG, V22, P2, DOI 10.1111/j.1540-8191.2007.00331.x; Imoto K, 2005, J ENDOVASC THER, V12, P258, DOI 10.1583/03-1120R.1; Kawahito K, 2003, ANN THORAC SURG, V76, P1471, DOI 10.1016/S0003-4975(03)00899-3; Lentini Salvatore, 2011, J Emerg Trauma Shock, V4, P273, DOI 10.4103/0974-2700.82221; Neri E, 2001, J THORAC CARDIOV SUR, V121, P552, DOI 10.1067/mtc.2001.112534; Saxena P, 2011, J CARDIAC SURG, V26, P634, DOI 10.1111/j.1540-8191.2011.01346.x	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-4975	1552-6259		ANN THORAC SURG	Ann. Thorac. Surg.	DEC	2014	98	6					E131	E133		10.1016/j.athoracsur.2014.08.059		3	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	AU6WX	WOS:000345743200002		
J	Lambert, C; Kormos, J				Lambert, Craig; Kormos, Judit			Complexity, Accuracy, and Fluency in Task-based L2 Research: Toward More Developmentally Based Measures of Second Language Acquisition	APPLIED LINGUISTICS			English	Editorial Material							TEXT CONSTRUCTION; LANGUAGE; ADOLESCENTS; DISCOURSE; UTTERANCE; CHILDREN; CORPUS; ADULTS; UNIT; CAF	This article surveys how complexity, accuracy, and fluency (CAF) have been operationalized in studies of task-based L2 production, pointing out some problems with this approach and the need for more precise information about L2 development during task performance. Research into developing L1 text construction ability is then discussed and some approaches for establishing measures of the relevant constructs in L2 performance are suggested.	[Lambert, Craig] Univ Kitakyushu, Fac Foreign Studies, Kitakyushu, Fukuoka, Japan; [Kormos, Judit] Univ Lancaster, Dept Linguist & English Language, Lancaster LA1 4YW, England	Lambert, C (reprint author), Univ Kitakyushu, Fac Foreign Studies, Kitakyushu, Fukuoka, Japan.	lambert@kitakyu-u.ac.jp					Foster P, 2000, APPL LINGUIST, V21, P354, DOI 10.1093/applin/21.3.354; Bard EG, 1996, LANGUAGE, V72, P32, DOI 10.2307/416793; Pallotti G, 2009, APPL LINGUIST, V30, P590, DOI 10.1093/applin/amp045; Nippold MA, 2005, J SPEECH LANG HEAR R, V48, P1048, DOI 10.1044/1092-4388(2005/073); Biber D, 2011, TESOL QUART, V45, P5, DOI 10.5054/tq.2011.244483; Bosker HR, 2013, LANG TEST, V30, P159, DOI 10.1177/0265532212455394; Larsen-Freeman D, 2009, APPL LINGUIST, V30, P579, DOI 10.1093/applin/amp043; Nippold MA, 2005, LANG SPEECH HEAR SER, V36, P125, DOI 10.1044/0161-1461(2005/012); Norris JM, 2009, APPL LINGUIST, V30, P555, DOI 10.1093/applin/amp044; Diessel H, 2001, COGN LINGUIST, V12, P97, DOI 10.1515/cogl.12.2.97; Berman RA, 2008, J CHILD LANG, V35, P735, DOI 10.1017/S0305000908008787; BARDOVIHARLIG K, 1992, TESOL QUART, V26, P390, DOI 10.2307/3587016; Bassano D, 2007, DEVELOPMENTAL SCI, V10, P588, DOI 10.1111/j.1467-7687.2007.00629.x; Berman RA, 2007, DISCOURSE PROCESS, V43, P79, DOI 10.1207/s15326950dp4302_1; Byrnes Heidi, 2010, MODERN LANGUAGE J S1, V94; CROOKES G, 1990, APPL LINGUIST, V11, P183, DOI 10.1093/applin/11.2.183; De Jong N., 2012, APPL PSYCHOLINGUIST, V34, P893; Fang ZH, 2006, J LIT RES, V38, P247, DOI 10.1207/s15548430jlr3803_1; Halliday M. A. K., 1993, WRITING SCI LITERACY; Halliday M. A. K., 1999, CONSTRUING EXPERIENC; Hunt K. W., 1965, GRAMMATICAL STRUCTUR; Kormos J., 2004, SYSTEM, V32, P145, DOI DOI 10.1016/J.SYSTEM.2004.01.001; Munro Murray J., 2001, STUDIES 2 LANGUAGE A, V23, P451; Nippold M., 2004, LANGUAGE DEV CHILDHO, P1; Norris JM, 2012, TRENDS APPL LINGUIST, V6, P221; Ravid Dorit, 2010, FIRST LANG, V30, P3, DOI DOI 10.1177/0142723709350531; Robinson P., 2011, 2 LANGUAGE TASK COMP; RUBIN DL, 1982, J CHILD LANG, V9, P497; RUBIN DL, 1979, RES TEACH ENGL, V13, P293; Schmid M., 2011, DYNAMIC APPROACH 2 L, P39; Skehan P., 2014, PROCESSING PERSPECTI; Thewissen J, 2013, MOD LANG J, V97, P77, DOI 10.1111/j.1540-4781.2012.01422.x; Towell R., 2005, FOCUS FRENCH FOREIGN, P210; Vedder I., 2012, DIMENSIONS L2 PERFOR; Verspoor M. H., 2011, DYNAMIC APPROACH 2 L; White R., 1995, GUIDELINES, V17, P93; Yule G, 1997, REFERENTIAL COMMUNIC	37	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6001	1477-450X		APPL LINGUIST	Appl. Lingusit	DEC	2014	35	5					607	614		10.1093/applin/amu047		8	Linguistics	Linguistics	AU7ZC	WOS:000345815700006		
J	Igarashi, T				Igarashi, Taro			Winner Boundary Window, Tokyo, Japan	ARCHITECTURAL REVIEW			English	Article									Tohoku Univ, Sendai, Miyagi 980, Japan	Igarashi, T (reprint author), Tohoku Univ, Sendai, Miyagi 980, Japan.							0	0	0	EMAP BUSINESS PUBLISHING LTD	LONDON	151 ROSEBERY AVE, LONDON EC1R 4QX, ENGLAND	0003-861X			ARCHIT REV	Archit. Rev.	DEC	2014	236	1414					38	47				12	Architecture	Architecture	AU4WS	WOS:000345609900011		
J	Lee, KD; Choi, SH; Kim, DH; Lee, HY; Choi, KC				Lee, Kyung Dong; Choi, Seon-Hee; Kim, Da Hye; Lee, Hye-Young; Choi, Ki-Choon			Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting	ARCHIVES OF PHARMACAL RESEARCH			English	Article						Folic acid; Dextran succinate; Polyelectrolyte complex; Chitosan; Nanoparticle	IRON-OXIDE NANOPARTICLES; ION-COMPLEX FORMATION; TRANS-RETINOIC ACID; INCORPORATED NANOPARTICLES; ANTITUMOR-ACTIVITY; GENE DELIVERY; GLIOMA-CELLS; CARCINOMA; MICELLES; CARRIER	Folic acid-decorated self-organized nanoparticles were fabricated to target folate receptor of cancer cells. Doxorubicin (DOX) was conjugated with carboxyl group of dextran backbone using succinic anhydride (DexSU-DOX). DOX-loaded self-organized nanoparticles were prepared by complexation with folic acid-grafted chitosan (ChitoFA) and DexSU-DOX. Nanoparticles in the aqueous environment have spherical shapes with average size less than 100 nm and their sizes were increased by coated with ChitoPEG or ChitoFA. At cell culture study with KB cells, ChitoFA coated nanoparticles (FADex NP) revealed folate-receptor mediated endocytosis to cancer cells and cell viability was significantly changed by folate receptor targeting. Tumor xenograft model of KB cells also showed similar results, i.e. FAdex NP efficiently inhibited growth of tumor compared to the treatment group with blocking of folate receptor. These results indicated that DOX-loaded nanoparticles of FADex NP are promising vehicle for anticancer drug targeting.	[Lee, Kyung Dong] Dongsin Univ, Dept Oriental Med Mat, Naju 520714, South Korea; [Choi, Seon-Hee] Pusan Natl Univ, Sch Med, Dept Med Sci, Yangsan 626770, Gyeonnam, South Korea; [Kim, Da Hye] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane, Japan; [Lee, Hye-Young] Yeonsung Univ, Dept Beauty Stylist, Anyang 430749, Gyeonggido, South Korea; [Choi, Ki-Choon] Rural Dev Adm, Natl Inst Anim Sci, Grassland & Forages Res Ctr, Cheonan 331808, Chungnam, South Korea	Choi, KC (reprint author), Rural Dev Adm, Natl Inst Anim Sci, Grassland & Forages Res Ctr, Cheonan 331808, Chungnam, South Korea.	choiwh@korea.kr					Dosio F, 2010, CURR OPIN INVEST DR, V11, P1424; Bowman K, 2006, INT J NANOMED, V1, P117, DOI 10.2147/nano.2006.1.2.117; Jeong YI, 2012, COLLOID SURFACE B, V90, P28, DOI 10.1016/j.colsurfb.2011.09.043; Jeong YI, 2010, COLLOID SURFACE B, V79, P149, DOI 10.1016/j.colsurfb.2010.03.037; Cabral H, 2011, NAT NANOTECHNOL, V6, P815, DOI [10.1038/nnano.2011.166, 10.1038/NNANO.2011.166]; Cadee JA, 2000, J BIOMED MATER RES, V50, P397; GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245; Jeong YI, 2008, J PHARM SCI-US, V97, P1268, DOI 10.1002/jps.21103; Zhou XJ, 2012, INT J NANOMED, V7, P5465, DOI 10.2147/IJN.S33965; Akiyoshi K, 1998, J CONTROL RELEASE, V54, P313, DOI 10.1016/S0168-3659(98)00017-0; Mbakidi JP, 2013, BIOORG MED CHEM LETT, V23, P2486, DOI 10.1016/j.bmcl.2013.03.039; Jeong YI, 2006, J PHARM SCI-US, V95, P2348, DOI 10.1002/jps.20586; Saito S, 2012, INT J NANOMED, V7, P5415, DOI 10.2147/IJN.S33709; Kumar M, 2012, INT J NANOMED, V7, P3503, DOI 10.2147/IJN.S32694; Lee HY, 2011, INT J NANOMED, V6, P2879, DOI 10.2147/IJN.S26458; Ichinose K, 2000, ANTI-CANCER DRUG, V11, P33, DOI 10.1097/00001813-200001000-00006; Janes KA, 2001, ADV DRUG DELIVER REV, V47, P83, DOI 10.1016/S0169-409X(00)00123-X; Jeong YI, 2013, INT J NANOMED, V8, P485, DOI 10.2147/IJN.S40580; Wang W, 2012, INT J NANOMED, V7, P2513, DOI 10.2147/IJN.S31915; Lim SH, 2010, INT J PHARMACEUT, V387, P209, DOI 10.1016/j.ijpharm.2009.11.023; Liu XY, 2012, INT J NANOMED, V7, P2853, DOI 10.2147/IJN.S29788; Modi S, 2006, CURR PHARM DESIGN, V12, P4785, DOI 10.2174/138161206779026272; Zwicke GL, 2012, NANO REV, P3	23	1	1	PHARMACEUTICAL SOC KOREA	SEOUL	1489-3 SUHCHO-DONG, SUHCHO-KU, SEOUL 137-071, SOUTH KOREA	0253-6269	1976-3786		ARCH PHARM RES	Arch. Pharm. Res.	DEC	2014	37	12					1546	1553		10.1007/s12272-014-0489-z		8	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU5GW	WOS:000345636000006		
J	Furukawa, M; Miyata, K; Kawasome, C; Himeda, Y; Takeuchi, K; Koga, T; Hirao, Y; Umehara, K				Furukawa, Masayuki; Miyata, Kenichi; Kawasome, Chie; Himeda, Yoshiko; Takeuchi, Kenji; Koga, Toshihisa; Hirao, Yukihiro; Umehara, Ken			Liquid chromatography-tandem mass spectrometry method for determining tolvaptan and its nine metabolites in rat serum: application to a pharmacokinetic study	ARCHIVES OF PHARMACAL RESEARCH			English	Article						Tolvaptan; Metabolite; Pharmacokinetics; LC-MS/MS; Serum; Rat	VASOPRESSIN V-2-RECEPTOR ANTAGONIST; OPC-41061; POTENT	Tolvaptan is a competitive vasopressin V-2-receptor antagonist that inhibits water reabsorption in the renal collecting ducts. A selective and sensitive liquid chromatography-tandem mass spectrometry method for determining tolvaptan and its nine metabolites in rat serum was developed and validated. An analogue of tolvaptan was used as an internal standard. Sample preparation involved protein precipitation following solid-phase extraction. Chromatographic separation was performed on a C-18 reversed-phase column with a linear gradient elution. The flow rate was 0.25 mL/min, and total run time was 30 min. The analytes were detected by tandem mass spectrometry using an electrospray ionization interface in positive ion mode and multiple reaction monitoring. The calibration curve showed linearity over the concentration range from 5 to 1,000 ng/mL for each analyte. The lower limit of quantification using 0.1 mL of rat serum was 5 ng/mL for each analyte. Precision did not exceed 5.7 %, and accuracy as relative error were within +/- A 7.5 % for all analytes. The validated method was successfully applied to evaluate the pharmacokinetics of oral tolvaptan in rats, indicating the systemic exposure to tolvaptan in females eight times larger than that in males.	[Furukawa, Masayuki; Kawasome, Chie; Himeda, Yoshiko; Takeuchi, Kenji; Koga, Toshihisa; Hirao, Yukihiro; Umehara, Ken] Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, Kawaguchi, Tokushima 7710192, Japan; [Miyata, Kenichi] Otsuka Pharmaceut Co Ltd, Formulat Res Inst, Kawaguchi, Tokushima 7710182, Japan	Furukawa, M (reprint author), Otsuka Pharmaceut Co Ltd, Tokushima Res Inst, 463-10 Kagasuno, Kawaguchi, Tokushima 7710192, Japan.	Furukawa.Masayuki@otsuka.jp					Yamamura Y, 1998, J PHARMACOL EXP THER, V287, P860; Pei Q, 2013, J CHROMATOGR B, V913, P84, DOI 10.1016/j.jchromb.2012.11.027; Shoaf SE, 2011, J CLIN PHARMACOL, V51, P761, DOI 10.1177/0091270010376193; Dixon Megan B, 2008, Ther Clin Risk Manag, V4, P1149; Furukawa M, 2011, TOLVAPTAN CARDIOV S1, V25, pS83; Ghali JK, 2009, NAT REV DRUG DISCOV, V8, P611, DOI 10.1038/nrd2946; Hori Masatsugu, 2011, Cardiovasc Drugs Ther, V25 Suppl 1, pS1, DOI 10.1007/s10557-011-6298-4; KATO R, 1992, TOXICOL LETT, V64-5, P661, DOI 10.1016/0378-4274(92)90245-F; Kondo K, 1999, BIOORGAN MED CHEM, V7, P1743, DOI 10.1016/S0968-0896(99)00101-7; Miyazaki T, 2007, CARDIOVASC DRUG REV, V25, P1; Miyazaki T, 2013, HEPATOL RES, V43, P1224, DOI 10.1111/hepr.12073; Sakaide I., 2013, J INT MED RES, V41, P835	12	1	1	PHARMACEUTICAL SOC KOREA	SEOUL	1489-3 SUHCHO-DONG, SUHCHO-KU, SEOUL 137-071, SOUTH KOREA	0253-6269	1976-3786		ARCH PHARM RES	Arch. Pharm. Res.	DEC	2014	37	12					1578	1587		10.1007/s12272-014-0352-2		10	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AU5GW	WOS:000345636000010		
J	Takeda, K; Kawamoto, Y; Iida, M; Omata, Y; Zou, CC; Kato, M				Takeda, Kozue; Kawamoto, Yoshiyuki; Iida, Machiko; Omata, Yasuhiro; Zou, Cunchao; Kato, Masashi			Commentary to Pastore et al. (2014): Epidermal growth factor receptor signaling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors	ARCHIVES OF TOXICOLOGY			English	Editorial Material							ACTIVE PROTEIN-KINASES; RET; ACTIVATION		[Takeda, Kozue; Kawamoto, Yoshiyuki] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Unit Environm Hlth Sci, Kasugai, Aichi 4878501, Japan; [Iida, Machiko; Omata, Yasuhiro; Zou, Cunchao; Kato, Masashi] Nagoya Univ, Dept Occupat & Environm Hlth, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan	Kato, M (reprint author), Nagoya Univ, Dept Occupat & Environm Hlth, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	katomasa@med.nagoya-u.ac.jp					Adly MA, 2008, J AM ACAD DERMATOL, V58, P238, DOI 10.1016/j.jaad.2007.10.014; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kato M, 2000, MOL BIOL CELL, V11, P93; Narita N, 2009, ONCOGENE, V28, P3058, DOI 10.1038/onc.2009.164; Pastore S, 2014, ARCH TOXICOL, V88, P1189, DOI 10.1007/s00204-014-1244-4; Kawamoto Y, 2004, J BIOL CHEM, V279, P14213, DOI 10.1074/jbc.M312600200; El-Abaseri TB, 2005, CANCER RES, V65, P3958, DOI 10.1158/0008-5472.CAN-04-2204; Kato M, 2010, J CELL BIOCHEM, V110, P399, DOI 10.1002/jcb.22550; Knight JDR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000982; Lichtenberger Beate M, 2013, Sci Transl Med, V5, p199ra111, DOI 10.1126/scitranslmed.3005886; Mascia F, 2013, SCI TRANSL MED, V5, DOI DOI 10.1126/SCITRANSLMED.3005773; NAKAMURA K, 1993, ONCOGENE, V8, P3133; Nakashima I, 2011, ENZYME RES, V2011; Ohshima Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010279; PASTORE, 2014, ARCH TOXICOL, V88, P1189; Takeda K, 2006, FEBS LETT, V580, P839, DOI 10.1016/j.febslet.2006.01.005; Takeda K, 2001, ANTIOXID REDOX SIGN, V3, P473, DOI 10.1089/15230860152409103	17	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5761	1432-0738		ARCH TOXICOL	Arch. Toxicol.	DEC	2014	88	12					2319	2320		10.1007/s00204-014-1373-9		2	Toxicology	Toxicology	AU6GG	WOS:000345701100019		
J	Akasaki, Y; Alvarez-Garcia, O; Saito, M; Carames, B; Iwamoto, Y; Lotz, MK				Akasaki, Yukio; Alvarez-Garcia, Oscar; Saito, Masahiko; Carames, Beatriz; Iwamoto, Yukihide; Lotz, Martin K.			FoxO Transcription Factors Support Oxidative Stress Resistance in Human Chondrocytes	ARTHRITIS & RHEUMATOLOGY			English	Article							PLACEBO-CONTROLLED TRIALS; PAIN CLINICAL-TRIALS; KNEE OSTEOARTHRITIS; IMMPACT RECOMMENDATIONS; OARSI RECOMMENDATIONS; CONTINUOUS OUTCOMES; ASSAY SENSITIVITY; REPORT DATABASE; METAANALYSIS; HIP	Objective. A major signaling pathway that regulates cellular aging is the insulin/insulin-like growth factor 1 (IGF-1)/phosphatidylinositol 3-kinase (PI3K)/ Akt/FoxO transcription factor axis. We previously observed that FoxO transcription factors are dysregulated in aged and OA cartilage. The objective of this study was to investigate the impact of down-regulated FoxO transcription factors on chondrocytes. Methods. Small interfering RNAs (siRNAs) targeting FOXO1 (siFOXO1) and FOXO3 (siFOXO3) were transfected into human articular chondrocytes. Cell viability following treatment with the oxidant tert-butylhydroperoxide (tBHP) was measured by MTT assay. Caspase 3/7 activation and apoptotic cells were examined. Gene and protein expression of antioxidant proteins and autophagy-related proteins and changes in inflammatory mediators following treatment with interleukin-1 were assessed. Cells transfected with FOXO plasmids were also analyzed. Results. Cell viability was significantly reduced by siFOXO after treatment with tBHP. Apoptosis accompanied by caspase activation was significantly increased in siFOXO-transfected chondrocytes. Knockdown of FOXO1 and FOXO1 3 resulted in significant reductions in levels of glutathione peroxidase 1 (GPX-1), catalase, light chain 3 (LC3), Beclin1, and sirtuin 1 (SIRT-1) proteins following treatment with tBHP. In contrast, the constitutive active form of FOXO3 increased cell viability while inducing GPX-1, Beclin1, and LC3 in response to tBHP. Expression and production of ADAMTS-4 and chemerin were significantly increased in siFOXO-transfected chondrocytes. Conclusion. Reduced expression of FoxO transcription factors in chondrocytes increased susceptibility to cell death induced by oxidative stress. This was associated with reduced levels of antioxidant proteins and autophagy-related proteins. Our data provide evidence for a key role of FoxO transcription factors as regulators of chondrocyte oxidative stress resistance and tissue homeostasis.	[Akasaki, Yukio; Alvarez-Garcia, Oscar; Saito, Masahiko; Carames, Beatriz; Lotz, Martin K.] Scripps Res Inst, La Jolla, CA 92037 USA; [Iwamoto, Yukihide] Kyushu Univ, Fukuoka 812, Japan	Lotz, MK (reprint author), Scripps Res Inst, Dept Mol & Expt Med MEM 161, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	mlotz@scripps.edu			NIH [AG-007996]; Sam and Rose Stein Endowment Fund	Supported by NIH grant AG-007996 and the Sam and Rose Stein Endowment Fund.	Dworkin RH, 2010, PAIN, V150, P12, DOI 10.1016/j.pain.2010.02.002; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Curtin F, 2002, STAT MED, V21, P2131, DOI 10.1002/sim.1205; Quessy SN, 2008, PAIN, V138, P479, DOI 10.1016/j.pain.2008.06.024; Berlin JA, 2002, STAT MED, V21, P371, DOI 10.1002/sim.1023; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Doherty M, 2009, OSTEOARTHR CARTILAGE, V17, P1255, DOI 10.1016/j.joca.2009.03.023; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Hauser W, 2011, PAIN, V152, P1709, DOI 10.1016/j.pain.2011.01.050; Katz N, 2005, NEUROLOGY, V65, pS32; Trijau S, 2010, OSTEOARTHR CARTILAGE, V18, P1012, DOI 10.1016/j.joca.2010.04.005; Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI [10.1016/j.joca.2007.12.013, 10.1016/j.joca.2010.01.013]; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Hedges LV, 2010, RES SYNTH METHODS, V1, P39, DOI 10.1002/jrsm.5; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI [10.7326/0003-4819-155-1-201107050-00006, 10.1059/0003-4819-155-1-201107050-00006]; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Bjordal JM, 2007, EUR J PAIN, V11, P125, DOI 10.1016/j.ejpain.2006.02.013; Reichenbach S, 2007, ANN INTERN MED, V146, P580; Dworkin RH, 2012, PAIN, V153, P1148, DOI 10.1016/j.pain.2012.03.003; Irizarry MC, 2009, CLIN J PAIN, V25, P469, DOI 10.1097/AJP.0b013e31819ddded; Gewandter JS, 2014, PAIN, V155, P1683, DOI 10.1016/j.pain.2014.05.025; Bafeta A, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e813; Dworkin RH, 2011, PAIN, V152, pS107, DOI 10.1016/j.pain.2010.11.008; Dworkin RH, 2011, OSTEOARTHR CARTILAGE, V19, P483, DOI 10.1016/j.joca.2011.02.020; Dworkin RH, 2013, NEUROLOGY, V81, P1; European Medicines Agency, 2001, INT C HARM TOP E10 C; Farrar JT, 2014, PAIN, V155, P1622, DOI 10.1016/j.pain.2014.05.009; Gentelle-Bonnassies S, 2000, ARTHRIT CARE RES, V13, P280, DOI 10.1002/1529-0131(200010)13:5<280::AID-ANR6>3.0.CO;2-6; Greene K, 2012, PAIN, V153, P1794, DOI 10.1016/j.pain.2012.06.004; Harris RE, 2005, ARTHRITIS RHEUM, V52, P3670, DOI 10.1002/art.21407; Higgins JP, 2008, COCHRANE HDB SYSTEMA; Institute of Medicine (US) Forum on Drug Discovery Development and Translation, 2010, WORKSH SUMM; Jensen MP, 2011, HDB PAIN ASSESSMENT, P19; National Collaborating Centre for Chronic Conditions, 2008, OST NAT CLIN GUID CA; Nuesch E, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3515; Rappaport BA, 2010, ANESTHESIOLOGY, V112, P509, DOI 10.1097/ALN.0b013e3181cf4279; Scott-Lennox JA, 2001, ARTHRITIS RHEUM, V44, P1599, DOI 10.1002/1529-0131(200107)44:7<1599::AID-ART283>3.0.CO;2-N; Svensson O, 2006, ANN RHEUM DIS, V65, P781, DOI 10.1136/ard.2005.040519; Wandel S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4675; Whitehead A, 2002, METAANALYSIS CONTROL	43	13	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	DEC	2014	66	12					3349	3358		10.1002/art.38868		10	Rheumatology	Rheumatology	AU4HK	WOS:000345571200012		
J	Terao, C; Ohmura, K; Yamada, R; Kawaguchi, T; Shimizu, M; Tabara, Y; Takahashi, M; Setoh, K; Nakayama, T; Kosugi, S; Sekine, A; Matsuda, F; Mimori, T				Terao, Chikashi; Ohmura, Koichiro; Yamada, Ryo; Kawaguchi, Takahisa; Shimizu, Masakazu; Tabara, Yasuharu; Takahashi, Meiko; Setoh, Kazuya; Nakayama, Takeo; Kosugi, Shinji; Sekine, Akihiro; Matsuda, Fumihiko; Mimori, Tsuneyo		Nagahama Study Grp	Association Between Antinuclear Antibodies and the HLA Class II Locus and Heterogeneous Characteristics of Staining Patterns The Nagahama Study	ARTHRITIS & RHEUMATOLOGY			English	Article							AICARDI-GOUTIERES-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DNA-DEGRADATION ACTIVITY; EXONUCLEASE TREX1; MUTATIONS; GENE; VASCULOPATHY	Objective. While antinuclear antibodies (ANAs) are observed in healthy populations as well as in patients with autoimmune diseases such as systemic lupus erythematosus (SLE), the detailed genetic background of ANAs has remained unclear. We undertook this study to identify the genetic determinants of ANAs in the general population in order to elucidate the underlying mechanisms of ANA production and to distinguish disease susceptibility genes from ANA production genes. Methods. A total of 9,575 Japanese volunteers were registered, and their ANA levels were quantified using indirect immunofluorescence to analyze correlates of ANA positivity. Genetic studies were performed using 7,148 of the 9,575 subjects. We performed a genome-wide association study using 3,185 subjects genotyped for 303,506 single-nucleotide polymorphisms (SNPs), followed by a replication study of 3,963 subjects. HLA-DRB1 and HLA-DQB1 alleles were imputed, and associations between ANA positivity and the SNPs or the HLA alleles associated with SLE were analyzed. Results. Female sex and old age were associated with ANA positivity, except for the nucleolar pattern. The T allele of rs2395185 in the HLA locus, which was in moderate linkage disequilibrium with HLADRB1* 0405, was significantly associated with ANA positivity (P 1.3 10 11). The T allele of rs2395185 displayed increasing effects on the frequency of speckled and homogeneous patterns (P 7.5 10 12 and P 2.2 10 11, respectively) but decreasing effects on the frequency of the nucleolar pattern (P 0.0045). The 7 SNPs and 4 HLA-DRB1 alleles associated with SLE did not display strong associations with ANA positivity. Conclusion. SNP rs2395185 linked with HLADRB1* 0405 is a genetic determinant of ANA production in the Japanese population. Overlapping of loci for susceptibility to SLE and to ANA positivity was limited. The nucleolar pattern showed different associations from other staining patterns, both with correlates of ANA positivity and with the HLA locus.	[Terao, Chikashi; Ohmura, Koichiro; Yamada, Ryo; Kawaguchi, Takahisa; Shimizu, Masakazu; Tabara, Yasuharu; Takahashi, Meiko; Setoh, Kazuya; Nakayama, Takeo; Kosugi, Shinji; Sekine, Akihiro; Matsuda, Fumihiko; Mimori, Tsuneyo] Kyoto Univ, Kyoto 6068507, Japan	Terao, C (reprint author), Kyoto Univ, Grad Sch Med, Ctr Genom Med, Sakyo Ku, Shogoin Kawahara Cho 54, Kyoto 6068507, Japan.	a0001101@kuhp.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kyoto University; Japan Society for the Promotion of Science; Takeda Science Foundation	Supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant-in-Aid for Scientific Research), Kyoto University (University Grant), the Japan Society for the Promotion of Science (Program for Enhancing Systematic Education in Graduate School Grant), and the Takeda Science Foundation (research grant).	Zhou Q, 2014, NEW ENGL J MED, V370, P911, DOI 10.1056/NEJMoa1307361; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Olivieri I, 2013, LUPUS, V22, P1064, DOI 10.1177/0961203313498800; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; Lee-Kirsch MA, 2007, J MOL MED-JMM, V85, P531, DOI 10.1007/s00109-007-0199-9; Sestak AL, 2011, ANN RHEUM DIS, V70, pI37, DOI 10.1136/ard.2010.138057; Lehtinen DA, 2008, J BIOL CHEM, V283, P31649, DOI 10.1074/jbc.M806155200; Bhattacharyya S, 2011, P NATL ACAD SCI USA, V108, P9554, DOI 10.1073/pnas.1017296108; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Vogt J, 2013, AM J MED GENET A, V161A, P338, DOI 10.1002/ajmg.a.35712; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; DesSilva U, 2007, J BIOL CHEM, V282, P10537; Elkan PN, 2014, NEW ENGL J MED, V370, P921, DOI 10.1056/NEJMoa1307362; Orebaugh CD, 2011, J BIOL CHEM, V286, P40246, DOI 10.1074/jbc.M111.297903	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	DEC	2014	66	12					3395	3403		10.1002/art.38867		9	Rheumatology	Rheumatology	AU4HK	WOS:000345571200017		
J	Muro, Y; Nakashima, R; Hosono, Y; Sugiura, K; Mimori, T; Akiyama, M				Muro, Yoshinao; Nakashima, Ran; Hosono, Yuji; Sugiura, Kazumitsu; Mimori, Tsuneyo; Akiyama, Masashi			Autoantibodies to DNA Mismatch Repair Enzymes in Polymyositis/Dermatomyositis and Other Autoimmune Diseases: A Possible Marker of Favorable Prognosis	ARTHRITIS & RHEUMATOLOGY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; FLI-1 TRANSCRIPTION FACTOR; TUBULAR EPITHELIAL-CELLS; ETS FAMILY; LEUKEMIA-VIRUS; RENAL-DISEASE; T-CELLS; IL-6; NEPHRITIS; MICE	Objective. Myositis-specific autoantibodies (MSAs) are useful tools for identifying clinical subsets of patients with idiopathic inflammatory myopathies (IIMs). There have been few reports on antibodies to some DNA mismatch repair enzymes (MMREs) in patients with IIMs. This study was undertaken to determine the frequencies and clinical associations of antibodies to 7 types of MMREs (MLH1, MLH3, MSH2, MSH3, MSH6, PMS1, and PMS2) in patients with IIMs and other systemic autoimmune diseases. Methods. Clinical data and serum samples were collected from 239 Japanese patients with IIMs (147 with adult dermatomyositis, 13 with juvenile dermatomyositis, 57 with polymyositis, and 22 with myositis overlap syndrome). One hundred patients with other diseases, including 40 with systemic lupus erythematosus (SLE), were assessed as disease controls. The presence of anti-MMRE antibodies in serum was examined by immunoprecipitation, enzyme-linked immunosorbent assay, and immunoprecipitation/Western blotting. Results. Anti-MMRE antibodies were found in 15 patients with IIMs and 3 patients with SLE. They were restricted to MLH1, PMS1, MSH2, and PMS2, with simultaneous positivity for more than one of these antibodies occurring in some patients. Nine IIM pa-tients with anti-MMREs also had other MSAs and their associated clinical features. All patients with antiMMREs were still living at the time of the present analysis. Conclusion. Anti-MMRE antibodies, which often coexist with other MSAs, may be serologic markers for good prognosis in IIMs.	[Muro, Yoshinao; Sugiura, Kazumitsu; Akiyama, Masashi] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4668550, Japan; [Nakashima, Ran; Hosono, Yuji; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Kyoto, Japan	Muro, Y (reprint author), Nagoya Univ, Grad Sch Med, Dept Dermatol, Div Connect Tissue Dis & Autoimmun,Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	ymuro@med.nagoya-u.ac.jp	Sugiura, Kazumitsu /M-8913-2014; MURO, Yoshinao/M-8883-2014; 	Sugiura, Kazumitsu /0000-0002-5207-4592; Muro, Yoshinao/0000-0003-2329-8375	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23591618, 23249058]; Ministry of Health, Labor, and Welfare of Japan	Supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (grants 23591618 to Dr. Muro and 23249058 to Dr. Akiyama) and the Ministry of Health, Labor, and Welfare of Japan (grant to Dr. Muro).	ALEXOPOULOS E, 1990, KIDNEY INT, V37, P100, DOI 10.1038/ki.1990.14; Anderson MK, 1999, DEVELOPMENT, V126, P3131; ANDUS T, 1987, FEBS LETT, V221, P18, DOI 10.1016/0014-5793(87)80344-7; Thaler R, 2011, J BIOL CHEM, V286, P5578, DOI 10.1074/jbc.M110.166181; Hill GS, 2002, KIDNEY INT, V61, P2176, DOI 10.1046/j.1523-1755.2002.00357.x; Sabry A, 2006, CYTOKINE, V35, P148, DOI 10.1016/j.cyto.2006.07.023; OKADA M, 1988, J IMMUNOL, V141, P1543; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; Zhang XK, 2004, J IMMUNOL, V173, P6481; LINKERISRAELI M, 1991, J IMMUNOL, V147, P117; BENDAVID Y, 1991, GENE DEV, V5, P908, DOI 10.1101/gad.5.6.908; TAKEMURA T, 1994, VIRCHOWS ARCH, V424, P459; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Zhang XK, 2008, J IMMUNOL, V181, P1644; Apostolidis SA, 2011, J INTERF CYTOK RES, V31, P769, DOI 10.1089/jir.2011.0029; Suzuki E, 2012, CLIN IMMUNOL, V145, P201, DOI 10.1016/j.clim.2012.09.006; Spyropoulos DD, 2000, MOL CELL BIOL, V20, P5643, DOI 10.1128/MCB.20.15.5643-5652.2000; Chun HY, 2007, J CLIN IMMUNOL, V27, P461, DOI 10.1007/s10875-007-9104-0; Viedt C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015609.31253.7F; ZHANG LQ, 1995, MOL CELL BIOL, V15, P6961; Mathenia J, 2010, CLIN EXP IMMUNOL, V162, P362, DOI 10.1111/j.1365-2249.2010.04245.x; Illei GG, 2010, ARTHRITIS RHEUM-US, V62, P542, DOI 10.1002/art.27221; Borchers AT, 2012, AUTOIMMUN REV, V12, P174, DOI 10.1016/j.autrev.2012.08.018; TANG B, 1991, INT IMMUNOL, V3, P273, DOI 10.1093/intimm/3.3.273; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Yoshizaki K, 1998, SPRINGER SEMIN IMMUN, V20, P247, DOI 10.1007/BF00832010; Svenson JL, 2010, GENES IMMUN, V11, P161, DOI 10.1038/gene.2009.73; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Liang BL, 2006, IMMUNOLOGY, V119, P296, DOI 10.1111/j.1365-2567.2006.02433.x; Sato S, 2014, CLIN EXP IMMUNOL, V177, P102, DOI 10.1111/cei.12310; KIBERD BA, 1993, J AM SOC NEPHROL, V4, P58; Ohl K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432595; Cash H, 2010, J RHEUMATOL, V37, P60, DOI 10.3899/jrheum.090194; BOUCHER A, 1986, KIDNEY INT, V29, P1043, DOI 10.1038/ki.1986.105; CASTIGLIONE A, 1988, NEPHRON, V50, P14, DOI 10.1159/000185110; Czuwara-Ladykowska J, 2001, J BIOL CHEM, V276, P20839, DOI 10.1074/jbc.M010133200; DAMICO G, 1995, AM J KIDNEY DIS, V26, P124, DOI 10.1016/0272-6386(95)90165-5; FUKATSU A, 1991, LAB INVEST, V65, P61; FUKATSU A, 1993, LAB INVEST, V69, P58; Georgiou P, 1996, INT J ONCOL, V9, P9; HIRANO T, 1988, IMMUNOL LETT, V17, P41, DOI 10.1016/0165-2478(88)90099-5; Hodge DR, 1996, ONCOGENE, V12, P11; Keller ET, 1996, FRONT BIOSCI, V1, P340; Nowling TK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3528; Papas Takis S., 1997, Leukemia (Basingstoke), V11, P557; TANABE O, 1988, J IMMUNOL, V141, P3875	50	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	DEC	2014	66	12					3457	3462		10.1002/art.38866		6	Rheumatology	Rheumatology	AU4HK	WOS:000345571200023		
J	Hirata, S; Hanami, K; Marotta, A; Tanaka, Y				Hirata, Shintaro; Hanami, Kentaro; Marotta, Anthony; Tanaka, Yoshiya			14-3-3eta Informs Joint Pathological Mechanisms of Treatment Response to Assist with T2T Strategies	ARTHRITIS & RHEUMATOLOGY			English	Meeting Abstract									[Hirata, Shintaro; Hanami, Kentaro; Tanaka, Yoshiya] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka 807, Japan; [Marotta, Anthony] Augurex Life Sci Corp, N Vancouver, BC, Canada								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2326-5191	2326-5205		ARTHRITIS RHEUMATOL	Arthritis Rheumatol.	DEC	2014	66	12				L18	3537	3537				1	Rheumatology	Rheumatology	AU4HK	WOS:000345571200054		
J	Kaya, M; Suziki, T; Minowa, T; Yamashita, T				Kaya, Mitsunori; Suziki, Tomoyuki; Minowa, Takeshi; Yamashita, Toshihiko			Ligamentum Teres Injury Is Associated With the Articular Damage Pattern in Patients With Femoroacetabular Impingement	ARTHROSCOPY-THE JOURNAL OF ARTHROSCOPIC AND RELATED SURGERY			English	Article							HIP ARTHROSCOPY; OUTCOMES; CLASSIFICATION; DYSPLASIA; PATHOLOGY; TEARS	Purpose: The objective of this study was to investigate the association between ligamentum teres injury and the hip joint cartilage damage pattern in patients with femoroacetabular impingement. Methods: We compared articular cartilage damage between ligamentum terese-intact and ruptured hips. Data were collected for 77 consecutive patients with femoroacetabular impingement who underwent hip arthroscopy. The locations of the chondral lesions were recorded on anatomic articular maps using the geographic zone method. The patients were divided into 2 groups (ligamentum teres-intact and-injured groups), and the incidence and degree of cartilage injury were compared between the 2 groups by use of the Mann-Whitney U test. Results: In patients with ligamentum teres injury, chondral damage extended to the middle-inferior area of the acetabulum (7.6% [ grade 1] in ligamentum tereseintact group and 66.6% [ grade 1, 12.1%; grade 2, 42.4%; grade 3, 12.1%] in ligamentum tereseinjured group, P <.01) and the apex of the femoral head (anterior apex: 7.1% [ grade 1, 3.8%; grade 2, 3.3%] in intact group and 42.4% [ grade 1, 30.3%; grade 2, 12.1%] in injured group, P <.01; middle apex: 7.6% [ grade 1, 3.8%; grade 2, 3.8%] in intact group and 63.5% [ grade 1, 42.4%; grade 2, 18.1%; grade 3, 3.0%] in injured group, P 04; posterior apex: 7.6% [ grade 1, 3.8%; grade 2, 3.8%] in intact group and 42.4% [ grade 1, 30.3%; grade 2, 12.1%] in injured group, P <.01). Conclusions: This study showed the association between ligamentum teres injury and articular cartilage damage in the inferior middle part of the acetabulum and the apex of the femoral head in patients treated for femoroacetabular impingement.	[Kaya, Mitsunori; Suziki, Tomoyuki; Yamashita, Toshihiko] Sapporo Med Univ, Sch Med, Dept Orthoped Surg, Sapporo, Hokkaido 0608543, Japan; [Minowa, Takeshi] Asari Chuo Hosp, Otaru, Hokkaido, Japan	Kaya, M (reprint author), Sapporo Med Univ, Sch Med, Dept Orthoped Surg, Chuo Ku, S-1,W-16, Sapporo, Hokkaido 0608543, Japan.	kayamitsunori@yahoo.co.jp					Amenabar Tomas, 2012, Arthrosc Tech, V1, pe169, DOI 10.1016/j.eats.2012.07.002; Philippon MJ, 2010, AM J SPORT MED, V38, P99, DOI 10.1177/0363546509346393; Li GA, 2006, J BONE JOINT SURG AM, V88A, P1826, DOI 10.2106/JBJS.E.00539; Simpson JM, 2011, ARTHROSCOPY, V27, P436, DOI 10.1016/j.arthro.2010.09.016; Martin RL, 2013, KNEE SURG SPORT TR A, V21, P1689, DOI 10.1007/s00167-012-2262-5; Philippon MJ, 2012, J BONE JOINT SURG BR, V94B, P1494, DOI 10.1302/0301-620X.94B11.28576; Martin RL, 2012, KNEE SURG SPORT TR A, V20, P1209, DOI 10.1007/s00167-011-1663-1; Philippon MJ, 2009, ARTHROSCOPY, V25, P169, DOI 10.1016/j.arthro.2008.09.013; O'Donnell J, 2014, AM J SPORT MED, V42, P138, DOI 10.1177/0363546513510683; Ilizaliturri VM, 2008, ARTHROSCOPY, V24, P534, DOI 10.1016/j.arthro.2007.11.019; Byrd JWT, 2004, ARTHROSCOPY, V20, P385, DOI 10.1016/j.arthro.2004.01.025; Domb BG, 2013, AM J SPORT MED, V41, P2591, DOI 10.1177/0363546513499154; Gray AJR, 1997, ARTHROSCOPY, V13, P575, DOI 10.1016/S0749-8063(97)90182-1; Nelitz M, 1999, BRIT J RADIOL, V72, P331; Lynch TS, 2013, AM J SPORT MED, V41, P1174, DOI 10.1177/0363546513476281; Delaunay S, 1997, SKELETAL RADIOL, V26, P75; Botser IB, 2011, AM J SPORT MED, V39, p117S, DOI 10.1177/0363546511413865; Byrd JWT, 2001, CLIN SPORT MED, V20, P749; FREDENSBORG N, 1976, ACTA ORTHOP SCAND, V47, P403; Imam S, 2011, INT ORTHOP, V35, P1427, DOI 10.1007/s00264-011-1278-7; International Cartilage Repair Society (ICRS), 1998, ICRS NEWSL, P5; Kusuma M, 2004, ARTHROSCOPY, V20, P64; Lindner Dror, 2013, Arthrosc Tech, V2, pe21, DOI 10.1016/j.eats.2012.10.002; Philippon MJ, 2012, IOC MANUAL SPORTS IN, P310; Stone KR, 1997, OPERATIVE TECHNIQUES, V7, P305, DOI 10.1016/S1048-6666(97)80034-1; Villar RN, 1992, HIP ARTHROSCOPY; Wiberg G, 1939, ACTA CHIR SCAND    S, V83, P58; ZAMBER R W, 1989, Arthroscopy, V5, P258, DOI 10.1016/0749-8063(89)90139-4	28	1	1	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-8063	1526-3231		ARTHROSCOPY	Arthroscopy	DEC	2014	30	12					1582	1587		10.1016/j.arthro.2014.06.013		6	Orthopedics; Surgery	Orthopedics; Surgery	AU8OK	WOS:000345855700011		
J	Rudnitskii, AG; Safutdinov, ER; Popov, MV; Oreshko, VV; Potapov, VA; Gupta, Y; Sekido, M; Takefuji, K				Rudnitskii, A. G.; Safutdinov, E. R.; Popov, M. V.; Oreshko, V. V.; Potapov, V. A.; Gupta, Y.; Sekido, M.; Takefuji, K.			Pulsar distances estimated from the 21-cm absorption line	ASTRONOMY REPORTS			English	Article							ASTROMETRY; PARALLAXES	The radial velocities of the 21-cm absorption lines in the spectra of the pulsars B1937+21, J0332+5434, J0738-4042, J0835-4510, J1559-4438, J1645-0317, J1752-2806, J1825-0935, and J2157+4017 have been measured. Distance estimates have been obtained for six of these objects. The observations were conducted on the 34-m radio telescope of the Kashima Space TechnologyCenter (Japan) and the Giant Metrewave Radio Telescope (GMRT) in India. The data are in a good agreement with the results of other studies.	[Rudnitskii, A. G.; Safutdinov, E. R.; Popov, M. V.] Russian Acad Sci, PN Lebedev Phys Inst, Astro Space Ctr, Moscow 117997, Russia; [Oreshko, V. V.; Potapov, V. A.] Russian Acad Sci, PN Lebedev Phys Inst, Ctr Astro Space, Pushchino Radio Astron Observ, Pushchino 142290, Moscow Oblast, Russia; [Gupta, Y.] Tata Inst Fundamental Res, Natl Ctr Radio Astrophys, Pune 411007, Maharashtra, India; [Sekido, M.; Takefuji, K.] Natl Inst Informat & Communicat Technol, Kashima Space Technol Ctr, Ibaraki 3148501, Japan	Rudnitskii, AG (reprint author), Russian Acad Sci, PN Lebedev Phys Inst, Astro Space Ctr, Profsoyuznaya Ul 84-32, Moscow 117997, Russia.	almax1024@gmail.com	Popov, Mikhail/M-6118-2015; Rudnitskiy, Alexey/M-6073-2013; Oreshko, Vasily/N-2568-2015; Potapov, Vladimir/N-2975-2015; Safutdinov, Egor/O-9767-2015	Rudnitskiy, Alexey/0000-0003-1798-9444; 			Brisken WF, 2002, ASTROPHYS J, V571, P906, DOI 10.1086/340098; Fryer C, 1998, ASTROPHYS J, V496, P333, DOI 10.1086/305348; FICH M, 1989, ASTROPHYS J, V342, P272, DOI 10.1086/167591; TAYLOR JH, 1993, ASTROPHYS J, V411, P674, DOI 10.1086/172870; Chatterjee S, 2009, ASTROPHYS J, V698, P250, DOI 10.1088/0004-637X/698/1/250; KERR FJ, 1986, MON NOT R ASTRON SOC, V221, P1023; Manchester RN, 2005, ASTRON J, V129, P1993, DOI 10.1086/428488; Reid MJ, 2004, ASTROPHYS J, V616, P872, DOI 10.1086/424960; Soglasnov VA, 2004, ASTROPHYS J, V616, P439, DOI 10.1086/424908; Eisenhauer F, 2005, ASTROPHYS J, V628, P246, DOI 10.1086/430667; Verbiest JPW, 2009, MON NOT R ASTRON SOC, V400, P951, DOI 10.1111/j.1365-2966.2009.15508.x; Caraveo PA, 2001, ASTROPHYS J, V561, P930, DOI 10.1086/323377; Cordes J. M., 2003, ARXIVASTROPH0301598; Cordes J. M., 2002, ARXIVASTROPH0207156; Deller AT, 2009, ASTROPHYS J, V690, P198, DOI [10.1088/0004-637X/690/1/198, 10.1088/0004-637/690/1/198]; FOMALONT EB, 1984, MON NOT R ASTRON SOC, V210, P113; GREEN DA, 1984, MON NOT R ASTRON SOC, V209, P449; Meeks M. L., 1976, METHODS EXPT PHYS, V12; SALTER MJ, 1979, NATURE, V280, P477, DOI 10.1038/280477a0; Verbiest JPW, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/1/39	20	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1063-7729	1562-6881		ASTRON REP+	Astron. Rep.	DEC	2014	58	12					897	905		10.1134/S1063772914120087		9	Astronomy & Astrophysics	Astronomy & Astrophysics	AU7EN	WOS:000345763800003		
J	Jung, J; Furutani, H; Uematsu, M; Park, J				Jung, Jinyoung; Furutani, Hiroshi; Uematsu, Mitsuo; Park, Jisoo			Distributions of atmospheric non-sea-salt sulfate and methanesulfonic acid over the Pacific Ocean between 48 degrees N and 55 degrees S during summer	ATMOSPHERIC ENVIRONMENT			English	Article						Non-sea-salt sulfate; Methanesulfonic acid; Methanesulfonic acid to non-sea-salt sulfate ratio North and South Pacific; Marine aerosols	MARINE BOUNDARY-LAYER; COASTAL ANTARCTIC AEROSOL; METHANE SULFONIC-ACID; DIMETHYL SULFIDE; NORTH PACIFIC; PARTICULATE SULFATE; SIZE DISTRIBUTIONS; SULFUR EMISSIONS; SPECIES SULFATE; SOUTH-PACIFIC	Atmospheric concentrations of non-sea-salt sulfate (nss-SO42-) and methanesulfonic acid (MSA) were measured over the Pacific Ocean between 48 degrees N and 55 degrees S during the KH-08-2 and MR08-06 cruises in summers of 2008 and 2009, in order to investigate spatial distributions of each species and MSA/nss-SO42- ratio. In the subarctic western North Pacific, mean concentrations of nss-SO42- and MSA in bulk (fine + coarse) aerosols were 1.1 mu g m(-3) and 0.061 mu g m(-3), whereas those in the South Pacific were 0.25 mu g m(-3) and 0.043 mu g m(-3), respectively. In the subtropical western North Pacific, it was observed that nss-SO i- concentration sharply increased from 0.45 mu g m(-3) up to 4.2 mu g m(-3) under the dominant influence of the Kilauea volcano, while that of MSA remained low. Mean MSA/nss-SO42- ratio observed in the South Pacific was approximately 3.7 times higher than that in the subarctic western North Pacific, although the mean MSA concentration in the subarctic western North Pacific was a factor of 1.4 higher than that in the South Pacific. The distributions of nss-SO42-, MSA, and MSA/nss-SO42- ratio suggested that aerosol nss-SO42- plays a key role in the latitudinal variation in MSA/nss-SO42- ratio over the North and South Pacific during summer periods, and that high MSA concentrations in the subarctic western North Pacific and the South Pacific were related to high biological productivity and low air temperature. During the cruises, an inverse relationship (r = -0.72, p < 0.01) was observed between satellite-derived chlorophyll a concentration and air temperature, showing that high biological productivity occurred at high latitudes, where air temperature were relatively low, in both hemispheres during the summer periods. Although both MSA concentration and MSA/nss-SO42- ratio showed inverse and positive relationships with air temperature and chlorophyll a concentration, respectively, the correlations between these variables were weak, suggesting that the distributions of MSA concentration and MSA/nss-SO42- ratio over the North and South Pacific during the summer periods were influenced by more complex factors. Estimates using the MSA/nss-SO42- ratios measured in different latitude regions in the Pacific Ocean indicated that the contributions from biogenic sources accounted for 9.6-58% of the total nss-SO42- in aerosols collected in the subarctic western North Pacific, 15-85% in the subtropical western North Pacific, 10-70% in the central North Pacific, and 12-97% in the South Pacific, showing strong influence of anthropogenic nss-SO42- in the subarctic western North Pacific despite the higher mean concentration of MSA in the subarctic western North Pacific than in the South Pacific. (C) 2014 Elsevier Ltd. All rights reserved.	[Jung, Jinyoung; Furutani, Hiroshi; Uematsu, Mitsuo] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Jung, Jinyoung; Park, Jisoo] Korea Polar Res Inst, Inchon 406840, South Korea	Jung, J (reprint author), Korea Polar Res Inst, 26 Songdomirae Ro, Inchon 406840, South Korea.	jinyoungjung@kopri.re.kr			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [18067005]; project titled 'Korea-Polar Ocean in Rapid Transition (KOPRI) - Ministry of Oceans and Fisheries, Korea [PM13020]; Korea Polar Research Institute project [PE14040]	We are grateful to the captains and crews of R/V Hakuho Maru and R/V Mirai for their enthusiastic assistance during the KH-08-2 and MR08-06 cruises. This study was supported by funds from the Grant-in-Aid for Scientific Research in Priority Areas "Western Pacific Air-Sea Interaction Study (W-PASS)" under Grant No.18067005 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This research is a contribution to the Surface Ocean Lower Atmosphere Study (SOLAS) Core Project of the International Geosphere-Biosphere Programme (IGBP). Jinyoung Jung was supported by the project titled 'Korea-Polar Ocean in Rapid Transition (KOPRI, PM13020)', funded by the Ministry of Oceans and Fisheries, Korea. Jisoo Park was supported by the Korea Polar Research Institute project (PE14040).	Albu M, 2006, PHYS CHEM CHEM PHYS, V8, P728, DOI 10.1039/b512536g; Castebrunet H, 2009, ATMOS CHEM PHYS, V9, P9449; Quinn PK, 2011, NATURE, V480, P51, DOI 10.1038/nature10580; SAVOIE DL, 1989, NATURE, V339, P685, DOI 10.1038/339685a0; SALTZMAN ES, 1986, J ATMOS CHEM, V4, P227, DOI 10.1007/BF00052002; Nakamura T, 2005, ATMOS ENVIRON, V39, P1749, DOI 10.1016/j.atmosenv.2004.11.037; Arimoto R, 1996, J GEOPHYS RES-ATMOS, V101, P2011, DOI 10.1029/95JD01071; BATES TS, 1992, J GEOPHYS RES-ATMOS, V97, P9859, DOI 10.1029/92JD00411; Barnes I, 2006, CHEM REV, V106, P940, DOI 10.1021/cr020529+; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Jung J, 2013, ATMOS CHEM PHYS, V13, P411, DOI 10.5194/acp-13-411-2013; Yuan T, 2011, ATMOS CHEM PHYS, V11, P7119, DOI 10.5194/acp-11-7119-2011; Kerminen VM, 1997, TELLUS B, V49, P159, DOI 10.1034/j.1600-0889.49.issue2.4.x; WAYNE RP, 1991, ATMOS ENVIRON A-GEN, V25, P1, DOI 10.1016/0960-1686(91)90192-A; Andreae MO, 1997, SCIENCE, V276, P1052, DOI 10.1126/science.276.5315.1052; Lu Z, 2010, ATMOS CHEM PHYS, V10, P6311, DOI 10.5194/acp-10-6311-2010; Kettle AJ, 2000, J GEOPHYS RES-ATMOS, V105, P26793, DOI 10.1029/2000JD900252; Park KT, 2013, GEOPHYS RES LETT, V40, P155, DOI 10.1029/2012GL054560; Kloster S, 2006, BIOGEOSCIENCES, V3, P29; Jung JY, 2011, J ATMOS CHEM, V68, P157, DOI 10.1007/s10874-012-9218-5; Kettle AJ, 1999, GLOBAL BIOGEOCHEM CY, V13, P399, DOI 10.1029/1999GB900004; Becagli S, 2013, ATMOS ENVIRON, V79, P681, DOI 10.1016/j.atmosenv.2013.07.032; Park J, 2010, DEEP-SEA RES PT I, V57, P604, DOI 10.1016/j.dsr.2010.01.004; BATES TS, 1994, J GEOPHYS RES-OCEANS, V99, P7835, DOI 10.1029/93JC02782; SAVOIE DL, 1994, J GEOPHYS RES-ATMOS, V99, P3587, DOI 10.1029/93JD03337; Rossi MJ, 2003, CHEM REV, V103, P4823, DOI 10.1021/cr020507n; Arimoto R, 2001, GEOPHYS RES LETT, V28, P3645, DOI 10.1029/2000GL012714; AYERS GP, 1991, NATURE, V349, P404, DOI 10.1038/349404a0; AYERS GP, 1986, J ATMOS CHEM, V4, P173, DOI 10.1007/BF00053777; BURGERMEISTER S, 1990, J GEOPHYS RES-ATMOS, V95, P20607, DOI 10.1029/JD095iD12p20607; Chen L., 2012, J GEOPHYS RES, V117; DUCE R A, 1991, Global Biogeochemical Cycles, V5, P193, DOI 10.1029/91GB01778; Eguchi K, 2011, SOLA, V7, P77, DOI 10.2151/sola.2011-020; Gondwe M., 2003, GLOBAL BIOGEOCHEM CY, V17; Gondwe M., 2004, GLOBAL BIOGEOCHEM CY, V18; HUEBERT BJ, 1993, J GEOPHYS RES-ATMOS, V98, P16985, DOI 10.1029/92JD02818; Huebert B.J., 2004, GEOPHYS RES LETT, V31; Huebert BJ, 1996, J GEOPHYS RES-ATMOS, V101, P4413, DOI 10.1029/95JD02044; HYNES AJ, 1986, J PHYS CHEM-US, V90, P4148, DOI 10.1021/j100408a062; Kameyama S, 2013, GEOPHYS RES LETT, V40, P3986, DOI 10.1002/grl.50654; Kiene RP, 1996, MAR CHEM, V54, P69, DOI 10.1016/0304-4203(96)00006-0; Lana A., 2011, GLOBAL BIOGEOCHEM CY, V25; Legrand M, 1998, J GEOPHYS RES-ATMOS, V103, P10991, DOI 10.1029/98JD00929; Lin CT, 2012, ATMOS ENVIRON, V62, P615, DOI 10.1016/j.atmosenv.2012.08.052; Matsumoto K, 1998, ATMOS ENVIRON, V32, P1931, DOI 10.1016/S1352-2310(97)00499-8; Mihalopoulos N, 2007, ATMOS ENVIRON, V41, P6860, DOI 10.1016/j.atmosenv.2007.04.039; Millero F.J., 1992, CHEM OCEANOGR, P531; Minikin A, 1998, J GEOPHYS RES-ATMOS, V103, P10975, DOI 10.1029/98JD00249; ODowd CD, 1997, J GEOPHYS RES-ATMOS, V102, P12839, DOI 10.1029/96JD02749; Ooki A, 2007, ATMOS ENVIRON, V41, P81, DOI 10.1016/j.atmosenv.2006.08.003; PROSPERO JM, 1985, J GEOPHYS RES-ATMOS, V90, P10586, DOI 10.1029/JD090iD06p10586; PSZENNY AAP, 1992, J ATMOS CHEM, V14, P273, DOI 10.1007/BF00115239; PSZENNY AAP, 1989, J GEOPHYS RES-ATMOS, V94, P9818, DOI 10.1029/JD094iD07p09818; QUINN PK, 1990, J GEOPHYS RES-ATMOS, V95, P16405, DOI 10.1029/JD095iD10p16405; Saltzman ES, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025629; SALTZMAN ES, 1983, J GEOPHYS RES-OC ATM, V88, P897, DOI 10.1029/JC088iC15p10897; Sasakawa M., 2002, J GEOPHYS RES, V107; Sasakawa M., 2003, J GEOPHYS RES, V108; Savoie D. L., 2002, J GEOPHYS RES, V107; SAVOIE DI, 1993, J ATMOS CHEM, V17, P95, DOI 10.1007/BF00702821; Simo R., 2002, GLOBAL BIOGEOCHEM CY, V16; SINGH HB, 1988, J ATMOS CHEM, V7, P261, DOI 10.1007/BF00130933; Swanson D., 2009, EOS T AM GEOPHYS UN, V90, P427, DOI DOI 10.1029/2009EO460003; Turekian VC, 2001, GEOPHYS RES LETT, V28, P1491, DOI 10.1029/2000GL012296; Vallina S.M., 2006, GLOBAL BIOGEOCHEM CY, V20; Wang D.-H., 1985, SEA FOG, P51; Xu G., 2013, J GEOPHYS RES, V118, P1; Yang GP, 2009, ATMOS ENVIRON, V43, P2196, DOI 10.1016/j.atmosenv.2009.01.011	68	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	DEC	2014	99						374	384		10.1016/j.atmosenv.2014.10.009		11	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AU7TS	WOS:000345804400039		
J	Mizuguchi, C; Hata, M; Dhanasekaran, P; Nickel, M; Okuhira, K; Phillips, MC; Lund-Katz, S; Saito, H				Mizuguchi, Chiharu; Hata, Mami; Dhanasekaran, Padmaja; Nickel, Margaret; Okuhira, Keiichiro; Phillips, Michael C.; Lund-Katz, Sissel; Saito, Hiroyuki			Fluorescence study of domain structure and lipid interaction of human apolipoproteins E3 and E4	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Article						Apolipoprotein E; Domain structure; Lipid interaction; Trp fluorescence; Fluorescence resonance energy transfer	INDUCED CONFORMATIONAL-CHANGE; RECEPTOR-BINDING ACTIVITY; C-TERMINAL DOMAIN; A-I; ALZHEIMER-DISEASE; LIPOPROTEIN PREFERENCES; ASSOCIATION; PARTICLES; STABILITY; ISOFORMS	Human apolipoprotein E (apoE) isoforms exhibit different conformational stabilities and lipid-binding properties that give rise to altered cholesterol metabolism among the isoforms. Using Trp-substituted mutations and sitedirected fluorescence labeling, we made a comprehensive comparison of the conformational organization of the N- and C-terminal domains and lipid interactions between the apoE3 and apoE4 isoforms. Trp fluorescence measurements for selectively Trp-substituted variants of apoE isoforms demonstrated that apoE4 adopts less stable conformations in both the N- and C-terminal domains compared to apoE3. Consistent with this, the conformational reorganization of the N-terminal helix bundle occurs at lower guanidine hydrochloride concentration in apoE4 than in apoE3 as monitored by fluorescence resonance energy transfer (FRET) from Trp residues to acrylodan attached at the N-terminal helix. Upon binding of apoE3 and apoE4 variants to egg phosphatidylcholine small unilamellar vesicles, similar changes in Trp fluorescence or FRET efficiency were observed for the isoforms, indicating that the opening of the N-terminal helix bundle occurs similarly in apoE3 and apoE4. Introduction of mutations into the C-terminal domain of the apoE isoforms to prevent self-association and maintain the monomeric state resulted in great increase in the rate of binding of the C-terminal helices to a lipid surface. Overall, our results demonstrate that the different conformational organizations of the N- and C-terminal domains have a minor effect on the steady-state lipid-binding behavior of apoE3 and apoE4: rather, self-association property is a critical determinant in the kinetics of lipid binding through the C-terminal helices of apoE isoforms. (C) 2014 Elsevier B.V. All rights reserved.	[Mizuguchi, Chiharu; Hata, Mami; Okuhira, Keiichiro; Saito, Hiroyuki] Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, Tokushima 7708505, Japan; [Dhanasekaran, Padmaja; Nickel, Margaret; Phillips, Michael C.; Lund-Katz, Sissel] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Lipid Res Grp,Gastroenterol Hepatol & Nutr Div, Philadelphia, PA 19104 USA	Saito, H (reprint author), Univ Tokushima, Grad Sch Pharmaceut Sci, Inst Hlth Biosci, 1-78-1 Shomachi, Tokushima 7708505, Japan.	hsaito@tokushima-u.ac.jp			NIH [HL56083]; japan Society for the Promotion of Science [25293006, 25670014]	This work was supported by NIH grant HL56083 (to S.L.K.) and Grant-in-Aid for Scientific Research 25293006 and 25670014 (to H.S.) from the japan Society for the Promotion of Science.	Bains GK, 2012, BIOCHEMISTRY-US, V51, P6207, DOI 10.1021/bi3005285; Garai K, 2010, BIOCHEMISTRY-US, V49, P9533, DOI 10.1021/bi101407m; Georgiadou D, 2013, J LIPID RES, V54, P164, DOI 10.1194/jlr.M030965; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1; Morrow JA, 1999, PROTEIN EXPRES PURIF, V16, P224, DOI 10.1006/prep.1999.1069; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Chroni A, 2008, BIOCHEMISTRY-US, V47, P9071, DOI 10.1021/bi800469r; Morrow JA, 2002, J BIOL CHEM, V277, P50380, DOI 10.1074/jbc.M204898200; Huang RYC, 2011, BIOCHEMISTRY-US, V50, P9273, DOI 10.1021/bi2010027; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; WESTERLUND JA, 1993, J BIOL CHEM, V268, P15745; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Mahley RW, 2012, NEURON, V76, P871, DOI 10.1016/j.neuron.2012.11.020; Gau B, 2011, BIOCHEMISTRY-US, V50, P8117, DOI 10.1021/bi200911c; Argyri L, 2014, J BIOL CHEM, V289, P12931, DOI 10.1074/jbc.M113.538124; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; Nguyen D, 2009, BIOCHEMISTRY-US, V48, P3025, DOI 10.1021/bi9000694; Zhang YH, 2007, BIOCHEMISTRY-US, V46, P10722, DOI 10.1021/bi700672v; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P4240, DOI 10.1021/bi060023b; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; Zhong N, 2009, J BIOL CHEM, V284, P6027, DOI 10.1074/jbc.R800009200; Hauser PS, 2011, PROG LIPID RES, V50, P62, DOI 10.1016/j.plipres.2010.09.001; Frieden C, 2013, PROTEIN SCI, V22, P1820, DOI 10.1002/pro.2379; Frieden C, 2012, P NATL ACAD SCI USA, V109, P8913, DOI 10.1073/pnas.1207022109; Nguyen D, 2014, BIOCHEMISTRY-US, V53, P4025, DOI 10.1021/bi500340z; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; DONG LM, 1994, J BIOL CHEM, V269, P22358; Garai K, 2010, PROTEIN SCI, V19, P66, DOI 10.1002/pro.283; Garai K, 2011, BIOCHEMISTRY-US, V50, P2550, DOI 10.1021/bi1020106; Georgiadou D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027037; Getz GS, 2009, J LIPID RES, V50, pS156, DOI 10.1194/jlr.R800058-JLR200; Kono M, 2008, BIOCHEMISTRY-US, V47, P11340, DOI 10.1021/bi801503r; Koyama M, 2009, BIOCHEMISTRY-US, V48, P2529, DOI 10.1021/bi802317v; Li H, 2013, ARTERIOSCL THROM VAS, V33, P687, DOI 10.1161/ATVBAHA.112.301193; Lu B, 2000, J BIOL CHEM, V275, P20775, DOI 10.1074/jbc.M003508200; Mahley RW, 1999, J LIPID RES, V40, P1933; Mizuguchi C, 2012, BIOCHEMISTRY-US, V51, P5580, DOI 10.1021/bi300672s; Morrow JA, 2000, BIOCHEMISTRY-US, V39, P11657, DOI 10.1021/bi000099m; Narayanaswami V, 2001, J BIOL CHEM, V276, P37853; Nguyen D, 2010, BIOCHEMISTRY-US, V49, P10881, DOI 10.1021/bi1017655; Patel AB, 2010, BIOCHEMISTRY-US, V49, P1766, DOI 10.1021/bi901902e; Saito H, 2003, J BIOL CHEM, V278, P40723, DOI 10.1074/jbc.M304814200; Saito H, 2004, J BIOL CHEM, V279, P20974, DOI 10.1074/jbc.M402043200; Saito H, 2001, J BIOL CHEM, V276, P40949, DOI 10.1074/jbc.M106337200; Sakamoto T, 2008, BIOCHEMISTRY-US, V47, P2968, DOI 10.1021/bi701923h; Sivashanmugam A, 2009, J BIOL CHEM, V284, P14657, DOI 10.1074/jbc.M901012200; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; Zaiou M, 2000, J LIPID RES, V41, P1087	51	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981	0006-3002		BBA-MOL CELL BIOL L	Biochim. Biophys. Acta Mol. Cell Biol. Lipids	DEC	2014	1841	12					1716	1724		10.1016/j.bbalip.2014.09.019		9	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	AU6QT	WOS:000345727800010		
J	Usuyama, N; Shiraishi, Y; Sato, Y; Kume, H; Homma, Y; Ogawa, S; Miyano, S; Imoto, S				Usuyama, Naoto; Shiraishi, Yuichi; Sato, Yusuke; Kume, Haruki; Homma, Yukio; Ogawa, Seishi; Miyano, Satoru; Imoto, Seiya			HapMuC: somatic mutation calling using heterozygous germ line variants near candidate mutations	BIOINFORMATICS			English	Article							GENOME SEQUENCING DATA; POINT MUTATIONS; CANCER GENOME; ALGORITHMS; EVOLUTION; CATALOG; ANALYZE; MOUSE	Motivation: Identifying somatic changes from tumor and matched normal sequences has become a standard approach in cancer research. More specifically, this requires accurate detection of somatic point mutations with low allele frequencies in impure and heterogeneous cancer samples. Although haplotype phasing information derived by using heterozygous germ line variants near candidate mutations would improve accuracy, no somatic mutation caller that uses such information is currently available. Results: We propose a Bayesian hierarchical method, termed HapMuC, in which power is increased by using available information on heterozygous germ line variants located near candidate mutations. We first constructed two generative models (the mutation model and the error model). In the generative models, we prepared candidate haplotypes, considering a heterozygous germ line variant if available, and the observed reads were realigned to the haplotypes. We then inferred the haplotype frequencies and computed the marginal likelihoods using a variational Bayesian algorithm. Finally, we derived a Bayes factor for evaluating the possibility of the existence of somatic mutations. We also demonstrated that our algorithm has superior specificity and sensitivity compared with existing methods, as determined based on a simulation, the TCGA Mutation Calling Benchmark 4 datasets and data from the COLO-829 cell line.	[Usuyama, Naoto; Shiraishi, Yuichi; Miyano, Satoru; Imoto, Seiya] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo 1088639, Japan; [Sato, Yusuke; Kume, Haruki; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Tokyo 1138655, Japan; [Sato, Yusuke; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan	Imoto, S (reprint author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo 1088639, Japan.	imoto@ims.u-tokyo.ac.jp			 [22134004]	This work was partly supported by Grant-in-Aid for Scientific Research on Innovative Areas (22134004).	Albers CA, 2011, GENOME RES, V21, P961, DOI 10.1101/gr.112326.110; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Roth A, 2012, BIOINFORMATICS, V28, P907, DOI 10.1093/bioinformatics/bts053; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cilibrasi R, 2005, LECT NOTES COMPUT SC, V3692, P128; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; He D, 2010, BIOINFORMATICS, V26, pi183, DOI 10.1093/bioinformatics/btq215; Genovese G, 2013, AM J HUM GENET, V93, P411, DOI 10.1016/j.ajhg.2013.07.002; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Larson DE, 2012, BIOINFORMATICS, V28, P311, DOI 10.1093/bioinformatics/btr665; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Goya R, 2010, BIOINFORMATICS, V26, P730, DOI 10.1093/bioinformatics/btq040; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Beal M., 2003, THESIS U COLL LONDON; Chiaromonte F, 2002, PAC S BIOCOMPUT, V7, P115; Genovese LM, 2008, IEEE ACM T COMPUT BI, V5, P492, DOI 10.1109/TCBB.2008.67; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Shiraishi Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt126	34	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	DEC 1	2014	30	23					3302	3309		10.1093/bioinformatics/btu537		8	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	AU8DT	WOS:000345827400002		
J	Maruyama, Y; Strawderman, WE				Maruyama, Yuzo; Strawderman, William E.			Robust Bayesian variable selection in linear models with spherically symmetric errors	BIOMETRIKA			English	Article						Bayesian variable selection; Fully Bayes method; Model selection consistency; Posterior odds	PRIORS	This paper studies Bayesian variable selection in linear models with general spherically symmetric error distributions. We construct the posterior odds based on a separable prior, which arises as a class of mixtures of Gaussian densities. The posterior odds for comparing among nonnull models are shown to be independent of the error distribution, if this is spherically symmetric. Because of this invariance, we refer to our method as a robust Bayesian variable selection method. We demonstrate that our posterior odds have model selection consistency, and that our class of prior functions are the only ones within a large class which are robust in our sense.	[Maruyama, Yuzo] Univ Tokyo, Ctr Spatial Informat Sci, Kashiwa, Chiba 2778568, Japan; [Strawderman, William E.] Rutgers State Univ, Dept Stat, Piscataway, NJ 08854 USA	Maruyama, Y (reprint author), Univ Tokyo, Ctr Spatial Informat Sci, Kashiwa, Chiba 2778568, Japan.	maruyama@csis.u-tokyo.ac.jp; straw@stat.rutgers.edu			Japan Society for the Promotion of Science; Simons Foundation	We are very grateful to the editor, associate editor, and referees for insights that helped us to substantially strengthen this paper. The work of the first author was partially supported by the Japan Society for the Promotion of Science. The work of the second author was partially supported by the Simons Foundation.	Berger JO, 2009, ANN STAT, V37, P905, DOI 10.1214/07-AOS587; Clyde M, 2004, STAT SCI, V19, P81, DOI 10.1214/088342304000000035; George EI, 2000, BIOMETRIKA, V87, P731, DOI 10.1093/biomet/87.4.731; Liang F, 2008, J AM STAT ASSOC, V103, P410, DOI 10.1198/016214507000001337; Maruyama Y, 2011, ANN STAT, V39, P2740, DOI 10.1214/11-AOS917; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Smith M, 1996, J ECONOMETRICS, V75, P317, DOI 10.1016/0304-4076(95)01763-1; Berger J., 1998, SANKHYA A, V60, P307; Dellaportas P, 2012, STAT SCI, V27, P232, DOI 10.1214/11-STS369; TIERNEY L, 1986, J AM STAT ASSOC, V81, P82, DOI 10.2307/2287970	10	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-3444	1464-3510		BIOMETRIKA	Biometrika	DEC	2014	101	4					992	998		10.1093/biomet/asu039		7	Biology; Mathematical & Computational Biology; Statistics & Probability	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology; Mathematics	AU8DZ	WOS:000345827900019		
J	Hidaka, S				Hidaka, S.			General type-token distribution	BIOMETRIKA			English	Article						Poisson-binomial distribution; Species sampling; Type-token ratio	NUMBER; POPULATION	We consider the problem of estimating the number of types in a corpus using the number of types observed in a sample of tokens from that corpus. We derive exact and asymptotic distributions for the number of observed types, conditioned on the number of tokens and the latent type distribution. We use the asymptotic distributions to derive an estimator of the latent number of types and validate this estimator numerically.	Japan Adv Inst Sci & Technol, Sch Knowledge Sci, Nomi, Ishikawa, Japan	Hidaka, S (reprint author), Japan Adv Inst Sci & Technol, Sch Knowledge Sci, 1-1 Asahidai, Nomi, Ishikawa, Japan.	shhidaka@jaist.ac.jp			Artificial Intelligence Research Promotion Foundation; JSPS KAKENHI	The author is grateful to Takuma Torii, Akira Masumi and Dr Neeraj Kashyap for useful discussions and for their helpful comments on early versions of the manuscript. This work was supported by the Artificial Intelligence Research Promotion Foundation, JSPS KAKENHI Grant-in-Aid for Scientific Research B and the Grant-in-Aid for Challenging Exploratory Research.	ALLENBY R. B. J. T., 2011, J APPL PROB; EWENS WJ, 1972, THEOR POPUL BIOL, V3, P87, DOI 10.1016/0040-5809(72)90035-4; Chen SX, 1997, STAT SINICA, V7, P875; HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; McCarthy PM, 2010, BEHAV RES METHODS, V42, P381, DOI 10.3758/BRM.42.2.381; Fernandez M, 2010, IEEE T AERO ELEC SYS, V46, P803, DOI 10.1109/TAES.2010.5461658; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; BRAINERD B, 1982, J APPL PROBAB, V19, P785, DOI 10.2307/3213831; BRAINERD B, 1972, J APPL PROBAB, V9, P507, DOI 10.2307/3212322; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO MT, 1992, STAT SINICA, V2, P189; Gale William A., 1995, J QUANT LINGUIST, V2, P217, DOI 10.1080/09296179508590051; GOODMAN LA, 1949, ANN MATH STAT, V20, P572, DOI 10.1214/aoms/1177729949; Herdan G., 1960, TYPE TOKEN MATH TXB; Huillet T, 2009, ENVIRONMETRICS, V20, P853, DOI 10.1002/env.977; Jarvis S., 2002, LANG TEST, V19, P57, DOI DOI 10.1016/S1060-3743(02)00124-8; Kornai A., 2002, GLOTTOMETRICS, V4, P61; Le Cam L., 1960, PAC J MATH, V10, P1181; Malvern D., 2012, ENCY APPL LINGUISTIC; MALVERN DD, 2002, LANG TEST, V0019; McCarthy P. M., 2007, LANG TEST, V24, P459, DOI DOI 10.1177/0265532207080767; PITMAN J, 1995, PROBAB THEORY REL, V102, P145, DOI 10.1007/BF01213386; Shah B.K., 1994, AM STAT, V27, P123; Tweedie FJ, 1998, COMPUT HUMANITIES, V32, P323, DOI 10.1023/A:1001749303137; WANG YH, 1993, STAT SINICA, V3, P295; Zipf G., 1949, HUMAN BEHAV PRINCIPL	27	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-3444	1464-3510		BIOMETRIKA	Biometrika	DEC	2014	101	4					999	1002		10.1093/biomet/asu035		4	Biology; Mathematical & Computational Biology; Statistics & Probability	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology; Mathematics	AU8DZ	WOS:000345827900020		
J	Ghoran, SH; Saeidnia, S; Babaei, E; Kiuchi, F; Dusek, M; Eigner, V; Khalaji, AD; Soltani, A; Ebrahimi, P; Mighani, H				Ghoran, Salar Hafez; Saeidnia, Soodabeh; Babaei, Esmaeil; Kiuchi, Fumiyuki; Dusek, Michal; Eigner, Vaclav; Khalaji, Aliakbar Dehno; Soltani, Alireza; Ebrahimi, Pouneh; Mighani, Hossein			Biochemical and biophysical properties of a novel homoisoflavonoid extracted from Scilla persica HAUSSKN	BIOORGANIC CHEMISTRY			English	Article						Cytotoxic activity; Scillapersicone; Liliaceae; Scilla persica; Single-crystal X-ray; Theoretical analysis	BORON-NITRIDE NANOTUBES; OPHIOPOGON-JAPONICUS; AB-INITIO; IN-VITRO; NERVOSA; BULBS; CONSTITUENTS; STILBENOIDS	In this study isolation and structural elucidation of a homoisoflavonoid, 3-(3',4'-dihydroxybenzyl)-8-hydroxy- 5,7-dimethoxychroman-4-one (Scillapersicone 1), is reported from Scilla persica HAUSSKN. The structure was solved by a single crystal X-ray analysis. The unit cell parameters are a = 11.7676 (2) angstrom, b = 20.1174 (4) angstrom, c = 7.8645 (9) angstrom, beta = 93.544 (2)degrees, V = 1858.23 (7) angstrom(3), monoclinic space group P2(1)/c and four symmetry equivalent molecules in an unit cell. The structure was consistent with the UV, IR, 1D and 2D NMR, HRFAB-MS data. The optimized molecular geometry agrees closely that obtained from the single crystal X-ray crystallography. Furthermore, cytotoxicity of this compound was evaluated by MTT assay on AGS and WEHI-164 cancerous cell lines. (C) 2014 Elsevier Inc. All rights reserved.	[Ghoran, Salar Hafez; Saeidnia, Soodabeh] Univ Tehran Med Sci, Med Plants Res Ctr, Fac Pharm, Tehran 1417614411, Iran; [Ghoran, Salar Hafez; Khalaji, Aliakbar Dehno; Ebrahimi, Pouneh; Mighani, Hossein] Golestan Univ, Dept Chem, Fac Sci, Gorgan 4913815759, Iran; [Babaei, Esmaeil] Univ Tabriz, Sch Nat Sci, Dept Anim Biol, Tabriz, Iran; [Kiuchi, Fumiyuki] Keio Univ, Dept Pharmaceut Sci, Fac Pharm, Tokyo, Japan; [Dusek, Michal; Eigner, Vaclav] Inst Phys AS CR, Vvi, Prague 18221 8, Czech Republic; [Soltani, Alireza] Islamic Azad Univ, Gorgan Branch, Dept Chem, Gorgan, Iran	Ghoran, SH (reprint author), Univ Tehran Med Sci, Med Plants Res Ctr, Fac Pharm, Tehran 1417614411, Iran.	S.Hafezghoran@gu.ac.ir	Dusek, Michal/B-7316-2011		Golestan University Research Council; Tabriz University Research Council; Grant Agency of the Czech Republic [14-03276S]	The authors wish to thank Mr. Abbas Biglari (Zanjan Institute of Chemistry for NMR spectroscopic measurements, and Dr. Ahmad Reza Gohari and other MPRC colleagues (Medicinal Plants Research Center, Tehran University of Medical Sciences) for their support in isolation and purification process. The authors are also grateful to Golestan University and Tabriz University Research Councils for partial support of this work and the project (14-03276S) of the Grant Agency of the Czech Republic.	Amschler G, 1996, PLANTA MED, V62, P534, DOI 10.1055/s-2006-957964; Mutanyatta J, 2003, PHYTOCHEMISTRY, V62, P797, DOI 10.1016/S0031-9422(02)00622-2; Soltani A, 2012, APPL SURF SCI, V263, P619, DOI 10.1016/j.apsusc.2012.09.122; Kou J, 2006, BIOL PHARM BULL, V29, P1267, DOI 10.1248/bpb.29.1267; Yen CT, 2010, BIOORG MED CHEM LETT, V20, P1037, DOI 10.1016/j.bmcl.2009.12.041; Palatinus L, 2007, J APPL CRYSTALLOGR, V40, P786, DOI 10.1107/S0021889807029238; Ramalho TC, 2004, BIOPHYS CHEM, V110, P267, DOI 10.1016/j.bpc.2004.03.002; Babaei E, 2012, INT IMMUNOPHARMACOL, V12, P226, DOI 10.1016/j.intimp.2011.11.015; Srinivas KVNS, 2003, PHYTOCHEMISTRY, V63, P789, DOI 10.1016/S0031-9422(03)00325-X; HUTCHINGS A, 1989, BOTHALIA, V19, P111; Baei MT, 2011, COMPUT THEOR CHEM, V970, P30, DOI 10.1016/j.comptc.2011.05.021; Bangani V, 1999, PHYTOCHEMISTRY, V51, P947, DOI 10.1016/S0031-9422(99)00155-7; Bezabih M, 2009, NAT PROD COMMUN, V4, P1367; Choi SB, 2004, LIFE SCI, V75, P2653, DOI 10.1016/j.lfs.2004.04.039; Della Loggia R., 1989, PLANTA MED, V55, P587, DOI 10.1055/s-2006-962120; DEWICK PM, 1975, PHYTOCHEMISTRY, V14, P983, DOI 10.1016/0031-9422(75)85172-7; Frisch M.J., 1998, GAUSSIAN 98; Ghoran S. Hafez, 2014, J GORGAN U MED SCI, V16, P106; Heller W., 1981, PROG CHEM ORG NAT PR, V4, P105; Ishibashi H, 2001, BRIT J PHARMACOL, V132, P461, DOI 10.1038/sj.bjp.0703818; JURANEK I, 1993, PHARMAZIE, V48, P310; KAMANO Y, 1974, J ORG CHEM, V39, P2629, DOI 10.1021/jo00931a041; Kuono I., 1973, TETRAHEDRON LETT, P4569; Milach G., 1997, TOXICOLOGY, V124, P179; MIMAKI Y, 1993, B CHEM SOC JPN, V66, P1182, DOI 10.1246/bcsj.66.1182; Mozzafarian V., 1997, DICT NAMES IRANIAN P, P489; Nguyen AT, 2006, PHYTOCHEMISTRY, V67, P2159, DOI 10.1016/j.phytochem.2006.06.021; Petricek V., 2008, STRUCTURE DETERMINAT; Shim JS, 2004, PLANTA MED, V70, P171, DOI 10.1055/s-2004-815496; Siddalah V, 2006, BIOORGAN MED CHEM, V14, P2545, DOI 10.1016/j.bmc.2005.11.031; Sievanen E, 2010, J MOL STRUCT, V979, P172, DOI 10.1016/j.molstruc.2010.06.021; Silayo A, 1999, PHYTOCHEMISTRY, V52, P947, DOI 10.1016/S0031-9422(99)00267-8; Yan J, 2012, PHYTOCHEMISTRY, V80, P37, DOI 10.1016/j.phytochem.2012.05.014; Zhou Yi-Feng, 2008, Chinese Journal of Natural Medicines, V6, P201, DOI 10.3724/SP.J.1009.2008.00201	34	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0045-2068	1090-2120		BIOORG CHEM	Bioorganic Chem.	DEC	2014	57						51	56		10.1016/j.bioorg.2014.08.001		6	Biochemistry & Molecular Biology; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	AU6FD	WOS:000345698000006		
J	Islam, MN; Islam, MS; Hoque, MA; Kato, T; Nishino, N; Ito, A; Yoshida, M				Islam, Md. Nurul; Islam, Md. Shahidul; Hoque, Md. Ashraful; Kato, Tamaki; Nishino, Norikazu; Ito, Akihiro; Yoshida, Minoru			Bicyclic tetrapeptide histone deacetylase inhibitors with methoxymethyl ketone and boronic acid zinc-binding groups	BIOORGANIC CHEMISTRY			English	Article						Histone deacetylase inhibitors; Bicyclic tetrapeptides; Ring-closing metathesis; Methoxymethyl ketone; Boronic acid	CYCLIC TETRAPEPTIDES; POTENT; LIGAND	Histone deacetylase (HDAC) inhibitors are a class of potential therapeutics for the treatment of cancer. Bicyclic tetrapeptides equipped with methoxymethyl ketone and boronic acid as zinc-binding group were designed and synthesized. The inhibitory activities of these compounds were evaluated against HDAC enzymes. The cell-free and cell-based assay data showed that both potency and selectivity changed with the change in zinc-binding group. Boronic acid-based compound showed poor activity whereas methoxymethyl ketone-based compound displayed impressive activity in both cell-free and cell-based conditions. (C) 2014 Elsevier Inc. All rights reserved.	[Islam, Md. Nurul; Islam, Md. Shahidul; Hoque, Md. Ashraful; Kato, Tamaki; Nishino, Norikazu] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan; [Islam, Md. Nurul; Islam, Md. Shahidul] Rajshahi Univ, Dept Chem, Fac Sci, Rajshahi 6205, Bangladesh; [Hoque, Md. Ashraful] Rajshahi Univ, Dept Biochem & Mol Biol, Fac Sci, Rajshahi 6205, Bangladesh; [Ito, Akihiro; Yoshida, Minoru] RIKEN, Chem Genet Lab, Adv Sci Inst, Chem Genom Res Grp, Saitama 3510198, Japan	Islam, MN (reprint author), Rajshahi Univ, Dept Chem, Fac Sci, Rajshahi 6205, Bangladesh.	mnurulchem@gmail.com	Ito, Akihiro/A-6100-2015; Yoshida, Minoru/C-8049-2014		Kitakyushu Foundation for the Advancement of Industry, Science and Technology (FAIS); Japan Student Services Organization (JASSO)	This study was supported by Kitakyushu Foundation for the Advancement of Industry, Science and Technology (FAIS) and Japan Student Services Organization (JASSO).	Nishino N, 2008, BIOORGAN MED CHEM, V16, P437, DOI 10.1016/j.bmc.2007.09.021; Komatsu Y, 2001, CANCER RES, V61, P4459; Zain J, 2010, EXPERT REV HEMATOL, V3, P187, DOI [10.1586/ehm.10.9, 10.1586/EHM.10.9]; Furumai R, 2002, CANCER RES, V62, P4916; Islam NM, 2010, BIOORG MED CHEM LETT, V20, P997, DOI 10.1016/j.bmcl.2009.12.054; Bhuiyan MPI, 2006, BIOORGAN MED CHEM, V14, P3438, DOI 10.1016/j.bmc.2005.12.063; Suzuki T, 2006, J MED CHEM, V49, P4809, DOI 10.1021/jm060554y; Mwakwari SC, 2010, CURR TOP MED CHEM, V10, P1423; Michaelides MR, 2001, BIOORG MED CHEM LETT, V11, P1553, DOI 10.1016/S0960-894X(01)00031-2; Islam MS, 2012, AMINO ACIDS, V42, P2103, DOI 10.1007/s00726-011-0947-6; Jose B, 2004, BIOORG MED CHEM LETT, V14, P5343, DOI 10.1016/j.bmcl.2004.08.016; Butler KV, 2008, CURR PHARM DESIGN, V14, P505; Nishino N, 2004, BIOORG MED CHEM LETT, V14, P2427, DOI 10.1016/j.bmcl.2004.03.018; Suzuki N, 2009, J MED CHEM, V52, P2909, DOI 10.1021/jm900125m; Ververis Katherine, 2013, Biologics, V7, P47, DOI 10.2147/BTT.S29965	15	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0045-2068	1090-2120		BIOORG CHEM	Bioorganic Chem.	DEC	2014	57						121	126		10.1016/j.bioorg.2014.10.003		6	Biochemistry & Molecular Biology; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	AU6FD	WOS:000345698000014		
J	Kawano, S; Uchino, S; Endo, A; Saito, K; Iwai, K; Kase, Y; Takinami, M				Kawano, Shinji; Uchino, Shigehiko; Endo, Arata; Saito, Keita; Iwai, Kenichi; Kase, Yoichi; Takinami, Masanori			Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation	BLOOD COAGULATION & FIBRINOLYSIS			English	Article						antithrombin; disseminated intravascular coagulation; low-dose antithrombin; septic shock; systemic inflammatory syndrome	CRITICALLY-ILL PATIENTS; HIGH-DOSE ANTITHROMBIN; INTENSIVE-CARE UNITS; SEVERE SEPSIS; DOUBLE-BLIND; CONTROLLED TRIAL; MULTICENTER; THERAPY; METAANALYSIS; GUIDELINES	Antithrombin III (ATIII) of low doses (1500-3000 units per day for 3-5 days) has been used for treatment of disseminated intravascular coagulation (DIC) for decades in Japan. In this study, we have examined the impact of ATIII practice change on outcome in critically ill patients with sepsis and DIC. From April 2005 to September 2008, all septic patients admitted to our ICU were divided into two groups: before withdrawing ATIII (period 1) and after withdrawing ATIII (period 2). Patients treated with ATIII in the period 1 and those not treated with ATIII in the period 2 were then matched according to the similar Acute Physiology and Chronic Health Evaluation II scores (+/- 3) and the same diagnosis grouping. Sensitivity analysis was also conducted for patients with DIC. Forty-one out of 98 patients (41.8%) in the period 1 and only one out of 80 patients (1.3%) in the period 2 were treated with ATIII. Thirty pairs of the patients were matched. There was no difference between the two groups regarding the platelet counts and Sepsis-related Organ Failure Assessment scores at day 1 and day 4. A subgroup analysis was conducted with 12 patients diagnosed with DIC out of the 30 pairs. There was no difference between the two DIC groups for platelet counts, Sepsis-related organ failure assessment scores and DIC score at day 1 and also day 4. Although not significant, hospital mortality tended lower in the period 2. This study found that withdrawing ATIII administration from management of septic patients with or without DIC did not influence outcome.	[Kawano, Shinji; Uchino, Shigehiko; Endo, Arata; Saito, Keita; Iwai, Kenichi; Kase, Yoichi; Takinami, Masanori] Jikei Univ, Sch Med, Dept Anesthesiol, Intens Care Unit, Tokyo, Japan	Kawano, S (reprint author), Jikei Univ, Sch Med, Dept Anesthesiol, Intens Care Unit,Minato Ku, Nishi Shinbashi 3-19-18, Tokyo, Japan.	kwnsnj@jikei.ac.jp					Afshari A, 2007, BRIT MED J, V335, P1248, DOI 10.1136/bmj.39398.682500.25; Aibiki M, 2007, SHOCK, V28, P141, DOI 10.1097/shk.0b013e31803422c4; BONE RC, 1992, CRIT CARE MED, V20, P864; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Iba T, 2002, SHOCK, V18, P389, DOI 10.1097/00024382-200211000-00001; Levi M, 2009, BRIT J HAEMATOL, V145, P24, DOI 10.1111/j.1365-2141.2009.07600.x; Vincent JL, 1998, CRIT CARE MED, V26, P1793; Kienast J, 2006, J THROMB HAEMOST, V4, P90, DOI 10.1111/j.1538-7836.2005.01697.x; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Gando S, 2006, CRIT CARE MED, V34, P625, DOI 10.1097/01.CCM.0000202209.42491.38; Baudo F, 1998, INTENS CARE MED, V24, P336, DOI 10.1007/s001340050576; DICKNEITE G, 1993, THROMB HAEMOSTASIS, V69, P98; Eisele B, 1998, INTENS CARE MED, V24, P663, DOI 10.1007/s001340050642; FOURRIER F, 1993, CHEST, V104, P882, DOI 10.1378/chest.104.3.882; Freeman BD, 2015, SHOCK, V20, P5; Gando S, 2006, AM J HEMATOL, V81, P907, DOI 10.1002/ajh.20969; Iba T, 2013, THROMB RES, V131, P383, DOI 10.1016/j.thromres.2013.03.012; Iba T, 2012, THROMB RES, V130, P129; Lee WL, 2000, INTENS CARE MED, V26, P1701, DOI 10.1007/s001340051349; Liumbruno G, 2009, BLOOD TRANSFUS-ITALY, V7, P325, DOI 10.2450/2009.0116-09; Messori A, 2002, CRIT CARE, V6, P447, DOI 10.1186/cc1540; Sawamura A, 2009, CLIN APPL THROMB-HEM, V15, P561, DOI 10.1177/1076029608323497; Uchiba M, 1998, THROMB RES, V89, P233, DOI 10.1016/S0049-3848(98)00012-7	23	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0957-5235	1473-5733		BLOOD COAGUL FIBRIN	Blood Coagul. Fibrinolysis	DEC	2014	25	8					795	800		10.1097/MBC.0000000000000115		6	Hematology	Hematology	AT4QZ	WOS:000344927000002		
J	Takamizawa, Y; Araki, M; Yoshida, N; Yoshioka, T; Miura, K				Takamizawa, Yasuyuki; Araki, Makoto; Yoshida, Noriko; Yoshioka, Teruaki; Miura, Kohei			A case of a severe factor XI deficiency in patient undergoing hemodialysis without the use of heparin	BLOOD COAGULATION & FIBRINOLYSIS			English	Article						chronic kidney disease; coagulation; factor XI deficiency; hemodialysis; the novel oral anticoagulants (NOACs); thrombosis	COAGULATION-FACTOR XI; SAFETY	Factor XI (FXI) deficiency is a rare hematologic disease, and shows a less severe bleeding tendency compared with what is generally observed in patients with hemophilia A and B. FXI has received a lot of attention in recent years as a new therapeutic target. Here, we present a case of 59-year-old male patient with chronic renal failure. The patient was found to have a markedly prolonged activated partial thromboplastin time (aPTT) during routine preoperative blood test before an arteriovenous fistula surgery. Finally, he was diagnosed with FXI deficiency. More than 6 months after the start of hemodialysis, no sign of blood clotting in the extracorporeal circuit has been observed. Of note, the patient did not receive any anticoagulant during hemodialysis, and he did not show any bleeding tendency even with aPTT more than 120s and FXI activity below 3% of normal in a patient with renal failure. To our knowledge, this is the first case report to demonstrate FXI deficiency exhibiting anticoagulant effect equivalent to heparin in dialysis.	[Takamizawa, Yasuyuki; Araki, Makoto; Yoshida, Noriko; Yoshioka, Teruaki; Miura, Kohei] Suwa Cent Hosp, Dept Nephrol, Chino, Nagano 3918503, Japan	Araki, M (reprint author), Suwa Cent Hosp, Dept Nephrol, 4300 Tamagawa, Chino, Nagano 3918503, Japan.	makaraki@kuhp.kyoto-u.ac.jp					Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Winkelmayer WC, 2011, CLIN J AM SOC NEPHRO, V6, P2662, DOI 10.2215/CJN.04550511; Lega JC, 2014, J THROMB HAEMOST, V12, P337, DOI 10.1111/jth.12486; Schumacher WA, 2010, ARTERIOSCL THROM VAS, V30, P388, DOI 10.1161/ATVBAHA.109.197178; Lowenberg EC, 2010, J THROMB HAEMOST, V8, P2349, DOI 10.1111/j.1538-7836.2010.04031.x; Seligsohn U, 2009, J THROMB HAEMOST, V7, P84, DOI 10.1111/j.1538-7836.2009.03395.x; Wu WM, 2008, J BIOL CHEM, V283, P18655, DOI 10.1074/jbc.M802275200	7	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0957-5235	1473-5733		BLOOD COAGUL FIBRIN	Blood Coagul. Fibrinolysis	DEC	2014	25	8					898	899		10.1097/MBC.0000000000000151		2	Hematology	Hematology	AT4QZ	WOS:000344927000020		
J	Kato, S; Murakami, H; Demura, S; Yoshioka, K; Kawahara, N; Tomita, K; Tsuchiya, H				Kato, S.; Murakami, H.; Demura, S.; Yoshioka, K.; Kawahara, N.; Tomita, K.; Tsuchiya, H.			Patient-reported outcome and quality of life after total en bloc spondylectomy for a primary spinal tumour	BONE & JOINT JOURNAL			English	Article							SURGICAL-TECHNIQUES; VERTEBRAL TUMORS; HEALTH SURVEY; LUNG-CANCER; FOLLOW-UP; SURGERY; SATISFACTION; RESECTION; SF-36	Total en bloc spondylectomy (TES) is the total resection of a vertebra containing a tumour. Many authors have investigated patient-reported outcomes after routine spinal surgery and surgery for tumours in general. However, this is the first report of patient-reported outcomes, including health-related quality of life (HRQoL) and satisfaction, after en bloc vertebral resection for a spinal tumour. Of the 54 patients who underwent TES for a primary tumour between 1993 and 2010, 19 died and four were lost to follow-up. In January 2012, a questionnaire was sent to the 31 surviving patients. This included the short form-36 to assess HRQoL and questions about the current condition of their disease, activities of daily living (ADL) and surgery. The response rate was high at 83.9% (26/31 patients). We found that most patients were satisfied and maintained good performance of their ADLs. The mental health status and social roles of the HRQoL scores were nearly equivalent to those of healthy individuals, regardless of the time since surgery. There was significant impairment of physical health in the early post-operative years, but this usually returned to normal approximately three years after surgery.	[Kato, S.; Murakami, H.; Demura, S.; Yoshioka, K.; Kawahara, N.; Tomita, K.; Tsuchiya, H.] Kanazawa Univ, Sch Med, Kanazawa, Ishikawa 920, Japan	Kato, S (reprint author), Kanazawa Univ, Sch Med, Dept Orthopaed Surg, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	skato323@gmail.com					Anderson PA, 2009, SPINE, V34, P176, DOI 10.1097/BRS.0b013e3181913cba; Sampath P, 2000, SPINE, V25, P670, DOI 10.1097/00007632-200003150-00004; Forni C, 2012, J SURG ONCOL, V105, P331, DOI 10.1002/jso.22088; Koslow S, 2013, ANN SURG ONCOL, V20, P3422, DOI 10.1245/s10434-013-3026-2; ROYCAMILLE R, 1981, REV CHIR ORTHOP, V67, P421; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Moller A, 2012, EUR J CARDIO-THORAC, V41, P362, DOI 10.1016/j.ejcts.2011.05.055; Toyone T, 2005, SPINE, V30, P2689, DOI 10.1097/01.brs.0000187876.14304.15; TOMITA K, 1994, INT ORTHOP, V18, P291; Kawahara N, 2009, ORTHOP CLIN N AM, V40, P47, DOI 10.1016/j.ocl.2008.09.004; Karanicolas PJ, 2013, ANN SURG, V257, P1039, DOI 10.1097/SLA.0b013e31828c4a19; Boriani S, 1996, SPINE, V21, P1569, DOI 10.1097/00007632-199607010-00017; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Yonemoto T, 2007, ANTICANCER RES, V27, P3621; Demura S, 2011, J NEUROSURG-SPINE, V14, P172, DOI 10.3171/2010.9.SPINE09878; Kato S, 2014, ANN SURG ONCOL, V21, P1330, DOI 10.1245/s10434-013-3333-7; Boriani S, 2012, SPINE, V37, pE37, DOI 10.1097/BRS.0b013e3182233ccd; Tomita K, 2006, J ORTHOP SCI, V11, P3, DOI 10.1007/s00776-005-0964-y; Tomita K, 1997, SPINE, V22, P324, DOI 10.1097/00007632-199702010-00018; Chi JH, 2008, NEUROSURG CLIN N AM, V19, P111, DOI 10.1016/j.nec.2007.10.004; Cloyd JM, 2010, NEUROSURGERY, V67, P435, DOI 10.1227/01.NEU.0000371987.85090.FF; Evers PD, 2014, WORLD J UROL, V32, P385, DOI 10.1007/s00345-013-1110-7; Kato S, 2010, J ORTHOP SCI, V15, P350, DOI 10.1007/s00776-010-1483-z; Kawahara N, 2011, SPINE, V36, P74, DOI 10.1097/BRS.0b013e3181cded6c; Murakami H, 2010, J NEUROSURG-SPINE, V13, P414, DOI 10.3171/2010.4.SPINE09365; Shabat S, 2005, EUR SPINE J, V14, P1027, DOI 10.1007/s00586-004-0808-z; STENER B, 1971, Journal of Bone and Joint Surgery British Volume, V53, P288; SUNDARESAN N, 1988, NEUROSURGERY, V23, P714; Tomita K, 1996, J BONE JOINT SURG AM, V78A, P1915; Toro A, 2012, SURG ONCOL, V21, P23; Welter S, 2013, ANN THORAC SURG, V95, P1006, DOI 10.1016/j.athoracsur.2012.11.059; Yamashita K, 2006, SPINE, V31, P2602, DOI 10.1097/01.brs.0000240717.25787.7d	32	0	0	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	2049-4394			BONE JOINT J	Bone Joint J.	DEC	2014	96B	12					1693	1698		10.1302/0301-620X.96B12.33832		6	Orthopedics; Surgery	Orthopedics; Surgery	AU8LD	WOS:000345847100020		
J	Fuji, S; Takano, K; Mori, T; Eto, T; Taniguchi, S; Ohashi, K; Sakamaki, H; Morishima, Y; Kato, K; Miyamura, K; Suzuki, R; Fukuda, T				Fuji, S.; Takano, K.; Mori, T.; Eto, T.; Taniguchi, S.; Ohashi, K.; Sakamaki, H.; Morishima, Y.; Kato, K.; Miyamura, K.; Suzuki, R.; Fukuda, T.			Impact of pretransplant body mass index on the clinical outcome after allogeneic hematopoietic SCT	BONE MARROW TRANSPLANTATION			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; GRAFT; OBESITY; ADULTS; THERAPY; CANCER; MALNUTRITION; MORTALITY	To elucidate the impact of pretransplant body mass index (BMI) on the clinical outcome, we performed a retrospective study with registry data including a total of 12 050 patients (age >= 18 years) who received allogeneic hematopoietic SCT (HSCT) between 2000 and 2010. Patients were stratified as follows: BMI < 18.5 kg/m(2), Underweight, n = 1791; 18.5 <= BMI < 25, Normal, n = 8444; 25. BMI >= 30, Overweight, n = 1591; BMI. 30, Obese, n = 224. The median age was 45 years (range, 18-77). A multivariate analysis showed that the risk of relapse was significantly higher in the underweight group and lower in the overweight and obese groups compared with the normal group (hazard ratio (HR), 1.16, 0.86, and 0.74, respectively). The risk of GVHD was significantly higher in the overweight group compared with the normal group. The risk of non-relapse mortality (NRM) was significantly higher in the overweight and obese group compared with the normal group (HR 1.19 and HR 1.43, respectively). The probability of OS was lower in the underweight group compared with the normal group (HR 1.10, P = 0.018). In conclusion, pretransplant BMI affected the risk of relapse and NRM after allogeneic HSCT. Underweight was a risk factor for poor OS because of an increased risk of relapse. Obesity was a risk factor for NRM.	[Fuji, S.; Takano, K.; Fukuda, T.] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Div, Tokyo 1040045, Japan; [Mori, T.] Keio Univ, Sch Med, Div Hematol, Tokyo, Japan; [Eto, T.] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan; [Taniguchi, S.] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Ohashi, K.; Sakamaki, H.] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Morishima, Y.] Aichi Canc Ctr Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Kato, K.] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Miyamura, K.] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Suzuki, R.] Nagoya Univ, Grad Sch Med, Dept HSCT Data Management & Biostat, Nagoya, Aichi, Japan	Fuji, S (reprint author), Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	sfuji@ncc.go.jp			Ministry of Health, Labor and Welfare, Japan	We thank the medical, nursing, data-processing, laboratory and clinical staffs at the participating centers for their important contributions to this study and their dedicated care of the patients. This study was supported in part by grants from the Ministry of Health, Labor and Welfare, Japan.	Atsuta Y, 2007, INT J HEMATOL, V86, P269, DOI 10.1532/IJH97.06239; Murata M, 2013, BIOL BLOOD MARROW TR, V19, P1183, DOI 10.1016/j.bbmt.2013.05.003; Sorror ML, 2005, BLOOD, V106, P2912, DOI 10.1182/blood-2005-05-2004; Schipper HS, 2012, TRENDS ENDOCRIN MET, V23, P407, DOI 10.1016/j.tem.2012.05.011; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; WEISDORF D, 1990, BLOOD, V75, P1024; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI [10.1016/S1470-2045(10)70218-7, 10.1016/51470-2045(10)70218-7]; Le Blanc K, 2003, HAEMATOLOGICA, V88, P1044; Oh H, 2005, BLOOD, V105, P1408, DOI 10.1182/blood-2004-06-2385; Fuji S, 2009, BIOL BLOOD MARROW TR, V15, P73, DOI 10.1016/j.bbmt.2008.10.029; Stratton RJ, 2004, BRIT J NUTR, V92, P799, DOI 10.1079/BJN20041258; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Navarro WH, 2010, BIOL BLOOD MARROW TR, V16, P1442, DOI 10.1016/j.bbmt.2010.04.009; Conde J, 2011, BIOFACTORS, V37, P413, DOI 10.1002/biof.185; POWIS G, 1987, CANCER CHEMOTH PHARM, V20, P219, DOI 10.1007/BF00570489; Morishita S, 2012, SUPPORT CARE CANCER, V20, P3161, DOI 10.1007/s00520-012-1460-5; Hoffmeister PA, 2013, BIOL BLOOD MARROW TR, V19, P1081, DOI 10.1016/j.bbmt.2013.04.017; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ferrara JLM, 2009, LANCET, V373, P1550, DOI 10.1016/S0140-6736(09)60237-3; Bosaeus I, 2008, SUPPORT CARE CANCER, V16, P447, DOI 10.1007/s00520-007-0388-7; Robin M, 2009, TRANSPLANTATION, V88, P1131, DOI 10.1097/TP.0b013e3181bc2583; Kondrup J, 2003, CLIN NUTR, V22, P415, DOI 10.1016/S0261-5614(03)00098-0; Baffy G, 2009, J HEPATOL, V51, P212, DOI 10.1016/j.jhep.2009.03.008; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Boullata JI, 2010, P NUTR SOC, V69, P543, DOI 10.1017/S0029665110001990; Coss CC, 2011, CURR OPIN CLIN NUTR, V14, P268, DOI 10.1097/MCO.0b013e3283455e21; DEEG HJ, 1995, BONE MARROW TRANSPL, V15, P461; GLUCKSBE.H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Hahn T, 2008, J CLIN ONCOL, V26, P5728, DOI 10.1200/JCO.2008.17.6545; Heinbokel T, 2013, TRANSPLANTATION, V96, P10, DOI 10.1097/TP.0b013e3182869d2f; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Lee KH, 2005, HAEMATOL-HEMATOL J, V90, P939; Murry D J, 1998, Int J Cancer Suppl, V11, P48; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Przepiorka D, 1994, BONE MARROW TRANSPLA; Tilg H, 2010, Minerva Gastroenterol Dietol, V56, P159; World Health Organisation, 2000, WHO TECH REP SER, V894, P1	38	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	DEC	2014	49	12					1505	1512		10.1038/bmt.2014.178		8	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	AU9IM	WOS:000345905300010		
J	Kato, K; Ohno, Y; Kamimura, T; Kusumoto, H; Tochigi, T; Jinnouchi, F; Kohno, K; Kuriyama, T; Henzan, H; Takase, K; Kawano, I; Kadowaki, M; Nawata, R; Muta, T; Eto, T; Iawasaki, H; Ohshima, K; Miyamoto, T; Akashi, K				Kato, K.; Ohno, Y.; Kamimura, T.; Kusumoto, H.; Tochigi, T.; Jinnouchi, F.; Kohno, K.; Kuriyama, T.; Henzan, H.; Takase, K.; Kawano, I.; Kadowaki, M.; Nawata, R.; Muta, T.; Eto, T.; Iawasaki, H.; Ohshima, K.; Miyamoto, T.; Akashi, K.			Long-term remission after high-dose chemotherapy followed by auto-SCT as consolidation for intravascular large B-cell lymphoma	BONE MARROW TRANSPLANTATION			English	Letter							RETROSPECTIVE ANALYSIS; TRANSPLANTATION; RITUXIMAB		[Kato, K.; Jinnouchi, F.; Kohno, K.; Kuriyama, T.; Miyamoto, T.; Akashi, K.] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosystem Sci, Fukuoka, Japan; [Ohno, Y.; Kusumoto, H.; Tochigi, T.] Kitakyushu Municipal Med Ctr, Dept Internal Med, Kitakyushu, Fukuoka, Japan; [Kamimura, T.] Harasanshin Hosp, Dept Hematol, Fukuoka, Japan; [Henzan, H.; Takase, K.; Kawano, I.; Kadowaki, M.; Nawata, R.; Muta, T.; Eto, T.] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan; [Iawasaki, H.; Akashi, K.] Kyushu Univ, Grad Sch Med Sci, Ctr Cellular & Mol Med, Fukuoka 812, Japan; [Ohshima, K.] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan	Kato, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosystem Sci, Fukuoka, Japan.	kojikato@intmed1.med.kyushu-u.ac.jp					Shimada K, 2010, CANCER SCI, V101, P1480, DOI 10.1111/j.1349-7006.2010.01555.x; Shimada K, 2008, J CLIN ONCOL, V26, P3189, DOI 10.1200/JCO.2007.15.4278; Shimada K, 2009, LANCET ONCOL, V10, P895, DOI 10.1016/S1470-2045(09)70140-8; Ferreri AJM, 2008, J CLIN ONCOL, V26, P5134, DOI 10.1200/JCO.2008.19.1841; Stiff PJ, 2013, NEW ENGL J MED, V369, P1681, DOI 10.1056/NEJMoa1301077; Ferreri AJ, 2008, J CLIN ONCOL, V26, P5136; Ferreri AJM, 2008, BRIT J HAEMATOL, V143, P253, DOI 10.1111/j.1365-2141.2008.07338.x; Koizumi M, 2001, BONE MARROW TRANSPL, V27, P1101, DOI 10.1038/sj.bmt.1703038; Yamaguchi M, 2001, BONE MARROW TRANSPL, V27, P89, DOI 10.1038/sj.bmt.1702735	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	DEC	2014	49	12					1543	1544		10.1038/bmt.2014.189		2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	AU9IM	WOS:000345905300017		
J	Nakano, N; Kubota, A; Tokunaga, M; Tokunaga, M; Itoyama, T; Makino, T; Takeuchi, S; Takatsuka, Y; Utsunomiya, A				Nakano, N.; Kubota, A.; Tokunaga, M.; Tokunaga, M.; Itoyama, T.; Makino, T.; Takeuchi, S.; Takatsuka, Y.; Utsunomiya, A.			High incidence of CMV infection in adult T-cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation	BONE MARROW TRANSPLANTATION			English	Letter							CYTOMEGALOVIRUS; RECIPIENTS; DISEASE		[Nakano, N.; Kubota, A.; Tokunaga, M.; Tokunaga, M.; Itoyama, T.; Makino, T.; Takeuchi, S.; Takatsuka, Y.; Utsunomiya, A.] Imamura Bun In Hosp, Dept Hematol, Kagoshima, Japan	Nakano, N (reprint author), Imamura Bun In Hosp, Dept Hematol, Kagoshima, Japan.	nobunobuprince@yahoo.co.jp					Itonaga H, 2013, BIOL BLOOD MARROW TR, V19, P607, DOI 10.1016/j.bbmt.2013.01.011; Boeckh M, 2003, BLOOD, V101, P407, DOI 10.1182/blood-2002-03-0993; Junghanss C, 2002, BLOOD, V99, P1978, DOI 10.1182/blood.V99.6.1978; Nakamae H, 2009, BIOL BLOOD MARROW TR, V15, P694, DOI 10.1016/j.bbmt.2009.02.009; Nichols WG, 2002, J INFECT DIS, V185, P273, DOI 10.1086/338624; Stocchi R, 1999, HAEMATOLOGICA, V84, P71; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Ogata M, 2011, J MED VIROL, V83, P702, DOI 10.1002/jmv.22013	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0268-3369	1476-5365		BONE MARROW TRANSPL	Bone Marrow Transplant.	DEC	2014	49	12					1548	1549		10.1038/bmt.2014.204		2	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	AU9IM	WOS:000345905300019		
J	Muangmai, N; Yamagishi, Y; Maneekat, S; Kaewsuralikhit, C				Muangmai, Narongrit; Yamagishi, Yukimasa; Maneekat, Sinchai; Kaewsuralikhit, Chatcharee			The new species Neosiphonia thailandica sp nov (Rhodomelaceae, Rhodophyta) from the Gulf of Thailand	BOTANICA MARINA			English	Article						Neosiphonia thailandica sp nov.; rbcL; Rhodomelaceae; Rhodophyta; taxonomy; the Gulf of Thailand	TAXONOMIC NOTES; SEQUENCE DATA; MARINE-ALGAE; CERAMIALES; EPIPHYTISM; CHECKLIST; MODELS; JAPAN; KOREA; USA	We describe a new epiphytic red alga Neosiphonia thailandica sp. nov. based on a sample collected from Sri Rasha Harbor in the eastern upper Gulf of Thailand. This species grows epiphytically on Gracilaria fisheri, and it is distinguished from other members of the genus by a combination of morphological features: large and slender thalli with narrow axes (up to 15 cm height and 0.5 mm wide), ecortication, well-developed erect habit, few trichoblasts, and abundant adventitious endogenous branchlets occurring in various positions on the thalli. The morphological distinction of N. thailandica is supported by molecular phylogenetic analyses using partial rbcL sequences. Neosiphonia thailandica is positioned within a major clade of the genus Neosiphonia and clustered with Neosiphonia sphaerocarpa and Polysiphonia forfex.	[Muangmai, Narongrit; Kaewsuralikhit, Chatcharee] Kasetsart Univ, Ctr Adv Studies Agr & Food, Biodivers & Aquat Environm Res Unit, Bangkok 10900, Thailand; [Maneekat, Sinchai; Kaewsuralikhit, Chatcharee] Kasetsart Univ, Dept Fishery Biol, Fac Fisheries, Bangkok 10900, Thailand; [Muangmai, Narongrit] Victoria Univ Wellington, Sch Biol Sci, Wellington 6014, New Zealand; [Yamagishi, Yukimasa] Fukuyama Univ, Fac Life Sci & Biotechnol, Dept Marine Biotechnol, Fukuyama, Hiroshima 7290292, Japan	Kaewsuralikhit, C (reprint author), Kasetsart Univ, Ctr Adv Studies Agr & Food, Biodivers & Aquat Environm Res Unit, Bangkok 10900, Thailand.	ffischs@ku.ac.th			Center for Advanced Studies for Agriculture and Food, Kasetsart University, Thailand	We are extremely grateful to members of the Sriracha Fisheries Research Station, Faculty of Fisheries, Kasetsart University, in field collection. We also thank the anonymous reviewers for their constructive comments on the original manuscript and Dr. Giuseppe C. Zuccarello for the critical comments and for improving the English of the manuscript. Special thanks to Tatsuya Abe and Roku Futamata for helping with the molecular work and to Dr. Daisaku Ikeda for offering inspiration and encouragement to N.M. and Y.Y. This study is partially supported by the Center for Advanced Studies for Agriculture and Food, Kasetsart University, Thailand.	Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Stuercke B, 2008, PHYCOLOGIA, V47, P541, DOI 10.2216/08-09.1; Mamoozadeh NR, 2011, BOT MAR, V54, P269, DOI 10.1515/BOT.2011.036; FLETCHER RL, 1995, J APPL PHYCOL, V7, P325, DOI 10.1007/BF00004006; Vairappan CS, 2006, J APPL PHYCOL, V18, P611, DOI 10.1007/s10811-006-9062-6; Mamoozadeh NR, 2012, BOT MAR, V55, P317, DOI 10.1515/bot-2012-0147; Bustamante DE, 2013, BOT MAR, V56, P515, DOI 10.1515/bot-2013-0078; Wynne MJ, 2011, NOVA HEDWIGIA, P7; Hurtado AQ, 2009, J APPL PHYCOL, V21, P633, DOI 10.1007/s10811-008-9395-4; Hanyuda T, 2004, J PHYCOL, V40, P581, DOI 10.1046/j.1529-8817.2004.03159.x; Nguyen TV, 2013, BOT MAR, V56, P207, DOI 10.1515/bot-2013-0010; ROSENTHAL A, 1993, NUCLEIC ACIDS RES, V21, P173, DOI 10.1093/nar/21.1.173; Vairappan C, 2008, J APPL PHYCOL, V20, P477, DOI 10.1007/s10811-007-9299-8; Munoz J, 2010, J APPL PHYCOL, V22, P371, DOI 10.1007/s10811-009-9469-y; Bustamante DE, 2014, ALGAE-SEOUL, V29, P111, DOI 10.4490/algae.2014.29.2.111; Bustamante D.E., 2013, ALGAE, V28, P79; Bustamante DE, 2012, BOT MAR, V55, P359, DOI 10.1515/bot-2012-0146; Choi HG, 2001, CAN J BOT, V79, P1465; Drummond A. J., 2009, TRACER V1 5; Kim B, 2014, ALGAE-SEOUL, V29, P183, DOI 10.4490/algae.2014.29.3.183; Kim MS, 2005, NOVA HEDWIGIA, V81, P163, DOI 10.1127/0029-5035/2005/0081-0163; Kim Myung Sook, 1999, Phycological Research, V47, P271, DOI 10.1111/j.1440-1835.1999.tb00308.x; Kim Myung-Sook, 2003, Algae, V18, P107; Kim M.S., 2008, MONOGRAPH SERIES, V2, P33; Leonardi PI, 2006, EUR J PHYCOL, V41, P247, DOI 10.1080/09670260600645659; Masuda M, 2001, BOT MAR, V44, P467, DOI 10.1515/BOT.2001.053; Muangmai M., 2012, BIODIVERS J, V3, P247; Nam K.W., 2012, ALGAL FLORA KOREA, V4, P1; Pham MHT, 2011, CAMERA OBSCURA, P1, DOI 10.1215/02705346-2010-013; Rambaut A., 2009, FIGTREE VER 1 3 1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Segi T., 1951, REP FAC FISH PREF U, V1, P167; Silvestro M., 2012, ORG DIVERS EVOL, V12, P335; Womersley H. B. S., 2003, The marine benthic flora of southern Australia. Part IIID: Ceramiales - Delesseriaceae, Sarcomeniaceae, Rhodomelaceae; Yamagishi Y, 2014, PHYCOL RES, V62, P63, DOI 10.1111/pre.12038; Yamagishi Yukimasa, 2000, Phycological Research, V48, P27, DOI 10.1111/j.1440-1835.2000.tb00127.x	36	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0006-8055	1437-4323		BOT MAR	Bot. Marina	DEC	2014	57	6					459	467		10.1515/bot-2014-0042		9	Plant Sciences; Marine & Freshwater Biology	Plant Sciences; Marine & Freshwater Biology	AU5FH	WOS:000345632100005		
J	Hori, D; Brown, C; Ono, M; Rappold, T; Sieber, F; Gottschalk, A; Neufeld, KJ; Gottesman, R; Adachi, H; Hogue, CW				Hori, D.; Brown, C.; Ono, M.; Rappold, T.; Sieber, F.; Gottschalk, A.; Neufeld, K. J.; Gottesman, R.; Adachi, H.; Hogue, C. W.			Arterial pressure above the upper cerebral autoregulation limit during cardiopulmonary bypass is associated with postoperative delirium	BRITISH JOURNAL OF ANAESTHESIA			English	Article						cardiac surgery; cardiopulmonary bypass; cerebral autoregulation; delirium	NEAR-INFRARED SPECTROSCOPY; BLOOD-FLOW; RANDOMIZED-TRIAL; SERUM CREATININE; CARDIAC-SURGERY; BRAIN; OUTCOMES; OXYGENATION; ANESTHESIA; THRESHOLD	Background. Mean arterial pressure (MAP) below the lower limit of cerebral autoregulation during cardiopulmonary bypass (CPB) is associated with complications after cardiac surgery. However, simply raising empiric MAP targets during CPB might result in MAP above the upper limit of autoregulation (ULA), causing cerebral hyperperfusion in some patients and predisposing them to cerebral dysfunction after surgery. We hypothesized that MAP above an ULA during CPB is associated with postoperative delirium. Methods. Autoregulation during CPB was monitored continuously in 491 patients with the cerebral oximetry index (COx) in this prospective observational study. COx represents Pearson's correlation coefficient between low-frequency changes in regional cerebral oxygen saturation (measured with near-infrared spectroscopy) and MAP. Delirium was defined throughout the postoperative hospitalization based on clinical detection with prospectively defined methods. Results. Delirium was observed in 45 (9.2%) patients. Mechanical ventilation for >48 h [odds ratio (OR), 3.94; 95% confidence interval (CI), 1.72-9.031 preoperative antidepressant use (OR, 3.0; 95% CI, 1.29-6.96), prior stroke (OR, 2.79; 95% CI, 1.12-6.96), congestive heart failure (OR, 2.68; 95% CI, 1.28-5.62), the product of the magnitude and duration of MAP above an ULA (mm Hg h; OR, 1.09; 95% CI, 1.03-1.15), and age (per year of age; OR, 1.01; 95% CI, 1.01-1.07) were independently associated with postoperative delirium. Conclusions. Excursions of MAP above the upper limit of cerebral autoregulation during CPB are associated with risk for delirium. Optimizing MAP during CPB to remain within the cerebral autoregulation range might reduce risk of delirium.	[Hori, D.; Ono, M.] Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Div Cardiac Surg,Dept Surg, Baltimore, MD 21287 USA; [Brown, C.; Rappold, T.; Sieber, F.; Gottschalk, A.; Hogue, C. W.] Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21287 USA; [Neufeld, K. J.] Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Dept Psychiat, Baltimore, MD 21287 USA; [Gottesman, R.] Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Dept Neurol, Baltimore, MD 21287 USA; [Adachi, H.] Jichi Med Univ, Saitama Med Ctr, Dept Cardiovasc Surg, Saitama, Japan	Hogue, CW (reprint author), Johns Hopkins Univ, Sch Med, Johns Hopkins Hosp, Dept Anesthesiol & Crit Care Med, 1800 Orleans Ave,Zayed 6208B, Baltimore, MD 21287 USA.	chogue2@jhmi.edu			Mid-Atlantic Affiliate of the American Heart Association [103363]; National Institutes of Health [R01HL092259, R01AG033615, R01AG029656-01A1]; Mentored Career Development Award from the National Institutes of Health [5KL2RR025006, R03 AG042331]; Jahnigen Career Development Award	Funded in part by grant-in-aid number 103363 from the Mid-Atlantic Affiliate of the American Heart Association (C.W.H.); grants R01HL092259 (C.W.H.), R01AG033615 (F.S.), and R01AG029656-01A1 (F.S.) from the National Institutes of Health; Mentored Career Development Award 5KL2RR025006 and R03 AG042331 from the National Institutes of Health (C.B.); and the Jahnigen Career Development Award (C.B.).	Joshi B, 2010, ANESTH ANALG, V110, P321, DOI 10.1213/ANE.0b013e3181c6fd12; Marcantonio ER, 1998, AM J MED, V105, P380, DOI 10.1016/S0002-9343(98)00292-7; HARRIS DN, 1993, LANCET, V342, P586, DOI 10.1016/0140-6736(93)91412-F; Rudolph JL, 2009, CIRCULATION, V119, P229, DOI 10.1161/CIRCULATIONAHA.108.795260; Gullestad L, 2012, CARDIOLOGY, V122, P23, DOI 10.1159/000338166; Sieber Frederick E, 2009, Anesthesiol Clin, V27, P451, DOI 10.1016/j.anclin.2009.07.009; Williams-Russo P, 1999, ANESTHESIOLOGY, V91, P926, DOI 10.1097/00000542-199910000-00011; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Joshi B, 2012, ANESTH ANALG, V114, P503, DOI 10.1213/ANE.0b013e31823d292a; Saczynski JS, 2012, NEW ENGL J MED, V367, P30, DOI 10.1056/NEJMoa1112923; Auerbach AD, 2013, JAMA INTERN MED, V173, P1075, DOI 10.1001/jamainternmed.2013.714; Brady KM, 2010, ANESTH ANALG, V111, P191, DOI 10.1213/ANE.0b013e3181e054ba; Ono M, 2012, BRIT J ANAESTH, V109, P391, DOI 10.1093/bja/aes148; Cho SY, 2013, ANESTH ANALG, V117, P1436, DOI 10.1213/ANE.0b013e3182a8fa97; Ono M, 2014, J THORAC CARDIOV SUR, V147, P483, DOI 10.1016/j.jtcvs.2013.07.069; Inouye SK, 2001, ARCH INTERN MED, V161, P2467, DOI 10.1001/archinte.161.20.2467; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159; Gottesman RF, 2010, ANN NEUROL, V67, P338, DOI 10.1002/ana.21899; Aggarwal M, 2006, CARDIOL CLIN, V24, P135, DOI 10.1016/j.ccl.2005.09.002; Ono M, 2013, CRIT CARE MED, V41, P464, DOI 10.1097/CCM.0b013e31826ab3a1; Hogue CW, 2006, ANESTH ANALG, V103, P21, DOI 10.1213/01.ANE.0000220035.82989.79; Meng L, 2011, BRIT J ANAESTH, V107, P209, DOI 10.1093/bja/aer150; Simon SE, 2006, J AM MED DIR ASSOC, V7, P412, DOI 10.1016/j.jamda.2006.02.006; GOLD JP, 1995, J THORAC CARDIOV SUR, V110, P1302, DOI 10.1016/S0022-5223(95)70053-6; Plochl W, 1999, ANESTHESIOLOGY, V90, P183, DOI 10.1097/00000542-199901000-00024; Lassnigg A, 2008, CRIT CARE MED, V36, P1129, DOI 10.1097/CCM.0b013e318169181a; Levy JH, 2003, ANN THORAC SURG, V75, pS715, DOI 10.1016/S0003-4975(02)04701-X; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; GREELEY WJ, 1989, CIRCULATION, V80, P209; HENRIKSEN L, 1983, J THORAC CARDIOV SUR, V86, P202; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Kazmierski J, 2013, CRIT CARE, V17, DOI 10.1186/cc12548; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; STOCKARD JJ, 1973, NEUROLOGY, V23, P521; Taylor K M, 1990, Semin Thorac Cardiovasc Surg, V2, P300	36	4	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	DEC	2014	113	6					1009	1017		10.1093/bja/aeu319		9	Anesthesiology	Anesthesiology	AU8BP	WOS:000345822000017		
J	Fukagawa, H; Koyama, T; Fukuda, K				Fukagawa, H.; Koyama, T.; Fukuda, K.			kappa-Opioid receptor mediates the antinociceptive effect of nitrous oxide in mice	BRITISH JOURNAL OF ANAESTHESIA			English	Article						anaesthetics gases, nitrous oxide; anaesthetics volatile; mice, knockout; potency, analgesic; receptors, opioid, kappa	MINIMUM ALVEOLAR CONCENTRATION; NOCICEPTIN RECEPTOR; INDUCED ANALGESIA; SPINAL-CORD; RATS; SEVOFLURANE; MORPHINE; NEURONS; ANTAGONIST; KNOCKOUT	Background. Our previous reports demonstrated that genetic deletion of mu-opioid receptor has no influence on the anaesthetic and antinociceptive effects of nitrous oxide (N2O) in mice, and that an antagonist selective for kappa-opioid receptor (KOP), but not that selective for delta-opioid receptor, suppresses the antinociceptive effect of N2O. However, it is not known whether genetic deletion of KOP affects the N2O actions. Methods. We measured the minimum alveolar concentration (MAC) of volatile anaesthetics in the absence and presence of N2O. The antinociceptive action of N2O was tested by an acetic acid-writhing test and a hot-plate test. The number of c-Fos-immunopositive cells in sections from the lumbar spinal cord was counted to test whether the descending inhibitory system participates in the pharmacological action of N2O. The hypnotic action of N2O was assessed by measuring the N2O-induced decrease in the EC50 for loss of the righting reflex (EC50-LORR) of sevoflurane. Results. Sevoflurane MAC was not significantly reduced by N2O and its antinociceptive action was almost completely abolished in KOP-knockout (KO) mice. The N2O-induced increase in c-Fos-immunopositive cells in laminae III-IV of the lumbar spinal cord was significant in wild-type (WT), but not in KOP-KO mice. In contrast, sevoflurane EC50-LORR was similarly reduced by N2O in WT and KOP-KO mice. Conclusions. Our study suggests that N2O demonstrates its antinociceptive action and reduces sevoflurane MAC in mice through KOP activation, whereas its hypnotic potency is not dependent on KOP activation.	[Fukagawa, H.; Koyama, T.; Fukuda, K.] Kyoto Univ Hosp, Dept Anesthesia, Sakyo Ku, Kyoto 6068507, Japan	Fukuda, K (reprint author), Kyoto Univ Hosp, Dept Anesthesia, Sakyo Ku, Shogoin Kawahara Cho, Kyoto 6068507, Japan.	kfukuda@kuhp.kyoto-u.ac.jp			Japan Society for the Promotion of Science (Tokyo, Japan) Kakenhi [21249081]	This work was supported by the Japan Society for the Promotion of Science (Tokyo, Japan) Kakenhi: Grant-in Aid for Scientific Research (A) 21249081.	VONVOIGTLANDER PF, 1983, J PHARMACOL EXP THER, V224, P7; Petrenko AB, 2007, ANESTHESIOLOGY, V106, P1177, DOI 10.1097/01.anes.0000267601.09764.e6; Fujinaga M, 2002, MOL NEUROBIOL, V25, P167, DOI 10.1385/MN:25:2:167; Georgiev SK, 2008, PAIN, V134, P24, DOI 10.1016/j.pain.2007.03.026; KATOH T, 1987, ANESTHESIOLOGY, V66, P301, DOI 10.1097/00000542-198703000-00006; Cope JL, 2010, EUR J PHARMACOL, V626, P234, DOI 10.1016/j.ejphar.2009.09.059; Woolfe G, 1944, J PHARMACOL EXP THER, V80, P300; Dahan A, 2001, ANESTHESIOLOGY, V94, P824, DOI 10.1097/00000542-200105000-00021; Sawamura S, 2000, J NEUROSCI, V20, P9242; KOSTER R, 1959, FED PROC, V18, P412; Simonin F, 1998, EMBO J, V17, P886, DOI 10.1093/emboj/17.4.886; BERKOWITZ BA, 1977, J PHARMACOL EXP THER, V203, P539; WHITE PF, 1974, ANESTHESIOLOGY, V40, P52, DOI 10.1097/00000542-197401000-00012; PRESLEY RW, 1990, J NEUROSCI, V10, P323; Toda Y, 1999, PATHOL INT, V49, P479, DOI 10.1046/j.1440-1827.1999.00875.x; EGER EI, 1965, ANESTHESIOLOGY, V26, P771, DOI 10.1097/00000542-196511000-00012; Fukuda K, 2009, MILLERS ANESTHESIA, P769; Hashimoto T, 2001, ANESTHESIOLOGY, V95, P463, DOI 10.1097/00000542-200108000-00031; Himukashi S, 2006, ANESTH ANALG, V103, P738, DOI 10.1213/01.ane.0000230601.64098.cc; Jevtovic-Todorovic V, 1998, NAT MED, V4, P460, DOI 10.1038/nm0498-460; Koyama T, 2010, J ANESTH, V24, P297, DOI 10.1007/s00540-010-0886-5; Koyama T, 2009, J ANESTH, V23, P301, DOI 10.1007/s00540-009-0739-2; Koyama T, 2009, BRIT J ANAESTH, V103, P744, DOI 10.1093/bja/aep246; Liao M, 2006, ANESTH ANALG, V102, P1452, DOI 10.1213/01.ane.0000204254.87933.f6; MCDONALD CE, 1994, J PHARMACOL EXP THER, V269, P601; Petrenko AB, 2013, EUR J PHARMACOL, V698, P200, DOI 10.1016/j.ejphar.2012.10.034; Russell GB, 1998, CAN J ANAESTH, V45, P466; Sawamura S, 2003, ANESTHESIOLOGY, V99, P708, DOI 10.1097/00000542-200309000-00028	28	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	DEC	2014	113	6					1032	1038		10.1093/bja/aeu254		7	Anesthesiology	Anesthesiology	AU8BP	WOS:000345822000020		
J	Perez, NM; Somoza, L; Hernandez, PA; de Vallejo, LG; Leon, R; Sagiya, T; Biain, A; Gonzalez, FJ; Medialdea, T; Barrancos, J; Ibanez, J; Sumino, H; Nogami, K; Romero, C				Perez, Nemesio M.; Somoza, Luis; Hernandez, Pedro A.; de Vallejo, Luis Gonzalez; Leon, Ricardo; Sagiya, Takeshi; Biain, Ander; Gonzalez, Francisco J.; Medialdea, Teresa; Barrancos, Jose; Ibanez, Jesus; Sumino, Hirochika; Nogami, Kenji; Romero, Carmen			Evidence from acoustic imaging for submarine volcanic activity in 2012 off the west coast of El Hierro (Canary Islands, Spain)	BULLETIN OF VOLCANOLOGY			English	Article						Acoustic imaging; Submarine volcanic activity; Precursory signature; El Hierro; Canary Islands	EAST-PACIFIC-RISE; SOIL-GAS RADON; HYDROTHERMAL PLUMES; ERUPTION; OCEAN; RIDGE; 21-DEGREES-N; CONSTRUCTION; INSIGHTS; DEPOSITS	We report precursory geophysical, geodetic, and geochemical signatures of a new submarine volcanic activity observed off the western coast of El Hierro, Canary Islands. Submarine manifestation of this activity has been revealed through acoustic imaging of submarine plumes detected on the 20-kHz chirp parasound subbottom profiler (TOPAS PS18) mounted aboard the Spanish RV Hesperides on June 28, 2012. Five distinct " filament-shaped" acoustic plumes emanating from the flanks of mounds have been recognized at water depth between 64 and 88 m on a submarine platform located NW El Hierro. These plumes were well imaged on TOPAS profiles as " flares" of high acoustic contrast of impedance within the water column. Moreover, visible plumes composed of white rafts floating on the sea surface and sourcing from the location of the submarine plumes were reported by aerial photographs on July 3, 2012, 5 days after acoustic plumes were recorded. In addition, several geophysical and geochemical data support the fact that these submarine vents were preceded by several precursory signatures: (i) a sharp increase of the seismic energy release and the number of daily earthquakes of magnitude >= 2.5 on June 25, 2012, (ii) significant vertical and horizontal displacements observed at the Canary Islands GPS network (Nagoya University-ITERGRAFCAN) with uplifts up to 3 cm from June 25 to 26, 2012, (iii) an anomalous increase of the soil gas radon activity, from the end of April until the beginning of June reaching peak values of 2.7 kBq/m(3) on June 3, 2012, and (iv) observed positive peak in the air-corrected value of He-3/He-4 ratio monitored in ground waters (8.5 atmospheric He-3/He-4 ratio (RA)) at the northwestern El Hierro on June 16, 2012. Combiningthese submarine and subaerial information, we suggest these plumes are the consequence of submarine vents exhaling volcanic gas mixed with fine ash as consequence of an event of rapid rise of volatile- rich magma beneath the NW submarine ridge of El Hierro. These precursory signals have revealed important to improve and optimize the detection of early warning signals of volcanic unrest episodes at El Hierro.	[Perez, Nemesio M.; Hernandez, Pedro A.; de Vallejo, Luis Gonzalez; Sagiya, Takeshi; Barrancos, Jose; Ibanez, Jesus; Romero, Carmen] Inst Volcanol Canarias INVOLCAN, Puerto La Cruz, Canary Islands, Spain; [Somoza, Luis; Leon, Ricardo; Biain, Ander; Gonzalez, Francisco J.; Medialdea, Teresa] IGME, Marine Geol Div, Madrid, Spain; [Perez, Nemesio M.; Hernandez, Pedro A.; Barrancos, Jose] ITER, Div Environm Res, Granadilla De Abona, Canary Islands, Spain; [de Vallejo, Luis Gonzalez] Univ Complutense Madrid, Fac Ciencias Geol, Madrid, Spain; [Sagiya, Takeshi] Nagoya Univ, Disaster Mitigat Res Ctr, Nagoya, Aichi 4648601, Japan	Hernandez, PA (reprint author), ITER, Div Environm Res, Granadilla De Abona, Canary Islands, Spain.	phdez@iter.es	Somoza, Luis/C-1400-2010; Medialdea, Teresa/G-2647-2015; Leon, Ricardo/G-8314-2015; Gonzalez, F. Javier/C-1416-2010; Perez Rodriguez, Nemesio /H-9295-2015; Barrancos, Jose/H-7681-2015; 	Sumino, Hirochika/0000-0002-4689-6231; Somoza, Luis/0000-0001-5451-2288; Medialdea, Teresa/0000-0002-7969-5751; Leon, Ricardo/0000-0001-5598-0710; Gonzalez, F. Javier/0000-0002-6311-1950; Perez Rodriguez, Nemesio /0000-0003-1410-7717; Barrancos, Jose/0000-0002-6224-5471; IBANEZ, JESUS/0000-0002-9846-8781			La Rocca M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023974; PALMER DR, 1986, J ACOUST SOC AM, V80, P888, DOI 10.1121/1.393912; BAKER ET, 1987, EARTH PLANET SC LETT, V85, P59, DOI 10.1016/0012-821X(87)90021-5; Sandri L, 2004, B VOLCANOL, V66, P263, DOI 10.1007/s00445-003-0309-7; SMITH DK, 1988, J GEOPHYS RES-SOLID, V93, P2899, DOI 10.1029/JB093iB04p02899; Burgisser A, 2002, EARTH PLANET SC LETT, V202, P405, DOI 10.1016/S0012-821X(02)00789-6; HAY AE, 1984, SCIENCE, V225, P1154, DOI 10.1126/science.225.4667.1154; RONA PA, 1991, GEOPHYS RES LETT, V18, P2233, DOI 10.1029/91GL02897; Rivera J, 2013, GEOLOGY, V41, P355, DOI 10.1130/G33863.1; Guillou H, 1996, J VOLCANOL GEOTH RES, V73, P141, DOI 10.1016/0377-0273(96)00021-2; Greinert J, 2006, EARTH PLANET SC LETT, V244, P1, DOI [10.1016/j.epsl.2006.02.011, 10.1016/j.epsl.2006.02.01]; WOODS AW, 1991, B VOLCANOL, V53, P559, DOI 10.1007/BF00298156; Masson DG, 1996, GEOLOGY, V24, P231, DOI 10.1130/0091-7613(1996)024<0231:CCOTVI>2.3.CO;2; Rona PA, 2002, MAR GEOPHYS RES, V23, P147, DOI 10.1023/A:1022481315125; MACDONALD KC, 1980, EARTH PLANET SC LETT, V48, P1, DOI 10.1016/0012-821X(80)90163-6; Sparks RSJ, 2003, EARTH PLANET SC LETT, V210, P1, DOI 10.1016/S0012-821X(03)00124-9; BENSON BB, 1980, J SOLUTION CHEM, V9, P895, DOI 10.1007/BF00646402; Head JW, 2003, J VOLCANOL GEOTH RES, V121, P155, DOI 10.1016/S0377-0273(02)00425-0; Stroncik NA, 2009, CONTRIB MINERAL PETR, V157, P593, DOI 10.1007/s00410-008-0354-5; CONVERSE DR, 1984, EARTH PLANET SC LETT, V69, P159, DOI 10.1016/0012-821X(84)90080-3; Pinault JL, 1996, J GEOPHYS RES-SOL EA, V101, P3157, DOI 10.1029/95JB03121; Altamimi Z, 2011, J GEODESY, V85, P457, DOI 10.1007/s00190-011-0444-4; Padron E, 2013, GEOLOGY, V41, P539, DOI 10.1130/G34027.1; Matsuda J, 2002, GEOCHEM J, V36, P191; Kumagai H, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003337; ORR MH, 1978, J GEOPHYS RES-OC ATM, V83, P4062, DOI 10.1029/JC083iC08p04062; Longpre MA, 2014, GEOLOGY, V42, P315, DOI 10.1130/G35165.1; La Rocca M, 2009, SCIENCE, V323, P620, DOI 10.1126/science.1167112; Ibanez JM, 2012, GEOPHYS J INT, V191, P659, DOI 10.1111/j.1365-246X.2012.05629.x; THOMSON RE, 1989, J GEOPHYS RES-OCEANS, V94, P4709, DOI 10.1029/JC094iC04p04709; Capasso G, 2005, B VOLCANOL, V68, P118, DOI 10.1007/s00445-005-0427-5; CARRACEDO JC, 1994, J VOLCANOL GEOTH RES, V60, P225, DOI 10.1016/0377-0273(94)90053-1; Chiharu A, 2007, 5 INT S UND TECHN TO; Dach R., 2007, BERNESE GPS SOFTWARE; Dybedal J, 1994, OCEANS 94, V1, P634; Friedman P, 2012, NAT SCI, V4, P1002; Friedman PD, 2007, EXP FLUIDS, V42, P751, DOI 10.1007/S00348-007-0283-5; Garcia-Yeguas A, 2014, GEOPHYS J INT, V199, P1739, DOI 10.1093/gji/ggu339; Hernandez Pacheco A, 1982, REV U AZORES CN, V3, P83; Melian G, 2014, J GEOPHYS RES-SOL EA, V119, P6976, DOI 10.1002/2014JB011013; Middleton G., 1976, MARINE SEDIMENT TRAN, P197; Mogi K., 1958, B EARTHQ RES I TOKYO, V36, P99; Navarro JM, 1994, AGUA HIERRO RESUMEN, P1; Padilla GD, 2013, GEOCHEM GEOPHY GEOSY, V14, P432, DOI 10.1029/2012GC004375; Perez NM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052410; Sagiya T, 2012, CRUSTAL DEFORMATION; SMITH DK, 1992, J GEOPHYS RES-SOL EA, V97, P1645, DOI 10.1029/91JB02507; Somoza L, 2004, MAR GEOL, V203, P119, DOI 10.1016/S0025-3227(03)00285-8; Somoza L, 2012, GEO TEMAS, P601; Sparks R.S.J., 1997, VOLCANIC PLUMES, P574; Sumino H, 2001, J MASS SPECTROM SOC, V49, P61; Suzuki YJ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003460	52	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0258-8900	1432-0819		B VOLCANOL	Bull. Volcanol.	DEC	2014	76	12								10.1007/s00445-014-0882-y		15	Geosciences, Multidisciplinary	Geology	AW0EE	WOS:000345962300003		
J	Funakoshi, T; Suzuki, M; Tamura, K				Funakoshi, Tomohiro; Suzuki, Maya; Tamura, Kazuo			Infectious complications in cancer patients treated with anti-EGFR monoclonal antibodies cetuximab and panitumumab: A systematic review and meta-analysis	CANCER TREATMENT REVIEWS			English	Review						Anti-EGFR monoclonal antibody; Cetuximab; Febrile neutropenia; Infection; Meta-analysis; Panitumumab; Systematic review	CELL LUNG-CANCER; METASTATIC COLORECTAL-CANCER; RANDOMIZED PHASE-II; OPEN-LABEL; CLINICAL-TRIALS; PLUS CETUXIMAB; 1ST-LINE TREATMENT; COLON-CANCER; NECK-CANCER; WILD-TYPE	Background: Clinical trials have reported a substantial variation in the risk of infection related to anti-EGFR monoclonal antibodies (mAbs) cetuximab and panitumumab. We performed a systematic review and meta-analysis to assess the infection risk in cancer patients treated with anti-EGFR mAbs. Patients and methods: We searched PubMed and the ASCO online database of meeting abstracts up to January 2014 for relevant clinical trials. Eligible studies included randomized controlled trials (RCTs) of cetuximab and panitumumab that reported adequate safety data for grade 3-4 infection or febrile neutropenia (FN). The summary incidence, relative risk (RR) and 95% confidence intervals (Cis) were calculated. Results: A total of 14,957 patients from 28 trials were included. Treatment with anti-EGFR mAbs was associated with an increased risk of high-grade infection (RR, 1.49; 95% CI, 1.33-1.66; P < 0.001) and FN (RR, 1.27; 95% CI, 1.09-1.48; P = 0.002). The incidence of high-grade infection and FN due to anti-EGFR mAbs was 9.3% (95% CI, 7.2-12.0%) and 5.3% (95% CI, 3.3-8.3%), respectively. A significantly increased risk of high-grade infection was observed in all subgroups analyses (type of anti-EGFR mAb, therapy of control arm and duration of treatment) except for tumor type (only colorectal cancer and non-small cell lung cancer (NSCLC) groups had the increased risk). Subgroup analyses revealed a significantly increased risk of FN in the following subgroups: cetuximab, NSCLC and treatment duration longer than the median of all trials (3.1 months). Conclusions: The use of anti-EGFR mAbs is associated with a significantly higher risk of high-grade infection and febrile neutropenia. (C) 2014 Elsevier Ltd. All rights reserved.	[Funakoshi, Tomohiro] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Suzuki, Maya] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Tamura, Kazuo] Fukuoka Univ Hosp, Dept Med, Div Med Oncol Hematol & Infect Dis, Fukuoka, Japan	Funakoshi, T (reprint author), Univ N Carolina, Lineberger Comprehens Canc Ctr, 170 Manning Dr,CB 7305, Chapel Hill, NC 27599 USA.	tomohiro.funakoshi@unchealth.unc.edu					Cao YF, 2010, CANCER CHEMOTH PHARM, V66, P37, DOI 10.1007/s00280-009-1131-5; Tveit KM, 2012, J CLIN ONCOL, V30, P1755, DOI 10.1200/JCO.2011.38.0915; Seymour MT, 2013, LANCET ONCOL, V14, P749, DOI 10.1016/S1470-2045(13)70163-3; Hecht JR, 2009, J CLIN ONCOL, V27, P672, DOI 10.1200/JCO.2008.19.8135; Lewkowicz P, 2005, IMMUNOL LETT, V96, P203, DOI 10.1016/j.imlet.2004.08.012; Peeters M, 2010, J CLIN ONCOL, V28, P4706, DOI 10.1200/JCO.2009.27.6055; Helbling D, 2013, ANN ONCOL, V24, P718, DOI 10.1093/annonc/mds519; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Seruga B, 2011, J CLIN ONCOL, V29, P174, DOI 10.1200/JCO.2010.31.9624; Rosell R, 2008, ANN ONCOL, V19, P362, DOI 10.1093/annonc/mdm474; Lynch TJ, 2010, J CLIN ONCOL, V28, P911, DOI 10.1200/JCO.2009.21.9618; Pirker R, 2009, LANCET, V373, P1525, DOI 10.1016/S0140-6736(09)60569-9; Kim ES, 2013, LANCET ONCOL, V14, P1326, DOI 10.1016/S1470-2045(13)70473-X; Egger M, 1997, BRIT MED J, V315, P629; Butts CA, 2007, J CLIN ONCOL, V25, P5777, DOI 10.1200/JCO.2007.13.0856; Galizia G, 2006, ANN SURG ONCOL, V13, P823, DOI 10.1245/ASO.2006.05.052; Alberts SR, 2012, JAMA-J AM MED ASSOC, V307, P1383, DOI 10.1001/jama.2012.385; Vermorken JB, 2013, LANCET ONCOL, V14, P697, DOI 10.1016/S1470-2045(13)70181-5; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Dewdney A, 2012, J CLIN ONCOL, V30, P1620, DOI 10.1200/JCO.2011.39.6036; Crosby T, 2013, LANCET ONCOL, V14, P627, DOI 10.1016/S1470-2045(13)70136-0; Petrelli F, 2012, EXPERT OPIN DRUG SAF, V11, pS9, DOI 10.1517/14740338.2011.606213; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Lordick F, 2013, LANCET ONCOL, V14, P490, DOI 10.1016/S1470-2045(13)70102-5; Moher D, 2009, ANN INTERN MED, V151, P264; Vinante F, 2013, TOXINS, V5, P1180, DOI 10.3390/toxins5061180; Herbst RS, 2002, CANCER, V94, P1593, DOI 10.1002/cncr.10372; Richards D, 2013, EUR J CANCER, V49, P2823, DOI 10.1016/j.ejca.2013.04.022; [Anonymous], COMM TOX CRIT VERS 3; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02A646; Govindan R, 2011, J CLIN ONCOL, V29, P3120, DOI 10.1200/JCO.2010.33.4979; Van den Heuvel MM, 2014, RADIOTHER ONCOL, V110, P126, DOI 10.1016/j.radonc.2013.10.009; Sobrero AF, 2008, J CLIN ONCOL, V26, P2311, DOI 10.1200/JCO.2007.13.1193; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fleming MT, 2012, CLIN GENITOURIN CANC, V10, P6, DOI 10.1016/j.clgc.2011.11.003; Garden BC, 2012, J AM ACAD DERMATOL, V67, P400, DOI 10.1016/j.jaad.2011.10.009; Koh Y, 2013, J CLIN ONCOL S, V31; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Lee CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050163; Li KJ, 2014, MOLECULES, V19, P1328, DOI 10.3390/molecules19011328; Petrelli F, 2012, ANN ONCOL, V23, P1672, DOI 10.1093/annonc/mdr592; Qi WX, 2013, J CHEMOTHER; Tebbutt NC, 2013, J CLIN ONCOL S, V31; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wang Long, 2011, Drugs R D, V11, P317, DOI 10.2165/11598190-000000000-00000; Wirth LJ, 2013, J CLIN ONCOL S, V31	51	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0305-7372	1532-1967		CANCER TREAT REV	Cancer Treat. Rev.	DEC	2014	40	10					1221	1229		10.1016/j.ctrv.2014.09.002		9	Oncology	Oncology	AU7UM	WOS:000345806700011		
J	Okugawa, Y; Toiyama, Y; Hur, K; Toden, S; Saigusa, S; Tanaka, K; Inoue, Y; Mohri, Y; Kusunoki, M; Boland, CR; Goel, A				Okugawa, Yoshinaga; Toiyama, Yuji; Hur, Keun; Toden, Shusuke; Saigusa, Susumu; Tanaka, Koji; Inoue, Yasuhiro; Mohri, Yasuhiko; Kusunoki, Masato; Boland, C. Richard; Goel, Ajay			Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis	CARCINOGENESIS			English	Article							CELL LUNG-CANCER; MESENCHYMAL TRANSITION; POOR-PROGNOSIS; HOTAIR; MALAT-1; CARCINOMA; SURVIVAL; TRANSCRIPTION; METHYLATION; EXPRESSION	The prognosis of gastric cancer (GC) patients with peritoneal dissemination remains poor, and a better understanding of the underlying mechanisms is critical for the development of new treatments that will improve survival in these patients. This study aimed to clarify the clinical and biological role of two key metastasis-associated long non-coding RNAs (lncRNAs) in GC. We analyzed the expression levels of two lncRNAs-Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) and HOX-Antisense Intergenic RNA (HOTAIR)-by real-time reverse transcription PCR in 300 gastric tissues (150 GC and 150 adjacent normal mucosa), and in seven GC cell lines. Functional characterization for the role of HOTAIR in GC was performed by small interfering RNA (siRNA) knockdown, followed by series of in-vitro and in-vivo experiments. Expression of both lncRNAs was significantly higher in cancerous tissues than in corresponding normal mucosa, and higher expression of these lncRNAs significantly correlated with peritoneal metastasis in GC patients. In addition, elevated HOTAIR expression emerged both as an independent prognostic and risk factor for peritoneal dissemination. SiRNA knockdown of HOTAIR in GC cells significantly inhibited cell proliferation, migration and invasion, but concurrently enhanced the anoikis rate in transfected cells. In an in vivo assay, HOTAIR siRNA-transfected MKN45 cells injected into nude mice inhibited the growth of xenograft tumors and peritoneal metastasis compared with controls. Our data provide novel evidence for the biological and clinical significance of HOTAIR expression as a potential biomarker for identifying patients with peritoneal metastasis, and as a novel therapeutic target in patients with gastric neoplasia.	[Okugawa, Yoshinaga; Toiyama, Yuji; Hur, Keun; Toden, Shusuke; Boland, C. Richard; Goel, Ajay] Baylor Univ, Gastrointestinal Canc Res Lab, Charles Sammons Canc Ctr, Div Gastroenterol,Dept Internal Med,Med Ctr, Dallas, TX 75246 USA; [Toiyama, Yuji; Saigusa, Susumu; Tanaka, Koji; Inoue, Yasuhiro; Mohri, Yasuhiko; Kusunoki, Masato] Mie Univ, Dept Gastrointestinal & Pediat Surg, Div Reparat Med, Inst Life Sci,Grad Sch Med, Tsu, Mie 5148507, Japan	Goel, A (reprint author), Baylor Univ, Gastrointestinal Canc Res Lab, Charles Sammons Canc Ctr, Div Gastroenterol,Dept Internal Med,Med Ctr, 35000 Gaston Ave,Suite H-250, Dallas, TX 75246 USA.	ajay.goel@baylorhealth.edu			Takeda science foundation, Japan; National Cancer Institute [R01 CA72851]; National Institutes of Health; Baylor Research Institute; Charles A Sammons Cancer Center; Baylor University Medical Center	Grant in Aid for Scientific Research from Takeda science foundation, Japan to Y.O.; National Cancer Institute (R01 CA72851), National Institutes of Health, Baylor Research Institute to A.G. and C.R.B.; Charles A Sammons Cancer Center, Baylor University Medical Center to A.G.	Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007; Luo JH, 2006, HEPATOLOGY, V44, P1012, DOI 10.1002/hep.21328; Kim K, 2013, ONCOGENE, V32, P1616, DOI 10.1038/onc.2012.193; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Sasako M, 2008, NEW ENGL J MED, V359, P453, DOI 10.1056/NEJMoa0707035; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Lai MC, 2012, MED ONCOL, V29, P1810, DOI 10.1007/s12032-011-0004-z; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Guo FJ, 2010, ACTA BIOCH BIOPH SIN, V42, P224, DOI 10.1093/abbs/gmq008; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Nie Y, 2013, CANCER SCI, V104, P458, DOI 10.1111/cas.12092; Lin R, 2007, ONCOGENE, V26, P851, DOI 10.1038/sj.onc.1209846; Yoo CH, 2000, BRIT J SURG, V87, P236, DOI 10.1046/j.1365-2168.2000.01360.x; Chisholm KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047998; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Xu ZY, 2013, INT J BIOL SCI, V9, P587, DOI 10.7150/ijbs.6339; Li DD, 2013, AM J PATHOL, V182, P64, DOI 10.1016/j.ajpath.2012.08.042; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Yamada K, 2006, CANCER SCI, V97, P106, DOI 10.1111/j.1349-7006.2006.00147.x; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Thomassen I, 2014, INT J CANCER, V134, P622, DOI 10.1002/ijc.28373; Ying L, 2012, MOL BIOSYST, V8, P2289, DOI 10.1039/c2mb25070e; Woo CJ, 2007, CELL, V129, P1257, DOI 10.1016/j.cell.2007.06.014; Zhang JX, 2013, NEURO-ONCOLOGY, V15, P1595, DOI 10.1093/neuonc/not131; Fellenberg J, 2007, MODERN PATHOL, V20, P1085, DOI 10.1038/modpathol.3800937; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Kogo R, 2011, CANCER RES, V71, P6320, DOI 10.1158/0008-5472.CAN-11-1021; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Carninci P, 2008, NAT CELL BIOL, V10, P1023, DOI 10.1038/ncb0908-1023; Ishizone S, 2006, CHEMOTHERAPY, V52, P301, DOI 10.1159/000096002; Li X., 2013, BRIT J CANCER, V109, P12; Liu ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077293; Okugawa Y, 2013, BRIT J CANCER, V108, P121, DOI 10.1038/bjc.2012.499; Sun Y, 2009, BREAST CANCER RES TR, V118, P185, DOI 10.1007/s10549-008-0171-6; Wang XT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003756	43	20	21	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0143-3334	1460-2180		CARCINOGENESIS	Carcinogenesis	DEC	2014	35	12					2731	2739		10.1093/carcin/bgu200		9	Oncology	Oncology	AU8HC	WOS:000345836200012		
J	Maeda, Y; Akita, T; Kohyama, M				Maeda, Yasushi; Akita, Tomoki; Kohyama, Masanori			High Activity of Gold/Tin-Dioxide Catalysts for Low-Temperature CO Oxidation: Application of a Reducible Metal Oxide to a Catalyst Support	CATALYSIS LETTERS			English	Article						Heterogeneous catalysis; CO oxidation; Oxide supports; Gold; Tin-Dioxide; Perimeter interface	AU CATALYSTS; AU/TIO2; INTERFACE; STABILITY; DRIFTS; OXYGEN; TIO2; SIZE; SNO2	Au/SnO2 catalysts were prepared by both the solid grinding (SG) method and the deposition precipitation (DP) method. Compared to samples prepared by the DP method, the SG samples showed remarkably high activity for low-temperature CO oxidation, because of a more efficient Au deposition on SnO2 by the SG method. Detailed analysis revealed that the perimeter interface between Au and SnO2 is the active site for catalysis. The present results suggest that the activity of Au/oxide catalysts is associated with the reducibility of the metal oxide supports at the perimeter interface.	[Maeda, Yasushi; Akita, Tomoki; Kohyama, Masanori] Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, Ikeda, Osaka 5638577, Japan	Maeda, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Res Inst Ubiquitous Energy Devices, 1-8-31 Midorigaoka, Ikeda, Osaka 5638577, Japan.	y-maeda@aist.go.jp	Maeda, Yasushi/M-3417-2015		JSPS KAKENHI [26286054]	This work was supported by JSPS KAKENHI Grant number 26286054.	Schubert MM, 2001, CATAL LETT, V76, P143, DOI 10.1023/A:1012365710979; Liu XY, 2013, NANO TODAY, V8, P403, DOI 10.1016/j.nantod.2013.07.005; Widmann D, 2011, ANGEW CHEM INT EDIT, V50, P10241, DOI 10.1002/anie.201102062; Fujitani T, 2011, ANGEW CHEM INT EDIT, V50, P10144, DOI 10.1002/anie.201104694; Li N, 2013, APPL CATAL B-ENVIRON, V142, P523, DOI 10.1016/j.apcatb.2013.05.068; HARUTA M, 1987, CHEM LETT, P405, DOI 10.1246/cl.1987.405; Maeda Y, 2013, J AM CHEM SOC, V135, P906, DOI 10.1021/ja310999c; Haruta M, 2011, FARADAY DISCUSS, V152, P11, DOI 10.1039/c1fd00107h; Wang SR, 2006, J MOL CATAL A-CHEM, V259, P245, DOI 10.1016/j.molcata.2006.06.021; Wang SR, 2009, CATAL COMMUN, V10, P640, DOI 10.1016/j.catcom.2008.11.009; Okumura M, 1998, CATAL LETT, V51, P53, DOI 10.1023/A:1019020614336; Tsubota S, 1998, CATAL LETT, V56, P131, DOI 10.1023/A:1019069315071; Overbury SH, 2006, J CATAL, V241, P56, DOI 10.1016/j.jcat.2006.04.018; Wang SR, 2006, MATER LETT, V60, P1706, DOI 10.1016/j.matlet.2005.12.003; Huang J, 2013, REACT KINET MECH CAT, V108, P403, DOI 10.1007/s11144-012-0515-4; Haruta M., 1997, CATAL SURV JPN, V1, P61, DOI DOI 10.1023/A:1019068728295; Kobayashi T, 1989, CHEM EXPRESS, V14, P217; Moreau F, 2006, CATAL TODAY, V114, P362, DOI 10.1016/j.cattod.2006.02.074; Rodriguez-Santiago V, 2009, LANGMUIR, V25, P8101, DOI 10.1021/la900611u	19	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1011-372X	1572-879X		CATAL LETT	Catal. Lett.	DEC	2014	144	12					2086	2090		10.1007/s10562-014-1376-4		5	Chemistry, Physical	Chemistry	AU8JX	WOS:000345843700012		
J	Mimura, N; Hiyoshi, N; Date, M; Fujitani, T; Dumeignil, F				Mimura, Naoki; Hiyoshi, Norihito; Date, Masakazu; Fujitani, Tadahiro; Dumeignil, Franck			Microscope Analysis of Au-Pd/TiO2 Glycerol Oxidation Catalysts Prepared by Deposition-Precipitation Method	CATALYSIS LETTERS			English	Article						Nanoparticle catalyst; Glycerol oxidation; High-resolution EDS analysis	LIQUID-PHASE OXIDATION; PLATINUM-BISMUTH CATALYST; SELECTIVE OXIDATION; BIMETALLIC CATALYSTS; AU; PD; NANOPARTICLES; TEMPERATURE; OXYGEN; MONO	Gold-palladium bimetallic nanoparticle catalysts prepared by a deposition-precipitation method were effective for aerobic oxidation of glycerol to carboxylic acids. The role of palladium was to suppress C-C bond cleavage that is responsible for the formation of C2 by-product molecules. The nanoparticles were observed by microscope techniques, which further enabled characterizing the respective locations of Au and Pd within the particles.	[Mimura, Naoki; Hiyoshi, Norihito] Natl Inst Adv Ind Sci & Technol, Res Ctr Compact Chem Syst, Miyagino Ku, Sendai, Miyagi 9838551, Japan; [Date, Masakazu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Fujitani, Tadahiro] Natl Inst Adv Ind Sci & Technol, Res Inst Innovat Sustainable Chem, Tsukuba, Ibaraki 3058565, Japan; [Dumeignil, Franck] Univ Lille Sci & Technol 1, UMR CNRS 8181, UCCS, F-59655 Villeneuve Dascq, France; [Dumeignil, Franck] Maison Univ, Inst Univ France, F-75005 Paris, France	Mimura, N (reprint author), Natl Inst Adv Ind Sci & Technol, Res Ctr Compact Chem Syst, Miyagino Ku, 4-2-1 Nigatake, Sendai, Miyagi 9838551, Japan.	n.mimura@aist.go.jp; franck.dumeignil@univ-lille1.fr			Japan Society for the Promotion of Science (JSPS) KAKENHI [25340130]; International Research Group 'EC-SAW' (Environmental Catalysis for Sustaining Clean Air and Water)	A part of this work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number 25340130 and by the International Research Group 'EC-SAW' (Environmental Catalysis for Sustaining Clean Air and Water) between CNRS and AIST.	KIMURA H, 1993, APPL CATAL A-GEN, V105, P147, DOI 10.1016/0926-860X(93)80245-L; Katryniok B, 2011, GREEN CHEM, V13, P1960, DOI 10.1039/c1gc15320j; Skrzynska E, 2014, APPL CATAL A-GEN, V482, P245, DOI 10.1016/j.apcata.2014.06.005; HUTCHINGS GJ, 1985, J CATAL, V96, P292, DOI 10.1016/0021-9517(85)90383-5; Ketchie WC, 2007, J CATAL, V250, P264, DOI 10.1016/j.jcat.2007.06.011; Dimitratos N, 2005, APPL CATAL A-GEN, V291, P210, DOI 10.1016/j.apcata.2005.01.044; KIMURA H, 1993, APPL CATAL A-GEN, V96, P217, DOI 10.1016/0926-860X(90)80011-3; Bianchi CL, 2005, CATAL TODAY, V102, P203, DOI 10.1016/j.cattod.2005.02.003; Pagliaro M, 2007, ANGEW CHEM INT EDIT, V46, P4434, DOI 10.1002/anie.200604694; Ajaikumar S, 2011, APPL CATAL A-GEN, V392, P11, DOI 10.1016/j.apcata.2010.10.015; Skrzynska E, 2014, J MOL CATAL A-CHEM, V382, P71, DOI 10.1016/j.molcata.2013.11.007; Ketchie WC, 2007, TOP CATAL, V44, P307, DOI 10.1007/s11244-007-0304-x; Lopez-Sanchez JA, 2008, PHYS CHEM CHEM PHYS, V10, P1921, DOI 10.1039/b719345a; Mimura N, 2014, RSC ADV, V4, P33416, DOI 10.1039/c4ra04960h; Sandoval A, 2011, J CATAL, V281, P40, DOI 10.1016/j.jcat.2011.04.003; Kondrat SA, 2014, CHEMSUSCHEM, V7, P1326, DOI 10.1002/cssc.201300834; Dimitratos N, 2009, PHYS CHEM CHEM PHYS, V11, P4952, DOI 10.1039/b904317a; Brett GL, 2011, ANGEW CHEM INT EDIT, V50, P10136, DOI 10.1002/anie.201101772; HARUTA M, 1993, J CATAL, V144, P175, DOI 10.1006/jcat.1993.1322; Shen YH, 2010, CHEM-EUR J, V16, P7368, DOI 10.1002/chem.201000740; Haruta M, 1987, CATAL LETT, V16, P405; Pagliaro M, 2010, RSC GREEN CHEM SER, P1; Skrzynska E, 2012, CHEMSUSCHEM, V5, P2065, DOI 10.1002/cssc.201200173	23	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1011-372X	1572-879X		CATAL LETT	Catal. Lett.	DEC	2014	144	12					2167	2175		10.1007/s10562-014-1382-6		9	Chemistry, Physical	Chemistry	AU8JX	WOS:000345843700021		
J	Wang, J; Yan, CY; Li, YN; Hirata, K; Yamamoto, M; Yan, N; Hu, Q				Wang, Jing; Yan, Chuangye; Li, Yini; Hirata, Kunio; Yamamoto, Masaki; Yan, Nieng; Hu, Qi			Crystal structure of a bacterial homologue of SWEET transporters	CELL RESEARCH			English	Letter							ARABIDOPSIS; PROTEINS		[Wang, Jing; Yan, Chuangye; Li, Yini; Yan, Nieng; Hu, Qi] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Wang, Jing; Yan, Chuangye; Li, Yini; Yan, Nieng; Hu, Qi] Tsinghua Univ, Sch Life Sci, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Wang, Jing; Yan, Chuangye; Li, Yini; Yan, Nieng; Hu, Qi] Tsinghua Univ, Sch Life Sci, Ctr Struct Biol, Beijing 100084, Peoples R China; [Wang, Jing; Yan, Chuangye; Li, Yini; Yan, Nieng; Hu, Qi] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Hirata, Kunio; Yamamoto, Masaki] Res Infrastruct Grp, SR Life Sci Instrumentat Unit, Adv Photon Technol Div, Sayo, Hyogo 6795148, Japan	Yan, N (reprint author), Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	nyan@tsinghua.edu.cn; huqi10@tsinghua.org.cn					Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen J, 2013, CURR OPIN STRUC BIOL, V23, P492, DOI 10.1016/j.sbi.2013.03.011; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chardon F, 2013, CURR BIOL, V23, P697, DOI 10.1016/j.cub.2013.03.021; Guo WJ, 2014, PLANT PHYSIOL, V164, P777, DOI 10.1104/pp.113.232751; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Xu Y, 2014, NATURE, DOI [10.1038/na-ture13670, DOI 10.1038/NA-TURE13670]	9	6	7	INST BIOCHEMISTRY & CELL BIOLOGY	SHANGHAI	SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA	1001-0602	1748-7838		CELL RES	Cell Res.	DEC	2014	24	12					1486	1489		10.1038/cr.2014.144		4	Cell Biology	Cell Biology	AU9EP	WOS:000345894800011		
J	Fernandes, HL; Stevenson, IH; Phillips, AN; Segraves, MA; Kording, KP				Fernandes, Hugo L.; Stevenson, Ian H.; Phillips, Adam N.; Segraves, Mark A.; Kording, Konrad P.			Saliency and Saccade Encoding in the Frontal Eye Field During Natural Scene Search	CEREBRAL CORTEX			English	Article						attention; fixation choice; generalized linear models; natural stimuli; neural data analysis; visuomotor integration	SELECTIVE VISUAL-ATTENTION; POSTERIOR PARIETAL CORTEX; TOP-DOWN CONTROL; SUPERIOR COLLICULUS; TARGET SELECTION; RECEPTIVE-FIELDS; MOTOR CORTEX; BOTTOM-UP; NEURONAL-ACTIVITY; NEURAL SELECTION	The frontal eye field (FEF) plays a central role in saccade selection and execution. Using artificial stimuli, many studies have shown that the activity of neurons in the FEF is affected by both visually salient stimuli in a neuron's receptive field and upcoming saccades in a certain direction. However, the extent to which visual and motor information is represented in the FEF in the context of the cluttered natural scenes we encounter during everyday life has not been explored. Here, we model the activities of neurons in the FEF, recorded while monkeys were searching natural scenes, using both visual and saccade information. We compare the contribution of bottom-up visual saliency (based on low-level features such as brightness, orientation, and color) and saccade direction. We find that, while saliency is correlated with the activities of some neurons, this relationship is ultimately driven by activities related to movement. Although bottom-up visual saliency contributes to the choice of saccade targets, it does not appear that FEF neurons actively encode the kind of saliency posited by popular saliency map theories. Instead, our results emphasize the FEF's role in the stages of saccade planning directly related to movement generation.	[Fernandes, Hugo L.; Kording, Konrad P.] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Fernandes, Hugo L.; Kording, Konrad P.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Fernandes, Hugo L.] Inst Gulbenkian Ciencias, PDBC, P-2780 Oeiras, Portugal; [Fernandes, Hugo L.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780 Oeiras, Portugal; [Stevenson, Ian H.] Univ Calif Berkeley, Redwood Ctr Theoret Neurosci, Berkeley, CA 94720 USA; [Phillips, Adam N.] Tamagawa Univ, Brain Sci Inst, Machida, Tokyo 1948610, Japan; [Phillips, Adam N.; Segraves, Mark A.] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA; [Kording, Konrad P.] Northwestern Univ, Dept Engn Sci & Appl Math, Chicago, IL 60611 USA; [Kording, Konrad P.] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA	Fernandes, HL (reprint author), Northwestern Univ, Rehabil Inst Chicago, 345 E Super St,Attn Kording Lab Rm 1479, Chicago, IL 60611 USA.	hugoguh@gmail.com	Kording, Konrad/A-1233-2007; 	Kording, Konrad/0000-0001-8408-4499; Stevenson, Ian/0000-0002-1428-5946	Fundacao para a Ciencia e Tecnologia [SFRH/BD/33525/2008]; National Institutes of Health [1R01NS063399, 2P01NS044393, 5R01EY008212, 5T32EY007128, 1R01EY021579]; National Science Foundation (CRCNS program)	This work was supported by the Fundacao para a Ciencia e Tecnologia (SFRH/BD/33525/2008 to H.L.F.), the National Institutes of Health (1R01NS063399, 2P01NS044393, 5R01EY008212 and 5T32EY007128, 1R01EY021579) and by the National Science Foundation (CRCNS program).	Hatsopoulos NG, 2007, J NEUROSCI, V27, P5105, DOI 10.1523/JNEUROSCI.3570-06.2007; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387; Thompson KG, 2005, J NEUROPHYSIOL, V93, P337, DOI 10.1152/jn.00330.2004; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040; Peng XM, 2008, J NEUROPHYSIOL, V100, P796, DOI 10.1152/jn.01188.2007; Sato TR, 2003, NEURON, V38, P637, DOI 10.1016/S0896-6273(03)00237-X; Wainwright MJ, 2002, NEURAL INF PROCESS S, P203; Ingram JN, 2008, EXP BRAIN RES, V188, P223, DOI 10.1007/s00221-008-1355-3; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; MOHLER CW, 1973, BRAIN RES, V61, P385, DOI 10.1016/0006-8993(73)90543-X; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713; Howard IS, 2009, J NEUROPHYSIOL, V102, P1902, DOI 10.1152/jn.00013.2009; Dias EC, 1999, J NEUROPHYSIOL, V81, P2191; McPeek RM, 2002, J NEUROPHYSIOL, V88, P2019, DOI 10.1152/jn.00181.2002; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Smyth D, 2003, J NEUROSCI, V23, P4746; Gottlieb JP, 1998, NATURE, V391, P481; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Wardak C, 2010, CEREB CORTEX, V20, P2464, DOI 10.1093/cercor/bhp315; Melloni L, 2012, CEREB CORTEX, V22, P2943, DOI 10.1093/cercor/bhr384; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Bichot NP, 1999, NAT NEUROSCI, V2, P549; Dias EC, 1995, J NEUROPHYSIOL, V74, P2744; Oliva A, 2003, IEEE IMAGE PROC, P253; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; BIZZI E, 1968, EXP BRAIN RES, V6, P69; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; Serences JT, 2006, TRENDS COGN SCI, V10, P38, DOI 10.1016/j.tics.2005.11.008; Betsch BY, 2004, BIOL CYBERN, V90, P41, DOI 10.1007/s00422-003-0434-6; Fecteau JH, 2006, TRENDS COGN SCI, V10, P382, DOI 10.1016/j.tics.2006.06.011; SEGRAVES MA, 1992, J NEUROPHYSIOL, V68, P1967; Hyvarinen A, 2003, J OPT SOC AM A, V20, P1237, DOI 10.1364/JOSAA.20.001237; Ehinger KA, 2009, VIS COGN, V17, P945, DOI 10.1080/13506280902834720; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; SCHILLER PH, 1980, J NEUROPHYSIOL, V44, P1175; Vinje WE, 2002, J NEUROSCI, V22, P2904; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Kayser C, 2003, J NEUROPHYSIOL, V90, P1910, DOI 10.1152/jn.00195.2003; Kayser C, 2004, CURR OPIN NEUROBIOL, V14, P468, DOI 10.1016/j.conb.2004.06.002; Turano KA, 2003, VISION RES, V43, P333, DOI 10.1016/S0042-6989(02)00498-4; Constantinidis C, 2005, J NEUROSCI, V25, P233, DOI 10.1523/JNEUROSCI.3379-04.2005; Sommer MA, 2001, J NEUROPHYSIOL, V85, P1673; Heinzl H, 2003, COMPUT STAT DATA AN, V44, P253, DOI 10.1016/S0167-9473(03)00062-8; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Everling S, 2000, J NEUROSCI, V20, P387; O'Shea J, 2004, J COGNITIVE NEUROSCI, V16, P1060, DOI 10.1162/0898929041502634; Srivastava A, 2003, J MATH IMAGING VIS, V18, P17, DOI 10.1023/A:1021889010444; SUZUKI H, 1977, BRAIN RES, V126, P497, DOI 10.1016/0006-8993(77)90600-X; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603; Ray S, 2009, J NEUROPHYSIOL, V102, P3091, DOI 10.1152/jn.00270.2009; Bichot NP, 1996, NATURE, V381, P697, DOI 10.1038/381697a0; Zhou HH, 2011, NEURON, V70, P1205, DOI 10.1016/j.neuron.2011.04.032; Ahrens MB, 2008, NETWORK-COMP NEURAL, V19, P35, DOI 10.1080/09548980701813936; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; Walther D, 2006, NEURAL NETWORKS, V19, P1395, DOI 10.1016/j.neunet.2006.10.001; Theunissen FE, 2001, NETWORK-COMP NEURAL, V12, P289; MacEvoy SP, 2008, J NEUROPHYSIOL, V99, P460, DOI 10.1152/jn.00612.2007; Arcizet F, 2011, CEREB CORTEX, V21, P2498, DOI 10.1093/cercor/bhr035; Baldi P., 2006, ADV NEURAL INFORM PR, V18, P547; Bengio Y, 2004, J MACH LEARN RES, V5, P1089; Berg DJ, 2009, J VISION, V9, DOI 10.1167/9.5.19; BIZZI E, 1970, Experimental Brain Research, V10, P151; Borji A., 2012, IEEE T IMAGE PROCESS, V22, P55; BURMAN DD, 1994, J NEUROPHYSIOL, V71, P1266; Burrows BE, 2009, J NEUROSCI, V29, P15169, DOI 10.1523/JNEUROSCI.3710-09.2009; CAVE KR, 1990, COGNITIVE PSYCHOL, V22, P225, DOI 10.1016/0010-0285(90)90017-X; Einhauser W, 2006, VISION RES, V46, P1194, DOI 10.1016/j.visres.2005.08.032; Einhauser W., 2008, J VISION, V8, P1, DOI [10.1167/8.14.18, DOI 10.1167/8.14.18]; Elazary L., 2008, J VISION, V8, P1, DOI DOI 10.1167/8.3.3; Ferrier D., 1875, PHILOS T R SOC LON B, V165, P433, DOI 10.1098/rstl.1875.0016; Foulsham T, 2011, NEURAL NETWORKS, V24, P665, DOI 10.1016/j.neunet.2011.01.004; Haslinger R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039699; Hays AV, 1982, WESCON C P, V2, P1; Kayser C, 2006, VISION RES, V46, P2535, DOI 10.1016/j.visres.2006.02.003; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Mazer JA, 2003, NEURON, V40, P1241, DOI 10.1016/S0896-6273(03)00764-5; Murthy A, 2001, J NEUROPHYSIOL, V86, P2634; Pearl J., 1988, PROBABILISTIC REASON; Phillips AN, 2010, J NEUROPHYSIOL, V103, P1238, DOI 10.1152/jn.00776.2009; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Saleh M, 2010, J NEUROSCI, V30, P17079, DOI 10.1523/JNEUROSCI.2558-10.2010; Sato T, 2001, NEURON, V30, P583, DOI 10.1016/S0896-6273(01)00304-X; SCHALL JD, 1991, J NEUROPHYSIOL, V66, P559; Scholkopf B., 2002, LEARNING KERNELS SUP; SEGRAVES MA, 1993, J NEUROPHYSIOL, V69, P1880; Soltani A, 2010, J NEUROSCI, V30, P12831, DOI 10.1523/JNEUROSCI.1517-10.2010; Sommer MA, 1997, EXP BRAIN RES, V116, P229, DOI 10.1007/PL00005752; Thompson K. G., 2005, PROG BRAIN RES, V147, P249, DOI DOI 10.1016/S0079-6123(04)47019-8; TREISMAN A, 1988, Q J EXP PSYCHOL-A, V40, P201; Tseng PH, 2009, J VISION, V9, DOI 10.1167/9.7.4; Van Hateren JH, 1998, P R SOC LOND B, V265; Vogel J, 2007, INT J COMPUT VISION, V72, P133, DOI 10.1007/s11263-006-8614-1; Weliky M, 2003, NEURON, V37, P703, DOI 10.1016/S0896-6273(03)00022-9; Willmore B, 2000, PERCEPTION, V29, P1017, DOI 10.1068/p2963; Yarbus A. L., 1967, EYE MOVEMENTS VISION; Zhao Q, 2011, J VISION, V11, DOI 10.1167/11.3.9	109	3	3	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1047-3211	1460-2199		CEREB CORTEX	Cereb. Cortex	DEC	2014	24	12					3232	3245		10.1093/cercor/bht179		14	Neurosciences	Neurosciences & Neurology	AU8HX	WOS:000345838300012		
J	Schulte, A; Situ, X; Saito, S; Wunsch, B				Schulte, Adrian; Situ, Xingci; Saito, Susumu; Wuensch, Bernhard			Bromolactamization: Key Step in the Stereoselective Synthesis of Enantiomerically Pure, cis-Configured Perhydropyrroloquinoxalines	CHIRALITY			English	Article						bromolactamization; cis-configured perhydroquinoxaline; proline; pyroglutamate; stereoselectivity; kinetic resolution	5-HT3 RECEPTOR AGONISTS; DERIVATIVES	Compounds based on the pyrroloquinoxaline system can interact with serotonin 5-HT3, cannabinoid CB1, and -opioid receptors. Herein, a chiral pool synthesis of diastereomerically and enantiomerically pure bromolactam (S,R,R,R)-14A is presented. Introduction of the cyclohexenyl ring at the N-atom of (S)-proline derivatives 8 or methyl (S)-pyroglutamate (12) led to the N-cyclohexenyl substituted pyrrolidine derivatives 4 and 13, respectively. All attempts to cyclize the (S)-proline derivatives 4 with a basic pyrrolidine N-atom via [3+2] cycloaddition, aziridination, or bromolactamization failed. Fast aromatization occurred during treatment of cyclohexenamines under halolactamization conditions. In contrast, reaction of a 1:1 mixture of diastereomeric pyroglutamates (S,R)-13bA and (S,S)-13bB with (LiOBu)-Bu-t and NBS provided the tricyclic bromolactam (S,R,R,R)-14A with high diastereoselectivity from (S,R)-13bA, but did not transform the diastereomer (S,S)-13bB. The different behavior of the diastereomeric pyroglutamates (S,R)-13bA and (S,S)-13bB is explained by different energetically favored conformations. Chirality 26:793-800, 2014. (c) 2014 Wiley Periodicals, Inc.	[Schulte, Adrian; Situ, Xingci; Wuensch, Bernhard] Univ Munster, Inst Pharmazeut & Med Chem, D-48149 Munster, Germany; [Saito, Susumu] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Saito, Susumu] Nagoya Univ, Inst Adv Res, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Wunsch, B (reprint author), Univ Munster, Inst Pharmazeut & Med Chem, Corrensstr 48, D-48149 Munster, Germany.	wuensch@uni-muenster.de	Saito, Susumu/E-9282-2012	Saito, Susumu/0000-0003-0749-2020	IRTG Munster - Nagoya; Deutsche Forschungsgemeinschaft	This work was performed within the framework of the International Research Training Group 'Complex Functional Systems in Chemistry: Design, Synthesis and Applications' in collaboration with the University of Nagoya. Financial support of this project by the IRTG Munster - Nagoya and the Deutsche Forschungsgemeinschaft is gratefully acknowledged.	Szabo G, 2009, BIOORG MED CHEM LETT, V19, P3471, DOI 10.1016/j.bmcl.2009.05.010; Tsuruoka R, 2009, J ORG CHEM, V74, P1691, DOI 10.1021/jo8025737; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Desplat V, 2010, J ENZYM INHIB MED CH, V25, P204, DOI 10.3109/14756360903169881; Campiani G, 1997, J MED CHEM, V40, P3670, DOI 10.1021/jm970376w; Broggini G, 1998, J CHEM RES-S, P688, DOI 10.1039/a802931h; Campiani G, 1999, J MED CHEM, V42, P4362, DOI 10.1021/jm990151g; Cert A, 1998, J CHROMATOGR A, V823, P291, DOI 10.1016/S0021-9673(98)00183-6; Chos YH, 2008, SYNTHESIS-STUTTGART, P2467; Grande F, 2009, EXPERT OPIN INV DRUG, V18, P555, DOI [10.1517/13543780902858815 , 10.1517/13543780902858815]; HALFPENNY PR, 1989, J MED CHEM, V32, P1620, DOI 10.1021/jm00127a036; Jews SS, 1999, HETEROCYCLES, V50, P677; Jorda-Gregori JM, 1999, TETRAHEDRON-ASYMMETR, V10, P1135, DOI 10.1016/S0957-4166(99)00084-1; KNAPP S, 1988, J ORG CHEM, V53, P4006, DOI 10.1021/jo00252a024; KUMAR G, 1989, HETEROCYCLES, V29, P1997; LEONARD NJ, 1950, J AM CHEM SOC, V72, P2980, DOI 10.1021/ja01163a049; REES DC, 1987, J HETEROCYCLIC CHEM, V24, P1297; Shen MH, 2004, J ORG CHEM, V69, P7906, DOI 10.1021/jo0488006; Snyde SA, 2011, ALDRICHIM ACTA, V44, P27; Trost BM, 2009, J AM CHEM SOC, V131, P4190, DOI 10.1021/ja809697p; Yeung YY, 2007, TETRAHEDRON LETT, V48, P7567, DOI 10.1016/j.tetlet.2007.08.113; Zengs Q, 2012, Chinese Patent, Patent No. [CN 102766004 (A), 102766004]; Ziegler K, 1942, LIEBIGS ANN CHEM, V551, P80	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0899-0042	1520-636X		CHIRALITY	Chirality	DEC	2014	26	12					793	800		10.1002/chir.22350		8	Chemistry, Medicinal; Chemistry, Analytical; Chemistry, Organic; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	AU5EO	WOS:000345630200005		
J	Hirashio, S; Nakashima, A; Doi, S; Anno, K; Aoki, E; Shimamoto, A; Yorioka, N; Kohno, N; Masaki, T; Tahara, H				Hirashio, Shuma; Nakashima, Ayumu; Doi, Shigehiro; Anno, Kumiko; Aoki, Eriko; Shimamoto, Akira; Yorioka, Noriaki; Kohno, Nobuoki; Masaki, Takao; Tahara, Hidetoshi			Telomeric G-Tail Length and Hospitalization for Cardiovascular Events in Hemodialysis Patients	CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							MONONUCLEAR-CELLS; MORTALITY; OVERHANG; DISEASE; STRESS; ASSOCIATION; SENESCENCE; CANCER; BLOOD; ENDS	Background and objectives Telomeric G-tails play a pivotal role in maintaining the intramolecular loop structure of telomeres. Previous in vitro studies have suggested that the erosion of telomeric G-tails triggers cellular senescence, leading to organ dysfunction and atherosderosis. The authors recently established a method to measure telomeric G-tail length using a hybridization protection assay. Using this method, this study investigated whether telomeric G-tail length could be used as a novel predictor for future cardiovascular events in hemodialysis patients. Design, setting, participants, & measurements A prospective observational study was performed involving a cohort of 203 Japanese hemodialysis patients to examine the lengths of telomeric G-tails and total telomeres and subsequent cardiovascular events during a median follow-up period of 48 months. The lengths of telomeric G-tails and total telomeres were also measured in 203 participants who did not have CKD and who were age- and sex-matched to hemodialysis patients. Results The lengths of telomeric G-tails and total telomeres were significantly shorter in hemodialysis patients than in control subjects. Telomeric G-tails, but not total telomeres, were independently and negatively associated with clinical history of cardiovascular disease. During follow-up, 80 cardiovascular events occurred. Total telomere length did not predict cardiovascular events. However, the length of telomeric G-tails was associated with new-onset cardiovascular events (hazard ratio per log luminescence signals, 0.12; 95% confidence interval, 0.12 to 0.50) that persisted after adjustment for age, sex, diabetes mellitus, clinical history of cardiovascular disease, inflammation, use of vitamin D, and serum levels of phosphate and intact parathyroid hormone. Conclusions Longer telomeric G-tail length is associated with a lower risk of future cardiovascular events in hemodialysis patients.	[Hirashio, Shuma; Nakashima, Ayumu; Doi, Shigehiro; Masaki, Takao] Hiroshima Univ Hosp, Dept Nephrol, Hiroshima, Japan; [Anno, Kumiko; Aoki, Eriko; Shimamoto, Akira; Tahara, Hidetoshi] Hiroshima Univ, Dept Cellular & Mol Biol, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Kohno, Nobuoki] Hiroshima Univ, Dept Mol & Internal Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Yorioka, Noriaki] Hiroshima Kidney Org, Gen Inc Assoc, Hiroshima, Japan	Tahara, H (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Cellular & Mol Biol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	toshi@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20014015]; Hiroshima University [23300363, 23650626]	This work was supported by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (20014015 to H.T), and Grants-in-Aid for Scientific Research (23300363 and 23650626 to H.T) from Hiroshima University.	Houben JMJ, 2008, FREE RADICAL BIO MED, V44, P235, DOI 10.1016/j.freeradbiomed.2007.10.001; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; PAYNE RB, 1973, BRIT MED J, V4, P643; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Ogami M, 2004, ARTERIOSCL THROM VAS, V24, P546, DOI 10.1161/01.ATV.0000117200.46938.e7; Epel ES, 2009, AGING-US, V1, P81; Wills LP, 2011, J AM SOC NEPHROL, V22, P39, DOI 10.1681/ASN.2010060662; Blasco MA, 2005, EMBO J, V24, P1095, DOI 10.1038/sj.emboj.7600598; Nakai S, 2010, THER APHER DIAL, V14, P505, DOI 10.1111/j.1744-9987.2010.00893.x; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Menon MC, 2013, ANN NY ACAD SCI, V1301, P21, DOI 10.1111/nyas.12283; Tsirpanlis G, 2006, AM J NEPHROL, V26, P91, DOI 10.1159/000092031; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Tahara H, 2006, ONCOGENE, V25, P1955, DOI 10.1038/sj.onc.1209217; Schiffrin EL, 2007, CIRCULATION, V116, P85, DOI 10.1161/CIRCULATIONAHA.106.678342; Stewart SA, 2003, NAT GENET, V33, P492, DOI 10.1038/ng1127; Anno K, 2007, BIOCHEM BIOPH RES CO, V353, P926, DOI 10.1016/j.bbrc.2006.12.112; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Lin KW, 2005, J CELL MOL MED, V9, P977, DOI 10.1111/j.1582-4934.2005.tb00395.x; Tahara H, 2005, NAT METHODS, V2, P829, DOI 10.1038/NMETH797; Carrero JJ, 2008, J INTERN MED, V263, P302, DOI 10.1111/j.1365-2796.2007.01890.x; Block GA, 2004, J AM SOC NEPHROL, V15, P2208, DOI 10.1097/01.ASN.0000133041.27682.A2; Fyhrquist F, 2012, ANN MED, V44, pS138, DOI 10.3109/07853890.2012.660497; Benetos A, 2001, HYPERTENSION, V37, P381; Betjes MGH, 2011, KIDNEY INT, V80, P209, DOI 10.1038/ki.2011.110; DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205; Guan JZ, 2007, MOL CELL BIOCHEM, V304, P353, DOI 10.1007/s11010-007-9518-2; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Markkanen E, 2012, P NATL ACAD SCI USA, V109, P437, DOI 10.1073/pnas.1110449109; Ramirez R, 2005, AM J KIDNEY DIS, V45, P353, DOI 10.1053/j.ajkd.2004.10.022; Tahara H, 2011, METHODS MOL BIOL, V735, P55, DOI 10.1007/978-1-61779-092-8_6	31	3	3	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1555-9041	1555-905X		CLIN J AM SOC NEPHRO	Clin. J. Am. Soc. Nephrol.	DEC	2014	9	12					2117	2122		10.2215/CJN.10010913		6	Urology & Nephrology	Urology & Nephrology	AU9YL	WOS:000345947800016		
J	Takasu, M; Tani, C; Kaichi, Y; Sakoda, Y; Kiguchi, M; Date, S; Kuroda, Y; Sakai, A; Awai, K				Takasu, Miyuki; Tani, Chihiro; Kaichi, Yoko; Sakoda, Yasuko; Kiguchi, Masao; Date, Shuji; Kuroda, Yoshiaki; Sakai, Akira; Awai, Kazuo			A Longitudinal Computed Tomography Study of Lenalidomide and Bortezomib Treatment for Multiple Myeloma: Trabecular Microarchitecture and Biomechanics Assessed Using Multidetector Computed Tomography	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA			English	Article						CT-based finite element analysis; Lenalidomide; Multidetector computed tomography; Multiple myeloma	PLUS DEXAMETHASONE; IN-VIVO; VERTEBRAL STRENGTH; WORKING GROUP; BONE-DISEASE; INHIBITOR; DIAGNOSIS; BEHAVIOR	The effects of lenalidomide and bortezomib on the microarchitecture and biomechanics of bones were investigated using clinical computed tomography (CT)-based finite element modeling (FEM). Failure load and stiffness were decreased in the bortezomib group and increased significantly in the lenalidomide group at the second CT scan. In the lenalidomide group, response to chemotherapy was positively associated with increased bone strength. Background: Bone disease is a common feature in patients with multiple myeloma. In this study, we investigated whether lenalidomide, similar to bortezomib, affects the microarchitecture and biomechanics of bones using clinical CT-based FEM. Materials and Methods: Bone lesions were evaluated using whole-body 64-section multidetector CT scan. For microstructural- and CT/FEM analyses, the volume of interest was defined as a 10-mm thickness of the central part of the L3 vertebral body. Microstructural parameters and mechanical properties were calculated using a 3-D image analysis system. The changes from baseline to the second examination within groups were calculated. Relationships between baseline disease characteristics and percent changes of trabecular parameters were assessed using Spearman correlation analysis. Results: Thirty-two patients were treated with bortezomib and 18 patients were treated with lenalidomide. At the second CT scan, apparent trabecular number, failure load, and stiffness were decreased in the bortezomib group and failure load and stiffness were increased significantly in the lenalidomide group. In the lenalidomide group, response to chemotherapy was positively associated with increases in failure load (p = 0.57; P < .05) and stiffness (p = 0.50; P < .05). Conclusion: Lenalidomide treatment resulted in significant increases in CT/FEM-derived estimates of bone strength. Response to chemotherapy predicted lenalidomide-induced bone changes and good responders had increased bone strength. (C) 2014 Elsevier Inc. All rights reserved.	[Takasu, Miyuki; Tani, Chihiro; Kaichi, Yoko; Kiguchi, Masao; Date, Shuji; Awai, Kazuo] Hiroshima Univ, Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima 7348551, Japan; [Sakoda, Yasuko] Hiroshima Red Cross Hosp, Dept Radiol, Hiroshima, Japan; [Sakoda, Yasuko] Atom Bomb Survivors Hosp, Hiroshima, Japan; [Kuroda, Yoshiaki] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima 7348551, Japan; [Sakai, Akira] Fukushima Med Univ, Sch Med, Dept Radiat Life Sci, Fukushima, Japan	Takasu, M (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Diagnost Radiol, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	my-takasu@syd.odn.ne.jp			Japan and International Myeloma Foundation Japan	M.T. is supported by Japan and International Myeloma Foundation Japan's Research Grants 2012, which provided funding for the Japan Myeloma Study Group, 35 Gengo Moriokarnachi Obushi Aichi, Japan. They had no role in the conduct of this research.	Terpos E, 2009, ANN ONCOL, V20, P1303, DOI 10.1093/annonc/mdn796; Terpos E, 2005, ANN ONCOL, V16, P1223, DOI 10.1093/annonc/mdi235; Zangari M, 2011, HAEMATOL-HEMATOL J, V96, P333, DOI 10.3324/haematol.2010.031302; Ito M, 2005, J BONE MINER RES, V20, P1828, DOI 10.1359/JBMR.050610; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; Giuliani N, 2007, BLOOD, V110, P334, DOI 10.1182/blood-2006-11-059188; Terpos E, 2014, AM J HEMATOL, V89, P34, DOI 10.1002/ajh.23577; Kyle RA, 2003, MAYO CLIN PROC, V78, P21; Feng R, 2007, BRIT J HAEMATOL, V139, P385, DOI 10.1111/j.1365-2141.2007.06772.x; Boissy P, 2008, LEUKEMIA RES, V32, P1661, DOI 10.1016/j.leukres.2008.02.019; Breitkreutz I, 2008, LEUKEMIA, V22, P1925, DOI 10.1038/leu.2008.174; Takasu M, 2011, RADIOLOGY, V260, P472, DOI 10.1148/radiol.11101746; GENANT HK, 1993, J BONE MINER RES, V8, P1137; Cheung AM, 2008, JAMA-J AM MED ASSOC, V299, P1468, DOI 10.1001/jama.299.12.1468; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Dimopoulos M, 2009, LEUKEMIA, V23, P1545, DOI 10.1038/leu.2009.89; Ozaki S, 2007, INT J HEMATOL, V86, P180, DOI 10.1532/IJH97.07030; FAULKNER KG, 1991, RADIOLOGY, V179, P669; CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954; Baur-Melnyk A, 2005, EUR J RADIOL, V55, P56, DOI 10.1016/j.ejrad.2005.01.017; BREKELMA.WA, 1972, ACTA ORTHOP SCAND, V43, P301, DOI 10.3109/17453677208998949; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Hongming Huang, 2009, Leuk Res, V33, P115, DOI 10.1016/j.leukres.2008.07.028; Imai K, 2008, SPINE, V33, P27, DOI 10.1097/BRS.0b013e31815e3993; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Laib A, 1998, Technol Health Care, V6, P329; Laib A, 1999, COMPUT MED IMAG GRAP, V23, P69, DOI 10.1016/S0895-6111(98)00071-8; Terpos E, 2010, ANN ONCOL, V27, P1561; Ulrich D, 1998, Technol Health Care, V6, P421	30	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	2152-2650	2152-2669		CL LYMPH MYELOM LEUK	Clin. Lymphoma Myeloma Leuk.	DEC	2014	14	6					485	492		10.1016/j.clml.2014.07.009		8	Oncology; Hematology	Oncology; Hematology	AU5XQ	WOS:000345677300010		
J	Arakawa, K; Konoshita, T; Makino, Y; Ishizuka, T				Arakawa, Kenichiro; Konoshita, Tadashi; Makino, Yasukazu; Ishizuka, Tamotsu			Image of the month: Blue toe in a male with cholesterol embolisation syndrome	CLINICAL MEDICINE			English	Editorial Material									[Arakawa, Kenichiro; Konoshita, Tadashi; Makino, Yasukazu; Ishizuka, Tamotsu] Univ Fukui, Fac Med Sci, Fukui 9101193, Japan	Konoshita, T (reprint author), Univ Fukui, Fac Med Sci, Dept Internal Med 3, 23-3 Matsuokashimoaizuki, Fukui 9101193, Japan.	konosita@u-fukui.ac.jp					Saric M, 2011, CURR OPIN CARDIOL, V26, P472, DOI 10.1097/HCO.0b013e32834b7fdd; Fukumoto Y, 2003, J AM COLL CARDIOL, V42, P211, DOI 10.1016/S0735-1097(03)00579-5; Modi KS, 2001, J AM SOC NEPHROL, V12, P1781	3	0	0	ROY COLL PHYS LONDON EDITORIAL OFFICE	LONDON	11 ST ANDREWS PLACE REGENTS PARK, LONDON NW1 4LE, ENGLAND	1470-2118	1473-4893		CLIN MED	Clin. Med.	DEC	2014	14	6					688	689				2	Medicine, General & Internal	General & Internal Medicine	AU7YA	WOS:000345813000027		
J	Umezawa, R; Ota, H; Takanami, K; Ichinose, A; Matsushita, H; Saito, H; Takase, K; Jingu, K				Umezawa, R.; Ota, H.; Takanami, K.; Ichinose, A.; Matsushita, H.; Saito, H.; Takase, K.; Jingu, K.			MRI findings of-radiation-induced myocardial damage in patients with oesophageal cancer	CLINICAL RADIOLOGY			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; INDUCED HEART-DISEASE; HYPERTROPHIC CARDIOMYOPATHY; MEDIASTINAL RADIOTHERAPY; DILATED CARDIOMYOPATHY; ASSOCIATION; FIBROSIS; CHEMORADIOTHERAPY; DEFECTS	AIM: To evaluate radiation-induced myocardial damage after mediastinal radiotherapy using MRI. MATERIALS AND METHODS: Between May 2010 and April 2011, delayed contrast-enhanced MRI was performed for patients who had maintained a complete response to curative radiotherapy for oesophageal cancer for more than 6 months. The patients received radiotherapy with a median total dose of 66 Gy (60-70 Gy) for the primary tumour and metastatic lymph nodes. Images of MRI were analysed by a 17-segment method recommended by the American Heart Association. A segment included mainly in the 40 Gy dose line was defined as Segment 40 Gy, a segment included mainly in the 60 Gy dose line as Segment 60 Gy, and a segment out of the radiation fields as Segment OUT. The percentage of late gadolinium enhancement (LGE) was examined in those categories. The layer in which LGE was predominantly distributed was evaluated for each patient. RESULTS: Four hundred and eight segments in 24 patients were analysed. The median interval from completion of radiotherapy to MRI was 23.5 months (range 6-88 months). LGE was detected in 12 of the 24 patients. LGE was detected in 15.38% of Segment 40 Gy cases, 21.21% of Segment 60 Gy cases, and 0% of Segment OUT cases. LGE in mid-myocardial and subendocardial layers was detected in 11 patients and one patient, respectively. CONCLUSION: LGE suggesting radiation induced myocardial fibrosis was observed by performing delayed contrast-enhanced MRI. Care should be taken when planning radiotherapy to avoid late cardiac damage. (C) 2014 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.	[Umezawa, R.; Matsushita, H.; Jingu, K.] Tohoku Univ, Dept Radiat Oncol, Sch Med, Sendai, Miyagi 9808574, Japan; [Ota, H.; Takanami, K.; Ichinose, A.; Takase, K.] Tohoku Univ, Dept Diagnost Radiol, Sch Med, Sendai, Miyagi 9808574, Japan; [Saito, H.] Tohoku Univ, Grad Sch Med, Dept Diagnost Image Anal, Sendai, Miyagi 9808574, Japan	Umezawa, R (reprint author), Tohoku Univ, Dept Radiat Oncol, Sch Med, Aoba Ku, 1-1 Seiryou Machi, Sendai, Miyagi 9808574, Japan.	reirei513@hotmail.com	Ota, Hideki/A-3717-2012	Ota, Hideki/0000-0002-7239-3152			Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; ALLAN IM, 1988, BRIT J CANCER, V58, P34, DOI 10.1038/bjc.1988.156; Machann W, 2011, INT J RADIAT ONCOL, V79, P1117, DOI 10.1016/j.ijrobp.2009.12.054; Choudhury L, 2002, J AM COLL CARDIOL, V40, P2156, DOI 10.1016/S0735-1097(02)02602-5; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Lancellotti P, 2013, J AM SOC ECHOCARDIOG, V26, P1013, DOI 10.1016/j.echo.2013.07.005; Adams MJ, 2003, CRIT REV ONCOL HEMAT, V45, P55, DOI 10.1016/S1040-8428(01)00227-X; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Andratschke N, 2011, RADIOTHER ONCOL, V100, P160, DOI 10.1016/j.radonc.2010.08.010; Schellong G, 2010, PEDIATR BLOOD CANCER, V55, P1145, DOI 10.1002/pbc.22664; Aleman BMP, 2007, BLOOD, V109, P1878, DOI 10.1182/blood-2006-07-034405; Darby SC, 2010, INT J RADIAT ONCOL, V76, P656, DOI 10.1016/j.ijrobp.2009.09.064; Marks LB, 2005, INT J RADIAT ONCOL, V63, P214, DOI 10.1016/j.ijrobp.2005.01.029; Gayed IW, 2006, J NUCL MED, V47, P1756; Ishikura S, 2003, J CLIN ONCOL, V21, P2697, DOI 10.1200/JCO.2003.03.055; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Assomull RG, 2006, J AM COLL CARDIOL, V48, P1977, DOI 10.1016/j.jacc.2006.07.049; Jingu K, 2013, DIS ESOPHAGUS, V26, P522, DOI 10.1111/j.1442-2050.2012.01396.x; Seddon B, 2002, RADIOTHER ONCOL, V64, P53, DOI 10.1016/S0167-8140(02)00133-0; Wagner A, 2003, LANCET, V361, P374, DOI 10.1016/S0140-6736(03)12389-6; Barjaktarovic Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027811; Eny KM, 2005, LUPUS, V14, P351, DOI 10.1191/0961203305lu2091oa; Khan R, 2013, INT J CARDIOVAS IMAG, V29, P395, DOI 10.1007/s10554-012-0107-4; LAUK S, 1985, INT J RADIAT ONCOL, V11, P801; Olivotto I, 2011, J AM COLL CARDIOL, V58, P839, DOI 10.1016/j.jacc.2011.05.018	25	2	3	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0009-9260	1365-229X		CLIN RADIOL	Clin. Radiol.	DEC	2014	69	12					1273	1279		10.1016/j.crad.2014.08.010		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AU6QN	WOS:000345727200010		
J	Komazaki, Y; Fujiwara, T; Ogawa, T; Sato, M; Suzuki, K; Yamagata, Z; Moriyama, K				Komazaki, Yuko; Fujiwara, Takeo; Ogawa, Takuya; Sato, Miri; Suzuki, Kohta; Yamagata, Zentaro; Moriyama, Keiji			Association between malocclusion and headache among 12-to 15-year-old adolescents: a population-based study	COMMUNITY DENTISTRY AND ORAL EPIDEMIOLOGY			English	Article						adolescent; epidemiology; headache; Japan; malocclusion	IDIOPATHIC INTRACRANIAL HYPERTENSION; ORTHODONTIC TREATMENT NEED; EXPERIMENTAL OCCLUSAL INTERFERENCES; OF-THE-LITERATURE; TEMPOROMANDIBULAR DISORDERS; EMERGENCY-DEPARTMENT; SOCIOECONOMIC-STATUS; OBESE ADOLESCENTS; RISK-FACTOR; LIFE-STYLE	ObjectivesHeadaches are a common problem among adolescents, and malocclusion is a possible risk factor. The purpose of this study was to investigate the association between malocclusion and headache among Japanese adolescents aged 12-15years using a population-based sample. MethodsA total of 938 adolescents (94.7% of the target population in Koshu City) participated. A modified version of the Index of Orthodontic Treatment Need (IOTN) was used by orthodontists to evaluate occlusal characteristics, and the frequency of headaches (none, rarely, sometimes) was assessed via questionnaire (N=938). Ordered logistic regression analyses were used to analyze the association between malocclusion and headache. ResultsThe prevalence of malocclusion diagnosed using the modified version of the IOTN was 44.9%. Multiple ordered logistic regression analyses showed that the odds ratio (OR) of having malocclusion for headache was 1.38 (95% confidence interval [CI]: 1.06-1.80), after adjustment for demographics, lifestyle, and dental status including orthodontic treatment history and tooth size. Moreover, among occlusal traits, lower crowding was independently associated with headache (OR: 1.64, 95% CI: 1.07-2.51). ConclusionsWe found that malocclusion, especially lower crowding, was associated with headache in a population-based sample of adolescents aged 12-15years in Japan. Further study is needed to elucidate the mechanisms by which malocclusion affects headache.	[Komazaki, Yuko; Ogawa, Takuya; Moriyama, Keiji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial Reconstruct & Funct, Sect Maxillofacial Orthognath,Div Maxillofacial N, Tokyo, Japan; [Komazaki, Yuko; Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan; [Ogawa, Takuya; Moriyama, Keiji] Tokyo Med & Dent Univ, Hard Tissue Genome Res Ctr, Tokyo, Japan; [Sato, Miri; Yamagata, Zentaro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Ctr Birth Cohort Studies, Yamanashi, Japan; [Suzuki, Kohta; Yamagata, Zentaro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Hlth Sci, Yamanashi, Japan	Fujiwara, T (reprint author), Natl Res Inst Child Hlth & Dev, Dept Social Med, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	fujiwara-tk@ncchd.go.jp					Abboud Marcus, 2002, J Orofac Orthop, V63, P264, DOI 10.1007/s00056-002-0033-5; Abend NS, 2010, SEMIN PEDIATR NEUROL, V17, P123, DOI 10.1016/j.spen.2010.04.001; Ando N, 2007, BRAIN DEV-JPN, V29, P482, DOI 10.1016/j.braindev.2007.01.003; Sadeghianrizi A, 2005, EUR J ORTHODONT, V27, P550, DOI 10.1093/ejo/cji048; Gottesman RF, 2012, NEUROLOGIST, V18, P245, DOI 10.1097/NRL.0b013e31826754e1; Bruni O, 1999, CEPHALALGIA, V19, P57; Rasmussen BK, 2001, CEPHALALGIA, V21, P774, DOI 10.1046/j.1468-2982.2001.00248.x; SILBERT PL, 1995, NEUROLOGY, V45, P1517; PULLINGER AG, 1993, J DENT RES, V72, P968, DOI 10.1177/00220345930720061301; Conicella E, 2008, HEADACHE, V48, P1005, DOI 10.1111/j.1526-4610.2007.01052.x; CHRISTENSEN LV, 1995, J ORAL REHABIL, V22, P515, DOI 10.1111/j.1365-2842.1995.tb01197.x; Dodick DW, 2003, HEADACHE, V43, P282, DOI 10.1046/j.1526-4610.2003.03055.x; Lateef TM, 2009, J CHILD NEUROL, V24, P536, DOI 10.1177/0883073808327831; Ohrn K, 2002, ACTA ODONTOL SCAND, V60, P193, DOI 10.1080/000163502760147936; Ballegaard V, 2008, CEPHALALGIA, V28, P832, DOI 10.1111/j.1468-2982.2008.01597.x; BROOK PH, 1989, EUR J ORTHODONT, V11, P309; Thilander B, 2002, ANGLE ORTHOD, V72, P146; Schwartz BS, 1998, JAMA-J AM MED ASSOC, V279, P381, DOI 10.1001/jama.279.5.381; Friedman DI, 2002, NEUROLOGY, V59, P1492; Hering-Hanit R, 2003, CEPHALALGIA, V23, P332, DOI 10.1046/j.1468-2982.2003.00576.x; Yilmaz U, 2014, EUR J PAEDIATR NEURO, V18, P163, DOI 10.1016/j.ejpn.2013.11.003; Kranick SM, 2013, NEUROLOGY, V80, P1452, DOI 10.1212/WNL.0b013e31828cf81e; Chai NC, 2014, HEADACHE, V54, P219, DOI 10.1111/head.12296; Goncalves DAG, 2010, HEADACHE, V50, P231, DOI 10.1111/j.1526-4610.2009.01511.x; Schievink WI, 2013, J PEDIATR-US, V163, P504, DOI 10.1016/j.jpeds.2013.01.055; Lewis DW, 2000, HEADACHE, V40, P200, DOI 10.1046/j.1526-4610.2000.00029.x; Suzuki K, 2011, INT J OBESITY, V35, P53, DOI 10.1038/ijo.2010.198; Belman AL, 2002, NEUROL CLIN, V20, P983, DOI 10.1016/S0733-8619(02)00019-1; Bertoli Fernanda Mara de Paiva, 2007, Arq Neuropsiquiatr, V65, P251, DOI 10.1590/S0004-282X2007000200012; Blume H, 2010, PEDIATR ANN, V39, P431, DOI 10.3928/00904481-20100623-10; Boardman HF, 2005, HEADACHE, V45, P657, DOI 10.1111/j.1526-4610.2005.05133.x; Borzabadi-Farahani A, 2011, ACTA ODONTOL SCAND, V69, P2, DOI 10.3109/00016357.2010.516732; Burnett CA, 2000, HEADACHE, V40, P813, DOI 10.1046/j.1526-4610.2000.00147.x; Chan EK, 2011, J CHILD NEUROL, V26, P761, DOI 10.1177/0883073810389042; CHRISTENSEN LV, 1995, J ORAL REHABIL, V22, P521, DOI 10.1111/j.1365-2842.1995.tb01198.x; CINDY CN, 2014, HEADACHE, V54, P459; Deli R, 2012, COMMUNITY DENT ORAL, V40, P71, DOI 10.1111/j.1600-0528.2011.00669.x; Dmytrenko MI, 2012, LIK SPRAVA, V8, P84; EVANS R, 1987, EUR J ORTHODONT, V9, P314; Germa A, 2010, COMMUNITY DENT ORAL, V38, P171, DOI 10.1111/j.1600-0528.2009.00515.x; Goncalves DAG, 2009, NEUROLOGY, V73, P645, DOI 10.1212/WNL.0b013e3181b389c2; Heatherley SV, 2006, J CHILD PSYCHOL PSYC, V47, P135, DOI 10.1111/j.1469-7610.2005.01457.x; Hinotsume S, 1988, Shoni Shikagaku Zasshi, V26, P535; Hinotsume S, 1986, Shoni Shikagaku Zasshi, V24, P415; Honorat R, 2011, ARCH PEDIATRIE, V18, P1139, DOI 10.1016/j.arcped.2011.08.017; Iwasaki T, 2001, SHONI SHIKAGAKU ZASS, V39, P712; Katoh Y, 1998, INT DENT J, V48, P405; Kimoto K, 2002, J ORAL REHABIL, V29, P430, DOI 10.1046/j.1365-2842.2002.00853.x; Koktekir BE, 2012, CORNEA, V31, P1414, DOI 10.1097/ICO.0b013e318247ec2a; Komazaki Y, 2012, J WORLD FED ORTHOD, V1, P2212; Lambourne C, 2007, AM J ORTHOD DENTOFAC, V132, P754, DOI 10.1016/j.ajodo.2006.03.033; Liljestrom MR, 2007, ACTA ODONTOL SCAND, V65, P134, DOI 10.1080/00016350601106165; Linder-Aronson S, 1974, Trans Eur Orthod Soc, P233; Luc ME, 2006, PEDIATR NEUROL, V34, P7, DOI 10.1016/j.pediatrneurol.2005.06.009; McNamara James A. Jr., 1995, Journal of Orofacial Pain, V9, P73; Medina LS, 1997, RADIOLOGY, V202, P819; Moschiano F, 2012, NEUROL SCI, V33, pS87, DOI 10.1007/s10072-012-1048-3; Sacco S, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-80; Shapiro RE, 2007, NEUROL SCI, V28, pS179, DOI 10.1007/s10072-007-0773-5; Shaw WC, 1993, ORTHODONTICS OCCLUSA, P262; Sonnesen L, 2001, EUR J ORTHODONT, V23, P179, DOI 10.1093/ejo/23.2.179; Souames M, 2006, EUR J ORTHODONT, V28, P605, DOI 10.1093/ejo/cjl045; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; Sykes KT, 2013, PAIN PHYSICIAN, V16, P399; Talarska D, 2005, Rocz Akad Med Bialymst, V50 Suppl 1, P126; Tickle M, 1999, COMMUNITY DENT ORAL, V27, P413, DOI 10.1111/j.1600-0528.1999.tb02040.x; Torelli P, 2009, HEADACHE, V49, P744, DOI 10.1111/j.1526-4610.2009.01390.x; Victorio MC, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0336-x; Watanabe A, 2009, ORTHOD WAVES JAPANES, V68, P142	69	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0301-5661	1600-0528		COMMUNITY DENT ORAL	Community Dentist. Oral Epidemiol.	DEC	2014	42	6					572	580		10.1111/cdoe.12111		9	Dentistry, Oral Surgery & Medicine; Public, Environmental & Occupational Health	Dentistry, Oral Surgery & Medicine; Public, Environmental & Occupational Health	AU6EE	WOS:000345695000010		
J	Su, R; Sun, CM; Zhang, C; Pham, TD				Su, Ran; Sun, Changming; Zhang, Chao; Pham, Tuan D.			A novel method for dendritic spines detection based on directional morphological filter and shortest path	COMPUTERIZED MEDICAL IMAGING AND GRAPHICS			English	Article						Dendritic spines; Dendrite; Backbone extraction; Boundary detection; Shortest path	SCANNING MICROSCOPY IMAGES; COMPUTATIONAL APPROACH; SHAPE-ANALYSIS; ALGORITHM; ENHANCEMENT; RECONSTRUCTION; IDENTIFICATION; SEGMENTATION; PLASTICITY; DYNAMICS	Dendritic spines are tiny membranous protrusions from neuron's dendrites. They play a very important role in the nervous system. A number of mental diseases such as Alzheimer's disease and mental retardation are revealed to have close relations with spine morphologies or spine number changes. Spines have various shapes, and spine images are often not of good quality; hence it is very challenging to detect spines in neuron images. This paper presents a novel pipeline to detect dendritic spines in 2D maximum intensity projection (MIP) images and a new dendrite backbone extraction method is developed in the pipeline. The strategy for the backbone extraction approach is that it iteratively refines the extraction result based on directional morphological filtering and improved Hessian filtering until a satisfactory extraction result is obtained. A shortest path method is applied along a backbone to extract the boundary of the dendrites. Spines are then segmented from the dendrites outside the extracted boundary. Touching spines will be split using a marker-controlled watershed algorithm. We present the results of our algorithm on real images and compare our algorithm with two other spine detection methods. The results show that the proposed approach can detect dendrites and spines more accurately. Measurements and classification of spines are also made in this paper. (C) 2014 Elsevier Ltd. All rights reserved.	[Su, Ran; Sun, Changming; Zhang, Chao] CSIRO Computat Informat, N Ryde, NSW 1670, Australia; [Su, Ran; Zhang, Chao] Univ New S Wales, Sch Engn & Informat Technol, Canberra, ACT 2600, Australia; [Pham, Tuan D.] Univ Aizu, Res Ctr Adv Informat Sci & Technol, Aizu Res Cluster Med Engn & Informat, Aizu Wakamatsu, Fukushima 9658580, Japan	Su, R (reprint author), Agcy Sci & Technol Res, Bioinformat Inst, 30 Biopolis St,07-01 Matrix, Singapore 138671, Singapore.	suran.tju@gmail.com; changming.sun@csiro.au; kone.zhang@gmail.com; tdpham@u-aizu.ac.jp	Sun, Changming/A-3276-2008; Su, Ran/L-2323-2015	Sun, Changming/0000-0001-5943-1989; Su, Ran/0000-0001-5922-0364			Zhang Y, 2007, NEUROIMAGE, V36, P346, DOI 10.1016/j.neuroimage.2007.02.044; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Roberts TF, 2010, NATURE, V463, P948, DOI 10.1038/nature08759; Su R, 2014, PATTERN RECOGN, V47, P3193, DOI 10.1016/j.patcog.2014.04.024; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Najman L, 1996, IEEE T PATTERN ANAL, V18, P1163, DOI 10.1109/34.546254; Fan J, 2009, NEUROINFORMATICS, V7, P113, DOI 10.1007/s12021-009-9047-0; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130; Mukai H, 2011, CEREB CORTEX, V21, P2704, DOI 10.1093/cercor/bhr059; Su R, 2012, PATTERN RECOGN, V45, P3695, DOI 10.1016/j.patcog.2012.04.013; Couprie C, 2011, IEEE T PATTERN ANAL, V33, P1384, DOI 10.1109/TPAMI.2010.200; Breen EJ, 1996, COMPUT VIS IMAGE UND, V64, P377, DOI 10.1006/cviu.1996.0066; Zhou WG, 2008, LECT NOTES COMPUT SC, V5242, P18; Soille P, 2001, IEEE T PATTERN ANAL, V23, P1313, DOI 10.1109/34.969120; Koh IYY, 2002, NEURAL COMPUT, V14, P1283, DOI 10.1162/089976602753712945; Hasbani MJ, 2001, J NEUROSCI, V21, P2393; Pudney C, 1998, COMPUT VIS IMAGE UND, V72, P404, DOI 10.1006/cviu.1998.0680; Hassouna MS, 2005, PROC CVPR IEEE, P458; HELMAN JL, 1991, IEEE COMPUT GRAPH, V11, P36, DOI 10.1109/38.79452; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Bhatt DH, 2009, ANNU REV PHYSIOL, V71, P261, DOI 10.1146/annurev.physiol.010908.163140; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Truc PTH, 2009, COMPUT VIS IMAGE UND, V113, P101, DOI 10.1016/j.cviu.2008.07.009; Janoos F, 2009, MED IMAGE ANAL, V13, P167, DOI 10.1016/j.media.2008.06.019; KOLB B, 1993, BEHAV NEUROSCI, V107, P799, DOI 10.1037//0735-7044.107.5.799; Sun CM, 2003, PATTERN RECOGN, V36, P709, DOI 10.1016/S0031-3203(02)00085-7; Cheng J, 2007, J NEUROSCI METH, V165, P122, DOI 10.1016/j.jneumeth.2007.05.020; Bai WJ, 2007, CYTOM PART A, V71A, P818, DOI 10.1002/cyto.a.20431; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679; DANIELSSON PE, 1980, COMPUT VISION GRAPH, V14, P227, DOI 10.1016/0146-664X(80)90054-4; Du Buf H., 1999, Proceedings 10th International Conference on Image Analysis and Processing, DOI 10.1109/ICIAP.1999.797682; Fan J, 2007, LIF SCI SYST APPL WO, P233; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Lang S, 2011, J COMPUT NEUROSCI, V31, P533, DOI 10.1007/s10827-011-0316-1; Meyer F., 1990, Journal of Visual Communication and Image Representation, V1, DOI 10.1016/1047-3203(90)90014-M; NIBLACK CW, 1992, CVGIP-GRAPH MODEL IM, V54, P420, DOI 10.1016/1049-9652(92)90026-T; Pedrosa GV, 2010, PATTERN RECOGN LETT, V31, P1658, DOI 10.1016/j.patrec.2010.05.013; Petrosino A, 2000, IEEE T IMAGE PROCESS, V9, P277, DOI 10.1109/83.821742; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; RUSAKOV DA, 1995, J NEUROSCI METH, V60, P11, DOI 10.1016/0165-0270(94)00215-3; Serra J., 1982, IMAGE ANAL MATH MORP; Su R, 2012, IEEE ENG MED BIO, P5343; Su R, 2012, P 27 IM VIS COMP NZ, P91; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Watzel R, 1995, DAGM S BIEL, P160; Weaver CM, 2004, NEURAL COMPUT, V16, P1353, DOI 10.1162/089976604323057425; Xu XY, 2006, I S BIOMED IMAGING, P554; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1171; Zhang C, 2013, J MICROSC-OXFORD, V251, P57, DOI 10.1111/jmi.12043; ZHANG TY, 1984, COMMUN ACM, V27, P236, DOI 10.1145/357994.358023	54	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0895-6111	1879-0771		COMPUT MED IMAG GRAP	Comput. Med. Imaging Graph.	DEC	2014	38	8					793	802		10.1016/j.compmedimag.2014.07.006		10	Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging	Engineering; Radiology, Nuclear Medicine & Medical Imaging	AU7UP	WOS:000345807000015		
J	Li, Z; Su, CY; Chen, X				Li, Zhi; Su, Chun-Yi; Chen, Xinkai			Modeling and inverse adaptive control of asymmetric hysteresis systems with applications to magnetostrictive actuator	CONTROL ENGINEERING PRACTICE			English	Article						Asymmetric hysteresis; Asymmetric shifted Prandtl-Ishlinskii (ASPI) model; Prescribed adaptive control; Magnetostrictive actuator	UNCERTAIN NONLINEAR-SYSTEMS; COMPENSATION; BACKLASH; DESIGN	When uncertain systems are actuated by smart material based actuators, the systems exhibit hysteresis nonlinearities and corresponding control is becoming a challenging task, especially with magnetostrictive actuators which are dominated by asymmetric hystereses. The common approach for overcoming the hysteresis effect is inverse compensation combining with robust adaptive control. Focusing on the asymmetric hysteresis phenomenon, an asymmetric shifted Prandtl-Ishlinskii (ASPI) model and its inverse are developed and a corresponding analytical expression for the inverse compensation error is derived. Then, a prescribed adaptive control method is applied to mitigate the compensation error and simultaneously guaranteeing global stability of the closed loop system with a prescribed transient and steady-state performance of the tracking error without knowledge of system parameters. The effectiveness of the proposed control scheme is validated on a magnetostrictive actuated platform. (C) 2014 Elsevier Ltd. All rights reserved.	[Li, Zhi; Su, Chun-Yi] Concordia Univ, Dept Mech & Ind Engn, Montreal, PQ, Canada; [Chen, Xinkai] Shibaura Inst Technol, Dept Elect & Informat Syst, Minuma Ku, Saitama 3378570, Japan	Su, CY (reprint author), Concordia Univ, Dept Mech & Ind Engn, Montreal, PQ, Canada.	cysu@alcor.concordia.ca					Aljanaideh O, 2013, SMART MATER STRUCT, V22, DOI 10.1088/0964-1726/22/2/025027; Su CY, 2005, IEEE T AUTOMAT CONTR, V50, P2069, DOI 10.1109/TAC.860260; Riccardi L, 2013, IEEE T CONTR SYST T, V21, P2011, DOI 10.1109/TCST.2012.2222645; Esbrook A, 2013, IEEE T CONTR SYST T, V21, P725, DOI 10.1109/TCST.2012.2192734; Zhou J, 2012, IEEE T AUTOMAT CONTR, V57, P2627, DOI 10.1109/TAC.2012.2190208; Jiang H, 2010, IEEE T ULTRASON FERR, V57, P1200, DOI 10.1109/TUFFC.2010.1533; Bechlioulis CP, 2008, IEEE T AUTOMAT CONTR, V53, P2090, DOI 10.1109/TAC.2008.929402; TAO G, 1993, AUTOMATICA, V29, P323, DOI 10.1016/0005-1098(93)90126-E; Rakotondrabe M, 2011, IEEE T AUTOM SCI ENG, V8, P428, DOI 10.1109/TASE.2010.2081979; Bechlioulis CP, 2009, AUTOMATICA, V45, P532, DOI 10.1016/j.automatica.2008.08.012; Karunanidhi S, 2010, SENSOR ACTUAT A-PHYS, V157, P185, DOI 10.1016/j.sna.2009.11.014; Krejci P, 2001, IEE P-CONTR THEOR AP, V148, P185, DOI 10.1049/ip-cta:20010375; Zhang XY, 2011, IET CONTROL THEORY A, V5, P1868, DOI 10.1049/iet-cta.2010.0711; Li Z, 2014, IEEE T AUTOM SCI ENG, V11, P613, DOI 10.1109/TASE.2013.2284437; TAO G, 1995, IEEE T AUTOMAT CONTR, V40, P200, DOI 10.1109/9.341778; Zhang TL, 2004, SMART MATER STRUCT, V13, P473, DOI 10.1088/0964-1726/13/3/004; Xiao SL, 2013, IEEE T CONTR SYST T, V21, P1549, DOI 10.1109/TCST.2012.2206029; Zhou J, 2004, IEEE T AUTOMAT CONTR, V49, P1751, DOI 10.1109/tac.2004.835398; Olabi AG, 2008, MATER DESIGN, V29, P469, DOI 10.1016/j.matdes.2006.12.016; Kuhnen K, 2003, EUR J CONTROL, V9, P407, DOI 10.3166/ejc.9.407-418; Brokate M., 1996, HYSTERESIS PHASE TRA; Granas A., 2003, FIXED POINT THEORY; Janaideh A., 2008, IEEE C DEC CONTR, P5182; Janaideh A. M., 2012, IEEE C DEC CONTR, P1597; Jiang CG, 2008, 2008 7TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-23, P2221; JILES DC, 1986, J MAGN MAGN MATER, V61, P48, DOI 10.1016/0304-8853(86)90066-1; Krejci P., 1986, INT SERIES MATH SCI; Kristic I. K. M., 1995, NONLINEAR ADAPTIVE C; Li Z, 2012, IET CONTROL THEORY A, V6, P1, DOI 10.1049/iet-cta.2010.0740; Preisach F, 1935, Z PHYS, V94, P277, DOI 10.1007/BF01349418; Smith R. C., 2005, SMART MAT SYSTEMS MO; Wang Chuan-li, 2012, Journal of Coal Science and Engineering (China), V16, DOI 10.1007/s12404-010-0217-3; Yang BT, 2012, SENSOR ACTUAT A-PHYS, V179, P193, DOI 10.1016/j.sna.2012.02.045	33	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0967-0661	1873-6939		CONTROL ENG PRACT	Control Eng. Practice	DEC	2014	33						148	160		10.1016/j.conengprac.2014.09.004		13	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	AU6RD	WOS:000345728700014		
J	Izawa, K				Izawa, Kunihiko			FREE-LIVING STAGES OF THE PARASITIC COPEPOD LERNANTHROPINUS LABRACOGLOSSAE IZAWA, 2014 (SIPHONOSTOMATOIDA, LERNANTHROPIDAE), REARED FROM EGGS	CRUSTACEANA			English	Article							DEVELOPMENTAL-STAGES; JAPANESE ELASMOBRANCHS; FAMILY; REDESCRIPTION; YAMAGUTI	Free-living stages, comprising two naupliar stages and the infective copepodid I, of the parasitic copepod Lernanthropinus labracoglossae Izawa, 2014 are described. The larvae were reared from eggs detached from an ovigerous female, recovered from the branchial lamellae of the Japanese actinopterygian fish Labracoglossa argentiventris Peter, 1866 (Kyphosidae). The number of naupliar stages prior to copepodopid I in the Lernanthropidae is the same as in the Caligidae, Pseudohatschekidae and Trebiidae. The copepodid I of the species has a frontal filament, as do representatives of the Caligidae, Pandaridae and Trebiidae. However, this is regarded as a vestigial feature in the last two families. Copepodid I of L. labracoglossae has a 6-segmented antennule, including the naked first segment, as do the first copepodids of eudactylinid copepods.	Izawa Marine Biol Lab, Tsu, Mie 5140062, Japan	Izawa, K (reprint author), Izawa Marine Biol Lab, 795-16 Kannonji, Tsu, Mie 5140062, Japan.	izawakun@sea.plala.or.jp					Ohtsuka S, 2009, J NAT HIST, V43, P1779, DOI 10.1080/00222930902993757; Cabral R., 1984, ANN PARASITOL HUM CO, V59, P189; Humes A. G., 1964, Crustaceana, V6, P238, DOI 10.1163/156854064X00650; HUYS R., 1991, COPEPOD EVOLUTION, P1; Izawa K, 2013, CRUSTACEANA, V86, P739, DOI 10.1163/15685403-00003199; Izawa K, 2011, CRUSTACEANA, V84, P1269, DOI 10.1163/001121611X590102; Izawa K, 2010, CRUSTACEANA, V83, P313, DOI 10.1163/001121609X12591347509329; Izawa K, 2010, CRUSTACEANA, V83, P829, DOI 10.1163/001121610X498863; Izawa K, 2012, CRUSTACEANA, V85, P1589, DOI 10.1163/15685403-00003129; Izawa K, 1996, J CRUSTACEAN BIOL, V16, P406, DOI 10.2307/1548896; Izawa K., 1969, Report of the Faculty of Fisheries Prefectural University of Mie, V6, P127; Izawa K, 2014, CRUSTACEANA, V87, P1521, DOI 10.1163/15685403-00003373; KABATA Z., 1979, PARASITIC COPEPODA B, P1; Kim Il-Hoi, 1993, P16; Lin CL, 1997, J NAT HIST, V31, P1483, DOI 10.1080/00222939700770801; Tang D, 2010, SYST PARASITOL, V77, P215, DOI 10.1007/s11230-010-9269-4	16	2	2	BRILL ACADEMIC PUBLISHERS	LEIDEN	PLANTIJNSTRAAT 2, P O BOX 9000, 2300 PA LEIDEN, NETHERLANDS	0011-216X	1568-5403		CRUSTACEANA	Crustaceana	DEC	2014	87	14					1691	1698		10.1163/15685403-00003377		8	Marine & Freshwater Biology	Marine & Freshwater Biology	AU5WQ	WOS:000345674800009		
J	Sakai, K				Sakai, Katsushi			ON EMPHASIZING THE STABILIZATION OF THE NAMES OF THE INFRAORDERS OF GHOST SHRIMPS, THALASSINIDEA LATREILLE, 1831 AND CALLIANASSIDEA DANA, 1852 (DECAPODA, PLEOCYEMATA)	CRUSTACEANA			English	Article									Shikoku Univ, Tokushima 7711192, Japan	Sakai, K (reprint author), Shikoku Univ, Tokushima 7711192, Japan.	ksakai@mf.pikara.ne.jp					Poore GCB, 2014, CRUSTACEANA, V87, P1258, DOI 10.1163/15685403-00003354; MANNING RB, 1991, P BIOL SOC WASH, V104, P764; Sakai K, 2014, CRUSTACEANA, V87, P129, DOI 10.1163/15685403-00003281; Borradaile L.A., 1903, ANN MAGAZINE NATURAL, V12, P534, DOI DOI 10.1080/00222930308678891; Dana J.D., 1852, P ACADEMY NATURAL SC, V1851, P10; De Saint Laurent M., 1971, B MUS NATL HIST NAT, V42, p[1259, 1]; Dworschak P.C., 2012, TREATISE ZOOLOGY A B, V9B, P109; HUXLEY T. H., 1879, P ZOOL SOC LOND, V1878, P752; Kossmann R., 1880, ZOOLOGISCHE ERGEBNIS, V1880, P67; LATREILLE P. A., 1831, COURS ENTOMOLOGIE HI, pi; Poore Gary C. B., 1994, Memoirs of the Museum of Victoria, V54, P79; Robles R., 2009, DECAPOD CRUSTACEAN P, V18, P309; de Saint-Laurent M., 1979, Bulletin de l'Office National des Peches Republique Tunisienne, V3, P15; SAKAI K., 2006, CRUSTACEANA, V78, P1353; Sakai Katsushi, 1992, Naturalists, V4, P1	15	3	3	BRILL ACADEMIC PUBLISHERS	LEIDEN	PLANTIJNSTRAAT 2, P O BOX 9000, 2300 PA LEIDEN, NETHERLANDS	0011-216X	1568-5403		CRUSTACEANA	Crustaceana	DEC	2014	87	14					1738	1741		10.1163/15685403-00003380		4	Marine & Freshwater Biology	Marine & Freshwater Biology	AU5WQ	WOS:000345674800015		
J	Yoshimura, T				Yoshimura, Takashi			Takashi Yoshimura	CURRENT BIOLOGY			English	Editorial Material									[Yoshimura, Takashi] Nagoya Univ, Physiol Anim Lab, Nagoya, Aichi 4648601, Japan; [Yoshimura, Takashi] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648601, Japan; [Yoshimura, Takashi] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Seasonal Biol, Okazaki, Aichi 4448585, Japan	Yoshimura, T (reprint author), Nagoya Univ, Physiol Anim Lab, Nagoya, Aichi 4648601, Japan.	takashiy@agr.nagoya-u.ac.jp						0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0960-9822	1879-0445		CURR BIOL	Curr. Biol.	DEC 1	2014	24	23					R1108	R1109				2	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AU7WH	WOS:000345808700002		
J	Yamazaki, K; Watanabe, T; Koyasu, T; Ochiai, N; Igarashi, T; Liang, SG; Koyama, Y; Ishida, Y				Yamazaki, K.; Watanabe, T.; Koyasu, T.; Ochiai, N.; Igarashi, T.; Liang, S. -G.; Koyama, Y.; Ishida, Y.			Cytological aspects of an ovarian sex cord tumour with annular tubules	CYTOPATHOLOGY			English	Letter									[Yamazaki, K.; Watanabe, T.; Koyasu, T.; Koyama, Y.; Ishida, Y.] Teikyo Univ, Dept Pathol, Chiba Med Ctr, Ichihara, Chiba 2990111, Japan; [Ochiai, N.; Igarashi, T.; Liang, S. -G.] Teikyo Univ, Dept Obstet & Gynecol, Chiba Med Ctr, Ichihara, Chiba 2990111, Japan	Yamazaki, K (reprint author), Teikyo Univ, Dept Pathol, Chiba Med Ctr, 3426-3 Anesaki, Ichihara, Chiba 2990111, Japan.	yamas@med.teikyo-u.ac.jp					YOUNG RH, 1982, CANCER, V50, P1384, DOI 10.1002/1097-0142(19821001)50:7<1384::AID-CNCR2820500726>3.0.CO;2-5; DAVIDOFF MS, 1990, CELL TISSUE RES, V262, P253, DOI 10.1007/BF00309880; Govender D, 2004, J CLIN PATHOL, V57, P802, DOI 10.1136/jcp.2004.015982; Hirschman SA, 1998, DIAGN CYTOPATHOL, V18, P362, DOI 10.1002/(SICI)1097-0339(199805)18:5<362::AID-DC12>3.0.CO;2-G; Ryan LJ, 2006, DIAGN CYTOPATHOL, V34, P576, DOI 10.1002/dc.20504; Tavassoli FA, 2003, WHO CLASSIFICATION T, P146	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0956-5507	1365-2303		CYTOPATHOLOGY	Cytopathology	DEC	2014	25	6					414	416		10.1111/cyt.12112		3	Cell Biology; Pathology	Cell Biology; Pathology	AU6CM	WOS:000345690200009		
J	Lam, WK; Cheung, CY				Lam, Wing-keung; Cheung, Ching-yuen			Guest Editors' Introduction	DAO-A JOURNAL OF COMPARATIVE PHILOSOPHY			English	Editorial Material									[Lam, Wing-keung] Univ Tokyo, Coll Arts & Sci, Tokyo 1538902, Japan; [Cheung, Ching-yuen] Chinese Univ Hong Kong, Dept Japanese Studies, Shatin, Hong Kong, Peoples R China	Cheung, CY (reprint author), Chinese Univ Hong Kong, Dept Japanese Studies, Shatin, Hong Kong, Peoples R China.	cchingyuen@hotmail.com						0	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1540-3009	1569-7274		DAO	Dao	DEC	2014	13	4					451	452		10.1007/s11712-014-9412-z		2	Asian Studies; Philosophy	Asian Studies; Philosophy	AU4ZM	WOS:000345616800001		
J	Asakura, T				Asakura, Tomomi			Philosophy of Doctrinal Classification: KOYAMA Iwao and Mou Zongsan	DAO-A JOURNAL OF COMPARATIVE PHILOSOPHY			English	Article						MOU Zongsan; KOYAMA Iwao; NISHIDA Kitaro; Tiantai Buddhism; Buddhistic ontology; Logic of basho	BUDDHISM	Doctrinal classification or the panjiao acurrency signae center dot (TM) system of Chinese Buddhism has been rediscovered and renewed in modern East Asian philosophy since both the Kyoto School and New Confucianism clarified the philosophical meaning of this intellectual tradition. The theoretical relation between these two modern reconsiderations, however, has not yet been studied. I analyze the theory of panjiao in KAiyama Iwao e <<similar to a +/-+/- a(2)(c) c"center dot (1905-1993) and Mou Zongsan c parts per thousand Ya (R) ua parts per thousand (1909-1995) so as to identify and extract, despite their apparent irrelevance, the same type of philosophical argument concerning the ontological character of yuanjiao ae"ae center dot (TM). My analysis shows that Mou's distinction between the "two-door mind" paradigm and Buddhistic ontology in his interpretation of Tiantai acurrency sign (c) a degrees Buddhism corresponds to KAiyama's distinction between an idealistic system and the existential turn in his generalized panjiao system.	Hokkaido Univ Educ Kushiro, Fac Educ, Kushiro, Hokkaido 0858580, Japan	Asakura, T (reprint author), Hokkaido Univ Educ Kushiro, Fac Educ, 1-15-55 Shiroyama, Kushiro, Hokkaido 0858580, Japan.	asak_tm@yahoo.co.jp					Ando Toshio, 1953, TIANTAIS THEORY NATU; Asakura T, 2011, PHILOS EAST WEST, V61, P647; Asakura Tomomi, 2014, PHILOS E ASIA KYOTO; Asakura Tomomi, 2011, INQUIRY GOOD CENTENN; Asakura Tomomi, 2013, NATL CENTRAL U J HUM, V54, P1; Chan Serina, 2011, THOUGHT MOU ZONGSAN; Chan WC, 2011, J CHINESE PHILOS, V38, P174; Chan Wing-cheuk, 1990, LEGEIN J, V4, P79; Chan Wing-cheuk, 2005, DAO J COMP PHILOS, V5, P73; Clower Jason, 2010, UNLIKELY BUDDHOLGIST; Hanazawa Hidefumi, 1999, KOYAMA IWAO; Hiromatsu Wataru, 1989, OVERCOMING MODERNITY; Koyama Iwao, 2007, COLLECTED WORKS KOYA, V1; Koyama Iwao, 2008, COLLECTED WORKS KOYA, V3; Koyama Iwao, 2007, COLLECTED WORKS KOYA, V2; Koyama Iwao, 2009, COLLECTED WORKS KOYA, V5; Koyama Iwao, 2009, COLLECTED WORKS KOYA, V6; Mori Tetsuro, 2009, COLLECTED WORKS KOYA, V5; Mou Zongsan, 1990, 14 LECT CONVERGENCE; Mou Zongsan, 1985, PERFECT GOOD; Mou Zongsan, 1977, BUDDHA NATURE PRAJNA; Mou Zongsan, 1983, 19 LECT CHINESE PHIL; Nishitani K., 1982, RELIG NOTHINGNESS; Suares Peter, 2011, KYOTO SCH TAKEOVER H; Tamura Yoshiro, 1965, STUDY KAMAKURA NEW B; Tanabe Hajime, 1986, PHILOS METANOETICS; Tang ASK, 2011, J CHINESE PHILOS, V38, P238	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1540-3009	1569-7274		DAO	Dao	DEC	2014	13	4					453	468		10.1007/s11712-014-9397-7		16	Asian Studies; Philosophy	Asian Studies; Philosophy	AU4ZM	WOS:000345616800002		
J	Yoshimura, T; Sugie, K; Endo, H; Suzuki, K; Nishioka, J; Ono, T				Yoshimura, Takeshi; Sugie, Koji; Endo, Hisashi; Suzuki, Koji; Nishioka, Jun; Ono, Tsuneo			Organic matter production response to CO2 increase in open subarctic plankton communities: Comparison of six microcosm experiments under iron-limited and -enriched bloom conditions	DEEP-SEA RESEARCH PART I-OCEANOGRAPHIC RESEARCH PAPERS			English	Article						CO2; Ocean acidification; Phytoplankton; Organic matter; Iron; Pacific	TRANSPARENT EXOPOLYMER PARTICLES; NUTRIENT CONSUMPTION RATIO; OCEAN ACIDIFICATION; ELEVATED CO2; MARINE-PHYTOPLANKTON; SEAWATER ACIDIFICATION; COASTAL PHYTOPLANKTON; CARBONATE CHEMISTRY; MESOCOSM EXPERIMENT; EMILIANIA-HUXLEYI	Increase in seawater pCO(2) and the corresponding decrease in pH caused by the increasing atmospheric CO2 concentration (i.e., ocean acidification) may affect organic matter production by phytoplankton communities. Organic matter production forms the basis of marine food webs and plays a crucial role in oceanic CO2 uptake through the biological carbon pump, and hence will potentially affect future marine ecosystem dynamics. However, responses of organic matter production in open ocean plankton ecosystems to CO2 increase have not been fully examined. We conducted on-deck microcosm experiments using high nutrient, low chlorophyll (HNLC) waters in the western subarctic Pacific and oceanic Bering Sea basin in summer 2008 and 2009, respectively, to examine the impacts of elevated CO2 on particulate and dissolved organic matter (i.e., POM and DOM, respectively) production. Iron deficient natural plankton communities were incubated for 7-14 days under multiple CO2 levels with and without iron enrichments (hereafter +Fe and -Fe treatments, respectively). By combining with our previous experiments at two sites, we created a comprehensive dataset on responses of organic matter production to CO2 increase during macronutrient replete conditions in HNLC waters. Significant differences in net particulate organic carbon production among CO2 treatments were observed only in the -Fe treatments, whereas that in net dissolved organic carbon production were mainly observed in the +Fe treatments, suggesting that CO2 may affect different processes depending on the Fe nutritional status. However, impacts of CO2 were not consistent among experiments and were much smaller than the consistent positive effects of Fe enrichment. In contrast, no significant differences among the CO2 treatments were observed for organic carbon partitioning into POM and DOM, and carbon to nitrogen ratio of net produced POM. We conclude that CO2 does not play a primary role, but could have secondary effects on controlling the organic matter production under macronutrient replete conditions in HNLC waters. On the other hand, in a nutrient-depleted, declining phase of the phytoplankton bloom induced by Fe enrichment, carbon overconsumption was found in an experiment with elevated CO2 conditions suggesting that CO2 impacts might become more significant in such environments. (C) 2014 Elsevier Ltd. All rights reserved.	[Yoshimura, Takeshi; Sugie, Koji] Cent Res Inst Elect Power Ind, Abiko, Chiba 2701194, Japan; [Sugie, Koji] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2330061, Japan; [Endo, Hisashi; Suzuki, Koji] Hokkaido Univ, JST CREST, Fac Environm Earth Sci, Kita Ku, Sapporo, Hokkaido 0600810, Japan; [Nishioka, Jun] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Ono, Tsuneo] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan	Yoshimura, T (reprint author), Cent Res Inst Elect Power Ind, 1646 Abiko, Abiko, Chiba 2701194, Japan.	ytakeshi@criepi.denken.or.jp	Nishioka, Jun/F-5314-2011		CRIEPI [060215];  [22681004]	We acknowledge the field assistance of the captain, officers, crew, and scientists aboard the R/V Hakuho-maru. We thank K. Sugita and A. Tsuzuku for their help on land in preparing the experiments, A. Murayama for nutrients analysis, and A. Matsuoka for POC and PN analysis. We also thank C. Norman for his help to improve the English of the manuscript. We acknowledge the editor and two anonymous reviewers for providing valuable comments that improved the manuscript significantly. This work was conducted in the framework of the Plankton Ecosystem Response to CO<INF>2</INF> Manipulation Study (PERCOM), and was supported by grants from CRIEPI (#060215) and Grants-in-Aid for Scientific Research (#22681004).	Losh JL, 2012, MAR ECOL PROG SER, V468, P31, DOI 10.3354/meps09981; Falkowski P, 2012, NATURE, V483, pS17, DOI 10.1038/483S17a; Riebesell U, 2008, BIOGEOSCIENCES, V5, P1157; Engel A, 2014, J PLANKTON RES, V36, P641, DOI 10.1093/plankt/fbt125; Schulz KG, 2013, BIOGEOSCIENCES, V10, P161, DOI 10.5194/bg-10-161-2013; Biswas H, 2012, BIODIVERS CONSERV, V21, P1309, DOI 10.1007/s10531-011-0209-7; Rossoll D, 2013, MAR ECOL PROG SER, V486, P37, DOI 10.3354/meps10352; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Tanaka T, 2008, BIOGEOSCIENCES, V5, P669; Lenton A, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2011GB004095; Yoshimura T, 2013, J OCEANOGR, V69, P601, DOI 10.1007/s10872-013-0196-2; Arrigo KR, 2007, NATURE, V450, P491, DOI 10.1038/450491a; Feng YY, 2009, MAR ECOL PROG SER, V388, P13, DOI 10.3354/meps08133; Kim JM, 2006, LIMNOL OCEANOGR, V51, P1629; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Breitbarth E, 2010, BIOGEOSCIENCES, V7, P1065; Yuan W, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025174; Aoyama M, 2012, ANAL SCI, V28, P911; Feng Y, 2010, DEEP-SEA RES PT I, V57, P368, DOI 10.1016/j.dsr.2009.10.013; Takahashi T, 2014, MAR CHEM, V164, P95, DOI 10.1016/j.marchem.2014.06.004; Langer G, 2009, BIOGEOSCIENCES, V6, P2637; Boyd PW, 2004, NATURE, V428, P549, DOI 10.1038/nature02437; Price NM, 2005, LIMNOL OCEANOGR, V50, P1159; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Melancon J, 2014, LIMNOL OCEANOGR, V59, P55, DOI 10.4319/lo.2014.59.1.0055; Nishioka J, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006321; Passow U, 2012, MAR ECOL PROG SER, V470, P249, DOI 10.3354/meps09985; MacGilchrist GA, 2014, BIOGEOSCIENCES, V11, P3695, DOI 10.5194/bg-11-3695-2014; Sakurai Y, 2007, DEEP-SEA RES PT II, V54, P2526, DOI 10.1016/j.dsr2.2007.02.007; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Hopkinson BM, 2010, LIMNOL OCEANOGR, V55, P2011, DOI 10.4319/lo.2010.55.5.2011; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Borchard C, 2012, BIOGEOSCIENCES, V9, P3405, DOI 10.5194/bg-9-3405-2012; Olgun N, 2013, MAR ECOL PROG SER, V488, P81, DOI 10.3354/meps10403; Liu JW, 2010, AQUAT MICROB ECOL, V61, P291, DOI 10.3354/ame01446; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Millero FJ, 2009, OCEANOGRAPHY, V22, P72; Shi DL, 2010, SCIENCE, V327, P676, DOI 10.1126/science.1183517; Trimborn S, 2009, J EXP MAR BIOL ECOL, V376, P26, DOI 10.1016/j.jembe.2009.05.017; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; Hopkinson BM, 2011, P NATL ACAD SCI USA, V108, P3830, DOI 10.1073/pnas.1018062108; Hoffmann LJ, 2012, MAR ECOL PROG SER, V470, P191, DOI 10.3354/meps10082; Sunda WG, 2010, SCIENCE, V327, P654, DOI 10.1126/science.1186151; Yamada N, 2010, J OCEANOGR, V66, P233; Thornton DCO, 2014, EUR J PHYCOL, V49, P20, DOI 10.1080/09670262.2013.875596; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1353, DOI 10.4319/lo.2010.55.3.1353; Rost B, 2008, MAR ECOL PROG SER, V373, P227, DOI 10.3354/meps07776; Yang GY, 2012, MAR ENVIRON RES, V79, P142, DOI 10.1016/j.marenvres.2012.06.002; Endo H, 2013, J EXP MAR BIOL ECOL, V439, P160, DOI 10.1016/j.jembe.2012.11.003; Wu Y, 2010, BIOGEOSCIENCES, V7, P2915, DOI 10.5194/bg-7-2915-2010; Yoshimura T, 2010, J EXP MAR BIOL ECOL, V395, P191, DOI 10.1016/j.jembe.2010.09.001; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985; EDMOND JM, 1970, DEEP-SEA RES, V17, P737, DOI 10.1016/0011-7471(70)90038-0; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897; Dore JE, 2009, P NATL ACAD SCI USA, V106, P12235, DOI 10.1073/pnas.0906044106; Tsuda A, 2003, SCIENCE, V300, P958, DOI 10.1126/science.1082000; Engel A, 2008, BIOGEOSCIENCES, V5, P509; Boyd PW, 2005, LIMNOL OCEANOGR, V50, P1872; CULBERSO.C, 1970, J MAR RES, V28, P15; Czerny J, 2013, BIOGEOSCIENCES, V10, P3109, DOI 10.5194/bg-10-3109-2013; Dickson A. G., 2007, GUIDE BEST PRACTICES; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; DUPONT S, 2013, NATURE, V498; Endres S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099228; Hansell DA, 2005, EOS T AM GEOPHYS UN, V86, P318, DOI [DOI 10.1029/2005EO350003, 10.1029/2004GL020684.w]; Hansen HP, 1999, METHODS SEAWATER ANA, P159, DOI DOI 10.1002/9783527613984.CH10; Hoppe CJM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079890; Iwamoto Y, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045906; JOHNSON K, 1985, ART MAG, V59, P2; Losh JL, 2013, NEW PHYTOL, V198, P52, DOI 10.1111/nph.12143; Nishioka J, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016853; Pierrot D., 2006, ORNLCDIAC105A US DEP; RICHIER S, 2014, BIOGEOSCIENCES DISCU, V11, P3489, DOI DOI 10.5194/BGD-11-3489-2014; RIDAL JJ, 1990, MAR CHEM, V29, P19, DOI 10.1016/0304-4203(90)90003-U; Sugie K, 2013, J PHYCOL, V49, P475, DOI 10.1111/jpy.12054; Sugie K, 2013, BIOGEOSCIENCES, V10, P6309, DOI 10.5194/bg-10-6309-2013; Suzuki K, 2002, LIMNOL OCEANOGR, V47, P1581; SUZUKI R, 1990, Journal of the Oceanographical Society of Japan, V46, P190, DOI 10.1007/BF02125580; Tagliabue A, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003929; TAKEDA S, 1995, MAR CHEM, V50, P219, DOI 10.1016/0304-4203(95)00037-R; Tortell PD, 1996, NATURE, V383, P330, DOI 10.1038/383330a0; Tsuda A, 2007, J OCEANOGR, V63, P983, DOI 10.1007/s10872-007-0082-x; Yoshimura T, 2010, DEEP-SEA RES PT I, V57, P1454, DOI 10.1016/j.dsr.2010.08.003; YOSHIMURA T, 2010, COMP NUTR WORLDS OCE, P91; Yoshimura T, 2013, LIMNOL OCEANOGR-METH, V11, P239, DOI 10.4319/lom.2013.11.239	87	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0967-0637	1879-0119		DEEP-SEA RES PT I	Deep-Sea Res. Part I-Oceanogr. Res. Pap.	DEC	2014	94						1	14		10.1016/j.dsr.2014.08.004		14	Oceanography	Oceanography	AU8AW	WOS:000345820100001		
J	Saito, H; Murata, M; Hashimoto, J				Saito, Hiroaki; Murata, Masakazu; Hashimoto, Jun			Lipid characteristics of a seep clam, Mesolinga soliditesta: Comparison with those of two coastal clams, Meretrix lamarckii and Ruditapes philippinarum	DEEP-SEA RESEARCH PART I-OCEANOGRAPHIC RESEARCH PAPERS			English	Article						Chemoecology; Clam; Docosapentaenoic acid; Icosapentaenoic acid; Marine-grazing food chain; Polyunsaturated fatty acids; Symbiotic microorganisms; Seep animal	FATTY-ACID-COMPOSITION; OYSTER CRASSOSTREA-GIGAS; DEEP HYDROTHERMAL VENT; CALYPTOGENA-PHASEOLIFORMIS; CODAKIA-ORBICULARIS; LUCINID BIVALVES; MEMBRANE-LIPIDS; BACTERIA; MUSSELS; SEDIMENTS	The lipids and fatty acids of two coastal clams, Meretrix lamarckii and Ruditapes philippinarum, collected at 5 and 1 m of depth, and a seep clam, Mesolinga soliditesta, collected at 331 m of depth, were examined to assess their lipid physiology and trophic relationship with their diets. The major fatty acids of lipids in Mer. lamarckii and R. philippinarum were 14:0, 16:0, 18:0, 16:1n-7, 18:1n-9, 18:1n-7, 20:4n-6, 20:5n-3, and 22:6n-3, while those of Mes. soliditesta were 16:0,18:0, 16:1n-7, 18:1n-7, 20:1n-7, 20:1n-13, 20:2n-7, 15 (Delta 5,13-20:2), and 22:2n-7,15 (Delta 7,15-22:2). The major polyunsaturated fatty acids (PUFAs) in the Mer. lamarckii and R. philippinarum lipids consisted of various n-3 and n-6 long-chain (LC) PUFAs, such as 20:4n-6, 22:4n-6, 20:5n-3, 22:5n-3, and 22:6n-3, while those in Mes. soliditesta muscle and viscera included various n-4 family PUFAs (18:3n-7, 18:4n-4, 20:2n-7, and 20:3n-7) with limited kinds of n-3 and n-6 PUFAs (20:4n-6 and 20:5n-3). These findings indicate that, like other common shallow-water clams, Mer. lamarckii and R. philippinarum ingest phytoplanktonic n-3 and n-6 LC-PUFAs, whereas Mes. soliditesta utilizes limited kinds of n-3 and n-6 LC-PUFAs. In contrast to the other two bivalves species, Mes. soliditesta yielded various n-4 and n-7 (n-4/n-7) PUFAs, which were assimilated from the chemosynthetic symbionts. The high diversity of PUFAs contained in the Mes. soliditesta lipids (n-3, n-4 family, and n-6 PUFAs) suggests that this species mixotrophically utilized both photosynthetic products and vent chemosynthetic nutrition derived from geothermal energy. (C) 2014 Elsevier Ltd. All rights reserved.	[Saito, Hiroaki; Murata, Masakazu; Hashimoto, Jun] Ishikawa Prefectural Univ, Nonoichi, Ishikawa 9218836, Japan	Saito, H (reprint author), Ishikawa Prefectural Univ, 1-308 Suematsu, Nonoichi, Ishikawa 9218836, Japan.	hiroakis@ishikawa-pu.ac.jp			Fisheries Research Agency of Japan	The authors are especially indebted to the captains and crews of the Research Vessel "Natsushima," and the submersible "Shinkai 2000" operation teams for their cooperation and enthusiasm throughout the work, and to the Japan Marine Science and Technology Center for providing us an opportunity to use the submersible. The authors also thank Ms. Sumiko Terada, Ms. Mikiko Tanaka, and Mr. Akihito Takashima for their skilled technical assistance. H.S. performed all aspects of the study including the design of the experiments, analyzing the data, and writing the manuscript. We especially thank the Associate Editor and five anonymous reviewers for constructive feedback This work was supported in part by the research projects from the Fisheries Research Agency of Japan. M.M. assisted in collecting Mes. soliditesta. J.H. provided advice and discussion on preparing the manuscript.	ANDERSON AE, 1995, AM ZOOL, V35, P121; Pernet F, 2007, J EXP BIOL, V210, P2999, DOI 10.1242/jeb.006007; Caro A, 2009, APPL ENVIRON MICROB, V75, P3304, DOI 10.1128/AEM.02659-08; Budge SM, 2001, MAR CHEM, V76, P285, DOI 10.1016/S0304-4203(01)00068-8; ABRAJANO TA, 1994, ORG GEOCHEM, V21, P611, DOI 10.1016/0146-6380(94)90007-8; JAHNKE LL, 1995, APPL ENVIRON MICROB, V61, P576; THOMPSON PA, 1992, MAR BIOL, V113, P645, DOI 10.1007/BF00349708; FULLARTON JG, 1995, J MAR BIOL ASSOC UK, V75, P455; BENMLIH F, 1992, J LIPID RES, V33, P1797; NAPOLITANO GE, 1992, MAR BIOL, V113, P71, DOI 10.1007/BF00367640; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; DELONG EF, 1986, APPL ENVIRON MICROB, V51, P730; Kraffe E, 2004, LIPIDS, V39, P59, DOI 10.1007/s11745-004-1202-x; Phleger CF, 2005, COMP BIOCHEM PHYS B, V141, P196, DOI 10.1016/j.cbpc.2005.03.001; Aranda-Burgos JA, 2014, AQUACULTURE, V420, P38, DOI 10.1016/j.aquaculture.2013.10.032; VOLKMAN JK, 1989, J EXP MAR BIOL ECOL, V128, P219, DOI 10.1016/0022-0981(89)90029-4; Pazos AJ, 2003, COMP BIOCHEM PHYS B, V134, P367, DOI 10.1016/S1096-4959(02)00286-5; Yano Y, 1998, APPL ENVIRON MICROB, V64, P479; Logue JA, 2000, J EXP BIOL, V203, P2105; BERG CJ, 1985, LIPIDS, V20, P116, DOI 10.1007/BF02534217; DANDO PR, 1994, MAR ECOL PROG SER, V107, P169, DOI 10.3354/meps107169; Delaporte M, 2005, COMP BIOCHEM PHYS A, V140, P460, DOI 10.1016/j.cbpb.2005.02.009; Duplessis MR, 2004, MAR BIOL, V145, P551, DOI 10.1007/s00227-004-1350-6; FANG JS, 1993, COMP BIOCHEM PHYS B, V104, P287, DOI 10.1016/0305-0491(93)90370-K; Fernandez-Reiriz MJ, 2006, COMP BIOCHEM PHYS B, V144, P229, DOI 10.1016/j.cbpb.2006.02.015; FOLCH J, 1957, J BIOL CHEM, V226, P497; FULLARTON JG, 1995, J MAR BIOL ASSOC UK, V75, P445; Gaever S.V., 2009, MAR BIOL, V156, P1289; Hurtado MA, 2012, COMP BIOCHEM PHYS B, V163, P172, DOI 10.1016/j.cbpb.2012.05.011; KLUYTMANS JH, 1985, COMP BIOCHEM PHYS B, V81, P959, DOI 10.1016/0305-0491(85)90097-5; Knief C, 2003, ENVIRON MICROBIOL, V5, P1155, DOI 10.1046/j.1462-2920.2003.00510.x; Le Grand F, 2011, COMP BIOCHEM PHYS A, V159, P383, DOI 10.1016/j.cbpa.2011.04.006; Okutani Takashi, 1997, Venus the Japanese Journal of Malacology, V56, P271; Pond DW, 1998, APPL ENVIRON MICROB, V64, P370; Pranal V, 1996, MAR ECOL PROG SER, V142, P175, DOI 10.3354/meps142175; Saito H, 2004, LIPIDS, V39, P997, DOI 10.1007/s11745-004-1322-3; Saito H, 2010, J PHYCOL, V46, P665, DOI 10.1111/j.1529-8817.2010.00848.x; Saito H, 2010, LIPIDS, V45, P537, DOI 10.1007/s11745-010-3436-x; Saito H, 2007, LIMNOL OCEANOGR, V52, P1910, DOI 10.4319/lo.2007.52.5.1910; Saito H, 2010, J OLEO SCI, V59, P281, DOI 10.5650/jos.59.281; Saito H, 2008, J CHROMATOGR A, V1200, P242, DOI 10.1016/j.chroma.2008.05.094; Saito H, 2007, J CHROMATOGR A, V1163, P247, DOI 10.1016/j.chroma.2007.06.016; Sasaki Takenori, 2005, Venus (Tokyo), V64, P87; Southward EC, 2001, J MAR BIOL ASSOC UK, V81, P655; SPIRO B, 1986, MAR ECOL PROG SER, V28, P233, DOI 10.3354/meps028233; THIELE OW, 1984, EUR J BIOCHEM, V139, P131, DOI 10.1111/j.1432-1033.1984.tb07986.x; Vahirua-Lechat I, 2008, AQUAC RES, V39, P1739, DOI 10.1111/j.1365-2109.2008.02050.x	47	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0967-0637	1879-0119		DEEP-SEA RES PT I	Deep-Sea Res. Part I-Oceanogr. Res. Pap.	DEC	2014	94						150	158		10.1016/j.dsr.2014.09.008		9	Oceanography	Oceanography	AU8AW	WOS:000345820100011		
J	Oishi, S; Jaswal, VK; Lillard, AS; Mizokawa, A; Hitokoto, H; Tsutsui, Y				Oishi, Shigehiro; Jaswal, Vikram K.; Lillard, Angeline S.; Mizokawa, Ai; Hitokoto, Hidefumi; Tsutsui, Yoshiro			Cultural Variations in Global Versus Local Processing: A Developmental Perspective	DEVELOPMENTAL PSYCHOLOGY			English	Article						perception; culture; life span	SEROTONIN TRANSPORTER GENE; UNITED-STATES; INDIVIDUALISM-COLLECTIVISM; HIERARCHICAL PATTERNS; SELECTIVE ATTENTION; CONTEXT-SENSITIVITY; AMERICAN MOTHERS; NORTH-AMERICAN; REMOTE CULTURE; BIG PICTURE	We conducted 3 studies to explore cultural differences in global versus local processing and their developmental trajectories. In Study 1 (N = 363), we found that Japanese college students were less globally oriented in their processing than American or Argentine participants. We replicated this effect in Study 2 (N = 1,843) using a nationally representative sample of Japanese and American adults ages 20 to 69, and found further that adults in both cultures became more globally oriented with age. In Study 3 (N = 133), we investigated the developmental course of the cultural difference using Japanese and American children, and found it was evident by 4 years of age. Cultural variations in global versus local processing emerge by early childhood, and remain throughout adulthood. At the same time, both Japanese and Americans become increasingly global processors with age.	[Oishi, Shigehiro; Jaswal, Vikram K.; Lillard, Angeline S.] Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA; [Mizokawa, Ai] Meiji Gakuin Univ, Fac Psychol, Tokyo, Japan; [Hitokoto, Hidefumi] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Tsutsui, Yoshiro] Konan Univ, Fac Econ, Kobe, Hyogo, Japan	Oishi, S (reprint author), Univ Virginia, Dept Psychol, Charlottesville, VA 22904 USA.	soishi@virginia.edu		Jaswal, Vikram/0000-0002-7667-1252			MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Lillard A, 1998, PSYCHOL BULL, V123, P3, DOI 10.1037/0033-2909.123.1.3; Kitayama S, 2006, J PERS SOC PSYCHOL, V91, P369, DOI 10.1037/0022-3514.91.3.369; Imada T, 2013, DEVELOPMENTAL SCI, V16, P198, DOI 10.1111/desc.12016; TOMASELLO M, 1993, BEHAV BRAIN SCI, V16, P495; Davidoff J, 2008, COGNITION, V108, P702, DOI 10.1016/j.cognition.2008.06.004; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Chiao JY, 2010, P R SOC B, V277, P529, DOI 10.1098/rspb.2009.1650; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; ZahnWaxler C, 1996, CHILD DEV, V67, P2462, DOI 10.1111/j.1467-8624.1996.tb01868.x; Webster C, 2010, J ACAD MARKET SCI, V38, P691, DOI 10.1007/s11747-009-0185-6; Kimchi R, 2005, PSYCHOL SCI, V16, P282, DOI 10.1111/j.0956-7976.2005.01529.x; Scherf KS, 2009, CHILD DEV, V80, P162, DOI 10.1111/j.1467-8624.2008.01252.x; Porporino M, 2004, INT J BEHAV DEV, V28, P358, DOI 10.1080/01650250444000063; Talhelm T, 2014, SCIENCE, V344, P603, DOI 10.1126/science.1246850; Medin DL, 2004, PSYCHOL REV, V111, P960, DOI 10.1037/0033-295x.111.4.960; Duffy S, 2009, J EXP CHILD PSYCHOL, V102, P351, DOI 10.1016/j.jecp.2008.06.006; Caparos S, 2012, COGNITION, V122, P80, DOI 10.1016/j.cognition.2011.08.013; Masuda T, 2008, PERS SOC PSYCHOL B, V34, P1260, DOI 10.1177/0146167208320555; Kuwabara M, 2012, J EXP CHILD PSYCHOL, V113, P20, DOI 10.1016/j.jecp.2012.04.009; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Lopez A, 1997, COGNITIVE PSYCHOL, V32, P251, DOI 10.1006/cogp.1997.0651; Oishi S, 2010, PERSPECT PSYCHOL SCI, V5, P5, DOI 10.1177/1745691609356781; Enns JT, 2000, J ADULT DEV, V7, P41, DOI 10.1023/A:1009503118377; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037//0003-066X.54.3.165; Schimmack U, 2002, COGNITION EMOTION, V16, P705, DOI 10.1080/02699930143000590; Norenzayan A, 2005, PSYCHOL BULL, V131, P763, DOI 10.1037/0033-2909.131.5.763; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Li SC, 2003, PSYCHOL BULL, V129, P171, DOI 10.1037/0033-2909.129.2.171; BORNSTEIN MH, 1992, CHILD DEV, V63, P808, DOI 10.2307/1131235; McKone E, 2010, VISION RES, V50, P1540, DOI 10.1016/j.visres.2010.05.010; Burack JA, 2000, DEV PSYCHOL, V36, P731, DOI 10.1037//0012-1649.36.6.731; BRONFENBRENNER U, 1977, AM PSYCHOL, V32, P513, DOI 10.1037/0003-066X.32.7.513; Gasper K, 2002, PSYCHOL SCI, V13, P34, DOI 10.1111/1467-9280.00406; Hicks JA, 2007, COGNITION EMOTION, V21, P1577, DOI 10.1080/02699930701347304; Kuwabara M, 2011, J COGN DEV, V12, P502, DOI 10.1080/15248372.2011.554927; FERNALD A, 1993, CHILD DEV, V64, P637; Norenzayan A, 2002, COGNITIVE SCI, V26, P653, DOI 10.1207/s15516709cog2605_4; Oishi S, 2010, PERSPECT PSYCHOL SCI, V5, P356, DOI 10.1177/1745691610374588; Azuma H., 1981, CHILDS COGNITIVE DEV; BALTES PB, 1987, DEV PSYCHOL, V23, P611, DOI 10.1037/0012-1649.23.5.611; Bialystok E., 2006, LIFESPAN COGNITION M; BORNSTEIN MH, 1989, DEV REV, V9, P171, DOI 10.1016/0273-2297(89)90028-2; Boyd R., 1985, CULTURE EVOLUTIONARY; Bruner J., 1990, ACTS MEANING; Caparos S, 2013, PSYCHOL SCI, V24, P206, DOI 10.1177/0956797612452569; CAUDILL W, 1966, PSYCHIATR, V29, P344; CAUDILL WA, 1973, J NERV MENT DIS, V157, P323, DOI 10.1097/00005053-197311000-00003; Davies R., 2002, JAPANESE MIND UNDERS; de Fockert JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026337; De Neve JE, 2012, J NEUROSCI PSYCHOL E, V5, P193, DOI 10.1037/a0030292; De Neve JE, 2011, J HUM GENET, V56, P456, DOI 10.1038/jhg.2011.39; Dennis TA, 2002, CHILD DEV, V73, P1803, DOI 10.1111/1467-8624.00507; Doi T., 1973, ANATOMY DEPENDENCE; Dukette D, 2001, DEVELOPMENTAL SCI, V4, P233, DOI 10.1111/1467-7687.00168; Fernandez MP, 1996, TECHNOL CULT, V37, P221, DOI 10.2307/3106815; Gibson J. J., 1979, ECOLOGICAL APPROACH; Hess R. D., 1991, EDUC RES, V20, P2, DOI DOI 10.3102/0013189X020009002; Imada T, 2012, J CROSS CULT PSYCHOL, V43, P576, DOI 10.1177/0022022110383312; KASHIWAGI K, 1977, JPN J EDUC PSYCHOL, V25, P242; Kato-Otani E., 2004, STORY TIME MOTHERS R; KIMCHI R, 1982, J EXP PSYCHOL HUMAN, V8, P521, DOI 10.1037/0096-1523.8.4.521; Kitayama S, 2002, COGNITION EMOTION, V16, P29, DOI 10.1080/0269993943000121; Lebra T., 1976, JAPANESE PATTERNS BE; Lewis C. C., 1995, ED HEARTS MINDS; Lobel A., 1970, FROG TOAD ARE FRIEND; Miki T., 2012, LETT JAPANESE TRANSL; Nisbett Richard E., 2003, GEOGRAPHY THOUGHT AS; Saito T., 2002, IDEAL JAPANESE TXB; SALKIND NJ, 1978, CHILD DEV, V49, P1024, DOI 10.1111/j.1467-8624.1978.tb04070.x; Schnall S, 2008, DEVELOPMENTAL SCI, V11, pF25, DOI 10.1111/j.1467-7687.2008.00709.x; SMITH JD, 1988, DEV PSYCHOL, V24, P46; Stevenson H. W., 1992, LEARNING GAP WHY OUR; Tooby J., 1992, ADAPTED MIND EVOLUTI, P19; Unsworth Sara J., 2012, J COGNITION CULTURE, V12, P17, DOI DOI 10.1163/156853712X633901; Wang HT, 2012, PERS SOC PSYCHOL B, V38, P1539, DOI 10.1177/0146167212455828	78	0	0	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0012-1649	1939-0599		DEV PSYCHOL	Dev. Psychol.	DEC	2014	50	12					2654	2665		10.1037/a0038272		12	Psychology, Developmental	Psychology	AU6WF	WOS:000345741400008		
J	Fujiwara, S; Ono, T; Minagi, Y; Fujiu-Kurachi, M; Hori, K; Maeda, Y; Boroumand, S; Nitschke, I; Ursula, V; Bohlender, J				Fujiwara, Shigehiro; Ono, Takahiro; Minagi, Yoshitomo; Fujiu-Kurachi, Masako; Hori, Kazuhiro; Maeda, Yoshinobu; Boroumand, Sara; Nitschke, Ina; Ursula, Vith; Bohlender, Joerg			Effect of Supraglottic and Super-supraglottic swallows on Tongue Pressure Production against Hard Palate	DYSPHAGIA			English	Article						Supraglottic swallow; Super-supraglottic swallow; Swallowing; Tongue; Pressure; Dysphagia; Deglutition; Deglutition disorders	EFFORTFUL SWALLOW; CHIN TUCK; VIDEOMANOMETRIC ANALYSIS; PHARYNGEAL DYSFUNCTION; AGE; DYSPHAGIA; MANEUVERS; GENERATION; STRENGTH; STROKE	The objectives of this study were to evaluate the state of tongue pressure production during supraglottic swallow (SS) and super-supraglottic swallow (SSS) performed by healthy adults, and to investigate the effects of these swallowing maneuvers on the oral stage of swallowing. The participants were 19 healthy individuals. Tongue pressure against the hard palate during swallowing was measured using a tongue pressure sensor sheet system with five pressure-sensitive points. The tasks comprised swallowing 5 mL of water by normal wet swallow, SS, and SSS, and the parameters for analysis were the duration, the maximal magnitude, and the integrated value of tongue pressure during swallowing. The duration of tongue pressure was significantly longer at the anterior-median part of the hard palate during both SS and SSS than with normal wet swallow. The maximal magnitude increased significantly only at the posterior part of the hard palate during SS, but at all points during SSS. The integrated value increased significantly only at the posterior-median part of the hard palate during SS, but at all points except the mid-median part of the hard palate during SSS. The maximal magnitude and integrated value were also significantly higher at the anterior-median and posterior circumferential parts during SSS than during SS. These results show that these two swallowing maneuvers, which are known primarily as techniques to protect the airway, also function to strengthen the tongue pressure produced by the contact between the tongue and the hard palate during swallowing and this effect is more pronounced during SSS.	[Fujiwara, Shigehiro; Ono, Takahiro; Minagi, Yoshitomo; Maeda, Yoshinobu] Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, Suita, Osaka 5650871, Japan; [Fujiu-Kurachi, Masako] Niigata Univ Rehabil, Dept Rehabil, Murakami, Japan; [Hori, Kazuhiro] Niigata Univ, Grad Sch Med & Dent Sci, Div Dysphagia Rehabil, Niigata, Japan; [Boroumand, Sara; Nitschke, Ina] Univ Zurich, Ctr Dent Med, Clin Masticatory Disorders Removable Prosthodont, Zurich, Switzerland; [Ursula, Vith; Bohlender, Joerg] Univ Zurich Hosp, Clin Otorhinolaryngol Head & Neck Surg, Dept Phoniatr & Logoped, CH-8091 Zurich, Switzerland	Ono, T (reprint author), Osaka Univ, Grad Sch Dent, Dept Prosthodont Gerodontol & Oral Rehabil, 1-8 Yamada Oka, Suita, Osaka 5650871, Japan.	ono@dent.osaka-u.ac.jp			Global COE Program "In Silico Medicine'' at Osaka University	This study was supported by the Global COE Program "In Silico Medicine'' at Osaka University.	Tamine K, 2010, J DENT RES, V89, P1097, DOI 10.1177/0022034510370801; LAZARUS C, 1993, HEAD NECK-J SCI SPEC, V15, P419, DOI 10.1002/hed.2880150509; KAHRILAS PJ, 1993, GASTROENTEROLOGY, V104, P152; Youmans SR, 2006, DYSPHAGIA, V21, P102, DOI 10.1007/s00455-006-9013-z; Fukuoka T, 2013, DYSPHAGIA, V28, P539, DOI 10.1007/s00455-013-9464-y; Lazarus C, 2002, FOLIA PHONIATR LOGO, V54, P171, DOI 10.1159/000063192; Donzelli J, 2004, ARCH OTOLARYNGOL, V130, P208, DOI 10.1001/archotol.130.2.208; Bulow M, 2001, DYSPHAGIA, V16, P190; Hirota N, 2010, STROKE, V41, P2982, DOI 10.1161/STROKEAHA.110.594960; Youmans SR, 2009, DYSPHAGIA, V24, P57, DOI 10.1007/s00455-008-9171-2; Crow HC, 1996, J GERONTOL A-BIOL, V51, pM247; Bulow M, 2002, DYSPHAGIA, V17, P197, DOI 10.1007/s00455-002-0050-y; Bulow M, 1999, DYSPHAGIA, V14, P67, DOI 10.1007/PL00009589; Nicosia MA, 2000, J GERONTOL A-BIOL, V55, pM634; Konaka K, 2010, EUR NEUROL, V64, P101, DOI 10.1159/000315140; Utanohara Y, 2008, DYSPHAGIA, V23, P286, DOI 10.1007/s00455-007-9142-z; CERENKO D, 1989, OTOLARYNG HEAD NECK, V100, P57; Froeschels E, 1955, J SPEECH HEAR DISORD, V20, P365; Fujiu-Kurachi M, 2014, DYSPHAGIA, V29, P17, DOI 10.1007/s00455-013-9471-z; Hayashi R, 2002, INT J PROSTHODONT, V15, P385; Hewitt A, 2008, DYSPHAGIA, V23, P16, DOI 10.1007/s00455-007-9089-0; Hori K, 2013, PHYSL REP, V1; Hori K, 2009, J PROSTHODONT RES, V5, P28; Hori K, 2011, DYSPHAGIA, V26, P238, DOI 10.1007/s00455-010-9292-2; Logemann JA, 1993, MANUAL VIDEOFLUOROSC, P54; MENDELSOHN MS, 1993, ANN OTO RHINOL LARYN, V102, P941; Nagao K, 2002, PROSTHODONT RES PRAC, V1, P16, DOI 10.2186/prp.1.16; Ohmae Y, 1996, ANN OTO RHINOL LARYN, V105, P123; Ono T, 2010, SENSORS-BASEL, V10, P176, DOI 10.3390/s100100176; ROBBINS J, 1995, J GERONTOL A-BIOL, V50, pM257; Shaker R, 1988, Dysphagia, V3, P79, DOI 10.1007/BF02412424	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-051X	1432-0460		DYSPHAGIA	Dysphagia	DEC	2014	29	6					655	662		10.1007/s00455-014-9556-3		8	Otorhinolaryngology	Otorhinolaryngology	AU5CK	WOS:000345624500003		
J	Inokuchi, H; Brodsky, MB; Gonzalez-Fernandez, M; Yoda, M; Hiraoka, T; Matsuo, K; Palmer, JB				Inokuchi, Haruhi; Brodsky, Martin B.; Gonzalez-Fernandez, Marlis; Yoda, Mitsumasa; Hiraoka, Takashi; Matsuo, Koichiro; Palmer, Jeffrey B.			Frequency of Stage II Oral Transport Cycles in Healthy Human	DYSPHAGIA			English	Article						Deglutition; Deglutition disorders; Mastication; Swallowing; Fluoroscopy; Food; Tongue; Oral cavity	FOOD CONSISTENCY; BOLUS AGGREGATION; MOVEMENTS; TONGUE; MASTICATION; PERCEPTION; KINEMATICS; BEHAVIORS; HARDNESS; JAW	Stage II transport (St2Tr) is propulsion of triturated food into the pharynx for storage before swallowing via tongue squeeze-back against the palate. To clarify the phenomenology of St2Tr, we examined the effects of food consistency and the number of chewing cycles on the number of St2Tr cycles in a chew-swallow sequence. We recorded chew-swallow sequences in lateral projection with videofluoroscopy of 13 healthy volunteers eating 6 g of hard (shortbread cookie), and soft foods (ripe banana and tofu) with barium. We counted the number of chewing and St2Tr cycles from food intake to terminal swallow. We used the Friedman test for bivariate analyses and negative binomial regression for multivariable analyses. On bivariate analysis, food consistency had a positive association with the number of chewing cycles (P = 0.013), but not with the number of St2Tr cycles (P = 0.27). Multivariable analysis, however, revealed a greater number of St2Tr cycles with hard than soft food (P a parts per thousand currency sign 0.01) and a trend toward negative correlation between the numbers of St2Tr and chewing cycles (P = 0.083). The number of chewing cycles needed to clear the mouth differs among food consistencies as demonstrated previously. Greater numbers of both St2Tr and chewing cycles were elicited with the hard than with the soft foods. Given the trend toward negative correlation, the association between the number of St2Tr cycles and that of chewing cycles deserves further study.	[Inokuchi, Haruhi; Brodsky, Martin B.; Gonzalez-Fernandez, Marlis; Yoda, Mitsumasa; Hiraoka, Takashi; Matsuo, Koichiro; Palmer, Jeffrey B.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Inokuchi, Haruhi] Univ Tokyo, Dept Rehabil Med, Bunkyo Ku, Tokyo 1138655, Japan; [Matsuo, Koichiro] Fujita Hlth Univ, Dept Dent, Toyoake, Aichi, Japan; [Palmer, Jeffrey B.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Palmer, Jeffrey B.] Johns Hopkins Univ, Sch Med, Ctr Funct Anat & Evolut, Baltimore, MD 21205 USA	Inokuchi, H (reprint author), Univ Tokyo, Dept Rehabil Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	haruhi.konishi0415@gmail.com			NIH/NIDCD [R01-DC02123]	This research was supported in part by NIH/NIDCD award No. R01-DC02123. We presented this study at the 20th Annual Meeting of Dysphagia Research Society, Toronto, Canada, March 7-10, 2012. All authors have no financial conflict of interests to disclose concerning the research.	Foster KD, 2011, J FOOD SCI, V76, pR49, DOI 10.1111/j.1750-3841.2010.02029.x; Steele CM, 2004, DYSPHAGIA, V19, P192, DOI 10.1007/s00455-004-0006-5; Engelen L, 2005, ARCH ORAL BIOL, V50, P739, DOI 10.1016/j.archoralbio.2005.01.004; Anderson K, 2002, J ORAL REHABIL, V29, P689, DOI 10.1046/j.1365-2842.2002.00862.x; Palmer JB, 2007, PHYSIOL BEHAV, V91, P66, DOI 10.1016/j.physbeh.2007.01.018; Taniguchi H, 2008, J APPL PHYSIOL, V105, P791, DOI 10.1152/japplphysiol.90485.2008; Fontijn-Tekamp FA, 2004, PHYSIOL BEHAV, V83, P431, DOI 10.1016/j.physbeh.2004.08.026; Hiiemae KM, 1999, DYSPHAGIA, V14, P31, DOI 10.1007/PL00009582; Saitoh E, 2007, DYSPHAGIA, V22, P100, DOI 10.1007/s00455-006-9060-5; LEOPOLD NA, 1983, ARCH PHYS MED REHAB, V64, P371; Hiiemae KM, 2003, CRIT REV ORAL BIOL M, V14, P413; Wintergerst AM, 2008, ARCH ORAL BIOL, V53, P369, DOI 10.1016/j.archoralbio.2007.10.012; van der Bilt A, 2011, EUR J ORAL SCI, V119, P427, DOI 10.1111/j.1600-0722.2011.00878.x; de Wijk RA, 2011, PHYSIOL BEHAV, V104, P423, DOI 10.1016/j.physbeh.2011.04.037; Hiiemae K, 1996, ARCH ORAL BIOL, V41, P175, DOI 10.1016/0003-9969(95)00112-3; Holman SD, 2013, DYSPHAGIA, V28, P178, DOI 10.1007/s00455-012-9427-8; Kim Dae Ha, 2012, Ann Rehabil Med, V36, P791, DOI 10.5535/arm.2012.36.6.791; Matsuo K, 2008, J APPL PHYSIOL, V104, P674, DOI 10.1152/japplphysiol.00527.2007; Palmer JB, 1998, ARCH PHYS MED REHAB, V79, P691, DOI 10.1016/S0003-9993(98)90046-6; PALMER J B, 1992, Dysphagia, V7, P187, DOI 10.1007/BF02493469; Peyron MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021167; Taniguchi H, 2013, DYSPHAGIA, V28, P419, DOI 10.1007/s00455-013-9453-1; THEXTON AJ, 1994, ARCH ORAL BIOL, V39, P599, DOI 10.1016/0003-9969(94)90136-8	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-051X	1432-0460		DYSPHAGIA	Dysphagia	DEC	2014	29	6					685	691		10.1007/s00455-014-9562-5		7	Otorhinolaryngology	Otorhinolaryngology	AU5CK	WOS:000345624500007		
J	Inokuchi, H; Gonzalez-Fernandez, M; Matsuo, K; Brodsky, MB; Yoda, M; Taniguchi, H; Okazaki, H; Hiraoka, T; Palmer, JB				Inokuchi, Haruhi; Gonzalez-Fernandez, Marlis; Matsuo, Koichiro; Brodsky, Martin B.; Yoda, Mitsumasa; Taniguchi, Hiroshige; Okazaki, Hideto; Hiraoka, Takashi; Palmer, Jeffrey B.			Electromyography of Swallowing with Fine Wire Intramuscular Electrodes in Healthy Human: Activation Sequence of Selected Hyoid Muscles	DYSPHAGIA			English	Article						Deglutition; Deglutition disorders; Electromyography; Electrodes; Rheology; Food; Spatiotemporal analysis	UPPER ESOPHAGEAL SPHINCTER; REFLEX PHARYNGEAL SWALLOW; SUPRAHYOID MUSCLES; FOOD CONSISTENCY; EMG ACTIVITY; BOLUS; PIG; JAW; STIMULATION; MUSCULATURE	Few studies have reported the activation sequence of the swallowing muscles in healthy human participants. We examined temporal characteristics of selected hyoid muscles using fine wire intramuscular electromyography (EMG). Thirteen healthy adults were studied using EMG of the anterior belly of digastric (ABD), geniohyoid (GH), sternohyoid (SH), and masseter (MA, with surface electrodes) while ingesting thin liquid, banana, tofu, and cookie (3 trials each). Onset timing was measured from rectified and integrated EMG. Data were analyzed using repeated-measures ANOVA with Bonferroni correction. When drinking thin liquid, MA, GH, and ABD were activated almost simultaneously, but SH was activated later (using GH onset as 0 s, MA -0.07 (-0.20 to 0.17) second [median (interquartile range)]; ABD 0.00 (-0.10 to 0.07) second; SH 0.17 (0.02 to 0.37) second; P < 0.01). With solid foods, MA contraction preceded GH and ABD; SH was last and delayed relative to liquid swallows (GH 0 s; MA -0.17 (-0.27 to 0.07) second; ABD 0.00 (-0.03 to 0.03) second; SH 0.37 (0.23 to 0.50) second; P < 0.01). The role of the MA differs between solids and liquids so the variation in its timing is expected. The synchronous contraction of GH and ABD was consistent with their role in hyolaryngeal elevation. The SH contracted later with solids, perhaps because if the longer duration of the swallow. The consistent pattern among foods supports the concept of a central pattern generator for pharyngeal swallowing.	[Inokuchi, Haruhi; Gonzalez-Fernandez, Marlis; Matsuo, Koichiro; Brodsky, Martin B.; Yoda, Mitsumasa; Taniguchi, Hiroshige; Okazaki, Hideto; Hiraoka, Takashi; Palmer, Jeffrey B.] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Inokuchi, Haruhi] Univ Tokyo, Dept Phys Med, Bunkyo Ku, Tokyo 1138655, Japan; [Matsuo, Koichiro] Fujita Hlth Univ, Dept Dent, Toyoake, Aichi, Japan; [Palmer, Jeffrey B.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Palmer, Jeffrey B.] Johns Hopkins Univ, Sch Med, Ctr Funct Anat & Evolut, Baltimore, MD 21205 USA; [Inokuchi, Haruhi] Univ Tokyo, Dept Rehabil Med, Bunkyo Ku, Tokyo 1138655, Japan	Inokuchi, H (reprint author), Univ Tokyo, Dept Rehabil Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	haruhi.konishi0415@gmail.com			NIH/NIDCD [R01-DC02123]	The late Dr. Karen Hiiemae contributed immensely to this work. We would like to thank Chune Yang for her extraordinary support and assistance. We appreciate the advices offered by Drs. Rebecca Z. German and Allan Thexton. This research was supported in part by NIH/NIDCD award No. R01-DC02123. We partially presented this study at the 17th and 18th Joint Annual Meeting of the Japanese Society of Dysphagia Rehabilitation, Sapporo, Japan, August 31-September 1, 2012.	Alkan Z, 2012, OTOLARYNG HEAD NECK, V147, P295, DOI 10.1177/0194599812439841; ANAPOL F, 1989, J EXP BIOL, V143, P1; German RZ, 2009, J NEUROPHYSIOL, V102, P1017, DOI 10.1152/jn.00100.2009; Thexton AJ, 2012, J APPL PHYSIOL, V112, P1512, DOI 10.1152/japplphysiol.00450.2011; Butler SG, 2009, J SPEECH LANG HEAR R, V52, P240, DOI 10.1044/1092-4388(2008/07-0092); Palmer PM, 1999, J SPEECH LANG HEAR R, V42, P1378; Taniguchi H, 2008, J APPL PHYSIOL, V105, P791, DOI 10.1152/japplphysiol.90485.2008; Saitoh E, 2007, DYSPHAGIA, V22, P100, DOI 10.1007/s00455-006-9060-5; Martin-Harris B, 2008, PHYS MED REHABIL CLI, V19, P769, DOI 10.1016/j.pmr.2008.06.004; Burnett TA, 2003, J APPL PHYSIOL, V94, P128, DOI 10.1152/japplphysiol.00406.2002; Vaiman M, 2004, OTOLARYNG HEAD NECK, V131, P548, DOI 10.1016/j.otohns.2004.03.013; Burnett TA, 2005, J NEUROPHYSIOL, V94, P4011, DOI 10.1152/jn.00025.2005; Celik M, 2005, LARYNGOSCOPE, V115, P138, DOI 10.1097/01.mlg.0000150690.85387.76; Coriolano MDWS, 2012, DYSPHAGIA, V27, P550, DOI 10.1007/s00455-012-9406-0; CROMPTON AW, 1975, NATURE, V258, P69, DOI 10.1038/258069a0; COOK IJ, 1989, AM J PHYSIOL, V257, pG748; Fitch WT, 2000, PHONETICA, V57, P205; GUYURON B, 1992, PLAST RECONSTR SURG, V90, P830, DOI 10.1097/00006534-199211000-00016; Guyuron B, 1992, PLAST RECONSTR SURG, V90, P838, DOI 10.1097/00006534-199211000-00017; Im Ikjae, 2012, Ann Rehabil Med, V36, P220, DOI 10.5535/arm.2012.36.2.220; Inagaki D, 2009, J ORAL REHABIL, V36, P176, DOI 10.1111/j.1365-2842.2008.01927.x; Konow N, 2010, J APPL PHYSIOL, V109, P439, DOI 10.1152/japplphysiol.00353.2010; Konow N, 2011, INTEGR COMP BIOL, V51, P235, DOI 10.1093/icb/icr040; Laitman Jeffrey T., 1993, Dysphagia, V8, P318, DOI 10.1007/BF01321770; Logemann JA, 1998, FOLIA PHONIATR LOGO, V50, P311, DOI 10.1159/000021473; Ohsawa S, 2001, ARCH PHYS MED REHAB, V82, P1737, DOI 10.1053/apmr.2001.26619; PALMER JB, 1989, ARCH PHYS MED REHAB, V70, P283; Palmer Jeffrey B., 1993, Dysphagia, V8, P209, DOI 10.1007/BF01354540; PALMER J B, 1992, Dysphagia, V7, P187, DOI 10.1007/BF02493469; PALMER JB, 1992, OTOLARYNG HEAD NECK, V106, P706; Palmer PM, 2005, DYSPHAGIA, V20, P210, DOI 10.1007/s00455-005-0017-x; PANCHERZ H, 1986, AM J ORTHOD DENTOFAC, V89, P122, DOI 10.1016/0002-9416(86)90088-6; Pearson WG, 2011, DYSPHAGIA, V26, P345, DOI 10.1007/s00455-010-9315-z; Sato K, 2009, ANN OTO RHINOL LARYN, V118, P30; SPIRO J, 1994, LARYNGOSCOPE, V104, P1376; Tamura Fumiyo, 2009, Int J Orofacial Myology, V35, P33; Thexton AJ, 2007, J APPL PHYSIOL, V102, P587, DOI 10.1152/japplphysiol.00456.2006; THEXTON AJ, 1994, ARCH ORAL BIOL, V39, P599, DOI 10.1016/0003-9969(94)90136-8; Vaiman M, 2009, HEAD FACE MED, V20, P9; Van Daele DJ, ANN OTOL RHINOL LARY, V114, P478	40	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-051X	1432-0460		DYSPHAGIA	Dysphagia	DEC	2014	29	6					713	721		10.1007/s00455-014-9566-1		9	Otorhinolaryngology	Otorhinolaryngology	AU5CK	WOS:000345624500010		
J	Nishihara, M				Nishihara, Michi			Preemptive investment game with alternative projects	ECONOMIC MODELLING			English	Article						Real options game; Options on multiple assets; Optimal stopping game; Max-option	REAL OPTIONS; IRREVERSIBLE INVESTMENT; DEVELOPMENT COMPETITION; STRATEGIC INVESTMENT; UNCERTAINTY; ASSETS; EQUILIBRIUM; DECISIONS; OLIGOPOLY; EXERCISE	This paper investigates a duopoly with two alternative investment projects. We examine a situation in which a firm cannot invest in any project that has been taken by the rival firm. The first mover's advantage in project choice leads to an equilibrium quite different from that in previous studies. Specifically, we show that in equilibrium, the investment time and the option value are between those in a duopoly with one project and a monopoly with one project. Moreover, we show that a high correlation between project values, unlike in a monopoly with two projects, plays a positive role in mitigating preemptive competition. The results complement the literature of real options games and of max-options and entail new empirical implications. (C) 2014 Elsevier B.V. All rights reserved.	Osaka Univ, Grad Sch Econ, Toyonaka, Osaka 5600043, Japan	Nishihara, M (reprint author), Osaka Univ, Grad Sch Econ, 1-7 Machikaneyama Cho, Toyonaka, Osaka 5600043, Japan.	nishihara@econ.osaka-u.ac.jp					Huisman KJM, 2003, EUR J OPER RES, V144, P209, DOI 10.1016/S0377-2217(01)00377-0; Decamps JP, 2006, ECON THEOR, V28, P425, DOI 10.1007/s00199-005-0629-2; Akdogu E, 2008, J FINANC QUANT ANAL, V43, P299; Weeds H, 2002, REV ECON STUD, V69, P729, DOI 10.1111/1467-937X.t01-1-00029; Nishihara M, 2010, J ECON MANAGE STRAT, V19, P1013, DOI 10.1111/j.1530-9134.2010.00276.x; Geltner D, 1996, J URBAN ECON, V39, P20, DOI 10.1006/juec.1996.0002; Grenadier SR, 2002, REV FINANC STUD, V15, P691, DOI 10.1093/rfs/15.3.691; Lambrecht B, 2003, J ECON DYN CONTROL, V27, P619, DOI 10.1016/S0165-1889(01)00064-1; Nishihara M, 2013, J BANK FINANC, V37, P1160, DOI 10.1016/j.jbankfin.2012.11.014; Bouis R, 2009, INT J IND ORGAN, V27, P320, DOI 10.1016/j.ijindorg.2008.10.003; Grenadier SR, 1996, J FINANC, V51, P1653, DOI 10.2307/2329533; Zhdanov A, 2007, J FINANC QUANT ANAL, V42, P709; Bobtcheff C, 2010, EUR J OPER RES, V206, P586, DOI 10.1016/j.ejor.2010.03.010; BOYLE PP, 1988, J FINANC QUANT ANAL, V23, P1, DOI 10.2307/2331019; Broadie M, 1997, MATH FINANC, V7, P241, DOI 10.1111/1467-9965.00032; Chevalier-Roignant B, 2011, EUR J OPER RES, V215, P639, DOI 10.1016/j.ejor.2011.05.038; Detemple J, 2006, AM STYLE DERIVATIVES; Huisman K. J. M., 2001, TECHNOLOGY INVESTMEN; Johnson H., 1987, J FINANCIAL QUANTITA, V22, P227; Jou JB, 2008, J FINANC QUANT ANAL, V43, P769; Miltersen K., 2004, EUR FINAN REV, V8, P355, DOI 10.1007/s10679-004-2543-z; Murto P, 2004, RAND J ECON, V35, P111, DOI 10.2307/1593732; Nishihara M, 2008, J OPER RES SOC JPN, V51, P55; Nishihara M., 2013, INT J MANAG SCI ENG, V8, P67; Nishihara M, 2012, J OPER RES SOC, V63, P107, DOI 10.1057/jors.2011.5; Pindyck R. S., 1994, INVESTMENT UNCERTAIN; Schwartz ES, 2007, REAL ESTATE ECON, V35, P1, DOI 10.1111/j.1540-6229.2007.00180.x; STULZ RM, 1982, J FINANC ECON, V10, P161, DOI 10.1016/0304-405X(82)90011-3; Villeneuve S., 1999, FINANC STOCH, V3, P295, DOI 10.1007/s007800050064	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0264-9993	1873-6122		ECON MODEL	Econ. Model.	DEC	2014	43						124	135		10.1016/j.econmod.2014.07.006		12	Economics	Business & Economics	AU7US	WOS:000345807300013		
J	Shibata, T				Shibata, Takashi			Market structure and R&D investment spillovers	ECONOMIC MODELLING			English	Article						Research and development (R&D); Oligopolistic market structure; R&D investment spillovers	RESEARCH JOINT VENTURES; COMPETITION; DUOPOLY	This paper examines research and development (R&D) investment spillovers across different market structures. In particular, we extend the recent work in Matsumura et al. (2013) to incorporate R&D investment spillovers. When the market is a duopoly, noncooperative (cooperative) R&D investment is preferred for small (large) spillovers of less (more) than half. We show that as a market structure becomes more competitive, noncooperative R&D investment is more likely to be preferred. Moreover, noncooperative R&D is not always decreasing with the intensity of competition, even though it is ultimately zero with perfect competition. Our theoretical results fit well with existing empirical findings. (C) 2014 Elsevier B.V. All rights reserved.	Tokyo Metropolitan Univ, Grad Sch Social Sci, Hachioji, Tokyo 1920397, Japan	Shibata, T (reprint author), Tokyo Metropolitan Univ, Grad Sch Social Sci, 1-1 Minami Osawa, Hachioji, Tokyo 1920397, Japan.	tshibata@tmu.ac.jp	Shibata, Takashi/J-6330-2014; 	Shibata, Takashi/0000-0001-9724-6469			Aghion P, 2005, Q J ECON, V120, P701, DOI 10.1093/qje/120.2.701; Matsumura T, 2013, ECON MODEL, V31, P541, DOI 10.1016/j.econmod.2012.12.016; BRANDER JA, 1983, BELL J ECON, V14, P225, DOI 10.2307/3003549; Brod A, 1999, J IND ECON, V47, P221; Amir R, 2000, INT J IND ORGAN, V18, P1013, DOI 10.1016/S0167-7187(00)00071-0; KAMIEN MI, 1992, AM ECON REV, V82, P1293; DASPREMONT C, 1988, AM ECON REV, V78, P1133; HENRIQUES I, 1990, AM ECON REV, V80, P638; DEBONDT R, 1992, INT J IND ORGAN, V10, P35, DOI 10.1016/0167-7187(92)90046-2; CYERT RM, 1973, AM ECON REV, V63, P24; De Bondt R., 1991, EUROPEAN J POLITICAL, V7, P345, DOI 10.1016/0176-2680(91)90018-X; Hinloopen J, 2000, RES EC, V54, P153, DOI 10.1006/reec.1999.0211; JAFFE AB, 1986, AM ECON REV, V76, P984; Miller N, 2002, MANAGERIAL DECISION, V23, P51, DOI 10.1002/mde.1045; Salant SW, 1998, INT J IND ORGAN, V16, P195; Schumpeter J, 1942, CAPITALISM SOCIALISM; SEADE J, 1980, J ECON THEORY, V23, P15, DOI 10.1016/0022-0531(80)90028-9; Shy O., 1995, IND ORG THEORY APPL; SUZUMURA K, 1992, AM ECON REV, V82, P1307; Symeonidis G, 2000, J ECON MANAGE STRAT, V9, P53, DOI 10.1162/105864000567792; Symeonidis G, 2008, J ECON MANAGE STRAT, V17, P247, DOI 10.1111/j.1530-9134.2008.00177.x	21	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0264-9993	1873-6122		ECON MODEL	Econ. Model.	DEC	2014	43						321	329		10.1016/j.econmod.2014.08.014		9	Economics	Business & Economics	AU7US	WOS:000345807300033		
J	Obata, Y; Kimura, S; Nakato, G; Iizuka, K; Miyagawa, Y; Nakamura, Y; Furusawa, Y; Sugiyama, M; Suzuki, K; Ebisawa, M; Fujimura, Y; Yoshida, H; Iwanaga, T; Hase, K; Ohno, H				Obata, Yuuki; Kimura, Shunsuke; Nakato, Gaku; Iizuka, Keito; Miyagawa, Yurika; Nakamura, Yutaka; Furusawa, Yukihiro; Sugiyama, Machiko; Suzuki, Keiichiro; Ebisawa, Masashi; Fujimura, Yumiko; Yoshida, Hisahiro; Iwanaga, Toshihiko; Hase, Koji; Ohno, Hiroshi			Epithelial-stromal interaction via Notch signaling is essential for the full maturation of gut-associated lymphoid tissues	EMBO REPORTS			English	Article						follicle-associated epithelium; gut-associated lymphoid tissues; intestinal epithelial cells; Notch signaling	LYMPHOTOXIN BETA-RECEPTOR; SUFFICIENT B-LYMPHOCYTES; FOLLICLE FORMATION; PEYERS-PATCHES; M-CELLS; ORGANOGENESIS; HOMEOSTASIS; MAINTENANCE; INTESTINE; RESPONSES	Intrinsic Notch signaling in intestinal epithelial cells restricts secretory cell differentiation. In gut-associated lymphoid tissue (GALT), stromal cells located beneath the follicle-associated epithelium (FAE) abundantly express the Notch ligand delta-like 1 (Dll1). Here, we show that mice lacking Rbpja gene encoding a transcription factor implicated in Notch signalingin intestinal epithelial cells have defective GALT maturation. This defect can be attributed to the expansion of goblet cells, which leads to the down-regulation of CCL20 in FAE. These data demonstrate that epithelial Notch signaling maintained by stromal cells contributes to the full maturation of GALT by restricting secretory cell differentiation in FAE.	[Obata, Yuuki; Nakamura, Yutaka; Furusawa, Yukihiro; Fujimura, Yumiko; Hase, Koji] Univ Tokyo, Int Res & Dev Ctr Mucosal Vaccines, Inst Med Sci, Div Mucosal Barriol, Tokyo, Japan; [Obata, Yuuki; Ohno, Hiroshi] Chiba Univ, Grad Sch Med & Pharmaceut Sci, Dept Immune Regulat, Chiba, Japan; [Obata, Yuuki; Nakato, Gaku; Ebisawa, Masashi; Ohno, Hiroshi] RIKEN, Ctr Integrat Med Sci, Lab Intestinal Ecosyst, Yokohama, Kanagawa, Japan; [Kimura, Shunsuke; Iwanaga, Toshihiko] Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Sapporo, Hokkaido, Japan; [Iizuka, Keito; Miyagawa, Yurika; Furusawa, Yukihiro; Fujimura, Yumiko; Hase, Koji] Keio Univ, Fac Pharm, Dept Biochem, Tokyo, Japan; [Sugiyama, Machiko; Yoshida, Hisahiro] RIKEN, Ctr Integrat Med Sci, Immunogenet Lab, Yokohama, Kanagawa, Japan; [Suzuki, Keiichiro] Kyoto Univ, Grad Sch Med, AK Project, Kyoto, Japan; [Hase, Koji] PRESTO, Japan Sci & Technol Agcy, Tokyo, Japan	Hase, K (reprint author), Univ Tokyo, Int Res & Dev Ctr Mucosal Vaccines, Inst Med Sci, Div Mucosal Barriol, Tokyo, Japan.	hase-kj@pha.keio.ac.jp; hiroshi.ohno@riken.jp	Ohno, Hiroshi/L-7899-2014; Kimura, Shunsuke/D-7093-2012	Ohno, Hiroshi/0000-0001-8776-9661; Kimura, Shunsuke/0000-0001-9408-2884	Japan Society for the Promotion of Science [24117723, 24249029, 252667]; Japan Science and Technology Agency; RIKEN RCAI Young Chief Investigator program; Uehara Memorial Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Toray Science Foundation; Takeda Science Foundation	This study was supported in part by grants from the Japan Society for the Promotion of Science (24117723 to KH, 24249029 to HO, and 252667 to YO), Japan Science and Technology Agency (KH), RIKEN RCAI Young Chief Investigator program (KH), Uehara Memorial Foundation (KH), Mochida Memorial Foundation for Medical and Pharmaceutical Research (KH), Toray Science Foundation (KH), and Takeda Science Foundation (HO).	Nishikawa SI, 2003, IMMUNOL REV, V195, P72, DOI 10.1034/j.1600-065X.2003.00063.x; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Rumbo M, 2004, GASTROENTEROLOGY, V127, P213, DOI 10.1053/j.gastro.2004.04.018; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hashi H, 2001, J IMMUNOL, V166, P3702; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Suzuki K, 2010, ADV IMMUNOL, V107, P153, DOI [10.1016/B978-0-12-381300-8.00006-X, 10.1016/S0065-277600)07003-3]; Lorenz RG, 2003, J IMMUNOL, V170, P5475; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Okuda M, 2007, J IMMUNOL, V179, P804; Honda K, 2001, J EXP MED, V193, P621, DOI 10.1084/jem.193.5.621; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Eberl G, 2009, MUCOSAL IMMUNOL, V2, P478, DOI 10.1038/mi.2009.114; Mach J, 2005, IMMUNOL REV, V206, P177, DOI 10.1111/j.0105-2896.2005.00281.x; McDonald KG, 2005, J IMMUNOL, V174, P5720; McDonald KG, 2007, AM J PATHOL, V170, P1229, DOI 10.2353/ajpath.2007.060817; Obata Y, 2012, J IMMUNOL, V188, P2427, DOI [10.4049/jimmunol.1101128, 10.4049/jimmunol.101128]; Varona R, 2001, J CLIN INVEST, V107, pR37, DOI 10.1172/JCI11297; Williams IR, 2004, IMMUNOL RES, V29, P283, DOI 10.1385/IR:29:1-3:283	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-221X	1469-3178		EMBO REP	EMBO Rep.	DEC	2014	15	12					1297	1304				8	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AU7FI	WOS:000345765800012		
J	Lee, KT; Wu, JCS; Brosse, N; Matsumura, Y				Lee, Keat Teong; Wu, Jeffrey C. S.; Brosse, Nicolas; Matsumura, Yukihiko			Editorial: Biofuels	ENERGY CONVERSION AND MANAGEMENT			English	Editorial Material									[Lee, Keat Teong] Univ Sains Malaysia, George Town, Malaysia; [Wu, Jeffrey C. S.] Natl Taiwan Univ, Taipei, Taiwan; [Brosse, Nicolas] Univ Lorraine, Lorraine, France; [Matsumura, Yukihiko] Hiroshima Univ, Hiroshima 730, Japan	Lee, KT (reprint author), Univ Sains Malaysia, George Town, Malaysia.		Matsumura, Yukihiko/D-5105-2011	Matsumura, Yukihiko/0000-0002-1341-0493				0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0196-8904	1879-2227		ENERG CONVERS MANAGE	Energy Conv. Manag.	DEC	2014	88						1077	1077		10.1016/j.enconman.2014.10.052		1	Thermodynamics; Energy & Fuels; Mechanics; Physics, Nuclear	Thermodynamics; Energy & Fuels; Mechanics; Physics	AU6PU	WOS:000345725400109		
J	Nittami, T; Speirs, LBM; Fukuda, J; Watanabe, M; Seviour, RJ				Nittami, Tadashi; Speirs, Lachlan B. M.; Fukuda, Junji; Watanabe, Masatoshi; Seviour, Robert J.			Fluorescence in situ hybridization probes targeting members of the phylum Candidatus Saccharibacteria falsely target Eikelboom type 1851 filaments and other Chloroflexi members	ENVIRONMENTAL MICROBIOLOGY REPORTS			English	Article							16S RIBOSOMAL-RNA; GREEN NONSULFUR BACTERIA; ACTIVATED-SLUDGE; OLIGONUCLEOTIDE PROBES; DIVISION TM7; IDENTIFICATION; ECOPHYSIOLOGY; ACCESSIBILITY; PHYSIOLOGY; PHYLOGENY	The FISH probe TM7-305 is thought to target the filamentous Eikelboom morphotype 0041 as a member of the Candidatus Saccharibacteria' (formerly TM7) phylum. However, with activated sludge samples in both Japan and Australia, this probe hybridized consistently with filamentous bacteria fitting the description of the morphotype 1851, which also responded positively to the CHL1851 FISH probe designed to target Chloroflexi members of this morphotype. 16S rRNA clone libraries from samples containing type 1851 TM7-305-positive filaments yielded Chloroflexi clones with high sequence similarity to Kouleothrix aurantiaca. These contained a variant TM7-305 probe target site possessing weakly destabilizing mismatches insufficient to prevent probe hybridization. Furthermore, the TM7-905 FISH probe, designed to target members of the entire Candidatus Saccharibacteria' phylum, also hybridized with the filament morphotypes 0041/0675, which responded also to the phylum level Chloroflexi probes. Many Chloroflexi sequences have only a single base mismatch to the TM7-905 probe target sequence. When competitor probes for both the TM7-305 and TM7-905 Chloroflexi non-target sites were applied, no fluorescent signal was seen in any of the filamentous organisms also hybridizing with the aforementioned Chloroflexi probes. These data indicate that these competitor probes must be included in hybridizations when both the TM7-905 and TM7-305 FISH probes are applied, to minimize potential false positive FISH results.	[Nittami, Tadashi; Fukuda, Junji; Watanabe, Masatoshi] Yokohama Natl Univ, Fac Engn, Div Mat Sci & Chem Engn, Yokohama, Kanagawa 240, Japan; [Speirs, Lachlan B. M.; Seviour, Robert J.] La Trobe Univ, Dept Microbiol, Bundoora, Vic 3086, Australia	Seviour, RJ (reprint author), La Trobe Univ, Dept Microbiol, Bundoora, Vic 3086, Australia.	r.seviour@latrobe.edu.au	Fukuda, Junji/B-9257-2011; 	Fukuda, Junji/0000-0002-7194-8099; Nittami, Tadashi/0000-0002-3338-7913	Japan Society for the Promotion of Science (JSPS) [23710087]; Australian Postgraduate Award PhD scholarship; La Trobe University	The authors thank the Environmental Planning Bureau of the Yokohama City Government for providing the activated sludge. Also, the authors wish to thank all other operators for supplying the biomass samples used in surveys conducted for this study. This research was supported by the Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Young Scientists (B) 23710087. The authors also thank Yokohama Academic Foundation for the partial support of this study. L.B.M. Speirs was a recipient of an Australian Postgraduate Award PhD scholarship, with additional funding by La Trobe University.	Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Kohno T, 2002, WATER SCI TECHNOL, V46, P111; Wagner M, 2003, CURR OPIN MICROBIOL, V6, P302, DOI 10.1016/S1369-5274(03)00054-7; Behrens S, 2003, APPL ENVIRON MICROB, V69, P1748, DOI 10.1128/AEM.69.3.1748-1758.2003; Gich F, 2001, ARCH MICROBIOL, V177, P1, DOI 10.1007/s00203-001-0354-6; Beer M, 2002, FEMS MICROBIOL LETT, V207, P179, DOI 10.1111/j.1574-6968.2002.tb11048.x; Brinig MM, 2003, APPL ENVIRON MICROB, V69, P1687, DOI 10.1128/AEM.69.3.1687-1694.2003; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Kuehbacher T, 2008, J MED MICROBIOL, V57, P1569, DOI 10.1099/jmm.0.47719-0; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593; Loy A, 2008, ENVIRON MICROBIOL, V10, P2894, DOI 10.1111/j.1462-2920.2008.01706.x; Kragelund C, 2007, FEMS MICROBIOL ECOL, V59, P671, DOI 10.1111/j.1574-6941.2006.00251.x; Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Nittami T, 2009, SYST APPL MICROBIOL, V32, P480, DOI 10.1016/j.syapm.2009.07.003; Fuchs BM, 1998, APPL ENVIRON MICROB, V64, P4973; Ferrari BC, 2005, APPL ENVIRON MICROB, V71, P8714, DOI 10.1128/AEM.71.12.8714-8720.2005; Yilmaz LS, 2011, APPL ENVIRON MICROB, V77, P1118, DOI 10.1128/AEM.01733-10; Martins AMP, 2004, WATER RES, V38, P793, DOI 10.1016/j.watres.2003.11.005; Ouverney CC, 2003, APPL ENVIRON MICROB, V69, P6294, DOI 10.1128/AEM.69.10.6294-6298.2003; Bjornsson L, 2002, MICROBIOL-SGM, V148, P2309; Kragelund C, 2011, FEMS MICROBIOL ECOL, V76, P451, DOI 10.1111/j.1574-6941.2011.01065.x; Cole JR, 2009, NUCLEIC ACIDS RES, V37, P141, DOI DOI 10.1093/NAR/GKN879; Daims H., 2005, MOL MICROBIAL ECOLOG, P213; Dinis JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021280; Jenkins D, 2004, MANUAL CAUSES CONTRO; Kragelund C, 2005, FEMS MICROBIOL ECOL, V54, P111, DOI 10.1016/j.femsec.2005.03.002; Kragelund C., 2009, FISH HDB BIOL WASTEW, P33; Lane D. J., 1991, NUCL ACID TECHNIQUES, V4, P115, DOI DOI 10.1002/JOBM.3620310616; McIlroy SJ, 2011, ENVIRON MICROBIOL, V13, P33, DOI 10.1111/j.1462-2920.2010.02306.x; McIlroy SJ, 2011, ENVIRON SCI TECHNOL, V45, P8794, DOI 10.1021/es2018576; Nielsen P. H., 2009, FISH HDB BIOL WASTEW; Rasband WS, 1997, IMAGEJ; Seviour R, 2010, MICROBIAL ECOLOGY OF ACTIVATED SLUDGE, P1; Thomsen TR, 2006, WATER SCI TECHNOL, V54, P237, DOI 10.2166/wst.2006.392; Thomsen TR, 2002, ENVIRON MICROBIOL, V4, P383, DOI 10.1046/j.1462-2920.2002.00316.x	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-2229			ENV MICROBIOL REP	Environ. Microbiol. Rep.	DEC	2014	6	6					611	617		10.1111/1758-2229.12172		7	Environmental Sciences; Microbiology	Environmental Sciences & Ecology; Microbiology	AU6GU	WOS:000345702700009		
J	Kuroki, M; Igarashi, Y; Ishii, M; Arai, H				Kuroki, Miho; Igarashi, Yasuo; Ishii, Masaharu; Arai, Hiroyuki			Fine-tuned regulation of the dissimilatory nitrite reductase gene by oxygen and nitric oxide in Pseudomonas aeruginosa	ENVIRONMENTAL MICROBIOLOGY REPORTS			English	Article							ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATOR; ANAEROBIC RESPIRATION; AEROBIC RESPIRATION; DNR; ANR; DENITRIFICATION; EXPRESSION; FNR; PROMOTER	Nitrite reductase (NIR) catalyses the reduction of nitrite to nitric oxide (NO) in the denitrification pathway. In Pseudomonas aeruginosa, expression of the gene encoding NIR (nirS) is induced by NO and is under control of the NO-sensing regulator DNR (dissimilatory nitrate respiration regulator). Because DNR is under control of the oxygen-sensing regulator ANR (anaerobic regulator of arginine deiminase and nitrate reductase), nirS is expressed only under low oxygen and anaerobic conditions. Both ANR and DNR are FNR (fumarate and nitrate reductase regulator)-type regulators and recognize the consensus FNR-binding motif. The motif of the nirS promoter is thought to be recognized only by DNR, and not by ANR. Here, mutant strains expressing either ANR or DNR were constructed and used to analyse the role of ANR and DNR in the activation of nirS expression. Analysis of transcriptional activity by microarray and quantitative reverse transcription polymerase chain reaction revealed that nirS is transcribed under low oxygen conditions in an ANR-dependent manner, although the expression level was 10-fold lower than that of the DNR-dependent expression. An artificial promoter containing the FNR-binding motif of the nirS promoter was also twofold upregulated by ANR. These results indicate that low-level expression of NIR in the presence of nitrite may provide NO as a trigger for the full expression of denitrification genes when oxygen is depleted.	[Kuroki, Miho; Igarashi, Yasuo; Ishii, Masaharu; Arai, Hiroyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Arai, H (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	aharai@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS)	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS).	Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; Savli H, 2003, J MED MICROBIOL, V52, P403, DOI 10.1099/jmm.0.05132-0; Arai H, 2005, J BACTERIOL, V187, P3960, DOI 10.1128/JB.187.12.3960-3968.2005; Rompf A, 1998, MOL MICROBIOL, V29, P985, DOI 10.1046/j.1365-2958.1998.00980.x; Toyofuku M, 2008, J BACTERIOL, V190, P7947, DOI 10.1128/JB.00968-08; Cooper M, 2003, MICROBIOL-SGM, V149, P1275, DOI 10.1099/mic.0.26017-0; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Giardina G, 2008, J MOL BIOL, V378, P1002, DOI 10.1016/j.jmb.2008.03.013; Pessi G, 2000, J BACTERIOL, V182, P6940, DOI 10.1128/JB.182.24.6940-6949.2000; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Unden G, 2002, J MOL MICROB BIOTECH, V4, P263; Choi KH, 2006, NAT PROTOC, V1, P153, DOI 10.1038/nprot.2006.24; Castiglione N, 2009, MICROBIOL-SGM, V155, P2838, DOI 10.1099/mic.0.028027-0; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Kakishima K, 2007, BIOCHEM BIOPH RES CO, V355, P587, DOI 10.1016/j.bbrc.2007.02.017; GAMPER M, 1991, J BACTERIOL, V173, P4742; ARAI H, 1995, FEBS LETT, V371, P73, DOI 10.1016/0014-5793(95)00885-D; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; FARINHA MA, 1990, J BACTERIOL, V172, P3496; Yoon SS, 2002, DEV CELL, V3, P593, DOI 10.1016/S1534-5807(02)00295-2; Arai H, 2013, BIOSCI BIOTECH BIOCH, V77, P111, DOI 10.1271/bbb.120601; Toyofuku M, 2007, J BACTERIOL, V189, P4969, DOI 10.1128/JB.00289-07; Arai H, 2003, MICROBIOL-SGM, V149, P29, DOI 10.1099/mic.0.25936-0; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Arai H, 2008, J BACTERIOL, V190, P286, DOI 10.1128/JB.01375-07; Arai H, 2013, BIOSCI BIOTECH BIOCH, V77, P198, DOI 10.1271/bbb.120656; Arai H, 1997, MOL MICROBIOL, V25, P1141, DOI 10.1046/j.1365-2958.1997.5431906.x; Hasegawa N, 1998, FEMS MICROBIOL LETT, V166, P213, DOI 10.1111/j.1574-6968.1998.tb13892.x; Kawakami T, 2010, ENVIRON MICROBIOL, V12, P1399, DOI 10.1111/j.1462-2920.2009.02109.x; Krieger R, 2002, MOL GENET GENOMICS, V267, P409, DOI 10.1007/s00438-002-0672-7; Sambrook J., 1989, MOL CLONING LAB MANU; SAWERS RG, 1991, MOL MICROBIOL, V5, P1469, DOI 10.1111/j.1365-2958.1991.tb00793.x; Schobert M, 2010, FUTURE MICROBIOL, V5, P603, DOI [10.2217/fmb.10.16, 10.2217/FMB.10.16]; Yoon SS, 2007, EMBO J, V26, P3662, DOI 10.1038/sj.emboj.7601787	37	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1758-2229			ENV MICROBIOL REP	Environ. Microbiol. Rep.	DEC	2014	6	6					792	801		10.1111/1758-2229.12212		10	Environmental Sciences; Microbiology	Environmental Sciences & Ecology; Microbiology	AU6GU	WOS:000345702700029		
J	Takiguchi, M; Yoshihisa, A; Miura, S; Shimizu, T; Nakamura, Y; Yamauchi, H; Iwaya, S; Owada, T; Miyata, M; Abe, S; Sato, T; Suzuki, S; Suzuki, H; Saitoh, S; Takeishi, Y				Takiguchi, Mai; Yoshihisa, Akiomi; Miura, Shunsuke; Shimizu, Takeshi; Nakamura, Yuichi; Yamauchi, Hiroyuki; Iwaya, Shoji; Owada, Takashi; Miyata, Makiko; Abe, Satoshi; Sato, Takamasa; Suzuki, Satoshi; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika			Impact of body mass index on mortality in heart failure patients	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION			English	Article						Adiponectin; body mass index; heart failure; right heart function; troponin T; tumour necrosis factor-alpha	RIGHT-VENTRICULAR FUNCTION; INDEPENDENT RISK-FACTOR; ACUTE CORONARY SYNDROME; CARDIAC CACHEXIA; CARDIOVASCULAR-DISEASE; PLASMA ADIPONECTIN; SERUM ADIPONECTIN; EUROPEAN-SOCIETY; OBESITY PARADOX; ELDERLY-MEN	BackgroundHigher body mass index (BMI) is associated with incident heart failure (HF), but paradoxically associated with better prognosis, recognized as the obesity paradox in HF. However, the impact of BMI on detailed prognosis on HF and the mechanism of obesity paradox remain still unclear. Materials and methodsWe researched consecutive 648 patients admitted for HF as follows: underweight (BMI<185kg/m(2), n=86), normal (185BMI<25, n=380), overweight (25BMI<30, n=147) and obese (30BMI, n=35) and compared the results from their laboratory tests and echocardiography. We also followed cardiac and all-cause mortality. ResultsObese group had a higher prevalence of obesity-related comorbidity (hypertension, diabetes, dyslipidemia); however, tumour necrosis factor-, adiponectin, troponin T and systolic pulmonary arterial pressure were higher in the underweight group than in the other groups (P<005, respectively). Left and right ventricular systolic function did not differ among the groups. In the Kaplan-Meier analysis, cardiac and all-cause mortality progressively increased from obese to overweight, normal and underweight group. Importantly, in the Cox proportional hazard analyses after adjusting for known risk factors, BMI was an independent predictor of cardiac and all-cause mortality (P<001, respectively) in HF patients. ConclusionsBody mass index was an independent predictor of cardiac death and all-cause mortality in HF patients. Furthermore, lower BMI was associated with higher circulating levels of tumour necrosis factor-, adiponectin and troponin T and higher systolic pulmonary arterial pressure.	[Takiguchi, Mai; Yoshihisa, Akiomi; Miura, Shunsuke; Shimizu, Takeshi; Nakamura, Yuichi; Yamauchi, Hiroyuki; Iwaya, Shoji; Owada, Takashi; Miyata, Makiko; Abe, Satoshi; Sato, Takamasa; Suzuki, Satoshi; Suzuki, Hitoshi; Saitoh, Shu-ichi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol & Hematol, Fukushima 9601295, Japan; [Yoshihisa, Akiomi; Suzuki, Satoshi; Takeishi, Yasuchika] Fukushima Med Univ, Dept Adv Cardiac Therapeut, Fukushima 9601295, Japan	Yoshihisa, A (reprint author), Fukushima Med Univ, Dept Cardiol & Hematol, 1 Hikarigaoka, Fukushima 9601295, Japan.	yoshihis@fmu.ac.jp			Japan Society for the Promotion of Science [25461061]; Japanese Ministry of Health, Labor, and Welfare, Tokyo, Japan	This study was supported in part by a grant-in-aid for Scientific Research (No. 25461061) from the Japan Society for the Promotion of Science and grants-in-aid from the Japanese Ministry of Health, Labor, and Welfare, Tokyo, Japan.	Abe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100618; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; McEntegart MB, 2007, EUR HEART J, V28, P829, DOI 10.1093/eurheartj/ehm033; Wilson SR, 2011, AM HEART J, V161, P1147, DOI 10.1016/j.ahj.2011.02.014; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Anker SD, 2003, LANCET, V361, P1077, DOI 10.1016/S0140-6736(03)12892-9; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Sandek A, 2007, J AM COLL CARDIOL, V50, P1561, DOI 10.1016/j.jacc.2007.07.016; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Kenchaiah S, 2007, CIRCULATION, V116, P627, DOI 10.1161/CIRCULATIONAHA.106.679779; Schulze PC, 2002, INT J CARDIOL, V85, P141, DOI 10.1016/S0167-5273(02)00243-7; Levey AS, 2006, ANN INTERN MED, V145, P247; Simera I, 2010, EUR J CLIN INVEST, V40, P35, DOI 10.1111/j.1365-2362.2009.02234.x; Ghio S, 2013, EUR J HEART FAIL, V15, P408, DOI 10.1093/eurjhf/hfs208; Wannamethee SG, 2007, ARCH INTERN MED, V167, P1510, DOI 10.1001/archinte.167.14.1510; White HD, 2011, J AM COLL CARDIOL, V57, P2406, DOI 10.1016/j.jacc.2011.01.029; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Anker SD, 1997, CIRCULATION, V96, P526; Melenovsky V, 2013, J AM COLL CARDIOL, V62, P1660, DOI 10.1016/j.jacc.2013.06.046; Anker SD, 1999, EUR HEART J, V20, P683, DOI 10.1053/euhj.1998.1446; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Fonarow GC, 2007, AM HEART J, V153, P74, DOI 10.1016/j.ahj.2006.09.007; Clark AL, 2012, AM J CARDIOL, V110, P77, DOI 10.1016/j.amjcard.2012.02.050; Kelley WE, 2009, CLIN CHEM, V55, P2098, DOI 10.1373/clinchem.2009.130799; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Tsutamoto T, 2007, EUR HEART J, V28, P1723, DOI 10.1093/eurheartj/ehm154; Efstathiou SP, 2005, STROKE, V36, P1915, DOI 10.1161/01.STR.0000177874.29849.f0; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Horwich TB, 2001, J AM COLL CARDIOL, V38, P789, DOI 10.1016/S0735-1097(01)01448-6; Ai M, 2011, ATHEROSCLEROSIS, V217, P543, DOI 10.1016/j.atherosclerosis.2011.05.035; Frystyk J, 2007, J CLIN ENDOCR METAB, V92, P571, DOI 10.1210/jc.2006-1067; Anker SD, 1999, CHEST, V115, P836, DOI 10.1378/chest.115.3.836; Berry C, 2000, EUR HEART J, V21, P521, DOI 10.1053/euhj.1999.1882; CARR JG, 1989, AM J CARDIOL, V63, P709, DOI 10.1016/0002-9149(89)90256-7; Florea VG, 2002, AM HEART J, V144, P45, DOI 10.1067/mhj.2002.123314; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lavie CJ, 2013, JACC-HEART FAIL, V1, P93, DOI 10.1016/j.jchf.2013.01.006; Libera Luciano Dalla, 2004, Curr Opin Clin Nutr Metab Care, V7, P435, DOI 10.1097/01.mco.0000134374.24181.5b; Nakamura Y, 2014, CIRC J, V78, P890, DOI 10.1253/circj.CJ-13-1372; PITTMAN JG, 1964, NEW ENGL J MED, V271, P403, DOI 10.1056/NEJM196408202710807; POEHLMAN ET, 1994, ANN INTERN MED, V121, P860; Shah R, 2014, J AM COLL CARDIOL, V63, P778, DOI 10.1016/j.jacc.2013.09.072; Szwejkowski BR, 2012, EUR J HEART FAIL, V14, P162, DOI 10.1093/eurjhf/hfr159	43	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2972	1365-2362		EUR J CLIN INVEST	Eur. J. Clin. Invest.	DEC	2014	44	12					1197	1205		10.1111/eci.12354		9	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	AU7CW	WOS:000345759100007		
J	Zai, H; Matsueda, K; Kusano, M; Urita, Y; Saito, Y; Kato, H				Zai, Hiroaki; Matsueda, Kei; Kusano, Motoyasu; Urita, Yoshihisa; Saito, Youichi; Kato, Hiroki			Effect of acotiamide on gastric emptying in healthy adult humans	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION			English	Article						C-13 breath test; acotiamide; gastric emptying	ACID BREATH TEST; PLACEBO-CONTROLLED TRIAL; FUNCTIONAL DYSPEPSIA; HYDROCHLORIDE Z-338; POSTPRANDIAL SYMPTOMS; THERAPEUTIC-EFFICACY; NITRIC-OXIDE; DOUBLE-BLIND; NIZATIDINE; SOLIDS	BackgroundAcotiamide is a first-in-class drug that is used to treat functional dyspepsia (FD). It is considered that acotiamide acts as an antagonist on muscarinic autoreceptors in the enteric nervous system and inhibits acetylcholinesterase activity. We examined the effect of acotiamide on gastric emptying in healthy adult humans. Materials and methodsTwelve healthy adult males were enrolled in this double-blind crossover study. Acotiamide or placebo was administered orally in the 12 subjects 30min before ingestion of a nutritional liquid meal (400Kcal/400mL). Six of the 12 participants took 100mg of acotiamide or placebo, and six of the 12 participants took 300mg of acotiamide or placebo in a double-blind crossover fashion. All subjects underwent measurement of gastric emptying by the C-13 breath test. ResultsAfter the meal with placebo was ingested, the %dose/h curve ascended. The %dose/h curve after a meal with 100 or 300mg of acotiamide ascended in an identical manner compared with the results with placebo. No significant differences were observed at any studied time point, and there were no significant changes in gastric emptying parameters (gastric emptying coefficient, t-1/2ex and t-lag ex). ConclusionsA single administration of 100 or 300mg of acotiamide did not affect gastric emptying after a liquid meal in healthy adult humans. Acotiamide has profound effects on restoring delayed gastric emptying and impaired accommodation in patients with FD but may have no effect on gastric emptying in healthy subjects. Such pharmacological actions have not been observed in previous gastroprokinetic studies.	[Zai, Hiroaki; Urita, Yoshihisa] Toho Univ, Sch Med, Fac Med, Dept Gen Med & Emergency Care, Tokyo, Japan; [Matsueda, Kei] Sakura Life Clin, Tokyo, Japan; [Kusano, Motoyasu] Gunma Univ Hosp, Dept Endoscopy & Endoscop Surg, Maebashi, Gumma, Japan; [Saito, Youichi; Kato, Hiroki] Zeria Pharmaceut Co Ltd, R&D, Tokyo, Japan	Zai, H (reprint author), Toho Univ, Omori Med Ctr, Dept Gen Med & Emergency Care, 6-11-1 Omori Nishi, Ota, Tokyo 1438541, Japan.	hiroaki.zai@med.toho-u.ac.jp			Zeria Pharmaceutical Co., Ltd	This study was supported by a grant from Zeria Pharmaceutical Co., Ltd. The authors especially thank the late Zen Itoh (Professor Emeritus of Gunma University) for his general supervision.	Adam B, 2009, GASTROENTEROLOGY, V136, pA535; Akaike Hironari, 2010, J Smooth Muscle Res, V46, P31; Kuiken SD, 2002, AM J GASTROENTEROL, V97, P1661; Kawachi M, 2011, EUR J PHARMACOL, V666, P218, DOI 10.1016/j.ejphar.2011.05.049; Nagahama K, 2012, NEUROGASTROENT MOTIL, V24, P566, DOI 10.1111/j.1365-2982.2012.01912.x; Talley NJ, 2000, ALIMENT PHARM THERAP, V14, P1653, DOI 10.1046/j.1365-2036.2000.00868.x; Hallerback BI, 2002, ALIMENT PHARM THERAP, V16, P959, DOI 10.1046/j.1365-2036.2002.01236.x; Vanheel H, 2013, NEUROGASTROENT MOTIL, V25, P911, DOI 10.1111/nmo.12227; Tack J, 2009, NEUROGASTROENT MOTIL, V21, P272, DOI 10.1111/j.1365-2982.2009.01261.x; Vanheel H, 2013, NAT REV GASTRO HEPAT, V10, P142, DOI 10.1038/nrgastro.2012.255; Kuiken SD, 2002, GUT, V51, P212, DOI 10.1136/gut.51.2.212; Teramoto H, 2012, EXP PHYSIOL, V97, P516, DOI 10.1113/expphysiol.2011.061457; Matsueda K, 2011, DIGESTION, V84, P261, DOI 10.1159/000332404; Sarnelli G, 2004, AM J PHYSIOL-GASTR L, V287, pG988, DOI 10.1152/ajpgi.00419.2003; Seto K, 2008, NEUROGASTROENT MOTIL, V20, P1051, DOI 10.1111/j.1365-2982.2008.01135.x; Matsueda K, 2012, GUT, V61, P821, DOI 10.1136/gutjnl-2011-301454; GHOOS YF, 1993, GASTROENTEROLOGY, V104, P1640; Farre R, 2013, GASTROENTEROLOGY, V145, P566, DOI 10.1053/j.gastro.2013.05.018; Azpiroz F, 2013, J GASTROENTEROL, V49, P206; Boeckxstaens GE, 2002, AM J GASTROENTEROL, V97, P40; Kusunoki H, 2012, NEUROGASTROENT MOTIL, V24, P540, DOI 10.1111/j.1365-2982.2012.01897.x; Kusunoki H, 2012, NEUROGASTROENT MOTIL, V24, pe250, DOI DOI 10.1111/J.1365-2982.2012.01897.X; MAES BD, 1994, GUT, V35, P333, DOI 10.1136/gut.35.3.333; Maes BD, 1998, GASTROENTEROLOGY, V114, P856, DOI 10.1016/S0016-5085(98)70608-0; MAES BD, 1995, ALIMENT PHARM THERAP, V9, P11; Maes BD, 1998, EUR J CLIN INVEST, V28, P197; Matsueda K, 2010, NEUROGASTROENT MOTIL, V22, P618, DOI 10.1111/j.1365-2982.2009.01449.x; Matsunaga Y, 2011, J PHARMACOL EXP THER, V336, P791, DOI 10.1124/jpet.110.174847; Parkman HP, 1998, DIGEST DIS SCI, V43, P497, DOI 10.1023/A:1018846604627; Tack J, 2013, NAT REV GASTRO HEPAT, V10, P134, DOI 10.1038/nrgastro.2013.14; Tack J, 2011, EXPERT OPIN INV DRUG, V20, P701, DOI 10.1517/13543784.2011.562890; Takeuchi K, 2000, WORLD J GASTROENTERO, V6, P651; UEKI S, 1993, J PHARMACOL EXP THER, V264, P152; Vanheel H, 2013, GUT, V63, P262; Zai H, 2009, DIGESTION, V79, P13, DOI 10.1159/000167861; Zarling EJ, 1999, CLIN THER, V21, P2038, DOI 10.1016/S0149-2918(00)87235-5	36	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2972	1365-2362		EUR J CLIN INVEST	Eur. J. Clin. Invest.	DEC	2014	44	12					1215	1221		10.1111/eci.12367		7	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	AU7CW	WOS:000345759100009		
J	Luo, L; Yamamoto, H				Luo, Lan; Yamamoto, Hisashi			Iron(II)-Catalyzed Asymmetric Epoxidation of Trisubstituted alpha,beta-Unsaturated Esters	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Synthetic methods; Asymmetric synthesis; Epoxidation; Enantioselectivity; Iron	HIGHLY ENANTIOSELECTIVE EPOXIDATION; ELECTRON-DEFICIENT OLEFINS; KETONES; COMPLEXES; CATALYSTS; ENONES	The asymmetric epoxidation of trisubstituted ,-unsaturated esters was developed. The oxidation utilizes a pseudo-C-2-symmetric iron(II) catalyst [Fe(L*)(2)(CH3CN)(OTf)](OTf) (Tf = trifluoromethylsulfonyl) and peracetic acid as oxidant and yields ,-epoxy esters with high enantiomeric purity (up to 99%ee).	[Luo, Lan; Yamamoto, Hisashi] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Yamamoto, Hisashi] Chubu Univ, Mol Catalyst Res Ctr, Kasugai, Aichi 4878501, Japan	Yamamoto, H (reprint author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	yamamoto@uchicago.edu	Yamamoto, Hisashi/G-6344-2011		US National Institutes of Health (NIH) [2R01GM068433]	This work was supported by the US National Institutes of Health (NIH) (2R01GM068433). The authors thank Dr. Yasuhiro Nishikawa for his preliminary experimental results. Dr. Antoni Jurkiewicz and Dr. Jin Qin are thanked for their assistance in NMR spectroscopy and mass spectrometry, respectively.	Corey EJ, 1999, ORG LETT, V1, P1287, DOI 10.1021/ol990964z; Wu XY, 2002, J AM CHEM SOC, V124, P8792, DOI 10.1021/ja020478y; Diez D, 2008, CURR ORG SYNTH, V5, P186, DOI 10.2174/157017908785133429; Porter MJ, 2000, CHEM COMMUN, P1215, DOI 10.1039/b001780i; Cusso O, 2013, J AM CHEM SOC, V135, P14871, DOI 10.1021/ja4078446; Gelalcha FG, 2014, ADV SYNTH CATAL, V356, P261, DOI 10.1002/adsc.201300716; CHANG SB, 1994, J AM CHEM SOC, V116, P6937, DOI 10.1021/ja00094a059; KATSUKI T, 1980, J AM CHEM SOC, V102, P5974, DOI 10.1021/ja00538a077; Arai S, 1998, TETRAHEDRON LETT, V39, P7563, DOI 10.1016/S0040-4039(98)01646-3; Lygo B, 1998, TETRAHEDRON LETT, V39, P1599, DOI 10.1016/S0040-4039(97)10779-1; Nishikawa Y, 2011, J AM CHEM SOC, V133, P8432, DOI 10.1021/ja201873d; JULIA S, 1980, ANGEW CHEM INT EDIT, V19, P929, DOI 10.1002/anie.198009291; ZHANG W, 1990, J AM CHEM SOC, V112, P2801, DOI 10.1021/ja00163a052; Bougauchi M, 1997, J AM CHEM SOC, V119, P2329, DOI 10.1021/ja964037o; Elston C. L., 1997, ANGEW CHEM, V109, P379, DOI 10.1002/ange.19971090414; Elston CL, 1997, ANGEW CHEM INT EDIT, V36, P410, DOI 10.1002/anie.199704101; Enders D, 1996, ANGEW CHEM INT EDIT, V35, P1725, DOI 10.1002/anie.199617251; Enders D., 1996, ANGEW CHEM, V108, P1827, DOI 10.1002/ange.19961081530; Julia S., 1980, ANGEW CHEM, V92, P968, DOI 10.1002/ange.19800921137; Kakei H, 2005, J AM CHEM SOC, V127, P8962, DOI 10.1021/ja052466t; Weiss KM, 2011, CHEM REC, V11, P18, DOI 10.1002/tcr.201000006	21	2	2	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	DEC	2014		35					7803	7805		10.1002/ejoc.201403220		3	Chemistry, Organic	Chemistry	AU8DL	WOS:000345826600007		
J	Horino, Y; Takahashi, Y; Kobayashi, R; Abe, H				Horino, Yoshikazu; Takahashi, Yu; Kobayashi, Ryota; Abe, Hitoshi			Palladium-Catalyzed Cyclopropanation of Strained Alkenes with 3-Pinacolatoboryl-1-arylallyl Carboxylates	EUROPEAN JOURNAL OF ORGANIC CHEMISTRY			English	Article						Cyclopropanation; Palladium; Carbenoids; Isomerization	BIS-PI-ALLYLPALLADIUM; TRANSITION-METAL CHEMISTRY; ASYMMETRIC ALLYLATION; ALLYLIC ALCOHOLS; CYCLOADDITION REACTIONS; AMPHIPHILIC ALLYLATION; COMPLEXES; ACETATES; HETEROCYCLES; ALDEHYDES	The palladium-catalyzed cyclopropanation of strained alkenes with 3-pinacolatoboryl-1-arylallyl carboxylates was explored. The reactions proceeded smoothly under mild conditions, and the cyclopropanation products were obtained in good to high yields with high diastereoselectivities if CsF, 18-crown-6, and molecular sieves were used as additives. The reaction was hypothesized to proceed through the formation of a putative palladacyclobutene intermediate that needed to be considered to explain the observed stereochemistry.	[Horino, Yoshikazu; Takahashi, Yu; Kobayashi, Ryota; Abe, Hitoshi] Toyama Univ, Grad Sch Sci & Engn, Dept Appl Chem, Gofu Ku, Toyama 930855, Japan	Horino, Y (reprint author), Toyama Univ, Grad Sch Sci & Engn, Dept Appl Chem, Gofu Ku, Toyama 930855, Japan.	horino@eng.u-toyama.ac.jp			Japan Society for the Promotion of Science [24550115]	This work was financially supported by the Japan Society for the Promotion of Science through a Grant-in-Aid for Scientific Research (C) (grant number 24550115).	Nakamura H, 1996, J AM CHEM SOC, V118, P6641, DOI 10.1021/ja9608858; Tamaru Y, 1999, J ORGANOMET CHEM, V576, P215, DOI 10.1016/S0022-328X(98)01060-2; Clavier H, 2013, ADV SYNTH CATAL, V355, P403, DOI 10.1002/adsc.201200903; KEINAN E, 1983, J ORG CHEM, V48, P1769, DOI 10.1021/jo00158a038; Chen SF, 2008, TETRAHEDRON LETT, V49, P6781, DOI 10.1016/j.tetlet.2008.09.024; Zanoni G, 2004, ANGEW CHEM INT EDIT, V43, P846, DOI 10.1002/anie.200352743; Mecking S, 1996, ORGANOMETALLICS, V15, P2650, DOI 10.1021/om960061z; Khanna A, 2013, ORG LETT, V15, P3158, DOI 10.1021/ol401383m; TROST BM, 1989, J AM CHEM SOC, V111, P4430, DOI 10.1021/ja00194a043; TROST BM, 1977, TETRAHEDRON, V33, P2615, DOI 10.1016/0040-4020(77)80284-6; Kimura M, 2000, TETRAHEDRON LETT, V41, P3627, DOI 10.1016/S0040-4039(00)00429-9; Weaver JD, 2011, CHEM REV, V111, P1846, DOI 10.1021/cr1002744; Aggarwal VK, 2001, ORG LETT, V3, P2785, DOI 10.1021/ol0164177; Trepanier VE, 2007, ORGANOMETALLICS, V26, P30, DOI 10.1021/om0609416; TAKAHARA JP, 1992, J AM CHEM SOC, V114, P2577, DOI 10.1021/ja00033a034; Noguchi H, 2008, ORG LETT, V10, P377, DOI 10.1021/ol702420x; Walter MD, 2009, J AM CHEM SOC, V131, P9055, DOI 10.1021/ja9025598; Trost BM, 1996, CHEM REV, V96, P395, DOI 10.1021/cr9409804; Doyle MP, 2002, J ORG CHEM, V67, P602, DOI 10.1021/jo016135k; Horino Y, 2014, ORG LETT, V16, P3184, DOI 10.1021/ol501643x; Araki S, 2000, ORG LETT, V2, P847, DOI 10.1021/ol005610i; Nakamura K, 1999, J ORG CHEM, V64, P2614, DOI 10.1021/jo9901081; TROST BM, 1979, J AM CHEM SOC, V101, P6429, DOI 10.1021/ja00515a046; Lautens M, 1996, CHEM REV, V96, P49, DOI 10.1021/cr950016l; Zhu SF, 2005, ORG LETT, V7, P2333, DOI 10.1021/ol050556x; Noguchi H, 2007, J AM CHEM SOC, V129, P758, DOI 10.1021/ja067975p; OHE K, 1993, J ORG CHEM, V58, P1173, DOI 10.1021/jo00057a033; Ohno H, 2004, J AM CHEM SOC, V126, P8744, DOI 10.1021/ja048693x; Horino Y, 2012, ADV SYNTH CATAL, V354, P828, DOI 10.1002/adsc.201100806; Sha SC, 2013, J AM CHEM SOC, V135, P17602, DOI 10.1021/ja409511n; Genady AR, 2011, ORG BIOMOL CHEM, V9, P7180, DOI 10.1039/c1ob05952a; Trost BM, 2006, J AM CHEM SOC, V128, P13328, DOI 10.1021/ja0640750; Kimura M, 2003, ANGEW CHEM INT EDIT, V42, P3392, DOI 10.1002/anie.200351182; Rubin M, 2007, CHEM REV, V107, P3117, DOI 10.1021/cr050988l; Shintani R, 2007, ANGEW CHEM INT EDIT, V46, P5901, DOI 10.1002/anie.200701529; Ohtaka M, 2004, TETRAHEDRON LETT, V45, P7339, DOI 10.1016/j.tetlet.2004.08.008; Trost BM, 2003, CHEM REV, V103, P2921, DOI 10.1021/cr020027w; CASTANET Y, 1979, TETRAHEDRON LETT, P3221; del Amo JC, 2004, ORGANOMETALLICS, V23, P5021, DOI 10.1021/om049455d; den Hartog T, 2014, ORG LETT, V16, P1100, DOI 10.1021/ol403695b; DOYLE MP, 1984, TETRAHEDRON LETT, V25, P4087, DOI 10.1016/S0040-4039(01)90188-1; GomezBengoa E, 1997, ANGEW CHEM INT EDIT, V36, P767, DOI 10.1002/anie.199707671; Gomez-Bengoa E., 1997, ANGEW CHEM, V109, P795, DOI 10.1002/ange.19971090727; Kimura M., 2003, ANGEW CHEM, V115, P3514, DOI 10.1002/ange.200351182; Labrosse JR, 2003, EUR J ORG CHEM, P2813, DOI 10.1002/ejoc.200300071; Nakamura H, 1998, J AM CHEM SOC, V120, P4242, DOI 10.1021/ja973540d; Nakamura H, 1997, J AM CHEM SOC, V119, P8113, DOI 10.1021/ja971599e; Nakamura H, 2001, J AM CHEM SOC, V123, P372, DOI 10.1021/ja002931g; Nakamura H, 2011, TETRAHEDRON LETT, V52, P426, DOI 10.1016/j.tetlet.2010.11.082; Nakamura I, 2003, J ORG CHEM, V68, P2297, DOI 10.1021/jo0268431; OHE K, 1990, J AM CHEM SOC, V112, P9646, DOI 10.1021/ja00182a038; Ohno H, 2008, ORG LETT, V10, P1171, DOI 10.1021/ol800063d; Ohno H., 2003, ANGEW CHEM, V115, P1791, DOI 10.1002/ange.200250589; Ohno H, 2003, ANGEW CHEM INT EDIT, V42, P1749, DOI 10.1002/anie.200250589; Sebelius S, 2003, ORG LETT, V5, P3065, DOI 10.1021/ol035052i; Shintani R., 2007, ANGEW CHEM, V119, P6005, DOI 10.1002/ange.200701529; Shukla KH, 2008, J ORG CHEM, V73, P6283, DOI 10.1021/jo8010254; Solin N., 2003, ANGEW CHEM, V115, P3784, DOI 10.1002/ange.200351477; Solin N, 2003, ANGEW CHEM INT EDIT, V42, P3656, DOI 10.1002/anie.2003511477; Solin N, 2005, ORG LETT, V7, P689, DOI 10.1021/ol0475010; Szabo KJ, 2014, PINCER AND PINCER-TYPE COMPLEXES: APPLICATIONS IN ORGANIC SYNTHESIS AND CATALYSIS, P95; Tanioka Y, 2014, J ORG CHEM, V79, P5301, DOI 10.1021/jo500357f; TROST BM, 1977, J AM CHEM SOC, V99, P1649, DOI 10.1021/ja00447a064; TROST BM, 1983, J AM CHEM SOC, V105, P5942, DOI 10.1021/ja00356a052; TSUJI J, 1969, ACCOUNTS CHEM RES, V2, P144, DOI 10.1021/ar50017a003; Tsukada N, 2000, TETRAHEDRON LETT, V41, P4181, DOI 10.1016/S0040-4039(00)00600-6; Tsukada N, 2000, ORG LETT, V2, P655, DOI 10.1021/ol991406n; Wallner OA, 2002, ORG LETT, V4, P1563, DOI 10.1021/ol0257777; Yamamoto Y, 2005, TOP ORGANOMETAL CHEM, V14, P211; Yoshida M, 2005, TETRAHEDRON LETT, V46, P3669, DOI 10.1016/j.tetlet.2005.03.138; Yoshida M, 2010, TETRAHEDRON, V66, P2675, DOI 10.1016/j.tet.2010.02.023; Zanoni G., 2004, ANGEW CHEM, V116, P864, DOI 10.1002/ange.200352743	72	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-193X	1099-0690		EUR J ORG CHEM	Eur. J. Org. Chem.	DEC	2014		35					7818	7822		10.1002/ejoc.201403284		5	Chemistry, Organic	Chemistry	AU8DL	WOS:000345826600011		
J	Ito, Y; Kawamoto, T; Moriyama, K				Ito, Yosuke; Kawamoto, Tatsuo; Moriyama, Keiji			The orthopaedic effects of bone-anchored maxillary protraction in a beagle model	EUROPEAN JOURNAL OF ORTHODONTICS			English	Article							CLASS-III MALOCCLUSION; FACEMASK THERAPY; 3-DIMENSIONAL ASSESSMENT; SKELETAL ANCHORAGE; EXPANSION; TRACTION; IMPLANTS; GROWTH; MASK	BACKGROUND/OBJECTIVES: The purpose of this study was to establish an animal model of bone-anchored maxillary protraction (BAMP) and verify the effects of such treatment in this model. SUBJECTS/METHODS: Ten total immature (90-day-old) male beagle dogs were used. On Day -20, one miniplate per jaw quadrant was placed and secured with screws. From Day 0 to Day 60, miniplates in the dogs in the intermaxillary traction group (group T, n = 5) were loaded with coil springs. In the control group (group C, n = 5), the miniplates received no force. Every 20 days from Day -20, all dogs were assessed by measuring body weight, taking photographs, and acquiring standardized lateral cephalometric radiographs using a specially designed cephalostat. Cephalometric analyses were performed and the two groups compared. New bone formation was labelled by double-fluorochrome administration with calcein and tetracycline. Animals were sacrificed at Day 60, and bone sections of zygomaticomaxillary sutures were analysed using histomorphometry with fluorescence microscopy. Groups were compared with Mann-Whitney U-tests (P < 0.05). RESULTS: Cephalometric analysis indicated significant maxillary advancement and retroclination of maxillary incisors in group T, with concomitant significant posterior relocation of the condyles and proclination of the mandibular incisors. In histological analysis, vigorous bone apposition at the zygomaticomaxillary suture was only detected in group T. LIMITATIONS: Further histological studies would clarify the effects of BAMP on the mandible, especially on temporomandibular articulation. CONCLUSIONS/IMPLICATIONS: Our results, using this newly developed animal model, support the orthopaedic effects of BAMP.	[Ito, Yosuke; Kawamoto, Tatsuo; Moriyama, Keiji] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial Reconstruct & Funct, Sect Maxillofacial Orthognath, Tokyo 1138549, Japan	Kawamoto, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial Reconstruct & Funct, Sect Maxillofacial Orthognath,Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.	t-kawamoto.mort@tmd.ac.jp			Japanese Ministry of Education, The Global Center of Excellence Program, 'International Research Center for Molecular Science in Tooth and Bone Diseases'; Ministry of Education, Culture, Sports, Science and Technology of Japan [21592592, 23390471, 25893072]	Japanese Ministry of Education, The Global Center of Excellence Program, 'International Research Center for Molecular Science in Tooth and Bone Diseases'; Grants-in-Aid for Scientific Research, The Ministry of Education, Culture, Sports, Science and Technology of Japan (21592592, 23390471, 25893072).	De Clerck H, 2010, AM J ORTHOD DENTOFAC, V138, P577, DOI 10.1016/j.ajodo.2009.10.037; Kircelli BH, 2008, AM J ORTHOD DENTOFAC, V133, P440, DOI 10.1016/j.ajodo.2007.06.011; Heymann GC, 2010, AM J ORTHOD DENTOFAC, V137, P274, DOI 10.1016/j.ajodo.2009.07.009; GUYER EC, 1986, ANGLE ORTHOD, V56, P7; Cevidanes L, 2010, ANGLE ORTHOD, V80, P799, DOI 10.2319/111709-651.1; Singer SL, 2000, ANGLE ORTHOD, V70, P253; Sugawara J, 2004, AM J ORTHOD DENTOFAC, V125, P130, DOI 10.1016/S0889-5406(03)00682-6; Nguyen T, 2011, AM J ORTHOD DENTOFAC, V140, P790, DOI 10.1016/j.ajodo.2011.04.025; De Clerck H, 2012, AM J ORTHOD DENTOFAC, V142, P25, DOI 10.1016/j.ajodo.2012.01.017; Enacar A, 2003, AM J ORTHOD DENTOFAC, V123, P571, DOI 10.1016/S0889-5406(03)00052-0; Kama JD, 2006, EUR J ORTHODONT, V28, P496, DOI 10.1093/ejo/cjl011; Turley PK, 2002, AM J ORTHOD DENTOFAC, V122, P349, DOI 10.1067/mod.2002.127295; PARFITT AM, 1987, J BONE MINER RES, V2, P595; JACOBSON A, 1974, AM J ORTHOD DENTOFAC, V66, P140, DOI 10.1016/0002-9416(74)90233-4; De Clerck HJ, 2009, J ORAL MAXIL SURG, V67, P2123, DOI 10.1016/j.joms.2009.03.007; Cornelis MA, 2008, J ORAL MAXIL SURG, V66, P1439, DOI 10.1016/j.joms.2008.01.037; Gallagher RW, 1998, AM J ORTHOD DENTOFAC, V113, P612, DOI 10.1016/S0889-5406(98)70220-3; ROBERTS WE, 1989, ANGLE ORTHOD, V59, P247; Baik HS, 1995, AM J ORTHOD DENTOFAC, V108, P583, DOI 10.1016/S0889-5406(95)70003-X; Battagel J M, 1993, Eur J Orthod, V15, P347; Coben S E, 1955, AM J ORTHOD, V41, P407, DOI 10.1016/0002-9416(55)90153-6; Dahlberg G, 1940, STAT METHODS MED BIO; De Clerck Hugo, 2002, J Clin Orthod, V36, P455; Deguchi T, 2011, CLIN IMPLANT DENT R, V13, P197, DOI 10.1111/j.1708-8208.2009.00197.x; DOWNS WB, 1948, AM J ORTHOD DENTOFAC, V34, P812, DOI 10.1016/0002-9416(48)90015-3; HOUSTON WJB, 1983, AM J ORTHOD DENTOFAC, V83, P382, DOI 10.1016/0002-9416(83)90322-6; Kim S, 2008, AM J ORTHOD DENTOFAC, V133; LOSKEN A, 1994, CLEFT PALATE-CRAN J, V31, P17, DOI 10.1597/1545-1569(1994)031<0017:CCSONC>2.3.CO;2; Onar V, 1999, ANAT HISTOL EMBRYOL, V28, P253, DOI 10.1046/j.1439-0264.1999.00202.x; Ricketts RM, 1960, ANGLE ORTHOD, V30, P103; Stalmans K, 2003, Orthod Craniofac Res, V6, P104, DOI 10.1034/j.1600-0854.2003. c250.x; TWEED CH, 1946, AM J ORTHOD ORAL SUR, V32, P175, DOI 10.1016/0096-6347(46)90001-4; Vande Vannet Bart, 2007, Eur J Orthod, V29, P437, DOI 10.1093/ejo/cjm078; Wang Y, 2006, J CRANIOFAC SURG, V17, P68, DOI 10.1097/01.scs.0000188343.75870.d4	34	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0141-5387	1460-2210		EUR J ORTHODONT	Eur. J. Orthodont.	DEC	2014	36	6					632	640		10.1093/ejo/cjt083		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AU9DF	WOS:000345891100003		
J	Suzuki, E; Kashima, S; Kawachi, I; Subramanian, SV				Suzuki, Etsuji; Kashima, Saori; Kawachi, Ichiro; Subramanian, S. V.			Prefecture-level economic conditions and risk of suicide in Japan: a repeated cross-sectional analysis 1975-2010	EUROPEAN JOURNAL OF PUBLIC HEALTH			English	Article							INCOME INEQUALITY; HEALTH; EPIDEMIOLOGY; GENERATION; PREVENT; AREA	Background: Geographical inequalities in suicide have risen dramatically across 47 prefectures in Japan since 1995. We sought to examine temporal changes in the associations between prefecture-level economic conditions and completed suicide during the recent 35 years, controlling for individual composition in each prefecture. Methods: Based on quinquennial vital statistics and census data from 1975 to 2010, we analysed the entire population aged 25-64 years. The total number of suicides was 87 553 men and 34 559 women. As indicators of prefecture-level economic conditions, we used average yearly income, average savings and income inequality (measured by Gini coefficients for yearly income). For each sex, we estimated odds ratios and 95% credible intervals for suicide using multilevel logistic regression models, with cells at level 1, years at level 2 and prefectures at level 3. Results: Even after adjusting for individual age, occupation and time trends, low average savings at prefecture level were associated with a higher risk of suicide among men (odds ratio in low vs. high savings: 1.13, 95% credible interval: 1.05-1.21), whereas no clear patterns were observed with other economic indicators. When we further examined the associations in year-specific models by conducting a two-level analysis, both average yearly income and average savings were inversely associated with suicide risk in recent years. No clear association was found between income inequality and suicide risk for either sex. Conclusion: The present findings suggest that low area socioeconomic status may be driving the growing geographical inequalities in suicide in Japan, primarily among men.	[Suzuki, Etsuji] Okayama Univ, Dept Epidemiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Kashima, Saori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Kawachi, Ichiro; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	Suzuki, E (reprint author), 2-5-1 Shikata Cho,Kita Ku, Okayama 7008558, Japan.	etsuji-s@cc.okayama-u.ac.jp			The Okayama Medical Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Robert Wood Johnson Investigator Award in Health Policy Research	This work was supported by The Okayama Medical Foundation and Grant-in-Aid for Scientific Research, Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. SVS was supported by a Robert Wood Johnson Investigator Award in Health Policy Research.	Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Cummins S, 2005, HEALTH PLACE, V11, P249, DOI 10.1016/j.healthplace.2004.05.003; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Knox KL, 2004, AM J PUBLIC HEALTH, V94, P37, DOI 10.2105/AJPH.94.1.37; Li ZY, 2011, SOC SCI MED, V72, P608, DOI 10.1016/j.socscimed.2010.11.008; Yoshimasu Kouichi, 2008, Environmental Health and Preventive Medicine, V13, P243, DOI 10.1007/s12199-008-0037-x; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Dejong TM, 2010, J AFFECT DISORDERS, V124, P90, DOI 10.1016/j.jad.2009.10.020; Merlo J, 2009, J EPIDEMIOL COMMUN H, V63, P1043, DOI 10.1136/jech.2009.088310; Riva M, 2007, J EPIDEMIOL COMMUN H, V61, P853, DOI 10.1136/jech.2006.050740; Maris RW, 2002, LANCET, V360, P319, DOI 10.1016/S0140-6736(02)09556-9; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Chen YY, 2012, EPIDEMIOL REV, V34, P129, DOI 10.1093/epirev/mxr025; Rehkopf DH, 2006, PSYCHOL MED, V36, P145, DOI 10.1017/S003329170500588X; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Subramanian SV, 2001, ENVIRON PLANN A, V33, P399, DOI 10.1068/a3357; Windfuhr K, 2011, INTERNATIONAL HANDBOOK OF SUICIDE PREVENTION: RESEARCH, POLICY AND PRACTICE, P27; Kelly BD, 2009, SOC PSYCH PSYCH EPID, V44, P971, DOI 10.1007/s00127-009-0018-4; Browne WJ, 2012, MCMC ESTIMATION MLWI; Cabinet Office Government of Japan, PREF ACC; Chen J, 2009, JPN WORLD ECON, V21, P140, DOI 10.1016/j.japwor.2008.06.001; Durkheim E., 1951, SUICIDE STUDY SOCIOL; Fukuda Y, 2005, INT J EPIDEMIOL, V34, P100; Fushimi M, 2006, PSYCHIAT CLIN NEUROS, V60, P289, DOI 10.1111/j.1440-1819.2006.01504.x; Hasegawa T., 2001, CHALLENGING INEQUITI, P90; Hendin H., 2008, SUICIDE SUICIDE PREV, P7; Inagaki K, 2010, J APPL ECON, V13, P113; Ministry of Health Labour and Welfare Japan, 2013, OUTL VIT STAT JAP; Ministry of Health Labour and Welfare Japan, REP VIT STAT OCC IND; Naess O, 2010, SCAND J PUBLIC HEALT, V38, P119, DOI 10.1177/1403494810384646; Okamoto M, 2013, ENVIRON HEALTH PREV, V18, P306, DOI 10.1007/s12199-012-0321-7; Patel V, 2010, INT J EPIDEMIOL, V39, P1411, DOI 10.1093/ije/dyq199; Platt S, 2011, INTERNATIONAL HANDBOOK OF SUICIDE PREVENTION: RESEARCH, POLICY AND PRACTICE, P211; Rasbash J, 2013, MLWIN VERSION 2 27; Raudenbush S. W., 2002, HIERARCHICAL LINEAR; Statistics Bureau Ministry of Internal Affairs and Communications, NAT SURV FAM INC EXP; Statistics Bureau Ministry of Internal Affairs and Communications Japan, JAP STAND OCC CLASS; Statistics Bureau Ministry of Internal Affairs and Communications Japan, POP CENS; Suzuki E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063443; Tollefsen IM, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-9	40	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1101-1262	1464-360X		EUR J PUBLIC HEALTH	Eur. J. Public Health	DEC	2014	24	6					949	954		10.1093/eurpub/cku023		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AU9EB	WOS:000345893200017		
J	Kajiya, K; Matsumoto-Okazaki, Y; Sawane, M; Fukada, K; Takasugi, Y; Akai, T; Saito, N; Mori, Y				Kajiya, Kentaro; Matsumoto-Okazaki, Yuko; Sawane, Mika; Fukada, Kaedeko; Takasugi, Yuya; Akai, Tomonori; Saito, Naoki; Mori, Yuichiro			Electric current-induced lymphatic activation	EXPERIMENTAL DERMATOLOGY			English	Article						calcium influx; direct current; lymphatic	MOLECULAR-MECHANISMS; FIELDS; CELLS	The lymphatic system in skin plays important roles in drainage of wastes and in the afferent phase of immune response. We previously showed that activation of vascular endothelial growth factor receptor (VEGFR), specifically the VEGFC/VEGFR-3 pathway, attenuates oedema and inflammation by promoting lymphangiogenesis, suggesting a protective role of lymphatic vessels against skin inflammation. However, it remains unknown how physical stimuli promote lymphatic function. Here, we show that lymphatic endothelial cells (LECs) are activated by direct-current (DC) electrical stimulation, which induced extension of actin filaments of LECs, increased calcium influx into LECs, and increased phosphorylation of p38 mitogen-activated protein kinase (MAPK). An inhibitor of focal adhesion kinase, which plays a role in cellular adhesion and motility, diminished the DC-induced extension of F-actin and abrogated p38 phosphorylation. Time-lapse imaging revealed that pulsed-DC stimulation promoted proliferation and migration of LECs. Overall, these results indicate that electro-stimulation activates lymphatic function by activating p38 MAPK.	[Kajiya, Kentaro; Matsumoto-Okazaki, Yuko; Sawane, Mika; Fukada, Kaedeko; Saito, Naoki; Mori, Yuichiro] Shiseido Res Ctr, Yokohama, Kanagawa 2248558, Japan; [Takasugi, Yuya; Akai, Tomonori] Dai Nippon Printing, Tokyo, Japan	Kajiya, K (reprint author), Shiseido Res Ctr, Tsuzuki Ku, 2-2-1 Hayabuchi, Yokohama, Kanagawa 2248558, Japan.	kentaro.kajiya@to.shiseido.co.jp					Sawane M, 2012, EXP DERMATOL, V21, P22, DOI 10.1111/j.1600-0625.2012.01498.x; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Zhao ZQ, 2012, STEM CELL RES, V8, P38, DOI 10.1016/j.scr.2011.08.001; Kajiya K, 2005, EMBO J, V24, P2885, DOI 10.1038/sj.emboj.7600763; Rockson SG, 2008, J AM COLL CARDIOL, V52, P799, DOI 10.1016/j.jacc.2008.06.005; Planas-Paz L, 2012, EMBO J, V31, P788, DOI 10.1038/emboj.2011.456; Bai H, 2004, ARTERIOSCL THROM VAS, V24, P1234, DOI 10.1161/01.ATV.0000131265.76828.8a; Jahr S, 2008, J REHABIL MED, V40, P645, DOI 10.2340/16501977-0225; Kajiya K, 2012, AM J PATHOL, V180, P1273, DOI 10.1016/j.ajpath.2011.11.008	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	DEC	2014	23	12					936	938		10.1111/exd.12562		3	Dermatology	Dermatology	AU6EA	WOS:000345694500018		
J	Woodside, JDS; Gutowski, M; Fall, L; James, PE; McEneny, J; Young, IS; Ogoh, S; Bailey, DM				Woodside, John D. S.; Gutowski, Mariusz; Fall, Lewis; James, Philip E.; McEneny, Jane; Young, Ian S.; Ogoh, Shigehiko; Bailey, Damian M.			Systemic oxidative-nitrosative-inflammatory stress during acute exercise in hypoxia; implications for microvascular oxygenation and aerobic capacity	EXPERIMENTAL PHYSIOLOGY			English	Article							ACUTE MOUNTAIN-SICKNESS; DYNAMIC CEREBRAL AUTOREGULATION; SKELETAL-MUSCLE; FREE-RADICALS; INCREMENTAL EXERCISE; HIGH-ALTITUDE; CELLULAR MECHANISMS; LIPID-PEROXIDATION; EXCHANGE KINETICS; HYPOBARIC HYPOXIA	New Findings What is the central question of this study? Exercise performance is limited during hypoxia by a critical reduction in cerebral and skeletal tissue oxygenation. To what extent an elevation in systemic free radical accumulation contributes to microvascular deoxygenation and the corresponding reduction in maximal aerobic capacity remains unknown. What is the main finding and its importance? We show that altered free radical metabolism is not a limiting factor for exercise performance in hypoxia, providing important insight into the fundamental mechanisms involved in the control of vascular oxygen transport. Exercise performance in hypoxia may be limited by a critical reduction in cerebral and skeletal tissue oxygenation, although the underlying mechanisms remain unclear. We examined whether increased systemic free radical accumulation during hypoxia would be associated with elevated microvascular deoxygenation and reduced maximal aerobic capacity (V.O2 max ). Eleven healthy men were randomly assigned single-blind to an incremental semi-recumbent cycling test to determine V.O2 max in both normoxia (21% O-2) and hypoxia (12% O-2) separated by a week. Continuous-wave near-infrared spectroscopy was employed to monitor concentration changes in oxy- and deoxyhaemoglobin in the left vastus lateralis muscle and frontal cerebral cortex. Antecubital venous blood samples were obtained at rest and at V.O2 max to determine oxidative (ascorbate radical by electron paramagnetic resonance spectroscopy), nitrosative (nitric oxide metabolites by ozone-based chemiluminescence and 3-nitrotyrosine by enzyme-linked immunosorbent assay) and inflammatory stress biomarkers (soluble intercellular/vascular cell adhesion1 molecules by enzyme-linked immunosorbent assay). Hypoxia was associated with increased cerebral and muscle tissue deoxygenation and lower .O2 max (P<0.05 versus normoxia). Despite an exercise-induced increase in oxidative-nitrosative-inflammatory stress, hypoxia per se did not have an additive effect (P>0.05 versus normoxia). Consequently, we failed to observe correlations between any metabolic, haemodynamic and cardiorespiratory parameters (P>0.05). Collectively, these findings suggest that altered free radical metabolism cannot explain the elevated microvascular deoxygenation and corresponding lower .O2 max in hypoxia. Further research is required to determine whether free radicals when present in excess do indeed contribute to the premature termination of exercise in hypoxia.	[Woodside, John D. S.] UCL, Inst Cardiovasc Sci, Vasc Physiol Unit, London, England; [Gutowski, Mariusz] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Fall, Lewis; Bailey, Damian M.] Univ South Wales, Fac Life Sci & Educ, Neurovasc Res Lab, Pontypridd CF37 4AT, M Glam, Wales; [James, Philip E.] Cardiff Univ, Sch Med, Wales Heart Res Inst, Pontypridd, M Glam, Wales; [McEneny, Jane; Young, Ian S.] Queens Univ Belfast, Nutr & Metab Grp, Ctr Publ Hlth, Belfast, Antrim, North Ireland; [Ogoh, Shigehiko] Toyo Univ, Dept Biomed Engn, Kawagoe, Saitama, Japan	Bailey, DM (reprint author), Univ South Wales, Fac Life Sci & Educ, Neurovasc Res Lab, Pontypridd CF37 4AT, M Glam, Wales.	damian.bailey@southwales.ac.uk			British Cycling Federation	This study was funded in part by the British Cycling Federation.	Ferreira LF, 2008, J APPL PHYSIOL, V104, P853, DOI 10.1152/japplphysiol.00953.2007; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; DeLorey DS, 2003, J APPL PHYSIOL, V95, P113, DOI 10.1152/japplphysiol.00956.2002; Nauser T, 2002, J PHYS CHEM A, V106, P4084, DOI 10.1021/jp025518z; Subudhi AW, 2011, J APPL PHYSIOL, V111, P1727, DOI 10.1152/japplphysiol.00569.2011; Clanton T, 2005, J APPL PHYSIOL, V99, P1245, DOI 10.1152/japplphysiol.00609.2005; Amann M, 2007, J PHYSIOL-LONDON, V581, P389, DOI 10.1113/j.physiol.2007.129700; Richardson RS, 2007, AM J PHYSIOL-HEART C, V292, pH1516, DOI 10.1152/ajpheart.01045.2006; Vollaard NBJ, 2005, SPORTS MED, V35, P1045, DOI 10.2165/00007256-200535120-00004; Mantovani G, 2006, CANCER EPIDEM BIOMAR, V15, P1030, DOI 10.1158/1055-9965.EPI-05-0538; Jackson MJ, 2008, FREE RADICAL BIO MED, V44, P132, DOI 10.1016/j.freeradbiomed.2007.06.003; Grassi B, 2003, J APPL PHYSIOL, V95, P149, DOI 10.1152/japplphysiol.00695.2002; Subudhi AW, 2007, J APPL PHYSIOL, V103, P177, DOI 10.1152/japplphysiol.01460.2006; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Diederich ER, 2002, CARDIOVASC RES, V56, P479, DOI 10.1016/S0008-6363(02)00545-X; Bailey DM, 2010, J PHYSIOL-LONDON, V588, P4837, DOI 10.1113/jphysiol.2010.194704; Ewing JF, 1998, FREE RADICAL BIO MED, V25, P621, DOI 10.1016/S0891-5849(98)00083-5; Calbet JAL, 2003, AM J PHYSIOL-REG I, V284, pR291, DOI 10.1152/ajpregu.00155.2002; Bailey DM, 2013, CHEST, V143, P444, DOI 10.1378/chest.12-0728; Bailey DM, 2004, AM J PHYSIOL-HEART C, V287, pH1689, DOI 10.1152/ajpheart.00148.2004; Wang J, 1997, CLIN EXP PHARMACOL P, V24, P418, DOI 10.1111/j.1440-1681.1997.tb01212.x; VANDERZEE P, 1992, ADV EXP MED BIOL, V316, P143; DUNCAN A, 1995, PHYS MED BIOL, V40, P295, DOI 10.1088/0031-9155/40/2/007; Richardson RS, 2001, J APPL PHYSIOL, V91, P1845; Bowen TS, 2013, EXP PHYSIOL, V98, P1585, DOI 10.1113/expphysiol.2013.073270; Ferreira LF, 2006, ACTA PHYSIOL, V186, P223, DOI 10.1111/j.1748-1716.2006.01523.x; Rasmussen P, 2007, J CEREBR BLOOD F MET, V27, P1082, DOI 10.1038/sj.jcbfm.9600416; Bailey DM, 2006, J CEREBR BLOOD F MET, V26, P99, DOI 10.1038/sj.jcbfm.9600169; Ferrari M, 2011, PHILOS T R SOC A, V369, P4577, DOI 10.1098/rsta.2011.0230; Evans M, 2000, CIRCULATION, V101, P1773; Casey DP, 2012, J PHYSIOL-LONDON, V590, P6321, DOI 10.1113/jphysiol.2012.242396; KAYSER B, 1994, J APPL PHYSIOL, V76, P634; Gandevia SC, 2001, PHYSIOL REV, V81, P1725; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Richardson RS, 2006, J PHYSIOL-LONDON, V571, P415, DOI 10.1113/jphysiol.2005.102327; Rooks CR, 2010, PROG NEUROBIOL, V92, P134, DOI 10.1016/j.pneurobio.2010.06.002; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955; Noakes TD, 2001, J EXP BIOL, V204, P3225; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Marsh SA, 2005, INT J CARDIOL, V99, P165, DOI 10.1016/j.ijcard.2004.02.005; Bailey DM, 2001, CLIN SCI, V101, P465, DOI 10.1042/CS20010065; Bailey DM, 2001, HIGH ALT MED BIOL, V2, P21, DOI 10.1089/152702901750067882; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; Frenette PS, 1996, NEW ENGL J MED, V335, P43, DOI 10.1056/NEJM199607043350108; Verges S, 2012, AM J PHYSIOL-REG I, V302, pR903, DOI 10.1152/ajpregu.00555.2011; Amann M, 2006, J PHYSIOL-LONDON, V575, P937, DOI 10.1113/jphysiol.2006.113936; Vogiatzis I, 2011, J PHYSIOL-LONDON, V589, P4027, DOI 10.1113/jphysiol.2011.210880; Bailey DM, 2009, CELL MOL LIFE SCI, V66, P3583, DOI 10.1007/s00018-009-0145-9; Bailey DM, 2011, EXP PHYSIOL, V96, P1196, DOI 10.1113/expphysiol.2011.060178; Bailey DM, 2009, J PHYSIOL-LONDON, V587, P73, DOI 10.1113/jphysiol.2008.159855; Bailey DM, 2011, J CEREBR BLOOD F MET, V31, P1020, DOI 10.1038/jcbfm.2011.2; Bailey DM, 2009, AM J PHYSIOL-REG I, V297, pR1283, DOI 10.1152/ajpregu.00366.2009; Bailey DM, 2004, CLIN SCI, V107, P589; Bailey DM, 2009, STROKE, V40, P2205, DOI 10.1161/STROKEAHA.108.543959; Bailey DM, 2007, STROKE, V38, P1946, DOI 10.1161/STROKEAHA.106.475376; BOUISSOU P, 1986, EUR J APPL PHYSIOL O, V55, P290, DOI 10.1007/BF02343801; Davison GW, 2006, CLIN SCI, V110, P133, DOI 10.1042/CS20050135; Davison GW, 2012, J PHYSIOL BIOCHEM, V68, P377, DOI 10.1007/s13105-012-0149-z; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Fogarty MC, 2010, ENVIRON MOL MUTAGEN, V52, P35; Gatterer H, 2013, INT J SPORTS MED, V34, P1, DOI 10.1055/s-0032-1312584; Hirasawa A, 2014, CLIN PHYSIOL FUNCT I, DOI [10.1111/cpf.12156, DOI 10.1111/CPF.12156]; Jasper H. H., 1958, ELECTROENCEPHALOGRAP, V10, P371, DOI DOI 10.1016/0013-4694(58)90053-1; MacIntosh BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085163; McCully K K, 2000, Exerc Sport Sci Rev, V28, P123; Pattwell D, 2003, AM J PHYSIOL-HEART C, V284, pH2400, DOI 10.1152/ajpheart.00931.2002; Quaresima V, 2009, J APPL PHYSIOL, V107, P371, DOI 10.1152/japplphysiol.00215.2009; Reid MB, 2011, J PHYSIOL-LONDON, V589, P2171, DOI 10.1113/jphysiol.2010.203356; Schumacker Paul T, 2011, Proc Am Thorac Soc, V8, P477, DOI 10.1513/pats.201103-032MW; Subudhi AW, 2008, AM J PHYSIOL-HEART C, V294, pH164, DOI 10.1152/ajpheart.01104.2007; VansBeekvelt MC, 2001, J APPL PHYSIOL, V90, P511; Wagner PD, 2010, HIGH ALT MED BIOL, V11, P209, DOI 10.1089/ham.2009.1058; WILLIAMS NH, 1982, AUST J CHEM, V35, P1133	73	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-0670	1469-445X		EXP PHYSIOL	Exp. Physiol.	DEC 1	2014	99	12					1648	1662		10.1113/expphysiol.2014.081265		15	Physiology	Physiology	AU8NX	WOS:000345854200015		
J	Park, S; Fujishita, C; Komatsu, T; Kim, SE; Chiba, T; Mori, R; Shimokawa, I				Park, Seongjoon; Fujishita, Chika; Komatsu, Toshimitsu; Kim, Sang Eun; Chiba, Takuya; Mori, Ryoichi; Shimokawa, Isao			NPY antagonism reduces adiposity and attenuates age-related imbalance of adipose tissue metabolism	FASEB JOURNAL			English	Article						adipocytes; lipid metabolism; sirtuins	BODY-MASS INDEX; HORMONE-SENSITIVE LIPASE; FATTY-ACID OXIDATION; Y GENE-EXPRESSION; NEUROPEPTIDE-Y; GLUCOSE-INTOLERANCE; INSULIN SENSITIVITY; CALORIC RESTRICTION; FEEDING-BEHAVIOR; BROWN ADIPOCYTES	An orexigenic hormone, neuropeptide Y (NPY), plays a role not only in the hypothalamic regulation of appetite, but also in the peripheral regulation of lipid metabolism. However, the intracellular mechanisms triggered by NPY to regulate lipid metabolism are poorly understood. Here we report that NPY deficiency reduces white adipose tissue (WAT) mass and ameliorates the age-related imbalance of adipose tissue metabolism in mice. Gene expression involved in adipogenesis/lipogenesis was found to decrease, whereas proteins involved in lipolysis increased in gonadal WAT (gWAT) of NPY-knockout mice. These changes were associated with an activated SIRT1- and PPAR gamma-mediated pathway. Moreover, the age-related decrease of de novo lipogenesis in gWAT and thermogenesis in inguinal WAT was inhibited by NPY deficiency. Further analysis using 3T3-L1 cells showed that NPY inhibited lipolysis through the Y1 receptor and enhanced lipogenesis following a reduction in cAMP response element-binding protein (CREB) and SIRT1 protein expression. Therefore, NPY appears to act as a key regulator of adipose tissue metabolism via the CREB-SIRT1 signaling pathway. Taken together, NPY deficiency reduces adiposity and ameliorates the age-related imbalance of adipose tissue metabolism, suggesting that antagonism of NPY may be a promising target for drug development to prevent age-related metabolic diseases.	[Park, Seongjoon; Fujishita, Chika; Komatsu, Toshimitsu; Kim, Sang Eun; Chiba, Takuya; Mori, Ryoichi; Shimokawa, Isao] Nagasaki Univ, Sch Med, Grad Sch Biomed Sci, Dept Pathol, Nagasaki 8528523, Japan	Park, S (reprint author), Nagasaki Univ, Sch Med, Grad Sch Biomed Sci, Dept Pathol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	psj10262000@yahoo.co.kr			Japan Society for the Promotion of Science (JSPS) [22390042]; JSPS Asian Core Program	The authors are grateful to the staff at the Biomedical Research Center (Center for Frontier Life Sciences, Nagasaki University, Nagasaki City, Japan) for their technical assistance and animal care. The authos also thank Yutaka Araki, Yuko Moriyama, and Chika Matsumoto for excellent technical assistance. This work was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science (JSPS; no. 22390042) and the JSPS Asian Core Program.	Koubova J, 2003, GENE DEV, V17, P313, DOI 10.1101/gad.1052903; Noriega LG, 2011, EMBO REP, V12, P1069, DOI 10.1038/embor.2011.151; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI 10.1038/nrg862; ROUBENOFF R, 1995, AM J PUBLIC HEALTH, V85, P726, DOI 10.2105/AJPH.85.5.726; Bradley RL, 2005, OBES RES, V13, P653, DOI 10.1038/oby.2005.73; McDonald RB, 1999, J BIOENERG BIOMEMBR, V31, P507, DOI 10.1023/A:1005404708710; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Muzumdar R, 2008, AGING CELL, V7, P438, DOI 10.1111/j.1474-9726.2008.00391.x; Chao PT, 2011, CELL METAB, V13, P573, DOI 10.1016/j.cmet.2011.02.019; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Yang KP, 2008, FASEB J, V22, P2452, DOI 10.1096/fj.07-100735; Zhu M, 2004, EXP GERONTOL, V39, P1049, DOI 10.1016/j.exger.2004.03.024; GRUENEWALD DA, 1994, ENDOCRINOLOGY, V134, P2383, DOI 10.1210/en.134.6.2383; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Flier JS, 1997, P NATL ACAD SCI USA, V94, P4242, DOI 10.1073/pnas.94.9.4242; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Wu DY, 2007, J IMMUNOL, V179, P4829; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Smith SJ, 2000, NAT GENET, V25, P87; Mott JW, 1999, AM J CLIN NUTR, V69, P1007; Ahn J, 2013, EMBO MOL MED, V5, P1602, DOI 10.1002/emmm.201302647; Herskovits AZ, 2013, CELL RES, V23, P746, DOI 10.1038/cr.2013.70; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Dietrich MO, 2010, J NEUROSCI, V30, P11815, DOI 10.1523/JNEUROSCI.2234-10.2010; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bannon AW, 2000, BRAIN RES, V868, P79, DOI 10.1016/S0006-8993(00)02285-X; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Serradeil-Le Gal C, 2000, FEBS LETT, V475, P150, DOI 10.1016/S0014-5793(00)01649-5; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Gabriely I, 2002, DIABETES, V51, P2951, DOI 10.2337/diabetes.51.10.2951; Ueno M, 2008, AM J PHYSIOL-ENDOC M, V294, pE1109, DOI 10.1152/ajpendo.00016.2008; Veyrat-Durebex C, 2013, NEUROPEPTIDES, V47, P163, DOI 10.1016/j.npep.2013.01.001; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Rogers NH, 2012, AGING CELL, V11, P1074, DOI 10.1111/acel.12010; Sugatani J, 2014, FASEB J, V28, P440, DOI 10.1096/fj.13-233262; Araki S, 2004, GERONTOLOGY, V50, P206, DOI 10.1159/000078349; Beck B, 2006, PHILOS T R SOC B, V361, P1159, DOI 10.1098/rstb.2006.1855; Benz V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037794; Chakrabarti P, 2011, J LIPID RES, V52, P1693, DOI 10.1194/jlr.M014647; Chiba T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04517; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Dhillon SS, 2011, INT J OBESITY, V35, P198, DOI 10.1038/ijo.2010.124; Greenberg AS, 2006, AM J CLIN NUTR, V83, p461S; Heiman ML, 2003, ENDOCRINE, V20, P149, DOI 10.1385/ENDO:20:1-2:149; Heo M, 2003, STAT MED, V22, P1911, DOI 10.1002/sim.1218; Ishihara A, 2006, P NATL ACAD SCI USA, V103, P7154, DOI 10.1073/pnas.0510320103; JHANWARUNIYAL M, 1990, BRAIN RES, V536, P331, DOI 10.1016/0006-8993(90)90045-D; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Lafontan M., 2009, PROG LIPID RES, V48, P275; LEITER EH, 1988, FASEB J, V2, P2807; Niehof M, 1997, MOL CELL BIOL, V17, P3600; Reusch JEB, 2002, J BIOL CHEM, V277, P1426, DOI 10.1074/jbc.M107923200; Rojas JM, 2012, AM J PHYSIOL-ENDOC M, V303, pE1479, DOI 10.1152/ajpendo.00351.2012; Ruohonen S. T., 2012, INT J PEPT, V2012; SAHU A, 1992, MOL BRAIN RES, V15, P15, DOI 10.1016/0169-328X(92)90145-2; STANLEY BG, 1986, PEPTIDES, V7, P1189; STANLEY BG, 1993, BRAIN RES, V604, P304; WETTSTEIN JG, 1995, PHARMACOL THERAPEUT, V65, P397, DOI 10.1016/0163-7258(95)98598-K; Xu C, 2013, AM J TRANSL RES, V5, P412; Yang JN, 2007, ACTA PHYSIOL, V190, P63, DOI 10.1111/j.1748-1716.2007.01690.x; ZARJEVSKI N, 1993, ENDOCRINOLOGY, V133, P1753, DOI 10.1210/en.133.4.1753	64	3	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2014	28	12					5337	5348		10.1096/fj.14-258384		12	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AU9EN	WOS:000345894500027		
J	Tanaka, T; Iino, M; Goto, K				Tanaka, Toshiaki; Iino, Mitsuyoshi; Goto, Kaoru			Knockdown of Sec8 enhances the binding affinity of c-Jun N-terminal kinase (JNK)-interacting protein 4 for mitogen-activated protein kinase kinase 4 (MKK4) and suppresses the phosphorylation of MKK4, p38, and JNK, thereby inhibiting apoptosis	FEBS JOURNAL			English	Article						c-Jun N-terminal kinase (JNK); c-Jun N-terminal kinase-interacting protein 4 (JIP4); itogen-activated protein kinase kinase 4 (MKK4); p38; Sec8	MAP-KINASE; SCAFFOLD PROTEINS; SEC6/8 COMPLEX; REACTIVE OXYGEN; HELA-CELLS; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; MAMMALIAN-CELLS; PATHWAY; MEMBRANE	The exocyst complex, also called the Sec6/8 complex, is important for targeting exocytic vesicles to specific docking sites on the plasma membrane in yeast and mammalian cells. In addition to these original findings, recent results of studies suggest that Sec8 is also involved in oncogenesis, although the functional implications of Sec8 in cancer cells are not well understood. c-Jun N-terminal kinase-interacting protein 4 (JIP4) is a scaffold protein that plays a crucial role in the regulation of mitogen-activated protein kinase (MAPK) signaling cascades. The present study examined how Sec8 is involved in JIP4-mediated MAPK signaling under apoptotic conditions. It was found that Sec8 binds to and regulates JIP4, and that knockdown of Sec8 enhances the binding of JIP4 to MAPK kinase 4, thereby decreasing the phosphorylation of MAPK kinase 4, JNK, and p38. These results raise the possibility that Sec8 serves as an important regulator of MAPK signaling cascades.	[Tanaka, Toshiaki; Goto, Kaoru] Yamagata Univ, Sch Med, Dept Anat & Cell Biol, Yamagata 9909585, Japan; [Tanaka, Toshiaki; Iino, Mitsuyoshi] Yamagata Univ, Sch Med, Dept Dent Oral & Maxillofacial Surg Plast & Recon, Yamagata 9909585, Japan	Tanaka, T (reprint author), Yamagata Univ, Sch Med, Dept Anat & Cell Biol, 2-2-2 Iida Nishi, Yamagata 9909585, Japan.	ttanaka@med.id.yamagata-u.ac.jp					Yoshioka K, 2004, J BIOCHEM, V135, P657, DOI 10.1093/jb/mvh079; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; TERBUSH DR, 1995, J CELL BIOL, V130, P299, DOI 10.1083/jcb.130.2.299; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Tanaka T, 2012, FEBS LETT, V586, P924, DOI 10.1016/j.febslet.2012.02.026; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Yeaman C, 2001, J CELL BIOL, V155, P593, DOI 10.1083/jcb.200107088; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Sumbayev VV, 2005, ARCH BIOCHEM BIOPHYS, V436, P406, DOI 10.1016/j.abb.2005.02.021; Tanaka T, 2013, J CELL SCI, V126, P2785, DOI 10.1242/jcs.118711; Whitmarsh AJ, 2006, BIOCHEM SOC T, V34, P828; Hasegawa Y, 2012, INT J MOL SCI, V13, P9363, DOI 10.3390/ijms13079363; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Reiser V, 2000, NAT CELL BIOL, V2, P620; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Tanaka T, 2014, FEBS J, V281, P1068, DOI 10.1111/febs.12669; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Hazuka CD, 1999, J NEUROSCI, V19, P1324; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Ho CY, 2010, J CELL BIOCHEM, V110, P725, DOI 10.1002/jcb.22583; Eke I, 2013, CANCER RES, V73, P297, DOI 10.1158/0008-5472.CAN-12-2021; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Gillis PA, 2009, J VIROL, V83, P1767, DOI 10.1128/JVI.01944-08; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Lee MW, 2002, FEBS LETT, V512, P313, DOI 10.1016/S0014-5793(02)02225-1; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Yamagishi N, 2008, FEBS J, V275, P4558, DOI 10.1111/j.1742-4658.2008.06598.x; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Locasale JW, 2007, P NATL ACAD SCI USA, V104, P13307, DOI 10.1073/pnas.0706311104; Dard N, 2006, BIOESSAYS, V28, P146, DOI 10.1002/bies.20351; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Chen S, 2011, J BIOL CHEM, V286, P10201, DOI 10.1074/jbc.M110.175273; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Liu JL, 2009, MOL BIOL CELL, V20, P3763, DOI 10.1091/mbc.E08-09-0967; Matern HT, 2001, P NATL ACAD SCI USA, V98, P9648, DOI 10.1073/pnas.171317898; Nihalani D, 2003, J BIOL CHEM, V278, P28694, DOI 10.1074/jbc.M304212200; Shin DM, 2000, J CELL BIOL, V150, P1101, DOI 10.1083/jcb.150.5.1101; Yamamoto A, 2013, J CANCER RES CLIN, V139, P533, DOI 10.1007/s00432-012-1356-2; YASHAR B, 1995, MOL CELL BIOL, V15, P6545; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893	46	1	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	DEC	2014	281	23					5237	5250		10.1111/febs.13063		14	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AU6EJ	WOS:000345695700006		
J	Okuda, A; Matsusaki, M; Higashino, Y; Masuda, T; Urade, R				Okuda, Aya; Matsusaki, Motonori; Higashino, Yuki; Masuda, Taro; Urade, Reiko			Disulfide bond formation activity of soybean quiescin sulfhydryl oxidase	FEBS JOURNAL			English	Article						endoplasmic reticulum; protein disulfide isomerase; protein folding; quiescin sulfhydryl oxidase (QSOX); soybean	ENDOPLASMIC-RETICULUM STRESS; SEMINAL-VESICLE SECRETION; ISOMERASE FAMILY PROTEINS; SEED-STORAGE PROTEINS; THIOREDOXIN DOMAIN; MOLECULAR-CLONING; REDOX HOMEOSTASIS; GENE-EXPRESSION; IN-VITRO; QSOX	Multiple enzymatic systems can catalyse protein disulfide bond formation in the endoplasmic reticulum (ER) of eukaryotic cells. The enzyme quiescin sulfhydryl oxidase (QSOX) catalyses disulfide bond formation in unfolded proteins via the reduction of oxygen. We found two QSOX homologues in the soybean genome database, Glycine max QSOX (GmQSOX) 1 and GmQSOX2, which encode proteins composed of an N-terminal signal peptide, a thioredoxin-like domain, an FAD-binding domain, Erv/ALR, and a transmembrane region near the C terminus. We subsequently cloned two GmQSOX1 cDNAs, GmQSOX1a and GmQSOX1b, which may be generated by alternative splicing. The GmQSOX1a, GmQSOX1b and GmQSOX2 mRNA levels increased during seed storage protein synthesis in the cotyledon, and were also upregulated under conditions causing ER stress. Recombinant GmQSOX1 expressed in Escherichia coli formed disulfide bonds on reduced and denatured RNase A, but did not show any refolding activity. The reduced and denatured RNase A was effectively refolded by recombinant GmQSOX1 in the presence of the soybean protein disulfide isomerase family protein GmPDIL-2 in the absence of glutathione redox buffer, suggesting that GmQSOX1 plays a role in protein folding in the ER.	[Okuda, Aya; Matsusaki, Motonori; Higashino, Yuki; Masuda, Taro; Urade, Reiko] Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Kyoto, Japan	Urade, R (reprint author), Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Kyoto, Japan.	urade@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science [18658055]; Program for Promotion of Basic Research Activities for Innovative Biosciences; Takano Life Science Research Foundation	This work was supported by a Grant in Aid for Scientific Research (No. 18658055) from the Japan Society for the Promotion of Science, a grant from the Program for Promotion of Basic Research Activities for Innovative Biosciences, and a grant from the Takano Life Science Research Foundation.	Alejandro S, 2007, EMBO J, V26, P3203, DOI 10.1038/sj.emboj.7601757; Kakihana T, 2012, ANTIOXID REDOX SIGN, V16, P763, DOI 10.1089/ars.2011.4238; Chakravarthi S, 2007, BIOCHEM J, V404, P403, DOI 10.1042/BJ20061510; Wadahama H, 2007, FEBS J, V274, P687, DOI 10.1111/j.1742-4658.2006.05613.x; Hoober KL, 1999, J BIOL CHEM, V274, P22147, DOI 10.1074/jbc.274.32.22147; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Alon A, 2012, NATURE, V488, P414, DOI 10.1038/nature11267; Howell SH, 2013, ANNU REV PLANT BIOL, V64, P477, DOI 10.1146/annurev-arplant-050312-120053; Rancy PC, 2008, BIOCHEMISTRY-US, V47, P12047, DOI 10.1021/bi801604x; Nguyen VD, 2011, J MOL BIOL, V406, P503, DOI 10.1016/j.jmb.2010.12.039; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010; Kodali VK, 2010, ANTIOXID REDOX SIGN, V13, P1217, DOI 10.1089/ars.2010.3098; PACE CN, 1995, PROTEIN SCI, V4, P2411; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Kodali VK, 2010, BIOCHEMISTRY-US, V49, P2075, DOI 10.1021/bi902222s; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Dias-Gunasekara S, 2005, J BIOL CHEM, V280, P33066, DOI 10.1074/jbc.M505023200; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086; Tury A, 2006, CELL TISSUE RES, V323, P91, DOI 10.1007/s00441-005-0043-x; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Jaje J, 2007, BIOCHEMISTRY-US, V46, P13031, DOI 10.1021/bi7016975; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; Raje S, 2003, BIOCHEMISTRY-US, V42, P4560, DOI 10.1021/bi030003z; Heckler EJ, 2008, BIOCHEMISTRY-US, V47, P4955, DOI 10.1021/bi702522q; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Urade R, 2007, FEBS J, V274, P1152, DOI 10.1111/j.1742-4658.2007.05664.x; Hatahet F, 2009, ANTIOXID REDOX SIGN, V11, P2807, DOI 10.1089/ARS.2009.2466; Wang L, 2014, ANTIOXID REDOX SIGN, V20, P545, DOI 10.1089/ars.2013.5236; SCOTT MP, 1992, P NATL ACAD SCI USA, V89, P658, DOI 10.1073/pnas.89.2.658; Araki K, 2012, ANTIOXID REDOX SIGN, V16, P790, DOI 10.1089/ars.2011.4418; Cabibbo A, 2000, J BIOL CHEM, V275, P4827, DOI 10.1074/jbc.275.7.4827; COPPOCK DL, 1993, CELL GROWTH DIFFER, V4, P483; Coppock DL, 1998, GENOMICS, V54, P460, DOI 10.1006/geno.1998.5605; CREIGHTON TE, 1977, J MOL BIOL, V113, P329, DOI 10.1016/0022-2836(77)90145-0; EREKENTUMER N, 1982, J BIOL CHEM, V257, P4016; Iwasaki K, 2009, FEBS J, V276, P4130, DOI 10.1111/j.1742-4658.2009.07123.x; Kamauchi S, 2008, FEBS J, V275, P2644, DOI 10.1111/j.1742-4658.2008.06412.x; KIM CS, 1990, AGR BIOL CHEM TOKYO, V54, P1543; Limor-Waisberg K, 2012, FEBS LETT, V586, P4119, DOI 10.1016/j.febslet.2012.10.003; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P613, DOI 10.1021/bi00217a004; Nam YW, 1997, PLANT PHYSIOL, V115, P1629, DOI 10.1104/pp.115.4.1629; OSTROWSKI MC, 1979, BIOCHEM BIOPH RES CO, V87, P171, DOI 10.1016/0006-291X(79)91662-0; OSTROWSKI MC, 1980, BIOCHEMISTRY-US, V19, P2639, DOI 10.1021/bi00553a016; Portes KF, 2008, J MOL HISTOL, V39, P217, DOI 10.1007/s10735-007-9156-8; Rudolf J, 2013, BIOCHEM J, V454, P181, DOI 10.1042/BJ20130360; Rutkevich LA, 2012, MOL BIOL CELL, V23, P2017, DOI 10.1091/mbc.E12-02-0102; Wadahama H, 2008, FEBS J, V275, P399, DOI 10.1111/j.1742-4658.2007.06199.x; Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200; Wittke I, 2003, CANCER RES, V63, P7742	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	DEC	2014	281	23					5341	5355		10.1111/febs.13079		15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AU6EJ	WOS:000345695700013		
J	Fujiyama, S; Abe, Y; Tani, J; Urabe, M; Sato, K; Aramaki, T; Katayama, T; Ueda, T				Fujiyama, Saki; Abe, Yoshito; Tani, Junya; Urabe, Masashi; Sato, Kenji; Aramaki, Takahiko; Katayama, Tsutomu; Ueda, Tadashi			Structure and mechanism of the primosome protein DnaT-functional structures for homotrimerization, dissociation of ssDNA from the PriB.ssDNA complex, and formation of the DnaT.ssDNA complex	FEBS JOURNAL			English	Article						DnaT; PriB; primosome; protein structure; replication restart	STALLED REPLICATION FORKS; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI K-12; PHI X174-TYPE PRIMOSOME; RESTART PRIMOSOME; CRYSTAL-STRUCTURE; PRIB; BINDING; SYSTEM; AAA(+)	In Escherichia coli, the primosome plays an essential role in replication restart after dissociation of replisomes at the damaged replication fork. As well as PriA and PriB, DnaT, an ssDNA-binding protein, is a key member of the primosome. In this study, limited proteolysis indicated that E. coli DnaT was composed of two domains, consistent with the results of recent studies using Klebsiella pneumonia DnaT. We also found that a specific 24-residue region (Phe42-Asp66) in the N-terminal domain (1-88) was crucial for DnaT trimerization. Moreover, we determined the structure of the DnaT C-terminal domain (89-179) by NMR spectroscopy. This domain included three a-helices and a long flexible C-terminal tail, similar to the C-terminal subdomain of the AAA+ ATPase family. The neighboring histidines, His136 and His137, at a position corresponding to the AAA+ sensor II motif, were suggested to form an ssDNA-binding site. Furthermore, we found that the acidic linker between the two domains had an activity for dissociating ssDNA from the PriB.ssDNA complexes in a manner supported by the conserved acidic residues Asp70 and Glu76. Thus, these findings provide a novel structural basis for understanding the mechanism of DnaT in exposure of ssDNA and reloading of the replicative helicase at the stalled replication fork.	[Fujiyama, Saki; Abe, Yoshito; Tani, Junya; Urabe, Masashi; Sato, Kenji; Aramaki, Takahiko; Ueda, Tadashi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Prot Struct Funct & Design, Fukuoka 8128582, Japan; [Katayama, Tsutomu] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Fukuoka 8128582, Japan	Ueda, T (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Prot Struct Funct & Design, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ueda@phar.kyushu-u.ac.jp	Abe, Yoshito/D-8370-2012	Abe, Yoshito/0000-0002-0016-8490	JSPS KAKENHI [23570140]; Japan Foundation for Applied Enzymology	We thank Edanz editing service for improving the English usage in our manuscript. This work was supported by JSPS KAKENHI Grant Number 23570140 to Y. Abe and T. Katayama and a grant from the Japan Foundation for Applied Enzymology to Y. Abe. The work on ITC measurement was supported by the Platform for Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ALLEN GC, 1993, J BIOL CHEM, V268, P19204; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Abe Y, 2007, J BIOL CHEM, V282, P17816, DOI 10.1074/jbc.M701841200; Szymanski MR, 2013, BIOCHEMISTRY-US, V52, P1858, DOI 10.1021/bi3015696; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Huang YH, 2013, GENES CELLS, V18, P1007, DOI 10.1111/gtc.12095; Mueller-Cajar O, 2011, NATURE, V479, P194, DOI 10.1038/nature10568; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Neuwald AF, 1999, GENOME RES, V9, P27; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mechali M, 2013, CURR OPIN GENET DEV, V23, P124, DOI 10.1016/j.gde.2013.02.010; Szymanski MR, 2013, BIOCHEMISTRY-US, V52, P1845, DOI 10.1021/bi301568w; Huang CY, 2006, NUCLEIC ACIDS RES, V34, P3878, DOI 10.1093/nar/gkl536; Cox MM, 2000, NATURE, V404, P37; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; LEE EH, 1991, P NATL ACAD SCI USA, V88, P3029, DOI 10.1073/pnas.88.8.3029; Jung JW, 2005, J BIOCHEM MOL BIOL, V38, P550; ARAI K, 1981, J BIOL CHEM, V256, P5281; Aramaki T, 2013, GENES CELLS, V18, P723, DOI 10.1111/gtc.12069; Fujiyama S, 2014, BBA-PROTEINS PROTEOM, V1844, P299, DOI 10.1016/j.bbapap.2013.10.015; Güntert Peter, 2004, Methods Mol Biol, V278, P353; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Huang YH, 2013, BIOCHEM BIOPH RES CO, V442, P147, DOI 10.1016/j.bbrc.2013.11.069; Liu J, 1996, J BIOL CHEM, V271, P15656; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Lopper M, 2004, STRUCTURE, V12, P1967, DOI 10.1016/j.str.2004.09.004; Lovett ST, 2005, MOL CELL, V17, P751, DOI 10.1016/j.molcel.2005.03.002; Masai H, 2010, BIOESSAYS, V32, P687, DOI 10.1002/bies.200900196; McCool JD, 2004, GENETICS, V167, P569, DOI 10.1534/genetics.103.025296; Ng JY, 1996, J BIOL CHEM, V271, P15642; Sandler SJ, 2000, GENETICS, V155, P487; Sandler SJ, 2000, ESCHERICHIA COLI; Sandler SJ, 1999, MOL MICROBIOL, V34, P91, DOI 10.1046/j.1365-2958.1999.01576.x; Sandler SJ, 2001, MOL MICROBIOL, V41, P697, DOI 10.1046/j.1365-2958.2001.02547.x; Sasaki K, 2007, EMBO J, V26, P2584, DOI 10.1038/sj.emboj.7601697; Shioi S, 2005, BIOCHEM BIOPH RES CO, V326, P766, DOI 10.1016/j.bbrc.2004.11.104; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5	42	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	DEC	2014	281	23					5356	5370		10.1111/febs.13080		15	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AU6EJ	WOS:000345695700014		
J	Ueno, S; Bodri, D; Uchiyama, K; Okimura, T; Okuno, T; Kobayashi, T; Kato, K				Ueno, Satoshi; Bodri, Daniel; Uchiyama, Kazuo; Okimura, Tadashi; Okuno, Takashi; Kobayashi, Tamotsu; Kato, Keiichi			Developmental potential of zona pellucida-free oocytes obtained following mild in vitro fertilization	FERTILITY AND STERILITY			English	Article						Zona pellucida; blastocyst culture; minimal ovarian stimulation; in vitro fertilization	MINIMAL OVARIAN STIMULATION; EMBRYO-TRANSFER; SINGLE-CENTER; IVF; PREGNANCY; SYSTEM; COHORT; TRIAL; STAGE	Objective: To determine the developmental potential of oocytes in which the zona pellucida was damaged and subsequently removed, producing "zona-free'' (ZF) oocytes that were cultured until the blastocyst stage. Design: ZF eggs from cycles with more than one oocytes retrieved (n = 97) were compared with zona-intact (ZI) oocytes originating from the same patient. Setting: Private infertility clinic. Patient(s): Infertile patients (n = 135) undergoing minimal ovarian stimulation or natural-cycle in vitro fertilization treatment during 2010-2012. Intervention(s): ZF oocytes undergoing intracytoplasmic sperm injection (ICSI) fertilization, blastocyst culture, elective vitrification, and subsequent single vitrified-thawed blastocyst transfer (SVBT). Main Outcome Measure(s): Rate of fertilization, cleavage, and blastocyst development. Live birth rate and neonatal outcome in subsequent SVBT cycles. Result(s): There were no significant differences in fertilization (77% vs. 77%), cleavage (75% vs. 75%), or blastocyst development rates (39% vs. 32%) between the internally controlled ZF and ZI groups, respectively. Survival after thawing (90% vs. 100%) and live birth rates (37% vs. 36%) per thawed blastocyst were also similar. Newborns originating from all ZF and ZI oocytes had a similar gestational age at delivery (38.3 +/- 3.7 wk vs. 39.5 +/- 1.5 wk) and birth weight (3,115 +/- 946 g vs. 3,010 +/- 441 g). Conclusion(s): Our retrospective comparative study suggests that ZF eggs could be as successfully fertilized and cultured until the blastocyst stage as ZI control eggs without adversely affecting subsequent pregnancy rates and basic neonatal outcome. (C) 2014 by American Society for Reproductive Medicine.	[Ueno, Satoshi; Uchiyama, Kazuo; Okimura, Tadashi; Okuno, Takashi; Kobayashi, Tamotsu; Kato, Keiichi] Kato Ladies Clin, Tokyo, Japan; [Bodri, Daniel] Kobe Motomachi Yume Clin, Kobe, Hyogo, Japan	Ueno, S (reprint author), Kato Ladies Clin, Shinjuku Ku, 7-20-3 Nishishinjuku, Tokyo 1600023, Japan.	scsosob@gmail.com					Verberg MFG, 2009, HUM REPROD UPDATE, V15, P13, DOI 10.1093/humupd/dmn056; Bodri D, 2014, FERTIL STERIL, V101, P1001, DOI 10.1016/j.fertnstert.2014.01.016; Vajta G, 2000, MOL REPROD DEV, V55, P256, DOI 10.1002/(SICI)1098-2795(200003)55:3<256::AID-MRD3>3.3.CO;2-Z; SUZUKI H, 1995, BIOL REPROD, V53, P78, DOI 10.1095/biolreprod53.1.78; Fauser BCJM, 2010, HUM REPROD, V25, P2678, DOI 10.1093/humrep/deq247; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Bodri D, 2011, FERTIL STERIL, V95, P2263, DOI 10.1016/j.fertnstert.2011.03.028; Nargund G, 2007, HUM REPROD, V22, P2801, DOI 10.1093/humrep/dem285; Teramoto S, 2007, REPROD BIOMED ONLINE, V15, P134; Shapiro BS, 2011, FERTIL STERIL, V96, P344, DOI 10.1016/j.fertnstert.2011.05.050; Bodri D, 2014, REPROD BIOMED ONLINE, V28, P572, DOI 10.1016/j.rbmo.2014.01.002; Ding J, 1999, HUM REPROD, V14, P476, DOI 10.1093/humrep/14.2.476; Hsieh Y Y, 2001, Chang Gung Med J, V24, P599; Kato K, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-35; Rankin T, 1996, Mol Hum Reprod, V2, P889, DOI 10.1093/molehr/2.11.889; Shu YM, 2010, REPROD BIOMED ONLINE, V21, P527, DOI 10.1016/j.rbmo.2010.04.033; Stanger JD, 2001, HUM REPROD, V16, P164, DOI 10.1093/humrep/16.1.164; Takahashi K, 1999, HUM REPROD, V14, P2677, DOI 10.1093/humrep/14.10.2677; Takeshima K, 2014, J ASSIST REPROD GEN, V31, P477, DOI 10.1007/s10815-014-0181-8; Vajta G, 2010, REPROD BIOMED ONLINE, V21, P17, DOI 10.1016/j.rbmo.2010.03.014	20	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0015-0282	1556-5653		FERTIL STERIL	Fertil. Steril.	DEC	2014	102	6					1602	1607		10.1016/j.fertnstert.2014.08.025		6	Obstetrics & Gynecology; Reproductive Biology	Obstetrics & Gynecology; Reproductive Biology	AU4YF	WOS:000345613600020		
J	Fukumoto, Y				Fukumoto, Yasuhide			IUTAM Symposium on Vortex Dynamics: Formation, Structure and Function, 10-14 March 2013, Fukuoka, Japan Preface	FLUID DYNAMICS RESEARCH			English	Editorial Material									Kyushu Univ, Inst Math Ind, Fukuoka 812, Japan	Fukumoto, Y (reprint author), Kyushu Univ, Inst Math Ind, Fukuoka 812, Japan.							0	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	DEC	2014	46	6							060001	10.1088/0169-5983/46/6/060001		2	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AU9LF	WOS:000345913500001		
J	Ishii, K; Kitagawa, S; Ishigaki, M; Adachi, S				Ishii, Katsuya; Kitagawa, Shyun; Ishigaki, Masahiro; Adachi, Shizuko			Vortical flow structure of thermoacoustic oscillations in a closed tube	FLUID DYNAMICS RESEARCH			English	Article; Proceedings Paper	IUTAM Symposium on Vortex Dynamics - Formation, Structure and Function	MAR 10-14, 2013	Kyushu Univ Sch Med, Fukuoka, JAPAN	IUTAM, Japan World Exposit 70, Commemorat Org, Japan Sci & Technol Agcy, CREST, Minist Educ, Culture, Sports, Sci & Technol, Kyushu Univ, Grad Sch Math, Global COE Program, Res Inst Appl Mech, Kyushu Univ, Inst Math	Kyushu Univ Sch Med		DRIVEN ACOUSTIC-OSCILLATIONS; AIRFOIL; HELIUM	Spontaneous thermoacoustic oscillations of a gas in a closed cylindrical tube are studied. Numerical simulations of the flow field in the tube on which a temperature gradient along the axis is imposed are performed by solving the axisymmetric compressible Navier-Stokes equations. The wall temperature of the hot part near both ends (300 K) and that of the cold part near the center (20 K) are fixed. The computations are done for various values of the length ratio xi of the hot part to the cold part between 0.3 and 1.0, and steady oscillatory states are obtained. These states are divided into three groups according to the magnitude of the pressure amplitude. The state in each group has distinguished features of the flow field. We analyze the effect of vortices on the structure of the temperature distribution. The difference of the boundary layer thickness between the hot part and the cold part is shown to play an important role.	[Ishii, Katsuya] Nagoya Univ, Ctr Informat Technol, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kitagawa, Shyun] Nagoya Univ, Grad Sch Engn, Dept Computat Sci & Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Ishigaki, Masahiro] Japan Atom Energy Agcy, Tokai, Ibaraki 3191195, Japan; [Adachi, Shizuko] Tokyo Int Univ, Sch Business & Commerce, Kawagoe, Saitama 3501197, Japan	Ishii, K (reprint author), Nagoya Univ, Ctr Informat Technol, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	ishii@cc.nagoya-u.ac.jp					YAZAKI T, 1980, J LOW TEMP PHYS, V41, P45, DOI 10.1007/BF00117229; Shimizu D, 2010, J APPL PHYS, V107, DOI 10.1063/1.3298465; SHIDA Y, 1987, AIAA J, V25, P408, DOI 10.2514/3.9638; ROTT N, 1973, Z ANGEW MATH PHYS, V24, P54, DOI 10.1007/BF01593998; Ishii K, 1997, J PHYS SOC JPN, V66, P1995, DOI 10.1143/JPSJ.66.1995; Ishigaki M, 2011, FLUID DYN RES, V43, DOI 10.1088/0169-5983/43/4/041403; ROTT N, 1969, Z ANGEW MATH PHYS, V20, P230, DOI 10.1007/BF01595562; Sugimoto N, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2990763; YAZAKI T, 1980, PHYS LETT A, V79, P407, DOI 10.1016/0375-9601(80)90277-7; TACONIS KW, 1949, PHYSICA, V15, P733, DOI 10.1016/0031-8914(49)90078-6; YAZAKI T, 1990, PHYS REV LETT, V64, P2515, DOI 10.1103/PhysRevLett.64.2515; Ishigaki M, 2012, NONLINEAR ACOUSTICS, P291; Ishigaki M, 2008, THEOR APPL MECH JAPA, V56, P307; KRAMERS HA, 1949, PHYSICA, V15, P971, DOI 10.1016/0031-8914(49)90061-0; YAZAKI T, 1993, PHYS REV E, V48, P1806, DOI 10.1103/PhysRevE.48.1806	15	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	DEC	2014	46	6							061408	10.1088/0169-5983/46/6/061408		14	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AU9LF	WOS:000345913500009		
J	Kida, S				Kida, Shigeo			Theoretical prediction of a bright pattern of reflective flakes in a precessing sphere	FLUID DYNAMICS RESEARCH			English	Article; Proceedings Paper	IUTAM Symposium on Vortex Dynamics - Formation, Structure and Function	MAR 10-14, 2013	Kyushu Univ Sch Med, Fukuoka, JAPAN	IUTAM, Japan World Exposit 70, Commemorat Org, Japan Sci & Technol Agcy, CREST, Minist Educ, Culture, Sports, Sci & Technol, Kyushu Univ, Grad Sch Math, Global COE Program, Res Inst Appl Mech, Kyushu Univ, Inst Math	Kyushu Univ Sch Med		FLOW; VISUALIZATION; PARTICLES; MOTIONS; LIQUID	Non-trivial bright patterns of reflective flakes recently observed experimentally and numerically in a precessing sphere are reproduced theoretically by the use of a small flat-plate model of flakes with diffusion effects of Brownian motion and the asymptotic velocity field in the double limit of large Reynolds numbers and small Poincare numbers. It is shown that what is visualized by flakes is not the local flow field but the overall contribution of the velocity gradient, induced by the conical shear layers, over the whole orbit of flakes. It is suggested that Brownian motion plays a significant role to the orientation distribution of flakes.	Doshisha Univ, Org Adv Res & Educ, Kyotanabe 6100394, Japan	Kida, S (reprint author), Doshisha Univ, Org Adv Res & Educ, Tatara Miyakodani 1-3, Kyotanabe 6100394, Japan.	kida.shigeo.32r@st.kyoto-u.ac.jp					Abcha N, 2008, EXP FLUIDS, V45, P85, DOI 10.1007/s00348-008-0465-9; Kida S, 2011, J FLUID MECH, V680, P150, DOI 10.1017/jfm.2011.154; BUSSE FH, 1968, J FLUID MECH, V33, P739, DOI 10.1017/S0022112068001655; MALKUS WVR, 1968, SCIENCE, V160, P259, DOI 10.1126/science.160.3825.259; LEAL LG, 1971, J FLUID MECH, V46, P685, DOI 10.1017/S0022112071000788; VANYO J, 1995, GEOPHYS J INT, V121, P136, DOI 10.1111/j.1365-246X.1995.tb03516.x; Gauthier G, 1998, PHYS FLUIDS, V10, P2147, DOI 10.1063/1.869736; Goto S, 2011, J FLUID MECH, V683, P417, DOI 10.1017/jfm.2011.299; Hinch E. J., 1991, PERTURBATION METHODS; Kida S, 2013, FLUID DYN RES, V45, DOI 10.1088/0169-5983/45/2/025503; Noir J., 2001, Geophysical Research Letters, V28, DOI 10.1029/2001GL012956; Noir J, 2001, J FLUID MECH, V437, P283; ROBERTS PH, 1963, ASTROPHYS J, V137, P777, DOI 10.1086/147555; SAVAS O, 1985, J FLUID MECH, V152, P235, DOI 10.1017/S0022112085000672; STEWARTSON K, 1963, J FLUID MECH, V17, P1, DOI 10.1017/S0022112063001063; Van Dyke M., 1982, ALBUM FLUID MOTION	16	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	DEC	2014	46	6							061404	10.1088/0169-5983/46/6/061404		25	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AU9LF	WOS:000345913500005		
J	Kobayashi, T; Akamura, T; Nagao, Y; Iwasaki, T; Nakano, K; Takahashi, K; Aoyagi, M				Kobayashi, Taizo; Akamura, Takahiro; Nagao, Yuki; Iwasaki, Takuya; Nakano, Ken'ichiro; Takahashi, Kin'ya; Aoyagi, Mutsumi			Interaction between compressible fluid and sound in a flue instrument	FLUID DYNAMICS RESEARCH			English	Article; Proceedings Paper	IUTAM Symposium on Vortex Dynamics - Formation, Structure and Function	MAR 10-14, 2013	Kyushu Univ Sch Med, Fukuoka, JAPAN	IUTAM, Japan World Exposit 70, Commemorat Org, Japan Sci & Technol Agcy, CREST, Minist Educ, Culture, Sports, Sci & Technol, Kyushu Univ, Grad Sch Math, Global COE Program, Res Inst Appl Mech, Kyushu Univ, Inst Math	Kyushu Univ Sch Med		AERODYNAMIC SOUND; VORTEX-SOUND; ORGAN PIPE	In order to study the generation of (aerodynamic) sound in flue instruments, we numerically apply Howe's energy corollary for a two-dimensional model of a flue instrument. Howe's energy corollary enables us to estimate the energy transfer between the fluid flow and acoustic field. To implement it, separating the acoustic field from the fluid flow is needed. However the complete method to numerically achieve it has not been established yet. In this work, we develop an approximate method, which has been recently proposed in their experimental studies by Yoshikawa et al (2012 J. Sound Vib. 331 2558-77) and others, and we apply it to the simulation of the model instrument. We first calculate fluid flow and acoustic oscillation simultaneously by a compressible fluid solver. Next referring to the information on the acoustic oscillation obtained we set up a pressure source on an acoustic solver and reproduce almost the same acoustic oscillation with it. Combining those results, we are able to calculate Howe's energy corollary. The numerical result shows that the aerodynamic sound is generated from the oscillating jet rather than the vortices shed by the collision of it with the edge of the mouth opening, namely vortex shedding.	[Kobayashi, Taizo; Aoyagi, Mutsumi] Kyushu Univ, Res Inst Informat Technol, Higashi Ku, Fukuoka 8128581, Japan; [Akamura, Takahiro; Iwasaki, Takuya; Nakano, Ken'ichiro; Takahashi, Kin'ya] Kyushu Inst Technol, Phys Labs, Iizuka, Fukuoka 8208502, Japan; [Nagao, Yuki] Kyushu Univ, Res Informat Sci & Elect Engn, Higashi Ku, Fukuoka 8128581, Japan	Kobayashi, T (reprint author), Kyushu Univ, Res Inst Informat Technol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tkoba@cc.kyushu-u.ac.jp; takahasi@mse.kyutech.ac.jp					Goldstein ME, 2003, J FLUID MECH, V488, P315, DOI 10.1017/S0022112003004890; Miyamoto M, 2013, ACTA ACUST UNITED AC, V99, P154, DOI 10.3813/AAA.918599; Goldstein ME, 2005, J FLUID MECH, V526, P337, DOI 10.1017/S0022112004002885; HOWE MS, 1975, J FLUID MECH, V71, P625, DOI 10.1017/S0022112075002777; POWELL A, 1964, J ACOUST SOC AM, V36, P177, DOI 10.1121/1.1918931; Bamberger A, 2005, 4 EUR C AC BUD, P665; Fabre B, 2011, ANNU REV FLUID MECH, V44, P1; Finnegan S L, 2010, J PRESS VESS-T ASME, V132, P04130; Howe M. S., 1998, ACOUSTICS FLUID STRU; Howe M.S., 1984, J APPL MATH, V32, P187; LIGHTHILL MJ, 1952, PROC R SOC LON SER-A, V211, P564, DOI 10.1098/rspa.1952.0060; Mur G, 1998, IEEE T ELECTROMAGN C, V40, P100, DOI 10.1109/15.673614; Rossing T. D., 1998, PHYS MUSICAL INSTRUM; Sinayoko S, 2011, J FLUID MECH, V668, P335, DOI 10.1017/S0022112010004672; Wagner C., 2007, LARGE EDDY SIMULATIO; Yoshikawa S, 2012, J SOUND VIB, V331, P2558, DOI 10.1016/j.jsv.2012.01.026	16	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	DEC	2014	46	6							061411	10.1088/0169-5983/46/6/061411		14	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AU9LF	WOS:000345913500012		
J	Nelson, RB; Sakajo, T				Nelson, Rhodri B.; Sakajo, Takashi			Trapped vortices in multiply connected domains	FLUID DYNAMICS RESEARCH			English	Article; Proceedings Paper	IUTAM Symposium on Vortex Dynamics - Formation, Structure and Function	MAR 10-14, 2013	Kyushu Univ Sch Med, Fukuoka, JAPAN	IUTAM, Japan World Exposit 70, Commemorat Org, Japan Sci & Technol Agcy, CREST, Minist Educ, Culture, Sports, Sci & Technol, Kyushu Univ, Grad Sch Math, Global COE Program, Res Inst Appl Mech, Kyushu Univ, Inst Math	Kyushu Univ Sch Med		VORTEX EQUILIBRIA; FLOW	This paper details a generalized method to, within some numerical tolerance, compute vortex equilibria in the presence of many obstacles. Given a conformal mapping z (zeta) between a pre-image circular domain and the physical domain, stationary conditions for the point vortices and the desired Kutta conditions are constructed and then solved using a Brownian Ratchets scheme. The method is applied to a Kasper Wing (three plate) configuration and results are compared to those of a single plate. The lift experienced by the main plate is seen to be sensitive to the placement of the two additional plates but their presence can be force enhancing for certain configurations.	[Nelson, Rhodri B.; Sakajo, Takashi] Kyoto Univ, Dept Math, Sakyo Ku, Kyoto 6068501, Japan	Nelson, RB (reprint author), Kyoto Univ, Dept Math, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	rhodri@math.kyoto-u.ac.jp					Baker H.F., 1897, ABELIAN FUNCTIONS AB; Bunyakin AV, 1998, J FLUID MECH, V358, P283, DOI 10.1017/S0022112097008203; Cox J, 1973, SOARING, V37, P20; Crowdy D, 2005, P ROY SOC A-MATH PHY, V461, P2477, DOI 10.1098/rspa.2005.1492; Crowdy D, 2006, P R SOC A, V462, P1387, DOI 10.1098/rspa.2005.1631; Crowdy D, 2010, THEOR COMP FLUID DYN, V24, P9, DOI 10.1007/s00162-009-0098-5; Crowdy D., 2007, COMPUT METH FUNCT TH, V7, P293, DOI DOI 10.1007/BF03321646; Crowdy DG, 2006, EUR J MECH B-FLUID, V25, P459, DOI 10.1016/j.euromechflu.2005.11.005; Donelli R, 2009, AIAA J, V47, P451, DOI 10.2514/1.37662; HUANG MK, 1982, AIAA J, V20, P292, DOI 10.2514/3.7913; Kruppa E, 1977, AIAA 13 ANN M TECHN, P1977; Newton PK, 2007, P R SOC A, V463, P1525, DOI 10.1098/rspa.2007.1832; Saffman P. G., 1992, VORTEX DYNAMICS; SAFFMAN PG, 1977, STUD APPL MATH, V57, P107; Sakajo T, 2012, P ROY SOC A-MATH PHY, V468, P1175, DOI 10.1098/rspa.2011.0617; Trefethen L. N., 1997, NUMERICAL LINEAR ALG; Walton D, 1974, SOARING, V38, P26; Xia X, 2013, ARXIV12056859; Zannetti L, 2003, THEOR COMP FLUID DYN, V16, P211, DOI 10.1007/s00162-002-0080-y	19	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	DEC	2014	46	6							061402	10.1088/0169-5983/46/6/061402		16	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AU9LF	WOS:000345913500003		
J	Nishiyama, T				Nishiyama, Takahiro			Algebraic approach to non-integrability of Bajer-Moffatt's steady Stokes flow	FLUID DYNAMICS RESEARCH			English	Article; Proceedings Paper	IUTAM Symposium on Vortex Dynamics - Formation, Structure and Function	MAR 10-14, 2013	Kyushu Univ Sch Med, Fukuoka, JAPAN	IUTAM, Japan World Exposit 70, Commemorat Org, Japan Sci & Technol Agcy, CREST, Minist Educ, Culture, Sports, Sci & Technol, Kyushu Univ, Grad Sch Math, Global COE Program, Res Inst Appl Mech, Kyushu Univ, Inst Math	Kyushu Univ Sch Med		LINEAR-DIFFERENTIAL EQUATIONS; ABC-FLOW; HAMILTONIAN-SYSTEMS; INTEGRABILITY; STREAMLINES; A=B	Non-integrability of the streamline system of equations for a steady Stokes flow, which Bajer and Moffatt introduced by the name of stretch-twist-fold flow, is discussed by an algebraic method without assuming its closeness to an integrable system. In the author's previous paper, the non-existence of a real meromorphic first integral of the streamline system was proved on the basis of Ziglin's theory and the differential Galois theory, where a parameter was assumed not to belong to a set of exceptional values. In this paper, this assumption is proved to be removable by making further use of some results from the differential Galois theory. The road to this result is explained in the form of a recipe in order to make clear how the differential Galois theory is applied.	Yamaguchi Univ, Dept Appl Sci, Ube, Yamaguchi 7558611, Japan	Nishiyama, T (reprint author), Yamaguchi Univ, Dept Appl Sci, Ube, Yamaguchi 7558611, Japan.	t-nishi@yamaguchi-u.ac.jp					Maciejewski A, 2002, PHYS LETT A, V303, P265, DOI 10.1016/S0375-9601(02)01259-8; BAJER K, 1990, J FLUID MECH, V212, P337, DOI 10.1017/S0022112090001999; Ayoul M, 2010, CR MATH, V348, P1323, DOI 10.1016/j.crma.2010.10.024; Baider A, 1996, FIELDS I COMMUN, V7, P5; BAJER K, 1994, CHAOS SOLITON FRACT, V4, P895, DOI 10.1016/0960-0779(94)90130-9; Bogoyavlenskij OI, 1998, COMMUN MATH PHYS, V196, P19, DOI 10.1007/s002200050412; Khesin B.A., 1998, TOPOLOGICAL METHODS; Kimura T., 1969, FUNKC EKVACIOJ-SER I, V12, P269; KOVACIC JJ, 1986, J SYMB COMPUT, V2, P3, DOI 10.1016/S0747-7171(86)80010-4; Li JB, 1998, B AUST MATH SOC, V57, P1; Li WL, 2012, J DIFFER EQUATIONS, V252, P5518, DOI 10.1016/j.jde.2012.01.004; MEZIC I, 1994, J NONLINEAR SCI, V4, P157, DOI 10.1007/BF02430631; Morales Ruiz J J, 2000, REGUL CHAOTIC DYN, V5, P251; Morales Ruiz J.J., 1999, DIFFERENTIAL GALOIS; MORALES JJ, 1994, J DIFFER EQUATIONS, V107, P140, DOI 10.1006/jdeq.1994.1006; Nishiyama T, 2014, ERGOD THEOR DYN SYST, V34, P616, DOI 10.1017/etds.2012.130; Schutz Bernard F, 1980, GEOMETRICAL METHODS; Singer M F, 1990, COMPUTER ALGEBRA DIF, P3; SINGER MF, 1993, J SYMB COMPUT, V16, P9, DOI 10.1006/jsco.1993.1032; SINGER MF, 1995, APPL ALGEBR ENG COMM, V6, P1, DOI 10.1007/BF01270928; Vainshtein DL, 1996, CHAOS, V6, P67, DOI 10.1063/1.166151; ZIGLIN SL, 1982, FUNCT ANAL APPL+, V16, P181; Ziglin SL, 1998, CHAOS, V8, P272, DOI 10.1063/1.166305; Ziglin SL, 1996, FUNCT ANAL APPL+, V30, P137, DOI 10.1007/BF02509455; Zung NT, 2002, MATH RES LETT, V9, P217	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	DEC	2014	46	6							061426	10.1088/0169-5983/46/6/061426		9	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AU9LF	WOS:000345913500027		
J	Ohya, Y				Ohya, Yuji			Bluff body flow and vortex-its application to wind turbines	FLUID DYNAMICS RESEARCH			English	Article; Proceedings Paper	IUTAM Symposium on Vortex Dynamics - Formation, Structure and Function	MAR 10-14, 2013	Kyushu Univ Sch Med, Fukuoka, JAPAN	IUTAM, Japan World Exposit 70, Commemorat Org, Japan Sci & Technol Agcy, CREST, Minist Educ, Culture, Sports, Sci & Technol, Kyushu Univ, Grad Sch Math, Global COE Program, Res Inst Appl Mech, Kyushu Univ, Inst Math	Kyushu Univ Sch Med		FLAT PLATES; FLANGED DIFFUSER; TRAILING EDGES; CYLINDERS	Some interesting phenomena of vortex flows we have found in past experimental research are described. For a given flow configuration, multiple flow patterns can exist and a sudden change from one flow pattern to another can occur. We observed the alternate switching of the flow patterns with irregular periods around a bluff body. The change of vortex flow pattern around a bluff body with geometrical parameters or stratification is not always continuous but often shows a sudden change in the whole flow pattern. Based on our research on vortex flows, an innovative application of the vortex flow to a shrouded wind turbine is made in which the power output of a wind turbine is remarkably enhanced. Unlike the majority of conventional aerodynamic machinery, which tends to minimize vortex shedding, the vortex formation of our 'brimmed' shroud plays an important role in capturing and concentrating wind energy. Furthermore, aerodynamic noise is reduced in this design. The blade tip vortex is weakened by a counter-rotating vortex generated along the inner side of the shroud as they travel downstream, making the shrouded wind turbine much quieter than conventional turbines.	Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 816, Japan	Ohya, Y (reprint author), Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 816, Japan.	ohya@riam.kyushu-u.ac.jp	Kyushu, RIAM/F-4018-2015				Abe K, 2006, WIND STRUCT, V9, P413; Ohya Y, 2008, J WIND ENG IND AEROD, V96, P524, DOI 10.1016/j.jweia.2008.01.006; CHERRY NJ, 1984, J FLUID MECH, V144, P13, DOI 10.1017/S002211208400149X; OHYA Y, 1992, J FLUID MECH, V236, P445, DOI 10.1017/S0022112092001472; BEARMAN PW, 1973, J FLUID MECH, V61, P499, DOI 10.1017/S0022112073000832; BROOKS TF, 1986, AIAA J, V24, P246, DOI 10.2514/3.9252; GILBERT BL, 1983, J ENERG RESOUR-ASME, V105, P46; BEARMAN PW, 1972, AERONAUT QUART, V23, P229; NAKAMURA Y, 1991, J FLUID MECH, V222, P437, DOI 10.1017/S0022112091001167; Ohya Y, 2010, ENERGIES, V3, P634, DOI 10.3390/en3040634; Arakawa C, 2005, EARTH SIMULAT, V2, P11; Bearman P W, 1980, T ASME, V102, P265; HAYASHI M, 1986, J FLUID MECH, V164, P1, DOI 10.1017/S0022112086002446; Hucho W-H, 1987, AERODYNAMICS ROAD VE; Morris P J, 2004, P 42 AIAA AER SCI M; NAKAMURA Y, 1986, J FLUID MECH, V164, P77, DOI 10.1017/S0022112086002471; Ohya Y, 2013, OPEN J FLUID DYN, V3, P311; OHYA Y, 1994, J FLUID STRUCT, V8, P325, DOI 10.1006/jfls.1994.1015; OHYA Y, 1990, PHYS FLUIDS A-FLUID, V2, P481, DOI 10.1063/1.857746; Ohya Y., 1989, ENCY FLUID MECH, V2, P323; Sovran G, 1978, GEN MOTORS RES LAB; Takahashi S, 2012, ENERGIES, V5, P5229, DOI 10.3390/en5125229; Zdravkovich M. M., 1977, Transactions of the ASME. Series I, Journal of Fluids Engineering, V99	23	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	DEC	2014	46	6							061423	10.1088/0169-5983/46/6/061423		14	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AU9LF	WOS:000345913500024		
J	Shimizu, M; Manneville, P; Duguet, Y; Kawahara, G				Shimizu, Masaki; Manneville, Paul; Duguet, Yohann; Kawahara, Genta			Splitting of a turbulent puff in pipe flow	FLUID DYNAMICS RESEARCH			English	Article; Proceedings Paper	IUTAM Symposium on Vortex Dynamics - Formation, Structure and Function	MAR 10-14, 2013	Kyushu Univ Sch Med, Fukuoka, JAPAN	IUTAM, Japan World Exposit 70, Commemorat Org, Japan Sci & Technol Agcy, CREST, Minist Educ, Culture, Sports, Sci & Technol, Kyushu Univ, Grad Sch Math, Global COE Program, Res Inst Appl Mech, Kyushu Univ, Inst Math	Kyushu Univ Sch Med		EQUILIBRIUM PUFF; SHEAR FLOWS; TRANSITION; SYSTEMS; STATES; SLUGS	The transition to turbulence of the flow in a pipe of constant radius is numerically studied over a range of Reynolds numbers where turbulence begins to expand by puff splitting. We first focus on the case Re = 2300 where splitting occurs as discrete events. Around this value only long-lived pseudo-equilibrium puffs can be observed in practice, as typical splitting times become very long. When Re is further increased, the flow enters a more continuous puff splitting regime where turbulence spreads faster. Puff splitting presents itself as a two-step stochastic process. A splitting puff first emits a chaotic pseudopod made of azimuthally localized streaky structures at the downstream (leading) laminar-turbulent interface. This structure can later expand azimuthally as it detaches from the parent puff. Detachment results from a collapse of turbulence over the whole cross-section of the pipe. Once the process is achieved a new puff is born ahead. Large-deviation consequences of elementary stochastic processes at the scale of the streak are invoked to explain the statistical nature of splitting and the Poisson-like distributions of splitting times reported by Avila et al (2011 Science 333 192-6).	[Shimizu, Masaki; Kawahara, Genta] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan; [Manneville, Paul] Ecole Polytech, CNRS, UMR 7646, LadHyX, F-91128 Palaiseau, France; [Duguet, Yohann] Univ Paris 11, LIMSI CNRS, UPR 3251, F-91403 Orsay, France	Shimizu, M (reprint author), Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan.	shimizu@me.es.osaka-u.ac.jp					Moxey D, 2010, P NATL ACAD SCI USA, V107, P8091, DOI 10.1073/pnas.0909560107; SREENIVASAN KR, 1986, PHYSICA D, V23, P246, DOI 10.1016/0167-2789(86)90134-X; Kawahara G, 2012, ANNU REV FLUID MECH, V44, P203, DOI 10.1146/annurev-fluid-120710-101228; Faranda D, 2014, CHAOS SOLITON FRACT, V64, P26, DOI 10.1016/j.chaos.2014.01.008; Hinrichsen H, 2000, ADV PHYS, V49, P815, DOI 10.1080/00018730050198152; Duguet Y, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.034502; Eckhardt B, 2008, PHILOS T R SOC A, V366, P1297, DOI 10.1098/rsta.2007.2132; Goldenfeld N, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.035304; Barkley D, 2011, J PHYS CONF SER, V318, DOI 10.1088/1742-6596/318/3/032001; Nishi M, 2008, J FLUID MECH, V614, P425, DOI 10.1017/S0022112008003315; Avila K, 2011, SCIENCE, V333, P192, DOI 10.1126/science.1203223; WYGNANSKI I, 1975, J FLUID MECH, V69, P283, DOI 10.1017/S0022112075001449; POMEAU Y, 1986, PHYSICA D, V23, P3, DOI 10.1016/0167-2789(86)90104-1; Waleffe F, 1997, PHYS FLUIDS, V9, P883, DOI 10.1063/1.869185; Duguet Y, 2010, J FLUID MECH, V663, P180, DOI 10.1017/S0022112010003435; Manneville P, 2011, THEOR COMP FLUID DYN, V25, P407, DOI 10.1007/s00162-010-0215-5; Holzner M, 2013, J FLUID MECH, V723, P140, DOI 10.1017/jfm.2013.127; Avila M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.063012; Avila M, 2013, PHYS REV LETT, V110; BANDYOPADHYAY PR, 1986, J FLUID MECH, V163, P439, DOI 10.1017/S0022112086002379; Barkley D, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016309; Berge P, 1998, ESPACE CHAOTIQUE; Chate H., 1995, NATO ASI SER B-PHYS, V341, P111; Clusel M, 2008, INT J MOD PHYS B, V22, P3311, DOI 10.1142/S021797920804853X; Coles D., 1962, MECANIQUE TURBULENCE, P229; Duguet Y, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.3009874; Duguet Y, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.066315; Hof B, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.214501; Lemoult G, 2013, J FLUID MECH, V731, DOI 10.1017/jfm.2013.388; Lindgren R, 1959, ARK FYS, V15, P503; Manneville P, 2012, FLUID DYN RES, V44, DOI 10.1088/0169-5983/44/3/031412; Manneville P, 2011, FLUID DYN RES, V43, DOI 10.1088/0169-5983/43/6/065501; Reynolds O., 1883, P R SOC LONDON, V35, P84, DOI 10.1098/rspl.1883.0018; Romanov V. A., 1973, FUNCTIONAL ANAL APPL, V7, P137, DOI 10.1007/BF01078886; Rotta J, 1956, ING ARCH, V24, P258, DOI 10.1007/BF00536526; SALWEN H, 1980, J FLUID MECH, V98, P273, DOI 10.1017/S0022112080000146; Samanta K, 2011, J FLUID MECH, V681, P193; Shimizu M, 2009, FLUID DYN RES, V41, DOI 10.1088/0169-5983/41/4/045501; Shimizu M, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.114401; Sipos M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.035304; WYGNANSK.IJ, 1973, J FLUID MECH, V59, P281, DOI 10.1017/S0022112073001576	41	2	2	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	DEC	2014	46	6							061403	10.1088/0169-5983/46/6/061403		13	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AU9LF	WOS:000345913500004		
J	Yasuda, T; Goto, S; Kawahara, G				Yasuda, Tatsuya; Goto, Susumu; Kawahara, Genta			Quasi-cyclic evolution of turbulence driven by a steady force in a periodic cube	FLUID DYNAMICS RESEARCH			English	Article; Proceedings Paper	IUTAM Symposium on Vortex Dynamics - Formation, Structure and Function	MAR 10-14, 2013	Kyushu Univ Sch Med, Fukuoka, JAPAN	IUTAM, Japan World Exposit 70, Commemorat Org, Japan Sci & Technol Agcy, CREST, Minist Educ, Culture, Sports, Sci & Technol, Kyushu Univ, Grad Sch Math, Global COE Program, Res Inst Appl Mech, Kyushu Univ, Inst Math	Kyushu Univ Sch Med		HOMOGENEOUS ISOTROPIC TURBULENCE; NEAR-WALL TURBULENCE; ENERGY CASCADE	The quasi-cyclic evolution of turbulence driven by a steady force in a periodic cube is investigated by means of large-eddy simulations with vanishing kinematic viscosity. By constraining the domain size so that only a single series of energy cascade events can take place, quasi-cyclic motions of multi-scale coherent vortices with a period of about 20T are realized. (Here, T denotes the turnover time of the largest eddies.) The observed cycle is composed of four periods characterized by activities of the largest- and smallest-resolvable-scale eddies. Vigorous energy cascade events, which last for about 2T, are observed between the two moments when large- and small-scale eddies are active. Even though we have examined only a special case of steady forces, such cyclic behavior of turbulence is likely to capture the essential dynamics of the regeneration cycle of multi-scale coherent structures, that is, the energy cascade in homogeneous isotropic turbulence at high Reynolds numbers.	[Yasuda, Tatsuya; Goto, Susumu; Kawahara, Genta] Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan	Yasuda, T (reprint author), Osaka Univ, Grad Sch Engn Sci, Toyonaka, Osaka 5608531, Japan.	tatsuya.yasuda@tes.me.es.osaka-u.ac.jp					Hughes TJR, 2001, PHYS FLUIDS, V13, P505, DOI 10.1063/1.1332391; Kawahara G, 2012, ANNU REV FLUID MECH, V44, P203, DOI 10.1146/annurev-fluid-120710-101228; JIMENEZ J, 1991, J FLUID MECH, V225, P213, DOI 10.1017/S0022112091002033; HAMILTON JM, 1995, J FLUID MECH, V287, P317, DOI 10.1017/S0022112095000978; Frisch U., 1995, TURBULENCE LEGACY AN; Goto S, 2008, J FLUID MECH, V605, P355, DOI 10.1017/S0022112008001511; Goto S, 2012, P 9 INT C FLOW DYN S; Goto S, 2012, PROG THEOR PHYS SUPP, P139; Goto S, 2013, P 14 EUR TURB C LYON; Horiuti K, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3567252; KIDA S, 1992, PHYS FLUIDS A-FLUID, V4, P1018, DOI 10.1063/1.858252; Kolmogorov A. N., 1941, DOKL AKAD NAUK SSSR, V30, P299; Landau L, 1959, FLUID MECH; Lilly D. K., 1967, P IBM SCI COMP S ENV, P195; MELANDER MV, 1993, PHYS REV E, V48, P2669, DOI 10.1103/PhysRevE.48.2669; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.C0;2, 10.1175/1520-0493(1963)091&LT;0099:GCEWTP&GT;2.3.CO;2(1963)]; Takahashi N, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1858532; van Veen L, 2006, FLUID DYN RES, V38, P19, DOI 10.1016/j.fluiddyn.2005.09.001; Woodruff SL, 2006, J FLUID MECH, V565, P95, DOI 10.1017/S0022112006001984; YOSHIZAWA A, 1994, PHYS REV E, V49, P4065, DOI 10.1103/PhysRevE.49.4065	20	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	DEC	2014	46	6							061413	10.1088/0169-5983/46/6/061413		12	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AU9LF	WOS:000345913500014		
J	Yoshida, J; Sano, O				Yoshida, Junya; Sano, Osamu			Erosion of the granular layer due to the collision of a vortex ring	FLUID DYNAMICS RESEARCH			English	Article; Proceedings Paper	IUTAM Symposium on Vortex Dynamics - Formation, Structure and Function	MAR 10-14, 2013	Kyushu Univ Sch Med, Fukuoka, JAPAN	IUTAM, Japan World Exposit 70, Commemorat Org, Japan Sci & Technol Agcy, CREST, Minist Educ, Culture, Sports, Sci & Technol, Kyushu Univ, Grad Sch Math, Global COE Program, Res Inst Appl Mech, Kyushu Univ, Inst Math	Kyushu Univ Sch Med		INSTABILITY; WALL; STABILITY; DYNAMICS; WAVES	The erosion of a granular layer due to the normal impact of a vortex ring was investigated experimentally. We observed two characteristic surface patterns, grooves and dimples, depending on the magnitude of the vortex ring, its travelling distance, and the properties of the granular material. In order to clarify these pattern formation mechanisms, we measured the temporal variation of the layer thickness using the transmitted light intensity, as well as the velocity field using particle image velocimetry. These patterns are found to be generated by successive collisions of the primary vortex ring and the secondary vortex ring which develops on the granular layer.	[Yoshida, Junya; Sano, Osamu] Tokyo Univ Agr & Technol, Dept Appl Phys, Koganei, Tokyo 1848588, Japan	Yoshida, J (reprint author), Tokyo Univ Agr & Technol, Dept Appl Phys, Koganei, Tokyo 1848588, Japan.	y.junya.0511@gmail.com					Adhikari D, 2009, FLUID DYN RES, V41, DOI 10.1088/0169-5983/41/5/051404; CHU CC, 1993, PHYS FLUIDS A-FLUID, V5, P662, DOI 10.1063/1.858650; Sullivan IS, 2008, J FLUID MECH, V609, P319, DOI 10.1017/S0022112008002292; WIDNALL SE, 1974, J FLUID MECH, V66, P35, DOI 10.1017/S0022112074000048; SHARIFF K, 1994, J FLUID MECH, V279, P351, DOI 10.1017/S0022112094003939; Fukumoto Y, 2005, J FLUID MECH, V526, P77, DOI 10.1017/S0022112004002678; SWEARINGEN JD, 1995, J FLUID MECH, V297, P1, DOI 10.1017/S0022112095002977; BOLDES U, 1973, PHYS FLUIDS, V16, P2005, DOI 10.1063/1.1694246; Masuda N, 2012, FLUID DYN RES, V44, DOI 10.1088/0169-5983/44/1/015501; SAFFMAN PG, 1978, J FLUID MECH, V84, P625, DOI 10.1017/S0022112078000385; Weigand A, 1997, EXP FLUIDS, V22, P447, DOI 10.1007/s003480050071; Munro RJ, 2009, PHYS FLUIDS, V21, DOI 10.1063/1.3083318; Yoshida J, 2012, FLUID DYN RES, V44, DOI 10.1088/0169-5983/44/1/015502; ORLANDI P, 1993, J FLUID MECH, V256, P615, DOI 10.1017/S0022112093002903; Naitoh T, 2002, PHYS FLUIDS, V14, P143, DOI 10.1063/1.1420745; Leweke T, 1998, J FLUID MECH, V360, P85, DOI 10.1017/S0022112097008331; BATCHELOR G. K., 1967, INTRO FLUID DYNAMICS; Bethke N, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4716000; Dyson F. W., 1893, PHIL T R SOC LOND A, V184A, P1041, DOI 10.1098/rsta.1893.0020; Feng HL, 2009, FLUID DYN RES, V41, DOI 10.1088/0169-5983/41/5/051405; Krutzsch CH, 1939, ANN PHYS-BERLIN, V35, P497; Lamb H., 1932, HYDRODYNAMICS; LIM TT, 1992, NATURE, V357, P225, DOI 10.1038/357225a0; Linden PF, 2004, P ROY SOC B-BIOL SCI, V271, P647, DOI 10.1098/rspb.2003.2601; Lugt H. J., 1983, VORTEX FLOW NATURE T; MAXWORTHY T, 1977, J FLUID MECH, V81, P465, DOI 10.1017/S0022112077002171; Nagata T, 2000, T JAPAN SOC MECH E B, V66, P990; Naito T, 1997, NAGARE, V16, P344; Naito T, 1996, NAGARE, V15, P45; Okude M, 2000, NAGARE, V19, P374; Oshima Y., 1973, NAT SCI REP OCHANOMI, V24, P61; Shariff K, 1992, ANNU REV FLUID MECH, V24, P235, DOI DOI 10.1146/ANNUREV.FL.24.010192.001315; Toyoda K, 2009, FLUID DYN RES, V41, DOI 10.1088/0169-5983/41/5/051402; WALKER JDA, 1987, J FLUID MECH, V181, P99, DOI 10.1017/S0022112087002027; WIDNALL SE, 1973, PROC R SOC LON SER-A, V332, P335, DOI 10.1098/rspa.1973.0029; YAMADA H, 1982, J PHYS SOC JPN, V51, P1663, DOI 10.1143/JPSJ.51.1663	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0169-5983	1873-7005		FLUID DYN RES	Fluid Dyn. Res.	DEC	2014	46	6							061421	10.1088/0169-5983/46/6/061421		11	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	AU9LF	WOS:000345913500022		
J	McLean, SJ; Ikegaya, H; Saukko, PJ; Zheng, HY; Itoh, K; Fushiki, S				McLean, Stuart J.; Ikegaya, Hiroshi; Saukko, Pekka J.; Zheng, Huang Yung; Itoh, Kyoko; Fushiki, Shinji			The utilization of stable isotope analysis for the estimation of the geographic origins of unidentified cadavers	FORENSIC SCIENCE INTERNATIONAL			English	Article						Stable isotope analysis; Identification; Geographic origin; Urine	VIRUS GENOTYPING OFFERS; HEAVY GEO-ELEMENTS; NUTRITION TRANSITION; LIGHT BIO; RATIOS; ASSIGNMENT; HYDROGEN; HAIR; DIET; TOOL	The number of unidentified cadavers is increasing worldwide and the effective methods which reveal their geographic origin are not well known. This study reports on the utilization of delta O-18, delta C-13, delta H-2 and delta N-15 ratios gained through stable isotope analysis of urine samples collected from eight locations: Chiba, Japan; Fuzhou, China; and Denpasar, Indonesia in our pilot study with data from healthy volunteers from five further locations from healthy volunteers: Melbourne and Perth, Australia; Qingdao, China; Turku, Finland and Oklahoma, USA. This study posits that the utilization of delta O-18 and delta H-2 is more feasible than delta C-13 and delta N-15 stable isotope ratios in differentiating or estimating the origin of human samples. Secondly, this study demonstrated that the delta O-18 and delta H-2 stable isotope ratios of urine samples from eight locations differed significantly. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[McLean, Stuart J.; Ikegaya, Hiroshi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Forens Med, Kyoto 6028566, Japan; [Saukko, Pekka J.] Univ Turku, Dept Forens Med, Turku 20520, Finland; [Zheng, Huang Yung] Fujian Med Univ, Union Hosp, Dept Urol, Fuzhou 350001, Peoples R China; [Itoh, Kyoko; Fushiki, Shinji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pathol & Appl Neurobiol, Kyoto 6028566, Japan	Ikegaya, H (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Forens Med, Kamigyo Ku, 456 Kajiicho, Kyoto 6028566, Japan.	ikegaya@koto.kpu-m.ac.jp					Kornexl BE, 1997, Z LEBENSM UNTERS F A, V205, P19, DOI 10.1007/s002170050117; HORN P, 1993, Z LEBENSM UNTERS FOR, V196, P407, DOI 10.1007/BF01190802; ANDRASKO J, 1993, J FORENSIC SCI, V38, P1161; Camin F, 2010, J AGR FOOD CHEM, V58, P570, DOI 10.1021/jf902814s; Yogo Y, 2004, REV MED VIROL, V14, P179, DOI 10.1002/rmv.428; Schmidt O, 2005, FOOD CHEM, V91, P545, DOI [10.1016/j.foodchem.2004.08.036, 10.1016/j.foochem.2004.08.036]; Petzke KJ, 2005, RAPID COMMUN MASS SP, V19, P1392, DOI 10.1002/rcm.1925; Huelsemann F, 2009, RAPID COMMUN MASS SP, V23, P2448, DOI 10.1002/rcm.4039; Rossmann A, 2000, EUR FOOD RES TECHNOL, V211, P32, DOI 10.1007/s002170050585; Bong YS, 2010, RAPID COMMUN MASS SP, V24, P155, DOI 10.1002/rcm.4366; Rossmann A, 2001, FOOD REV INT, V17, P347, DOI 10.1081/FRI-100104704; Ehleringer JR, 1999, FORENSIC SCI INT, V106, P27, DOI 10.1016/S0379-0738(99)00139-5; Nardoto GB, 2006, AM J PHYS ANTHROPOL, V131, P137, DOI 10.1002/ajpa.20409; Gulson BL, 1997, J FORENSIC SCI, V42, P787; Pillonel L, 2003, LEBENSM-WISS TECHNOL, V36, P615, DOI 10.1016/S0023-6438(03)00081-1; Solomon CT, 2009, OECOLOGIA, V161, P313, DOI 10.1007/s00442-009-1370-5; Rauch E, 2007, FORENSIC SCI INT, V168, P215, DOI 10.1016/j.forsciint.2006.02.011; Perini M, 2009, RAPID COMMUN MASS SP, V23, P2573, DOI 10.1002/rcm.4140; Beyser J, 2003, KRIMINALISTIK, V57, P443; Brescia MA, 2002, RAPID COMMUN MASS SP, V16, P2286, DOI 10.1002/rcm.860; Cattaneo C., 2010, FORENSIC SCI INT, V195, pe1; Cattaneo C, 2000, INT J LEGAL MED, V113, pN2; EPSTEIN S, 1976, EARTH PLANET SC LETT, V30, P241, DOI 10.1016/0012-821X(76)90251-X; Estep F.E., 1980, GEOCHIM COSMOCHIM AC, V44, P1197; Field A., 2009, DISCOVERING STAT USI; Holzl S, 2004, ANAL BIOANAL CHEM, V378, P270, DOI 10.1007/s00216-003-2203-8; Ikegaya H, 2008, J VIROL METHODS, V147, P78, DOI 10.1016/j.jviromet.2007.08.010; Ikegaya H, 2007, FORENSIC SCI INT, V173, P41, DOI 10.1016/j.forsciint.2007.01.022; Ikegaya H, 2008, FORENSIC SCI INT-GEN, V2, P54, DOI 10.1016/j.fsigen.2007.08.009; Ikegaya H, 2002, INT J LEGAL MED, V116, P242, DOI 10.1007/s00414-002-0297-8; Inoue H, 2010, J MED VIROL, V82, P903, DOI 10.1002/jmv.21666; Koch P.L., 1994, P63; Kornexl B., 1995, UNTERS FORSCH, V202, P55; Lee MJ, 2002, PUBLIC HEALTH NUTR, V5, P197, DOI 10.1079/PHN2001294; McLean S., 2013, FORENSIC SCI INT, V232, pe1; Moreno LA, 2002, EUR J CLIN NUTR, V56, P992, DOI 10.1038/sj.ejcn.1601414; Mutzel Rauch E., 2009, INT J LEGAL MED, V123, P35, DOI DOI 10.1007/S00414-008-0286-7; NAKAMURA K, 1982, BIOMED MASS SPECTROM, V9, P390, DOI 10.1002/bms.1200090906; Ousley S, 2009, AM J PHYS ANTHROPOL, V139, P68, DOI 10.1002/ajpa.21006; Panel on Dietary Reference Intakes for Electrolytes and Water Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 2005, DIET REF INT WAT POT; SCHIMMELMANN A, 1993, GEOPH MONOG SERIES, V78, P367; Tsukada H., 2005, J ENV RADIOACT, V81	42	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	DEC	2014	245						45	50		10.1016/j.forsciint.2014.10.011		6	Medicine, Legal	Legal Medicine	AU5DT	WOS:000345628100018		
J	Igari, Y; Hosoya, T; Hayashizaki, Y; Usui, A; Kawasumi, Y; Usui, K; Funayama, M				Igari, Yui; Hosoya, Tadashi; Hayashizaki, Yoshie; Usui, Akihito; Kawasumi, Yusuke; Usui, Kiyotaka; Funayama, Masato			Sudden death due to a cystic lesion in the cerebellum	FORENSIC SCIENCE INTERNATIONAL			English	Article						Hemangioblastoma; Cerebellar cyst; Hydrocephalus; Transforaminal herniation	CENTRAL-NERVOUS-SYSTEM; HEMANGIOBLASTOMAS	A middle-aged female patient with a depressive disorder presented to a mental hospital because of a 2-month worsening history of headache, dizziness, and nausea. The next morning, she was observed to be sleeping, but was then found dead 1 h later. Postmortem computed tomography and autopsy revealed a large cyst in the right cerebellar hemisphere, hydrocephalus, and transforaminal herniation. Careful observation revealed an approximately 0.4 cm x 0.8 cm slightly grayish discoloration in the cyst wall that was diagnosed as hemangioblastoma based on its histological features. Finally, we concluded that the cause of death in this case was attributable to the brain stem compression, which was caused by obstructive hydrocephalus secondary to the cystic hemangioblastoma in the cerebellum. The symptoms for 2 months before her death had most likely resulted from increased intracranial pressure. Hemangioblastomas usually appear as nodules in the wall of the cyst, but the tumor in our case looked like just a slightly grayish discoloration. Therefore, cystic lesions in the CNS need to be carefully examined. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Igari, Yui; Hosoya, Tadashi; Hayashizaki, Yoshie; Usui, Kiyotaka; Funayama, Masato] Tohoku Univ, Dept Forens Med, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Usui, Akihito; Kawasumi, Yusuke] Tohoku Univ, Course Radiol Technol, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808575, Japan	Igari, Y (reprint author), Tohoku Univ, Dept Forens Med, Grad Sch Med, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	igari@forensic.med.tohoku.ac.jp					Aldape KD, 2007, WHO CLASSIFICATION T, P184; Raz E, 2012, CANCER IMAGING, V12, P237, DOI 10.1102/1470-7330.2012.0028; Vortmeyer AO, 2013, ACTA NEUROPATHOL, V125, P333, DOI 10.1007/s00401-013-1091-z; Hussein MR, 2007, INT J EXP PATHOL, V88, P311, DOI 10.1111/j.1365-2613.2007.00535.x; NEUMANN HPH, 1989, J NEUROSURG, V70, P24, DOI 10.3171/jns.1989.70.1.0024; Burger P.C., 2002, SURG PATHOLOGY NERVO, V4th; Chen Y, 2006, NEUROSURGERY, V59, P660, DOI 10.1227/01.NEU.0000223372.18607.D7	7	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	DEC	2014	245						E25	E28		10.1016/j.forsciint.2014.10.017		4	Medicine, Legal	Legal Medicine	AU5DT	WOS:000345628100006		
J	Wang, J; Higashihara, T				Wang, Jin; Higashihara, Tomoya			Effects of catalyst loading amount on the synthesis of poly(3-hexylthiophene) via externally initiated Kumada catalyst-transfer polycondensation	FRONTIERS OF MATERIALS SCIENCE			English	Article						Kumada catalyst-transfer polycondensation (KCTP); poly(3-hexylthiophene) (P3HT); regioregularity (rr)	CHAIN-GROWTH POLYMERIZATION; CONTROLLED MOLECULAR-WEIGHT; REGIOREGULAR POLYTHIOPHENE; TRIBLOCK COPOLYMERS; LOW POLYDISPERSITY; BLOCK-COPOLYMERS; N-TYPE; BRUSHES; ROUTE; POLY(3-ALKYLTHIOPHENES)	A series of model polymerization are carried out via the one-pot externally initiated Kumada catalyst-transfer polycondensation (KCTP) of 2-bromo-5-chloromagnesium thiophene monomers, and the excess amount of initiators or catalysts are found no need to be isolated during the polycondensation process. Especially, the impacts of the nickel catalyst loading variation on regioregularity (rr), yield, molecular weight (M (n)), polydispersity (PDI) and initiation efficiency of poly(3-hexylthiophene) (P3HT) are systematically investigated. The H-1 NMR, size-exclusion chromatography (SEC), and MALDI-TOF mass spectroscopy results indicated that an excess amount of catalyst does not influence yield, rr, M (n), and PDI of P3HT, nor the initiation efficiency. However, the PDI of the product is broad, and the M (n) and rr values decreased in the absence of 1,3-bis (diphenylphosphino)propane (dppp). It can be concluded that the in-situ KCTP polymerization of P3HT is a practical and effective process. These results are especially valuable for the synthesis of all-conjugated block copolymers where macroinitiators are used.	[Wang, Jin] Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Adv Mat Div, Suzhou 215123, Peoples R China; [Higashihara, Tomoya] Yamagata Univ, Fac Engn, Dept Polymer Sci & Engn, Yonezawa, Yamagata 9928510, Japan; [Higashihara, Tomoya] Japan Sci & Technol Agcy JST, Kawaguchi, Saitama 3320012, Japan	Wang, J (reprint author), Chinese Acad Sci, Suzhou Inst Nanotech & Nanobion, Adv Mat Div, 398 Ruoshui Rd, Suzhou 215123, Peoples R China.	jwang2014@sinano.ac.cn	Wang, Jin/D-8495-2015		Japan Science and Technology Agency (JST), PRESTO program [JY 220176]	This work was supported by the Japan Science and Technology Agency (JST), PRESTO program (JY 220176).	Liu JS, 2002, ANGEW CHEM INT EDIT, V41, P329, DOI 10.1002/1521-3773(20020118)41:2<329::AID-ANIE329>3.0.CO;2-M; Javier AE, 2010, MACROMOLECULES, V43, P3233, DOI 10.1021/ma100519g; Senkovskyy V, 2010, MACROMOLECULES, V43, P10157, DOI 10.1021/ma1024889; Yokoyama A, 2008, MACROMOLECULES, V41, P7271, DOI 10.1021/ma8017124; Doubina N, 2012, LANGMUIR, V28, P1900, DOI 10.1021/la204117u; Sheina EE, 2004, MACROMOLECULES, V37, P3526, DOI 10.1021/ma0357063; Bilbrey JA, 2012, ACS MACRO LETT, V1, P995, DOI 10.1021/mz3002929; Senkovskyy V, 2010, MACROMOL SY, V291-292, P17, DOI 10.1002/masy.201050503; Okamoto K, 2011, POLYM CHEM-UK, V2, P2424, DOI 10.1039/c1py00171j; Yokoyama A, 2004, MACROMOLECULES, V37, P1169, DOI 10.1021/ma035396o; Senkovskyy V, 2007, J AM CHEM SOC, V129, P6626, DOI 10.1021/ja0710306; Miyakoshi R, 2006, J AM CHEM SOC, V128, P16012, DOI 10.1021/ja067107s; Wang J, 2013, ACS MACRO LETT, V2, P506, DOI 10.1021/mz400143y; Osaka I, 2008, ACCOUNTS CHEM RES, V41, P1202, DOI 10.1021/ar800130s; Miyakoshi R, 2005, J AM CHEM SOC, V127, P17542, DOI 10.1021/ja0556880; Yuan MJ, 2012, ACS MACRO LETT, V1, P392, DOI 10.1021/mz3000368; Wong M, 2012, ACS MACRO LETT, V1, P1266, DOI 10.1021/mz300333f; Liu JS, 2002, MACROMOLECULES, V35, P9882, DOI 10.1021/ma021362p; Doubina N, 2009, MACROMOL CHEM PHYSIC, V210, P1966, DOI 10.1002/macp.200900375; Doubina N, 2009, MACROMOLECULES, V42, P7670, DOI 10.1021/ma901410k; Miyakoshi R, 2004, MACROMOL RAPID COMM, V25, P1663, DOI 10.1002/marc.200400281; Iovu MC, 2005, MACROMOLECULES, V38, P8649, DOI 10.1021/ma051122k; Huang L, 2008, MACROMOLECULES, V41, P8944, DOI 10.1021/ma801538q; Bronstein HA, 2009, J AM CHEM SOC, V131, P12894, DOI 10.1021/ja9054977; Kiriy A, 2011, MACROMOL RAPID COMM, V32, P1503, DOI 10.1002/marc.201100316; Smeets A, 2009, MACROMOLECULES, V42, P7638, DOI 10.1021/ma901888h; Koch FPV, 2013, J AM CHEM SOC, V135, P13695, DOI 10.1021/ja4057932; Khanduyeva N, 2008, MACROMOLECULES, V41, P7383, DOI 10.1021/ma800889c; Khanduyeva N, 2009, J AM CHEM SOC, V131, P153, DOI 10.1021/ja8050734; Senkovskyy V, 2011, J AM CHEM SOC, V133, P19966, DOI 10.1021/ja208710x; Sontag SK, 2009, CHEM COMMUN, P3354, DOI 10.1039/b907264k; Wang J, 2013, POLYM CHEM-UK, V4, P5518, DOI 10.1039/c3py00979c; Wang J, 2013, MACROMOLECULES, V46, P1783, DOI 10.1021/ma400043s	33	0	0	HIGHER EDUCATION PRESS	BEIJING	SHATANHOU ST 55, BEIJING 100009, PEOPLES R CHINA	2095-025X	2095-0268		FRONT MATER SCI	Front. Mater. Sci.	DEC	2014	8	4					383	390		10.1007/s11706-014-0261-9		8	Materials Science, Multidisciplinary	Materials Science	AW1DZ	WOS:000346032000008		
J	Hagiwara, D; Suzuki, S; Kamei, K; Gonoi, T; Kawamoto, S				Hagiwara, Daisuke; Suzuki, Satoshi; Kamei, Katsuhiko; Gonoi, Tohru; Kawamoto, Susumu			The role of AtfA and HOG MAPK pathway in stress tolerance in conidia of Aspergillus fumigatus	FUNGAL GENETICS AND BIOLOGY			English	Article						Conidia; Stress-tolerance; AtfA; Trehalose; MAPK; Aspergillus fumigatus	TRANSCRIPTION FACTOR ATFA; OSMOTIC-STRESS; SACCHAROMYCES-CEREVISIAE; TREHALOSE BIOSYNTHESIS; SIGNALING PATHWAY; FUNGAL PATHOGENS; NIDULANS; RESPONSES; VIRULENCE; SYNTHASE	Aspergillus fumigatus is a life-threatening pathogenic fungus, whose conidium is the infectious agent of aspergillosis. To better understand the mechanism underlying the long-term viability of conidia, we characterized a bZip transcription factor, AtfA, with special reference to stress-tolerance in conidia. The atfA deletion mutant conidia showed significant sensitivity to high temperature and oxidative stress. The trehalose content that accumulated in conidia was reduced in the mutant conidia. Transcriptome analysis revealed that AtfA regulated several stress-protection-related genes such as catA, dprA, scf1, and conj at the conidiation stage. The upstream high-osmolarity glycerol pathway was also involved in conferring stress tolerance in conidia because Delta pbsB showed stress sensitivity and reduced trehalose in conidia. However, a mutant lacking the SakA mitogen-activated protein kinase (MAPK) produced normal conidia. We investigated another MAPK, MpkC, in relation with SakA, and the double deletion mutant, Delta sa-kA,mpkC, was defective in conidia stress tolerance. We concluded that MpkC is able to bypass SakA, and the two MAPKs redundantly regulate the conidia-related function of AtfA in A. fumigatus. (C) 2014 Elsevier Inc. All rights reserved.	[Hagiwara, Daisuke; Kamei, Katsuhiko; Gonoi, Tohru; Kawamoto, Susumu] Chiba Univ, MMRC, Chuo Ku, Chiba 2608673, Japan; [Suzuki, Satoshi] NFRI, Tsukuba, Ibaraki 3058642, Japan	Hagiwara, D (reprint author), Chiba Univ, MMRC, Chuo Ku, 1-8-1 Inohana, Chiba 2608673, Japan.	dhagi@chiba-u.jp			Noda Institute for Scientific Research; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Related Emerging Mycoses, a Cooperative Research Grant of NEKKEN; MEXT	We would like to thank Dr. Misako Ohkusu and Ms. Yumiko Nakano for experimental assistance. This work was supported by a Grant from the Noda Institute for Scientific Research to D.H. This work is also in part supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) Special Budget for Research Projects: The Project on Controlling Aspergillosis and the Related Emerging Mycoses, a Cooperative Research Grant of NEKKEN (2013), and a Grant-in-Aid for Scientific Research to D.H. from MEXT.	Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Kobayashi T, 2007, BIOSCI BIOTECH BIOCH, V71, P646, DOI 10.1271/bbb.60550; Welker S, 2010, MOL CELL, V39, P507, DOI 10.1016/j.molcel.2010.08.001; Bell W, 1998, J BIOL CHEM, V273, P33311, DOI 10.1074/jbc.273.50.33311; Puttikamonkul S, 2010, MOL MICROBIOL, V77, P891, DOI 10.1111/j.1365-2958.2010.07254.x; Fillinger S, 2001, MICROBIOL-SGM, V147, P1851; Bahn YS, 2008, EUKARYOT CELL, V7, P2017, DOI 10.1128/EC.00323-08; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Al-Bader N, 2010, INFECT IMMUN, V78, P3007, DOI 10.1128/IAI.00813-09; Furukawa K, 2005, MOL MICROBIOL, V56, P1246, DOI 10.1111/j.1365-2958.2005.04605.x; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310; Catlett NL, 2003, EUKARYOT CELL, V2, P1151, DOI 10.1128/EC.2.6.1151-1161.2003; Ruijter GJG, 2003, EUKARYOT CELL, V2, P690, DOI 10.1128/EC.2.4.690-698.2003; Paris S, 2003, INFECT IMMUN, V71, P3551, DOI 10.1128/IAI.71.6.3551-3562.2003; Reyes G, 2006, EUKARYOT CELL, V5, P1934, DOI 10.1128/EC.00178-06; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; Hagiwara D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080881; Hagiwara D, 2009, FUNGAL GENET BIOL, V46, P868, DOI 10.1016/j.fgb.2009.07.003; Hagiwara D, 2007, BIOSCI BIOTECH BIOCH, V71, P1003, DOI 10.1271/bbb.60665; Hagiwara D, 2008, BIOSCI BIOTECH BIOCH, V72, P2756, DOI 10.1271/bbb.80001; Han KH, 2002, MOL MICROBIOL, V43, P1065, DOI 10.1046/j.1365-2958.2002.02774.x; Herbert AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041975; Hoi JWS, 2011, MOL BIOL CELL, V22, P1896, DOI 10.1091/mbc.E10-11-0914; Kwon-Chung KJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003743; Lara-Rojas F, 2011, MOL MICROBIOL, V80, P436, DOI 10.1111/j.1365-2958.2011.07581.x; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Reinders A, 1997, MOL MICROBIOL, V24, P687, DOI 10.1046/j.1365-2958.1997.3861749.x; Sakamoto K, 2008, FUNGAL GENET BIOL, V45, P922, DOI 10.1016/j.fgb.2008.03.009; Sakamoto K, 2009, FUNGAL GENET BIOL, V46, P887, DOI 10.1016/j.fgb.2009.09.004; Shinohara ML, 2002, EUKARYOT CELL, V1, P33, DOI 10.1128/EC.1.1.33-43.2002; Suzuki S, 2013, FUNGAL GENET BIOL, V56, P42, DOI 10.1016/j.fgb.2013.04.008; Wyatt T. T., 2013, ADV APPL MICROBIOL, V85, P42	33	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1087-1845	1096-0937		FUNGAL GENET BIOL	Fungal Genet. Biol.	DEC	2014	73						138	149		10.1016/j.fgb.2014.10.011		12	Genetics & Heredity; Mycology	Genetics & Heredity; Mycology	AU7XU	WOS:000345812500014		
